FN Clarivate Analytics Web of Science
VR 1.0
PT S
AU Bauer, S
   Bauer-Gogonea, S
   Dansachmuller, M
   Graz, I
   Leonhartsberger, H
   Salhofer, H
   Schwodiauer, R
AF Bauer, S
   Bauer-Gogonea, S
   Dansachmuller, M
   Graz, I
   Leonhartsberger, H
   Salhofer, H
   Schwodiauer, R
BE Yuhas, DE
   Schneider, SC
TI Modern electrets
SO 2003 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1 AND 2
SE ULTRASONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT IEEE International Ultrasonics Symposium
CY OCT 05-08, 2003
CL Honolulu, HI
SP IEEE Ultrason, Ferroelect & Frequency Control Soc
ID PIEZOELECTRICITY; POLYMERS
AB Ferroelectrets are cellular dielectric materials with an internal bipolar electret charge that exhibit ferroelectric-like hysteresis and switching behavior. Ferroelectrets have found considerable interest for transducer applications, since they mimic piezoelectricity by their unusual electromechanical properties. They offer very high d(33) transducer coefficients, comparable with ferroelectric ceramics and typically 20 times larger than that of ferroelectric polymers like PVDF. Ferroelectrets therefore offer a huge potential for the development of large area sensors, as well as for acoustical, ultrasonics, biomedical, underwater and nondestructive testing applications.
C1 Johannes Kepler Univ, A-4040 Linz, Austria.
RP Bauer, S (reprint author), Johannes Kepler Univ, Altenberger Str 69, A-4040 Linz, Austria.
RI Bauer-Gogonea, Simona/F-8626-2013
CR DANSACHMULLER M, UNPUB APPL PHYS LETT
   Gerhard-Multhaupt R, 2002, IEEE T DIELECT EL IN, V9, P850, DOI 10.1109/TDEI.2002.1038668
   HILLENBRAND J, 2000, C EL INS DIEL PHEN I, P161
   Lindner M, 2002, J APPL PHYS, V91, P5283, DOI 10.1063/1.1459751
   LINDNER M, 2004, IEEE T DIEL ELEC APR
   Neugschwandtner GS, 2000, APPL PHYS LETT, V77, P3827, DOI 10.1063/1.1331348
   Neugschwandtner GS, 2001, J APPL PHYS, V89, P4503, DOI 10.1063/1.1355719
   Royer D., 2000, ELASTIC WAVES SOLIDS, V2
   Royer D, 2000, ELASTIC WAVES SOLIDS, V1
   Sessler G.M., 1999, ELECTRETS, V1
   Sessler G. M., 1999, ELECTRETS, V2
   Sessler GM, 1999, APPL PHYS LETT, V75, P3405, DOI 10.1063/1.125308
NR 12
TC 4
Z9 4
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 0-7803-7922-5
J9 ULTRASON
PY 2003
BP 370
EP 376
PG 7
WC Acoustics; Engineering, Biomedical; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA BY90R
UT WOS:000189492100081
DA 2018-10-20
ER

PT S
AU He, XL
AF He, XL
GP IEEE
   IEEE
TI Flip-chip packaging interconnect technology and reliability
SO 53RD ELECTRONIC COMPONENTS & TECHNOLOGY CONFERENCE, 2003 PROCEEDINGS
SE ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE
LA English
DT Proceedings Paper
CT 53rd Electronic Components and Technology Conference
CY MAY 27-30, 2003
CL NEW ORLEANS, LA
SP IEEE, CPMT, Electr Components, Assemblies & Mat Assoc, Electr Ind Alliance
AB Flip-chip packaging interconnect ensures higher density chip-on-board for higher performance and improved interconnect reliability. For highly integrated functionality of the microelectronic system, Flip-chip interconnect and wafer level packaging are the key modular technologies for the system-on-package (SOP) and the system in chip (SIC) paradigm of microelectronics packaging, which is critical for the development of optical components and micro-electromechanical system (MEMS) with higher performance semiconductors, i.e. nano wafers. The advancement of highly integrated opto device, MEMS and integrated opto MEMS is directly associated with sensors, actuators and biochip development, an area that represents emerging technology and intensive research for nanotechnology and biomedical applications in the near future.
   It is to meet the demand for advanced packaging with Flip-chip technology, including nano wafer level packaging, a course is to be constructed for both education and research purposes to address the principles and processes of Flip-chip interconnect, and introduce the challenges for its advancement. This would not only provide education and training to students, the future workforce, but also bridge the gap between current and future technology development. The multi-media course will impart the knowledge to both students on-campus and researchers and engineers in distance. The cross-disciplinary nature of the course material and its emphasis on integrated multi-disciplinary research and development methodology will broaden students' horizon and enhance their research ability. It will also, potentially, open up opportunities for collaboration between researchers in relevant areas.
C1 Univ Wisconsin, Dept Mech Engn & Aerosp, Milwaukee, WI 53211 USA.
RP He, XL (reprint author), Univ Wisconsin, Dept Mech Engn & Aerosp, Milwaukee, WI 53211 USA.
CR *ASME, J ELECT PACKAGING
   BALDWIN D, 1999, LOW COST NEXT GENERA
   *GEORG I TECH PACK, 1998, GEORG I TECHN PACK R
   Lau J., 2000, LOW COST FLIP CHIP T
   Lau J. H., 1996, FLIP CHIP TECHNOLOGI
   TUMMALA R, 1997, MICROELECTRONICS HDB
   2000, P EL COMP TECHN C OR
   2000, IEEE T COMP PACK TEC, V23
   2001, P ELECT COMPONENTS T
   2003, MRS B            JAN, V28
NR 10
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0569-5503
BN 0-7803-7991-5
J9 ELEC COMP C
PY 2003
BP 748
EP 752
DI 10.1109/ECTC.2003.1216368
PG 5
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Optics
SC Computer Science; Engineering; Optics
GA BW87U
UT WOS:000183448100122
DA 2018-10-20
ER

PT S
AU Harsanyi, G
   Ballun, G
   Bojta, P
   Gordon, P
   Santha, H
AF Harsanyi, G
   Ballun, G
   Bojta, P
   Gordon, P
   Santha, H
GP IEEE
   IEEE
TI Multimedia for MEMS technologies and packaging education
SO 53RD ELECTRONIC COMPONENTS & TECHNOLOGY CONFERENCE, 2003 PROCEEDINGS
SE ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE
LA English
DT Proceedings Paper
CT 53rd Electronic Components and Technology Conference
CY MAY 27-30, 2003
CL NEW ORLEANS, LA
SP IEEE, CPMT, Electr Components, Assemblies & Mat Assoc, Electr Ind Alliance
ID INTERNET COURSE
AB MSTs (Micro-Systems Technologies) including our subject MEMS (Micro-Electro-Mechanical Systems) represent a progressive area of electrical/ mechanical/biomedical engineering. They allow the manufacture of miniature (micrometer level) electro-mechanical devices. These devices can both replace conventional, devices and sub-systems at a fraction of their cost, with enhanced reliability and durability and, frequently open up entirely new applications where the size and cost of devices based on conventional technology has prevented their use. Microsystems technology is a potentially disruptive technology. It is set to have enormous impact across the industrial spectrum. Already the technology is sufficiently mature for MST based components and sub-systems to be available for incorporation. into a wide range of existing equipment and systems. Its take up is set to take-off dramatically over the next five years, with substantial impact on the performance and competitiveness of many "every day" products and systems for industrial and consumer market. To supply this field with well-educated engineers with interdisciplinary knowledge, it is necessary to teach them basic sciences, technology, applications, and designing aspects (reliability, packaging, etc.) belonging to the topic of. MSTs. Also the knowledge of user engineers should be upgraded possibly in a form of distance learning. Conventional teaching methods, based on lectures, static, written materials, laboratories, etc., has become rather difficult at all levels of MST education, recently. The main objective of the described project here is the development of a multimedia supported education material that teaches/overviews, the theoretical background, manufacturing, as well as practical application of microelectronics, micro-electro/opto/mechanical systems and their packaging technologies in order to prepare experts for designing next generation intelligent micro/nanointegrated systems in the new century. The new approach tries to exploit all advantages of multimedia computer aided teaching not only for keeping the competitiveness but also in order to overcome the specific difficulties of the particular area. The modem educational software tool can secure up to date information, easy-to-understand visualisation of the 3D MEMS structures and interactive examples of the subject. The course material will be available both on the internet and on CDs for the technical community, for other university professors for teaching, and also will continuously be developed. The paper will highlight the structure of the course material and demonstrate the. animated examples.
C1 Budapest Univ Technol & Econ, Dept Elect Technol, H-1521 Budapest, Hungary.
RP Harsanyi, G (reprint author), Budapest Univ Technol & Econ, Dept Elect Technol, H-1521 Budapest, Hungary.
RI Harsanyi, Gabor/H-6263-2012
OI Harsanyi, Gabor/0000-0002-8514-8842
CR Harsanyi G, 2000, P ELECTR C, P1034, DOI 10.1109/ECTC.2000.853296
   HARSANYI G, 1992, POLYM FILMS SENSOR A, P435
   HARSANYI G, SENSEDU INTERNET BAS
   HARSANYI G, 2001, P 51 IEEE EL COMP TE, P1255
   HARSANYI G, 2002, P 52 IEEE EL COMP TE, P753
   Harsanyi G, 2002, IEEE SENS J, V2, P34, DOI 10.1109/7361.987059
NR 6
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0569-5503
BN 0-7803-7991-5
J9 ELEC COMP C
PY 2003
BP 753
EP 759
DI 10.1109/ECTC.2003.1216369
PG 7
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Optics
SC Computer Science; Engineering; Optics
GA BW87U
UT WOS:000183448100123
DA 2018-10-20
ER

PT S
AU Engel, A
   Becker, HJ
   Sohr, O
   Haspel, R
   Rupertus, V
AF Engel, A
   Becker, HJ
   Sohr, O
   Haspel, R
   Rupertus, V
BE Duparre, A
   Singh, B
TI Advanced industrial fluorescence metrology used for qualification of
   high quality optical materials
SO ADVANCED CHARACTERIZATION TECHNIQUES FOR OPTICS, SEMICONDUCTORS, AND
   NANOTECHNOLOGIES
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Advanced Characterization Techniques for Optics
   Semiconductors and Nanotechnologies
CY AUG 03-05, 2003
CL SAN DIEGO, CA
SP SPIE
ID CAF2
AB Schott Glas is developing and producing the optical material for various specialized applications in telecommunication, biomedical, optical, and micro lithography technology.
   The requirements on quality for optical materials are extremely high and still increasing. For example in micro lithography applications the impurities of the material are specified to be in the low ppb range.
   Usually the impurities in the lower ppb range are determined using analytical methods like LA ICP-MS and Neutron Activation Analysis. On the other hand absorption and laser resistivity of optical material is qualified with optical methods like precision spectral photometers and in-situ transmission measurements using UV lasers. Analytical methods have the drawback that they are time consuming and rather expensive, whereas the sensitivity for the absorption method will not be sufficient to characterize the future needs (coefficient much below 10(-3) cm(-1)).
   In order to achieve the current and future quality requirements a Jobin Yvon FLUOROLOG 3.22 fluorescence spectrometer is employed to enable fast and precise qualification and analysis.
   The main advantage of this setup is the combination of highest sensitivity (more than one order of magnitude higher sensitivity than state of the art UV absorption spectroscopy) and fast measurement and evaluation cycles (several minutes compared to several hours necessary for chemical analytics). An overview is given for spectral characteristics and using specified standards. Moreover correlations to the material qualities are shown. In particular we have investigated the elementary fluorescence and absorption of rare earth element impurities as well as defects induced luminescence originated by impurities.
C1 Schott Glas, D-55014 Mainz, Germany.
RP Engel, A (reprint author), Schott Glas, Hattenbergstr 10, D-55014 Mainz, Germany.
CR DEROSE P, 2003, FLUOR WORKSH BAM BER
   EHRT D, 2001, P INT C GLASS ED SCO, V1, P84
   ENGEL A, 2000, 1 157 NM S DAN POINT, P391
   ENGEL A, 2001, HIGH QUALITY CAF2 US, P177
   ENGEL A, 2002, SPIE P, V4779, P117
   GEFFKEN W, 1962, GLASTECHN BERICHTE, V35, P27
   *JOGIS, 031975 JOGIS
   Mizuguchi M, 1999, J OPT SOC AM B, V16, P1153, DOI 10.1364/JOSAB.16.001153
   MUHLIG C, 2003, CAF2 ARF LITHOGRAPHY, P257
   PACK DW, 1989, PHYS REV B, V40, P9930, DOI 10.1103/PhysRevB.40.9930
   Pick H., 1972, Optical properties of solids, P653
   RAVI BG, 1992, INT J MOD PHYS B, V6, P2809, DOI 10.1142/S0217979292002255
   Stroud J. S., 1971, J AM CERAM SOC, V54, P8
   Wolfbeis O. S., 1993, FLUORESCENCE SPECTRO
   1995, ATOMIC SPECTROSCOPY, V16
   2002, C OPT SPECTR COSP 20
NR 16
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5061-8
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5188
BP 182
EP 189
DI 10.1117/12.506814
PG 8
WC Instruments & Instrumentation; Materials Science, Characterization &
   Testing; Materials Science, Coatings & Films; Optics; Physics, Condensed
   Matter
SC Instruments & Instrumentation; Materials Science; Optics; Physics
GA BY25D
UT WOS:000188460400019
DA 2018-10-20
ER

PT S
AU Agathopoulos, S
   Pina, S
   Correia, RN
AF Agathopoulos, S
   Pina, S
   Correia, RN
BE Lewinsohn, CA
   Singh, M
   Loehman, R
TI A review of recent investigations on zirconia joining for biomedical
   applications
SO ADVANCES IN JOINING OF CERAMICS
SE CERAMIC TRANSACTIONS
LA English
DT Proceedings Paper
CT International Symposium on Joning of Ceramics held at the 104th Annual
   Meeting of the American-Ceramic-Society
CY APR 28-MAY 01, 2002
CL ST LOUIS, MO
SP Amer Ceram Soc
ID LIQUID-ALLOY SYSTEMS; METAL SYSTEMS; INTERFACIAL ENERGIES; WETTABILITY;
   TITANIUM; ADHESION; JOINTS; MICROSTRUCTURE; AL2O3; WORK
AB In this article, selected earlier and current research data have been gleaned in order to provide a general perspective on zirconia. joining at high temperatures, specifically aimed for biomedical applications. Since non-reactive zirconia/metal systems result in low adhesion joints, this article addresses its interest on reactive systems which involve Ti, either as component of brazing fillers or as bulk material in form of Ti or TiAlV. The case of direct bonding of zirconia, with Ti as well as the influence of Ag-Cu, Pt, Au, Ag and Zr as brazing agents in the joining process and the stability of the resulting joint are discussed in detail. The microstructure of the interfaces is presented with regard to biomedical applications and the anticipated mechanical performance of the joints.
C1 Univ Aveiro, Ceram & Glass Engn Dept, P-3810193 Aveiro, Portugal.
RP Agathopoulos, S (reprint author), Univ Aveiro, Ceram & Glass Engn Dept, P-3810193 Aveiro, Portugal.
RI Pina, Sandra/H-8133-2013
OI Pina, Sandra/0000-0002-4361-1253
CR Agathopoulos S, 2002, KEY ENG MAT, V206-2, P487, DOI 10.4028/www.scientific.net/KEM.206-213.487
   AGATHOPOULOS S, 1997, CERAMIC T, V77, P75
   AGATHOPOULOS S, 1994, THESIS U PATRAS PATR
   CHATAIN D, 1986, J CHIM PHYS PCB, V83, P561, DOI 10.1051/jcp/1986830561
   Correia RN, 1998, J MATER SCI, V33, P215, DOI 10.1023/A:1004378520526
   DOGAMALA RF, 1973, J AM CERAM SOC, V56, P584
   Emiliano JV, 1996, MATER SCI FORUM, V207-, P145, DOI 10.4028/www.scientific.net/MSF.207-209.145
   EUSTATHOPOULOS N, 1994, J PHYS III, V4, P1865, DOI 10.1051/jp3:1994244
   Garandet JP, 1998, SCRIPTA MATER, V38, P1391, DOI 10.1016/S1359-6462(98)00057-8
   GOGOTSKI GA, 1994, CERAM INT, V20, P343, DOI 10.1016/0272-8842(94)90052-3
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   IMESON D, 1990, I PHYS C SER, V98, P171
   KELKAR GP, 1994, J MATER RES, V9, P2244, DOI 10.1557/JMR.1994.2244
   KUBASCHEWSKI O, 1955, J I MET, V84, P440
   LEE YM, 1993, SCRIPTA METALL MATER, V29, P371, DOI 10.1016/0956-716X(93)90515-T
   Lin KF, 1998, SCRIPTA MATER, V39, P1333, DOI 10.1016/S1359-6462(98)00328-5
   Lin KF, 1999, J AM CERAM SOC, V82, P3179
   MCDONALD JE, 1965, T METALL SOC AIME, V233, P512
   MOORHEAD AJ, 1988, CERAMIC MICROSTRUCTU, P949
   MORTENSEN A, 1992, INT MATER REV, V37, P101, DOI 10.1179/imr.1992.37.1.101
   Murray J. L., 1992, ASM HDB, V3
   Murray JL, 1987, B ALLOY PHASE DIAGRA, V6, P148
   NAIDICH JV, 1981, PROG SURF MEMBR SCI, V14, P353
   NICHOLAS MG, 1994, SCRIPTA METALL MATER, V31, P1091, DOI 10.1016/0956-716X(94)90532-0
   NIKOLOPOULOS P, 1989, CERAM INT, V15, P201, DOI 10.1016/0272-8842(89)90039-4
   NIKOLOPOULOS P, 1994, J MATER SCI, V29, P4393, DOI 10.1007/BF00414227
   Nikolopoulos P., 1992, Journal of the European Ceramic Society, V10, P415, DOI 10.1016/0955-2219(92)90016-7
   NIKOLOPOULOS P, 1987, J MATER SCI LETT, V6, P1429, DOI 10.1007/BF01689311
   PAULASTO M, 1995, J ALLOY COMPD, V220, P136, DOI 10.1016/0925-8388(94)06026-6
   PAULASTO M, 1993, CERAM T, V35, P165
   PAULASTO M, 1995, THESIS HELSINKI U TE
   PEYTOUR C, 1990, J MATER SCI LETT, V9, P1129, DOI 10.1007/BF00721864
   PEYTOUR C, 1990, C PHYSIQUE, V51, P897
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   RAUH EG, 1980, J AM CERAM SOC, V63, P239, DOI 10.1111/j.1151-2916.1980.tb10711.x
   SOTIROPOULOU D, 1993, J MATER SCI, V28, P356, DOI 10.1007/BF00357807
   Sotiropoulou D, 1996, J ADHES SCI TECHNOL, V10, P989, DOI 10.1163/156856196X00058
   TOMSIA AP, 1995, CHALLENGING FUTURE A, P347
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
NR 39
TC 6
Z9 6
U1 0
U2 5
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 1042-1122
BN 1-57498-153-6
J9 CERAM TRANS
PY 2003
VL 138
BP 135
EP 147
PG 13
WC Materials Science, Ceramics
SC Materials Science
GA BX25C
UT WOS:000184738700007
DA 2018-10-20
ER

PT S
AU Flack, WW
   Nguyen, HA
   Capsuto, E
AF Flack, WW
   Nguyen, HA
   Capsuto, E
BE Fedynyshyn, TH
TI Characterization of an ultra-thick positive photoresist for
   electroplating applications
SO ADVANCES IN RESIST TECHNOLOGY AND PROCESSING XX, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 20th Annual Conference on Advances in Resist Technology and Processing
CY JAN 24-26, 2003
CL SANTA CLARA, CA
SP SPIE, Int SEMATECH, Semicond Equipment Mat Int
DE advanced packaging; MEMS; thick photoresist; electroplating; process
   optimization
AB The performance requirements for ultra-thick photoresists have increased rapidly with the dramatic growth in new lithographic applications that require electroplating processes. Two of the main applications for ultra-thick photoresists are nanotechnology (MEMS) and advanced packaging. Flipchip packaging has become widely adopted to address electrical device performance and chip form factor considerations. The growth in the nanotechnology market is driven by a wide range of products, which include accelerometers, ink jet print heads, biomedical sensors and optical switches.
   Electroplating levels for these applications require a photosensitive polymer material capable of coating, exposing and plating with conventional semiconductor equipment and standard ancillary process chemicals. A single coat step to achieve the final photoresist thickness is critical to minimize the number of process steps and cycle time. The sidewall profile, aspect ratio, electroplating durability and subsequent stripability of the photoresist are all important. This study characterized a novel positive photoresist (ShinEtsu SIPR 711 OM) for the use as a 65 mum thick single coat electroplating level on copper.
   The lithographic performance of the ultra-thick positive photoresist was optimized using a broad band, low numerical aperture, 1X stepper to control critical dimensions (CD), sidewall angles and aspect ratios. Cross sectional SEM analysis, process linearity, and process latitude plots were used to establish the lithographic capabilities. High aspect ratio structures were then electroplated using the optimized photoresist process to demonstrate photoresist durability and stripability. A recommended process flow is described for this photoresist and stepper.
C1 Ultratech Stepper Inc, San Jose, CA 95134 USA.
   Shin Etsu MicroSi Inc, Phoenix, AZ 85044 USA.
RP Flack, WW (reprint author), Ultratech Stepper Inc, San Jose, CA 95134 USA.
CR FLACK W, 1998, SPIE, V3512
   FLACK W, 1999, SPIE, V3678
   FLACK W, 1998, SPIE, V3333
   FLORES, 1993, SPIE, V1927
   KNUTTI J, SPIE, V3511
   Levinson H. J., 2001, PRINCIPLES LITHOGRAP
   MANSFIELD S, 2000, SPIE, V4000
   PATTERSON D, 2001, ADV PACKAGING    JUL
   RANJAN M, 2002, ADV PACKAGING    AUG
   SOLOMON G, 2001, ADV PACKAGING    NOV
   TODD B, 1999, SPIE, V3874
   WHITE L, 1987, SPIE, V772, P239
NR 12
TC 1
Z9 1
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4844-3
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5039
BP 1257
EP 1271
DI 10.1117/12.483748
PG 15
WC Materials Science, Coatings & Films; Optics; Imaging Science &
   Photographic Technology; Polymer Science
SC Materials Science; Optics; Imaging Science & Photographic Technology;
   Polymer Science
GA BX07Y
UT WOS:000184199500133
DA 2018-10-20
ER

PT J
AU Nguyen, VM
   Peschard, K
AF Nguyen, VM
   Peschard, K
TI Anthropology, inequality, and disease: A review
SO ANNUAL REVIEW OF ANTHROPOLOGY
LA English
DT Review
DE embodiment; biopolitics; structural violence; commodification;
   infectious diseases; biomedicine
ID HEALTH INEQUALITIES; SOCIAL INEQUALITIES; INCOME INEQUALITY; MEDICAL
   ANTHROPOLOGY; HUMAN-RIGHTS; POOR PEOPLE; POLITICS; MORTALITY; VIOLENCE;
   POVERTY
AB Anthropological approaches broaden and deepen our understanding of the finding that high levels of socioeconomic inequality correlate with worsened health outcomes across an entire society. Social scientists have debated whether such societies are unhealthy because of diminished social cohesion, psychobiological pathways, or the material environment. Anthropologists have questioned these mechanisms, emphasizing that fine-grained ethnographic studies reveal that social cohesion is locally and historically produced; psychobiological pathways involve complex, longitudinal biosocial dynamics suggesting causation cannot be viewed in purely biological terms; and material factors in health care need to be firmly situated within a broad geopolitical analysis. As a result, anthropological scholarship argues that this finding should be understood within a theoretical framework that avoids the pitfalls of methodological individualism, assumed universalism, and unidirectional causation. Rather, affliction must be understood as the embodiment of social hierarchy, a form of violence that for modem bodies is increasingly sublimated into differential disease rates and can be measured in terms of variances in morbidity and mortality between social groups. Ethnographies on the terrain of this neoliberal global health economy suggest that the violence of this inequality will continue to spiral as the exclusion of poorer societies from the global economy worsens their health-an illness poverty trap that, with few exceptions, has been greeted by a culture of indifference that is the hallmark of situations of extreme violence and terror. Studies of biocommodities and biomarkets index the processes by which those who are less well off trade in their long-term health for short-term gain, to the benefit of the long-term health of better-off individuals. Paradoxically, new biomedical technologies have served to heighten the commodification of the body, driving this trade in biological futures as well as organs and body parts.
C1 McGill Univ, Dept Social Studies Med, Montreal, PQ H2A 1X1, Canada.
   McGill Univ, Dept Anthropol, Montreal, PQ H3A 2T7, Canada.
RP Nguyen, VM (reprint author), McGill Univ, Dept Social Studies Med, Montreal, PQ H2A 1X1, Canada.
EM vinh-kim.nguyen@staff.mcgill.ca; karineeliane.peschard@mail.mcgill.ca
CR Adams V, 1998, MED ANTHROPOL Q, V12, P74, DOI 10.1525/maq.1998.12.1.74
   Adas Michael, 1989, MACHINES MEASURE MEN
   Agamben G., 1998, HOMO SACER SOVEREIGN
   Anderson D. M., 1995, REVEALING PROPHETS P
   Anheier H, 2002, BRIT J SOCIOL, V53, P343, DOI 10.1080/0007131022000000545
   ANNANDALE E, 2000, GENDER INEQUALITIES
   Appadurai Arjun, 1988, SOCIAL LIFE THINGS
   ARNOLD D, 1993, SOC HIST MED, V6, P385, DOI 10.1093/shm/6.3.385
   Aronowitz RA, 2001, ANN INTERN MED, V134, P803, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00002
   Ashforth A., 1999, MADUMBO MAN BEWITCHE
   AYME M, 2002, SOC SCI MED, V55, P1929
   BAER H, 1996, MED ANTHROPOL Q, V6, P451
   Bateman C, 2001, LANCET, V358, P1539, DOI 10.1016/S0140-6736(01)06586-2
   Benjamin Walter, 1969, ILLUMINATIONS, P253
   BERLANT LG, 1991, QUEEN AM GOES WASHIN
   Bettcher DW, 2000, B WORLD HEALTH ORGAN, V78, P521
   Bierlich B, 1999, MED ANTHROPOL Q, V13, P316, DOI 10.1525/maq.1999.13.3.316
   BODDY J, 1994, ANNU REV ANTHROPOL, V23, P407
   Bond P, 2000, CITIES GOLD TOWNSHIP
   BOODY J, 1989, WOMBS ALIEN SPIRITS
   BOURDIEU P, 1998, MISERE MONDE
   Bourgois Philippe, 1996, SEARCH RESPECT SELLI
   Braveman P, 2002, SOC SCI MED, V54, P1621, DOI 10.1016/S0277-9536(01)00331-8
   Bridgman R, 2001, AM ANTHROPOL, V103, P779, DOI 10.1525/aa.2001.103.3.779
   BROCK DH, 1984, CULTURE BIOMEDICINE
   Brodwin PE, 1997, MED ANTHROPOL Q, V11, P69, DOI 10.1525/maq.1997.11.1.69
   Broughton Chad, 2001, BERKELEY J SOCIOL, V41, P17
   Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472
   BULARD M, 2000, MONDE DIPL, V1, P8
   BUTT L, 2002, MED ANTHROPOL, V21, P31
   BUTT L, 2002, MED ANTHR, V2, P1
   Caldeira TPR, 1996, PUBLIC CULTURE, V8, P303, DOI 10.1215/08992363-8-2-303
   CAMBROSIO A, 1992, MED ANTHROPOL Q, V6, P362, DOI 10.1525/maq.1992.6.4.02a00040
   Campbell C, 2002, SOC SCI MED, V55, P643, DOI 10.1016/S0277-9536(01)00193-9
   Casper MJ, 1996, MED ANTHROPOL Q, V10, P523, DOI 10.1525/maq.1996.10.4.02a00080
   Cattell V, 2001, SOC SCI MED, V52, P1501, DOI 10.1016/S0277-9536(00)00259-8
   Cheah P, 1997, PUBLIC CULTURE, V9, P233, DOI 10.1215/08992363-9-2-233
   CHURCHILL N, 1995, URBAN ANTHROP, V24, P5
   Clarke AE, 1996, MED ANTHROPOL Q, V10, P601, DOI 10.1525/maq.1996.10.4.02a00120
   Clarke PM, 2002, SOC SCI MED, V55, P1923, DOI 10.1016/S0277-9536(01)00321-5
   Coburn D, 2000, SOC SCI MED, V51, P135, DOI 10.1016/S0277-9536(99)00445-1
   Coffield CD, 2000, ADV GEND RES, V4, P55
   Cohen L, 1999, DAEDALUS, V128, P135
   COMAROFF J, 1999, CODESRIA B, V17, P1
   COMAROFF J, 1985, BODY POWER SPIRIT RE
   COMAROFF J, 1994, MODERNITY ITS MALCON
   CONRAD P, 1992, ANNU REV SOCIOL, V18, P209, DOI 10.1146/annurev.so.18.080192.001233
   CUSSINS C, 1998, DIFFERENCES MED UNRA, P261
   de Jong J., 2002, TRAUMA WAR VIOLENCE
   Dean M., 1999, GOVERNMENTALITY POWE
   DESJARLAIS R, 1993, BODY EMOTION AESTHET
   Desjarlais R., 1995, WORLD MENTAL HLTH
   Diamond J., 1997, GUNS GERMS STEEL FAT
   Donohoe M, 2003, SOC SCI MED, V56, P573, DOI 10.1016/S0277-9536(02)00055-2
   Douglas M., 1996, PURITY DANGER ANAL C
   Dozon J. P., 1991, CAHIERS DETUDES AFRC, V31, P135
   Dozon JP, 2001, CRITIQUE SANTE PUBLI
   DOZON JP, 1995, CAUSE PROPHETES
   DRESSLER WW, 1993, MED ANTHROPOL Q, V7, P325, DOI 10.1525/maq.1993.7.4.02a00030
   Elkana Yehhuda, 2002, UNRAVELING TIES SOCI
   Ellis S., 1999, MASK ANARCHY
   Elstad JI, 1998, SOCIOL HEALTH ILL, V20, P598, DOI 10.1111/1467-9566.00121
   Elyachar J, 2002, PUBLIC CULTURE, V14, P493, DOI 10.1215/08992363-14-3-493
   Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349
   EVANS RG, 1994, WHY SOME PEOPLE HLTH
   Faber DR, 2002, ENVIRON HEALTH PERSP, V110, P277, DOI 10.1289/ehp.02110s2277
   Fabri RH, 2002, INT J GYNECOL OBSTET, V76, P87, DOI 10.1016/S0020-7292(01)00544-6
   Farmer P., 1999, INFECT INEQUALITIES
   FARMER P, 1992, AIDS ACCUSATION HAIT
   Farmer Paul, 1997, SOCIAL SUFFERING, P261
   FARQUHAR J, 1994, CULT ANTHROPOL, V9, P471, DOI 10.1525/can.1994.9.4.02a00020
   Farquhar J., 1994, KNOWING PRACTICE CLI
   Fassin D., 1996, ESPACE POLITIQUE SAN
   Fassin D., 1992, POUVOIR MALADIE AFRI
   Forbes A, 2001, SOC SCI MED, V53, P801, DOI 10.1016/S0277-9536(00)00383-X
   Galea S, 2002, SOC SCI MED, V55, P1373, DOI 10.1016/S0277-9536(01)00274-X
   Geissler P W, 1998, Anthropol Med, V5, P63, DOI 10.1080/13648470.1998.9964549
   Good BJ, 1993, MED RATIONALITY EXPE
   Goodman Alan H., 1998, BUILDING NEW BIOCULT
   Graham H, 2002, SOC SCI MED, V55, P2005, DOI 10.1016/S0277-9536(01)00343-4
   Hacking Ian, 2000, SOCIAL CONSTRUCTION
   Haraway D., 1996, MODEST WITNESS 2 MIL
   Hebdige Dick, 1979, SUBCULTURE MEANING S
   Hogle Linda F, 2002, Med Anthropol, V21, P275, DOI 10.1080/01459740214077
   Hutson S., 1994, YOUTH HOMELESSNESS C
   ILLICH I, 1977, MED NEMESIS EXPORTAT
   Irwin Alec, 2002, MED ANTHROPOL, V21, P25
   Jacobs J., 1961, DEATH LIFE GREAT AM
   Jenkins JH, 1998, MED ANTHROPOL Q, V12, P122, DOI 10.1525/maq.1998.12.1.122
   Kangas Beth, 2002, Med Anthropol, V21, P35, DOI 10.1080/01459740210620
   Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491
   Kawachi I, 2002, HLTH NATIONS WHY INE
   KAWACHI I, 1999, INCOME INEQUALITY HL, V1
   Keck Margaret E., 1998, ACTIVISTS BORDERS AD
   KELLEY L, 2003, HLTH IMPACTS GLOBALI
   Kim J. Y., 2000, DYING GROWTH GLOBAL
   KIRMAYER LJ, 1992, MED ANTHROPOL Q, V6, P323, DOI 10.1525/maq.1992.6.4.02a00020
   KUNITZ SJ, 2001, POVERTY INEQUALITY H
   Latour Bruno, 1993, WE HAVE NEVER BEEN M
   Lau Kimberly, 2000, NEW AGE CAPITALISM M
   Le Pape Marc, 1997, ENERGIE SOCIALE ABID
   LECLERC A, 2001, INEGALITES SOCIALES
   LEGGETT T, 2002, RAINBOW VICE DRUGS S
   LEVY BS, 1997, WAR PUBLIC HLTH
   LEWIS IM, 1978, CULTURE INEQUALITY
   LEWIS IM, 1991, WOMENS MED ZARBORI C
   LEWONTIN RC, 2000, TRIPLE HELIX GENE OR
   LIPPMAN A, 1991, AM J LAW MED, V17, P15
   LLOYDSHERLOCK P, 2000, HEATHCARE REFORM POV
   LOCK M, 1993, ANNU REV ANTHROPOL, V22, P133, DOI 10.1146/annurev.an.22.100193.001025
   LOCK M, 1998, ANTHR TODAY, V14, P7, DOI DOI 10.2307/2783351
   LOCK M, 2000, LIVING WORKING NEW M
   LOCK M, 1998, PRAGMATIC WOMEN BODY
   Lock M. M., 1995, ENCOUNTERS AGING MYT
   Lomas J, 1998, SOC SCI MED, V47, P1181, DOI 10.1016/S0277-9536(98)00190-7
   Lupton D, 1994, MED CULTURE ILLNESS
   LUPTON D., 1999, RISK
   Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8
   Lyon-Callo V, 2000, MED ANTHROPOL Q, V14, P328, DOI 10.1525/maq.2000.14.3.328
   Lyons M, 1992, COLONIAL DIS SOCIAL
   MACGAFFEY J, 2000, CONGOPARIS
   MAERTENS JT, 1978, DESSIN PEAU
   Maffesoli M, 1995, TIME TRIBES DECLINE
   Malkki L, 1998, PUBLIC CULTURE, V10, P431, DOI 10.1215/08992363-10-2-431
   Malkki Liisa Helena, 1995, PURITY EXILE VIOLENC
   MANN JM, 1999, HLTH HUMAN RIGHTS
   Marmot Michael G., 1986, CLASS HLTH RES LONGI, P21
   Marshall Patricia A., 2000, GLOBAL HLTH POLICY L, P205
   MARWICK M, 1991, WITCHCRAFT SORCERY
   Marx Karl, 1873, CAPITAL, V1
   MASCIALEES FE, 1992, TATTOO TORTURE MULTI
   Maskovsky J, 2000, Med Anthropol, V19, P121
   McGinn T, 2000, INT FAM PLAN PERSPEC, V26, P174, DOI 10.2307/2648255
   Mclean C, 2003, SOC SCI MED, V56, P657, DOI 10.1016/S0277-9536(02)00063-1
   Miller P., 1991, FOUCAULT EFFECT STUD
   Mol A, 1998, DIFFERENCES MED UNRA
   Moore H. L., 1994, CUTTING TREES GENDER
   Mullings L., 2001, STRESS RESILIENCE SO
   Navarro V, 2001, SOC SCI MED, V52, P481, DOI 10.1016/S0277-9536(00)00197-0
   Navarro Vicente, 2002, POLITICAL EC SOCIAL
   Negri Antonio, 2001, EMPIRE
   Newman KS, 2001, AM ANTHROPOL, V103, P762, DOI 10.1525/aa.2001.103.3.762
   NGUYEN V. K., 2002, ANTHR SOC, V26, P69
   NICHTER M, 2002, NEW HORIZONS MED ANT
   Novas C, 2000, ECON SOC, V29, P485
   Ong Aihwa, 1987, SPIRIT RESISTANCE CA
   Osiel Mark, 2001, MASS ATROCITY ORDINA
   OSTLIN P, 2002, GENDER INEQUALITIES
   Packard Randall M, 1989, WHITE PLAGUE BLACK L
   *PAN I, 2002, PAT PILLS PUBL HLTH
   Pandolfi M., 2001, MULTITUDES, V3, P97
   Pandolfi M., 1990, CULT MED PSYCHOL, V15, P275
   Parker R, 2002, AM J PUBLIC HEALTH, V92, P343, DOI 10.2105/AJPH.92.3.343
   Pearce N, 2003, AM J PUBLIC HEALTH, V93, P122, DOI 10.2105/AJPH.93.1.122
   Petersen A, 1997, FOUCAULT HLTH MED
   Peterson F. A., 1998, HLTH MARKETS NEW COM
   Pfeiffer J, 2002, MED ANTHROPOL Q, V16, P176, DOI 10.1525/maq.2002.16.2.176
   Popay J, 1998, SOCIOL HEALTH ILL, V20, P619, DOI 10.1111/1467-9566.00122
   PUTNAM RD, 1995, J DEMOCRACY, V0006
   Rabinow P, 2002, CULT ANTHROPOL, V17, P135, DOI 10.1525/can.2002.17.2.135
   Ragone Helena, 1999, TRANSFORMATIVE MOTHE, P65
   Richey L, 1999, J MOD AFR STUD, V37, P457, DOI 10.1017/S0022278X99003110
   Rylko-Bauer B, 2002, MED ANTHROPOL Q, V16, P476, DOI 10.1525/maq.2002.16.4.476
   Samuelsen H, 2001, MED ANTHROPOL Q, V15, P130, DOI 10.1525/maq.2001.15.1.130
   Santana P, 2002, SOC SCI MED, V55, P33, DOI 10.1016/S0277-9536(01)00218-0
   Scheper-Hughes Nancy, 2001, BODY SOC, V7, P1, DOI DOI 10.1177/1357034X0100700201
   SCHEPERHUGHES N, 1992, DEATH WEEPING VIOLEN
   Schoepf B.G., 1998, PRAGMATIC WOMEN BODY, P98
   Sen A, 1981, POVERTY FAMINES ESSA
   Sharp LA, 2001, AM ANTHROPOL, V103, P112, DOI 10.1525/aa.2001.103.1.112
   Sharp Lesley A, 2002, Med Anthropol, V21, P369, DOI 10.1080/01459740214075
   SHORE C, 1997, ANTHR POLICY CRITICA
   Simon CM, 1999, MED ANTHROPOL Q, V13, P141, DOI 10.1525/maq.1999.13.2.141
   Sobo Elisa J., 1995, CHOOSING UNSAFE SEX
   Steinberg Ted, 2000, ACTS GOD UNNATURAL H
   Strandsbjerg C, 2000, AFR AFFAIRS, V99, P395, DOI 10.1093/afraf/99.396.395
   Subramanian SV, 2002, ANNU REV PUBL HEALTH, V23, P287, DOI 10.1146/annurev.publhealth.23.100901.140540
   Summerfield D, 1998, RETHINKING TRAUMA WA, P9
   SWANSON MW, 1977, J AFR HIST, V18, P387, DOI 10.1017/S0021853700027328
   SZATHMARY EJE, 1990, MED ANTHROPOL Q, V4, P315, DOI 10.1525/maq.1990.4.3.02a00040
   TAUSSIG M, 1992, COLONIALISM CULTURE
   Tsing A, 2000, CULT ANTHROPOL, V15, P327, DOI 10.1525/can.2000.15.3.327
   TSING AL, 1994, REALM DIAMOND QUEEN
   Turner T. S., 1980, NOT WORK ALONE CROSS, P112
   Turshen M, 1984, POLITICAL ECOLOGY DI
   Vercellone C., 2002, MULTITUDES, V10, P11
   Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97
   WAITZKIN H, 1981, INT J HEALTH SERV, V11, P77, DOI 10.2190/5CDV-P4FE-Y6HN-JACD
   Werbner P., 1999, SOCIAL ANTHR, V7, P17, DOI DOI 10.1017/S0964028299000026
   White L., 2000, SPEAKING VAMPIRES RU
   Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X
   *WHO EDM, 1999, GLOB ACC DRUGS PERSP
   Wilkinson R.G, 1996, UNHEALTHY SOC AFFICT
   Wilkinson RG, 1998, SOCIOL HEALTH ILL, V20, P578, DOI 10.1111/1467-9566.00120
   WILLEMS D, 1998, DIFFERENCES MED UNRA, P105
   Wolfson M, 1999, BRIT MED J, V319, P953, DOI 10.1136/bmj.319.7215.953
   Woodward A, 1997, IARC SCI PUBL, P361
   Wright Peter, 1982, PROBLEM MED KNOWLEDG
   YOUNG A, 1992, PATHS ASIAN MED KNOW
   ZOLA IK, 1972, SOCIOL REV, V20, P487, DOI 10.1111/j.1467-954X.1972.tb00220.x
NR 200
TC 109
Z9 111
U1 1
U2 60
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0084-6570
EI 1545-4290
J9 ANNU REV ANTHROPOL
JI Annu. Rev. Anthropol.
PY 2003
VL 32
BP 447
EP 474
DI 10.1146/annurev.anthro.32.061002.093412
PG 28
WC Anthropology
SC Anthropology
GA 746LY
UT WOS:000186748900021
DA 2018-10-20
ER

PT J
AU West, JL
   Halas, NJ
AF West, JL
   Halas, NJ
TI Engineered nanomaterials for biophotonics applications: Improving
   sensing, imaging, and therapeutics
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE nanotechnology; nanoparticle; optics; biosensor; quantum dot; gold
   colloid; plasmon resonant particle; nanoshell
ID LABELS
AB Advances in chemistry and physics are providing an expanding array of nanostructured materials with unique and powerful optical properties. These nanomaterials provide a new set of tools that are available to biomedical engineers, biologists, and medical scientists who seek new tools as biosensors and probes of biological fluids, cells, and tissue chemistry and function. Nanomaterials are also being used to develop optically controlled devices for applications such as modulated drug delivery as well as optical therapeutics. This review discusses applications that have been successfully demonstrated using nanomaterials including semiconductor nanocrystals, gold nanoparticles, gold nanoshells, and silver plasmon resonant particles.
C1 Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
   Rice Univ, Dept Elect & Comp Engn, Houston, TX 77005 USA.
RP West, JL (reprint author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
RI West, Jennifer/A-4582-2008
OI West, Jennifer/0000-0001-8550-2875
CR Averitt RD, 1997, PHYS REV LETT, V78, P4217, DOI 10.1103/PhysRevLett.78.4217
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078
   Goldman ER, 2002, J AM CHEM SOC, V124, P6378, DOI 10.1021/ja0125570
   Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228
   Hayat MA, 1989, COLLOIDAL GOLD PRINC
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   HIRSCH LR, 2003, IN PRESS NANOSHELL A
   HIRSCH LR, 2003, IN PRESS RAPID WHOLE
   Oldenburg SJ, 2002, ANAL BIOCHEM, V309, P109, DOI 10.1016/S0003-2697(02)00410-4
   Oldenburg SJ, 1998, CHEM PHYS LETT, V288, P243, DOI 10.1016/S0009-2614(98)00277-2
   Schultz S, 2000, P NATL ACAD SCI USA, V97, P996, DOI 10.1073/pnas.97.3.996
   Sershen SR, 2000, J BIOMED MATER RES, V51, P293, DOI 10.1002/1097-4636(20000905)51:3<293::AID-JBM1>3.0.CO;2-T
   Shah N, 2001, P NATL ACAD SCI USA, V98, P4420, DOI 10.1073/pnas.071511098
   Welch A. J., 1995, OPTICAL THERMAL RESP
NR 17
TC 635
Z9 650
U1 11
U2 320
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1523-9829
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2003
VL 5
BP 285
EP 292
DI 10.1146/annurev.bioeng.5.011303.120723
PG 12
WC Engineering, Biomedical
SC Engineering
GA 742AV
UT WOS:000186493800010
PM 14527314
DA 2018-10-20
ER

PT J
AU Gunatillake, PA
   Martin, DJ
   Meijs, GF
   McCarthy, SJ
   Adhikari, R
AF Gunatillake, PA
   Martin, DJ
   Meijs, GF
   McCarthy, SJ
   Adhikari, R
TI Designing biostable polyurethane elastomers for biomedical implants
SO AUSTRALIAN JOURNAL OF CHEMISTRY
LA English
DT Review
ID ENZYME-INDUCED BIODEGRADATION; HARD-SEGMENT CHEMISTRY; MACRODIOLS
   PDMS-PHMO; MECHANICAL-PROPERTIES; POLYCARBONATE-POLYURETHANES;
   PHASE-SEPARATION; BLOCK POLYMERS; LOW-MODULUS; IN-VITRO; MORPHOLOGY
AB The chemical structure, synthesis, morphology, and properties of polyurethane elastomers are briefly discussed. The current understanding of the effect of chemical structure and the associated morphology on the stability of polyurethanes in the biological environments is reviewed. The degradation of conventional polyurethanes appears as surface or deep cracking, stiffening, and deterioration of mechanical properties, such as flex-fatigue resistance. Polyester and poly( tetramethylene oxide) based polyurethanes degrade by hydrolytic and oxidative degradation of ester and ether functional groups, respectively. The recent approaches to develop polyurethanes with improved long-term biostability are based on developing novel polyether, hydrocarbon, polycarbonate, and siloxane macrodiols to replace degradation-prone polyester and polyether macrodiols in polyurethane formulations. The new approaches are discussed with respect to synthesis, properties and biostability based on reported in vivo studies. Among the newly developed materials, siloxane-based polyurethanes have exhibited excellent biostability and are expected to find many applications in biomedical implants.
C1 CSIRO Mol Sci, Clayton 3169, Australia.
   Univ Queensland, Dept Chem Engn, Brisbane, Qld 4072, Australia.
RP Gunatillake, PA (reprint author), CSIRO Mol Sci, Bag 10, Clayton 3169, Australia.
RI He, Yong/F-8752-2012; Gunatillake, Pathiraja/A-1375-2008
OI Gunatillake, Pathiraja/0000-0002-7035-8214; Martin,
   Darren/0000-0002-8537-6765
CR Adhikari R, 1999, J APPL POLYM SCI, V73, P573, DOI 10.1002/(SICI)1097-4628(19990725)73:4<573::AID-APP13>3.0.CO;2-N
   Adhikari R, 1999, J APPL POLYM SCI, V74, P2979, DOI 10.1002/(SICI)1097-4628(19991213)74:12<2979::AID-APP25>3.0.CO;2-F
   Adhikari R, 2002, J APPL POLYM SCI, V83, P736, DOI 10.1002/app.2268
   Anderson JM, 1998, POLYM INT, V46, P163, DOI 10.1002/(SICI)1097-0126(199807)46:3<163::AID-PI972>3.0.CO;2-9
   ASSINK RA, 1981, J APPL POLYM SCI, V26, P3689, DOI 10.1002/app.1981.070261115
   Bernacca GM, 2002, J BIOMED MATER RES, V61, P138, DOI 10.1002/jbm.10149
   Bernacca GM, 2002, BIOMATERIALS, V23, P45, DOI 10.1016/S0142-9612(01)00077-1
   BLACKWELL J, 1979, J POLYM SCI POL LETT, V17, P447, DOI 10.1002/pol.1979.130170709
   BONART R, 1968, J MACROMOL SCI PHYS, V2, P116
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BRANDWOOD A, 1994, J BIOMAT SCI-POLYM E, V6, P41, DOI 10.1163/156856295X00742
   BRUNETTE CM, 1981, POLYM ENG SCI, V21, P163, DOI 10.1002/pen.760210309
   CHRIST FR, 1992, J BIOMED MATER RES, V26, P607
   CHRISTENSON EM, 2002, T 28 ANN M SOC BIOM, P111
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1992, P 4 WORLD BIOM C, P661
   COURY AJ, 1993, Patent No. 4873308
   COURY AJ, 1990, T 16 ANN M SOC BIOM, P158
   DAVIS MW, 1985, T 11 ANN M SOC BIOM, P54
   Dieterich D., 1985, POLYURETHANE HDB, P11
   EBERT M, 2002, T 28 ANN M SOC BIOM, P407
   EISENBACH CD, 1994, MACROMOL RAPID COMM, V15, P395, DOI 10.1002/marc.1994.030150502
   Frisch KC, 1996, CELL POLYM, V15, P395
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   Gunatillake P. A., 2001, BIOMEDICAL APPL POLY, P160
   Gunatillake PA, 2000, J APPL POLYM SCI, V76, P2026, DOI 10.1002/(SICI)1097-4628(20000628)76:14<2026::AID-APP5>3.0.CO;2-X
   GUNATILLAKE PA, 1992, POLYM INT, V27, P275, DOI 10.1002/pi.4990270313
   GUNATILLAKE PA, 1992, J APPL POLYM SCI, V46, P319, DOI 10.1002/app.1992.070460213
   Gunatillake PA, 1997, J APPL POLYM SCI, V63, P1373, DOI 10.1002/(SICI)1097-4628(19970307)63:10<1373::AID-APP18>3.0.CO;2-5
   GUNATILLAKE PA, 1998, Patent No. 9800546
   GUNATILLAKE PA, 1996, Patent No. 9700619
   GUNATILLAKE PA, 1999, T 25 ANN M SOC BIOM, P369
   GUNATILLAKE PA, 1995, Patent No. 5403912
   GUNATILLAKE PA, 2001, T 2M ANN M SOC BIOM, P128
   HEPBURN C, 1991, POLYURETHANE ELASTOM, P29
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HONG JL, 1992, POLYMER, V33, P4347, DOI 10.1016/0032-3861(92)90278-5
   HUH DS, 1971, POLYM ENG SCI, V11, P369, DOI 10.1002/pen.760110504
   ITO Y, 1989, CRIT REV BIOCOMPAT, V5, P45
   KENNEDY JP, 1985, J ELASTOM PLAST, V17, P82, DOI 10.1177/009524438501700108
   KWEI TK, 1982, J APPL POLYM SCI, V27, P2891, DOI 10.1002/app.1982.070270815
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LEUNG LM, 1986, MACROMOLECULES, V19, P706, DOI 10.1021/ma00157a038
   LYMAN DJ, 1960, J POLYM SCI, V45, P49, DOI 10.1002/pol.1960.1204514505
   Martin DJ, 1996, J APPL POLYM SCI, V60, P557, DOI 10.1002/(SICI)1097-4628(19960425)60:4<557::AID-APP9>3.0.CO;2-N
   Martin DJ, 1996, J APPL POLYM SCI, V62, P1377
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   Martin DJ, 2001, BIOMATERIALS, V22, P973, DOI 10.1016/S0142-9612(00)00262-3
   Martin DJ, 1999, J APPL POLYM SCI, V71, P937
   Martin DJ, 2000, BIOMATERIALS, V21, P1021, DOI 10.1016/S0142-9612(99)00271-9
   Matheson LA, 2002, J BIOMED MATER RES, V61, P505, DOI 10.1002/jbm.10286
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   McCarthy SJ, 1997, BIOMATERIALS, V18, P1387, DOI 10.1016/S0142-9612(97)00083-5
   MCCARTHY SJ, 2000, 6 WORLD BIOM C T SOC, P82
   MEIJS GF, 1991, Patent No. 9200338
   MEIJS GF, 1997, T 23 ANN M SOC BIOM, P176
   MEIJS GF, 1997, 7 ANN C AUSTR SOC BI, P28
   MEIJS GF, 1991, Patent No. 9100270
   Murayama T, 1978, DYNAMIC MECH ANAL PO
   NUNES RW, 1982, POLYM ENG SCI, V22, P205, DOI 10.1002/pen.760220402
   OPIER Z, 1980, J POLYM SCI PP, V18, P1469
   Phillips R E, 1988, J Biomater Appl, V3, P207, DOI 10.1177/088532828800300204
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Pinchuk L., 1992, US Patent, Patent No. [5,133,742, 5133742]
   POLMANTEER KE, 1988, HDB ELASTOMERS, P5521
   RATNER BD, 1989, COMPREHENSIVE POLYM, V7, P201
   RHODES NP, 2001, T 25 ANN M SOC BIOM
   SCHNEIDER NS, 1975, J MACROMOL SCI PHYS, VB 11, P527, DOI 10.1080/00222347508219422
   Schollenberger CS, 1973, J ELASTOPLAST, V5, P222
   Schubert MA, 1997, J BIOMED MATER RES, V35, P319, DOI 10.1002/(SICI)1097-4636(19970605)35:3<319::AID-JBM6>3.0.CO;2-K
   SEYMOUR RW, 1973, MACROMOLECULES, V6, P48, DOI 10.1021/ma60031a008
   SIRCAR AK, 1997, THERMAL CHARACTERIZA, V1, P888
   SIRCAR AK, 1997, THERMAL CHARACTERIZA, V1, P484
   SPECKHARD TA, 1986, RUBBER CHEM TECHNOL, V59, P405, DOI 10.5254/1.3538208
   SPECKHARD TA, 1983, POLYM ENG SCI, V23, P337, DOI 10.1002/pen.760230608
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES K, 1998, POLYM PREPR, V39, P520
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   SZYCHER M, 1983, J ELASTOM PLAST, V15, P81, DOI 10.1177/009524438301500205
   Szycher M., 1991, BLOOD COMPATIBLE MAT, P33
   SZYCHER M, 1995, J BIOMATER APPL, V8, P210
   SZYCHER M, 1985, ASTM STP, V859, P308
   Szycher M., 1999, U. S. Patent, Patent No. [5,863,627, 5863627]
   SZYCHER M, 1991, Patent No. 9106621
   SZYCHER M, 1991, Patent No. 9204390
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Tanzi MC, 2000, J BIOMATER APPL, V14, P325, DOI 10.1106/7TJU-H1YA-4NYT-XL84
   Thoma R J, 1988, J Biomater Appl, V3, P180, DOI 10.1177/088532828800300203
   VANBOGART JWC, 1980, J MACROMOL SCI PHYS, VB17, P267, DOI 10.1080/00222348008213125
   WARD R, 2002, T 28 ANN M SOC BIOM, P130
   Ward R. S., 2000, MED DEVICE DIAGN IND, V22, P68
   WARD RS, 1996, T ASAIO M WASH DC, P17
   WARD RS, 1995, MED PLASTICS BIO SPR, P34
   WARD RS, 2000, T 6 WORLD BIOM C, V1, P431
   Wirpsza Z., 1993, POLYURETHANES CHEM T, P139
   WOODS G, 1987, ICI POLKYURETHANES B, P175
   YAMAMOTO T, 1989, POLYM J, V21, P895, DOI 10.1295/polymj.21.895
   YUI N, 1985, POLYM J, V17, P969, DOI 10.1295/polymj.17.969
NR 102
TC 81
Z9 83
U1 7
U2 81
PU C S I R O PUBLISHING
PI COLLINGWOOD
PA 150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA
SN 0004-9425
J9 AUST J CHEM
JI Aust. J. Chem.
PY 2003
VL 56
IS 6
BP 545
EP 557
DI 10.1071/CH02168
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA 688WW
UT WOS:000183461100003
DA 2018-10-20
ER

PT S
AU Costa, ROR
   Pereira, MM
   Lameiras, FS
   Vasconcelos, WL
AF Costa, ROR
   Pereira, MM
   Lameiras, FS
   Vasconcelos, WL
BE BenNissan, B
   Sher, D
   Walsh, W
TI In vitro study of apatite precipitation on poly(2-hydroxyethyl
   methacrylate)-silica hybrids with controlled surface areas
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE hybrids; biomaterials; apatite; in vitro; sol-gel; TMOS; SBF
ID GEL
AB The study of sol-gel derived organic-inorganic hybrids as biomaterials seems to be promising, since it may generate lightweight structural hybrids with high toughness and bone-like elastic modulus, as well as materials for other biomedical applications, such as drug delivery systems, biocatalysts and biosensors. Hybrids of poly(2-hydroxyethyl methacrylate) (PHEMA), a polymer that has been employed in a wide variety of biomedical applications, and silica-gel, which exhibits a well-known bioactivity, were produced. The obtained hybrids were characterized and their in vitro ability to induce the formation of a calcium phosphate layer on the surface was evaluated. The surface area of hybrids decreased with increasing amounts of PHEMA so that hybrids with more than similar to40% PHEMA are virtually non-porous. All hybrids induced the formation of a calcium phosphate layer on their surfaces when soaked into simulated body fluid. The induction time varied according to the polymer content.
C1 Nucl Technol Dev Ctr, CDTN, CNEN, BR-30123970 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-30160030 Belo Horizonte, MG, Brazil.
RP Costa, ROR (reprint author), Nucl Technol Dev Ctr, CDTN, CNEN, Rua Prof Mario Werneck,Campus UFMG, BR-30123970 Belo Horizonte, MG, Brazil.
CR AVNIR D, 1994, CHEM MATER, V6, P1605, DOI 10.1021/cm00046a008
   Bosch P, 1996, J POLYM SCI POL CHEM, V34, P3289
   BRENNAN AB, 1994, KIRKOTHMER ENCY CHEM, V12, P644
   Costa ROR, 2002, J NON-CRYST SOLIDS, V304, P84, DOI 10.1016/S0022-3093(02)01008-6
   COSTA ROR, 2002, UNPUB J MAT SCI
   Dziubla TD, 2001, BIOMATERIALS, V22, P2893, DOI 10.1016/S0142-9612(01)00035-7
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Huang ZH, 1997, POLYMER, V38, P521, DOI 10.1016/S0032-3861(96)00561-7
   Kamitakahara M, 2001, J SOL-GEL SCI TECHN, V21, P75, DOI 10.1023/A:1011261617377
   KLEE D, 2000, ADV POLYM SCI, V149, P1
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Wen JY, 1996, CHEM MATER, V8, P1667, DOI 10.1021/cm9601143
   YANO S, 1994, J APPL POLYM SCI, V54, P163, DOI 10.1002/app.1994.070540203
NR 15
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 195
EP 198
DI 10.4028/www.scientific.net/KEM.240-242.195
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600040
DA 2018-10-20
ER

PT S
AU Bibby, JK
   Mummery, PM
   Bubb, N
   Wood, DJ
AF Bibby, JK
   Mummery, PM
   Bubb, N
   Wood, DJ
BE BenNissan, B
   Sher, D
   Walsh, W
TI Novel bioactive coatings for biomedical applications
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE bioactive coatings; mullite; fluorapatite; plasma spray; EPD
ID HYDROXYAPATITE
AB There are thousands of implant operations every year that give significant pain relief to patients. Even small improvements can reduce the need for further revision surgery. Improving the bonding of an implant, by using a bioactive coating, increases the rate of fixture of the implant, reducing the healing time. The original artificial bioactive coatings, calcium phosphates and hydroxyapatite, were absorbed quickly by the body. This leaves the substrate bear, resulting in loosening of the implant. Hench developed bioactive glass ceramics in the 1970s that were longer lasting and bonded to bone. Due to the low fracture toughness of these glass-ceramics, these materials are used for non-load bearing components, or more commonly, as coatings. Many different methods of coating have been suggested with varying degrees of success. This paper compares coatings fabricated by plasma spraying and electrophoretic-deposition and studies the effect of heat treatment on the coating quality, adhesion, phase distribution and bioactivity of apatite-mullite glass-ceramic LG112 on Ti6Al4V.
C1 Univ Manchester, Inst Sci & Technol, Manchester Mat Sci Ctr, Manchester M1 7HS, Lancs, England.
   Leeds Dent Inst, Div Restorat Dent, Leeds LS2 9LU, W Yorkshire, England.
RP Bibby, JK (reprint author), Univ Manchester, Inst Sci & Technol, Manchester Mat Sci Ctr, Grosvenor St, Manchester M1 7HS, Lancs, England.
CR BREME J, 1995, BIOMATERIALS, V16, P239, DOI 10.1016/0142-9612(95)92123-N
   *HENCH, HENCH ONL LECT NOT
   HENCH L, 1993, INTRO BIOCERAMICS
   Massaro C, 2001, J BIOMED MATER RES, V58, P651, DOI 10.1002/jbm.1065
NR 4
TC 2
Z9 2
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 279
EP 282
DI 10.4028/www.scientific.net/KEM.240-242.279
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600060
DA 2018-10-20
ER

PT S
AU Mucalo, MR
   Johnson, GS
   Worth, A
   Horne, JG
   Burbridge, HM
   Bruce, WJ
   Anderson, IA
AF Mucalo, MR
   Johnson, GS
   Worth, A
   Horne, JG
   Burbridge, HM
   Bruce, WJ
   Anderson, IA
BE BenNissan, B
   Sher, D
   Walsh, W
TI The use of New Zealand animal bone as bioceramic bone xenografts:
   Concept to clinical study
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE bone; defatting; deproteination; clinical trials; Xenografts;
   implantation
ID BIOMEDICAL APPLICATIONS; CANCELLOUS BONE; YIELD MATERIALS
AB This study describes the processing, characterisation and subsequent clinical trialling of abattoir-derived New Zealand animal bone as shapeable xenografts suitable for biomedical implantation into the body as a bone replacement material. Bovine bone cubes extracted from condyles were boiled in water to remove meat and bulk fat, refluxed in methyl acetate to remove residual fat and then deproteinated in hypochlorite solution to bring about deproteination. Spectroscopic, microscopic and mechanical characterisation of the cubes as a function of processing showed that the cubes had retained their osseous architecture after processing, consisted of hydroxycarbonate apatite and had reduced mechanical strength which enabled them to be cut to the desired shape by surgical instruments. A clinical study, in which cores of the xenografts were implanted into the femurs of sheep, showed that the cubes had osteoconductive potential.
C1 Univ Waikato, Dept Chem, Hamilton, New Zealand.
   Massey Univ, Vet Teaching Hosp, Ctr Compan Anim Hlth, Palmerston North, New Zealand.
   Univ Otago, Wellington Sch Med, Wellington, New Zealand.
   Univ Auckland, Dept Engn Sci, Auckland, New Zealand.
RP Mucalo, MR (reprint author), Univ Waikato, Dept Chem, Private Bag 3105, Hamilton, New Zealand.
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR Anderson LA, 2000, J MATER SCI-MATER M, V11, P743
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P427, DOI 10.1023/A:1008987908917
NR 2
TC 1
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 427
EP 429
DI 10.4028/www.scientific.net/KEM.240-242.427
PG 3
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600096
DA 2018-10-20
ER

PT S
AU Huang, J
   Brooks, RA
   Best, SM
   Bonfield, W
AF Huang, J
   Brooks, RA
   Best, SM
   Bonfield, W
BE BenNissan, B
   Sher, D
   Walsh, W
TI Evaluation of the biocompatibility of nano-sized carbonate-substituted
   hydroxyapatite after hydrothermal treatment
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE nanosize; carbonate-substituted hydroxyapatite; hydrothermal treatment;
   biocompatibility; LDH; TNF-alpha; confocal microscopy
AB A hydrothermal treatment has been applied in this study to control the crystallinity and morphology of nanometre scale carbonate-substituted hydroxyapatite (C-HA) crystallites. Transmission electron microscopy showed that the morphology of C-HA was changed from acicular to rod-like by the treatment, while, selected area diffraction patterns changed from the ringed pattern of an amorphous material to the spotted pattern of a polycrystalline material. The increase in the crystallinity of C-HA was also confirmed by X-ray diffraction and infrared spectroscopy. Biocompatibility testing showed that there was some evidence of LDH release from primary human monocytes/macrophages when in contact with high concentrations of C-HA crystallites, but there was no significant release of inflammatory cytokine TNF-alpha. Moreover, the nano-sized C-HA crystallites were not cytotoxic to human osteoblast-like MG63 cells and normal actin cytoskeletal organization was observed. These results indicate the biocompatibility of these nano-sized C-HA crystallites, which may offer the potential to formulate composites for biomedical applications.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 2QQ, England.
RP Huang, J (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.
CR BONFIELD W, 1987, MET MATER, V3, P712
   BONFIELD W, 1999, Patent No. 9932401
   Dalby MJ, 2002, BIOMATERIALS, V23, P569, DOI 10.1016/S0142-9612(01)00139-9
   Harada Y, 1996, J BIOMED MATER RES, V31, P19, DOI 10.1002/(SICI)1097-4636(199605)31:1<19::AID-JBM3>3.3.CO;2-L
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P139
   Sun JS, 1997, BIOMATERIALS, V18, P683, DOI 10.1016/S0142-9612(96)00183-4
   Wimhurst JA, 2001, J BONE JOINT SURG BR, V83B, P278, DOI 10.1302/0301-620X.83B2.10392
NR 7
TC 1
Z9 1
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 485
EP 488
DI 10.4028/www.scientific.net/KEM.240-242.485
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600110
DA 2018-10-20
ER

PT S
AU Kokubo, T
AF Kokubo, T
BE BenNissan, B
   Sher, D
   Walsh, W
TI Novel inorganic materials for biomedical applications
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE bioactive metal; apatite-polymer composite; cancer treatment; bone
   graft; SBF; hybrids
ID SIMULATED BODY-FLUID; BONELIKE APATITE FORMATION; BIOACTIVE TITANIUM
   METAL; SURFACE-STRUCTURE; FORMING ABILITY; GEL; GLASSES; TI
AB The essential requirement for artificial material to bond to living bone is the formation of bonelike apatite layer on its surface in the living body. Some functional groups such as Si-OH and Ti-OH are effective for the apatite nucleation in the living body. On the basis of these findings, bioactive Ti metals and its alloys with high fracture toughnesses were developed by NaOH and heat treatments. Nanoapatite-polymer fiber composites were developed by modification of polymer surfaces with CaO-SiO2 or TiO2 gel and soaking in simulated body fluid (SBF). Some ceramic microsphere also can play an important role in in situ treatment of deep-seated cancers. For example, Y2O3 polycrystalline microspheres 20 to 30 mum in diameter were developed for in situ radiotherapy of liver cancer. Magnetite (Fe3O4) polycrystalline microspheres were developed for in situ hyperthermia of cancers.
C1 Kyoto Univ, Dept Chem Mat, Grad Sch Engn, Sakyo Ku, Kyoto 6068501, Japan.
RP Kokubo, T (reprint author), Kyoto Univ, Dept Chem Mat, Grad Sch Engn, Sakyo Ku, Kyoto 6068501, Japan.
CR Day DE, 1993, INTRO BIOCERAMICS, P305
   EBISAWA Y, 1991, NIPPON SERAM KYO GAK, V99, P7
   EHRHARDT GJ, 1987, NUCL MED BIOL, V14, P233
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HIMENO T, 2001, BIOCERAMICS, V14, P637
   IKENAGA M, 1993, J ORTHOP RES, V11, P849, DOI 10.1002/jor.1100110611
   JARCHO M, 1977, J BIOENG, V1, P79
   KAWASHITA M, 2001, BIOCERAMICS, V14, P645
   KAWASHITA M, 1999, BIOCERAMICS, V12, P555
   Kim HM, 1999, J BIOMED MATER RES, V45, P100, DOI 10.1002/(SICI)1097-4636(199905)45:2<100::AID-JBM4>3.0.CO;2-0
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   KIM HM, 2000, BIOCERAMICS, V13, P227
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1989, BIOCERAMICS, V1, P157
   KOKUBO T, 2000, BIOCERAMICS, V13, P3
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P139
   LI P, 1992, T 4 WORLD BIOM C BER, P4
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Loty C, 2000, J BIOMED MATER RES, V49, P423, DOI 10.1002/(SICI)1097-4636(20000315)49:4<423::AID-JBM1>3.3.CO;2-Z
   Miyazaki T, 2000, J BIOMED MATER RES, V50, P35, DOI 10.1002/(SICI)1097-4636(200004)50:1<35::AID-JBM6>3.0.CO;2-8
   Miyazaki T, 2001, J CERAM SOC JPN, V109, P929, DOI 10.2109/jcersj.109.1275_929
   Miyazaki T, 2001, J SOL-GEL SCI TECHN, V21, P83, DOI 10.1023/A:1011265701447
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   OHTSUKI C, 1995, J CERAM SOC JPN, V103, P449, DOI 10.2109/jcersj.103.449
   OHTSUKI C, 1991, J BIOMED MATER RES, V25, P1363, DOI 10.1002/jbm.820251105
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   Oyane A, 2002, J CERAM SOC JPN, V110, P248, DOI 10.2109/jcersj.110.248
   OYANE A, 2001, MAT SCI 21 CENTURY, VB, P75
   Takadama H, 2001, J BIOMED MATER RES, V55, P185, DOI 10.1002/1097-4636(200105)55:2<185::AID-JBM1005>3.3.CO;2-G
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   Uchida M, 2001, J AM CERAM SOC, V84, P2041
   WILSON J, 1993, INTRO BIOCERAMICS, P63
   YAMAMURO T, 1993, INTRO BIOCERAMICS, P89
NR 36
TC 4
Z9 5
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 523
EP 528
DI 10.4028/www.scientific.net/KEM.240-242.523
PG 6
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600119
DA 2018-10-20
ER

PT S
AU Goller, G
   Oktar, FN
   Toykan, D
   Kayali, ES
AF Goller, G
   Oktar, FN
   Toykan, D
   Kayali, ES
BE BenNissan, B
   Sher, D
   Walsh, W
TI The improvement of titanium reinforced hydroxyapatite for biomedical
   applications
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE biocomposite; hydroxyapatite; titanium
AB The addition of different amounts of inclusions to brittle hydroxyapatite (HA) gives the advantage of tailoring and predicting the possible mechanical properties of the biocomposite. Biocomposite materials have been developed in order to combine the properties of bioactive material with the better mechanical properties of a second phase. Titanium, having superior biocompatibility, mechanical properties and corrosion resistance, is suitable as a reinforcement phase for biomedical applications. This study focuses on the effects of sintering temperature and the amount of reinforcement phase on the mechanical properties of HA-Ti composites. The HA material used was derived from freshly-extracted human teeth with calcination at 850degreesC. Titanium powders were mixed by 5 and 10 wt % with HA and have been subjected to sintering at 1200 and 1300degreesC for three hours. Density, microhardness, and compressive strength measurements have been carried out. Microstructures have been investigated by SEM and the phase analysis has been determined by the x-ray diffraction analysis. The best mechanical properties have been obtained by sintering at 1300degreesC for three hours with the addition of 10 wt % Ti to HA.
C1 Istanbul Tech Univ, Dept Met & Mat Engn, Istanbul, Turkey.
   Marmara Univ, New Technol R&D Ctr, Istanbul, Turkey.
RP Goller, G (reprint author), Istanbul Tech Univ, Dept Met & Mat Engn, Istanbul, Turkey.
OI Goller, Gultekin/0000-0003-4680-3936
CR Knepper M, 1997, BIOMATERIALS, V18, P1523, DOI 10.1016/S0142-9612(97)00066-5
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   OKTAR FN, IN PRESS CERAMICS IN
   Salih V, 2001, BIOMATERIALS, V22, P2817, DOI 10.1016/S0142-9612(01)00026-6
   TANNER KE, 1994, BRIT CERAMIC T, V93
   WILLIAMS DF, TITANIUM METAL IMP 2
NR 6
TC 15
Z9 15
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 619
EP 622
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600142
DA 2018-10-20
ER

PT S
AU Wei, M
   Vellinga, D
   Leavesley, D
   Evans, J
   Upton, Z
AF Wei, M
   Vellinga, D
   Leavesley, D
   Evans, J
   Upton, Z
BE BenNissan, B
   Sher, D
   Walsh, W
TI Cell attachment and proliferation on hydroxyapatite and ion substituted
   hydroxyapatites
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE Partially fluoride substituted hydroxyapatite; hydroxyapatite; cell
   attachment; cell proliferation
ID BONE
AB Hydroxyapatite (HA), partially fluoride substituted hydroxyapatite (fHA), and fluorapatite (FA) were synthesized in-house and characterised. Cell attachment and proliferation on polystyrene, titanium, HA, fHA and FA were investigated. It was found that fHA was a promising biomaterial. This material supports osteoblast cell attachment equivalent to that observed with polystyrene (plastic tissue culture well), titanium (a widely used metal implant material), HA and FA. However, it is significantly superior to these materials in inducing proliferation of the human osteoblast cell line. The cell proliferation rate on fHA is more than double the rate of the remaining materials, including HA, a widely used biomaterial. fHA may thus be a potential candidate biomaterial for biomedical applications.
C1 Univ Connecticut, Dept Met & Mat Engn, Storrs, CT 06269 USA.
   Queensland Univ Technol, Ctr Rehabil Sci & Engn, Brisbane, Qld 4001, Australia.
   Queensland Univ Technol, Sch Life Sci, Brisbane, Qld 4001, Australia.
RP Vellinga, D (reprint author), Univ Connecticut, Dept Met & Mat Engn, 97 N Eagleville Rd,Unit 3136, Storrs, CT 06269 USA.
RI Leavesley, David/C-9532-2009; Upton, Zee/I-9777-2012
OI Leavesley, David/0000-0002-1033-5459; 
CR BRAUN M, 1995, J MATER SCI-MATER M, V6, P150, DOI 10.1007/BF00120291
   Clemens JAM, 1997, J BIOMED MATER RES, V36, P55, DOI 10.1002/(SICI)1097-4636(199707)36:1<55::AID-JBM7>3.0.CO;2-K
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   Gross KA, 2002, J BIOMED MATER RES, V63, P106, DOI 10.1002/jbm.10090
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P139
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   TRAVERIACROS A, 1980, ACTA GEOL HISP, V15, P15
NR 9
TC 3
Z9 3
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 671
EP 674
DI 10.4028/www.scientific.net/KEM.240-242.671
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600154
DA 2018-10-20
ER

PT S
AU Baccalaro, M
   Gadow, R
   von Niessen, K
AF Baccalaro, M
   Gadow, R
   von Niessen, K
BE Sundar, V
   Rusin, RP
   Rutiser, CA
TI Manufacturing of thermally sprayed tricalcium phosphate (TCP) coatings
   for biomedical applications
SO BIOCERAMICS: MATERIALS AND APPLICATIONS IV
SE CERAMIC TRANSACTIONS
LA English
DT Proceedings Paper
CT Symposium on Bioceramics held at the 105th Annual Meeting of the
   American-Ceramic-Society
CY APR 27-30, 2003
CL NASHVILLE, TN
SP Amer Ceram Soc
AB Resorbable calcium phosphates for biomedical applications play an important role in a growing number of surgical disciplines. In contrast to bioactive materials like hydroxyapatite (HAP), which are intended to remain stable and chemically unchanged as long as possible in the human body, resorbable bioceramics are applied to dissolve gradually in body environment and new bone will replace the absorbed material. Tricalcium phosphate (TCP) appears to be the most suitable bioceramic of this type. It is known in its two polymorphs, the high temperature alpha-TCP and the more stable beta-TCP phase. A promising application of these bioceramics is the coating of bioinert metal alloys, bioresorbable polymeric substrates or composite structures made thereof. The use of a TCP coating for a structural composite implant makes it possible to realize surfaces which dissolve gradually in the body and lead to bone formation. The spray-granulation technique was applied to produce new beta-TCP powders suitable for Atmospheric Plasma Spraying (APS) with different grain size and grain size distributions. The powders were sprayed onto commercially available titan rods and onto aramide fabrics, in order to investigate the possibility to apply these bioceramics coating also to thermally sensitive substrates. The phase change from beta to alpha and therefore the presence and amount of beta-phase in the coatings after plasma spraying is strongly influenced by the powder mean grain size and by the heat content of the plasma during plasma spray deposition. XRD qualitative and quantitative analysis revealed that the obtained coatings are made of pure alpha-TCP, mixtures of alpha- and beta- phase and, after a post heat treatment, pure beta-TCP. The porosity of the coatings was determined by electronic image processing.
C1 Univ Stuttgart, Inst Mfg Technol Ceram Components & Composites, D-70569 Stuttgart, Germany.
RP Baccalaro, M (reprint author), Univ Stuttgart, Inst Mfg Technol Ceram Components & Composites, Allmandring 7B, D-70569 Stuttgart, Germany.
CR Adamson A. W., 1976, PHYS CHEM SURFACES
   Alexander L., 1948, Analytical Chemistry, V20, P886, DOI 10.1021/ac60022a002
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
   LEGEROS JP, 1993, ADV SERIES CERAMICS, V1
   LINDE AG, 1990, VERFAHRENSPEKTRUM BE
   Pawlowski L., 1995, SCI ENG THERMAL SPRA
   Reed J. S., 1995, PRINCIPLES CERAMIC P
   RIDDICK TM, 1968, ZETAMETER MANUAL
NR 8
TC 0
Z9 0
U1 0
U2 1
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 1042-1122
BN 1-57498-202-8
J9 CERAM TRANS
PY 2003
VL 147
BP 25
EP 34
PG 10
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials
SC Engineering; Materials Science
GA BY27K
UT WOS:000188655200003
DA 2018-10-20
ER

PT S
AU Ricciardi, L
   Pitz, I
   Al-Sarawi, SF
   Varadan, V
   Abbott, D
AF Ricciardi, L
   Pitz, I
   Al-Sarawi, SF
   Varadan, V
   Abbott, D
BE RodriguezVazquez, A
   Abbott, D
   Carmona, R
TI Investigation into the future of RFID in biomedical applications
SO BIOENGINEERED AND BIOINSPIRED SYSTEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Bioengineered and Bioinspired Systems
CY MAY 19-21, 2003
CL MASPALOMAS, SPAIN
SP SPIE, Spanish Govt, Canary Govt, Canary Isl Special Zone, Res Inst Appl Microelect, Univ Las Palmas Gran Canaria, Sch Telecommun Engn, Univ Las Palmas Gran Canaria, Dept Elect Engn & Control
DE RFID; SAW devices; coding; microvalve
AB This paper focuses on the future of Radio Frequency Identification (RFID) systems in biomedical applications. It discusses current technology, restrictions and applications and also illustrates possible future development. We mainly focus on actuator devices and introduce some of the concepts for RFID sensors. Basically, Radio Frequency Identification is a technology that is analogous to the working principle of magnetic bar code systems. Our proposed solution is to exploit an exciting new development in making circuits on polymers without the need of battery power. This solution exploits the principle of a Surface Acoustic Wave (SAW) device on a polymer substrate. The SAW device is a set of interdigitated conducting fingers on the polymer substrate. If an appropriate RF signal is sent to the device, the fingers act as microantennas that pick up the signal, and this energy is then converted into acoustic waves that travel across the surface of the polymer substrate. Being a flexible polymer, the acoustic waves cause stress that can either contract or stretch the material. In our case we want to use RFID technology for biomedical applications. We want to use this technology for devices, which are implanted in the human body and controlled or observed by a radio frequency signal.
C1 Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RP Ricciardi, L (reprint author), Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RI Abbott, Derek/E-8352-2011
OI Abbott, Derek/0000-0002-0945-2674; Al-Sarawi, Said/0000-0002-3242-8197
CR Dario P, 2000, J MICROMECH MICROENG, V10, P235, DOI 10.1088/0960-1317/10/2/322
   de Leeuw D, 1999, PHYS WORLD, V12, P31
   ENDERLING S, 2001, SMART ELECT MEMS 2 P, V4236, P204
   FISCH H, PATIENTS GUIDE VASEC
   Gabriel C., 1996, NALOETR19960037
   Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770
   Kohl M, 1996, SENSOR ACTUAT A-PHYS, V53, P416, DOI 10.1016/0924-4247(96)01143-0
   Low LM, 2000, SENSOR ACTUAT B-CHEM, V67, P149, DOI 10.1016/S0925-4005(00)00396-8
   Madou M J, 1994, US Patent, Patent No. [No 5368704, 5368704]
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   MARTINI F, 1992, FUNDAMENTALS ANAT PH, P669
   MOFFETT D, 1993, HUMAN PHYSL FDN FRON, P688
   Puente C, 2001, J INST BRIT TELECOMM, V2, P92
   SCHMIDT F, 1996, IEEE INT FREQ CONTR, P208
   SOBEK D, 1994, P SOL STAT SENS ACT, P260
   Varadan V. K., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4236, P194, DOI 10.1117/12.418758
   VARADAN VK, 2000, SMART MATER STRUCT, P379
   Varadan VV, 1998, P SOC PHOTO-OPT INS, V3328, P49, DOI 10.1117/12.320197
   VERNON T, 1999, RADIO WORLD      SEP
   Vinoy KJ, 2001, MICROW OPT TECHN LET, V29, P215, DOI 10.1002/mop.1136
NR 20
TC 11
Z9 11
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4979-2
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5119
BP 199
EP 209
DI 10.1117/12.501209
PG 11
WC Computer Science, Artificial Intelligence; Engineering, Biomedical
SC Computer Science; Engineering
GA BX01T
UT WOS:000183951000023
DA 2018-10-20
ER

PT J
AU Chan, CK
   Chu, IM
AF Chan, CK
   Chu, IM
TI Crystalline and dynamic mechanical behaviors of synthesized poly(sebacic
   anhydride-co-ethylene glycol)
SO BIOMATERIALS
LA English
DT Article
DE poly(ethylene glycol); poly(sebacic anhydride); crystallinity; dynamic
   mechanical analysis
ID MULTIBLOCK COPOLYMERS; POLY(ETHYLENE GLYCOL); PHASE-BEHAVIOR;
   POLYANHYDRIDES; DEGRADATION; POLYMERS; NMR; MOBILITY; BLENDS
AB A novel biomaterial: poly(sebacic anhydride-co-ethylene glycol) was synthesized by introducing poly(ethylene glycol) (PEG) into a polyanhydride system. This copolymer was synthesized using sebacic acid and PEG via melt-condensation polymerization. The crystalline behavior of these synthesized products was studied, and compared to that of polymer blends of poly(sebacic anhydride) (PSA) and PEG. The crystallinity of PSA chain segments can be significantly enhanced by increasing chain mobility via the introduction of PEG. The crystallinity of the PSA component in copolymers was substantially greater than that of blends. However, the crystalline growth of the PEG segments was totally hindered by the presence of PSA chain segments, such that no crystal for PEG component was found in these copolymers. Besides, a dynamic mechanical analysis of these materials was also performed to provide additional information concerning visco-elastic behavior for other biomedical applications, where it was found that the viscous behavior in copolymers was more significant than in neat PSA and PEG. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 300, Taiwan.
RP Chu, IM (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 300, Taiwan.
CR Brus J, 2000, MACROMOLECULES, V33, P6448, DOI 10.1021/ma000533s
   Chan CK, 2002, BIOMATERIALS, V23, P2353, DOI 10.1016/S0142-9612(01)00370-2
   Chan CK, 2001, POLYMER, V42, P6823, DOI 10.1016/S0032-3861(01)00178-1
   Chen XH, 1997, MACROMOLECULES, V30, P4295, DOI 10.1021/ma970385e
   CHU PP, 1999, J POLYM SCI POL PHYS, V35, P1155
   DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217
   FENG HQ, 1993, MAKROMOL CHEM, V194, P2257
   Gan ZH, 1996, J APPL POLYM SCI, V59, P961, DOI 10.1002/(SICI)1097-4628(19960207)59:6<961::AID-APP8>3.0.CO;2-N
   Georgi U, 1997, J SOL-GEL SCI TECHN, V8, P507, DOI 10.1007/BF02436890
   Hanes J, 1996, MACROMOLECULES, V29, P5279, DOI 10.1021/ma960393f
   HARTMANN M, 1989, MAKROMOL CHEM, V190, P2133
   HATAKEYAMA, 1994, THERMAL ANAL FUNDAME, P117
   Hollinger J.O., 1995, BIOMEDICAL APPL SYNT
   HU DSG, 1994, J APPL POLYM SCI, V51, P473, DOI 10.1002/app.1994.070510310
   Huh KM, 1999, POLYMER, V40, P6147, DOI 10.1016/S0032-3861(98)00822-2
   Jiang HL, 1999, POLYM INT, V48, P47, DOI 10.1002/(SICI)1097-0126(199901)48:1<47::AID-PI107>3.0.CO;2-X
   Kim KS, 1999, J APPL POLYM SCI, V72, P341, DOI 10.1002/(SICI)1097-4628(19990418)72:3<341::AID-APP4>3.0.CO;2-D
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   MATHIOWITZ E, 1988, J APPL POLYM SCI, V35, P755, DOI 10.1002/app.1988.070350316
   Penning JP, 1996, MACROMOLECULES, V29, P77, DOI 10.1021/ma950651t
   PEPPAS NA, 1993, ADV POLYM SCI, V107
   SCHMIDT-ROHR K, 1992, MACROMOLECULES, V25, P3273, DOI 10.1021/ma00038a037
   UHRICH KE, 1995, MACROMOLECULES, V28, P2184, DOI 10.1021/ma00111a012
   WU MP, 1994, J BIOMED MATER RES, V28, P387, DOI 10.1002/jbm.820280314
NR 24
TC 23
Z9 25
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2003
VL 24
IS 1
BP 47
EP 54
AR PII S0142-9612(02)00242-9
DI 10.1016/S0142-9612(02)00242-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 615HW
UT WOS:000179240600006
PM 12417177
DA 2018-10-20
ER

PT J
AU Dong, ZL
   Khor, KA
   Quek, CH
   White, TJ
   Cheang, P
AF Dong, ZL
   Khor, KA
   Quek, CH
   White, TJ
   Cheang, P
TI TEM and STEM analysis on heat-treated and in vitro plasma-sprayed
   hydroxyapatite/Ti-6Al-4V composite coatings
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; Ti-6Al-4V alloy; composite; plasma spraying;
   transmission electron microscopy
ID CALCIUM-PHOSPHATE COATINGS; BIOMEDICAL APPLICATIONS; MICROSTRUCTURE;
   REINFORCEMENT; TITANIUM; AL2O3
AB A cogent understanding of the microstructure, and indeed nano-structure, of hydroxyapatite (HA) and the interface between Ti-6Al-4V and HA is crucial to its appropriateness as a biomaterials. This paper reports the analysis of plasma-sprayed HA/Ti-6Al-4V composites by transmission electron microscopy (TEM) and scanning transmission electron microscopy (STEM) to elucidate the intricate nature of the materials following plasma spray processing and in vitro evaluation. The novel Ti-6Al-4V/HA composite coating, with approximately 48 wt% HA, had demonstrated attractive tensile adhesion strength (similar to28 MPa) and improved Young's modulus (similar to55 GPa). Experimental results demonstrated that amorphous calcium phosphate and fine HA grains were formed during rapid splat solidification in the as-sprayed composite coatings. Small Ti-6Al-4V grains were observed adjacent to the amorphous calcium phosphate. The coatings were further heat treated at 600 C for 6h, and significant crystallisation of the amorphous calcium phosphate phase took place. However, complete crystallisation was not achieved at this temperature, as the coatings invariably contained a small amount of amorphous calcium phosphate phase in some local regions. After immersion in simulated body fluid for 2 weeks and 10 weeks, TEM and STEM confirmed that the interfaces inside the coating maintained good microstructural integrity. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
   IESE, Singapore 639798, Singapore.
   Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
RP Khor, KA (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Nanyang Ave, Singapore 639798, Singapore.
RI Khor, Khiam Aik/G-2827-2010; Dong, Zhili/A-2249-2011; Khor, Khiam Aik
   (Michael)/B-6929-2009; White, Tim/A-8145-2008
OI Dong, Zhili/0000-0001-8116-6747; White, Tim/0000-0002-4380-9403; KHOR,
   Khiam/0000-0003-1954-8423
CR BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   Chang E, 1997, J MATER SCI-MATER M, V8, P193, DOI 10.1023/A:1018583522322
   Choi JW, 1998, J AM CERAM SOC, V81, P1743
   Dasarathy H, 1996, J BIOMED MATER RES, V31, P81, DOI 10.1002/(SICI)1097-4636(199605)31:1<81::AID-JBM10>3.0.CO;2-P
   Haddow DB, 1998, J SOL-GEL SCI TECHN, V13, P261, DOI 10.1023/A:1008699421635
   HAMAN JD, 1995, J THERM SPRAY TECHN, V4, P179, DOI 10.1007/BF02646110
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HERO H, 1994, J BIOMED MATER RES, V28, P343, DOI 10.1002/jbm.820280308
   Jillavenkatesa A, 1998, J MATER SCI, V33, P4111, DOI 10.1023/A:1004436732282
   Khor KA, 1997, JOM-J MIN MET MAT S, V49, P51, DOI 10.1007/BF02915482
   Khor KA, 2000, MAT SCI ENG A-STRUCT, V281, P221, DOI 10.1016/S0921-5093(99)00717-0
   Kokubo T., 1990, HDB BIOACTIVE CERAMI, P41
   Kong YM, 1999, J AM CERAM SOC, V82, P2963
   Kyeck S., 1999, Materials Science Forum, V308-311, P368
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   ONG JL, 1991, J AM CERAM SOC, V74, P2301, DOI 10.1111/j.1151-2916.1991.tb08301.x
   QUEK CH, 1999, THESIS NANYANG TECHN
   RANZ X, 1998, P 15 INT THERM SPRAY, P1343
   Singh RK, 1996, MATER MANUF PROCESS, V11, P481, DOI 10.1080/10426919608947498
   UNAL O, 1990, J ELECTRON MICR TECH, V14, P307, DOI 10.1002/jemt.1060140404
   WANG BC, 1993, SURF COAT TECH, V58, P107, DOI 10.1016/0257-8972(93)90181-M
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   Yamashita K, 1996, J AM CERAM SOC, V79, P3313, DOI 10.1111/j.1151-2916.1996.tb08111.x
NR 23
TC 47
Z9 49
U1 3
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2003
VL 24
IS 1
BP 97
EP 105
AR PII S0142-9612(02)00267-3
DI 10.1016/S0142-9612(02)00267-3
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 615HW
UT WOS:000179240600012
PM 12417183
DA 2018-10-20
ER

PT J
AU Brevig, T
   Kruhne, U
   Kahn, RA
   Ahl, T
   Beyer, M
   Pedersen, LH
AF Brevig, T
   Kruhne, U
   Kahn, RA
   Ahl, T
   Beyer, M
   Pedersen, LH
TI Hydrodynamic guiding for addressing subsets of immobilized cells and
   molecules in microfluidic systems
SO BMC BIOTECHNOLOGY
LA English
DT Article
ID C-REACTIVE PROTEIN; RHEUMATOID-ARTHRITIS; SURFACES; CYTOKINE; DELIVERY;
   RISK
AB Background: The interest in microfluidics and surface patterning is increasing as the use of these technologies in diverse biomedical applications is substantiated. Controlled molecular and cellular surface patterning is a costly and time-consuming process. Methods for keeping multiple separate experimental conditions on a patterned area are, therefore, needed to amplify the amount of biological information that can be retrieved from a patterned surface area. We describe, in three examples of biomedical applications, how this can be achieved in an open microfluidic system, by hydrodynamically guiding sample fluid over biological molecules and living cells immobilized on a surface.
   Results: A microfluidic format of a standard assay for cell-membrane integrity showed a fast and dose-dependent toxicity of saponin on mammalian cells. A model of the interactions of human mononuclear leukocytes and endothelial cells was established. By contrast to static adhesion assays, cell-cell adhesion in this dynamic model depended on cytokine-mediated activation of both endothelial and blood cells. The microfluidic system allowed the use of unprocessed blood as sample material, and a specific and fast immunoassay for measuring the concentration of C-reactive protein in whole blood was demonstrated.
   Conclusion: The use of hydrodynamic guiding made multiple and dynamic experimental conditions on a small surface area possible. The ability to change the direction of flow and produce two-dimensional grids can increase the number of reactions per surface area even further. The described microfluidic system is widely applicable, and can take advantage of surfaces produced by current and future techniques for patterning in the micro- and nanometer scale.
C1 Inst Biotechnol, Dept Mol Characterizat, DK-2970 Horsholm, Denmark.
   CelTor Biosyst Inc, Windamere Venture Partners LLC, San Diego, CA 92130 USA.
RP Brevig, T (reprint author), Inst Biotechnol, Dept Mol Characterizat, Kogle Alle 2, DK-2970 Horsholm, Denmark.
EM tbr@bioteknologisk.dk; ulrich.kruhne@teknologisk.dk;
   rka@bioteknologisk.dk; thomas.ahl@visiopharm.com; mbe@nanonord.com;
   lap@bioteknologisk.dk
CR Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916
   Brody JP, 1996, BIOPHYS J, V71, P3430, DOI 10.1016/S0006-3495(96)79538-3
   Burghardt Robert C., 1994, P1231
   CARLOS T, 1991, BLOOD, V77, P2266
   CARLOS TM, 1990, IMMUNOL REV, V114, P5, DOI 10.1111/j.1600-065X.1990.tb00559.x
   Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297
   Chou HP, 1999, P NATL ACAD SCI USA, V96, P11, DOI 10.1073/pnas.96.1.11
   Christodoulides N, 2002, ANAL CHEM, V74, P3030, DOI 10.1021/ac011150a
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   de Ferranti S, 2002, CLIN CHIM ACTA, V317, P1, DOI 10.1016/S0009-8981(01)00797-5
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Fu AY, 1999, NAT BIOTECHNOL, V17, P1109
   HAMMARBACK JA, 1985, J NEUROSCI RES, V13, P213, DOI 10.1002/jnr.490130115
   Hodder PS, 1997, ANALYST, V122, P883, DOI 10.1039/a701750b
   Hofmann O, 2002, ANAL CHEM, V74, P5243, DOI 10.1021/ac025777k
   Horakova K, 1999, GEN PHYSIOL BIOPHYS, V18, P63
   KOCH AE, 1994, J CLIN INVEST, V93, P921, DOI 10.1172/JCI117097
   KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Patel N, 1998, FASEB J, V12, P1447
   Roberts WL, 2001, CLIN CHEM, V47, P418
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Schulte TH, 2002, CLIN CHIM ACTA, V321, P1, DOI 10.1016/S0009-8981(02)00093-1
   Sundberg S. A., 2000, DRUG DISCOV TODAY, V5, P92
   Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545
   Tarkkinen P, 2002, CLIN CHEM, V48, P269
   Yousaf MN, 2001, P NATL ACAD SCI USA, V98, P5992, DOI 10.1073/pnas.101112898
NR 27
TC 13
Z9 13
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND
SN 1472-6750
J9 BMC BIOTECHNOL
JI BMC Biotechnol.
PY 2003
VL 3
AR 10
DI 10.1186/1472-6750-3-10
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 763WX
UT WOS:000188124400010
PM 12875662
OA DOAJ Gold
DA 2018-10-20
ER

PT B
AU Pan, TR
   Zheng, W
   Lei, M
   Cavanagh, B
   Ziaie, B
AF Pan, TR
   Zheng, W
   Lei, M
   Cavanagh, B
   Ziaie, B
GP IEEE
   IEEE
TI A remotely adjustable check-valve array with an electrochemical release
   mechanism for implantable biomedical microsystems
SO BOSTON TRANSDUCERS'03: DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 12th International Conference on Solid-State Sensors, Actuators and
   Microsystems (TRANSDUCERS 03)
CY JUN 08-12, 2003
CL BOSTON, MA
SP IEEE, Elect Devices Soc
DE electrochemical release; implantable biomedical microsystem;
   microfluidics; microvalve
ID MEMS; RESIST; SU-8
AB In this paper, we present a remotely adjustable check-valve array with an electrochemical release mechanism for implantable biomedical microsystems. A SU-8 polymer layer deposited on the top of a gold sacrificial layer was used as the valve structural material. A constant DC current obtained via a telemetry link was used to electrochemically dissolve the gold sacrificial layer and activate the valves. 3x3 and 4x4 arrays each containing three different size valves (50x50, 100x100 and 200x200 pm) were fabricated and tested. A current density of 35 mA/cm(2) resulted in the dissolution of a 3000Angstrom gold sacrificial layer in 30 seconds with the final release completed in 1-2 minutes.
C1 Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA.
RP Pan, TR (reprint author), Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN 55455 USA.
EM tingrui@ece.umn.edu
CR Conradie EH, 2002, J MICROMECH MICROENG, V12, P368, DOI 10.1088/0960-1317/12/4/303
   Guerin L. J., 1997, P TRANSD 97 CHIC IL, P1419
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   LABIANCA N, 1995, P SOC PHOTO-OPT INS, V2438, P846, DOI 10.1117/12.210413
   Lorenz H, 1997, J MICROMECH MICROENG, V7, P121, DOI 10.1088/0960-1317/7/3/010
   Lorenz H, 1998, MICROELECTRON ENG, V42, P371, DOI 10.1016/S0167-9317(98)00086-0
   Low LM, 2000, SENSOR ACTUAT B-CHEM, V67, P149, DOI 10.1016/S0925-4005(00)00396-8
   PAN T, 2002, P EMBS BMES 2002 HOU
   Santini JT, 1999, NATURE, V397, P335
   Santini JT, 2000, ANGEW CHEM INT EDIT, V39, P2397
   Zhang JL, 2001, J UNIV SCI TECHNOL B, V8, P20
NR 11
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7731-1
PY 2003
BP 115
EP 118
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BX19B
UT WOS:000184567300029
DA 2018-10-20
ER

PT S
AU Kober, C
   Sader, R
   Zeilhofer, HF
AF Kober, C
   Sader, R
   Zeilhofer, HF
BE Lemke, HU
   Inamura, K
   Doi, K
   Vannier, MW
   Farman, AG
   Reiber, JHC
TI Segmentation and visualization of the inner structure of craniofacial
   hard tissue
SO CARS 2003: COMPUTER ASSISTED RADIOLOGY AND SURGERY, PROCEEDINGS
SE INTERNATIONAL CONGRESS SERIES
LA English
DT Proceedings Paper
CT 17th International Congress and Exhibition of Computer Assisted
   Radiology and Surgery
CY JUN 25-28, 2003
CL LONDON, ENGLAND
SP Amer Acad Oral & Maxillofacial Radiol, BAR, BIR, CRS, CURAC, DGBMT, DRG, EFSUMB, ESCR, ESEM, EuroPACS, Gesell Informatik, GMDS, IADMFR, IERAC, IEEE, Japanese Coll Radiol, Japan Radiol Soc, JSOMR, NVvR, Osterreich Rontgen Gesell, OWGTM, PMSR, Royal Coll Radiologists, Soc Francaise Radiol Med, SGR SSR, SICTCA, SIRM, SPIE, SRS, TUB, WABT
DE image segmentation; inner structure visualization; material anisotropy;
   inner skeleton; craniofacial hard tissue
AB In the biomedical context, image segmentation is the process of dividing an image into different subregions, usually different organs or tissue types. But mostly, the gray values of the inner voxels and, by this, the major part of the information remain unused. The purpose of this work is a new way of segmentation and visualization of these voxels. Concerning treatment planning for clinical cases, we deliver a macroscopic view of bone respective tissue quality. For the simulation branch, we contribute to an improved individual inhomogencous and anisotropic description of the material law. (C) 2003 Published by Elsevier Science B.V.
C1 Univ Appl Sci Osnabruck, Dept Mech Engn, D-49009 Osnabruck, Germany.
RP Kober, C (reprint author), Univ Appl Sci Osnabruck, Dept Mech Engn, Albrechtstr 30, D-49009 Osnabruck, Germany.
EM c.kober@fh-osnabrueck.de; rsader@uhbs.ch; hfzeilhofer@uhbs.ch
CR *AM, AM US GUID AM REF MA
   *NAT LIBR MED, 1995, VIS HUM PROJ
   Stalling D, 1998, INT CONGR SER, V1165, P137
NR 3
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0531-5131
BN 0-444-51387-6
J9 INT CONGR SER
JI Int. Congr. Ser.
PY 2003
VL 1256
BP 1257
EP 1262
DI 10.1016/S0531-5131(03)00367-4
PG 6
WC Computer Science, Interdisciplinary Applications; Radiology, Nuclear
   Medicine & Medical Imaging; Surgery
SC Computer Science; Radiology, Nuclear Medicine & Medical Imaging; Surgery
GA BX53F
UT WOS:000185617600192
DA 2018-10-20
ER

PT J
AU Yue, DM
   Yu, J
   Zhang, Q
   Zhang, LQ
AF Yue, DM
   Yu, J
   Zhang, Q
   Zhang, LQ
TI Preparation of nano-porous materials(I) by polymerization of amphiphile
   self-assemblies
SO CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
LA English
DT Review
DE polymerization; amphiphile; self-assembly; nano-porous material;
   lyotropic liquid crystalline
ID LIQUID-CRYSTALLINE PHASES; BINARY SURFACTANT/WATER SYSTEMS; IN-SITU
   POLYMERIZATION; ACRYLATE-ACRYLIC-ACID; HETEROPHASE POLYMERIZATION;
   EMULSION POLYMERIZATION; REACTIVE SURFACTANTS; 2-DIMENSIONAL
   POLYMERIZATION; LIPID BILAYERS; CYTOMIMETIC BIOMATERIALS
AB The polymerization of amphiphilic self-assemblies is a promising method to synthesize nano-structured materials with novel properties. These materials have many attractive features for their application in biomedical area and materials science, such as catalysis, separation, surface modification, and therapeutics areas. A general review on the polymerization of lipids and surfactant self-assemblies to amphiphilic self-assemblies is given in this paper with 49 references. The polymerization and the subsequently resulted structure of lipids in different morphologies are summarized. The polymerization of polymerizable surfactants (surfmers) in emulsion and liquid crystalline phases are also discussed. The potential application of new nano-porous materials is briefly described.
C1 Case Western Reserve Univ, Cleveland, OH 44106 USA.
   Beijing Univ Chem Technol, Coll Mat Sci & Engn, Beijing 100029, Peoples R China.
RI zhang, liqun/S-7337-2016
OI zhang, liqun/0000-0003-0291-4351
CR ANDERSON DM, 1991, PHYSICA A, V176, P151, DOI 10.1016/0378-4371(91)90438-I
   ANDERSON DM, 1989, ACS S SER, V384, P204
   Antonietti M, 1999, MACROMOLECULES, V32, P1383, DOI 10.1021/ma9812478
   ANTONIETTI M, 1997, ANGEW CHEM INT EDIT, V36, P911
   AVEI D, 1999, POLYM PREP-ACS, V40, P784
   BRUCE AA, 1996, ADV POLYM SCI, V126, P54
   BURN PL, 1992, NATURE, V356, P47, DOI 10.1038/356047a0
   CHOUBAL M, 1989, J POLYM SCI POL CHEM, V27, P1873, DOI 10.1002/pola.1989.080270608
   COCHIN D, 1993, MACROMOLECULES, V26, P5765, DOI 10.1021/ma00073a034
   Cox JK, 1999, CURR OPIN COLLOID IN, V4, P52, DOI 10.1016/S1359-0294(99)00004-7
   DENTON JM, 1993, J PHYS CHEM-US, V97, P756, DOI 10.1021/j100105a037
   Dreja M, 1996, MACROMOL RAPID COMM, V17, P825, DOI 10.1002/marc.1996.030171110
   EVANS DF, 1997, COLLOIDAL DOMAIN PHY
   FERGUSON P, 1993, POLYMER, V34, P3281, DOI 10.1016/0032-3861(93)90403-W
   Guyot A, 1996, CURR OPIN COLLOID IN, V1, P580, DOI 10.1016/S1359-0294(96)80095-1
   GUYOT A, 1994, ADV POLYM SCI, V111, P45
   Hide F, 1996, CHEM PHYS LETT, V256, P424, DOI 10.1016/0009-2614(96)00450-2
   HOLMBERG K, 1992, PROG ORG COAT, V20, P325, DOI 10.1016/0033-0655(92)80022-O
   LAMPARSKI H, 1995, MACROMOLECULES, V28, P1786, DOI 10.1021/ma00110a010
   LEE YS, 1995, J AM CHEM SOC, V117, P5573, DOI 10.1021/ja00125a019
   LEI JT, 1994, MACROMOLECULES, V27, P1381, DOI 10.1021/ma00084a016
   Li F, 1999, J POLYM SCI POL CHEM, V37, P2863
   MARKOWITZ MA, 1994, ACS SYM SER, V556, P264
   MARKOWITZ MA, 1994, BIOCHEM BIOPH RES CO, V203, P296, DOI 10.1006/bbrc.1994.2181
   Marra KG, 1997, LANGMUIR, V13, P5697, DOI 10.1021/la970473s
   Marra KG, 1997, MACROMOLECULES, V30, P6483, DOI 10.1021/ma970481f
   McGrath KM, 1996, COLLOID POLYM SCI, V274, P316, DOI 10.1007/BF00654052
   McGrath KM, 1996, COLLOID POLYM SCI, V274, P612, DOI 10.1007/BF00653057
   McGrath KM, 1996, COLLOID POLYM SCI, V274, P499, DOI 10.1007/BF00655224
   McGrath KM, 1996, COLLOID POLYM SCI, V274, P399, DOI 10.1007/BF00652461
   MEIER H, 1994, MACROMOLECULES, V27, P7581, DOI 10.1021/ma00104a012
   O'Brien DF, 1998, ACCOUNTS CHEM RES, V31, P861, DOI 10.1021/ar970140m
   PALCOS CM, 1992, POLYM ORGANIZED MEDI, P283
   Ravoo BJ, 1996, LANGMUIR, V12, P5773, DOI 10.1021/la960322+
   REGEN SL, 1982, J AM CHEM SOC, V104, P791, DOI 10.1021/ja00367a023
   SADOWNIK A, 1986, J AM CHEM SOC, V108, P7789, DOI 10.1021/ja00284a050
   Schoonbrood HAS, 1997, J POLYM SCI POL CHEM, V35, P2561, DOI 10.1002/(SICI)1099-0518(19970930)35:13<2561::AID-POLA3>3.0.CO;2-U
   Schoonbrood HAS, 1997, MACROMOLECULES, V30, P6034, DOI 10.1021/ma9701494
   Schoonbrood HAS, 1997, MACROMOLECULES, V30, P6024, DOI 10.1021/ma9701447
   SELLS TD, 1994, MACROMOLECULES, V27, P226, DOI 10.1021/ma00079a034
   Sisson TM, 1996, MACROMOLECULES, V29, P8321, DOI 10.1021/ma961104q
   Smith RC, 1997, J AM CHEM SOC, V119, P4092, DOI 10.1021/ja963837w
   Spontak RJ, 1999, CURR OPIN COLLOID IN, V4, P140, DOI 10.1016/S1359-0294(99)00023-0
   Srisiri W, 1997, J AM CHEM SOC, V119, P4866, DOI 10.1021/ja970052x
   Srisiri W, 1998, LANGMUIR, V14, P1921, DOI 10.1021/la970897m
   Svenson S, 1999, LANGMUIR, V15, P4464, DOI 10.1021/la981690b
   TATE MW, 1989, BIOCHEMISTRY-US, V28, P4245, DOI 10.1021/bi00436a019
   TIEKE B, 1992, POLYM ORG MEDIA, P105
   Unzue MJ, 1997, J APPL POLYM SCI, V66, P1803, DOI 10.1002/(SICI)1097-4628(19971128)66:9<1803::AID-APP20>3.0.CO;2-U
NR 49
TC 1
Z9 4
U1 1
U2 10
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 1005-9040
EI 2210-3171
J9 CHEM RES CHINESE U
JI Chem. Res. Chin. Univ.
PD JAN
PY 2003
VL 19
IS 1
BP 112
EP 119
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 673NF
UT WOS:000182586500024
DA 2018-10-20
ER

PT S
AU Morgner, U
   Wagenblast, P
   Ell, R
   Seitz, W
   Ippen, EP
   Fujimoto, JG
   Kartner, FX
AF Morgner, U
   Wagenblast, P
   Ell, R
   Seitz, W
   Ippen, EP
   Fujimoto, JG
   Kartner, FX
BE Neev, J
   Ostendorf, A
   Schaffer, CB
TI Broadband laser light sources for commercial and biomedical applications
SO COMMERCIAL AND BIOMEDICAL APPLICATIONS OF ULTRAFAST LASERS III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Commercial and Biomedical Applications of Ultrafast Lasers
   III
CY JAN 28-30, 2003
CL SAN JOSE, CA
SP SPIE, Clark MRX, Coherent, IMRA Amer Inc, Spectra Phys, Positive Light Inc
DE broadband laser oscillators; femtosecond laser pulses; optical coherence
   tomography
ID OPTICAL COHERENCE TOMOGRAPHY; DOUBLE-CHIRPED MIRRORS; TI-SAPPHIRE LASER;
   MULTILAYER INTERFERENCE COATINGS; PULSES; GENERATION; SPECTRA
AB Novel optical components enable the generation of the shortest pulses and broadest spectra from Kerr-Lens mode-locked laser oscillators without extracavity spectral broadening, namely 20-fs-pulses from Cr4+:YAG around 1.5 mum, 14-fs-pulses from Cr:forsterite around 1.3 mum, 5-fs-pulses from Ti:sapphire around 0.8 mum, and 10-fs-Pulses from Cr3+:LiCAF around 0.8 mum. Key components are well adapted phase correcting mirrors ("double-chirped mirrors") which allow for high reflectivity and dispersion compensation in bandwidths up to one octave.
   In parallel to the development of new broadband light sources based on femtosecond technology micron resolution imaging with Optical Coherence Tomography using theses sources has been achieved. The availability of the high resolution OCT technology for future clinical applications will depend on the development of low cost, compact sources of ultrabroad bandwidth light. Especially Cr3+:LiCAF is a very promising material for femtosecond laser sources as compact replacements for Ti:sapphire oscillators because of its low quantum defect, a broadband emission range around 800 nm, and an absorption band in a spectral range where high-brightness laser diodes are available.
C1 Max Planck Inst Kernphys, D-69117 Heidelberg, Germany.
RP Morgner, U (reprint author), Max Planck Inst Kernphys, D-69117 Heidelberg, Germany.
RI Morgner, Uwe/U-9155-2017
OI Morgner, Uwe/0000-0001-5103-9632
CR Chen Y, 1999, J OPT SOC AM B, V16, P1999, DOI 10.1364/JOSAB.16.001999
   Chudoba C, 2001, OPT LETT, V26, P292, DOI 10.1364/OL.26.000292
   Drexler W, 1999, OPT LETT, V24, P1221, DOI 10.1364/OL.24.001221
   Drexler W, 2001, NAT MED, V7, P502, DOI 10.1038/86589
   Ell R, 2001, OPT LETT, V26, P373, DOI 10.1364/OL.26.000373
   Fujimoto JG, 2000, OPT PHOTONICS NEWS, V11, P24, DOI 10.1364/OPN.11.1.000024
   Gabel KM, 1998, OPT COMMUN, V157, P327, DOI 10.1016/S0030-4018(98)00526-4
   Isemann A, 2002, APPL PHYS B-LASERS O, V74, P299, DOI 10.1007/s003400200820
   Kartner FX, 1997, OPT LETT, V22, P831, DOI 10.1364/OL.22.000831
   Kartner FX, 2001, J OPT SOC AM B, V18, P882, DOI 10.1364/JOSAB.18.000882
   Matuschek N, 2000, APPL PHYS B-LASERS O, V71, P509, DOI 10.1007/s003400000426
   Matuschek N, 1998, IEEE J SEL TOP QUANT, V4, P197, DOI 10.1109/2944.686724
   Matuschek N, 1997, IEEE J QUANTUM ELECT, V33, P295, DOI 10.1109/3.555995
   Matuschek N, 2000, APPL OPTICS, V39, P1626, DOI 10.1364/AO.39.001626
   Morgner U, 2000, OPT LETT, V25, P111, DOI 10.1364/OL.25.000111
   Morgner U, 1999, OPT LETT, V24, P411, DOI 10.1364/OL.24.000411
   Povazay B, 2002, OPT LETT, V27, P1800, DOI 10.1364/OL.27.001800
   RIPIN DJ, 2001, OPT LETT, V26, P61
   Sutter DH, 1999, OPT LETT, V24, P631, DOI 10.1364/OL.24.000631
   SZIPOCS R, 1994, OPT LETT, V19, P201, DOI 10.1364/OL.19.000201
   UEMURA S, 2002, CLEO TECHNICAL DIGES, pCME6
   Wagenblast PC, 2002, OPT LETT, V27, P1726, DOI 10.1364/OL.27.001726
NR 22
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4778-1
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4978
BP 32
EP 37
DI 10.1117/12.478581
PG 6
WC Engineering, Biomedical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BX22Q
UT WOS:000184695400004
DA 2018-10-20
ER

PT S
AU Ozono, K
   Obara, M
   Sakuma, J
AF Ozono, K
   Obara, M
   Sakuma, J
BE Neev, J
   Ostendorf, A
   Schaffer, CB
TI Ablation processing of biomedical materials by ultrashort laser pulse
   ranging from 50 fs through 2 ps
SO COMMERCIAL AND BIOMEDICAL APPLICATIONS OF ULTRAFAST LASERS III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Commercial and Biomedical Applications of Ultrafast Lasers
   III
CY JAN 28-30, 2003
CL SAN JOSE, CA
SP SPIE, Clark MRX, Coherent, IMRA Amer Inc, Spectra Phys, Positive Light Inc
DE femtosecond laser; hydroxyapatite; human tooth; ferntosecond laser
   ablation; hard tissues
ID ER-YAG LASER; HARD-TISSUE ABLATION; FEMTOSECOND; FIBERS
AB In recent years, femtosecond laser processing of human hard/soft tissues has been studied. Here, we have demonstratedablation etching of hydroxyapatite. Hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) is a key component of human tooth and human bone. The human bone is mainly made of hydroxyapatite oriented along the collagen. The micromachining of hydroxyapatite is highly required for orthopedics and dentistry. The important issue is to preserve the chemical property of the ablated surface. If chemical properties of hydroxyapatite change once, the human bone or tooth cannot grow again after laser processing. As for nanosecond laser ablation (for example excimer laser ablation), the relative content of calcium and phosphorus in (Ca-10(PO4)(6)(OH)(2)) is found to change after laser ablation. We used here pulsewidth tunable output from 50 fs through 2 ps at 820 nm and 1 kpps. We measured calcium spectrum and phosphorus spectrum of the ablated surface of hydroxyapatite by XPS. As a result, the chemical content of calcium and phosphorus is kept unchanged before and after 50-fs - 2-ps laser ablation. We also demonstrated ablation processing of human tooth with Ti:sapphire laser, and precise ablation processing and microstructure fabrication. are realized.
C1 Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
RP Ozono, K (reprint author), Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
CR Chaiyavej S, 2000, LASER SURG MED, V27, P341, DOI 10.1002/1096-9101(2000)27:4<341::AID-LSM7>3.0.CO;2-S
   Hirayama Y, 2001, J APPL PHYS, V90, P6447, DOI 10.1063/1.1415066
   Junbiao Z, 2001, NUCL INSTRUM METH A, V475, P630
   KANAI M, 2002, APLS 2002 SEPT 17 20
   KANAI M, 2003, LASE 2003 JAN 25 31
   KRUEGER J, 1999, APPL PHYS A, V69, pS403
   Majaron B, 1998, APPL PHYS B-LASERS O, V66, P479, DOI 10.1007/s003400050423
   Matsuura Y, 2002, J APPL PHYS, V91, P887, DOI 10.1063/1.1425070
   Neev J, 1996, IEEE J SEL TOP QUANT, V2, P790, DOI 10.1109/2944.577301
   NEWESELY H, 1972, MECH ACTION TRACE EL
   Niemz M, 1996, LASER TISSUE INTERAC
   Ozono K, 2001, OPT COMMUN, V189, P103, DOI 10.1016/S0030-4018(01)01002-1
   Perry MD, 1999, J APPL PHYS, V85, P6803, DOI 10.1063/1.370197
   Sasaki KM, 2002, LASER SURG MED, V31, P79, DOI 10.1002/lsm.10074
   Stanislawki M, 2001, APPL PHYS B-LASERS O, V72, P115, DOI 10.1007/s003400000517
   TANAKA J, 1999, J SURFACE SCI SOC JA, V20, P600
NR 16
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4778-1
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4978
BP 208
EP 213
DI 10.1117/12.478589
PG 6
WC Engineering, Biomedical; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BX22Q
UT WOS:000184695400023
DA 2018-10-20
ER

PT J
AU Coffey, AB
   Brazier, A
   Tierney, M
   Gately, AG
   O'Bradaigh, CM
AF Coffey, AB
   Brazier, A
   Tierney, M
   Gately, AG
   O'Bradaigh, CM
TI Development of thin-walled fibre-reinforced structures for medical
   applications
SO COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING
LA English
DT Article; Proceedings Paper
CT International Conference for Manufacturing of Advanced Composites
CY SEP 26-27, 2001
CL BELFAST, NORTH IRELAND
DE aramid fibre; tape; adhesion
ID COMPOSITES
AB There is a need in biomedical engineering for thin-walled, high-performance structures, which could be used as catheters, or as replacement implants in the body. This paper investigates the basic issues associated with filament winding of thin-walled structures, in which an ultra-thin layer (<0.05 mm) reinforcing material is wound onto a polymer tube. Current techniques such as over-braiding of stainless steel and carbon fibre have difficulties producing a wall thickness below about 0.1 mm with high volume fractions. This process will involve filament winding of thin layers of aramid with polymer matrices. These layers are wound onto a continuously moving extruded inner polymer core and the wound structure will be over-coated using over-extrusion and dipping techniques. The adhesion between the fibre and matrix will be investigated. The objective is to produce high-performance thin-walled polymer structures whose properties are designed, or tailored to the particular application. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Athlone Inst Technol, Athlone, Ireland.
   Natl Univ Ireland Univ Coll Galway, Composite Res Unit, Galway, Ireland.
RP Coffey, AB (reprint author), Athlone Inst Technol, Athlone, Ireland.
RI O Bradaigh, Conchur/G-5347-2013
OI O Bradaigh, Conchur/0000-0002-8048-4222
CR BRINKMAN RD, 1993, SPE ANTEL P MAY
   BURTON RH, 1986, MECHANICAL PROPERTIE, P269
   EDULA M, 1989, J THERMOPLAST COMPOS, V2, P154
   FUJITA A, 1993, J REINF PLAST COMP, V12, P156, DOI 10.1177/073168449301200203
   GOTO A, 1995, T JAPAN SOC MECH ENG, V61, P50
   GUPTA SKA, 1998, POLYM-PLAST TECHNOL, V37, P201
   KOENIG MF, 1994, POLYM DEGRAD STABIL, V45, P139, DOI 10.1016/0141-3910(94)90189-9
   Koleske J. V., 1978, POLYM BLENDS, V2, P369
   KUMAMARU F, 1983, POLYM COMPOSITE, V4, P141, DOI 10.1002/pc.750040210
   KWEI TK, 1967, J APPL PHYS, V38, P2512, DOI 10.1063/1.1709938
   Lelah M. D., 1986, POLYURETHANES MED
   MASOUKA S, 1968, J POLYM SCI POL LETT, V6, P87
   MENG H, 1995, RUBBRE COMPOS PROCES, V23
   NEITZEL M, 1995, P 4 JAP INT AMPE S, P136
   RUSSELL JC, Patent No. 9416748
   Sala G, 1996, COMPOS PART A-APPL S, V27, P387, DOI 10.1016/1359-835X(95)00035-Z
   SCHUMER G, 1996, J THERMOPLAST COMPOS, V9, P237
   WAN TY, 1997, BULK SURFACE PHOTO G, V1, P111
   YOSIMITSU Y, 1995, P 4 JAP INT SAMPE S, P147
   1997, MEDT P AMST 21 OCT
NR 20
TC 2
Z9 3
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-835X
J9 COMPOS PART A-APPL S
JI Compos. Pt. A-Appl. Sci. Manuf.
PY 2003
VL 34
IS 6
BP 535
EP 542
DI 10.1016/S1359-835X(03)00062-9
PG 8
WC Engineering, Manufacturing; Materials Science, Composites
SC Engineering; Materials Science
GA 688KT
UT WOS:000183434500009
DA 2018-10-20
ER

PT J
AU Abu Bakar, MS
   Cheang, P
   Khor, KA
AF Abu Bakar, MS
   Cheang, P
   Khor, KA
TI Mechanical properties of injection molded
   hydroxyapatite-polyetheretherketone biocomposites
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Conference on Materials for Advanced Technologies
   (ICMAT2001)
CY JUL 01-06, 2001
CL SINGAPORE, SINGAPORE
SP Mat Res Soc
DE mechanical properties; injection molding; biocomposites
ID POLYETHYLENE COMPOSITES; BEHAVIOR
AB Bioactive composites comprising synthetic hydroxyapatite (HA) particulate and semi-crystalline polyetheretherketone (PEEK) polymer were produced for biomedical application. HA particulates were incorporated into PEEK polymer matrix through a series of processing stages involving melt compounding, granulating and injection molding. This investigation presents the processing route employed and the mechanical properties of HA-PEEK composites. In general, Young's modulus, compressive strength and micro indentation hardness increased with increasing amount of HA particulate. On the other hand, tensile strength and strain to failure decreased with increasing HA loading. The tensile strength and Young's modulus of HA-PEEK composites were found to be within the bounds of bony tissue. These results suggest that the bioactive HA-PEEK composites have the potential for use as an alternative material for load-bearing orthopedic application. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Nanyang Technol Univ, Adv Mat Res Ctr, Biomed Engn Res Ctr, Singapore 639798, Singapore.
RP Abu Bakar, MS (reprint author), Nanyang Technol Univ, Adv Mat Res Ctr, Biomed Engn Res Ctr, Nanyang Ave, Singapore 639798, Singapore.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR ABUBAKAR MS, 1999, P 1 INT S THERM PROP, P289
   ABUBAKAR MS, 1999, THESIS NANYANG TU
   ABUBAKAR MS, 1999, J MATER PROCESS TECH, V89, P462
   AKAY M, 1992, ADV COMPOS LETT, V1, P74
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   COGSWELL FN, 1992, PLAST RUB COMPOS PRO, V18, P249
   Corvelli A.A., 1997, J ADV MAT, P2
   EVANS GP, 1990, J MATER SCI-MATER M, V1, P38, DOI 10.1007/BF00705352
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   George J, 1996, POLYMER, V37, P5421, DOI 10.1016/S0032-3861(96)00386-2
   Lawson AC, 1998, P I MECH ENG H, V212, P413, DOI 10.1243/0954411981534187
   SARASUA JR, 1995, J MATER SCI, V30, P3501, DOI 10.1007/BF00349901
   Sim CP, 1997, J MATER PROCESS TECH, V69, P75, DOI 10.1016/S0924-0136(96)00044-1
   *VICTR PLC, PEEK TECHN LIT
   WANG M, 1994, BRIT CERAM T, V93, P91
NR 15
TC 66
Z9 66
U1 5
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PY 2003
VL 63
IS 3-4
BP 421
EP 425
AR PII S0266-3538(02)00230-0
DI 10.1016/S0266-3538(02)00230-0
PG 5
WC Materials Science, Composites
SC Materials Science
GA 645WZ
UT WOS:000181004600010
DA 2018-10-20
ER

PT B
AU McGeough, JA
   Ebeid, SJ
   Fahmy, RT
   Habib, SS
AF McGeough, JA
   Ebeid, SJ
   Fahmy, RT
   Habib, SS
BE McGeough, JA
TI Ultrasonic precision cutting
SO COMPUTER-AIDED PRODUCTION ENGINEERING
LA English
DT Proceedings Paper
CT 18th International Conference on Computer-aided Production Engineering
   (CAPE 2003)
CY MAR 18-19, 2003
CL UNIV EDINBURGH, EDINBURGH, SCOTLAND
HO UNIV EDINBURGH
AB Ultrasonic machining processes have attained a recognized status in manufacturing. USM can be used successfully for cutting of precise components. USM has solved many problems for the medical, aerospace, electronics and automotive industries. Various processes are able to be combined in rotary ultrasonic machining where, the machining efficiency could be increased. New methods for grinding ceramics and hard materials by using non-rotational tools have been developed.
   The objective of the present paper is to highlight the state-of-the art of hybrid and recent USM processes. Moreover, the paper summarizes the latest technologies regarding precision cutting and ultrasonic assistance for medical applications. Ultrasonic precision cutting proves to be promising in the micro machining field as well as in biomedical applications and it looks to be a beneficial tool in the coming era of nano-technology.
C1 Univ Edinburgh, Div Engn, Edinburgh EH8 9YL, Midlothian, Scotland.
RP McGeough, JA (reprint author), Univ Edinburgh, Div Engn, Edinburgh EH8 9YL, Midlothian, Scotland.
CR BENKIRANE Y, 1999, ANN CIRP, V481, P135
   COULSON A, 1999, USE HARMONIC SCALPEL
   DROBINSKI D, 1997, Patent No. 5649935
   DROBINSKI D, 1993, J INT CARDIOLOGY, V62, P157
   EGASHIRA K, 1999, ANN CIRP, V48, P131
   GUO ZN, 1997, J MATER PROCESS TECH, P63823
   JANA JK, 1973, J INS ENG, V54, P36
   KHAIRY ABE, 1990, WEAR, V137, P187, DOI 10.1016/0043-1648(90)90135-W
   KOMARAIAH M, 1993, INT J MACH TOOL MANU, V33, P495, DOI 10.1016/0890-6955(93)90055-Y
   KREMER D, 1983, EL P 7 INT S BIRM UK, P67
   LAU WS, 1994, ANN CIRP, V431, P177
   Markov A. I., 1977, Machines and Tooling, V48, P45
   McGeough JA., 2002, MICROMACHINING ENG M
   MCGEOUGH JA, 1988, ADV METHODS MACHINGI
   MORIWAKI T, 1995, ANN CIRP, V44, P31, DOI DOI 10.1016/S0007-8506(07)62269-0
   MULT HC, 1996, J MATER PROCESS TECH, P62287
   NEILSON RD, 1993, MACH VIBR, V2, P136
   PANDEY PC, 1992, PRODUCTION ENG SCI
   RAMU BLA, 1989, J MECH WORK TECHNOL, V20, P365
   Shamoto E., 1999, ANN CIRP, V48, P441
   SOUNDARARAJAN V, 1986, INT J MACH TOOL MANU, V26, P307, DOI 10.1016/0020-7357(86)90008-9
   Suzuki K., 1993, ANN CIRP, V42, P375
   THOE TB, 1999, J MAT P TECH
   VENKATESH VC, 1983, J MECH WORK TECH, P8247
   WIERCIGROCH M, 1993, MACH VIBR, V2, P187
   YUE TM, 1996, ANN CIRP, V451, P169
   Zhang QH, 1999, J MATER PROCESS TECH, V88, P180, DOI 10.1016/S0924-0136(98)00400-2
   ZHAO J, 2000, INT J MACH TOOL MANU, P40795
NR 28
TC 0
Z9 0
U1 0
U2 0
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
BN 1-86058-404-7
PY 2003
BP 349
EP 356
PG 8
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Industrial; Engineering, Manufacturing
SC Computer Science; Engineering
GA BW43E
UT WOS:000181965800034
DA 2018-10-20
ER

PT J
AU Blackwood, DJ
AF Blackwood, DJ
TI Biomaterials: Past successes and future problems
SO CORROSION REVIEWS
LA English
DT Article
DE biomedical applications; surgical implants; dental amalgams
ID SHAPE-MEMORY ALLOYS; CORROSION BEHAVIOR; SURGICAL IMPLANTS; POROUS
   TITANIUM; PITTING CORROSION; STAINLESS-STEELS; DENTAL AMALGAM;
   CASE-HISTORIES; RESISTANCE; NICKEL
AB The practice of using metals and alloys to repair or replace human body parts is now well established. This paper will briefly review the successes and, in reality, the remarkably few failures of the traditional materials mainly titanium alloys, cobalt-chrome alloys, amalgams and stainless steels. The paper will then concentrate on the problems likely to be encountered before new advanced, but not necessarily corrosion resistant, materials can be successfully used for in-vivo purposes. Two of the most important parameters in determining the suitability of a material for biomedical applications are its biocompatibility and corrosion resistance. With regard to these two parameters pure titanium appears to be almost the perfect biomaterial. Unfortunately, many surgical and-dental applications require materials with specific mechanical properties, such as high strength or ductility, which pure titanium is unable to provide. Hence materials such as the Ti6Al4V alloy and 316L stainless steels are used despite their poorer corrosion resistance, occasionally with undesirable consequences. Furthermore, there is a desire to make use of a number of advanced materials, such as: memory-shaped alloys, porous materials and composites, low precious metal amalgams and rare earth magnets. Unfortunately, nearly all of these materials have inadequate corrosion resistances to be used directly in-vivo without some form of protection. However, it is obvious that most of the traditional techniques for reducing corrosion rates, such as controlling the environment and cathodic protection, cannot be applied to biomaterials, even coatings are of only limited use since many orthopaedic and dental devices are subjected to wearing and abrasion processes. As a result it has traditionally been considered that the only successful method of reducing corrosion within the human body is to fabricate the implants from a corrosion resistant alloy. However, although this approach may eventually be successful in some areas, for example it may be possible to. use alloying additions to design a highly corrosion resistant memory-shape alloy; it is highly unlikely that such an approach will be successful with respect to rare earth magnets. One challenge therefore appears to be to design biocompatible coatings that can resist both the chemical and mechanical environments, which are often poorly defined for both orthopaedic and dental applications, without degrading the very property that is required in the advance material. Potential examples of these applications are hydroxyapatite (HA) coatings on porous titanium, titanium or titanium nitride films on Ni-Ti memory-shaped alloys and very high chromium ferritic stainless steel claddings, on rare earth magnets.
C1 Natl Univ Singapore, Dept Mat Sci, Singapore 119260, Singapore.
RP Blackwood, DJ (reprint author), Natl Univ Singapore, Dept Mat Sci, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
RI Blackwood, Daniel/F-4289-2011
OI Blackwood, Daniel/0000-0002-4897-3536
CR BANOCZY J, 1979, ORAL SURG ORAL MED O, V48, P319, DOI 10.1016/0030-4220(79)90031-8
   BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9
   Bechtol C. O., 1975, ORTHOP REV, V4, P23
   Becker BS, 1995, POWDER METALL, V38, P305, DOI 10.1179/pom.1995.38.4.305
   Blackwood DJ, 2002, CORROS SCI, V44, P395, DOI 10.1016/S0010-938X(01)00080-4
   Blackwood DJ, 2000, CORROS SCI, V42, P481, DOI 10.1016/S0010-938X(99)00103-1
   BLACKWOOD DJ, 1988, ELECTROCHIM ACTA, V33, P1143, DOI 10.1016/0013-4686(88)80206-8
   Blackwood DJ, 2001, J MAGN MAGN MATER, V223, P103, DOI 10.1016/S0304-8853(00)00716-2
   BLACKWOOD DJ, 2002, P 15 INT CORR C GRAN
   BRANSDEN AS, 1990, J MOD OPTIC, V37, P813, DOI 10.1080/09500349014550871
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P355, DOI 10.1002/jbm.820210308
   Bundy K. J., 1985, ASTM STP, V859, P73
   Cahoon J R, 1968, J Biomed Mater Res, V2, P1, DOI 10.1002/jbm.820020102
   CHEW BR, 2002, THESIS NATL U SINGAP
   Ciolac S, 2000, REV CHIM-BUCHAREST, V51, P36
   Clerc CO, 1997, J BIOMED MATER RES, V38, P229, DOI 10.1002/(SICI)1097-4636(199723)38:3<229::AID-JBM7>3.0.CO;2-R
   CURTIS RV, 1992, DENT MATER, V8, P240
   Disegi JA, 1999, AM SOC TEST MATER, V1361, P49, DOI 10.1520/STP12373S
   Disegi JA, 1997, SO BIOMM ENGN CONF P, P129, DOI 10.1109/SBEC.1997.583231
   EDWARDS BJ, 1985, ATSM STP, V859, P11
   Eley BM, 1997, BRIT DENT J, V182, P247, DOI 10.1038/sj.bdj.4809360
   Endo K., 1998, ZAIRYO TO KANKYO, V47, P570
   Fontana M. G., 1987, CORROSION ENG
   Frangini S, 2001, MATER CORROS, V52, P372, DOI 10.1002/1521-4176(200105)52:5<372::AID-MACO372>3.0.CO;2-O
   FUSAYAMA T, 1963, J DENT RES, V42, P1183, DOI 10.1177/00220345630420051301
   GALANTE J, 1972, CLIN ORTHOP RELAT R, P237
   Gil FX, 1996, J MATER SCI-MATER M, V7, P403, DOI 10.1007/BF00122008
   GREEN ND, 1985, ATSM STP, V859, P5
   Hayashi K, 1999, BIOMATERIALS, V20, P111, DOI 10.1016/S0142-9612(98)00011-8
   HEINTZ C, 2001, CHIR FORUM EXP KLIN, P483
   HILLE GH, 1966, J MATER, V1, P373
   Hubler R, 1999, SURF COAT TECH, V116, P1111, DOI 10.1016/S0257-8972(99)00221-2
   Hughes A. N., 1978, Engineering in Medicine, V7, P135
   JACKSONBURROWS H, 1975, J BONE JT SURG     B, V57, P148
   Jedwab J, 1974, Acta Orthop Belg, V40, P877
   Jones DA., 1996, PRINCIPLES PREVENTIO
   JOSKA L, 2002, P 15 INT CORR C GRAN
   JOYSTONBECHAL S, 1994, DENTAL UPDATE, P366
   Kenny ED, 1999, SURFACE ENG, V15, P415, DOI 10.1179/026708499101516812
   Kondo S, 2000, JPN J APPL PHYS 1, V39, P6216, DOI 10.1143/JJAP.39.6216
   LECLERC MF, 1994, CORROSION, V1, P2
   Lemons JE, 1998, SURF COAT TECH, V104, P135
   Liang P. G., 1973, ORTHOP CLIN N AM, V4, P249
   LUCAS LC, 1982, J BIOMED MATER RES, V16, P799, DOI 10.1002/jbm.820160606
   Lund J.W.G., 1982, Progress phycol. Res., V1, P1
   Makjanic J, 1998, NEUROSCI LETT, V240, P123, DOI 10.1016/S0304-3940(97)00940-3
   Mantovani D, 2000, JOM-J MIN MET MAT S, V52, P36, DOI 10.1007/s11837-000-0082-4
   MEARS DC, 1975, J BIOMED MATER RES, V9, P133, DOI 10.1002/jbm.820090417
   Montague A, 1996, J BIOMED MATER RES, V32, P519, DOI 10.1002/(SICI)1097-4636(199612)32:4<519::AID-JBM4>3.0.CO;2-U
   Morita M, 1998, J JPN SOC TRIBOLOGIS, V43, P429
   MORITA M, 1988, J BIOMED MATER RES, V22, P529, DOI 10.1002/jbm.820220608
   Mueller H J, 1970, J Biomed Mater Res, V4, P29, DOI 10.1002/jbm.820040105
   Newton T, 2002, CHEM BRIT, V38, P24
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   NORMAND B, 1996, P 9 NAT THERM SPRAY, P73
   Pan J, 2000, J ELECTROCHEM SOC, V147, P1021, DOI 10.1149/1.1393307
   PEI XM, 2001, THESIS NATL U SINGAP
   PIKELNY A, 2002, 201 EL SOC M PHIL
   Probster L, 1992, INT J ORAL MAXILLOF, V7, P390
   RIEU J, 1995, P 8 INT C SURF MOD T, P43
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   ROSTOKER W, 1974, J BIOMED MATER RES, V8, P407, DOI 10.1002/jbm.820080609
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   SARKAR NK, 1987, J ORAL REHABIL, V14, P27, DOI 10.1111/j.1365-2842.1987.tb00690.x
   SCALES JT, 1959, J BONE JOINT SURG BR, V41, P810
   SEAH KHW, 1995, CORROS SCI, V37, P1333, DOI 10.1016/0010-938X(95)00033-G
   Sella C., 1987, ADV BIOMATER, V7, P119
   Sheehan J.P, 1985, ASTM STP, V859, P57
   Shenhar A, 2000, SURF COAT TECH, V126, P210, DOI 10.1016/S0257-8972(00)00524-7
   Sloter L. E., 1985, ASTM STP, V859, P93
   Solar RJ, 1979, ASTM STP, P259
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   Starosvetsky D, 2001, J MATER SCI-MATER M, V12, P145, DOI 10.1023/A:1008922111376
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   STEWART J, 1992, CORROS SCI, V33, P457, DOI 10.1016/0010-938X(92)90074-D
   SYRETT BC, 1978, CORROSION, V34, P138, DOI 10.5006/0010-9312-34.4.138
   SYRETT BC, 1978, ASTM STP, V684, P229
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   Thong PSP, 1997, NUCL INSTRUM METH B, V130, P460, DOI 10.1016/S0168-583X(97)00239-5
   TRAISNEL M, 1990, Clinical Materials, V5, P309, DOI 10.1016/0267-6605(90)90030-Y
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   Villermaux F, 1997, MATER RES SOC SYMP P, V459, P477
   VONFRAUNHOFER JA, 1994, CORROISION, V1, P2
   VONKNOCH M, 2002, IN PRESS J ARTHROPLA
   Walker G.D., 1974, J BIOMED MAT RES S, V5, P11
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   YU J, 1993, CORROS SCI, V35, P587, DOI 10.1016/0010-938X(93)90193-K
   ZITTER H, 1991, WERKST KORROS, V42, P455
   ZITTER H, 1981, WERKST KORROS, V32, P324
NR 90
TC 39
Z9 41
U1 1
U2 30
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-6005
EI 2191-0316
J9 CORROS REV
JI Corros. Rev.
PY 2003
VL 21
IS 2-3
BP 97
EP 124
PG 28
WC Electrochemistry; Metallurgy & Metallurgical Engineering; Materials
   Science, Coatings & Films
SC Electrochemistry; Metallurgy & Metallurgical Engineering; Materials
   Science
GA 690ZT
UT WOS:000183580900003
DA 2018-10-20
ER

PT B
AU Panchapakesan, B
   Sivakumar, K
   Lu, SX
AF Panchapakesan, B
   Sivakumar, K
   Lu, SX
BE Lee, R
   Lall, P
   Kowalski, GJ
   Agonafer, D
   Malshe, AP
TI Metallic nanowires from carbon nanotube building blocks: The effect of
   atomic defects on the nanotube influencing nanowire growth
SO ELECTRONIC AND PHOTONIC PACKAGING, ELECTRICAL SYSTEMS AND PHOTONIC
   DESIGN AND NANOTECHNOLOGY - 2003
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress
CY NOV 15-21, 2003
CL Washington, DC
SP ASME, Fluid Power Syst & Technol Div, ASME, Micro Elect Mech Syst Div, ASME, Fluids Engn Div, ASME, Bioengn Div, ASME, Appl Mech Div, ASME, Elect & Photon Packaging Div, ASME, Mfg Engn Div, ASME, Adv Energy Syst Div, ASME, Aerosp Div
ID ROOM-TEMPERATURE; SILVER NANOWIRES; QUANTUM WIRES
AB Manipulation and control of matter at the nano- and atomic level are crucial for the success of nano-scale sensors and actuators. The ability to control and synthesize multilayer structures using carbon nanotubes that will enable to build electronic devices within a nanotube is still in its infancy. In this paper, we present results on selective electric field assisted deposition of metals on carbon nanotubes realizing metallic nanowire structures. Silver and platinum nanowires has been fabricated using this approach due to its applications in chemical sensing as catalytic materials to sniff toxic agents and in the area of biomedical nanotechnology for construction of artificial muscles. The electric field assisted technique allows the deposition of metals with high degree of selectivity on carbon nanotubes by manipulating the charges on the surface of the nanotubes. The thickness and the growth of the nanowires was altered by inducing defects on the initial surface of the nanotubes that affected the local current densities and electrochemical reduction of silver and platinum on those defect sites. SEM and TEM investigations revealed silver and platinum nanowires between 10 nm-100 rim in diameter. Relatively higher metal deposition was achieved in defect related sites or places where the nanotubes criss-crossed each other, due to the high current densities in these sites. The present technique is versatile and enables the fabrication of host of different types of metallic and semiconducting nanowires using carbon nanotube templates for nanoelectronics and myriad of sensor applications. Further, nanowires can also serve as model systems for studying quantum size effects in these dimensions.
C1 Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.
RP Panchapakesan, B (reprint author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.
CR Akiyama H, 1996, PHYS REV B, V53, P10520, DOI 10.1103/PhysRevB.53.R10520
   Barbic M, 2002, J APPL PHYS, V91, P9341, DOI 10.1063/1.1476071
   BLOCH J, 1994, EUROPHYS LETT, V28, P501, DOI 10.1209/0295-5075/28/7/008
   Charlier JC, 2002, ACCOUNTS CHEM RES, V35, P1063, DOI 10.1021/ar010166k
   Cui Y, 2003, NANO LETT, V3, P149, DOI 10.1021/nl025875l
   DRESSELAHAUS DG, 1998, NANOTECHNOLOGY CARBO
   DRESSELHAUS MS, 1998, NANOTECHNOLOGY
   Fujiwara A, 2002, APPL PHYS LETT, V80, P4567, DOI 10.1063/1.1487451
   Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367
   Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h
   Ijima S., 1991, NATURE, V354, P56
   Johnson JC, 2002, NAT MATER, V1, P106, DOI 10.1038/nmat728
   KAPON E, 1992, APPL PHYS LETT, V60, P477, DOI 10.1063/1.106641
   Klemic JF, 2001, NAT BIOTECHNOL, V19, P924, DOI 10.1038/nbt1001-924
   Li C, 2003, APPL PHYS LETT, V82, P1613, DOI 10.1063/1.1559438
   MADOU M, 1997, FUNDMENTALS MICROFAB
   Obare SO, 2001, NANO LETT, V1, P601, DOI 10.1021/nl0156134
   SAKAKI H, 1980, JAPANESE J APPL PHYS, V19
   Xia, 2003, ADV MAT, V15
   Xia Y., 2003, ADV MAT, V15
   Zhan JH, 2000, ADV MATER, V12, P1348, DOI 10.1002/1521-4095(200009)12:18<1348::AID-ADMA1348>3.0.CO;2-X
   Zhang DB, 2001, CHEM MATER, V13, P2753, DOI 10.1021/cm0105007
   Zhang Y, 2000, APPL PHYS LETT, V77, P3015, DOI 10.1063/1.1324731
   Zhang Y, 2000, CHEM PHYS LETT, V331, P35, DOI 10.1016/S0009-2614(00)01162-3
NR 24
TC 0
Z9 0
U1 1
U2 5
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
BN 0-7918-3714-9
PY 2003
BP 193
EP 201
PG 9
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Optics
SC Engineering; Materials Science; Optics
GA BAJ32
UT WOS:000222522400026
DA 2018-10-20
ER

PT S
AU Shi, ZW
   Li, Y
   Zhou, H
   Zeng, YH
AF Shi, ZW
   Li, Y
   Zhou, H
   Zeng, YH
BE Zhang, GJ
   Zhao, HJ
   Wang, ZY
   Jiang, H
   Jiang, J
   Li, G
   Wang, Q
   Wei, C
TI The application of one multimode fiber optical sensor in optical
   tomography technology
SO FIFTH INTERNATIONAL SYMPOSIUM ON INSTRUMENTATION AND CONTROL TECHNOLOGY
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 5th International Symposium on Instrumentation and Control Technology
CY OCT 24-27, 2003
CL BEIJING, PEOPLES R CHINA
SP Natl Nat Sci Fdn China, Chinese Soc Aeronaut & Astronaut, China Instrument & Control Soc, Chinese Soc Astronaut, Chinese Assoc Automat, SPIE, Beijing Univ Aeronaut & Astronaut, Univ Paderborn, Univ Essen, Hiroshima Shudo Univ, Pusan Natl Univ
DE optical fiber; optical tomography; lens
AB Optical tomography technique is very important in changing conventional techniques for the development of imaging science. It will be applied widely in the fields of biomedical imaging, material structure analyzing and blurry martial target distinguishing etc. In this paper, we introduce the application of a multimode optical fiber sensor in tomography technology. Optic fiber with polished terminations requires the incident ray within a certain angle, so it usually causes deficiency of the light power entered into the optical fiber and diffuse the emergent ray, so polished terminations make it difficult to receive and detect the emergent rays. In order to solve the two problems above, a sphere lens is designed for one termination and a cylinder lens is designed for the other termination. This paper uses mathematics to analyze the relationship between the sphere lens radius, the cylinder lens radius, refractive index of the optical fiber. The relationship between the scanning angles and the numbers of the numbers of the received optical fiber is researched in the air medium, and the designing method for the sphere lens and the cylinder lens are present.
C1 Guangdong Univ Technol, Sch Informat Engn, Guangzhou 510643, Peoples R China.
RP Shi, ZW (reprint author), Guangdong Univ Technol, Sch Informat Engn, Guangzhou 510643, Peoples R China.
CR GOFF DR, 1996, FIBER OPTIC REF GUID
   LIU YC, 1997, PRINCIPLE DESIGNING
   RAMLI N, 1999, 1 WORLD C IND PROC T, P517
   YANG LS, 1997, DEV LASER PHOTOELECT
   ZHOU CS, 1992, OPTIC FIBER COMMUNIC
NR 5
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5137-1
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5253
BP 105
EP 109
DI 10.1117/12.521457
PG 5
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Instruments & Instrumentation; Optics; Imaging Science & Photographic
   Technology
SC Automation & Control Systems; Computer Science; Instruments &
   Instrumentation; Optics; Imaging Science & Photographic Technology
GA BY15E
UT WOS:000187954200024
DA 2018-10-20
ER

PT B
AU Fries, C
   Fries, D
   Broadbent, H
   Steimle, G
   Kaltenbacher, E
   Sasserath, J
AF Fries, C
   Fries, D
   Broadbent, H
   Steimle, G
   Kaltenbacher, E
   Sasserath, J
BE Kandlikar, SG
TI Direct write patterning of microchannels
SO FIRST INTERNATIONAL CONFERENCE ON MICROCHANNELS AND MINICHANNELS
LA English
DT Proceedings Paper
CT 1st International Conference on Microchannels and Minichannels
CY APR 24-25, 2003
CL Rochester, NY
SP Amer Soc Mech Engineers, Rochester Inst Technol
AB Microchannel-based master molds or final devices are typically produced using a series of resist deposition, exposure, development and etching steps. These steps can then be repeated to create multilayer fluidic structures. Traditional fabrication of these devices requires the use of a physical mask for the photolithographic exposure process. In the research and development environment, where designs are constantly undergoing changes, or in rapid-time-to-device applications, this can be a costly and time-consuming practice.
   We have employed a novel, micron-scale resolution maskless photoimaging/patterning tool that permits the creation of small, arbitrary features. This microdevice printer is useful for constructing fluidic channels, devices, structures and packages utilizing any photoimageable or photoreactive material that can be applied towards fabrication of integrated microfluidic-based systems. The fabrication technology can provide features down to 20 microns simultaneously over a 2x2 cm(2) field of view. Additionally, manual stitching techniques can yield unlimited field-of-view for large area fluidic patterns with high-resolution elements.
   The instrument relies on the use of microoptics and spatial light modulation to create the required 2D aerial image for photoimprinting. The instrument creates mask-free designs on planar and curved surfaces and has been applied to a variety of materials, including metals, ceramics, organic polymers and semiconductors. We have demonstrated the utility of the instrument for creating mechanical, optical, fluidic and electronic components and combinations that would form the basis of integrated microfluidic systems, microanalytical systems and micrototal analysis systems (uTAS). We have also created fluidic channels having structures integrated within the channel geometry. The technology has widespread applications in the MEMS, bioMEMS, microcooling technologies and sensor markets. A further extension of the technology is the application of the direct printer to rapid prototyping of microchannels and minichannels for fuel cells, microrefrigerators, heat exchangers, and biomedical devices.
C1 Intelligent Micro Patterning LLC, St Petersburg, FL USA.
RP Fries, C (reprint author), Intelligent Micro Patterning LLC, St Petersburg, FL USA.
CR Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   EMMELIUS M, 1989, ANGEW CHEM INT EDIT, V28, P1445, DOI 10.1002/anie.198914453
   FRIES DP, 2002, ADV TECHN WORKSH IMA
   HAYESA DJ, 1998, ADH JOIN COAT TECHN
   MCCLELLAND JJ, 1993, SCIENCE, V262, P877, DOI 10.1126/science.262.5135.877
   Merkel T, 1999, SENSOR ACTUAT A-PHYS, V77, P98, DOI 10.1016/S0924-4247(99)00062-X
   Metz S, 2001, LAB CHIP, V1, P29, DOI 10.1039/b103896f
   Nguyen NT, 2001, SENSOR ACTUAT A-PHYS, V88, P104, DOI 10.1016/S0924-4247(00)00500-8
   Varadan V. K., 2001, MICROSTEREOLITHOGRAP
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
   YANG R, 2002, ADV PACKAGING MA MAR, P17
NR 11
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 0-7918-3667-3
PY 2003
BP 787
EP 794
DI 10.1115/ICMM2003-1103
PG 8
WC Engineering, Mechanical
SC Engineering
GA BAK65
UT WOS:000222636600097
DA 2018-10-20
ER

PT S
AU Uenishi, K
   Takatsugu, M
   Kobayashi, KF
AF Uenishi, K
   Takatsugu, M
   Kobayashi, KF
BE Miyamoto, I
   Ostendorf, A
   Sugioka, K
   Helvajian, H
TI Pseudo-elastic and bio-chemical properties of Ti-Ni shape memory alloy
   wires micro-welded by YAG laser
SO FOURTH INTERNATIONAL SYMPOSIUM ON LASER PRECISION MICROFABRICATION
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 4th International Symposium on Laser Precision Microfabrication
CY JUN 21-24, 2003
CL MUNICH, GERMANY
SP Japan Laser Proc Soc, WLT, Inst Phys & Chem Res, SPIE, Japan Soc Precis Engn, Japan Soc Appl Phys, Japan Welding Soc, Laser Soc Japan, Japan Inst Elect Packaging, High Temp Soc Japan, Microjoining & Assembly Technol Elect
DE YAG Laser; micro welding; shape memory alloy; biomaterials; tensile
   strength; corrosion resistance; medical devices; pseudo-elastic;
   immersion test
ID STAINLESS-STEEL
AB In order to investigate the applicability of laser micro welding to the fabrication of medical devices, Ti-Ni based shape memory alloy biomaterials wires were micro spot melted by using YAG laser. By the optimization of laser conditions such as laser power or pulse duration, sound spot melted wires free from, any defects were prepared and the width of the melted metal was reduced to about 0.2mm for the 0.15mm diameter wires. Compared with the SUS304 wires, melting of shape memory alloy wires needed more precise control of laser conditions although it needed smaller power input. Melted metal exhibited a rapidly quenched microstructure. The spot melted wires showed 70% of tensile strength and almost the same super-elastic behavior compared with base materials. Besides, it was confirmed by immersion test and by measurement of anodic polarization curve that NT-E4 wires still retain a sound corrosion resistance in a quasi biological environment by laser spot melting. Crosswise or parallel joints was also successfully prepared by laser spot welding of wires, suggesting the laser micro welding is applicable to the fabrication of biomedical devices.
C1 Osaka Univ, Grad Sch Engn, Dept Mfg Sci, Suita, Osaka 5650871, Japan.
RP Uenishi, K (reprint author), Osaka Univ, Grad Sch Engn, Dept Mfg Sci, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.
CR HAMANAKA H, 1998, MAT JAPAN, V37, P834
   HIROSE A, 1990, J JPN I MET, V54, P262, DOI 10.2320/jinstmet1952.54.3_262
   Seki M, 2000, J JPN I MET, V64, P632, DOI 10.2320/jinstmet1952.64.8_632
   TSUBOI A, 2000, LASER RES, V28, P413
   Uenishi K, 2003, P SOC PHOTO-OPT INS, V4830, P57, DOI 10.1117/12.499698
   Uenishi K, 2002, MATER TRANS, V43, P3083, DOI 10.2320/matertrans.43.3083
   YONEYAMA T, 2000, NONDESRUCTIVE INSPEC, V49, P420
NR 7
TC 0
Z9 0
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4869-9
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5063
BP 282
EP 286
DI 10.1117/12.540551
PG 5
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering;
   Optics; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Metallurgy & Metallurgical Engineering; Optics;
   Physics
GA BY26Q
UT WOS:000188594500052
DA 2018-10-20
ER

PT S
AU Herfurth, HJ
   Witte, R
   Heinemann, S
AF Herfurth, HJ
   Witte, R
   Heinemann, S
BE Miyamoto, I
   Ostendorf, A
   Sugioka, K
   Helvajian, H
TI Microjoining of dissimilar materials for life science applications
SO FOURTH INTERNATIONAL SYMPOSIUM ON LASER PRECISION MICROFABRICATION
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 4th International Symposium on Laser Precision Microfabrication
CY JUN 21-24, 2003
CL MUNICH, GERMANY
SP Japan Laser Proc Soc, WLT, Inst Phys & Chem Res, SPIE, Japan Soc Precis Engn, Japan Soc Appl Phys, Japan Welding Soc, Laser Soc Japan, Japan Inst Elect Packaging, High Temp Soc Japan, Microjoining & Assembly Technol Elect
DE dissimilar materials; laser microjoining; biocompatibility; implantable
   device
AB Implantable microsystems currently under development have the potential to significantly impact the future treatment of disease. Functions of such implants will include localized sensing of temperature and pressure, electrical stimulation of neural tissue and the delivery of drugs. The devices are designed to be long-term implants that are remotely powered and controlled for many applications. The development of new, biocompatible materials and manufacturing processes that ensure long-lasting functionality and reliability are critical challenges. Important factors in the assembly of such systems are the small size of the features, the heat sensitivity of integrated electronics and media, the precision alignment required to hold small tolerances, and the type of materials and material combinations to be hermetically scaled. Laser micromachining has emerged as a compelling solution to address these manufacturing challenges. This paper will describe the latest achievements in microjoining of metallic and non-metallic materials. The focus is on glass, metal and polymers that have been joined using CO2, Nd:YAG and diode lasers. Results in joining similar and dissimilar materials in different joint configurations are presented, as well as requirements for sample preparation and fixturing. The potential for applications in the biomedical sector will be demonstrated.
C1 Fraunhofer Ctr Laser Technol, Plymouth, Devon, England.
RP Herfurth, HJ (reprint author), Fraunhofer Ctr Laser Technol, Plymouth, Devon, England.
CR JEFFREY K, 2001, CARDIAC PACEMAKER IM
   SANTINI JT, 2002, P 4 INT S BIOMEMS CA
NR 2
TC 6
Z9 6
U1 1
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4869-9
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5063
BP 292
EP 296
DI 10.1117/12.541153
PG 5
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering;
   Optics; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Metallurgy & Metallurgical Engineering; Optics;
   Physics
GA BY26Q
UT WOS:000188594500054
DA 2018-10-20
ER

PT S
AU Zheng, CL
   Cui, FZ
   Xu, Z
AF Zheng, CL
   Cui, FZ
   Xu, Z
BE Pan, W
   Gong, J
   Zhang, L
   Chen, L
TI Fabrication of Ti-O gradient biomedical film on Ti6Al4V by DC glow
   plasma oxidizing
SO FUNCTIONALLY GRADED MATERIALS VII
SE Materials Science Forum
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Functionally Graded Materials (FGM2002)
CY OCT 15-18, 2002
CL BEIJING, PEOPLES R CHINA
SP Chinese Ceram Soc, Natl Nat Sci Fdn China, Tsinghua Univ, Wuham Univ Technol, Shanghai Inst Ceram
DE Ti-O film; Ti6Al4V; plasma; oxidizing
ID IMMERSION ION-IMPLANTATION; TITANIUM-ALLOYS; COATINGS; CARBON
AB Ti-O film is a kind of biocompatible surface materials. In this paper, a new method, DC glow discharge plasma oxidizing, has been used in synthesizing Ti-O gradient films on Ti6A14V substrates. The effects of ion bombardment and process parameters on the structures of titanium oxide layers have been investigated. It can be concluded that DC glow plasma oxidizing is more efficient in preparation of dens, hard, and high adhesive Ti-O graded biomedical films on titanium alloys. In the condition of hollow cathode discharge, the ion bombardment enhances ionization of oxygen, promotes the oxygen permeation and facilitates the formation of the oxide of low valence states of titanium. In addition, blood compatibility of the Ti-O films was evaluated by measuring the dynamic clotting time as well as the platelet consumption rate. The results indicate that the Ti-O films possess better blood compatibility than that of Ti6A14V, 316L stainless steel and NiTi alloy.
C1 Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   Taiyuan Univ Technol, Surface Engn Inst, Shanxi 030024, Peoples R China.
RP Zheng, CL (reprint author), Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
CR Bally AR, 1998, SURF COAT TECH, V108, P166, DOI 10.1016/S0257-8972(98)00629-X
   Banakh O, 2002, SURF COAT TECH, V151, P272, DOI 10.1016/S0257-8972(01)01605-X
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   Borgioli F, 2001, SURF COAT TECH, V141, P103, DOI 10.1016/S0257-8972(01)01164-1
   BUDINSKI KG, 1991, WEAR, V151, P203, DOI 10.1016/0043-1648(91)90249-T
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   GOODMAN SL, 1995, CELL MATER, V5, P15
   Han Y, 2002, SURF COAT TECH, V154, P314, DOI 10.1016/S0257-8972(02)00036-1
   Karim B, 1996, BIOMATERIALS, V17, P491
   Lapostolle F, 2000, SURF COAT TECH, V135, P1, DOI 10.1016/S0257-8972(00)00721-0
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   LIU JX, 2000, FUNCTIONAL MAT, V31, P584
   Rinner M, 2000, SURF COAT TECH, V132, P111, DOI 10.1016/S0257-8972(00)00712-X
   RIZZO A, 1996, MATER SCI FORUM, V225, P161
   Sonoda T, 1998, SURF SCI, V402, P241, DOI 10.1016/S0039-6028(98)00032-6
   Sonoda T, 2001, THIN SOLID FILMS, V386, P227, DOI 10.1016/S0040-6090(00)01655-2
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   XU Z, Patent No. 47332539
   Zhang F, 1998, SURF COAT TECH, V104, P146, DOI 10.1016/S0257-8972(98)00434-4
   [郑传林 Zheng Chuanlin], 2002, [北京科技大学学报, Journal of University Science and Technology Beijing], V24, P44
   ZHENG CL, IN PRESS NUCL INST B
   ZHENG CL, 2002, J KOREAN VACUUM SCI, V6, P16
NR 22
TC 2
Z9 2
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 0-87849-915-6; 0-87849-915-6
J9 MATER SCI FORUM
PY 2003
VL 423-4
BP 335
EP 340
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW83Z
UT WOS:000183317500067
DA 2018-10-20
ER

PT S
AU Xiao, XD
   Herring, ME
   Haushalter, J
   Lee, S
   Kalogerakis, KS
   Faris, GW
AF Xiao, XD
   Herring, ME
   Haushalter, J
   Lee, S
   Kalogerakis, KS
   Faris, GW
BE Savitsky, AP
   Bornhop, DL
   Raghavachari, R
   Achilefu, SA
TI Optical property measurements of a novel type of upconverting reporter
SO GENETICALLY ENGINEERED AND OPTICAL PROBES FOR BIOMEDICAL APPLICATIONS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Genetically Engineered and Optical Probes for Biomedical
   Applications
CY JAN 27-28, 2003
CL SAN JOSE, CA
SP SPIE
DE upconverting chelates; biomedical diagnostics; optical reporters;
   contrast agents; optical labels
ID LANTHANIDE LUMINESCENCE; MECHANISMS; ASSAYS
AB We have recently developed a new type of reporter (upconverting chelate) for biomedical diagnostics. For this reporter, the light is absorbed and emitted by a lanthanide ion, rather than an organic molecule, as is the case for a typical fluorescent dye. These materials do not photobleach and have no autofluorescent background. We focus in this paper on neodymium ions complexed with the familiar chelating agents, EDTA, DPA, DTPA and DOTA. We have performed experimental measurements with one- and two-color laser light excitation for different chelate compounds. The samples are excited using two Nd:YAG-pumped dye laser systems that provide laser light near 587 nm and 800 nm. For one-color excitation, the emitted light depends quadratically on the incident laser power, as expected. Three strongly emitting lines are observed, located near 360 nm, 387 nm, and 417 nm. We observed more efficient upconversion in EDTA although the DPA chelates show comparable ground state absorbance. We have studied the influence of temporal delay between the two laser pulses and obtained the decay lifetime of the first intermediate state in the various chelated compounds.
C1 SRI Int, Mol Phys Lab, Menlo Pk, CA 94025 USA.
RP Faris, GW (reprint author), SRI Int, Mol Phys Lab, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.
EM gregory.faris@sri.com
CR AUZEL FE, 1973, P IEEE, V61, P758, DOI 10.1109/PROC.1973.9155
   DICKSON EFG, 1995, J PHOTOCH PHOTOBIO B, V27, P3
   GAMELIN DR, 2000, TOPICS CURRENT CHEM, V214
   HNATOWICH DJ, 1983, SCIENCE, V220, P613, DOI 10.1126/science.6836304
   LENTH W, 1990, J LUMIN, V45, P346, DOI 10.1016/0022-2313(90)90190-M
   Scheps R, 1996, PROG QUANT ELECTRON, V20, P271, DOI 10.1016/0079-6727(95)00007-0
   SOINI E, 1983, CLIN CHEM, V29, P65
   TEMPLETON EFG, 1991, CLIN CHEM, V37, P1506
   Valiente R, 2002, J CHEM PHYS, V116, P5196, DOI 10.1063/1.1446430
   Wright J. C., 1976, Radiationless processes in molecules and condensed phases, P239
NR 10
TC 3
Z9 3
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4767-6
J9 PROC SPIE
PY 2003
VL 4967
BP 172
EP 178
DI 10.1117/12.479841
PG 7
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BX34C
UT WOS:000184995400021
DA 2018-10-20
ER

PT S
AU Castillo, M
   Moore, JJ
   Schowengerdt, FD
   Ayers, RA
   Zhang, X
   Umakoshi, M
   Yi, HC
   Guigne, JY
AF Castillo, M
   Moore, JJ
   Schowengerdt, FD
   Ayers, RA
   Zhang, X
   Umakoshi, M
   Yi, HC
   Guigne, JY
BE Narayanan, R
TI Effects of gravity on combustion synthesis of functionally graded
   biomaterials
SO GRAVITATIONAL EFFECTS IN PHYSICO-CHEMICAL PROCESSES
SE ADVANCES IN SPACE RESEARCH
LA English
DT Article; Proceedings Paper
CT Symposium on Gravitational Effects in Physico-Chemical Processes held at
   the 34th COSPAR Scientific Assembly
CY OCT 10-19, 2002
CL HOUSTON, TEXAS
SP Comm Space Res, Comm Int Council Sci Unions
AB Combustion synthesis, or self-propagating, high temperature synthesis is currently being used at the Colorado School of Mines to produce advanced materials for biomedical applications. These biomaterials include ceramic, intermetallic, and metal-matrix composites for applications ranging from structural to oxidation- and wear-resistant materials, e.g., TiC-Ti, TiC-Cr3C2, MOSi2-SiC, NiAl-TiB2, to engineered porous composites, e.g., B4C-Al2O3, Ti-TiBx, Ni-Ti, Ca-3(PO4)(2) and glass-ceramic composites, e.g., CaO-SiO2-BaO-Al2O3-TiB2. The goal of the functionally graded biomaterials project is to develop new materials, graded in porosity and composition, which will combine the desirable mechanical properties of implant, e.g., NiTi, with the bone-growth enhancement properties of porous biodegradable ceramics, e.g., Ca-3(PO4)(2). Recent experiments on the NASA parabolic flight (KC-135) aircraft have shown that gravity plays an important role in controlling the structure and properties of materials produced by combustion synthesis. The results of these studies, which will be presented at the conference, will provide valuable input to the design of experiments to be done in Space-DRUMS(TM), a containerless materials processing facility scheduled to be placed on the International Space Station in 2003. (C) 2003 COSPAR. Published by Elsevier Ltd. All rights reserved.
C1 Colorado Sch Mines, Ctr Commercial Applicat Combust Space, Golden, CO 80401 USA.
   Guigne Int Ltd, Paradise, NF A1L 1C1, Canada.
RP Castillo, M (reprint author), Colorado Sch Mines, Ctr Commercial Applicat Combust Space, 1500 Illinois St, Golden, CO 80401 USA.
RI Ayers, Reed/E-5558-2011
CR GORTCHEVA VP, 1997, J MATER SCI, V8, P297
   MOORE JJ, 1994, PROCESSING FABRICATI, V3, P817
   PETERS FM, 2000, FUNCTIONALLY GRADED, V114, P97
NR 3
TC 13
Z9 13
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI KIDLINGTON
PA THE BOULEVARD, LANGFORD LANE,, KIDLINGTON OX5 1GB, OXFORD, ENGLAND
SN 0273-1177
J9 ADV SPACE RES
PY 2003
VL 32
IS 2
BP 265
EP 270
DI 10.1016/S0273-1177(03)00392-2
PG 6
WC Engineering, Aerospace; Astronomy & Astrophysics; Geosciences,
   Multidisciplinary; Meteorology & Atmospheric Sciences; Physics,
   Multidisciplinary
SC Engineering; Astronomy & Astrophysics; Geology; Meteorology &
   Atmospheric Sciences; Physics
GA BX86G
UT WOS:000186667600021
DA 2018-10-20
ER

PT B
AU Sivakumar, K
   Panchapakesan, B
AF Sivakumar, K
   Panchapakesan, B
BE Badawy, W
   Moussa, W
TI Electric field assisted deposition of nanowires from carbon nanotubes
   for nanoelectronics and sensor applications
SO INTERNATIONAL CONFERENCE ON MEMS, NANO AND SMART SYSTEMS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on MEMS, NANO and Smart Systems
CY JUL 20-23, 2003
CL BANFF, CANADA
SP iCore, MANCEF, Micronet R&D, Natl Inst Nano Technol, Univ Alberta, Univ Calgary
AB Manipulation and control of matter at the nano- and atomic level are crucial for the success of nano-scale sensors and actuators. The ability to control and synthesize multilayer structures using carbon nanotubes that will enable to build electronic devices within a nanotube is still in its infancy. In this paper, we present results on selective electric field assisted deposition of metals on carbon nanotubes realizing metallic nanowire structures. Silver and platinum nanowires has been fabricated using this approach due to its applications in chemical sensing as catalytic materials to sniff toxic agents and in the area of biomedical nanotechnology for construction of artificial muscles. The electric field assisted deposition allows the deposition of metals with high degree of selectivity on carbon nanotubes by manipulating the characs on the surface of the nanotubes. SEM and TEM investigations revealed silver and platinum nanowires between 10 nm-100 nm in diameter. The present technique is versatile and enables the fabrication of host of different types of metallic and semiconducting nanowires using carbon nanotube templates for nanoelectronics and myriad of sensor applications. Further, nanowires can also serve as model systems for studying quantum size effects at these dimensions.
C1 Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.
RP Sivakumar, K (reprint author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.
CR AKIYAMA H, 1996, PHYSICAL REV B
   BLOCH J, 1994, EUROPHYS LETT, V28, P501, DOI 10.1209/0295-5075/28/7/008
   DRESSELHAUS G, GRAPHITE FIBERS FILA, V5
   DRESSELHAUS MS, 1998, NANOTECHNOLOGY CARBO
   Ijima S., 1991, NATURE, V354
   IJIMA S, 1993, NATURE, V363
   SAKAKI H, 1980, JAPANESE J APPL PHYS, V19
   WEISMULLER J, 2003, SCIENCE, V300
   Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087
NR 9
TC 0
Z9 0
U1 0
U2 0
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
BN 0-7695-1947-4
PY 2003
BP 203
EP 208
DI 10.1109/ICMENS.2003.1221993
PG 6
WC Computer Science, Artificial Intelligence; Engineering,
   Multidisciplinary; Engineering, Electrical & Electronic; Materials
   Science, Multidisciplinary; Optics
SC Computer Science; Engineering; Materials Science; Optics
GA BX34B
UT WOS:000184994600038
DA 2018-10-20
ER

PT J
AU Gordon, R
   Melvin, CA
AF Gordon, R
   Melvin, CA
TI Reverse engineering the embryo: a graduate course in developmental
   biology for engineering students at the University of Manitoba, Canada
SO INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE reverse engineering; embryo; developmental biology; education;
   biomedical engineering
ID PRIMARY NEURAL INDUCTION; SURFACE CONTRACTION; MORPHOGENESIS;
   DIFFERENTIATION; TENSEGRITY; MECHANICS; DESIGN; WAVES
AB Our desire to educate engineers to be able to understand the component processes of embryogenesis, is driven by the notion that only when principles borrowed from mathematics, fluid mechanics, materials science, etc. are applied to classical problems in developmental biology, will sufficient comprehension be achieved to permit successful understanding and therapeutic manipulation of embryos. As it now stands, biologists seldom possess either skills or interest in those areas of endeavor. Thus, we have determined that it is easier to educate engineers in the principles of developmental biology than to help biologists deal with the complexities of engineering. We describe a graduate course that has been taken, between 1999 and 2002, by 17 engineering students. Our goal is to prepare them to reverse engineer the embryo, i.e., to look at it as an object or process whose construction, albeit self-construction, might be explicable in terms of engineering principles applied at molecular, cellular and whole embryo levels.
C1 Univ Manitoba, Dept Radiol, Winnipeg, MB R3T 2N2, Canada.
   Univ Manitoba, Dept Elect & Comp Engn, Winnipeg, MB R3T 2N2, Canada.
RP Gordon, R (reprint author), Univ Manitoba, Dept Radiol, Winnipeg, MB R3T 2N2, Canada.
CR ADAM G, 1968, STRUCTURAL CHEM MOL, P198
   BRODLAND GW, 1994, J MORPHOL, V219, P131, DOI 10.1002/jmor.1052190203
   BRODLAND GW, 1990, J BIOMECH ENG-T ASME, V112, P319, DOI 10.1115/1.2891190
   CHIKOFSKY EJ, 1990, IEEE SOFTWARE, V7, P13, DOI 10.1109/52.43044
   CHRUSCH DD, 2002, C P 2002 IEEE CAN C
   DEMBSKI W., 1999, INTELLIGENT DESIGN B
   DICTUS WJAG, 1984, DEV BIOL, V101, P201, DOI 10.1016/0012-1606(84)90130-1
   Feller W., 1968, INTRO PROBABILITY TH, VI
   Fitelson B, 1999, PHILOS SCI, V66, P472, DOI 10.1086/392699
   GINGERICH Owen, 1994, EVIDENCE PURPOSE SCI, P21
   Gordon R, 2000, RIV BIOL-BIOL FORUM, V93, P349
   GORDON R, 1985, J EMBRYOL EXP MORPH, V89, P229
   GORDON R, 1994, INT REV CYTOL, V150, P243
   GORDON R, 1970, P NATL ACAD SCI USA, V67, P338, DOI 10.1073/pnas.67.1.338
   GORDON R, 1994, INT REV CYTOL, V150, P373
   GORDON R, 1987, CELL BIOPHYS, V11, P177, DOI 10.1007/BF02797122
   GORDON R, 1966, P NATL ACAD SCI USA, V56, P1497, DOI 10.1073/pnas.56.5.1497
   GORDON R, 1999, APPL RADIOL, V28, P12
   GORDON R, 1993, CAROLINA TIPS, V56, P9
   Gordon R., 1999, HIERARCHICAL GENOME
   GORDON R, 1992, B CAN SOC THEOR BIOL, V10, P4
   GORDON R, 1983, COMPUTING BIOL SCI, P23
   Gould S. J., 1996, FULL HOUSE SPREAD EX
   His W., 1888, ROY SOC EDINBURGH P, V15, P287
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   INGBER DE, 1994, INT REV CYTOL, V150, P173
   JAYAS DS, 2002, CAN C EL COMP ENG
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Martin CC, 1997, RUSSIAN J DEV BIOL, V28, P71
   MELVIN C, 2002, C P 2002 IEEE CAN C, P270
   Nieuwkoop PD, 1999, INT J DEV BIOL, V43, P615
   Nieuwkoop PD, 1996, INT J DEV BIOL, V40, P661
   Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9
   PAULOS JA, 1990, INNUMERACY MATH ILLI
   SAMUELSON P, 1990, IEEE SOFTWARE, V7, P90, DOI 10.1109/52.43054
   SOBER E, 2003, IN PRESS BLACKWELL G
   VANDENBRAND M, 1997, ACM SOFTWARE ENG NOT, V22, P56
NR 37
TC 6
Z9 6
U1 0
U2 1
PU U B C PRESS
PI BILBAO
PA UNIV BASQUE COUNTRY, EDITORIAL SERVICES, PO BOX 1397, E-48080 BILBAO,
   SPAIN
SN 0214-6282
J9 INT J DEV BIOL
JI Int. J. Dev. Biol.
PY 2003
VL 47
IS 2-3
SI SI
BP 183
EP 187
PG 5
WC Developmental Biology
SC Developmental Biology
GA 664QF
UT WOS:000182071200016
PM 12705668
DA 2018-10-20
ER

PT B
AU Eisinberg, A
   Izzo, I
   Valdastri, P
   Menciassi, A
   Dario, P
AF Eisinberg, A
   Izzo, I
   Valdastri, P
   Menciassi, A
   Dario, P
GP IEEE
   IEEE
TI A portable sensorized micro end-effector for operating in biomedical
   test-benches
SO IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON
   INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4
LA English
DT Proceedings Paper
CT IEEE/RSJ International Conference on Intelligent Robots and Systems
CY OCT 27-31, 2003
CL LAS VEGAS, NV
SP IEEE Robot & Automat Soc, IEEE Ind Elect Soc, Robot Soc Japan, Soc Instruments & Control Engineers, New Technol Fdn
AB This paper is focused on a portable sensorized micro end-effector purposely designed for operating in biomedical test-benches. The gripper, previously designed and fabricated in various materials exploiting different technologies, has been devised to perform tasks of micromanipulation and characterization of biological tissues once integrated into the workstation developed in the authors' lab. The last model of the gripper prototype has been integrated in a "smart" mounting, with on board electronics for signal processing, and further improvements are planned in order to enhance the portability of the tool. Actually, for the development of novel tools and methodologies in the fields of biomedical engineering and computer assisted surgery (CAS), ever-growing importance have both in vitro and in vivo tests, aimed at validating methods and at optimizing innovative tools. The selected gripper, fabricated in stainless steel by laser machining, is equipped with commercial semiconductor strain gauges as force sensors.
C1 Scuola Super Sant Anna, CRIM Lab, I-56025 Pisa, Italy.
RP Eisinberg, A (reprint author), Scuola Super Sant Anna, CRIM Lab, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RI Menciassi, Arianna/A-2664-2010; Valdastri, Pietro/A-2840-2010
OI Valdastri, Pietro/0000-0002-2280-5438
CR Choy Young Bin, 2002, Journal of Biomechanics, V35, P1671
   Dario P, 1996, IEEE-ASME T MECH, V1, P137, DOI 10.1109/3516.506150
   Dario P, 2000, J MICROMECH MICROENG, V10, P235, DOI 10.1088/0960-1317/10/2/322
   EISINBERG A, 2002, THESIS PISA ITALY
   Menciassi A., 2002, P IEEE RSJ INT C INT, V2, P1591
   MENCIASSI A, 1999, THESIS PISA ITALY
   SZILITOROK T, 2001, HEART, P86
   VALDASTRI P, 2002, THESIS PISA ITALY
   ZARA JM, 1999, P IEEE ULTR S, P1173
NR 9
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7860-1
PY 2003
BP 2589
EP 2593
PG 5
WC Robotics
SC Robotics
GA BY14F
UT WOS:000187883300419
DA 2018-10-20
ER

PT J
AU Torosyan, G
   Nerkararyan, K
   Avetisyan, Y
   Beigang, R
AF Torosyan, G
   Nerkararyan, K
   Avetisyan, Y
   Beigang, R
TI Generation of narrowband tunable THz-radiation via optical rectification
   in periodically poled materials
SO JOURNAL OF BIOLOGICAL PHYSICS
LA English
DT Article
DE optical rectification; poled materials; Terahertz generation
ID LITHIUM-NIOBATE; TERAHERTZ RADIATION
AB The generation of tunable THz-radiation via optical rectification of fs-pulses in periodically poled nonlinear materials is reported and its application for biomedical sensing using THz-senors based on planar wave guides is discussed in detail.
C1 Univ Kaiserslautern, Fachbereich Phys, D-6750 Kaiserslautern, Germany.
   Yerevan State Univ, Dept Microwave Engn, Yerevan 375049, Armenia.
RI Avetisyan, Yuri/R-8321-2018
OI Avetisyan, Yuri/0000-0003-1389-1028
CR Lee YS, 2000, APPL PHYS LETT, V77, P2488, DOI 10.1063/1.1318725
   Lee YS, 2000, APPL PHYS LETT, V77, P1244, DOI 10.1063/1.1290046
   Lee YS, 2000, APPL PHYS LETT, V76, P2505, DOI 10.1063/1.126390
   Weiss C, 2001, OPT EXPRESS, V8, P497, DOI 10.1364/OE.8.000497
   Weiss C, 2001, OPT LETT, V26, P563, DOI 10.1364/OL.26.000563
NR 5
TC 1
Z9 1
U1 1
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0092-0606
J9 J BIOL PHYS
JI J. Biol. Phys.
PY 2003
VL 29
IS 2-3
BP 287
EP 293
DI 10.1023/A:1024417531233
PG 7
WC Biophysics
SC Biophysics
GA 693EN
UT WOS:000183703600026
PM 23345846
DA 2018-10-20
ER

PT J
AU Ma, L
   Gao, CY
   Mao, ZW
   Shen, JC
   Hu, XQ
   Han, CM
AF Ma, L
   Gao, CY
   Mao, ZW
   Shen, JC
   Hu, XQ
   Han, CM
TI Thermal dehydration treatment and glutaraldehyde cross-linking to
   increase the biostability of collagen-chitosan porous scaffolds used as
   dermal equivalent
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE collagen; chitosan; DHT; glutaraldehyde; dermis; tissue engineering
ID DEEP BURN COVERAGE; MECHANICAL-PROPERTIES; ARTIFICIAL SKIN; TISSUE;
   CHITIN; BIOMATERIAL; THICKNESS; DESIGN; DOGS
AB A biodegradable scaffold for skin-tissue engineering was designed using collagen and chitosan, which are common materials for biomedical application. The scaffolds containing different amounts of chitosan were prepared by mixing the collagen and chitosan solutions followed by removal of the solvent using a freeze-drying method. The cross-linking treatment of these scaffolds was performed using the dehydrothermal treatment (DHT) method or glutaraldehyde (GA) to increase their biostability. The effect of the chitosan concentration and the cross-linking methods on the morphology of these scaffolds was studied by SEM. The water retention and the biodegradability in vitro of various collagen-chitosan scaffolds were investigated. Finally the biocompatibility of the collagen-chitosan (10 wt% chitosan) scaffold treated with different cross-linking methods was evaluated using a in vivo animal test. A mild inflammatory reaction could be detected in the early stages, and GA treatment can decrease the inflammatory reaction in a long-term implantation. After implantation for four weeks, all kinds of scaffolds, especially the GA-treated scaffolds (Col-GA) were filled with a large number of fibroblasts and were vascularized to a certain extent. These results suggest that the GA-treated scaffold has an increased biostability and excellent biocompatibility. It can be a potential candidate for skin-tissue engineering.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
   Zhejiang Univ, Affiliated Hosp 2, Fac Burn, Hangzhou 310027, Peoples R China.
RP Gao, CY (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RI mao, zhengwei/I-5785-2012
OI Gao, Changyou/0000-0001-5084-7208
CR Augustin C, 1997, SKIN PHARMACOL, V10, P63
   BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DAMOUR O, 1994, CLIN MATER, V15, P273, DOI 10.1016/0267-6605(94)90057-4
   Eppley BL, 2001, PLAST RECONSTR SURG, V107, P757, DOI 10.1097/00006534-200103000-00016
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Kojima K, 1998, CARBOHYD POLYM, V37, P109, DOI 10.1016/S0144-8617(98)00055-1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Ma HY, 2001, CHINESE J CATAL+, V22, P3
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   OKAMOTO Y, 1993, J VET MED SCI, V55, P743, DOI 10.1292/jvms.55.743
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   SU CH, 1997, BIOMATERIALS, V18, P567
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   Thomson R. C., 1997, ADV BIOPOLYM, V122, P245
   TSUBOI R, 1995, J DERMATOL SCI, V10, P82
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   WEADOCK K, 1984, BIOMAT MED EV ARTIF, V11, P293
   WIDMER MS, 1980, FRONTIERS TISSUE ENG, P107
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   Yannas IV., 1995, BIOMEDICAL ENG HDB, P1619
NR 29
TC 45
Z9 57
U1 1
U2 19
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 8
BP 861
EP 874
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 734BZ
UT WOS:000186036500008
PM 14533863
DA 2018-10-20
ER

PT J
AU Ehteshami, G
   Singh, A
   Coryell, G
   Massia, S
   He, JP
   Raupp, G
AF Ehteshami, G
   Singh, A
   Coryell, G
   Massia, S
   He, JP
   Raupp, G
TI Glial cell and fibroblast cytotoxicity study on 4026-cyclotene
   photosensitive benzocyclobutene (BCB) polymer films
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE photosensitive benzocyclobutene; neural prosthetics; immobilized
   dextran; cell-resistant surface
ID DEXTRAN
AB Photosensitive benzocyclobutene (photo-BCB) is a class of polymers with the trade name Cyclotene(TM). The photoimagable property of Cyclotene(TM) makes it suitable for the manufacture of microelectronic devices. The motivation behind this study is that we see an exciting application of photo-BCB as substrates in implantable microelectronic biomedical devices due to several desirable properties distinctive from other polymer materials. To our knowledge, however, photo-BCB has never been tested for biomedical implant applications, as evidenced by the lack reported data on its biocompatibility. This study takes the first step towards assessing photo-BCB biocompatibility by evaluating the cytotoxicity and cell adhesion behavior of Cyclotene 4026(TM) coatings exposed to monolayers of glial and fibroblast cells in vitro. It can be concluded from these studies that photo-BCB films deposited on silicon wafers using microfabrication processes did not adversely affect 3T3 fibroblast and T98-G glial cell function in vitro. We also successfully rendered photo-BCB films non-adhesive (no significant fibroblast or glial cell adhesion) with surface immobilized dextran using methods developed for other biomaterials and applications. Future work will further develop prototype photo-BCB microelectrode devices for chronic neural implant applications.
C1 Arizona State Univ, Harrington Dept Bioengn, Tempe, AZ 85287 USA.
   Arizona State Univ, Dept Chem & Mat Engn, Tempe, AZ 85287 USA.
RP Massia, S (reprint author), Arizona State Univ, Harrington Dept Bioengn, POB 879709, Tempe, AZ 85287 USA.
EM smassia@asu.edu
CR BOTHRA S, 1994, J ELECT MAT, V23, P825
   DUDLEY B, 1997, IBM TECH DISCLOSURE, V40, P119
   FINCHEM E, 1994, P US C GAAS MAN TECH, P163
   GARROU PE, 1997, 1 JOINT INT EL MAN S, P261
   KANE CF, 1995, IEEE PHOTONIC TECH L, V7, P535, DOI 10.1109/68.384535
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   MASSIA SP, 2003, IN PRESS BIOMATERIAL, V24
   MATSUI K, 1995, P ISHM, P396
   Mills ME, 1997, MICROELECTRON ENG, V33, P327, DOI 10.1016/S0167-9317(96)00061-5
   MIS JD, 1996, P INT S MICR, P295
   PERETTIE D, 1992, P SOC PHOTO-OPT INS, V1665, P331, DOI 10.1117/12.60402
   Rogers B, 1997, 3RD INTERNATIONAL SYMPOSIUM ON ADVANCED PACKAGING MATERIALS - PROCESSES, PROPERTIES, AND INTERFACES - PROCEEDINGS, P15, DOI 10.1109/ISAPM.1997.581244
   Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800
   ROWLAND SA, 1995, J APPL BIOMATER, V6, P1, DOI 10.1002/jab.770060102
   SKINNER P, 1996, INT J MICROCIRCUITS, V18, P358
   Trudel J, 2002, BIOMATERIALS, V23, P3299, DOI 10.1016/S0142-9612(02)00009-1
NR 17
TC 4
Z9 4
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 10
BP 1105
EP 1116
DI 10.1163/156856203769231592
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 753BA
UT WOS:000187210500007
PM 14661882
DA 2018-10-20
ER

PT J
AU Hu, YQ
   Zhu, KJ
AF Hu, YQ
   Zhu, KJ
TI Preparation, characterization and properties of poly(2,2-dimethyl
   trimethylene carbonate-co-epsilon-caprolactone)-block-poly(ethylene
   glycol)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biodegradable polymers; poly(epsilon-caprolactone); poly(ethylene
   glycol); poly (2,2-dimethyl trimethylene
   carbonate-co-epsilon-caprolactone)-block-poly(ethylene glycol)
ID RING-OPENING POLYMERIZATION; PLA/PEO/PLA TRIBLOCK COPOLYMERS;
   EPSILON-CAPROLACTONE; 2,2-DIMETHYLTRIMETHYLENE CARBONATE; POLY(ETHYLENE
   GLYCOL); HYDROLYTIC DEGRADATION; BLOCK COPOLYMERS; L-LACTIDE; POLYMERS;
   ACID
AB Degradable terpolymers were synthesized by bulk copolymerization of 2,2-dimethyl trimethyle necarbonate (DTC), epsilon-caprolactone (CL) and poly(ethylene glycol) (PEG) using stannous octoate as catalyst at 140degreesC for 36 h. The molar ratio in feed of DTC to CL was fixed at 20: 80. The molecular weight and the mol% of PEG were varied in order to obtain copolymers with different properties. The copolymers were characterized by H-1-NMR, C-13-NMR, FT-IR, GPC and DSC. It was found that the hydrophilicity of these materials increased with increasing PEG content in the copolymers, according to the measurements of static contact angles of distilled water on the surface of polymer films. Mechanical tests and hydrolytic degradation assays showed that copolymers of different degradability and mechanical properties could be tailored by adjusting the compositions. For the copolymer T-4 (11.9 mol% of PEG with Mn 2000), the tensile strength and the elastic modulus could reach 6.2 MPa and 25 MPa, respectively. It took only 4 weeks for the copolymer T-4 to degrade to 83% (M-n,M-t /M-n,M-0) and 10 weeks to 63% in 0.1 M PBS at pH 7.4 and 37degreesC. There was no obvious acceleration of degradation rate in vivo in comparison with that in vitro. These materials might be useful for nerve regeneration guides and other biomedical applications.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Zhu, KJ (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
EM kjzhu@ipsm.zju.edu.cn
CR BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   Barrows TH, 1986, CLIN MATER, V1, P233
   Bogdanov B, 1998, POLYMER, V39, P1631, DOI 10.1016/S0032-3861(97)00444-8
   Cai J, 1998, POLYMER, V39, P4409, DOI 10.1016/S0032-3861(97)10346-9
   CERRAI P, 1989, POLYMER, V30, P338, DOI 10.1016/0032-3861(89)90126-2
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   CUTRIGHT DE, 1972, ORAL SURG ORAL MED O, V33, P28, DOI 10.1016/0030-4220(72)90204-6
   ENDO M, 1987, MACROMOLECULES, V20, P2982, DOI 10.1021/ma00178a005
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Fambri L, 1997, POLYMER, V38, P79, DOI 10.1016/S0032-3861(96)00486-7
   Gan ZH, 1996, J APPL POLYM SCI, V59, P961, DOI 10.1002/(SICI)1097-4628(19960207)59:6<961::AID-APP8>3.0.CO;2-N
   GRIJPMA DW, 1991, POLYM BULL, V25, P327, DOI 10.1007/BF00316902
   HARRIS JM, 1985, J MACROMOL SCI R M C, VC25, P325, DOI 10.1080/07366578508081960
   HOLLINGER JO, 1983, J BIOMED MATER RES, V17, P71, DOI 10.1002/jbm.820170107
   HOVESTADT W, 1992, POLYMER, V33, P1941, DOI 10.1016/0032-3861(92)90497-K
   Jiang HL, 1999, POLYM INT, V48, P47, DOI 10.1002/(SICI)1097-0126(199901)48:1<47::AID-PI107>3.0.CO;2-X
   KEUL H, 1988, MAKROMOL CHEM, V189, P2303
   Kowalski A, 2000, MACROMOLECULES, V33, P1964, DOI 10.1021/ma991751s
   KRICHELDORF HR, 1984, MACROMOLECULES, V17, P2173, DOI 10.1021/ma00140a051
   KRICHELDORF HR, 1988, MACROMOLECULES, V21, P286, DOI 10.1021/ma00180a002
   KRICHELDORF HR, 1991, MAKROMOL CHEM, V192, P2391
   Kricheldorf HR, 1998, MACROMOL CHEM PHYSIC, V199, P283, DOI 10.1002/(SICI)1521-3935(19980201)199:2<283::AID-MACP283>3.3.CO;2-0
   Lee SY, 1999, EUR POLYM J, V35, P2147, DOI 10.1016/S0014-3057(99)00024-5
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   LUNDBERG RD, 1969, J POLYM SCI A1, V7, P2915, DOI 10.1002/pol.1969.150071014
   PASCH H, 1995, J CHROMATOGR A, V699, P21, DOI 10.1016/0021-9673(95)00061-Q
   Qian HT, 2000, POLYM DEGRAD STABIL, V68, P423, DOI 10.1016/S0141-3910(00)00031-8
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   Schmidt P, 1996, MACROMOLECULES, V29, P3674, DOI 10.1021/ma951489x
   SEARLES S, 1960, J AM CHEM SOC, V82, P2928, DOI 10.1021/ja01496a062
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WURM B, 1992, MAKROMOL CHEM-RAPID, V13, P9
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
NR 33
TC 2
Z9 2
U1 1
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 12
BP 1363
EP 1376
DI 10.1163/156856203322599707
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 770XU
UT WOS:000188757300005
PM 14870940
DA 2018-10-20
ER

PT J
AU Xu, RJ
   Manias, E
   Snyder, AJ
   Runt, J
AF Xu, RJ
   Manias, E
   Snyder, AJ
   Runt, J
TI Low permeability biomedical polyurethane nanocomposites
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyurethane; nanocomposite; permeability; cardiac assist device;
   membrane
ID LAYERED SILICATE NANOCOMPOSITES; POLY(URETHANE UREA); MODEL;
   TEMPERATURE; COPOLYMERS; MORPHOLOGY
AB In this article we describe our continuing research on a novel nanocomposite approach for reducing gas permeability through biomedical polyurethane membranes. Nanocomposites were prepared using commercially available poly(urethane urea)s (PUU) and two organically modified layered silicates (OLS). Wide-angle X-ray diffraction experiments showed that the silicate layer spacing in the nanocomposites increased significantly compared with the neat OLS, signifying the formation of intercalated PUU/OLS structures. The nanocomposite materials exhibit increased modulus with increasing OLS content, while maintaining polymer strength and ductility. Water vapor permeability was reduced by about fivefold at the highest OLS contents, as a result of PUU/inorganic composite formation. (C) 2002 Wiley Periodicals, Inc.
C1 Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
   Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA.
   Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Surg, Hershey, PA 17033 USA.
RP Runt, J (reprint author), Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
EM runt@matse.psu.edu
RI Manias, Evangelos/A-7557-2011; He, Yong/F-8752-2012
OI Manias, Evangelos/0000-0003-0705-0601; 
FU NHLBI NIH HHS [N01-HV-58156]
CR Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7
   Coleman MM, 1997, MACROMOL CHEM PHYSIC, V198, P117, DOI 10.1002/macp.1997.021980110
   CUSSLER EL, 1988, J MEMBRANE SCI, V38, P161, DOI 10.1016/S0376-7388(00)80877-7
   Fredrickson GH, 1999, J CHEM PHYS, V110, P2181, DOI 10.1063/1.477829
   Garrett JT, 2002, MACROMOLECULES, V35, P161, DOI 10.1021/ma010915d
   Giannelis EP, 1999, ADV POLYM SCI, V138, P107
   Krishnamoorti R, 1996, CHEM MATER, V8, P1728, DOI 10.1021/cm960127g
   LeBaron PC, 1999, APPL CLAY SCI, V15, P11, DOI 10.1016/S0169-1317(99)00017-4
   Lincoln DM, 2001, POLYMER, V42, P9975, DOI 10.1016/S0032-3861(01)00542-0
   Manias E, 2001, CHEM MATER, V13, P3516, DOI 10.1021/cm0110627
   McCarthy SJ, 1997, BIOMATERIALS, V18, P1387, DOI 10.1016/S0142-9612(97)00083-5
   MEUSE CW, 1992, MACROMOLECULES, V25, P925, DOI 10.1021/ma00028a064
   PAIKSUNG CS, 1980, MACROMOLECULES, V13, P117, DOI 10.1021/ma60073a023
   Strawhecker KE, 2000, CHEM MATER, V12, P2943, DOI 10.1021/cm000506g
   Vaia RA, 1997, MACROMOLECULES, V30, P7990, DOI 10.1021/ma9514333
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Wang Z, 1998, CHEM MATER, V10, P3769, DOI 10.1021/cm980448n
   Weisberg DM, 2000, MACROMOLECULES, V33, P4380, DOI 10.1021/ma9919920
   WEISBERG DM, 2002, UNPUB
   WEN J, 1997, MACROMOLECULES, V16, P7206
   Xu RJ, 2001, MACROMOLECULES, V34, P337, DOI 10.1021/ma0013657
   Yang MJ, 1999, J BIOMED MATER RES, V48, P13
   YEH J, 1994, J MATER SCI LETT, V13, P1390, DOI 10.1007/BF00405040
   Zilg C, 1999, ADV MATER, V11, P49, DOI 10.1002/(SICI)1521-4095(199901)11:1<49::AID-ADMA49>3.0.CO;2-N
NR 24
TC 69
Z9 71
U1 0
U2 9
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN 1
PY 2003
VL 64A
IS 1
BP 114
EP 119
DI 10.1002/jbm.a.10377
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 670RQ
UT WOS:000182423000013
PM 12483703
DA 2018-10-20
ER

PT J
AU Knowles, JC
AF Knowles, JC
TI Phosphate based glasses for biomedical applications
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID CONTROLLED-RELEASE GLASS; POLYHYDROXYBUTYRATE COMPOSITE; DEGRADABLE
   COMPOSITES; OXYNITRIDE GLASSES; SOLUBLE GLASSES; BONE; FLUORIDE;
   METAPHOSPHATE; POLYMER; SYSTEM
AB Biomaterials and tissue engineering are rapidly expanding fields for research and also commercial exploitation. A greater understanding of the interaction of materials with cells has allowed implant materials to be designed with the aim of promoting a specific biological response. Phosphate-based glasses are a unique group of materials that offer great potential for hard and soft tissue engineering. The move from passive inert implant materials to active degradable materials indicates that phosphate glasses may have a role in tissue engineering. Whilst significant work has been carried out to elucidate the structure of these materials, there is a paucity of data to correlate this information with the physical properties such as dissolution rate. This paper details some of the basic properties of these materials and how these may be exploited in the design of a biomaterial. Also a review of some of the current and potential clinical uses for these materials is included.
C1 UCL, Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
RP Knowles, JC (reprint author), UCL, Eastman Dent Inst, Div Biomat & Tissue Engn, 256 Grays Inn Rd, London WC1X 8LD, England.
RI Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446
CR ABDULHALIM I, 1994, OPT QUANT ELECTRON, V26, P997, DOI 10.1007/BF00304999
   Abrahams I, 1997, J CHEM SOC DALTON, P1483, DOI 10.1039/a701029j
   AHMED I, 2003, BIOMATERIALS, DOI DOI 10.1016/S0142-9612(03)00547-7
   ALLEN WM, 1984, VET REC, V115, P55, DOI 10.1136/vr.115.3.55
   ALLEN WM, 1978, VET SCI COMMUN, V2, P73, DOI 10.1007/BF02291434
   ALLEN WM, 1982, VET PHARM TOXICOL, P183
   ALLEN WM, 1984, TEMA, V5, P1
   ALLEN WM, 1985, VET REC, V116, P174
   Babin V, 2003, PHYS STATUS SOLIDI A, V196, P484, DOI 10.1002/pssa.200306449
   Batyaev IM, 2003, TECH PHYS LETT+, V29, P327, DOI 10.1134/1.1573305
   BROW RK, 1990, J NON-CRYST SOLIDS, V116, P39, DOI 10.1016/0022-3093(90)91043-Q
   Cartmell SH, 1998, J MATER SCI-MATER M, V9, P1, DOI 10.1023/A:1008830025416
   CHEN WS, 1991, BIOMATERIALS, V12, P561, DOI 10.1016/0142-9612(91)90051-B
   Click CA, 2003, J NON-CRYST SOLIDS, V319, P95, DOI 10.1016/S0022-3093(02)01962-2
   Clifford A, 2001, J MATER SCI, V36, P3955, DOI 10.1023/A:1017974306184
   Cole JM, 2001, J PHYS-CONDENS MAT, V13, P4105, DOI 10.1088/0953-8984/13/18/318
   Cole JM, 2001, J PHYS-CONDENS MAT, V13, P6659, DOI 10.1088/0953-8984/13/31/307
   CURZON MEJ, 1988, CARIES RES, V22, P99
   Das SS, 2003, J POWER SOURCES, V114, P346, DOI 10.1016/S0378-7753(02)00604-3
   Delahaye F, 1998, J NON-CRYST SOLIDS, V242, P25, DOI 10.1016/S0022-3093(98)00784-4
   Fernandez M, 2002, J MATER SCI-MATER M, V13, P1251, DOI 10.1023/A:1021135314619
   Franks K, 2000, J MATER SCI-MATER M, V11, P609, DOI 10.1023/A:1008949527695
   FRANKS K, 2000, THESIS U LONDON
   Gilchrist T, 1998, BRIT J PLAST SURG, V51, P231, DOI 10.1054/bjps.1997.0243
   GILCHRIST T, 1991, BIOMATERIALS, V12, P76, DOI 10.1016/0142-9612(91)90136-X
   Gough JE, 2002, J BIOMED MATER RES, V59, P481, DOI 10.1002/jbm.10020
   Hoppe U, 1996, J NON-CRYST SOLIDS, V195, P138, DOI 10.1016/0022-3093(95)00524-2
   Hudgens JJ, 1998, J NON-CRYST SOLIDS, V223, P21, DOI 10.1016/S0022-3093(97)00347-5
   Hwang BC, 1999, ELECTRON LETT, V35, P1007, DOI 10.1049/el:19990668
   KIRKPATRICK RJ, 1995, SOLID STATE NUCL MAG, V5, P9, DOI 10.1016/0926-2040(95)00042-O
   Knowles J. C., 1994, BIOCERAMICS, V7, P85
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   KNOWLES JC, 1994, J INTEL MAT SYST STR, V5, P122, DOI 10.1177/1045389X9400500115
   Knowles JC, 2001, BIOMATERIALS, V22, P3091, DOI 10.1016/S0142-9612(01)00057-6
   KNOWLES JC, 1993, J MATER SCI-MATER M, V4, P102, DOI 10.1007/BF00120377
   Latia A, 2003, J OPTOELECTRON ADV M, V5, P185
   Lenihan DV, 1998, J HAND SURG-BRIT EUR, V23B, P588, DOI 10.1016/S0266-7681(98)80007-7
   LOEHMAN RE, 1980, J NON-CRYST SOLIDS, V42, P433, DOI 10.1016/0022-3093(80)90042-3
   LU YL, 1995, J MATER SCI, V30, P5705, DOI 10.1007/BF00356709
   Luklinska ZB, 1997, J MATER SCI-MATER M, V8, P379, DOI 10.1023/A:1018589018205
   MARTIN SW, 1991, EUR J SOL STATE INOR, V28, P163
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mountjoy G, 2001, J NON-CRYST SOLIDS, V279, P20, DOI 10.1016/S0022-3093(00)00406-3
   Mulligan AM, 2003, BIOMATERIALS, V24, P1797, DOI 10.1016/S0142-9612(02)00577-X
   MULLIGAN AM, 2003, IN PRESS J BIOMED MA
   Ni J, 2002, MAT SCI ENG C-BIO S, V20, P101, DOI 10.1016/S0928-4931(02)00019-X
   Ravikumar RVSSN, 2003, SOLID STATE COMMUN, V126, P251, DOI 10.1016/s0038-1098(03)00132-7
   REIDMEYER MR, 1995, J NON-CRYST SOLIDS, V181, P201, DOI 10.1016/S0022-3093(94)00511-7
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Salih V, 2000, J MATER SCI-MATER M, V11, P615, DOI 10.1023/A:1008901612674
   Savitski VG, 2003, APPL PHYS B-LASERS O, V76, P253, DOI 10.1007/s00340-002-1070-x
   SCHRIMPF C, 1983, J NON-CRYST SOLIDS, V56, P153, DOI 10.1016/0022-3093(83)90461-1
   Shelby JE, 1997, INTRO GLASS SCI TECH
   Shih PY, 2003, MATER CHEM PHYS, V80, P299, DOI 10.1016/S0254-0584(02)00516-3
   SWENSON J, 2003, PHYS REV LETT, V90
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   TOUMBA KJ, 1993, CARIES RES, V27, P43, DOI 10.1159/000261601
   Toumba KJ, 1997, J DENT RES, V76, P1041
   Toumba KJ, 1997, J DENT RES, V76, P964
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Ylinen P, 2002, INT J ORAL MAX SURG, V31, P405, DOI 10.1054/ijom.2002.0252
   Zachariasen WH, 1932, J AM CHEM SOC, V54, P3841, DOI 10.1021/ja01349a006
NR 62
TC 221
Z9 223
U1 3
U2 57
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2003
VL 13
IS 10
BP 2395
EP 2401
DI 10.1039/b307119g
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 724PT
UT WOS:000185496500001
DA 2018-10-20
ER

PT J
AU Pugh, DV
   Dursun, A
   Corcoran, SG
AF Pugh, DV
   Dursun, A
   Corcoran, SG
TI Formation of nanoporous platinum by selective dissolution of Cu from
   Cu0.75Pt0.25
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID STRESS-CORROSION CRACKING; MOLTEN CALCIUM-CHLORIDE; SCATTERING
   PROPERTIES; BINARY-ALLOYS; COPPER; MECHANISM; KINETICS; AL2CUMG; METALS;
   MODEL
AB This paper gives results demonstrating the production of nanoporous platinum through the de-alloying of Cu0.75Pt0.25 alloy in 1 M H2SO4. Both field emission scanning electron microscopy and small angle neutron scattering confirm the presence of porosity with a diameter of approximately 3.4 nm. This is the smallest porosity quantitatively reported from a de-alloying process to date. The small size is attributed to the extremely small values of surface diffusivity expected for Pt at room temperature, effectively eliminating room-temperature coarsening processes. The results also show that larger length scales can be achieved through coarsening at elevated temperatures. The ease of production of porous platinum makes it attractive for possible applications, such as high surface area electrodes for biomedical devices or as catalyst materials.
C1 Virginia Polytech Inst & State Univ, Dept Mat Sci & Engn, Blacksburg, VA 24061 USA.
RP Pugh, DV (reprint author), Virginia Polytech Inst & State Univ, Dept Mat Sci & Engn, Blacksburg, VA 24061 USA.
CR Abrams R.B., 1922, Transactions of the American Electrochemical Society, V42, P39
   Agamalian M, 1997, J APPL CRYSTALLOGR, V30, P345, DOI 10.1107/S0021889896014343
   Ateya BG, 1997, J ELECTROCHEM SOC, V144, P2606, DOI 10.1149/1.1837872
   BERK NF, 1987, PHYS REV LETT, V58, P2718, DOI 10.1103/PhysRevLett.58.2718
   BERK NF, 1991, PHYS REV A, V44, P5069, DOI 10.1103/PhysRevA.44.5069
   Buchheit RG, 1997, J ELECTROCHEM SOC, V144, P2621, DOI 10.1149/1.1837874
   CAHN JW, 1965, J CHEM PHYS, V42, P93, DOI 10.1063/1.1695731
   CASSAGNE TB, 1986, METALL TRANS A, V17, P703, DOI 10.1007/BF02643991
   Chen GZ, 2000, NATURE, V407, P361, DOI 10.1038/35030069
   CHEN JS, 1993, CORROS SCI, V34, P2071, DOI 10.1016/0010-938X(93)90061-K
   CHEN SH, 1991, J APPL CRYSTALLOGR, V24, P721, DOI 10.1107/S0021889891001462
   CHEN SH, 1990, PROG COLL POL SCI S, V81, P30
   Corcoran SG, 1997, MATER RES SOC SYMP P, V451, P93
   CORCORAN SG, 1999, P EL SOC S CRIT FACT, V3, P500
   CORCORAN SG, 1994, P S SCATT MAT SCI MA, V2, pA377
   CORCORAN SG, 2002, UNPUB
   Dimitrov N, 2000, J ELECTROCHEM SOC, V147, P3283, DOI 10.1149/1.1393896
   DURSUN A, UNPUB
   Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529
   FORTY AJ, 1980, PHILOS MAG A, V42, P295, DOI 10.1080/01418618008239360
   Fray D, 2000, MRS BULL, V25, P11
   FRITZ JD, 1991, J ELECTROCHEM SOC, V138, P3209, DOI 10.1149/1.2085394
   GARDIAZABAL JI, 1980, J ELECTROCHEM SOC, V127, P259, DOI 10.1149/1.2129652
   GARDIAZABAL JI, 1980, J ELECTROCHEM SOC, V127, P255, DOI 10.1149/1.2129651
   KABIUS B, 1986, SURFACES INHIBITION, P562
   KELLY RG, 1993, AM SOC TEST MATER, V1188, P94, DOI 10.1520/STP18065S
   LI R, 1992, PHYS REV LETT, V68, P1168, DOI 10.1103/PhysRevLett.68.1168
   MOFFAT TP, 1991, J ELECTROCHEM SOC, V138, P3224, DOI 10.1149/1.2085396
   Newman R. C., 1989, British Corrosion Journal, V24, P143
   NEWMAN RC, 1988, CORROS SCI, V28, P1183, DOI 10.1016/0010-938X(88)90127-8
   PICKERING HW, 1983, CORROS SCI, V23, P1107, DOI 10.1016/0010-938X(83)90092-6
   PICKERING HW, 1967, J ELECTROCHEM SOC, V114, P698, DOI 10.1149/1.2426709
   PICKERING HW, 1982, CORROS SCI, V22, P621, DOI 10.1016/0010-938X(82)90043-9
   Pickering HW, 1967, FUNDAMENTAL ASPECTS, P159
   PRYOR MJ, 1984, J ELECTROCHEM SOC, V131, P1230, DOI 10.1149/1.2115793
   PUGH D, UNPUB
   SIERADZKI K, 1989, PHILOS MAG A, V59, P713, DOI 10.1080/01418618908209817
   SIERADZKI K, 1985, PHILOS MAG A, V51, P95, DOI 10.1080/01418618508245272
   SIERADZKI K, 1987, J PHYS CHEM SOLIDS, V48, P1101, DOI 10.1016/0022-3697(87)90120-X
   SIERADZKI K, 1993, J ELECTROCHEM SOC, V140, P2868, DOI 10.1149/1.2220924
   SIERADZKI K, 2002, J ELECTROCHEM SOC, V149, P370
   SIERADZKI K, UNPUB
   Simmonds MC, 1998, CORROS SCI, V40, P43, DOI 10.1016/S0010-938X(97)00109-1
   Smith AJ, 1999, J APPL ELECTROCHEM, V29, P1085, DOI 10.1023/A:1003637410133
   SWANN PR, 1969, CORROSION, V25, P147, DOI 10.5006/0010-9312-25.4.147
   TEUBNER M, 1987, AIP, V5, P3195
   TISCHER RP, 1958, Z ELEKTROCHEM, V62, P50
   TOMSETT AD, 1987, APPL CATAL, V33, P119, DOI 10.1016/S0166-9834(00)80588-6
   TOMSETT AD, 1990, J MATER SCI, V25, P4106, DOI 10.1007/BF00582489
   WILLIAMS DE, 1991, NATURE, V350, P216, DOI 10.1038/350216a0
NR 50
TC 188
Z9 191
U1 4
U2 78
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD JAN
PY 2003
VL 18
IS 1
BP 216
EP 221
DI 10.1557/JMR.2003.0030
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 634VW
UT WOS:000180363400030
DA 2018-10-20
ER

PT J
AU Baidya, KP
   Ramakrishna, S
   Rahman, M
   Ritchie, A
   Huang, ZM
AF Baidya, KP
   Ramakrishna, S
   Rahman, M
   Ritchie, A
   Huang, ZM
TI An investigation on the polymer composite medical device-external
   fixator
SO JOURNAL OF REINFORCED PLASTICS AND COMPOSITES
LA English
DT Article
DE fiber reinforced polymer composite; Ilizarov external fixator;
   radiolucency; total mass attenuation coefficient (TMAC); in-plane
   compressive strength; axial stiffness
ID VERTEBRAL BODY REPLACEMENT; RADIOLUCENT
AB Primary impetus for the development of composite materials for medical usage came from orthopedic implant application. In case of metal alloys stiffness mismatch causes stress shielding in applications such as bone plates, total hip replacement, and total knee replacement. Moreover, the metal alloys and ceramics are radio opaque, and in some cases they result in undesirable artifacts in X-ray radiography. In the case of polymer composite materials the radio transparency can be adjusted by adding contrast medium to the polymer. More over the polymer composite materials are fully compatible with the modern diagnostic methods such as computed tomography (CT) and magnetic resonance imaging (MRI) as they are non-magnetic.
   The current study reports the development of a radiolucent fiber reinforced polymer composite material for a biomedical device, Ilizarov external fixator. Material fabrication and characterization are described. Quantitative X-ray radiographic analysis was carried out to choose the best from the probable materials. The Finite Element Method (FEM) was employed to determine the worst possible in service loading condition, and the ring dimensions were modified accordingly. Half ring prototypes were produced using two types of composite materials: knitted aramid fiber fabric reinforced epoxy and random short carbon (RSC) fiber reinforced epoxy. The in-plane compressive strength and axial stiffness of the complete frame were measured according to ASTM specifications. The performance was evaluated and compared to an existing system in simulated in-service conditions.
C1 Tongji Univ, Dept Engn Mech, Shanghai 200092, Peoples R China.
   Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
   Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Huang, ZM (reprint author), Tongji Univ, Dept Engn Mech, 1239 Siping Rd, Shanghai 200092, Peoples R China.
RI Rahman, Mustafizur/G-1998-2012
CR [Anonymous], 1995, ANN BOOK ASTM STANDA
   [Anonymous], 1997, ANN BOOK ASTM STANDA
   [Anonymous], 1997, STANDARD TEST METHOD
   CARTER DR, 1985, BIOMECH TRAUMA NORWA, P157
   CHOU TW, 1988, TEXTILE STRUCTURE CO, P99
   Christel P., 1991, HIGH PERFORMANCE BIO, P499
   Ciappetta P, 1997, NEUROSURGERY, V41, P1203, DOI 10.1097/00006123-199711000-00040
   Claes L, 1999, J BIOMED MATER RES, V48, P82, DOI 10.1002/(SICI)1097-4636(199921)48:1<82::AID-JBM14>3.3.CO;2-Z
   COMPTON AH, 1935, XRAYS THEORY EXPT
   FLEMING B, 1989, CLIN ORTHOP RELAT R, P95
   FRANKEL VH, 1988, B HOSP JOINT DIS ORT, V48, P17
   FREDRICK J, 1992, CLIN ORTHOP RELAT R, V280, P11
   FREDRICK JK, 1990, B HOSP J DIS ORTHOP, V50, P88
   GOLYAKHOVSKY V, 1993, OPERATIVE MANUAL ILI
   GREEN SA, 1992, CLIN ORTHOP RELAT R, V280, P22
   HUISKES R, 1986, J ORTHOPAED RES, V4, P68, DOI 10.1002/jor.1100040108
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   ILIZAROV GA, 1988, B HOSP JOINT DIS ORT, V48, P1
   KEMPSON GE, 1981, INJURY, V12, P297, DOI 10.1016/0020-1383(81)90205-9
   Lin TW, 1997, J BIOMED MATER RES, V36, P137, DOI 10.1002/(SICI)1097-4636(199708)36:2<137::AID-JBM1>3.0.CO;2-L
   *MACN CORP, 1998, PATR US MAN
   NOMINE AM, 1982, LOW CYCLE FATIGUE LI
   *NUS NUCL MICR DIV, 1999, MASS ATT XDB SOFTW
   OKUDERA H, 1994, ACTA NEUROCHIR, V127, P121, DOI 10.1007/BF01808559
   PAUWELS F, 1980, BIOMECHANICS LOCOMOT
   PODOLSKY A, 1990, T ORTHOP RES, V15, P416
   POWEL PC, 1994, ENG POLYM POLYM LAMI
   Rothbart H. A., 1996, MECH DESIGN HDB
   ROWLEY DI, 1985, ARCH ORTHOP TRAUM SU, V103, P402, DOI 10.1007/BF00435449
   SCHNEIDER E, 1989, CLIN ORTHOP RELAT R, P200
   Skalak R., 1987, HDB BIOENGINEERING
   WHITESIDE LA, 1989, CLIN ORTHOP RELAT R, P138
   WYTCH R, 1991, INJURY, V22, P41, DOI 10.1016/0020-1383(91)90160-G
NR 33
TC 3
Z9 4
U1 1
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 0731-6844
J9 J REINF PLAST COMP
JI J. Reinf. Plast. Compos.
PY 2003
VL 22
IS 6
BP 563
EP 590
DI 10.1106/073168403023292
PG 28
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 679HY
UT WOS:000182915700005
DA 2018-10-20
ER

PT J
AU Yabuta, T
   Bescher, EP
   Mackenzie, JD
   Tsuru, K
   Hayakawa, S
   Osaka, A
AF Yabuta, T
   Bescher, EP
   Mackenzie, JD
   Tsuru, K
   Hayakawa, S
   Osaka, A
TI Synthesis of PDMS-based porous materials for biomedical applications
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 11th International Workshop on Glasses, Cermics, Hydrids and
   Nanocomposites from Gels (Sol-Gel 2001)
CY SEP 16-21, 2001
CL ABANO TERME, ITALY
DE ormosil; porous hybrid; bioactivity; apatite deposition; simulated body
   fluid
ID ORGANICALLY MODIFIED SILICATES; APATITE FORMATION; GEL
AB Polydimethylsiloxane (PDMS) and tetraethoxysilane (TEOS)-based porous organically modified silicates (ORMOSILs) for biomedical applications were synthesized through a sol-gel process, using sucrose particles as templates. These materials were characterized by Si-29 CP-MAS NMR spectroscopy, thin film X-ray diffraction, and scanning electron microscopy. Their bioactivity was evaluated using a simulated body fluid (SBF) of Kokubo recipe. These materials had a bimodal porous structure with pores of 300-500 mum and 10-50 mum in diameter. NMR showed that the silanol groups of the PDMS chain cross-linked to silica derived from the hydrolysis and condensation of TEOS. The samples containing Ca(II) exhibited apatite deposition on the pore walls within 3 days in SBF.
C1 Okayama Univ, Fac Engn, Biomat Lab, Okayama 7008530, Japan.
   Univ Calif Los Angeles, Dept Mat Sci, Los Angeles, CA 90095 USA.
RP Yabuta, T (reprint author), Okayama Univ, Fac Engn, Biomat Lab, Okayama 7008530, Japan.
RI HAYAKAWA, Satoshi/B-2104-2011
OI HAYAKAWA, Satoshi/0000-0002-1097-8614
CR BABONNEAU F, 1994, POLYHEDRON, V13, P1123, DOI 10.1016/S0277-5387(00)80249-1
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   HU Y, 1992, J MATER SCI, V27, P4415, DOI 10.1007/BF00541574
   IWAMOTO T, 1993, J NON-CRYST SOLIDS, V159, P65, DOI 10.1016/0022-3093(93)91282-8
   KOKUBO T, 1991, NIPPON SERAM KYO GAK, V99, P965
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Tsuru K, 1997, J MATER SCI-MATER M, V8, P157, DOI 10.1023/A:1018523203667
   WILSON J, 1993, INTRO BIOCERAMICS, P63
   YAMAMURO T, 1993, INTRO BIOCERAMICS, P89
NR 13
TC 33
Z9 36
U1 2
U2 28
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD JAN
PY 2003
VL 26
IS 1-3
BP 1219
EP 1222
DI 10.1023/A:1020772521781
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 607JU
UT WOS:000178789100226
DA 2018-10-20
ER

PT J
AU Lee, LJ
AF Lee, LJ
TI BioMEMS and micro-/nano-processing of polymers - An overview
SO JOURNAL OF THE CHINESE INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Review
DE BioMEMS; biochips; drug delivery; tissue scaffolds; microfluidics;
   microfabrication; nanofabrication
ID SCANNING PROBE LITHOGRAPHY; MU-TAS APPLICATIONS; MESOPOROUS SILICA;
   DRUG-DELIVERY; MICROFLUIDIC DEVICES; IMMUNOSORBENT-ASSAY; RELEASE
   SYSTEMS; IN-VITRO; FABRICATION; MICROFABRICATION
AB The miniaturization of biomedical and biochemical devices for micro-electromechanical systems (BioMEMS) has gained a great deal of attention in recent years. Products include biochips/biosensors, drug delivery devices, tissue scaffolds, and bioreactors. In the past, MEMS devices have been fabricated almost exclusively in silicon, glass or quartz because of the similar technology available in the microelectronics industry. For applications in the biochemistry and biomedical field, polymeric materials are a desirable choice because of their lower cost, good processibility, and biocompatibility. Polymer micro-/nanofabrication techniques, however, are still not well developed. In this paper, we briefly introduce various BioMEMS applications, basic microfluidic principles and functions, and processing techniques for micro-/nano-scale structures.
C1 Ohio State Univ, Dept Chem Engn, Columbus, OH 43210 USA.
RP Lee, LJ (reprint author), Ohio State Univ, Dept Chem Engn, 140 W 19th Ave, Columbus, OH 43210 USA.
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Becker H, 1998, P SOC PHOTO-OPT INS, V3515, P177, DOI 10.1117/12.322081
   Becker H, 2000, ELECTROPHORESIS, V21, P12, DOI 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.3.CO;2-Z
   Bell CL, 1995, ADV POLYM SCI, V122, P125
   Bousse L, 2000, ANNU REV BIOPH BIOM, V29, P155, DOI 10.1146/annurev.biophys.29.1.155
   Branebjerg J, 1996, PROC IEEE MICR ELECT, P441, DOI 10.1109/MEMSYS.1996.494022
   Brott LL, 2001, NATURE, V413, P291, DOI 10.1038/35095031
   Cao X, 2001, BIOMED MICRODEVICES, V3, P109, DOI 10.1023/A:1011494008729
   Carrilho E, 2000, ELECTROPHORESIS, V21, P55
   CHEN JW, 2002, SPE ANTEC P, P1153
   CHOI JW, 2000, SOL STAT SENS ACT WO, P52
   Chou CF, 2000, ELECTROPHORESIS, V21, P81, DOI 10.1002/(SICI)1522-2683(20000101)21:1<81::AID-ELPS81>3.0.CO;2-#
   Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85
   CHOU SY, 2001, MRS BULL, P521
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Conlisk AT, 2002, ANAL CHEM, V74, P2139, DOI 10.1021/ac011198o
   Dam TH, 1999, REV SCI INSTRUM, V70, P3982, DOI 10.1063/1.1150024
   DELUCA PP, 1993, ACS SYM SER, V520, P53
   Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Desai TA, 1999, BIOMED MICRODEVICES, V2, P11, DOI 10.1023/A:1009903215959
   Dunkel K, 1998, J MICROMECH MICROENG, V8, P301, DOI 10.1088/0960-1317/8/4/007
   Edwards DA, 2002, AICHE J, V48, P2, DOI 10.1002/aic.690480102
   EHRFELD W, 1995, RADIAT PHYS CHEM, V45, P349, DOI 10.1016/0969-806X(93)E0007-R
   Eichman J. D., 2000, PHARM SCI TECHNOL TO, V3, P232, DOI DOI 10.1016/S1461-5347(00)00273-X
   ELWENSPOEK M, 1994, J MICROMECH MICROENG, V4, P227, DOI 10.1088/0960-1317/4/4/008
   Evans J, 1997, PROC IEEE MICR ELECT, P96
   FAHRENBERG J, 1995, J MICROMECH MICROENG, V5, P169, DOI 10.1088/0960-1317/5/2/029
   FINDLAY JB, 1993, CLIN CHEM, V39, P1927
   Freemantle M, 1999, CHEM ENG NEWS, V77, P27, DOI 10.1021/cen-v077n008.p027
   Gad-el-Hak M, 1999, J FLUID ENG-T ASME, V121, P5, DOI 10.1115/1.2822013
   Gallardo BS, 1999, SCIENCE, V283, P57, DOI 10.1126/science.283.5398.57
   Giordano N, 2001, J PHYS-CONDENS MAT, V13, pR271, DOI 10.1088/0953-8984/13/15/201
   Glasgow IK, 1999, SENSOR MATER, V11, P269
   Goll C, 1997, J MICROMECH MICROENG, V7, P224, DOI 10.1088/0960-1317/7/3/038
   Gracias DH, 2002, ADV MATER, V14, P235, DOI 10.1002/1521-4095(20020205)14:3<235::AID-ADMA235>3.0.CO;2-B
   Green PW, 1995, J MICROELECTROMECH S, V4, P170, DOI 10.1109/84.475543
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   GUAN J, 2002, FABRICATION POLYM MI
   HAGMANN P, 1989, INT POLYM PROC, V4, P188, DOI 10.3139/217.890188
   Handique K, 2000, ANAL CHEM, V72, P4100, DOI 10.1021/ac000064s
   HANEMANN T, POLYM PREPRINTS, V39, P657
   HANSFORD D, 2002, COMMUNICATION
   Harsh KF, 1999, SENSOR ACTUAT A-PHYS, V77, P237, DOI 10.1016/S0924-4247(99)00220-4
   Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+
   Ho CM, 1998, ANNU REV FLUID MECH, V30, P579, DOI 10.1146/annurev.fluid.30.1.579
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huo QS, 1997, CHEM MATER, V9, P14, DOI 10.1021/cm960464p
   Jacak L., 2000, European Journal of Physics, V21, P487, DOI 10.1088/0143-0807/21/6/301
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Jensen KF, 1999, AICHE J, V45, P2051, DOI 10.1002/aic.690451003
   Jeoung E, 2001, LANGMUIR, V17, P6396, DOI 10.1021/la010531g
   Juang YJ, 2002, POLYM ENG SCI, V42, P539, DOI 10.1002/pen.10970
   Jun TK, 1998, J APPL PHYS, V83, P5658, DOI 10.1063/1.367419
   Kaetsu I, 1999, RADIAT PHYS CHEM, V55, P193, DOI 10.1016/S0969-806X(98)00326-0
   KANG K, 2002, UNPUB RHEOL ACTA
   KELLY KW, 1999, P NOV MICR OPT BIOM
   Kim KJ, 1997, J MEMBRANE SCI, V123, P303, DOI 10.1016/S0376-7388(96)00232-3
   KING KR, 2002, MRS SPR S
   Koch M, 1998, J MICROMECH MICROENG, V8, P123, DOI 10.1088/0960-1317/8/2/020
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Kricka LJ, 2001, CLIN CHIM ACTA, V307, P219, DOI 10.1016/S0009-8981(01)00451-X
   Krishnan M, 2001, CURR OPIN BIOTECH, V12, P92, DOI 10.1016/S0958-1669(00)00166-X
   Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129
   KROGER N, 2000, BIOMINERALISATION, P151
   Kulinsky L, 1999, PROC SPIE, V3606, P158, DOI 10.1117/12.350057
   LAI S, 2002, ANN TECH C SOC PLAST, V3, P2703
   Lai SY, 2002, MATER RES SOC SYMP P, V729, P17
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Langer R, 1998, NATURE, V392, P5
   Lanza R. P., 1995, SCI AM SCI MED, P16
   Lauks IR, 1998, ACCOUNTS CHEM RES, V31, P317, DOI 10.1021/ar9700670
   LEE LJ, IN PRESS PRINCIPLES
   Lee M, 2001, MOL THER, V4, P339, DOI 10.1006/mthe.2001.0458
   Li Y., 2001, BIOTECHNOL BIOPROC E, V6, P311
   LIU RH, 2000, SOL STAT SENS ACT WO, P222
   Lowman AM, 1997, MACROMOLECULES, V30, P4959, DOI 10.1021/ma970399k
   LUM P, 1999, Patent No. 5932315
   Madou M. J., 2002, FUNDAMENTALS MICROFA
   Madou MJ, 2001, BIOMED MICRODEVICES, V3, P245, DOI 10.1023/A:1011419515576
   Madou MJ, 1998, P SOC PHOTO-OPT INS, V3259, P80, DOI 10.1117/12.307314
   MADOU MJ, 2001, COMMUNICATION
   MARTONE C, 1996, RIV STOR LETT RELIG, V32, P173
   McCormick RM, 1997, ANAL CHEM, V69, P2626, DOI 10.1021/ac9701997
   Metz S, 2001, LAB CHIP, V1, P29, DOI 10.1039/b103896f
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Momma C, 1997, APPL SURF SCI, V109, P15, DOI 10.1016/S0169-4332(96)00613-7
   MORONEY RM, 1990, ULTR S P HON HI, V1, P355
   MURPHY JC, 2002, APPL SPECTROSC, V56, pA16
   Piotter V, 1997, P SOC PHOTO-OPT INS, V3223, P91, DOI 10.1117/12.284469
   Piotter V, 1999, P SOC PHOTO-OPT INS, V3680, P456, DOI 10.1117/12.341233
   Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534
   Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536
   Ramos BL, 1996, ANAL CHEM, V68, P1245, DOI 10.1021/ac950579x
   RANSOHOFF TC, 1987, AICHE J, V33, P753, DOI 10.1002/aic.690330508
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Roberts MA, 1997, ANAL CHEM, V69, P2035, DOI 10.1021/ac961038q
   Rossier JS, 2001, LAB CHIP, V1, P153, DOI 10.1039/b104772h
   Ruprecht R, 1995, P SOC PHOTO-OPT INS, V2639, P146, DOI 10.1117/12.221272
   Sammarco TS, 1999, AICHE J, V45, P350, DOI 10.1002/aic.690450215
   Sanders GHW, 2000, TRAC-TREND ANAL CHEM, V19, P364, DOI 10.1016/S0165-9936(00)00011-X
   Santini JT, 1999, NATURE, V397, P335
   Sato K, 2000, ANAL CHEM, V72, P1144, DOI 10.1021/ac991151r
   Sayah A, 2000, SENSOR ACTUAT A-PHYS, V84, P103, DOI 10.1016/S0924-4247(99)00346-5
   Schaffer E, 2000, NATURE, V403, P874
   Scheer HC, 2001, MICROELECTRON ENG, V56, P311, DOI 10.1016/S0167-9317(01)00569-X
   Schift H, 2001, NANOTECHNOLOGY, V12, P173, DOI 10.1088/0957-4484/12/2/321
   Schift H, 2000, MICROELECTRON ENG, V53, P171, DOI 10.1016/S0167-9317(00)00289-6
   Schwarz MA, 2001, LAB CHIP, V1, P1, DOI 10.1039/b103795c
   Schwesinger N, 1996, J MICROMECH MICROENG, V6, P99, DOI 10.1088/0960-1317/6/1/023
   Scranton AB, 1995, ADV POLYM SCI, V122, P1
   SEIDEL P, 1998, NEXT GENERATION LITH
   Shrewsbury PJ, 2001, BIOMED MICRODEVICES, V3, P225, DOI 10.1023/A:1011415414667
   Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724
   Snyder MR, 1999, MOD PLAST, V76, P85
   Stone HA, 2001, AICHE J, V47, P1250, DOI 10.1002/aic.690470602
   Stroock AD, 2000, PHYS REV LETT, V84, P3314, DOI 10.1103/PhysRevLett.84.3314
   Sugimura H, 1999, J VAC SCI TECHNOL B, V17, P1605, DOI 10.1116/1.590798
   Texter J, 2001, AICHE J, V47, P1706, DOI 10.1002/aic.690470802
   Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126
   Tolbert SH, 1997, SCIENCE, V278, P264, DOI 10.1126/science.278.5336.264
   Torres-Lugo M, 1999, MACROMOLECULES, V32, P6646, DOI 10.1021/ma990541c
   Traitel T, 2000, BIOMATERIALS, V21, P1679, DOI 10.1016/S0142-9612(00)00050-8
   TUCKER CL, 1989, COMPUTER MODELING PO
   Vacanti JP, 1999, LANCET, V354, pSI32
   Vo-Dinh T, 2000, FRESEN J ANAL CHEM, V366, P540, DOI 10.1007/s002160051549
   Wang J, 2001, ELECTROANAL, V13, P983, DOI 10.1002/1521-4109(200108)13:12<983::AID-ELAN983>3.0.CO;2-#
   WANG KL, 2001, OPTICS NANOSTRUCTURE, P515
   WARRINGTON RO, 1999, P NOV MICR OPT BIOME, P67
   Wilder K, 1998, J VAC SCI TECHNOL B, V16, P3864, DOI 10.1116/1.590425
   WIMBERGERFRIEDL R, 1999, P SPE ANTEC, V57, P476
   Woias P, 2000, MESA MG, P277
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yang PD, 1998, CHEM MATER, V10, P2033, DOI 10.1021/cm980201q
   Yu LY, 2002, POLYM ENG SCI, V42, P871, DOI 10.1002/pen.10998
   YUE J, 1991, J AM CHEM SOC, V113, P2665, DOI 10.1021/ja00007a046
   Zhao DY, 1999, CHEM MATER, V11, P1174, DOI 10.1021/cm980782j
NR 140
TC 10
Z9 10
U1 1
U2 10
PU CHINESE INST CHEMICAL ENGINEER
PI TAIPEI
PA NATL TSING HUA UNIV, HSINCHU, DEPT CHEMICAL ENGINEERING, TAIPEI 300,
   TAIWAN
SN 0368-1653
J9 J CHIN INST CHEM ENG
JI J. Chin. Inst. Chem. Eng.
PD JAN
PY 2003
VL 34
IS 1
BP 25
EP 46
PG 22
WC Engineering, Chemical
SC Engineering
GA 670TQ
UT WOS:000182425500006
DA 2018-10-20
ER

PT J
AU Marshall, SJ
   Balooch, M
   Habelitz, S
   Balooch, G
   Gallagher, R
   Marshall, GW
AF Marshall, SJ
   Balooch, M
   Habelitz, S
   Balooch, G
   Gallagher, R
   Marshall, GW
TI The dentin-enamel junction - a natural, multilevel interface
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article; Proceedings Paper
CT International Workshop on Interfaces: Ceramic and metal Interfaces:
   Control at the Atomic Level
CY JUN 23-27, 2002
CL OVIEDO, SPAIN
DE biomedical applications; hardness; interfaces; mechanical properties
ID MECHANICAL-PROPERTIES; DENTINOENAMEL JUNCTION; FRACTURE PROPERTIES;
   HUMAN-TEETH; AFM
AB Teeth contain two major calcified tissues, enamel and dentin, that are joined by an interface known as the dentin-enamel junction (DEJ). Enamel is the hard and brittle outer portion of the tooth that cuts and grinds food and dentin is composed of a tougher biological composite, that can absorb and distribute stresses. The DEJ is a complex and critical structure uniting these two dissimilar calcified tissues and acts to prevent the propagation of cracks from enamel into dentin. The DEJ has a three-level structure, 25-100 mum scallops with their convexities directed toward the dentin and concavities toward the enamel; 2-5 mum microscallops; and a smaller scale structure. Mechanical properties measurements, chemical differences and imaging have been used to determine the functional width of the DEJ. AFM based nanoindentation gave values of 11.8 mum, microRaman yielded a width of 7.0 mum, while the smaller probe used for AFM nanoscratching yielded 2.0 mum, and values from dynamic modulus mapping were less than 1 mum. The unique architecture of the DEJ may account for this variation based on enamel-dentin phase intermixing. The ultimate goal is to use the DEJ as a biomimetic model for other interfaces joining dissimilar materials. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, Div Biomat & Bioengn, San Francisco, CA 94143 USA.
RP Marshall, SJ (reprint author), Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, Div Biomat & Bioengn, Box 0758, San Francisco, CA 94143 USA.
OI Marshall, Grayson W/0000-0001-8921-3253
CR AR Ten Cate, 1994, ORAL HISTOLOGY DEV S
   Bhaskar S. N., 1991, ORBANS ORAL HISTOLOG
   Doerner MF, 1986, J MATER RES, V1, P601, DOI 10.1557/JMR.1986.0601
   ELMOWAFY OM, 1986, J DENT RES, V65, P677, DOI 10.1177/00220345860650050901
   Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2
   Gallagher RR, 2003, J BIOMED MATER RES A, V64A, P372, DOI 10.1002/jbm.a.10436
   Habelitz S, 2001, ARCH ORAL BIOL, V46, P173, DOI 10.1016/S0003-9969(00)00089-3
   Habelitz S, 2001, J STRUCT BIOL, V135, P294, DOI 10.1006/jsbi.2001.4409
   LE TQ, 2001, J DENT RES, V80, P763
   LIN CP, 1994, J DENT RES, V73, P1072, DOI 10.1177/00220345940730050901
   LIN CP, 1993, J HISTOCHEM CYTOCHEM, V41, P381, DOI 10.1177/41.3.8429200
   LIN CP, 1993, STRUCTURE FUNCTION P
   Lingg B, 2003, J DENT RES, V80, P1700
   Marshall G W Jr, 1993, Quintessence Int, V24, P606
   Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z
   Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6
   Pioch T, 1996, Quintessence Int, V27, P711
   RASMUSSEN ST, 1976, J DENT RES, V55, P154, DOI 10.1177/00220345760550010901
   RASMUSSEN ST, 1984, J DENT RES, V63, P1279, DOI 10.1177/00220345840630110501
   SCHOUR, 1960, NOYES ORAL HISTOLOGY
   SCHULZE K, IN PRESS J BIOMED MA
   SCOTT JH, 1971, INTRO DENT ANATOMY
   White SN, 2000, J AM CERAM SOC, V83, P238, DOI 10.1111/j.1151-2916.2000.tb01181.x
   WHITTAKER DK, 1978, J ANAT, V125, P323
   Xu HHK, 1998, J DENT RES, V77, P472, DOI 10.1177/00220345980770030601
NR 25
TC 49
Z9 54
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. European Ceram. Soc.
PY 2003
VL 23
IS 15
BP 2897
EP 2904
DI 10.1016/S0955-2219(03)00301-7
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 722NF
UT WOS:000185381600022
DA 2018-10-20
ER

PT S
AU Papazoglou, TG
   Zacharakis, G
AF Papazoglou, TG
   Zacharakis, G
BE Mueller, G
   Tuchin, VV
   Matvienko, GG
   Werner, C
   Panchenko, VY
TI LIF after excitation with ultrafast laser irradiation, the response of a
   single cell and the effect of its scattering environment
SO LASER APPLICATIONS IN MEDICINE, BIOLOGY AND ENVIRONMENTAL SCIENCE
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Conference on Laser, Applications, and Technologies
CY JUN 22-27, 2002
CL RUSSIAN ACAD, PRESIDIUM BLDG, MOSCOW, RUSSIA
SP M V Lomonosov Moscow State Univ, European Phys Soc, IEEE, Lasers & Electro-Opt Soc, Int Union Pure & Appl Phys, Opt Soc Amer, SPIE Russia Chapter, USAF, European Off Aerosp Res & Dev, Minist Ind, Sci, & Technol Russian Federat, Russian Fdn Basic Res, Minist Educ Russian Federat, United Phys Soc Russian Federat
HO RUSSIAN ACAD, PRESIDIUM BLDG
DE laser-induced fluorescence; ultrafast laser irradiation
ID SPONTANEOUS EMISSION; PHOTON STATISTICS; LOCALIZATION; LIGHT; MEDIA;
   PHYSICS; GENERATION; CRYSTALS
AB New and fascinating field of highly scattering gain media, random lasers and the study of the behavior of such materials of biological significance is presented. Especially the study of the behaviour of various fluorophores embedded in highly scattering matrices. The observed fluorescence signal of the fluorophore quenches in both temporal and spectral domains due to the intense scattering that the photons undergo. This happens when the excitation energy reaches and exceeds a threshold value. Above that value the narrowed fluorescence exhibits the same features as the excitation laser pulse. Lifetime in the order of 50 psec and spectral FWHM in the order of few nanometers are observed. For energies bellow the threshold value the amplification is negligible and the samples behave exactly as those without scatterers. As the excitation energy increases the laser action requirements are fulfilled and the sudden narrowing takes place.
   Similar studies are underway when various fluorophores are embedded in biological tissues. The final goal is to take advantage of this effect towards a more spatially and spectrally confined agent in Photodynamic Therapy of target tissue lesions on skin or other types of superficial lesions. Very promising in the field of skin PDT would be thin polymer sheets with various dyes, which could be applied directly on the lesion and allow the selection of different irradiation wavelengths using the same laser as excitation source. Thus, improving by far the efficiency of the destruction of different types of cancerous cells.
   In the biomedical arena, the materials high conversion efficiency per unit volume (greater than or equal to 50 percent in a 250 mum thickness) allows for wavelength-shifted catheters and laser creams, potentially useful for the removal of tattoos and other skin discolorations. In addition, random lasers can be used for wavelength shifting the installed base of lasers for other applications such as photodynamic therapy where narrow-band excitations are required for drugs such as benzoporphyrin derivatives (BPD). As far as detection is concerned random lasers could be implemented in various applications such as medical imaging. The combined use of these materials with chromophores that are selectively absorbed by malignant tumors and the narrowband emission along with the high-emitted intensity could boost the detection efficiency.
C1 Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Laser & Applicat Div, Iraklion 71110, Greece.
RP Papazoglou, TG (reprint author), Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Laser & Applicat Div, POB 1527, Iraklion 71110, Greece.
RI Papazoglou, Theodore/B-4794-2015
OI Papazoglou, Theodore/0000-0002-2789-8880
CR ANDERSON PW, 1985, PHILOS MAG B, V52, P505, DOI 10.1080/13642818508240619
   Beenakker CWJ, 1998, PHYS REV LETT, V81, P1829, DOI 10.1103/PhysRevLett.81.1829
   Cao H, 1999, PHYS REV LETT, V82, P2278, DOI 10.1103/PhysRevLett.82.2278
   Cao H, 2001, PHYS REV LETT, V86, P4524, DOI 10.1103/PhysRevLett.86.4524
   Frolov SV, 1999, PHYS REV B, V59, pR5284, DOI 10.1103/PhysRevB.59.R5284
   Frolov SV, 1999, OPT COMMUN, V162, P241, DOI 10.1016/S0030-4018(99)00089-9
   GENACK AZ, 1994, NATURE, V368, P400, DOI 10.1038/368400a0
   GOUEDARD C, 1993, J OPT SOC AM B, V10, P2358, DOI 10.1364/JOSAB.10.002358
   JOHN S, 1995, PHYS REV LETT, V74, P3419, DOI 10.1103/PhysRevLett.74.3419
   JOHN S, 1991, PHYS TODAY, V44, P32, DOI 10.1063/1.881300
   LAWANDY NM, 1994, NATURE, V368, P436, DOI 10.1038/368436a0
   LETOKHOV VS, 1968, SOV PHYS JETP-USSR, V26, P835
   Mitchell M, 1997, NATURE, V387, P880, DOI 10.1038/43136
   PRADHAN P, 1994, PHYS REV B, V50, P9644, DOI 10.1103/PhysRevB.50.9644
   RAMAKRISHNA SA, 1999, B INDIAN LASER ACAD, V11, P1
   SIDDIQUE M, 1995, OPT COMMUN, V117, P475, DOI 10.1016/0030-4018(95)00176-9
   Verdeyen J. T., 2000, LASER ELECT
   Wiersma D, 2000, NATURE, V406, P132, DOI 10.1038/35018184
   WIERSMA D, THESIS
   Wiersma DS, 1997, NATURE, V390, P671
   YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059
   Zacharakis G, 2000, OPT LETT, V25, P923, DOI 10.1364/OL.25.000923
NR 22
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5022-7
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5149
BP 29
EP 38
DI 10.1117/12.518633
PG 10
WC Environmental Sciences; Medicine, Research & Experimental; Optics;
   Physics, Applied; Spectroscopy
SC Environmental Sciences & Ecology; Research & Experimental Medicine;
   Optics; Physics; Spectroscopy
GA BX71D
UT WOS:000186183400004
DA 2018-10-20
ER

PT J
AU Ulatowska-Jarza, A
   Komorowska, M
   Podbielska, H
AF Ulatowska-Jarza, A
   Komorowska, M
   Podbielska, H
TI EPR studies of defects in pure sol-gel matrices and their influence on
   cytotoxicity of the material
SO MATERIALS SCIENCE-POLAND
LA English
DT Article
DE sol-gel; xerogel; electron paramagnetic resonance (EPR); cytotoxicity
ID ELECTRON-SPIN-RESONANCE; QUARTZ
AB Sol-gel based biomaterials may be used for various applications, including biomedical ones. In this respect it is important to investigate the influence of sol-gel matrices on biological systems in order to establish their cytotoxic activity. The results of EPR studies of sol-gels are described in this work. They demonstrate that various defects are present in sol-gel matrices: surface defects, peroxy-centres or hydrogen-related centres. These defects arise spontaneously during the gelation, being responsible for cytotoxicity of sol-gels. It was found that the ratio of the number of solvent moles to the number of precursor moles (the molar ratio R) is one of the factors determining the level of cytotoxicity. More defects were present in samples prepared with a lower molar ratio R. A higher concentration of defects was detected in freshly prepared samples, as compared to samples aged for a longer time.
C1 Wroclaw Univ Technol, Inst Phys, Bioopt Grp, PL-50370 Wroclaw, Poland.
RP Ulatowska-Jarza, A (reprint author), Wroclaw Univ Technol, Inst Phys, Bioopt Grp, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.
RI Podbielska, Halina/A-7311-2012
OI Podbielska, Halina/0000-0001-7162-8530
CR CONROY JFT, 2000, J SOL-GEL SCI TECHN, V18, P296
   Griscom D. L., 1990, Reviews of Solid State Science, V4, P565
   GRISCOM DL, 1987, J NON-CRYST SOLIDS, V92, P295, DOI 10.1016/S0022-3093(87)80047-9
   HALLIBURTON LE, 1989, APPL RADIAT ISOTOPES, V40, P859
   Ikeya M., 1993, NEW APPL ELECT SPIN
   Klonkowski AM, 1996, J MATER CHEM, V6, P579, DOI 10.1039/jm9960600579
   Klonkowski AM, 1998, J MATER CHEM, V8, P1245, DOI 10.1039/a708131f
   Klonkowski AM, 1999, MICROPOR MESOPOR MAT, V31, P175, DOI 10.1016/S1387-1811(99)00068-2
   KORDAS G, 1985, J NON-CRYST SOLIDS, V71, P327, DOI 10.1016/0022-3093(85)90303-5
   Ulatowska-Jarza A, 2000, Polim Med, V30, P45
   Ulatowska-Jarza A, 2001, P SOC PHOTO-OPT INS, V4597, P81, DOI 10.1117/12.446641
   ULATOWSKAJARZA A, 2001, THESIS WROCLAW U TEC
   WEIL JA, 1984, PHYS CHEM MINER, V10, P149, DOI 10.1007/BF00311472
   WOLF AA, 1985, J NON-CRYST SOLIDS, V71, P345, DOI 10.1016/0022-3093(85)90305-9
NR 14
TC 1
Z9 1
U1 0
U2 1
PU OFICYNA WYDAWNICZA POLITECHNIKI WROCLAWSKIEJ
PI WROCLAW
PA WYBRZEZE WYSPIANSKIEGO 27, 50-370 WROCLAW, POLAND
SN 0137-1339
J9 MATER SCI-POLAND
JI Mater. Sci.
PY 2003
VL 21
IS 4
BP 487
EP 494
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 760ND
UT WOS:000187839700013
DA 2018-10-20
ER

PT S
AU Amador, R
   Loske, AM
   Sacristan, E
   Rodriguez, AO
AF Amador, R
   Loske, AM
   Sacristan, E
   Rodriguez, AO
BE Bruce, N
   GamboaDeBuen, I
   MartinezDavalos, A
   RodriguezVillafuerte, M
TI Magnetic resonance imaging applied to biomedical porous media
SO MEDICAL PHYSICS
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 7th Mexican Symposium on Medical Physics
CY MAR 24-26, 2003
CL MEXICO CITY, MEXICO
SP Soc Mexicana Fis, Univ Nacl Autonoma Mexico, Centro Invest & Estudios Avanzados, Centro Latinoamer Fis
ID SPIN-ECHO; MR; WATER
AB Magnetic Resonance Imaging has been used to study the ingress of water into porous materials, as found in oil reservoir. These magnetic resonance methods to generate images of porous media can be used in biomedical applications, since some biological tissues are comprised of multiple small, fluid-filled compartments, such as cells. Biliary and renal calculi show this kind of porous structure. We applied standard spin-echo sequences to produce images of a spherical model which mimics renal calculi. A dual-frequency coil previously developed by our group was used to generate images on a 4.7T Bruker animal imager. Phantom images were acquired and showed a relatively poor signal-to-noise ratio. These encouraging results motivate a further investigation into the application of other imaging sequences such a diffusion-weighted and oscillating gradient-echo sequences. This work should be performed with clinical magnetic resonance imagers if a clinical application is sought.
C1 Inovamed, Mexico City 01010, DF, Mexico.
RP Amador, R (reprint author), Inovamed, Andes 2, Mexico City 01010, DF, Mexico.
CR Amador-Baheza R, 2002, AIP CONF PROC, V630, P153
   BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1
   Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022
   BEAULIEU CF, 1993, MAGNET RESON MED, V30, P201, DOI 10.1002/mrm.1910300208
   DUMOULIN CL, 1986, MAGNET RESON MED, V3, P282, DOI 10.1002/mrm.1910030211
   Gore JC, 2001, MAGN RESON IMAGING, V19, P295, DOI 10.1016/S0730-725X(01)00239-9
   HASSE A, 1989, J MAGN RESON, V67, P388
   HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602
   Khrapitchev AA, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051203
   Laurent WM, 2000, J MAGN RESON IMAGING, V12, P488, DOI 10.1002/1522-2586(200009)12:3<488::AID-JMRI15>3.0.CO;2-5
   Loske AM, 2001, AIP CONF PROC, V593, P99
   MANSFIELD P, 1992, MAGN RESON IMAGING, V10, P741, DOI 10.1016/0730-725X(92)90406-P
   Mukherji SK, 2002, J NEURO-OPHTHALMOL, V22, P118, DOI 10.1097/01.WNO.0000019698.15867.57
   Schachter M, 2000, J MAGN RESON, V147, P232, DOI 10.1006/jmre.2000.2203
NR 14
TC 0
Z9 0
U1 0
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 0-7354-0151-9
J9 AIP CONF PROC
PY 2003
VL 682
BP 145
EP 150
PG 6
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA BX56Y
UT WOS:000185703600022
DA 2018-10-20
ER

PT J
AU Dvorak, JA
AF Dvorak, JA
TI The application of atomic force microscopy to the study of living
   vertebrate cells in culture
SO METHODS
LA English
DT Article
DE atomic force microscopy; scanning probe; Dvorak chamber; live cells
ID FIELD OPTICAL MICROSCOPY; SCANNING FORCE; SURFACE; CONTRAST
AB Atomic force microscopy (AFM), a relatively new variant of scanning probe microscopy developed for the material sciences, is becoming an increasingly important tool in other disciplines. In this review I describe in nontechnical terms some of the basic aspects of using AFM to study living vertebrate cells. Although AFM has some unusual attributes such as an ability to be used with living cells, AFM also has attributes that make its use in cell biology a real challenge. This review was written to encourage researchers in the biological and biomedical sciences to consider AFM as a potential (and potent) tool for their cell biological research. Published by Elsevier Science (USA).
C1 NIAID, Lab Malaria & Vector Res, Biophys & Biochem Parasitol Sect, NIH, Bethesda, MD 20892 USA.
RP Dvorak, JA (reprint author), NIAID, Lab Malaria & Vector Res, Biophys & Biochem Parasitol Sect, NIH, Bldg 4,Room B2-11,MSC 0425,4 Ctr Dr, Bethesda, MD 20892 USA.
CR A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3
   Akaki M, 2001, PARASITOL RES, V87, P193, DOI 10.1007/PL00008574
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   Cleveland J, 1997, US Patent, Patent No. 5670712
   DVORAK JA, 1971, EXP CELL RES, V68, P144, DOI 10.1016/0014-4827(71)90596-9
   Dvorak JA, 1998, EXP CELL RES, V242, P69, DOI 10.1006/excr.1998.4077
   HENDERSON E, 1994, PROG SURF SCI, V46, P39, DOI 10.1016/0079-6816(94)90006-X
   HILLNER PE, 1994, SCANNING, V17, P144
   HORBER JKH, 1992, SCANNING MICROSCOPY, V6, P919
   JAKOBY WB, 1979, METHODS ENZYMOLOGY L, V58
   Meixner AJ, 1998, CELL MOL BIOL, V44, P673
   Nagao E, 1999, BIOPHYS J, V76, P3289, DOI 10.1016/S0006-3495(99)77481-3
   Nagao E, 1998, J MICROSC-OXFORD, V191, P8
   Pang GKH, 2000, ULTRAMICROSCOPY, V81, P35, DOI 10.1016/S0304-3991(99)00164-3
   Parker R.C., 1961, METHODS TISSUE CULTU
   POLLACK R, 1973, READINGS IN MAMMALIA
   PUTMAN CAJ, 1993, ULTRAMICROSCOPY, V48, P177, DOI 10.1016/0304-3991(93)90180-6
   Revenko I, 2000, J APPL PHYS, V87, P526, DOI 10.1063/1.371894
   STEMMER A, 1995, J MICROSC-OXFORD, V178, P28, DOI 10.1111/j.1365-2818.1995.tb03577.x
   Subramaniam V, 1998, CELL MOL BIOL, V44, P689
   Tokumasu F, 2002, J ELECTRON MICROSC, V51, P1, DOI 10.1093/jmicro/51.1.1
   Vinckier A, 1996, REV SCI INSTRUM, V67, P387, DOI 10.1063/1.1146601
   Zhang YY, 1996, BIOPHYS J, V71, P2168, DOI 10.1016/S0006-3495(96)79418-3
   Zhong Q, 1993, SURF SCI LETT, V290, P688
   Zimmermann H, 1999, EUR BIOPHYS J BIOPHY, V28, P516, DOI 10.1007/s002490050234
NR 26
TC 37
Z9 42
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
J9 METHODS
JI Methods
PD JAN
PY 2003
VL 29
IS 1
BP 86
EP 96
AR PII S1046-2023(02)00284-0
DI 10.1016/S1046-2023(02)00284-0
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 642RP
UT WOS:000180818200009
PM 12543074
DA 2018-10-20
ER

PT S
AU Witte, R
   Herfurth, HJ
   Bauer, I
AF Witte, R
   Herfurth, HJ
   Bauer, I
BE Yasaitis, JA
   PerezMaher, MA
   Karam, JM
TI Microjoining of dissimilar materials for optoelectronic and biomedical
   applications
SO MICROMACHINING AND MICROFABRICATION PROCESS TECHNOLOGY VIII
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Micromachining and Microfabrication Process Technology
   VIII
CY JAN 27-29, 2003
CL SAN JOSE, CA
SP SPIE
DE laser micromachining; glass; silicon; sapphire; polymers; implantable
   Microsystems
AB Advanced microsystems for optoelectronic and biomedical applications incorporate a variety of non-metallic materials such as glass, silicon, sapphire and polymers. Examples include switches and multiplexers for fiber-optical data transmission. in telecommunications, and innovative implantable microsystems currently being. developed to monitor, stimulate and deliver drugs. Laser micromachining has proven to be an effective tool to address specific manufacturing challenges for these devices. Investigations have been conducted on laser ablation for precise localized material removal, laser cutting, and drilling; and application data for a range of relevant materials already exists. In contrast, applications of laser joining are currently limited to microwelding and soldering of metals. The assembly of SMD's and the sealing of pacemakers are typical examples.
   This paper will describe the latest achievements in laser microjoining of dissimilar materials. The focus will be on glass, metal and polymer that have been joined using CO2, Nd:YAG and diode lasers. Results in joining similar and dissimilar materials in different joint configurations will be presented, as well as requirements for sample preparation and fixturing. The potential for applications in the optoelectronic and biomedical sector will be demonstrated.
C1 Fraunhofer Ctr Laser Technol, Plymouth, MI USA.
RP Witte, R (reprint author), Fraunhofer Ctr Laser Technol, Plymouth, MI USA.
CR GILLNER A, 2000, P AKL 2000, P239
   LEGEWIE F, 1998, P WW 98 S 12 MIKR MU
   SANTINI JT, 2002, BIOMEMS 2002 P CAMBR
   SCHOTT AG, 2001, BOROFLOAT 33 PRODUCT
   Tong Q.-Y, 1999, SEMICONDUCTOR WAFER
   Wild MJ, 2001, SENSOR ACTUAT A-PHYS, V93, P63, DOI 10.1016/S0924-4247(01)00622-7
NR 6
TC 8
Z9 8
U1 2
U2 7
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4779-X
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4979
BP 226
EP 233
DI 10.1117/12.478282
PG 8
WC Engineering, Manufacturing; Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BW54U
UT WOS:000182378500026
DA 2018-10-20
ER

PT S
AU Singleton, L
   Detemple, P
   Frese, I
   Klotzbucher, T
   Bauer, HD
AF Singleton, L
   Detemple, P
   Frese, I
   Klotzbucher, T
   Bauer, HD
BE Johnson, EG
TI Plastic micro-optical components with the LIGA technology
SO MICROMACHINING TECHNOLOGY FOR MICRO-OPTICS AND NANO-OPTICS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Micromachining Technology for Micro-Optics and Nano-Optics
CY JAN 28-29, 2003
CL SAN JOSE, CA
SP SPIE, Semicond Equipment & Mat Int, SolidState Technol, Sandia Natl Lab
DE LIGA; deep x-ray lithography; DXRL; PMMA; optical components;
   waveguides; moulding
ID X-RAY-LITHOGRAPHY; DESIGN
AB Moulding of plastics enables optical features to be integrated into a single unit. This is particularly an advantage for product designs that impose space and weight constraints. Therefore, the use of plastic for biomedical and non telecommunications orientated optical applications continues to grow as design engineers take advantage of the ease of fabrication and the material flexibility.
   Deep X-ray LIGA presents itself as a method ideally suited for the production of moulds for the manufacture of plastic microcomponents. LIGA is synonymous for the lithography preferably carried out with synchrotron radiation X-rays, although many other lithography and non-lithography methods for master production have been developed in the last few years. Nevertheless, the exceptional resist heights, the enormous accuracy and low runout as well as the low sidewall roughnesses cannot be copied by these other methods of master production. In particular, the low sidewall roughnesses achieved through deep X-ray LIGA is essential for the manufacture of waveguide coupling systems based on polymers. The design and conceptualisation of such waveguides systems is presented here. In addition however, the exceptional resist heights and low runout can be employed to produce passive structures for the packaging of optical components.
   This paper provides an overview of the deep X-ray LIGA technology, emphasizing its strengths and application areas. Considerations for the design and manufacture of the plastic structures are also elucidated.
C1 Inst Mikrotech Mainz GmbH, D-55129 Mainz, Germany.
RP Singleton, L (reprint author), Inst Mikrotech Mainz GmbH, Carld Zeiss Str 18-20, D-55129 Mainz, Germany.
OI Klotzbucher, Thomas/0000-0002-4630-2966
CR Bauer HD, 2000, SYNTHETIC MET, V115, P13, DOI 10.1016/S0379-6779(00)00293-9
   BOGDANOV A, USE SU 8 PHOTORESIST
   Cremers C, 2001, MICROSYST TECHNOL, V7, P11, DOI 10.1007/s005420000054
   Ehrfeld W, 1998, J VAC SCI TECHNOL B, V16, P3526, DOI 10.1116/1.590490
   EISENMANN H, 1993, J VAC SCI TECHNOL B, V11, P2741, DOI 10.1116/1.586594
   Feiertag G, 1997, J MICROMECH MICROENG, V7, P323, DOI 10.1088/0960-1317/7/4/008
   FEIERTAG G, VDI FORTSCHRITTBERIC, V9
   Kruger S, 2000, P SOC PHOTO-OPT INS, V4178, P77
   Kufner S, 2000, ADVANCED MICROSYSTEMS FOR AUTOMOTIVE APPLICATIONS 2000, P297, DOI 10.1007/978-3-642-18146-7_24
   KUFNER S, 2000, IFAC 2000 TRANSPORTA, P74
   Luttge R, 1999, MICROELECTRON ENG, V46, P247, DOI 10.1016/S0167-9317(99)00073-8
   LUTTGE R, 1998, P MICR SYST TECHN, P661
   Paatzsch T, 1998, P SOC PHOTO-OPT INS, V3276, P16, DOI 10.1117/12.302386
   POPP M, 2001, THESIS U MAINZ
   POPP M, 2000, 4 WORKSH OPT RECH 7
   Schmidt A, 2001, MICROELECTRON ENG, V57-8, P761, DOI 10.1016/S0167-9317(01)00479-8
   Schmidt A, 1998, P SOC PHOTO-OPT INS, V3512, P252, DOI 10.1117/12.324067
   Singleton L, 2002, P SOC PHOTO-OPT INS, V4690, P1180, DOI 10.1117/12.474195
   SINGLETON L, 2002, P SPIE PF10 MEMS MOE
   SINGLETON L, 2001, P SOC PHOTO-OPT INS, P182
NR 20
TC 5
Z9 5
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4784-6
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4984
BP 29
EP 37
DI 10.1117/12.499993
PG 9
WC Optics; Physics, Applied
SC Optics; Physics
GA BW40G
UT WOS:000181866000004
DA 2018-10-20
ER

PT S
AU Stock, ML
   Endert, H
   Patel, R
AF Stock, ML
   Endert, H
   Patel, R
BE Johnson, EG
TI "Time-tailored" laser pulses: a new approach for laser micromachining
   and microfabrication processing
SO MICROMACHINING TECHNOLOGY FOR MICRO-OPTICS AND NANO-OPTICS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Micromachining Technology for Micro-Optics and Nano-Optics
CY JAN 28-29, 2003
CL SAN JOSE, CA
SP SPIE, Semicond Equipment & Mat Int, SolidState Technol, Sandia Natl Lab
DE micromachining; microfabrication; short-pulsed lasers; fiber lasers;
   fiber amplifiers; nanosecond lasers; picosecond lasers; femtosecond
   lasers
ID AMPLIFICATION SYSTEMS; FIBER LASER; HIGH-ENERGY
AB We describe novel designs for production of laser pulses from the nanosecond to the femtosecond regime which allow optimization to specific material processing requirements. These lasers are based on use of multimode Yb:fiber amplifiers (MM YDFA) to provide microJoule-level output in a single-mode beam. First, we present laser designs based on MM YDFA that produce 10 kHz- 5 MHz pulses of picosecond and femtosecond duration. Next, by seeding a MM YDFA with pre-shaped nanosecond laser diode seed pulses, we have created a laser that provides temporally nearly-rectangular output pulses. The duration is adjustable between 4 and 20 ns, with sharp rise times of <1.5 ns, and repetition rate of up to 20 kHz. Output pulse energy of >15 microJoules is maintained over the full tuning range. With this "tailorable" pulse design, control of laser energy deposition in confined laser interaction zones ("dosage") can be user-optimized in real-time from the controller. For example, in biomedical microelectronics and other applications where the creation of micron-size features (in width and in depth) is required the user can adjust dosage in response to measured structural changes over the material. Results of Si wafer and other material micromachining using this unique temporally-tailored pulsed laser are presented.
C1 IMRA Amer Inc, Ann Arbor, MI 48105 USA.
RP Stock, ML (reprint author), IMRA Amer Inc, 1044 Woodridge Ave, Ann Arbor, MI 48105 USA.
CR Alvarez-Chavez JA, 2000, OPT LETT, V25, P37, DOI 10.1364/OL.25.000037
   Dominic V, 1999, ELECTRON LETT, V35, P1158, DOI 10.1049/el:19990792
   Fermann ME, 2000, APPL PHYS B-LASERS O, V70, pS13, DOI 10.1007/s003400000287
   Galvanauskas A, 2001, IEEE J SEL TOP QUANT, V7, P504, DOI 10.1109/2944.974221
   Galvanauskas A, 2001, OPT LETT, V26, P935, DOI 10.1364/OL.26.000935
   GALVANAUSKAS A, 2000, C LAS EL OPT CLEO
   SNITZER E, 1961, PHYS REV LETT, V7, P444, DOI 10.1103/PhysRevLett.7.444
   SNITZER E, 1961, J APPL PHYS, V32, P36, DOI 10.1063/1.1735955
   STOCK ML, 1994, OPT COMMUN, V106, P249, DOI 10.1016/0030-4018(94)90331-X
   STRICKLAND D, 1985, OPT COMMUN, V56, P219, DOI 10.1016/0030-4018(85)90120-8
NR 10
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4784-6
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4984
BP 202
EP 209
DI 10.1117/12.477843
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA BW40G
UT WOS:000181866000023
DA 2018-10-20
ER

PT S
AU Mecham, JB
   Kang, Y
   Davis, B
   Arregui, FJ
   Matias, IR
   Clause, RO
AF Mecham, JB
   Kang, Y
   Davis, B
   Arregui, FJ
   Matias, IR
   Clause, RO
BE Gannot, I
TI Multilayered self-assembled optical fiber sensors for biomedical
   applications
SO OPTICAL FIBERS AND SENSORS FOR MEDICAL APPLICATIONS III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optical Fibers and Sensors for Medical Applications III
CY JAN 25-28, 2003
CL SAN JOSE, CA
SP SPIE
AB We report recent developments in the design and fabrication of molecularly self-assembled thin film materials that may be incorporated with optical fiber waveguides to form humidity and other gas sensors of use in biomedical diagnostic systems. Optical fiber distal end sensors based on this concept may be fabricated by molecularly self-assembling selected polymers and functionalized inorganic nanoclusters into multilayered optical thin films on the cleaved and polished flat ends of singlemode optical fibers. Prior work reported at this meeting has studied the synthesis process and sensor dynamics, including sensor 10-90% risetime on the order of microseconds. This paper briefly reviews that work but then reports new developments in the synthesis of the sensor films.
C1 NanoSon Inc, Blacksburg, VA 24060 USA.
RP Mecham, JB (reprint author), NanoSon Inc, 1485 S Main St, Blacksburg, VA 24060 USA.
RI Arregui, Francisco/A-7030-2013; Matias, Ignacio R./D-7483-2016
OI Arregui, Francisco/0000-0002-3311-0834; Matias, Ignacio
   R./0000-0002-2229-6178
CR ARREGUI F, 1999, P 13 OFS KONJ KOR
   Arregui FJ, 2000, IEICE T ELECTRON, VE83C, P360
   Arregui FJ, 1999, OPT LETT, V24, P596, DOI 10.1364/OL.24.000596
   ARREGUI FJ, 1999, SENSORS ACTUATORS B
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dejours P, 1966, RESPIRATION
   LALLI JH, 2003, P SPIE, V4991
   Liu YJ, 1999, SMART MATER STRUCT, V8, P100, DOI 10.1088/0964-1726/8/1/011
NR 8
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4757-9
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4957
BP 157
EP 161
DI 10.1117/12.476740
PG 5
WC Engineering, Biomedical; Instruments & Instrumentation; Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BX31Y
UT WOS:000184939100020
DA 2018-10-20
ER

PT S
AU Plucinski, J
AF Plucinski, J
BE Nowakowski, A
   Kosmowski, BB
TI Estimation of optical parameters of highly scattering materials by
   time-ofiflight spectroscopy
SO OPTICAL METHODS, SENSORS, IMAGE PROCESSING, AND VISUALIZATION IN
   MEDICINE
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optical Methods, Sensors, Image Processing and
   Visualization in Medicine
CY SEP 10-13, 2004
CL Gdansk, POLAND
SP Minist Sci & Informat, Poland, SPIE Poland Chapter, Gdansk Univ Technol, Dept Biomed Engn, Polish Soc Biomed Engn, Polish Acad Sci, Comm Biocybernet & Biomed Engn
DE Time-of-flight spectroscopy; highly scattering material; photon
   migration; inverse problem; Monte Carlo method; diffuse method;
   biomedical optics
ID RANDOM-MEDIA; COHERENT
AB Optical measurement methods are indispensable tool in biomedical research, providing invaluable information on optical properties of biological tissues. However, the application of these techniques is a big challenge, as most tissues are highly scattering materials whose optical properties cannot be measured in a straightforward way, due to multiple scattering of photons. Therefore, new optical measurement techniques and methods for highly scattering media are being developed to address this problem. One of the very promising techniques is time-of-flight spectroscopy. The paper presents problems encountered in reconstruction of basic optical parameters of tissues or other highly scattering materials from optical time-of-flight spectroscopy measurement data. To estimate the reconstruction accuracy of optical parameters (i.e. absorption coefficient, scattering coefficient, anisotropy factor and refractive index) the test data were generated by a computer program simulating light propagation in highly scattering material by Monte Carlo method. Following, a set of computer programs based on diffusion equation and optimization algorithms such as simplex method and genetic method were used to reconstruct optical parameters from the test data. Finally, by comparing reconstructed optical parameters with those used for generation of the test data, the accuracy of reconstructing algorithms it was estimated.
C1 Gdansk Univ Technol, Dept Optoelect, PL-80952 Gdansk, Poland.
RP Plucinski, J (reprint author), Gdansk Univ Technol, Dept Optoelect, Ul Narutowicza 11-12, PL-80952 Gdansk, Poland.
RI Plucinski, Jerzy/H-5735-2018
OI Plucinski, Jerzy/0000-0001-5166-8957
CR Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1
   HASELGROVE J, 1991, P SOC PHOTO-OPT INS, V1431, P30, DOI 10.1117/12.44175
   ILGIEWICZ J, 2002, THESIS GDANSK U TECH
   Ishimaru A., 1978, WAVE PROPAGATION SCA
   Jacques S. L., 1993, MED OPTICAL TOMOGRAP, P211
   LIU F, 1991, OPT LETT, V16, P351, DOI 10.1364/OL.16.000351
   PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331
   PLUCINSKI J, 1999, 50 SEM OPT MED DIAGN, P63
   PLUCINSKI J, 2002, P SPIE INT SOC OPTIC, V5064, P69
   PLUCINSKI J, 2001, P SPIE INT SOC OPT E, V4516, P20
   Rutkowska D., 1997, SIECI NEURONOWE ALGO
   SOBOL M, 1994, PRACTICAL INTRO MONT
   Walters F.H., 1991, SEQUENTIAL SIMPLEX O
   YOO KM, 1990, OPT LETT, V15, P320, DOI 10.1364/OL.15.000320
   YOO KM, 1990, PHYS REV LETT, V64, P2647, DOI 10.1103/PhysRevLett.64.2647
   YOO KM, 1993, MED OPTICAL TOMOGRAP, P425
NR 16
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5442-7
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5505
BP 19
EP 24
DI 10.1117/12.577605
PG 6
WC Physics, Applied; Radiology, Nuclear Medicine & Medical Imaging
SC Physics; Radiology, Nuclear Medicine & Medical Imaging
GA BAQ30
UT WOS:000223200200004
DA 2018-10-20
ER

PT S
AU Jedrzejewska-Szczerska, M
   Hypszer, R
AF Jedrzejewska-Szczerska, M
   Hypszer, R
BE Nowakowski, A
   Kosmowski, BB
TI White-light interferometric temperature sensor for biomedical diagnostic
SO OPTICAL METHODS, SENSORS, IMAGE PROCESSING, AND VISUALIZATION IN
   MEDICINE
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optical Methods, Sensors, Image Processing and
   Visualization in Medicine
CY SEP 10-13, 2004
CL Gdansk, POLAND
SP Minist Sci & Informat, Poland, SPIE Poland Chapter, Gdansk Univ Technol, Dept Biomed Engn, Polish Soc Biomed Engn, Polish Acad Sci, Comm Biocybernet & Biomed Engn
DE temperature sensor; white-light interferometer; Fabry-Perot
   interferometer
ID LOW-COHERENCE INTERFEROMETRY
AB A monomode and multimode fibre white-light interferometric temperature sensor for biomedical applications is presented. The sensor uses a low-finesse Fabry-Perot interferometer working in reflective mode. Dependence of material parameters on fringe visibility is discussed and both construction of the sensor has been optimized with respect to fringe visibility. This new sensor system is expected to be a practical approach for many medical applications.
C1 Gdansk Univ Technol, Dept Optoelect, PL-80952 Gdansk, Poland.
RP Jedrzejewska-Szczerska, M (reprint author), Gdansk Univ Technol, Dept Optoelect, Ul Narutowicza 11-12, PL-80952 Gdansk, Poland.
OI Jedrzejewska-Szczerska, Malgorzata/0000-0003-4628-6158
CR CHEN S, 1993, ELECTRON LETT, V29, P334, DOI 10.1049/el:19930226
   Chen YC, 2002, OPT LETT, V27, P903, DOI 10.1364/OL.27.000903
   Choi HS, 1997, OPT LETT, V22, P1814, DOI 10.1364/OL.22.001814
   HYPSZER R, 1996, 41 INT WISS K, P535
   JEDRZEJEWSKASZC.M, 2000, 7 K NAUK TECHN EL EL, P679
   JEDRZEJEWSKASZC.M, 2003, P SOC PHOTO-OPT INS, V5258, P202
   Rao YJ, 1996, MEAS SCI TECHNOL, V7, P981, DOI 10.1088/0957-0233/7/7/001
NR 7
TC 1
Z9 1
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5442-7
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5505
BP 72
EP 77
DI 10.1117/12.577902
PG 6
WC Physics, Applied; Radiology, Nuclear Medicine & Medical Imaging
SC Physics; Radiology, Nuclear Medicine & Medical Imaging
GA BAQ30
UT WOS:000223200200013
DA 2018-10-20
ER

PT S
AU Kiernan, G
   Barron, V
   Blond, D
   Drury, A
   Coleman, J
   Murphy, R
   Cadek, M
   Blau, W
AF Kiernan, G
   Barron, V
   Blond, D
   Drury, A
   Coleman, J
   Murphy, R
   Cadek, M
   Blau, W
BE Blau, WJ
   Donegan, JF
   Duke, AF
   MacCraith, JA
   McMillan, ND
   OConnor, GM
   OMongain, E
   Toal, V
   McLaughlin, JA
TI Characterisation of nanotube based artificial muscles materials
SO OPTO-IRELAND 2002: OPTICS AND PHOTONICS TECHNOLOGIES AND APPLICATIONS,
   PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optics and Photonics Technologies and Applications
CY SEP 05-06, 2002
CL GALWAY, IRELAND
SP SPIE, Enterprise Ireland, European Off Aerosp Res & Dev, IDA Ireland, Ind Res & Technol Unit, Natl Ctr Laser Appl, Natl Ctr Sensor Res, Natl Microelectr Res Ctr, Natl Univ Ireland Galway, NO Ireland Bioengn Ctr, Optron Ireland, Opt Soc Amer, Sci Fdn Ireland
DE multiwalled carbon nanotubes; polyurethan e; PmPV; actuators
ID POLYURETHANE ELASTOMER PUE; CARBON NANOTUBES; ACTUATORS; POLYMER
AB Today, many materials are being investigated as possible artificial muscle devices. Nanotubes and conducting polymers are two of the most attractive materials for this application, because of their low operating voltage. In this research, a number of materials are investigated, including nanotube based polymer composites. Methods of characterisation include thermal analysis using thermal gravimetric analysis (TGA) and differential scanning calorimetry (DSC). Scanning electron microscopy (SEM), transmission electron microscopy (TEM), hot stage microscopy and polarized light microscopy were used to evaluate the morphology of the composites. Fourier transform infrared spectroscopy was used as a compliment to the DSC and hot stage microscopy to examine the crystallinity. Gel permeation chromatography (GPC) was employed to determine the effect of the nanotubes on the molecular weight of the polymer. Since the application of this research is a biomedical device, the biocompatibility of the composites was examined using contact angle analysis and cytotoxicity tests. In summary, results to date indicate that these materials have promise as possible artificial muscle devices.
C1 Trinity Coll Dublin, Dept Phys, Mat Ireland Polymer Res Ctr, Dublin 2, Ireland.
RP Kiernan, G (reprint author), Trinity Coll Dublin, Dept Phys, Mat Ireland Polymer Res Ctr, Dublin 2, Ireland.
RI Barron, Valerie/C-5941-2014
OI Barron, Valerie/0000-0001-5520-0649
CR Barisci JN, 2000, J ELECTROANAL CHEM, V488, P92, DOI 10.1016/S0022-0728(00)00179-0
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   BAUGHMAN RH, 1996, SYNTHETIC MET, V78, P399
   Cadek M, 2002, CARBON, V40, P923, DOI 10.1016/S0008-6223(01)00221-4
   Drury A, 2001, SYNTHETIC MET, V119, P151, DOI 10.1016/S0379-6779(00)01299-6
   Dujardin E, 1998, ADV MATER, V10, P1472, DOI 10.1002/(SICI)1521-4095(199812)10:17<1472::AID-ADMA1472>3.0.CO;2-R
   DUJARDIN E, 1994, SCIENCE, V265, P1850, DOI 10.1126/science.265.5180.1850
   Ebbesen TW, 1996, J PHYS CHEM SOLIDS, V57, P951, DOI 10.1016/0022-3697(95)00381-9
   Fraysse J, 2001, CURR APPL PHYS, V1, P407, DOI 10.1016/S1567-1739(01)00048-7
   Fraysse J, 2002, CARBON, V40, P1735, DOI 10.1016/S0008-6223(02)00041-6
   KILBRIDE BE, UNPUB EXPT OBSERVATI
   Kyokane J, 2001, SYNTHETIC MET, V121, P1129, DOI 10.1016/S0379-6779(00)00987-5
   Kyokane J, 1999, SYNTHETIC MET, V103, P2366, DOI 10.1016/S0379-6779(98)00708-5
   Mc Carthy B, 2001, CHEM PHYS LETT, V350, P27, DOI 10.1016/S0009-2614(01)01184-8
   Minett A, 2002, CURR APPL PHYS, V2, P61, DOI 10.1016/S1567-1739(01)00100-6
   OTERO TF, 1995, BIOELECTROCH BIOENER, V38, P411, DOI 10.1016/0302-4598(95)01802-L
   Panhuis MI, 2001, SYNTHETIC MET, V121, P1187
   Spinks GM, 2001, P SOC PHOTO-OPT INS, V4329, P199, DOI 10.1117/12.432646
   UEDA T, 1997, SYNTHETIC MET, V85, P1414
NR 19
TC 2
Z9 2
U1 1
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4657-2
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4876
BP 775
EP 782
DI 10.1117/12.463907
PN 1&2
PG 8
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BW56V
UT WOS:000182425100086
DA 2018-10-20
ER

PT B
AU Celasun, S
   Ozturk, Y
AF Celasun, S
   Ozturk, Y
BE Matsuno, K
   Ecer, A
   Periaux, J
   Satofuka, N
   Fox, P
TI CEF model in the industrial application of non-Newtonian fluids
SO PARALLEL COMPUTATIONAL FLUID DYNAMICS: NEW FRONTIERS AND
   MULTI-DISCIPLINARY APPLICATIONS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Parallel Computational Fluid Dynamics Conference
CY MAY 20-22, 2002
CL KANSAI SCI CITY, JAPAN
SP Best Syst Inc, CD adapco Japan Co Ltd, Compaq Comp KK, Engineous Japan Inc, Fuji Res Inst Corp, Fujitsu Info Software Technol Ltd, Fujitsu Prime Software Technol Ltd, Fujitsu Ltd, Hewlett Packard Japan Ltd, Hitachi Ltd, IBM Japan Ltd, KGT Inc, NEC Corp, Nihon ESI KK, Platform Comp KK, Res Ctr Computat Mech Inc, SGI Japan Ltd, Tokyo Electron Ltd, Vinas Co Ltd
DE finite element method; non-Newtonian fluids; industrial applications
AB Among the constitutive equations developed from the continuum mechanics viewpoint, the second-order Rivlin-Ericksen model is generally preferred because it describes the real behaviour of the fluids with sufficient accuracy, and also because its application is not very cumbersome. On the other hand, the material coefficients used being constant, it is not in good agreement with experimental results in case the shear strain-rate is not very small.
   The (CEF) Criminale-Ericksen-Filbey constitutive equation removes this draw-back by taking these coefficients variable and dependent of the shear strain-rate.
   As an example, we can consider the settling of small particles in a non-Newtonian fluid medium. The knowledge of the rate of settling of particles in practice is particularly significant in determining the shelflife of materials such as foodstuffs, cleaning materials and many others. Thus, this problem has great importance in many natural and physical processes and in a large number of industrial applications such as chemical, genetic and biomedical engineering operations.
C1 Fac Mech Engn, TR-80191 Istanbul, Turkey.
RP Celasun, S (reprint author), Fac Mech Engn, TR-80191 Istanbul, Turkey.
CR Barnes H. A., 1989, INTRO RHEOLOGY
   BIRD R, 1987, DYNAMICS POLY LIQUID, V1
   Rameshwaran P, 1998, INT J NUMER METH FL, V26, P851, DOI 10.1002/(SICI)1097-0363(19980415)26:7<851::AID-FLD704>3.0.CO;2-4
   Tanner R. I., 1988, ENG RHEOLOGY
   Zienkiewicz O.C., 1994, FINITE ELEMENT METHO, V1
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
BN 0-444-50680-2
PY 2003
BP 467
EP 474
DI 10.1016/B978-044450680-1/50059-0
PG 8
WC Computer Science, Theory & Methods; Mechanics
SC Computer Science; Mechanics
GA BX04N
UT WOS:000184048900058
DA 2018-10-20
ER

PT B
AU Shishkin, D
   Geskin, E
   Goldenberg, B
   Petrenko, O
AF Shishkin, D
   Geskin, E
   Goldenberg, B
   Petrenko, O
BE Mittal, KL
TI Ice-air blast cleaning: Case studies
SO PARTICLES ON SURFACES 8: DETECTION, ADHESION AND REMOVAL
LA English
DT Proceedings Paper
CT 8th International Symposium on Particles on Surfaces
CY JUN 24-26, 2002
CL Providence, RI
DE ice-air blasting; ice particle production; derusting; depainting;
   graffiti removal; biomedical applications
AB Ice blasting constitutes one of the most promising emerging cleaning techniques. The ice-air blasting generates minimal waste materials, requires portable, comparatively inexpensive facilities and most of all there is virtually no substrate damage in the course of blasting. This paper discusses the results of an experimental study on ice cleaning. Different techniques for ice powder production are analyzed and the conceptual designs of various ice blasting systems are discussed. Special attention is paid to the current and potential applications of ice-based cleaning. The case studies involve decontamination of electronic devices, precision mechanical parts, soft plastics, biological materials, etc. Derusting and depainting of steel and graffiti removal were also explored. The analysis performed enables us to identify the potential applications of the ice blasting in industry, civil engineering and medicine.
C1 New Jersey Inst Technol, Dept Mech Engn, Newark, NJ 07102 USA.
RP Geskin, E (reprint author), New Jersey Inst Technol, Dept Mech Engn, Newark, NJ 07102 USA.
CR Fletcher N. H, 1970, CHEM PHYS ICE
   HARIMA I, 1992, Patent No. 04360766
   Hobbs P. V., 1974, ICE PHYS
   *HOSH AM INC, 1998, IC MAK MAN INSTR
   HUFFMAN J, 2001, Patent No. 6301908
   LIU B, 1998, JETTING TECHNOLOGY, P203
   MICHAEL B, 1978, ION MECH
   Sanderson T. J. O, 1988, ICE MECH RISKS OFFSH
   SHINICHI H, 1997, Patent No. 09225830
   SHISHKIN D, 2003, SURFACE CONTAMINATIO, V1
   SHISHKIN D, 2001, CLEANER TIMES, V27, P17
   VISSISOUK S, 1994, Patent No. 5367838
NR 12
TC 0
Z9 0
U1 0
U2 3
PU VSP BV-C/O BRILL ACAD PUBL
PI LEIDEN
PA PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
BN 90-6764-392-0
PY 2003
BP 153
EP 166
PG 14
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BAT42
UT WOS:000223428200008
DA 2018-10-20
ER

PT S
AU Epstein, RA
AF Epstein, RA
BE Kieff, FS
TI Steady the course: Property rights in genetic material
SO PERSPECTIVES ON PROPERTIES OF THE HUMAN GENOME PROJECT
SE ADVANCES IN GENETICS INCORPORATING MOLECULAR GENETIC MEDICINE
LA English
DT Article; Proceedings Paper
CT Conference on Intellectual Property and the Human Genome Project
CY APR 12-13, 2002
CL Washington Univ, St Louis, MO
HO Washington Univ
ID INTELLECTUAL PROPERTY; SCIENTIFIC-RESEARCH; BIOMEDICAL-RESEARCH;
   EFFICIENT BREACH; LIABILITY RULES; PATENT; LAW; SCIENCE; COMMONS; NORMS
C1 Univ Chicago, Sch Law, Chicago, IL 60637 USA.
   Hoover Inst War Revolut & Peace, Stanford, CA 94305 USA.
RP Epstein, RA (reprint author), Univ Chicago, Sch Law, Chicago, IL 60637 USA.
CR ANDERSON C, 1994, SCIENCE, V263, P909, DOI 10.1126/science.8310287
   [Anonymous], 2001, NATURE, V409, P745
   AYRES I, 1995, YALE LAW J, V104, P1027, DOI 10.2307/797059
   Ayres Ian, 1995, YALE LAW J, V104, P1036
   Bernstein L, 1996, U PENN LAW REV, V144, P1765, DOI 10.2307/3312639
   BESSEN J, 1999, 1199 MIT
   Buchanan JM, 2000, J LAW ECON, V43, P1, DOI 10.1086/467445
   CALABRESI G, 1972, HARVARD LAW REV, V85, P1089, DOI 10.2307/1340059
   CARLTON DENNIS W., 2000, MODERN IND ORG, P398
   Coase R., 1960, FIRM MARKET LAW, P75
   Coase RH, 1946, ECONOMICA-NEW SER, V13, P169, DOI 10.2307/2549764
   CORNISH WR, 1996, INTELLECTUAL PROPERT, P291
   CRASWELL R, 1988, SOUTHERN CALIF LAW R, V61, P629
   DEMAINE, STAN L REV, V55, P305
   Demaine LT, 2002, STANFORD LAW REV, V55, P303, DOI 10.2307/1229595
   Doll JJ, 1998, SCIENCE, V280, P689, DOI 10.1126/science.280.5364.689
   DUCOR PG, 1998, PATENTING RECOMBINAN, P157
   EISENBERG RS, 1996, U CHI L SCH ROUNDTAB, V3, P557
   Enserink M, 2000, SCIENCE, V287, P1196, DOI 10.1126/science.287.5456.1196
   ENSERINK M, 2000, SCIENCE, V287, P1197
   EPSTEIN RA, 1994, SOC PHILOS POLICY, V11, P17, DOI 10.1017/S0265052500004416
   Epstein RA, 2001, INDIANA LAW J, V76, P803
   Epstein RA, 1997, YALE LAW J, V106, P2091, DOI 10.2307/797162
   EPSTEIN RA, 1980, J LEGAL STUD, V9, P253, DOI 10.1086/467639
   EPSTEIN RA, 1989, J LEGAL STUD, V18, P105, DOI 10.1086/468142
   EPSTEIN RA, 1993, BARGAINING STATE, P36
   EPSTEIN RA, 1985, TAKINGS PRIVATE PROP, P182
   Epstein Richard, 1998, PRINCIPLES FREE SOC
   Epstein Richard A., 1996, U CHI L SCH ROUNDTAB, V3, P575
   Epstein Richard A., 1982, GA L REV, V16, P775
   FRIEDMANN D, 1989, J LEGAL STUD, V18, P1, DOI 10.1086/468138
   Gitter DM, 2001, NEW YORK U LAW REV, V76, P1623
   HARDIN G, 1968, SCIENCE, V162, P1243
   Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698
   HOLDERNESS CG, 1989, J LEGAL STUD, V18, P181, DOI 10.1086/468145
   HOLMAN, 1996, SCIENCE, V272, P643
   Holman MA, 2000, IOWA LAW REV, V85, P735
   Kieff F. Scott, 2001, MINN LAW REV, V85, P721
   Kieff FS, 2001, MINN LAW REV, V85, P697
   Kieff FS, 2001, NORTHWEST U LAW REV, V95, P691
   Lessig L, 2001, FUTURE IDEAS FATE CO
   MERGES RP, 1990, COLUMBIA LAW REV, V90, P839, DOI 10.2307/1122920
   Merges RP, 1996, CALIF LAW REV, V84, P1293, DOI 10.2307/3480996
   MERGES RP, 1990, COLUMBIA LAW REV, V90, P866
   Mueller JM, 2001, WASH LAW REV, V76, P1
   MUELLER JM, 2001, WASH L REV, V76, P58
   Nussbaum Martha C., 1998, CLONES CLONES FACTS
   OSTROM E, 1990, GOVT COMMONS
   PECKHAM B, 1985, J CONT L, V11, P421
   PECKHAM B, 1985, J CONT L, V11, P389
   Rai AK, 1999, NORTHWEST U LAW REV, V94, P77
   RAI AK, 1999, NORTHWEST U LAW REV, V94, P126
   RIFKIN J, 2001, HOUSTON CHRON   0702, pC5
   RIFKIN J, 1998, BIOTECH CENTURY
   ROSE C, 1986, U CHICAGO LAW REV, V53, P711, DOI 10.2307/1599583
   SHAPIRO C, 2000, NAVIGATING PATENT TH, P119
   Smaglik P, 2000, NATURE, V404, P322
   Smith HE, 2000, J LEGAL STUD, V29, P131, DOI 10.1086/468066
   Walsh JP, 2003, SCIENCE, V299, P1021, DOI 10.1126/science.299.5609.1021
   Woodbine G., 1968, BRACTON LAWS CUSTOMS
   2001, NATURE, V409, P15
   2001, FED REF, V66, P1092
   2001, FED REF, V66, P1098
NR 63
TC 10
Z9 10
U1 0
U2 1
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0065-2660
BN 0-12-017650-5
J9 ADV GENET
PY 2003
VL 50
BP 153
EP 194
DI 10.1016/S0065-2660(03)50008-6
PG 42
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Social
   Issues; Social Sciences, Biomedical
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Social
   Issues; Biomedical Social Sciences
GA BEK95
UT WOS:000237631600008
PM 14714690
DA 2018-10-20
ER

PT S
AU Obara, M
   Ozono, K
   Kanai, M
   Sekita, H
   Atanasov, PA
AF Obara, M
   Ozono, K
   Kanai, M
   Sekita, H
   Atanasov, PA
BE Pique, A
   Sugioka, K
   Herman, PR
   Fieret, J
   Bachmann, FG
   Dubowski, JJ
   Hoving, W
   Washio, K
   Geohegan, DB
   Trager, F
   Murakami, K
TI Femtosecond laser processing tailored for biomedical materials and laser
   power delivery through optical fibers
SO PHOTON PROCESSING IN MICROELECTRONICS AND PHOTONICS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Photon Processing in Microelectronics and Photonics II
CY JAN 27-30, 2003
CL SAN JOSE, CA
SP SPIE
DE hard tissue ablation; tooth; bone; plastic surgery; fiber delivery;
   femtosecond laser
ID ER-YAG LASER; HARD-TISSUE ABLATION; PULSES; GENERATION
AB We have been working on the tailored ablation processing of advanced materials using femtosecond lasers. Here we would like to focus on the femtosecond laser processing tailored for hydroxyapatite. Hydroxyapatite is a key material of human tooth and human bone. The human bone is made of hydroxyapatite oriented along the collagen. The micromachining of human bone is highly required for medicine. The medical issue is how to preserve the chemical property of the laser-ablated surface. By use of pulsewidth tunable femtosecond laser (50fs - 2ps, 1.5mJ, 1kpps), we compared the relative content of calcium and phosphorus. The relative content of calcium and phosphorus is kept unchanged before and after laser ablation. For these medical applications, the intense femtosecond laser delivery through optical fibers is required. It is theoretically shown that it is possible to deliver the 900 fs pulses of 0.1 mJ/pulse through a I m-long graded index fiber with a 200 mum core diameter if the fiber has the optimum refractive index profile. We therefore conclude that graded index multimode fibers give better spatial distributions of the output transverse mode than hollow fibers or step index multimode fibers, and can deliver larger pulse energy than single mode fibers.
C1 Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
RP Obara, M (reprint author), Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1,Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
CR Agrawal G. P., 1995, NONLINEAR FIBER OPTI
   Asawa CK, 2000, APPL OPTICS, V39, P2029, DOI 10.1364/AO.39.002029
   Chaiyavej S, 2000, LASER SURG MED, V27, P341, DOI 10.1002/1096-9101(2000)27:4<341::AID-LSM7>3.0.CO;2-S
   Clark SW, 2001, OPT LETT, V26, P1320, DOI 10.1364/OL.26.001320
   Efimov OM, 1998, J OPT SOC AM B, V15, P193, DOI 10.1364/JOSAB.15.000193
   Hirayama Y, 2001, J APPL PHYS, V90, P6447, DOI 10.1063/1.1415066
   Junbiao Z, 2001, NUCL INSTRUM METH A, V475, P630
   KANAI M, 2002, APLS 2002 SEPT 17 20
   Konig K, 1999, CELL MOL BIOL, V45, P195
   KRUEGER J, 1999, APPL PHYS A, V69, pS403
   Majaron B, 1998, APPL PHYS B-LASERS O, V66, P479, DOI 10.1007/s003400050423
   Matsuura Y, 2002, J APPL PHYS, V91, P887, DOI 10.1063/1.1425070
   MATSUURA Y, 2002, J APPL PHYS, V92, P887
   Neev J, 1996, IEEE J SEL TOP QUANT, V2, P790, DOI 10.1109/2944.577301
   NEWESELY H, 1972, MECH ACTION TRACE EL
   Niemz M, 1996, LASER TISSUE INTERAC
   Ozono K, 2001, OPT COMMUN, V189, P103, DOI 10.1016/S0030-4018(01)01002-1
   Perry MD, 1999, J APPL PHYS, V85, P6803, DOI 10.1063/1.370197
   Sasaki KM, 2002, LASER SURG MED, V31, P79, DOI 10.1002/lsm.10074
   Smith NI, 2001, APPL PHYS LETT, V79, P1208, DOI 10.1063/1.1397255
   Stanislawki M, 2001, APPL PHYS B-LASERS O, V72, P115, DOI 10.1007/s003400000517
   TANAKA J, 1999, J SURFACE SCI SOC JA, V20, P600
   Xing QR, 2001, P SOC PHOTO-OPT INS, V4276, P42, DOI 10.1117/12.428014
NR 23
TC 2
Z9 2
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4777-3
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4977
BP 123
EP 135
DI 10.1117/12.479575
PG 13
WC Engineering, Manufacturing; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BX33C
UT WOS:000184964100015
DA 2018-10-20
ER

PT S
AU Huang, N
   Yang, P
   Leng, YX
   Chen, JY
   Wang, J
   Sun, H
   Wan, GJ
   Chu, PK
   Leng, Y
AF Huang, N
   Yang, P
   Leng, YX
   Chen, JY
   Wang, J
   Sun, H
   Wan, GJ
   Chu, PK
   Leng, Y
BE Falconer, IS
   Dewar, RL
   Khachan, J
TI Surface modification of blood contacting biomedical implants by plasma
   processes
SO PLASMA PHYSICS
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT International Congress on Plasma Physics
CY JUL 15-19, 2002
CL SYDNEY, AUSTRALIA
SP Int Union Pure & Appl Phys, Australian Inst Phys, New S Wales Dept State & Reg Dev
ID BIOCOMPATIBILITY; ADHESION
AB Surface modification is becoming an increasingly popular method to Improve the surface properties of biomedical materials and implants. Among the techniques plasma processes have been attracting attention because of their high effect and low cost. In this paper some application of plasma processes such as plasma modification, plasma polymerization, films synthesis, and plasma based ion implantation etc to modify blood contacting biomaterials and implants are presented. The authors work on the surface modification of artificial heart valves, stents and catheter etc. are provided. The further development of this discipline is discussed.
C1 SW Jiaotong Univ, Dept Mat Engn, Inst Biomat Surface Engn, Chengdu 610031, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Dept Mat Engn, Inst Biomat Surface Engn, Chengdu 610031, Peoples R China.
RI Wan, GJ/A-3648-2009; Chu, Paul/B-5923-2013; Wan, Guojiang/A-6651-2013
OI Chu, Paul/0000-0002-5581-4883; Wan, Guojiang/0000-0002-1636-5405
CR BOLZ A, 1990, ARTIF ORGANS, V144, P260
   CHANGJIANG P, UNPUB FUNCTIONAL MAT
   CHEN JY, IN PRESS BIOMATERIAL
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   Kawamoto Y, 1997, J MATER SCI-MATER M, V8, P551, DOI 10.1023/A:1018598714996
   Monties JR, 1997, ARTIF ORGANS, V21, P730, DOI 10.1111/j.1525-1594.1997.tb03731.x
   Nan H., 1998, BIOMATERIALS, V19, P771
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   WANG J, 2001, 5 AS S BIOM MAT ASBM
   YANG P, IN PRESS IN VIVO STU
   Zhang Q, 2002, J BIOMED MATER RES, V60, P502, DOI 10.1002/jbm.1294
NR 12
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 0-7354-0133-0
J9 AIP CONF PROC
PY 2003
VL 669
BP 330
EP 334
PG 5
WC Physics, Fluids & Plasmas
SC Physics
GA BX04A
UT WOS:000184031800082
DA 2018-10-20
ER

PT J
AU Altpeter, H
   Bevis, MJ
   Gomes, ME
   Cunha, AM
   Reis, RL
AF Altpeter, H
   Bevis, MJ
   Gomes, ME
   Cunha, AM
   Reis, RL
TI Shear controlled orientation in injection moulding of starch based
   blends intended for medical applications
SO PLASTICS RUBBER AND COMPOSITES
LA English
DT Article
ID MECHANICAL-PROPERTIES; EPSILON-CAPROLACTONE; POLYMERS
AB Biodegradable polymeric implants are considered to be good alternatives to metallic implants in several temporary applications. Aliphatic polyesters have been extensively investigated and have been employed in several biomedical applications. More recently, biodegradable starch based polymeric blends have also been considered as alternative materials. In this study, the effect of shear controlled orientation injection moulding (SCORIM) on the mechanical properties and degradation behaviour of starch-polylactide and starch-poly(ethylene-co-vinyl alcohol) blends has been investigated and compared with those produced by conventional injection moulding. The changes in these properties has also been studied when using an hydroxyapatite filler to reinforce the polymeric matrixes. The SCORIM processing enhanced the unidirectional mechanical properties substantially. The incorporation of hydroxyapatite into the polymer matrix had a stiffening effect but also reduced the strength and toughness. Generally, the mechanical properties deteriorated substantially in vitro. Reinforcement by hydroxyapatite was found to be less effective than expected in a wet environment. (C) 2003 IoM Communications Ltd.
C1 Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
   Univ Minho, Dept Polymer Engn, P-4800 Guimaraes, Portugal.
RP Altpeter, H (reprint author), Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
RI Gomes, Manuela/B-6282-2009; Group, 3Bs/E-4374-2012; Reis, Rui
   L./A-8938-2008
OI Gomes, Manuela/0000-0002-2036-6291; Group, 3Bs/0000-0002-5195-3456;
   Reis, Rui L./0000-0002-4295-6129; Cunha M., Antonio/0000-0003-3860-7732
CR ALLAN PS, 1985, Patent No. 2170140
   ANDREOPOULOS AG, 1994, J ELASTOM PLAST, V26, P308, DOI 10.1177/009524439402600401
   BERGSMA JE, 1998, J CRANIO MAXILLOFAC, V26, P17
   Corden TJ, 2000, BIOMATERIALS, V21, P713, DOI 10.1016/S0142-9612(99)00236-7
   Kalay G, 1999, J APPL POLYM SCI, V73, P2473, DOI 10.1002/(SICI)1097-4628(19990919)73:12<2473::AID-APP16>3.3.CO;2-F
   Kalay G, 1997, J POLYM SCI POL PHYS, V35, P415, DOI 10.1002/(SICI)1099-0488(199702)35:3<415::AID-POLB2>3.0.CO;2-R
   Kalay G, 1997, KUNSTST-PLAST EUR, V87, P768
   Nakamura T, 1998, J BIOMED MATER RES, V42, P475, DOI 10.1002/(SICI)1097-4636(19981215)42:4<475::AID-JBM1>3.0.CO;2-B
   OGBONNA CI, 1995, J APPL POLYM SCI, V58, P2131, DOI 10.1002/app.1995.070581126
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.3.CO;2-9
   Sinclair RG, 1996, J MACROMOL SCI PURE, VA33, P585, DOI 10.1080/10601329608010880
   SOUSA RA, 2000, J APPL POLYM SCI, V77, P1300
   Tormala P, 1998, P I MECH ENG H, V212, P101, DOI 10.1243/0954411981533872
   VERT M, 1995, J MACROMOL SCI PURE, VA32, P787, DOI 10.1080/10601329508010289
   von Oepen R, 1992, Clin Mater, V10, P21, DOI 10.1016/0267-6605(92)90080-D
NR 15
TC 7
Z9 7
U1 0
U2 7
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 1465-8011
J9 PLAST RUBBER COMPOS
JI Plast. Rubber Compos.
PY 2003
VL 32
IS 4
BP 173
EP 181
DI 10.1179/146580103225001372
PG 9
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 692ZT
UT WOS:000183690700006
DA 2018-10-20
ER

PT S
AU Mukkamala, R
   Kushner, AM
   Bertozzi, CR
AF Mukkamala, R
   Kushner, AM
   Bertozzi, CR
BE Bohidar, HB
   Dubin, P
   Osada, Y
TI Hydrogel polymers from alkylthio acrylates for biomedical applications
SO POLYMER GELS: FUNDAMENTALS AND APPLICATIONS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Polymers Gels
CY MAR 26-30, 2000
CL SAN FRANCISCO, CALIFORNIA
SP Amer Chem Soc
ID PENDANT MONOSACCHARIDES; PROTEIN ADSORPTION; SURFACE; SULFOXIDE)
AB We have developed new acrylate monomers having pendent sulfide, sulfoxide and sulfone functional groups, and their cross-linked hydrogel polymers. Herein, the physicochemical characteristics including bulk and surface hydrophilicity, affinity for protein adsorption on the surfaces of these hydrogels are discussed. The sulfoxide hydrogels possess high degree of hydrophilicity and low affinity for in-vitro protein adsorption on their surfaces, thus showing potential to be new materials for use in biomedical applications, especially for soft contact lens preparation. Our results show that replacing sulfoxide functionality with sulfide or sulfone groups causes significant changes in polymer properties. Some of the mixed hydrogels derived from sulfide/sulfone acrylates and 2-hydroxyethy methacrylate (HEMA) exhibit low to moderate hydrophilicity, but exceptional resistance to in-vitro protein adsorption. (C) 2003 American Chemical Society.
C1 Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RP Mukkamala, R (reprint author), Rohm & Haas Chem Co, Proc Chem Lab, 1900 Tidal Rd, Deer Pk, TX 77536 USA.
CR ADAMSON AW, 1990, PHYSICAL CHEM SURFAC
   Allcock HR, 1998, MACROMOLECULES, V31, P8036, DOI 10.1021/ma980758r
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BARBASSI F, 1994, POLYM SURFACES PHYSI
   BERTOZZI CR, 2000, Patent No. 6107365
   BRASH JL, 1987, PROTEINS INTERFACES
   BRIGGS D, 1990, PRACTICAL SURFACE AN, V1
   CHEN Q, 1997, 214 ACS NAT M LAS VE
   Deng L, 1996, J AM CHEM SOC, V118, P5136, DOI 10.1021/ja960461d
   GARDELLA JA, 1988, APPL SURF SCI, V31, P72, DOI 10.1016/0169-4332(88)90025-6
   GUDMUNDSSON OG, 1985, ARCH OPHTHALMOL-CHIC, V103, P196
   Holly FJ, 1979, J POLYM SCI PS, V66, P409
   Hong Y, 1996, J BIOMED MATER RES, V30, P441, DOI 10.1002/(SICI)1097-4636(199604)30:4<441::AID-JBM2>3.0.CO;2-P
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Koyama E, 1998, MACROMOLECULES, V31, P1495, DOI 10.1021/ma9709819
   LEAHY CD, 1990, OPTOMETRY VISION SCI, V67, P504, DOI 10.1097/00006324-199007000-00008
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   MIREJOVSKY D, 1991, OPTOMETRY VISION SCI, V68, P858, DOI 10.1097/00006324-199111000-00005
   MORRA M, 1992, J COLLOID INTERF SCI, V149, P84, DOI 10.1016/0021-9797(92)90393-Z
   MUKKAMALA R, 2000, POLYM PREPRINTS, V41, P733
   MUKKAMALA R, UNPUB MACROMOLECULES
   NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P2663, DOI 10.1002/macp.1994.021950733
   NAKAMAE K, 1993, MAKROMOL CHEM-RAPID, V14, P413
   NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P1953, DOI 10.1002/macp.1994.021950606
   Ottenbrite R, 1996, HYDROGELS BIODEGRADA
   Oyama T, 1998, POLYM BULL, V40, P615, DOI 10.1007/s002890050299
   Peppas N. A., 1986, HYDROGELS MED PHARM, V2
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Phillips AJ, 1989, CONTACT LENSES
   Prager MD, 1997, J BIOMED MATER RES, V36, P119, DOI 10.1002/(SICI)1097-4636(199707)36:1<119::AID-JBM14>3.3.CO;2-K
   REFEJO MF, 1979, J POLYM SCI PS, V66, P227
   Sanda F, 1998, POLYMER, V39, P5543, DOI 10.1016/S0032-3861(97)10201-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Tsuruta T, 1996, ADV POLYM SCI, V126, P1
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   WHEELER JC, 1996, J LONG-TERM EFF MED, V6, P3
NR 36
TC 2
Z9 2
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3761-1
J9 ACS SYM SER
PY 2003
VL 833
BP 163
EP 174
PG 12
WC Chemistry, Multidisciplinary; Polymer Science
SC Chemistry; Polymer Science
GA BW36V
UT WOS:000181755600011
DA 2018-10-20
ER

PT J
AU Ostrovskaya, LY
   Perevertailo, VM
   Matveeva, LA
   Milani, P
   Ralchenko, VG
   Shpilevsky, EM
AF Ostrovskaya, LY
   Perevertailo, VM
   Matveeva, LA
   Milani, P
   Ralchenko, VG
   Shpilevsky, EM
TI Characterization of different carbon nanomaterials promising for
   biomedical and sensor applications by the wetting method
SO POWDER METALLURGY AND METAL CERAMICS
LA English
DT Article
DE wettability; surface energy; surface topography; carbon film properties
   and applications
ID THIN-FILMS; DIAMOND
AB Using the methods of wetting (sessile drop), AFM, and Raman spectroscopy, we studied the surface properties of fullerene and metal-fullerene films as well as nanostructured cluster-assembled carbon films produced by supersonic cluster beam deposition. These materials exhibit unique features due to their structure and are new promising materials for biomedical and sensor applications. The wettability of the carbon films with liquids of different polarities (water, glycerin) was investigated by measuring the contact angle under normal conditions as a function of the surface morphology and roughness as well as the concentration of doping metals (Ti, Al, Cu, Sn) in Me - C-60 films. Based on the contact angle measurements the surface energy of these films has been estimated by Fowke's method. It is shown that contact angle measurements (wettability) allow one to obtain information on the properties of a carbon film surface (integrity, uniformity, roughness, presence of impurities in the surface layer, and reactivity). The wettability can be exploited for surface engineering control in the application of nanostructured coatings in medicine, electrochemistry, electronics, and tribology.
C1 Natl Acad Sci Ukraine, Inst Superhard Mat, Kiev, Ukraine.
   Natl Acad Sci Ukraine, Inst Semicond Phys, Kiev, Ukraine.
   Univ Milan, I-20122 Milan, Italy.
   Russian Acad Sci, Inst Gen Phys, Moscow, Russia.
   Belarusian State Univ, Minsk 220050, Byelarus.
RP Ostrovskaya, LY (reprint author), Natl Acad Sci Ukraine, Inst Superhard Mat, Kiev, Ukraine.
RI Ralchenko, Victor/V-1290-2017
OI Ralchenko, Victor/0000-0002-2213-4224
CR ADAMSON AW, 1990, PHYSICAL CHEM SURFAC
   Bukhtiyarov VI, 2001, USP KHIM+, V70, P167
   Butter R. S., 1995, Journal of Chemical Vapor Deposition, V3, P182
   Diederich L, 1999, APPL PHYS LETT, V75, P2662, DOI 10.1063/1.125111
   Ferrari AC, 1999, EUROPHYS LETT, V46, P245, DOI 10.1209/epl/i1999-00251-7
   FOWKES FM, 1965, AM CHEM SOC, V87, P1
   Gusev AI, 1998, USP FIZ NAUK+, V168, P55, DOI 10.3367/UFNr.0168.199801c.0055
   HADDON RC, 1993, SCIENCE, V261, P1545, DOI 10.1126/science.261.5128.1545
   HANSEN JO, 1989, J COLLOID INTERF SCI, V130, P347, DOI 10.1016/0021-9797(89)90114-8
   LETTINGTON AH, 1993, PHILOS T ROY SOC A, V342, P287, DOI 10.1098/rsta.1993.0022
   LITVIN PM, 2001, 8 INT C PHYS TECHN T, P131
   MATVEEVA LA, 2000, SPRING M EUR MAT RES, P26
   Milani P., 2001, Nanostructured Carbon for Advanced Applications. Proceedings of the NATO Advanced Study Institute, P53
   MITURA S, 2000, NANOTECHNOLOGY MAT S
   OGAREV VA, 1978, KOLLOID ZH, V40, P153
   Ostrovskaya L, 2002, DIAM RELAT MATER, V11, P845, DOI 10.1016/S0925-9635(01)00636-7
   OSTROVSKAYA L, 2002, P INT S FULL FULL LI, P119
   Ostrovskaya L. Yu., 2001, Journal of Superhard Materials, V23, P62
   PEREVERTAILO VM, 1999, P 4 INT S DIAM FILMS, P197
   SHPAK AP, 2001, CLUSTER NANOSTRUCTUR
   Shpilevskii E. M., 1998, MAT TEKHNOL INSTRUM, V3, P105
   SHPILEVSKY EM, 2000, SPRING M EUR MAT RES, P9
   SVECHNIKOV SV, 1998, MODERN MAT SCI 21 CE, P352
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   ZORIN VP, 2000, FULLERENES FULLERENE, P132
NR 25
TC 7
Z9 7
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1068-1302
EI 1573-9066
J9 POWDER METALL MET C+
JI Powder Metall. Met. Ceram.
PD JAN-FEB
PY 2003
VL 42
IS 1-2
BP 1
EP 8
DI 10.1023/A:1023978613302
PG 8
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 700LT
UT WOS:000184114000001
DA 2018-10-20
ER

PT S
AU Oikonomou, A
   Amin, SA
   Naguib, RNG
   Todman, A
   Al-Omishy, H
AF Oikonomou, A
   Amin, SA
   Naguib, RNG
   Todman, A
   Al-Omishy, H
GP IEEE
TI Breast self examination training through the use of multimedia: A
   prototype multimedia application
SO PROCEEDINGS OF THE 25TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: A NEW BEGINNING
   FOR HUMAN HEALTH
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 25th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY SEP 17-21, 2003
CL Cancun, MEXICO
SP IEEE Engn Med & Biol Soc, Coral, Univ Autonome Metropolitana, Sandia Natl Lab
DE breast cancer
AB This paper presents the final version of a prototype multimedia application for training women on performing Breast Self Examination (BSE) in the right way. The application was developed for the purposes of an evaluation study on the effectiveness of three different BSE training media: leaflets, videos and multimedia applications. Since the British National Health Service (NHS) does not offer BSE training at the moment in the form of a multimedia application, a prototype had to be developed and compared against the existing material of leaflets and videos. The paper presents a novel video playback approach, the main differences between the BSE multimedia application and other traditional training approaches already in use by the NHS at the moment, the benefits of using multimedia in biomedical training and education and the final applications structure along with the evaluation criteria for the applications effectiveness and the comparison methodology that will be used to compare its effectiveness against leaflets and videos.
C1 Coventry Univ, BIOCORE, Sch Math & Informat Sci, Coventry, W Midlands, England.
RP Oikonomou, A (reprint author), Coventry Univ, BIOCORE, Sch Math & Informat Sci, Coventry, W Midlands, England.
OI Naguib, Raouf/0000-0001-6807-7993; Amin, Saad/0000-0003-4118-8970
CR ANGLIN G, 1996, HDB RES ED COMMUNICA
   BAUM M, 1998, FAST FACTS BREAST CA
   Elsom-Cook M., 2001, PRINCIPLES INTERACTI
   FARADAY P, 1997, COMP HUM INT C ATL
   OIKONOMOU A, 2001, BREAST SELF EXAMINAT
   SCHWIER R, 1993, INTERCTIVE MULTIMEDI
   Tannenbaum R.S., 1998, THEORETICAL FDN MULT
   2000, GLOBOSCAN DATABASC
NR 8
TC 3
Z9 3
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7789-3
J9 P ANN INT IEEE EMBS
PY 2003
VL 25
BP 1295
EP 1298
DI 10.1109/IEMBS.2003.1279506
PN 1-4
PG 4
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Medicine, Research &
   Experimental; Neurosciences; Radiology, Nuclear Medicine & Medical
   Imaging
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Research & Experimental Medicine; Neurosciences & Neurology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BY50W
UT WOS:000189395300339
DA 2018-10-20
ER

PT S
AU Gonzalez, R
   Castillo, V
   Suaste, E
AF Gonzalez, R
   Castillo, V
   Suaste, E
GP IEEE
TI Pyroelectric properties of Pb-0.88(Ln)(0.08)Ti0.98Mn0.02O3 (Ln = La, Sm,
   Eu) piezoceramics for biomedical use.
SO PROCEEDINGS OF THE 25TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: A NEW BEGINNING
   FOR HUMAN HEALTH
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 25th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY SEP 17-21, 2003
CL Cancun, MEXICO
SP IEEE Engn Med & Biol Soc, Coral, Univ Autonome Metropolitana, Sandia Natl Lab
DE ferroelectric ceramic; pyroelectricity; rare-earth elements;
   pyroelectric ceramic
ID TITANATE
AB In this work are studied the pyroelectric properties of Pb-0.88(Ln)(0.08)Ti0.98Mn0.02O3 (Ln = La, Sm, Eu) ferroelectric ceramic system. These type of ferroelectric ceramics presents high values in the following characteristics: dielectric constant, Curie temperature, electromechanical anisotropy, and frequencies of operation.. These properties make them useful for applications such as: the detection of infrared radiation, ultrasonic transducers for biomedical applications. The relationship between dielectric constant and temperature measurements as well as pyroelectric measurements using the technique of Byer-Roundy were performed. Values of the pyroelectric coefficient and figure of merit for infrared detector materials were obtained.
C1 Inst Politecn Nacl, CINVESTAV, Dept Ingn Elect, Secc Bioelect, Mexico City 07000, DF, Mexico.
RP Gonzalez, R (reprint author), Inst Politecn Nacl, CINVESTAV, Dept Ingn Elect, Secc Bioelect, Apdo Postal 14-740, Mexico City 07000, DF, Mexico.
CR BYER RL, 1972, IEEE T SON ULTRASON, VSU19, P333, DOI 10.1109/T-SU.1972.29679
   CHYNOWETH AG, 1956, J APPL PHYS, V27, P78, DOI 10.1063/1.1722201
   GLASS AM, 1968, PHYS REV, V172, P564, DOI 10.1103/PhysRev.172.564
   GLASS AM, 1969, J APPL PHYS, V40, P4699, DOI 10.1063/1.1657277
   JAFFE B, 1955, J RES NAT BUR STAND, V55, P239, DOI 10.6028/jres.055.028
   Perez Martinez O., 1995, Revista Mexicana de Fisica, V41, P85
   Ramirez-Rosales D, 2001, SOLID STATE COMMUN, V118, P371, DOI 10.1016/S0038-1098(01)00072-2
   Suaste-Gomez E., 2002, Ferroelectrics, V273, P273, DOI 10.1080/00150190211757
NR 8
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7789-3
J9 P ANN INT IEEE EMBS
PY 2003
VL 25
BP 3032
EP 3034
DI 10.1109/IEMBS.2003.1280779
PN 1-4
PG 3
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Medicine, Research &
   Experimental; Neurosciences; Radiology, Nuclear Medicine & Medical
   Imaging
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Research & Experimental Medicine; Neurosciences & Neurology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BY50W
UT WOS:000189395300785
DA 2018-10-20
ER

PT S
AU Mathieu, HJ
   Chevolot, Y
   Ruiz-Taylor, L
   Leonard, D
AF Mathieu, Han Joerg
   Chevolot, Yann
   Ruiz-Taylor, Laurence
   Leonard, Didier
BE Kausch, H
TI Engineering and Characterization of Polymer Surfaces for Biomedical
   Applications
SO RADIATION EFFECTS ON POLYMERS FOR BIOLOGICAL USE
SE Advances in Polymer Science
LA English
DT Review
DE Polymers; Surface analysis; Functionalization; Immobilization;
   Glycoengineering
ID RAY PHOTOELECTRON-SPECTROSCOPY; SILICON DIOXIDE SURFACES; ION
   MASS-SPECTROMETRY; MEAN FREE PATHS; CONTACT ANGLES; POLAR GROUPS;
   TOF-SIMS; IMMOBILIZATION; POLYSTYRENE; RADIATION
AB The application of synthetic polymers in the growing field of materials for medical applications is illustrated by examples from recent work at the Materials Institute of the swiss Federal Institute of Technology in Lausanne. The review highlights the need for functionalization and chemical control of material surfaces at a molecular/functional level. After a brief introduction into the surface chemical analysis tools, i.e., X-ray Photoelectron spectroscopy (XPs) and Time-of-Flight secondary Ion Mass spectrometry (ToF-SIMS) combined with contact angle measurements, phosphorylcholine blomimicking polymers as well as immobilization of carbohydrates on polystyrene are presented.
C1 [Mathieu, Han Joerg] Ecole Polytech Fed Lausanne, Mat Inst, CH-1015 Lausanne Epfl, Switzerland.
   [Chevolot, Yann] CNRS, Lab Goemar, UMR 1931, Stn Biol, F-29660 Roscoff, France.
   [Ruiz-Taylor, Laurence] Zyomyx Inc, Hayward, CA 94545 USA.
   [Leonard, Didier] GE Plast Europe, Microanal Grp, NL-4600 AC Bergen Op Zoom, Netherlands.
RP Mathieu, HJ (reprint author), Ecole Polytech Fed Lausanne, Mat Inst, CH-1015 Lausanne Epfl, Switzerland.
EM HansJoerg.Mathieu@EPFL.ch; chevolot@sb-roscoff.fr;
   LRuiz-Taylor@zyomyx.com; V017704@gepex.ge.com
OI Chevolot, Yann/0000-0003-3479-3371
FU University Hospital of Geneva (HUG); University Hospital of Lausanne
   (CHUV); University of Geneva; University of Lausanne; Swiss Federal
   Institute of Technology Lausanne (EPFL); Bundesamt fur Berufsbildung und
   Technologie (BBT/KTI), Bern [CTI-5170.1 MTs]
FX The authors would like to thank N. Xanthopoulos, G. Coullerez, and X.
   Gao for help with some of the experiments and discussions. Financial
   support is acknowledged from the Swiss Priority Program of Materials and
   the Common research program in Biomedical Engineering 1999-2002 between
   the University Hospitals of Geneva and Lausanne (HUG and CHUV), the
   Universities of Geneva and Lausanne, and the Swiss Federal Institute of
   Technology Lausanne (EPFL) as well as from the Bundesamt fur
   Berufsbildung und Technologie (BBT/KTI), Bern, contract no. CTI-5170.1
   MTs.
CR ANDERSON AB, 1994, 12 ANN M SOC BIOM BO
   ANDERSON AB, 1996, HER RW AM J NEUR, V17, P859
   Andrade J. D., 1988, POLYM SURFACE DYNAMI
   [Anonymous], 2001, 15472 ISO
   ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531
   BAENZIGER JU, 1980, J BIOL CHEM, V255, P4607
   Baumgartner JN, 1997, BIOMATERIALS, V18, P831, DOI 10.1016/S0142-9612(96)00197-4
   Beamson G., 1992, HIGH RESOLUTION XPS
   BENNINGHOVEN A, 1999, SIMS, V12
   BOKSANYI L, 1976, ADV COLLOID INTERFAC, V6, P95, DOI 10.1016/0001-8686(76)85001-4
   BRIGGS D, 1988, SURFACE INTERFACE AN, V13, P647
   Briggs D., 1992, PRACTICAL SURFACE AN, V2
   BRIGGS D, 1992, PRACTICAL SURFACE AN, V2, P367
   Briggs D., 1990, PRACTICAL SURFACE AN, V1
   BUCHWALTER LP, 1990, J VAC SCI TECHNOL A, V8, P781, DOI 10.1116/1.576917
   CHANEY R, 1987, FRESEN J ANAL CHEM, V326, P143
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   Chevolot Y, 2001, BIOORGAN MED CHEM, V9, P2943, DOI 10.1016/S0968-0896(01)00172-9
   CHEVOLOT Y, 1999, THESIS ECOLE POLYTEC
   CHEVOLOT Y, 1999, H CHEM, V10, P169
   CHILKOTI A, 1990, J VAC SCI TECHNOL A, V8, P2274, DOI 10.1116/1.576750
   CLARK DT, 1986, J ELECTRON SPECTROSC, V41, P399, DOI 10.1016/0368-2048(86)85017-4
   COLLIOUD A, 1993, BIOCONJUGATE CHEM, V4, P528, DOI 10.1021/bc00024a016
   CONNOR M, 1995, THESIS EPFL
   Coullerez G., 1999, J SURF ANAL, V5, P235
   DAVIES MC, 1990, CRIT REV BIOCOMPAT, V5, P297
   DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827
   ERARD JF, 1983, COLLOID SURFACE, V9, P109
   ERDTMANN M, 1994, BIOMATERIALS, V15, P1043, DOI 10.1016/0142-9612(94)90089-2
   Fowkes F.M., 1964, ADV CHEM SERIES, V43
   FRYDMAN E, 1997, J LAN, V13, P5089
   GAO H, 1995, BIOSENS BIOELECTRON, V10, P317, DOI 10.1016/0956-5663(95)96850-X
   GAO H, 1997, H ACTUAT, V38, P38
   GARBASSI F, 1994, POLYM SURFACES PHYSI, P161
   Garbassi F., 1994, POLYM SURFACES PHYS
   GOBET J, 1984, ADSORPT SCI TECHNOL, V1, P111
   GOODE R, 1993, COMMERCIAL AND CONSUMER LAW, P3
   GUIRE PE, 1990, Patent No. 4979959
   GUIRE PE, 1990, Patent No. 4973493
   HAGENHOFF B, 1997, SIMS, V11
   HATANAKA K, 1994, AKA CAR CHEM, V13, P603
   HAUSER H, 1975, PHOSPHOLIPID MODEL M
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HEARN MJ, 1988, SURF INTERFACE ANAL, V11, P198, DOI 10.1002/sia.740110405
   Hermanson GT, 1992, IMMOBILIZED AFFINITY
   HOLLOWAY P. J., 1970, Pesticide Science, V1, P156, DOI 10.1002/ps.2780010411
   HOLLY FJ, 1975, J BIOMED MATER RES, V9, P315, DOI 10.1002/jbm.820090307
   HUBBELL JA, 1995, CHEM ENG NEWS, V73, P42, DOI 10.1021/cen-v073n011.p042
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1990, SEITAI ZAIRYO, V8, P231
   ISHIHARA K, 1992, NAKA N J MAT, V26, P1543
   JUSTES DR, 1997, SIMS, V11
   KADOMA Y, 1978, YAMAUCH J, V35, P423
   KAWASAKI T, 1976, J BIOL CHEM, V251, P12
   KOBAYASHI K, 1994, METHOD ENZYMOL, V242, P226
   KOBAYASHI K, 1994, METHOD ENZYMOL, V247, P409
   KOROSI G, 1981, J COLLID SURF, V2, P315
   LAVIELLE L, 1985, J COLLOID INTERF SCI, V106, P438, DOI 10.1016/S0021-9797(85)80017-5
   LAVIELLE L, 1985, A J, V106, P446
   LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001
   Lelah M. D., 1986, POLYURETHANES MED
   Leonard D, 2001, SURF INTERFACE ANAL, V31, P457, DOI 10.1002/sia.1071
   Leonard D, 1998, SURF INTERFACE ANAL, V26, P783, DOI 10.1002/(SICI)1096-9918(199810)26:11<783::AID-SIA420>3.0.CO;2-O
   LEONARD D, 1998, MATH HJ ANA, V26, P793
   Li DQ, 1996, COLLOID SURFACE A, V116, P1, DOI 10.1016/0927-7757(96)03582-0
   MALISSARD M, 1999, BIOCONJUGATE CHEM, V16, P125
   Marieb E. N., 1998, HUMAN ANATOMY PHYSL
   Mathieu HJ, 2001, SURF INTERFACE ANAL, V32, P3, DOI 10.1002/sia.995
   MATHIEU HJ, 2001, NONDESTRUCTIVE ELEME, P201
   MONSIGNY M, 1995, BIOFUTUR, P27
   Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o
   ONYIRIUKA EC, 1990, APPL SPECTROSC, V44, P808, DOI 10.1366/0003702904086975
   PETRAK K, 1994, ADV DRUG DELIVER REV, V13, P211, DOI 10.1016/0169-409X(94)90012-4
   PEYSER P, 1989, POLYM HDB, P209
   PHILLIPS MC, 1972, BIOCHIM BIOPHYS ACTA, V290, P397, DOI 10.1016/0005-2736(72)90084-3
   Powell CJ, 1999, J PHYS CHEM REF DATA, V28, P19, DOI 10.1063/1.556035
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   RIEDO F, 1978, HELV CHIM ACTA, V61, P1912, DOI 10.1002/hlca.19780610533
   RUIZ L, 1995, BIOMIMETIC COATINGS
   RUIZ L, 1997, THESIS ECOLE POLYTEC
   RUIZ L, 1999, MATH HJ J E, V10, P931
   RUIZ L, 1998, MATH HJ, V19, P987
   SCHWARTZ AL, 1990, ANNU REV IMMUNOL, V8, P195, DOI 10.1146/annurev.iy.08.040190.001211
   Seah M. P., 1979, Surface and Interface Analysis, V1, P2, DOI 10.1002/sia.740010103
   SIGRIST H, 1995, OPT ENG, V34, P2339, DOI 10.1117/12.201815
   SIGRIST H, 2000, Patent No. 9911242232110
   STAPEL D, 1999, SIMS, V12
   STORP S, 1985, SPECTROCHIM ACTA B, V40, P745, DOI 10.1016/0584-8547(85)80124-5
   Swain PS, 1998, LANGMUIR, V14, P6772, DOI 10.1021/la980602k
   TANUMA S, 1994, SURF INTERFACE ANAL, V21, P165, DOI 10.1002/sia.740210302
   VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97
   Vickerman J. C., 1997, SURFACE ANAL PRINCIP
   Vickerman J. C., 2001, TOF SIMS SURFACE ANA
   Vickerman JC, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P135
   WALLISER A, 1992, 92MUHL0248 U HAUT AL
   Williams D.J., 1992, P1
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, V4
   WIRPSZA Z, 1993, POLYM SCI SERIES
   YAMASHITA K, 1989, MET, V179, P331
   Yianni YP, 1992, STRUCTURAL DYNAMIC P, P187
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Youngblood JP, 1999, MACROMOLECULES, V32, P6800, DOI 10.1021/ma9903456
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
   Zisman W. A., 1964, CONTACT ANGLE WETTAB, P1, DOI DOI 10.1021/BA-1964-0043.CH001
NR 105
TC 19
Z9 19
U1 0
U2 15
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 978-3-540-44020-8
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2003
VL 162
BP 1
EP 34
PG 34
WC Polymer Science
SC Polymer Science
GA BSC11
UT WOS:000284100800002
DA 2018-10-20
ER

PT S
AU Gupta, B
   Anjum, N
AF Gupta, Bhuvanesh
   Anjum, Nishat
BE Kausch, H
TI Plasma and Radiation-Induced Graft Modification of Polymers for
   Biomedical Applications
SO RADIATION EFFECTS ON POLYMERS FOR BIOLOGICAL USE
SE Advances in Polymer Science
LA English
DT Review
DE Polymer; Biomaterial; Radiation; Plasma; Graft Polymerization;
   Modification
ID LOW-TEMPERATURE PLASMA; SURFACE-MODIFICATION; ACRYLIC-ACID; BLOOD
   COMPATIBILITY; 2-HYDROXYETHYL METHACRYLATE; SILICONE-RUBBER;
   POLY(ETHYLENE-TEREPHTHALATE) FILMS; ULTRAFILTRATION MEMBRANES; COLLAGEN
   IMMOBILIZATION; TREATED POLYETHYLENE
AB Polymers have generated considerable interest in a number of innovative domains for biomedical applications. There is a great need to develop and design polymers for better acceptability to the biosystem that includes the blood and tissue compatibility and a perfect cell-material interaction. The modification of existing polymers by careful designing of the macromolecular architecture is one of the most attractive ways to develop such biomaterials. Plasma and high-energy radiation, such as gamma radiation and electron beam lead to enough activation of polymers so that specific monomer may be grafted. The extent of modification, i.e., the degree of grafting may be easily controlled by the careful variation of the radiation exposure and reaction conditions. The graft modification may be carried out almost on all polymers with the creation of a desired functional chemistry both on the surface and in the bulk matrix. such biomaterials are being used for implants, sutures, tissue engineering, and as structured surface materials. The most recent innovation in the development of biomaterials has been in the area of tissue engineering where human cells are seeded on top of a polymer support and are harvested as tissue. The grafting method is extremely attractive as the modified biomaterial is obtained in the purest form possible. The grafting is applicable to almost all polymer-monomer combinations with enormous possibilities of physico-chemical and biological characteristics.
C1 [Gupta, Bhuvanesh; Anjum, Nishat] Indian Inst Technol, Dept Text Technol, New Delhi 110016, India.
RP Gupta, B (reprint author), Indian Inst Technol, Dept Text Technol, New Delhi 110016, India.
EM bgupta@textile.iitd.ernet.in
CR ABSOLOM DR, 1988, J BIOMED MATER RES, V22, P215, DOI 10.1002/jbm.820220306
   ALEXANDER JW, 1967, ANN SURG, V165, P192, DOI 10.1097/00000658-196702000-00005
   BAE J, 1999, KAN, V20, P529
   Bisson I, 2002, BIOMATERIALS, V23, P3149, DOI 10.1016/S0142-9612(02)00061-3
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   BUCKENSKA J, 1996, J APPL POLYM SCI, V61, P567
   BURES P, 2001, PEPPA NA J, V72, P25
   BURG KJL, 2001, INT FIBER J, V16, P38
   Chapiro A., 1962, RAD CHEM POLYM SYSTE
   Chen H, 1999, J APPL POLYM SCI, V72, P1699, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1699::AID-APP6>3.0.CO;2-9
   COHN D, 1987, J APPL POLYM SCI, V31, P1
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Eckert AW, 2000, BIOMATERIALS, V21, P441
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gupta B, 2000, J APPL POLYM SCI, V77, P1401, DOI 10.1002/1097-4628(20000808)77:6<1401::AID-APP28>3.0.CO;2-T
   Gupta B, 2000, J APPL POLYM SCI, V77, P1331, DOI 10.1002/1097-4628(20000808)77:6<1331::AID-APP18>3.0.CO;2-M
   Gupta B, 2002, J APPL POLYM SCI, V86, P1118, DOI 10.1002/app.11129
   Gupta B, 2001, J APPL POLYM SCI, V81, P2993, DOI 10.1002/app.1749
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Gupta B, 2000, J APPL POLYM SCI, V78, P1083, DOI 10.1002/1097-4628(20001031)78:5<1083::AID-APP170>3.0.CO;2-5
   GUPTA B, 2000, POLYM PREPRINTS, V4, P1040
   GUPTA B, 1994, POLYM ADVAN TECHNOL, V5, P493
   GUPTA BD, 1990, J MACROMOL SCI CHEM, VA27, P831, DOI 10.1080/10601329008544808
   HAN DK, 1991, J BIOMED MATER RES, V25, P561, DOI 10.1002/jbm.820250502
   HAYAT U, 1992, BIOMATERIALS, V13, P801, DOI 10.1016/0142-9612(92)90022-G
   HELMUS MN, 1984, J BIOMED MATER RES, V18, P165, DOI 10.1002/jbm.820180207
   HILBORN J, Patent No. 9824562
   HOFFMAN AS, 1972, KRAFT AM ART, V18, P10
   HSIUE GH, 1993, J POLYM SCI POL CHEM, V31, P3327, DOI 10.1002/pola.1993.080311321
   HSIUE GH, 1993, J BIOMAT SCI-POLYM E, V5, P205
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Jen M.Y., 1998, J MEMBRANE SCI, V138, P19
   Kabanov VY, 1997, NUCL INSTRUM METH B, V131, P291, DOI 10.1016/S0168-583X(97)00393-5
   KAMATH KR, 1994, J APPL BIOMATER, V5, P163, DOI 10.1002/jab.770050210
   KANG I, 1997, LEE YM, V18, P1099
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   Kato K, 2000, J ADHES SCI TECHNOL, V14, P635, DOI 10.1163/156856100742807
   KIAEI D, 1995, RADIAT PHYS CHEM, V46, P191, DOI 10.1016/0969-806X(95)00012-M
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KIM EJ, 1998, PARKY, V19, P239
   KIM H, 2001, NAKAMURE, V22, P2489
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   KISHIDA A, 1991, BIOMATERIALS, V12, P786, DOI 10.1016/0142-9612(91)90031-5
   KO TM, 1993, J APPL POLYM SCI, V47, P1601, DOI 10.1002/app.1993.070470908
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Kwon OH, 1999, J APPL POLYM SCI, V71, P631, DOI 10.1002/(SICI)1097-4628(19990124)71:4<631::AID-APP15>3.0.CO;2-G
   LANGER R, 1993, VACANTI TISSUE ENG S, V260, P920
   LEE HB, 1972, AM CHEM SOC POLYM PR, V13, P729
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   LEE SD, 1994, J APPL POLYM SCI, V54, P1279, DOI 10.1002/app.1994.070540909
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   Oehr C, 1999, SURF COAT TECH, V116, P25, DOI 10.1016/S0257-8972(99)00201-7
   Park JS, 1998, J APPL POLYM SCI, V69, P2213, DOI 10.1002/(SICI)1097-4628(19980912)69:11<2213::AID-APP13>3.0.CO;2-#
   RATNER BD, 1974, J APPL POLYM SCI, V18, P3183, DOI 10.1002/app.1974.070181101
   RATNER BD, 1978, J BIOENG, V2, P313
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   REVAGADE N, 2001, THESIS IIT DELHI IND
   RICHEY T, 2000, MAT Y, V21, P1057
   SANO S, 1993, BIOMATERIALS, V20, P529
   Sharma C P, 1987, J Biomater Appl, V2, P205, DOI 10.1177/088532828700200202
   SINGH DK, 1994, J APPL POLYM SCI, V53, P1115, DOI 10.1002/app.1994.070530814
   SINGH H, 1989, ANGEW MAKROMOL CHEM, V172, P87, DOI 10.1002/apmc.1989.051720108
   SUN YH, 1986, J BIOACT COMP POLYM, V1, P317
   SUZUKI M, 1986, MACROMOLECULES, V19, P1808
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   TOMITA N, 1994, J APPL BIOMATER, V5, P175, DOI 10.1002/jab.770050211
   TYAGI PK, 1993, J MACROMOL SCI PURE, VA30, P303, DOI 10.1080/10601329308009408
   UCHIDA E, 1990, J APPL POLYM SCI, V41, P677, DOI 10.1002/app.1990.070410317
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   Ulbricht M, 1996, J MEMBRANE SCI, V111, P193, DOI 10.1016/0376-7388(95)00207-3
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W
   UYAMA Y, 1990, J APPL POLYM SCI, V39, P489, DOI 10.1002/app.1990.070390301
   VANKAMPEN CL, 1979, J BIOMED MATER RES, V13, P517, DOI 10.1002/jbm.820130402
   VANWACHEM PB, 1985, J MAT, V6, P403
   WARD TL, 1982, POLYM PHOTOCHEM, V2, P109, DOI 10.1016/0144-2880(82)90034-3
   Wise DL, 1995, ENCY HDB BIOMATERIAL
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   ZHANG F, 2001, BIO, V56, P324
NR 84
TC 36
Z9 38
U1 5
U2 36
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 978-3-540-44020-8
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2003
VL 162
BP 35
EP 61
PG 27
WC Polymer Science
SC Polymer Science
GA BSC11
UT WOS:000284100800003
DA 2018-10-20
ER

PT S
AU Bertsch, A
   Jiguet, S
   Bernhard, P
   Renaud, P
AF Bertsch, A
   Jiguet, S
   Bernhard, P
   Renaud, P
BE Pique, A
   Holmes, AS
   Dimos, DB
TI Microstereolithography: a review
SO RAPID PROTOTYPING TECHNOLOGIES
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Rapid Prototyping Technologies
CY DEC 03-05, 2002
CL BOSTON, MA
SP Mat Res Soc, Def Adv Res Projects Agcy, Natl Sci Fdn, USN, Off Naval Res
ID SPATIAL LIGHT-MODULATOR; 3-DIMENSIONAL MICROFABRICATION;
   MICROSTEREOPHOTOLITHOGRAPHY; POLYMERIZATION
AB Microstereolithography is a technology at the interface of the microengineering and rapid prototyping domains. It has evolved from the stereolithography technique, and is also based on a light-induced layer-stacking manufacturing, As the resolution of the microstereolithography technique is far better than the one of rapid prototyping technologies, this technique is of particular interest in the microengineering domain where its 3D capability allows the production of components no other microfabrication technique can create.
   The first developments of the microstereolithography technique have started in 1993 and different research teams have developed machines since, using different approaches. This paper reviews the major microstereolithography processes developed until now.
   Microstereolithography is starting to be a commercially available manufacturing process. As the market for miniaturized products grows rapidly, there is an increasing need for high-resolution small size prototype parts. If the production of small mechanical components is the first commercial application of microstereolithography, this technology can also produce useful components for the microrobotic, microfluidic, microsystems and biomedical fields. Current research in the microstereolithography field is focused on using ceramic composites as material to manufacture complex three-dimensional parts that can be sintered to produce pure alumina microcomponents.
C1 Swiss Fed Inst Technol, EPFL, STI, IMM, CH-1015 Lausanne, Switzerland.
RP Bertsch, A (reprint author), Swiss Fed Inst Technol, EPFL, STI, IMM, LMIS4, CH-1015 Lausanne, Switzerland.
RI Bertsch, Arnaud/U-5753-2017; Renaud, P/A-6994-2011
OI Bertsch, Arnaud/0000-0002-1044-0478; Renaud, P/0000-0001-5199-1252
CR Andre A.J., 1984, French Patent, Patent No. 8411241
   Ballandras S, 1997, SENSOR ACTUAT A-PHYS, V62, P741, DOI 10.1016/S0924-4247(97)01574-4
   BELUZE L, 1999, SPIE S DES TEST MICR
   BERNHARD P, 1997, RAPID PROTOTYPING RE
   Bertsch A, 1997, MICROSYST TECHNOL, V3, P42, DOI 10.1007/s005420050053
   Bertsch A, 1999, SENSOR ACTUAT A-PHYS, V73, P14, DOI 10.1016/S0924-4247(98)00249-0
   BERTSCH A, 1995, 4 ASS EUR PROT RAP P
   Bertsch A, 2000, RAPID PROTOTYPING J, V6, P259, DOI 10.1108/13552540010373362
   BOHLMANN H, 2001, 4 INT WORKSH HIGH AS
   Chatwin C, 1998, APPL OPTICS, V37, P7514, DOI 10.1364/AO.37.007514
   Farsari M, 1999, OPT LETT, V24, P549, DOI 10.1364/OL.24.000549
   HORNBECK LJ, 1997, EL IM EI 97 PROJ DIS
   Hull C, 1986, US Patent, Patent No. [4,575,330, 4575330, US 4575330 A]
   Ikuta K., 2001, TRANSD 01 EUR 15 WOR
   IKUTA K, 2000, INT MICR NAN C
   IKUTA K, 1993, 6 IEEE WORKSH MICR E
   IKUTA K, 1998, 11 IEEE WORKSH MICR
   Ji TS, 2001, SMART MATER STRUCT, V10, P1224, DOI 10.1088/0964-1726/10/6/311
   Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130
   LOUBERE V, 1998, 4 JAP FRANC C 2 AS E
   Maruo S, 1997, OPT LETT, V22, P132, DOI 10.1364/OL.22.000132
   Maruo S, 2000, APPL PHYS LETT, V76, P2656, DOI 10.1063/1.126742
   MARUO S, 2001, 14 IEEE INT C MICR E
   MARUO S, 1996, SPIE OPT SCI NEW TEC
   Nakamoto T, 1996, J MICROMECH MICROENG, V6, P240, DOI 10.1088/0960-1317/6/2/006
   TAKAGI T, 1994, 7 IEEE WORKSH MICR E
   TAKAGI T, 1993, 4 INT S MICR MACH HA
   Zhang X, 1998, ASME, V66, P3
   Zissi S., 1996, Microsystem Technologies, V2, P97, DOI 10.1007/s005420050023
   ZISSI S, 1994, 3 ASS EUR PROT RAP P
NR 30
TC 11
Z9 11
U1 2
U2 27
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-695-8
J9 MATER RES SOC SYMP P
PY 2003
VL 758
BP 3
EP 15
PG 13
WC Engineering, Biomedical; Engineering, Manufacturing; Optics; Physics,
   Condensed Matter
SC Engineering; Optics; Physics
GA BX10Y
UT WOS:000184306500001
DA 2018-10-20
ER

PT S
AU Cooper, KP
AF Cooper, KP
BE Pique, A
   Holmes, AS
   Dimos, DB
TI Layered manufacturing: Challenges and opportunities
SO RAPID PROTOTYPING TECHNOLOGIES
SE Materials Research Society Symposium Proceedings
LA English
DT Proceedings Paper
CT Symposium on Rapid Prototyping Technologies
CY DEC 03-05, 2002
CL BOSTON, MA
SP Mat Res Soc, Def Adv Res Projects Agcy, Natl Sci Fdn, USN, Off Naval Res
ID FABRICATION; COMPONENTS; PROTOTYPES; POLYMERS
AB Layered Manufacturing (LM) refers to computer-aided manufacturing processes in which parts are made in sequential layers relatively quickly. Parts that are produced by LM can be formed from a wide range of materials such as photosensitive polymers, metals and ceramics in sizes from a centimeter to a few meters with sub-millimeter feature resolutions. LM has found use in diverse areas including biomedical engineering, pharmaceuticals, aerospace, defense, electronics and design engineering. The promise of LM is the capability to make customized complex-shaped functional parts without specialized tooling and without assembly. LM is still a few years away from fully realizing its promise but its potential for manufacturing remains high. A few of the fundamental challenges in materials processing confronting the community are improving the quality of the surface finish, eliminating residual stress, controlling local composition and microstructure, achieving fine feature size and dimensional tolerance and accelerating processing speed. Until these challenges are met, the applicability of LM and its commercialization will be restricted. Sustained scientific activity in LM has advanced over the past decade into many different areas of manufacturing and has enabled exploration of novel processes and development of hybrid processes. The research community of today has the opportunity to shape the future direction of science research to realize the full potential of LM.
C1 USN, Res Lab, Div Mat Sci & Technol, Washington, DC 20375 USA.
RP Cooper, KP (reprint author), USN, Res Lab, Div Mat Sci & Technol, Washington, DC 20375 USA.
CR Allahverdi M, 2001, PROCEEDINGS OF THE 2001 12TH IEEE INTERNATIONAL SYMPOSIUM ON APPLICATIONS OF FERROELECTRICS, VOLS I AND II, P381, DOI 10.1109/ISAF.2000.941576
   ANDERSON RL, 2002, S RAP PROT MAT TMS F
   Arcella FG, 2000, JOM-J MIN MET MAT S, V52, P28, DOI 10.1007/s11837-000-0028-x
   ARCELLA FG, COMMUNICATION
   BEAMAN JJ, 1987, N AM MAN RES C P, P636
   Beluze L, 1999, PROC SPIE, V3680, P808, DOI 10.1117/12.341277
   Beuth J, 2001, JOM-J MIN MET MAT S, V53, P36, DOI 10.1007/s11837-001-0067-y
   CHAVEZ P, 2000, LENSTM PROCESS FUELI
   CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851
   Chrisey DB, 2000, APPL SURF SCI, V154, P593, DOI 10.1016/S0169-4332(99)00465-1
   Cohen A, 1998, SOL FREEFORM FABRIC, P161
   Cooper KP, 2002, RAPID PROTOTYPING OF MATERIALS, PROCEEDINGS, P119
   Crocker JE, 1998, JOM-J MIN MET MAT S, V50, P21, DOI 10.1007/s11837-998-0300-z
   DANFORTH SC, 1998, NAV RES REV, VL, P27
   DAVE D, 1995, SFF SYN P U TEX AUST, P64
   DUTY C, 1999, CERAM ENG SCI P, V20, P347
   Griffith ML, 1996, SOL FREEFORM FABRIC, P125
   HAN W, 2002, IN PRESS ASME T
   Hofmeister W., 1999, JOM E, V51
   JAFARI MA, IN PRESS J RAPID PRO
   Kietzman JW, 1997, SOL FREEFORM FABRIC, P133
   KOLISCH S, 2002, AMPTIAC Q, V6, P3
   LI X, 1995, SFF S P U TEX AUST, P314
   MARCH AL, 2001, ECONOMIST       0714, P63
   Mazumder J, 1997, JOM-J MIN MET MAT S, V49, P55, DOI 10.1007/BF02914687
   MERZ R, 1994, SOL FREEF FABR S U T, P1
   ORME M, 1995, SOLID FREEFORM FABRI, P88
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   SACHS E, 1992, J ENG IND-T ASME, V114, P481
   SACHS E, 1995, SOLID FREE FORM FABR, P448
   SACHS E, 2001, SFF S P, P596
   Taminger K M B, 2002, 2002 INT C MET POWD, P51
   Vaidyanathan R, 2000, JOM-J MIN MET MAT S, V52, P34, DOI 10.1007/s11837-000-0066-4
   VENTURA S, 2000, ONRS WOOD HOL M MAY
   VENTURA S, 1997, P 7 INT C RAP PROT S, P271
   Zhang W, 1999, SOL FREEFORM FABRIC, P591
   Zimbeck WR, 2000, MATER RES SOC SYMP P, V625, P173, DOI 10.1557/PROC-625-173
NR 37
TC 1
Z9 1
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-695-8
J9 MATER RES SOC SYMP P
PY 2003
VL 758
BP 23
EP 34
PG 12
WC Engineering, Biomedical; Engineering, Manufacturing; Optics; Physics,
   Condensed Matter
SC Engineering; Optics; Physics
GA BX10Y
UT WOS:000184306500003
DA 2018-10-20
ER

PT B
AU Albanese, R
   Medina, R
   Penn, J
AF Albanese, R
   Medina, R
   Penn, J
BE Smith, RC
   Demetriou, MA
TI Mathematics and electromagnetic theory
SO RESEARCH DIRECTIONS IN DISTRIBUTED PARAMETER SYSTEMS
SE FRONTIERS IN APPLIED MATHEMATICS
LA English
DT Proceedings Paper
CT Conference on Future Directions in Distributed Parameter Systems
CY OCT, 2000
CL N CAROLINA STATE UNIV, RALEIGH, NC
HO N CAROLINA STATE UNIV
AB This chapter examines certain aspects of modern electromagnetic theory. The chapter addresses electromagnetic theory from the point of view of physics, biology and engineering applications. Details of electromagnetic energy absorption within a material are presented. Electromagnetic energy is stored within a medium as kinetic and potential energy and is dissipated as thermal energy. Biomedical effects can be related to either energy dissipation or thermalization, or to stored energy. Thermalization can result in increases in rates of protein denaturation. It is shown that the creation of a thermal field using electromagnetic energy can result in chemical fluxes within a medium. Energy storage within molecules can become localized to certain molecular sub-components and this could pose a hazard. Active engineering applications of electromagnetic theory include imaging and energy localization within media for therapy or other manipulative purposes.
C1 USAF, Res Lab, Biomech & Computat Branch, Brooks AFB, TX 78235 USA.
RP Albanese, R (reprint author), USAF, Res Lab, Biomech & Computat Branch, Brooks AFB, TX 78235 USA.
CR ALBANESE RA, 1984, NONLINEAR ELECTRODYN, P277
   Banks H. T., 2000, FRONTIERS APPL MATH, VFR21
   Borden B., 1999, RADAR IMAGING AIRBOR
   COHEN H, 1971, STUDIES APPL MATH
   Colton D., 1992, INVERSE ACOUSTIC ELE
   DIEHL JF, 1990, SAFETY IRRADIATED FO
   Drabowitch S., 1998, MODERN ANTENNAS, DOI London
   DURNEY CH, 1982, INTRO MODERN ELECTRO
   Franceschetti G., 1999, SYNTHETIC APERTURE R
   Frey A., 1994, NATURE ELECTROMAGNET
   GHATAK AK, 1972, INTRO LATTICE DYNAMI
   KLAUENBERG BJ, 1995, NATO ASI SERIES
   Kraniauskas P, 1992, TRANSFORMS SIGNALS S
   LAGNESE JE, 1989, SIAM J CONTROL OPTIM, V27, P374, DOI 10.1137/0327019
   Lee W. C., 1995, MOBILE CELLULAR TELE
   Main IG, 1984, VIBRATIONS WAVES PHY
   MUSANTE CJ, 1998, THESIS N CAROLINA ST
   Oughstun K. E., 1994, ELECTROMAGNETIC PULS
   PROHOFSKY E, 1995, STAT MECH STABILITY
NR 19
TC 2
Z9 2
U1 0
U2 0
PU SIAM
PI PHILADELPHIA
PA 3600 UNIV CITY SCIENCE CENTER, PHILADELPHIA, PA 19104-2688 USA
BN 0-89871-548-2
J9 FRONT APP M
PY 2003
BP 1
EP 15
DI 10.1137/1.9780898717525.ch1
PG 15
WC Automation & Control Systems; Operations Research & Management Science;
   Mathematics, Applied
SC Automation & Control Systems; Operations Research & Management Science;
   Mathematics
GA BY36D
UT WOS:000189045800001
DA 2018-10-20
ER

PT B
AU Telenkov, SA
   Dave, DP
   Milner, TE
AF Telenkov, SA
   Dave, DP
   Milner, TE
BE Thompson, DO
   Chimenti, DE
TI Low-coherence optical probe for non-contact detection of photothermal
   and photoacoustic phenomena in biomaterials
SO REVIEW OF PROGRESS IN QUANTITATIVE NONDESTRUCTIVE EVALUATION, VOLS 22A
   AND 22B
SE REVIEW OF PROGRESS IN QUANTITATIVE NONDESTRUCTIVE EVALUATION
LA English
DT Proceedings Paper
CT 29th Annual Review of Progress in Quantitative Nondestructive Evaluation
CY JUL 14-19, 2002
CL WESTERN WASHINGTON UNIV, BELLINGHAM, WA
HO WESTERN WASHINGTON UNIV
ID TOMOGRAPHY
AB Laser-induced mechanical deformations in materials can be detected without contact using various optical methods. We have developed a low-coherence optical probe to monitor thermal elastic deformations and acoustic transients in materials exposed to laser excitation. Our approach utilizes principles from low-coherence interferometry with phase-sensitive detection of the coherence function of backscattered light from two spatially separated sites in a test material. High spatial resolution and sensitivity of the optical probe may be used to identify subsurface light-absorbing structures in turbid media and determine optical properties non-invasively. The low-coherence optical sensor may prove useful for non-contact studies of tissue-like materials in biomedical engineering.
C1 Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
RP Telenkov, SA (reprint author), Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
CR Brezinski ME, 1999, IEEE J SEL TOP QUANT, V5, P1185, DOI 10.1109/2944.796345
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   Chen ZP, 1997, OPT LETT, V22, P64, DOI 10.1364/OL.22.000064
   de Boer JF, 2002, J BIOMED OPT, V7, P359, DOI 10.1117/1.1483879
   HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   MONCHALIN JP, 1985, REV SCI INSTRUM, V56, P543, DOI 10.1063/1.1138284
   Sobol EN, 1999, IEEE J QUANTUM ELECT, V35, P532, DOI 10.1109/3.753657
NR 8
TC 0
Z9 0
U1 0
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
BN 0-7354-0117-9
J9 REV PROG Q
PY 2003
VL 20
BP 852
EP 858
PN A&B
PG 7
WC Acoustics; Engineering, Electrical & Electronic; Instruments &
   Instrumentation; Materials Science, Characterization & Testing; Optics
SC Acoustics; Engineering; Instruments & Instrumentation; Materials
   Science; Optics
GA BW52Z
UT WOS:000182317500111
DA 2018-10-20
ER

PT J
AU Faubel, W
   Heissler, S
   Pyell, U
   Ragozina, N
AF Faubel, W
   Heissler, S
   Pyell, U
   Ragozina, N
TI Photothermal trace detection in capillary electrophoresis for biomedical
   diagnostics and toxic materials (invited)
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on Photoacoustic and Photothermal
   Phenomena (12 ICPPP)
CY JUN 24-27, 2002
CL UNIV TORONTO, TORONTO, CANADA
HO UNIV TORONTO
ID CHROMATOGRAPHY
AB Two applications of a near-field thermal lens capillary electrophoresis detector in the deep ultraviolet region (pump beam 257 nm wavelength) will be presented: (1) Capillary electrophoretic determination of the pharmaceuticals Tramadol, Verapamil, and Papaverin. Direct separation techniques were used for the different classes of substances with characteristic absorbance spectra. The combination of capillary electrophoresis and the highly sensitive detection with thermal lens spectroscopy permits the analysis of nanoliter volume samples common in biomedical diagnostics without any preconcentration step. (2) The determination of (nonfluorescent) nitro aromatic explosives in contaminated soil. These compounds are detected with the laboratory built thermal lens detector after their separation by micellar electrokinetic chromatography. Its shown that this type of detection makes it possible to obtain limits of detection 1-2 orders of magnitude lower than those obtained with classical absorption spectrometric detection. (C) 2003 American Institute of Physics.
C1 Forschungszentrum Karlsruhe, Inst Instrumentelle Analyt, D-76021 Karlsruhe, Germany.
   Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany.
RP Faubel, W (reprint author), Forschungszentrum Karlsruhe, Inst Instrumentelle Analyt, Postfach 3640, D-76021 Karlsruhe, Germany.
CR Bialkowski S.E., 1996, CHEM ANAL, V134
   Bonneil E, 1999, J Capill Electrophor Microchip Technol, V6, P61
   GUPTA R, 1992, PROGR PHOTOTHERMAL P, V1, P96
   KLEIBOHMER W, 1993, J CHROMATOGR, V638, P349, DOI 10.1016/0021-9673(93)83448-2
   Malik AK, 2000, CHEM SOC REV, V29, P275, DOI 10.1039/a907422h
   Malik AK, 2001, CRIT REV ANAL CHEM, V31, P223, DOI 10.1080/20014091076758
   Malina M, 1999, J ENDOVASC SURG, V6, P97
   Melanson JE, 2001, ANAL CHEM, V73, P1809, DOI 10.1021/ac001301u
   Pyell U, 2001, FRESEN J ANAL CHEM, V371, P691, DOI 10.1007/s002160100981
   Qi M, 1999, J CHROMATOGR A, V853, P131, DOI 10.1016/S0021-9673(99)00688-3
   Ragozina N, 2002, ANAL CHEM, V74, P4480, DOI 10.1021/ac020095i
   Tang T, 2002, ANAL CHEM, V74, P725, DOI 10.1021/ac010874j
   Throckmorton DJ, 2002, ANAL CHEM, V74, P784, DOI 10.1021/ac011077o
   Vizioli N M, 1999, J Capill Electrophor Microchip Technol, V6, P109
   Xiang R, 2002, ANAL CHEM, V74, P762, DOI 10.1021/ac010968t
NR 15
TC 6
Z9 6
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD JAN
PY 2003
VL 74
IS 1
BP 491
EP 494
DI 10.1063/1.1523135
PN 2
PG 4
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 636JQ
UT WOS:000180451900058
DA 2018-10-20
ER

PT J
AU Niinomi, M
AF Niinomi, Mitsuo
TI Recent research and development in titanium alloys for biomedical
   applications and healthcare goods
SO SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
LA English
DT Review
DE Titanium alloy; Low rigidity; Super elastic; Shape memory; Bioactive
   surface modification; Dental precision casting; Healthcare goods
AB Nb, Ta and Zr are the favorable non-toxic alloying elements for titanium alloys for biomedical applications. Low rigidity titanium alloys composed of non-toxic elements are getting much attention. The advantage of low rigidity titanium alloy for the healing of bone fracture and the remodeling of bone is successfully proved by fracture model made in tibia of rabbit. Ni-free super elastic and shape memory titanium alloys for biomedical applications are energetically developed. Titanium alloys for not only implants, but also dental products like crowns, dentures, etc. are also getting much attention in dentistry. Development of investment materials suitable for titanium alloys with high melting point is desired in dental precision castings. Bioactive surface modifications of titanium alloys for biomedical applications are very important for achieving further developed biocompatibility. Low cost titanium alloys for healthcare goods, like general wheel chairs, etc. has been recently proposed. (C) 2003 Elsevier Ltd. All rights reserved.
C1 [Niinomi, Mitsuo] Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1,Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1,Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
EM niinomi@sp-mac4.tutpse.tut.ac.jp
CR Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   Akahori T, 2000, METALL MATER TRANS A, V31, P1949, DOI 10.1007/s11661-000-0222-z
   Akahori T, 2002, METALL MATER TRANS A, V33, P503, DOI 10.1007/s11661-002-0112-7
   BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   Cui FZ, 1997, J MATER SCI-MATER M, V8, P403, DOI 10.1023/A:1018597320022
   Daimatsu Y., 2001, P FALL M JPN I MET, P401
   Doi H, 1998, J JPN SOC DENT MAT D, V17, P247
   Eylon D., 1991, METALS HDB, V2, P634
   Fukunaga K., 2001, P FALL M JIM, P308
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   Hanawa T., 1998, MAT JPN, V37, P853
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   Hatori T., 2001, P INT C BIOM COMB AN, P28
   Hattori T., 2002, J JPN CLIN BIOMECH, V23, P299
   Hiromoto H., 2002, P ANN M JPN I MET, P443
   Hosoda H., 2001, P FALL M JPN I MET, P401
   Ikeda M., 2003, P ANN M JIM, P130
   Ikeda M., 2003, CAMP ISIJ, V16, P613
   Kasuga T, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P265
   Kasuga T, 2001, BIOMATERIALS, V22, P577, DOI 10.1016/S0142-9612(00)00216-7
   KATO K, 1997, J JPN SOC DENT MAT D, V16, P45
   Kawahara H., 1963, J JPN SOC DENT APPAR, V4, P65
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   KOBAYASHI E, 1995, J J DENT MAT, V14, P321
   Kobayashi E., 1995, J JPN SOC DENT MAT D, V14, P406
   KOVACS P, 1993, TITANIUM '92: SCIENCE AND TECHNOLOGY, VOLS 1-3, P2705
   Kuroda D, 2000, TETSU TO HAGANE, V86, P610, DOI 10.2355/tetsutohagane1955.86.9_610
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   MAESHIMA T., 2003, ANN M JIM, P134
   Mishra A. K., 1996, ASTM STP, V1272, P96
   Miyazaki T., 1987, J DENT MAT, V6, P633
   Miyazaki T., 1987, JPN J DENT MAT, V6, P437
   Nakazawa K, 1999, J JPN I MET, V63, P1600, DOI 10.2320/jinstmet1952.63.12_1600
   Niinomi M, 2003, MATERIALS LIFETIME SCIENCE & ENGINEERING, P223
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 1999, JOM-J MIN MET MAT S, V51, P32, DOI 10.1007/s11837-999-0091-x
   Niinomi M, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P3
   NIINOMI M., 1998, MAT SCI ENG A-STRUCT, V243, P243
   Niinomi M., 2003, NETSUSHORI, V42, P409
   Niinomi M., 1998, MAT JAPAN, V37, P843
   Niinomi M., 2002, MAT JPN, V41, P221
   Niinomi M., 2001, METALL MATER TRANS A, V32A, P477
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Nonami T., 1998, MAT JPN, V37, P856
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1996, J JPN I MET, V60, P902, DOI 10.2320/jinstmet1952.60.9_902
   OKUNO O, 1996, J JPN SOC BIOMATER, V14, P267
   Otomo H., 2003, P FALL M JPN I MET, P324
   Saito S., 2001, 26 WORKSH JSPS 156 C, P7
   Soma T., 2003, P ANN M JAP LIGHT ME, P81
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Uggowitzer P. J., 1997, ADV POWDER METALL PA, V3, P18113
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
   Wang KK, 1996, ASTM STP, V1272, P76
   YAMAMOTO A, 1995, J JPN I MET, V59, P463, DOI 10.2320/jinstmet1952.59.4_463
   Yamamuro T, 1989, J JPN SOC BIOMATER, V7, P19
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
   Yoshinari M, 1997, J BIOMED MATER RES, V37, P60, DOI 10.1002/(SICI)1097-4636(199710)37:1<60::AID-JBM8>3.0.CO;2-H
   Yoshinari M, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P129
   Yoshitani S., 2000, CAMP ISIJ, V13, P1345
NR 61
TC 187
Z9 189
U1 1
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1468-6996
EI 1878-5514
J9 SCI TECHNOL ADV MAT
JI Sci. Technol. Adv. Mater.
PY 2003
VL 4
IS 5
BP 445
EP 454
DI 10.1016/j.stam.2003.09.002
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA V44CP
UT WOS:000209727400007
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Ogawa, R
   Watanabe, J
   Ishihara, K
AF Ogawa, Ryo
   Watanabe, Junji
   Ishihara, Kazuhiko
TI Domain-controlled polymer alloy composed of segmented polyurethane and
   phospholipid polymer for biomedical applications
SO SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
LA English
DT Article
DE 2-Methacryloyloxyethyl phosphorylcholine polymer; Segmented
   polyurethane; Polymer alloy; Phase separation; Thermal analysis; Blood
   compatibility
AB Segmented polyurethane(SPU)s are block polymers which have a good elastic property and thermoplasticity. However, the biocompatibility of SPU is not sufficient, and a living organism rejects the SPU as a foreign material. Thus, some modification is needed to provide excellent biocompatibility and retain the good physical characteristics of the SPUs. In this study, we blended the 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer with SPU to prepare an SPU/MPC polymer alloy. We investigated the effects of the molecular weight (M-w) of the MPC polymer on the microdomain structure and mechanical property of the polymer alloy. When the MPC polymer with a higher M-w was blended with SPU, the polymer alloy underwent a reduction in mechanical strength. On the other hand, even when the lower M-w of the MPC polymer was blended with SPU, differential scanning calorimetric analysis revealed that the MPC polymer chains did not disrupt the crystallinity of the hard segments of SPU and the polymer alloy could maintain its physical properties the same as that of the original SPU. We investigated the adsorption of immunoglobulin (IgG) on the surface of the polymer alloy for evaluation of its fundamental biocompatibility. The SPU/MPC polymer alloy lowered the amount of adsorbed IgG compared to that on SPU. This means that the blending of the MPC polymer significantly improved the biocompatibility of the SPU. We succeeded in preparing an SPU/MPC polymer alloy that possesses both the good mechanical property of SPU and the improved biocompatibility using MPC polymers. (C) 2003 Elsevier Ltd. All rights reserved.
C1 [Ogawa, Ryo; Watanabe, Junji; Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Dept Mat Engn, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ishihara@bmw.t.u-tokyo.ac.jp
FU Ministry of Education, Culture, Sports, Science, and Technology of
   Japan; JSPS [13480288]
FX This research was supported by a Grant for 21st Century COE Program
   'Human-Friendly Materials based on Chemistry' from the Ministry of
   Education, Culture, Sports, Science, and Technology of Japan, and by a
   Grant-in-Aid for Scientific Research (B) (13480288) from JSPS. We
   thanked the members of the Division of Organic Materials, Institute of
   Biomaterials and Bioengineering, Tokyo Medical and Dental University,
   for their support of the TEM observations.
CR BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P499, DOI 10.1002/jbm.820270411
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   HAN DK, 1991, J BIOMED MATER RES, V25, P561, DOI 10.1002/jbm.820250502
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Ishihara K, 1996, J BIOMED MATER RES, V32, P401, DOI 10.1002/(SICI)1097-4636(199611)32:3<401::AID-JBM13>3.0.CO;2-J
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   Ishihara K, 2000, SCI TECHNOL ADV MAT, V1, P131, DOI 10.1016/S1468-6996(00)00012-7
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki K., 2001, J BIOMED MATER RES, V52, P72
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LEUNG LM, 1986, MACROMOLECULES, V19, P706, DOI 10.1021/ma00157a038
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   Ogawa R, 2002, J BIOMED MATER RES, V62, P214, DOI 10.1002/jbm.10339
   Okkema A.Z., 1990, BIOMATERIALS, P3
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   PITT WG, 1988, BIOMATERIALS, V9, P36, DOI 10.1016/0142-9612(88)90067-1
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   Yoneyama T, 2000, ARTIF ORGANS, V24, P23, DOI 10.1046/j.1525-1594.2000.06433.x
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 28
TC 14
Z9 16
U1 1
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1468-6996
EI 1878-5514
J9 SCI TECHNOL ADV MAT
JI Sci. Technol. Adv. Mater.
PY 2003
VL 4
IS 6
BP 523
EP 530
DI 10.1016/j.stam.2003.10.030
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA V44CQ
UT WOS:000209727500007
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Patoor, E
AF Patoor, E
BE Lagoudas, DC
TI Micromechanical approach of stress-induced phase transformation
SO SMART STRUCTURES AND MATERIALS 2003: ACTIVE MATERIALS: BEHAVIOR AND
   MECHANICS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2003 Conference
CY MAR 02-06, 2003
CL SAN DIEGO, CA
SP SPIE, ASME, SEM, Boeing Co, Rhombus Consultant Grp, CSA Engn Inc, ISIS Canada, USAF, Off Sci Res, DARPA, Ceram Soc Japan, Intelligent Mat Forum, USA Res Off, Jet Propuls Lab, USN, Off Res, Natl Sci Fdn, USN, Res Lab
DE micromechanics; mechanical behavior; phase transition; shape memory
   alloys; thin film
ID SHAPE-MEMORY ALLOYS; CONSTITUTIVE BEHAVIOR; PLASTIC-DEFORMATION;
   POLYCRYSTALS; TEXTURE
AB Stress-induced martensitic phase transformation is responsible of very important phenomena like superelasticity or two-way shape memory in shape memory alloys. These phenomena are at the origin of many innovative products in industrial fields like aerospace or biomedical applications. To reach the best design is a very difficult task for applications using shape memory alloys: due to the existence of a phase transformation, these materials can no longer be considered as homogeneous and macroscopic approaches failed to give an accurate description of their behavior. The recent trend using SNM thin film as microactuator in microdevice increase the need of reliable design tools. Modems concepts developed in micromechanics and finite element analysis are well adapted to deal with these problems. Intra and intergranular stresses building from transformation strain incompatibilities in bulk materials or thin films are well accounted using these tools, even when complex loading conditions or different initial crystallographic texture are considered.
C1 Ecole Natl Super Arts & Metiers, CNRS, UMR 7554, Mecan & Phys Mat Lab, Metz, France.
RP Patoor, E (reprint author), Ecole Natl Super Arts & Metiers, CNRS, UMR 7554, Mecan & Phys Mat Lab, 4 Rue Augustin Fresnel, Metz, France.
CR Bhattacharya K, 1996, ACTA MATER, V44, P529, DOI 10.1016/1359-6454(95)00198-0
   Eshelby J. D., 1961, PROGR SOLID MECH, V2, P87
   FEHRI OF, 1987, SCRIPTA MED, V21, P771
   Gall K, 1999, INT J PLASTICITY, V15, P69, DOI 10.1016/S0749-6419(98)00060-6
   Gao XJ, 2000, INT J PLASTICITY, V16, P1345, DOI 10.1016/S0749-6419(00)00013-9
   Gillet Y, 1998, J INTEL MAT SYST STR, V9, P366, DOI 10.1177/1045389X9800900505
   HILL R, 1983, J MECH PHYS SOLIDS, V31, P347, DOI 10.1016/0022-5096(83)90004-2
   KRONER E, 1961, ACTA METALL MATER, V9, P155, DOI 10.1016/0001-6160(61)90060-8
   Mura T., 1987, MICROMECHANICS DEFEC
   Niclaeys C, 2002, INT J PLASTICITY, V18, P1619, DOI 10.1016/S0749-6419(02)00032-3
   NICLAEYS C, 2002, THESIS METZ U
   ONO N, 1988, T JPN I MET, V29, P267, DOI 10.2320/matertrans1960.29.267
   ORTIN J, 1988, ACTA METALL MATER, V36, P1873, DOI 10.1016/0001-6160(88)90291-X
   PATOOR E, 1988, ARCH MECH, V40, P775
   PATOOR E, 1997, CISM LECT NOTES, V368, P121
   Siredey N, 1999, INT J SOLIDS STRUCT, V36, P4289, DOI 10.1016/S0020-7683(98)00196-6
   SUN QP, 1993, J MECH PHYS SOLIDS, V41, P1, DOI 10.1016/0022-5096(93)90060-S
   SUN QP, 1993, J MECH PHYS SOLIDS, V41, P19, DOI 10.1016/0022-5096(93)90061-J
   WALPOLE LJ, 1967, PROC R SOC LON SER-A, V300, P270, DOI 10.1098/rspa.1967.0170
   Weschler M. S., 1953, T AIME, V197, P1503
NR 20
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4858-3
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5053
BP 271
EP 281
DI 10.1117/12.498561
PG 11
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BX48F
UT WOS:000185392900030
DA 2018-10-20
ER

PT S
AU Sokolowski, WM
   Hayashi, S
AF Sokolowski, WM
   Hayashi, S
BE Baz, AM
TI Applications of cold hibernated elastic memory (CHEM) structures
SO SMART STRUCTURES AND MATERIALS 2003: SMART STRUCTURES AND INTEGRATED
   SYSTEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2003 Conference
CY MAR 02-06, 2003
CL SAN DIEGO, CA
SP SPIE, ASME, SEM, Boeing Co, Rhombus Consultant Grp, CSA Engn Inc, ISIS Canada, USAF, Off Sci Res, DARPA, Ceram Soc Japan, Intelligent Mat Forum, USA Res Off, Jet Propuls Lab, USN, Off Res, Natl Sci Fdn, USN, Res Lab
DE expandable structures; shape memory polymers; open cellular structures;
   glass transition temperature Tg; glassy and rubbery states
AB Experiments and analyses have confirmed the feasibility of an innovative, new class of very simple, reliable, low mass; low packaging volume, and low-cost self-deployable structures for space and commercial applications. The material technology called "cold hibernated elastic memory" (CHEM) utilizes shape memory polymers in open cellular (foam) structures. The CHEM foams are self-deployable and are using the foam's elastic recovery plus their shape memory to erect structures. These structures are under development by the NASA's Jet Propulsion Laboratory (JPL) and Mitsubishi Heavy Industries (MHI). Currently, the CHEM structure concept is well formulated with clear space and commercial applications.
   The CHEM structures are described here and their major advantages are identified over other expandable/deployable structures. Previous experimental results were very encouraging and indicated that the CHEM foam technology can perform robustly in the Earth environment as well as in space. Some potential space applications were studied under various programs at JPL with promising results. Although the space community will be the major beneficiary, a lot of potential commercial and biomedical applications are also foreseen for the "earth environment" and are described in this paper as well.
C1 CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA.
RP Sokolowski, WM (reprint author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.
CR HAYASHI S, 1993, JSME INT J, V1, P35
   HAYASHI S, 1993, P SPI POL DIV 35 ANN
   HAYASHI S, 1988, MITSUBISHI TECHN B, V184
   HAYASHI S, 1993, INT PROGR URETHANES, V6
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   SOKOLOWSKI W, 1998, 2 NAT SPAC INFL WORK
   SOKOLOWSKI W, IN PRESS I PHYSICS J
   SOKOLOWSKI W, 2003, NASA TECH BRIEFS, V27
   SOKOLOWSKI W, NPO30657 NASA
   SOKOLOWSKI W, 2001, NASA TECH BRIEFS, V25
   Sokolowski W., 1999, P SPIE 99 INT S SMAR
   SOKOLOWSKI W, NPO30742 NASA
   SOKOLOWSKI W, NPO30272 NASA
NR 13
TC 8
Z9 8
U1 1
U2 14
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4861-3
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5056
BP 534
EP 544
DI 10.1117/12.483480
PG 11
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BX45J
UT WOS:000185332300054
DA 2018-10-20
ER

PT S
AU Guo, B
   Wang, Y
   Peng, C
   Luo, GP
   Le, HQ
AF Guo, B
   Wang, Y
   Peng, C
   Luo, GP
   Le, HQ
BE Levenson, RM
   Bearman, GH
   MahadevanJansen, A
TI Microscopic spectral imaging using mid-infrared semiconductor lasers
SO SPECTRAL IMAGING: INSTRUMENTATION, APPLICATIONS, AND ANALYSIS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Spectral Imaging - Instrumentation, Applications and
   Analysis II
CY JAN   26, 2003
CL SAN JOSE, CA
SP SPIE
DE mid-infrared; spectroscopic imaging; mid-infrared semiconductor lasers;
   quantum cascade lasers
AB Infrared micro-spectroscopy is a useful tool for basic research and biomedical applications. Conventional microspectroscopic imaging apparatuses use thermal sources for sample illumination, which have low brightness, low optical spectral intensity, and high noise. This work evaluates the system engineering advantages of using mid-infrared semiconductor lasers that offer orders-of magnitude higher brightness, spectral intensity, and lower noise. A laser-based microscopic spectral imaging system with focal plane array detectors demonstrated a high signal-to-noise ratio (>20 dB) at video frame rate for a large illuminated area. Microscopic spectral imaging with fixed-wavelength and tunable lasers of 4.6, 6, and 9.3-mum wavelength was applied to a number of representative samples that consist of biological tissues (plant and animal) and solid material (a stack of laminated polymers). Transmission spectral images with similar to30-dB dynamic range were obtained with clear evidence of spectral features for different samples. The potential of more advanced systems with a wide coverage of spectral bands is discus sed.
C1 Univ Houston, Dept Elect & Comp Engn, Photon Device & Syst Labs, Houston, TX 77204 USA.
RP Guo, B (reprint author), Univ Houston, Dept Elect & Comp Engn, Photon Device & Syst Labs, Houston, TX 77204 USA.
CR Bailey JA, 2000, APPL SPECTROSC, V54, P159, DOI 10.1366/0003702001949122
   Colarusso P, 1998, APPL SPECTROSC, V52, p106A, DOI 10.1366/0003702981943545
   Crocombe R. A., 1997, MICROSCOPY MICROA S2, V3, P863
   ESAU K, 1967, PLANT ANAT
   Haka AS, 2000, APPL SPECTROSC, V54, P753, DOI 10.1366/0003702001950049
   KODALI DR, 1991, APPL SPECTROSC, V45, P1310, DOI 10.1366/0003702914335878
   Koenig JL, 2001, ANAL CHEM, V73, p360A, DOI 10.1021/ac012471p
   Lasch P, 2002, BIOPOLYMERS, V67, P335, DOI 10.1002/bip.10095
   LEVENSON RM, 2000, AM LAB, P26
   Lewis E. N., 1996, US Patent Application, Patent No. [5 528 368, 5528368]
   LEWIS EN, 1995, ANAL CHEM, V67, P3377, DOI 10.1021/ac00115a003
   Luo GP, 2002, IEEE J QUANTUM ELECT, V38, P486, DOI 10.1109/3.998621
   Luo GP, 2001, APPL PHYS LETT, V78, P2834, DOI 10.1063/1.1371524
   MANTSCH HH, 1996, INFRARED SPECTROCOPY
   MARCOTT C, 1999, VIB SPECTROSC, V19, P23
   Messerschmidt R. G., 1988, INFRARED MICROSPECTR
   Rafferty DW, 2002, APPL SPECTROSC, V56, P284, DOI 10.1366/0003702021954791
   TREADO PJ, 1994, APPL SPECTROSC REV, V29, P1, DOI 10.1080/05704929408000896
   Van der Weerd J, 2002, APPL SPECTROSC, V56, P275, DOI 10.1366/0003702021954683
NR 19
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4759-5
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4959
BP 1
EP 11
DI 10.1117/12.477942
PG 11
WC Engineering, Biomedical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BX33F
UT WOS:000184965700001
DA 2018-10-20
ER

PT J
AU Bindig, U
   Gersonde, I
   Meinke, M
   Becker, Y
   Muller, G
AF Bindig, U
   Gersonde, I
   Meinke, M
   Becker, Y
   Muller, G
TI Fibre-optic IR-spectroscopy for biomedical diagnostics
SO SPECTROSCOPY-AN INTERNATIONAL JOURNAL
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Biomedical Spectroscopy
CY JUL 07-10, 2002
CL CARDIFF, WALES
ID EVANESCENT-WAVE SPECTROSCOPY; COATED AGCLBR FIBERS; SILVER-HALIDE
   FIBERS; INFRARED-SPECTROSCOPY; CHALCOGENIDE GLASS; FTIR SPECTROSCOPY;
   SKIN TISSUE; SENSORS; FEWS
AB The use of microscopy is a valuable means of gaining vital information for medical diagnostics. Due to a number of recent technological developments advances have been made in IR microscopy and in particular, rapid detection methods. Microscopic examination methods usually involve sampling followed by a method of sample purification or preparation. The advantages of the IR analytical method are that it is based on a direct, non-destructive measurement of sample material and that the resulting IR spectra provide extensive and specific information about the sample composition and structure. The course of a disease can lead to either formation or loss of organic compounds in metabolism as well as changes within the biological matrix. Corresponding changes can also be expected in the IR-signature in view to the grading of alteration. Our preliminary IR microscopic investigations compared diseased and healthy tissue samples individually and basic information was obtained about the tissue specific spectral signature, taking account of biological variance. Human tissue samples taken from the colon were used for these studies. Given the number of endoscopic applications used in minimally invasive medicine, we hope to establish the IR fibre based procedure as an optical biopsy method for tissue diagnostics. The aqueous environment as well as the IR radiation source, signal detection and the flexible wave guide type will be a limiting factor for an IR system. The hygiene requirements are particularly high for a fibre based system to be used for in vivo applications.
   First experiments were used to check the transmission of the IR microspectroscopic data. Fibre supported measurements were made in ATR and remission. High powered IR laser diodes were tested in subsequent trials for application in biomedicine. First results are presented on the way to an IR-endo-spectroscopic system.
C1 Laser & Med Technol GmbH Berlin, D-14195 Berlin, Germany.
   Free Univ Berlin, Inst Med Phys & Laser Med, Univ Hosp Benjamin Franklin, D-14195 Berlin, Germany.
CR Afanasyeva NI, 1998, P SOC PHOTO-OPT INS, V3257, P260, DOI 10.1117/12.306092
   Argov S, 2002, J BIOMED OPT, V7, P248, DOI 10.1117/1.1463051
   ARTJUSHENKO VG, 1994, SPIE, V2025, P137
   Baulsir CF, 1996, ADV DRUG DELIVER REV, V21, P191, DOI 10.1016/S0169-409X(96)00407-3
   Bindig U, 2001, SENSOR ACTUAT B-CHEM, V74, P37, DOI 10.1016/S0925-4005(00)00709-7
   Bormashenko E, 2002, OPT ENG, V41, P295, DOI 10.1117/1.1430424
   Bormashenko E, 1999, P SOC PHOTO-OPT INS, V3570, P100, DOI 10.1117/12.336947
   Brooks A, 1998, P SOC PHOTO-OPT INS, V3262, P173, DOI 10.1117/12.309469
   Bruch R, 1997, P SOC PHOTO-OPT INS, V2970, P408, DOI 10.1117/12.275022
   BUNIMOVICH D, 1993, J MOL STRUCT, V292, P125, DOI 10.1016/0022-2860(93)80095-D
   Diem M, 1999, APPL SPECTROSC, V53, p148A, DOI 10.1366/0003702991946712
   Frank J, 2000, APPL SPECTROSC, V54, P1417, DOI 10.1366/0003702001948376
   Goldberg D. E, 1989, GENETIC ALGORITHMS S
   Gotshal Y, 1997, SENSOR ACTUAT B-CHEM, V42, P157, DOI 10.1016/S0925-4005(97)80331-0
   Harrington JA, 2000, FIBER INTEGRATED OPT, V19, P211, DOI 10.1080/01468030050058794
   Hocde S, 2001, SOLID STATE SCI, V3, P279, DOI 10.1016/S1293-2558(00)01135-3
   HOCDE S, 2000, P SPIE BIOMONITORING, V4158, P49
   Jackson M, 1998, P SOC PHOTO-OPT INS, V3257, P24, DOI 10.1117/12.306098
   Kerslake EDS, 1996, ADV DRUG DELIVER REV, V21, P205, DOI 10.1016/S0169-409X(96)00408-5
   Kupper L, 2001, J MOL STRUCT, V565, P497, DOI 10.1016/S0022-2860(00)00935-2
   Kupper L, 2001, J MOL STRUCT, V563, P173, DOI 10.1016/S0022-2860(00)00804-8
   Mardia KV, 1979, MULTIVARIATE ANAL
   Reiclin J, 2000, P SOC PHOTO-OPT INS, V4129, P305, DOI 10.1117/12.390627
   SCRIPACHEV IV, 2002, IN PRESS SPIE
   Sukuta S, 1999, LASER SURG MED, V24, P382, DOI 10.1002/(SICI)1096-9101(1999)24:5<382::AID-LSM9>3.0.CO;2-G
   Uemura Takero, 1999, Frontiers of Medical and Biological Engineering, V9, P137
   Weng S F, 2000, Am Clin Lab, V19, P20
   Werle P, 2002, OPT LASER ENG, V37, P101, DOI 10.1016/S0143-8166(01)00092-6
   Wu JG, 2001, BIOPOLYMERS, V62, P185, DOI 10.1002/bip.1013
NR 29
TC 8
Z9 8
U1 2
U2 8
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0712-4813
J9 SPECTROSC-INT J
JI Spectr.-Int. J.
PY 2003
VL 17
IS 2-3
BP 323
EP 344
DI 10.1155/2003/172702
PG 22
WC Biochemical Research Methods; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 665MB
UT WOS:000182123800019
OA Bronze, Other Gold
DA 2018-10-20
ER

PT S
AU Horton, JA
   Parsell, DE
AF Horton, JA
   Parsell, DE
BE Egami, T
   Greer, AL
   Inoue, A
   Ranganathan, S
TI Biomedical potential of a zirconium-based bulk metallic glass
SO SUPERCOOLED LIQUIDS, GLASS TRANSITION AND BULK METALLIC GLASSES
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Supercooled Liquids, Glass Transition and Bulk Metallic
   Glasses
CY DEC 02-06, 2002
CL BOSTON, MA
SP Mat Res Soc, DARPA, Liquidmetal Technol
ID AMORPHOUS-ALLOYS
AB Due to their unique mechanical properties, bulk metallic glasses (BMG) have potential for biomedical applications. Biocompatibility and corrosion tests of a zirconium-based BMG showed comparable behavior to current implant alloys. Mechanical properties, such as an elastic limit of 2% and a yield strength of 1700 MPa, are significantly higher than current implant alloys. In addition, it was found that medical MRI images of BMG, possibly due to the amorphous structure, are significantly better than other alloys even though the reference alloy contains 14:6 at.% Ni. Nickel-free compositions also retained similar glass forming characteristics and showed even better MRI images. Edge holding for cutting tool applications was demonstrated. Fatigue tests were performed in simulated body conditions and directly compared to Ti-6 Al-4 V. While one specimen failed at more than 3,000,000 cycles at 500 MPa, there was much scatter in the data. Further concentration on processing issues to produce pore free material is needed to produce reliable material for prototype development. Potential uses, especially associated with an interventional MRI for MRI guided surgeries, will be discussed.
C1 Oak Ridge Natl Lab, Met & Ceram Div, Oak Ridge, TN 37831 USA.
RP Horton, JA (reprint author), Oak Ridge Natl Lab, Met & Ceram Div, POB 2008, Oak Ridge, TN 37831 USA.
RI BAI, JIE/D-7448-2016; Greer, Alan Lindsay/G-1977-2011; Inoue,
   Akihisa/E-5271-2015
CR AHMED T, 1995, TITANIUM 95 SCI TECH, P1760
   INOUE A, 1995, MATER T JIM, V36, P866, DOI 10.2320/matertrans1989.36.866
   Johnson WL, 1996, MATER SCI FORUM, V225, P35, DOI 10.4028/www.scientific.net/MSF.225-227.35
   Liu CT, 1998, METALL MATER TRANS A, V29, P1811, DOI 10.1007/s11661-998-0004-6
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   THOMPSON JE, UNPUB
NR 6
TC 7
Z9 7
U1 0
U2 7
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-691-5
J9 MATER RES SOC SYMP P
PY 2003
VL 754
BP 179
EP 184
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Physics, Condensed Matter
SC Materials Science; Metallurgy & Metallurgical Engineering; Physics
GA BX31C
UT WOS:000184907800026
DA 2018-10-20
ER

PT J
AU Long, CR
   Walker, SC
   Tang, RT
   Westhusin, ME
AF Long, CR
   Walker, SC
   Tang, RT
   Westhusin, ME
TI New commercial opportunities for advanced reproductive technologies in
   horses, wildlife, and companion animals
SO THERIOGENOLOGY
LA English
DT Article; Proceedings Paper
CT 29th Annual Conference of the International-Embryo-Transfer-Society
CY JAN 11-15, 2003
CL AUCKLAND, NEW ZEALAND
SP Int Embryo Transfer Soc
DE reproductive biotechnology; cloning; embryo transfer
ID SUCCESSFUL IN-VITRO; DOMESTIC CAT EMBRYOS; INTRACYTOPLASMIC SPERM
   INJECTION; OVARIAN OOCYTES INVITRO; DEER CERVUS-ELAPHUS; MITOCHONDRIAL
   GENOTYPE; MAMMALIAN DEVELOPMENT; BITCH OOCYTES; MATURATION;
   FERTILIZATION
AB As advanced reproductive technologies become more efficient and repeatable in livestock and laboratory species, new opportunities will evolve to apply these techniques to alternative and non-traditional species. This will result in new markets requiring unique business models that address issues of animal welfare and consumer acceptance on a much different level than the livestock sector. Advanced reproductive technologies and genetic engineering will be applied to each species in innovative ways to provide breeders more alternatives for the preservation and propagation of elite animals in each sector. The commercialization of advanced reproductive techniques in these niche markets should be considered a useful tool for conservation of genetic material from endangered or unique animals as well as production of biomedical models of human disease. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Viagen Inc, College Stn, TX 77845 USA.
   Texas A&M Univ, Dept Vet Physiol & Pathol, College Stn, TX USA.
RP Long, CR (reprint author), Viagen Inc, 3312 Longmire Dr, College Stn, TX 77845 USA.
EM chuck.long@viagen.com
OI Long, Charles/0000-0003-4330-0786; Westhusin, Mark/0000-0002-6126-6211
CR Bainbridge DRJ, 1999, THERIOGENOLOGY, V51, P891, DOI 10.1016/S0093-691X(99)00036-9
   Berg D. K., 1995, Theriogenology, V43, P166, DOI 10.1016/0093-691X(95)92320-9
   Berg DK, 2002, ANIM REPROD SCI, V70, P65, DOI 10.1016/S0378-4320(01)00199-3
   Berg DK, 2002, ANIM REPROD SCI, V70, P85, DOI 10.1016/S0378-4320(01)00201-9
   BERG DK, 1995, THERIOGENOLOGY, V44, P247, DOI 10.1016/0093-691X(95)00174-7
   BOLAMBA D, 1997, BIOL REPROD S, V1, P96
   Carnevale EM, 1996, VET CLIN N AM-EQUINE, V12, P47
   CARNEY NJ, 1991, THERIOGENOLOGY, V36, P23, DOI 10.1016/0093-691X(91)90430-L
   Chapman SA, 1999, THERIOGENOLOGY, V51, P280, DOI 10.1016/S0093-691X(99)91839-3
   Choi YH, 2002, REPRODUCTION, V123, P455, DOI 10.1530/rep.0.1230455
   Choi YH, 2002, BIOL REPROD, V67, P561, DOI 10.1095/biolreprod67.2.561
   COCHRAN R, 1998, P 7 INT S EQ REP, P135
   Comizzoli P, 2001, THERIOGENOLOGY, V55, P649, DOI 10.1016/S0093-691X(01)00433-2
   DellAquila ME, 1997, THERIOGENOLOGY, V47, P1139, DOI 10.1016/S0093-691X(97)00095-2
   DRESSER BL, 1988, J EXP ZOOL, V246, P180, DOI 10.1002/jez.1402460210
   ENGLAND GCW, 1993, J REPROD FERTIL, P243
   Farstad W, 1998, ANIM REPROD SCI, V53, P35, DOI 10.1016/S0378-4320(98)00125-0
   FARSTAD W, 1993, J REPROD FERTIL, P219
   Farstad W, 2000, ANIM REPROD SCI, V60, P375, DOI 10.1016/S0378-4320(00)00106-8
   *FDN BIOM RES, 2002, BDN BIOM RES REP
   FENNESSY PF, 1994, THERIOGENOLOGY, V41, P133, DOI 10.1016/S0093-691X(05)80058-5
   Franz LC, 2002, THERIOGENOLOGY, V58, P679, DOI 10.1016/S0093-691X(02)00861-0
   Freistedt P, 1999, THERIOGENOLOGY, V51, P285, DOI 10.1016/S0093-691X(99)91844-7
   FULTON RM, 1998, THERIOGENOLOGY, V51, P285
   Galli C, 2002, THERIOGENOLOGY, V58, P705, DOI 10.1016/S0093-691X(02)00771-9
   Gastal MO, 2002, THERIOGENOLOGY, V58, P725, DOI 10.1016/S0093-691X(02)00843-9
   Gomez MC, 2000, REPROD FERT DEVELOP, V12, P423, DOI 10.1071/RD00126
   GOODROWE KL, 1991, BIOL REPROD, V45, P466, DOI 10.1095/biolreprod45.3.466
   GOODROWE KL, 1989, J REPROD FERTIL, P73
   Hadjantonakis AK, 2001, HISTOCHEM CELL BIOL, V115, P49, DOI 10.1007/s004180000233
   Hewitt DA, 1999, VET REC, V144, P237, DOI 10.1136/vr.144.9.237
   Hewitt DA, 1998, THERIOGENOLOGY, V49, P1083, DOI 10.1016/S0093-691X(98)00058-2
   Hewitt DA, 1997, J REPROD FERTIL, P83
   Hinrichs K, 2002, THERIOGENOLOGY, V58, P675, DOI 10.1016/S0093-691X(02)00802-6
   HINRICHS K, 1998, P 7 INT S EQ REPR, P129
   Hoffert KA, 1997, MOL REPROD DEV, V48, P208, DOI 10.1002/(SICI)1098-2795(199710)48:2<208::AID-MRD8>3.0.CO;2-W
   Howard JoGayle, 1999, P449
   Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402
   Ikawa M, 1998, FEBS LETT, V430, P83, DOI 10.1016/S0014-5793(98)00593-6
   Jalkanen L, 1998, ANIM REPROD SCI, V54, P139, DOI 10.1016/S0378-4320(98)00143-2
   KANDA M, 1995, J VET MED SCI, V57, P641, DOI 10.1292/jvms.57.641
   KINNEY GM, 1979, BIOL REPROD, V20, pA96
   KRZYWINSKI A, 1976, P144
   Lazzari G, 2002, THERIOGENOLOGY, V58, P709, DOI 10.1016/S0093-691X(02)00777-X
   Li XH, 2002, BIOL REPROD, V66, P1288, DOI 10.1095/biolreprod66.5.1288
   MAHI CA, 1976, J EXP ZOOL, V196, P189, DOI 10.1002/jez.1401960206
   MCKINNON AO, 1988, COMP CONT EDUC PRACT, V10, P343
   MCKINNON AO, 1998, P 7 INT S EQ REPR U, P137
   Meirelles FV, 2001, GENETICS, V158, P351
   NICKSON DA, 1993, J REPROD FERTIL, P231
   PALMER E, 1991, J REPROD FERTIL, P375
   Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344
   PLATZ CC, 1978, J REPROD FERTIL, V52, P279
   Pollard J. W., 1995, Theriogenology, V43, P301, DOI 10.1016/0093-691X(95)92455-I
   POPE CE, 1994, THERIOGENOLOGY, V42, P513, DOI 10.1016/0093-691X(94)90689-G
   Pope CE, 1999, THERIOGENOLOGY, V51, P291, DOI 10.1016/S0093-691X(99)91850-2
   Pope CE, 1997, J REPROD FERTIL, P69
   Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443
   Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206
   Riera FL, 1993, EQUINE VET J S, V25, P116
   ROTA A, 1998, THESIS SWEDISH AGR U
   SCHMID RL, 1998, P 7 INT S EQ REPR, P139
   Schramm RD, 1995, REPROD FERT DEVELOP, V7, P1061, DOI 10.1071/RD9951061
   SCOTT I, 2000, 17 NZ VET ASS DEER B
   Sissener TR, 1996, THERIOGENOLOGY, V45, P541, DOI 10.1016/0093-691X(95)00401-S
   Smith LC, 2000, THERIOGENOLOGY, V53, P35, DOI 10.1016/S0093-691X(99)00238-1
   Squires EL, 1999, THERIOGENOLOGY, V51, P91, DOI 10.1016/S0093-691X(98)00234-9
   SQUIRES EL, 1995, B COLORADO STATE U, P7
   Swanson WF, 1999, THERIOGENOLOGY, V51, P174, DOI 10.1016/S0093-691X(99)91733-8
   Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262
   THEISS T, 1997, THESIS LUDWIGMAXIMIL
   TSUTSUI T, 1989, JPN J VET SCI, V51, P797
   VOGELSANG SG, 1985, EQUINE VET J S, V3, P89
   Wolfe BA, 1996, J REPROD FERTIL, V106, P135
   WOOD TC, 1995, J REPROD FERTIL, V104, P315
   Wood TC, 1997, J REPROD FERTIL, V110, P355
   Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900
   YAMADA S, 1993, J REPROD FERTIL, P227
   Yamamoto Y, 1982, J Reprod Fertil Suppl, V32, P399
NR 79
TC 8
Z9 9
U1 1
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0093-691X
EI 1879-3231
J9 THERIOGENOLOGY
JI Theriogenology
PD JAN 1
PY 2003
VL 59
IS 1
BP 139
EP 149
AR PII S0093-691X(02)01266-9
DI 10.1016/S0093-691X(02)01266-9
PG 11
WC Reproductive Biology; Veterinary Sciences
SC Reproductive Biology; Veterinary Sciences
GA 635NA
UT WOS:000180404600013
PM 12499025
DA 2018-10-20
ER

PT S
AU Hosoda, H
   Fukui, Y
   Inamura, T
   Wakashima, K
   Miyazaki, S
   Inoue, K
AF Hosoda, H
   Fukui, Y
   Inamura, T
   Wakashima, K
   Miyazaki, S
   Inoue, K
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Mechanical properties of Ti-base shape memory alloys
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE mechanical properties; Ti base alloy; shape memory alloy;
   superelasticity
ID MARTENSITIC TRANSFORMATIONS
AB Shape memory alloys (SMA) such as Ti-Ni are widely used in the biomedical field due to their unique functions of shape memory effect (SME) and superelasticity (SE). However, a drawback of Ti-Ni SMAs in the biomedical applications is the toxicity of the constitute element Ni, in other words, Ni hypersensitivity. Thus we have conducted to develop new Ni free SMAs composed of non-toxic elements as a new class of biomedical functional materials. In the present study, the mechanical and shape memory properties of some Ti-base shape memory alloys we have found are described. The alloy systems selected were Ti-Nb-Al and Ti-Nb-Ga. Both the alloys were made by Ar arc melting method followed by a homogenization treatment at 1273K for 7.2ks, cold rolling and then a solution treatment at 1273K for 1.8ks. Tensile tests were done to evaluate SME and SE. It was found that both TiNbAl and TiNbGa alloys exhibit SE at room temperature, and that the SE behavior changes depending on the deformation strain. 2.4% superelastic strain obtained for the TiNbAl alloy after the cyclic deformation of 3.2%. Besides the SE behavior becomes stable after two cyclic deformation under the constant maximum. strain. It is summarized that these Ti-base SMAs exhibit large potential for practical biomedical use.
C1 Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan.
   Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
   Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
RP Hosoda, H (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.
RI Inamura, Tomonari/E-5712-2014; Miyazaki, Shuichi/A-3113-2012
OI Miyazaki, Shuichi/0000-0003-3849-4176
CR Biggs T, 2001, METALL MATER TRANS A, V32, P1881, DOI 10.1007/s11661-001-0001-5
   DONKERSLOOT HC, 1970, J LESS-COMMON MET, V20, P83, DOI 10.1016/0022-5088(70)90092-5
   ECKELMEYER KH, 1976, SCRIPTA METALL MATER, V10, P667, DOI 10.1016/0036-9748(76)90339-2
   HONMA T, 1980, TITANIUM 80 SCI TECH, V2, P1455
   Hosoda H, 1996, J JPN I MET, V60, P793, DOI 10.2320/jinstmet1952.60.9_793
   HOSODA H, IN PRESS MRS P
   HUMBEEK JV, 2001, 4 PAC RIM INT C ADV, V2, P1871
   Saburi T, 1998, SHAPE MEMORY MAT, P49
   TAKAHASHI Y, 2003, IN PRESS MRS J, V28
   TSUJI M, 2003, IN PRESS MRS P
NR 10
TC 51
Z9 51
U1 3
U2 15
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3121
EP 3125
DI 10.4028/www.scientific.net/MSF.426-432.3121
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400502
DA 2018-10-20
ER

PT S
AU Ishihara, K
   Watanabe, J
   Iwasaki, Y
AF Ishihara, K
   Watanabe, J
   Iwasaki, Y
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Bioinspired polymer surfaces for prevention of bioresponse
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE biomaterials; polymer surface; bioinspired polymer; biocompatibility;
   protein adsorption-resistance; surface modification;
   2-methacryloyloxyethyl phosphorylcholine
ID PHOSPHOLIPID POLYMERS; 2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE; PROTEIN
   ADSORPTION; BLOOD
AB Conventional polymer materials using in the biomedical field do not have enough biocompatibility and blood compatibility; therefore, infusion of an anticoagulant is required during clinical treatments when using these medical devices, to avoid clot formation. To improve their blood compatibility and prevent clotting, some surface modification methods using newly designed polymeric materials have been studied. One of the most effective polymers for this purpose is phospholipid polymer (MPC polymer), which is prepared with inspiration from biomembrane surface. In this communication, molecular design and fundamental performance of MPC polymers are described. Moreover, improvement of the bio/blood compatibility of the medical devices using the MPC polymers to suppress unfavorable bioreactions at the interface between the medical devices and living organisms are explained.
C1 Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, 1996, MACROMOL S, V101, P405
   Sato T, 2000, J POLYM SCI POL CHEM, V38, P509, DOI 10.1002/(SICI)1099-0518(20000201)38:3<509::AID-POLA17>3.0.CO;2-M
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
NR 7
TC 2
Z9 2
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3171
EP 3175
DI 10.4028/www.scientific.net/MSF.426-432.3171
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400510
DA 2018-10-20
ER

PT S
AU Vaidyanathan, TK
   Vaidyanathan, J
   Ivan, DJ
AF Vaidyanathan, TK
   Vaidyanathan, J
   Ivan, DJ
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Long-term viscoelastic behavior of dental composites
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE longterm creep and stress relaxation; time-temperature superposition
   principle; dental composites
ID TIME-TEMPERATURE SUPERPOSITION; HIGH-MOLECULAR-WEIGHT; MECHANICAL
   PROPERTIES; AMORPHOUS POLYMERS; CREEP-BEHAVIOR
AB Deformation and relaxation response of biomedical polymers on application and removal of stress, respectively, are critically important in the clinical durability of prosthetic appliances using these materials. The material responses are both short-range and long-range. Although short-range responses can be studied in short-time experiments, the longterm responses are critically more important to assess risks in longterm clinical applications. The objective of this investigation was to use WLF methods of time-temperature superposition to study longterm creep and stress relaxation in dental composites. While composite matrix and filler components contribute to creep and stress relaxation, the major differences in dental composites are due to filler/resin volume ratio and filler particle size and distribution effects. In this study, three distinctly different composite materials were evaluated for longterm creep and stress relaxation effects. The composites included a microfilled composite, a mini-particle hybrid composite and a small-particle hybrid composite. Creep and stress relaxation effects were monitored for 10-minute durations at 5degreesC intervals between 32 and 117 degreesC in a TA Instruments DMA model 2980. The validity of WLF equation to creep compliance and stress relaxation data was analyzed using least square method. The results show excellent fit of creep and stress relaxation data shift as per WLF model. Extended master curves for creep compliance and stress relaxation were computed and analyzed. The longterm creep and stress relaxation effects were two to five times higher than the corresponding short-time values. Creep and relaxation effects of different composites also showed wide differences, indicating influence of filler and resin contributions to the overall behavior.
C1 Univ Med & Dent New Jersey, Dept Restorat Dent, New Jersey Dent Sch, Newark, NJ 07103 USA.
RP Vaidyanathan, TK (reprint author), Univ Med & Dent New Jersey, Dept Restorat Dent, New Jersey Dent Sch, 110 Bergen St, Newark, NJ 07103 USA.
CR CAVAILLE JY, 1987, J POLYM SCI POL PHYS, V25, P1235, DOI 10.1002/polb.1987.090250605
   Dean D, 1998, J POLYM SCI POL PHYS, V36, P2971, DOI 10.1002/(SICI)1099-0488(19981130)36:16<2971::AID-POLB12>3.3.CO;2-I
   Deng M, 1998, J BIOMED MATER RES, V40, P214, DOI 10.1002/(SICI)1097-4636(199805)40:2<214::AID-JBM6>3.0.CO;2-O
   HANS CD, 1993, POLYMER, V34, P2533
   MATSUMOTO DS, 1988, POLYM ENG SCI, V28, P1313, DOI 10.1002/pen.760282005
   MOEHLENPATH AE, 1971, POLYM ENG SCI, V11, P128
   MOEHLENPATH AE, 1972, POLY SCI ENG, V10, P170
   PROVDER T, 1993, POLYM MAT SCI ENG, V69, P148
   Simon PP, 1999, J POLYM SCI POL PHYS, V37, P127, DOI 10.1002/(SICI)1099-0488(19990115)37:2<127::AID-POLB3>3.0.CO;2-F
   Vaidyanathan TK, 2003, DENT MATER, V19, P46, DOI 10.1016/S0109-5641(02)00009-X
   WILLIAMS ML, 1955, J AM CHEM SOC, V77, P3701, DOI 10.1021/ja01619a008
   WOO EM, 1993, J APPL POLYM SCI, V50, P1683, DOI 10.1002/app.1993.070501002
NR 12
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3195
EP 3200
DI 10.4028/www.scientific.net/MSF.426-432.3195
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400514
DA 2018-10-20
ER

PT S
AU Ohya, Y
AF Ohya, Y
BE Chandra, T
   Torralba, JM
   Sakai, T
TI New class of lacitic acid copolymers with reactive and hydrophilic
   segments for degradable biomedical materials
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE poly(lactic acid); polydepsipeptide; biodegradable polymers; biomedical
   materials; amphiphilic structure; microparticles; drug delivery system;
   tissue engineering
ID TRIMETHYLSILYL PROTECTION METHOD; FUNCTIONALIZED PENDANT GROUPS;
   DEPSIPEPTIDE COPOLYMERS; ENZYMATIC-HYDROLYSIS; DIBLOCK COPOLYMERS;
   THIOL-GROUPS; L-LACTIDE; BIODEGRADATION; MICROSPHERES
AB Poly(L-lactic acid) (PLA) and their copolymers have a great potential for biodegradable medical materials. However limitation of their use still exists because of their crystallinity, hydrophobicity, luck of functionality, and so on. For further improvement of their properties and functionalities, various lactic acid copolymers having reactivity and amphiphilic structures were designed. In this paper, the author introduces the synthetic methods and properties of the novel lactic acid copolymers, poly(depsipeptide-random-LA), poly(depsipeptide-block-LA) and PLA-grafted polysaccharides.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Suita, Osaka 5648680, Japan.
RP Ohya, Y (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
CR Ohya Y, 2001, BIOMEDICAL POLYMERS AND POLYMER THERAPEUTICS, P139
   Ohya Y, 1998, MACROMOL CHEM PHYSIC, V199, P2017, DOI 10.1002/(SICI)1521-3935(19980901)199:9<2017::AID-MACP2017>3.0.CO;2-9
   Ohya Y, 1998, MACROMOLECULES, V31, P4662, DOI 10.1021/ma980377d
   Ouchi T, 2002, BIOMACROMOLECULES, V3, P885, DOI 10.1021/bm0200231
   Ouchi T, 2002, J POLYM SCI POL CHEM, V40, P1426, DOI 10.1002/pola.10226
   Ouchi T, 2002, J POLYM SCI POL CHEM, V40, P1218, DOI 10.1002/pola.10211
   Ouchi T, 1999, MACROMOL CHEM PHYSIC, V200, P436, DOI 10.1002/(SICI)1521-3935(19990201)200:2<436::AID-MACP436>3.0.CO;2-6
   OUCHI T, 1993, MAKROMOL CHEM-RAPID, V14, P825
   Ouchi T, 1996, MACROMOL CHEM PHYSIC, V197, P1823, DOI 10.1002/macp.1996.021970604
   Ouchi T, 1998, J POLYM SCI POL CHEM, V36, P1283, DOI 10.1002/(SICI)1099-0518(199806)36:8<1283::AID-POLA11>3.0.CO;2-2
   Ouchi T, 1997, J POLYM SCI POL CHEM, V35, P377
   Ouchi T, 2000, DES MONOMERS POLYM, V3, P279, DOI 10.1163/156855500300160230
NR 12
TC 1
Z9 1
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3231
EP 3236
DI 10.4028/www.scientific.net/MSF.426-432.3231
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400520
DA 2018-10-20
ER

PT S
AU Uenishi, K
   Seki, M
   Kunimasa, T
   Takatsugu, M
   Kobayashi, KF
   Ikeda, T
   Tsuboi, A
AF Uenishi, K
   Seki, M
   Kunimasa, T
   Takatsugu, M
   Kobayashi, KF
   Ikeda, T
   Tsuboi, A
BE Miyamoto, I
   Kobayashi, KF
   Sugioka, K
   Poprawe, R
   Helvajian, H
TI YAG laser micro welding of stainless steel and shape memory alloy
SO THIRD INTERNATIONAL SYMPOSIUM ON LASER PRECISION MICROFABRICATION
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd International Symposium on Laser Precision Microfabrication
CY MAY 27-31, 2002
CL OSAKA, JAPAN
SP Japan Laser Proc Soc, Osaka Univ, Grad Sch Engn, Inst Phys & Chem Res, High Temp Soc Japan, Natl Univ Singapore, Data Storage Inst, SPIE, Commemorat Assoc Japan World Exposit 1970, USAF Off Sci Res, Asian Off Aerosp Res & Dev, Kao Fdn Arts & Sci, Asahi Glass Fdn
DE stainless steel; YAG Laser; micro welding; shape memory alloy;
   biomaterials; tensile strength; corrosion resistance; medical devices;
   super-elastic
AB In order to investigate the applicability of laser micro welding to the fabrication of medical devices, SUS304 stainless steel and Ti-Ni based shape memory alloy biomaterials wires were micro spot melted by using YAG laser. By the optimization of laser conditions such as laser power or pulse duration, sound spot melted wires free from any defects were prepared and the width of the melted metal was reduced to about 0.3mm for the 0.35mm diameter wires. Compared with the SUS304 wires, melting of shape memory alloy wires needed more precise control of laser conditions although it needed smaller power input. Melted metal exhibited a rapidly quenched microstructure. The spot melted wires showed comparable tensile strength or super-elastic behavior with base materials. Besides, by the microstructural observation and corrosion test in a quasi biological environment, corrosion resistance was estimated to be hardly degraded by spot melting. Crosswise or parallel joints was also successfully prepared by laser spot welding of wires, suggesting the laser micro welding is applicable to the fabrication of biomedical devices.
C1 Osaka Univ, Grad Sch Engn, Dept Mfg Sci, Suita, Osaka 5650871, Japan.
RP Uenishi, K (reprint author), Osaka Univ, Grad Sch Engn, Dept Mfg Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.
CR ARATA Y, 1975, J HIGH TEMP SOC, V1, P160
   HAMANAKA H, 1998, MAT JAPAN, V37, P834
   HIROSE A, 1990, J JPN I MET, V54, P262, DOI 10.2320/jinstmet1952.54.3_262
   KOKAWA H, 1996, MAT JAPAN, V35, P655
   Kunimasa T., 2001, Journal of the Society of Materials Science, Japan, V50, P1218
   Seki M, 2000, J JPN I MET, V64, P632, DOI 10.2320/jinstmet1952.64.8_632
   TSUBOI A, 2000, LASER RES, V28, P413
   UENISHI K, UNPUB MAT T
   YONEYAMA I, 2000, NONDESRUCTIVE INSPEC, V49, P420
   ZHANG WP, 1989, THESIS OSAKA U
NR 10
TC 8
Z9 9
U1 0
U2 13
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4601-7
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4830
BP 57
EP 62
DI 10.1117/12.499698
PG 6
WC Materials Science, Ceramics; Optics; Physics, Condensed Matter
SC Materials Science; Optics; Physics
GA BW43Q
UT WOS:000181979300010
DA 2018-10-20
ER

PT S
AU Li, M
   Morris, N
   Keirstead, MS
   Soboyejo, W
AF Li, M
   Morris, N
   Keirstead, MS
   Soboyejo, W
BE Miyamoto, I
   Kobayashi, KF
   Sugioka, K
   Poprawe, R
   Helvajian, H
TI Surface modification of titanium alloy using a Q-switched diode-pumped
   solid state laser at 355 nm
SO THIRD INTERNATIONAL SYMPOSIUM ON LASER PRECISION MICROFABRICATION
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd International Symposium on Laser Precision Microfabrication
CY MAY 27-31, 2002
CL OSAKA, JAPAN
SP Japan Laser Proc Soc, Osaka Univ, Grad Sch Engn, Inst Phys & Chem Res, High Temp Soc Japan, Natl Univ Singapore, Data Storage Inst, SPIE, Commemorat Assoc Japan World Exposit 1970, USAF Off Sci Res, Asian Off Aerosp Res & Dev, Kao Fdn Arts & Sci, Asahi Glass Fdn
DE laser micromachining; surface modification; titanium alloy; biomedical
   applications
ID FATIGUE-CRACK GROWTH; TI-6AL-4V
AB The current paper presents die: results of recent studies of the effects of laser processing parameters on the microstructure and surface topology of laser grooved Ti-6Al-4V surfaces used for biomedical applications. Laser micro-grooves are produced using a diode pumped solid state (DPSS) lasers at 355 nm and different pulse repetition frequencies (PRF). The underlying microstructures and surface topologies of the grooves are then characterized using scanning electron microscopy (SEM). Laser/material interaction mechanisms are discussed and optimal laser processing parameters are developed. The implications of the microstructural and topological features are then assessed for cell/surface interactions and adhesion.
C1 Spectra Phys Inc, OEM Business Unit, Mountain View, CA 94043 USA.
RP Li, M (reprint author), Spectra Phys Inc, OEM Business Unit, 1305 Terra Bella Ave, Mountain View, CA 94043 USA.
CR ANSLEME K, 1999, J MATER SCI-MATER M, V10, P815
   CHESNUTT J, 1980, AIME, P1875
   Dubey S, 1997, ACTA MATER, V45, P2777, DOI 10.1016/S1359-6454(96)00380-1
   GREGORY BJK, 1994, HDB FATIGUE CRACK PR, P281
   HALL IW, 1978, MATER SCI ENG, V32, P241, DOI 10.1016/0025-5416(78)90138-6
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   HAYES WC, 1997, BASIC ORTHOPAEDIC
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   RATNER BD, 1996, BIOMATERIALS SCI ENG
   Ricci JL, 2001, KEY ENG MAT, V198-1, P179, DOI 10.4028/www.scientific.net/KEM.198-199.179
   RICCI JL, 2000, BONE REPONSE LASER M
   Sinha V, 2000, MAT SCI ENG A-STRUCT, V287, P30, DOI 10.1016/S0921-5093(00)00817-0
   Soboyejo ABO, 2001, FATIGUE FRACT ENG M, V24, P225, DOI 10.1046/j.1460-2695.2001.00404.x
   Soboyejo WO, 2001, KEY ENG MAT, V198-1, P203, DOI 10.4028/www.scientific.net/KEM.198-199.203
   SOBOYEJO WO, IN PRESS J BIOMEDICA
   Suresh S., 1998, FATIGUE MAT
   Wang JHC, 2000, J BIOMECH, V33, P729, DOI 10.1016/S0021-9290(00)00013-0
   YODER GR, 1979, ENG FRACT MECH, V11, P805, DOI 10.1016/0013-7944(79)90138-3
NR 19
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4601-7
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4830
BP 206
EP 211
DI 10.1117/12.486569
PG 6
WC Materials Science, Ceramics; Optics; Physics, Condensed Matter
SC Materials Science; Optics; Physics
GA BW43Q
UT WOS:000181979300037
DA 2018-10-20
ER

PT S
AU Singleton, L
   Detemple, P
   Lowe, H
AF Singleton, L
   Detemple, P
   Lowe, H
BE Behringer, UFW
   Courtois, B
   Khounsary, AM
   Uttamchandani, DG
TI Variants of the LIGA technology for the production of plastic
   microcomponents.
SO MEMS/MOEMS: ADVANCES IN PHOTONIC COMMUNICATIONS, SENSING, METROLOGY,
   PACKAGING AND ASSEMBLY
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on MEMS/MOEMS - Advances in Photonic Communications, Sensing,
   Metrology, Packaging and Assembly
CY OCT 28-29, 2002
CL BRUGGE, BELGIUM
SP SPIE
DE LIGA; deep X-ray lithography; DXR-L; PMMA; optical components;
   waveguides; moulding
AB Moulding of plastics enables fluidic and optical features to be integrated into a single element. This is particularly an advantage for product designs that impose space and weight constraints. Therefore, the use of plastic for biomedical and non telecommunications orientated optical applications continues to grow as design engineers take advantage of the ease of fabrication and the material flexibility.
   LIGA presents itself as a method ideally suited for the production of moulds for the manufacture of plastic microcomponents. Although LIGA is synonymous for lithography using synchrotron radiation X-rays, many other lithography and non-lithography methods for master production have been developed in the last few years, offering cost effective solutions to template production. These include UV LIGA methods, where deep resists such as SU-8 and AZ 4562, are employed for the master production. In addition, excimer laser micromachining offers a cost effective and efficient method for master fabrication, which later forms a template for electroforming. Furthermore, the use of Advanced Silicon Etching methods to prestructure silicon templates for electroforming, allows to the production of stepped mould inserts, which are particularly useful for microfluidic applications.
   This paper provides an overview of the different technologies, emphasizing the strengths and application areas of the different master structuring technologies. Considerations for the electroforming of microstructured mould inserts are also presented.
C1 Inst Mikrotech Mainz GmbH, D-55129 Mainz, Germany.
RP Singleton, L (reprint author), Inst Mikrotech Mainz GmbH, Carl Zeiss Str 18-20, D-55129 Mainz, Germany.
EM singleton@imm-mainz.de
CR BOGDANOV A, USE SU 8 PHOTORESIST
   Cremers C, 2001, MICROSYST TECHNOL, V7, P11, DOI 10.1007/s005420000054
   FEIERTAG G, VDI FORTSCHRITTBER 9, V242
   FEIERTAG G, 1997, J MICROMECH MICROENG, P23
   Singh TN, 2001, INDIAN J ENG MATER S, V8, P182
   Singleton L, 2002, P SOC PHOTO-OPT INS, V4690, P1180, DOI 10.1117/12.474195
NR 6
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4740-4
J9 PROC SPIE
PY 2003
VL 4945
BP 112
EP 121
PG 10
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BW60K
UT WOS:000182548700014
DA 2018-10-20
ER

PT J
AU Gref, R
   Rodrigues, J
   Couvreur, P
AF Gref, R
   Rodrigues, J
   Couvreur, P
TI Polysaccharides grafted with polyesters: Novel amphiphilic copolymers
   for biomedical applications
SO MACROMOLECULES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; DEXTRANS
AB New amphiphilic polysaccharides with controlled structure were synthesized by coupling between a carboxylic function present on preformed polyester chains and a hydroxyl group naturally present on polysaccharides. First, the synthesis of poly(E-caprolactone) monocarboxylic acid (R-PCLCO2H) was carried out by ring-opening uncatalyzed polymerization of monomer in the presence of a carboxylic acid (R-CO2H). R-PCL-CO2H was then reacted with carbonyl diimidazole, and the resulting activated intermediate (imidazolide) was further reacted with dextran (Dex) at different molar ratios to obtain amphiphilic copolymers with various hydrophilic-lipophilic balance. The coupling reaction was followed by GPC, indicating a total conversion. The copolymers were further characterized by GPC, H-1 NMR, and FTIR. Nanoparticles of less than 200 nm, with potential interest for controlled release of bioactive compounds, were successfully prepared by using these new materials.
C1 Univ Paris Sud, Fac Pharm, CNRS, UMR 8612,Sch Pharm, F-92296 Chatenay Malabry, France.
   Univ Fed Pernambuco, Recife, PE, Brazil.
RP Gref, R (reprint author), Univ Paris Sud, Fac Pharm, CNRS, UMR 8612,Sch Pharm, Tour D5,1er Etage,5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.
RI COUVREUR, Patrick/G-4844-2011; Gref, Ruxandra/F-1487-2011; Rodrigues da
   Silva, Jaqueline/F-6814-2012
OI COUVREUR, Patrick/0000-0001-7961-5443; Gref,
   Ruxandra/0000-0002-7869-0908; 
CR Bae YH, 2000, J CONTROL RELEASE, V64, P3, DOI 10.1016/S0168-3659(99)00126-1
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   BETHELL GS, 1981, J CHROMATOGR, V219, P361
   BIXLER KJ, 1990, POLYM PREPR, V31, P494
   Breitenbach A, 2000, J CONTROL RELEASE, V64, P167, DOI 10.1016/S0168-3659(99)00134-0
   Choi EJ, 1999, MACROMOLECULES, V32, P7402, DOI 10.1021/ma981453f
   Donabedian DH, 1998, MACROMOLECULES, V31, P1032, DOI 10.1021/ma961741g
   Dubois P, 1999, POLYMER, V40, P3091, DOI 10.1016/S0032-3861(98)00110-4
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X
   Li YX, 1998, POLYMER, V39, P3087, DOI 10.1016/S0032-3861(97)10048-9
   Listinsky JJ, 1998, AM J CLIN PATHOL, V110, P425
   Nouvel C, 2002, POLYMER, V43, P1735, DOI 10.1016/S0032-3861(01)00778-9
   Ohya Y, 1998, MACROMOL CHEM PHYSIC, V199, P2017, DOI 10.1002/(SICI)1521-3935(19980901)199:9<2017::AID-MACP2017>3.0.CO;2-9
   Rutot D, 2001, POLYM DEGRAD STABIL, V73, P561, DOI 10.1016/S0141-3910(01)00142-2
   Schwach G, 1997, J POLYM SCI POL CHEM, V35, P3431, DOI 10.1002/(SICI)1099-0518(19971130)35:16<3431::AID-POLA10>3.0.CO;2-G
   Staab H. A., 1962, ANGEW CHEM INT EDIT, V1, P351, DOI DOI 10.1002/ANIE.196203511
   Stahn R, 2000, TUMOR BIOL, V21, P176, DOI 10.1159/000030124
   vanDijkWolthuis WNE, 1997, POLYMER, V38, P6235, DOI 10.1016/S0032-3861(97)00189-4
   ZHANG QJ, 1994, MACROMOL CHEM PHYSIC, V195, P2401, DOI 10.1002/macp.1994.021950709
NR 21
TC 105
Z9 112
U1 1
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD DEC 31
PY 2002
VL 35
IS 27
BP 9861
EP 9867
DI 10.1021/ma021132a
PG 7
WC Polymer Science
SC Polymer Science
GA 630CC
UT WOS:000180089100004
DA 2018-10-20
ER

PT J
AU Schneider, JP
   Pochan, DJ
   Ozbas, B
   Rajagopal, K
   Pakstis, L
   Kretsinger, J
AF Schneider, JP
   Pochan, DJ
   Ozbas, B
   Rajagopal, K
   Pakstis, L
   Kretsinger, J
TI Responsive hydrogels from the intramolecular folding and self-assembly
   of a designed peptide
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID ANTIPARALLEL BETA-SHEET; PROTEIN SECONDARY STRUCTURE; RHEOLOGICAL
   PROPERTIES; AQUEOUS-SOLUTION; AMINO-ACIDS; GELS; FIBRILS; OLIGOPEPTIDE;
   PROPENSITIES; NUCLEATION
AB A general peptide design is presented that links the pH-dependent intramolecular folding of P-hairpin peptides to their propensity to self-assemble, affording hydrogels rich in beta-sheet. Chemical responsiveness has been specifically engineered into the material by linking intramolecular folding to changes in solution pH, and mechanical responsiveness, by linking hydrogelation to self-assembly. Circular dichroic and infrared spectroscopies show that at low pH individual peptides are unstructured, affording a low-viscosity aqueous solution. Under basic conditions, intramolecular folding takes place, affording amphiphilic beta-hairpins that intermolecularly self-assemble. Rheology shows that the resulting hydrogel is rigid but is shear-thinning. However, quick mechanical strength recovery after cessation of shear is observed due to the inherent self-assembled nature of the scaffold. Characterization of the gelation process, from the molecular level up through the macroscopic properties of the material, suggests that by linking the intramolecular folding of small designed peptides to their ability to self-assemble, responsive materials can be prepared. Cryo-transmission electron and laser scanning confocal microscopies reveal a water-filled porous scaffold on both the nano- and microscale. The environmental responsiveness, morphology, and peptidic nature make this hydrogel a possible material candidate for biomedical and engineering technology.
C1 Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.
   Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA.
RP Schneider, JP (reprint author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.
RI Schneider, Joel/N-2610-2014; Rajagopal, Karthikan/B-7888-2009
FU NCRR NIH HHS [P29 RR 015588]
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   BEAN JW, 1992, J AM CHEM SOC, V114, P5328, DOI 10.1021/ja00039a050
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Bekele H, 1999, J AM CHEM SOC, V121, P7266, DOI 10.1021/ja991416j
   Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N
   Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P2163, DOI 10.1002/1521-3773(20010601)40:11<2163::AID-ANIE2163>3.0.CO;2-U
   BRACK A, 1975, NATURE, V256, P383, DOI 10.1038/256383a0
   Brown CL, 2002, J AM CHEM SOC, V124, P6846, DOI 10.1021/ja0261271
   Burkoth TS, 2000, J AM CHEM SOC, V122, P7883, DOI 10.1021/ja000645z
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Choo DW, 1996, MACROMOLECULES, V29, P355, DOI 10.1021/ma950703e
   Clark TD, 1998, J AM CHEM SOC, V120, P8949, DOI 10.1021/ja981485i
   Collier JH, 2001, J AM CHEM SOC, V123, P9463, DOI 10.1021/ja011535a
   Cubberley MS, 2001, CURR OPIN CHEM BIOL, V5, P650, DOI 10.1016/S1367-5931(01)00261-7
   Daniel C, 2001, RHEOL ACTA, V40, P39, DOI 10.1007/s003970000124
   Das G, 2001, ANGEW CHEM INT EDIT, V40, P4657, DOI 10.1002/1521-3773(20011217)40:24<4657::AID-ANIE4657>3.0.CO;2-Y
   De Alba E, 1999, PROTEIN SCI, V8, P854
   DIAZ H, 1993, TETRAHEDRON, V49, P3533, DOI 10.1016/S0040-4020(01)90213-3
   GAY NJ, 1991, FEBS LETT, V291, P87, DOI 10.1016/0014-5793(91)81110-T
   GRATHWOHL C, 1976, BIOPOLYMERS, V15, P2025, DOI 10.1002/bip.1976.360151012
   Guinier A, 1955, SMALL ANGLE SCATTERI
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hassan CM, 2000, J APPL POLYM SCI, V76, P2075, DOI 10.1002/(SICI)1097-4628(20000628)76:14<2075::AID-APP11>3.0.CO;2-V
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Janek K, 1999, BIOCHEMISTRY-US, V38, P8246, DOI 10.1021/bi990510+
   JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302
   Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6
   KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0
   KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953
   Lashuel HA, 2000, J AM CHEM SOC, V122, P5262, DOI 10.1021/ja9937831
   Lee J, 2001, MACROMOLECULES, V34, P4114, DOI 10.1021/ma0015673
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   McMillan RA, 2000, MACROMOLECULES, V33, P4809, DOI 10.1021/ma9921091
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0
   Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626
   NAIR CM, 1979, J CHEM SOC CHEM COMM, P1183, DOI 10.1039/c39790001183
   Nesloney CL, 1996, J AM CHEM SOC, V118, P5836, DOI 10.1021/ja952472x
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Owen DH, 2000, CONTRACEPTION, V62, P321, DOI 10.1016/S0010-7824(00)00184-0
   Pastrana-Rios B, 2001, BIOCHEMISTRY-US, V40, P9074, DOI 10.1021/bi0155145
   Pelletier E, 2001, BIOMACROMOLECULES, V2, P946, DOI 10.1021/bm010060c
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Perka C, 2000, J BIOMED MATER RES, V49, P305, DOI 10.1002/(SICI)1097-4636(20000305)49:3<305::AID-JBM2>3.0.CO;2-9
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   POROD G, 1982, SMALL ANGLE XRAY SCA, P46
   Powers ET, 2001, J AM CHEM SOC, V123, P775, DOI 10.1021/ja005528i
   Prudhomme RK, 1996, LANGMUIR, V12, P4651, DOI 10.1021/la951506b
   Qu Y, 2000, J AM CHEM SOC, V122, P5014, DOI 10.1021/ja9935761
   Rapaport H, 2000, J AM CHEM SOC, V122, P12523, DOI 10.1021/ja002238t
   Rapaport H, 1999, J AM CHEM SOC, V121, P1186, DOI 10.1021/ja982420i
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   SINGH MA, 1993, J APPL CRYSTALLOGR, V26, P787, DOI 10.1107/S0021889893005527
   Stanger HE, 1998, J AM CHEM SOC, V120, P4236, DOI 10.1021/ja973704q
   Struthers MD, 1996, J AM CHEM SOC, V118, P3073, DOI 10.1021/ja954014u
   SUREWICZ WK, 1987, P NATL ACAD SCI USA, V84, P7028, DOI 10.1073/pnas.84.20.7028
   SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0
   SUREWICZ WK, 1988, J BIOL CHEM, V263, P786
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   Terech P, 1998, BER BUNSEN PHYS CHEM, V102, P1630, DOI 10.1002/bbpc.19981021124
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960
   XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349
   Xu B, 1997, LANGMUIR, V13, P2447, DOI 10.1021/la960799l
   Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
NR 72
TC 556
Z9 572
U1 28
U2 418
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD DEC 18
PY 2002
VL 124
IS 50
BP 15030
EP 15037
DI 10.1021/ja027993g
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 625LB
UT WOS:000179817000049
PM 12475347
DA 2018-10-20
ER

PT J
AU Mungikar, AA
   Forciniti, D
AF Mungikar, AA
   Forciniti, D
TI Computer simulations and neutron reflectivity of proteins at interfaces
SO CHEMPHYSCHEM
LA English
DT Review
DE interfaces; molecular dynamics; Monte Carlo simulations; neutron
   reflectivity
ID BROWNIAN DYNAMICS SIMULATION; SELF-ASSEMBLED MONOLAYERS; SOLID-LIQUID
   INTERFACES; SILICA-WATER INTERFACE; MOLECULAR-DYNAMICS; KINETIC-MODEL;
   ADSORPTION; SURFACES; LYSOZYME; LAYERS
AB Computer simulations in conjunction with neutron reflectivity is an excellent combination for the study of biological materials at solid-liquid interfaces: Both techniques have excellent resolution levels (Angstroms) and they are mature. A stronger interaction between physicists and biologists will allow the use of these two approaches in topics of biological biomedical interest.
C1 Univ Missouri, Dept Chem Engn, Rolla, MO 65409 USA.
RP Forciniti, D (reprint author), Univ Missouri, Dept Chem Engn, Rolla, MO 65409 USA.
CR ALMALAH K, 1995, J COLLOID INTERF SCI, V170, P261, DOI 10.1006/jcis.1995.1096
   Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.0.CO;2-U
   Anderson RE, 2000, J CHEM PHYS, V112, P9167, DOI 10.1063/1.481537
   ANDRADE JD, 1992, PURE APPL CHEM, V64, P1777, DOI 10.1351/pac199264111777
   Arnold GE, 1997, BIOPHYS J, V73, P1147, DOI 10.1016/S0006-3495(97)78147-5
   Asthagiri D, 1997, LANGMUIR, V13, P6761, DOI 10.1021/la970608u
   Berendsen H, 1981, INTERMOLECULAR FORCE, V11, P331
   Brusatori MA, 1999, J COLLOID INTERF SCI, V219, P333, DOI 10.1006/jcis.1999.6496
   BUJANNUNEZ MC, 1993, MOL PHYS, V80, P431, DOI 10.1080/00268979300102361
   Cabane B., 1986, SURFACTANT SOLUTIONS, V22, P57
   DICKINSON E, 1993, J CHEM SOC FARADAY T, V89, P3453, DOI 10.1039/ft9938903453
   FORCINITI D, 1999, P AICHE ANN M DALL T
   FRAGNETO G, 1995, SCIENCE, V267, P657, DOI 10.1126/science.7839141
   Fragneto-Cusani G, 2001, J PHYS-CONDENS MAT, V13, P4973, DOI 10.1088/0953-8984/13/21/322
   Jackler G, 2002, LANGMUIR, V18, P6565, DOI 10.1021/la025605i
   JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016
   Juffer AH, 1996, J COMPUT CHEM, V17, P1783, DOI 10.1002/(SICI)1096-987X(199612)17:16<1783::AID-JCC1>3.0.CO;2-J
   KAWAGUCHI M, 1992, ADV COLLOID INTERFAC, V37, P219, DOI 10.1016/0001-8686(92)80085-C
   Kneller LR, 2001, BIOPHYS J, V80, P2248, DOI 10.1016/S0006-3495(01)76197-8
   Krueger S, 2001, CURR OPIN COLLOID IN, V6, P111, DOI 10.1016/S1359-0294(01)00073-5
   Kuroda Y, 1999, J PHYS CHEM B, V103, P11064, DOI 10.1021/jp9912511
   LU DR, 1993, J BIOMAT SCI-POLYM E, V4, P323, DOI 10.1163/156856293X00591
   Lu JR, 1998, J COLLOID INTERF SCI, V206, P212, DOI 10.1006/jcis.1998.5680
   Malmsten M, 1996, J COLLOID INTERF SCI, V178, P160, DOI 10.1006/jcis.1996.0104
   NORDE W, 1979, J COLLOID INTERF SCI, V71, P350, DOI 10.1016/0021-9797(79)90245-5
   Oberholzer MR, 1997, J CHEM PHYS, V107, P9157, DOI 10.1063/1.475207
   Oberholzer MR, 1999, LANGMUIR, V15, P3905, DOI 10.1021/la981199k
   Petrash S, 1997, BIOTECHNOL PROGR, V13, P635, DOI 10.1021/bp970068r
   Pitt WG, 1997, J COLLOID INTERF SCI, V185, P258, DOI 10.1006/jcis.1996.4607
   RAGHAVAN K, 1991, J CHEM PHYS, V94, P2110, DOI 10.1063/1.459934
   Ramsden J. J., 1993, Q REV BIOPHYS, V27, P41
   Ravichandran S, 2001, J PHYS CHEM B, V105, P3610, DOI 10.1021/jp010223r
   Ravichandran S, 2000, BIOPHYS J, V78, P110, DOI 10.1016/S0006-3495(00)76577-5
   ROTH CM, 1993, LANGMUIR, V9, P962, DOI 10.1021/la00028a015
   Russell T. P., 1990, Material Science Reports, V5, P171, DOI 10.1016/S0920-2307(05)80002-7
   Russell TP, 1996, PHYSICA B, V221, P267, DOI 10.1016/0921-4526(95)00937-X
   SARKAR D, 1992, INDIAN J BIOCHEM BIO, V29, P135
   Schulz JC, 1999, J PHYS CHEM B, V103, P11057, DOI 10.1021/jp990827j
   Schweighofer KJ, 1996, LANGMUIR, V12, P3747, DOI 10.1021/la951061r
   Shelley JC, 1996, MOL PHYS, V88, P385, DOI 10.1080/00268979650026406
   Shepherd CM, 2001, BIOPHYS J, V80, P579, DOI 10.1016/S0006-3495(01)76039-0
   Song D, 2001, J CHEM PHYS, V115, P8089, DOI 10.1063/1.1409403
   Song D, 2000, J COLLOID INTERF SCI, V221, P25, DOI 10.1006/jcis.1999.6560
   Soper AK, 1997, J CHEM PHYS, V106, P247, DOI 10.1063/1.473030
   STAMM M, 1992, PHYSICS POLYM SURFAC, P163
   Su TJ, 1998, J COLLOID INTERF SCI, V203, P419, DOI 10.1006/jcis.1998.5545
   Su TJ, 1998, LANGMUIR, V14, P438, DOI 10.1021/la970623z
   Takahara Y, 2001, CHEM MATER, V13, P1194, DOI 10.1021/cm000572i
   VanTassel PR, 1997, J CHEM PHYS, V106, P761, DOI 10.1063/1.473164
   VOGLER EA, 1993, LANGMUIR, V9, P497, DOI 10.1021/la00026a023
   Wahlgren M, 1997, J COLLOID INTERF SCI, V188, P121, DOI 10.1006/jcis.1996.4715
   Wijmans CM, 1999, LANGMUIR, V15, P8344, DOI 10.1021/la990812c
   Wijmans CM, 1999, PHYS CHEM CHEM PHYS, V1, P2141, DOI 10.1039/a808990f
   Yu CH, 2000, J MOL STRUCT, V556, P95, DOI 10.1016/S0022-2860(00)00655-4
   Zhdanov VP, 1998, J CHEM PHYS, V109, P6497, DOI 10.1063/1.477296
NR 55
TC 10
Z9 10
U1 0
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1439-4235
J9 CHEMPHYSCHEM
JI ChemPhysChem
PD DEC 16
PY 2002
VL 3
IS 12
BP 993
EP 999
DI 10.1002/cphc.200290015
PG 7
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 630MR
UT WOS:000180112300001
PM 12516208
DA 2018-10-20
ER

PT J
AU Balatsouras, DG
   Kaberos, A
   Korres, SG
   Kandiloros, D
   Ferekidis, E
   Economou, C
AF Balatsouras, DG
   Kaberos, A
   Korres, SG
   Kandiloros, D
   Ferekidis, E
   Economou, C
TI Internet resources available to otolaryngologists
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Article
DE computer communication networks; Internet; otolaryngology
ID TELEMEDICINE APPLICATIONS; GUIDE; LANE
AB During recent years, the Internet has evolved into the largest computer network in the world, allowing access to vast amounts of information and services. Medical information is increasingly available to both patients and professionals, and ever more biomedical resources are becoming available on-line to assist in research, clinical medicine, and education. The Internet has always provided useful resources to otolaryngologists, implemented at various academic departments and national organizations or by specialists or specific medical web sites offering technical, scientific, and biomedical information. The purpose of this article is to provide as complete a list as possible of the World Wide Web sites accessible through the Internet that are of interest to otolaryngologists. It summarizes different types of resources available, including educational material, audiology sites, outcomes research, discussion lists, research laboratories, publications, medical libraries, news and medical conferences, organizations, academic departments, otolaryngological and medical resources, medical and surgical equipment and suppliers, and miscellaneous other sites of interest to otolaryngologists. This review is intended to present the wealth of the accessible information on the Internet and to promote the use of the network to otolaryngologists who do not have extensive experience in computers or telecommunications.
C1 Natl Tech Univ Athens, Ippokration Hosp, ENT Dept, Athens, Greece.
   Tzanion Gen Hosp, ENT Dept, Piraeus, Greece.
RP Balatsouras, DG (reprint author), 23 Achaion Str, Athens 15343, Greece.
CR BALATSOURAS DG, 2002, ANN OTOL RHINOL LARY
   Burgess LPA, 1999, LARYNGOSCOPE, V109, P1433, DOI 10.1097/00005537-199909000-00014
   Burton MJ, 1996, ARCH OTOLARYNGOL, V122, P115
   GLOWNIAK JV, 1995, ANN INTERN MED, V123, P123, DOI 10.7326/0003-4819-123-2-199507150-00008
   Heneghan C, 1999, IEEE ENG MED BIOL, V18, P53, DOI 10.1109/51.775489
   HUTCHINSON D, 1997, HEAD NECK NURS, V15, P9
   Johns ME, 1996, ARCH OTOLARYNGOL, V122, P925
   JOHNSON AJ, 1997, B AM ACAD OTOLARYNGO, P16
   Kuppersmith RB, 1996, ARCH OTOLARYNGOL, V122, P921
   Kuppersmith RB, 1996, OTOLARYNG HEAD NECK, V115, P335, DOI 10.1016/S0194-5998(96)70048-7
   Kuppersmith RB, 1997, OTOLARYNG HEAD NECK, V116, P497, DOI 10.1016/S0194-5998(97)70301-2
   LINDBERG DAB, 1993, JAMA-J AM MED ASSOC, V269, P3124, DOI 10.1001/jama.269.24.3124
   Meikle MB, 1997, OTOLARYNG HEAD NECK, V117, P698, DOI 10.1016/S0194-5998(97)70055-X
   Murphy KR, 1998, OTOLARYNG CLIN N AM, V31, P309, DOI 10.1016/S0030-6665(05)70050-5
   Pallen M, 1995, BRIT MED J, V311, P1626, DOI 10.1136/bmj.311.7020.1626
   PALLEN M, 1995, BRIT MED J, V311, P1422, DOI 10.1136/bmj.311.7017.1422
   Rothschild M, 1996, OTOLARYNG HEAD NECK, V115, P123, DOI 10.1016/S0194-5998(96)70147-X
   Rothschild MA, 1999, JAMA-J AM MED ASSOC, V281, P971, DOI 10.1001/jama.281.11.971
   Saada AA, 1998, J LARYNGOL OTOL, V112, P854
   Shea JJ, 1996, AM J OTOL, V17, P187
   Tan AKW, 1997, J OTOLARYNGOL, V26, P31
NR 21
TC 8
Z9 8
U1 0
U2 1
PU ANNALS PUBL CO
PI ST LOUIS
PA 4507 LACLEDE AVE, ST LOUIS, MO 63108 USA
SN 0003-4894
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD DEC
PY 2002
VL 111
IS 12
BP 1139
EP 1143
DI 10.1177/000348940211101214
PG 5
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 626DJ
UT WOS:000179856800014
PM 12498378
DA 2018-10-20
ER

PT J
AU Edwards, MB
   Ordidge, RJ
   Thomas, DL
   Hand, JW
   Taylor, KM
AF Edwards, MB
   Ordidge, RJ
   Thomas, DL
   Hand, JW
   Taylor, KM
TI Translational and rotational forces on heart valve prostheses subjected
   ex vivo to a 4.7-T MR system
SO JOURNAL OF MAGNETIC RESONANCE IMAGING
LA English
DT Article
DE heart valves; magnetic resonance imaging; translational and rotational
   forces; MRI safety; implants
ID HIGH-FIELD-STRENGTH; BIOMEDICAL IMPLANTS; POTENTIAL HAZARDS;
   MAGNETIC-FIELDS; ANEURYSM CLIPS; SAFETY; DEVICES
AB Purpose: To assess the magnetic field interactions on 60 heart valve prostheses subjected to a 4.7 T MR system. It addresses the question of whether heart valves deemed safe at 1.5 T may pose safety hazards as patients are exposed to increased static magnetic fields.
   Materials and Methods: Ex vivo testing was performed to evaluate translational and rotational forces on 60 heart valves using previously described techniques.
   Results: Translational forces were detected on 58 heart valves ranging from 0.5degrees to 7.5degrees. Seven valves exhibited paramagnetic/weakly ferromagnetic behavior, and 51 valves exhibited diamagnetic behavior. Rotational forces were observed for 46 valves.
   Conclusions: Criteria previously used for safety assessment of heart valve prostheses and expressed in terms of magnetic forces suggest the forces observed in this study arc compatible with the safe use of these valves in magnetic resonance (MR) systems with static fields up to 4.7 T.
C1 Hammersmith Hosp, Dept Cardiothorac Surg, United Kingdom Heart Valve Registry, London W12 0NN, England.
   UCL, Dept Phys Med, London, England.
   Hammersmith Hosp, Radiol Sci Unit, London W12 0NN, England.
RP Edwards, MB (reprint author), Hammersmith Hosp, Dept Cardiothorac Surg, United Kingdom Heart Valve Registry, Du Cane Rd, London W12 0NN, England.
EM m.b.edwards@ic.ac.uk
RI Ordidge, Roger/F-2755-2010
OI Hand, Jeffrey/0000-0002-4898-9511; Thomas, David/0000-0003-1491-1641;
   Ordidge, Roger/0000-0002-1005-3654
CR BOUTIN RD, 1994, AM J ROENTGENOL, V162, P189, DOI 10.2214/ajr.162.1.8273663
   Bromage P R, 1991, J Clin Anesth, V3, P382, DOI 10.1016/0952-8180(91)90180-U
   BUCHLI R, 1988, MAGNET RESON MED, V7, P255, DOI 10.1002/mrm.1910070302
   Condon B, 2000, J MAGN RESON IMAGING, V12, P171, DOI 10.1002/1522-2586(200007)12:1<171::AID-JMRI19>3.0.CO;2-W
   Edwards MB, 1999, J HEART VALVE DIS, V8, P697
   Hasenkam JM, 1999, EUR J CARDIO-THORAC, V16, P300, DOI 10.1016/S1010-7940(99)00215-8
   HASSLER M, 1986, Journal de Radiologie (Paris), V67, P661
   HATHOUT G, 1992, JMRI-J MAGN RESON IM, V2, P93, DOI 10.1002/jmri.1880020117
   High WB, 2000, J MAGN RESON IMAGING, V12, P122, DOI 10.1002/1522-2586(200007)12:1<122::AID-JMRI14>3.3.CO;2-3
   Kanal E, 1996, RADIOLOGY, V200, P576, DOI 10.1148/radiology.200.2.8685361
   Kangarlu A, 2000, J MAGN RESON IMAGING, V12, P107, DOI 10.1002/1522-2586(200007)12:1<107::AID-JMRI12>3.3.CO;2-X
   Magin RL, 2000, J MAGN RESON IMAGING, V12, P140, DOI 10.1002/1522-2586(200007)12:1<140::AID-JMRI15>3.0.CO;2-D
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   Pride GL, 2000, J MAGN RESON IMAGING, V12, P198, DOI 10.1002/1522-2586(200007)12:1<198::AID-JMRI22>3.0.CO;2-T
   Pruefer D, 2001, J HEART VALVE DIS, V10, P410
   RANDALL PA, 1988, AM J CARDIOL, V62, P973, DOI 10.1016/0002-9149(88)90907-1
   Robertson NM, 2000, PHYS MED BIOL, V45, P3793, DOI 10.1088/0031-9155/45/12/320
   Sawyer-Glover AM, 2000, J MAGN RESON IMAGING, V12, P92, DOI 10.1002/1522-2586(200007)12:1<92::AID-JMRI11>3.0.CO;2-7
   Schenck JF, 2000, J MAGN RESON IMAGING, V12, P2, DOI 10.1002/1522-2586(200007)12:1<2::AID-JMRI2>3.0.CO;2-V
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SOULEN RL, 1985, RADIOLOGY, V154, P705, DOI 10.1148/radiology.154.3.3969474
   Williams MD, 2001, OTOL NEUROTOL, V22, P158, DOI 10.1097/00129492-200103000-00007
   YUH WTC, 1991, JMRI-J MAGN RESON IM, V1, P711, DOI 10.1002/jmri.1880010617
NR 23
TC 6
Z9 7
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1053-1807
J9 J MAGN RESON IMAGING
JI J. Magn. Reson. Imaging
PD DEC
PY 2002
VL 16
IS 6
BP 653
EP 659
DI 10.1002/jmri.10201
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 621VC
UT WOS:000179610900004
PM 12451578
OA Bronze
DA 2018-10-20
ER

PT J
AU Shellock, FG
AF Shellock, FG
TI Biomedical implants and devices: Assessment of magnetic field
   interactions with a 3.0-Tesla MR system
SO JOURNAL OF MAGNETIC RESONANCE IMAGING
LA English
DT Article
DE magnetic resonance, safety; magnetic resonance imaging, implants;
   magnetic resonance, bioeffects; magnetic resonance, high field; magnetic
   resonance imaging
ID GUGLIELMI DETACHABLE COILS; ANEURYSM CLIPS; METALLIC IMPLANTS; POTENTIAL
   HAZARDS; IMAGING ARTIFACTS; FERROMAGNETISM; SAFETY; COMPATIBILITY;
   STENTS; CLAMPS
AB Purpose: To evaluate magnetic field interactions for 109 different biomedical implants and devices in association with exposure to a 3.0-Tesla magnetic resonance (MR) system.
   Materials and Methods: A total of 109 implants and devices (aneurysm clips, 32: clips, fasteners, and staples, 10; coils and stents, 10; heart valve prostheses and annuloplasty rings, 12; orthopedic implants, five; suture materials, 13; vascular access ports and accessories, 13; miscellaneous implants and devices, 14) were tested for magnetic field interactions at 3.0-Tesla using previously-described, standardized techniques to assess magnetic field translational attraction and torque.
   Results: The deflection angles and torque measurements ranged, respectively, from 0 to 16degrees and 0 to +2 for the aneurysm clips; 0 to 90degrees and 0 to +4 for the clips, fasteners, and staples; 0 to 47degrees and 0 to +4 for the coils and stents; 0 to 4degrees and 0 to + 1 for the heart valve prostheses and annuloplasty rings; 0 to 12degrees and 0 to +2 for the orthopedic implants; 0 to 13degrees and 0 to + 2 for the suture materials; 0 to 52degrees and 0 to + 4 for the vascular access ports and accessories; and 0 to 28degrees and 0 to +3 for the miscellaneous implants and devices.
   Conclusion: Of the 109 implants and devices assessed for magnetic field interactions at 3.0-Tesla, four (4%) are potentially unsafe based on deflection angle criteria. The implications of these results for patients undergoing MR procedures at 3.0-Tesla is discussed. Notably, these results are specific to the 3.0-Tesla MR system used for this evaluation.
C1 Univ So Calif, Keck Sch Med, Los Angeles, CA USA.
   Inst Magnet Resonance Safety Educ & Res, Los Angeles, CA USA.
RP Shellock, FG (reprint author), 7511 McConnell Ave, Los Angeles, CA 90045 USA.
CR [Anonymous], 2002, ANN BOOK ASTM STAND, V13.01, P1576
   BARRAFATO D, 1984, CAN J SURG, V27, P509
   BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   Edwards M B, 2000, J Magn Reson Imaging, V12, P363, DOI 10.1002/1522-2586(200008)12:2<363::AID-JMRI21>3.0.CO;2-3
   Frank H, 1992, EUR J RADIOL, V2, P555
   GIRARD MJ, 1992, RADIOLOGY, V184, P874, DOI 10.1148/radiology.184.3.1509084
   Greatbatch W, 2002, J MAGN RESON IMAGING, V16, P97, DOI 10.1002/jmri.10129
   HASSLER M, 1986, Journal de Radiologie (Paris), V67, P661
   Hennemeyer CT, 2001, RADIOLOGY, V219, P732, DOI 10.1148/radiology.219.3.r01jn33732
   Hug J, 2000, RADIOLOGY, V216, P781, DOI 10.1148/radiology.216.3.r00se03781
   Kanal E, 1999, RADIOLOGY, V210, P563, DOI 10.1148/radiology.210.2.r99fe59563
   Kangarlu A, 2000, J MAGN RESON IMAGING, V12, P107, DOI 10.1002/1522-2586(200007)12:1<107::AID-JMRI12>3.3.CO;2-X
   KLUCZNIK RP, 1993, RADIOLOGY, V187, P855, DOI 10.1148/radiology.187.3.8497645
   LYONS CJ, 1989, SPINE, V14, P670, DOI 10.1097/00007632-198907000-00004
   MARSHALL MW, 1991, CARDIOVASC INTER RAD, V14, P163, DOI 10.1007/BF02577720
   MECHLIN M, 1984, AM J ROENTGENOL, V143, P1281, DOI 10.2214/ajr.143.6.1281
   MESGARZADEH M, 1985, SKELETAL RADIOL, V14, P205, DOI 10.1007/BF00355565
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   NYEHNUIS JA, 1999, IEEE T, V35, P4133
   Pride GL, 2000, J MAGN RESON IMAGING, V12, P198, DOI 10.1002/1522-2586(200007)12:1<198::AID-JMRI22>3.0.CO;2-T
   REZAI AR, 2002, J MAGN RESON IMAGING, V15, P141
   Sawyer-Glover AM, 2000, J MAGN RESON IMAGING, V12, P92, DOI 10.1002/1522-2586(200007)12:1<92::AID-JMRI11>3.0.CO;2-7
   Schenck JF, 2001, MAGNETIC RESONANCE PROCEDURES: HEALTH EFFECTS AND SAFETY, P1
   Shellock F G, 1995, J Magn Reson Imaging, V5, P481
   Shellock F G, 2000, J Magn Reson Imaging, V12, P214, DOI 10.1002/1522-2586(200008)12:2<214::AID-JMRI2>3.0.CO;2-K
   Shellock F.G., 2001, MAGNETIC RESONANCE P
   SHELLOCK FG, 1992, JMRI-J MAGN RESON IM, V2, P225, DOI 10.1002/jmri.1880020217
   Shellock FG, 2000, J MAGN RESON IMAGING, V12, P30, DOI 10.1002/1522-2586(200007)12:1<30::AID-JMRI4>3.0.CO;2-S
   Shellock FG, 1998, RADIOLOGY, V207, P822, DOI 10.1148/radiology.207.3.9609911
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   Shellock FG, 1999, AM J ROENTGENOL, V173, P543, DOI 10.2214/ajr.173.3.10470877
   Shellock FG, 1998, RADIOLOGY, V206, P838, DOI 10.1148/radiology.206.3.9494511
   Shellock FG, 1997, RADIOLOGY, V203, P568, DOI 10.1148/radiology.203.2.9114123
   Shellock FG, 2001, J MAGN RESON IMAGING, V14, P295, DOI 10.1002/jmri.1185
   Shellock FG, 1996, MAGN RESON IMAGING, V14, P443, DOI 10.1016/0730-725X(95)02114-9
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   Shellock FG, 2001, J MAGN RESON IMAGING, V13, P152, DOI 10.1002/1522-2586(200101)13:1<152::AID-JMRI1023>3.0.CO;2-C
   Shellock FG, 1998, RADIOLOGY, V207, P587, DOI 10.1148/radiology.207.3.9609877
   Shellock FG, 1999, AM J ROENTGENOL, V172, P1417, DOI 10.2214/ajr.172.5.10227529
   Shellock FG, 1996, MAGN RESON IMAGING, V14, P1093, DOI 10.1016/S0730-725X(96)00114-2
   Shellock FG, 2003, REFERENCE MANUAL MAG
   SHGELLOCK FG, 2001, GUIDE MR PROCEDURES
   Smith CD, 2001, MAGNETIC RESONANCE PROCEDURES: HEALTH EFFECTS AND SAFETY, P393
   Smith CD, 2000, J APPL PHYS, V87, P6188, DOI 10.1063/1.372651
   SOULEN RL, 1985, RADIOLOGY, V154, P705, DOI 10.1148/radiology.154.3.3969474
   SOULEN RL, 1986, RADIOLOGY, V158, P279
   TEITELBAUM GP, 1989, CARDIOVASC INTER RAD, V12, P125, DOI 10.1007/BF02577374
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   TEITELBAUM GP, 1990, AM J NEURORADIOL, V11, P267
NR 50
TC 126
Z9 130
U1 0
U2 11
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1053-1807
J9 J MAGN RESON IMAGING
JI J. Magn. Reson. Imaging
PD DEC
PY 2002
VL 16
IS 6
BP 721
EP 732
DI 10.1002/jmri.10207
PG 12
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 621VC
UT WOS:000179610900012
PM 12451586
OA Bronze
DA 2018-10-20
ER

PT J
AU Scharnweber, D
   Beutner, R
   Rossler, S
   Worch, H
AF Scharnweber, D
   Beutner, R
   Rossler, S
   Worch, H
TI Electrochemical behavior of titanium-based materials - are there
   relations to biocompatibility?
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ANODIC OXIDE-FILMS; GROWTH-RATE; TIO2 FILMS; OXIDATION; LAYERS
AB For biomedical applications the physico-chemical properties of oxide layers, always present in titanium-based materials, are of special interest because the biological system is in direct contact only with these oxides. Using electrochemical impedance spectroscopy and galvanostatic polarization it is shown that the different compositions of c.p.-titanium, Ti6Al4V, and Ti6Al7Nb result in different physico-chemical properties of air formed passive layers and anodic oxide layers. This may have a direct impact on the biocompatibility of these materials. Results of impedance spectroscopy distinctly differ in the flatband potentials as well as in the donor densities of air-formed passive layers with Ti6Al7Nb showing an approximately 50% smaller donor density than the other materials. Anodic galvanostatic polarization results in voltage-charge density curves with distinct differences in the Faraday efficiency epsilon of the oxide formation between Ti6Al7Nb and c.p.-titanium/Ti6Al4V, especially for low current densities. These effects correlate strongly with the donor densities in the air formed passive films of the examined materials.
   SEM-images of anodic oxide layers show a blister containing surface morphology of the outer part of the oxide layers for all materials. This morphology is probably caused by oxygen evolution, a process which relies on the transfer of electrons through the growing anodic oxide layers and strongly depends on the donor density in the air formed passive layers. Again, the much more pronounced morphology on c.p. titanium/Ti6Al4V agrees with the different donor densities in the air formed passive layers on the materials.
   These findings correlate with the good biocompatibility of Ti6Al7Nb and suggest that conduction mechanisms, in air formed passive layers and anodic oxide layers, contribute to processes that determine the biocompatibility of these materials. (C) 2002 Kluwer Academic Publishers.
C1 Dresden Univ Technol, Inst Mat Sci, D-01062 Dresden, Germany.
RP Scharnweber, D (reprint author), Dresden Univ Technol, Inst Mat Sci, D-01062 Dresden, Germany.
RI Scharnweber, Dieter/B-3382-2010
CR BLACKWOOD DJ, 1989, ELECTROCHIM ACTA, V34, P1505, DOI 10.1016/0013-4686(89)87033-1
   BOUKAMP BA, 1993, EQUIVALENT CIRCUIT V
   DYER CK, 1978, J ELECTROCHEM SOC, V125, P1032, DOI 10.1149/1.2131616
   GERISCHER H, 1990, ELECTROCHIM ACTA, V35, P1677, DOI 10.1016/0013-4686(90)87067-C
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   KHALIL N, 1986, ELECTROCHIM ACTA, V31, P1279, DOI 10.1016/0013-4686(86)80148-7
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   KUDELKA S, 1995, BER BUNSEN PHYS CHEM, V99, P1020, DOI 10.1002/bbpc.199500025
   Nogami G, 1996, J ELECTROCHEM SOC, V143, P3600, DOI 10.1149/1.1837259
   Ohtsuka T, 1998, CORROS SCI, V40, P951, DOI 10.1016/S0010-938X(98)00032-8
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Piazza S, 1997, BER BUNSEN PHYS CHEM, V101, P932, DOI 10.1002/bbpc.19971010608
   ROSSLER S, 2002, COLLOID SURFACE B, V26, P387, DOI DOI 10.1016/S0927-7765(02)00025-5
   SCHARNWEBER D, 1998, METALS BIOMATERIALS, P101
   Textor M., 2001, TITANIUM MED, P171
   THULL R, 1998, METALS BIOMATERIALS, P289
   TORRESI RM, 1987, ELECTROCHIM ACTA, V32, P1291, DOI 10.1016/0013-4686(87)85058-2
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
NR 18
TC 52
Z9 52
U1 1
U2 14
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2002
VL 13
IS 12
BP 1215
EP 1220
DI 10.1023/A:1021118811893
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 616PF
UT WOS:000179311600019
PM 15348668
DA 2018-10-20
ER

PT J
AU Chen, F
   Wang, ZC
   Lin, CJ
AF Chen, F
   Wang, ZC
   Lin, CJ
TI Preparation and characterization of nano-sized hydroxyapatite particles
   and hydroxyapatite/chitosan nano-composite for use in biomedical
   materials
SO MATERIALS LETTERS
LA English
DT Article
DE hydroxyapatite; chitosan; nano-sized; particles; fibers; composite
ID POLYETHYLENE COMPOSITES; BIOCERAMICS; COATINGS
AB Natural bone is actually an inorganic/organic composite mainly made up of nano-structure hydroxyapatite (Ca-10(PO4)(6)(OH)(2), HAp) and collagen fibers. It is of most importance to synthesize nano-composites of inorganic/organic in order to have good biocompatibility, high bioactivity and great bonding properties. In this work, HAp nano-particle and HAp/chitosan (CTS) nanocomposite with a homogeneous microstructure were prepared and characterized. It is proposed that the nano-structure of hydroxyapatite/chitosan composite will have the best biomedical properties in the biomaterials applications. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Xiamen Univ, Dept Chem, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China.
   Xiamen Univ, Dept Mat Sci & Engn, Xiamen 361005, Peoples R China.
RP Lin, CJ (reprint author), Xiamen Univ, Dept Chem, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China.
RI Lin, CJ/G-3392-2010; Wang, Z.C./G-4133-2010
CR Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ito M, 1999, J BIOMED MATER RES, V45, P204, DOI 10.1002/(SICI)1097-4636(19990605)45:3<204::AID-JBM7>3.0.CO;2-4
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   Muzzarelli RAA, 2001, CARBOHYD POLYM, V45, P35, DOI 10.1016/S0144-8617(00)00205-8
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Viala S, 1998, ANN CHIM-SCI MAT, V23, P69, DOI 10.1016/S0151-9107(98)80025-1
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Wang M, 2000, MATER LETT, V44, P119, DOI 10.1016/S0167-577X(00)00026-4
NR 12
TC 198
Z9 219
U1 6
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD DEC
PY 2002
VL 57
IS 4
BP 858
EP 861
AR PII S0167-577X(02)00885-6
DI 10.1016/S0167-577X(02)00885-6
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 618HK
UT WOS:000179412500014
DA 2018-10-20
ER

PT J
AU Shi, W
   Kamiya, A
   Sonoda, T
   Watazu, A
   Zhu, J
   Katou, K
   Yamada, T
   Asahina, T
AF Shi, W
   Kamiya, A
   Sonoda, T
   Watazu, A
   Zhu, J
   Katou, K
   Yamada, T
   Asahina, T
TI Effects of magnesia particle addition on mechanical and bioactive
   properties of magnesia/titanium composite
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE bioactivity; titanium matrix composite; magnesia; hot-press; tensile
   strength
ID COATINGS; ALLOY; DEPOSITION; IMPLANTS; BEHAVIOR; STRENGTH; FILMS
AB In order to develop new titanium matrix composite for surface-coating titanium used in biomedical field, magnesia particles were added into pure titanium through hot press sintering method. Samples fabricated at the temperature of 973 K and at the pressure of 55 MPa were used to investigate the effects of magnesia addition on the properties of the new composite. In the fabricated samples, uniform dispersion of magnesia particles in titanium matrix was successfully obtained and no reaction layer was observed at interface between magnesia particles and titanium matrix. The volume fraction (V-f) and the size of magnesia particles mainly influenced tensile strength of the samples. When the size of magnesia particles was in the range of 25-90 mum, tensile strength of the composite was increased with increase of V-f till 5%. With respect to biocompatible property, the results of simulated body fluid immersion test showed that an apatite surface layer was formed on the fabricated magnesia/titanium composite samples, which would be benefit to bonding of the material to surrounding bone when it would be implanted into human body.
C1 Natl Inst Adv Ind Sci & Technol, Chubu Res Ctr, Inst Struct & Engn Mat, Highly Durable Mat Grp, Nagoya, Aichi 4638560, Japan.
RP Shi, W (reprint author), Natl Inst Adv Ind Sci & Technol, Chubu Res Ctr, Inst Struct & Engn Mat, Highly Durable Mat Grp, Nagoya, Aichi 4638560, Japan.
CR Choi JM, 2000, BIOMATERIALS, V21, P469, DOI 10.1016/S0142-9612(99)00186-6
   GEMEZVEGA JM, 2000, BIOMATERIALS, V21, P105
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   Lim SCV, 2001, MATER SCI TECH SER, V17, P823, DOI 10.1179/026708301101510591
   MILLER WS, 1991, SCRIPTA METALL MATER, V25, P33, DOI 10.1016/0956-716X(91)90349-6
   Pazo A, 1998, ACTA MATER, V46, P2551, DOI 10.1016/S1359-6454(98)80039-6
   Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0
   Schrooten J, 2000, BIOMATERIALS, V21, P1461, DOI 10.1016/S0142-9612(00)00027-2
   SHI W, IN PRESS MAT SCI E A
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   SRIVATSAN TS, 1993, J MATER SCI, V28, P611, DOI 10.1007/BF01151235
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
   Varma VK, 2001, MATER SCI TECH SER, V17, P93, DOI 10.1179/026708301101509016
   YANG J, 1990, ACTA METALL MATER, V38, P2613, DOI 10.1016/0956-7151(90)90273-J
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 17
TC 0
Z9 0
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2002
VL 43
IS 12
BP 3020
EP 3024
DI 10.2320/matertrans.43.3020
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 640GX
UT WOS:000180681300016
OA Bronze
DA 2018-10-20
ER

PT J
AU Song, Y
   Yang, R
   Guo, ZX
AF Song, Y
   Yang, R
   Guo, ZX
TI First principles estimation of bulk modulus and theoretical strength of
   titanium alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE bulk modulus; theoretical strength; titanium alloy; biomedical
   application
ID METALS
AB Titanium alloys are favorable implant materials for medical applications, due to their desirable mechanical properties and biochemical compatibility. However, current bio-titanium alloys were formulated principally by trial and error, which by no means represents the optimum. Here a theoretical investigation of the influence of alloying elements and interstitial elements on the bulk modulus and theoretical strength of alpha-titanium was presented. The bulk modulus and theoretical strength were estimated from the binding energy against the unit cell volume curves calculated by means of first principles discrete variational cluster method. The results of the calculation suggested that the 3d elements Cr, Mn, Fe, and Co, as well as all the interstitial elements considered in this study (H, B, C, N and O), are capable of enhancing the relative admissible strain of alpha-titanium.
C1 Univ London Queen Mary & Westfield Coll, Dept Mat, London E1 4NS, England.
   Chinese Acad Sci, Met Res Inst, Titanium Alloy Lab, Shenyang 110016, Peoples R China.
RP Song, Y (reprint author), Univ London Queen Mary & Westfield Coll, Dept Mat, Mile End Rd, London E1 4NS, England.
RI Guo, Zheng Xiao/C-1706-2009
OI Guo, Zheng Xiao/0000-0001-5404-3215
CR Deyirmenjian VB, 1995, PHYS REV B, V52, P15191, DOI 10.1103/PhysRevB.52.15191
   Ellis DE, 1999, ADV QUANTUM CHEM, V34, P51, DOI 10.1016/S0065-3276(08)60531-6
   FISHER ES, 1968, T METALL SOC AIME, V242, P1575
   HEDIN L, 1971, J PHYS PART C SOLID, V4, P2064, DOI 10.1088/0022-3719/4/14/022
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Niinomi M, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P3
   Sandera P, 1997, MAT SCI ENG A-STRUCT, V234, P370, DOI 10.1016/S0921-5093(97)00170-6
   Song Y, 1999, PHYS REV B, V59, P14220, DOI 10.1103/PhysRevB.59.14220
   Song Y, 2002, PHILOS MAG A, V82, P1345, DOI 10.1080/01418610110113011
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Song Y, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P273
   Song Y, 2001, PHILOS MAG A, V81, P321, DOI 10.1080/01418610108214306
   TANG R, 1969, SCRIPTA METALL MATER, V3, P485, DOI 10.1016/0036-9748(69)90136-7
NR 13
TC 11
Z9 11
U1 0
U2 11
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2002
VL 43
IS 12
BP 3028
EP 3031
DI 10.2320/matertrans.43.3028
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 640GX
UT WOS:000180681300018
OA Bronze
DA 2018-10-20
ER

PT J
AU Uenishi, K
   Seki, M
   Takatsugu, M
   Kunimasa, T
   Kobayashi, KF
   Ikeda, T
   Tsuboi, A
AF Uenishi, K
   Seki, M
   Takatsugu, M
   Kunimasa, T
   Kobayashi, KF
   Ikeda, T
   Tsuboi, A
TI Microstructure and tensile strength of stainless steel wires micro spot
   melted by YAG laser
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE micro laser welding; spot melting; crosswise joint; rapid
   solidification; Nd : YAG laser; stainless steel; biomaterials; joint
   strength; corrosion resistance
AB SUS304 stainless steel wire was micro spot melted by using YAG laser to investigate the applicabilty to the fabrication of biomedical devices. Effects of laser conditions such as laser power input or pulse duration were investigated on the microstructure and tensile strength of spot melted wires. Width of the melted metal decreased by laser irradiation with a shorter pulse duration and was about 0.3 mm for the 0.35 mm diameter wires. On the contrary, laser spot melting with a shorter pulse duration needed more precise control of laser conditions to achieve the sound melting free from burn out of the samples. Similarly, melting of thinner wire needed more precise control of laser conditions. Melted metal exhibited a rapidly quenched austenite cell microstructure with a cell size of less than about 5 mum. Tensile strength of the spot melted wires was 660 MPa, which was almost the same as that of annealed base materials. Besides, corrosion resistance in a quasi biological environment was hardly degraded by spot melting. Crosswise joints was also successfully prepared by laser spot welding of wires, suggesting the laser micro welding is applicable to the fabrication of biomedical devices.
C1 Osaka Univ, Grad Sch Engn, Dept Mfg Sci, Suita, Osaka 5650871, Japan.
   Fine Proc Co Ltd, Elect Mat Div, Nagoya, Aichi 4570823, Japan.
RP Uenishi, K (reprint author), Osaka Univ, Grad Sch Engn, Dept Mfg Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
CR ARAKI Y, 1975, J HIGH TEMPER SOC, V1, P160
   Chang WS, 2002, J MATER PROCESS TECH, V120, P208, DOI 10.1016/S0924-0136(01)00716-6
   HAMANAKA H, 1998, MAT JAPAN, V37, P834
   KOKAWA H, 1996, MAT JAPAN, V35, P655
   NAKAO Y, 1991, Q J JPN WELD SOC, V9, P97
   NAKAO Y, 1991, Q J JPN WELD SOC, V9, P111
   NISHIMOTO K, 1995, ISIJ INT, V35, P1265, DOI 10.2355/isijinternational.35.1265
   NISHIMOTO K, 1995, 9178394 IIW, P1
   NISHIMOTO K, 1997, J JPN WELD SOC, V66, P24
   Seki M, 2000, J JPN I MET, V64, P632, DOI 10.2320/jinstmet1952.64.8_632
   UENISHI K, 2002, P INT C LAS ADV MAT
   YONEYAMA T, 2000, NONDESRUCTIVE INSPEC, V49, P420
   ZHANG WP, 1989, THESIS OSAKA U
NR 13
TC 6
Z9 6
U1 0
U2 11
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2002
VL 43
IS 12
BP 3083
EP 3087
DI 10.2320/matertrans.43.3083
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 640GX
UT WOS:000180681300027
OA Bronze
DA 2018-10-20
ER

PT J
AU Dyck, I
AF Dyck, I
TI Beyond the clinic: Restructuring the environment in chronic illness
   experience
SO OTJR-OCCUPATION PARTICIPATION AND HEALTH
LA English
DT Article
DE environment; occupation; body; chronic illness; geography
ID GEOGRAPHIES; PEOPLE; SPACE; WOMEN
AB This article discusses research on the daily routines of women with chronic illness that focused on the relationship between body and environment. The analysis draws on insights from feminist theories of the body and human geography that explore the connections among the material or corporeal body, its representation in biomedical discourse and other dominant social ideas about the "able" body, and lived experience. The discussion, which is based on in-depth interviews with women about their daily lives in the spaces of home, neighborhood, and workplace, demonstrates the women's restructuring, of their daily routines and environments as they respond to both the material changing of their body and its marking as "deviant." The analysis emphasizes the powerful influence of dominant social norms about the body, which may cast certain bodies as "out of place," not just physically but socially. The theoretical ideas are applied to case examples from occupational therapy, and implications, for practice are suggested. Following from the analysis, an important focus of intervention is exploration of ways to restructure space and work with clients on issues of social identify.
C1 Univ British Columbia, Sch Rehabil Sci, Vancouver, BC V5Z 1M9, Canada.
RP Dyck, I (reprint author), Univ British Columbia, Sch Rehabil Sci, Vancouver, BC V5Z 1M9, Canada.
CR Barnes Colin, 1996, EXPLORING DIVIDE ILL, P39
   Canadian Association of Occupational Therapists, 1997, EN OCC OCC THER PERS
   Chouinard V, 1997, ENVIRON PLANN D, V15, P379
   CROW L, 1996, ENCOUNTERS STRANGERS
   DYCK I, 1995, SOC SCI MED, V40, P307, DOI 10.1016/0277-9536(94)E0091-6
   DYCK I, 1996, ATLANTIS, V21, P54
   DYCK I, 1995, HEALTH PLACE, V1, P139
   Dyck I, 1999, MIND BODY SPACES GEO, P119
   DYCK I, 1997, PUTTING HLTH PLACE L, P102
   FOUCAULT M, 1974, ARCHAEOLOGY KNOWLEDG
   Foucault Michel, 1981, HIST SEXUALITY, VI
   French Sally, 1993, DISABLING BARRIERS E
   Gleeson B., 1999, GEOGRAPHIES DISABILI
   Grosz Elizabeth, 1994, VOLATILE BODIES CORP
   Hall E, 2000, AREA, V32, P21, DOI 10.1111/j.1475-4762.2000.tb00111.x
   Jongbloed L., 1996, CANADIAN J REHABILIT, V9, P213
   Jongbloed L., 1998, CANADIAN J OCCUPATIO, V65, P193
   Kitchin R, 1998, DISABIL SOC, V13, P343, DOI 10.1080/09687599826678
   Morris J, 1992, DISABILITY HANDICAP, V7, P157, DOI [10.1080/02674649266780181, DOI 10.1080/02674649266780181]
   Moss P, 1997, SOC SCI MED, V45, P23, DOI 10.1016/S0277-9536(96)00305-X
   Moss P., 1999, ANTIPODE, V31, P372, DOI DOI 10.1111/1467-8330.00110
   Moss P, 1996, ENVIRON PLANN D, V14, P631
   MOSS P, 1999, EMBODIED GEOGRAPHIES, P157
   MOSS P, IN PRESS BODY WOMEN
   OBRIEN P, 2001, THESIS U BRIT COLUMB
   Oliver M, 1990, POLITICS DISABLEMENT
   Parr H, 1999, ENVIRON PLANN D, V17, P673, DOI 10.1068/d170673
   Pile S, 1995, MAPPING SUBJECT GEOG, P1
   REINHARDT L, 2000, THESIS U BRIT COLUMB
   Shildrick M., 1996, BODY SOC, V2, P93
   Shilling Chris, 1993, BODY SOCIAL THEORY
   Turner B. S, 1997, FOUCAULT HLTH MED, pix
   Wendell Susan, 1996, REJECTED BODY
   Williams Simon J., 1998, LIVED BODY SOCIOLOGI
   Wilton RD, 1996, HEALTH PLACE, V2, P69, DOI 10.1016/1353-8292(95)00040-2
   ZOLA IK, 1991, J HEALTH SOC BEHAV, V32, P1, DOI 10.2307/2136796
NR 36
TC 11
Z9 11
U1 0
U2 3
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 1539-4492
J9 OTJR-OCCUP PARTICI H
JI OTJR-Occup. Particip. Health
PD WIN
PY 2002
VL 22
SU 1
BP 52S
EP 60S
DI 10.1177/15394492020220S107
PG 9
WC Rehabilitation
SC Rehabilitation
GA 593CK
UT WOS:000177973800007
DA 2018-10-20
ER

PT J
AU Liang, CH
   Mou, ZQ
AF Liang, CH
   Mou, ZQ
TI Electrochemical behaviour of commercially pure titanium and Co-Cr alloy
   in Ringer's solution
SO RARE METALS
LA English
DT Article
DE Ringer's solution; biomedical material; electrochemical behaviors
ID CORROSION
AB The electrochemical behaviors of commercially pure titanium (CP Ti) and Co-Cr alloy in Ringer's solution have been investigated. The results indicate that the electric potential of passive region for CP Ti is up to 3000 mV, and its passive current density is 3.078 muA/cm(2). The excellent corrosion resistance of CP Ti can be attributed to the formation of TiO2 oxide film. The passive region of Co-Cr alloy is 770 mV, which is narrower than that of CP Ti. However, no hysteresis loops are found in the reverse scanning curves of Cu-Cr alloy. A complex oxide film Of CO3O4 CO2O3, and Cr2O3 formed on the surface provides Co-Cr alloy with a stable electrochemistry property. The corrosion rates of the crevice samples increase with the pH value of medium decreasing. The electron probe microanalyzer (EPMA) analysis indicates that Ti in CP Ti and Co, Cr in Co-Cr alloy dissolve in crevice area due to the Sealed-Cell effect.
C1 Dalian Univ Technol, Sch Chem Engn, Dalian 116012, Peoples R China.
RP Liang, CH (reprint author), Dalian Univ Technol, Sch Chem Engn, Dalian 116012, Peoples R China.
CR BUNDY KJ, 1986, J BIOMED MATER RES, V20, P493, DOI 10.1002/jbm.820200406
   ITAGAKI M, 1991, CORROSION ENG, V40, P254
   Liang CH, 2001, T NONFERR METAL SOC, V11, P579
   LIANG CH, 1994, ACTA METALLURGICA SI, V30, P165
   LUCAS LC, 1982, J BIOMED MATER RES, V16, P799, DOI 10.1002/jbm.820160606
   PARK JB, 1979, BIOMATERIALS INTRO, P187
   YANG W, 1984, CORROS SCI, V24, P691, DOI 10.1016/0010-938X(84)90059-3
NR 7
TC 2
Z9 2
U1 0
U2 3
PU NONFERROUS METALS SOCIETY CHINA
PI BEIJING
PA 2 XINJIEKOUWAI ST, BEIJING 100088, PEOPLES R CHINA
SN 1001-0521
J9 RARE METALS
JI Rare Metals
PD DEC
PY 2002
VL 21
IS 4
BP 266
EP 270
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 629NC
UT WOS:000180054900005
DA 2018-10-20
ER

PT J
AU Hanawa, T
AF Hanawa, Takao
TI Evaluation techniques of metallic biomaterials in vitro
SO SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
LA English
DT Article
DE Metallic biomaterials; Corrosion; Surface oxide; Fretting fatigue;
   Cytotoxicity
AB Metals and alloys are widely used as biomedical materials and are important in medicine and they cannot be replaced with ceramics or polymers at present mainly because of their high strength and toughness. Since safety is the most important property of biomaterials, corrosion-resistant materials such as stainless steel, Co-Cr-Mo alloy, commercially pure titanium, and titanium alloys are employed as biomaterials. Evaluation techniques for corrosion with culturing cells, the characterization of reconstruction of surface oxide film, fretting fatigue, cytotoxicity, and biocompatibility are reviewed in this paper. These techniques are original and characteristics in the field of biomaterials that should contribute to the proper evaluations of biomaterials in vitro. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 [Hanawa, Takao] Natl Res Inst Met, Biomat Res Team, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
RP Hanawa, T (reprint author), Natl Res Inst Met, Biomat Res Team, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
EM hanawa@takao.nims.go.jp
CR BLACK J, 1984, BIOL PERFORMANCE MAT
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   HANAWA T, 1992, J JPN I MET, V56, P1168, DOI 10.2320/jinstmet1952.56.10_1168
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   Hanawa T., 2000, CORROSION ENG, V49, P687
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   Hiromoto S, 2002, CORROS SCI, V44, P955, DOI 10.1016/S0010-938X(01)00110-X
   Kelly E. J., 1982, MOD ASPECT ELECTROC, P319
   MARUYAMA N, 1995, J JAPANESE SOC BIOMA, V13, P14
   MARUYAMA N, 1999, J JPN SOC BIOMATER, V17, P172
   MORITA M, 1988, J BIOMED MATER RES, V22, P529, DOI 10.1002/jbm.820220608
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   Mu Y., 2002, J MAT SCI M IN PRESS
   Nakazawa K, 1999, J JPN I MET, V63, P1600, DOI 10.2320/jinstmet1952.63.12_1600
   Yamamoto A, 1999, J BIOMED MATER RES, V47, P396, DOI 10.1002/(SICI)1097-4636(19991205)47:3<396::AID-JBM15>3.0.CO;2-R
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   YAMAMOTO A, 1995, J JPN I MET, V59, P463, DOI 10.2320/jinstmet1952.59.4_463
   Yamamoto A, 2002, J BIOMED MATER RES, V59, P176, DOI 10.1002/jbm.1231
   Yamamoto A., 1996, J JPN SOC BIOMATER, V14, P158
   Yamamoto A., 2000, J JPN SOC BIOMATER, V18, P87
NR 25
TC 65
Z9 68
U1 1
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1468-6996
EI 1878-5514
J9 SCI TECHNOL ADV MAT
JI Sci. Technol. Adv. Mater.
PD DEC
PY 2002
VL 3
IS 4
BP 289
EP 295
DI 10.1016/S1468-6996(02)00028-1
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA V43OX
UT WOS:000209691800002
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Lee, KY
   Bouhadir, KH
   Mooney, DJ
AF Lee, KY
   Bouhadir, KH
   Mooney, DJ
TI Evaluation of chain stiffness of partially oxidized polyguluronate
SO BIOMACROMOLECULES
LA English
DT Article
ID POLY(ALDEHYDE GULURONATE) HYDROGELS; INTRINSIC-VISCOSITY;
   POLYMER-SOLUTIONS; ALGINATE; RIGIDITY; BEHAVIOR; STRENGTH
AB The chain stiffness of macromolecules is considered critical in their design and applications. This study utilizes polyguluronate derived from alginate, a typical polysaccharide widely utilized in many biomedical applications, as a model macromolecule to investigate how the chain stiffness can be tightly regulated by partial oxidation: Alginate has a backbone of inherently rigid alpha-L-guluronate (i.e., polyguluronate) and more flexible beta-D-mannuronate., The chain stiffness of the polyguluronate was specifically studied in this paper, as this component plays a critical role in the formation of alginate hydrogels with divalent cations and is the dominant factor in determining the chain stiffness of alginate. We have utilized size-exclusion chromatography, equipped with refractive index, viscosity, and light-scattering detectors, to determine the intrinsic viscosity and the weight-average molecular Weight of each fraction of samples. The chain stiffness of partially oxidized polyguluronate was then evaluated from the exponent of the Mark-Houwink equation and the persistence length. We have found that partial oxidation can be used to tightly regulate the steric hindrance and stiffness of the polyguluronate backbone. This approach to control the chain stiffness of inherently rigid polysaccharides by partial oxidation may find many applications in biomedical utilization of these materials.
C1 Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   Amer Univ Beirut, Dept Chem, Beirut 110236, Lebanon.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Chem Engn, 3074 HH Dow Bldg,2300 Hayward St, Ann Arbor, MI 48109 USA.
OI Lee, Kuen Yong/0000-0002-5759-5952
FU NIDCR NIH HHS [R01 DE13033]
CR AHARONI SM, 1982, MACROMOLECULES, V15, P1311, DOI 10.1021/ma00233a019
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Billmeyer FW, 1984, TXB POLYM SCI
   BOHDANECKY M, 1983, MACROMOLECULES, V16, P1483, DOI 10.1021/ma00243a014
   Bouhadir KH, 1999, POLYMER, V40, P3575, DOI 10.1016/S0032-3861(98)00550-3
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   DRAGET KI, 1990, TIBTECH, V8, P71
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Hirose E, 1999, MACROMOLECULES, V32, P8629, DOI 10.1021/ma990813b
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Kakali F, 1996, MACROMOLECULES, V29, P4759, DOI 10.1021/ma951104a
   Kikuchi A, 1999, J CONTROL RELEASE, V58, P21, DOI 10.1016/S0168-3659(98)00141-2
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106
   Kratochvil P., 1987, CLASSICAL LIGHT SCAT
   LARSEN B, 1969, CARBOHYD RES, V10, P186, DOI 10.1016/S0008-6215(00)81107-6
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee KY, 2001, J BIOMED MATER RES, V56, P228, DOI 10.1002/1097-4636(200108)56:2<228::AID-JBM1089>3.0.CO;2-9
   MACKIE W, 1980, BIOPOLYMERS, V19, P1839, DOI 10.1002/bip.1980.360191012
   MASTUMOTO A, 1999, EUR POLYM J, V35, P2107
   MORRIS ER, 1980, CARBOHYD RES, V81, P305, DOI 10.1016/S0008-6215(00)85661-X
   NORISUYE T, 1993, PROG POLYM SCI, V18, P543, DOI 10.1016/0079-6700(93)90017-7
   Norisuye T, 1996, POLYM J, V28, P357, DOI 10.1295/polymj.28.357
   NORISUYE T, 1982, POLYM J, V14, P143, DOI 10.1295/polymj.14.143
   Ritacco H, 2000, PHYS CHEM CHEM PHYS, V2, P5243, DOI 10.1039/b004657o
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shimizu M, 1996, MACROMOLECULES, V29, P6724, DOI 10.1021/ma951790d
   SMIDSROD O, 1973, CARBOHYD RES, V26, P125, DOI 10.1016/S0008-6215(00)85029-6
   SMIDSROD O, 1971, BIOPOLYMERS, V10, P1213, DOI 10.1002/bip.360100711
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Temyanko E, 2001, MACROMOLECULES, V34, P582, DOI 10.1021/ma0013511
   TSUJI T, 1975, POLYM J, V7, P558, DOI 10.1295/polymj.7.558
   WITTINGTON SG, 1971, BIOPOLYMERS, V10, P1481
   YAMAKAWA H, 1974, MACROMOLECULES, V7, P128, DOI 10.1021/ma60037a024
   YAMAKAWA H, 1985, J CHEM PHYS, V83, P2607, DOI 10.1063/1.449254
   YAU WW, 1979, MODERN SIZE EXCLUSIO
NR 37
TC 42
Z9 44
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2002
VL 3
IS 6
BP 1129
EP 1134
DI 10.1021/bm025567h
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 615GB
UT WOS:000179236500001
PM 12425648
DA 2018-10-20
ER

PT J
AU Brunius, CF
   Edlund, U
   Albertsson, AC
AF Brunius, CF
   Edlund, U
   Albertsson, AC
TI Synthesis and in vitro degradation of poly(N-vinyl-2-pyrrolidone)-based
   graft copolymers for biomedical applications
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE poly(vinyl pyrrolidone) (PVP); biomaterial; graft copolymer; dextran;
   degradation
ID EXPANDERS; OLIGOMERS; NMR
AB This work is devoted to the design of a novel family of hydrosoluble biomaterials: poly(N-vinyl-2-pyrrolidone) (PVP)-based graft copolymers. A synthesis route has been elaborated in which omega-functionalized PVP is prepared via chain-transfer radical polymerization, end-group modified, and subsequently grafted onto a polyhydroxylated backbone, typically dextran or poly(vinyl alcohol). The resulting graft copolymer biomaterials are designed for use in various biomedical applications, particularly as materials with a stronger potential for plasma expansion than already existing products have. The graft copolymers are potentially degradable because the PVP grafts are connected to the polyol backbone via a hydrolytically labile carbonate or ester linkage. The degradation of the graft copolymers was performed in vitro over a period of 6 weeks. (C) 2002 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 40: 3652-3661, 2002.
C1 Royal Inst Technol, Dept Polymer Technol, S-10044 Stockholm, Sweden.
RP Albertsson, AC (reprint author), Royal Inst Technol, Dept Polymer Technol, S-10044 Stockholm, Sweden.
RI Albertsson, Ann-Christine/Q-6107-2016
OI Albertsson, Ann-Christine/0000-0001-8696-9143; Brunius,
   Carl/0000-0003-3957-870X; /0000-0002-1631-1781
CR BARABAS E, 1989, ENCY POLYM SCI ENG, V17, P198
   BARON JF, 1998, VOLUME REPLACEMENT
   Boldt J, 2000, INTENS CARE MED, V26, P1181, DOI 10.1007/s001340000625
   Brunius CF, 2001, MACROMOL RAPID COMM, V22, P1474, DOI 10.1002/1521-3927(20011201)22:18<1474::AID-MARC1474>3.0.CO;2-7
   Dutta K, 1999, J POLYM SCI POL CHEM, V37, P3922, DOI 10.1002/(SICI)1099-0518(19991101)37:21<3922::AID-POLA7>3.0.CO;2-J
   KAMINSKI MV, 1992, CRIT CARE CLIN, V8, P311
   Kanekiyo M, 1998, J MOL STRUCT, V447, P49, DOI 10.1016/S0022-2860(98)00300-7
   KLOTZ U, 1987, CLIN PHARMACOKINET, V12, P123, DOI 10.2165/00003088-198712020-00003
   Marten F. L., 1985, ENCY POLYM SCI TECHN, V17, P167
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   Molyneux P., 1984, WATER SOLUBLE SYNTHE, VII
   RANUCCI E, 1995, MACROMOL CHEM PHYS, V196, P763, DOI 10.1002/macp.1995.021960307
   Ranucci E, 2000, MACROMOL CHEM PHYSIC, V201, P1219, DOI 10.1002/1521-3935(20000801)201:12<1219::AID-MACP1219>3.0.CO;2-G
   RANUCCI E, 1996, POLYM MAT ENCY, V3, P2053
   Roberts JS, 1998, DRUGS, V55, P621, DOI 10.2165/00003495-199855050-00002
   Robyt J. F, 1986, ENCY POLYM SCI ENG, P752
   Treib J, 1999, INTENS CARE MED, V25, P258, DOI 10.1007/s001340050833
   Warren BB, 1997, ANESTH ANALG, V84, P206, DOI 10.1097/00000539-199701000-00037
NR 18
TC 26
Z9 26
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD NOV 1
PY 2002
VL 40
IS 21
BP 3652
EP 3661
DI 10.1002/pola.10468
PG 10
WC Polymer Science
SC Polymer Science
GA 603EQ
UT WOS:000178546200011
DA 2018-10-20
ER

PT J
AU Gurappa, I
AF Gurappa, I
TI Development of appropriate thickness ceramic coatings on 316 L stainless
   steel for biomedical applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE stainless steel; ceramic coatings; corrosion resistance; biomaterials
ID HYDROXYAPATITE COATINGS; DEPOSITION; CORROSION
AB In this study, ceramics such as alumina, magnesia-stabilized zirconia (MSZ) and yttria-stabilized zirconia (YSZ) of different thicknesses have been deposited over 316 L stainless steel substrate by the air plasma spray (APS) technique. The coated specimens were characterized by scanning electron microscopy (SEM), metallography and X-ray diffraction (XRD) techniques. The coatings of different thicknesses were evaluated for corrosion resistance by various electrochemical techniques in deaerated Hank's solution of pH 7.4 at 37 degreesC, which simulates body fluid conditions. The results revealed that among four different thicknesses of alumina, the 150-mum-thick alumina coating provides good protection and increases the breakdown potential. While all thicknesses of MSZ coating provides very good protection, breakdown potential increases considerably for the 150-mum-thick coating. The breakdown potential increases marginally for the 50-mum-thick YSZ coating. Among the three types of coatings, the MSZ coating has been identified as a suitable coating material and its optimum thickness is 150 mum as it increases the breakdown to a maximum value. Therefore, the present results show that the plasma-sprayed MSZ ceramic coating of 150 mum helps in improving the corrosion resistance of 316 L stainless steel considerably. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Def Met Res Lab, Hyderabad 500058, Andhra Pradesh, India.
RP Gurappa, I (reprint author), Def Met Res Lab, Kanchanbagh PO, Hyderabad 500058, Andhra Pradesh, India.
EM igpl@rediffmail.com
CR [Anonymous], 1986, ASTM STAND SPEC, pF138
   *ASTM, 1982, ASTM STAND SPEC, pF55
   BROWN SD, 1978, 4 ANN INT BIOM S 29
   Chen JY, 1997, J BIOMED MATER RES, V34, P15, DOI 10.1002/(SICI)1097-4636(199701)34:1<15::AID-JBM3>3.0.CO;2-Q
   Costa MA, 2000, J MATER SCI-MATER M, V11, P141, DOI 10.1023/A:1008975507654
   DING XF, 1995, J CERAM SOC JPN, V103, P867, DOI 10.2109/jcersj.103.867
   DOBBS HS, 1978, ASTM STP, V684
   Feng B., 2001, KEY ENG MATER, V192-195, P167
   Gao W, 2001, ADV MATER, V13, P1001, DOI 10.1002/1521-4095(200107)13:12/13<1001::AID-ADMA1001>3.0.CO;2-V
   Gonzalez-Carrasco JL, 1998, MATER MANUF PROCESS, V13, P431, DOI 10.1080/10426919808935260
   Gurrappa I, 2001, CORROS PREVENT CONTR, V48, P23
   HENDRY J, 2000, 6 WORLD BIOM C T, P1538
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   Hwang K, 2000, SURF COAT TECH, V123, P252, DOI 10.1016/S0257-8972(99)00512-5
   Kawahara H., 1987, CLIN MAT, V2, P181
   Kim TN, 1998, SURF COAT TECH, V99, P20, DOI 10.1016/S0257-8972(97)00121-7
   Lemons JE, 1998, SURF COAT TECH, V104, P135
   MAIWARD D, 1996, BIOMATERIALS, V17, P491
   MEINERT K, 1958, SURF COAT TECH, V103, P58
   Meyer M, 1999, Z METALLKD, V90, P1092
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   Oh KT, 1998, SURF COAT TECH, V110, P4, DOI 10.1016/S0257-8972(98)00537-4
   PONTON HCB, 1992, J MATER SCI-MATER M, V3, P283
   REUS J, 2000, SURF COAT TECH, V130, P224
   Santos J. D. S., 1990, Surface Engineering, V6, P209
   SONODA T, 1999, BR CERAM P, V60, P231
   SUTOW EJ, 1981, BIOCOMPATIBILITY CLI, V1, P45
NR 27
TC 41
Z9 43
U1 4
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD NOV 1
PY 2002
VL 161
IS 1
BP 70
EP 78
AR PII S0257-8972(02)00380-8
DI 10.1016/S0257-8972(02)00380-8
PG 9
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 598KY
UT WOS:000178276100010
DA 2018-10-20
ER

PT J
AU de Grey, ADNJ
AF de Grey, ADNJ
TI Bioremediation meets biomedicine: therapeutic translation of microbial
   catabolism to the lysosome
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Editorial Material
ID MAMMALIAN-CELLS; GENE-THERAPY; LIPOFUSCIN; DEGRADATION; PATHWAY
AB Lysosomal degradation of damaged macromolecules is imperfect: many cell types accumulate lysosomal aggregates with age. Some such deposits are known, or are strongly suspected, to cause age-related disorders such as atherosclerosis and neurodegeration. It is possible that they also influence the rate of aging in general. Lysosomal degradation involves extensive cooperation between the participating enzymes: each generates a substrate for others until breakdown of the target material to recyclable units (such as amino acids) is complete. Hence, the age-related accumulation of lysosomal aggregates might be markedly retarded, or even reversed, by introducing just a few bacterial or fungal enzymes -'xenohydrolases'- that can degrade molecules that our natural machinery cannot. This article examines the feasibility and biomedical potential of such lysosomal enhancement as an approach to retarding or treating age-related physiological decline and disease.
C1 Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England.
RP de Grey, ADNJ (reprint author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.
CR Bowers WE, 1998, TRENDS CELL BIOL, V8, P330, DOI 10.1016/S0962-8924(98)01314-2
   Brazil MI, 2000, J BIOL CHEM, V275, P16941, DOI 10.1074/jbc.M000937200
   Brix K, 2001, BIOL CHEM, V382, P717, DOI 10.1515/BC.2001.087
   Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827
   Brooks AI, 2002, P NATL ACAD SCI USA, V99, P6216, DOI 10.1073/pnas.082011999
   Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x
   Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9
   Davies S, 2001, FREE RADICAL BIO MED, V31, P256, DOI 10.1016/S0891-5849(01)00582-2
   DEGREY ADN, 2001, J AM AGING ASSOC, V24, P118
   Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899
   Gura T, 2001, SCIENCE, V291, P1692, DOI 10.1126/science.291.5509.1692
   HANNOVER A, 1842, KGL DANSKE VIDENSK K, V10, P1
   Ikeda K, 2000, NEUROSCI LETT, V284, P187, DOI 10.1016/S0304-3940(00)01009-0
   Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303
   Knosalla C, 2002, FRONT BIOSCI, V7, pD1280, DOI 10.2741/knosalla
   Koransky ML, 2002, TRENDS CARDIOVAS MED, V12, P108, DOI 10.1016/S1050-1738(01)00158-X
   Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3
   Lim F, 2001, MOL CELL NEUROSCI, V18, P702, DOI 10.1006/mcne.2001.1051
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   MARTIN GM, 1979, FED PROC, V38, P1962
   NAKANO M, 1993, MECH AGEING DEV, V66, P243, DOI 10.1016/0047-6374(93)90011-F
   Nelson N, 1999, PHYSIOL REV, V79, P361
   Novelli EM, 2001, EXPERT OPIN BIOL TH, V1, P857, DOI 10.1517/14712598.1.5.857
   Poenaru L, 2001, ANN MED, V33, P28, DOI 10.3109/07853890109002057
   Pointing SB, 2001, APPL MICROBIOL BIOT, V57, P20, DOI 10.1007/s002530100745
   Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4
   Roberts WC, 1998, AM J CARDIOL, V82, P627, DOI 10.1016/S0002-9149(98)00385-3
   Schenk D, 2001, DNA CELL BIOL, V20, P679, DOI 10.1089/10445490152717532
   Schiffmann R, 2002, DRUGS, V62, P733, DOI 10.2165/00003495-200262050-00002
   Shamsi FA, 2001, INVEST OPHTH VIS SCI, V42, P3041
   Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819
   Shir A, 2001, CELL MOL NEUROBIOL, V21, P645, DOI 10.1023/A:1015143819375
   Snellinx Z, 2002, ENVIRON SCI POLLUT R, V9, P48, DOI 10.1007/BF02987316
   Terman A, 1999, EXP GERONTOL, V34, P943, DOI 10.1016/S0531-5565(99)00070-4
   Terman A, 2001, REDOX REP, V6, P15, DOI 10.1179/135100001101535996
   Wang B, 1998, J BIOL CHEM, V273, P32000, DOI 10.1074/jbc.273.48.32000
   Wisniewski KE, 2001, NEUROLOGY, V57, P576, DOI 10.1212/WNL.57.4.576
   Woods NB, 2002, LEUKEMIA, V16, P563, DOI 10.1038/sj/leu/2402447
   Zhang HG, 1998, NAT BIOTECHNOL, V16, P1045, DOI 10.1038/3488
   Zhao H, 2002, CELL MOL LIFE SCI, V59, P694, DOI 10.1007/s00018-002-8458-y
NR 40
TC 17
Z9 19
U1 0
U2 4
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD NOV
PY 2002
VL 20
IS 11
BP 452
EP 455
AR PII S0167-7799(02)02062-0
DI 10.1016/S0167-7799(02)02062-0
PG 4
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 606HE
UT WOS:000178727900007
PM 12413818
DA 2018-10-20
ER

PT J
AU Tsukada, M
   Katoh, H
   Wilson, D
   Shin, BS
   Arai, T
   Murakami, R
   Freddi, G
AF Tsukada, M
   Katoh, H
   Wilson, D
   Shin, BS
   Arai, T
   Murakami, R
   Freddi, G
TI Production of antimicrobially active silk proteins by use of
   metal-containing dyestuffs
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE birefringence; silk protein; fibers; dyes
ID FIBERS
AB The work presented here discusses a new technique for preparing silk fibers and films with persistent antimicrobial activity through use of metallic dyestuffs during the fiber dyeing process. The length of the silk fibers investigated contracted when the fibers were immersed in concentrated neutral salt solutions, such as calcium or potassium nitrate, at elevated temperature levels. The birefringence and molecular orientation of the silk fibroin molecules became less ordered by the action of the neutral salt solutions, resulting in increased dyestuff absorption. Subsequently, contracted silk fibers were dyed with metallic dyestuffs containing Cr or Cu for the purpose of obtaining silk fibers with antimicrobial activity. Silk fibers dyed with metallic dyestuffs showed significant antimicrobial activity against the plant pathogen Cornebacterium and the human pathogen Coli bacillus. Tensile strength of the silk fibers after the salt shrinking and dyeing processes did not show a significant change, whereas the elongation at break was increased slightly. The techniques described here for preparing significantly active antimicrobial silk fibers are effective and economic ways of providing new materials for industrial and biomedical applications. (C) 2002 Wiley Periodicals, Inc.
C1 Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan.
   Stn Sperimentale Seta, I-20133 Milan, Italy.
   Sangju Natl Univ, Dept Text Engn, Sangju 742711, South Korea.
   Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA.
RP Tsukada, M (reprint author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan.
CR Arai T, 2001, J APPL POLYM SCI, V80, P297, DOI 10.1002/1097-4628(20010411)80:2<297::AID-APP1099>3.3.CO;2-Q
   Freddi G., 1996, POLYM MAT ENCY, V10, P7734
   FREDDI G, IN PRESS J APPL POLY
   KATO H, 1990, Journal of Sericultural Science of Japan, V59, P280
   NAYAK PL, 1990, P INT M GRAFT PROC P, P85
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   SHIOZAKI H, 1971, MAKROMOLEKUL CHEM, V143, P25
   SHIOZAKI H, 1969, POLYM LETT, V7, P325
   TANAKA Y, 1989, SEN-I GAKKAISHI, V45, P147
   TANAKA Y, 1972, MAKROMOL CHEM, V152, P217
   TSUKADA M, 1992, J APPL POLYM SCI, V46, P1945, DOI 10.1002/app.1992.070461107
   TSUKADA M, 1993, J APPL POLYM SCI, V50, P1519, DOI 10.1002/app.1993.070500905
NR 12
TC 10
Z9 10
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 31
PY 2002
VL 86
IS 5
BP 1181
EP 1188
DI 10.1002/app.11061
PG 8
WC Polymer Science
SC Polymer Science
GA 586XV
UT WOS:000177612200017
DA 2018-10-20
ER

PT J
AU Wang, YM
   Chen, MW
   Zhou, FH
   Ma, E
AF Wang, YM
   Chen, MW
   Zhou, FH
   Ma, E
TI High tensile ductility in a nanostructured metal
SO NATURE
LA English
DT Article
ID NANOCRYSTALLINE COPPER; DEFORMATION-BEHAVIOR; PLASTIC-DEFORMATION;
   STRAIN; TEMPERATURE
AB Nanocrystalline metals-with grain sizes of less than 100 nm-have strengths exceeding those of coarse-grained and even alloyed metals(1,2), and are thus expected to have many applications. For example, pure nanocrystalline Cu (refs 1-7) has a yield strength in excess of 400 MPa, which is six times higher than that of coarse-grained Cu. But nanocrystalline materials often exhibit low tensile ductility at room temperature, which limits their practical utility. The elongation to failure is typically less than a few per cent; the regime of uniform deformation is even smaller(1-7). Here we describe a thermomechanical treatment of Cu that results in a bimodal grain size distribution, with micrometre-sized grains embedded inside a matrix of nanocrystalline and ultrafine (<300 nm) grains. The matrix grains impart high strength, as expected from an extrapolation of the Hall-Petch relationship. Meanwhile, the inhomogeneous microstructure induces strain hardening mechanisms(8-11) that stabilize the tensile deformation, leading to a high tensile ductility-65% elongation to failure, and 30% uniform elongation. We expect that these results will have implications in the development of tough nanostructured metals for forming operations and high-performance structural applications including microelectromechanical and biomedical systems.
C1 Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
   Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.
RP Ma, E (reprint author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
RI CHEN, Mingwei/A-4855-2010; Ma, En/A-3232-2010; Wang, Yinmin
   (Morris)/F-2249-2010
OI CHEN, Mingwei/0000-0002-8274-3099; Chen, Mingwei/0000-0002-2850-8872;
   Wang, Yinmin (Morris)/0000-0002-7161-2034
CR ANDRADE U, 1994, ACTA METALL MATER, V42, P3183, DOI 10.1016/0956-7151(94)90417-0
   Asgari S, 1997, METALL MATER TRANS A, V28, P1781, DOI 10.1007/s11661-997-0109-3
   BLEWITT TH, 1957, J APPL PHYS, V28, P651, DOI 10.1063/1.1722824
   CALLISTER WD, 1994, MATER SCI ENG, P167
   Dieter G.E., 1986, MECH METALLURGY, P290
   Gao H, 1999, J MECH PHYS SOLIDS, V47, P1239, DOI 10.1016/S0022-5096(98)00103-3
   Gertsman VY, 1996, MATER SCI FORUM, V225, P739, DOI 10.4028/www.scientific.net/MSF.225-227.739
   HART EW, 1967, ACTA METALL MATER, V15, P351, DOI 10.1016/0001-6160(67)90211-8
   HERTZBERG RW, 1989, DEFORMATION FRACTURE, P392
   Hibbard GD, 2002, SCRIPTA MATER, V47, P83, DOI 10.1016/S1359-6462(02)00098-2
   Huang JY, 1996, ACTA MATER, V44, P1211, DOI 10.1016/1359-6454(95)00231-6
   Hughes DA, 1997, ACTA MATER, V45, P3871, DOI 10.1016/S1359-6454(97)00027-X
   HUMPHREYS FJ, 1995, RECRYSTALLIZATION RE, P314
   Jia D, 2001, APPL PHYS LETT, V79, P611, DOI 10.1063/1.1384000
   Koch CC, 1999, MRS BULL, V24, P54, DOI 10.1557/S0883769400051551
   Lergos M., 2000, PHILOS MAG A, V80, P1017
   Lu L, 2000, J MATER RES, V15, P270, DOI 10.1557/JMR.2000.0043
   Lu L, 2000, SCIENCE, V287, P1463, DOI 10.1126/science.287.5457.1463
   McFadden SX, 1999, NATURE, V398, P684
   McFadden SX, 2000, MATER LETT, V45, P345, DOI 10.1016/S0167-577X(00)00131-2
   Sanders PG, 1997, MAT SCI ENG A-STRUCT, V234, P77, DOI 10.1016/S0921-5093(97)00185-8
   Sanders PG, 1997, ACTA MATER, V45, P4019, DOI 10.1016/S1359-6454(97)00092-X
   Valiev RZ, 2002, J MATER RES, V17, P5, DOI 10.1557/JMR.2002.0002
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Wang YM, 2002, APPL PHYS LETT, V80, P2395, DOI 10.1063/1.1465528
   WANG YM, IN PRESS MAT SCI E A
   Weertman JR, 1999, MRS BULL, V24, P44, DOI 10.1557/S088376940005154X
   Wei Q, 2002, APPL PHYS LETT, V81, P1240, DOI 10.1063/1.1501158
   Youngdahl CJ, 2001, SCRIPTA MATER, V44, P1475, DOI 10.1016/S1359-6462(01)00712-6
NR 29
TC 1644
Z9 1704
U1 35
U2 576
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD OCT 31
PY 2002
VL 419
IS 6910
BP 912
EP 915
DI 10.1038/nature01133
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 609MN
UT WOS:000178909700039
PM 12410306
DA 2018-10-20
ER

PT J
AU Li, YH
   Rong, LJ
   Li, YY
AF Li, YH
   Rong, LJ
   Li, YY
TI Compressive property of porous NiTi alloy synthesized by combustion
   synthesis
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE mechanical properties; shape memory alloy; combustion synthesis; porous
   material; porosity
ID SHAPE-MEMORY ALLOYS; MECHANICAL-PROPERTIES; NICKEL-TITANIUM; BONE;
   BEHAVIOR; APPOSITION; ANISOTROPY; INGROWTH; IMPLANT; TISSUE
AB Porous NiTi shape memory alloy (SMA) is a promising biomedical material applied as a human implant. Compressive properties of porous NiTi SMAs fabricated by combustion synthesis were investigated in this paper by compression tests. The results indicated that the nominal ultimate compressive strength and strain of porous NiTi SMAs were dependent on porosity and independent on strain rate. The compressive strength of porous NiTi SMA met the basic strength demand of human cancellous bone with corresponding porosity. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RP Li, YH (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
OI Li, Yong-Hua/0000-0003-0005-3789
CR ASHBY MF, 1983, METALL TRANS A, V14, P1755, DOI 10.1007/BF02645546
   Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   CARTER DR, 1976, SCIENCE, V194, P1174, DOI 10.1126/science.996549
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   GIBSON LJ, 1989, MAT SCI ENG A-STRUCT, V110, P1, DOI 10.1016/0921-5093(89)90154-8
   GJUNTER VE, 2000, DELAY LAW NEW CLASS, P11
   HENCH LL, 1982, BIOMATERIALS INTERFA, P100
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li BY, 2000, INTERMETALLICS, V8, P881, DOI 10.1016/S0966-9795(00)00024-8
   Li BY, 2000, METALL MATER TRANS A, V31, P1867, DOI 10.1007/s11661-006-0242-4
   Li BY, 1998, J MATER RES, V13, P2847, DOI 10.1557/JMR.1998.0389
   Li BY, 2000, MAT SCI ENG A-STRUCT, V281, P169, DOI 10.1016/S0921-5093(99)00729-7
   Li BY, 1998, MAT SCI ENG A-STRUCT, V255, P70, DOI 10.1016/S0921-5093(98)00780-1
   Li BY, 2000, J MATER RES, V15, P10, DOI 10.1557/JMR.2000.0004
   Li BY, 2001, SCRIPTA MATER, V44, P823, DOI 10.1016/S1359-6462(00)00653-9
   Li BY, 2000, INTERMETALLICS, V8, P643, DOI 10.1016/S0966-9795(99)00140-5
   Li YH, 2001, J ALLOY COMPD, V325, P259, DOI 10.1016/S0925-8388(01)01382-2
   Munir Z. A., 1989, Material Science Reports, V3, P277, DOI 10.1016/0920-2307(89)90001-7
   RATNER BD, 1996, BIOMATERIALS SCI INT, P17
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
NR 23
TC 51
Z9 53
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD OCT 28
PY 2002
VL 345
IS 1-2
BP 271
EP 274
AR PII S0925-8388(02)00412-7
DI 10.1016/S0925-8388(02)00412-7
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 609EZ
UT WOS:000178891800045
DA 2018-10-20
ER

PT J
AU Foo, CWP
   Kaplan, DL
AF Foo, CWP
   Kaplan, DL
TI Genetic engineering of fibrous proteins: spider dragline silk and
   collagen
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE spider dragline silk; collagen; genetic engineering; fibrous proteins;
   biomaterials
ID HUMAN PROLYL 4-HYDROXYLASE; BACULOVIRUS EXPRESSION SYSTEM;
   DISULFIDE-ISOMERASE SUBUNIT; YEAST PICHIA-PASTORIS; NEPHILA-CLAVIPES;
   ALPHA-SUBUNIT; BETA-SUBUNIT; TRANSGENIC MICE; I PROCOLLAGEN; REQUIRES
   COEXPRESSION
AB Various strategies have been employed to genetically engineer fibrous proteins. Two examples, the subject of this review, include spider dragline silk from Nephila clavipes and collagen. These proteins are highlighted because of their unique mechanical and biological properties related to controlled release, biomaterials and tissue engineering. Cloning and expression of native genes and synthetic artificial variants of the consensus sequence repeats from the native genes has been accomplished. Expression of recombinant silk and collagen proteins has been reported in a variety of host systems, including bacteria, yeast, insect cells, plants and mammalian cells. Future utility for these proteins for biomedical materials is expected to increase as needs expand for designer materials with tailored mechanical properties and biological interactions to elicit specific responses in vitro and in vivo. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA.
   Tufts Univ, Ctr Bioengn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biol & Chem Engn, 4 Colby St, Medford, MA 02155 USA.
FU NIAMS NIH HHS [R01 AR46563-01]; NIDCR NIH HHS [R01 DE13405-01]
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ALTMAN GH, 2001, FASEB J, V16, P270
   ALTMAN GH, 2001, FASEB J, V10, P1096
   Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   BECKWITT R, 1994, J BIOL CHEM, V269, P6661
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   CAPPELLO J, 1990, TRENDS BIOTECHNOL, V8, P309, DOI 10.1016/0167-7799(90)90207-E
   Cappello J., 1992, CURR OPIN STRUC BIOL, V2, P582
   Colman A, 1998, Biochem Soc Symp, V63, P141
   CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905
   CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Denny M.W., 1980, MECH PROPERTIES BIOL, P247
   ELSON ML, 1993, DERMATOL CLIN, V11, P361, DOI 10.1016/S0733-8635(18)30274-2
   EYRE DR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P119
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083
   FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8
   Fukushima Y, 1998, BIOPOLYMERS, V45, P269, DOI 10.1002/(SICI)1097-0282(19980405)45:4<269::AID-BIP1>3.0.CO;2-J
   GELMAN RA, 1979, J BIOL CHEM, V254, P180
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   HELAAKOSKI T, 1989, P NATL ACAD SCI USA, V86, P4392, DOI 10.1073/pnas.86.12.4392
   HELAAKOSKI T, 1995, P NATL ACAD SCI USA, V92, P4427, DOI 10.1073/pnas.92.10.4427
   Heslot H, 1998, BIOCHIMIE, V80, P19, DOI 10.1016/S0300-9084(98)80053-9
   Hinman M B, 1994, SILK POLYM MAT SCI B, P222
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Hood EE, 1999, CURR OPIN BIOTECH, V10, P382, DOI 10.1016/S0958-1669(99)80069-X
   JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KADLER KE, 1995, PROTEIN PROFILES EXT, V1
   KAPLAN D, 1994, ACS S SERIES, V544
   Kaplan D. L., 1998, PROTEIN BASED MAT
   KAPLAN DL, 1992, MATER RES SOC S P, V255, P19
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   Kielty Cay M., 1993, P103
   Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9
   KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245
   KIVIRIKKO KI, 1989, FASEB J, V3, P1609
   Kivirikko KI, 1992, POSTTRANSLATIONAL MO, P1
   KOIVU J, 1987, J BIOL CHEM, V262, P6447
   Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lees JF, 1997, EMBO J, V16, P908, DOI 10.1093/emboj/16.5.908
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Mayne R, 1993, CURR OPIN CELL BIOL, V5, P883, DOI 10.1016/0955-0674(93)90039-S
   Mazzorana M, 1996, J BIOL CHEM, V271, P29003, DOI 10.1074/jbc.271.46.29003
   MELLO CM, 1994, ACS SYM SER, V544, P67
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Paleyanda RK, 1997, NAT BIOTECHNOL, V15, P971, DOI 10.1038/nbt1097-971
   PIHLAJANIEMI T, 1995, PROG NUCLEIC ACID RE, V50, P225, DOI 10.1016/S0079-6603(08)60816-8
   PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Prunkard D, 1996, NAT BIOTECHNOL, V14, P867, DOI 10.1038/nbt0796-867
   RIELSE J, 1998, J CELL BIOCHEM, V71, P313
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   Ruszczak Z, 1999, DERMATOLOGY, V199, P285, DOI 10.1159/000018305
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sezutsu H, 2000, J MOL EVOL, V51, P329, DOI 10.1007/s002390010095
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   STINSON SC, 1990, CHEM ENG, P26
   Stromqvist M, 1996, TRANSGENIC RES, V5, P475
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   TILLINGHAST EK, 1977, J EXP ZOOL, V202, P213, DOI 10.1002/jez.1402020210
   Tirrell DA, 1991, CURR OPIN STRUC BIOL, V1, P638, DOI 10.1016/S0959-440X(05)80089-2
   Toman PD, 1999, TRANSGENIC RES, V8, P415, DOI 10.1023/A:1008959924856
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   VANDERREST M, 1993, CURR OPIN STRUC BIOL, V3, P430, DOI 10.1016/S0959-440X(05)80117-4
   VANDERREST M, 1991, FASEB J, V5, P2814
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467
   WALLACE DG, 1983, BIOPOLYMERS, V25, P1793
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   Winkler S., 2000, REV MOL BIOTECHNOL, V74, P85
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou YT, 2001, BIOMACROMOLECULES, V2, P111, DOI 10.1021/bm005598h
NR 97
TC 109
Z9 114
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD OCT 18
PY 2002
VL 54
IS 8
BP 1131
EP 1143
AR PII S0169-409X(02)00061-3
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 615QC
UT WOS:000179257000006
PM 12384311
DA 2018-10-20
ER

PT J
AU Govorun, VM
   Archakov, AI
AF Govorun, VM
   Archakov, AI
TI Proteomic technologies in modern biomedical science
SO BIOCHEMISTRY-MOSCOW
LA English
DT Review
DE proteomics; biotechnology; electrophoresis; chromatography; protein chip
ID IMMOBILIZED PH GRADIENTS; 2-DIMENSIONAL GEL-ELECTROPHORESIS; COMPLEX
   PROTEIN MIXTURES; DESORPTION/IONIZATION MASS-SPECTROMETRY; BIOMOLECULAR
   INTERACTION ANALYSIS; ESCHERICHIA-COLI PROTEOME;
   SACCHAROMYCES-CEREVISIAE; POLYACRYLAMIDE GELS; IDENTIFICATION
   TECHNOLOGY; MEMBRANE-PROTEINS
AB This review highlights modern technologies employed in proteomics. Methods of sample preparations are discussed with special emphasis on the requirements for preparation of biological material, which may seriously influence the results of proteomic studies. Methods of solubilization, electrophoresis, chromatographic protein separation, and visualization of protein spots in gels are described. Modern methods of mass spectrometry used in proteomic studies include combination of protein chips with mass spectrometry. The review also describes approaches of functional proteomics, i.e., interactomics, and also bioinformatic resources used in proteomics for image analysis of 2D-gel-electrophoresis and for identification of protein sequences by mass spectra.
C1 Russian Acad Med Sci, Orekhovich Inst Biomed Chem, Moscow 119992, Russia.
   Minist Hlth Russian Federat, Inst Physicochem Med, Moscow 119992, Russia.
RP Govorun, VM (reprint author), Russian Acad Med Sci, Orekhovich Inst Biomed Chem, Pogodinskaya Ul 10, Moscow 119992, Russia.
RI Archakov, Alexander/B-5194-2012
CR Adam BL, 2001, PROTEOMICS, V1, P1264, DOI 10.1002/1615-9861(200110)1:10<1264::AID-PROT1264>3.0.CO;2-R
   Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h
   Andersen JS, 2000, FEBS LETT, V480, P25, DOI 10.1016/S0014-5793(00)01773-7
   ANDERSON NG, 1982, CLIN CHEM, V28, P739
   ANDERSON NG, 1978, ANAL BIOCHEM, V85, P331, DOI 10.1016/0003-2697(78)90229-4
   Anderson NL, 2000, CURR OPIN BIOTECH, V11, P408, DOI 10.1016/S0958-1669(00)00118-X
   Appel RD, 1997, ELECTROPHORESIS, V18, P2735, DOI 10.1002/elps.1150181507
   Appel RD, 1996, ELECTROPHORESIS, V17, P540, DOI 10.1002/elps.1150170324
   Bilban Martin, 2002, Current Issues in Molecular Biology, V4, P57
   BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6
   Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1
   BOLON P, 2002, PROT PEPT ARR PITF P
   Buttner K, 2001, ELECTROPHORESIS, V22, P2908, DOI 10.1002/1522-2683(200108)22:14<2908::AID-ELPS2908>3.0.CO;2-M
   Cahill DJ, 2001, J IMMUNOL METHODS, V250, P81, DOI 10.1016/S0022-1759(01)00325-8
   Champion KM, 2001, PROTEOMICS, V1, P1133, DOI 10.1002/1615-9861(200109)1:9<1133::AID-PROT1133>3.3.CO;2-J
   Chaurand P, 1999, J AM SOC MASS SPECTR, V10, P91, DOI 10.1016/S1044-0305(98)00145-7
   Costa P, 1999, ELECTROPHORESIS, V20, P1098, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<1098::AID-ELPS1098>3.3.CO;2-Q
   DUNN MJ, 1993, GEL ELECTROPHORESIS
   EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998
   FENN JB, 1990, MASS SPECTROM REV, V9, P37, DOI 10.1002/mas.1280090103
   FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97
   Futcher B, 1999, MOL CELL BIOL, V19, P7357
   Garrels JI, 1997, ELECTROPHORESIS, V18, P1347, DOI 10.1002/elps.1150180810
   Gevaert K, 2000, ELECTROPHORESIS, V21, P1145, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1145::AID-ELPS1145>3.0.CO;2-Z
   GORG A, 1980, J BIOCHEM BIOPH METH, V3, P273, DOI 10.1016/0165-022X(80)90008-1
   GORG A, 1993, BIOCHEM SOC T, V21, P130
   GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913
   GORG A, 1991, ELECTROPHORESIS, V12, P653, DOI 10.1002/elps.1150120910
   GREEN DM, 1966, SIGNAL DETECTION THE
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720
   Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797
   Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690
   GYGI SP, 2000, USING MASS SPECTROME, P31
   He MY, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e73
   Herbert B, 2000, ELECTROPHORESIS, V21, P3639, DOI 10.1002/1522-2683(200011)21:17<3639::AID-ELPS3639>3.0.CO;2-V
   Herbert BR, 1998, ELECTROPHORESIS, V19, P845, DOI 10.1002/elps.1150190540
   Herbert BR, 2001, TRENDS BIOTECHNOL, V19, pS3, DOI 10.1016/S0167-7799(01)01796-6
   HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193
   HumpherySmith I, 1997, ELECTROPHORESIS, V18, P1217, DOI 10.1002/elps.1150180804
   Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498
   Jones MB, 2002, PROTEOMICS, V2, P76, DOI 10.1002/1615-9861(200201)2:1<76::AID-PROT76>3.0.CO;2-O
   Jonscher KR, 1997, ANAL BIOCHEM, V244, P1, DOI 10.1006/abio.1996.9877
   KAMO M, 1995, ELECTROPHORESIS, V16, P423, DOI 10.1002/elps.1150160169
   Knezevic V, 2001, PROTEOMICS, V1, P1271, DOI 10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.3.CO;2-Y
   Kussmann M, 2000, METH MOL B, V146, P405, DOI 10.1385/1-59259-045-4:405
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lemkin PF, 1997, ELECTROPHORESIS, V18, P2759, DOI 10.1002/elps.1150181510
   Link AJ, 1999, NAT BIOTECHNOL, V17, P676
   LINK AJ, 1999, 2D PROTEOME ANAL PRO
   MACLAREN JA, 1971, TEXT RES J, V41, P713, DOI 10.1177/004051757104100819
   Malmqvist M, 1997, CURR OPIN CHEM BIOL, V1, P378, DOI 10.1016/S1367-5931(97)80077-4
   MATSUI NM, 1999, 2D PROTEOME ANAL PRO, P211
   Mirgorodskaya OA, 2000, RAPID COMMUN MASS SP, V14, P1226, DOI 10.1002/1097-0231(20000730)14:14<1226::AID-RCM14>3.0.CO;2-V
   Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x
   Molloy MP, 2000, ANAL BIOCHEM, V280, P1, DOI 10.1006/abio.2000.4514
   Moseley MA, 2001, TRENDS BIOTECHNOL, V19, pS10, DOI 10.1016/S0167-7799(01)01793-0
   Natsume T, 2001, TRENDS BIOTECHNOL, V19, pS28, DOI 10.1016/S0167-7799(01)01797-8
   NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5
   NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603
   Nordhoff E, 2001, ELECTROPHORESIS, V22, P2844, DOI 10.1002/1522-2683(200108)22:14<2844::AID-ELPS2844>3.3.CO;2-Z
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104
   PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T
   Pasquali C, 1997, ELECTROPHORESIS, V18, P2573, DOI 10.1002/elps.1150181413
   PERDEW GH, 1983, ANAL BIOCHEM, V135, P453, DOI 10.1016/0003-2697(83)90711-X
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Perrot M, 1999, ELECTROPHORESIS, V20, P2280, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2280::AID-ELPS2280>3.3.CO;2-H
   PETERSOHN A, 2001, J BACTERIOL, V183, P1517
   Pleissner Klaus-Peter, 2001, P131
   Qin J, 1997, ANAL CHEM, V69, P4002, DOI 10.1021/ac970489n
   Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303
   Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615
   Roepstorff P, 2000, EXS, V88, P81
   Ruegg U T, 1977, Methods Enzymol, V47, P111
   Santoni V, 1998, PLANT J, V16, P633, DOI 10.1046/j.1365-313x.1998.00335.x
   Santoni V, 1999, ELECTROPHORESIS, V20, P705, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<705::AID-ELPS705>3.3.CO;2-H
   Service RF, 2000, SCIENCE, V287, P2136, DOI 10.1126/science.287.5461.2136
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Smilansky Z, 2001, ELECTROPHORESIS, V22, P1616, DOI 10.1002/1522-2683(200105)22:9<1616::AID-ELPS1616>3.0.CO;2-Z
   Spengler B, 1997, J MASS SPECTROM, V32, P1019, DOI 10.1002/(SICI)1096-9888(199711)32:10<1019::AID-JMS595>3.0.CO;2-G
   SZABO A, 1995, CURR OPIN STRUC BIOL, V5, P699, DOI 10.1016/0959-440X(95)80064-6
   Taylor JA, 1996, RAPID COMMUN MASS SP, V10, P679, DOI 10.1002/(SICI)1097-0231(199604)10:6<679::AID-RCM528>3.0.CO;2-Q
   Tonella L, 2001, PROTEOMICS, V1, P409, DOI 10.1002/1615-9861(200103)1:3<409::AID-PROT409>3.0.CO;2-M
   Twerenbold D, 2001, PROTEOMICS, V1, P66, DOI 10.1002/1615-9861(200101)1:1<66::AID-PROT66>3.0.CO;2-S
   Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009
   Veeser S, 2001, PROTEOMICS, V1, P856
   Vlahou A, 2001, AM J PATHOL, V158, P1491, DOI 10.1016/S0002-9440(10)64100-4
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   WASINGER VC, 1995, ELECTROPHORESIS, V16, P1090, DOI 10.1002/elps.11501601185
   WESTERMEIER R, 2001, P PROT FOR 2001 TU M, P53
   Wilkins MR, 1998, ELECTROPHORESIS, V19, P3199, DOI 10.1002/elps.1150191824
   Wilkins MR, 1997, PROTEOME RES NEW FRO
   Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519
   Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e
   Wright GL, 1999, PROSTATE CANCER P D, V2, P264
   Wulfkuhle JD, 2001, PROTEOMICS, V1, P1205, DOI 10.1002/1615-9861(200110)1:10<1205::AID-PROT1205>3.3.CO;2-O
   Yan JX, 2000, ELECTROPHORESIS, V21, P3657, DOI 10.1002/1522-2683(200011)21:17<3657::AID-ELPS3657>3.0.CO;2-2
   Yates Jr, 2000, METH MOL B, V146, P17, DOI 10.1385/1-59259-045-4:17
   Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o
NR 99
TC 39
Z9 48
U1 0
U2 4
PU MAIK NAUKA/INTERPERIODICA
PI NEW YORK
PA C/O KLUWER ACADEMIC-PLENUM PUBLISHERS, 233 SPRING ST, NEW YORK, NY
   10013-1578 USA
SN 0006-2979
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD OCT
PY 2002
VL 67
IS 10
BP 1109
EP 1123
DI 10.1023/A:1020959106412
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 620AH
UT WOS:000179510200008
PM 12460109
DA 2018-10-20
ER

PT J
AU Davis, DH
   Giannoulis, CS
   Johnson, RW
   Desai, TA
AF Davis, DH
   Giannoulis, CS
   Johnson, RW
   Desai, TA
TI Immobilization of RGD to < 111 > silicon surfaces for enhanced cell
   adhesion and proliferation
SO BIOMATERIALS
LA English
DT Article
DE RGD peptide; surface rnodification; silicon; cell adhesion; cell
   proliferation; biocompatibility
ID AFFINITY LIGANDS; ATTACHMENT; PEPTIDE; PROTEINS
AB The ability of biomaterial surfaces to regulate cell behavior requires control over surface chemistry and microstructure. One of the greatest challenges with silicon-based biomedical microdevices such as those recently developed for neural stimulation, implantable encapsulation, biosensors. and drug delivery, is to improve biocompatibility and tissue integration. This may be achieved by modifying the exposed silicon surface with bioactive peptides. In this study. Arg-Gly Asp (RGD) peptide conjugated surfaces were prepared and characterized, The effect of these Surfaces on fibroblast adhesion and proliferation was examined over 4 days. Silicon surfaces coupled with a synthetic RGD peptide, as characterized with X-ray photoelectron spectroscopy and atomic force microscopy, display enhanced cell proliferation and bioactivity. Results demonstrate an almost three-fold greater cell attachment/proliferation on RGD immobilized surfaces compared to unmodified (control) silicon surfaces. Modulating the biological response of inorganic materials such as silicon will allow Lis to design more appropriate interfaces for implantable diagnostic and therapeutic silicon-based microdevices. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Abbott Labs, Abbott Pk, IL 60064 USA.
   Univ Illinois, Coll Engn, Dept Bioengn MC 063, Chicago, IL 60607 USA.
RP Desai, TA (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
RI Zhou, Feng/E-9510-2011
CR Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   CUATRECASAS P, 1971, ANNU REV BIOCHEM, V40, P259, DOI 10.1146/annurev.bi.40.070171.001355
   Desai TA, 2000, BIOMOL ENG, V17, P23, DOI 10.1016/S1389-0344(00)00063-0
   FALB RD, 1971, FED PROC, V30, P1688
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HOFFMAN A S, 1992, Clinical Materials, V11, P61, DOI 10.1016/0267-6605(92)90030-W
   KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391
   LEE T, 1994, PSYCHOL CRIME LAW, V1, P11, DOI 10.1080/10683169408411932
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   MANDENIUS CF, 1984, ANAL BIOCHEM, V137, P106, DOI 10.1016/0003-2697(84)90354-3
   MAOZ R, 1988, J CHIM PHYS PCB, V85, P1059, DOI 10.1051/jcp/1988851059
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RASMUSSEN JR, 1977, J AM CHEM SOC, V99, P4736, DOI 10.1021/ja00456a035
   Ratner BD, 1997, SURFACE MODIFICATION OF POLYMERIC BIOMATERIALS, P1
   Ratner BD, 1996, BIOMATERIALS SCI INT, P105
   SUGAWARA T, 1995, J BIOMED MATER RES, V29, P1047, DOI 10.1002/jbm.820290904
   WEIGEL PH, 1979, J BIOL CHEM, V254, P830
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 23
TC 80
Z9 87
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2002
VL 23
IS 19
BP 4019
EP 4027
AR PII S0142-9612(02)00152-7
DI 10.1016/S0142-9612(02)00152-7
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 577ZV
UT WOS:000177093700012
PM 12162335
DA 2018-10-20
ER

PT J
AU Lachmann, PJ
AF Lachmann, PJ
TI Stem cell therapy: medical advance or moral challenge?
SO COMPTES RENDUS BIOLOGIES
LA English
DT Article
DE stem cells; disease; moral
AB My professional lifetime has seen progress in the biomedical sciences that beggars belief. This has lead to astonishing advances in the ability to prevent and treat disease and, in the developed world at least, people live longer and healthier lives than ever before. Paradoxically, this has gone hand in hand with the growth of a vocal and influential anti-science lobby that not only rejects much modern science-but is also deeply suspicious of new medical interventions. The prospect of cell therapy in the near or middle future is their current target especially where the use of embryonic stem cells or of cell nuclear transfer techniques is concerned. The prospect of cell therapy is welcomed with enthusiasm by patients with genetic and degenerative diseases who hope to benefit from them. On the other hand the whole idea is regarded as repugnant by the anti-science lobby. While some of this opposition is essentially luddite in nature, there are some more persuasive arguments raised particularly to any research than uses embryonic or foetal materials. These arguments will be examined critically. The moral problems of denying the sick the hope of effective treatments have to be weighed against those seen in the development of such treatments. (This article is closely based on an already published paper. P. Lachmann, Stem cell research: why is it regarded as a threat? An investigation of the economic and ethical arguments made against research with human embryonic stem cells. EMBO Rep. 2 (3) (2001) 165-168).
C1 Ctr Vet Sci, Microbial Immunol Grp, Cambridge CB3 0ES, England.
RP Lachmann, PJ (reprint author), Ctr Vet Sci, Microbial Immunol Grp, Madingley Rd, Cambridge CB3 0ES, England.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS CEDEX 15
PA 23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE
SN 1631-0691
J9 CR BIOL
JI C. R. Biol.
PD OCT
PY 2002
VL 325
IS 10
BP 1049
EP 1051
DI 10.1016/S1631-0691(02)01526-3
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 626GX
UT WOS:000179864400010
PM 12494503
DA 2018-10-20
ER

PT J
AU Jung, H
   Kim, HJ
   Hong, S
   Hong, JO
   Jeong, HK
   Je, JH
   Kim, BR
   Yoo, HS
AF Jung, H
   Kim, HJ
   Hong, S
   Hong, JO
   Jeong, HK
   Je, JH
   Kim, BR
   Yoo, HS
TI Computed microtomography (mu CT) with unmonochromatized synchrotron
   X-rays for cancerous human breast tissue and mouse vertebra
SO IEEE TRANSACTIONS ON NUCLEAR SCIENCE
LA English
DT Article
DE computed microtomography (mu CT); modulation transfer function (MTF);
   spatial resolution; synchrotron radiation; unmonochromatized X-ray
ID RADIATION MICROTOMOGRAPHY; PHANTOM; IMAGE
AB The use of X-ray computed microtomography (muCT) has increased in biomedical research and industrial applications. The inherited high quality of synchrotron radiation (SR) X-rays including high flux, collimation, and coherence, has been used recently to produce radiographic images with high spatial resolution and contrast. A simple and stable imaging system using an unmonochromatized SR source based on the principle of phase contrast X-ray imaging consists of a charge-coupled device (CCD) detector coupled with an optical lens system at the Pohang Light Source (PLS) 5C1 beamline. The spatial resolution of the imaging system was determined using the modulation transfer function (MTF), which was measured by step-by step calculations obtained from sharp edge images. Projection image data were obtained at 250 steps over 180 degrees of rotation with an acquisition time, depending on the imaged object materials, of 30 to 150 ms per projection image. The tomographic images were reconstructed using a simple filtered backprojection algorithm to reconstruct two-dimensional (2-D) images using projection data which may, include characteristics of beam collimation and phase contrast . Although the use of a monochromatic X-ray beam has previously demonstrated to provide high resolution and enhanced contrast, our approach uses an unmonochromatized SR X-ray beam and shows similar image capability, without the needs for sophisticated X-ray optics, in an exposure time which is significantly less, by two orders of magnitude, than that for the monochromatic SR system. The current PLS 5C1 SR imaging system can produce projection images at a spatial resolution of 8.3 mum over a field of view of about 5 nun at an exposure time of 30 ms per projection image for 1.5 x optical magnification. This study presents the results of SR muCT images of cancerous human breast tissue containing microcalcifications, mouse lumbar vertebra, and mouse coccygeal vertebra. The unmonochromatized SR muCT imaging system provides an effective means of evaluating microstructures, not only in biomedical specimens but also in inorganic samples.
C1 Yonsei Univ, Coll Med, Res Inst Radiol Sci,Project Med Sci BK21, Dept Radiol,Seodaemoon Ku, Seoul 120751, South Korea.
   Pohang Univ Sci & Technol, Pohang 790784, South Korea.
RP Jung, H (reprint author), Yonsei Univ, Coll Med, Res Inst Radiol Sci,Project Med Sci BK21, Dept Radiol,Seodaemoon Ku, Seoul 120751, South Korea.
CR Beckmann F, 1997, J COMPUT ASSIST TOMO, V21, P539, DOI 10.1097/00004728-199707000-00006
   Bonse U, 1996, PROG BIOPHYS MOL BIO, V65, P133, DOI 10.1016/S0079-6107(96)00011-9
   Dowd BA, 1999, P SOC PHOTO-OPT INS, V3772, P224, DOI 10.1117/12.363725
   Fetterly KA, 2000, MED PHYS, V27, P2669, DOI 10.1118/1.1326449
   Hwu Y, 1999, J APPL PHYS, V86, P4613, DOI 10.1063/1.371411
   HWU Y, 2001, NUCL INSTRUMENTS MET, P1294
   Kim HJ, 2001, PROC SPIE, V4320, P409, DOI 10.1117/12.430898
   Kim HJ, 2001, IEEE T NUCL SCI, V48, P837, DOI 10.1109/23.940172
   Kleuker U, 1998, PHYS MED BIOL, V43, P2911, DOI 10.1088/0031-9155/43/10/017
   Lee KH, 2002, YONSEI MED J, V43, P25, DOI 10.3349/ymj.2002.43.1.25
   Meyer RR, 2000, MICROSC RES TECHNIQ, V49, P269
   Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736
   Shimizu F, 2000, PROC SPIE, V3977, P196
   Stamatakis HC, 2000, DENTOMAXILLOFAC RAD, V29, P28, DOI 10.1038/sj.dmfr.4600497
   Takeda T, 1998, J SYNCHROTRON RADIAT, V5, P1133, DOI 10.1107/S0909049597020116
   Takeda T, 2000, RADIOLOGY, V214, P298, DOI 10.1148/radiology.214.1.r00ja08298
   Umetani K, 2000, PROC SPIE, V3977, P522, DOI 10.1117/12.384528
NR 17
TC 3
Z9 3
U1 0
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9499
J9 IEEE T NUCL SCI
JI IEEE Trans. Nucl. Sci.
PD OCT
PY 2002
VL 49
IS 5
BP 2262
EP 2267
DI 10.1109/TNS.2002.803814
PN 1
PG 6
WC Engineering, Electrical & Electronic; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA 614FH
UT WOS:000179177300036
DA 2018-10-20
ER

PT J
AU Tucker, RC
AF Tucker, RC
TI Thermal spray coatings: Broad and growing applications
SO INTERNATIONAL JOURNAL OF POWDER METALLURGY
LA English
DT Article
AB Cost effective metallic, ceramic, cermet and polymeric coatings may be deposited by thermal spraying. This article reviews the factors that must be considered in selecting the coating materials, coating process, quality issues and current applications. Thermal spray coating applications are classified here by function and industry, Primary functions served are wear and corrosion resistance, friction control, thermal resistance or conductance, thermal emission or absorption, electrical resistance or conductance, optical reflection or absorption, and catalysts. By industry, thermal spray coatings find application in aircraft gas turbine engines and non-propulsion components, metal fabrication, oil and gas production, power generation, petrochemical processes, textile machinery, automotive components, biomedical (prostheses), and the urban infrastructure (bridges).
C1 Tucker Grp LLC, Brownsburg, IN 46112 USA.
RP Tucker, RC (reprint author), Tucker Grp LLC, 61 Ridgeway Dr, Brownsburg, IN 46112 USA.
CR *AC STAT PRINT CO, 1963, MET FLAM SPRAY MAN, P1
   GAGE RM, 1962, Patent No. 3016477
   Poorman R., 1955, US Patent, Patent No. 2714563
   SMITH GH, 1958, Patent No. 2861900
NR 4
TC 8
Z9 8
U1 0
U2 3
PU AMER POWDER METALLURGY INST
PI PRINCETON
PA 105 COLLEGE ROAD EAST, PRINCETON, NJ 08540 USA
SN 0888-7462
J9 INT J POWDER METALL
JI Int. J. Powder Metall.
PD OCT
PY 2002
VL 38
IS 7
BP 45
EP 53
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 610HA
UT WOS:000178953600009
DA 2018-10-20
ER

PT J
AU Sommer, AP
   Hassinen, HI
   Kajander, EO
AF Sommer, AP
   Hassinen, HI
   Kajander, EO
TI Light-induced replication of nanobacteria: A preliminary report
SO JOURNAL OF CLINICAL LASER MEDICINE & SURGERY
LA English
DT Article
ID STONE FORMATION
AB Objective: The purpose of the present study was to investigate the effect of light on nanobacteria. Background Data: Since their first description in literature, it is not clear whether the nanoparticles called "nanobacteria" are alive or not. The 80-1000-nm-sized spherical particles are protected by a crystalline carbonate apatite shell and are culturable in cell culture media. Present in mammalians, including humans, nanobacteria seem to cause diseases related to biomineralization processes. Mesoscopic structures found on Martian meteorites and terrestrial rocks indicated that nanobacteria-like biological objects forming apatite, a material fairly transparent to visible light, could have been present on the primitive Earth during an era with the sun as the principal terrestrial energy source. Materials and Methods: To evaluate possible biomedical effects of therapeutically relevant irradiation sources on nanobacteria, we irradiated nanobacteria cultures with polarized light and laser-light at low, nonthermal energy density levels. Results: Our observations indicated that nanobacteria are alive. Polarized white light was found to clearly accelerate their replication in vitro, resulting in significant dose-dependent increases in the turbidity of the cultures, compared to nonirradiated controls. Laser irradiation did not affect their replication. Conclusion: The possibility that primordial and present nanobacteria could have been not only exposed to, but actively harvested, solar irradiation for their own development suggests itself. Considering that there exists no published material on the action of light on nanobacteria, the reported effects are expected to have an impact on modeling biomineralization processes, associated photoreceptor mechanisms, and astrobiological and evolutionary theories-on Earth and in space.
C1 Univ Ulm, Cent Inst Biomed Engn, Dept Biomat, ENSOMA Lab, D-89081 Ulm, Germany.
   Univ Kuopio, Dept Biochem, FIN-70211 Kuopio, Finland.
RP Sommer, AP (reprint author), Univ Ulm, Cent Inst Biomed Engn, Dept Biomat, ENSOMA Lab, D-89081 Ulm, Germany.
CR Abbott A, 1999, NATURE, V401, P105, DOI 10.1038/43525
   Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x
   Ciftcioglu N, 2002, ANTIMICROB AGENTS CH, V46, P2077, DOI 10.1128/AAC.46.7.2007-2086.2002
   CIFTCIOGLU N, 1998, PATHOPHYSIOLOGY, V4, P259
   HARVIMA R, 2001, MIN KUOP FINL
   Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x
   Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796
   Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274
   SOMMER A, 1995, BIOMED TECH, V40, P133, DOI 10.1515/bmte.1995.40.5.133
   Sommer AP, 2001, J CLIN LASER MED SUR, V19, P29, DOI 10.1089/104454701750066910
   SOMMER AP, 2001, J CLIN LASER MED SUR, V19, P109
   SOMMER AP, UNPUB ADDED HUMAN BL
NR 12
TC 21
Z9 22
U1 1
U2 2
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1044-5471
J9 J CLIN LASER MED SUR
JI J. Clin. Laser Med. Sur.
PD OCT
PY 2002
VL 20
IS 5
BP 241
EP 244
DI 10.1089/10445470260420731
PG 4
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA 608YP
UT WOS:000178876000002
PM 12470452
DA 2018-10-20
ER

PT J
AU Naraghi, K
   Sahli, N
   Belbachir, M
   Franta, E
   Lutz, PJ
AF Naraghi, K
   Sahli, N
   Belbachir, M
   Franta, E
   Lutz, PJ
TI Structured degradable poly(ether) hydrogels based on linear bifunctional
   macromonomers
SO POLYMER INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT Conference on Polymers in the 3rd Millennium
CY SEP 02-06, 2001
CL MONTPELLIER, FRANCE
SP Soc Chem Ind & Polymer Int, IEEE Dielectr & Electr Insulat Soc, IAE, SISM, WILEY, IEEE, DEIS
DE poly(ethylene oxide); poly(1,3-dioxolane); hydrogels; degradable;
   macromonomers; homopolymerization
ID OXIDE) MACROMONOMERS; NETWORKS; HOMOPOLYMERIZATION
AB Hydrogels based on poly(ethylene oxide) (PEO) are suitable materials for numerous biomedical applications. Among the different ways to design such hydrogels, homopolymerization of bifunctional PEO macromonomers represents a promising approach. The present work discusses the extension of this crosslinking procedure to prepare degradable hydrogels. Poly(1,3-dioxolane) (PDXL) hydrogels were synthesized directly in water (or in organic solvents) by free-radical homopolymerization of alpha,omega-methacryloyloxy PDXL macromonomers. They were investigated as gels swollen to equilibrium in THF CH2Cl2 or in water. In each case, the amount of extractable material, the extent of equilibrium swelling and the uniaxial compression modulus were determined. Nethertheless, PDXL chains contain acetal groups sensitive to acidic degradation. Hydrogels constituted of hydrophilic poly(ethylene oxide) (PEO) chains containing a short central PDXL block were obtained from a,w-methacryloyloxy PEO-block-1,3-PDXL-block-PEO macromonomers. The variation of the mechanical properties of pure PDXL networks, when placed in acidic media, was followed by uniaxial compression modulus measurements. (C) 2002 Society of Chemical Industry.
C1 Inst Charles Sadron, CNRS, UPR 22, F-67083 Strasbourg, France.
   Univ Oran, Lab Chim Polymeres, Oran, Algeria.
RP Lutz, PJ (reprint author), Inst Charles Sadron, CNRS, UPR 22, 6 Rue Boussingault, F-67083 Strasbourg, France.
EM lutz@ics.u-strasbg.fr
CR BAILEY FE, 1976, POLYETHYLENE OXDIE
   Carrot G, 1998, POLYM BULL, V40, P181, DOI 10.1007/s002890050240
   DUBROVSKII SA, 1999, POLYM SCI SER A+, V41, P1062
   DUPREZ FE, 1999, AMPHIPHILIC MULTICOM
   FRANTA E, 1990, MAKROMOL CHEM-M SYMP, V32, P169, DOI 10.1002/masy.19900320115
   FRANTA E, 1990, MAKROMOL CHEM, V191, P1689
   GNANOU Y, 1987, MAKROMOL CHEM, V188, P2111
   GOETHALS EJ, 1993, J MACROMOL SCI PURE, VA30, P679, DOI 10.1080/10601329308021254
   GRAHAM NB, 1987, HYDROGELS MED PHARM
   Harris M.J, 1992, POLYETHYLENE GLYCOL
   Hild G, 1998, PROG POLYM SCI, V23, P1019, DOI 10.1016/S0079-6700(97)00055-5
   ITO K, 1991, MACROMOLECULES, V24, P3977, DOI 10.1021/ma00014a001
   KUMPANENKO EN, 1970, J POLYM SCI A1, V8, P2375, DOI 10.1002/pol.1970.150080906
   LEADER GR, 1973, ANAL CHEM, V45, P1700, DOI 10.1021/ac60331a029
   Lutz PJ, 2001, MACROMOL SYMP, V164, P277, DOI 10.1002/1521-3900(200102)164:1<277::AID-MASY277>3.0.CO;2-E
   NORMANT H, 1960, B SOC CHIM FR, P354
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   SCHMITT B, 1995, MACROMOL SYMP, V93, P117, DOI 10.1002/masy.19950930116
   WEISS P, 1977, MAKROMOL CHEM, V141, P145
   Zhang J, 2000, MACROMOLECULES, V33, P102, DOI 10.1021/ma991398q
NR 20
TC 12
Z9 12
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD OCT
PY 2002
VL 51
IS 10
BP 912
EP 922
DI 10.1002/pi.898
PG 11
WC Polymer Science
SC Polymer Science
GA 612YN
UT WOS:000179103200014
DA 2018-10-20
ER

PT J
AU Ulanski, P
   Janik, I
   Kadlubowski, S
   Kozicki, M
   Kujawa, P
   Pietrzak, M
   Stasica, P
   Rosiak, JM
AF Ulanski, P
   Janik, I
   Kadlubowski, S
   Kozicki, M
   Kujawa, P
   Pietrzak, M
   Stasica, P
   Rosiak, JM
TI Polymeric biomaterials synthesized by radiation techniques - Current
   studies at IARC, Poland
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Polymers for Advanced Technologies
CY SEP 02-06, 2001
CL ELAT, ISRAEL
SP ACS, EPF, Israel Chem & Polymer & Plast Soc, Japan Chem & Polymer Soc
DE biomaterial; hydrogel; implant; drug delivery; ionizing radiation
ID INDUCED CROSS-LINKING; AQUEOUS-SOLUTION; POLY(VINYL METHYL-ETHER);
   PULSE-RADIOLYSIS; IRRADIATION; HYDROGELS; CHITOSAN; ALCOHOL); NANOGELS;
   PRODUCT
AB For over 15 years the Institute of Applied Radiation Chemistry in Lodz, Poland, has been involved in studies on new polymeric biomaterials. Some of the technologies developed employ radiation techniques for the synthesis Of crosslinked products (mainly hydrogels), for surface modification and for sterilization. An example of a mature technology of this kind is hydrogel wound dressings, now being produced on a large scale and available on the market in many Central European countries. Another advanced project is a hydrogel system for healing endometrium cancer by precise, local drug delivery. Preliminary clinical tests with over 70 patients have been completed with very good results.
   Current research projects, besides further development of the above mentioned systems, include: a hydrogel-based system for local, controlled drug delivery, polymer materials for encapsulation of living cells and for the construction of hybrid artificial organs, a new approach to the synthesis of polymeric material for intervertebral disc implant, temperature-sensitive membranes and supports for cell cultures; hydrogel phantoms for low-dose, three-dimensional radiation dosimetry; degradation-resistant nanogels and microgels for biomedical purposes (e.g. synovial fluid substitute); hydrogel-based dietary products and adjustment of the molecular weight of biopolymers by ultrasound and ionizing radiation. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Tech Univ Lodz, Inst Appl Radiat Chem, PL-93590 Lodz, Poland.
RP Ulanski, P (reprint author), Tech Univ Lodz, Inst Appl Radiat Chem, Wroblewskiego 15, PL-93590 Lodz, Poland.
EM ulanskip@mitr.p.lodz.pl
RI Ulanski, Piotr/S-9103-2018; Sanguansri, Luz/B-6630-2011; Kujawa,
   Piotr/D-5142-2013; Kozicki, Marek/M-2744-2018
OI Ulanski, Piotr/0000-0002-4310-3574; Sanguansri, Luz/0000-0003-1908-7604;
   Kozicki, Marek/0000-0002-8396-4344; Kadlubowski,
   Slawomir/0000-0003-0648-5208
CR Charlesby A, 1960, ATOMIC RAD POLYM
   Darwis D, 2002, RADIAT PHYS CHEM, V63, P539, DOI 10.1016/S0969-806X(01)00636-3
   DeRossi D., 1991, POLYM GELS FUNDAMENT
   Funke W, 1998, ADV POLYM SCI, V136, P139
   Gebelein C. G., 1994, BIOTECHNOLOGY BIOACT
   Goosen M. F. A., 1997, APPL CHITIN CHITOSAN
   GORE JC, 1984, PHYS MED BIOL, V29, P1189, DOI 10.1088/0031-9155/29/10/002
   HIRASA O, 1986, KOBUNSHI, V35, P1100
   Janik I, 2000, J CHEM SOC PERK T 2, P2041, DOI 10.1039/b004777p
   KOLODZIEJCZYK M, 2001, 9 BRG WORKSH 62 ICB
   Kozicki M, 2002, RADIAT PHYS CHEM, V65, P133, DOI 10.1016/S0969-806X(02)00209-8
   Kozicki M, 1999, ENG BIOMATER, V2, P11
   KUJAWA P, 1997, 6 INT WORKSH BIOENC
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MAEDA H, 1994, J POLYM SCI POL PHYS, V32, P91, DOI 10.1002/polb.1994.090320112
   MARYANSKI MJ, 1993, MAGN RESON IMAGING, V11, P253, DOI 10.1016/0730-725X(93)90030-H
   MUZZARELLI RAA, 1977, CHITIN
   PARK JB, 1992, BIOMATERIALS INTRO
   Peppas N. A., 1986, HYDROGELS MED PHARM, V2
   RAY CD, Patent No. 5824093
   ROSIAK J, 1992, J RADIOAN NUCL CH AR, V159, P87, DOI 10.1007/BF02041021
   ROSIAK J, 1990, RADIAT PHYS CHEM, V36, P747
   Rosiak J. M., 1989, US patent, Patent No. [US4871490, 4871490]
   ROSIAK JM, 1994, J CONTROL RELEASE, V31, P9, DOI 10.1016/0168-3659(94)90246-1
   Rosiak JM, 1999, RADIAT PHYS CHEM, V55, P139, DOI 10.1016/S0969-806X(98)00319-3
   ROSIAK JM, 1988, RADIAT PHYS CHEM, V52, P307
   ROSIAK JM, 1991, ACS S SERIES, V475, P271
   ROSIAK JM, 1996, MED SCI MONIT, V2, P78
   Sabharwal S, 1999, RADIAT PHYS CHEM, V54, P643, DOI 10.1016/S0969-806X(98)00299-0
   Schnabel W., 1981, POLYM DEGRADATION PR
   SHALABY WS, 1994, BIOMEDICAL POLYM
   SILVER F, 1989, BIOCOMPATIBILITY INT, V1
   Spohr R., 1998, New Astronomy Reviews, V42, P189, DOI 10.1016/S1387-6473(98)00004-9
   Stasica P, 2000, ENG BIOMATER, V3, P9
   Ulanski P, 1996, J CHEM SOC PERK T 2, P13, DOI 10.1039/p29960000013
   Ulanski P, 1999, NUCL INSTRUM METH B, V151, P356, DOI 10.1016/S0168-583X(99)00085-3
   Ulanski P, 1998, RADIAT PHYS CHEM, V52, P289, DOI 10.1016/S0969-806X(98)00155-8
   Ulanski P, 2000, J CHEM SOC PERK T 2, P2022, DOI 10.1039/b003952g
   ULANSKI P, 1994, MACROMOL CHEM PHYSIC, V195, P1443, DOI 10.1002/macp.1994.021950427
   Ulanski P, 2002, RADIAT PHYS CHEM, V63, P533, DOI 10.1016/S0969-806X(01)00549-7
   ULANSKI P, 1994, CHITIN WORLD, P572
   ULANSKI P, 2000, ADV CHITIN SCI, V4, P429
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Wang BL, 1997, LANGMUIR, V13, P6108, DOI 10.1021/la970599p
NR 44
TC 19
Z9 19
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD OCT-DEC
PY 2002
VL 13
IS 10-12
BP 951
EP 959
DI 10.1002/pat.249
PG 9
WC Polymer Science
SC Polymer Science
GA 640GA
UT WOS:000180679000032
DA 2018-10-20
ER

PT J
AU Iwasaki, Y
   Sawada, S
   Ishihara, K
   Khang, G
   Lee, HB
AF Iwasaki, Y
   Sawada, S
   Ishihara, K
   Khang, G
   Lee, HB
TI Reduction of surface-induced inflammatory reaction on PLGA/MPC polymer
   blend
SO BIOMATERIALS
LA English
DT Article
DE phospholipid polymer; PLGA; biocompatibility; RT-PCR; IL-1 beta
ID IMPROVED BLOOD COMPATIBILITY; MESSENGER-RNA EXPRESSION; PHOSPHOLIPID
   POLAR GROUP; RT-PCR ANALYSIS; PROTEIN-ADSORPTION; BIOMEDICAL POLYMERS;
   BIOLOGICAL RESPONSES; PLATELET-ADHESION; POLYLACTIC-ACID;
   BIOCOMPATIBILITY
AB Poly(lactide-co-glycolide) (PLGA) has been believed to be a good biocompatible material for tissue engineering due to its biodegradability and non-toxicity of the monomer. However, the inflammatory reaction of adherent cells on the surface has not been discussed sufficiently. We hypothesized that the inflammatory reaction of adherent cells on PLGA might occur and could be reduced by blending a 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer (PMEH) with the PLGA. PLGA/PMEH blend membranes were prepared by a solvent evaporation technique. The thermal properties of the PLGA/PMEH membrane were determined using a differential scanning calorimeter. The glass transition temperature of the PLGA/PMEH membranes was slightly decreased compared to that of a PLGA membrane. X-ray photoelectron spectrum analysis revealed that the MPC unit was exposed on the PLGA/PMEH membrane and that the surface concentration of the MPC unit on the membrane was increased with an increase in the concentration of the PMEH in the blended membrane. NIH-3T3 mouse fibroblast cells were cultured on the PLGA/PMEH membrane for 2 days. The number of adherent cells on the PLGA/PMEH membrane was decreased with an increase in the concentration of the PMEH. Using the RT-PCR method, the amount of an inflammatory cytokine, IL-1beta, mRNA expressed from adherent human premyelocytic leukemia cells on PLGA and PLGA/PMEH membranes were determined. On a PLGA/PMEH membrane containing 0.2 wt% of PMEH, the expression of IL-1beta mRNA was significantly lower than that on PLGA, but no difference in the number of adherent cells was found. Therefore, the MPC polymer was a useful additive for reducing the inflammatory reaction of adherent cells on PLGA. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   Univ Tokyo, Sch Engn, Dept Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   Chonbuk Natl Univ, Dept Polymer Sci & Engn, Chonju 561756, South Korea.
   Korea Res Inst Sci & Technol, Biomat Lab, Taejon 305606, South Korea.
RP Iwasaki, Y (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
RI Khang, Gilson/B-2109-2013; Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR Agrawal C.M., 1995, ENCY HDB BIOMATERI A, V2, P1055
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P851
   BRADY JM, 1973, J BIOMED MATER RES, V7, P155, DOI 10.1002/jbm.820070204
   DINARELLO CA, 1984, REV INFECT DIS, V6, P51
   FUQUA SAW, 1990, BIOTECHNIQUES, V9, P206
   Hasegawa T, 2001, BIOMATERIALS, V22, P243, DOI 10.1016/S0142-9612(00)00180-0
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1999, BIOMATERIALS, V20, P1545, DOI 10.1016/S0142-9612(99)00052-6
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Ishihara K, 1996, J BIOMED MATER RES, V32, P401, DOI 10.1002/(SICI)1097-4636(199611)32:3<401::AID-JBM13>3.0.CO;2-J
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Kato S, 1998, BIOMATERIALS, V19, P821, DOI 10.1016/S0142-9612(97)00240-8
   Khang G, 2001, KOREA POLYM J, V9, P107
   Kishida A, 1996, BIOMATERIALS, V17, P1301, DOI 10.1016/0142-9612(96)88675-3
   Lewis DH, 1990, BIODEGRADABLE POLYM, V45, P1
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Sawada S., 1999, T SOC BIOMATER, V25, P231
   Williams DF, 1979, CORROSION DEGRADATIO, P61
   Yoneyama T, 2000, ARTIF ORGANS, V24, P23, DOI 10.1046/j.1525-1594.2000.06433.x
NR 29
TC 92
Z9 93
U1 2
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2002
VL 23
IS 18
BP 3897
EP 3903
AR PII S0142-9612(02)00135-7
DI 10.1016/S0142-9612(02)00135-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 579EM
UT WOS:000177165700014
PM 12164195
DA 2018-10-20
ER

PT J
AU Zoulgami, M
   Lucas-Girot, A
   Michaud, V
   Briard, P
   Gaude, J
   Oudadesse, H
AF Zoulgami, M
   Lucas-Girot, A
   Michaud, V
   Briard, P
   Gaude, J
   Oudadesse, H
TI Synthesis and physico-chemical characterization of a
   polysialate-hydroxyapatite composite for potential biomedical
   application
SO EUROPEAN PHYSICAL JOURNAL-APPLIED PHYSICS
LA English
DT Article
ID CALCIUM-PHOSPHATE; SILICATE
AB New composite materials based on aluminosilicate materials were developed to be used in orthopaedic or maxillo-facial surgery. They are called geopolymers or polysialate-siloxo (PSS) and were studied alone or mixed with hydroxyapatite (HAP). The properties of these materials were investigated for potential use in biological or surgery applications. In this work, the chemistry involved in materials preparation was described. Samples were characterized by some physico-chemical methods like X-ray diffraction (XRD), infrared spectrometry (IR) and electron dispersion X-ray spectrometry (EDX). Results indicate that the mixing hydroxyapatite-geopolymer (PSS) leads to a neutral porous composite material with interesting physico-chemical properties. A preliminary evaluation of its cytotoxicity reveals an harmlessness towards fibroblasts. These properties allow to envisage this association as a potential biomaterial.
C1 LCSIM, Grp Cristallochim & Biomat, UMR 6511, F-35042 Rennes, France.
RP Zoulgami, M (reprint author), LCSIM, Grp Cristallochim & Biomat, UMR 6511, Bat 10B,Campus Beaulieu,263 Ave Gen Leclerc,CS 74, F-35042 Rennes, France.
OI Michaud, veronique/0000-0001-5699-740X
CR DAVIDOVITS J, 1991, J THERM ANAL, V37, P1633, DOI 10.1007/BF01912193
   de Aza PN, 2000, J MICROSC-OXFORD, V197, P60
   Deany I L, 1996, Crit Rev Oral Biol Med, V7, P134
   Ehlers E. G., 1972, INTERPRETATION GEOLO
   Elliott JC, 1994, STUDIES INORGANIC CH, V18
   HENCH LL, 1986, CIBA F SYMP, V121, P231
   Kawasaki A, 1996, J DENT, V24, P429, DOI 10.1016/0300-5712(95)00101-8
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   MacDonald SA, 2000, J NON-CRYST SOLIDS, V275, P72, DOI 10.1016/S0022-3093(00)00121-6
   MARQUET V, 1997, POROUS MAT TISSUE EN, V250
   Martens M., 1984, NATURAL LIVING BIOMA, P89
   Miyaji F, 1999, BIOMATERIALS, V20, P913, DOI 10.1016/S0142-9612(98)00235-X
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PARKES JB, 1992, BIOMATERIALS INTRO
   Shevtsova N. N., 1981, MOSCOW U CHEM BULL, V36, P117
   VANJAARSWELD JGS, 1996, MINER ENG, V10, P659
   Zoulgami M, 2001, BIOMATERIALS, V22, P1933, DOI 10.1016/S0142-9612(00)00384-7
NR 17
TC 11
Z9 11
U1 1
U2 11
PU E D P SCIENCES
PI LES ULIS CEDEXA
PA 7, AVE DU HOGGAR, PARC D ACTIVITES COURTABOEUF, BP 112, F-91944 LES ULIS
   CEDEXA, FRANCE
SN 1286-0042
J9 EUR PHYS J-APPL PHYS
JI Eur. Phys. J.-Appl. Phys
PD SEP
PY 2002
VL 19
IS 3
BP 173
EP 179
DI 10.1051/epjap:2002063
PG 7
WC Physics, Applied
SC Physics
GA 598ZA
UT WOS:000178306400003
DA 2018-10-20
ER

PT J
AU Ota, Y
   Iwashita, T
   Kasuga, T
   Abe, Y
   Seki, A
AF Ota, Y
   Iwashita, T
   Kasuga, T
   Abe, Y
   Seki, A
TI Bone formation following implantation of fibrous calcium compounds
   (beta-Ca(PO3)(2), CaCO3(aragonite)) into bone marrow
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FIBERS; CERAMICS; COMPOSITES; WHISKERS
AB Bone formation around three types of fibrous calcium-containing crystals has been examined histologically using rats. The implanted materials are (i) calcium metaphosphate (beta-Ca(PO3)(2)) fibers having aspect ratios of 15-80 with 2-20 mum in diameter, (ii) beta-Ca(PO3)(2)) fibers surface-modified using dilute NaOH and (iii) calcium carbonate (CaCO3; aragonite phase) whiskers having aspect ratios of 15-40 with 0.5-3 mum in diameter. beta-Ca(PO3)(2) fibers show a mechanically high strength with a low modulus of elasticity, and the surface-modified fibers have a thin layer consisting of a calcium orthophosphate phase. CaCO3 whiskers were used for comparison reasons. The materials were implanted for 4, 8, and 12 weeks into bone defects created in the bone marrow of rat tibiae. Cancellous bone formation was observed around beta-Ca(PO}(3))(2) fibers, the surface-modified fibers and CaCO3 whiskers after implantation for 12, 4 and 4 weeks, respectively. CaCO3 whiskers were scarcely observed after 12 weeks for resorbing. The calcium phosphate fibrous materials show combined advantages of mechanically high strength for toughening a matrix phase and biological activities; thus, these materials may prove to be useful for novel applications in the biomedical field. (C) 2002 Kluwer Academic Publishers.
C1 Yabashi Ind Co Ltd, Akasaka, Ogki 5032213, Japan.
   Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
   Chubu Univ, Coll Engn, Kasugai, Aichi 4838501, Japan.
   Mitsubishi Chem Safety Inst Ltd, Kashima Lab, Hasaki 3140255, Japan.
RP Ota, Y (reprint author), Yabashi Ind Co Ltd, 4278-1 Okubo, Akasaka, Ogki 5032213, Japan.
CR ABE Y, 1984, J AM CERAM SOC, V67, P142
   BAHSKAR SN, 1971, ORAL SURG, V32, P336
   Bonfield W., 1984, NATURAL LIVING BIOMA, P43
   DEWITH G, 1989, J MATER SCI, V24, P3411, DOI 10.1007/BF01139073
   FUJINO A, 1995, INT J OCCUP ENV HEAL, V1, P21
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   Hench L. L., 1993, INTRO BIOCERAMICS, P1
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KASUGA T, 1992, NIPPON SERAM KYO GAK, V100, P1088
   Kasuga T, 1999, J MATER RES, V14, P418, DOI 10.1557/JMR.1999.0060
   KASUGA T, 1995, J AM CERAM SOC, V78, P245
   Kasuga T, 1996, J AM CERAM SOC, V79, P1821, DOI 10.1111/j.1151-2916.1996.tb08001.x
   Kasuga T, 2000, J MATER SCI-MATER M, V11, P223, DOI 10.1023/A:1008916226079
   Knepper M, 1997, BIOMATERIALS, V18, P1523, DOI 10.1016/S0142-9612(97)00066-5
   LIN ST, 1994, BIOMATERIALS, V15, P1057, DOI 10.1016/0142-9612(94)90091-4
   NAKAJIMA S, 1988, KOBUNSHI RONBUNSHU, V45, P423, DOI 10.1295/koron.45.423
   OTA Y, 1995, J AM CERAM SOC, V78, P1983, DOI 10.1111/j.1151-2916.1995.tb08924.x
   Ota Y., 1989, U. S. Patent, Patent No. [4,824,654, 4824654]
   Park K, 1997, J MATER SCI LETT, V16, P985, DOI 10.1023/A:1018585432105
   TSUDA T, 1997, P 9 INT C OCC RESP D, P596
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
NR 21
TC 12
Z9 14
U1 0
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2002
VL 13
IS 9
BP 895
EP 900
DI 10.1023/A:1016560615112
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 578DJ
UT WOS:000177101900013
PM 15348556
DA 2018-10-20
ER

PT J
AU Hayward, SW
AF Hayward, SW
TI Approaches to modeling stromal-epithelial interactions
SO JOURNAL OF UROLOGY
LA English
DT Review
DE urogenital system; epithelium; stromal cells; gene expression;
   biomedical technology
ID UROGENITAL SINUS MESENCHYME; MOUSE PROSTATE RECONSTITUTIONS; TRACHEAL
   CELL-MIGRATION; RODENT URINARY-BLADDER; RAT VENTRAL PROSTATE;
   GENE-EXPRESSION; BRANCHING MORPHOGENESIS; IN-VITRO; INDUCED
   CARCINOGENESIS; SEMINAL-VESICLE
AB Purpose: Techniques that can be used to examine the molecular mechanisms of stromal-epithelial interactions are described.
   Materials and Methods: A historical perspective of available techniques is provided. Recent developments and examples are used to illustrate and provide descriptive literature references for these methods. Since the possibilities for manipulating experimental systems are enormous and rapidly expanding, the reader should be aware that this review is an overview of how data have been and could be obtained rather than a comprehensive listing of what has been achieved. This review focuses on studies performed in the organs of the urogenital tract to illustrate techniques that are available.
   Results: Recent technological innovations have impacted our ability to manipulate specific components and pathways of stromal-epithelial interactions. They include rapid developments in transgenic and gene knockout mouse technology, and the development of highly efficacious gene delivery and expression systems.
   Conclusions: These technologies have the potential to transform our understanding of the mechanistic basis of intercellular communication and point the way toward new therapeutic approaches for benign and malignant proliferative conditions.
C1 Vanderbilt Univ, Med Ctr, Dept Urol Surg,Prostate Canc Ctr, Dept Canc Biol,Vanderbilt Ingram Comprehens Canc, Nashville, TN 37240 USA.
RP Hayward, SW (reprint author), Vanderbilt Univ, Med Ctr, Dept Urol Surg,Prostate Canc Ctr, Dept Canc Biol,Vanderbilt Ingram Comprehens Canc, Nashville, TN 37240 USA.
OI Hayward, Simon/0000-0002-6059-6550
FU NCI NIH HHS [CA94603]; NIDDK NIH HHS [DK52721]
CR Aboseif S, 1999, DIFFERENTIATION, V65, P113, DOI 10.1046/j.1432-0436.1999.6520113.x
   ALARID ET, 1994, P NATL ACAD SCI USA, V91, P1074, DOI 10.1073/pnas.91.3.1074
   Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8
   Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325
   Bellusci S, 1997, DEVELOPMENT, V124, P4867
   Buchanan David L., 1998, Endocrinology, V139, P4345, DOI 10.1210/en.139.10.4345
   CHAPPLE CR, 1991, J UROLOGY, V146, P1637, DOI 10.1016/S0022-5347(17)38203-4
   CHUNG LWK, 1995, CANCER SURV, V23, P33
   COHEN P, 1992, J CLIN ENDOCR METAB, V75, P1046, DOI 10.1210/jcem.75.4.1383255
   Cohn MA, 2001, NUCLEIC ACIDS RES, V29, P3335, DOI 10.1093/nar/29.16.3335
   Cunha G. R., 1987, ASSESSMENT CURRENT C, P273
   CUNHA GR, 1983, J CELL BIOL, V96, P1662, DOI 10.1083/jcb.96.6.1662
   CUNHA GR, 1981, J STEROID BIOCHEM, V14, P1317, DOI 10.1016/0022-4731(81)90338-1
   CUNHA GR, 1992, J ANDROL, V13, P465
   CUNHA GR, 1980, BIOL REPROD, V22, P19, DOI 10.1095/biolreprod22.1.19
   DELBUONO R, 1992, DEVELOPMENT, V114, P67
   DONJACOUR AA, 1993, ENDOCRINOLOGY, V132, P2342, DOI 10.1210/en.132.6.2342
   Donjacour AA, 1998, DIFFERENTIATION, V62, P227, DOI 10.1046/j.1432-0436.1998.6250227.x
   FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41
   FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302
   Gao J, 2001, CANCER RES, V61, P5038
   GLASSER SR, 1988, J CELL BIOL, V107, P2409, DOI 10.1083/jcb.107.6.2409
   GLASSER SR, 1993, MICROSC RES TECHNIQ, V25, P106, DOI 10.1002/jemt.1070250204
   Habib F K, 2000, Prostate Suppl, V9, P15
   HADLEY MA, 1985, J CELL BIOL, V101, P1511, DOI 10.1083/jcb.101.4.1511
   HAFFEN K, 1987, J PEDIATR GASTR NUTR, V6, P14, DOI 10.1097/00005176-198701000-00005
   Haraguchi R, 2001, DEVELOPMENT, V128, P4241
   Haughney PC, 1998, BIOL REPROD, V59, P93, DOI 10.1095/biolreprod59.1.93
   Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x
   Hayward SW, 1997, BRIT J UROL, V79, P18, DOI 10.1111/j.1464-410X.1997.tb16917.x
   HAYWARD SW, 1992, J CELL SCI, V102, P361
   HODGES GM, 1977, CANCER RES, V37, P3720
   Hudson DL, 2000, LAB INVEST, V80, P1243, DOI 10.1038/labinvest.3780132
   JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0
   JULIAN J, 1992, ENDOCRINOLOGY, V130, P68, DOI 10.1210/en.130.1.68
   Kurita T, 2001, CELL DEATH DIFFER, V8, P192, DOI 10.1038/sj.cdd.4400797
   Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708
   Lang SH, 2000, BRIT J CANCER, V82, P990, DOI 10.1054/bjoc.1999.1029
   LANG SH, 2002, CELL GROWTH DIFFN, V12, P631
   LANGHOFER M, 1993, J CELL SCI, V105, P753
   LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136
   Lipschutz JH, 1997, PROSTATE, V32, P35
   Macintosh CA, 1998, CANCER RES, V58, P23
   MARTIKAINEN P, 1983, ANAT RECORD, V207, P279, DOI 10.1002/ar.1092070206
   McNeal J E, 1984, Prog Clin Biol Res, V145, P27
   Nemeth JA, 1999, CANCER RES, V59, P1987
   Nemeth JA, 2000, CLIN EXP METASTAS, V18, P231, DOI 10.1023/A:1006752903175
   NEUBAUER BL, 1983, J CELL BIOL, V96, P1671, DOI 10.1083/jcb.96.6.1671
   Oligino T, 1998, GENE THER, V5, P491, DOI 10.1038/sj.gt.3300612
   Olumi AF, 1999, CANCER RES, V59, P5002
   Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4
   Phillips JL, 2001, CANCER RES, V61, P8143
   REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428
   RIDDELLE KS, 1992, J CELL SCI, V103, P475
   RIDDELLE KS, 1991, J CELL BIOL, V112, P159, DOI 10.1083/jcb.112.1.159
   RonnovJessen L, 1996, PHYSIOL REV, V76, P69
   SCHOCKETT PE, 1996, P NATL ACAD SCI USA, V93, P5173
   Steers WD, 1999, EXP PHYSIOL, V84, P137, DOI 10.1111/j.1469-445X.1999.tb00079.x
   Sugimura Y, 1996, INT J DEV BIOL, V40, P941
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   THOMPSON TC, 1992, J STEROID BIOCHEM, V43, P79, DOI 10.1016/0960-0760(92)90190-T
   THOMPSON TC, 1993, MOL CARCINOGEN, V7, P165, DOI 10.1002/mc.2940070307
   THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9
   Thomson AA, 1999, DEVELOPMENT, V126, P3693
   Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0
   Wang YH, 2000, CANCER RES, V60, P6008
   Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225
   WHITE TEK, 1990, IN VITRO CELL DEV B, V26, P636
   WU XR, 1993, J CELL SCI, V106, P31
   Yang G, 1997, PROSTATE, V33, P151, DOI 10.1002/(SICI)1097-0045(19971101)33:3<151::AID-PROS1>3.0.CO;2-M
   Yang G, 1997, PROSTATE, V33, P157
   Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698
NR 72
TC 23
Z9 23
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD SEP
PY 2002
VL 168
IS 3
BP 1165
EP 1172
AR UNSP 0022-5347/02/1683-1165/0
DI 10.1097/01.ju.0000024994.97494.c9
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 585TA
UT WOS:000177539600082
PM 12187262
DA 2018-10-20
ER

PT J
AU Wang, YF
   Yan, YH
   Dai, HL
   Li, MJ
AF Wang, YF
   Yan, YH
   Dai, HL
   Li, MJ
TI Preparation of hydroxyapatite fibers by the homogeneous precipitation
   method
SO JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION
LA English
DT Article
DE hydroxyapatite fibers; homogeneous precipitation; precursor
ID FIBROUS HYDROXYAPATITE; GEL SYSTEM; GROWTH
AB This paper discussed the preparing process of hydroxyapatite fibers which were widely used as reinforcement for biomedical materials by homogeneous precipitation method. The needle-like hydroxyapatite crystals were synthesized in an aqueous system. They were transferred from, precursors-dicalcium phosphate anhydrate and octacalcium phosphate crystals. The reaction conditions were well controlled in order to obtain crystals in given morphology. The products were characterized by X-ray powder diffractometry (XRD), scanning electron microscopy (SEM) and infrared spectroscopy (IR). They were verified to be hydroxyapatite crystals with needle-like in shape.
C1 Wuhan Univ Technol, Biomed Mat & Engn Ctr, Wuhan 430070, Peoples R China.
CR AOKI H, 1992, SCI MED APPL HYDROXY, P137
   CHOUEKA A, 1995, J BIOMED MATER RES, V29, P1309
   Ito A, 1996, J CRYST GROWTH, V163, P311, DOI 10.1016/0022-0248(95)00955-8
   KAMIYA K, 1989, J MATER SCI, V24, P827, DOI 10.1007/BF01148764
   Kandori K, 1997, J AM CERAM SOC, V80, P1157
   KINOSHITA M, 1990, GYPSUM LIME, V227, P19
   READEY MJ, 1992, J AM CERAM SOC, V75, P3452, DOI 10.1111/j.1151-2916.1992.tb04448.x
   SAIDA Y, 1993, Patent No. 517110
   TANAHASHI M, 1992, J MATER SCI-MATER M, V3, P48, DOI 10.1007/BF00702944
   WOJCIECH L, 1998, J AM CERAM SOC, V81, P765
   WU MX, 1990, J AM CERAM SOC, V73, P3497, DOI 10.1111/j.1151-2916.1990.tb06483.x
NR 11
TC 5
Z9 6
U1 1
U2 9
PU JOURNAL WUHAN UNIV TECHNOLOGY
PI WUHAN
PA WUHAN UNIV TECHNOLOGY, WUHAN 430070, PEOPLES R CHINA
SN 1000-2413
J9 J WUHAN UNIV TECHNOL
JI J. Wuhan Univ. Technol.-Mat. Sci. Edit.
PD SEP
PY 2002
VL 17
IS 3
BP 39
EP 41
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 628QH
UT WOS:000180007400010
DA 2018-10-20
ER

PT J
AU Mailley, SC
   Hyland, M
   Mailley, P
   McLaughlin, JM
   McAdams, ET
AF Mailley, SC
   Hyland, M
   Mailley, P
   McLaughlin, JM
   McAdams, ET
TI Electrochemical and structural characterizations of electrodeposited
   iridium oxide thin-film electrodes applied to neuro stimulating
   electrical signal
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 3rd Maghreb/Europe Meeting on Materials and Their Applications for
   Devices and Physical, Chemical and Biological Sensors
CY OCT 29-30, 2001
CL HAMMAMET, TUNISIA
DE iridium oxide; anodically deposited IrQ(x); films; electrical nerve
   stimulation
ID SALINE; IR
AB Thin-film technology takes more and more importance in the development of biomedical devices dedicated to functional neurostimulation. Our research about the design of implantable neurostimulating electrode is oriented toward thin-film cuff electrodes based on PTFE substrate covered by a gold/iridium oxide film. A gold-sputtered film serves as adhesion layer and current collector whereas iridium oxide acts as an electrochemical actuator. The latter is obtained under galvanostatic oxidation and for various electrodeposited charge densities (from 11 to 116 mC/cm(2)). This paper deals with the design and the characterization of the iridium oxide interfaces and their in vitro application in model nonproteic electrolyte. Microstructural characterization was developed using SEM and AFM. The optimal microstructural organisation was obtained for electrodeposition charge densities from 46 to 70 mC/cm(2). The analysis of the interface electrochemical behaviour was carried out by cyclic voltammetry, impedance spectroscopy and square-wave signal. The electrode material shows redox reversible system at 0.5 V/SCE, enabling low-resistance interface and facilitating charge transfer. The optimum electrochemical properties and the optimum microstructure, regarding a biocompatible electrical stimulation, were recorded for electrodeposition charges from 46 to 70 mC/cm(2). (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Ulster, No Ireland Bioengn Ctr, Newtownabbey BT37 0QB, Antrim, North Ireland.
   CEA Grenoble, Lab Electrochim & Struct Interfaces, DRFMC S13M EMSI, F-38054 Grenoble 9, France.
RP Mailley, SC (reprint author), Univ Ulster, No Ireland Bioengn Ctr, Newtownabbey BT37 0QB, Antrim, North Ireland.
OI McLaughlin, James/0000-0001-6026-8971
CR AGNEW WF, 1986, EXP NEUROL, V92, P162, DOI 10.1016/0014-4886(86)90132-9
   ARDIZZONE S, 1981, J ELECTROANAL CHEM, V126, P287, DOI 10.1016/S0022-0728(81)80437-8
   Baur JE, 1998, J ELECTROANAL CHEM, V443, P208, DOI 10.1016/S0022-0728(97)00532-9
   BEEBE X, 1988, IEEE T BIO-MED ENG, V35, P494, DOI 10.1109/10.2122
   BIRSS V, 1984, J ELECTROCHEM SOC, V131, P1502, DOI 10.1149/1.2115881
   Blau A, 1997, BIOSENS BIOELECTRON, V12, P883, DOI 10.1016/S0956-5663(97)00017-1
   BRUMMER SB, 1977, IEEE T BIO-MED ENG, V24, P59, DOI 10.1109/TBME.1977.326218
   Frohlich R, 1996, J MATER SCI-MATER M, V7, P393, DOI 10.1007/BF00122006
   GOTTESFELD S, 1979, J ELECTROCHEM SOC, V126, P742, DOI 10.1149/1.2129131
   Hyland M, 1996, ANALYST, V121, P705, DOI 10.1039/an9962100705
   KARAM SK, 1983, J ELECTROCHEM SOC, V130, P766
   LANDOLT D, 1997, CORROSION CHIMIE SUR, V12, P90
   LEE IS, 1991, J BIOMED MATER RES, V25, P1039, DOI 10.1002/jbm.820250810
   LILLY JC, 1955, SCIENCE, V121, P468, DOI 10.1126/science.121.3144.468
   LINQUETTEMAILLE.S, UNPUB
   MAILLEY SC, 1999, UNPUB WORKSH NEUR SE
   Marzouk SAM, 1998, ANAL CHEM, V70, P5054, DOI 10.1021/ac980608e
   MCCREERY DB, 1987, IEEE T BIOMED ENG, V34
   MCHARDY J, 1980, BIOMATERIALS, V1, P129, DOI 10.1016/0142-9612(80)90034-4
   MORTON SL, 1994, J ELECTROCHEM SOC, V141, P122, DOI 10.1149/1.2054671
   Petit MA, 1998, J ELECTROANAL CHEM, V444, P247, DOI 10.1016/S0022-0728(97)00570-6
   SCHIAVONE LM, 1981, J ELECTROCHEM SOC, V128, P1339, DOI 10.1149/1.2127632
   Silva TM, 1998, ELECTROCHIM ACTA, V43, P203, DOI 10.1016/S0013-4686(97)00226-0
   WEILAND J, E COMMUNICATION
NR 24
TC 61
Z9 62
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD SEP 1
PY 2002
VL 21
IS 1-2
SI SI
BP 167
EP 175
AR PII S0928-4931(02)00098-X
DI 10.1016/S0928-4931(02)00098-X
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 592YD
UT WOS:000177963700025
DA 2018-10-20
ER

PT J
AU Nelson, RM
   Merz, JF
AF Nelson, RM
   Merz, JF
TI Voluntariness of consent for research - An empirical and conceptual
   review
SO MEDICAL CARE
LA English
DT Article; Proceedings Paper
CT Conference on Making Informed Consent Meaningful
CY MAR 07-09, 2001
CL WASHINGTON, D.C.
SP Dept Vet Affairs, Off Res & Dev
DE voluntariness; undue influence; coercion; informed consent;
   manipulation; persuasion
ID ENTER CLINICAL-TRIALS; BLIND CONTROLLED EXPERIMENT; INFORMED CONSENT;
   BREAST-CANCER; PSYCHOLOGICAL-RESEARCH; PATIENTS PERCEPTIONS; INDIVIDUAL
   AUTONOMY; BIOMEDICAL-RESEARCH; AFRICAN-AMERICANS; DECISION-MAKING
AB This article explores the vulnerability of research subjects either to undue influence or to coercion. The authors present a brief review of the requirement for voluntariness in research, and what is known about research participation. They then examine characteristics of potential subjects, researchers, researcher actions, and the research setting that can influence the voluntariness of subject's decisions to participate. Throughout the paper, empirical work that relates to voluntariness is used to illustrate the conceptual material. Voluntariness is viewed as an issue of self-control. Threats to voluntariness can arise from vulnerabilities of potential subjects as well as from characteristics of the researcher, the researcher's acts, and the research setting. Moral concerns about potential influences may be assessed by the likelihood that they will control or dominate a potential subject's decision to participate in research. Policy responses may be appropriate where the probability of control is too high.
C1 Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesia, Philadelphia, PA 19104 USA.
   Univ Penn, Childrens Hosp Philadelphia, Dept Crit Care Med, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Mol & Cellular Engn, Philadelphia, PA USA.
   Univ Penn, Ctr Bioeth, Philadelphia, PA USA.
RP Nelson, RM (reprint author), Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesia, CCM,9th Floor,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.
CR Abramovitch R, 1995, ETHICS BEHAV, V5, P25, DOI 10.1207/s15327019eb0501_3
   Aby JS, 1996, ANN ALLERG ASTHMA IM, V76, P348, DOI 10.1016/S1081-1206(10)60036-1
   Advisory Committee on Human Radiation Experiences, 1995, FIN REP ADV COMM HUM
   Albrecht TL, 1999, J CLIN ONCOL, V17, P3324, DOI 10.1200/JCO.1999.17.10.3324
   APPELBAUM PS, 1987, INFORMED CONSENT LEG
   Bigrigg A, 1999, Eur J Contracept Reprod Health Care, V4, P128
   Black H., 1979, BLACKS LAW DICT
   Bleyer WA, 1997, J ADOLESCENT HEALTH, V21, P366, DOI 10.1016/S1054-139X(97)00110-9
   Bromhead HJ, 1997, BRIT MED J, V314, P1126
   BROWN LM, 1989, J CLIN EPIDEMIOL, V42, P561
   Bucholz KK, 1996, ANN EPIDEMIOL, V6, P228, DOI 10.1016/1047-2797(96)00002-6
   CHANG RW, 1990, J BONE JOINT SURG AM, V72A, P1451, DOI 10.2106/00004623-199072100-00004
   CONSTANTINE WL, 1993, J DEV BEHAV PEDIATR, V14, P1
   Council for International Organizations of Medical Sciences, 1993, INT ETH GUID BIOM RE
   Crawley B, 1997, Ophthalmic Epidemiol, V4, P157
   DALY M, 1992, CANCER EPIDEM BIOMAR, V1, P413
   DAUGHERTY C, 1995, J CLIN ONCOL, V13, P1062, DOI 10.1200/JCO.1995.13.5.1062
   Daugherty CK, 1997, ANN INTERN MED, V126, P892, DOI 10.7326/0003-4819-126-11-199706010-00008
   DAWES PJD, 1993, J LARYNGOL OTOL, V107, P775
   DEHN TCB, 1994, BRIT MED J, V309, P126, DOI 10.1136/bmj.309.6947.126
   *DEP HHS OFF INSP, 1998, I REV BOARDS THEIR R
   *DEP HHS OFF INSP, 2000, RECR HUM SUBJ PRESS
   *DEP HHS OFF INSP, 1998, I REV BOARDS TIM REF
   Diamond Mark R, 1992, Ethics Behav, V2, P101, DOI 10.1207/s15327019eb0202_3
   DIAZ T, 1995, J ACQ IMMUN DEF SYND, V10, P562
   Du Mont J., 1996, CANADIAN J HUMAN SEX, V5, P185
   EICHENWALD K, 1999, NY TIMES        0622
   EICHENWALD K, 1999, NY TIMES        0516
   EICHENWALD K, 1999, NY TIMES        0517
   EPSTEIN LC, 1969, ARCH INTERN MED, V123, P682, DOI 10.1001/archinte.123.6.682
   Faden RR, 1996, JAMA-J AM MED ASSOC, V276, P403
   FADEN RR, 1986, HIST THEORY INFORMED
   Faden Ruth R, 1994, AIDS Public Policy J, V9, P151
   FETTING JH, 1990, J CLIN ONCOL, V8, P1476, DOI 10.1200/JCO.1990.8.9.1476
   GALLO C, 1995, LANCET, V346, P1060, DOI 10.1016/S0140-6736(95)91741-1
   GOODMAN NW, 1984, ANAESTHESIA, V39, P911, DOI 10.1111/j.1365-2044.1984.tb06582.x
   Gorelick PB, 1998, J NATL MED ASSOC, V90, P141
   GOTAY CC, 1991, SOC SCI MED, V33, P569, DOI 10.1016/0277-9536(91)90214-W
   Grant CH, 2000, HEALTH COMMUN, V12, P23, DOI 10.1207/S15327027HC1201_02
   Grilo CM, 1998, COMPR PSYCHIAT, V39, P323, DOI 10.1016/S0010-440X(98)90043-8
   Hankins C, 1998, CAN MED ASSOC J, V159, P1359
   Harris Y, 1996, J NATL MED ASSOC, V88, P630
   Hays RB, 1999, J ACQ IMMUN DEF SYND, V20, P164, DOI 10.1097/00042560-199902010-00009
   HODGES RE, 1967, JAMA-J AM MED ASSOC, V202, P177
   *HOUGHT MIFFL CO, 1991, AM HER DICT ENGL LAN
   Hudmon K S, 1999, J Cancer Educ, V14, P83
   HUNTER CP, 1987, CANCER TREAT REP, V71, P559
   Jenkins RA, 1998, J ACQ IMMUN DEF SYND, V18, P171, DOI 10.1097/00042560-199806010-00009
   Kahneman D., 1982, JUDGEMENT UNCERTAINT
   Karim QA, 1998, AM J PUBLIC HEALTH, V88, P637, DOI 10.2105/AJPH.88.4.637
   Karlawish JHT, 2001, NEUROLOGY, V56, P789, DOI 10.1212/WNL.56.6.789
   Kass NE, 1996, HASTINGS CENT REP, V26, P25, DOI 10.2307/3528467
   KETAI R, 1981, AM J PSYCHIAT, V138, P531
   KODISH E, 1995, J CLIN ONCOL, V13, P1817, DOI 10.1200/JCO.1995.13.7.1817
   Latterman Jessica, 2001, American Journal of Bioethics, V1, P45, DOI 10.1162/152651601300169040
   Lee M M, 1999, J Cancer Educ, V14, P88
   LIDZ CW, 1984, INF CONS STUD DEC PS
   LLEWELLYNTHOMAS HA, 1991, SOC SCI MED, V32, P35, DOI 10.1016/0277-9536(91)90124-U
   LOGUE G, 1995, J MED PHILOS, V20, P57, DOI 10.1093/jmp/20.1.57
   LYNOE N, 1991, BRIT MED J, V303, P610, DOI 10.1136/bmj.303.6803.610
   Marquis Don, 1989, Hypatia, V4, P140
   McCrady BS, 1999, J CONSULT CLIN PSYCH, V67, P186, DOI 10.1037//0022-006X.67.2.186
   MENGES RJ, 1973, AM PSYCHOL, V28, P1030, DOI 10.1037/h0036040
   MERZ JF, 1990, J LEGAL MED, V11, P321, DOI 10.1080/01947649009510831
   MINOGUE BP, 1995, J MED PHILOS, V20, P43, DOI 10.1093/jmp/20.1.43
   Mohanna K, 1999, BRIT J OBSTET GYNAEC, V106, P892, DOI 10.1111/j.1471-0528.1999.tb08426.x
   Morrison TC, 1997, CONTROL CLIN TRIALS, V18, P383, DOI 10.1016/S0197-2456(97)00025-1
   Morrow David J, 1996, N Y Times Web, pF10
   MORROW DJ, 1996, NY TIMES        0929, pF10
   Moser DK, 2000, NURS RES, V49, P109, DOI 10.1097/00006199-200003000-00008
   *MRC CAN, 1998, TRIC POL STAT ETH CO
   Muncie HL, 1997, J AM GERIATR SOC, V45, P929, DOI 10.1111/j.1532-5415.1997.tb02961.x
   *NAT BIOETH ADV CO, 1998, RES INV PERS MENT DI
   *NAT HLTH MRC, 1999, NAT STAT ETH COND RE
   Ondrusek N, 1998, J MED ETHICS, V24, P158, DOI 10.1136/jme.24.3.158
   Parker Lisa S, 1994, IRB, V16, P6, DOI 10.2307/3563573
   PENMAN DT, 1984, J CLIN ONCOL, V2, P849, DOI 10.1200/JCO.1984.2.7.849
   *PRES COMM STUD ET, 1982, MAK HLTH CAR DEC, V1
   RIECKEN HW, 1982, JAMA-J AM MED ASSOC, V248, P344, DOI 10.1001/jama.248.3.344
   ROBERSON NL, 1994, CANCER, V74, P2687, DOI 10.1002/1097-0142(19941101)74:9+<2687::AID-CNCR2820741817>3.0.CO;2-B
   Rogers AS, 1997, J ADOLESCENT HEALTH, V21, P374, DOI 10.1016/S1054-139X(97)00173-0
   ROSEN CE, 1978, HOSP COMMUNITY PSYCH, V29, P161
   Scheibel RS, 1998, J NEUROTRAUM, V15, P685, DOI 10.1089/neu.1998.15.685
   SCHUBERT DSP, 1984, PSYCHIAT RES, V12, P313, DOI 10.1016/0165-1781(84)90047-7
   Searight H R, 1996, J Am Board Fam Pract, V9, P14
   SHELDON JM, 1993, CANCER INVEST, V11, P57, DOI 10.3109/07357909309020261
   Shimm David S, 1992, IRB, V14, P7, DOI 10.2307/3564537
   SIMES RJ, 1986, BRIT MED J, V293, P1065, DOI 10.1136/bmj.293.6554.1065
   SIMINOFF LA, 1989, J CLIN ONCOL, V7, P1192, DOI 10.1200/JCO.1989.7.9.1192
   SMIGEL K, 1995, J NATL CANCER I, V87, P952, DOI 10.1093/jnci/87.13.952
   Snowdon C, 1999, CONTROL CLIN TRIALS, V20, P149, DOI 10.1016/S0197-2456(98)00049-X
   Stephenson J, 1997, JAMA-J AM MED ASSOC, V277, P1827, DOI 10.1001/jama.277.23.1827
   Stone VE, 1997, J GEN INTERN MED, V12, P150, DOI 10.1007/s11606-006-5022-8
   SUBPART D, 1991, ADDITIONAL DHHS PROT
   Sugarman J, 1998, J AM GERIATR SOC, V46, P517, DOI 10.1111/j.1532-5415.1998.tb02477.x
   SULMASY DP, 1994, J CLIN ETHIC, V5, P189
   SUTHERLAND HJ, 1991, SOC SCI MED, V32, P725, DOI 10.1016/0277-9536(91)90152-3
   TABAK N, 1995, CANCER NURS, V18, P89
   TAYLOR KM, 1984, NEW ENGL J MED, V310, P1363, DOI 10.1056/NEJM198405243102106
   TENNSTEDT SL, 1992, J GERONTOL, V47, pS313, DOI 10.1093/geronj/47.6.S313
   THOMPSON RA, 1990, CHILD DEV, V61, P1
   Ubel PA, 1997, J INVEST MED, V45, P561
   *US DEP HHS FOOD D, 2000, GUIDE I REV BOARDS C
   *US FOOD DRUG ADM, 1998, RECR STUD SUBJ PAYM
   *US GEN ACC OFF, 2000, VA RESEARCH PROT HUM
   Valimaki M, 1996, NURS ETHICS, V3, P329, DOI 10.1177/096973309600300406
   vandenBerg L, 1997, EUR J ANAESTH, V14, P287, DOI 10.1046/j.1365-2346.1997.00125.x
   Verheggen FWSM, 1998, PATIENT EDUC COUNS, V35, P111, DOI 10.1016/S0738-3991(98)00060-3
   WAGER E, 1995, BRIT MED J, V311, P734, DOI 10.1136/bmj.311.7007.734
   WARREN JW, 1986, NEW ENGL J MED, V315, P1124, DOI 10.1056/NEJM198610303151804
   WEINTRAUB J, 1980, J PUBLIC HEALTH DENT, V40, P141, DOI 10.1111/j.1752-7325.1980.tb01861.x
   WEISSMAN L, 1972, J CLIN PHARMACOL N D, V12, P95, DOI 10.1002/j.1552-4604.1972.tb00152.x
   Welton AJ, 1999, BRIT MED J, V318, P1114, DOI 10.1136/bmj.318.7191.1114
   Woods SW, 2000, PSYCHIATR SERV, V51, P79, DOI 10.1176/ps.51.1.79
   Workman RH, 2000, PSYCHIATR SERV, V51, P359, DOI 10.1176/appi.ps.51.3.359
   *WORLD MED ASS, 2000, ETH PRINC MED RES IN
   Wragg JA, 2000, SOC SCI MED, V51, P453, DOI 10.1016/S0277-9536(99)00477-3
   Young Daniel R, 1990, IRB, V12, P1, DOI 10.2307/3564107
   ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203
   2001, FED REG, V66, P20589
   2002, INT C HARM GOOD CLIN
NR 121
TC 36
Z9 36
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0025-7079
J9 MED CARE
JI Med. Care
PD SEP
PY 2002
VL 40
IS 9
SU S
BP 69
EP 80
DI 10.1097/01.MLR.0000023958.28108.9C
PG 12
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 591HU
UT WOS:000177874300010
DA 2018-10-20
ER

PT J
AU Ackman, RG
AF Ackman, RG
TI The gas chromatograph in practical analyses of common and uncommon fatty
   acids for the 21st century
SO ANALYTICA CHIMICA ACTA
LA English
DT Review
DE gas-liquid chromatography; fatty acid methyl esters; flame ionization
   detector corrections; fatty acid identification technology; flexible
   fused silica columns; GC-MS of fatty acid derivatives
ID CHAIN-LENGTH VALUES; RANDOMIZED CONTROLLED TRIAL; LIQUID-CHROMATOGRAPHY;
   METHYL-ESTERS; MASS-SPECTROMETRY; CAPILLARY COLUMNS; HIGH-ACCURACY;
   DOCOSAHEXAENOIC ACID; ADIPOSE-TISSUE; TERM INFANTS
AB This is the fiftieth anniversary of the first publication on what became simply known as GLC (gas-liquid chromatography). It is therefore appropriate to point out that GLC was devised to solve an analytical problem with short chain fatty acids and has never looked back from its biomedical beginnings. The research applications have spread into volatile lipids and related materials of all kinds, and the common analyses of fatty acids extend from the fats in our diets into a sequence of complex developments in body biochemistry. Because of the basic simplicity of GLC, technical modifications have often been the result of independent redesign and developments by researchers. These were soon picked up by instrument manufacturers and this is the reason one can stress "practical analyses" in the title of this review. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Dalhousie Univ, Canadian Inst Fisheries Technol, Halifax, NS B3J 2X4, Canada.
RP Ackman, RG (reprint author), Dalhousie Univ, Canadian Inst Fisheries Technol, POB 1000, Halifax, NS B3J 2X4, Canada.
EM robert.ackman@dal.ca
CR Ackman R. G., 2001, INFORM - International News on Fats, Oils and Related Materials, V12, P998
   Ackman R. G., 1994, INFORM, V5, P1119
   ACKMAN R G, 1981, Progress in Lipid Research, V20, P773, DOI 10.1016/0163-7827(81)90143-0
   Ackman R. G., 1995, P82
   ACKMAN RG, 1964, J AM OIL CHEM SOC, V41, P377, DOI 10.1007/BF02654818
   ACKMAN RG, 1974, J AM OIL CHEM SOC, V51, P42, DOI 10.1007/BF00000011
   ACKMAN RG, 1967, LIPIDS, V2, P502, DOI 10.1007/BF02533181
   ACKMAN RG, 1992, FOOD RES INT, V25, P453, DOI 10.1016/0963-9969(92)90170-A
   ACKMAN RG, 1976, J CHROMATOGR SCI, V14, P568, DOI 10.1093/chromsci/14.12.568
   ACKMAN RG, 1963, J AM OIL CHEM SOC, V40, P564, DOI 10.1007/BF02822467
   ACKMAN RG, 1973, CAN I FOOD SC TECH J, V6, P159, DOI 10.1016/S0315-5463(73)74006-2
   ACKMAN RG, 1968, COMP BIOCHEM PHYSIOL, V24, P549, DOI 10.1016/0010-406X(68)91008-6
   ACKMAN RG, 1980, J AM OIL CHEM SOC, V57, pA821
   ACKMAN RG, 1980, FETT WISS TECHNOL, V82, P351, DOI 10.1002/lipi.19800820903
   ACKMAN RG, 1963, J AM OIL CHEM SOC, V40, P558, DOI 10.1007/BF02822466
   ACKMAN RG, 1971, CAN INST F SCI TEC J, V4, P169, DOI 10.1016/S0008-3860(71)74224-X
   ACKMAN RG, 1981, CHEM IND-LONDON, P715
   Ackman RG, 1999, ADVANCES IN CONJUGATED LINOLEIC ACID RESEARCH, VOL 1, P283
   ACKMAN RG, 1989, J AM OIL CHEM SOC, V66, P293, DOI 10.1007/BF02653277
   Ackman RG, 2000, J AM OIL CHEM SOC, V77, P831, DOI 10.1007/s11746-000-0133-2
   ACKMAN RG, 1981, CAN I FOOD SC TECH J, V14, P103, DOI 10.1016/S0315-5463(81)72719-6
   ACKMAN RG, 1994, FOOD CHEM, V50, P45, DOI 10.1016/0308-8146(94)90091-4
   ACKMAN RG, 1972, PROGR CHEM FATS OTHE, V12, P230
   ACKMAN RG, 1998, FATTY ACIDS HUMAN NU, P303
   ACKMAN RG, 1999, ADV CONJUGATED LINOL, P61
   ALBERTYN DE, 1982, J CHROMATOGR, V247, P47, DOI 10.1016/S0021-9673(00)84855-4
   Amirav A, 1997, ANAL CHEM, V69, P1248, DOI 10.1021/ac960484a
   Amirav A, 2001, AM LAB, V33, P28
   ANDO Y, 1989, J AM OIL CHEM SOC, V66, P1323, DOI 10.1007/BF03022755
   AOAC, 2001, OFF METH AN AOAC INT
   *AOCS, 1998, OFF METH REC PRACT A
   BADINGS HT, 1983, J CHROMATOGR, V279, P493, DOI 10.1016/S0021-9673(01)93650-7
   BANNON CD, 1982, J CHROMATOGR, V247, P63, DOI 10.1016/S0021-9673(00)84856-6
   BANNON CD, 1985, J AM OIL CHEM SOC, V62, P1501, DOI 10.1007/BF02541903
   BANNON CD, 1982, J CHROMATOGR, V247, P71, DOI 10.1016/S0021-9673(00)84857-8
   BANNON CD, 1987, J CHROMATOGR, V404, P340, DOI 10.1016/S0021-9673(01)86874-6
   Bartle K. D., 1984, OPEN TUBULAR COLUMN
   BERG J, 1989, AM LAB, V21, P92
   BERNER DL, 1992, INFORM, V3, P965
   Birch EE, 2000, DEV MED CHILD NEUROL, V42, P174, DOI 10.1017/S0012162200000311
   Boue C, 2000, LIPIDS, V35, P561, DOI 10.1007/s11745-000-556-4
   *CARD REV GROUP CO, 1994, 46 CARD REV GROUP CO, P2
   Carpenter DE, 1993, METHODS ANAL NUTR LA, P85
   CASSIDY DM, 1989, J CHROMATOGR-BIOMED, V491, P1, DOI 10.1016/S0378-4347(00)82814-5
   Chardigny JM, 2001, EUR J LIPID SCI TECH, V103, P478, DOI [10.1002/1438-9312(200107)103:7<478::AID-EJLT478>3.3.CO;2-1, 10.1002/1438-9312(200107)103:7<478::AID-EJLT478>3.0.CO;2-A]
   Chin S. F., 1992, Journal of Food Composition and Analysis, V5, P185, DOI 10.1016/0889-1575(92)90037-K
   CHRISTIE WW, 1987, LIPIDS, V22, P224, DOI 10.1007/BF02533983
   Christie WW, 2000, EUR J LIPID SCI TECH, V102, P23, DOI 10.1002/(SICI)1438-9312(200001)102:1<23::AID-EJLT23>3.3.CO;2-I
   CHRISTIE WW, 1988, J CHROMATOGR, V447, P305
   CHRISTIE WW, 1989, GAS CHROMATOGRAPHY L
   CHRISTIE WW, 1993, INFORM, V4, P85
   *COUNC EUR, 1999, EUR TREAT SER, V50
   Craske J.D., 1988, J AM OIL CHEM SOC, V65, P1190
   CRASKE JD, 1987, J AM OIL CHEM SOC, V64, P1413, DOI 10.1007/BF02636990
   CRASKE JD, 1995, J AM OIL CHEM SOC, V72, P995, DOI 10.1007/BF02660711
   CRASKE JD, 1988, J AM OIL CHEM SOC, V65, P262, DOI 10.1007/BF02636413
   CRASKE JD, 1986, J AM OIL CHEM SOC, V63, P427
   CRASKE JD, 1993, J AM OIL CHEM SOC, V70, P325, DOI 10.1007/BF02552702
   DANDENEAU R, 1979, AM LAB           SEP, P61
   David F, 1999, AM LAB, V31, P18
   Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502
   DIBOUNE M, 1992, JPEN-PARENTER ENTER, V16, P136, DOI 10.1177/0148607192016002136
   Ettre L.S., 1965, OPEN TUBULAR COLUMNS
   Ettre LS, 2001, LC GC N AM, V19, P712
   ETTRE LS, 1985, ANAL CHEM, V57, P1419
   FARQUHAR JW, 1959, NUTR REV, V17, P1
   FAY L, 1991, J CHROMATOGR, V541, P89, DOI 10.1016/S0021-9673(01)95986-2
   Golay M. J. E., 1957, GAS CHROMATOGRAPHY, P1
   GROB K, 1992, HRC-J HIGH RES CHROM, V15, P190
   GROB K, 1994, ANAL CHEM, V66, pA1009, DOI 10.1021/ac00092a001
   GROB K, 1991, COLUMN INJECTION CAP
   Grob K., 2001, SPLIT SPLITLESS INJE
   HARVEY DJ, 1992, ADV LIPID METHODOLOG, V1, P19
   HIBINO H, 1984, YUKAGAKU, V33, P625
   Holman RT, 1998, J NUTR, V128, p427S, DOI 10.1093/jn/128.2.427S
   House SD, 1997, J AOAC INT, V80, P555
   Ikeda I, 1998, LIPIDS, V33, P897, DOI 10.1007/s11745-998-0286-7
   Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304
   Itabashi Y., 1980, Journal of Japan Oil Chemists' Society [Yukagaku], V29, P855
   JAMES AT, 1952, BIOCHEM J, V50, P679, DOI 10.1042/bj0500679
   JAMIESON GR, 1975, J CHROMATOGR SCI, V13, P491, DOI 10.1093/chromsci/13.10.491
   JENNINGS W, 1986, J CHROMATOGR SCI, V24, P34, DOI 10.1093/chromsci/24.1.34
   JENNINGS W, 1978, GAS CHROMATOGRAPHY G
   Jorgensen MH, 1996, LIPIDS, V31, P99, DOI 10.1007/BF02522418
   JOSEPH JD, 1992, J AOAC INT, V75, P488
   Kramer JKC, 1997, LIPIDS, V32, P1219, DOI 10.1007/s11745-997-0156-3
   KRAMER JKG, 1985, J CHROMATOGR SCI, V23, P54, DOI 10.1093/chromsci/23.2.54
   Krauss RM, 2000, CIRCULATION, V102, P2284
   KRUPCIK J, 1985, J CHROMATOGR, V346, P33, DOI 10.1016/S0021-9673(00)90491-6
   KUKSIS A, 2001, INFORM, V12, P679
   Kumar R, 1999, AM LAB, V31, P32
   LAMBERTO M, 1995, ANAL BIOCHEM, V230, P224, DOI 10.1006/abio.1995.1467
   LAUTAMO R, 1998, AM LAB NEWS ED   DEC, V30, P28
   LIEBICH HM, 1991, J CHROMATOGR-BIOMED, V572, P1, DOI 10.1016/0378-4347(91)80468-R
   LUTHRIA DL, 1993, LIPIDS, V28, P561, DOI 10.1007/BF02536089
   MAYZAUD P, 1976, CHROMATOGRAPHIA, V9, P321, DOI 10.1007/BF02268834
   MAYZAUD P, 1978, LIPIDS, V13, P24, DOI 10.1007/BF02533362
   MCWILLIAM IG, 1983, CHROMATOGRAPHIA, V17, P241, DOI 10.1007/BF02263031
   Mossoba MM, 2001, J AOAC INT, V84, P1144
   O'Connor DL, 2001, PEDIATRICS, V108, P359, DOI 10.1542/peds.108.2.359
   PAGE BD, 1995, FOOD ADDIT CONTAM, V12, P129, DOI 10.1080/02652039509374287
   PASCAL JC, 1976, COMP BIOCHEM PHYS B, V53, P111, DOI 10.1016/0305-0491(76)90108-5
   Precht D, 2001, LIPIDS, V36, P827, DOI 10.1007/s11745-001-0791-8
   Precht D, 2001, LIPIDS, V36, P213, DOI 10.1007/s11745-001-0710-z
   Precht D, 1997, FETT-LIPID, V99, P319, DOI 10.1002/lipi.19970990904
   Ratnayake W. M. N., 2001, Journal of Oleo Science, V50, P339
   RATNAYAKE WMN, 1989, LIPIDS, V24, P630, DOI 10.1007/BF02535080
   RATNAYAKE WMN, 1990, J CHROMATOGR SCI, V28, P633, DOI 10.1093/chromsci/28.12.633
   RATNAYAKE WN, 1979, LIPIDS, V14, P580, DOI 10.1007/BF02533536
   SCHOMBURG G, 1981, J CHROMATOGR, V204, P85, DOI 10.1016/S0021-9673(00)81642-8
   SEBEDIO JL, 1981, LIPIDS, V16, P461, DOI 10.1007/BF02535015
   SEBEDIO JL, 1979, J AM OIL CHEM SOC, V56, P15, DOI 10.1007/BF02671754
   SEBEDIO JL, 1993, ADV LIPID METHODOLOG, V2, P139
   Sehat N, 1998, LIPIDS, V33, P963, DOI 10.1007/s11745-998-0293-8
   SHAHIDI F, 2001, P ACS S SER, V788, P330
   SHANTHA NC, 1990, J CHROMATOGR-BIOMED, V533, P1, DOI 10.1016/S0378-4347(00)82182-9
   SHANTHA NC, 1993, J AOAC INT, V76, P644
   SHIBAHARA A, 1983, YUKAGAKU, V32, P18
   SIDISKY LM, 1991, HRC-J HIGH RES CHROM, V14, P191
   SIPOS JC, 1980, J CHROMATOGR SCI, V18, P389
   SJOBERG P, 1985, J CHROMATOGR, V344, P167, DOI 10.1016/S0378-4347(00)82017-4
   Spitzer V, 1996, PROG LIPID RES, V35, P387, DOI 10.1016/S0163-7827(96)00011-2
   STRANSKY K, 1992, HRC-J HIGH RES CHROM, V15, P730
   Stransky K, 1997, HRC-J HIGH RES CHROM, V20, P143
   Sugano M, 2000, AM J CLIN NUTR, V71, p189S, DOI 10.1093/ajcn/71.1.189S
   TANDE T, 1992, J AM OIL CHEM SOC, V69, P1124, DOI 10.1007/BF02541048
   TEIRLYNCK OA, 1985, J CHROMATOGR, V342, P399, DOI 10.1016/S0378-4347(00)84534-X
   Turner A, 2000, MAR CHEM, V68, P203, DOI 10.1016/S0304-4203(99)00078-X
   ULBERTH F, 1992, HRC-J HIGH RES CHROM, V15, P54
   Ulberth F., 2000, Lipid Technology, V12, P135
   WOLFF JP, 1995, FETT WISS TECHNOL, V97, P49, DOI 10.1002/lipi.19950970203
   WOLFF RL, 1995, J AM OIL CHEM SOC, V72, P1197, DOI 10.1007/BF02540988
   WOLFF RL, 1994, J AM OIL CHEM SOC, V71, P907, DOI 10.1007/BF02540472
   2001, J AOAC, V84, pA45
NR 134
TC 116
Z9 119
U1 0
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
EI 1873-4324
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD AUG 16
PY 2002
VL 465
IS 1-2
BP 175
EP 192
AR PII S0003-2670(02)00098-3
DI 10.1016/S0003-2670(02)00098-3
PG 18
WC Chemistry, Analytical
SC Chemistry
GA 584JK
UT WOS:000177463300011
DA 2018-10-20
ER

PT J
AU Brodbeck, WG
   Patel, J
   Voskerician, G
   Christenson, E
   Shive, MS
   Nakayama, Y
   Matsuda, T
   Ziats, NP
   Anderson, JM
AF Brodbeck, WG
   Patel, J
   Voskerician, G
   Christenson, E
   Shive, MS
   Nakayama, Y
   Matsuda, T
   Ziats, NP
   Anderson, JM
TI Biomaterial adherent macrophage apoptosis is increased by hydrophilic
   and anionic substrates in vivo
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID SURFACE-CHEMISTRY; CELL APOPTOSIS; BIOCOMPATIBILITY; POLYURETHANES;
   BIOSTABILITY; EXPRESSION; ADHESION; DEATH
AB An in vivo rat cage implant system was used to identify potential surface chemistries that prevent failure of implanted biomedical devices and prostheses by limiting monocyte adhesion and macrophage fusion into foreign-body giant cells while inducing adherent-macrophage apoptosis. Hydrophobic, hydrophilic, anionic, and cationic surfaces were used for implantation. Analysis of the exudate surrounding the materials revealed no differences between surfaces in the types or levels of cells present. Conversely, the proportion of adherent cells undergoing apoptosis was increased significantly on anionic and hydrophilic surfaces (46 +/- 3.7 and 57 +/- 5.0%, respectively) when compared with the polyethylene terephthalate base surface. Additionally, hydrophilic and anionic substrates provided decreased rates of monocyte/macrophage adhesion and fusion. These studies demonstrate that biomaterial-adherent cells undergo material-dependent apoptosis in vivo, rendering potentially harmful macrophages nonfunctional while the surrounding environment of the implant remains unaffected.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44139 USA.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44139 USA.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 8128482, Japan.
   Natl Cardiovasc Ctr, Dept Bioengn, Osaka 5620025, Japan.
RP Brodbeck, WG (reprint author), Case Western Reserve Univ, Sch Med, Inst Pathol, Room 306, Cleveland, OH 44106 USA.
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
FU NIGMS NIH HHS [F32 GM020380, GM-20380]; NHLBI NIH HHS [HL-33849,
   HL-55714, R01 HL055714]
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   BRODBECK WG, 2001, J LAB CLIN MED, V139, P90
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Fabre T, 1999, J BIOMED MATER RES, V44, P429, DOI 10.1002/(SICI)1097-4636(19990315)44:4<429::AID-JBM9>3.0.CO;2-C
   Honma T, 1996, VIRCHOWS ARCH, V428, P165
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Labow RS, 1997, J BIOMAT SCI-POLYM E, V8, P779, DOI 10.1163/156856297X00317
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Shive MS, 2000, P NATL ACAD SCI USA, V97, P6710, DOI 10.1073/pnas.110463197
   SHIVE MS, 2001, J BIOMED MATER RES, V60, P148
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 21
TC 139
Z9 144
U1 0
U2 15
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 6
PY 2002
VL 99
IS 16
BP 10287
EP 10292
DI 10.1073/pnas.162124199
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 582HC
UT WOS:000177343200015
PM 12122211
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Wu, YH
   Yang, BJ
   Han, GC
   Zong, BY
   Ni, HQ
   Luo, P
   Chong, TC
   Low, TS
   Shen, ZX
AF Wu, YH
   Yang, BJ
   Han, GC
   Zong, BY
   Ni, HQ
   Luo, P
   Chong, TC
   Low, TS
   Shen, ZX
TI Fabrication of a class of nanostructured materials using carbon
   nanowalls as the templates
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID NANOTUBES; ARRAYS
AB Well aligned carbon nanowalls with a thickness of a few nanometers and a lateral size in the micrometer range have been grown on various types of substrates. The nanowalls exhibit a remarkably different surface morphology as compared to fullerenes and carbon nanotubes, in particular their two-dimensionality and high surface area. In this work, we focused on the second aspect and developed a templating method to fabricate a class of nanostructured materials based on the novel surface morphology of the carbon nanowalls. These structures may have potential applications in batteries, gas sensors, catalysts, a light-emission detection, field-emission, and biomedical devices.
C1 Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117576, Singapore.
   Data Storage Inst, Singapore 117608, Singapore.
   Natl Univ Singapore, Dept Phys, Singapore 119260, Singapore.
RP Wu, YH (reprint author), Natl Univ Singapore, Dept Elect & Comp Engn, 4 Engn Dr 3, Singapore 117576, Singapore.
RI Chong, Tow Chong/B-9822-2009; Wu, Yihong/D-3056-2012; Zong,
   Bao-Yu/E-6910-2012; Shen, Zexiang/B-6988-2011
OI Zong, BaoYu/0000-0003-2025-1395
CR BATCHTOLD A, 1999, NATURE, V397, P673
   Dresselhaus M.S., 1996, SCI FULLERENES CARBO
   Falvo MR, 1997, NATURE, V389, P582
   Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744
   Goyal M, 2001, COLLOID SURFACE A, V190, P229, DOI 10.1016/S0927-7757(01)00656-2
   Joo SH, 2001, NATURE, V412, P169, DOI 10.1038/35084046
   Kazakova O, 2001, J APPL PHYS, V90, P2440, DOI 10.1063/1.1389526
   Okada S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.146803
   WAKABAYASHI K, 2001, PHYS REV B, V64, DOI ARTN 5428
   Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971
   Wu YH, 2002, ADV MATER, V14, P64, DOI 10.1002/1521-4095(20020104)14:1<64::AID-ADMA64>3.0.CO;2-G
   Wu YH, 2002, NANO LETT, V2, P355, DOI 10.1021/nl015693b
   WU YH, 2001, MRS 2001 SPRING M SA
NR 13
TC 60
Z9 62
U1 1
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD AUG
PY 2002
VL 12
IS 8
BP 489
EP 494
DI 10.1002/1616-3028(20020805)12:8<489::AID-ADFM489>3.0.CO;2-X
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 582HR
UT WOS:000177345200003
DA 2018-10-20
ER

PT J
AU Lee, JW
   Gardella, JA
AF Lee, JW
   Gardella, JA
TI Surface perspectives in the biomedical applications of
   poly(alpha-hydroxy acid)s and their associated copolymers
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Review
DE biocompatibility; biodegradable polymers; surface analysis
ID ATOMIC-FORCE MICROSCOPY; HUMAN-ENDOTHELIAL-CELLS; ION MASS-SPECTROMETRY;
   STRUCTURE PROPERTY RELATIONSHIPS; FUNCTIONALIZED PENDANT GROUPS; PLASMON
   RESONANCE ANALYSIS; BIODEGRADABLE POLYMER; AQUEOUS-MEDIA; DRUG-DELIVERY;
   IN-VITRO
AB Impressive advances in biotechnology, bioengineering, and biomaterials with unique properties have led to increased interest in polymers and other novel materials in biological and biomedical research and development over the past two decades. Although biomaterials have already made an enormous impact in biomedical research and clinical practice, there is a need for better understanding of the surface and interfacial chemistry between tissue (or cells) and biomedical materials. This is because the detailed physicochemical events related to the biological response to the surface of materials still often remain obscure, even though surface properties are important determinants of biomedical material function. In this regard, data available in the literature show the complexity of the interactions (surface reorganization, nonspecific/specific protein adsorption, and chemical reactions such as acid-base, ion pairing, ion exchange, hydrogen bonding, divalent-ion bridging) and the interrelationship between biological environments, interfacial properties, and surface functional groups responsible for the biological responses. Because of the multidisciplinary nature of surface and interfacial phenomena at the surface of biomedical polymers, this review focuses on several aspects of current work published on poly(alpha-hydroxy acid)s and their associated copolymers:
   surface structure-biomedical function relationships;
   physicochemical strategies for surface modification; and, finally,
   synthetic strategies to increase biocompatibility for specific in-vivo and/or in-vitro biomedical applications.
C1 SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.
RP Gardella, JA (reprint author), SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.
EM gardella@acsu.buffalo.edu
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Akizawa T., 1989, T AM SOC ART INT ORG, V35, P333
   ALBERTSSON AC, 1995, J MACROMOL SCI PURE, VA32, P41, DOI 10.1080/10601329508011063
   Allen S, 1997, TRENDS BIOTECHNOL, V15, P101, DOI 10.1016/S0167-7799(97)01015-9
   ALONSO MJ, 1993, PHARMACEUT RES, V10, P945, DOI 10.1023/A:1018942118148
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   ANDERSON J M, 1985, Critical Reviews in Biocompatibility, V1, P111
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ASANO M, 1992, Membrane, V17, P216
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   Bartus RT, 1998, SCIENCE, V281, P1161, DOI 10.1126/science.281.5380.1161
   Blainey BL, 1991, BIOFOULING, V4, P309
   BlancoPrieto MJ, 1997, J CONTROL RELEASE, V43, P81, DOI 10.1016/S0168-3659(96)01474-5
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   BURKHARDT CA, 1992, THESIS STATE U NEW Y
   Chasin M, 1990, BIODEGRADABLE POLYM
   Chen JX, 1999, MACROMOLECULES, V32, P7380, DOI 10.1021/ma990205w
   Chen JX, 2000, MACROMOLECULES, V33, P4726, DOI 10.1021/ma992148c
   CHEN X, 1995, J PHYS CHEM-US, V99, P11537, DOI 10.1021/j100029a036
   CHICKERING D, 1992, P INT S CONTR REL BI, V19, P88
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Cleland J. L., 1994, FORMULATION DELIVERY
   COFFIN MD, 1992, PHARMACEUT RES, V9, P200, DOI 10.1023/A:1018981222092
   Cohen S, 1994, Int J Technol Assess Health Care, V10, P121
   *CONTR REL SOC, 1996, P INT C ADV CONTR DE
   COUVREUR P, 1993, ADV DRUG DELIVER REV, V10, P141, DOI 10.1016/0169-409X(93)90046-7
   DAVIES MC, 1989, SURF INTERFACE ANAL, V14, P115, DOI 10.1002/sia.740140304
   Davies MC, 1996, MACROMOLECULES, V29, P2205, DOI 10.1021/ma950889h
   DAVIES MC, 1990, BIOMATERIALS, V11, P228, DOI 10.1016/0142-9612(90)90002-8
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   FENG XD, 1983, J POLYM SCI POL LETT, V21, P593, DOI 10.1002/pol.1983.130210802
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   GARDELLA JA, 1984, ANAL CHEM, V56, P1169, DOI 10.1021/ac00271a026
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GRAHAM SW, 1981, J BIOMED MATER RES, V15, P349, DOI 10.1002/jbm.820150307
   Gregoriadis G., 1979, DRUG CARRIERS BIOL M
   Greisler HP, 1996, BIOMATERIALS, V17, P329, DOI 10.1016/0142-9612(96)85571-2
   HANKER JS, 1988, SCIENCE, V242, P885, DOI 10.1126/science.3055300
   HAWK GL, 1972, PREP BIOCHEM, V2, P193, DOI 10.1080/00327487208061469
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   HSIEH HJ, 1993, J CELL PHYSIOL, V154, P143, DOI 10.1002/jcp.1041540118
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   IKADA Y, 1984, ADV POLYM SCI, V57, P103
   INTVELD PJA, 1992, MAKROMOL CHEM, V193, P1927
   INTVELD PJA, 1992, MAKROMOL CHEM, V193, P2713
   INTVELD PJA, 1990, MAKROMOL CHEM, V191, P1813
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Ivanova T, 1997, COLLOID SURFACE B, V8, P217, DOI 10.1016/S0927-7765(96)01331-8
   JACKANICZ TM, 1973, CONTRACEPTION, V8, P227, DOI 10.1016/0010-7824(73)90033-4
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   JALIL R, 1990, J MICROENCAPSUL, V7, P297, DOI 10.3109/02652049009021842
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Kader A, 1998, DRUG DEV IND PHARM, V24, P535, DOI 10.3109/03639049809085654
   KATO T, 1981, POLYM J, V13, P1037, DOI 10.1295/polymj.13.1037
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   KENLEY RA, 1987, MACROMOLECULES, V20, P2398, DOI 10.1021/ma00176a012
   KIM SW, 1980, CRC CRIT R BIOCOMP, V1, P229
   KIMURA Y, 1989, POLYMER, V30, P1342, DOI 10.1016/0032-3861(89)90058-X
   KITCHELL JP, 1985, METHOD ENZYMOL, V112, P436
   KLOMPMAKER J, 1991, BIOMATERIALS, V12, P810, DOI 10.1016/0142-9612(91)90066-J
   KRICHELDORF HR, 1987, MAKROMOL CHEM, V188, P1861
   KYDONIEUS A, 1991, TREATISE CONTROLLED
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   LEE J, 1989, J COLLOID INTERF SCI, V131, P252, DOI 10.1016/0021-9797(89)90166-5
   Lee JW, 2001, MACROMOLECULES, V34, P3928, DOI 10.1021/ma0022351
   LEE JW, 2002, UNPUB PHARM RES
   LEE JW, 2001, THESIS STATE U NEW Y
   LI SM, 1990, J MATER SCI-MATER M, V1, P131, DOI 10.1007/BF00700872
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Lim F., 1984, BIOMEDICAL APPL MICR
   Lim YB, 2000, J AM CHEM SOC, V122, P6524, DOI 10.1021/ja001033h
   LUCKHAM PF, 1991, ADV COLLOID INTERFAC, V34, P191, DOI 10.1016/0001-8686(91)80051-K
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MATHIOWITZ E, 1990, SCANNING MICROSCOPY, V4, P329
   MATHIOWITZ E, 1993, MACROMOLECULES, V26, P6756, DOI 10.1021/ma00077a010
   MIDDLETON JC, 1998, MED PLAST BIOMAT MAR, P30
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   NILSSON CG, 1975, AM J OBSTET GYNECOL, V122, P90, DOI 10.1016/0002-9378(75)90619-5
   Ottenbrite R, 1996, HYDROGELS BIODEGRADA
   OUCHI T, 1989, MAKROMOL CHEM, V190, P1523
   OUCHI T, 1993, MAKROMOL CHEM-RAPID, V14, P825
   Ouchi T, 1996, MACROMOL CHEM PHYSIC, V197, P1823, DOI 10.1002/macp.1996.021970604
   Ouchi T, 1998, J POLYM SCI POL CHEM, V36, P1283, DOI 10.1002/(SICI)1099-0518(199806)36:8<1283::AID-POLA11>3.0.CO;2-2
   Ouchi T, 1997, J POLYM SCI POL CHEM, V35, P377
   OWENS NF, 1987, J CELL SCI, V87, P667
   PARK H, 1985, Journal of Controlled Release, V2, P47, DOI 10.1016/0168-3659(85)90032-X
   Park K, 2000, CONTROLLED DRUG DELI
   Park K., 1997, CONTROLLED DRUG DELI
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PREISSNER KT, 1988, BLOOD, V71, P1581
   Quirk RA, 2000, MACROMOLECULES, V33, P258, DOI 10.1021/ma9916133
   Rafati H, 1997, J CONTROL RELEASE, V43, P89, DOI 10.1016/S0168-3659(96)01475-7
   REBERT NW, 1994, MACROMOLECULES, V27, P5533, DOI 10.1021/ma00098a003
   REEVE MS, 1994, MACROMOLECULES, V27, P825, DOI 10.1021/ma00081a030
   Schmidt P, 1996, MACROMOLECULES, V29, P3674, DOI 10.1021/ma951489x
   SHAH SS, 1992, J CONTROL RELEASE, V18, P261, DOI 10.1016/0168-3659(92)90171-M
   SHAKESHEFF KM, 1995, LANGMUIR, V11, P3921, DOI 10.1021/la00010a049
   SHALABY SW, 1994, POLYM BIOL BIOMEDICA
   Shard AG, 1996, MACROMOLECULES, V29, P748, DOI 10.1021/ma950622i
   SHEN MS, 1992, J ADHES SCI TECHNOL, V6, P995
   SHEU MS, 1991, POLYM PREPRINTS, V32, P239
   Sipehia R, 1996, ARTIF CELL BLOOD SUB, V24, P51, DOI 10.3109/10731199609117431
   SIPEHIA R, 1993, BIOMAT ARTIF CELL IM, V21, P647, DOI 10.3109/10731199309117389
   SONG CX, 1983, POLYM COMMUN, V3, P177
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   THERIN M, 1992, BIOMATERIALS, V13, P594, DOI 10.1016/0142-9612(92)90027-L
   TICE TR, 1984, PHARM TECHNOL, V11, P26
   UYAMA Y, 1988, J APPL POLYM SCI, V36, P1087, DOI 10.1002/app.1988.070360509
   VERT M, 1991, J CONTROL RELEASE, V16, P15, DOI 10.1016/0168-3659(91)90027-B
   Wang D, 1997, MACROMOLECULES, V30, P5688, DOI 10.1021/ma9701752
   WANG HT, 1991, J CONTROL RELEASE, V17, P23, DOI 10.1016/0168-3659(91)90127-Y
   Wise DL, 1995, ENCY HDB BIOMATERIAL
   Yang ZH, 1999, LANGMUIR, V15, P8405, DOI 10.1021/la990260y
   Yin M, 1999, MACROMOLECULES, V32, P7711, DOI 10.1021/ma9907183
   ZHOU QX, 1990, MACROMOLECULES, V23, P3399, DOI 10.1021/ma00216a002
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
NR 132
TC 24
Z9 25
U1 0
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
EI 1618-2650
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD AUG
PY 2002
VL 373
IS 7
BP 526
EP 537
DI 10.1007/s00216-002-1339-2
PG 12
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 587TK
UT WOS:000177658800003
PM 12185564
DA 2018-10-20
ER

PT J
AU Schnabelrauch, M
   Vogt, S
   Larcher, Y
   Wilke, I
AF Schnabelrauch, M
   Vogt, S
   Larcher, Y
   Wilke, I
TI Biodegradable polymer networks based on oligolactide macromers:
   synthesis, properties and biomedical applications
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT E-MRS 2001 Spring Meeting
CY JUN 05-08, 2001
CL STRASBOURG, FRANCE
DE biodegradable polymers; lactide; oligomers; scaffolds; polymer networks;
   tissue engineering
ID SCAFFOLDS
AB presence of suitable initiators (di- and polyols, amino acid esters) and subsequent endgroup-functionalization of the formed oligolactides with methacrylate moities. The obtained liquid macromers are valuable building blocks for the preparation of biocompatible polymer networks. Based on these macromers, the fabrication and the material properties including biodegradation behaviour of highly porous polymer network devices will be described. The application of these materials as resorbable scaffolds in tissue engineering will be discussed. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 INNOVENT Technologieentwicklung EV, D-07745 Jena, Germany.
   Res Ctr Med Engn & Biotechnol EV, D-99947 Bad Langensalza, Germany.
RP Schnabelrauch, M (reprint author), INNOVENT Technologieentwicklung EV, Prussingstr 27B, D-07745 Jena, Germany.
EM ms@innovent-jena.de
CR Coullerez G, 2000, J MATER SCI-MATER M, V11, P505, DOI 10.1023/A:1008948325177
   Dunn Richard L., 1995, P17
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   PERRIN DE, 1997, HDB BIODEGRADABLE PO, P3
   Roller MB, 1996, SOC PLAST E, V42, P2848
   Shalaby SW, 1994, BIOMEDICAL POLYM DES, P1
   Wang N, 1997, J BIOMAT SCI-POLYM E, V8, P905
   WENZ R, 1998, BIOMATERIALS SURG, P132
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 10
TC 29
Z9 32
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD AUG
PY 2002
VL 19
IS 2-6
SI SI
BP 295
EP 298
AR PII S1389-0344(02)00034-5
DI 10.1016/S1389-0344(02)00034-5
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 598GD
UT WOS:000178266800041
PM 12202198
DA 2018-10-20
ER

PT J
AU Edwards, BE
AF Edwards, BE
TI A comprehensive laser safety program for the research university setting
SO HEALTH PHYSICS
LA English
DT Article
DE operational topic; lasers; medical radiation; radiation protection
AB Laser safety often receives less attention and fewer rcsources than other institutional safety and health program elements. This diminished support occurs despite the fact that laser-related occupational injuries and deaths greatly exceed those caused by biomedical research use of radioactive material. Therefore, a small emphasis on laser safety can potentially produce a much greater return on investment than more conventional health physics programs. Developing and implementing a formal comprehensive laser safety program enhances sale laser use and offers a great professional development opportunity in this important area of health physics expertise. This paper outlines such a university laser safety program.
C1 Duke Univ, Div Radiat Safety, Durham, NC 27710 USA.
   Amer Natl Standards Inst, Washington, DC 20036 USA.
RP Edwards, BE (reprint author), Duke Univ, Div Radiat Safety, Box 3155, Durham, NC 27710 USA.
CR [Anonymous], 2000, Z13612000 ANSI
   *ANSI, 2000, Z13652000 ANSI
   EDWARDS B, 2002, OPERATIONAL RAD SAFE, V82, pS37
   National Council on Radiation Protection and Measurements, 1983, 71 NCRP
   National Council on Radiation Protection and Measurements, 2000, 134 NCRP
   *ROCKW LAS IND, 2002, LAS ACC DAT
NR 6
TC 1
Z9 1
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD AUG
PY 2002
VL 83
IS 8
SU S
BP S32
EP S35
DI 10.1097/00004032-200208001-00011
PG 4
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 575KG
UT WOS:000176945000009
PM 12132726
DA 2018-10-20
ER

PT J
AU Liu, J
   Zhou, YX
   Deng, ZS
AF Liu, J
   Zhou, YX
   Deng, ZS
TI Sinusoidal heating method to noninvasively measure tissue perfusion
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE bioheat transfer; blood perfusion; instrumentation; noninvasive
   measurement; phase shift; sinusoidal heating
ID PULSE DECAY METHOD; BLOOD PERFUSION; THERMAL-CONDUCTIVITY; PHASE-SHIFT;
   IN-VIVO; TEMPERATURE; SURFACE
AB Noninvasively measuring the tissue blood perfusion has been an important however difficult problem in the biomedical engineering field. Based on the newly developed phase-shift principle, an improved sinusoidal heating method to estimate the perfusion was proposed in this paper to replace the original heating algorithm. The phase shift between the sinusoidal heat flux and the surface temperature response was both theoretically and experimentally revealed to be a time-dependent value which however will approach a constant value after a sufficiently long time. Only using this constant phase shift can the perfusion be properly estimated. Following the theory, an instrument consisting of low-frequency sinusoidal signal generator, power amplifier, heating plate, temperature and heat flux monitoring unit, as well as the data-acquisition system was carefully constructed. It allows generating a high-quality sinusoidal heat flux whose frequency and magnitude can be easily regulated. An auxiliary heat-conducting plate was introduced to simultaneously measure the surface temperature and the heat flux, which are hard to do otherwise. Experiments on human bodies were performed and the forearm perfusion was estimated and then validated through a constant surface heating experiment. Several issues related to the instrument integration and perfusion measurement were discussed. The instrument was a tested through experiments on nonperfused materials and good results were obtained. These efforts will help to build a compact device for noninvasively measuring the human perfusion, which may have significant applications in future clinics.
C1 Chinese Acad Sci, Tech Inst Phys & Chem, Cryogen Lab, Beijing 100080, Peoples R China.
RP Liu, J (reprint author), Chinese Acad Sci, Tech Inst Phys & Chem, Cryogen Lab, POB 2711, Beijing 100080, Peoples R China.
CR Anderson G. T., 1990, P ADV MEAS COMP TEMP, V147, P31
   ANDERSON GT, 1992, IEEE T BIO-MED ENG, V39, P877, DOI 10.1109/10.256420
   ARKIN H, 1994, IEEE T BIO-MED ENG, V41, P97, DOI 10.1109/10.284920
   ARKIN H, 1986, J BIOMECH ENG-T ASME, V108, P208, DOI 10.1115/1.3138604
   ARKIN H, 1989, ASME, V111, P276
   BALASUBRAMANIAM TA, 1974, ASME, V93, P296
   Bowman H. F., 1985, HEAT TRANSFER MED BI, V1, P193
   CARSLAW HS, 1986, CONDUCTION HEAT SOLI, P64
   CASTELLANA FS, 1983, ANN BIOMED ENG, V11, P101, DOI 10.1007/BF02367494
   CHATO JC, 1968, THERMAL PROBLEMS BIO, P16
   CHEN MM, 1981, J BIOMECH ENG-T ASME, V103, P253
   Deng ZS, 2000, MED ENG PHYS, V22, P693, DOI 10.1016/S1350-4533(01)00015-7
   DIEDERICH CJ, 1989, J BIOMECH ENG-T ASME, V111, P55, DOI 10.1115/1.3168340
   FOUQUET Y, 1993, ADV BIOHEAT MASS TRA, P53
   HOLMES KR, 1997, ALL WORKSH FUT BIOTH, P1
   HOLTI G, 1979, NONINVASIVE PHYSL ME, V1, P113
   Liu J, 1999, IEEE T BIO-MED ENG, V46, P1037, DOI 10.1109/10.784134
   Liu J, 1996, IEEE T BIO-MED ENG, V43, P847, DOI 10.1109/10.508547
   Michener M., 1991, ADV BIOL HEAT MASS T, V189, P1
   OREILLY TB, 1996, ADV BIOL HEAT MASS T, V34, P67
   PATEL PA, 1987, ASME, V109, P300
   PATERA AT, 1979, P ADV BIOENG WINT AN, P187
   PENNES HH, 1948, J APPL PHYSIOL, V1, P93
   Saidel GM, 2001, MED BIOL ENG COMPUT, V39, P126, DOI 10.1007/BF02345276
   SCOTT EP, 1997, ADV BIOL HEAT MASS T, V37, P205
   Valvano J.W., 1987, P ASME WINT ANN M TH, P1
   VALVANO JW, 1984, J BIOMECH ENG-T ASME, V106, P192
   VALVANO JW, 1987, P 6 SO BIOM ENG C, pA1
   WALSH JT, 1984, ADV BIOENG, P5
   WEI D, 1994, ASME, V117, P74
   WEI DT, 1990, IEEE T BIO-MED ENG, V37, P1159, DOI 10.1109/10.64457
   XU LX, 1999, BIOFLUID METHODS TEC, pCH5
   1982, HDB ELECT ENG, V2, P44
NR 33
TC 11
Z9 12
U1 0
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD AUG
PY 2002
VL 49
IS 8
BP 867
EP 877
DI 10.1109/TBME.2002.800769
PG 11
WC Engineering, Biomedical
SC Engineering
GA 574UZ
UT WOS:000176909100014
PM 12148826
DA 2018-10-20
ER

PT J
AU Kumar, KVSS
   Sai, KP
   Babu, M
AF Kumar, KVSS
   Sai, KP
   Babu, M
TI Application of frog (Rana tigerina Daudin) skin collagen as a novel
   substrate in cell culture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE skin collagen; Rana tigerina; fibril formation; reconstitution; cell
   proliferation; wound healing
ID DRESSINGS; MATRIX; GROWTH
AB Collagen and collagen-based materials have extensive application in biomedical devices and tissue engineering. The current paper pertains to the application of frog (Rana tigerina Daudin) skin collagen as a novel substrate in cell culture. The study deals with the behavior, morphology, and physiology of keratinocytes and fibroblasts over dry and reconstituted collagen substratum, which are the key cells involved in wound repair. The advantage of using frog skin collagen as a substratum lies in the ease with which the reconstituted gel can be formed. Further, frog skin collagen is highly hydrophilic, which may be attributed to the fact that amphibians, as the first vertebrates connecting water and land, must have evolved certain physiologic specializations. These studies also contribute to the hypothesis that part of the healing efficacy of frog skin may be due to the collagen since proliferation, migration, and differentiation of epithelial cells are prime requisites for a normal healing mechanism. (C) 2002 Wiley Periodicals, Inc.
C1 Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
RP Babu, M (reprint author), 2 Iyyasami Nagar, E Tambaram 600054, Chennai, India.
CR ABRAMO AC, 1992, BRIT J PLAST SURG, V45, P117, DOI 10.1016/0007-1226(92)90170-3
   AREM A, 1985, CLIN PLAST SURG, V12, P209
   CARVER N, 1991, INT J DERMATOL, V30, P540
   CHVAPIL M, 1984, OTOLARYNG CLIN N AM, V17, P265
   Doillon C J, 1988, J Biomater Appl, V2, P562
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   GRINNELL F, 1986, CELL TISSUE RES, V246, P13
   KANEKO Y, 1995, IN VITRO CELL DEV-AN, V31, P178
   KLEINMAN HK, 1982, IMMUNOCHEMISTRY EXTR, V2
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PRIESTLEY GC, 1991, CELL BIOL INT REP, V15, P59
   Sai K. Purna, 1995, Indian Journal of Experimental Biology, V33, P673
   Sai KP, 1998, IN VITRO CELL DEV-AN, V34, P561
   Sai KP, 2001, COMP BIOCHEM PHYS B, V128, P81
   Sai P, 2000, BURNS, V26, P54
   SHETTIGAR UR, 1982, ARTIF ORGANS, V6, P256
   Smith David J. Jr., 1995, Journal of Burn Care and Rehabilitation, V16, P317, DOI 10.1097/00004630-199505000-00018
   YAMADA N, 1995, SCAND J PLAST RECONS, V29, P211, DOI 10.3109/02844319509050129
NR 21
TC 9
Z9 10
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2002
VL 61
IS 2
BP 197
EP 202
DI 10.1002/jbm.10016
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 557PY
UT WOS:000175918000004
PM 12007199
DA 2018-10-20
ER

PT J
AU Gottenbos, B
   Busscher, HJ
   van der Mei, HC
AF Gottenbos, B
   Busscher, HJ
   van der Mei, HC
TI Pathogenesis and prevention of biomaterial centered infections
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FOREIGN-BODY INFECTION; BACTERIAL ADHESION; TOTAL HIP; VOICE PROSTHESES;
   IN-VIVO; SURFACES; BIOCOMPATIBILITY; TRANSLOCATION; COLONIZATION;
   POLYMERS
AB One of the major drawbacks in the use of biomedical materials is the occurrence of biomaterials centered infections. After implantation, the host interacts with a biomaterial by forming a conditioning film on its surface and an immune reaction towards the foreign material. When microorganisms can reach the biomaterials surface they can adhere to it. Adhesion of microorganisms to an implant is mediated by their physico-chemical surface properties and the properties of the biomaterials surface itself. Subsequent surface growth of the microorganisms will lead to a mature biofilm and infection, which is difficult to eradicate by antibiotics. The purpose of this review is to give an overview of the mechanisms involved in biomaterials centered infection and the possible methods to prevent these infections. (C) 2002 Kluwer Academic Publishers.
C1 Univ Groningen, Fac Med Sci, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Fac Med Sci, Dept Cell Biol & Histol, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Fac Med Sci, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR AHLBERG A, 1978, CLIN ORTHOP RELAT R, P69
   AKIYAMA H, 1979, J UROLOGY, V121, P40, DOI 10.1016/S0022-5347(17)56652-5
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   ANDERSON JM, 1988, ASAIO T, V34, P1401
   Asaria RHY, 1999, RETINA-J RET VIT DIS, V19, P447, DOI 10.1097/00006982-199909000-00014
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   BENGTSON S, 1987, ACTA ORTHOP SCAND, V58, P529, DOI 10.3109/17453678709146393
   BERG RD, 1975, INFECT IMMUN, V11, P320
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
   CARLSSON AS, 1978, J BONE JOINT SURG AM, V60, P1059, DOI 10.2106/00004623-197860080-00007
   CHARNLEY J, 1972, CLIN ORTHOP RELAT R, P167
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   Dougherty S H, 1982, Curr Probl Surg, V19, P217
   Duchmann R, 1996, EUR J IMMUNOL, V26, P934, DOI 10.1002/eji.1830260432
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   ELKENAWY R, 1998, J CONTROLED RELEASE, V50, P145
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   FITZGERALD RH, 1985, AM J MED, V78, P225, DOI 10.1016/0002-9343(85)90389-4
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   FOO MC, 1972, INFECT IMMUN, V6, P525
   GEESEY GG, 1990, ANNU REV MICROBIOL, V44, P579
   Gilbert P, 1997, Adv Dent Res, V11, P160
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GUO W, 1993, SCAND J GASTROENTERO, V28, P393, DOI 10.3109/00365529309098238
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HUNTER G, 1977, J BONE JOINT SURG BR, V59, P293
   JACKSON JH, 1988, HEMATOL ONCOL CLIN N, V2, P317
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   LIDWELL OM, 1982, BRIT MED J, V285, P10, DOI 10.1136/bmj.285.6334.10
   MAHIEU HF, 1986, ARCH OTOLARYNGOL, V112, P321
   MANILOFF G, 1987, CLIN ORTHOP RELAT R, P194
   MAYER KH, 1982, PROG CARDIOVASC DIS, V25, P43, DOI 10.1016/0033-0620(82)90003-2
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   NICKEL JC, 1994, J ANTIMICROB CHEMOTH, V33, P31, DOI 10.1093/jac/33.suppl_A.31
   POELSTRA KA, 2000, J BIOMED MATER RES, V50, P224
   Printzen G, 1996, INJURY, V27, P9
   Rediske AM, 1999, ANTIMICROB AGENTS CH, V43, P1211, DOI 10.1128/AAC.43.5.1211
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Spijker HT, 1999, COLLOID SURFACE B, V15, P89, DOI 10.1016/S0927-7765(99)00056-9
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330
   van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X
   Van Oss C. J., 1991, BIOFOULING, V4, P25
   VandenHoogen FJA, 1996, ACTA OTO-LARYNGOL, V116, P119, DOI 10.3109/00016489609137724
   VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
   vanWachem PB, 1997, J BIOMED MATER RES, V35, P217, DOI 10.1002/(SICI)1097-4636(199705)35:2<217::AID-JBM10>3.0.CO;2-E
   WELLS CL, 1987, ARCH SURG-CHICAGO, V122, P48
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 58
TC 81
Z9 86
U1 2
U2 22
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2002
VL 13
IS 8
BP 717
EP 722
DI 10.1023/A:1016175502756
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 572EN
UT WOS:000176760600001
PM 15348557
DA 2018-10-20
ER

PT J
AU Mayo, SC
   Miller, PR
   Wilkins, SW
   Davis, TJ
   Gao, D
   Gureyev, TE
   Paganin, D
   Parry, DJ
   Pogany, A
   Stevenson, AW
AF Mayo, SC
   Miller, PR
   Wilkins, SW
   Davis, TJ
   Gao, D
   Gureyev, TE
   Paganin, D
   Parry, DJ
   Pogany, A
   Stevenson, AW
TI Quantitative X-ray projection microscopy: phase-contrast and
   multi-spectral imaging
SO JOURNAL OF MICROSCOPY-OXFORD
LA English
DT Article
DE holography; phase contrast; phase retrieval; X-ray microscopy; X-ray
   ultramicroscope
ID SYNCHROTRON-RADIATION; BIOLOGICAL SPECIMENS; TOMOGRAPHY; RESOLUTION;
   RECONSTRUCTION; ALGORITHM; RADIOGRAPHY; DIFFRACTION; HOLOGRAPHY;
   RETRIEVAL
AB We outline a new approach to X-ray projection microscopy in a scanning electron microscope (SEM), which exploits phase contrast to boost the quality and information content of images. These developments have been made possible by the combination of a high-brightness field-emission gun (FEG)-based SEM, direct detection CCD technology and new phase retrieval algorithms. Using this approach we have been able to obtain spatial resolution of < 0.2 &mu;m and have demonstrated novel features such as: (i) phase-contrast enhanced visibility of high spatial frequency image features (e.g. edges and boundaries) over a wide energy range; (ii) energy-resolved imaging to simultaneously produce multiple quasi-monochromatic images using broad-band polychromatic illumination; (iii) easy implementation of microtomography; (iv) rapid and robust phase/amplitude-retrieval algorithms to enable new real-time and quantitative modes of microscopic imaging. These algorithms can also be applied successfully to recover object-plane information from intermediate-field images, unlocking the potentially greater contrast and resolution of the intermediate-field regime. Widespread applications are envisaged for fields such as materials science, biological and biomedical research and microelectronics device inspection. Some illustrative examples are presented. The quantitative methods described here are also very relevant to projection microscopy using other sources of radiation, such as visible light and electrons.
C1 CSIRO, Mfg Sci & Technol, Clayton Sth MDC, Vic 3169, Australia.
RP Wilkins, SW (reprint author), CSIRO, Mfg Sci & Technol, PB33, Clayton Sth MDC, Vic 3169, Australia.
RI Davis, Timothy/B-7773-2012; Gureyev, Timur/A-9209-2011; Mayo,
   Sheridan/A-4952-2010; paganin, david/B-9717-2009
OI Davis, Timothy/0000-0002-7299-4900; Gureyev, Timur/0000-0002-1103-0649;
   Mayo, Sheridan/0000-0002-7333-5472; Paganin, David/0000-0002-7758-7140
CR ADE H, 1999, AIP C P, P197
   Allman BE, 2000, J OPT SOC AM A, V17, P1732, DOI 10.1364/JOSAA.17.001732
   AOKI S, 1974, JPN J APPL PHYS, V13, P1385, DOI 10.1143/JJAP.13.1385
   ARISTOV VV, 1979, J APPL CRYSTALLOGR, V12, P19, DOI 10.1107/S0021889879011699
   ARISTOV VV, 1994, P 4 INT C XRAY MICR, V4
   ARNDT UW, 1966, SINGLE CRYSTAL DIFFR, P185
   BAEZ AV, 1952, J OPT SOC AM, V42, P756, DOI 10.1364/JOSA.42.000756
   Berglund M, 2000, J MICROSC-OXFORD, V197, P268
   Bronnikov AV, 1999, OPT COMMUN, V171, P239, DOI 10.1016/S0030-4018(99)00575-1
   Burge RE, 1997, ULTRAMICROSCOPY, V69, P259, DOI 10.1016/S0304-3991(97)00050-8
   CAZAUX J, 1993, J PHYS IV, V3, P2099, DOI 10.1051/jp4:19937334
   Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023
   Cloetens P, 1997, J APPL PHYS, V81, P5878, DOI 10.1063/1.364374
   COSSLETT VE, 1960, XRAY MICROSCOPY
   COWLEY JM, 1995, DIFFRACTION PHYSICS
   DEFRISE M, 1994, IEEE T MED IMAGING, V13, P186, DOI 10.1109/42.276157
   Denbeaux G, 2001, NUCL INSTRUM METH A, V467, P841, DOI 10.1016/S0168-9002(01)00480-6
   dePaiva RF, 1996, REV SCI INSTRUM, V67, P2251, DOI 10.1063/1.1147043
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   FISCHER P, 1999, AIP C P, P205
   FORD TW, 1999, AIP C P, P119
   GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0
   Gao DC, 1998, RADIOGRAPHICS, V18, P1257, DOI 10.1148/radiographics.18.5.9747618
   GERCHBERG RW, 1972, OPTIK, V35, P237
   GRANGEAT P, 1990, MATH METHODS TOMOGRA, P66
   Gureyev TE, 1999, J PHYS D APPL PHYS, V32, P563, DOI 10.1088/0022-3727/32/5/010
   Gureyev TE, 2001, PHYS REV LETT, V86, P5827, DOI 10.1103/PhysRevLett.86.5827
   Gureyev TE, 1998, OPT COMMUN, V147, P229, DOI 10.1016/S0030-4018(97)00637-8
   Gureyev TE, 1998, OPT COMMUN, V154, P391
   Gureyev TE, 1998, J OPT SOC AM A, V15, P579, DOI 10.1364/JOSAA.15.000579
   HORN HRF, 1978, SCANNING, V1, P100
   HOWELLS MR, 1986, J OPT SOC AM A, V3, P2171, DOI 10.1364/JOSAA.3.002171
   KIRKPATRICK P, 1948, J OPT SOC AM, V38, P766, DOI 10.1364/JOSA.38.000766
   KIRZ J, 1995, Q REV BIOPHYS, V28, P33, DOI 10.1017/S0033583500003139
   LARABELL CA, 1999, AIP C P, P107
   Leitenberger W, 2001, J APPL PHYS, V90, P538, DOI 10.1063/1.1378810
   LUMB DH, 1990, NUCL INSTRUM METH A, V290, P559, DOI 10.1016/0168-9002(90)90576-R
   LUMB DH, 1988, NUCL INSTRUM METH A, V273, P696, DOI 10.1016/0168-9002(88)90081-2
   Magowan C, 1997, P NATL ACAD SCI USA, V94, P6222, DOI 10.1073/pnas.94.12.6222
   MARTON L, 1939, INTERNAL REPORT
   MCNULTY I, 1992, SCIENCE, V256, P1009, DOI 10.1126/science.256.5059.1009
   Medenwaldt R, 1998, REV SCI INSTRUM, V69, P2974, DOI 10.1063/1.1149042
   MEYERILSE W, 2000, AIP C P
   Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498
   MILLER PR, 2001, Patent No. 0100750
   MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472
   NIXON WC, 1955, NATURE, V175, P1078, DOI 10.1038/1751078b0
   NUGENT KA, 1991, J MOD OPTIC, V38, P553, DOI 10.1080/09500349114552781
   Nugent KA, 1996, PHYS REV LETT, V77, P2961, DOI 10.1103/PhysRevLett.77.2961
   PAGANIN D, 2002, IN PRESS J MICROSC
   Pogany A, 1997, REV SCI INSTRUM, V68, P2774, DOI 10.1063/1.1148194
   Robinson IK, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.195505
   SAYRE D, 1995, ACTA CRYSTALLOGR A, V51, P237, DOI 10.1107/S0108767394011803
   SAYRE D, 1995, ACTA CRYSTALLOGR A, V51, P810, DOI 10.1107/S0108767395009238
   SCHMAHL G, 1995, REV SCI INSTRUM, V66, P1282, DOI 10.1063/1.1145955
   SMITH BD, 1990, OPT ENG, V29, P524, DOI 10.1117/12.55621
   SMITH BD, 1985, IEEE T MED IMAGING, V4, P14, DOI 10.1109/TMI.1985.4307689
   Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073
   Spence J. C., 1988, EXPT HIGH RESOLUTION
   TEAGUE MR, 1983, J OPT SOC AM, V73, P1434, DOI 10.1364/JOSA.73.001434
   Tiller JB, 2000, OPT COMMUN, V183, P7, DOI 10.1016/S0030-4018(00)00852-X
   VANDYCK D, 1987, OPTIK, V77, P125
   VONARDENNE M, 1939, NATURWISSENSCHAFTEN, V27, P485
   Weiss D, 2000, ULTRAMICROSCOPY, V84, P185, DOI 10.1016/S0304-3991(00)00034-6
   WHITE V, 1992, J VAC SCI TECHNOL B, V10, P3141, DOI 10.1116/1.585944
   Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0
   WILKINS SW, 1997, Patent No. 9800237
   YADA K, 1989, J ELECTRON MICROSC, V38, P321
   YADA K, 1994, P 4 INT C XRAY MICR, V4, P171
   YADA K, 1988, P 2 INT C XRAY MICR, V2, P323
   Yoshimura H, 2000, J ELECTRON MICROSC, V49, P621, DOI 10.1093/oxfordjournals.jmicro.a023851
   ZWORYKIN VK, 1945, ELECT OPTICS ELECT M, P111
NR 72
TC 123
Z9 127
U1 1
U2 27
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc.-Oxf.
PD AUG
PY 2002
VL 207
BP 79
EP 96
AR UNSP JMI_1046.fm
DI 10.1046/j.1365-2818.2002.01046.x
PN 2
PG 18
WC Microscopy
SC Microscopy
GA 584JY
UT WOS:000177464500001
PM 29381202
DA 2018-10-20
ER

PT J
AU Gurappa, I
AF Gurappa, I
TI Characterization of different materials for corrosion resistance under
   simulated body fluid conditions
SO MATERIALS CHARACTERIZATION
LA English
DT Article
DE titanium; cobalt-based alloy; simulated body fluid conditions; corrosion
   resistance
ID ALLOYING ELEMENTS; TITANIUM-ALLOYS
AB A systematic characterization study has been carried out on different materials such as commercial purity titanium, Ti-6Al-4V, 316L stainless steel, and a cobalt-based alloy under simulated body fluid conditions at 37 degreesC. Breakdown potential, corrosion rates, pitting/crevice corrosion resistance, and the ability to form protective oxide scales were evaluated and compared. The advantages of the titanium alloy over other materials were highlighted. An attempt has also been made to study the. suitability of titanium alloy, IMI 834, for biomedical applications. AC impedance measurements were also carried out in order to provide supportive evidence for the above results. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Def Met Res Lab, Surface Engn Grp, Hyderabad 500058, Andhra Pradesh, India.
RP Gurappa, I (reprint author), Def Met Res Lab, Surface Engn Grp, Kanchanbagh PO, Hyderabad 500058, Andhra Pradesh, India.
CR Donachie M., 1998, ADV MATER PROCESS, V7, P63
   Granchi D, 1998, J MATER SCI-MATER M, V9, P31, DOI 10.1023/A:1008878527233
   Gurrappa I, 2002, J ALLOY COMPD, V339, P241, DOI 10.1016/S0925-8388(01)02005-9
   Gurrappa I, 2001, CORROS PREVENT CONTR, V48, P23
   Gurrappa I, 2001, CORROS PREVENT CONTR, V48, P116
   GURRAPPA I, UNPUB J MAT SCI LETT
   GURRAPPA I, 2000, P GLOB 2000 CORR M M, V1, P561
   HARUYUKI K, 1992, B JAPAN I METALS, V31, P1033
   KUMAR P, 1985, ASTM STP, V859, P30
   Leitao E, 1998, J MATER SCI-MATER M, V9, P543, DOI 10.1023/A:1008896106994
   MACDONALD DD, 1981, ASTM STP, V727, P110
   MANSFELD F, 1982, CORROSION, V38, P478, DOI 10.5006/1.3577363
   MANSFELD F, 1982, CORROSION, V38, P570, DOI 10.5006/1.3577304
   MANSFIELD F, 1981, CORROSION, V36, P301
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   OKAZAKI Y, 1994, MATER T JIM, V35, P58, DOI 10.2320/matertrans1989.35.58
   SOLAR RJ, 1974, J BIOMED MATER RES, V5, P219
   Steinemann S. G., 1980, CORROSION SURG IMPLA, P1
   THERIN M, 1991, J MATER SCI-MATER M, V2, P1, DOI 10.1007/BF00701681
NR 19
TC 140
Z9 146
U1 2
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
J9 MATER CHARACT
JI Mater. Charact.
PD AUG
PY 2002
VL 49
IS 1
BP 73
EP 79
AR PII S1044-5803(02)00320-0
DI 10.1016/S1044-5803(02)00320-0
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 622JF
UT WOS:000179643400008
DA 2018-10-20
ER

PT J
AU Friedrich, CR
AF Friedrich, CR
TI Micromechanical machining of high aspect ratio prototypes
SO MICROSYSTEM TECHNOLOGIES
LA English
DT Article; Proceedings Paper
CT 12th Annual Symposium on Information Storage and Processing Systems
CY JUN 28-29, 2001
CL SANTA CLARA, CALIFORNIA
SP ASME
ID PRECISION
AB Micromechanical machining uses physical cutting tools in high precision machines to fabricate parts with micrometers features and sub-micrometer tolerances. An advantage of this process is the ability to use any machinable material, quick process planning and material removal, and three-dimensional geometry only limited by the machine and tools used. Disadvantages are that forces are placed on micro cutting tools causing deflection and possible breaking. Deflection reduces process precision and tool breakage results in repeated set up, slower production, and poorer tolerances. Nevertheless, these processes have created many diverse prototypes ranging from biomedical to space applications.
C1 Michigan Technol Univ, Dept Mech Engn Engn Mech, Houghton, MI 49931 USA.
RP Friedrich, CR (reprint author), Michigan Technol Univ, Dept Mech Engn Engn Mech, Houghton, MI 49931 USA.
CR Arcona C, 1998, J MANUF SCI E-T ASME, V120, P700, DOI 10.1115/1.2830209
   Friedrich C, 1997, MICROSYST TECHNOL, V4, P21, DOI 10.1007/s005420050085
   LI J, 1998, P 1998 ASME INT MECH, V39, P363
   MCGUYER J, 2001, IN PRESS P 20 SO BIO
NR 4
TC 20
Z9 21
U1 0
U2 3
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0946-7076
J9 MICROSYST TECHNOL
JI Microsyst. Technol.
PD AUG
PY 2002
VL 8
IS 4-5
BP 343
EP 347
DI 10.1007/s00542-001-0167-1
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Materials Science;
   Physics
GA 594VV
UT WOS:000178073000021
DA 2018-10-20
ER

PT J
AU Risbud, MV
   Sittinger, M
AF Risbud, MV
   Sittinger, M
TI Tissue engineering: advances in in vitro cartilage generation
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; IN-VITRO; ARTIFICIAL TISSUES; PERFUSION CULTURE;
   BONE-MARROW; CHONDROCYTES; SCAFFOLDS; PROTEINS; POLYMER; BMP-2
AB Damaged or diseased articular cartilage frequently leads to progressive debilitation resulting in a marked decrease in the quality of life. Tissue engineering, a budding field in modem biomedical sciences, promises creation of viable substitutes for failing organs or tissues. It represents the amalgamation of rapid developments in cellular and molecular biology on the one hand and material, chemical and mechanical engineering on the other. Current tissue engineering approaches are mainly focused on the restoration of pathologically altered tissue structure based on the transplantation of cells in combination with supportive matrices and biomolecules. The ability to manipulate and reconstitute tissue stricture and function in vitro has tremendous clinical implications and is likely to have a key role in cell and gene therapies in coming years.
C1 Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.
   Humboldt Univ, Expt Rheumatol & Tissue Engn Lab, German Rheumatism Res Ctr, D-10117 Berlin, Germany.
   Humboldt Univ, Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany.
RP Risbud, MV (reprint author), Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.
CR Aigner T, 2002, CELL MOL LIFE SCI, V59, P5, DOI 10.1007/s00018-002-8400-3
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
   BUJIA J, 1994, ANN RHEUM DIS, V53, P229, DOI 10.1136/ard.53.4.229
   Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396
   Cibelli JB, 2002, SCI AM, V286, P44, DOI 10.1038/scientificamerican0102-44
   Feldmann M, 2001, CURR DIRECT AUTOIMMU, V3, P188
   Gerson SL, 1999, NAT MED, V5, P262, DOI 10.1038/6470
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284
   Honda M, 2000, J ORAL MAXIL SURG, V58, P767, DOI 10.1053/joms.2000.7262
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kaps C, 2002, ARTHRITIS RHEUM, V46, P149, DOI 10.1002/1529-0131(200201)46:1<149::AID-ART10058>3.0.CO;2-W
   Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   Martin I, 2000, BIORHEOLOGY, V37, P141
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   Riew KD, 1998, CALCIFIED TISSUE INT, V63, P357, DOI 10.1007/s002239900540
   Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224
   Risbud M, 2001, BIOGERONTOLOGY, V2, P117, DOI 10.1023/A:1011585117310
   Roche S, 2001, BIOMATERIALS, V22, P9, DOI 10.1016/S0142-9612(00)00084-3
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   SAMPATH TK, 1984, P NATL ACAD SCI-BIOL, V81, P3419, DOI 10.1073/pnas.81.11.3419
   Schultz O, 1997, ARTHRITIS RHEUM, V40, P1420, DOI 10.1002/art.1780400809
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   SITTINGER M, 1994, THESIS U REGENSBURG
   Tetlow LC, 2001, ARTHRITIS RHEUM, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.3.CO;2-3
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
NR 36
TC 177
Z9 181
U1 1
U2 12
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD AUG
PY 2002
VL 20
IS 8
BP 351
EP 356
AR PII S0167-7799(02)02016-4
DI 10.1016/S0167-7799(02)02016-4
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 578YL
UT WOS:000177148600020
PM 12127283
DA 2018-10-20
ER

PT J
AU Zimmerman, SC
   Wendland, MS
   Rakow, NA
   Zharov, I
   Suslick, KS
AF Zimmerman, SC
   Wendland, MS
   Rakow, NA
   Zharov, I
   Suslick, KS
TI Synthetic hosts by monomolecular imprinting inside dendrimers
SO NATURE
LA English
DT Article
ID MOLECULAR RECOGNITION; CORED DENDRIMERS; POLYMERS; PORPHYRINS;
   ARCHITECTURE; METATHESIS; EVOLUTION; BINDING
AB Synthetic host systems capable of selectively binding guest molecules are of interest for applications ranging from separations and chemical or biological sensing to the development of biomedical materials. Such host systems can be efficiently prepared by 'imprinting' polymers or inorganic materials with template molecules, which, upon removal, leave behind spatially arranged functional groups that act as recognition sites(1-4). However, molecularly imprinted polymers have limitations, including incomplete template removal, broad guest affinities and selectivities, and slow mass transfer(5-8). An alternative strategy for moulding desired recognition sites uses combinatorial libraries of assemblies that are made of a relatively small number of molecules, interconverting in dynamic equilibrium; upon addition of a target molecule, the library equilibrium shifts towards the best hosts(9-11). Here we describe the dynamic imprinting of dendritic macromolecules with porphyrin templates to yield synthetic host molecules containing one binding site each. The process is based on our general strategy to prepare cored dendrimers(12,13), and involves covalent attachment of dendrons to a porphyrin core, cross-linking of the end-groups of the dendrons, and removal of the porphyrin template by hydrolysis. In contrast to more traditional polymer imprinting, our approach ensures nearly homogeneous binding sites and quantitative template removal. Moreover, the hosts are soluble in common organic solvents and amenable to the incorporation of other functional groups, which should facilitate further development of this system for novel applications.
C1 Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.
RP Zimmerman, SC (reprint author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.
RI Zimmerman, Steven/E-4244-2010; Suslick, Kenneth/C-3281-2011; ZHAROV,
   ILYA/B-3166-2013
OI Zimmerman, Steven/0000-0002-5333-3437; Suslick,
   Kenneth/0000-0001-5422-0701; Wendland, Michael/0000-0002-3581-3349
CR ADLER AD, 1967, J ORG CHEM, V32, P476, DOI 10.1021/jo01288a053
   ANDERSSON L, 1984, TETRAHEDRON LETT, V25, P5211, DOI 10.1016/S0040-4039(01)81566-5
   Balzani V, 2001, COORDIN CHEM REV, V219, P545, DOI 10.1016/S0010-8545(01)00351-4
   Bhyrappa P, 1996, J AM CHEM SOC, V118, P5708, DOI 10.1021/ja953474k
   Coates GW, 1996, J AM CHEM SOC, V118, P229, DOI 10.1021/ja9532603
   COLLMAN JP, 1978, J AM CHEM SOC, V100, P2761, DOI 10.1021/ja00477a031
   Cousins GRL, 2000, CURR OPIN CHEM BIOL, V4, P270, DOI 10.1016/S1367-5931(00)00088-0
   DANDLIKER PJ, 1996, ANGEW CHEM INT EDIT, V34, P2725
   HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027
   Katz A, 1999, MACROMOLECULES, V32, P4113, DOI 10.1021/ma981445z
   Katz A, 2000, NATURE, V403, P286, DOI 10.1038/35002032
   Klekota B, 1999, TRENDS BIOTECHNOL, V17, P205, DOI 10.1016/S0167-7799(99)01305-0
   Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066
   Matsui J, 2000, J AM CHEM SOC, V122, P5218, DOI 10.1021/ja000064+
   Newkome G.R., 2001, DENDRIMERS DENDRONS
   Ogoshi H, 1999, CURR OPIN CHEM BIOL, V3, P736, DOI 10.1016/S1367-5931(99)00033-2
   Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028
   RHO TY, 1994, SYNTHETIC COMMUN, V24, P253, DOI 10.1080/00397919408013824
   Sadamoto R, 1996, J AM CHEM SOC, V118, P3978, DOI 10.1021/ja952855v
   Sanders J. K. M., 1996, COMPREHENSIVE SUPRAM, V9, P131
   Schultz LG, 2001, ANGEW CHEM INT EDIT, V40, P1962, DOI 10.1002/1521-3773(20010518)40:10<1962::AID-ANIE1962>3.0.CO;2-J
   SELLERGREN B, 1993, J CHROMATOGR, V635, P39
   SHEA KJ, 1994, TRENDS POLYM SCI, V2, P166
   Trnka TM, 2001, ACCOUNTS CHEM RES, V34, P18, DOI 10.1021/ar000114f
   VLATAKIS G, 1993, NATURE, V361, P645, DOI 10.1038/361645a0
   Wendland MS, 1999, J AM CHEM SOC, V121, P1389, DOI 10.1021/ja983097m
   WULFF G, 1972, ANGEW CHEM INT EDIT, V11, P341
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
NR 28
TC 319
Z9 325
U1 8
U2 100
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD JUL 25
PY 2002
VL 418
IS 6896
BP 399
EP 403
DI 10.1038/nature00877
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 576MU
UT WOS:000177009700033
PM 12140553
DA 2018-10-20
ER

PT J
AU Muzikant, AL
   Hsu, EW
   Wolf, PD
   Henriquez, CS
AF Muzikant, AL
   Hsu, EW
   Wolf, PD
   Henriquez, CS
TI Region specific modeling of cardiac muscle: Comparison of simulated and
   experimental potentials
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE bidomain-model; electrograms; diffusion tensor MRI; heart modeling;
   fibers
ID BIDOMAIN MODEL; FIBER-ORIENTATION; SYNCYTIAL TISSUES; TRABECULAR MUSCLE;
   MAMMALIAN HEART; MYOCARDIUM; PROPAGATION; ACTIVATION; CONDUCTION;
   ANISOTROPY
AB This article investigates the quantitative predictive capabilities of region-specific models by comparing experimental electrograms obtained from in vivo mapping of the ventricular free wall with those obtained through simulation of a region specific three-dimensional bidomain model that incorporates measured fiber orientations. Epicardial electrograms were recorded from canine left ventricles during and after unipolar pacing using a 528-channel electrode plaque. Fiber directions throughout the tissue were estimated from diffusion-weighted MRI and from pace mapping. Electrograms were computed in the bidomain model with experimentally derived properties during paced activations at the same spatiotemporal resolution as those recorded experimentally. Epicardial potentials from model and experiment were directly compared, and sensitivities of these comparisons to reference electrode location and to the choice of material properties were analyzed. The comparisons performed here demonstrate, that (1) the stimulus artifact can be used to estimate the in vivo myocardial fiber architecture, (2) the correlation between simulated and experimental electrograms decreases with increasing pacing depth, and (3) the quantitative comparisons between bidomain model and expertmental data are sensitive to, both the description of the fiber architecture, and the location of the unipolar reference electrode, but relatively insensitive to moderate changes in the bidomain conductivities. (C) 2002 Biomedical Engineering Society.
C1 Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   Physiome Sci Inc, Princeton, NJ USA.
RP Henriquez, CS (reprint author), Duke Univ, Dept Biomed Engn, POB 90281,136 Hudson Hall, Durham, NC 27708 USA.
EM ch@duke.edu
FU NHLBI NIH HHS [R29-HL-57478]
CR Antzelevitch C, 1999, J CARDIOVASC ELECTR, V10, P1124, DOI 10.1111/j.1540-8167.1999.tb00287.x
   CABO C, 1990, IEEE T BIO-MED ENG, V37, P500, DOI 10.1109/10.55640
   Cherry EM, 2000, PHYS REV LETT, V84, P1343, DOI 10.1103/PhysRevLett.84.1343
   CLERC L, 1976, J PHYSIOL-LONDON, V255, P335, DOI 10.1113/jphysiol.1976.sp011283
   COLLI-FRANZONE P, 1993, J CARDIOVASC ELECTR, V4, P144, DOI 10.1111/j.1540-8167.1993.tb01219.x
   COLLI-FRANZONE P, 1990, MATH BIOSCI, V101, P155, DOI 10.1016/0025-5564(90)90020-Y
   COLLI-FRANZONE P, 1993, J CARDIOVASC ELECTR, V4, P438
   Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311
   GANDER W., 1994, FITTING CIRCLES ELLI
   Harrild DM, 2000, J ELECTROCARDIOL, V33, P241, DOI 10.1054/jelc.2000.8239
   HENRIQUEZ CS, 1993, CRIT REV BIOMED ENG, V21, P1
   Henriquez CS, 1996, J CARDIOVASC ELECTR, V7, P424, DOI 10.1111/j.1540-8167.1996.tb00548.x
   Hsu EW, 1998, AM J PHYSIOL-HEART C, V274, pH1627, DOI 10.1152/ajpheart.1998.274.5.H1627
   KINCAID DR, 1982, ACM T MATH SOFTWARE, V8, P302, DOI 10.1145/356004.356009
   KRASSOWSKA W, 1994, IEEE T BIO-MED ENG, V41, P143, DOI 10.1109/10.284925
   LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571
   LEON LJ, 1991, J ELECTROCARDIOL, V24, P17, DOI 10.1016/0022-0736(91)90078-Z
   Muzikant AL, 1997, J CARDIOVASC ELECTR, V8, P281, DOI 10.1111/j.1540-8167.1997.tb00791.x
   Muzikant AL, 1998, PROG BIOPHYS MOL BIO, V69, P205, DOI 10.1016/S0079-6107(98)00008-X
   NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117
   NEU JC, 1993, CRIT REV BIOMED ENG, V21, P137
   NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365
   PLONSEY R, 1986, ANN BIOMED ENG, V14, P307, DOI 10.1007/BF02367405
   POLLARD AE, 1993, CIRC RES, V72, P744, DOI 10.1161/01.RES.72.4.744
   ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701
   ROBERTS DE, 1982, CIRC RES, V50, P342, DOI 10.1161/01.RES.50.3.342
   ROGERS JM, 1994, IEEE T BIO-MED ENG, V41, P743, DOI 10.1109/10.310090
   ROTH BJ, 1991, CIRC RES, V68, P162, DOI 10.1161/01.RES.68.1.162
   Roth BJ, 1997, IEEE T BIO-MED ENG, V44, P326, DOI 10.1109/10.563303
   SELVESTER RH, 1970, CIRC RES, V27, P619, DOI 10.1161/01.RES.27.4.619
   TACCARDI B, 1994, CIRCULATION, V90, P3076, DOI 10.1161/01.CIR.90.6.3076
   Vetter FJ, 2001, ANN BIOMED ENG, V29, P414, DOI 10.1114/1.1366670
   WEIDMANN S, 1970, J PHYSIOL-LONDON, V210, P1041, DOI 10.1113/jphysiol.1970.sp009256
   WOLF PD, 1990, P FALL 1990 ANN M BI
NR 34
TC 24
Z9 24
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL-AUG
PY 2002
VL 30
IS 7
BP 867
EP 883
DI 10.1114/1.1509453
PG 17
WC Engineering, Biomedical
SC Engineering
GA 603NN
UT WOS:000178566100001
PM 12398418
DA 2018-10-20
ER

PT J
AU Zhang, M
   Li, XH
   Gong, YD
   Zhao, NM
   Zhang, XF
AF Zhang, M
   Li, XH
   Gong, YD
   Zhao, NM
   Zhang, XF
TI Properties and biocompatibility of chitosan films modified by blending
   with PEG
SO BIOMATERIALS
LA English
DT Article
DE chitosan; polyethylene glycol (PEG); mechanical properties;
   biocompatibility
ID POLYETHYLENE-GLYCOL; MORPHOLOGY; GROWTH; SURFACES; ADHESION; PROTEIN;
   CELLS
AB Chitosan (beta-1,4-D-glucosamine), a polysaccharide with excellent biological properties. has been widely used in biomedical fields, but many barriers still exist to its broader usage due to its chemical and physical limitations. Further work is needed to improve these properties. but changes of the chemical and physical properties will influence its biocompatibility, so the biological attribute of modified chitosan must he evaluated. In this study, the biocompatibility of chitosan modified by several methods was carefully evaluated at the cellular and protein levels using different physical and biological methods. The results provide a theoretical basis for screening biomaterials.
   We studied the properties of fife kinds of materials made by blending chitosan with different types of polyethylene glycol (PEG). The properties included physical and chemical properties. such as mechanical strength. static contact angle. spectroscopy. thermodynamic attributes and so on. The mechanical properties were slightly improved with the proper amount of PEG, but the improvement was not obvious and was destroyed by the wrong proportion of PEG. Cultures of the cells and amounts and structures of the adsorbed proteins on different materials showed that the PEG effectively improved the biocompatibility of the materials, The PEG enhanced the protein adsorption, cell adhesion, growth and proliferation. but the effects were impaired by excessive PEG. The experiments also demonstrated that the optimum PEG concentration helped to maintain the natural structure of the protein adsorbed on the materials and that maintaining the natural structure benefited cell growth.
   Analysis of the results based on the intramolecular and intermolecular interaction forces leads to a basic theory for the modification of biomaterials. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
RP Zhang, XF (reprint author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
CR Chandy T, 1998, J APPL POLYM SCI, V70, P2143, DOI 10.1002/(SICI)1097-4628(19981212)70:11<2143::AID-APP7>3.0.CO;2-L
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   HANS E, 1998, BIOMATERIALS, V19, P397
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Jiang WH, 1998, J POLYM SCI POL PHYS, V36, P1275, DOI 10.1002/(SICI)1099-0488(199806)36:8<1275::AID-POLB2>3.0.CO;2-R
   PARTER CM, 1991, BIOMATERIALS, V12, P7228
   RATHKE TD, 1994, J MACROMOL SCI R M C, VC34, P375, DOI 10.1080/15321799408014163
   Ruardy TG, 1997, J COLLOID INTERF SCI, V188, P209, DOI 10.1006/jcis.1997.4769
   Samarskii AA, 1998, DOKL AKAD NAUK BELAR, V42, P13
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Smetana K, 1997, BIOMATERIALS, V18, P1009, DOI 10.1016/S0142-9612(97)00037-9
   Suzuki T, 1997, J FERMENT BIOENG, V84, P128, DOI 10.1016/S0922-338X(97)82541-X
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Won CY, 1998, POLYMER, V39, P6677, DOI 10.1016/S0032-3861(98)00032-9
   Won CY, 1998, J POLYM SCI POL CHEM, V36, P2949, DOI 10.1002/(SICI)1099-0518(19981130)36:16<2949::AID-POLA13>3.0.CO;2-A
   YAO KD, 1995, J MACROMOL SCI R M C, VC35, P155, DOI 10.1080/15321799508014592
   Zileinski B.A., 1994, BIOMATERIALS, V15, P1049
NR 18
TC 302
Z9 326
U1 10
U2 123
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2002
VL 23
IS 13
BP 2641
EP 2648
AR PII S0142-9612(01)00403-3
DI 10.1016/S0142-9612(01)00403-3
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 554DM
UT WOS:000175718600003
PM 12059013
DA 2018-10-20
ER

PT J
AU Filmon, R
   Grizon, F
   Basle, MF
   Chappard, D
AF Filmon, R
   Grizon, F
   Basle, MF
   Chappard, D
TI Effects of negatively charged groups (carboxymethyl) on the
   calcification of poly(2-hydroxyethyl methacrylate)
SO BIOMATERIALS
LA English
DT Article
DE 2-hydroxyethyl methacrylate; bone substitute; bone mineralization;
   alkaline phosphatase; non-collagenous proteins
ID SIMULATED BODY-FLUID; ALKALINE-PHOSPHATASE; IN-VITRO; BONE; COMPOSITE;
   HYDROXYAPATITE; HYDROGELS; DISEASE; CALCIUM; CELLS
AB Poly(2-hydroxyethyl methacrylate) (pHEMA) has potentially wide biomedical applications: it is biocompatible, allows immobilization of cells or bioactive molecules and has a hardness comparable to bone. We previously reported that immobilization of alkaline phosphatase (AlkP) in pHEMA can initiate mineralization in a manner that mimics the calcification of cartilage and woven bone. Because numerous proteins known to initiate mineralization possess acidic species, we have modified the neutral electrical surface of pHEMA by carboxymethylation (CM). We have studied the effects of these negative groups on the calcification process in vitro. Calibrated pellets of pHEMA were prepared and carboxymethylated by soaking with 0.5 m bromoacetic acid in 2 M NaOH. Pellets of pHEMA, pHEMA-AlkP and pHEMA-CM were incubated during 5, 10 and 15 days in two types of body fluid: normal (I X) and 1.5X concentration of ions. Nodules of hydroxyapatite developed on pHEMA-AlkP and pHEMA-CM but not on pHEMA. Hydroxyapatite crystals were dissolved in HCl allowing calcium to be dosed. CM significantly increased the amount of deposited Ca by 1.8 folds in the 1X fluid and 15.8 folds in the 1.5X fluid. The presence of AlkP considerably increased the amount of deposited Ca: 25.9 folds in 1X and 23.3 in 1.5X. ROS 17/2.8 osteoblast-like cells were seeded on the materials and examined by confocal microscopy after phalloidin staining. Cells grown on pHEMA alone appeared round, while cells grown on the crystals deposited on the pHEMA-CM or PHEMA-AlkP were flattened. The presence of AlkP favours the mineralization process more than the existence of surface negative groups on the polymer. Cells preferentially adhere to the polymer when hydroxyapatite crystals were developed. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 LHEA GEROM, Lab Histol Embryol, Fac Med, F-49045 Angers, France.
   CHU Angers, F-49045 Angers, France.
   Fac Med, Serv Commun Imagerie & Anal Microscop, F-49045 Angers, France.
RP Chappard, D (reprint author), LHEA GEROM, Lab Histol Embryol, Fac Med, F-49045 Angers, France.
CR ANDERSON HC, 1989, LAB INVEST, V60, P320
   ARSENAULT AL, 1984, J CELL BIOL, V98, P911, DOI 10.1083/jcb.98.3.911
   BEERTSEN W, 1992, J CLIN INVEST, V89, P1974, DOI 10.1172/JCI115805
   BONNUCCI E, 1987, SCAN MICROSC, V1, P1089
   BUCK BE, 1989, CLIN ORTHOP RELAT R, P129
   CHAPPARD D, 1993, BIOMATERIALS, V14, P507, DOI 10.1016/0142-9612(93)90238-W
   CIFKOVA I, 1987, BIOMATERIALS, V8, P30, DOI 10.1016/0142-9612(87)90024-X
   Filmon R, 2002, BONE, V30, P152, DOI 10.1016/S8756-3282(01)00634-2
   Filmon R, 1997, J HISTOTECHNOL, V20, P343
   Filmon R., 1996, Cells and Materials, V6, P11
   Filmon R, 2000, J BIOMAT SCI-POLYM E, V11, P849, DOI 10.1163/156856200744057
   Garrett Q, 1998, BIOMATERIALS, V19, P2175, DOI 10.1016/S0142-9612(98)00125-2
   Gehron-Robey P, 1996, OSTEOPOROSIS, P95
   GOBEL RJ, 1987, BIOMATERIALS, V8, P285, DOI 10.1016/0142-9612(87)90116-5
   GOLUB EE, 1992, BONE MINER, V17, P272
   HARRISON G, 1995, J BONE MINER RES, V10, P568, DOI 10.1002/jbmr.5650100409
   Hoshi K, 2001, J BONE MINER RES, V16, P289, DOI 10.1359/jbmr.2001.16.2.289
   LEONE FA, 1997, TRENDS COMP BIOCH PH, V3, P57
   LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526
   Lombello CB, 2000, CYTOBIOS, V101, P115
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   MONTHEARD JP, 1997, DESK REFERENCE FUNCT, P699
   Moreau MF, 2000, BIOMATERIALS, V21, P369, DOI 10.1016/S0142-9612(99)00193-3
   Rhee SH, 1999, BIOMATERIALS, V20, P2155, DOI 10.1016/S0142-9612(99)00118-0
   Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286
   SMETANA K, 1992, BIOMATERIALS, V13, P639, DOI 10.1016/0142-9612(92)90033-K
   SPRINCL L, 1981, J BIOMED MATER RES, V15, P437, DOI 10.1002/jbm.820150314
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P19, DOI 10.1163/156856299X00252
   VANDEMARK MR, 1987, J POLYM SCI POL LETT, V25, P327, DOI 10.1002/pol.1987.140250804
   VIJAYASEKARAN S, 2000, J BIOMAT SCI-POLYM E, V6, P599
   WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WUTHIER RE, 1982, CLIN ORTHOP RELAT R, P219
   YAMADA S, 1994, J BIOMED MATER RES, V28, P1357, DOI 10.1002/jbm.820281114
   ZAVREL V, 1993, BIOMATERIALS, V14, P1109, DOI 10.1016/0142-9612(93)90213-L
NR 35
TC 74
Z9 75
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2002
VL 23
IS 14
BP 3053
EP 3059
AR PII S0142-9612(02)00069-8
DI 10.1016/S0142-9612(02)00069-8
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 559FP
UT WOS:000176015400028
PM 12069348
DA 2018-10-20
ER

PT J
AU Simo, C
   Gallardo, A
   Parejo, C
   Roman, JS
   Barbas, C
   Cifuentes, A
AF Simo, C
   Gallardo, A
   Parejo, C
   Roman, JS
   Barbas, C
   Cifuentes, A
TI Monitoring ibuprofen enantiomers released from polymeric systems
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE controlled release; polymeric drug; ibuprofen enantiomers; chiral
   separation; capillary electrophoresis
ID MICROSTRUCTURAL ANALYSIS; METHACRYLIC CARRIERS; BIOMEDICAL INTEREST;
   SIDE-GROUPS; COPOLYMERS; SPECTROSCOPY; DERIVATIVES
AB Two methacrylic derivatives of ibuprofen (N-{4-[2-(4-isobutylphenyl)propionyloxy]phenyl} methacrylamide (MAI) and 2-[4-isobutylphenyl)propionyloxy] ethyl methacrylate (MEI)) were used together with 2-hydroxyethyl methacrylate (HEMA) to synthesize four polymeric materials: two hydrophobic homopolymers, PMAI and PMEI, and two hydrophilic copolymers containing 70% (w/w) HEMA, MAI-HEMA 30 and MEI-HEMA 30. The enantiomeric determination of R- and S-IBU released from these four systems has been carried out by capillary electrophoresis. Release of R- and S-IBU was monitored during in vitro assays done at 37 degreesC at pH 7.4 and 10 in buffered solutions and rat plasma. There is a hydrolytical activation in plasma and at pH 10 compared to pH 7.4; moreover, the release rate from the copolymers is much higher than from the homopolymers as a consequence of the greater hydrophilic character. A slight excess of the S-enantiomer of IBU is observed in all the experiments, being more relevant at higher release rates, i.e. copolymers at pH 10. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
   CSIC, Inst Fermentac Ind, E-28006 Madrid, Spain.
   Univ San Pablo CEu, Fac CC Expt & Tecn, Dept Ciencias Basicas, Madrid 28668, Spain.
RP Gallardo, A (reprint author), CSIC, Inst Ciencia & Tecnol Polimeros, Juan Cierva 3, E-28006 Madrid, Spain.
RI Barbas, Coral/K-3871-2014; Gallardo, Alberto/B-4794-2011; CIFUENTES,
   ALEJANDRO/B-4715-2011; Simo, Carolina/H-4146-2012
OI Barbas, Coral/0000-0003-4722-491X; Gallardo,
   Alberto/0000-0003-4614-4299; CIFUENTES, ALEJANDRO/0000-0002-7464-0217;
   Simo, Carolina/0000-0002-7140-0795
CR BOVEY FA, 1982, CHAIN MICROSTRUCTURE
   CECCHI R, 1981, J MED CHEM, V24, P622, DOI 10.1021/jm00137a026
   Chang CH, 1998, J POLYM SCI POL CHEM, V36, P1481, DOI 10.1002/(SICI)1099-0518(19980715)36:9<1481::AID-POLA16>3.0.CO;2-0
   CHANKVETADZE B, 1997, CAPILLARY ELECTROPHO
   Davaran S, 1998, EUR POLYM J, V34, P187
   Davaran S, 1997, J CONTROL RELEASE, V47, P41, DOI 10.1016/S0168-3659(96)01614-8
   FORT RJ, 1976, EUR POLYM J, V12, P685, DOI 10.1016/0014-3057(76)90036-7
   GALLARDO A, 1993, POLYMER, V34, P394, DOI 10.1016/0032-3861(93)90095-R
   GALLARDO A, 1994, POLYMER, V35, P2501, DOI 10.1016/0032-3861(94)90370-0
   Gallardo A, 2001, J CONTROL RELEASE, V71, P127, DOI 10.1016/S0168-3659(01)00212-7
   GALLARDO A, 1993, POLYMER, V34, P567, DOI 10.1016/0032-3861(93)90552-L
   KNIHINICKI RD, 1989, BIOCHEM PHARMACOL, V38, P4389, DOI 10.1016/0006-2952(89)90647-3
   LARSEN C, 1989, ACTA PHARM NORDICA, V2, P57
   LISO PA, 1995, J CONTROL RELEASE, V33, P429, DOI 10.1016/0168-3659(94)00122-B
   Parejo C, 2000, J BIOMAT SCI-POLYM E, V11, P1429, DOI 10.1163/156856200744327
   Parejo C, 1998, J MATER SCI-MATER M, V9, P803, DOI 10.1023/A:1008935926154
   SANROMAN J, 1990, MACROMOLECULES, V23, P3036, DOI 10.1021/ma00214a003
   SIMO C, 2002, J CHROMATOGR B, V767, P34
   Tan SC, 1999, ENANTIOMER, V4, P195
   Valero M, 1990, POLYMER, V31, P1216
NR 20
TC 13
Z9 13
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD JUL
PY 2002
VL 16
IS 1-2
BP 75
EP 82
AR PII S0928-0987(02)00059-3
DI 10.1016/S0928-0987(02)00059-3
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 573WV
UT WOS:000176855900009
PM 12113894
DA 2018-10-20
ER

PT J
AU Pithioux, M
   Lasaygues, P
   Chabrand, P
AF Pithioux, M
   Lasaygues, P
   Chabrand, P
TI An alternative ultrasonic method for measuring the elastic properties of
   cortical bone
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE ultrasonic methods; elastic properties; longitudinal and transverse
   velocities; transverse isotropic; orthotropic
ID WAVE-PROPAGATION
AB We studied the elastic properties of bone to analyze its mechanical behavior. The basic principles of ultrasonic methods are now well established for varying isotropic media. particularly in the field of biomedical engineering. However, little progress has been made in its application to anisotropic materials. This is largely due to the complex nature of wave propagation in these media. In the present study, the theory of elastic waves is essential because it relates the elastic moduli of a material to the velocity of propagation of these waves along arbitrary directions in a solid. Transducers are generally placed in contact with the samples which are often cubes with parallel faces that are difficult to prepare. The ultrasonic method used here is original. a rough preparation of the bone is sufficient and the sample is rotated. Moreover, to analyze heterogeneity of the structure we measure velocities in different points on the sample. The aim of the present study was to determine in vitro the anisotropic elastic properties of cortical bones. For this purpose. our method allowed measurement of longitudinal and transverse velocities (C-L and C-T) in longitudinal (fiber direction) and the radial directions (orthogonal to the fiber direction) of compact bones, Young's modulus E and Poisson's ratio v, were then deduced from the velocities measured considering the compact bone as transversely isotropic or orthotropic. The results are in line with those of other methods. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 CNRS, Lab Mecan & Acoust, F-13402 Marseille, France.
RP Pithioux, M (reprint author), CNRS, Lab Mecan & Acoust, 31 Ch Joseph Aiguier, F-13402 Marseille, France.
EM pithioux@lma.cnrs-mrs.fr
RI CHEN, Jiangang/A-1549-2011
CR ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   BONFIELD W, 1982, J BIOMED ENG, V4, P23, DOI 10.1016/0141-5425(82)90022-X
   CASTAGNEDE B, 1990, J APPL PHYS, V67, P2753, DOI 10.1063/1.345441
   Fung Y. C., 1981, BIOMECHANICS MECH PR
   HOBATHO MC, 1998, ANATOMICAL VARIATION
   KATZ JL, 1984, CALCIFIED TISSUE INT, V36, pS31
   KATZ JL, 1979, MECH PROPERTIES BIOL, V34, P137
   Lasaygues P, 2001, ULTRASONIC IMAGING, V23, P55, DOI 10.1177/016173460102300104
   LASAYGUES P, 1992, THESIS U AIX MARSEIL
   LASAYGUES P, 2001, UNPUB P IEEE ULTR AT
   LEFEBVRE JP, 1988, C DIFF EL AC DET INV, P287
   LIPSON SF, 1984, J BIOMECH, V17, P231, DOI 10.1016/0021-9290(84)90134-9
   Lowet G, 1996, J BIOMECH, V29, P1255, DOI 10.1016/0021-9290(96)00054-1
   Mehta SS, 1999, CONNECT TISSUE RES, V40, P189, DOI 10.3109/03008209909005282
   PITHIOUX M, 2000, THESIS U AIX MARSEIL
   REILLY DT, 1974, J BONE JOINT SURG AM, VA 56, P1001, DOI 10.2106/00004623-197456050-00012
   REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5
   Rose J. L., 1999, ULTRASONIC WAVES SOL
   SACHSE W, 1998, CHARACTERIZING HOMOG
   SEDLIN ED, 1966, ACTA ORTHOPEDIA SC S, V83, P5
   VIANO DC, 1995, BIOMECHANICS BONE TI
   YOON HS, 1976, J BIOMECH, V9, P407, DOI 10.1016/0021-9290(76)90118-4
NR 22
TC 59
Z9 61
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD JUL
PY 2002
VL 35
IS 7
BP 961
EP 968
AR PII S0021-9290(02)00027-1
DI 10.1016/S0021-9290(02)00027-1
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 569NR
UT WOS:000176608900010
PM 12052398
DA 2018-10-20
ER

PT J
AU Guida, A
   Hill, RG
   Towler, MR
   Eramo, S
AF Guida, A
   Hill, RG
   Towler, MR
   Eramo, S
TI Fluoride release from model glass ionomer cements
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID INVITRO; BONE
AB Glass ionomer cements (GICs) are an important class of biomedical material used extensively for color matched mercury free, dental restorations. GICs can release clinically beneficial amounts of fluoride and have acceptable handling properties which make them suitable as dental restoratives. The fluoride release of model GICs produced from specially synthesized fluoro-alumino-silicate glasses was studied. Nine glasses of varying fluoride content based on 4.5SiO(2)-3Al(2)O(3)-1.5P(2)O(5)-(5-Z)CaO-ZCaF(2) were synthesized and cement disks were prepared from them. The glass transition temperature reduced with increasing fluorine content of the glass. Fluoride ion release was measured into distilled water as a function of time for up to 140 days using a fluoride ion selective electrode. The quantity of fluoride released was found to be proportional to the fluorine content of the glass at all intervals time. The cumulative fluoride release was proportional to square root time. Substituting strontium for calcium in the glass had little influence on the fluoride release behavior of the cements. (C) 2002 Kluwer Academic Publishers.
C1 Univ Limerick, Dept Mat Sci & Technol, Limerick, Ireland.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
   Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
   Univ Perugia, Dept Restorat Dent, I-06100 Perugia, Italy.
RP Guida, A (reprint author), Univ Limerick, Dept Mat Sci & Technol, Plassey Pk, Limerick, Ireland.
RI Eramo, Stefano/A-9724-2018
OI Eramo, Stefano/0000-0002-3329-9200
CR ASMUSSEN E, 1983, ACTA ODONTOL SCAND, V41, P155, DOI 10.3109/00016358309162317
   BROOK IM, 1991, CLIN MAT, V4, P295
   CRANFIELD M, 1982, J DENT, V10, P333, DOI 10.1016/0300-5712(82)90028-8
   CRISP S, 1974, J DENT RES, V53, P1408, DOI 10.1177/00220345740530061901
   deBarra E., 1997, THESIS U LIMERICK
   DOHERTY P J, 1991, Clinical Materials, V7, P335, DOI 10.1016/0267-6605(91)90078-T
   DRIESSENS FCM, 1990, BIOMINERALS, P264
   FORSS H, 1993, J DENT RES, V72, P1257, DOI 10.1177/00220345930720081601
   FORSTEN L, 1991, SCAND J DENT RES, V99, P241
   Hadley PC, 1999, BIOMATERIALS, V20, P891, DOI 10.1016/S0142-9612(98)00246-4
   HATIBOVICKOFMAN S, 1991, SWED DENT J, V15, P253
   HILL RG, 1995, KEY ENG MAT, V99-1, P315, DOI 10.4028/www.scientific.net/KEM.99-100.315
   *ISO, 1986, ISO7489
   KENT BE, 1973, BRIT DENT J, V135, P322, DOI 10.1038/sj.bdj.4803083
   KUHN AT, 1985, BIOMATERIALS, V6, P37
   Marks LAM, 2000, BIOMATERIALS, V21, P1373, DOI 10.1016/S0142-9612(00)00026-0
   MEYER U, 1993, BIOMATERIALS, V14, P917, DOI 10.1016/0142-9612(93)90133-M
   MEYRON SD, 1984, INT ENDOD J, V17, P16
   MITRA SB, 1991, J DENT RES, V70, P75, DOI 10.1177/00220345910700011301
   MOUNT GJ, 1994, COLOUR ATLAS GLASS I
   MUZYNSKI BL, 1988, J PROSTHET DENT, V60, P41, DOI 10.1016/0022-3913(88)90347-2
   OKAZAKI M, 1982, J BIOMED MATER RES, V16, P851, DOI 10.1002/jbm.820160610
   Ray N. H., 1978, INORGANIC POLYM
   SAITO S, 1979, DENT DIAMOND, V4, P69
   SASANALUCKIT P, 1993, BIOMATERIALS, V14, P906, DOI 10.1016/0142-9612(93)90132-L
   SEPPA L, 1994, CARIES RES, V28, P406, DOI 10.1159/000262012
   Thevadass KP, 1996, BIOMATERIALS, V17, P425, DOI 10.1016/0142-9612(96)89659-1
   TURNER RT, 1989, J BONE MINER RES, V4, P477
   TVEIT AB, 1981, J ORAL REHABIL, V8, P237, DOI 10.1111/j.1365-2842.1981.tb00498.x
   Verbeeck RMH, 1998, BIOMATERIALS, V19, P509, DOI 10.1016/S0142-9612(97)00131-2
   VOLKER J, 1944, TUFTS DENT OUTLOOK, V18, P4
   WALLS AWG, 1986, J DENT, V14, P231, DOI 10.1016/0300-5712(86)90030-8
   WILLIAMS JA, 1996, T 5 WORLD BIOM C TOR, V2, P762
   ZOLLNER W, INT S DENT, P57
NR 34
TC 19
Z9 20
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2002
VL 13
IS 7
BP 645
EP 649
DI 10.1023/A:1015777406891
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 557TR
UT WOS:000175924700004
PM 15348573
DA 2018-10-20
ER

PT J
AU Ben-Nissan, B
   Pezzotti, G
AF Ben-Nissan, B
   Pezzotti, G
TI Bioceramics: Processing routes and mechanical evaluation
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Review
DE bioceramics; processing; fracture mechanics; polymer infiltration
ID CALCIUM-PHOSPHATE CERAMICS; BIOACTIVE GLASS; HYDROXYAPATITE COATINGS;
   BIOMIMETIC MATERIALS; STAINLESS-STEEL; BONE; BEHAVIOR; POLYETHYLENE;
   TITANIUM; SURFACE
AB An improved understanding of currently used bioceramics in human implants and in bone replacement materials could contribute significantly to the design of new generation prostheses and post-operative patient management strategies. Overall, the benefits of advanced ceramic materials in biomedical applications have been universally appreciated, specifically, in terms of their strength, biocompatibility and wear resistance. However, the amount of supporting data is not large and the continuous development of new characterization tools is pertinent for better understanding of the microstructure-properties relationship and in general for obtaining new directives for their further improvement. This paper gives an overview and re-examines key-issues which concern both processing and applications of ceramics as biomaterials. With doing this, we attempt to bring to the attention of the ceramic community the issues in current bioceramics.
C1 Univ Technol Sydney, Dept Chem Mat & Forens Sci, Broadway, NSW 2007, Australia.
   Kyoto Inst Technol, Dept Mat, Sakyo Ku, Kyoto 6068585, Japan.
RP Ben-Nissan, B (reprint author), Univ Technol Sydney, Dept Chem Mat & Forens Sci, POB 123, Broadway, NSW 2007, Australia.
CR AKSAY IA, 1991, CERAMICS 21 CENTURY, P136
   Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1
   ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808
   AOKI H, 1978, Patent No. 78110999
   BENNISSAN B, 1995, ENCY HDB BIOMATERI B, V1, P192
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   BORETOS JW, 1987, ADV CERAM MATER, V2, P15
   CALVERT P, 1988, J MATER SCI, V23, P3801, DOI 10.1007/BF01106796
   CALVERT P, 1995, BIOMIMETICS DESIGN P, P145
   Chai C.S., 1993, J AUST CERAM SOC, V29, P81
   Chai CS, 1999, J MATER SCI-MATER M, V10, P465, DOI 10.1023/A:1008992807888
   CHAI CS, 1995, MATER MANUF PROCESS, V10, P68
   CHEVALIER J, 1997, BIOCERAMICS, V10, P271
   CLARKE IC, 1992, CLIN ORTHOP RELAT R, P19
   Clarke IC, 2000, P I MECH ENG H, V214, P331, DOI 10.1243/0954411001535381
   COOK SD, 1995, J BONE JOINT SURG AM, V77A, P734, DOI 10.2106/00004623-199505000-00010
   Cottel C. M., 1992, J APPL BIOMATER, V3, P87
   CURREY JD, 1990, J BIOMECH, V23, P837, DOI 10.1016/0021-9290(90)90030-7
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   DEGROOT K, 1987, CERAMICS CLIN APPL, P381
   DEJONG WF, 1926, REC TAV CHIM, V45, P415
   DENHOLLANDER W, 1991, BIOMATERIALS, V12, P569, DOI 10.1016/0142-9612(91)90053-D
   DEWITH G, 1989, J MATER SCI, V24, P3411, DOI 10.1007/BF01139073
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   Dorre E., 1984, ALUMINA PROCESSING P
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   Friedlander GE, 1999, ORTHOP CLIN N AM, V30, P583, DOI 10.1016/S0030-5898(05)70111-5
   GATTI AM, 1990, BIOMATERIALS, V11, P513, DOI 10.1016/0142-9612(90)90068-2
   GAUTIER S, 1997, BIOCERAMICS, V10, P549
   HAYASHI K, 1989, J BIOMED MATER RES, V23, P1247, DOI 10.1002/jbm.820231103
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench L. L., 1991, CERAMICS 21 CENTURY, P519
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hu J, 2001, J MATER SCI LETT, V20, P85, DOI 10.1023/A:1006735319725
   Huaxia Ji, 1993, Journal of Materials Science, V28, P1941
   Huckstep R. L., 1991, Materials Forum, V15, P253
   Huiskes Rik, 1993, P63
   HULBERT SF, 1987, CERAMICS CLIN APPL, P3
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   KAMIYA K, 1989, J MATER SCI, V24, P827, DOI 10.1007/BF01148764
   KIM CY, 1992, J BIOMED MATER RES, V26, P1147, DOI 10.1002/jbm.820260905
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P157, DOI 10.1016/0142-9612(84)90051-6
   KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z
   KOKUBO T, 1991, NIPPON SERAM KYO GAK, V99, P965
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1989, BIOCERAMICS, V1, P157
   Kokubo T., 2000, J AUST CERAM SOC, V36, P37
   KOKUBO T, 1991, CERAMICS 21 CENTURY, P500
   KUHN KD, 2000, BONE CEMENTS
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Ladizesky NH, 1997, POLYM ADVAN TECHNOL, V8, P496, DOI 10.1002/(SICI)1099-1581(199708)8:8<496::AID-PAT676>3.0.CO;2-R
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   LOTTY C, 2000, J BIOMED MATER RES, V49, P423
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   MARQUIS P, 1993, CERAM TECH INT, V8, P99
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   OONISHI H, 1992, J LONG-TERM EFF MED, V2, P37
   Pezzotti G, 2001, MAT SCI ENG A-STRUCT, V316, P231, DOI 10.1016/S0921-5093(01)01250-3
   PEZZOTTI G, IN PRESS J BIOMED MA
   PIZZOFERRATO A, 1995, CURRENT OPINION ORTH, V6, P42
   RAMSELAAR MMA, 1991, J MATER SCI-MATER M, V2, P63, DOI 10.1007/BF00703460
   ROY DM, 1974, REFRACTORY MAT SERIS, V6, P187
   RUYS AJ, 1991, BIOCERAMICS, V4, P281
   SAIKKO V, 1994, WEAR, V176, P207, DOI 10.1016/0043-1648(94)90148-1
   Sarikaya M, 1995, BIOMIMETICS DESIGN P, P35
   SEGLISON D, 1997, CLIN ORTHOP RELAT R, V343, P213
   Sivakumar M, 1996, BIOMATERIALS, V17, P1709, DOI 10.1016/0142-9612(96)87651-4
   Sobel HL, 1997, J AM CERAM SOC, V80, P1706
   SPADARO JA, 1986, J BIOMED MATER RES, V20, P565, DOI 10.1002/jbm.820200504
   STANDARD OC, 1992, P INT CER C AUSTC 92, V2, P611
   TAKAGI M, 1992, J MATER SCI-MATER M, V3, P199, DOI 10.1007/BF00713450
   UHTOFF HT, 1983, J BONE JOINT SURG BR, V63, P66
   VANRAEMDONCK W, 1984, METAL CERAMIC BIOMAT, V2, P143
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Wolke JGC, 1998, J BIOMED MATER RES, V39, P524
   YOSHIMURA M, 1989, EUROCERAMICS, V3, P16
   ZEIGLER KA, 1992, CERAMICS ADDING VALU, V2, P623
   Zhang QQ, 1996, ARTIF CELL BLOOD SUB, V24, P693, DOI 10.3109/10731199609118892
   Zhang X, 1997, J MATER SCI, V32, P235, DOI 10.1023/A:1018568308926
   ZHITOMIRSKY I, 1987, J BIOMED MATER RES, V21, P1375
NR 83
TC 12
Z9 12
U1 1
U2 16
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JUL
PY 2002
VL 110
IS 7
BP 601
EP 608
DI 10.2109/jcersj.110.601
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 585HW
UT WOS:000177520200002
OA Bronze
DA 2018-10-20
ER

PT J
AU Grewe, PH
   Muller, KM
   Deneke, T
   Harrer, E
   Germing, A
   Mugge, A
   Lemke, B
AF Grewe, PH
   Muller, KM
   Deneke, T
   Harrer, E
   Germing, A
   Mugge, A
   Lemke, B
TI Stents: material, surface texture and design, in theory and practice
SO MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
LA English
DT Article
DE stent; metal; design; surface; restenosis
ID PALMAZ-SCHATZ STENT; PORCINE CORONARY-ARTERIES; BALLOON ANGIOPLASTY;
   RANDOMIZED TRIAL; INTRAVASCULAR ULTRASOUND; SILICON-CARBIDE; NITINOL
   STENT; NIR STENT; FOLLOW-UP; IMPLANTATION
AB Intravascular stenting has become standard practice in cardiology and interventional radiology. As part of their daily routine, interventional therapists have to choose from more than 50 different coronary stents for the optimal treatment of patients. Striking advances in biomedical engineering have triggered the production of numerous new and improved stent models, whose theoretical benefits have not yet been confirmed by large-scale clinical trials. Selecting appropriate stents for individual patients is frequently subject to the personal and, therefore, subjective experience of the interventional therapist. This paper reviews different stent materials and designs used in current trials and clinical practice. The theoretical benefits of individual parameters are discussed and correlated with up-to-date clinical results, particularly with a view to considering their favourable impact on intervention outcomes.
C1 Univ Hosp Bergmannsheil, Dept Cardiol & Angiol, D-44789 Bochum, Germany.
   Univ Hosp Bergmannsheil, Inst Pathol, D-44789 Bochum, Germany.
RP Grewe, PH (reprint author), Univ Hosp Bergmannsheil, Dept Cardiol & Angiol, Burkle Camp Platz 1, D-44789 Bochum, Germany.
CR Amon M, 1996, J MATER SCI-MATER M, V7, P273, DOI 10.1007/BF00058566
   Baim DS, 2001, AM J CARDIOL, V87, P152, DOI 10.1016/S0002-9149(00)01307-2
   Baim DS, 2001, AM J CARDIOL, V87, P157, DOI 10.1016/S0002-9149(00)01308-4
   BAUERSCHMIDT P, 1977, J BIOENG, V1, P261
   BOLZ A, 1992, BIOMED TECH, V37, P244, DOI 10.1515/bmte.1992.37.11.244
   Brayda-Bruno M, 2001, INT J ARTIF ORGANS, V24, P41
   CAMPBELL R, 1995, CIRCULATION, V91, P2995
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   Costa MA, 2000, AM J CARDIOL, V85, P135, DOI 10.1016/S0002-9149(99)00655-4
   Danzi GB, 2001, CATHETER CARDIO INTE, V52, P147, DOI 10.1002/1522-726X(200102)52:2<147::AID-CCD1038>3.0.CO;2-B
   DEGENFELD VG, 1999, Z KARDIOL, V88, P906
   DOTTER CT, 1964, CIRCULATION, V30, P654, DOI 10.1161/01.CIR.30.5.654
   Edelman ER, 2001, CIRCULATION, V103, P429
   FISCHER A, 2001, KORONARSTENTING, P17
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   FONTAINE AB, 1994, J VASC INTERV RADIOL, V5, P567, DOI 10.1016/S1051-0443(94)71555-4
   FRANZEN D, 1994, Z KARDIOL, V83, P155
   Grewe PH, 2000, AM J CARDIOL, V85, P554, DOI 10.1016/S0002-9149(99)00810-3
   Grewe PH, 2001, Z KARDIOL, V90, P630, DOI 10.1007/s003920170110
   Grewe PH, 1997, Z KARDIOL, V86, P990, DOI 10.1007/s003920050141
   GREWE PH, 1998, Z KARDIOL          S, V87, P152
   GREWE PH, 1998, Z KARDIOL          S, V87, P630
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   Harding SA, 2001, CATHETER CARDIO INTE, V54, P141, DOI 10.1002/ccd.1255
   Holmes DR, 2000, AM J CARDIOL, V86, P1073, DOI 10.1016/S0002-9149(00)01162-0
   KELBAEK H, 2001, EUR HEART J SUPPL, V22, P386
   Kiemeneij F, 2001, J AM COLL CARDIOL, V37, P1598, DOI 10.1016/S0735-1097(01)01207-4
   Kobayashi Y, 2001, J AM COLL CARDIOL, V37, P1329, DOI 10.1016/S0735-1097(01)01162-7
   Malik N, 2001, J Invasive Cardiol, V13, P193
   MICHANETZIS GPA, 1992, BIOMED TECH, V37, P29
   MIKETIC S, 2001, AM HEART J, V42, pE8
   Nageh T, 2001, AM HEART J, V141, P971, DOI 10.1067/mhj.2001.115301
   PIESSLINGERSCHW.W, 1996, 34 JAHR DT GES GALV, P155
   Rothman MT, 2001, CATHETER CARDIO INTE, V52, P249, DOI 10.1002/1522-726X(200102)52:2<249::AID-CCD1060>3.0.CO;2-T
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   STAAB ME, 1996, ENDOLUMINAL STENTING, P34
   VANDERGIESSEN WJ, 1992, CORONARY ARTERY DIS, V3, P631, DOI 10.1097/00019501-199207000-00014
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Verheye S, 1999, CATHETER CARDIO INTE, V48, P316, DOI 10.1002/(SICI)1522-726X(199911)48:3<316::AID-CCD19>3.0.CO;2-W
   WILLIAMS DF, 1985, J BIOMED MATER RES, V19, P313, DOI 10.1002/jbm.820190312
   Windecker S, 2001, EUR HEART J, V22, P483
   Yamamoto Y, 1999, CATHETER CARDIO INTE, V47, P251, DOI 10.1002/(SICI)1522-726X(199906)47:2<251::AID-CCD26>3.0.CO;2-M
   YOSHITOMI Y, 2001, AM HEART J, V142, P378
NR 45
TC 3
Z9 3
U1 0
U2 4
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 1364-5706
J9 MINIM INVASIV THER
JI Minim. Invasive Ther. Allied Technol.
PD JUL 01
PY 2002
VL 11
IS 4
BP 157
EP 163
DI 10.1080/136457002760273368
PG 7
WC Surgery
SC Surgery
GA 596EZ
UT WOS:000178152300004
DA 2018-10-20
ER

PT J
AU Zong, XH
   Kim, K
   Fang, DF
   Ran, SF
   Hsiao, BS
   Chu, B
AF Zong, XH
   Kim, K
   Fang, DF
   Ran, SF
   Hsiao, BS
   Chu, B
TI Structure and process relationship of electrospun bioabsorbable
   nanofiber membranes
SO POLYMER
LA English
DT Article
DE electrospinning; poly(lactic acid); biodegradable nanofiber
ID SYNCHROTRON SAXS/WAXD; THIN-FILMS; FIBERS; DEGRADATION; DEFORMATION
AB An electrospinning method was used to fabricate bioabsorbable amorphous poly(D,L-lactic acid) (PDLA) and semi-crystalline poly(L-lactic acid) (PLLA) nanofiber non-woven membranes for biomedical applications. The structure and morphology of electrospun membranes were investigated by scanning electron microscopy (SEM), differential scanning calorimetry (DSC), and synchrotron wide-angle X-ray diffraction/small angle X-ray scattering. SEM images showed that the fiber diameter and the nanostructured morphology depended on processing parameters such as solution viscosity (e.g. concentration and polymer molecular weight), applied electric field strength, solution feeding rate and ionic salt addition. The combination of different materials and processing parameters could be used to fabricate bead-free nanofiber non-woven membranes. Concentration and salt addition were found to have relatively larger effects on the fiber diameter than the other parameters. DSC and X-ray results indicated that the electrospun PLLA nanofibers were completely non-crystalline but had highly oriented chains and a lower glass transition temperature than the cast film. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.
   Stonybrook Technol & Appl Res Inc, Stony Brook, NY 11790 USA.
RP Hsiao, BS (reprint author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.
CR Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Butler SM, 1999, J CONTROL RELEASE, V58, P335, DOI 10.1016/S0168-3659(98)00173-4
   CHU CC, 1995, BIOMEDICAL ENG HDB, P611
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Esposito E, 1997, J MICROENCAPSUL, V14, P175, DOI 10.3109/02652049709015331
   GARTON CG, 1964, PROC R SOC LON SER-A, V280, P211, DOI 10.1098/rspa.1964.0141
   HERMANN JB, 1970, ARCH SURG-CHICAGO, V486, P100
   IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034
   King E, 1997, J APPL POLYM SCI, V66, P1681, DOI 10.1002/(SICI)1097-4628(19971128)66:9<1681::AID-APP6>3.0.CO;2-9
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P909, DOI 10.1002/pol.1981.180190601
   LIU W, 2000, POLYM PREPR, V41, P1193
   Ran S, 2001, POLYMER, V42, P1601, DOI 10.1016/S0032-3861(00)00460-2
   Ran SF, 2001, MACROMOLECULES, V34, P2569, DOI 10.1021/ma0016477
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   Zeleny J, 1914, PHYS REV, V3, P69, DOI 10.1103/PhysRev.3.69
   Zong XH, 1999, MACROMOLECULES, V32, P8107, DOI 10.1021/ma990630p
NR 22
TC 1167
Z9 1216
U1 32
U2 602
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD JUL
PY 2002
VL 43
IS 16
BP 4403
EP 4412
AR PII S0032-3861(02)00275-6
DI 10.1016/S0032-3861(02)00275-6
PG 10
WC Polymer Science
SC Polymer Science
GA 568HM
UT WOS:000176536400011
DA 2018-10-20
ER

PT J
AU Yang, P
   Huang, N
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Chen, F
   Chu, PK
AF Yang, P
   Huang, N
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Chen, F
   Chu, PK
TI In vivo study of Ti-O thin film fabricated by PIII
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Workshop on Plasma-Based Ion Implantation (PBII-2001)
CY JUN 25-28, 2001
CL GRENOBLE, FRANCE
SP CNRS, Univ Joseph Fourier, Inst Natl Polytechn Grenoble, European Commiss, Minist Affaires Etrangeres, Minist Educ Natl, Minist Defense/DGA, City Grenoble, Reg Rhone Alpes, Grenoble Alps METROPOLE
DE in vivo study; blood compatibility; biomaterial; plasma immersion ion
   implantation (PIII)
ID BLOOD COMPATIBILITY; BIOMATERIALS; MORPHOLOGY
AB Over the past decade, much attention has been paid to anti-thrombotic materials applied in artificial organs, Surface modification has shown potential to improve the anti-coagulation of blood-contacting biomedical devices and materials [1-3]. Our in vitro study of Ti-O thin films has recently shown that Ti-O thin films Possess Superior blood compatibility to low temperature isotropic pyrolytic carbon (LTI-carbon) [1]. In this work, we have focussed our attention onto the in vivo evaluation of Ti-O thin films fabricated by plasma immersion ion implantation (PIII). The samples of titanium coated by Ti-O thin films were implanted in dogs' hearts for I month. The results of the implantation showed that no thrombus was found on the surfaces of the Ti-O thin film, although the coagulation occurred on the surfaces of LTI-carbon. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 SW Jiatong Univ, Dept Mat Engn, Inst Surface Engn Biomat, Chengdu 610031, Sichuan, Peoples R China.
   Southeast Univ, Inst Med, Dept Chest Surg, Nanjing 210000, Jiangsu, Peoples R China.
   City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RP Huang, N (reprint author), SW Jiatong Univ, Dept Mat Engn, Inst Surface Engn Biomat, Chengdu 610031, Sichuan, Peoples R China.
RI Chu, Paul/B-5923-2013; Leng, Yongxiang/G-5488-2010
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   BRASH JL, 1979, J POLYM SCI POL SYM, P377
   CACCIAFESTA P, 6 WORLD BIOM C T SOC, P287
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   GOODMAN SL, 1995, CELL MATER, V5, P15
   Heublein B, 1998, J ENDOVASC SURG, V5, P32, DOI 10.1583/1074-6218(1998)005<0032:SCCSCE>2.0.CO;2
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Nojiri C, 1990, ASAIO Trans, V36, pM168
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   SIT PS, 6 WORLD BIOM C T SOC, P63
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   YANGS P, 6 WORLD BIOM C SOC B, P1025
NR 14
TC 35
Z9 42
U1 1
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 1
PY 2002
VL 156
IS 1-3
BP 284
EP 288
AR PII S0257-8972(02)00087-7
DI 10.1016/S0257-8972(02)00087-7
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 567JB
UT WOS:000176480700051
DA 2018-10-20
ER

PT J
AU Chen, JY
   Wang, LP
   Fu, KY
   Huang, N
   Leng, Y
   Leng, YX
   Yang, P
   Wang, J
   Wan, GJ
   Sun, H
   Tian, XB
   Chu, PK
AF Chen, JY
   Wang, LP
   Fu, KY
   Huang, N
   Leng, Y
   Leng, YX
   Yang, P
   Wang, J
   Wan, GJ
   Sun, H
   Tian, XB
   Chu, PK
TI Blood compatibility and sp(3)/sp(2) contents of diamond-like carbon
   (DLC) synthesized by plasma immersion ion implantation-deposition
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Workshop on Plasma-Based Ion Implantation (PBII-2001)
CY JUN 25-28, 2001
CL GRENOBLE, FRANCE
SP CNRS, Univ Joseph Fourier, Inst Natl Polytechn Grenoble, European Commiss, Minist Affaires Etrangeres, Minist Educ Natl, Minist Defense/DGA, City Grenoble, Reg Rhone Alpes, Grenoble Alps METROPOLE
DE plasma immersion ion implantation-deposition; diamond-like carbon (DLC)
   film; microstructures; blood compatibility
ID FILMS; HEMOCOMPATIBILITY; COATINGS
AB Diamond-like carbon (DLC) is an attractive biomedical material due to its high inertness and excellent mechanical properties. Using plasma immersion ion implantation-deposition (PIII-D), DLC films are fabricated on silicon substrates at room temperature. By changing the C2H2 to Ar (F-C2H2/F-Ar) flow ratio during deposition, the effects of the reactive gas pressure and flow ratio on the characteristics of the DLC films are systematically examined to correlate to the blood compatibility. The thickness, surface morphology, composition, structure, sp(3)/sp(2) content, as well as carbon-hydrogen bonding are studied using alpha-step profilometry, atomic force microscopy (AFM), Rutherford backscattering spectrometry (RBS), Raman spectroscopy, and Fourier transform infrared spectroscopy (FTIR), respectively. The blood compatibility of the film is evaluated using in vitro platelet adhesion investigation, and the quantity and morphology of the adherent platelets are investigated employing optical microscopy and scanning electron microscopy (SEM). The Raman D-band to G-band intensity ratio is consistent with the adherent platelet quantity. Both first increase and then decrease with higher F-C2H2/F-Ar flow ratios. This implies that the blood compatibility of the DLC films is influenced by the ratio of sp(3) to sp(2), not by the absolute sp(3) or sp(2) content, Our study suggests that DLC films with the proper sp(3) to sp(2) ratio and good blood compatibility can be fabricated by C2H2-Ar PIII-D using a suitable C2H2/Ar gas ratio. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Peoples R China.
   Hong Kong Univ Sci & Technol, Dept Engn Mech, Kowloon, Hong Kong, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
RI Leng, Y.X./C-2278-2012; Wan, Guojiang/A-6651-2013; Leng,
   Yang/B-3187-2010; Wan, GJ/A-3648-2009; Leng, Yongxiang/G-5488-2010; Chu,
   Paul/B-5923-2013
OI Wan, Guojiang/0000-0002-1636-5405; Chu, Paul/0000-0002-5581-4883; Leng,
   Y.X./0000-0001-6823-1233
CR ANGUS JC, 1988, PLASMA DEPOSITED THI, P89
   Bhushan B, 1999, DIAM RELAT MATER, V8, P1985, DOI 10.1016/S0925-9635(99)00158-2
   CHEN JY, 2000, J HIGH TECHNOL, V10, P8
   Colthup N. B., 1990, INTRO INFRARED RAMAN
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   Dollish F. R., 1974, CHARACTERISTIC RAMAN
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   He XM, 1999, THIN SOLID FILMS, V355, P167, DOI 10.1016/S0040-6090(99)00652-5
   He XM, 1999, J VAC SCI TECHNOL A, V17, P2525, DOI 10.1116/1.581991
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   KNIGHT DS, 1989, J MATER RES, V4, P385, DOI 10.1557/JMR.1989.0385
   MCCULLOCH DG, 1994, PHYS REV B, V50, P5909
   NAGAI I, 1990, J APPL PHYS, V67, P2890, DOI 10.1063/1.345428
   Neuville S, 1997, MRS BULL, V22, P22
   ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q
   RUSLI SF, 1998, J VAC SCI TECHNOL A, V16, P572
   SEO SC, 1995, J VAC SCI TECHNOL A, V13, P2856, DOI 10.1116/1.579604
   TAMOR MA, 1994, J APPL PHYS, V76, P3823, DOI 10.1063/1.357385
   THOMSON A, 1991, BIOMATERIALS, V2, P37
   Tran HS, 1999, J INVEST SURG, V12, P133
   Yu LJ, 2000, SURF COAT TECH, V128, P484, DOI 10.1016/S0257-8972(00)00626-5
NR 21
TC 107
Z9 114
U1 1
U2 30
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 1
PY 2002
VL 156
IS 1-3
BP 289
EP 294
AR PII S0257-8972(02)00089-0
DI 10.1016/S0257-8972(02)00089-0
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 567JB
UT WOS:000176480700052
DA 2018-10-20
ER

PT J
AU Leng, YX
   Huang, N
   Yang, P
   Chen, JY
   Sun, H
   Wang, J
   Wan, GJ
   Tian, XB
   Fu, RKY
   Wang, LP
   Chu, PK
AF Leng, YX
   Huang, N
   Yang, P
   Chen, JY
   Sun, H
   Wang, J
   Wan, GJ
   Tian, XB
   Fu, RKY
   Wang, LP
   Chu, PK
TI Structure and properties of biomedical TiO2 films synthesized by dual
   plasma deposition
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Workshop on Plasma-Based Ion Implantation (PBII-2001)
CY JUN 25-28, 2001
CL GRENOBLE, FRANCE
SP CNRS, Univ Joseph Fourier, Inst Natl Polytechn Grenoble, European Commiss, Minist Affaires Etrangeres, Minist Educ Natl, Minist Defense/DGA, City Grenoble, Reg Rhone Alpes, Grenoble Alps METROPOLE
DE titanium oxide; microstructure; microhardness; metal vacuum arc plasma
   source; surface morphology
ID TITANIUM-OXIDE FILMS; IMMERSION ION-IMPLANTATION; VACUUM-ARC DEPOSITION
AB Titanium metal and titanium alloys are among the most widely used materials in biomedical devices because of their relatively high corrosion resistance and good biocompatibility. It has been suggested that the physiochemical and dielectric properties of the surface native oxide play a crucial role in the biocompatibility. There is increasing evidence that titanium may be extensively released in vivo and. under certain conditions, accumulated in adjacent tissues or transported to distant organs, Therefore, it is necessary to synthesize thicker and denser TiO2 films on titanium to enhance its biomedical properties. In this paper, we discuss our fabrication technique utilizing dual plasma generated by metal vacuum arc and radio frequency. The films fabricated consist of rutile crystal, although the substrates are not heated. As the oxygen partial pressure is raised, the intensity of the (101) and (110) diffraction peaks increases, and that of the (002) diffraction peak decreases. The preferred orientation of the TiO2 film shifts from (002) to (110) as a result of the competition between the surface free energy and ion bombardment. At low oxygen pressure, the TiO2 grain growth is mainly affected by ion bombardment, whereas thermodynamic factors affect the film growth at higher oxygen partial pressure. When the oxygen partial pressure reaches 0.93X10(-2) Pa, further increase in the oxygen flow rate does not change the film composition. The film is completely oxidized and only comprises the TiO2 phase. The microhardness of the TiO2 films increases with the oxygen partial pressure and reaches a maximum value of 19 GPa at 1.7 X 10(-2) Pa. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
RI Leng, Yongxiang/G-5488-2010; Wan, GJ/A-3648-2009; Wan,
   Guojiang/A-6651-2013; Chu, Paul/B-5923-2013
OI Wan, Guojiang/0000-0002-1636-5405; Chu, Paul/0000-0002-5581-4883; Leng,
   Y.X./0000-0001-6823-1233
CR Amor SB, 1997, MAT SCI ENG B-SOLID, V47, P110, DOI 10.1016/S0921-5107(97)00027-5
   Bendavid A, 2000, THIN SOLID FILMS, V360, P241, DOI 10.1016/S0040-6090(99)00937-2
   Chu PK, 1997, REV SCI INSTRUM, V68, P1866, DOI 10.1063/1.1147959
   Chu PK, 2001, REV SCI INSTRUM, V72, P1660, DOI 10.1063/1.1340029
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   Henderson MA, 1999, SURF SCI, V419, P174, DOI 10.1016/S0039-6028(98)00778-X
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   LOBL P, 1994, THIN SOLID FILMS, V251, P72, DOI 10.1016/0040-6090(94)90843-5
   Mandl S, 2001, NUCL INSTRUM METH B, V178, P148, DOI 10.1016/S0168-583X(01)00513-4
   Mandl S, 2000, SURF COAT TECH, V125, P84, DOI 10.1016/S0257-8972(99)00559-9
   Martin N, 1996, THIN SOLID FILMS, V287, P154, DOI 10.1016/S0040-6090(96)08782-2
   Martin N, 1998, SURF COAT TECH, V107, P172, DOI 10.1016/S0257-8972(98)00647-1
   MATTHEWS A, 1980, THIN SOLID FILMS, V72, P541, DOI 10.1016/0040-6090(80)90545-3
   Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3
   Takikawa H, 1999, THIN SOLID FILMS, V348, P145, DOI 10.1016/S0040-6090(99)00054-1
   TENDYS J, 1988, APPL PHYS LETT, V53, P2143, DOI 10.1063/1.100299
   Treichel O, 2000, SURF COAT TECH, V123, P268, DOI 10.1016/S0257-8972(99)00522-8
NR 19
TC 34
Z9 43
U1 2
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 1
PY 2002
VL 156
IS 1-3
BP 295
EP 300
AR PII S0257-8972(02)00092-0
DI 10.1016/S0257-8972(02)00092-0
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 567JB
UT WOS:000176480700053
DA 2018-10-20
ER

PT J
AU Jeong, B
   Gutowska, A
AF Jeong, B
   Gutowska, A
TI Lessons from nature: stimuli-responsive polymers and their biomedical
   applications
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID BIODEGRADABLE THERMOSENSITIVE POLYMERS; MODIFIED POLY(ACRYLIC ACID);
   COPOLYMER AQUEOUS-SOLUTIONS; OXIDE) TRIBLOCK COPOLYMER; DRUG-DELIVERY
   SYSTEMS; GENE DELIVERY; IN-SITU; TEMPERATURE SENSITIVITY; SMART
   POLYMERS; SIDE-GROUPS
AB Response to stimulus is a basic process of living systems. Based on the lessons from nature, scientists have been designing useful materials that respond to external stimuli such as temperature, pH, light, electric field, chemicals and ionic strength. These responses are manifested as dramatic changes in one of the following: shape, surface characteristics, solubility, formation of an intricate molecular self-assembly or a sol-to-gel transition. Applications of stimuliresponsive, or 'smart, polymers in delivery of therapeutics, tissue engineering, bioseparations, sensors or actuators have been studied extensively and numerous papers and patents are evidence of rapid progress in this area. Understanding the structure-property relationship is essential for the further development and rational design of new functional smart materials. For example, kinetic and thermodynamic control of the coil-to-globule transition could be achieved through changes in polymer composition and topology.
C1 Ewha Womans Univ, Dept Chem, Seoul 120750, South Korea.
   Pacific NW Natl Lab, Richland, WA 99352 USA.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem, Seoul 120750, South Korea.
CR Ahn Y., 2001, US patent, Patent No. [US 6103528, 6103528]
   ALBERTS B, 1994, MOL BIOL CELL, P645
   Aoyagi T, 2000, J BIOMAT SCI-POLYM E, V11, P101, DOI 10.1163/156856200743526
   Benns JM, 2000, BIOCONJUGATE CHEM, V11, P637, DOI 10.1021/bc0000177
   Bhardwaj R, 1996, J PHARM SCI, V85, P915, DOI 10.1021/js960097g
   Boyd G, 2001, ANAL BIOCHEM, V297, P15, DOI 10.1006/abio.2001.5317
   Bromberg L, 1998, J PHYS CHEM B, V102, P1956, DOI 10.1021/jp9803687
   Bromberg L, 1998, J PHYS CHEM B, V102, P10736, DOI 10.1021/jp983162e
   Bromberg L, 1998, IND ENG CHEM RES, V37, P4267, DOI 10.1021/ie980358s
   BROWN W, 1992, J PHYS CHEM-US, V96, P6038, DOI 10.1021/j100193a072
   Bulmus V, 2000, BIOCONJUGATE CHEM, V11, P78, DOI 10.1021/bc9901043
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Choi YH, 1999, HUM GENE THER, V10, P2657, DOI 10.1089/10430349950016690
   DAGANI R, 1997, CHEM ENG NEWS, V9, P26
   FOYE WO, 1989, PRINCIPLES MED CHEM, P641
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gan LH, 2000, MACROMOLECULES, V33, P7893, DOI 10.1021/ma000928b
   GLATTER O, 1994, MACROMOLECULES, V27, P6046, DOI 10.1021/ma00099a017
   Godbey WT, 2001, J CONTROL RELEASE, V72, P115, DOI 10.1016/S0168-3659(01)00267-X
   Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5
   Hirokawa Y, 1999, MACROMOLECULES, V32, P7093, DOI 10.1021/ma990437v
   Hoffman AS, 2000, J BIOMED MATER RES, V52, P577, DOI 10.1002/1097-4636(20001215)52:4<577::AID-JBM1>3.3.CO;2-X
   Inoue T, 1997, POLYM GELS NETW, V5, P561, DOI 10.1016/S0966-7822(97)00029-4
   Irvin DJ, 2001, CHEM MATER, V13, P1143, DOI 10.1021/cm000792w
   IZUMI A, 2001, MACROMOLECULES, V32, P4342
   Jeong B, 1999, J CONTROL RELEASE, V62, P109, DOI 10.1016/S0168-3659(99)00061-9
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 1999, COLLOID SURFACE B, V16, P185, DOI 10.1016/S0927-7765(99)00069-7
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong B, 2000, MACROMOLECULES, V33, P8317, DOI 10.1021/ma000638v
   JEONG B, 2001, CHEM COMMUN, V16, P1516
   JORGENSEN EB, 1997, MACROMOLECULES, V30, P1347
   Kaneko Y, 1998, MACROMOLECULES, V31, P6099, DOI 10.1021/ma971899g
   Kim HK, 1999, ENZYME MICROB TECH, V25, P31, DOI 10.1016/S0141-0229(99)00031-9
   Kippelen B, 1998, SCIENCE, V279, P54, DOI 10.1126/science.279.5347.54
   KUJAWA P, 2001, MACROMOLECULES, V43, P4130
   Lackey CA, 1999, BIOCONJUGATE CHEM, V10, P401, DOI 10.1021/bc980109k
   Lee H, 1998, BIOTECHNOL PROGR, V14, P508, DOI 10.1021/bp9701224
   Lee SB, 1999, MACROMOLECULES, V32, P7820, DOI 10.1021/ma990645n
   Li H, 1997, MACROMOLECULES, V30, P1347, DOI 10.1021/ma961520a
   Lim YB, 2000, PHARMACEUT RES, V17, P811, DOI 10.1023/A:1007552007765
   Lim YB, 1999, J AM CHEM SOC, V121, P5633, DOI 10.1021/ja984012k
   LOU LY, 2000, MACROMOLECULES, V33, P4992
   Lou Y.Z., 1993, J CHEM SOC FARADAY T, V89, P539
   MALMSTEN M, 1992, MACROMOLECULES, V25, P5446, DOI 10.1021/ma00046a050
   MORTENSEN K, 1993, MACROMOLECULES, V26, P805, DOI 10.1021/ma00056a035
   Murthy N, 1999, J CONTROL RELEASE, V61, P137, DOI 10.1016/S0168-3659(99)00114-5
   Oya T, 1999, SCIENCE, V286, P1543, DOI 10.1126/science.286.5444.1543
   Park SY, 1999, MACROMOL RAPID COMM, V20, P269, DOI 10.1002/(SICI)1521-3927(19990501)20:5<269::AID-MARC269>3.0.CO;2-3
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Philippova OE, 1997, MACROMOLECULES, V30, P8278, DOI 10.1021/ma970957v
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   Song SC, 1999, MACROMOLECULES, V32, P2188, DOI 10.1021/ma981190p
   Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630
   THOMAS JL, 1995, J AM CHEM SOC, V117, P2949, DOI 10.1021/ja00115a039
   TOPP MDC, 1997, MACROMOLECULES, V30, P8618
   Torres-Lugo M, 1999, MACROMOLECULES, V32, P6646, DOI 10.1021/ma990541c
   Urtti A, 2000, J DRUG TARGET, V7, P413, DOI 10.3109/10611860009102216
   VandenBout DA, 1997, SCIENCE, V277, P1074, DOI 10.1126/science.277.5329.1074
   Vernon B, 1999, J BIOMAT SCI-POLYM E, V10, P183, DOI 10.1163/156856299X00126
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Yang J., 1994, MACROMOLECULES, V27, P670
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   Zareie HM, 2000, POLYMER, V41, P6723, DOI 10.1016/S0032-3861(00)00008-2
NR 69
TC 523
Z9 541
U1 10
U2 367
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD JUL
PY 2002
VL 20
IS 7
BP 305
EP 311
AR PII S0167-7799(02)01962-5
DI 10.1016/S0167-7799(02)01962-5
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 568KF
UT WOS:000176540400015
PM 12062976
DA 2018-10-20
ER

PT J
AU Yin, G
   Liu, Z
   Zhan, J
   Ding, FX
   Yuan, NJ
AF Yin, G
   Liu, Z
   Zhan, J
   Ding, FX
   Yuan, NJ
TI Impacts of the surface charge property on protein adsorption on
   hydroxyapatite
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE hydroxyapatite; zeta-potential; bovine serum albumin; adsorption;
   kinetics
ID LYSOZYME; EXCHANGE; ALBUMIN
AB Knowledge of the adsorption mechanism of biological molecules on hydroxyapatite (HAP) is essential to the application of HAP chromatography and to the development of HAP-based biomedical materials. Centered on the surface charge of HAP and its impacts on adsorption of proteins, the present study started with the characterization of delta-potential of HAP as a function of the chemical properties of solution in terms of concentration of ions of different types, ionic strength and pH. Then the adsorption of bovine serum albumin (BSA) on HAP was carried out at the same conditions to elucidate the effects of delta-potential on BSA adsorption and the replacement of BSA with PO43- in acidic buffer. A Langmuir isotherm was obtained, indicating a single layer adsorption of BSA on HAP. Finally, the apparent activation energy and the adsorption heat were interpreted from the adsorption at different temperatures. The low magnitude of both the apparent activation energy and the adsorption heat indicated that the fast adsorption of BSA on HAP was a physical adsorption process. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Tsing Hua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.
RP Liu, Z (reprint author), Tsing Hua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.
CR Akazawa T, 1996, J MATER SCI LETT, V15, P1319
   ATKINS P, 1994, PHYSICAL CHEM
   BARROUG A, 1989, COLLOID SURFACE, V37, P339, DOI 10.1016/0166-6622(89)80130-1
   Barroug A, 1998, J COLLOID INTERF SCI, V208, P147, DOI 10.1006/jcis.1998.5759
   Barroug A, 1997, J COLLOID INTERF SCI, V189, P37, DOI 10.1006/jcis.1997.4787
   BERRY JL, 1986, J BIOMED MATER RES, V20, P65, DOI 10.1002/jbm.820200107
   Bosma JC, 1998, AICHE J, V44, P2399, DOI 10.1002/aic.690441108
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   FENG L, 1994, BIOMATERIALS, V15, P323
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KAWASAKI T, 1985, EUR J BIOCHEM, V152, P361, DOI 10.1111/j.1432-1033.1985.tb09206.x
   Luo QL, 1998, J COLLOID INTERF SCI, V200, P104, DOI 10.1006/jcis.1997.5364
   MARTINSON HG, 1974, BIOCHEMISTRY-US, V13, P1641, DOI 10.1021/bi00705a013
   PEARCE EIF, 1981, CALCIFIED TISSUE INT, V33, P395, DOI 10.1007/BF02409462
   SHIRKHANZADEH M, 1994, MATER LETT, V21, P115, DOI 10.1016/0167-577X(94)90134-1
   TISELIUS A, 1956, ARCH BIOCHEM BIOPHYS, V65, P132, DOI 10.1016/0003-9861(56)90183-7
NR 16
TC 107
Z9 110
U1 2
U2 57
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
J9 CHEM ENG J
JI Chem. Eng. J.
PD JUN 28
PY 2002
VL 87
IS 2
BP 181
EP 186
AR PII S1385-8947(01)00248-0
DI 10.1016/S1385-8947(01)00248-0
PG 6
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 571PM
UT WOS:000176725800006
DA 2018-10-20
ER

PT J
AU Shin, MS
   Kim, SI
   Kim, IY
   Kim, NG
   Song, GG
   Kim, SJ
AF Shin, MS
   Kim, SI
   Kim, IY
   Kim, NG
   Song, GG
   Kim, SJ
TI Characterization of hydrogels based on chitosan and copolymer of
   poly(dimethylsiloxane) and poly(vinyl alcohol)
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE hydrogels; swelling
ID ACID) IPN HYDROGELS; POLY(ACRYLIC ACID); POLYMER NETWORK;
   INTERPENETRATING NETWORKS; ELECTRIC STIMULUS; SQUID CHITIN; BEHAVIOR;
   COMPLEX
AB Copolymers composed of poly(vinyl alcohol) (PVA) and poly(dimethylsiloxane) (PDMS) were crosslinked with chitosan to prepare semi-interpenetrating polymer network (IPN) hydrogels by an ultraviolet (UV) irradiation method for application as potential biomedical materials. PVA/PDMS copolymer and chitosan was cast to prepare hydrogel films, followed by a subsequent crosslinking with 2,2-dimethoxy-2-phenylacetophenone as a nontoxic photoinitiator by UV irradiation. Various semi-interpenetrating polymer networks (semi-IPNs) were prepared from different weight ratios of chitosan and the copolymer of PVA/PDMS. Photocrosslinked hydrogels exhibited an equilibrium water content (EWC) in the range of 65-95%. Swelling behaviors of these hydrogels were studied by immersion of the gels in various buffer solutions. Particularly, the PCN13 as the highest chitosan weight ratio in semi-IPN hydrogels showed the highest EWC in time-dependent and pH-dependent swelling. (C) 2002 Wiley Periodicals, Inc.
C1 Korea Orthoped & Rehabil Engn Ctr, Inchon 403120, South Korea.
   Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea.
   Chonbuk Natl Univ, Dept Bion & Biomed Engn, Chonju 561756, South Korea.
RP Kim, SJ (reprint author), Korea Orthoped & Rehabil Engn Ctr, Inchon 403120, South Korea.
CR Aharoni S. M., 1992, SYNTHESIS CHARACTERI
   DeRossi D., 1991, POLYM GELS FUNDAMENT
   GUDEMAN LF, 1995, J MEMBRANE SCI, V107, P239, DOI 10.1016/0376-7388(95)00120-7
   GUDEMAN LF, 1995, J APPL POLYM SCI, V55, P919, DOI 10.1002/app.1995.070550610
   Kim SY, 1999, J APPL POLYM SCI, V74, P1752, DOI 10.1002/(SICI)1097-4628(19991114)74:7<1752::AID-APP18>3.0.CO;2-H
   Kim SY, 1999, J APPL POLYM SCI, V73, P1675, DOI 10.1002/(SICI)1097-4628(19990829)73:9<1675::AID-APP8>3.0.CO;2-9
   KLEMPNER O, 1991, ADV CHEM SER, P239
   KURITA K, 1993, J POLYM SCI POL CHEM, V31, P485, DOI 10.1002/pola.1993.080310220
   KURITA K, 1994, J POLYM SCI POL CHEM, V32, P1027, DOI 10.1002/pola.1994.080320603
   Lee JW, 1999, J APPL POLYM SCI, V73, P113
   LOPOUR P, 1993, BIOMATERIALS, V14, P1051, DOI 10.1016/0142-9612(93)90204-F
   MUZZARELLI RAA, 1977, CHITIN
   NISHI S, 1989, POLYM J, V21, P393, DOI 10.1295/polymj.21.393
   Roberts G, 1992, CHITIN CHEM
   Shin HS, 1998, J APPL POLYM SCI, V69, P479, DOI 10.1002/(SICI)1097-4628(19980718)69:3<479::AID-APP7>3.0.CO;2-D
   Wang HF, 1997, J APPL POLYM SCI, V65, P1445
   Yao KD, 1998, POLYM INT, V45, P191, DOI 10.1002/(SICI)1097-0126(199802)45:2<191::AID-PI892>3.0.CO;2-K
   Yao KD, 1994, J POLYM SCI A, V32, P1213
   YAO KD, 1993, J APPL POLYM SCI, V48, P343
NR 19
TC 27
Z9 29
U1 2
U2 15
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 28
PY 2002
VL 84
IS 14
BP 2591
EP 2596
DI 10.1002/app.10365
PG 6
WC Polymer Science
SC Polymer Science
GA 547KM
UT WOS:000175331600003
DA 2018-10-20
ER

PT J
AU Zheng, YJ
   Mieie, M
   Mello, SV
   Mabrouki, M
   Andreopoulos, FM
   Konka, V
   Pham, SM
   Leblanc, RM
AF Zheng, YJ
   Mieie, M
   Mello, SV
   Mabrouki, M
   Andreopoulos, FM
   Konka, V
   Pham, SM
   Leblanc, RM
TI PEG-based hydrogel synthesis via the photodimerization of anthracene
   groups
SO MACROMOLECULES
LA English
DT Article
ID PHOTO-CROSS-LINKING; LIGNIN SUPRAMOLECULAR STRUCTURES; SCANNING
   ELECTRON-MICROSCOPY; REVERSIBLE PHOTODIMERIZATION; PHOTOCHEMICAL METHOD;
   EOSINYL MOIETIES; POLYMER-CHAIN; COUMARIN; PHOTOGELATION; FLUORESCENCE
AB Photo-cross-linking has received a considerable attention for the design of intelligent materials in biochemical and biomedical applications. In this report, we describe the synthesis and properties of a novel photoreversible poly(ethylene glycol)- (PEG-) based hydrogel system. 9-Anthracenecarboxylic acid was used to modify the hydroxyl groups of an eight-armed PEG polymer (molecular weight 20 000) and the degree of substitution was determined to be 87.4%. The PEG-anthracene macromers (PEG-AN) exhibited high photosensitivity at wavelengths close to visible light (absorption maxima at 366 and 380 nm) and underwent rapid and reversible photo-cross-linking upon exposure to alternating wavelengths of irradiation (365/254 nm) in the absence of photoinitiators or catalysts. Changes in light exposure and wavelength of irradiation reversibly altered the physicochemical properties of the PEG-AN hydrogel, including swellability, absorption spectrum, and topography.
C1 Univ Miami, Ctr Supramol Sci, Coral Gables, FL 33124 USA.
   Univ Miami, Dept Chem, Coral Gables, FL 33124 USA.
   Univ Miami, Dept Biomed Engn, Miami, FL 33136 USA.
RP Andreopoulos, FM (reprint author), Univ Miami, Ctr Supramol Sci, Coral Gables, FL 33124 USA.
RI Zheng, Yujun/H-9122-2012; MABROUKI, Mustapha/B-2421-2012; Zheng,
   Yujun/P-8975-2014
OI MABROUKI, Mustapha/0000-0001-8975-9803; Zheng, Yujun/0000-0001-7116-3067
CR Ali AH, 1998, J APPL POLYM SCI, V67, P441, DOI 10.1002/(SICI)1097-4628(19980118)67:3<441::AID-APP6>3.0.CO;2-M
   Andreopoulos FM, 1998, BIOMATERIALS, V19, P1343, DOI 10.1016/S0142-9612(97)00219-6
   Andreopoulos FM, 1996, J AM CHEM SOC, V118, P6235, DOI 10.1021/ja954117c
   Andreopoulos FM, 2000, J POLYM SCI POL CHEM, V38, P1466, DOI 10.1002/(SICI)1099-0518(20000501)38:9<1466::AID-POLA9>3.0.CO;2-8
   BAYLISS MA, 1990, CHEM COMMUN, P305
   Bouas-Laurent H, 2000, CHEM SOC REV, V29, P43, DOI 10.1039/a801821i
   BOUASLAURENT H, 1990, PHOTOCHROMISM MOL SY, P561
   Cao DR, 2001, ANGEW CHEM INT EDIT, V40, P186, DOI 10.1002/1521-3773(20010105)40:1<186::AID-ANIE186>3.0.CO;2-X
   CHEN Y, 1995, J POLYM SCI POL CHEM, V33, P2705, DOI 10.1002/pola.1995.080331604
   CHEN Y, 1994, J POLYM SCI POL CHEM, V32, P1867, DOI 10.1002/pola.1994.080321007
   Chen Y, 1997, J POLYM SCI POL CHEM, V35, P613
   CHUJO Y, 1993, MACROMOLECULES, V26, P5611, DOI 10.1021/ma00073a012
   CHUJO Y, 1990, MACROMOLECULES, V23, P2693, DOI 10.1021/ma00212a017
   Coursan M, 1996, MACROMOL CHEM PHYSIC, V197, P1599, DOI 10.1002/macp.1996.021970502
   Giammona G, 1999, BBA-GEN SUBJECTS, V1428, P29, DOI 10.1016/S0304-4165(99)00051-3
   HASHIDATE S, 1995, POLYM ADVAN TECHNOL, V6, P626, DOI 10.1002/pat.1995.220060906
   Hoogen N, 2000, J POLYM SCI POL CHEM, V38, P1903, DOI 10.1002/(SICI)1099-0518(20000515)38:10<1903::AID-POLA780>3.0.CO;2-Q
   HUANG JX, 1995, ACTA CHIM SINICA, V53, P1018
   ICHIMURA K, 1984, J POLYM SCI POL CHEM, V22, P2817, DOI 10.1002/pol.1984.170221108
   Imai Y, 2000, POLYM BULL, V45, P9, DOI 10.1007/s002890070050
   INAKI Y, 1993, J SYN ORG CHEM JPN, V51, P188, DOI 10.5059/yukigoseikyokaishi.51.188
   ISHII T, 1994, J PHOTOCH PHOTOBIO A, V83, P55, DOI 10.1016/1010-6030(94)03805-8
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Kato M, 1998, MACROMOL CHEM PHYSIC, V199, P881
   Kim SH, 1999, CARBOHYD POLYM, V40, P183, DOI 10.1016/S0144-8617(99)00053-3
   Kuckling D, 1999, MACROMOL SYMP, V142, P111, DOI 10.1002/masy.19991420112
   Laschewsky A, 2000, MACROMOL RAPID COMM, V21, P937, DOI 10.1002/1521-3927(20000801)21:13<937::AID-MARC937>3.0.CO;2-9
   LIPPERT T, 2000, MACROMOL MATER ENG, V283, P2000
   MATSUDA T, 1991, J T AM SOC ARTIF INT, V37, pM437
   McSkimming G, 2000, ANGEW CHEM INT EDIT, V39, P2167, DOI 10.1002/1521-3773(20000616)39:12<2167::AID-ANIE2167>3.0.CO;2-9
   Micic M, 2000, J COLLOID INTERF SCI, V231, P190, DOI 10.1006/jcis.2000.7136
   Micic M, 1999, SCANNING, V21, P394
   Micic M, 2000, SCANNING, V22, P288
   NAKAYAMA Y, 1992, J POLYM SCI POL CHEM, V30, P2451, DOI 10.1002/pola.1992.080301119
   NAKAYAMA Y, 1993, J POLYM SCI POL CHEM, V31, P977, DOI 10.1002/pola.1993.080310417
   Schinner R, 1998, BER BUNSEN PHYS CHEM, V102, P1710, DOI 10.1002/bbpc.19981021137
   SCRANTON AB, 1997, ACS S SERIES, V673
   Smeds KA, 1999, J MACROMOL SCI PURE, VA36, P981, DOI 10.1081/MA-100101577
   Subramanian K, 2000, EUR POLYM J, V36, P2343, DOI 10.1016/S0014-3057(00)00008-2
   SUI G, 2000, COLLOID SURFACE, V171, P15
   Sui GD, 2000, LANGMUIR, V16, P7847, DOI 10.1021/la0005762
   TAZUKE S, 1976, J POLYM SCI POL CHEM, V14, P2463, DOI 10.1002/pol.1976.170141013
   TORII T, 1993, POLYM J, V25, P173, DOI 10.1295/polymj.25.173
   TORII T, 1992, POLYM J, V24, P1057, DOI 10.1295/polymj.24.1057
   Zhang YL, 2000, J POLYM SCI POL CHEM, V38, P2392, DOI 10.1002/1099-0518(20000701)38:13<2392::AID-POLA120>3.0.CO;2-P
   Zheng YJ, 2001, ADV FUNCT MATER, V11, P37, DOI 10.1002/1616-3028(200102)11:1<37::AID-ADFM37>3.0.CO;2-V
NR 46
TC 87
Z9 92
U1 6
U2 94
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUN 18
PY 2002
VL 35
IS 13
BP 5228
EP 5234
DI 10.1021/ma012263z
PG 7
WC Polymer Science
SC Polymer Science
GA 562TR
UT WOS:000176215500050
DA 2018-10-20
ER

PT J
AU Dutkiewicz, JK
AF Dutkiewicz, JK
TI Superabsorbent materials from shellfish waste - A review
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Review
DE disposable absorbent; personal care; medical care; chitin; chitosan;
   superabsorbent; SAP; SAM
AB Increasing global demand for improved absorbent materials for body fluids in disposable medical and personal-care articles creates an incentive for new basic research and development of efficient absorbent materials and systems with additional benefits such as biodegradability or certain biomedical functions. Highly absorbing materials based on polyelectrolyte polymers can absorb up to 50 grams of body fluid per gram of dry mass. Currently available synthetic superabsorbents are not biodegradable in landfills and do not offer any value-added functions to personal and medical-care products. Various academic and industrial research groups have put considerable amounts of effort and resources toward development of new absorbent materials from natural polymers, which would decompose in landfills. The basic substrates in these studies have been mainly polysaccharides, particularly cellulose and starch. The most common approach has involved converting these polymers into carboxymethyl derivatives followed by structural cross-linking. Commercial synthetic superabsorbent polymers as well as those derived from cellulose and starch are essentially polyanionic. On the other hand, polycationic absorbers seem to have potential functional advantages over the polyanionic counterparts. Chitin is the second abundant natural polymer, whose main derivative, chitosan, becomes polycationic in acid media. Currently, the main source of this polysaccharide is shellfish waste. This review provides basic information about new superabsorbent materials based on chitosan salts, their properties and preparation. (C) 2002 Wiley Periodicals, Inc.
C1 Buckeye Technol Inc, Prod Dev, Memphis, TN 38108 USA.
RP Dutkiewicz, JK (reprint author), Buckeye Technol Inc, Prod Dev, 1001 Tillman,POB 80407, Memphis, TN 38108 USA.
CR BEIHOFFER T, 2001, Patent No. 6194631
   BUCHHOLTZ F, 1994, ACS S SERIES SCI TEC, V537, P27
   DUTKIEWICZ J, 1992, ADVANCES IN CHITIN AND CHITOSAN, P54
   Dutkiewicz J, 1997, Patent, Patent No. [5,599,916, 5599916]
   DUTKIEWICZ J, 2000, ADV POLYM MAT MED HY, P23
   Dutkiewicz J., 1989, CHITIN CHITOSAN, P719
   DUTKIEWICZ J, 2000, ADV POLYM MAT MED HY, P66
   DUTKIEWICZ J, 1992, CHITIN DERIVATIVES L, P45
   DUTKIEWICZ J, 1999, 3 INT C MEDT 99 SWP
   DUTKIEWICZ J, 1992, CHITIN CHITOSAN, P496
   Dutkiewicz J, 1990, J BIOACT COMPAT POL, V5, P293, DOI 10.1177/088391159000500305
   DUTKIEWICZ JB, 2001, Patent No. 6197322
   GELMAN R A, 1987, US patent, Patent No. [4,689,408, 4689408]
   Gross J. R., 1992, U.S. Patent, Patent No. [5,079,354, 5079354]
   HAGINO Y, 1995, POLYM MAT SCI ENG, V72, P249
   HOLLENBERG D, 1991, Patent No. 0405993
   KELKENBERG H, 1996, Patent No. 5496933
   NAGORSKI H, 1994, ACS S SERIES SCI TEC, V537, P100
   Ning X., 1993, U.S. Patent, Patent No. [5,247,072, 5247072]
   OLSEN R, 1989, CHITIN CHITOSAN, P813
   PALUMBO G, 2000, Patent No. 6068924
   QIN J, 1993, Patent No. 5550189
   Roberts GAF, 1992, CHITIN CHEM, P54, DOI DOI 10.1007/978-1-349-11545-7_
   ROBERTS GAF, 1992, CHITIN CHEM, P21
NR 24
TC 66
Z9 68
U1 1
U2 71
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2002
VL 63
IS 3
BP 373
EP 381
DI 10.1002/jbm.10231
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552CM
UT WOS:000175600700017
PM 12115771
DA 2018-10-20
ER

PT J
AU Holzapfel, GA
   Stadler, M
   Schulze-Bauer, CAJ
AF Holzapfel, GA
   Stadler, M
   Schulze-Bauer, CAJ
TI A layer-specific three-dimensional model for the simulation of balloon
   angioplasty using magnetic resonance imaging and mechanical testing
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE atherosclerosis; balloon angioplasty; stent; MRI; mechanical model;
   mechanical stresses; finite-element analysis
ID FINITE-ELEMENT ANALYSIS; IN-VIVO; ATHEROSCLEROTIC PLAQUE; HUMAN
   ARTERIES; WALL; ULTRASOUND; COMPONENTS; STRESSES; INVITRO; DISEASE
AB A detailed understanding of the mechanical procedure of balloon angioplasty requires three-dimensional (3D) modeling and efficient numerical simulations. We have developed a 3D model for eight distinct arterial components associated with specific mechanical responses. The 3D geometrical model is based on in vitro magnetic resonance imaging of a human stenotic postmortem artery and is represented by nonuniform rational B-spline surfaces. Mechanical tests of the corresponding vascular tissues provide a fundamental basis for the formulation of large strain constitutive laws, which model the typical anisotropic, highly nonlinear, and inelastic mechanical characteristics under supraphysiological loadings. The 3D finite-element realization considers the balloon-artery interaction and accounts for vessel-specific axial in situ prestretches. 3D stress states of the investigated artery during balloon expansion and stent deployment were analyzed. Furthermore, we studied the changes of the 3D stress state due to model simplifications, which are characterized by neglecting axial in situ prestretch, assuming plane strain states, and isotropic material responses, as commonly utilized in previous works. Since these simplifications lead to maximum stress deviations of up to 600%-where even the stress character may interchange-the associated models are, in general, inappropriate. The proposed approach provides a tool that has the potential (i) to improve procedural protocols and the design of interventional instruments on a lesion-specific basis, and (ii) to determine postangioplasty mechanical environments, which may be correlated with restenosis responses. (C) 2002 Biomedical Engineering Society.
C1 Graz Univ Technol, Inst Struct Anal Computat Biomech, A-8010 Graz, Austria.
RP Holzapfel, GA (reprint author), Graz Univ Technol, Inst Struct Anal Computat Biomech, Schiesstattgasse 14-B, A-8010 Graz, Austria.
CR *AM HEART ASS, 2000, 2001 HEART STROK STA
   Auricchio F, 2001, COMPUTER METHODS BIO, V4, P249, DOI DOI 10.1080/10255840108908007
   BE H, 1996, DATA BOOK MECH PROPE
   BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P445, DOI 10.1113/jphysiol.1961.sp006686
   BLOCK PC, 1984, AM J CARDIOL, V53, P69
   CastanedaZuniga W., 1985, IMPROVEMENT MYOCARDI, P138
   CASTANEDAZUNIGA WR, 1980, RADIOLOGY, V135, P565, DOI 10.1148/radiology.135.3.7384437
   COX RH, 1976, AM J PHYSIOL, V230, P462
   DIMARIO C, 1995, AM J CARDIOL, V75, P772, DOI 10.1016/S0002-9149(99)80409-3
   Fayad ZA, 2000, CIRCULATION, V101, P2503, DOI 10.1161/01.CIR.101.21.2503
   Fayad ZA, 2000, CIRCULATION, V102, P506
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Fung Y., 1990, BIOMECHANICS MOTION
   FUNG YC, 1979, AM J PHYSIOL, V237, pH620
   GASSER TC, UNPUB RATE INDEPENDE
   Gourisankaran V, 2000, CRIT REV BIOMED ENG, V28, P47, DOI 10.1615/CritRevBiomedEng.v28.i12.90
   Hibbett Karlsson Sorensen, 1998, ABAQUS STAND US MAN
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Holzapfel GA, 1996, COMPUT METHOD APPL M, V132, P45, DOI 10.1016/0045-7825(96)00999-1
   Holzapfel GA, 2001, HDB MAT BEHAV MODELS, P1049
   HOLZAPFEL GA, IN PRESS EUR J MEC A
   Holzapfel GA, 2000, NONLINEAR SOLID MECH
   HOLZAPFEL GA, 2000, MECH BIOL, V242, P141
   Hoschek J., 1993, FUNDAMENTALS COMPUTE
   Humphrey JD, 1995, CRIT REV BIOMED ENG, V23, P1
   Humphrey JD, 2002, CARDIOVASCULAR SOLID
   LEE RT, 1993, J AM COLL CARDIOL, V21, P777, DOI 10.1016/0735-1097(93)90112-E
   Luk-Pat GT, 1999, MAGNET RESON MED, V42, P762, DOI 10.1002/(SICI)1522-2594(199910)42:4<762::AID-MRM19>3.0.CO;2-M
   Macaya C, 1996, J AM COLL CARDIOL, V27, P255, DOI 10.1016/0735-1097(95)00473-4
   MARIO CD, 1995, AM J CARDIOL, V75, P772
   MARTIN AJ, 1995, JMRI-J MAGN RESON IM, V5, P93, DOI 10.1002/jmri.1880050117
   Nagtegaal J. C., 1974, Computer Methods in Applied Mechanics and Engineering, V4, P153, DOI 10.1016/0045-7825(74)90032-2
   Nichols W.W., 1998, MCDONALDS BLOOD FLOW, P73
   OH S, 1994, MED BIOL ENG COMPUT, V32, pS108, DOI 10.1007/BF02523336
   OKTAY HS, 1991, ASME 1991 BIOM S NEW, V120
   PATEL DJ, 1969, CIRC RES, V24, P1
   Piegel L., 1997, NURBS BOOK
   RHODIN JAG, 1980, HDB PHYSL 2, V2, P1, DOI DOI 10.1002/CPHY.CP020201
   RICHARDSON PD, 1989, LANCET, V2, P941
   RODRIGUEZ EK, 1994, J BIOMECH, V27, P455, DOI 10.1016/0021-9290(94)90021-3
   Rogers WJ, 2000, ARTERIOSCL THROM VAS, V20, P1824, DOI 10.1161/01.ATV.20.7.1824
   SCHULZEBAUER CAJ, UNPUB PASSIVE BIAXIA
   Shinnar M, 1999, ARTERIOSCL THROM VAS, V19, P2756, DOI 10.1161/01.ATV.19.11.2756
   Simo J., 1998, COMPUTATIONAL INELAS
   SIMO JC, 1991, COMPUT METHOD APPL M, V85, P273, DOI 10.1016/0045-7825(91)90100-K
   SIMO JC, 1985, COMPUT METHOD APPL M, V51, P177, DOI 10.1016/0045-7825(85)90033-7
   STARY HC, 1992, CIRCULATION, V85, P391, DOI 10.1161/01.CIR.85.1.391
   Taber LA, 1998, J BIOMECH ENG-T ASME, V120, P348, DOI 10.1115/1.2798001
   TABER LA, 1995, APPL MECH REV, V48, P487, DOI DOI 10.1115/1.3005109
   THE SHK, 1992, CIRCULATION, V86, P483, DOI 10.1161/01.CIR.86.2.483
   Toussaint JF, 1996, CIRCULATION, V94, P932, DOI 10.1161/01.CIR.94.5.932
   TOUSSAINT JF, 1995, ARTERIOSCL THROM VAS, V15, P1533
   Wriggers P, 1995, ARCH COMPUTATIONAL M, V2, P1
   YUAN C, 1995, JMRI-J MAGN RESON IM, V5, P561, DOI 10.1002/jmri.1880050515
   ZOLLIKOFER CL, 1984, RADIOLOGY, V153, P369, DOI 10.1148/radiology.153.2.6237385
NR 55
TC 154
Z9 161
U1 1
U2 19
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2002
VL 30
IS 6
BP 753
EP 767
DI 10.1114/1.1492812
PG 15
WC Engineering, Biomedical
SC Engineering
GA 587LA
UT WOS:000177640900002
PM 12220076
DA 2018-10-20
ER

PT J
AU Yakovlev, VV
   Ivanov, A
   Shcheslavskiy, V
AF Yakovlev, VV
   Ivanov, A
   Shcheslavskiy, V
TI High-energy femtosecond Cr4+: forsterite oscillators and their
   applications in biomedical and material sciences
SO APPLIED PHYSICS B-LASERS AND OPTICS
LA English
DT Article; Proceedings Paper
CT 3rd Ultrafast Optics Conference
CY JUL 22-26, 2001
CL QUEBEC CITY, CANADA
ID CHROMIUM-DOPED FORSTERITE; WAVE CR4+-FORSTERITE LASER; 3RD-HARMONIC
   GENERATION; FLUORESCENCE MICROSCOPY; ROOM-TEMPERATURE; CW OPERATION;
   MODE-LOCKING; TI-SAPPHIRE; PULSES; POWER
AB We have designed and successfully developed a long-cavity Cr4+:forsterite femtosecond oscillator, which delivers < 40 fs pulses with an energy per pulse of over 15 nJ. Complete self-starting is demonstrated. Ablation and phase transformations of semiconductor materials are achieved by the tight focusing of the laser output using a microscope objective. It is also demonstrated that Cr4+:forsterite has significant advantages over Ti: sapphire for multiphoton fluorescence and coherent non-linear optical microscopy.
C1 Univ Wisconsin, Dept Phys, Milwaukee, WI 53201 USA.
RP Yakovlev, VV (reprint author), Univ Wisconsin, Dept Phys, POB 413, Milwaukee, WI 53201 USA.
RI Yakovlev, Vladislav/P-4668-2015
CR Abraham E, 2000, OPT LETT, V25, P929, DOI 10.1364/OL.25.000929
   Agnesi A, 1997, OPT COMMUN, V135, P77, DOI 10.1016/S0030-4018(96)00604-9
   Balembois F, 1997, IEEE J QUANTUM ELECT, V33, P269, DOI 10.1109/3.552268
   Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442
   BIMBERG D, 1971, PHYS REV B-SOLID ST, V4, P3451, DOI 10.1103/PhysRevB.4.3451
   CARRIG TJ, 1993, IEEE J QUANTUM ELECT, V29, P2835, DOI 10.1109/3.248943
   CARRIG TJ, 1991, OPT LETT, V16, P1662, DOI 10.1364/OL.16.001662
   Cheng PC, 2001, PROC SPIE, V4262, P98, DOI 10.1117/12.424541
   Cho SH, 1999, OPT LETT, V24, P417, DOI 10.1364/OL.24.000417
   Chudoba C, 2001, OPT LETT, V26, P292, DOI 10.1364/OL.26.000292
   Daria V, 1998, JPN J APPL PHYS 2, V37, pL959, DOI 10.1143/JJAP.37.L959
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Golubovic B, 1997, OPT LETT, V22, P1704, DOI 10.1364/OL.22.001704
   Guo Y, 1996, APPL OPTICS, V35, P6810, DOI 10.1364/AO.35.006810
   GURDON JB, 1982, METHODS DEV BIOL, P75
   Haugland RP, 1997, HDB FLUORESCENT PROB
   Ivanov A, 2001, APPL OPTICS, V40, P6034, DOI 10.1364/AO.40.006034
   IVANOV AA, 1995, OPT COMMUN, V116, P131, DOI 10.1016/0030-4018(95)00064-F
   Jonusauskas G, 1998, OPT LETT, V23, P1918, DOI 10.1364/OL.23.001918
   Konig K, 1997, OPT LETT, V22, P135, DOI 10.1364/OL.22.000135
   Konig K, 1999, P SOC PHOTO-OPT INS, V3616, P100, DOI 10.1117/12.351834
   LEZNER M, 1998, PHYS REV LETT, V80, P4076
   LIBERTUN R, 1999, CLEO P, P469
   McKinnie IT, 1996, APPL OPTICS, V35, P4159, DOI 10.1364/AO.35.004159
   Muller M, 2000, J MICROSC-OXFORD, V197, P150
   Muller M, 1998, J MICROSC-OXFORD, V191, P266
   PARSA P, 1989, APPL OPTICS, V28, P2325, DOI 10.1364/AO.28.002325
   Patterson GH, 2000, BIOPHYS J, V78, P2159, DOI 10.1016/S0006-3495(00)76762-2
   Peleg G, 1999, P NATL ACAD SCI USA, V96, P6700, DOI 10.1073/pnas.96.12.6700
   PETRICEVIC V, 1988, APPL PHYS LETT, V52, P1040, DOI 10.1063/1.99203
   PETRICEVIC V, 1989, OPT LETT, V14, P612, DOI 10.1364/OL.14.000612
   PETROV GI, 2001, OPT LETT, V27, P655
   Potma EO, 2000, J OPT SOC AM B, V17, P1678, DOI 10.1364/JOSAB.17.001678
   Rotermund F, 2000, OPT LETT, V25, P746, DOI 10.1364/OL.25.000746
   Schaffer CB, 2001, OPT LETT, V26, P93, DOI 10.1364/OL.26.000093
   Schonle A, 1998, OPT LETT, V23, P325, DOI 10.1364/OL.23.000325
   SEAS A, 1992, OPT LETT, V17, P937, DOI 10.1364/OL.17.000937
   Sennaroglu A, 1998, IEEE J QUANTUM ELECT, V34, P1996, DOI 10.1109/3.720239
   SHCHESLAVSKII V, 2001, P SOC PHOTO-OPT INS, V4262, P192
   Shcheslavskiy V, 1999, IEEE J QUANTUM ELECT, V35, P1123, DOI 10.1109/3.777211
   Shcheslavskiy V, 2001, OPT LETT, V26, P1999, DOI 10.1364/OL.26.001999
   Shen YR, 2000, IEEE J SEL TOP QUANT, V6, P1375, DOI 10.1109/2944.902191
   Shimizu H, 2000, IEEE J QUANTUM ELECT, V36, P728, DOI 10.1109/3.845730
   Slobodchikov E, 1996, OPT LETT, V21, P354, DOI 10.1364/OL.21.000354
   SPENCE DE, 1991, OPT LETT, V16, P42, DOI 10.1364/OL.16.000042
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Tuchin V. V., 2000, TISSUE OPTICS
   VERDUN HR, 1991, OSA PROC, V10, P35
   Xu C, 1997, APPL PHYS LETT, V71, P2578, DOI 10.1063/1.119334
   Yakovlev VV, 2001, PROC SPIE, V4254, P97, DOI 10.1117/12.427951
   Yakovlev VV, 2001, P SOC PHOTO-OPT INS, V4267, P46, DOI 10.1117/12.424618
   YANOVSKY V, 1993, OPT LETT, V18, P1541, DOI 10.1364/OL.18.001541
   Zhang ZG, 1997, IEEE J QUANTUM ELECT, V33, P1975, DOI 10.1109/3.641312
   Zhavoronkov N, 1997, APPL OPTICS, V36, P8601, DOI 10.1364/AO.36.008601
   Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142
NR 55
TC 10
Z9 10
U1 0
U2 0
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0946-2171
J9 APPL PHYS B-LASERS O
JI Appl. Phys. B-Lasers Opt.
PD JUN
PY 2002
VL 74
SU S
BP S145
EP S152
DI 10.1007/s00340-002-0904-x
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA 590GY
UT WOS:000177812200024
DA 2018-10-20
ER

PT J
AU Keating, P
   Cambrosio, A
AF Keating, P
   Cambrosio, A
TI From screening to clinical research: The cure of leukemia and the early
   development of the cooperative oncology groups, 1955-1966
SO BULLETIN OF THE HISTORY OF MEDICINE
LA English
DT Article
DE cooperative oncology groups; clinical research; leukemia; cancer
   chemotherapy; National Cancer Institute; clinical trials; screening;
   United States
ID NATIONAL-CANCER-INSTITUTE; SICKLE-CELL-ANEMIA; HISTORIC MILESTONES;
   MEMORIAL LECTURE; CHEMOTHERAPY; MEDICINE; THERAPY; ORIGINS; DISEASE
AB Recent work in the history and sociology of biomedicine has emphasized the novelty of the biomedical enterprise as a distinctive institutional, material, and epistemological configuration. Since World War II, biology and medicine have become such tightly intertwined research enterprises that those working in biomedicine cannot predict whether a particular research project, clinical investigation, or even clinical intervention will result in biological or medical facts,. In this paper, we examine part of the process of the emergence of biomedicine by focusing on the development of clinical cancer trials in the United States in the years 1955-66, a period during which the clinical trials program run by the National Cancer Institute became autonomous from the Institute's screening program for anticancer compounds. We examine in particular the work carried out by the cooperative groups and the Acute Leukemia Task Force to which they belonged, analyzing the evolution of the relations between screening, chemotherapy, clinical trials, and clinical research.
C1 Univ Quebec, Dept Hist, Montreal, PQ H3C 3P8, Canada.
   McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 2T5, Canada.
RP Keating, P (reprint author), Univ Quebec, Dept Hist, Montreal, PQ H3C 3P8, Canada.
EM keating.peter@uqam.ca; alberto.cambrosio@mcgill.ca
CR Ahrens E. H., 1992, CRISIS CLIN RES OVER
   AMSTERDAMSKA O, 1998, MOL BIOL MED NEW PRA, P47
   BENNET JM, 1988, IMMUNOLOGIC APPROACH
   Bernard J, 1951, B MEM SOC MED HOPITA, V16, P621
   BISEL HF, 1956, BLOOD, V11, P676
   Brenner MK, 1999, SEMIN HEMATOL, V36, P73
   BUD RF, 1978, SOC STUD SCI, V8, P441
   BURCHENAL J H, 1960, Natl Cancer Inst Monogr, V3, P149
   BURCHENAL JH, 1975, CANCER-AM CANCER SOC, V35, P1121, DOI 10.1002/1097-0142(197504)35:4<1121::AID-CNCR2820350416>3.0.CO;2-B
   CAMBROSIO A, 2001, INT ENCY SOCIAL BEHA, V2, P1222
   CASKEY CT, 1992, CODE CODES SCI SOCIA, P112
   COOPER JD, 1965, SCIENCE, V148, P1433, DOI 10.1126/science.148.3676.1433
   Dausset Jean, 1998, CLIN OEIL VIE GRANDE
   DAVIS HC, 1980, CANCER RES IMPACT CO, P371
   DEVITA VT, 1984, CANCER TREAT REP, V68, P1
   ENDICOTT K M, 1958, J Chronic Dis, V8, P171, DOI 10.1016/0021-9681(58)90047-X
   ENDICOTT KM, 1957, INTERIM REPORT CANC
   ENDICOTT KM, 1966, COMMUNICATION   0917
   ENDICOTT KM, 1966, COMMUNICATION   0624
   FARBER S, 1956, ADV CANCER RES, V4, P1, DOI 10.1016/S0065-230X(08)60721-6
   Feldman SD, 1997, B HIST MED, V71, P623, DOI 10.1353/bhm.1997.0178
   FREI, 1983, CANC LETT, V9, P5
   FREI E, 1984, CANCER TREAT REP, V68, P21
   FREI E, 1958, BLOOD, V13, P1126
   FREI E, 1961, BLOOD, V18, P451
   FREI E, 1965, ADV CHEMOTHER, V2, P265
   FREI E., 1964, PROC AMER ASSOC CANCER RES, V5, P20
   FREIREICH EJ, 1963, BLOOD, V21, P699
   FREIREICH J, 1991, MILESTONES LEUKEMIA, P78
   Furth J., 1937, AM J CANCER, V31, P276, DOI DOI 10.1158/AJC.1937.276
   Gaudilliere J.-P., 1999, PRACTICES HUMAN GENE, P89
   GAUDILLIERE JP, 1993, COLLOQ INSE, V220, P213
   GAUDILLIERE JP, 1994, SCI BIOL MED FRANCE, P265
   GEHAN EA, 1990, STAT MED, V9, P871, DOI 10.1002/sim.4780090803
   GELLHORN A, 1955, CANCER RES         S, V3, P1
   GELLHORN A, 1959, CANC CHEMOTHER REP, V5, P7
   GOODMAN L, 1963, AM J SURG, V105, P574
   GOODRICH G, 1991, SO RES I ORAL HIST, P64
   Hall Stephen S, 1997, COMMOTION BLOOD LIFE
   Harris NL, 1999, ANN ONCOL, V10, P1419, DOI 10.1023/A:1008375931236
   HOLLAND J, 1968, 21 ANN S FUND CANC R, P453
   HOLLAND JF, 1995, CALGB NEWSL, V4, P6
   Keating P, 2000, CONFIGURATIONS, V8, P337, DOI 10.1353/con.2000.0021
   Keating P, 2001, J HIST MED ALL SCI, V56, P321, DOI 10.1093/jhmas/56.4.321
   KEATING P, 2000, 37 ANN M AM ASS HIST
   LASZLO J, 1995, CURE CHILDHOOD LEUKE, P220
   LAW LW, 1952, CANCER RES, V12, P871
   LAW LW, 1952, CANCER RES, V13, P871
   LEE STANLEY L., 1962, CANCER CHEMOTHER REPTS, V16, P151
   Li YP, 1997, BLOOD, V90, P306
   LOWY I, 1995, SCI CONTEXT, V8, P209
   LOWY I, 1994, J HIST BIOL, V27, P403, DOI 10.1007/BF01058992
   Lowy I., 1998, INVISIBLE IND MANUFA, P209
   Lowy I., 1996, BENCH BEDSIDE SCI HE
   LYON J, 1996, ALTERED FATES GENE T
   MARKS HM, 1997, PROGR EXPT SCI THERA
   *MED RES COUNC, 1963, BRIT MED J, V5, P7
   MELDRUM ML, 1994, THESIS STATE U NEW Y
   Morange M., 1998, LA PART DES GENES
   *NCI, 1967, ANN REP PROGR ACT, V1, P97
   *NIH NCI, 1958, ANN REPORT PROGRAM A, V1, P52
   *NIH NCI, 1960, ANN REPORT PROGRAM A, V1, P12
   NOWAK R, 1994, SCIENCE, V264, P1538, DOI 10.1126/science.8202708
   OSGOOD EE, 1952, JAMA-J AM MED ASSOC, V150, P1372, DOI 10.1001/jama.1952.03680140010003
   PATTERSON JT, 1987, DREAD DIS CANC MODER, P172
   PERLOFF M, 1982, CANC MED, P515
   PICARD JF, 1994, SCI BIOL MED FRANCE, P329
   Rheinberger Hans-Jorg, 1997, HIST EPISTEMIC THING
   RICHARDSON AP, 1966, REPORT CANC CHEMOTHE, P58
   SHEAR MJ, 1947, APPROACHES TUMOR CHE, P236
   Sinding C., 1991, CLIN CHERCHEUR GRAND
   SKIPPER HE, 1949, CANCER-AM CANCER SOC, V2, P475, DOI 10.1002/1097-0142(194905)2:3<475::AID-CNCR2820020311>3.0.CO;2-3
   SKIPPER HE, 1979, SEMIN ONCOL, V6, P506
   SKIPPER HE, 1964, B SO RES I, V17, P3
   SKIPPER HE, 1964, CANC CHEMOTHER REP, V35, P9
   SLOAN M, 1964, PROPOSAL ESTABLISHME
   SPENCER MC, 1965, CANC RES S, V25, P1
   TIERNEY LM, 1994, CURRENT MED DIAGNOSI, P67
   WAILOO K, 1991, B HIST MED, V65, P185
   WOOLDRIDGE DE, 1965, BIOMEDICAL SCI ITS A, P85
   ZUBROD, 1959, COMMUNICATION   1222
   ZUBROD C. G., 1966, CANCER CHEMOTHERAP REP, V50, P349
   ZUBROD CG, 1979, SEMIN ONCOL, V6, P490
   ZUBROD CG, 1980, MED PEDIATR ONCOL, V8, P107, DOI 10.1002/mpo.2950080202
   ZUBROD CG, 1984, CANCER TREAT REP, V68, P9
   ZUBROD CG, 1997, NCI ORAL HIST PROJEC, P71
   ZUBROD CG, 1962, 4 IBM MED S 22 26 OC
NR 87
TC 29
Z9 30
U1 0
U2 3
PU JOHNS HOPKINS UNIV PRESS
PI BALTIMORE
PA JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD
   21218-4363 USA
SN 0007-5140
J9 B HIST MED
JI Bull. Hist. Med.
PD SUM
PY 2002
VL 76
IS 2
BP 299
EP 334
DI 10.1353/bhm.2002.0074
PG 36
WC Health Care Sciences & Services; History & Philosophy Of Science
SC Health Care Sciences & Services; History & Philosophy of Science
GA 560CE
UT WOS:000176063400004
PM 12060792
DA 2018-10-20
ER

PT J
AU Boccaccini, AR
   Zhitomirsky, I
AF Boccaccini, AR
   Zhitomirsky, I
TI Application of electrophoretic and electrolytic deposition techniques in
   ceramics processing
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
ID YTTRIA-STABILIZED ZIRCONIA; OXIDE FUEL-CELLS; GLASS-MATRIX COMPOSITES;
   THIN-FILMS; ZINC-OXIDE; ELECTROCHEMICAL DEPOSITION; HYDROXYAPATITE
   COATINGS; EPITAXIAL ELECTRODEPOSITION; ORGANOCERAMIC FILMS;
   MICROMETER-SCALE
AB Electrodeposition is gaining increasing interest as a ceramic processing technique for a variety of technical applications. Major advances in the areas of electrophoretic deposition (EPD) and electrolytic deposition (ELD) achieved in the last 24 months include the . fabrication of: electrodes and films for solid oxide fuel cells, fibre-reinforced and graded ceramic composites, nanostructured materials as well as a variety of advanced films and coatings for electronic, biomedical optical, catalytic and electrochemical applications. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
   McMaster Univ, Dept Mat Sci & Engn, Hamilton, ON L8S 4L7, Canada.
RP Boccaccini, AR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
RI Boccaccini, Aldo/C-7905-2013
CR Affoune AM, 2001, LANGMUIR, V17, P547, DOI 10.1021/la001317f
   Ahlers CB, 2000, ELECTROCHIM ACTA, V45, P3379, DOI 10.1016/S0013-4686(00)00406-0
   Barton JK, 2001, CHEM MATER, V13, P952, DOI 10.1021/cm000707k
   Basu RN, 2001, J AM CERAM SOC, V84, P33, DOI 10.1111/j.1151-2916.2001.tb00604.x
   Boccaccini AR, 2001, COMPOS PART A-APPL S, V32, P997, DOI 10.1016/S1359-835X(00)00168-8
   Boccaccini AR, 2001, MATER LETT, V51, P225, DOI 10.1016/S0167-577X(01)00294-4
   Cattarin S, 2001, ELECTROCHIM ACTA, V46, P4229, DOI 10.1016/S0013-4686(01)00713-7
   Chen CY, 1999, ACTA MATER, V47, P2717, DOI 10.1016/S1359-6454(99)00140-8
   Chen FL, 2001, J EUR CERAM SOC, V21, P127, DOI 10.1016/S0955-2219(00)00195-3
   Chigane M, 2001, J ELECTROCHEM SOC, V148, pD96, DOI 10.1149/1.1376637
   Choi HC, 2001, CHEM COMMUN, P1614, DOI 10.1039/b104586p
   de Sena LA, 2002, J BIOMED MATER RES, V60, P1
   Dinamani M, 2001, MATER RES BULL, V36, P2043, DOI 10.1016/S0025-5408(01)00682-1
   Ferrari B, 2001, J AM CERAM SOC, V84, P733, DOI 10.1111/j.1151-2916.2001.tb00734.x
   Ferrari B, 2000, J EUR CERAM SOC, V20, P99, DOI 10.1016/S0955-2219(99)00152-1
   Gani M. S. J., 1994, IND CERAM, V14, P163
   Gao B, 2001, ADV MATER, V13, P1770, DOI 10.1002/1521-4095(200112)13:23<1770::AID-ADMA1770>3.0.CO;2-G
   Greil P, 2001, Z METALLKD, V92, P682
   Guelcher SA, 2000, POWDER TECHNOL, V110, P90, DOI 10.1016/S0032-5910(99)00271-5
   Hajjaji SE, 2001, SURF ENG, V17, P201
   HAJJAJI SE, 2001, APPL SURF SCI, V180, P293
   Hamagami J, 2002, KEY ENG MAT, V216, P53, DOI 10.4028/www.scientific.net/KEM.216.53
   Hatton B, 2001, J AM CERAM SOC, V84, P571, DOI 10.1111/j.1151-2916.2001.tb00700.x
   Hill LI, 2001, ELECTROCHEM SOLID ST, V4, pA180, DOI 10.1149/1.1402495
   Hossein-Babaei F, 2000, ELECTRON LETT, V36, P1815, DOI 10.1049/el:20001258
   Hosseinbabaei F, 2000, J EUR CERAM SOC, V20, P2165, DOI 10.1016/S0955-2219(00)00081-9
   Ishihara T, 2000, J AM CERAM SOC, V83, P1921
   Ishikawa Y, 2001, ELECTROCHIM ACTA, V46, P2819, DOI 10.1016/S0013-4686(01)00490-X
   Jeon BS, 2000, J ELECTROCHEM SOC, V147, P4356, DOI 10.1149/1.1394069
   Kanamura K, 2001, J POWER SOURCES, V97-8, P294, DOI 10.1016/S0378-7753(01)00678-4
   Karuppuchamy S, 2001, THIN SOLID FILMS, V397, P63, DOI 10.1016/S0040-6090(01)01356-6
   Kawachi M, 2001, PHYSICA C, V357, P1023, DOI 10.1016/S0921-4534(01)00512-3
   Kaya C, 2001, ACTA MATER, V49, P1189, DOI 10.1016/S1359-6454(01)00018-0
   Kaya C, 2001, J MATER SCI LETT, V20, P1465, DOI 10.1023/A:1017993509507
   Kaya C, 2000, J AM CERAM SOC, V83, P1885
   KE C, 2001, CHEM COMMUN, V8, P783
   Kooner S, 2000, J EUR CERAM SOC, V20, P631, DOI 10.1016/S0955-2219(99)00262-9
   Lessing PA, 2000, J MATER SCI, V35, P2913, DOI 10.1023/A:1004766424209
   Limmer SJ, 2002, ADV FUNCT MATER, V12, P59, DOI 10.1002/1616-3028(20020101)12:1<59::AID-ADFM59>3.0.CO;2-B
   Limmer SJ, 2001, ADV MATER, V13, P1269, DOI 10.1002/1521-4095(200108)13:16<1269::AID-ADMA1269>3.0.CO;2-S
   Liu R, 2001, CHEM MATER, V13, P508, DOI 10.1021/cm0007631
   Manocha LM, 2000, SCI ENG COMPOS MATER, V9, P219
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   MATTHEWS T, 2000, SOLID STATE IONICS, V128, P111
   Moreno R, 2000, AM CERAM SOC BULL, V79, P44
   Moritz K, 2002, KEY ENG MAT, V206-2, P193
   Negishi H, 2000, J ELECTROCHEM SOC, V147, P1682, DOI 10.1149/1.1393418
   Ngo E, 2001, APPL PHYS LETT, V79, P248, DOI 10.1063/1.1384899
   Nie X, 2001, J BIOMED MATER RES, V57, P612, DOI 10.1002/1097-4636(20011215)57:4<612::AID-JBM1208>3.0.CO;2-H
   Nomura K, 2001, J CERAM SOC JPN, V109, P915, DOI 10.2109/jcersj.109.1275_915
   Ochsenkuhn-Petropoulou M, 2001, J MATER PROCESS TECH, V108, P179, DOI 10.1016/S0924-0136(00)00749-4
   Pang SC, 2000, J MATER RES, V15, P2096, DOI 10.1557/JMR.2000.0302
   Pauporte T, 2001, J ELECTROCHEM SOC, V148, pC310, DOI 10.1149/1.1357175
   Pauporte T, 2000, ELECTROCHIM ACTA, V45, P3345, DOI 10.1016/S0013-4686(00)00405-9
   Peng ZY, 2001, J AM CERAM SOC, V84, P283
   Perez AT, 2001, EUROPHYS LETT, V55, P425, DOI 10.1209/epl/i2001-00431-5
   Put S, 2002, KEY ENG MAT, V206-2, P189, DOI 10.4028/www.scientific.net/KEM.206-213.189
   Put S, 2001, SCRIPTA MATER, V45, P1139, DOI 10.1016/S1359-6462(01)01126-5
   Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x
   Sarkar P, 2000, J AM CERAM SOC, V83, P1399, DOI 10.1111/j.1151-2916.2000.tb01400.x
   Seike T, 2002, J MATER CHEM, V12, P366, DOI 10.1039/b106774p
   Shrestha NK, 2001, SURF COAT TECH, V140, P175, DOI 10.1016/S0257-8972(01)01045-3
   Sides PJ, 2001, LANGMUIR, V17, P5791, DOI 10.1021/la0105376
   Smeets K, 2002, KEY ENG MAT, V206-2, P2069, DOI 10.4028/www.scientific.net/KEM.206-213.2069
   Solomentsev Y, 2000, LANGMUIR, V16, P9208, DOI 10.1021/la0005199
   Su B, 2001, J EUR CERAM SOC, V21, P1539, DOI 10.1016/S0955-2219(01)00059-0
   Subramanian V, 2001, J PHYS CHEM B, V105, P11439, DOI 10.1021/jp011118k
   Sumida T, 2001, CHEM LETT, P38, DOI 10.1246/cl.2001.38
   Therese GHA, 2000, CHEM MATER, V12, P1195, DOI 10.1021/cm990447a
   Timms LA, 2001, J MICROSC-OXFORD, V201, P316, DOI 10.1046/j.1365-2818.2001.00840.x
   Uchikoshi T, 2001, J MATER RES, V16, P321, DOI 10.1557/JMR.2001.0048
   Van der Biest OO, 1999, ANNU REV MATER SCI, V29, P327, DOI 10.1146/annurev.matsci.29.1.327
   Wang Z, 2000, SCRIPTA MATER, V42, P653, DOI 10.1016/S1359-6462(99)00414-5
   Wang ZH, 2002, J EUR CERAM SOC, V22, P183, DOI 10.1016/S0955-2219(01)00254-0
   Will J, 2001, J AM CERAM SOC, V84, P328
   Yen SK, 2001, BIOMATERIALS, V22, P125, DOI 10.1016/S0142-9612(00)00133-2
   Zhang JP, 2000, J AM CERAM SOC, V83, P2417
   Zhang XY, 2001, J ELECTROCHEM SOC, V148, pG398, DOI 10.1149/1.1378293
   Zhao C, 2000, BRIT CERAM T, V99, P284, DOI 10.1179/096797800681018
   Zhitomirsky I, 2000, AM CERAM SOC BULL, V79, P57
   Zhitomirsky I, 2000, MATER LETT, V46, P1, DOI 10.1016/S0167-577X(00)00133-6
   Zhitomirsky I, 2001, CERAM INT, V27, P149, DOI 10.1016/S0272-8842(00)00054-7
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
   Zhitomirsky I, 2001, JOM-J MIN MET MAT S, V53, P48, DOI 10.1007/s11837-001-0071-2
   Zhitomirsky I, 2001, MATER LETT, V50, P189, DOI 10.1016/S0167-577X(01)00223-3
   Zhitomirsky I, 2001, AM CERAM SOC BULL, V80, P41
   Zhitomirsky I, 2000, J EUR CERAM SOC, V20, P2055, DOI 10.1016/S0955-2219(00)00098-4
   Zhitomirsky I., 2002, ADV COLLOID INTERFAC, V97, P277
NR 88
TC 360
Z9 368
U1 9
U2 124
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD JUN
PY 2002
VL 6
IS 3
BP 251
EP 260
AR PII S1359-0286(02)00080-3
DI 10.1016/S1359-0286(02)00080-3
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 609GR
UT WOS:000178895700011
DA 2018-10-20
ER

PT J
AU Lusquinos, F
   Pou, J
   Arias, JL
   Boutinguiza, M
   Leon, B
   Perez-Amor, M
   Driessens, FCM
AF Lusquinos, F
   Pou, J
   Arias, JL
   Boutinguiza, M
   Leon, B
   Perez-Amor, M
   Driessens, FCM
TI Alloying of hydroxyapatite onto Ti6Al-4V by high power laser irradiation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE COATINGS; HEAT-TREATMENT; DEPOSITION
AB In the biomedical field, the synthetic hydroxyapatite [Ca(1)0(PO)(4)(OH)(2)], with similarity to the inorganic component of bone but brittle, has been considered as the appropriate coating on stronger implant materials, such as metallic implants, for presenting a surface which is conductive to bone formation.
   Many industrial and laboratory techniques were developed to apply hydroxyapatite onto metallic substrates, such as electrophoretic deposition, ion sputtering, hot isostatic pressing, pulsed laser deposition and the only widely used method commercially available: plasma spraying.
   This work presents a new approach on how to bind calcium phosphate (CaP) to the Ti alloy with a well-known technique in the metallurgical field: laser surface alloying, in order to overcome the drawbacks of plasma spraying. The analysis of the results obtained and the description of the phenomena that take place in the coating process will complete this explorative study. (C) 2002 Kluwer Academic Publishers.
C1 Univ Vigo, Dept Fis Aplicada, E-36200 Vigo, Spain.
   Univ Nijmegen, Calcio BV, Ohe En Laak, Netherlands.
RP Lusquinos, F (reprint author), Univ Vigo, Dept Fis Aplicada, Lagoas Marcosende 9, E-36200 Vigo, Spain.
RI Pou, Juan/A-1295-2013; New Materials Group, FA3/D-6799-2014
OI Pou, Juan/0000-0002-8848-5617; New Materials Group,
   FA3/0000-0003-4286-2015
CR ANTONOV EN, 1994, J PHYS IV, V4, P183, DOI 10.1051/jp4:1994441
   BAERI P, 1992, APPL SURF SCI, V54, P210, DOI 10.1016/0169-4332(92)90046-Z
   CHEANG P, 1995, J MATER PROCESS TECH, V48, P429, DOI 10.1016/0924-0136(94)01679-U
   CHEN TS, 1994, J MATER RES, V9, P1284, DOI 10.1557/JMR.1994.1284
   COTELL CM, 1992, J APPL BIOMATER, V3, P87, DOI 10.1002/jab.770030204
   FILIAGGI MJ, 1993, J BIOMED MATER RES, V27, P191, DOI 10.1002/jbm.820270208
   GarciaSanz FJ, 1997, J MATER SCI-MATER M, V8, P861, DOI 10.1023/A:1018549720873
   Hench L. L., 1993, INTRO BIOCERAMICS, P1
   JI HX, 1993, BIOMATERIALS, V14, P64, DOI 10.1016/0142-9612(93)90077-F
   KAY J F, 1992, Dental Clinics of North America, V36, P1
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   SARDIN G, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P225
   SHIRKHANZADEH M, 1994, MATER LETT, V18, P211, DOI 10.1016/0167-577X(94)90233-X
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   YAPING Z, 1993, SURF COAT TECH, V58, P125
NR 17
TC 18
Z9 22
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2002
VL 13
IS 6
BP 601
EP 605
DI 10.1023/A:1015187129141
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 542WM
UT WOS:000175068600010
PM 15348591
DA 2018-10-20
ER

PT J
AU Catledge, SA
   Fries, MD
   Vohra, YK
   Lacefield, WR
   Lemons, JE
   Woodard, S
   Venugopalan, R
AF Catledge, SA
   Fries, MD
   Vohra, YK
   Lacefield, WR
   Lemons, JE
   Woodard, S
   Venugopalan, R
TI Nanostructured ceramics for biomedical implants
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Review
DE nanostructured materials; mechanical properties; biomedical implants;
   diamond; hydroxyapatite; wear resistance
ID CHEMICAL-VAPOR-DEPOSITION; DIAMOND THIN-FILMS; CALCIUM-PHOSPHATE
   COATINGS; BEAM SPUTTER-DEPOSITION; NANOCRYSTALLINE DIAMOND;
   MECHANICAL-PROPERTIES; CARBON-FILMS; MICROWAVE PLASMAS; HYDROXYAPATITE
   COATINGS; TI-6AL-4V IMPLANTS
AB Recent progress in the synthesis, characterization, and biological compatibility of nanostructured ceramics for biomedical implants is reviewed. A major goal is to develop ceramic coating technology that can reduce the friction and wear in mating total joint replacement components, thus contributing to their significantly improved function and longer life span. Particular attention is focused on the enhancement of mechanical properties such as hardness, toughness, and friction coefficient and on the bioactivity as they pertain to the nanostructure of the material. The development of three nanostructured implant coatings is discussed: diamond, hydroxyapatite, and functionally graded metalloceramics based on the Cr-Ti-N ternary system. Nanostructured diamond produced by chemical vapor deposition (CVD) techniques and composed of nano-size diamond grains have particular promise because of the combination of ultrahigh hardness, improved toughness over conventional microcrystalline diamond, low friction, and good adhesion to titanium alloys. Nanostructured processing applied to hydroxyapatite coatings is used to achieve the desired mechanical characteristics and enhanced surface reactivity and has been found to increase osteoblast adhesion, proliferation, and mineralization. Finally, nanostructured metalloceramic coatings provide continuous variation from a nanocrystalline metallic bond at the interface to the hard ceramic bond on the surface and have the ability to overcome adhesion problems associated with ceramic hard coatings on metallic substrates.
C1 Univ Alabama, Dept Phys, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Prosthodont & Biomat, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Biomed Engn, Birmingham, AL 35294 USA.
RP Catledge, SA (reprint author), Univ Alabama, Dept Phys, Birmingham, AL 35294 USA.
FU NIDCR NIH HHS [1R01DE13952-01A1]
CR AGER JW, 1993, PHYS REV B, V48, P2601, DOI 10.1103/PhysRevB.48.2601
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   ANGUS JC, 1991, SCIENCE, V241, P643
   ANGUS JC, 1971, SINT ALMAZY, V3, P38
   *ASTM, 1909, ANN BOOK ASTM STAND, P48
   BADZIAN A, 1993, APPL PHYS LETT, V62, P3432, DOI 10.1063/1.109039
   BARNETT SA, 1993, PHYSICS THIN FILMS, V17
   Beck F, 2000, ELECTROCHIM ACTA, V45, P4691, DOI 10.1016/S0013-4686(00)00621-6
   BENMALEK M, 1991, SURF COAT TECH, V48, P181, DOI 10.1016/0257-8972(91)90001-D
   Bhattacharyya S, 2001, APPL PHYS LETT, V79, P1441, DOI 10.1063/1.1400761
   Bohr S, 1996, APPL PHYS LETT, V68, P1075, DOI 10.1063/1.115717
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P355, DOI 10.1002/jbm.820210308
   BUNDY FP, 1955, NATURE, V176, P51, DOI 10.1038/176051a0
   BURAKOWSKI T, 1999, SURG ENG METALS PRIN, P176
   Cao GZ, 1996, J APPL PHYS, V79, P1357, DOI 10.1063/1.361033
   CARSLEY JE, 1995, NANOSTRUCT MATER, V5, P441, DOI 10.1016/0965-9773(95)00257-F
   Catledge SA, 1999, J APPL PHYS, V86, P698, DOI 10.1063/1.370787
   Catledge SA, 1998, APPL PHYS LETT, V73, P181, DOI 10.1063/1.121748
   Catledge SA, 2002, J APPL PHYS, V91, P5347, DOI 10.1063/1.1464233
   CATLEDGE SA, UNPUB
   CATLEDGE SA, 1999, MATER RES SOC S P, P555
   CATLEDGE SA, 1999, THESIS U ALABAMA BIR
   CHEN TS, 1994, J MATER RES, V9, P565
   Cooper J. R., 1993, Clinical Materials, V14, P295, DOI 10.1016/0267-6605(93)90016-Z
   Corvin RB, 2002, APPL PHYS LETT, V80, P2550, DOI 10.1063/1.1467618
   CUCKLER JM, 1995, CLIN ORTHOP RELAT R, P57
   Dasarathy H, 1996, J BIOMED MATER RES, V31, P81, DOI 10.1002/(SICI)1097-4636(199605)31:1<81::AID-JBM10>3.0.CO;2-P
   DERBYSHIRE B, 1995, WEAR, V181, P258, DOI 10.1016/0043-1648(95)90032-2
   DERYAGIN BV, 1975, SCI AM, V233, P102
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   DRORY MD, 1995, MATER RES SOC S P, P383
   DUBLETON JH, 1988, J BIOMATER APPL, V3, P3
   ELSHERIK AM, 1992, SCRIPTA METALL MATER, V27, P1185, DOI 10.1016/0956-716X(92)90596-7
   Erdemir A, 1996, DIAMOND FILM TECHNOL, V6, P31
   Erdemir A, 1997, TRIBOL T, V40, P667, DOI 10.1080/10402009708983707
   Fausett B, 2000, ELECTROANAL, V12, P7, DOI 10.1002/(SICI)1521-4109(20000101)12:1<7::AID-ELAN7>3.0.CO;2-#
   FEDOSEEV DV, 1978, IZV AKAD NAUK SSSR S, V6, P152
   Field J. E., 1979, PROPERTIES DIAMOND
   FRIES M, UNPUB
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   Goyette AN, 1998, J PHYS D APPL PHYS, V31, P1975, DOI 10.1088/0022-3727/31/16/006
   Goyette AN, 1998, PLASMA SOURCES SCI T, V7, P149, DOI 10.1088/0963-0252/7/2/009
   GRUEN DM, 1995, J VAC SCI TECHNOL A, V13, P1628, DOI 10.1116/1.579742
   GRUEN DM, 1994, APPL PHYS LETT, V64, P1502, DOI 10.1063/1.111872
   Gruen DM, 1996, APPL PHYS LETT, V68, P1640, DOI 10.1063/1.115677
   Gruen DM, 1998, MRS BULL, V23, P32, DOI 10.1557/S088376940002933X
   Hahn H, 1997, NANOSTRUCT MATER, V9, P603, DOI 10.1016/S0965-9773(97)00135-9
   HARRIS SJ, 1990, APPL PHYS LETT, V56, P2298, DOI 10.1063/1.102946
   HUBLER R, 1993, SURF COAT TECH, V60, P561, DOI 10.1016/0257-8972(93)90153-F
   IWAKI M, 1983, NUCL INSTRUM METHODS, V209, P1129, DOI 10.1016/0167-5087(83)90930-4
   JIN S, 1994, APPL PHYS LETT, V65, P403, DOI 10.1063/1.112315
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Keblinski P, 1999, NANOSTRUCT MATER, V12, P339, DOI 10.1016/S0965-9773(99)00130-0
   KIFFER AD, 1956, SYNTHESIS DIAMOND CA
   KRAUSS AR, 1998, MATER RES SOC S P, P509
   KUMAR P, 1991, J BIOMED MATER RES, V25, P813, DOI 10.1002/jbm.820250703
   KUMAR RR, IN PRESS MAT LETT
   KUMAR RR, IN PRESS MAT SCI E A
   Kweh SWK, 2000, BIOMATERIALS, V21, P1223, DOI 10.1016/S0142-9612(99)00275-6
   LACEFIELD WR, 1994, J ORAL IMPLANTOL, V20, P214
   LACEFIELD WR, 1988, BIOCERAMICS MAT CHAR, P72
   LACEFIELD WR, 1991, CERAMICS SUBSTITUTIV, P167
   LACEFIELD WR, 1993, SURFACE MODIFICATION, V6, P591
   LACEFIELD WR, 1998, IMPLANT DENT, P7
   LANDER JJ, 1966, SURF SCI, V4, P241, DOI 10.1016/0039-6028(66)90004-5
   LOCHER R, 1994, APPL PHYS LETT, V65, P34, DOI 10.1063/1.113064
   LUCAS LC, 1993, COLLOID SURFACE A, V77, P141, DOI 10.1016/0927-7757(93)80110-Z
   Matsumoto S., 1982, JPN J APPL PHYS, V21, P183
   MCHARGUE CJ, 1991, APPL DIAMOND FILMS R
   Mitura S, 1999, CHAOS SOLITON FRACT, V10, P2165, DOI 10.1016/S0960-0779(98)00251-3
   Moon JM, 1999, J ELECTROANAL CHEM, V464, P230, DOI 10.1016/S0022-0728(99)00030-3
   MullerSebert W, 1996, APPL PHYS LETT, V68, P759, DOI 10.1063/1.116733
   Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2
   NAMBA Y, 1992, J APPL PHYS, V72, P1748, DOI 10.1063/1.351698
   *NAT CTR STAT, 1994, 1994 REP
   NEMANICH RJ, 1988, J VAC SCI TECHNOL A, V6, P1783, DOI 10.1116/1.575297
   Ogiso M, 1996, J BIOMED MATER RES, V30, P109
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   ONG JL, 1991, J AM CERAM SOC, V74, P230
   PAPPAS MJ, 1995, CLIN ORTHOP RELAT R, P64
   PETERSON CD, 1988, J BIOMED MATER RES, V22, P887, DOI 10.1002/jbm.820221005
   PLESKOV Y, 1987, J ELECTROANAL CHEM, V228, P18
   PRAEMER S, 1995, MUSCULOSKELETAL COND, P125
   Ramesham R, 1997, THIN SOLID FILMS, V300, P144, DOI 10.1016/S0040-6090(96)09504-1
   RAMESHAM R, 1995, MATER RES SOC S P, P383
   Ravi S, 1996, APPL PHYS LETT, V69, P491, DOI 10.1063/1.117763
   ROSTLUND T, 1989, BIOMATERIALS, V10, P176, DOI 10.1016/0142-9612(89)90020-3
   Saha S, 2000, CRIT REV BIOMED ENG, V28, P399
   SAMLENSKI R, 1995, APPL PHYS LETT, V67, P2798, DOI 10.1063/1.114788
   SAVVIDES N, 1992, J APPL PHYS, V72, P2791, DOI 10.1063/1.351530
   Schnupp R, 1998, BIOSENS BIOELECTRON, V13, P889, DOI 10.1016/S0956-5663(98)00057-8
   SHANKLAND WE, 1998, TMJ ITS MANY FACES
   Sharda T, 2000, APPL PHYS LETT, V77, P4304, DOI 10.1063/1.1333399
   Siegal MP, 2000, APPL PHYS LETT, V76, P3052, DOI 10.1063/1.126576
   Siegel R. W., 1997, MATER SCI FORUM, V851, P235
   SIZEMORE J, 1995, MATER RES SOC S P, P383
   SPITSYN BV, 1981, J CRYST GROWTH, V52, P219, DOI 10.1016/0022-0248(81)90197-4
   Sproul WD, 1996, SURF COAT TECH, V86, P170, DOI 10.1016/S0257-8972(96)02977-5
   Swain GM, 1998, MRS BULL, V23, P56, DOI 10.1557/S0883769400029389
   Toprani N, 2000, J MATER RES, V15, P1052, DOI 10.1557/JMR.2000.0151
   Veprek S, 1998, NANOSTRUCT MATER, V10, P679, DOI 10.1016/S0965-9773(98)00106-8
   Veprek S, 1997, THIN SOLID FILMS, V297, P145, DOI 10.1016/S0040-6090(96)09480-1
   Voevodin AA, 1998, J MATER SCI, V33, P319, DOI 10.1023/A:1004307426887
   VOHRA YK, 2001, Patent No. 6183818
   von Bolton W, 1911, Z ELKTROCHEM ANGEW P, V17, P971
   Wang SA, 1996, BIOMATERIALS, V17, P1965, DOI 10.1016/0142-9612(96)00020-8
   WEIGHTMAN B, 1986, BIOMATERIALS, V7, P20
   Whitehead R Y, 1993, Clin Mater, V12, P31, DOI 10.1016/0267-6605(93)90025-3
   WHITEHEAD RY, 1993, J BIOMED MATER RES, V27, P1501, DOI 10.1002/jbm.820271206
   WISBEY A, 1987, BIOMATERIALS, V8, P477, DOI 10.1016/0142-9612(87)90085-8
   Xu JS, 1997, ANAL CHEM, V69, pA591, DOI 10.1021/ac971791z
   Zarrabian M, 1997, APPL PHYS LETT, V70, P2535, DOI 10.1063/1.118912
   Zeng H, 1999, BIOMATERIALS, V20, P443, DOI 10.1016/S0142-9612(98)00190-2
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zhang C, 2001, J BIOMED MATER RES, V56, P342, DOI 10.1002/1097-4636(20010905)56:3<342::AID-JBM1102>3.0.CO;2-F
   Zhang CG, 2000, J BIOMED MATER RES, V50, P267, DOI 10.1002/(SICI)1097-4636(200005)50:2<267::AID-JBM22>3.0.CO;2-7
   Zhou D, 1997, J APPL PHYS, V82, P4546, DOI 10.1063/1.366190
   Zhou D, 1998, J APPL PHYS, V84, P1981, DOI 10.1063/1.368331
   Zhou D, 1998, J APPL PHYS, V83, P540, DOI 10.1063/1.366668
   Zuiker C, 1995, THIN SOLID FILMS, V270, P154, DOI 10.1016/0040-6090(95)06882-1
NR 120
TC 92
Z9 96
U1 3
U2 45
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUN-AUG
PY 2002
VL 2
IS 3-4
BP 293
EP 312
DI 10.1166/jnn.2002.116
PG 20
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 585RC
UT WOS:000177537500005
PM 12908255
DA 2018-10-20
ER

PT J
AU Sessle, BJ
AF Sessle, BJ
TI Integration of basic sciences into the predoctoral curriculum to study
   temporomandibular disorders and orofacial pain
SO JOURNAL OF OROFACIAL PAIN
LA English
DT Article; Proceedings Paper
CT 3rd Educational Conference on Develop the Curriculm in Temporomandibular
   Disorders and Orofacial Pain
CY APR, 2000
CL WASHINGTON, D.C.
DE biological sciences; behavioral sciences; curriculum; dentistry;
   temporomandibular disorders; orofacial pain; continuing education
ID JOINT
AB This paper outlines several aspects of the integration of basic sciences into the predoctoral dental curriculum. It addresses a number of the points or questions posed by the organizers of the Third Educational Conference to Develop the Curriculum in Temporomandibular Disorders and Orofacial Pain. The importance of the basic sciences for a comprehensive overview of knowledge bearing on temporomandibular disorders and orofacial pain is first emphasized, followed by considerations of what material should be taught and by whom. The paper concludes by considering at what stage of the curriculum this material should be included, bow the pertinent basics sciences should be taught, and under what circumstances. Under the term "basic sciences" are included not only relevant biomedical or biologic sciences such as physiology and anatomy, but also the behavioral sciences such as psychology and cognitive science.
C1 Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
RP Sessle, BJ (reprint author), Univ Toronto, Fac Dent, 124 Edward St, Toronto, ON M5G 1G6, Canada.
CR American Association of Dental Schools, 1992, J DENT EDUC, V56, P646
   Attanasio R, 2002, J OROFAC PAIN, V16, P176
   ATTANASIO R, 1992, J CRANIOMANDIB DISOR, V6, P123
   DEBONT LGM, 1995, PROG PAIN RES MANAG, V4, P133
   FIELD MJ, 1995, DENTAL ED CROSSRAODS
   LUND JPL, 2001, OROFACIAL PAIN BASIC
   Mohl ND, 1999, J OROFAC PAIN, V13, P227
   RUGH JD, 1994, TEMPOROMANDIBULAR JO, P208
   Sessle BJ, 1999, J OROFAC PAIN, V13, P238
   Stohler CS, 1999, J OROFAC PAIN, V13, P273
   STOREY AT, 1994, TEMPOROMANDIBULAR JO, P584
NR 11
TC 13
Z9 13
U1 0
U2 1
PU QUINTESSENCE PUBL CO INC
PI CAROL STREAM
PA 551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA
SN 1064-6655
J9 J OROFAC PAIN
JI J. Orofac. Pain
PD SUM
PY 2002
VL 16
IS 3
BP 181
EP 184
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 581KB
UT WOS:000177290100004
PM 12221733
DA 2018-10-20
ER

PT J
AU Tang, ZG
   Teoh, SH
   McFarlane, W
   Poole-Warren, LA
   Umezu, M
AF Tang, ZG
   Teoh, SH
   McFarlane, W
   Poole-Warren, LA
   Umezu, M
TI In vitro calcification of UHMWPE/PU composite membrane
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT International Conference on Materials for Advanced Technologies
   (ICMAT2001)
CY JUL 01-06, 2001
CL SINGAPORE, SINGAPORE
SP Mat Res Soc, Int Union Mat Res Soc
DE polyether polyurethane; biaxially drawn ultrahigh molecular weight
   polyethylene; composite; in vitro calcification
ID BIOMEDICAL APPLICATIONS; FATIGUE FAILURE; HEART-VALVE; POLYURETHANE
AB Polyurethane composite made from biaxially drawn ultrahigh molecular weight polyethylene (BDUHMWPE) is likely an alternative for polyurethane currently being plagued for medical applications. In this study, an in vitro calcification protocol was used to determine the relative resistance to calcification of the composite membranes. The results demonstrated that the composite membranes were susceptible to extrinsic calcification that was closely related to the matrix polyurethane material used. The calcification of the composite was different from that of the solution cast polyurethane membranes. The incorporation of hydrophobic reinforcement BDUHMWPE effectively postponed the calcification. The differences of calcification between composite and polyurethane were greatly due to the differences in surface structures and properties of the as-cast polyurethane. (C) 2002 Published by Elsevier Science B.V.
C1 Natl Univ Singapore, Dept Engn Mech, LBME, Singapore 117548, Singapore.
   Univ New S Wales, Grad Sch Biomed Engn, Kensington, NSW 2033, Australia.
   Waseda Univ, Dept Engn Mech, Tokyo, Japan.
RP Tang, ZG (reprint author), Natl Univ Singapore, Dept Engn Mech, LBME, Singapore 117548, Singapore.
OI Poole-Warren, Laura/0000-0002-4414-022X
CR AKUTSU T, 1959, J APPL PHYSIOL, V14, P1045
   Bernacca GM, 1997, J BIOMED MATER RES, V34, P371
   BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   GLASMACHER B, 1987, POLYURETHANES BIOMED, V2, P151
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   IMAMURA E, 1977, MAYO CLIN PROC, V52, P770
   Jansen J, 1991, ASAIO Trans, V37, pM451
   JANSEN J, 1992, J MED ENG TECHNOL, V16, P27, DOI 10.3109/03091909209021954
   KIRALY R, 1982, ARTIF ORGANS, V6, P190, DOI 10.1111/j.1525-1594.1982.tb04082.x
   LARSON RE, 1964, J THORAC CARDIOV SUR, V47, P720
   LEVY RJ, 1991, BIOMATERIALS, V12, P707, DOI 10.1016/0142-9612(91)90017-5
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   MOHRI H, 1973, J THORAC CARDIOV SUR, V65, P576
   NISTAL F, 1990, J THORAC CARDIOV SUR, V99, P1074
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   Tang ZG, 2000, COLLOID SURFACE B, V19, P19, DOI 10.1016/S0927-7765(00)00134-X
   Tang ZG, 2001, POLYMER, V42, P8153, DOI 10.1016/S0032-3861(01)00304-4
   TANG ZG, 1997, 9 INT C BIOM ENG SIN, P563
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
   Yang MJ, 1999, J BIOMED MATER RES, V48, P648, DOI 10.1002/(SICI)1097-4636(1999)48:5<648::AID-JBM8>3.0.CO;2-6
NR 22
TC 8
Z9 8
U1 2
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY 31
PY 2002
VL 20
IS 1-2
SI SI
BP 149
EP 152
AR PII S0928-4931(02)00025-5
DI 10.1016/S0928-4931(02)00025-5
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 560NM
UT WOS:000176088200021
DA 2018-10-20
ER

PT J
AU Kuo, MC
   Yen, SK
AF Kuo, MC
   Yen, SK
TI The process of electrochemical deposited hydroxyapatite coatings on
   biomedical titanium at room temperature
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT International Conference on Materials for Advanced Technologies
   (ICMAT2001)
CY JUL 01-06, 2001
CL SINGAPORE, SINGAPORE
DE hydroxyapatite; electrochemical deposition; Ti; room temperature process
ID CALCIUM-PHOSPHATE COATINGS; SIMULATED BODY-FLUID;
   ELECTROCRYSTALLIZATION; ELECTRODEPOSITION; SUBSTRATE; STABILITY; ALLOYS;
   BONE
AB Calcium phosphate (CaP) ceramics, especially hydroxyapatite (HA), have received much attention and have been clinically applied in orthopaedics and dentistry due to their excellent biocompatibility. Among several methods for preparing HA coating, electrochemical deposition is a relatively new and possible process. However, documented electrochemical processes were conducted at elevated temperature. In this study, uniform HA coatings have been directly deposited on titanium at room temperature. X-ray diffractometry (XRD) results demonstrated that dicalcium phosphate dihydrate (CaHPO4.2H(2)O, DCPD) was the main component of the coating deposited at lower current densities (1 and 5 mA/cm(2)). HA structure was obtained at current density above 10 mA/cm(2) and remained stable after heat treatment at 100-600 degreesC for 1 h. Part of HA phase was transformed into beta-TCP and became a biphasic calcium phosphate coating after annealing at 700 degreesC. Scratch tests showed that HA coating was not scraped off until a shear stress of 106.3 MPa. Coatings deposited at room temperature exhibited stronger adhesion than those at elevated temperature. HA coating revealed a dense inner layer and rough surface morphology which could fulfill the requisition of implant materials and be adequate to the attachment of bone tissue. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Natl Chung Hsing Univ, Inst Mat Engn, Taichung 40227, Taiwan.
RP Yen, SK (reprint author), Natl Chung Hsing Univ, Inst Mat Engn, 250 Kuo Kuang Rd, Taichung 40227, Taiwan.
CR BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Ding SJ, 1999, J BIOMED MATER RES, V44, P266, DOI 10.1002/(SICI)1097-4636(19990305)44:3<266::AID-JBM5>3.0.CO;2-4
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   Gottlander M, 1997, BIOMATERIALS, V18, P551, DOI 10.1016/S0142-9612(96)00168-8
   HUAXIA JI, 1992, J MATER SCI-MATER M, V3, P283
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   Lin JHC, 2000, MATER CHEM PHYS, V64, P229, DOI 10.1016/S0254-0584(00)00209-1
   LIN JHC, 1994, J MATER SCI-MATER M, V28, P1
   Lopatin CM, 1998, THIN SOLID FILMS, V326, P227, DOI 10.1016/S0040-6090(98)00531-8
   Piveteau LD, 2000, BIOMATERIALS, V21, P2193, DOI 10.1016/S0142-9612(00)00160-5
   POSNER AS, 1985, CLIN ORTHOP RELAT R, P87
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   REDEPENNING J, 1990, CHEM MATER, V2, P625, DOI 10.1021/cm00012a001
   Rodriguez-Lorenzo LM, 2001, BIOMATERIALS, V22, P583, DOI 10.1016/S0142-9612(00)00218-0
   SHIRKHANZADEH M, 1991, J MATER SCI LETT, V10, P1415, DOI 10.1007/BF00735695
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   SHIRKHANZADEH M, 1993, MATER LETT, V15, P392, DOI 10.1016/0167-577X(93)90103-5
   Verdonshot N., 1990, IMPLANTABLE TELEMETR, P249
   VIJAYARAGHAVAN TV, 1994, J MATER SCI LETT, V13, P1782, DOI 10.1007/BF00776358
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Wolke JGC, 1997, BIOMATERIALS, V18, P483, DOI 10.1016/S0142-9612(96)00164-0
NR 26
TC 225
Z9 242
U1 3
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY 31
PY 2002
VL 20
IS 1-2
SI SI
BP 153
EP 160
AR PII S0928-4931(02)00026-7
DI 10.1016/S0928-4931(02)00026-7
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 560NM
UT WOS:000176088200022
DA 2018-10-20
ER

PT J
AU Lendlein, A
   Langer, R
AF Lendlein, A
   Langer, R
TI Biodegradable, elastic shape-memory polymers for potential biomedical
   applications
SO SCIENCE
LA English
DT Article
ID POLYETHER-BASED POLYURETHANES; THERMOMECHANICAL PROPERTIES; BEHAVIOR;
   POLYNORBORNENE; COPOLYMERS; SERIES
AB The introduction of biodegradable implant materials as well as minimally invasive surgical procedures in medicine has substantially improved health care within the past few decades. This report describes a group of degradable thermoplastic polymers that are able to change their shape after an increase in temperature. Their shape-memory capability enables bulky implants to be placed in the body through small incisions or to perform complex mechanical deformations automatically. A smart degradable suture was created to illustrate the potential of these shape-memory thermoplastics in biomedical applications.
C1 mnemoSci GmbH, D-52074 Aachen, Germany.
   Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, Aachen, Germany.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Lendlein, A (reprint author), mnemoSci GmbH, Pauwelsstr 19, D-52074 Aachen, Germany.
EM a.lendlein@mnemoscience.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Charlesby A, 1960, ATOMIC RAD POLYM, P198
   CRUM R, 1985, SCIENCE, V230, P1375, DOI 10.1126/science.2416056
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   GRABLOWITZ HG, UNPUB
   Hodgson NCF, 2000, ANN SURG, V231, P436, DOI 10.1097/00000658-200003000-00018
   Hoer J, 2001, LANGENBECK ARCH SURG, V386, P218, DOI 10.1007/s004230000196
   Hooper KA, 1998, J BIOMED MATER RES, V41, P443, DOI 10.1002/(SICI)1097-4636(19980905)41:3<443::AID-JBM14>3.0.CO;2-J
   HU ZB, 1995, SCIENCE, V269, P525, DOI 10.1126/science.269.5223.525
   HUNTER J, 1993, MINIMALLY INVASIVE S
   Kagami Y, 1996, MACROMOL RAPID COMM, V17, P539, DOI 10.1002/marc.1996.030170806
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Lin JR, 1998, J APPL POLYM SCI, V69, P1563, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1563::AID-APP11>3.0.CO;2-W
   Lin JR, 1998, J APPL POLYM SCI, V69, P1575, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1575::AID-APP12>3.0.CO;2-U
   MAK AFT, 1998, HDB BIOMATERIAL PROP, P66
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   SAKURAI K, 1993, J APPL POLYM SCI, V47, P937, DOI 10.1002/app.1993.070470521
   SAKURAI K, 1994, POLYMER, V35, P4238, DOI 10.1016/0032-3861(94)90602-5
   SAKURAI K, 1989, J APPL POLYM SCI, V38, P1191, DOI 10.1002/app.1989.070380616
   SCHETKY LM, 1979, SCI AM, V241, P74, DOI 10.1038/scientificamerican1179-74
   SPANELBOROWSKI K, 1989, RES EXP MED, V189, P69, DOI 10.1007/BF01856032
   SWAIN MV, 1986, NATURE, V322, P234, DOI 10.1038/322234a0
   Takahashi T, 1996, J APPL POLYM SCI, V60, P1061
   Tobushi H, 1996, P SOC PHOTO-OPT INS, V2716, P46, DOI 10.1117/12.232168
   Tobushi H, 1996, J PHYS IV, V6, P377, DOI 10.1051/jp4:1996136
   Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2
NR 28
TC 1235
Z9 1279
U1 78
U2 989
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAY 31
PY 2002
VL 296
IS 5573
BP 1673
EP 1676
DI 10.1126/science.1066102
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 558PR
UT WOS:000175976200053
PM 11976407
DA 2018-10-20
ER

PT J
AU Griggs, JA
   Anusavice, KJ
   Mlecholsky, JJ
AF Griggs, JA
   Anusavice, KJ
   Mlecholsky, JJ
TI Devitrification and microstructural coarsening of a fluoride-containing
   barium aluminosilicate glass
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID CRYSTALLIZATION KINETICS; MECHANICAL-PROPERTIES; CERAMICS; MICA
AB Barium aluminosilicate (BAS) glass-ceramics have the potential to be used in the production of cast prostheses for biomedical applications because of their radiopacity and increased strength compared with traditional feldspathic porcelains. It is essential to understand the crystallization kinetics of these materials in order to fabricate products with increased fracture resistance rapidly. It was hypothesized that the addition of fluoride (F) to the composition of BAS glass would reduce the necessary processing time and temperatures by obviating the need for a separate crystal nucleation treatment. BASF glass was subjected to both linear non-isothermal and one-stage isothermal crystallization treatments, and the resulting glass-ceramics were characterized using x-ray diffraction, differential thermal analysis, and stereology. BASF glass had a low energy barrier to crystallization (397 kJ/mol) and transformed to 76 +/- 2% crystallinity within 30 min at 975degreesC. A fine-grained microstructure was produced by bulk crystallization without the need for a separate crystal nucleation stage. After the initial crystal precipitation, the mean crystal size and mean free path between crystals increased over time at elevated temperature by a diffusion rate-limited coarsening mechanism. (C) 2002 Kluwer Academic Publishers.
C1 Univ Florida, Dept Dent Biomat, Gainesville, FL 32610 USA.
   Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32610 USA.
RP Griggs, JA (reprint author), Baylor Coll Dent, Dept Biomat Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.
CR Bansal N.P., 1991, CERAM ENG SCI P, V12, P1222
   BANSAL NP, 1989, J MATER RES, V4, P1257, DOI 10.1557/JMR.1989.1257
   Boskovic S, 2000, CERAM INT, V26, P33, DOI 10.1016/S0272-8842(99)00016-4
   BOSKOVIC S, 1999, 9 WORLD ROUND TABLE, P167
   CHYUNG CK, 1972, ELECT MICROSCOPY STR, P1167
   Dell'Agli G, 2000, SOLID STATE IONICS, V127, P309, DOI 10.1016/S0167-2738(99)00298-2
   DRUMMOND CH, 1990, CERAM ENG SCI PROC, V11, P1072, DOI 10.1002/9780470313008.ch37
   EVANS AG, 1984, J AM CERAM SOC, V67, P255
   FABER KT, 1983, ACTA METALL MATER, V31, P565, DOI 10.1016/0001-6160(83)90046-9
   Frety N, 1996, J NON-CRYST SOLIDS, V195, P28, DOI 10.1016/0022-3093(95)00519-6
   FULLMAN RL, 1953, T AM I MIN MET ENG, V197, P447
   GREENWOOD GW, 1956, ACTA METALL MATER, V4, P243, DOI 10.1016/0001-6160(56)90060-8
   GROSSMAN DG, 1972, J AM CERAM SOC, V55, P446, DOI 10.1111/j.1151-2916.1972.tb11337.x
   HILLIARD JE, 1968, QUANTITATIVE MICROSC, P45
   Hyatt MJ, 1996, J MATER SCI, V31, P172, DOI 10.1007/BF00355142
   JUMAA QA, 1981, NUCLEATION CRYSTALLI, P218
   MacKenzie KJD, 1999, THERMOCHIM ACTA, V325, P5, DOI 10.1016/S0040-6031(98)00552-8
   Peterson IM, 1998, DENT MATER, V14, P80, DOI 10.1016/S0109-5641(98)00013-X
   TALMY IG, 1992, CRITICAL MAT PROCESS, V6, P687
   Thompson JY, 1996, J PROSTHET DENT, V76, P619, DOI 10.1016/S0022-3913(96)90440-0
   UNO T, 1992, NIPPON SERAM KYO GAK, V100, P315
   YINNON H, 1983, J NON-CRYST SOLIDS, V54, P253, DOI 10.1016/0022-3093(83)90069-8
   ZAYKOSKI JA, 1994, CERAM ENG SCI P, V15, P779
   Zhou WC, 1997, J MATER SCI, V32, P4833, DOI 10.1023/A:1018699418458
NR 24
TC 17
Z9 17
U1 0
U2 10
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD MAY 15
PY 2002
VL 37
IS 10
BP 2017
EP 2022
DI 10.1023/A:1015255300065
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 543HK
UT WOS:000175095300013
DA 2018-10-20
ER

PT J
AU Pikas, DJ
   Kirkpatrick, SM
   Tewksbury, E
   Brott, LL
   Naik, RR
   Stone, MO
   Dennis, WM
AF Pikas, DJ
   Kirkpatrick, SM
   Tewksbury, E
   Brott, LL
   Naik, RR
   Stone, MO
   Dennis, WM
TI Nonlinear saturation and lasing characteristics of green fluorescent
   protein
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID UPCONVERSION LASER; FIBER LASER; DYE-SOLUTION; ONE-PHOTON; BLUE;
   EXCITATION; DYNAMICS
AB Green fluorescent protein (GFP) has been of interest to researchers recently due to its use in nonlinear microscopy and biomedical applications. Through the use of nonlinear characterization, GFP has been previously shown to exhibit saturable nonlinear absorption. This nonlinear saturation suggests the possibility of a two-photon induced population inversion in GFP, which can lead to the use of GFP as a frequency upconversion laser material, particularly for bioMEMS devices. Here, we explore this population inversion and report on the ultrafast two-photon pumped lasing properties of GFP. Specifically, we report on the lasing threshold, spectral features and output-input energy characteristics. This is the first demonstration of ultrafast two-photon pumped lasing in a biological chromophore. Furthermore, GFP also appears to have a nearly cubic dependence of the saturation intensity on the concentration of GFP molecules. In this report, we also investigate this relationship by looking at the theoretical components affecting the saturation intensity to determine their dependence on GFP concentration.
C1 WPAFB, Air Force Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA.
   Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA.
   Univ Dayton, Dayton, OH 45469 USA.
   Wright State Univ, Dayton, OH 45435 USA.
RP Kirkpatrick, SM (reprint author), WPAFB, Air Force Res Lab, Mat & Mfg Directorate, Bldg 651 Suite 13005 P St, Wright Patterson AFB, OH 45433 USA.
CR Alfano R. R., 1989, SUPERCONTINUUM LASER
   ALLAIN JY, 1990, ELECTRON LETT, V26, P261, DOI 10.1049/el:19900174
   Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362
   De Angelis DA, 1998, P NATL ACAD SCI USA, V95, P12312, DOI 10.1073/pnas.95.21.12312
   Diels J.C., 1996, ULTRASHORT LASER PUL
   Gribovskii V. P., 1980, Soviet Journal of Quantum Electronics, V9, P1305, DOI 10.1070/QE1979v009n10ABEH009526
   GRUBB SG, 1992, ELECTRON LETT, V28, P1243, DOI 10.1049/el:19920785
   He GS, 1996, IEEE J QUANTUM ELECT, V32, P749, DOI 10.1109/3.492996
   He GS, 1996, APPL PHYS LETT, V68, P3549, DOI 10.1063/1.116633
   He GS, 1997, APPL PHYS LETT, V71, P1619, DOI 10.1063/1.119996
   He GS, 1998, APPL OPTICS, V37, P5720, DOI 10.1364/AO.37.005720
   He GS, 1997, OPT COMMUN, V140, P49, DOI 10.1016/S0030-4018(97)00149-1
   He GS, 1997, J APPL PHYS, V81, P2529, DOI 10.1063/1.364303
   HE GS, 1995, OPT LETT, V20, P2393, DOI 10.1364/OL.20.002393
   Henderson B., 1989, OPTICAL SPECTROSCOPY
   Huang K, 1987, STAT MECH
   Kirkpatrick SM, 2001, J PHYS CHEM B, V105, P2867, DOI 10.1021/jp0041609
   KIRKPATRICK SM, 1999, APPL PHYS A, V69, P1
   Kojima S, 1997, TETRAHEDRON LETT, V38, P2875, DOI 10.1016/S0040-4039(97)00486-3
   Maruo S, 1998, J MICROELECTROMECH S, V7, P411, DOI 10.1109/84.735349
   MCFARLANE RA, 1989, APPL PHYS LETT, V54, P2301, DOI 10.1063/1.101108
   Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961
   MITA Y, 1993, APPL PHYS LETT, V62, P802, DOI 10.1063/1.108583
   NGUYEN DC, 1989, APPL OPTICS, V28, P3553, DOI 10.1364/AO.28.003553
   PATEL CKN, 1966, PHYS REV LETT, V16, P971, DOI 10.1103/PhysRevLett.16.971
   POLLACK SA, 1989, APPL PHYS LETT, V54, P869, DOI 10.1063/1.100842
   Saleh B. E. A., 1991, FUNDAMENTALS PHOTONI
   Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7
   SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394
   SILVERSMITH AJ, 1987, APPL PHYS LETT, V51, P1977, DOI 10.1063/1.98316
   SMART RG, 1991, ELECTRON LETT, V27, P1307, DOI 10.1049/el:19910817
   Volkmer A, 2000, BIOPHYS J, V78, P1589, DOI 10.1016/S0006-3495(00)76711-7
   Ward W.W., 1998, GREEN FLUORESCENT PR
   WHITLEY TJ, 1991, ELECTRON LETT, V27, P1785, DOI 10.1049/el:19911110
   Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763
   YANG XH, 1993, APPL PHYS LETT, V62, P1071, DOI 10.1063/1.108798
   Yariv A., 1989, QUANTUM ELECT
   YOSHIDA T, 1975, JPN J APPL PHYS, V14, P1987, DOI 10.1143/JJAP.14.1987
NR 38
TC 19
Z9 19
U1 2
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAY 9
PY 2002
VL 106
IS 18
BP 4831
EP 4837
DI 10.1021/jp014643s
PG 7
WC Chemistry, Physical
SC Chemistry
GA 550DN
UT WOS:000175488500035
DA 2018-10-20
ER

PT J
AU Ling, P
   Taber, LA
   Humphrey, JD
AF Ling, P
   Taber, LA
   Humphrey, JD
TI Approach to quantify the mechanical behavior of the intact embryonic
   chick heart
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE cardiac development; stage 18 embryonic heart; experimental methods;
   regional strains; viscoelasticity
ID LEFT-VENTRICULAR MYOCARDIUM; VISCOELASTIC BEHAVIOR; CARDIAC-MUSCLE;
   STAGE-16; SYSTEM; MODEL
AB The heart undergoes remarkable changes during embryonic development due to genetic programing and epigenetic influences such as mechanical loads. An important goal is to develop mathematical models that describe and predict the influence of mechanics on cardiac development, yet the data needed to develop such models remain scant. In particular, prior data from embryonic hearts have come from one-dimensional tests, which reveal well the general characteristic behaviors but are not sufficient for quantifying the complex material behavior exhibited by most soft tissues. We developed a computer-controlled system for quantifying in vitro the multiaxial, regionally dependent mechanical response of the intact embryonic chick heart to controlled distension pressures such tests have not been accomplished heretofore but promise to contribute to our understanding for they better mimic the native loading conditions and geometry. Calibration of the device indicated that distending the hearts using low flow rates avoids significant viscous losses and thereby allows pressure to be measured directly over small ranges (0-2 min Hg) with good resolution (0.01 mm Hg). Likewise, an on-line video system allows two-dimensional strains to be measured regionally by tracking the motions of triplets of closely spaced (100 mum) microspheres to reasonable resolution (2.5 mum/pixel). Illustrative data from 18 hearts show the utility of the new system, confirm previous findings with regard to the strong viscoelastic response of the stage 18 embryonic chick heart, and provide guidance for the design of future experiments. (C) 2002 Biomedical Engineering Society.
C1 Texas A&M Univ, Zachry Engn Ctr 233, Dept Biomed Engn, College Stn, TX 77843 USA.
   Washington Univ, Dept Biomed Engn, St Louis, MO USA.
RP Humphrey, JD (reprint author), Texas A&M Univ, Zachry Engn Ctr 233, Dept Biomed Engn, College Stn, TX 77843 USA.
FU NHLBI NIH HHS [HL-46367]
CR CLARK DA, 1986, NEW ZEAL J AGR RES, V29, P407, DOI 10.1080/00288233.1986.10423493
   DOWNS J, 1990, IEEE T BIO-MED ENG, V37, P903, DOI 10.1109/10.58600
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   HSU FPK, 1995, IEEE T BIO-MED ENG, V42, P442, DOI 10.1109/10.376148
   HU N, 1989, CIRC RES, V65, P1665, DOI 10.1161/01.RES.65.6.1665
   Humphrey JD, 2002, CARDIOVASCULAR SOLID
   Lin DHS, 1998, J BIOMECH ENG-T ASME, V120, P504, DOI 10.1115/1.2798021
   LIN IE, 1995, J BIOMECH ENG-T ASME, V117, P343, DOI 10.1115/1.2794190
   LIN IE, 1994, J BIOMECH, V27, P311, DOI 10.1016/0021-9290(94)90007-8
   MANASEK FJ, 1984, GROWTH HEART HLTH DI, P105
   Manasek FJ, 1984, CONGENITAL HEART DIS, P359
   MANNING A, 1990, J ANAT, V168, P257
   Miller CE, 1997, J BIOMECH, V30, P985, DOI 10.1016/S0021-9290(97)00048-1
   Miller CE, 2000, J BIOMECH, V33, P615, DOI 10.1016/S0021-9290(99)00212-2
   Miller CE, 1997, J BIOMECH ENG-T ASME, V119, P445, DOI 10.1115/1.2798292
   MULIERI LA, 1989, CIRC RES, V65, P1441, DOI 10.1161/01.RES.65.5.1441
   PERREAULT CL, 1992, AM J PHYSIOL, V263, pH503
   PINTO JG, 1977, AM J PHYSIOL, V232, pH553
   Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O
   Sedmera D, 1997, ANAT REC, V248, P421
   TABER LA, 1995, DEV DYNAM, V203, P42, DOI 10.1002/aja.1002030105
   TABER LA, 1994, CIRC RES, V75, P896, DOI 10.1161/01.RES.75.5.896
   TABER LA, 1992, J BIOMECH ENG-T ASME, V114, P427, DOI 10.1115/1.2894091
   Taber LA, 2001, ANNU REV BIOMED ENG, V3, P1, DOI 10.1146/annurev.bioeng.3.1.1
   YANG M, 1991, J BIOMECH, V24, P587, DOI 10.1016/0021-9290(91)90291-T
   YANG M, 1994, J BIOMECH ENG-T ASME, V116, P213, DOI 10.1115/1.2895722
NR 26
TC 13
Z9 13
U1 0
U2 3
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2002
VL 30
IS 5
BP 636
EP 645
DI 10.1114/1.1483080
PG 10
WC Engineering, Biomedical
SC Engineering
GA 567YA
UT WOS:000176513600004
PM 12108838
DA 2018-10-20
ER

PT J
AU Li, G
   Suggs, J
   Gill, T
AF Li, G
   Suggs, J
   Gill, T
TI The effect of anterior cruciate ligament injury on knee joint function
   under a simulated muscle load: A three-dimensional computational
   simulation
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE ACL; knee; biomechanics; computational model; kinematics
ID PATELLAR TENDON AUTOGRAFT; 3-DIMENSIONAL MODEL; MATHEMATICAL-MODEL;
   IN-VIVO; GRAFT; RECONSTRUCTION; FORCES; CONTACT; GOAT
AB Understanding the biomechanical effect of various factors on knee behavior after anterior cruciate ligament (ACL) injury or reconstruction is instrumental for the development of an optimal surgical treatment of ACL injury that can better restore normal knee function. This paper presents the application of a three-dimensional (313) computational knee model for parametric studies of knee kinematics in response to simulated muscle loads. The knee model was constructed using the magnetic resonance images and biomechanical experimental data of the same cadaveric human knee specimen. The kinematics of the knee predicted by the computational model was compared with that measured from different specimens in a wide range of loading conditions and flexion angles. In general, the model predictions were within the range of experimental data. The model was then used to predict knee motion, ligament forces, and contact pressure in response to a simulated quadriceps force when the knee was ACL deficient. Partial ACL injury was simulated by reducing the stiffness of the ACL in the model. The results demonstrated that even with a reduction of 75% of the ACL stiffness, the ACL still carried a significant amount of the load (more than 58%) carried by an intact ACL. The kinematics (both tibial translation and rotation) varied less than 20% compared to that of the knee with intact ACL. The 3D computational model can be a powerful tool to simulate different variables that would influence knee function after ACL reconstruction, such as the initial tension of the ACL graft, the insertion sites of the graft, multibundle grafts, graft materials, and various physiological loading conditions. (C) 2002 Biomedical Engineering Society.
C1 MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Orthoped Biomech Lab,Massachusetts Gen Hosp, Boston, MA 02215 USA.
RP Li, G (reprint author), Orthopaed Biomech Lab, 330 Brookline Ave,RN 115, Boston, MA 02215 USA.
CR ABDELRAHMAN E, 1993, J BIOMECH ENG-T ASME, V115, P357, DOI 10.1115/1.2895498
   Allen CR, 1999, OSTEOARTHR CARTILAGE, V7, P110, DOI 10.1053/joca.1998.0166
   ANDRIACCHI TP, 1983, J BIOMECH, V16, P23, DOI 10.1016/0021-9290(83)90043-X
   ANDRIACCHI TP, 2002, T ORTH RES SOC DALL
   BACH BR, 1992, AM J SPORT MED, V20, P67, DOI 10.1177/036354659202000116
   BALLOCK RT, 1989, J ORTHOP RES, V7, P474, DOI 10.1002/jor.1100070404
   BEYNNON BD, 1994, AM J SPORT MED, V22, P812, DOI 10.1177/036354659402200613
   Beynnon BD, 1998, J BIOMECH, V31, P519, DOI 10.1016/S0021-9290(98)00044-X
   BLANKEVOORT L, 1991, J BIOMECH, V24, P1019, DOI 10.1016/0021-9290(91)90019-J
   Blankevoort L, 1996, J BIOMECH, V29, P955, DOI 10.1016/0021-9290(95)00149-2
   BUCKLEY SL, 1989, AM J SPORT MED, V17, P221, DOI 10.1177/036354658901700212
   BUTLER DL, 1986, J BIOMECH, V19, P425, DOI 10.1016/0021-9290(86)90019-9
   BUTLER JC, 1988, CLIN ORTHOP RELAT R, P150
   ESSINGER JR, 1989, J BIOMECH, V22, P1229, DOI 10.1016/0021-9290(89)90225-X
   GIBSON M, 1986, AM J SPORT MED, V14, P371, DOI 10.1177/036354658601400504
   HANLEY P, 1989, AM J SPORT MED, V17, P414, DOI 10.1177/036354658901700317
   Ishibashi Y, 1997, ARTHROSCOPY, V13, P177, DOI 10.1016/S0749-8063(97)90152-3
   Ishida H, 1996, AM J SPORT MED, V24, P510, DOI 10.1177/036354659602400417
   Kanamori A, 2000, ARTHROSCOPY, V16, P633, DOI 10.1053/jars.2000.7682
   Keira M, 1996, J ORTHOPAED RES, V14, P157, DOI 10.1002/jor.1100140125
   LEWIS JL, 1990, J ORTHOPAED RES, V8, P514, DOI 10.1002/jor.1100080407
   Li G, 1999, J BIOMECH ENG-T ASME, V121, P657, DOI 10.1115/1.2800871
   LI G, IN PRESS J ORTHOP RE
   Lundberg WR, 1997, J ORTHOPAED RES, V15, P645, DOI 10.1002/jor.1100150503
   Markolf KL, 1996, J BONE JOINT SURG AM, V78A, P1720, DOI 10.2106/00004623-199611000-00013
   MOST E, 2000, THESIS MIT CAMBRIDGE
   Mow VC, 1982, BIOMECHANICS PRINCIP, P47
   NG GY, 1995, J ORTHOP RES, V13, P602, DOI 10.1002/jor.1100130416
   NOYES FR, 1983, J BONE JOINT SURG AM, V65, P154, DOI 10.2106/00004623-198365020-00003
   OCONNOR JJ, 1993, J BONE JOINT SURG BR, V75, P41
   Shelburne KB, 1997, J BIOMECH, V30, P163, DOI 10.1016/S0021-9290(96)00119-4
   TASHMAN S, 2002, T ORTH RES SOC DALL
   WISMANS J, 1980, J BIOMECH, V13, P677, DOI 10.1016/0021-9290(80)90354-1
   Wu JZ, 1998, J BIOMECH ENG-T ASME, V120, P655, DOI 10.1115/1.2834758
NR 34
TC 62
Z9 67
U1 1
U2 8
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2002
VL 30
IS 5
BP 713
EP 720
DI 10.1114/1.1484219
PG 8
WC Engineering, Biomedical
SC Engineering
GA 567YA
UT WOS:000176513600011
PM 12108845
DA 2018-10-20
ER

PT J
AU Kancharla, VV
   Chen, SC
AF Kancharla, VV
   Chen, SC
TI Fabrication of biodegradable polymeric micro-devices using laser
   micromachining
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE laser micromachining; polymeric micro-device; biodegradable polymers;
   micro-channel; micro-hole array
AB Laser direct writing and percussion-drilling techniques are employed to fabricate two biodegradable micro-devices for biomedical engineering applications. Biodegradable polymeric material, poly-D-lactic acid (PDLA), and polymer poly-vinyl alcohol (PVA) were micropatterned by ultraviolet lasers. The morphology, dimensional accuracy, and surface conditions of the fabricated micro-devices after the laser ablation were studied using a scanning electron microscope (SEM) and a surface profilometer. The experimental results for producing micro-devices are reported. This work on laser micromachining of a biodegradable polymer for applications in biomedical engineering is the first of its kind and demonstrated that this technique is well suited to produce biodegradable microdevices with minimum thermal damage to the surrounding material.
C1 Iowa State Univ Sci & Technol, Ind & Mfg Syst Engn Dept, Ames, IA 50011 USA.
   Univ Texas, Mech Engn Dept, Austin, TX 78712 USA.
RP Kancharla, VV (reprint author), Iowa State Univ Sci & Technol, Ind & Mfg Syst Engn Dept, Ames, IA 50011 USA.
CR AMADA A, 2000, J MEMBRANE SCI, V176, P87
   Armani D, 1999, 12 IEEE INT C MICR E, P222
   Chen SC, 2000, J HEAT TRANS-T ASME, V122, P107, DOI 10.1115/1.521441
   CHEN YH, 1995, P SOC PHOTO-OPT INS, V3184, P202
   CURTIS A, 2001, PHYSICS MED BIOL, V46
   Deniz K. A., 2000, J MICROMECH MICROENG, V10, P80
   GANNEPALLI A, 1998, POLYM MAT SCI ENG P, V78, P3
   KARSTEN M, 1998, PHYS MED BIOL, V43, P7
   Lin LW, 1999, J MICROELECTROMECH S, V8, P78, DOI 10.1109/84.749406
   Matsui S, 1995, MATER RES SOC SYMP P, V380, P49, DOI 10.1557/PROC-380-49
   MATTHEW RA, 1997, ANAL CHEM, V69, P2035
   Meek MF, 1996, MICROSURG, V17, P555, DOI 10.1002/(SICI)1098-2752(1996)17:10<555::AID-MICR5>3.0.CO;2-P
   QIN D, 1998, TOP CURR CHEM, V194, P2
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P6
   SRINIVASAN R, 1990, LASERS POLYM SCI TEC, V3, P133
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
NR 16
TC 37
Z9 39
U1 0
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD MAY
PY 2002
VL 4
IS 2
BP 105
EP 109
DI 10.1023/A:1014679013888
PG 5
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 588HU
UT WOS:000177696700004
DA 2018-10-20
ER

PT J
AU Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
AF Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
TI Laser microfabricated model surfaces for controlled cell growth
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE microfabricated; surfaces; controlled cell growth; osteoblast
ID OXYGEN-CONTAINING FILMS; EXCIMER-LASER; MICROTEXTURED SILICONE;
   IN-VITRO; MICROARCHITECTURAL DESIGN; BIOMEDICAL APPLICATIONS;
   SUBCUTANEOUS IMPLANTS; PERCUTANEOUS IMPLANTS; TITANIUM SUBSTRATA;
   BEHAVIOR INVITRO
AB The relatively recent applications of microelectronics technology into the biological sciences arena has drastically revolutionized the field. New foreseeable applications include miniaturized, multiparametric biosensors for high performance multianalyte assays or DNA sequencing, biocomputers, and substrates for controlled cell growth (i.e. tissue engineering). The objectives of this work were to investigate a new method combining microphotolithographical techniques with laser excimer beam technology to create surfaces with well defined 3-D microdomains in order to delineate critical microscopic surface features governing material-cell interaction. Another obvious application of this study pertains to the fabrication of cell-based biosensors. Microfabricated surfaces were obtained with micron resolution, by 'microsculpturing' polymer model surfaces using a laser excimer KrF beam coupled with a microlithographic projection technique. The laser beam after exiting a mask was focused onto the polymer target surface via an optical setup allowing for a 10-fold reduction of the mask pattern. Various 3-D micropatterned features were obtained at the micron level. Reproducible submicron features could also be obtained using this method. Subsequently, model osteoblast-like cells were plated onto the laser microfabricated surfaces in order to study the effects of particular surface microtopography on preferential cell deposition and orientation. Preferential cell deposition was observed on surfaces presenting 'smooth' microtopographical transitions. This system may provide an interesting model for further insights into correlations between 3-D surface microtopography and cell response with new applications in the field biosensor, biomaterial and pharmaceutical engineering sciences (e.g. new cell based biosensors, controlled synthesis of immobilized cell derived active ingredients). (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Bordeaux 2, Natl Inst Hlth & Med Res, Biomat & Tissue Repair Unit, INSERM U443, F-33076 Bordeaux, France.
   Univ Bordeaux 1, CNRS, UMR 5803, Lab Physicochim Mol, F-33405 Talence, France.
RP Duncan, AC (reprint author), CNRS, 115 Ave Docteur Albert Schweitzer, F-3360 Pessac, France.
EM aduncan65@hotmail.com
CR Amirpour ML, 2001, ANAL CHEM, V73, P1560, DOI 10.1021/ac000907f
   BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1988, J BIOMED MATER RES, V22, P459, DOI 10.1002/jbm.820220603
   CHEHROUDI B, 1995, J BIOMED MATER RES, V29, P371, DOI 10.1002/jbm.820290312
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1992, J CELL SCI, V103, P287
   COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1997, J BIOMED MATER RES, V37, P539, DOI 10.1002/(SICI)1097-4636(19971215)37:4<539::AID-JBM13>3.0.CO;2-3
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   ERTEL SI, 1991, J COLLOID INTERF SCI, V147, P433, DOI 10.1016/0021-9797(91)90176-9
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GREEN AM, 1994, J BIOMED MATER RES, V28, P647, DOI 10.1002/jbm.820280515
   HIRONO T, 1988, BRAIN RES, V446, P189, DOI 10.1016/0006-8993(88)91314-5
   Hunt JA, 1995, J MATER SCI-MATER M, V6, P813, DOI 10.1007/BF00134323
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kapur R, 1999, J BIOMECH ENG-T ASME, V121, P65, DOI 10.1115/1.2798044
   Kasemo B, 1999, Adv Dent Res, V13, P8
   LAZARE S, 1986, J PHYS CHEM-US, V90, P2124, DOI 10.1021/j100401a028
   LAZARE S, 1989, LASER CHEM, V10, P25, DOI 10.1155/1989/18750
   LAZARE S, 1990, COMMUNICATION
   LEE JS, 1994, APPL PHYS LETT, V65, P400, DOI 10.1063/1.112314
   Matsuda T, 1996, J BIOMED MATER RES, V31, P235, DOI 10.1002/(SICI)1097-4636(199606)31:2<235::AID-JBM10>3.0.CO;2-K
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   NAKAYAMA Y, 1995, J BIOMED MATER RES, V29, P1295, DOI 10.1002/jbm.820291017
   NIINO H, 1989, APPL PHYS LETT, V54, P2159, DOI 10.1063/1.101154
   NIINO H, 1992, APPL PHYS LETT, V2697
   Pins GD, 2000, FASEB J, V14, P593
   Qu J, 1996, Oral Dis, V2, P102
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7
   SCHMIDT J, 1990, BIOMATERIALS, V12, P385
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1059, DOI 10.1016/0142-9612(92)90138-E
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P675
   SHIMO N, 1994, N-HOLLAND D, P109
   SHIMO N, 1990, MATER RES SOC SYMP P, V191, P91, DOI 10.1557/PROC-191-91
   Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Walboomers XF, 2000, BIOMATERIALS, V21, P629, DOI 10.1016/S0142-9612(99)00230-6
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   WALTER J, 1987, DEVELOPMENT, V101, P685
NR 53
TC 68
Z9 72
U1 0
U2 11
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAY
PY 2002
VL 17
IS 5
BP 413
EP 426
AR PII S0956-5663(01)00281-0
DI 10.1016/S0956-5663(01)00281-0
PG 14
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 539JX
UT WOS:000174867700009
PM 11888732
DA 2018-10-20
ER

PT J
AU Zhang, YQ
AF Zhang, YQ
TI Applications of natural silk protein sericin in biomaterials
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE silk protein; sericin; fibroin; functional biomaterials; biopolymer
AB Silk sericin is a natural macromolecular protein derived from silkworm Bombyx mori. During the various stages of producing raw silk and textile, sericin can be recovered for other uses. Also, sericin recovery reduces the environmental impact of silk manufacture. Sericin protein is useful because of its properties. The protein resists oxidation, is antibacterial, UV resistant, and absorbs and releases moisture easily. Sericin protein can be cross-linked, copolymerized, and blended with other macromolecular materials, especially artificial polymers, to produce materials with improved properties. The protein is also used as an improving reagent or a coating material for natural and artificial fibers, fabrics, and articles. The materials modified with sericin and sericin composites are useful as degradable biomaterials, biomedical materials, polymers for forming articles, functional membranes, fibers, and fabrics. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Soochow Univ, Biotechnol Lab Silkworm & Silk, Suzhou 215006, Peoples R China.
RP Zhang, YQ (reprint author), Soochow Univ, Biotechnol Lab Silkworm & Silk, 1 Shizi St, Suzhou 215006, Peoples R China.
OI Zhang, Yu-Qing/0000-0001-7670-386X
CR Ahn JS, 2001, J APPL POLYM SCI, V80, P274, DOI 10.1002/1097-4628(20010411)80:2<274::AID-APP1096>3.0.CO;2-G
   Akiyama D., 1993, J SERIC SCI JPN, V62, P392
   Annamaria S., 1998, INT BIODETER BIODEGR, V42, P203
   [Anonymous], 1994, [No title captured], Patent No. 06017372
   ASAKURA T, 1992, Patent No. 04053490
   Chisti Y, 1998, BIOSEPARATION BIOPRO, V2, P3
   DEMURA M, 1992, Journal of Sericultural Science of Japan, V61, P66
   FUJITA T, 1998, Patent No. 10195169
   Hatakeyama H., 1996, Japan Patent, Patent No. [08-012738A, 08012738]
   HIROTSU T, 1988, SEN-I GAKKAISHI, V44, P70
   IWAMOTO K, 1995, J SERIC SCI JPN, V65, P427
   KABAYAMA M, 2000, Patent No. 2000014592
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   KAZUHISA T, 2001, J BIOCH, V129, P979
   MASAKAZU Y, 2001, Patent No. 2001129371
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MIYAIRI S, 1978, J FERMENT TECHNOL, V56, P303
   Mizoguchi K., 1991, Japan Patent, Patent No. [03-284337A, 03284337]
   MORI K, 1997, Patent No. 09322911
   Murase M, 1994, Japan Patent, Patent No. [06-166850A, 06166850]
   NABESHIMA K, 1997, Patent No. 09158048
   Nakamura K., 2001, Japan Patent, Patent No. [2001106794, 2001-106794A]
   NOGATA A, 1997, Patent No. 09031847
   NOMURA M, 1996, Patent No. 08058006
   NOMURA M, 1996, Patent No. 08060547
   Nomura M., 1995, Japan Patent, Patent No. [07-292240, 07292240, 07-292240A]
   SUMITOMO K, 1997, Patent No. 09124796
   TAKAI Y, 1999, Patent No. 11350352
   Tamada Y., 1997, Japan Patent, Patent No. [09-227402A, 09227402]
   TANAKA T, 2001, Patent No. 2001055562
   Tsubouchi K, 1999, Japan patent, Patent No. [11-070160A, 11070160]
   Tsubouchi K., 1999, US Patent, Patent No. [US5951506, 5951506]
   Tsuchiya Y., 1987, SEN-I GAKKAISHI, V43, P283
   Tsukada M., 1999, Japan Patent, Patent No. [11-243948A, 11243948]
   Ueda K., 2000, Seiren Co Ltd. patent, Patent No. [JP 2000169595, 2000169595]
   Wang XQ, 1998, MOL HUM REPROD, V4, P295, DOI 10.1093/molehr/4.3.295
   X Li, 1996, China Patent, Patent No. [1116227A, 1116227]
   Yamada H, 1998, Japan Patent, Patent No. [10-001872A, 10001872]
   Yamada H., 1993, Japan Patent, Patent No. [05-339878A, 05339878]
   Yamada H., 1994, Jpn Patent, Patent No. [06-080741A, 06080741]
   YAMADA H, 1993, Patent No. [5345117, 05345117]
   Yamada H., 1993, Jpn Patent, Patent No. [05-345118A, 05345118]
   Yamada H, 1994, Japan Pat, Patent No. 06017373
   YASUSHI N, 1994, Patent No. 06018892
   Yoshii F, 2000, Japan Patent Publication Number, Patent No. [2000-169736, 2000169736]
   YOSHIKAWA M, 2001, Patent No. 2001129373
   2001, CHEM DAILY      0727
NR 47
TC 328
Z9 351
U1 7
U2 134
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD MAY
PY 2002
VL 20
IS 2
BP 91
EP 100
AR PII S0734-9750(02)00003-4
DI 10.1016/S0734-9750(02)00003-4
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 558VX
UT WOS:000175988600001
PM 14538058
DA 2018-10-20
ER

PT J
AU Bower, CK
   Parker, JE
   Higgins, AZ
   Oest, ME
   Wilson, JT
   Valentine, BA
   Bothwell, MK
   McGuire, J
AF Bower, CK
   Parker, JE
   Higgins, AZ
   Oest, ME
   Wilson, JT
   Valentine, BA
   Bothwell, MK
   McGuire, J
TI Protein antimicrobial barriers to bacterial adhesion: in vitro and in
   vivo evaluation of nisin-treated implantable materials
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE nisin; antimicrobial proteins
ID LISTERIA-MONOCYTOGENES; LANTIBIOTIC NISIN; SILICA SURFACES; ADSORPTION;
   INVITRO
AB A novel approach to controlling unwanted microbial adhesion in clinical environments is to inhibit the initial attachment of bacteria, rather than trying to remove them once they have adhered. Previous investigations have established that antimicrobial peptides such as nisin can adsorb to surfaces and still retain sufficient activity to inhibit pathogenic bacteria. We examined techniques of application of nisin in vitro to elucidate those most effective and practical for use on biomedical implants in vivo. Nisin adsorbed quickly on Polyvinyl chloride (PVC) suction catheter tubing, with only a slight gain in nisin activity as contact times increased from 10 s to 8 h. The activity of nisin adsorbed on PVC suction catheter tubing increased as solution concentrations increased from 0.01 to 2.0 mg/ml, and it decreased with aging in protein-free phosphate buffer for 48 h and with drying for up to 2 months. When exposed to three species of Gram-positive bacteria, nisin-treated PVC tubing demonstrated an ability to inhibit bacterial growth, while bacteria grew unchecked on catheter material that was untreated. We then examined the ability of nisin to retain its activity in vivo when placed on implants in blood vessels or the upper airway and whether nisin causes tissue reactions greater than untreated implants placed in sheep and ponies. Freshly prepared nisin was applied to Teflon(R) FEP intravenous catheters and to PVC tracheotomy tubes at the time of placement. using a concentration of 1.0 mg/ml and 10-s contact time. Tissue reactions in response to nisin adsorbed on intravenous catheters or tracheotomy tubes did not occur in sheep or ponies. respectively. Nisin activity was retained for more than 5 h but less than I week on intravenous catheters placed in the jugular veins of sheep, and the veins with short-term catheters showed fewer and less severe histologic abnormalities compared with controls, indicating a possible protective effect on vascular endothelium. Nisin activity was retained on PVC tracheotomy tubes maintained for 1-2 h in ponies, but not on tubes in place for 24 h. As the first preclinical trial of nisin-treated implantable materials. this study represents an important first step for developing the potentially broad use of protein antimicrobial films on implantable medical devices. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Oregon State Univ, Dept Bioengn, Corvallis, OR 97331 USA.
   Oregon State Univ, Dept Large Anim Clin Sci, Corvallis, OR 97331 USA.
   Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA.
CR Andrade J. D., 1996, INTERFACIAL PHENOMEN, P19
   ANDRADE JD, 1984, PURE APPL CHEM, V56, P1345, DOI 10.1351/pac198456101345
   BOWER CK, 1995, J IND MICROBIOL, V15, P227, DOI 10.1007/BF01569829
   BOWER CK, 1995, APPL ENVIRON MICROB, V61, P992
   Brash J. L., 1995, ACS SYM SER, V602, P1
   CHATTERJEE S, 1992, J ANTIBIOT, V45, P839, DOI 10.7164/antibiotics.45.839
   DAESCHEL MA, 1992, J FOOD PROTECT, V55, P731, DOI 10.4315/0362-028X-55.9.731
   Datta AR, 1997, APPL ENVIRON MICROB, V63, P4123
   DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424
   Elliott TSJ, 1998, J HOSP INFECT, V40, P193, DOI 10.1016/S0195-6701(98)90137-2
   GARCERA MJG, 1993, EUR J BIOCHEM, V212, P417, DOI 10.1111/j.1432-1033.1993.tb17677.x
   HURST A, 1981, ADV APPL MICROBIOL, V27, P85, DOI DOI 10.1016/S0065-2164(08)70342-3
   KELLNER R, 1988, EUR J BIOCHEM, V177, P53, DOI 10.1111/j.1432-1033.1988.tb14344.x
   Lakamraju M, 1996, J COLLOID INTERF SCI, V178, P495, DOI 10.1006/jcis.1996.0144
   LIBMAN H, 1984, ARCH INTERN MED, V144, P541, DOI 10.1001/archinte.144.3.541
   LIU W, 1990, APPL ENVIRON MICROB, V56, P2551
   Martin I, 1996, EUR J BIOCHEM, V239, P156, DOI 10.1111/j.1432-1033.1996.0156u.x
   Masschalck B, 2001, INT J FOOD MICROBIOL, V64, P325, DOI 10.1016/S0168-1605(00)00485-2
   Severina E, 1998, J ANTIMICROB CHEMOTH, V41, P341, DOI 10.1093/jac/41.3.341
   Shiba T., 1991, NISIN NOVEL LANTIBIO, P113
   STEVENS KA, 1991, APPL ENVIRON MICROB, V57, P3613
   WOJCIECHOWSKI PW, 1996, INTERFACIAL PHENOMEN, P1
   Worthington T, 2000, J HOSP INFECT, V46, P130, DOI 10.1053/jhin.2000.0810
NR 23
TC 44
Z9 46
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY
PY 2002
VL 25
IS 1
BP 81
EP 90
AR PII S0927-7765(01)00318-6
DI 10.1016/S0927-7765(01)00318-6
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 549DT
UT WOS:000175429800009
DA 2018-10-20
ER

PT J
AU Weisenberg, BA
   Mooradian, DL
AF Weisenberg, BA
   Mooradian, DL
TI Hemocompatibility of materials used in microelectromechanical systems:
   Platelet adhesion and morphology in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hemocompatibility; MEMS; platelet adhesion; platelet morphology
ID PYROLYTIC CARBON; WHOLE-BLOOD; SURFACE; ACTIVATION; POLYETHYLENE;
   AGGREGATION; ADSORPTION; BINDING; SENSOR; PLASMA
AB Microelectromechanical systems (MEMS) create an opportunity for the development of smaller, cheaper, and more precise biomedical instrumentation and devices. Little is known, however, about the hemocompatibility of the materials used to fabricate these devices. Because of the potentially harmful consequences of thrombus formation, a better understanding of blood interactions with bioMEMS materials is desirable. This study is an in vitro assessment of the hemocompatibility of silicon (Si), silicon dioxide (SiO2), silicon nitride (Si3N4), low-stress silicon nitride (Si1.0N1.1), SU-8 photoresist, and parylene thin films. A polycarbonate-based polyurethane, was used as a reference material. Experiments were carried out to detect differences in platelet adhesion or morphology after contact with these materials under static conditions. Platelet adhesion on Si, Si3N4, Si1.0N1.1 and SU-8 photoresist was significantly greater (P < 0.05) than platelet adhesion on polyurethane. Adhesion on parylene and SiO2 was not significantly different from on polyurethane (P < 0.05). The median platelet area and circularity were higher on polyurethane than all other materials. Materials that showed higher levels of platelet adhesion tended to have platelets that showed less spreading, except for SiO2, where platelets exhibited relatively low adhesion and spreading, This data suggests that Si, Si3N4, Si1.0N1.1, and SU-8 photoresist may be more reactive to platelets and therefore more thrombogenic than parylene, SiO2, and polyurethane. These results may be helpful in guiding the selection of materials for use in the development of blood-contacting microelectromechanical systems. (C) 2002 John Wiley Sons, Inc.
C1 Univ Minnesota, Biomed Engn Inst, Minneapolis, MN 55455 USA.
   Bio Vasc Inc, St Paul, MN 55114 USA.
RP Mooradian, DL (reprint author), Univ Minnesota, Biomed Engn Inst, Minneapolis, MN 55455 USA.
EM d.mooradian@biovascular.com
CR ALTENDORF E, 1998, MICRO TOTAL ANAL SYS, P73
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BAUMGARTNER HR, 1976, THROMB HAEMOSTASIS, V35, P124, DOI 10.1055/s-0038-1647919
   Bistue G, 1997, J MICROMECH MICROENG, V7, P244, DOI 10.1088/0960-1317/7/3/044
   CENNI E, 1995, BIOMATERIALS, V16, P973, DOI 10.1016/0142-9612(95)94903-X
   Chen Z, 1999, J BIOMAT SCI-POLYM E, V10, P901
   COURTNEY JM, 1994, BRIT MED BULL, V50, P966, DOI 10.1093/oxfordjournals.bmb.a072937
   ELAM JH, 1992, BIOMATERIALS, V13, P3, DOI 10.1016/0142-9612(92)90086-4
   Fontaine AB, 1996, J ENDOVASC SURG, V3, P276, DOI 10.1583/1074-6218(1996)003<0276:PSMOTS>2.0.CO;2
   Frank R, 1997, I&CS-INSTR CON SYST, V70, P41
   Goodman S L, 1991, J Biomater Sci Polym Ed, V2, P147, DOI 10.1163/156856291X00133
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   GOODMAN SL, 1984, SEM 1984, V1, P279
   GREISLER HP, 1990, J VASC SURG, V11, P665, DOI 10.1067/mva.1990.19423
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   Iguchi N, 1997, PACE, V20, P372, DOI 10.1111/j.1540-8159.1997.tb06188.x
   Kalvesten E, 1998, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE ELEVENTH ANNUAL INTERNATIONAL WORKSHOP PROCEEDINGS, P574
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   KANDA Y, 1981, ELECTRON LETT, V17, P558, DOI 10.1049/el:19810391
   KO TM, 1993, BIOMATERIALS, V14, P657
   LEYTIN VL, 1980, THROMB RES, V20, P335, DOI 10.1016/0049-3848(80)90236-4
   MASON RG, 1971, P SOC EXP BIOL MED, V137, P680
   MENZ W, 1994, MINIM INVAS NEUROSUR, V37, P21, DOI 10.1055/s-2008-1053444
   MIURA M, 1998, MUTAS 98, P85
   Noordegraaf J, 1997, Med Device Technol, V8, P14
   Ohori T, 1998, SENSOR ACTUAT A-PHYS, V64, P57, DOI 10.1016/S0924-4247(98)80058-7
   Park K, 1985, Trans Am Soc Artif Intern Organs, V31, P483
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   Petersen K, 1996, IEDM - INTERNATIONAL ELECTRON DEVICES MEETING, TECHNICAL DIGEST 1996, P239, DOI 10.1109/IEDM.1996.553575
   POOT A, 1988, BIOMATERIALS, V9, P126, DOI 10.1016/0142-9612(88)90110-X
   Roussel P, 1999, SENSOR ACTUAT A-PHYS, V74, P100, DOI 10.1016/S0924-4247(98)00330-6
   RUCKENSTEIN E, 1976, THROMB HAEMOSTASIS, V36, P334
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184, DOI 10.1111/j.1749-6632.1987.tb33040.x
   Spearing SM, 2000, ACTA MATER, V48, P179, DOI 10.1016/S1359-6454(99)00294-3
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 38
TC 83
Z9 85
U1 1
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 2002
VL 60
IS 2
BP 283
EP 291
DI 10.1002/jbm.10076
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 527YM
UT WOS:000174215600009
PM 11857435
DA 2018-10-20
ER

PT J
AU Chatterjee, J
   Haik, Y
   Chen, CJ
AF Chatterjee, J
   Haik, Y
   Chen, CJ
TI Polyethylene magnetic nanoparticle: a new magnetic material for
   biomedical applications
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE polyethylene; magnetic particles; ultrasonication; biomedical
   applications; nanoparticles; nanocomposite
ID MICROSPHERES; TEMPERATURE; PARTICLES
AB Polyethylene magnetic nanoparticles were synthesized by nonsolvent and temperature induced crystallization along with ultrasonication. Low molecular weight polyethylene wax and maghemite were used for forming the composite particles. These particles were further coated with avidin. The nanoparticles are characterized using STEM, AFM and SQUID. Nanomagnetic particles were found to have two distinct morphologies and have superparamagnetic properties. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 FAMU FSU Coll Engn, Dept Mech Engn, Biomagnet Engn Lab, Tallahassee, FL 32310 USA.
RP Haik, Y (reprint author), FAMU FSU Coll Engn, Dept Mech Engn, Biomagnet Engn Lab, 2525,Pottsdamer Str, Tallahassee, FL 32310 USA.
CR ALAMO RG, 1996, HDB POLYM PROPERTIES, P119
   BASSETT DC, 1981, PRINCIPLES POLYM MOR, P122
   Chatterjee J, 2001, J MAGN MAGN MATER, V225, P21, DOI 10.1016/S0304-8853(00)01223-3
   Chatterjee J, 2001, COLLOID POLYM SCI, V279, P1073, DOI 10.1007/s003960100523
   CHATTERJEE J, UNPUB LANGMUIR
   Dai JB, 2000, J APPL PHYS, V87, P7397, DOI 10.1063/1.372999
   Ding X, 2000, COLLOID POLYM SCI, V278, P459, DOI 10.1007/s003960050539
   Dresco PA, 1999, LANGMUIR, V15, P1945, DOI 10.1021/la980971g
   FURUSAWA K, 1994, COLLOID POLYM SCI, V272, P1104, DOI 10.1007/BF00652379
   HAGER HJ, 1974, Patent No. 3857931
   LEE J, 1995, COLLOID POLYM SCI, V273, P76
   MOLDAY RS, 1982, J IMMUNOL METHODS, V52, P353, DOI 10.1016/0022-1759(82)90007-2
   Sauzedde F, 1999, COLLOID POLYM SCI, V277, P846, DOI 10.1007/s003960050461
   Suslick KS, 1996, CHEM MATER, V8, P2172, DOI 10.1021/cm960056l
   VASSILIOU JK, 1993, J APPL PHYS, V73, P5109, DOI 10.1063/1.353784
   YARAVOY YK, 2000, J BIOMED MATER RES, V53, P152
NR 16
TC 72
Z9 78
U1 2
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD MAY
PY 2002
VL 246
IS 3
BP 382
EP 391
AR PII S0304-8853(02)00110-5
DI 10.1016/S0304-8853(02)00110-5
PG 10
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 563NW
UT WOS:000176263300007
DA 2018-10-20
ER

PT J
AU Kazanci, M
   Cohn, D
   Marom, G
   Ben-Bassat, H
AF Kazanci, M
   Cohn, D
   Marom, G
   Ben-Bassat, H
TI Surface oxidation of polyethylene fiber reinforced polyolefin biomedical
   composites and its effect on cell attachment
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HUMAN KERATINOCYTES
AB Three different compositions of butene-ethylene copolymer composites reinforced by polyethylene fibers and produced by filament winding are potentially suitable for biomedical applications. This study examines the effect of various processing and finishing conditions and of sterilization on the extent and composition of surface oxidation. An XPS analysis revealed only insignificant differences between the various treatments, while fibroblast cell attachment tests indicated good attachment with no signs of cytotoxity or cell degeneration for any of the materials. (C) 2002 Kluwer Academic Publishers.
C1 Hebrew Univ Jerusalem, Casali Inst Appl Chem, IL-91904 Jerusalem, Israel.
   Hadassah Univ Hosp, Expt Surg Lab, IL-91120 Jerusalem, Israel.
RP Kazanci, M (reprint author), Hebrew Univ Jerusalem, Casali Inst Appl Chem, IL-91904 Jerusalem, Israel.
CR BENBASSAT H, 1994, CELL MATER, V4, P37
   BENBASSAT H, BIOMATERIALS ENG DEV, V2, P155
   Costa L, 1998, BIOMATERIALS, V19, P659, DOI 10.1016/S0142-9612(97)00160-9
   Daly BM, 1998, J BIOMED MATER RES, V42, P523, DOI 10.1002/(SICI)1097-4636(19981215)42:4<523::AID-JBM7>3.0.CO;2-1
   Deng M, 1997, BIOMATERIALS, V18, P645, DOI 10.1016/S0142-9612(96)00194-9
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   FEIGELSHTEIN D, 2000, ADV COMPOS LETT, V9, P349
   France RM, 1998, CHEM MATER, V10, P1176, DOI 10.1021/cm970761+
   France RM, 1998, J MATER CHEM, V8, P37, DOI 10.1039/a705098d
   Jama C, 1999, SURF INTERFACE ANAL, V27, P653, DOI 10.1002/(SICI)1096-9918(199907)27:7<653::AID-SIA556>3.0.CO;2-0
   KAZANCI M, UNPUB J MAT SCI
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Oji MO, 1999, J MATER SCI-MATER M, V10, P869, DOI 10.1023/A:1008933318756
   Weissbuch I, 2000, CHEM-EUR J, V6, P725, DOI 10.1002/(SICI)1521-3765(20000218)6:4<725::AID-CHEM725>3.3.CO;2-5
NR 15
TC 10
Z9 10
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2002
VL 13
IS 5
BP 465
EP 468
DI 10.1023/A:1014789815441
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 532NT
UT WOS:000174482500005
PM 15348598
DA 2018-10-20
ER

PT J
AU Silva, RA
   Walls, M
   Rondot, B
   Belo, MD
   Guidoin, R
AF Silva, RA
   Walls, M
   Rondot, B
   Belo, MD
   Guidoin, R
TI Electrochemical and microstructural studies of tantalum and its oxide
   films for biomedical applications in endovascular surgery
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CORONARY-ARTERY DISEASE; PALMAZ-SCHATZ STENTS; BALLOON ANGIOPLASTY;
   CLINICAL-EXPERIENCE; PHOTOELECTROLYSIS; IMPLANTATION; ELECTRODES;
   OCCLUSION; LAYERS; METALS
AB The most popular coronary stents are made of 316L stainless steel and self-expandable Nitinol. Nevertheless, Ta has already been used to make stents for endovascular surgery and may constitute a good alternative to the other materials because of its higher corrosion resistance and radio-opacity property, which may facilitate the follow-up of stent catheterization. The characterization of Ta and its natural passive oxide films has been performed in a 0.15 M NaCl solution (simulated body fluid - SBF) using anodic polarizations, electrochemical impedance spectroscopy and photoelectrochemical techniques. Changes in microstructure have been observed by atomic force microscopy (AFM). Polarization curves show the existence of a current density increase between 1.40 and 1.80 V. Bode complex plots show that some perturbation of the film occurred in this potential interval which may be associated with a decrease in polarization resistance, Rp, indicating that the film may be less resistant to corrosive attack. Mott-Schottky capacity measurements show that the density of donors, Nd, varies with polarization. The optical band gap, E-g, which is equal to 4.1 eV did not show variations in our experiments. The localized formation on the electrode surface, in the above potential interval of a Ta compound (possibly an oxide-hydroxide) was observed by AFM, and this may explain the appearance of the current density peak and capacity behavior at those potentials. (C) 2002 Kluwer Academic Publishers.
C1 CIEA ISEP, P-4200 Oporto, Portugal.
   INEB, P-1450 Oporto, Portugal.
   CECM CNRS, F-94407 Vitry Sur Seine, France.
   IBQ, Quebec City, PQ G1L 3L5, Canada.
RP Silva, RA (reprint author), CIEA ISEP, Rua S Tome, P-4200 Oporto, Portugal.
OI Silva, Rui Alberto Goncalves/0000-0003-1359-1500
CR Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   BUTLER MA, 1977, J APPL PHYS, V48, P1914, DOI 10.1063/1.323948
   CLECHET P, 1976, CR ACAD SCI C CHIM, V282, P887
   COHEN DJ, 1995, CIRCULATION, V92, P2480, DOI 10.1161/01.CIR.92.9.2480
   COHEN DJ, 1993, J AM COLL CARDIOL, V22, P1052, DOI 10.1016/0735-1097(93)90415-W
   COHEN DJ, 1995, CIRCULATION, V92, P1859
   COLOMBO A, 1995, CIRCULATION, V91, P1676, DOI 10.1161/01.CIR.91.6.1676
   DEGRYSE R, 1975, J ELECTROCHEM SOC, V122, P711, DOI 10.1149/1.2134298
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   GARTNER WW, 1959, PHYS REV, V116, P84, DOI 10.1103/PhysRev.116.84
   GINLEY DS, 1977, J APPL PHYS, V48, P2019, DOI 10.1063/1.323911
   GOY JJ, 1995, CATHETER CARDIO DIAG, V34, P128, DOI 10.1002/ccd.1810340410
   HAMASAKI N, 1995, J AM COLL CARDIOL A, V239
   HAMM CW, 1995, AM HEART J, V129, P423, DOI 10.1016/0002-8703(95)90262-7
   JONHSON PF, 1977, J BIOMED MATER RES, V11, P637
   KERREC O, 1995, ELECTROCHIM ACTA, V40, P719, DOI 10.1016/0013-4686(94)00330-4
   KIEMENEIJ F, 1995, CATHETER CARDIO DIAG, V35, P301, DOI 10.1002/ccd.1810350405
   LOHRENGEL MM, 1994, ELECTROCHIM ACTA, V39, P1265, DOI 10.1016/0013-4686(94)E0046-3
   MACAGNO V, 1984, J ELECTROANAL CHEM, V180, P157, DOI 10.1016/0368-1874(84)83577-7
   MEHAN VK, 1995, CATHETER CARDIO DIAG, V34, P122, DOI 10.1002/ccd.1810340409
   PARK JB, 1984, BIOMATERIALS SCI ENG, P217
   Priestley KA, 1996, EUR HEART J, V17, P438
   Pypen CMJM, 1997, J MATER SCI-MATER M, V8, P781, DOI 10.1023/A:1018568830442
   ROBINSON NMK, 1995, J INVASIVE CARDIOL, V7, P156
   Schoneberger AA, 1996, NEW ENGL J MED, V335, P1160
   SCHULTZE JW, 1986, ELECTROCHIM ACTA, V31, P355, DOI 10.1016/0013-4686(86)80090-1
   Serruys PW, 1996, CIRCULATION, V93, P412, DOI 10.1161/01.CIR.93.3.412
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   SILVA RA, 1998, P 14 EUR C BIOM HAG, P37
   STACKPOOL GJ, 1995, P COMB ORTH RES SOC, P45
   STAUFFER JC, 1995, J INVASIVE CARDIOL, V7, P221
   Webb J, 1996, CATHETER CARDIO DIAG, V37, P120
NR 33
TC 35
Z9 37
U1 0
U2 17
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2002
VL 13
IS 5
BP 495
EP 500
DI 10.1023/A:1014779008598
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 532NT
UT WOS:000174482500010
PM 15348603
DA 2018-10-20
ER

PT J
AU Tan, L
   Crone, WC
   Sridharan, K
AF Tan, L
   Crone, WC
   Sridharan, K
TI Fretting wear study of surface modified Ni-Ti shape memory alloy
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BEHAVIOR; NITINOL; BIOCOMPATIBILITY; IMPLANTS; WIRE
AB A combination of shape memory characteristics, pseudoelasticity, and good damping properties make near-equiatomic nickel-titanium (Ni-Ti) alloy a desirable candidate material for certain biomedical device applications. The alloy has moderately good wear resistance, however, further improvements in this regard would be beneficial from the perspective of reducing wear debris generation, improving biocompatibility, and preventing failure during service. Fretting wear tests of Ni-Ti in both austenitic and martensitic microstructural conditions were performed with the goal of simulating wear which medical devices such as stents may experience during surgical implantation or service. The tests were performed using a stainless steel stylus counter-wearing surface under dry conditions and also with artificial plasma containing 80 g/L albumen protein as lubricant. Additionally, the research explores the feasibility of surface modification by sequential ion implantation with argon and oxygen to enhance the wear characteristics of the Ni-Ti alloy. Each of these implantations was performed to a dose of 3 x 10(17) atom/cm(2) and an energy of 50 kV, using the plasma source ion implantation process. Improvements in wear resistance were observed for the austenitic samples implanted with argon and oxygen. Ion implantation with argon also reduced the surface Ni content with respect to Ti due to differential sputtering rates of the two elements, an effect that points toward improved biocompatibility. (C) 2002 Kluwer Academic Publishers.
C1 Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
   Univ Wisconsin, Dept Engn Phys, Madison, WI 53706 USA.
RP Tan, L (reprint author), Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
RI Tan, Lizhen/A-7886-2009
OI Tan, Lizhen/0000-0002-3418-2450
CR Al-Waheidi E M, 1995, Quintessence Int, V26, P385
   Anders A, 2000, HDB PLASMA IMMERSION, P2
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   CHWIRUT DJ, 1997, SMST 97, P369
   CLAYTON P, 1993, WEAR, V162, P8002
   CONRAD JR, 1989, MAT SCI ENG A-STRUCT, V116, P197, DOI 10.1016/0921-5093(89)90146-9
   CRONE WC, 2000, SMST P INT C SHAP ME
   DHAN CM, 1990, SURF INTERFACE ANAL, V15, P349
   DUERIG TW, 1997, MED DEVICE DIAGN MAR
   DUNLAP CL, 1989, J AM DENT ASSOC, V118, P449, DOI 10.14219/jada.archive.1989.0174
   *FRENCH ASS STAND, 1990, 91141 AFNOR
   HALLING J, 1975, PRINCIPALS TRIBOLOGY
   Li DY, 1999, WEAR, V225, P777, DOI 10.1016/S0043-1648(98)00388-3
   Li DY, 1998, WEAR, V221, P116, DOI 10.1016/S0043-1648(98)00269-5
   Liang YN, 1996, WEAR, V198, P236, DOI 10.1016/0043-1648(96)06989-X
   MATSUNAMI N, 1980, ENERGY DEPENDENCE SP
   MOINE P, 1986, SCRIPTA METALL MATER, V20, P305, DOI 10.1016/0036-9748(86)90148-1
   MOINE P, 1987, SURF COAT TECH, V33, P479, DOI 10.1016/0257-8972(87)90212-X
   Pelton AR, 2000, MINIM INVASIV THER, V9, P107, DOI 10.3109/13645700009063057
   POPOOLA O, 1989, ACTA METALL MATER, V37, P867, DOI 10.1016/0001-6160(89)90013-8
   Ryhanen J, 2000, MINIM INVASIV THER, V9, P99, DOI 10.3109/13645700009063056
   Ryhanen J., 1999, THESIS OULU U FINLAN
   SANDSTROM PW, 1993, WEAR, V166, P163, DOI 10.1016/0043-1648(93)90258-N
   SARKAR AD, 1976, WEAR MAT, V18
   Stoeckel D, 2000, MINIM INVASIV THER, V9, P81, DOI 10.3109/13645700009063054
   TRIGWELL S, 1997, SHAPE MEMORY SUPEREL, P383
   Vandenkerckhove R, 1998, MATER SCI FORUM, V289-2, P1289, DOI 10.4028/www.scientific.net/MSF.289-292.1289
   Vander Voort GF, 1998, ADV MATER PROCESS, V154, P21
   WOLFF MR, 2000, COMMUNICATION   0616
NR 29
TC 23
Z9 23
U1 1
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2002
VL 13
IS 5
BP 501
EP 508
DI 10.1023/A:1014735225436
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 532NT
UT WOS:000174482500011
PM 15348604
DA 2018-10-20
ER

PT J
AU Li, YH
   Rong, LJ
   Li, YY
   Gunther, VE
AF Li, YH
   Rong, LJ
   Li, YY
   Gunther, VE
TI Influence of Ti powder characteristics on combustion synthesis of porous
   NiTi alloy
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE porous NiTi shape memory alloy; combustion synthesis; titanium powder
   characteristics
ID NICKEL-TITANIUM
AB Porous NiTi shape memory alloy (SMA) is a novel biomedical material used for human hard tissue implant. The influence of elemental titanium powder characteristics such as powder morphology, particle size and specific surface area (SSA) on the minimal ignition temperature, combustion temperature and final product of porous NiTi SMA fabricated by combustion synthesis method was investigated in this paper by scanning electron microscopy (SEM) and laser diffraction. The preliminary data indicated that the titanium powder characteristics had a strong effect on combustion synthesis of porous NiTi SMA.
C1 Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
   Sci Res Inst Med Mat & Shape Memory Implants, Tomsk 634034, Russia.
RP Li, YH (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RI Gunther, Viktor/O-6678-2014
OI Li, Yong-Hua/0000-0003-0005-3789
CR GUNTHER VE, 2000, DELAY LAW NEW CLASS, P157
   ISHIZAKI K, 1998, POROUS MAT PROCESS T, P13
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   LAKSHMIKANTHA MG, 1992, METALL TRANS A, V23, P23, DOI 10.1007/BF02660847
   Munir Z. A., 1989, Material Science Reports, V3, P277, DOI 10.1016/0920-2307(89)90001-7
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
NR 7
TC 4
Z9 4
U1 0
U2 2
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD MAY
PY 2002
VL 18
IS 3
BP 248
EP 250
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 559BB
UT WOS:000176003400014
DA 2018-10-20
ER

PT J
AU Klepper, CC
   Hazelton, RC
   Yadlowsky, EJ
   Carlson, EP
   Keitz, MD
   Williams, JM
   Zuhr, RA
   Poker, DB
AF Klepper, CC
   Hazelton, RC
   Yadlowsky, EJ
   Carlson, EP
   Keitz, MD
   Williams, JM
   Zuhr, RA
   Poker, DB
TI Amorphous boron coatings produced with vacuum arc deposition technology
SO JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A-VACUUM SURFACES AND FILMS
LA English
DT Article; Proceedings Paper
CT IUVSTA 15th International Congress/AVS 48th International Symposium/11th
   International Conference on Solid Surfaces
CY OCT 28-NOV 02, 2001
CL SAN FRANCISCO, CALIFORNIA
SP IUVSTA, AVS
ID FILMS; CARBON; EVAPORATION; CATHODE
AB In principle, boron (B) as a material has many excellent surface properties, including corrosion resistance, very high hardness, refractory properties, and a strong tendency to bond with most substrates. The potential technological benefits of the material have not been realized, because it is difficult to deposit it as coatings. B is difficult to evaporate, does not sputter well, and cannot be thermally sprayed. In this article, first successful deposition results from a robust system, based on the vacuum (cathodic) are technology, are reported. Adherent coatings have been produced on 1100 Al, CP-Ti, Ti-6Al-4V, 316 SS, hard chrome plate, and 52 100 steel. Composition and thickness analyses have been performed by Rutherford backscattering spectroscopy. Hardness (H) and modules (E) have been evaluated by nanoindentation. The coatings are very pure and have properties characteristic of B suboxides. A microhardness of up to 27 GPa has been measured on a 400-nm-thick film deposited on 52 100 steel, with a corresponding modulus of 180 GPa. This gives a very high value for the HIE ratio, a figure-of-merit for impact resistance of the film. A number of applications are contemplated. including corrosion/abrasion protection for die-casting dies and improved wear resistance for biomedical implants. (C) 2002 American Vacuum Society.
C1 HY Tech Res Corp, Radford, VA 24141 USA.
   Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.
RP Klepper, CC (reprint author), HY Tech Res Corp, Radford, VA 24141 USA.
OI Klepper, C.Christopher/0000-0001-9107-8337
CR ANDERS A, 1994, J VAC SCI TECHNOL B, V12, P815, DOI 10.1116/1.587351
   Anders A, 2001, J APPL PHYS, V89, P7764, DOI 10.1063/1.1371276
   Anders A, 1999, SURF COAT TECH, V120, P319, DOI 10.1016/S0257-8972(99)00460-0
   BADZIAN AR, 1988, APPL PHYS LETT, V53, P2495, DOI 10.1063/1.100528
   BOXMAN RL, 1992, SURF COAT TECH, V52, P39, DOI 10.1016/0257-8972(92)90369-L
   Brown IG, 1998, ANNU REV MATER SCI, V28, P243, DOI 10.1146/annurev.matsci.28.1.243
   CLUGGISH BP, 1998, IEEE T PLASMA SCI, V26, P6
   Doughty C, 1997, J VAC SCI TECHNOL A, V15, P2623, DOI 10.1116/1.580933
   GILLE G, 1984, THIN SOLID FILMS, V120, P109, DOI 10.1016/0040-6090(84)90365-1
   GORBATKIN SM, 1994, APPL PHYS LETT, V65, P2672, DOI 10.1063/1.112598
   Gorokhovsky VI, 2001, SURF COAT TECH, V140, P215, DOI 10.1016/S0257-8972(01)01023-4
   Klepper CC, 2001, FUSION TECHNOL, V39, P910
   Martin P. J., 1995, HDB VACUUM ARC SCI T
   MATTOX DM, 2001, VAC TECHNOL COAT, V2, P12
   Mitterer C, 2000, SURF COAT TECH, V125, P233, DOI 10.1016/S0257-8972(99)00557-5
   Murray FJ, 1995, REGUL TOXICOL PHARM, V22, P221, DOI 10.1006/rtph.1995.0004
   Richter F, 1999, SURF COAT TECH, V112, P43, DOI 10.1016/S0257-8972(98)00805-6
   Richter F, 1997, SURF COAT TECH, V90, P178, DOI 10.1016/S0257-8972(96)03116-7
   Schulke T, 1999, PLASMA SOURCES SCI T, V8, P567, DOI 10.1088/0963-0252/8/4/307
   SHEEHAN E, 2001, J BIOMED ENG, V29, pS146
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   TSUI TY, 1995, MATER RES SOC SYMP P, V356, P767
   Yucong W, 1997, SURF COAT TECH, V94-95, P60
   ZIEGLER JF, 1999, SRIM STOPPING RANGES
NR 24
TC 33
Z9 34
U1 0
U2 17
PU A V S AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0734-2101
J9 J VAC SCI TECHNOL A
JI J. Vac. Sci. Technol. A-Vac. Surf. Films
PD MAY-JUN
PY 2002
VL 20
IS 3
BP 725
EP 732
DI 10.1116/1.1464844
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 555RG
UT WOS:000175806600025
DA 2018-10-20
ER

PT J
AU Melnik, RVN
AF Melnik, RVN
TI Models for coupled kinetics and heat transfer in processing polymeric
   materials with applications to biochemical engineering
SO MODELLING AND SIMULATION IN MATERIALS SCIENCE AND ENGINEERING
LA English
DT Article
ID THERMOSET COMPOSITES; THERMAL-DEGRADATION; CURE; SIMULATION; BEHAVIOR;
   MATRIX; FIBER
AB Macroscopic properties of thermosetting polymers are strongly affected by thermal degradation. However, modelling the dynamics of thermal degradation is difficult due to an intrinsic coupling between reaction kinetics and heat transfer in polymeric materials. In this paper we consider mathematical models for degradation focusing on thermal degradation and shrinkage phenomena. We discuss in detail a mathematical model that allows modelling thermal degradation as a coupled process and develop an efficient procedure for numerical studies of this process. The developed procedure is then applied to modelling degradation of acrylic resins widely used in chemical biomedical engineering. Results of numerical experiments are presented.
C1 Univ So Denmark, MCI, DK-6400 Sonderborg, Denmark.
RP Melnik, RVN (reprint author), Univ So Denmark, MCI, Grundtvigs Alle 150, DK-6400 Sonderborg, Denmark.
CR Adolf DB, 1998, J MATER RES, V13, P530, DOI 10.1557/JMR.1998.0069
   Allen N. S., 1992, FUNDAMENTALS POLYM D
   Anthony GM, 1999, POLYM DEGRAD STABIL, V64, P353, DOI 10.1016/S0141-3910(98)00129-3
   Barre S, 1996, COMPOS PART A-APPL S, V27, P1169, DOI 10.1016/1359-835X(96)00075-9
   BROWN AS, 1989, AEROSPACE AM, V7, P19
   Buckmaster J, 1997, J COMPOS MATER, V31, P2, DOI 10.1177/002199839703100102
   CAUX X, 1989, POLYM COMPOSITE, V10, P140, DOI 10.1002/pc.750100212
   Colombini D, 1999, POLYMER, V40, P935, DOI 10.1016/S0032-3861(98)00303-6
   COVAS JA, 1994, RHEOLOGICAL FUNDAMEN, P385
   Dabrowski F, 2000, EUR POLYM J, V36, P273, DOI 10.1016/S0014-3057(99)00079-8
   Davies AR, 1998, J NON-NEWTON FLUID, V79, P235, DOI 10.1016/S0377-0257(98)00109-8
   DENG Y, 1994, MACROMOLECULES, V27, P5141, DOI 10.1021/ma00096a042
   Elliniadis S, 1996, MACROMOL SYMP, V112, P55, DOI 10.1002/masy.19961120109
   EMSLEY AM, 1995, POLYM DEGRAD STABIL, V49, P145, DOI 10.1016/0141-3910(95)00067-V
   FINA PE, 1999, PLAST ENG, V5, P49
   Flipsen TAC, 1996, ADV MATER, V8, P45, DOI 10.1002/adma.19960080107
   GABRISCH HJ, 1993, SAMPE J, V29, P23
   Gerard JF, 1996, MACROMOL SYMP, V108, P137, DOI 10.1002/masy.19961080112
   GIBBONS WM, 1994, MACROMOLECULES, V27, P771, DOI 10.1021/ma00081a023
   Hamid SH, 1992, HDB POLYM DEGRADATIO
   Juang YJ, 2001, POLYM ENG SCI, V41, P275, DOI 10.1002/pen.10727
   KIM C, 1995, J COMPOS MATER, V29, P1222, DOI 10.1177/002199839502900905
   Kinsey SP, 1997, J MATER PROCESS TECH, V63, P442, DOI 10.1016/S0924-0136(96)02662-3
   LEWIS G, 1996, BIOMED ENG SOC B, V20, P3
   MELNIK RVN, 2002, COMPUT MATH APPL
   MELNIK RVN, 2000, INT J MATH ALGORITHM, V2, P89
   MOHAN R, 1995, J REINF PLAST COMP, V14, P72, DOI 10.1177/073168449501400105
   Nzihou A, 1999, CHEM ENG J, V72, P53, DOI 10.1016/S1385-8947(98)00137-5
   Ortiz C, 1998, MACROMOLECULES, V31, P4074, DOI 10.1021/ma971439n
   PITCHUMANI R, 1993, J COMPOS MATER, V27, P613, DOI 10.1177/002199839302700604
   Porter D, 1995, GROUP INTERACTION MO
   Schnabel W., 1981, POLYM DEGRADATION PR
   SHEN SF, 1990, INT J NUMER METH ENG, V30, P1633, DOI 10.1002/nme.1620300819
   Staggs JEJ, 1999, FIRE SAFETY J, V32, P17, DOI 10.1016/S0379-7112(98)00026-5
   SUNG KH, 1989, J COMPOS MATER, V23, P1130
   Tokarski JS, 1997, COMPUT THEOR POLYM S, V7, P199, DOI 10.1016/S1089-3156(98)00007-5
   TORRE L, 1995, REV I FR PETROL, V50, P135
   Wachsen O, 1997, POLYM DEGRAD STABIL, V57, P87, DOI 10.1016/S0141-3910(96)00226-1
   ZHANG H, 2000, APPL MATH MODEL, P402
NR 39
TC 15
Z9 15
U1 0
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0965-0393
J9 MODEL SIMUL MATER SC
JI Model. Simul. Mater. Sci. Eng.
PD MAY
PY 2002
VL 10
IS 3
BP 341
EP 357
AR PII S0965-0393(02)35520-7
DI 10.1088/0965-0393/10/3/307
PG 17
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 561QT
UT WOS:000176154200009
DA 2018-10-20
ER

PT J
AU Baldini, F
   Mignani, AG
AF Baldini, F
   Mignani, AG
TI Optical-fiber medical sensors
SO MRS BULLETIN
LA English
DT Article
DE biomaterials; optoelectronic materials; optical-fiber sensors; optical
   properties
ID RAMAN-SPECTROSCOPY; RADIATION-THERAPY; DOSE MEASUREMENTS; BLOOD;
   RADIOTHERAPY; REFLECTANCE; WAVELENGTH; BIOSENSOR; TISSUE; SYSTEM
AB Optical-fiber sensors can be placed on the skin or inside the human body for the direct measurement of biomedical parameters. This article presents an overview of the most recent applications of optical-fiber sensors for biomedical purposes and those currently under development.
RI Mignani, Anna Grazia/B-3281-2010
OI Baldini, Francesco/0000-0002-2689-5952
CR Barker SLR, 1999, ANAL CHEM, V71, P2071, DOI 10.1021/ac9901081
   Berger AJ, 1999, APPL OPTICS, V38, P2916, DOI 10.1364/AO.38.002916
   Brenin DR, 1997, SURG ONCOL, V6, P99, DOI 10.1016/S0960-7404(97)00010-8
   Bueker H, 1999, P SOC PHOTO-OPT INS, V3746, P240
   Bueker H, 1997, OPT REV, V4, P130
   Cassis L. A., 1998, J NEAR INFRARED SPEC, V6, p21A
   CHANGE B, 1995, PHYS TODAY, V40, P34
   Clark HA, 1999, ANAL CHEM, V71, P4837, DOI 10.1021/ac990630n
   Cordek J, 1999, ANAL CHEM, V71, P1529, DOI 10.1021/ac980850l
   Cubeddu R, 1999, APPL OPTICS, V38, P3670, DOI 10.1364/AO.38.003670
   CUI W, 1990, IEEE T BIO-MED ENG, V37, P632, DOI 10.1109/10.55667
   Fang XH, 1999, J AM CHEM SOC, V121, P2921, DOI 10.1021/ja9837809
   Grant SA, 1997, SENSOR ACTUAT B-CHEM, V45, P35, DOI 10.1016/S0925-4005(97)00263-3
   Grant SA, 1999, IEEE T BIO-MED ENG, V46, P1207, DOI 10.1109/10.790497
   Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201
   Huston A.L., 1998, [No title captured], Patent No. 5811822
   Huston AL, 1999, P SOC PHOTO-OPT INS, V3746, P167
   Lin YP, 1998, P SOC PHOTO-OPT INS, V3245, P51, DOI 10.1117/12.312329
   Liu CH, 1991, LASERS LIFE SCI, V4, P23
   LUEGER A, 2000, CRITICAL CARE S1, V4, P148
   Manoharan R, 1998, PHOTOCHEM PHOTOBIOL, V67, P15, DOI 10.1562/0031-8655(1998)067<0015:RSAFPM>2.3.CO;2
   MENDELSON Y, 1988, IEEE T BIO-MED ENG, V35, P798, DOI 10.1109/10.7286
   Mignani AG, 1998, P SOC PHOTO-OPT INS, V3483, P99, DOI 10.1117/12.309649
   MIGNANI AG, 1997, OPTICAL FIBER SENSOR, V4, P129
   MIGNANI AG, 1995, REP PROG PHYS, V59, P1
   Oda M, 1996, PHYS MED BIOL, V41, P551, DOI 10.1088/0031-9155/41/3/015
   Qu JNY, 1999, APPL OPTICS, V38, P5491, DOI 10.1364/AO.38.005491
   RANCHOUX G, 2002, IN PRESS RAD PROTECT
   RAO YJ, 1996, IEEE J LIGHTWAVE TEC, V15, P779
   RAO YJ, 1997, P 12 C OPT FIB SENS, V16, P354
   ROY O, 1997, P 12 C OPT FIB SENS, V16
   Tan WH, 1999, ANAL CHEM, V71, p606A, DOI 10.1021/ac990671j
   THOMPSON RB, 1998, OPTICAL FBER SENSOR, V4, P67
   UGNELL H, 1994, P SOC PHOTO-OPT INS, V2331, P89
   Webb DJ, 2000, J BIOMED OPT, V5, P45, DOI 10.1117/1.429967
   Wehrle G, 2000, P SOC PHOTO-OPT INS, V4185, P310
NR 36
TC 10
Z9 10
U1 0
U2 7
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD MAY
PY 2002
VL 27
IS 5
BP 383
EP 387
DI 10.1557/mrs2002.123
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 552QR
UT WOS:000175631500017
DA 2018-10-20
ER

PT J
AU Benson, RS
AF Benson, RS
TI Use of radiation in biomaterials science
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 11th International Conference on Radiation Effects in Insulators
CY SEP 03-07, 2001
CL LISBON, PORTUGAL
DE biomaterials; ultraviolet and gamma radiation
ID SURFACE MODIFICATION; STERILIZATION; SCAFFOLDS
AB Radiation is widely used in the biomaterials science for surface modification. sterilization and to improve bulk properties. Radiation is also used to design of biochips, and in situ photopolymerizable of bioadhesives, The energy sources most commonly used in the irradiation of biomaterials are high-energy electrons, gamma radiation, ultraviolet (UV) and visible light. Surface modification involves placement of selective chemical moieties on the surface of a material by chemical reactions to improve biointeraction for cell adhesion and proliferation, hemocompatibility and water absorption. The exposure of a polymer to radiation, especially ionizing radiation, can lead to chain scission or crosslinking with changes in bulk and surface properties. Sterilization by irradiation is designed to inactivate most pathogens from the surface of biomedical devices. An overview of the use of gamma and UV radiation to improve surface tissue compatibility, bulk properties and surface properties for wear resistance, formation of hydrogels and Curing dental sealants and bone adhesives is presented. Gamma and vacuum ultraviolet (VUV) irradiated ultrahigh molecular weight polyethylene (UHMWPE) exhibit improvement in surface modulus and hardness. The Surface modulus and hardness of UHMWPE showed a dependence on type of radiation, dosage and processing. VUV surface modified e-PTFE vascular grafts exhibit increases in hydrophilicity and improvement towards adhesion of fibrin glue. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Tennessee, Knoxville, TN 37996 USA.
RP Benson, RS (reprint author), Univ Tennessee, 427-C Dougherty, Knoxville, TN 37996 USA.
CR Aldenhoff YBJ, 1997, BIOCONJUGATE CHEM, V8, P296, DOI 10.1021/bc970020z
   ANSETH KS, 1997, ACS S, V673
   BENSON RS, IN PRESS ANTEC
   Cezeaux JL, 1998, NUCL INSTRUM METH B, V141, P193, DOI 10.1016/S0168-583X(98)00089-5
   CHAWLA A S, 1974, Biomaterials Medical Devices and Artificial Organs, V2, P157
   Dadsetan M, 2001, J BIOMED MATER RES, V54, P540
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DORPEMA JW, 1990, RADIAT PHYS CHEM, V35, P357
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HOFFMAN AS, 1988, IAEA PUBLICATION
   John G, 2000, MAT SCI ENG C-BIO S, V13, P91, DOI 10.1016/S0928-4931(00)00181-8
   JULIO CA, 1994, BRAZ J MED BIOL RES, V27, P2565
   KAMATH KR, 1994, J APPL BIOMATER, V5, P163, DOI 10.1002/jab.770050210
   Kao FJ, 1997, J BIOMED MATER RES, V38, P191, DOI 10.1002/(SICI)1097-4636(199723)38:3<191::AID-JBM2>3.0.CO;2-K
   KING R, 1997, T SOC BIOMATER, P217
   KOWALSKI JB, 1996, BIOMATERIALS SCI
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   MATSUDA T, 1995, J BIOMED MATER RES, V29, P749, DOI 10.1002/jbm.820290611
   NEUMAN MR, 1995, BIOMEDICAL ENG HDB
   OHAN F, 2000, THESIS U TENNESSEE
   Peppas N. A., 1987, HYDROGELS MED PHARM
   PORTEDIRRIEU MC, 2000, JBMR, V52, P156
   Ries MD, 1996, CLIN ORTHOP RELAT R, P87
   ROSIAK JM, 1993, RADIAT PHYS CHEM, V42, P903, DOI 10.1016/0969-806X(93)90398-E
   Siegal MD, 1997, PUBLIC HEALTH REP, V112, P98
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   SZYMANKIEWICZ JR, 1997, SURF BIOMATER, P40
   vanderHeiden AP, 1997, J BIOMED MATER RES, V37, P282, DOI 10.1002/(SICI)1097-4636(199711)37:2<282::AID-JBM19>3.0.CO;2-G
   Ward JH, 2001, J BIOMED MATER RES, V56, P351, DOI 10.1002/1097-4636(20010905)56:3<351::AID-JBM1103>3.0.CO;2-A
NR 29
TC 111
Z9 117
U1 1
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD MAY
PY 2002
VL 191
BP 752
EP 757
AR PII S0168-583X(02)00647-X
DI 10.1016/S0168-583X(02)00647-X
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 571AH
UT WOS:000176692300143
DA 2018-10-20
ER

PT J
AU Montini, T
   Mangurian, C
   Bero, LA
AF Montini, T
   Mangurian, C
   Bero, LA
TI Assessing the evidence submitted in the development of a workplace
   smoking regulation: The case of Maryland
SO PUBLIC HEALTH REPORTS
LA English
DT Article
ID ENVIRONMENTAL TOBACCO-SMOKE; INDEX IMPACT FACTOR; PASSIVE SMOKING;
   MEDICAL JOURNALS; LUNG-CANCER; PUBLIC-HEALTH; NONSMOKING WOMEN;
   POLICY-MAKERS; SCIENCE; QUALITY
AB Objective. This study compared the characteristics of the basic science, biomedical, and socioeconomic literature submitted in 1993-1994 by supporters and opponents of the proposed workplace regulation of tobacco smoke developed by the Maryland Occupational Safety and Health (MOSH) Advisory Board.
   Methods. The authors retrospectively analyzed 544 written publications submitted to the MOSH Advisory Board regarding the proposed workplace regulation of tobacco smoke. Outcome measures included the type and year of publication and, for journal articles, the journal's peer review policy and impact factor.
   Results. Supporters of regulation submitted fewer documents (n = 164) than opponents (n = 380). Supporters of regulation submitted a lower proportion of conference proceedings and a higher proportion of government reports. The publications submitted to the regulators by the supporters of regulation were more recently published than the materials submitted by opponents. Journal articles represented more than half of the publications submitted; most were peer-reviewed. Supporters of regulation submitted articles from journals with higher impact factors (median impact factor 2.78) than did opponents of regulation (median 1.66; p=0.0005), and articles that were published more recently (median year of publication 1990) than those submitted by opponents (median 1989; p=0.0001).
   Conclusions. Public health advocates should highlight the scientific evidence base that supports tobacco control regulations. Public health advocates should encourage and support regulatory officials' use of the criteria of peer review, impact factor, and date of publication to prioritize their review of submitted documents in order to base policy on the best available evidence.
C1 Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
RP Bero, LA (reprint author), Univ Calif San Francisco, Dept Clin Pharm, 3333 Calif St,Suite 420, San Francisco, CA 94143 USA.
CR ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240
   Barnaby DP, 1998, ANN EMERG MED, V31, P78, DOI 10.1016/S0196-0644(98)70285-9
   Barnes D E, 1997, Tob Control, V6, P19
   Benitez-Bribiesca L, 1999, ARCH MED RES, V30, P161
   Bero LA, 1997, ANN INTERN MED, V127, P37, DOI 10.7326/0003-4819-127-1-199707010-00007
   BERO LA, 1994, JAMA-J AM MED ASSOC, V271, P612, DOI 10.1001/jama.271.8.612
   Bero LA, 2001, TOB CONTROL, V10, P329, DOI 10.1136/tc.10.4.329
   BERO LA, 1992, NEW ENGL J MED, V327, P1135, DOI 10.1056/NEJM199210153271606
   BERO LA, 1993, TOB CONTROL, V2, P103
   BRODY S, 1995, LANCET, V346, P1300, DOI 10.1016/S0140-6736(95)91904-X
   BROWNSON RC, 1992, AM J PUBLIC HEALTH, V82, P1525, DOI 10.2105/AJPH.82.11.1525
   Buffler PA, 1996, ENVIRON HEALTH PERSP, V104, P356, DOI 10.2307/3432671
   Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004
   CUMMINGS KM, 1990, ARCH ENVIRON HEALTH, V45, P74, DOI 10.1080/00039896.1990.9935929
   Denzin NK, 1989, RES ACT THEORETICAL
   DOBSON AJ, 1991, MED J AUSTRALIA, V154, P793
   DUNCAN DB, 1984, JAMA-J AM MED ASSOC, V251, P2658
   FONTHAM ETH, 1991, CANCER EPIDEM BIOMAR, V1, P35
   FOSTER WR, 1995, LANCET, V346, P1301
   Gallagher EJ, 1998, ANN EMERG MED, V31, P83, DOI 10.1016/S0196-0644(98)70286-0
   GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471
   GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1
   GLANTZ SA, 1994, FEBRUARY 1994 UPDATE
   HANSSON S, 1995, LANCET, V346, P906, DOI 10.1016/S0140-6736(95)92749-2
   Hecht F, 1998, CANCER GENET CYTOGEN, V104, P77, DOI 10.1016/S0165-4608(97)00459-7
   HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183
   HUSGAFVELPURSIAINEN K, 1987, INT ARCH OCC ENV HEA, V59, P337, DOI 10.1007/BF00405277
   *I SCI INF, 1994, SCI CIT IND 1994
   *I SCI INF, 1994, SOC SCI CIT IND 1994
   JACOBSON PD, 1993, J HEALTH POLIT POLIC, V18, P787
   Liguori A, 1996, Tob Control, V5, P37, DOI 10.1136/tc.5.1.37
   Linde A, 1998, EUR J ORAL SCI, V106, P525
   Montini T, 2001, TOB CONTROL, V10, P218, DOI 10.1136/tc.10.3.218
   Murphy P, 2001, SCI TECHNOL HUM VAL, V26, P278, DOI 10.1177/016224390102600302
   *NAT RES COUNC COM, 1986, ENV TOB SMOK MEAS EX
   *OF SURG GEN US, 1986, HLTH CONS INV SMOK R
   *OFF SURG GEN US, 1986, HLTH CONS INV SMOK R
   Opthof T, 1997, CARDIOVASC RES, V33, P1, DOI 10.1016/S0008-6363(96)00215-5
   Parascandola M, 1998, PUBLIC HEALTH REP, V113, P312
   Porta M, 1996, J EPIDEMIOL COMMUN H, V50, P606, DOI 10.1136/jech.50.6.606
   Rennie D, 1998, LANCET, V352, P18
   REPACE JL, 1980, SCIENCE, V208, P464, DOI 10.1126/science.7367873
   ROCHON PA, 1994, JAMA-J AM MED ASSOC, V272, P108, DOI 10.1001/jama.272.2.108
   Saper CB, 1999, J COMP NEUROL, V411, P1, DOI 10.1002/(SICI)1096-9861(19990816)411:1<1::AID-CNE1>3.0.CO;2-A
   SCHILLINGS EM, 2000, STATE LEGISLATED ACT
   SCHILLINGS EM, 2001, STATE LEGISLATED ACT
   Seglen PO, 1997, BRIT MED J, V314, P498
   SEGLEN PO, 1991, J INTERN MED, V229, P109, DOI 10.1111/j.1365-2796.1991.tb00316.x
   STEENLAND K, 1992, JAMA-J AM MED ASSOC, V267, P94, DOI 10.1001/jama.267.1.94
   STONE A, 1998, INT ENCY PUBLIC POLI, V4, P1943
   TAGER IB, 1989, NEW YORK STATE J MED, V89, P27
   TRICHOPOULOS D, 1981, INT J CANCER, V27, P1, DOI 10.1002/ijc.2910270102
   *US EPA OFF HLTH E, 1992, RESP HLTH EFF PASS S
   VAUGHAN WM, 1990, J AIR WASTE MANAGE, V40, P1012, DOI 10.1080/10473289.1990.10466741
   WELLS AJ, 1988, ENVIRON INT, V14, P249
   WHITE JR, 1980, NEW ENGL J MED, V302, P720, DOI 10.1056/NEJM198003273021304
   WHITE JR, 1991, CHEST, V100, P39, DOI 10.1378/chest.100.1.39
NR 57
TC 16
Z9 16
U1 0
U2 3
PU US GOVERNMENT PRINTING OFFICE
PI WASHINGTON
PA SUPERINTENDENT DOCUMENTS,, WASHINGTON, DC 20402-9325 USA
SN 0033-3549
J9 PUBLIC HEALTH REP
JI Public Health Rep.
PD MAY-JUN
PY 2002
VL 117
IS 3
BP 291
EP 298
DI 10.1016/S0033-3549(04)50163-2
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 617LW
UT WOS:000179364000009
PM 12432140
OA Green Published
DA 2018-10-20
ER

PT J
AU Nguyen, QT
   Kidder, JN
   Ehrman, SH
AF Nguyen, QT
   Kidder, JN
   Ehrman, SH
TI Hybrid gas-to-particle conversion and chemical vapor deposition for the
   production of porous alumina films
SO THIN SOLID FILMS
LA English
DT Article
DE aluminum oxide; chemical vapor deposition (CVD); deposition process;
   Fourier-transform infrared spectroscopy (FTIR)
ID HIGH-PRESSURE COMPACTION; SURFACE-AREA; WATER-VAPOR; ACETYLACETONATE;
   PHASE; KINETICS; GROWTH; SIZE
AB Porous alumina films can be found in a wide variety of materials, including filters, thermal insulation components, dielectrics, biomedical and catalyst supports, coatings and adsorbents. Production methods for these films are as equally diverse as their applications. In this work, a hybrid process based upon chemical vapor deposition and gas-to-particle conversion is presented as an alternative technique for producing porous alumina films, with the main advantages of solvent-free, low substrate-temperature operation. In this process, nanoparticles were produced in the vapor phase by reaction of aluminum acetylacetonate in the presence of oxygen. Downstream of this reaction zone, these nanoparticles were collected via thermophoresis onto a cooled substrate, forming a porous film. Some deposited films were subjected to post-processing in the form of annealing in air. Fourier-transform infrared spectra and X-ray energy-dispersive spectroscopy analysis confirmed the production of alumina at processing temperatures above 973 K. X-Ray diffraction revealed that the films were amorphous. Film thickness, ranging from 30 to 250 mum, and the average deposition rate were determined from scanning electron microscopy results. From transmission electron microscopy, the average primary particle size was determined to be approximately 18 nm and the formation of nanoparticle aggregates was evident. Annealing of the films at temperatures ranging from 523 to 1173 K in the presence of air did not have an effect on particle size. The specific surface area of the powder composing the films ranged from 10 to 185 m(2) g(-1), as determined from nitrogen gas adsorption by the Brunauer-Emmett-Teller method. (C) 2002 Elsevier Science B.V All rights reserved.
C1 Univ Maryland, Dept Chem Engn, College Pk, MD 20742 USA.
   Univ Maryland, Dept Mat & Nucl Engn, College Pk, MD 20742 USA.
RP Ehrman, SH (reprint author), Univ Maryland, Dept Chem Engn, College Pk, MD 20742 USA.
EM sehrman@glue.umd.edu
CR Battiston GA, 2001, CHEM VAPOR DEPOS, V7, P69, DOI 10.1002/1521-3862(200103)7:2<69::AID-CVDE69>3.0.CO;2-Q
   Biasini V, 1997, THIN SOLID FILMS, V297, P207, DOI 10.1016/S0040-6090(96)09432-1
   BIRD RB, 1960, TRANSPORT PHENOMENA, P342
   Chu PM, 1999, J RES NATL INST STAN, V104, P59, DOI 10.6028/jres.104.004
   Costa TMH, 1999, J PHYS CHEM B, V103, P4278, DOI 10.1021/jp983791o
   Craig BD, 1998, J AM CERAM SOC, V81, P3109, DOI 10.1111/j.1151-2916.1998.tb02745.x
   De la Torre SD, 1999, KEY ENG MAT, V2, P121, DOI 10.4028/www.scientific.net/KEM.161-163.121
   Dekker JP, 1997, J AM CERAM SOC, V80, P629, DOI 10.1111/j.1151-2916.1997.tb02878.x
   Doll T, 2000, APPL PHYS LETT, V76, P3635, DOI 10.1063/1.126731
   FOSS CA, 1993, ADV MATER, V5, P135, DOI 10.1002/adma.19930050214
   FRIEDLANDER SK, 1994, PHYS REV B, V49, P3622, DOI 10.1103/PhysRevB.49.3622
   FRIEDLANDER SK, 2000, SMOKE DUST HAZE FUND, P308
   FRIEDLANDER SK, 2000, SMOKE DUST HAZE, P50
   Gonzalez EJ, 1996, MATER MANUF PROCESS, V11, P951, DOI 10.1080/10426919608947544
   Huczko A, 2000, APPL PHYS A-MATER, V70, P365, DOI 10.1007/s003390051050
   KIM JS, 1993, THIN SOLID FILMS, V230, P156, DOI 10.1016/0040-6090(93)90509-N
   KOCH W, 1990, J COLLOID INTERF SCI, V140, P419, DOI 10.1016/0021-9797(90)90362-R
   KOZODOY RL, 1995, APPL OPTICS, V34, P7840, DOI 10.1364/AO.34.007840
   Lehtinen KEJ, 1996, J AEROSOL SCI, V27, P883, DOI 10.1016/0021-8502(96)00011-0
   MARUYAMA T, 1992, APPL PHYS LETT, V60, P322, DOI 10.1063/1.106699
   MINKINA VG, 1993, INORG MATER+, V29, P1400
   PARFITT L, 1995, J APPL PHYS, V77, P3029, DOI 10.1063/1.358652
   PENNER SS, 1995, ENERGY, V20, P331, DOI 10.1016/0360-5442(95)00003-Y
   Perry R. H., 1984, PERRYS CHEM ENG HDB, P3
   POUCHERT CJ, 1985, ALDRICH LIB FT IR SP, V2, P2
   Rhoten MC, 1997, CHEM MATER, V9, P1757, DOI 10.1021/cm960504p
   Sharma PK, 1998, J AM CERAM SOC, V81, P2732
   Windeler RS, 1997, AEROSOL SCI TECH, V27, P174, DOI 10.1080/02786829708965465
   YOLDAS BE, 1980, APPL OPTICS, V19, P1425, DOI 10.1364/AO.19.001425
NR 29
TC 21
Z9 21
U1 1
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD MAY 1
PY 2002
VL 410
IS 1-2
BP 42
EP 52
AR PII S0040-6090(02)00239-0
DI 10.1016/S0040-6090(02)00239-0
PG 11
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 563UV
UT WOS:000176276000007
DA 2018-10-20
ER

PT J
AU Riess, JG
AF Riess, JG
TI Blood substitutes and other potential biomedical applications of
   fluorinated colloids
SO JOURNAL OF FLUORINE CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 13th European Symposium on Fluorine Chemistry (ESFC-13)
CY JUL 15-20, 2001
CL BORDEAUX, FRANCE
DE perfluorocarbon; fluorosurfactant; fluorinated surfactant; fluorinated
   colloid; blood substitute; oxygen carrier; ultrasound contrast;
   diagnosis; emulsion; gel; self-assembly liposome; vesicle; drug delivery
ID ECHOCARDIOGRAPHIC CONTRAST AGENT; INTRAVENOUS PERFLUBRON EMULSION;
   ENDOCARDIAL BORDER DELINEATION; OXYGEN CARRIERS; MULTICOMPONENT
   MICROBUBBLES; PERFLUOROCARBON EMULSIONS; FLUOROCARBON EMULSIONS;
   HEALTHY-VOLUNTEERS; RANDOMIZED SAFETY; AMPHIPHILES
AB An oxygen carrying, heat-sterilized phospholipid-based emulsion of a fast excreted lipophilic fluorocarbon, perfluorooctyl bromide (perflubron). stabilized against molecular diffusion, has been developed to serve as a temporary blood substitute. It is expected to reduce exposure to donor blood and thereby help mitigate the pressure on our blood supply. A phase III clinical trial in Europe has demonstrated that use of the emulsion resulted in avoidance and reduction of donor blood transfusion in surgery patients. Further potential applications for fluorocarbon emulsions include use as a bridge to transfusion, treatment of myocardial ischemia and stroke, potentiation of radio and chemotherapy and preservation of organs destined for transplantation. Echogenic, injectable gaseous microbubbles. osmotically stabilized by perfluorohexane, provide an effective contrast agent for ultrasound imaging. Clinical trials have established improved imaging of the walls of the heart and, hence, assessment of cardiac function. The ability of improving detection of myocardial perfusion. blood flow abnormalities and solid tumors is also being investigated. Various families of fluorinated amphiphiles with modular molecular structures and polar heads derived from natural products have been synthesized. Due to their highly hydrophobic perfluoroalkylated tail chains, these amphiphiles readily self-assemble into stable fluorinated vesicles. tubules and other organized molecular systems with distinctive properties. Fluorosurfactants also allowed preparation of direct. reverse, apolar and multiple emulsions and gels. These fluorinated colloids have potential for the delivery of drugs and other bioactive materials. and provide unique tools in biomedical research. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Calif San Diego, San Diego, CA 92103 USA.
   Alliance Pharmaceut Corp, San Diego, CA 92121 USA.
RP Riess, JG (reprint author), JGR, F-06950 Falicon, France.
EM jriess@allp.com
CR Becher H, 2000, HDB CONTRAST ECHOCAR
   Brubach JB, 2001, J PHYS CHEM B, V105, P430, DOI 10.1021/jp002983s
   Cohen JL, 1998, J AM COLL CARDIOL, V32, P746, DOI 10.1016/S0735-1097(98)00311-8
   Dellamary LA, 2000, PHARMACEUT RES, V17, P168, DOI 10.1023/A:1007513213292
   Edwards CM, 1997, ADV EXP MED BIOL, V428, P489
   ELBERT R, 1984, J AM CHEM SOC, V106, P7687, DOI 10.1021/ja00337a005
   FAITHFULL NS, 2001, ADV EXP MED BIOL
   FLAIM SF, 1994, ARTIF CELL BLOOD SUB, V22, P1043, DOI 10.3109/10731199409138801
   FLAIM SF, 1998, RED BLOOD CELL SUBST, P79
   FLAIM SF, 1998, RED BLOOD CELL SUBST, P437
   Galiuto L, 1998, J AM COLL CARDIOL, V32, P1096, DOI 10.1016/S0735-1097(98)00349-0
   Giulieri F, 1996, CHEM-EUR J, V2, P1335, DOI 10.1002/chem.19960021022
   Goldberg B B, 2001, ULTRASOUND CONTRAST
   Halpern EJ, 2000, AM J ROENTGENOL, V174, P1575, DOI 10.2214/ajr.174.6.1741575
   Held P, 1997, TETRAHEDRON LETT, V38, P1937, DOI 10.1016/S0040-4039(97)00258-X
   Imae T, 1999, J COLLOID INTERF SCI, V212, P330, DOI 10.1006/jcis.1999.6094
   Kabalnov A, 1998, ULTRASOUND MED BIOL, V24, P739, DOI 10.1016/S0301-5629(98)00034-9
   Kabalnov A, 1998, ULTRASOUND MED BIOL, V24, P751, DOI 10.1016/S0301-5629(98)00033-7
   Katsuraya K, 1999, CARBOHYD RES, V315, P234, DOI 10.1016/S0008-6215(98)00315-2
   Keipert PE, 1996, ADV EXP MED BIOL, V388, P603
   Krafft M. P., 1998, NOVEL COSMETIC DELIV, P195
   Krafft MP, 1998, BIOCHIMIE, V80, P489, DOI 10.1016/S0300-9084(00)80016-4
   Krafft MP, 2001, LANGMUIR, V17, P6577, DOI 10.1021/la010587a
   Krafft MP, 2001, LANGMUIR, V17, P2872, DOI 10.1021/la001658t
   Krafft MP, 1998, SUBMICRONIC EMULSION, P235
   Lebeau L, 2001, J MOL BIOL, V308, P639, DOI 10.1006/jmbi.2001.4629
   Leese PT, 2000, ANESTH ANALG, V91, P804, DOI 10.1097/00000539-200010000-00008
   Lowe KC, 2001, J FLUORINE CHEM, V109, P59, DOI 10.1016/S0022-1139(01)00374-8
   Lowe KC, 1998, TRENDS BIOTECHNOL, V16, P272, DOI 10.1016/S0167-7799(98)01205-0
   MCCREATH GE, 1994, J CHROMATOGR A, V659, P275, DOI 10.1016/0021-9673(94)85069-0
   Menchen S, 1996, ELECTROPHORESIS, V17, P1451, DOI 10.1002/elps.1150170909
   MUKERJEE P, 1976, J PHYS CHEM-US, V80, P1388, DOI 10.1021/j100553a028
   Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462
   Noveck RJ, 2000, ANESTH ANALG, V91, P812, DOI 10.1097/00000539-200010000-00009
   PAVIA AA, 1994, P INT S CONTROL REL, V21, P87
   PRIVITERA N, 1995, BBA-LIPID LIPID MET, V1254, P1, DOI 10.1016/0005-2760(94)00153-P
   PRIVITERA N, 1995, INT J PHARM, V120, P73, DOI 10.1016/0378-5173(94)00411-W
   Riess J.G., 1996, HDB NONMEDICAL APPL, P97
   RIESS JG, 1984, ARTIF ORGANS, V8, P44, DOI 10.1111/j.1525-1594.1984.tb04243.x
   RIESS JG, 1994, J DRUG TARGET, V2, P455, DOI 10.3109/10611869408996822
   Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c
   Riess JG, 1998, BLOOD SUBSTITUTES PRESENT AND FUTURE PERSPECTIVES, P91, DOI 10.1016/B978-044420524-7/50008-4
   Riess JG, 2000, FLUORINE CHEMISTRY AT THE MILLENNIUM, P385, DOI 10.1016/B978-008043405-6/50034-7
   RIESS JG, 1988, BIOMATER ARTIF CELL, V16, P421, DOI 10.3109/10731198809132592
   RIESS JG, 1994, ADV EXP MED BIOL, V345, P227
   Riess JG, 2000, CARBOHYD RES, V327, P147, DOI 10.1016/S0008-6215(00)00012-4
   Riess JG, 1995, J LIPOS RES, V5, P413, DOI 10.3109/08982109509010232
   RIESS JG, 1992, J DISPER SCI TECHNOL, V13, P349, DOI 10.1080/01932699208943319
   Riess JG, 1998, BIOMATERIALS, V19, P1529, DOI 10.1016/S0142-9612(98)00071-4
   RIESS JG, 2002, IN PRESS TETRAHEDRON
   Sadtler VM, 1996, ANGEW CHEM INT EDIT, V35, P1976, DOI 10.1002/anie.199619761
   SANTAELLA C, 1993, FEBS LETT, V336, P481, DOI 10.1016/0014-5793(93)80860-W
   Schutt EG, 1996, ACAD RADIOL, V3, pS188, DOI 10.1016/S1076-6332(96)80530-7
   Senior P, 2000, ECHOCARDIOGR-J CARD, V17, P705
   Shibata O, 2000, LANGMUIR, V16, P10281, DOI 10.1021/la000929x
   Smith DJ, 2001, PHARMACEUT RES, V18, P1556, DOI 10.1023/A:1013078330485
   Spahn DR, 1999, ANESTHESIOLOGY, V91, P1195, DOI 10.1097/00000542-199911000-00009
   Spahn DR, 1999, CRIT CARE, V3, pR93, DOI 10.1186/cc364
   SPAHN DR, 2001, P ANN M EUR SOC AN G
   Stahler K, 1999, LANGMUIR, V15, P7565, DOI 10.1021/la990431z
   Tiemann K, 1999, ECHOCARDIOGR-J CARD, V16, P799, DOI 10.1111/j.1540-8175.1999.tb00132.x
   Vierling P, 2001, J FLUORINE CHEM, V107, P337, DOI 10.1016/S0022-1139(00)00378-X
   WEERS JG, 1994, ARTIF CELL BLOOD SUB, V22, P1175, DOI 10.3109/10731199409138813
   Weiss DJ, 1999, EXP LUNG RES, V25, P317
   Weiss DJ, 2001, MOL THER, V3, P734, DOI 10.1006/mthe.2001.0321
   ZUCK TF, 1994, CRIT REV CL LAB SCI, V31, P295, DOI 10.3109/10408369409084678
NR 66
TC 80
Z9 82
U1 2
U2 25
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0022-1139
EI 1873-3328
J9 J FLUORINE CHEM
JI J. Fluor. Chem.
PD APR 28
PY 2002
VL 114
IS 2
BP 119
EP 126
AR PII S0022-1139(02)00017-9
DI 10.1016/S0022-1139(02)00017-9
PG 8
WC Chemistry, Inorganic & Nuclear; Chemistry, Organic
SC Chemistry
GA 557DQ
UT WOS:000175892800004
DA 2018-10-20
ER

PT J
AU Blaum, K
   Geppert, C
   Schreiber, WG
   Hengstler, JG
   Muller, P
   Nortershauser, W
   Wendt, K
   Bushaw, BA
AF Blaum, K
   Geppert, C
   Schreiber, WG
   Hengstler, JG
   Muller, P
   Nortershauser, W
   Wendt, K
   Bushaw, BA
TI Trace determination of gadolinium in biomedical samples by diode
   laser-based multi-step resonance ionization mass spectrometry
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE biomedical samples; contrast agent; gadolinium; gadolinium-DTPA;
   magnetic resonance imaging; resonance ionization mass spectrometry;
   trace determination
ID IMAGING CONTRAST AGENTS; HYPERFINE-STRUCTURE; ISOTOPE SHIFTS;
   SPECTROSCOPY; GD; ULTRATRACE; ELEMENTS; TUMORS; CA-41; DTPA
AB The application of high-resolution multi-step resonance ionization mass spectrometry (RIMS) to the trace determination of the rare earth element gadolinium is described. Utilizing three-step resonant excitation into an autoionizing level, both isobaric and isotopic selectivity of >10(7) were attained. An overall detection efficiency of similar to10(-7) and an isotope specific detection limit of 1.5x10(9) atoms have been demonstrated. When targeting the major isotope Gd-158, this corresponds to a total Gd detection limit of 1.6 pg. Additionally, linear response has been demonstrated over a dynamic range of six orders of magnitude. The method has been used to determine the Gd content in various normal and tumor tissue samples, taken from a laboratory mouse shortly after injection of gadolinium diethylenetriaminepentaacetic acid dimeglumine (Gd-DTPA), which is used as a contrast agent for magnetic resonance imaging (MRI). The RIMS results show Gd concentrations that vary by more than two orders of magnitude (0.07-11.5 mug mL(-1)) depending on the tissue type. This variability is similar to that observed in MRI scans that depict Gd-DTPA content in the mouse prior to dissection, and illustrates the potential for quantitative trace analysis in microsamples of biomedical materials.
C1 Univ Mainz, Inst Phys, D-55099 Mainz, Germany.
   Univ Klin Mainz, Radiol Klin, D-55131 Mainz, Germany.
   Pacific NW Natl Lab, Richland, WA 99352 USA.
RP Blaum, K (reprint author), CERN, CH-1211 Geneva 23, Switzerland.
RI Hengstler, Jan/O-1415-2013; Nortershauser, Wilfried/A-6671-2013; Wendt,
   Klaus/D-7306-2011; Mueller, Peter/E-4408-2011
OI Nortershauser, Wilfried/0000-0001-7432-3687; Wendt,
   Klaus/0000-0002-9033-9336; Mueller, Peter/0000-0002-8544-8191;
   Hengstler, Jan/0000-0002-1427-5246; Schreiber, Laura/0000-0002-8827-1838
CR Becker JS, 2000, INT J MASS SPECTROM, V197, P1, DOI 10.1016/S1387-3806(99)00246-8
   BEEKMAN DW, 1980, INT J MASS SPECTROM, V34, P89, DOI 10.1016/0020-7381(80)85017-0
   Blaum K, 2000, INT J MASS SPECTROM, V202, P81, DOI 10.1016/S1387-3806(00)00237-2
   Blaum K, 1998, INT J MASS SPECTROM, V181, P67, DOI 10.1016/S1387-3806(98)14174-X
   Blaum K, 2001, AIP CONF PROC, V584, P141
   Blaum K, 1998, AIP CONF PROC, V454, P275
   Blaum K, 2000, EUR PHYS J D, V11, P37, DOI 10.1007/s100530070103
   BUSHAW BA, 1986, OPT LETT, V11, P422, DOI 10.1364/OL.11.000422
   Bushaw BA, 2001, J RADIOANAL NUCL CH, V247, P351, DOI 10.1023/A:1006761819893
   BUSHAW BA, 1997, AIP C P, V388, P115
   DAWSON P, 1993, KONTRASTMITTEL PRAXI
   Eichler B, 1997, RADIOCHIM ACTA, V79, P221
   EUGSTER O, 1970, J GEOPHYS RES, V75, P2753, DOI 10.1029/JB075i014p02753
   Frame EMS, 1998, ANALYST, V123, P675
   Geppert C, 2001, AIP CONF PROC, V584, P249
   GOHRROSENTHAL S, 1993, INVEST RADIOL, V28, P789
   GREAVES MJ, 1989, ANAL CHIM ACTA, V218, P265, DOI 10.1016/S0003-2670(00)80303-7
   HEMMERICH A, 1990, OPT LETT, V15, P372, DOI 10.1364/OL.15.000372
   HIDAKA H, 1995, ANAL CHEM, V67, P1437, DOI 10.1021/ac00104a021
   Hidaka H, 2000, EARTH PLANET SC LETT, V180, P29, DOI 10.1016/S0012-821X(00)00148-5
   HURST GS, 1979, REV MOD PHYS, V51, P767, DOI 10.1103/RevModPhys.51.767
   KAPPELER F, 1990, ASTROPHYS J, V354, P630
   MATHURDEVRE R, 1995, BRIT J RADIOL, V68, P225
   Muller P, 2000, EUR PHYS J D, V12, P33, DOI 10.1007/s100530070040
   Muller P, 2001, FRESEN J ANAL CHEM, V370, P508, DOI 10.1007/s002160100815
   Nortershauser W, 2000, APPL OPTICS, V39, P5590, DOI 10.1364/AO.39.005590
   Nortershauser W, 2000, PHYS REV A, V62
   SCHUHMANNGIAMPIERI G, 1991, INVEST RADIOL, V26, P969, DOI 10.1097/00004424-199111000-00008
   SPECK U, 1992, KONTRASTMITTEL UBERS
   STRICH G, 1985, RADIOLOGY, V154, P723, DOI 10.1148/radiology.154.3.3969477
   VAUGHAN MA, 1990, APPL SPECTROSC, V44, P587, DOI 10.1366/0003702904087488
   Verstraete KL, 2000, EUR J RADIOL, V34, P229, DOI 10.1016/S0720-048X(00)00202-3
   WISSHAK K, 1995, PHYS REV C, V52, P2762, DOI 10.1103/PhysRevC.52.2762
   Zhao WZ, 1998, REV SCI INSTRUM, V69, P3737, DOI 10.1063/1.1149171
NR 34
TC 30
Z9 30
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD APR
PY 2002
VL 372
IS 7-8
BP 759
EP 765
DI 10.1007/s00216-002-1268-0
PG 7
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 562FA
UT WOS:000176185700003
PM 12012186
DA 2018-10-20
ER

PT J
AU Bryjak, M
   Gancarz, I
   Pozniak, G
   Tylus, W
AF Bryjak, M
   Gancarz, I
   Pozniak, G
   Tylus, W
TI Modification of polysulfone membranes 4. Ammonia plasma treatment
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE microwave plasmas; surface analysis; membrane structure; ultrafiltration
ID ADVANCED ORGANIC FIBERS; ACID-BASE PROPERTIES; SURFACE MODIFICATION;
   GLOW-DISCHARGE; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   DOWNSTREAM TREATMENT; MICROWAVE PLASMA; NITROGEN PLASMA; KEVLAR FIBER
AB The effect of NH(3) and NH(3)/Ar plasma on ultrafiltration polysulfone membranes have been studied. Results of contact angle, FTIR-ATR and X-ray photoelectron spectroscopy experiments clearly showed that both plasmas introduced hydrophilic, nitrogen- and oxygen-containing moieties on the polymer surface and that NH(3)/Ar plasma was more efficient. That plasma was also more aggressive-signs of strong etching could be seen on the SEM pictures. Redeposition of etched material seemed to take place inside the pores. On the contrary, ammonia plasma was soft and caused cleaning the surface and pores enlargement. Performance of ammonia plasma modified membranes was greatly improved and independent on solution pH. The last observation proved amphoteric character of the surface. NH(3)/Ar plasma treatment gave membranes of acidic surface and filtration indices not so good as for ammonia plasma. (C) 2002 Published by Elsevier Science Ltd.
C1 Wroclaw Univ Technol, Inst Organ & Polymer Technol, PL-50370 Wroclaw, Poland.
   Wroclaw Univ Technol, Inst Inorgan Technol, PL-50370 Wroclaw, Poland.
RP Gancarz, I (reprint author), Wroclaw Univ Technol, Inst Organ & Polymer Technol, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.
EM igancarz@itots.ch.pwr.wroc.pl
RI Bryjak, Marek/P-8914-2016; Tylus, Wlodzimierz/I-9225-2018
OI Tylus, Wlodzimierz/0000-0001-6780-5100
CR ANDERSON GL, 1992, J ADHESION, V36, P213, DOI 10.1080/00218469208026527
   AREFIKHONSARI E, 1997, J POLYM PREP, V38, P1023
   Badey JP, 1996, POLYMER, V37, P1377, DOI 10.1016/0032-3861(96)81135-9
   BADEY JP, 1994, POLYMER, V35, P2472, DOI 10.1016/0032-3861(94)90365-4
   Ben Rejeb S, 1998, ANAL CHIM ACTA, V376, P133, DOI 10.1016/S0003-2670(98)00452-8
   BODINO F, 1996, POLYM PREP-ACS, V37, P82
   BROWN JR, 1993, J MATER SCI LETT, V12, P754, DOI 10.1007/BF00626711
   Brown JR, 1997, J MATER SCI, V32, P2599, DOI 10.1023/A:1018654501851
   Bryjak M, 1996, ANGEW MAKROMOL CHEM, V234, P21, DOI 10.1002/apmc.1996.052340103
   CHIN JW, 1993, J ADHESION, V41, P23, DOI 10.1080/00218469308026552
   Favia P, 1997, J PHYS IV, V7, P199, DOI 10.1051/jp4:1997415
   FAVIA P, 1996, SURFACE MODIFICATION, P69
   FAVIA P, 1995, POLYM PREP-ACS, V36, P93
   FAVIA P, 1996, PLASMAS POLYM, V1, P96
   FESSEHAIE MG, 1993, LANGMUIR, V9, P3077, DOI 10.1021/la00035a055
   Gancarz I, 1999, ACTA POLYM, V50, P317, DOI 10.1002/(SICI)1521-4044(19990901)50:9<317::AID-APOL317>3.0.CO;2-Q
   Gancarz I, 2000, EUR POLYM J, V36, P1563, DOI 10.1016/S0014-3057(99)00240-2
   Gancarz I, 1999, EUR POLYM J, V35, P1419, DOI 10.1016/S0014-3057(98)00240-7
   Girardeaux C., 1995, POLYM PREPR, V36, P91
   Griesser H. J., 1997, POLYM PREPR, V38, P1081
   KONIG U, 1997, POLYM PREPR POLYM CH, V38, P1079
   KUZNETSOV AY, 1993, J APPL POLYM SCI, V47, P1175
   Li VC, 1996, J AM CERAM SOC, V79, P700
   Lin JC, 1996, J COLLOID INTERF SCI, V182, P315, DOI 10.1006/jcis.1996.0470
   LIN JC, 1994, APPL POLYM SYMP SER, V54, P157
   Mathur A, 1996, J MATER SCI, V31, P1265, DOI 10.1007/BF00353106
   MATSUYAMA H, 1995, J MEMBRANE SCI, V99, P139, DOI 10.1016/0376-7388(94)00217-M
   MAY E, 1994, COLLOID POLYM SCI, V272, P1245
   MUTEL B, 1993, SURF INTERFACE ANAL, V20, P283, DOI 10.1002/sia.740200404
   NAKAYAMA Y, 1988, J POLYM SCI POL CHEM, V26, P559, DOI 10.1002/pola.1988.080260219
   Plawky U, 1996, J MATER SCI, V31, P6043, DOI 10.1007/BF01152157
   Radeva E, 1998, VACUUM, V51, P217, DOI 10.1016/S0042-207X(98)00162-6
   Shahidzadeh N, 1996, SURF SCI, V352, P888, DOI 10.1016/0039-6028(95)01292-3
   Shahidzadeh N, 1996, PLASMAS POLYM, V1, P27
   SHAHIDZADEHAHMA.N, 1995, COLLOID SURFACE A, V105, P227
   SHAHIDZADEHAHMADI N, 1995, J MATER CHEM, V5, P229, DOI 10.1039/jm9950500229
   Wu S, 1982, POLYM INTERFACE ADHE
   Wu SR, 1996, J APPL POLYM SCI, V62, P1347, DOI 10.1002/(SICI)1097-4628(19961128)62:9<1347::AID-APP5>3.0.CO;2-H
NR 38
TC 85
Z9 88
U1 1
U2 26
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
J9 EUR POLYM J
JI Eur. Polym. J.
PD APR
PY 2002
VL 38
IS 4
BP 717
EP 726
AR PII S0014-3057(01)00236-1
DI 10.1016/S0014-3057(01)00236-1
PG 10
WC Polymer Science
SC Polymer Science
GA 536LC
UT WOS:000174700700013
DA 2018-10-20
ER

PT J
AU Fan, CH
   Sun, J
   Longtin, JP
AF Fan, CH
   Sun, J
   Longtin, JP
TI Plasma absorption of femtosecond laser pulses in dielectrics
SO JOURNAL OF HEAT TRANSFER-TRANSACTIONS OF THE ASME
LA English
DT Article
DE heat transfer; laser; microscale; modeling plasma absorption
ID INDUCED BREAKDOWN; MULTIPHOTON ABSORPTION; TRANSPARENT LIQUIDS;
   OPTICAL-BREAKDOWN; SPATIAL DYNAMICS; AQUEOUS-MEDIA; WATER; NANOSECOND;
   IONIZATION; THRESHOLDS
AB Dielectric (high bandgap) materials represent an important and diverse class of materials in micro and nanotechnology, including MEMS devices, biomedical and bioengineering systems, multilayer thin film coatings, fiber optics, etc. Micromachining dielectrics using ultrafast lasers is an exciting and promising new research area with many significant advantages, including precision material removal, negligible heating of the workpiece, micron and sub-micron-size feature fabrication, and high aspect ratio features. During ultrafast laser processing of dielectrics, the intense laser pulse ionizes the irradiated material and produces an optical breakdown region, or plasma, that is characterized by a high density of free electrons. These high-density electrons can efficiently absorb a large fraction of the laser irradiance energy, part of which will then be coupled into the bulk material, resulting in material removal through direct vaporization. The energy deposited into the material depends on the time and space-dependent breakdown region, the plasma rise time, and the plasma absorption coefficient. Higher coup higher material removal rate; thus energy deposition is one of the most important issues for ultrafast laser materials processing, particularly for micron and sub-micron-scale laser materials processing. In the present work, a femtosecond breakdown model is developed to investigate energy deposition during ultrafast laser material interactions. One substantial contribution of the current work is that pulse propagation effects have been taken into account, which have been shown to become significant for pulse durations less than 10 ps. By accounting for the pulse propagation, the time and space-resolved plasma evolution can be characterized and used to determine the energy deposition through plasma absorption. With knowledge of the plasma absorption, changes in the pulse profile as it propagates in the focal region can be determined as well. Absorption of the laser pulse by plasma in water is compared with experimental data to validate the model, as water is a well characterized dielectric. The model, however, is also applicable to other transparent or moderately absorbing solid and liquid dielectric media during ultrafast laser-materials interactions.
C1 SUNY Stony Brook, Dept Mech Engn, Stony Brook, NY 11794 USA.
RP Fan, CH (reprint author), Univ Wisconsin, LOCI, 271 Anim Sci, Madison, WI 53706 USA.
CR DOCCHIO F, 1988, APPL OPTICS, V27, P3669, DOI 10.1364/AO.27.003669
   DOCCHIO F, 1988, APPL OPTICS, V27, P3661, DOI 10.1364/AO.27.003661
   Du D, 1996, APPL PHYS B-LASERS O, V63, P617
   Fan CH, 2001, APPL OPTICS, V40, P3124, DOI 10.1364/AO.40.003124
   FAN CH, 35 NAT HEAT TRANSF C
   Feng Q, 1997, IEEE J QUANTUM ELECT, V33, P127, DOI 10.1109/3.552252
   Hammer DX, 1997, APPL OPTICS, V36, P5630, DOI 10.1364/AO.36.005630
   KENNEDY PK, 1995, IEEE J QUANTUM ELECT, V31, P2241, DOI 10.1109/3.477753
   Kennedy PK, 1997, PROG QUANT ELECTRON, V21, P155, DOI 10.1016/S0079-6727(97)00002-5
   Korte F, 1999, APPL PHYS A-MATER, V69, pS7, DOI 10.1007/s003399900391
   Liu X, 1997, IEEE J QUANTUM ELECT, V33, P1706, DOI 10.1109/3.631270
   Longtin JP, 1999, CHEM ENG TECHNOL, V22, P77
   Longtin JP, 1997, INT J HEAT MASS TRAN, V40, P951, DOI 10.1016/0017-9310(96)00110-X
   Nahen K, 1996, IEEE J SEL TOP QUANT, V2, P861, DOI 10.1109/2944.577308
   NIKOGOSYAN DN, 1983, CHEM PHYS, V77, P131, DOI 10.1016/0301-0104(83)85070-8
   Noack J, 1999, IEEE J QUANTUM ELECT, V35, P1156, DOI 10.1109/3.777215
   Perry MD, 1999, J APPL PHYS, V85, P6803, DOI 10.1063/1.370197
   RAE SC, 1992, PHYS REV A, V46, P2077, DOI 10.1103/PhysRevA.46.2077
   RAIZER YP, 1966, SOV PHYS USPEKHI, V8, P650, DOI 10.1070/PU1966v008n05ABEH003027
   Shen Y. R., 1984, PRINCIPLES NONLINEAR
   Siegman A., 1986, LASERS
   STONE J, 1972, J OPT SOC AM, V62, P327, DOI 10.1364/JOSA.62.000327
   Stuart BC, 1996, J OPT SOC AM B, V13, P459, DOI 10.1364/JOSAB.13.000459
   Vogel A, 1996, IEEE J SEL TOP QUANT, V2, P847, DOI 10.1109/2944.577307
   Wang LJ, 2000, NATURE, V406, P277, DOI 10.1038/35018520
NR 25
TC 36
Z9 39
U1 1
U2 13
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0022-1481
J9 J HEAT TRANS-T ASME
JI J. Heat Transf.-Trans. ASME
PD APR
PY 2002
VL 124
IS 2
BP 275
EP 283
DI 10.1115/1.1445135
PG 9
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA 557PP
UT WOS:000175917200006
DA 2018-10-20
ER

PT J
AU Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
AF Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
TI Processing and mechanical properties of autogenous titanium implant
   materials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ALLOYS
AB Pure titanium and some of its alloys are currently considered as the most attractive metallic materials for biomedical applications due to their excellent mechanical properties, corrosion resistance, and biocompatibility. It has been demonstrated that titanium and titanium alloys are well accepted by human tissues as compared to other metals such as SUS316L stainless steel and Co-Cr-Mo type alloy. In the present study, highly porous titanium foams with porosities less than or equal to80% are produced by using a novel powder metallurgical process, which includes the adding of the selected spacers into the starting powders. The optimal process parameters are investigated. The porous titanium foams are characterized by using optical microscopy and scanning electron microscopy. The distribution of the pore size is measured by quantitative image analyses. The mechanical properties are investigated by compressive tests. This open-cellular titanium foams, with the pore size of 200-500 mum are expected to be a very promising biomaterial candidates for bone implants because its porous structure permits the ingrowths of new-bone tissues and the transport of body fluids. (C) 2002 Kluwer Academic Publisher.
C1 Natl Inst Adv Ind Sci & Techol, Inst Struct & Engn Mat, Kita Ku, Nagoya, Aichi 4628510, Japan.
RP Wen, CE (reprint author), Natl Inst Adv Ind Sci & Techol, Inst Struct & Engn Mat, Kita Ku, Hirate Cho, Nagoya, Aichi 4628510, Japan.
RI Chino, Yasumasa/L-9782-2018
OI Chino, Yasumasa/0000-0002-0725-8237; Wen, Cuie/0000-0001-8008-3536
CR *ASTM, 1994, F6789 ASTM
   *ASTM, 1994, F13682 ASTM
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Chang YS, 1996, BIOMATERIALS, V17, P1141, DOI 10.1016/0142-9612(96)85917-5
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   Cornell CN, 1999, ORTHOP CLIN N AM, V30, P591, DOI 10.1016/S0030-5898(05)70112-7
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gibson L. J., 1997, CELLULAR SOLIDS STRU, P1
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   LEMONS JE, 1987, ASTM STP, V953, P185
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 2001, BIOMATERIALS, V22, P599, DOI 10.1016/S0142-9612(00)00221-0
   Pineda LM, 1996, J BIOMED MATER RES, V31, P385
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   TAKADAMA H, 2001, KEY ENG MATER, V192, P51
   Wen C, 2000, MATER T JIM, V41, P1192, DOI 10.2320/matertrans1989.41.1192
   Yamada Y, 2000, PHIL MAG LETT, V80, P215, DOI 10.1080/095008300176182
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 22
TC 166
Z9 172
U1 1
U2 30
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2002
VL 13
IS 4
BP 397
EP 401
DI 10.1023/A:1014344819558
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 542PX
UT WOS:000175054400008
PM 15348615
DA 2018-10-20
ER

PT J
AU Oh, KT
   Kim, KN
   Lee, M
   Park, YS
AF Oh, KT
   Kim, KN
   Lee, M
   Park, YS
TI Corrosion wear of high molybdenum and nitrogen stainless steel for
   biomedical applications
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article
ID MOLECULAR-WEIGHT POLYETHYLENE; HIP PROSTHESES; SLIDING WEAR;
   PASSIVATION; TITANIUM; REPASSIVATION; TI-6AL-4V; PASSIVITY; BEHAVIOR;
   UHMWPE
AB The corrosion-wear property of high molybdenum and nitrogen stainless steel (UNS no. S32050) was investigated and compared with that of Ti, Ti6Al4V, CoCrMo, and 316L stainless steel used conventionally for biomedical applications. The corrosion resistance and corrosion-wear resistance of S32050 were examined using electrochemical methods. The stability of the passive film in a corrosion-wear system was evaluated. The corrosion-resistance of S32050 is as good as Ti alloys, because its passive film was enhanced due to the synergistic effect of the large amount of Mo and N addition. Therefore, it is predicted that S32050 can minimize the toxic effects by the released ions. The wear loss of UHMWPE (ultrahigh molecular weight polyethylene) to S32050 was less than that to Ti6Al4V and 316L stainless steel, and similar to the CoCrMo. There were no scratches on the S32050 surface after the corrosion-wear test. S32050 had a low current density and high pitting potential under wear and had corrosion-wear properties superior to Ti6Al4V and similar to the CoCrMo in Hank's solution. S32050 with good corrosion-wear resistance could supplement the deficiencies of Ti alloys and CoCrMo. Thus, S32050 is considered to have the probability to be good metallic material for biomedical applications. (C) 2002 The Electrochemical Society.
C1 Yonsei Univ, Coll Dent, Res Inst Dent Mat, Seoul 120752, South Korea.
   Yonsei Univ, Grad Sch, Dept Engn Met, Seoul 120749, South Korea.
RP Oh, KT (reprint author), Yonsei Univ, Coll Dent, Res Inst Dent Mat, Seoul 120752, South Korea.
CR ATKINSON JR, 1985, WEAR, V104, P217, DOI 10.1016/0043-1648(85)90049-3
   BLANCHET TA, 1989, TRIBOL T, V32, P371, DOI 10.1080/10402008908981902
   BROWN SA, 1981, J BIOMED MATER RES, V15, P479, DOI 10.1002/jbm.820150404
   BROWN SA, 1980, J BIOMED MATER RES, V14, P173, DOI 10.1002/jbm.820140208
   BROWN SA, 1981, J BIOMED MATER RES, V15, P867, DOI 10.1002/jbm.820150611
   Brunski JB, 1996, BIOMATERIALS SCI INT, P37
   CHAWLA SL, 1993, CORROSION CONTROL, P275
   CIGADA A, 1993, P NACE HOUST TX, P1938
   DAVIDSON JA, 1991, OR9102 SMITH NEPH
   DAVIDSON JA, 1991, P 5 INT C SURF MOD T
   DUMBLETON JH, 1978, WEAR, V49, P297, DOI 10.1016/0043-1648(78)90094-7
   EYERER P, 1987, J BIOMED MATER RES, V21, P275, DOI 10.1002/jbm.820210302
   GORE TA, 1981, ENG MED, V10, P89
   Halada GP, 1996, CORROSION, V52, P36, DOI 10.5006/1.3292093
   Hall RM, 1997, BIOMATERIALS, V18, P1017, DOI 10.1016/S0142-9612(97)00034-3
   HALL RM, 1994, WEAR, V175, P159, DOI 10.1016/0043-1648(94)90179-1
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   KIM YS, 1990, THESIS YONSEI U S KO, P8
   Kolman DG, 1996, J ELECTROCHEM SOC, V143, P1847, DOI 10.1149/1.1836914
   KOLMAN DG, 1995, J ELECTROCHEM SOC, V142, P2179, DOI 10.1149/1.2044272
   KUMAR P, 1991, J BIOMED MATER RES, V25, P813, DOI 10.1002/jbm.820250703
   LU YC, 1983, J ELECTROCHEM SOC, V130, P1774, DOI 10.1149/1.2120091
   MACIROWSKI T, 1981, T ANN M ORTH RES SOC, V6, P351
   MARCUS K, 1991, WEAR, V151, P323, DOI 10.1016/0043-1648(91)90259-W
   MARCUS K, 1994, WEAR, V178, P17, DOI 10.1016/0043-1648(94)90126-0
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   OLEFJORD I, 1991, ISIJ INT, V31, P134, DOI 10.2355/isijinternational.31.134
   Pan J, 2000, J ELECTROCHEM SOC, V147, P1021, DOI 10.1149/1.1393307
   PETERSON CD, 1988, J BIOMED MATER RES, V22, P887, DOI 10.1002/jbm.820221005
   Schutz R., 1987, METALS HDB
   SEDRIKS AJ, 1986, CORROSION, V42, P376, DOI 10.5006/1.3584918
   STEPHEN EW, 1994, CLIN ORTHOP RELAT R, V309, P176
   TURNER GD, 1981, THESIS U ALABAMA TUS
   WATERHOUSE RB, 1980, WEAR, V60, P357, DOI 10.1016/0043-1648(80)90234-3
   WILLENBRUCH RD, 1990, CORROS SCI, V31, P179, DOI 10.1016/0010-938X(90)90106-F
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WILLIAMS DF, 1981, BIOCOMPATIBILITY CLI, V1, P99
   WROBLEWSKI BM, 1986, CLIN ORTHOP RELAT R, V210, P27
NR 38
TC 9
Z9 9
U1 0
U2 7
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PD APR
PY 2002
VL 149
IS 4
BP B146
EP B153
DI 10.1149/1.1457984
PG 8
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA 532XE
UT WOS:000174499700030
DA 2018-10-20
ER

PT J
AU Nam, I
   Bae, JW
   Jee, KS
   Lee, JW
   Park, KD
   Yuk, SH
AF Nam, I
   Bae, JW
   Jee, KS
   Lee, JW
   Park, KD
   Yuk, SH
TI Poly(N-isopropylacrylamide-co-N-vinylpyrrolidone) as a novel implant
   materials: Preparation and thermo-gelling behavior
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE NIPAAm-NVP copolymers; implant materials; thermo-gelling
ID HYDROGELS; COPOLYMER; POLYMERS; RELEASE; TEMPERATURE; GELATION;
   CARRIERS; DELIVERY; GELS
AB Synthesis of polymers with controlled thermosensitive properties was carried out by conventional radical copolymerization of N-isopropylacrylamide (NIPAAm) with N-vinylpyrrolidone (NVP) taken as a hydrophilic comonomer. Lower activity of NVP rather than NIPAAm was revealed by gravimetric and H-1 NMR analysis. Thermosensitive properties of the copolymers were investigated. It was found that aqueous solutions of the copolymers undergo thermo-induced phase transition and become opaque, precipitate or gel with heating. After formation of the gels their significant contraction was observed at storage. Swelling degree and amount of expelled water were measured in dependence on the copolymer composition, temperature and ionic strength of environment medium and concentration of the solution. It was determined that in collapsed state gels exhibit quite high water content. According to physico-chemical properties of the copolymers observed they could be suitable for biomedical application as an injectable implant material.
C1 Ajou Univ, Dept Mol Sci & Technol, Suwon 442729, South Korea.
   Al Farabi Kazak State Natl Univ, Dept Macromol Chem, Almaty 480012, Kazakhstan.
   Han Nam Univ, Dept Polymer Sci & Technol, Taejon 561756, South Korea.
RP Nam, I (reprint author), Ajou Univ, Dept Mol Sci & Technol, 5 Wonchon Dong, Suwon 442729, South Korea.
CR ANUFRIEVA EV, 2000, EUR POLYM J, V37, P323
   BANKOVA N, 1996, EUR POLYM J, V3, P325
   Bauduin G, 1996, EUR POLYM J, V32, P501, DOI 10.1016/0014-3057(95)00157-3
   Bignotti F, 2000, POLYMER, V41, P8247, DOI 10.1016/S0032-3861(00)00177-4
   BOKIAS G, 2000, POLYMER, V42, P3657
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   DINARVAND R, 1995, J CONTROL RELEASE, V36, P221, DOI 10.1016/0168-3659(95)00035-7
   Han CK, 1998, POLYMER, V39, P2809, DOI 10.1016/S0032-3861(97)00612-5
   Hinrichs WLJ, 1999, J CONTROL RELEASE, V60, P249, DOI 10.1016/S0168-3659(99)00075-9
   JUNG JH, 1994, KOREA POLYM J, V2, P85
   Kurisawa M, 2000, J CONTROL RELEASE, V69, P127, DOI 10.1016/S0168-3659(00)00297-2
   Lee CB, 2000, POLYM-KOREA, V24, P168
   Min SK, 2001, KOREA POLYM J, V9, P143
   NURKEEVA ZS, 1992, MAKROMOL CHEM, V193, P1117
   NYSTROM B, 1995, LANGMUIR, V11, P750, DOI 10.1021/la00003a014
   Panda A, 2000, RADIAT PHYS CHEM, V58, P101, DOI 10.1016/S0969-806X(99)00349-7
   Ramkissoon-Ganorkar C, 1999, J CONTROL RELEASE, V59, P287, DOI 10.1016/S0168-3659(99)00006-1
   Ruel-Gariepy E, 2000, INT J PHARM, V203, P89, DOI 10.1016/S0378-5173(00)00428-2
   Yuk SH, 2000, KOREA POLYM J, V8, P89
   Zhai ML, 2000, RADIAT PHYS CHEM, V57, P481
NR 20
TC 11
Z9 11
U1 1
U2 11
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD APR
PY 2002
VL 10
IS 2
BP 115
EP 121
AR UNSP 1598-5032/04/115-07
DI 10.1007/BF03218300
PG 7
WC Polymer Science
SC Polymer Science
GA 548EQ
UT WOS:000175376000012
DA 2018-10-20
ER

PT J
AU Amis, EJ
   Xiang, XD
   Zhao, JC
AF Amis, EJ
   Xiang, XD
   Zhao, JC
TI Combinatorial materials science: What's new since Edison?
SO MRS BULLETIN
LA English
DT Article
DE alloys; biomedical materials; ceramics; combinatorial methods;
   diffusion; electron microprobe; electronic materials; electronic
   properties; evanescent microwave probe; mechanical properties;
   nanoindentation; optical materials; phase equilibria; photoluminescence;
   polymers; structural materials; thin films
ID DISCOVERY
AB Combinatorial methods are high-efficiency methods to create large composition "libraries" of materials, for example, continuous composition variations, and test those compositions systematically in parallel for specific properties of interest, in contrast to the time-consuming one-composition-at-a-time approach. These methods have captured the attention of the materials industry with the promise of providing new discoveries "faster, better, and cheaper." However, in the academic community, combinatorial methods often meet with less enthusiasm, perhaps due to the perception of combinatorial methodology as an Edisonian approach to science. The facts are quite to the contrary. in addition to impressive successes arising from the application of combinatorial methods to materials discovery, results coming out of systematic high-throughput investigations of complex materials phenomena (which would be too time-consuming or expensive to undertake) provide data leading to improvement in theories and models of materials chemistry and physics. Indeed, combinatorial methods provide a new paradigm for advancing a central scientific goal-the fundamental understanding of structure-property relationships of materials behavior.
C1 Natl Inst Stand & Technol, Div Polymer, Gaithersburg, MD 20899 USA.
   SRI Int, Menlo Pk, CA 94025 USA.
   GE Co, Global Res Ctr, Niskayuna, NY USA.
RP Amis, EJ (reprint author), Natl Inst Stand & Technol, Div Polymer, Gaithersburg, MD 20899 USA.
RI Xiang, Xiaodong/Q-7727-2018; Xiang, Xiaodong/A-5936-2017; Xiang,
   Xiaodong/A-9445-2012; Zhao, Ji-Cheng (JC)/H-4387-2012
OI Zhao, Ji-Cheng (JC)/0000-0002-4426-1080
CR BERLINCOURT TG, COMMUNICATION
   Doerner MF, 1986, J MATER RES, V1, P601, DOI 10.1557/JMR.1986.0601
   HAMMOND RH, 1979, IEEE T MAGN, V15, P619, DOI 10.1109/TMAG.1979.1060214
   HAMMOND RH, 1972, J APPL PHYS, V43, P2407, DOI 10.1063/1.1661511
   HANAK JJ, 1969, PHYS LETT A, VA 30, P201, DOI 10.1016/0375-9601(69)90936-0
   HANAK JJ, 1970, J MATER SCI, V5, P964, DOI 10.1007/BF00558177
   HARTSOUGH LD, 1971, SOLID STATE COMMUN, V9, P885, DOI 10.1016/0038-1098(71)90505-9
   KENNEDY K, 1965, J APPL PHYS, V36, P3808, DOI 10.1063/1.1713952
   KUO J, 1981, PHYS REV B, V23, P3230
   Meredith JC, 2000, MACROMOLECULES, V33, P5760, DOI 10.1021/ma0004662
   Meredith JC, 2000, MACROMOLECULES, V33, P9747, DOI 10.1021/ma001298g
   MEREDITH JC, 2001, ACS S SERIES
   MILLER NC, 1967, APPL PHYS LETT, V10, P86, DOI 10.1063/1.1754863
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PHILLIPS JC, 1989, PHYSICS HIGH T SUPER
   SAWATZKY E, 1969, IBM J RES DEV, V13, P696, DOI 10.1147/rd.136.0696
   Smith AP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015503
   Sucholeiki I., 2001, HIGH THROUGHPUT SYNT
   VANDOVER RB, 1993, CHEM MATER, V5, P32, DOI 10.1021/cm00025a010
   XIANG XD, 1995, SCIENCE, V268, P1738, DOI 10.1126/science.268.5218.1738
   Xiang XD, 1999, ANNU REV MATER SCI, V29, P149, DOI 10.1146/annurev.matsci.29.1.149
   Yoo YK, 2000, NATURE, V406, P704, DOI 10.1038/35021018
   Zhao JC, 2001, J MATER RES, V16, P1565, DOI 10.1557/JMR.2001.0218
   Zhao JC, 2001, ADV ENG MATER, V3, P143, DOI 10.1002/1527-2648(200103)3:3<143::AID-ADEM143>3.0.CO;2-F
NR 24
TC 65
Z9 66
U1 1
U2 26
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD APR
PY 2002
VL 27
IS 4
BP 295
EP 297
DI 10.1557/mrs2002.96
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 542MW
UT WOS:000175048500017
DA 2018-10-20
ER

PT J
AU Chu, PK
   Chen, JY
   Wang, LP
   Huang, N
AF Chu, PK
   Chen, JY
   Wang, LP
   Huang, N
TI Plasma-surface modification of biomaterials
SO MATERIALS SCIENCE & ENGINEERING R-REPORTS
LA English
DT Review
DE plasma processing and deposition; biomaterials
ID DIAMOND-LIKE CARBON; IMMERSION ION-IMPLANTATION; SILICONE-RUBBER
   MEMBRANE; GLOW-DISCHARGE PLASMA; LOW-TEMPERATURE; IN-VITRO;
   GRAFT-POLYMERIZATION; BLOOD COMPATIBILITY; BIOMEDICAL APPLICATIONS;
   TITANIUM-ALLOYS
AB Plasma-surface modification (PSM) is an effective and economical surface treatment technique for many materials and of growing interests in biomedical engineering. This article reviews the various common plasma techniques and experimental methods as applied to biomedical materials research, such as plasma sputtering and etching, plasma implantation, plasma deposition, plasma polymerization, laser plasma deposition, plasma spraying, and so on. The unique advantage of plasma modification is that the surface properties and biocompatibility can be enhanced selectively while the bulk attributes of the materials remain unchanged. Existing materials can, thus, be used and needs for new classes of materials may be obviated thereby shortening the time to develop novel and better biomedical devices. Recent work has spurred a number of very interesting applications in the biomedical field. This review article concentrates upon the current status of these techniques, new applications, and achievements pertaining to biomedical materials research. Examples described include hard tissue replacements, blood contacting prostheses, ophthalmic devices, and other products. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR Adler S, 1998, J HOSP INFECT, V40, P125, DOI 10.1016/S0195-6701(98)90091-3
   Allen Matthew, 1994, Clinical Materials, V17, P1, DOI 10.1016/0267-6605(94)90041-8
   *AM AC ORTH SURG, 1995, OTH RES SOC ANN M OR
   Amoruso S, 1999, J PHYS B-AT MOL OPT, V32, pR131, DOI 10.1088/0953-4075/32/14/201
   Anders S, 1996, J APPL PHYS, V79, P6785, DOI 10.1063/1.361523
   ANGUS JC, 1988, SCIENCE, V241, P877
   Ayhan F, 1998, J BIOACT COMPAT POL, V13, P65, DOI 10.1177/088391159801300106
   Baier RE, 1970, ADHESION BIOL SYSTEM
   Baquey C, 1999, NUCL INSTRUM METH B, V151, P255, DOI 10.1016/S0168-583X(99)00106-8
   Barraquer J, 1999, AM J OPHTHALMOL, V128, P232, DOI 10.1016/S0002-9394(99)00085-9
   Bathina MN, 1998, J AM COLL CARDIOL, V32, P1384, DOI 10.1016/S0735-1097(98)00401-X
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   BIALASIEWICZ AA, 1995, OPHTHALMIC RES, V27, P124, DOI 10.1159/000267857
   BISCHOFF R, 1998, P 11 C ESB TOUL FRAN
   Boxman RL, 1997, IEEE T PLASMA SCI, V25, P1174, DOI 10.1109/27.650894
   BULL SJ, 1992, DIAM RELAT MATER, V1, P1049, DOI 10.1016/0925-9635(92)90075-Y
   Calderon JG, 1998, J BIOMED MATER RES, V42, P597, DOI 10.1002/(SICI)1097-4636(19981215)42:4<597::AID-JBM16>3.0.CO;2-R
   Casaletto MP, 2001, APPL SURF SCI, V172, P167, DOI 10.1016/S0169-4332(00)00844-8
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Chandy T, 1999, INT J ARTIF ORGANS, V22, P547
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   Chang E, 1997, J MATER SCI-MATER M, V8, P193, DOI 10.1023/A:1018583522322
   Chang PCT, 1998, J BIOMED MATER RES, V39, P380
   CHAPPELL PJC, 1991, SURF INTERFACE ANAL, V17, P143, DOI 10.1002/sia.740170305
   CHARNLEY J, 1975, CLIN ORTHOP RELAT R, P170
   CHEN J, 2000, P 8 ASS C COMP MECH, P99
   CHEN JY, 2000, J HIGH TECHNOL, V10, P8
   CHEN JY, IN PRESS BIOMATERIAL
   CHEN JY, 2000, P 6 WORLD BIOM C T H, P1026
   CHEN JY, 2000, FUNCTIONAL MAT, V31, P212
   CHEN JY, IN PRESS SURF COATIN
   Chen KR, 1996, APPL SURF SCI, V96-8, P45, DOI 10.1016/0169-4332(95)00463-7
   Chen YJ, 2000, SYNTHETIC MET, V110, P47, DOI 10.1016/S0379-6779(99)00257-X
   CHENGWEI C, 1995, TRIBOL T, V38, P875
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Chu P.K., 1996, MAT SCI ENG R, VR17, P1
   CLARK DT, 1987, J POLYM SCI POL CHEM, V25, P2643, DOI 10.1002/pola.1987.080251002
   Clay KJ, 1998, DIAM RELAT MATER, V7, P1100, DOI 10.1016/S0925-9635(98)00159-9
   Cornell CN, 1998, CLIN ORTHOP RELAT R, pS267
   CROWNINSHIELD R, 1990, P T 36 ANN M ORTH RE, V15, P470
   CUI FZ, 1983, NUCL INSTRUM METHODS, V209, P881
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   CURTIS A, 1994, ENABLING TECHNOLOGIE, V99
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   DEARNALEY G, 1978, THIN SOLID FILMS, V54, P215, DOI 10.1016/0040-6090(78)90201-8
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   DRESCHER D, 1989, AM J ORTHOD DENTOFAC, V96, P397, DOI 10.1016/0889-5406(89)90324-7
   ENDERLE J, 1999, INTRO BIOMED ENG, P571
   Enderle J, 1999, INTRO BIOMEDICAL ENG, P538
   Fauchais P, 1997, IEEE T PLASMA SCI, V25, P1258, DOI 10.1109/27.650901
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Favia P., 1996, PLASMAS POLYM, V1, P299
   Ferraz MP, 1999, J MATER SCI-MATER M, V10, P567, DOI 10.1023/A:1008924516146
   Ferraz MP, 2000, BIOMATERIALS, V21, P813, DOI 10.1016/S0142-9612(99)00249-5
   Ferraz MP, 1999, J BIOMED MATER RES, V45, P376, DOI 10.1002/(SICI)1097-4636(19990615)45:4<376::AID-JBM13>3.0.CO;2-S
   Formichi M J, 1988, Ann Vasc Surg, V2, P14, DOI 10.1016/S0890-5096(06)60773-5
   FRASER D, 1997, BIOSENSORS BODY CONT, P10
   Fu L, 2001, SURF COAT TECH, V140, P263, DOI 10.1016/S0257-8972(01)01168-9
   Fu L, 2000, SURF COAT TECH, V127, P66, DOI 10.1016/S0257-8972(00)00559-4
   Fuhr G., 1995, Journal of Cellular Engineering Incorporating Molecular Engineering, V1, P47
   GADRI RB, 2000, UTK PLASMA STERILIZA, V131, P528
   Gogolewski S, 1996, J BIOMED MATER RES, V32, P227
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   GREISLER HP, 1991, ASAIO T, V37, pM72
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Guan JJ, 2000, EUR POLYM J, V36, P2707, DOI 10.1016/S0014-3057(00)00055-0
   Ha SW, 1997, SURF COAT TECH, V96, P293, DOI 10.1016/S0257-8972(97)00179-5
   HAN HX, 1988, SOLID STATE COMMUN, V65, P921, DOI 10.1016/0038-1098(88)90732-6
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   Hanawa T, 1996, CORROS SCI, V38, P1579, DOI 10.1016/0010-938X(96)00053-4
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   HANAWA T, 1993, J ELECTRON SPECTROSC, V63, P347, DOI 10.1016/0368-2048(93)80032-H
   Hanawa T, 1998, J MATER SCI-MATER M, V9, P89, DOI 10.1023/A:1008847014938
   HANAWA T, 1994, ASTM STP, V1196
   HANAWA T, 1994, J JPN SOC BIOMATER, V12, P209
   HARRIS WH, 1990, NEW ENGL J MED, V323, P725, DOI 10.1056/NEJM199009133231106
   HILL D, 1998, DESIGN ENG BIOMATERI, P143
   HILL D, 1998, DESIGN ENG BIOMATERI, V150
   HILL D, 1998, DESIGN ENG BIOMATERI, P1
   *HIMA, 1994, 941 HIMA
   HOEPPNER DW, 1994, WEAR, V173, P189, DOI 10.1016/0043-1648(94)90272-0
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   Hsiue GH, 1996, ARTIF ORGANS, V20, P1196
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   HUANG N, 1997, CHIN J BIOMED ENG, V16, P199
   HUANG N, 2000, P FABR ADV MAT, V8, P207
   HUANG N, 2000, P FABR ADV MAT 8, P341
   Inagaki N., 1996, PLASMA SURFACE MODIF
   Inoue H, 1997, J BIOMED MATER RES, V35, P255
   Inoue M, 1997, NUCL INSTRUM METH B, V121, P1, DOI 10.1016/S0168-583X(96)00431-4
   ITAGAKI N, 2000, THIN SOLID FILMS, V386, P152
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Ito Y, 2000, J INORG BIOCHEM, V79, P77, DOI 10.1016/S0162-0134(99)00159-2
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   Kapur R, 1996, J BIOMED MATER RES, V33, P205, DOI 10.1002/(SICI)1097-4636(199624)33:4<205::AID-JBM1>3.0.CO;2-T
   Kelly-Wintenberg K, 1999, J VAC SCI TECHNOL A, V17, P1539, DOI 10.1116/1.581849
   KIM HJ, 1995, IEEE T PLASMA SCI, V23, P252
   Kim HM, 2000, BIOMATERIALS, V21, P1129, DOI 10.1016/S0142-9612(99)00265-3
   Kim MK, 2001, J CATARACT REFR SURG, V27, P766, DOI 10.1016/S0886-3350(00)00701-X
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   Kizling MB, 1996, APPL CATAL A-GEN, V147, P1
   Krebs MC, 1998, INT J PHARMACEUT, V160, P75, DOI 10.1016/S0378-5173(97)00296-2
   Kumar R, 2001, J MATER PROCESS TECH, V113, P456, DOI 10.1016/S0924-0136(01)00611-2
   KURTZ SM, 1993, P T 39 ANN M ORTH RE, V18, P434
   Kurzweg H, 1998, BIOMATERIALS, V19, P1507, DOI 10.1016/S0142-9612(98)00067-2
   Kweh SWK, 2000, BIOMATERIALS, V21, P1223, DOI 10.1016/S0142-9612(99)00275-6
   Kwok DTK, 1999, J APPL PHYS, V86, P1817, DOI 10.1063/1.370974
   Lacefield W R, 1998, Implant Dent, V7, P315, DOI 10.1097/00008505-199807040-00010
   Latkany R, 1997, J BIOMED MATER RES, V36, P29, DOI 10.1002/(SICI)1097-4636(199707)36:1<29::AID-JBM4>3.3.CO;2-3
   LEE EH, 1994, J MATER RES, V9, P1043, DOI 10.1557/JMR.1994.1043
   LEE EH, 1993, NUCL INSTRUM METH B, V74, P326, DOI 10.1016/0168-583X(93)95070-L
   LEE JS, 1993, BIOMATERIALS, V14, P71
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Lee SD, 1996, BIOMATERIALS, V17, P587, DOI 10.1016/0142-9612(96)88709-6
   Leng YX, 2001, THIN SOLID FILMS, V398, P471, DOI 10.1016/S0040-6090(01)01448-1
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   LENG YX, 2001, P 6 INT WORKSH PLASM, P21
   Lerouge S, 2000, J BIOMED MATER RES, V52, P774
   Lerouge S, 2000, J BIOMED MATER RES, V51, P128, DOI 10.1002/(SICI)1097-4636(200007)51:1<128::AID-JBM17>3.0.CO;2-#
   Lerouge S., 2000, PLASMAS POLYM, V5, P31
   Lewis HGP, 2000, CHEM MATER, V12, P3488
   LI DJ, 1993, NUCL INSTRUM METH B, V82, P57
   Li DJ, 1997, CHINESE PHYS LETT, V14, P531
   LI JM, 1992, J VASC SURG, V15, P1010, DOI 10.1016/0741-5214(92)90457-J
   Liefeith K, 1998, BIOMED TECH, V43, P330, DOI 10.1515/bmte.1998.43.11.330
   LIN JC, 1995, BIOMATERIALS, V16, P1017
   Lloyd AW, 1998, PHARM SCI TECHNOL TO, V1, P363, DOI 10.1016/S1461-5347(98)00101-1
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lu Luo, 1993, Bio-Medical Materials and Engineering, V3, P223
   Lugscheider E, 1996, COMP MATER SCI, V7, P109, DOI 10.1016/S0927-0256(96)00068-7
   MAITZ MF, 2001, P 5 AS S BIOM MAT HO
   Mandl S, 2000, BIOMED TECH, V45, P193, DOI 10.1515/bmte.2000.45.7-8.193
   McKellop H, 2000, J BONE JOINT SURG AM, V82A, P1708, DOI 10.2106/00004623-200012000-00004
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   Michler T, 1998, DIAM RELAT MATER, V7, P459, DOI 10.1016/S0925-9635(97)00236-7
   Miyake S, 2000, SURF COAT TECH, V131, P171, DOI 10.1016/S0257-8972(00)00786-6
   MONETA GL, 1992, SABISTON REV SURG, P1528
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Mow VC, 1991, BASIC ORTHOPAEDIC BI, P245
   MOY E, 1994, COLLOID POLYM SCI, V272, P1245, DOI 10.1007/BF00657777
   MRAZ S, 1989, MACH DES, V61, P88
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Muguruma H, 1999, TRAC-TREND ANAL CHEM, V18, P62, DOI 10.1016/S0165-9936(98)00098-3
   MUSTARD JF, 1975, THROMB DIATH HAEMOST, V33, P444, DOI 10.1055/s-0038-1647838
   Ohl A, 1999, SURF COAT TECH, V116, P1006, DOI 10.1016/S0257-8972(99)00139-5
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   OKADA T, 1995, J BIOMAT SCI-POLYM E, V7, P171, DOI 10.1163/156856295X00689
   OKADA T, 1992, J BIOMED MATER RES, V26, P1569, DOI 10.1002/jbm.820261204
   OLIVER WC, 1984, METALL TRANS A, V15, P2221, DOI 10.1007/BF02647105
   Ong JL, 1998, BIOMATERIALS, V19, P455, DOI 10.1016/S0142-9612(97)00224-X
   PAPPAS DL, 1992, J APPL PHYS, V71, P5675, DOI 10.1063/1.350501
   PARK JB, 1992, BIOMATERIALS INTRO
   PARK SG, 2000, SURF COAT TECH, V133, P509
   Patil DS, 1998, J ALLOY COMPD, V278, P130, DOI 10.1016/S0925-8388(98)00601-X
   PICRAUX ST, 1984, SCIENCE, V226, P615, DOI 10.1126/science.226.4675.615
   RAIZER Y, 1991, GAS DISCHARGE PHYSIC
   Raizer Y. P., 1995, RADIO FREQUENCY CAPA
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   RATNER BD, 1996, BIOMATERIALS SCI INT, V2
   RATNER BD, 1990, PLASMA DEPOSITION TR, P416
   Ratner BD, 1996, BIOMATERIALS SCI INT, P105
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   RODRIGUEZ RJ, 1994, SPRINT DATABASE ION
   Rupp F, 1996, ADV MATER, V8, P254, DOI 10.1002/adma.19960080316
   Rutala WA, 1998, AM J INFECT CONTROL, V26, P393, DOI 10.1016/S0196-6553(98)70034-3
   Sanders DM, 2000, SURF COAT TECH, V133, P78, DOI 10.1016/S0257-8972(00)00879-3
   Schnelle T, 1996, LANGMUIR, V12, P801, DOI 10.1021/la950065t
   Schutze A, 1998, IEEE T PLASMA SCI, V26, P1685, DOI 10.1109/27.747887
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   Sergo V, 1997, BIOMATERIALS, V18, P477, DOI 10.1016/S0142-9612(96)00147-0
   Sharma C P, 1987, J Biomater Appl, V1, P533
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SIOSHANSI P, 1987, MATER SCI ENG, V90, P373, DOI 10.1016/0025-5416(87)90235-7
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V24-5, P767, DOI 10.1016/S0168-583X(87)80243-4
   SIOSHANSI P, 1985, J VAC SCI TECHNOL A, V3, P2670, DOI 10.1116/1.572811
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   Sipehia R, 1996, ARTIF CELL BLOOD SUB, V24, P51, DOI 10.3109/10731199609117431
   Smith CA, 2000, OPHTHALMOLOGY, V107, P1561, DOI 10.1016/S0161-6420(00)00174-3
   Soballe K, 1999, J LONG-TERM EFF MED, V9, P131
   Sodhi RNS, 1996, J ELECTRON SPECTROSC, V81, P269, DOI 10.1016/0368-2048(95)02665-7
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   STEELE JG, 1995, P PROT INT 2ACS S SE, V602
   Steinschaden A, 1997, SENSOR ACTUAT B-CHEM, V44, P365, DOI 10.1016/S0925-4005(97)00227-X
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   SUZUKI Y, 1988, NUCL INSTRUM METH B, V32, P120, DOI 10.1016/0168-583X(88)90193-0
   SUZUKI Y, 1990, Japanese Journal of Artificial Organs, V19, P1092
   Szabo G, 1999, J LONG-TERM EFF MED, V9, P247
   SZYCHER M, 1990, BIOMATERIALS 1990S 9
   SZYCHER M, 1990, BIOMATERIALS 1990S 8
   Szycher M., 1990, BIOMATERIALS 1990S P
   TATEISHI T, 1992, BIOCERAMICS, V2, P145
   TAYLOR SK, 1993, P T 39 ANN M ORTH RE, V18, P503
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   THE TC, 1996, BIOMATERIALS, V17, P1273
   THELEN H, 1995, FRESEN J ANAL CHEM, V353, P290, DOI 10.1007/BF00322054
   Tietze L, 2000, MRS BULL, V25, P33
   TORING CJ, 1990, J MATER RES, V5, P2490
   Tran HS, 1999, J INVEST SURG, V12, P133
   Uldall PR, 1993, DIALYSIS THERAPY, P5
   Urano Y, 1998, THIN SOLID FILMS, V316, P60, DOI 10.1016/S0040-6090(98)00389-7
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P555, DOI 10.1002/pola.1991.080290412
   Vassal S, 1998, AM J INFECT CONTROL, V26, P136, DOI 10.1016/S0196-6553(98)80032-1
   VENKATESAN T, 1985, NUCL INSTRUM METH B, V7-8, P461, DOI 10.1016/0168-583X(85)90413-6
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Wang LP, 2000, REV SCI INSTRUM, V71, P4435, DOI 10.1063/1.1327312
   Wang LP, 2001, J MATER SCI TECHNOL, V17, P29
   Wang LP, 2001, MAT SCI ENG A-STRUCT, V308, P176, DOI 10.1016/S0921-5093(00)01991-2
   Wang SY, 1997, NUCL INSTRUM METH B, V127, P1000, DOI 10.1016/S0168-583X(97)00047-5
   Whitcher FD, 1997, COMPUT STRUCT, V64, P1005, DOI 10.1016/S0045-7949(97)00014-X
   WILLIAMS JM, 1985, MATER SCI ENG, V69, P237, DOI 10.1016/0025-5416(85)90398-2
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   YANG P, IN PRESS SURF COATIN
   YEHIA A, 2000, P IEEE IND APPL C, V714
   Young JH, 1997, STERILIZATION TECHNO, P228
   Yushkov GY, 2000, J APPL PHYS, V88, P5618, DOI 10.1063/1.1321789
   Zeng ZM, 2000, IEEE T PLASMA SCI, V28, P394, DOI 10.1109/27.848098
   Zeng ZM, 1999, J VAC SCI TECHNOL B, V17, P851, DOI 10.1116/1.590666
   ZHANG JQ, 1986, MATER RES SOC S P, V55, P228
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
   Zhao HW, 2000, REV SCI INSTRUM, V71, P646, DOI 10.1063/1.1150337
   Zhao Q, 1999, BIOMATERIALS, V20, P595, DOI 10.1016/S0142-9612(98)00218-X
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
   ZILLA P, 1994, J VASC SURG, V19, P540, DOI 10.1016/S0741-5214(94)70083-4
   ZIMMERMAN J, 1992, HLTH CARE MED TECHNO
   Zisman W. A, 1964, ADV CHEM SER, P1
NR 238
TC 870
Z9 895
U1 21
U2 480
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0927-796X
J9 MAT SCI ENG R
JI Mater. Sci. Eng. R-Rep.
PD MAR 29
PY 2002
VL 36
IS 5-6
BP 143
EP 206
AR PII S0927-796X(02)00004-9
DI 10.1016/S0927-796X(02)00004-9
PG 64
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 538LV
UT WOS:000174818200001
DA 2018-10-20
ER

PT J
AU Ferruti, P
   Marchisio, MA
   Duncan, R
AF Ferruti, P
   Marchisio, MA
   Duncan, R
TI Poly(amido-amine)s: Biomedical applications
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Review
DE biological applications of polymers; heparin-absorbing resins; non-viral
   vectors; polyamines; polymer-anticancer drug conjugates
ID BASIC MULTIFUNCTIONAL POLYMERS; TERTIARY AMINO POLYMERS; RED-BLOOD-CELL;
   COMPLEX-FORMATION; IN-VITRO; MACROMOLECULAR CHAIN; ANTITUMOR-ACTIVITY;
   MACRO-INORGANICS; APPLIED MACROINORGANICS; HEPARINIZABLE MATERIALS
AB Feature Article: Poly(amido-amine)s (PAAs) are synthetic tert-amino polymers obtained by stepwise polyaddition of primary or secondary aliphatic amines to bis(acrylamide)s. Linear polymers are produced during the polymerisation of both primary mono(amine)s and secondary bis(amine)s. Under non-selective conditions primary bis(amine)s usually give crosslinked products upon reaction with bis(acrylamide)s, i.e., they react as tetrafunctional monomers. Furthermore, end-functionalised PAAs can be used to prepare block or graft copolymers, as well as crosslinked resins. PAAs can therefore be regarded as macromonomers as well. Generally, PAAs are soluble in water, chloroform, lower alcohols, dimethyl sulfoxide and other polar solvents (although amphoteric PAAs can only be dissolved in water). PAAs are degradable in aqueous solution by means of hydrolytic cleavage of the amidic bonds in their main chain that are activated by tert-amino groups present in ?-position. A vast library of PAA structures has now been reported that are suitable for numerous material and biomedical applications. Here we review the synthesis, characterisation and current biomedical uses of PAAs. Their use as heavy-metal-ion-complexing polymers, and polymers for heparin neutralisation in solution, fabrication of heparin-absorbing resins and heparinisable materials is discussed. As amphoteric PAAs are biocompatible and biodegradable polymer that moreover display intelligent stealth properties, they are currently under development as PAA/anticancer conjugates and non-viral vectors for intracytoplasmic delivery. The potential of this unique chemistry is reviewed.
C1 Univ Milan, Dipartimento Chim Organ & Ind, I-20133 Milan, Italy.
   Cardiff Univ, Welsh Sch Pharm, Ctr Polymer Therapeut, Cardiff CF10 3XF, S Glam, Wales.
RP Ferruti, P (reprint author), Univ Milan, Dipartimento Chim Organ & Ind, Via Venezian 21, I-20133 Milan, Italy.
EM paolo.ferruti@unimi.it; duncan@cf.ac.uk
OI Ferruti, Paolo/0000-0002-5404-440X
CR ALBANESE A, 1994, BIOMATERIALS, V15, P129, DOI 10.1016/0142-9612(94)90262-3
   ANDREANI F, 1981, J POLYM SCI POL LETT, V19, P443, DOI 10.1002/pol.1981.130190903
   ANGELONI AS, 1983, POLYM COMMUN, V24, P87
   ANGELONI AS, 1982, POLYMER, V23, P1693, DOI 10.1016/0032-3861(82)90197-5
   BARBUCCI R, 1980, J CHEM SOC DALTON, P253, DOI 10.1039/dt9800000253
   BARBUCCI R, 1986, MACROMOLECULES, V19, P37, DOI 10.1021/ma00155a007
   BARBUCCI R, 1991, POLYMER, V32, P897, DOI 10.1016/0032-3861(91)90517-M
   BARBUCCI R, 1983, POLYM COMMUN, V24, P26
   BARBUCCI R, 1979, POLYMER, V20, P1298, DOI 10.1016/0032-3861(79)90159-9
   BARBUCCI R, 1985, POLYMER, V26, P1349, DOI 10.1016/0032-3861(85)90310-6
   BARBUCCI R, 1982, GAZZ CHIM ITAL, V112, P105
   BARBUCCI R, 1978, POLYMER, V19, P1329, DOI 10.1016/0032-3861(78)90317-8
   BARBUCCI R, 1981, MACROMOLECULES, V14, P1203, DOI 10.1021/ma50006a013
   BARBUCCI R, 1980, POLYMER, V21, P81, DOI 10.1016/0032-3861(80)90171-8
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   BARBUCCI R, 1992, ADV BIOMAT, V10, P217
   BARBUCCI R, 1992, MAKROMOL CHEM, V193, P2979
   BARBUCCI R, 1987, BIOMATERIALS, V8, P306, DOI 10.1016/0142-9612(87)90120-7
   BARBUCCI R, 1989, BIOMATERIALS, V10, P429, DOI 10.1016/0142-9612(89)90136-1
   BARBUCCI R, 1991, INT J ARTIF ORGANS, V14, P499
   BARBUCCI R, 1991, J BIOMED MATER RES, V25, P1259, DOI 10.1002/jbm.820251007
   BARBUCCI R, 1984, MAKROMOL CHEM, V185, P1525
   BARBUCCI R, 1982, POLYMER, V23, P148, DOI 10.1016/0032-3861(82)90031-3
   BARBUCCI R, 1979, POLYMER, V20, P1061, DOI 10.1016/0032-3861(79)90295-7
   Barbucci R., 1980, POLYM AMINES AMMONIU, P263
   Barbucci R., 1978, ATTI ACCAD NAZ LINCE, V64, P481
   BARBUCCI R, 1985, BIOMATERIALS, V6, P107
   Barbucci R., 1988, POLYM MED, P3
   BARBUCCI R, 1981, J POLYM SCI PS, V69, P49
   BARBUCCI R, 1991, BIOMATERIALS, V12, P897
   BIGNOTTI F, 1994, MACROMOLECULES, V27, P7171, DOI 10.1021/ma00102a027
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Brocchini S., 1999, ENCY CONTROLLED DRUG, P786
   CALDWELL G, 1993, J APPL POLYM SCI, V50, P393, DOI 10.1002/app.1993.070500303
   CASALI M, 2002, J BIOACT COMPAT POLY, V16, P479
   CHU BCF, 1981, J PHARMACOL EXP THER, V219, P389
   CIMMINO S, 1993, J APPL POLYM SCI, V47, P631, DOI 10.1002/app.1993.070470407
   CITRO G, 1994, BRIT J CANCER, V69, P463, DOI 10.1038/bjc.1994.84
   DANUSSO F, 1967, CHIM IND-MILAN, V49, P826
   DANUSSO F, 1970, POLYMER, V11, P88, DOI 10.1016/0032-3861(70)90029-7
   DUNCAN R, 1994, J DRUG TARGET, V2, P341, DOI 10.3109/10611869409015915
   DUNCAN R, 1992, ANTI-CANCER DRUG, V3, P175, DOI 10.1097/00001813-199206000-00001
   Duncan R, 1996, STP PHARMA SCI, V6, P237
   DUNCAN R, 1999, PHARM SCI TECHNOL TO, V2, P441, DOI DOI 10.1016/S1461-5347(99)00211-4
   DUNCAN R, 2000, DRUG DELIVERY SYSTEM, P350
   Duncan R., 2001, P INT S CONTROLLED R, V28, P864
   ENDO Y, 1987, J BIOL CHEM, V262, P5908
   Ferraris P., 1980, POLYM AMINES AMMONIU, P305
   Ferruti P, 2000, MACROMOLECULES, V33, P7793, DOI 10.1021/ma000378h
   FERRUTI P, 1977, J POLYM SCI POL CHEM, V15, P2151, DOI 10.1002/pol.1977.170150909
   FERRUTI P, 1968, CHIM IND-MILAN, V50, P441
   FERRUTI P, 1984, BIOMATERIALS, V5, P234, DOI 10.1016/0142-9612(84)90021-8
   FERRUTI P, 1985, POLYMER, V26, P1336, DOI 10.1016/0032-3861(85)90309-X
   Ferruti P, 1999, MACROMOL CHEM PHYS, V200, P1644
   FERRUTI P, 1994, BIOMATERIALS, V15, P1235, DOI 10.1016/0142-9612(94)90275-5
   Ferruti P, 1998, MACROMOL CHEM PHYSIC, V199, P2565, DOI 10.1002/(SICI)1521-3935(19981101)199:11<2565::AID-MACP2565>3.0.CO;2-G
   FERRUTI P, 1967, CHIM IND-MILAN, V49, P831
   FERRUTI P, 1988, J POLYM SCI POL LETT, V26, P357, DOI 10.1002/pol.1988.140260805
   FERRUTI P, 1988, MAKROMOL CHEM-RAPID, V9, P807
   FERRUTI P, 1977, POLYMER, V18, P387, DOI 10.1016/0032-3861(77)90088-X
   FERRUTI P, 1989, POLYM COMMUN, V30, P157
   FERRUTI P, 1981, J CHEM SOC DALTON, P539, DOI 10.1039/dt9810000539
   FERRUTI P, 1982, J APPL POLYM SCI, V27, P2239, DOI 10.1002/app.1982.070270633
   FERRUTI P, 1982, BIOMATERIALS, V3, P33, DOI 10.1016/0142-9612(82)90058-8
   FERRUTI P, 1987, MAKROMOL CHEM-RAPID, V8, P549
   FERRUTI P, UNPUB
   FERRUTI P, 1984, ADV POLYM SCI, V58, P57
   FERRUTI P, 1994, J BIOMAT SCI-POLYM E, V6, P833
   FERRUTI P, 1982, P IUPAC MACR S 28 IN, P373
   Ferruti P., 1989, FRONTIERS MACROMOLEC, P567
   FERRUTI P, 1976, TRANSPL P, V1, P103
   Ferruti P., 1996, POLYM MAT ENCY, V5, P3334
   FERRUTI P, 1973, REACTIONS POLYMERS, P73
   FERRUTI P, 1983, BIOMATERIALS, V4, P217
   FERRUTI P, 1998, TARGETING DRUGS, V6, P207
   FERRUTI P, 1973, J MED CHEM, V16, P497
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   FRICK PG, 1966, SURGERY, V59, P721
   GARNETT MC, 1999, MRS BULL, P49
   Gianasi E, 1999, EUR J CANCER, V35, P994, DOI 10.1016/S0959-8049(99)00030-1
   Gorecki D. C., 1999, EMERG DRUGS, V4, P247
   GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3
   HARTMANN W, 1978, BIOCHIM BIOPHYS ACTA, V509, P474, DOI 10.1016/0005-2736(78)90241-9
   HERSH EM, 1998, SELF ASSEMBLING COMP, P421
   Kachalsici A., 1959, BIOCHIM BIOPHYS ACTA, V33, P120
   Kichler Antoine, 1997, Bioconjugate Chemistry, V8, P213, DOI 10.1021/bc970009z
   LORD JM, 1994, FASEB J, V8, P201
   LOZIER JN, 1994, HUM GENE THER, V5, P313, DOI 10.1089/hum.1994.5.3-313
   Maeda H., 1994, POLYM SITE SPECIFIC
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   MANDEL M, 1988, ENCY POLYM SCI ENG, V11, P739
   MARCHISI.MA, 1973, EXPERIENTIA, V29, P93, DOI 10.1007/BF01913274
   MARCHISIO AM, 1975, Patent No. 3865723
   MARCHISIO MA, 1971, EUR SURG RES, V3, P240
   MARCHISIO MA, 1972, EUR SURG RES, V4, P312
   MARCHISIO MA, 1988, POLYM MED, V2, P111
   MARCONI W, 1992, BIOMATERIALS, V13, P432, DOI 10.1016/0142-9612(92)90163-I
   MARTUSCELLI E, 1976, CHIM IND-MILAN, V58, P542
   Martuscelli E., 1978, POLYMER, V19, P1329
   NEUSE EW, 1995, J INORG ORGANOMET P, V5, P195, DOI 10.1007/BF01057892
   NEVO A, 1955, BIOCHIM BIOPHYS ACTA, V17, P536, DOI 10.1016/0006-3002(55)90416-9
   Ohya Y, 1996, J MACROMOL SCI PURE, VA33, P1005, DOI 10.1080/10601329608010901
   Pattrick NG, 2001, J CONTROL RELEASE, V77, P225, DOI 10.1016/S0168-3659(01)00476-X
   PESAVENTO M, 1983, J APPL POLYM SCI, V28, P3361, DOI 10.1002/app.1983.070281105
   RANUCCI E, 1991, Journal of Biomaterials Science Polymer Edition, V2, P303, DOI 10.1163/156856291X00197
   RANUCCI E, 1991, POLYMER, V32, P2876, DOI 10.1016/0032-3861(91)90122-Y
   RANUCCI E, 1995, POLYMER, V36, P2989, DOI 10.1016/0032-3861(95)94349-X
   RANUCCI E, 1993, POLYM J, V25, P625, DOI 10.1295/polymj.25.625
   RANUCCI E, 1991, MACROMOLECULES, V24, P3747, DOI 10.1021/ma00013a002
   Ranucci E., 1993, MATER ENG, V4, P37
   Richardson S, 1999, J DRUG TARGET, V6, P391, DOI 10.3109/10611869908996846
   Richardson SCW, 2001, BIOMACROMOLECULES, V2, P1023, DOI 10.1021/bm010079f
   RUSCONI L, 1982, POLYMER, V23, P1233, DOI 10.1016/0032-3861(82)90385-8
   RUSCONI L, 1982, MAKROMOL CHEM-RAPID, V3, P909
   SARTORE L, 1995, UNPUB
   Schacht E., 1994, [No title captured], Patent No. [WO9505200, 9505200]
   SCHECHTER B, 1986, CANCER BIOCHEM BIOPH, V8, P277
   SEYMOUR LW, 1994, BRIT J CANCER, V70, P636, DOI 10.1038/bjc.1994.363
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   Sohn YS, 1997, INT J PHARM, V153, P79
   STIRPE F, 1980, J BIOL CHEM, V255, P6947
   SUH J, 1994, BIOORG CHEM, V22, P318, DOI 10.1006/bioo.1994.1025
   TANZI MC, 1992, BIOMATERIALS, V13, P425, DOI 10.1016/0142-9612(92)90162-H
   TANZI MC, 1984, BIOMATERIALS, V5, P357, DOI 10.1016/0142-9612(84)90035-8
   TANZI MC, 1985, BIOMATERIALS, V6, P273, DOI 10.1016/0142-9612(85)90025-0
   TANZI MC, 1989, J BIOMED MATER RES, V23, P863, DOI 10.1002/jbm.820230805
   TANZI MC, 1984, POLYMER, V25, P863, DOI 10.1016/0032-3861(84)90019-3
   TANZI MC, 1987, POLYURETHANES BIOMED, V2, P197
   VANSTEENKISTE S, 1992, MAKROMOL CHEM, V193, P937
NR 129
TC 167
Z9 169
U1 4
U2 58
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1022-1336
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD MAR 28
PY 2002
VL 23
IS 5-6
BP 332
EP 355
DI 10.1002/1521-3927(20020401)23:5/6<332::AID-MARC332>3.0.CO;2-I
PG 24
WC Polymer Science
SC Polymer Science
GA 542MH
UT WOS:000175047300002
DA 2018-10-20
ER

PT J
AU Castner, DG
   Ratner, BD
AF Castner, DG
   Ratner, BD
TI Biomedical surface science: Foundations to frontiers
SO SURFACE SCIENCE
LA English
DT Review
DE atomic force microscopy; photoelectron spectroscopy; secondary ion mass
   spcctroscopy; self-assembly; biological compounds; biological molecules
   - proteins; solid-liquid interfaces
ID SELF-ASSEMBLED MONOLAYERS; SUM-FREQUENCY GENERATION; ATOMIC-FORCE
   MICROSCOPY; ION MASS-SPECTROMETRY; SCANNING-TUNNELING-MICROSCOPY;
   PRINCIPAL COMPONENT ANALYSIS; PROTEIN ADSORPTION; PLASMON RESONANCE;
   VIBRATIONAL SPECTROSCOPY; GOLD SURFACES
AB Surfaces play a vial role in biology and medicine with most biological reactions occurring at surfaces and interfaces. The foundations, evolution, and impact of biomedical surface science are discussed. In the 19th century, the first observations were made that surfaces control biological reactions. The advancements in surface science instrumentation that have occurred in the past quarter of a century have significantly increased our ability to characterize the surface composition and molecular structure of biomaterials. Similar advancements have occurred in material science and molecular biology. The combination of these advances have allowed the development of the biological model for surface science, where the ultimate goal is to gain a detailed understanding of how the surface properties of a material control the biological reactivity of a cell interacting with that surface. Numerous examples show that the surface properties of a material are directly related to in vitro biological performance such as protein adsorption and cell growth. The challenge is to fully develop the biological model for surface science in the highly complex and interactive in vivo biological environment. Examples of state-of-the-art biomedical surface science studies on surface chemical state imaging, molecular recognition surfaces, adsorbed protein films, and hydrated surfaces are presented. Future directions and opportunities for surface scientists working in biomedical research include exploiting biological knowledge, biomimetics, precision immobilization, self-assembly, nanofabrication, smart surfaces, and control of non-specific reactions. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Chem Engn, Seattle, WA 98195 USA.
   Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Bioengn, Seattle, WA 98195 USA.
RP Castner, DG (reprint author), Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Dept Chem Engn, Seattle, WA 98195 USA.
EM castner@nb.engr.washington.edu; ratner@uweb.engr.washington.edu
RI Zhou, Feng/E-9510-2011
CR Alivisatos AP, 1998, ADV MATER, V10, P1297
   Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   ANDRADE JD, 1980, MD DI
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1986, CHEMTECH, V16, P178
   BAIN CD, 1988, SCIENCE, V240, P62, DOI 10.1126/science.240.4848.62
   Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0
   BENNINGHOVEN A, 1994, SURF SCI, V299, P246, DOI 10.1016/0039-6028(94)90658-0
   BENNINGHOVEN A, 1977, ORG MASS SPECTROM, V12, P595, DOI 10.1002/oms.1210120914
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Blodgett KB, 1935, J AM CHEM SOC, V57, P1007, DOI 10.1021/ja01309a011
   BOHMIG SD, 1993, FRESEN J ANAL CHEM, V346, P223, DOI 10.1007/BF00321419
   BOLAND T, 1995, P NATL ACAD SCI USA, V92, P5297, DOI 10.1073/pnas.92.12.5297
   BOLAND T, 1994, LANGMUIR, V10, P3845, DOI 10.1021/la00022a074
   BOLAND T, 1998, SCANNING PROBE MICRO, V694, P342
   Bottomley LA, 1998, ANAL CHEM, V70, p425R
   Brown LR, 1996, J PHARM SCI, V85, P1341, DOI 10.1021/js9600686
   CANTARERO LA, 1980, ANAL BIOCHEM, V105, P375, DOI 10.1016/0003-2697(80)90473-X
   Carey DH, 1996, J AM CHEM SOC, V118, P9780, DOI 10.1021/ja952271t
   CASS T, 1997, IMMOBILIZED BIOMOLEC
   CHANEY RL, 1987, SURF INTERFACE ANAL, V10, P36, DOI 10.1002/sia.740100108
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   CHEN JP, 1990, BIOMATERIALS, V11, P631, DOI 10.1016/0142-9612(90)90020-Q
   Chinn J. A., 1994, Journal of Tissue Culture Methods, V16, P155, DOI 10.1007/BF01540643
   CLARK DT, 1977, PHYS SCRIPTA, V16, P307, DOI 10.1088/0031-8949/16/5-6/023
   CLARK DT, 1976, BIOCHIM BIOPHYS ACTA, V453, P533, DOI 10.1016/0005-2795(76)90149-5
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Dante S, 1999, LANGMUIR, V15, P193, DOI 10.1021/la980497e
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   DOOLITTLE RF, 1981, SCI AM, V245, P126, DOI 10.1038/scientificamerican1281-126
   DOUGLAS K, 1992, SCIENCE, V257, P642, DOI 10.1126/science.257.5070.642
   DREXLER KE, 1991, J VAC SCI TECHNOL B, V9, P1394, DOI 10.1116/1.585204
   EGGERS M, 1994, BIOTECHNIQUES, V17, P516
   FISCHER DA, 1989, REV SCI INSTRUM, V60, P1596, DOI 10.1063/1.1141041
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   FOWKES FM, 1963, J PHYS CHEM-US, V67, P2538, DOI 10.1021/j100806a008
   Fowkes FM, 1980, ADHESION ADSORPTION, P43
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   Frey W, 1996, LANGMUIR, V12, P1312, DOI 10.1021/la9505374
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   Fujimoto K, 2000, BIOMACROMOLECULES, V1, P515, DOI 10.1021/bm000082j
   GIRIFALCO LA, 1957, J PHYS CHEM-US, V61, P904, DOI 10.1021/j150553a013
   Gizeli E, 1997, ANAL CHEM, V69, P4808, DOI 10.1021/ac970519m
   Gracias DH, 1999, ACCOUNTS CHEM RES, V32, P930, DOI 10.1021/ar990034f
   Han WH, 1996, APPL PHYS LETT, V69, P4111, DOI 10.1063/1.117835
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HARPER GR, 1995, BIOMATERIALS, V16, P427, DOI 10.1016/0142-9612(95)98815-V
   HAUSSLING L, 1991, LANGMUIR, V7, P1837
   Heller M. J., 1991, Nanotechnology, V2, P165, DOI 10.1088/0957-4484/2/4/001
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   HICKMAN JJ, 1994, J VAC SCI TECHNOL A, V12, P607, DOI 10.1116/1.578844
   Hoffman AS, 2000, J BIOMED MATER RES, V52, P577, DOI 10.1002/1097-4636(20001215)52:4<577::AID-JBM1>3.3.CO;2-X
   HOFFMAN AS, 1974, J BIOMED MATER RES, V8, P77, DOI 10.1002/jbm.820080309
   Holland NB, 1998, NATURE, V392, P799
   Horbett T. A., 1996, INTERFACIAL PHENOMEN, P351
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Iwata H, 1998, MACROMOLECULES, V31, P3671, DOI 10.1021/ma971243n
   JEON NL, 1995, LANGMUIR, V11, P3024, DOI 10.1021/la00008a029
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jung OS, 2000, J AM CHEM SOC, V122, P9921, DOI 10.1021/ja001618b
   Kasas S, 1997, INT J IMAG SYST TECH, V8, P151, DOI 10.1002/(SICI)1098-1098(1997)8:2<151::AID-IMA2>3.0.CO;2-9
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kuboki Y, 1998, EUR J ORAL SCI, V106, P197, DOI 10.1111/j.1600-0722.1998.tb02176.x
   KUHN H, 1983, THIN SOLID FILMS, V99, P1, DOI 10.1016/0040-6090(83)90352-8
   KUNITAKE M, 1995, LANGMUIR, V11, P2337, DOI 10.1021/la00007a002
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e
   Laitenberger P, 1997, CHEM PHYS LETT, V279, P209, DOI 10.1016/S0009-2614(97)01037-3
   LANGER R, 1995, SCI AM, V273, P130
   LEE SJ, 1994, J VAC SCI TECHNOL A, V12, P2949, DOI 10.1116/1.578920
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   Li JT, 1996, COLLOID SURFACE B, V7, P9, DOI 10.1016/0927-7765(96)01269-6
   LIEDBERG B, 1993, SENSOR ACTUAT B-CHEM, V11, P63, DOI 10.1016/0925-4005(93)85239-7
   LOPEZ GP, 1993, MACROMOLECULES, V26, P3247, DOI 10.1021/ma00065a001
   LOPEZ GP, 1996, PLASMAS POLYM, V1, P127
   Malyankar UM, 2000, J BIOL CHEM, V275, P20959, DOI 10.1074/jbc.C000290200
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   Matsuzawa M, 1997, THIN SOLID FILMS, V305, P74, DOI 10.1016/S0040-6090(96)09527-2
   MERRILL EW, 1992, POLYETHYLENE GLYCOL, P199
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   Naughton G K, 1995, Tissue Eng, V1, P211, DOI 10.1089/ten.1995.1.211
   NAWROCKI J, 1988, J CHROMATOGR, V449, P1, DOI 10.1016/S0021-9673(00)94364-4
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J
   OLIVIERI MP, 1990, J ADHES SCI TECHNOL, V4, P197, DOI 10.1163/156856190X00216
   Pan YV, 2001, BIOMACROMOLECULES, V2, P32, DOI 10.1021/bm0000642
   Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765
   Patolsky F, 2000, J AM CHEM SOC, V122, P418, DOI 10.1021/ja992834r
   PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022
   Pertsin AJ, 2000, LANGMUIR, V16, P8829, DOI 10.1021/1a000340y
   Pertsin AJ, 1998, J PHYS CHEM B, V102, P4918, DOI 10.1021/jp9806617
   Plant AL, 1999, LANGMUIR, V15, P5128, DOI 10.1021/la981662t
   POMERANTZ M, 1985, THIN SOLID FILMS, V132, P153, DOI 10.1016/0040-6090(85)90466-3
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Pum D, 1995, SUPRAMOL SCI, V2, P193, DOI DOI 10.1016/0968-5677(96)89675-1)
   Quate CF, 1997, SURF SCI, V386, P259, DOI 10.1016/S0039-6028(97)00305-1
   Ratner B.D., 1996, INTERFACIAL PHENOMEN, P57
   Ratner BD, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P43
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   Ratner BD, 1998, MACROMOL SYMP, V130, P327, DOI 10.1002/masy.19981300128
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   RATNER BD, 1994, COLLOID SURFACE B, V2, P333, DOI 10.1016/0927-7765(94)80048-0
   RATNER BD, 1986, SPECTROSC-BIOMED APP, P107
   RATNER BD, 1982, ACS SYM SER, V199, P9
   RATNER BD, 1988, ENCY MED DEVICES INS, V1, P366
   RATNER BD, 1998, SCANNING PROBE MICRO, V694
   Reviakine I, 2000, LANGMUIR, V16, P1806, DOI 10.1021/la9903043
   RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131
   ROBERTS TA, 1995, MRS BULL, V20, P43
   ROSS CB, 1993, LANGMUIR, V9, P632, DOI 10.1021/la00027a002
   Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8
   Rowen L, 1997, SCIENCE, V278, P605, DOI 10.1126/science.278.5338.605
   RUDOLPH AS, 1994, J CELL BIOCHEM, V56, P183, DOI 10.1002/jcb.240560211
   Salafsky J, 1996, BIOCHEMISTRY-US, V35, P14773, DOI 10.1021/bi961432i
   Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354
   SHAPIRO RI, 1978, SURG FORUM, V29, P229
   SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0
   Shi HQ, 1999, NATURE, V398, P593
   SIEGBAHN K, 1982, SCIENCE, V217, P111, DOI 10.1126/science.217.4555.111
   Sisido M, 1998, BIOPOLYMERS, V47, P159, DOI 10.1002/(SICI)1097-0282(1998)47:2<159::AID-BIP5>3.0.CO;2-T
   Somorjai G. A., 1994, INTRO SURFACE CHEM C
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Su XC, 1997, CHEM PHYS LETT, V280, P302, DOI 10.1016/S0009-2614(97)01136-6
   Thomas CH, 1999, J BIOMECH ENG-T ASME, V121, P40, DOI 10.1115/1.2798041
   Tidwell CD, 2001, SURF INTERFACE ANAL, V31, P724, DOI 10.1002/sia.1101
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   TIEN HT, 2000, MEMBRANE BIOPHYSICS
   TOMALIA DA, 1993, ALDRICHIM ACTA, V26, P91
   ULMAN A, 1989, LANGMUIR, V5, P1147, DOI 10.1021/la00089a003
   Vogel G, 1999, SCIENCE, V283, P1432, DOI 10.1126/science.283.5407.1432
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   VROMAN L, 1964, THROMB DIATH HAEMOST, V10, P455, DOI 10.1055/s-0038-1654798
   WAGNER FT, 1988, ACS SYM SER, V378, P65
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   WAWKUSCHEWSKI A, 1993, LANGMUIR, V9, P2778, DOI 10.1021/la00035a008
   WHITESIDES GM, 1993, CRIT REV SURF CHEM, V3, P49
   WILLSE A, 1998, SIMS, V11, P843
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Zhang LQ, 2000, J COLLOID INTERF SCI, V228, P82, DOI 10.1006/jcis.2000.6910
   Zisman W. A, 1964, ADV CHEM SER, P1
NR 151
TC 901
Z9 910
U1 22
U2 451
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
EI 1879-2758
J9 SURF SCI
JI Surf. Sci.
PD MAR 10
PY 2002
VL 500
IS 1-3
BP 28
EP 60
AR PII S0039-6028(01)01587-4
DI 10.1016/S0039-6028(01)01587-4
PG 33
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 546YD
UT WOS:000175303400003
DA 2018-10-20
ER

PT J
AU Tirrell, M
   Kokkoli, E
   Biesalski, M
AF Tirrell, M
   Kokkoli, E
   Biesalski, M
TI The role of surface science in bioengineered materials
SO SURFACE SCIENCE
LA English
DT Review
DE adhesion; biological compounds; chemisorption; self-assembly; surface
   chemical reaction
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN MOLECULAR ARCHITECTURE; HYBRID
   BILAYER-MEMBRANES; POLYETHYLENE OXIDE; LIPID BILAYERS; CELL-ADHESION;
   IN-VITRO; PEPTIDE-AMPHIPHILES; CALCIUM-PHOSPHATE; BONE-FORMATION
AB Materials employed in biomedical technology are increasingly being designed to have specific, desirable biological interactions with their surroundings, rather than the older common practice of trying to adapt traditional materials to biomedical applications. Moreover, materials scientists are also increasingly deriving new lessons from naturally occurring materials (from mollusk shells to soft animal tissue) about useful composition-structure property relationships that might be mimicked with synthetic materials. Together, these two areas of effort constitute what we may call bioengineered materials. It is possible to set down a reasonably thorough set of characteristics that bioengineered materials have in common. Among these characteristics we discuss the following: self-assembly, bioengineered materials often rely on information content built into structural molecules to determine the order and organization of the material; hierarchical structure, in most bioengineered materials several different length scales of structure are essential and are formed spontaneously and simultaneously via self-assembly; precision synthesis, fundamental to biological material structures is the idea of macromolecules constructed in a precise manner; templating, ordered structures in bioengineered materials are often propagated from one element or set of instructions, to another; specific and non-specific interactions, the forces involved in holding biomaterials structures together. In the future, a carefully selected combination of this set of characteristics will enable us to bioengineer surfaces that are capable to direct and control a desired biological response. Eventually, such bioengineered surfaces will become important tools to comprehend and analyze how materials interact in nature. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Calif Santa Barbara, Coll Engn, Off Dean Engn, Dept Chem Engn, Santa Barbara, CA 93106 USA.
   Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA.
RP Tirrell, M (reprint author), Univ Calif Santa Barbara, Coll Engn, Off Dean Engn, Dept Chem Engn, Santa Barbara, CA 93106 USA.
RI Kokkoli, Efrosini/J-1656-2015
OI Kokkoli, Efrosini/0000-0001-7783-0158
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Anderson James M., 1996, P165
   Andrade JD, 1996, ADV CHEM SER, V248, P51
   Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019
   Biesalski M, 1999, MACROMOLECULES, V32, P2309, DOI 10.1021/ma980628i
   Bongrand P., 1984, CELL SURFACE DYNAMIC, P459
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Boxer SG, 2000, CURR OPIN CHEM BIOL, V4, P704, DOI 10.1016/S1367-5931(00)00139-3
   BRASH JL, 1987, ADV S SER ACS, V343
   Britland S, 1996, EXP BIOL ONLINE, V1, P2
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CHENG S, 1994, J MED CHEM, V37, P1, DOI 10.1021/jm00027a001
   CHO CS, 1993, J BIOMED MATER RES, V27, P199, DOI 10.1002/jbm.820270209
   Clark RAF, 1996, MOL CELLULAR BIOL WO
   CLARKE KI, 1993, J MATER SCI-MATER M, V4, P107, DOI 10.1007/BF00120378
   Costa N, 1998, MED ENG PHYS, V20, P602, DOI 10.1016/S1350-4533(98)00056-3
   Cui F. Z., 1996, Cells and Materials, V6, P31
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Denyer MCT, 1999, IN VITRO CELL DEV-AN, V35, P352
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Dillow AK, 1998, CURR OPIN SOLID ST M, V3, P252, DOI 10.1016/S1359-0286(98)80099-5
   Dori Y, 2000, J BIOMED MATER RES, V50, P75, DOI 10.1002/(SICI)1097-4636(200004)50:1<75::AID-JBM11>3.0.CO;2-A
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Duschl C, 1996, MAT SCI ENG C-BIOMIM, V4, P7, DOI 10.1016/0928-4931(95)00123-9
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7
   EVANS E, 1988, J FLUID MECH, V194, P553, DOI 10.1017/S0022112088003106
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   FLEER GJ, 1993, POLYM INTERFACES
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   Folch A, 1998, BIOTECHNOL PROGR, V14, P388, DOI 10.1021/bp980037b
   GALLIN JI, 1999, INFLAMMATION BASIC P
   Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651
   Gyorvary E, 1999, LANGMUIR, V15, P1337, DOI 10.1021/la980827v
   Hammer DA, 1996, ANNU REV MATER SCI, V26, P651
   HANCOX NM, 1972, BIOL BONE
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   HAUTANEN A, 1989, J BIOL CHEM, V264, P1437
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HICKMAN JJ, 1994, J VAC SCI TECHNOL A, V12, P607, DOI 10.1116/1.578844
   HOCH HC, 1996, NANOFABRICATION BIOS
   HORBETT TA, 1995, ADV S SER ACS, V602
   HORN RG, 1984, BIOCHIM BIOPHYS ACTA, V778, P224, DOI 10.1016/0005-2736(84)90466-8
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9
   HUMPHRIES MJ, 1990, J CELL SCI, V97, P585
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kirkpatrick CJ, 1999, J MATER SCI-MATER M, V10, P589, DOI 10.1023/A:1008946615663
   Klee D, 1999, ADV POLYM SCI, V149, P1
   KLEIN J, 1995, SCIENCE, V269, P816, DOI 10.1126/science.269.5225.816
   Klein J, 1996, ANNU REV MATER SCI, V26, P581, DOI 10.1146/annurev.ms.26.080196.003053
   Kokkoli E, 2001, LANGMUIR, V17, P369, DOI 10.1021/la0006059
   Kokkoli E, 1998, LANGMUIR, V14, P1189, DOI 10.1021/la970944a
   Kokkoli E, 1999, J COLLOID INTERF SCI, V209, P60, DOI 10.1006/jcis.1998.5862
   Kunz R, 1999, J MATER SCI-MATER M, V10, P649, DOI 10.1023/A:1008943909728
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lauffenburger DA, 1993, RECEPTORS MODELS BIN
   Lawson AC, 1998, P I MECH ENG H, V212, P413, DOI 10.1243/0954411981534187
   LEE JS, 1993, BIOMATERIALS, V14, P958, DOI 10.1016/0142-9612(93)90139-S
   Lehmann T, 1999, MACROMOL SYMP, V142, P1, DOI 10.1002/masy.19991420103
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   Logeart-Avramoglou D, 1999, J BIOMED MATER RES, V48, P578, DOI 10.1002/(SICI)1097-4636(1999)48:4<578::AID-JBM26>3.0.CO;2-8
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LUCKHAM PF, 1994, ADV COLLOID INTERFAC, V49, P341, DOI 10.1016/0001-8686(94)80019-7
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Majewski J, 1998, BIOPHYS J, V75, P2363, DOI 10.1016/S0006-3495(98)77680-5
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   MOULD AP, 1991, J BIOL CHEM, V266, P3579
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Napper DH, 1983, STERIC STABILIZATION
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   Pakalns T, 1999, BIOMATERIALS, V20, P2265, DOI 10.1016/S0142-9612(99)00157-X
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Parikh AN, 1999, LANGMUIR, V15, P5369, DOI 10.1021/la9813679
   PARNAS RS, 1994, RHEOL ACTA, V33, P485, DOI 10.1007/BF00366334
   Patel N, 1998, FASEB J, V12, P1447
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Plant AL, 1999, LANGMUIR, V15, P5128, DOI 10.1021/la981662t
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   PRASS W, 1987, BIOCHIM BIOPHYS ACTA, V900, P116, DOI 10.1016/0005-2736(87)90283-5
   Prucker O, 1998, MACROMOLECULES, V31, P592, DOI 10.1021/ma970660x
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Puu G, 1997, BBA-BIOMEMBRANES, V1327, P149, DOI 10.1016/S0005-2736(97)00052-7
   RATNER BD, 1996, BIOAMTERIALS INTRO M
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruhe J, 1999, J BIOMAT SCI-POLYM E, V10, P859, DOI 10.1163/156856299X00928
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Sackmann E, 2000, TRENDS BIOTECHNOL, V18, P58, DOI 10.1016/S0167-7799(99)01412-2
   Saneinejad S, 2000, J BIOMED MATER RES, V50, P465, DOI 10.1002/(SICI)1097-4636(20000615)50:4<465::AID-JBM1>3.3.CO;2-B
   Sarikaya M., 1995, BIOMIMETICS DESIGN P
   SAUTIER JM, 1991, CELL MATER, V1, P209
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schneider J, 1998, THIN SOLID FILMS, V327, P772, DOI 10.1016/S0040-6090(98)00784-6
   Schneider J, 1998, J AM CHEM SOC, V120, P3508, DOI 10.1021/ja972779r
   SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070
   Sprossler C, 1999, PHYS REV E, V60, P2171, DOI 10.1103/PhysRevE.60.2171
   Steinem C, 1996, BBA-BIOMEMBRANES, V1279, P169, DOI 10.1016/0005-2736(95)00274-X
   Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384
   Szleifer I, 2000, MACROMOL RAPID COMM, V21, P423, DOI 10.1002/(SICI)1521-3927(20000501)21:8<423::AID-MARC423>3.0.CO;2-J
   TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0
   UCHIDA M, 1991, MACROMOLECULES, V24, P3238, DOI 10.1021/ma00011a031
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   Vijayendran R, 1998, J CHEM PHYS, V108, P7783, DOI 10.1063/1.476214
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401
   VUKICEVIC S, 1990, CELL, V63, P437, DOI 10.1016/0092-8674(90)90176-F
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   WANG RZ, 1995, J MATER SCI LETT, V14, P498
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1992, FASEB J, V6, P879
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   Wilkinson CDW, 1998, J VAC SCI TECHNOL B, V16, P3132, DOI 10.1116/1.590451
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, V4
   Winger TM, 1996, BIOMATERIALS, V17, P437, DOI 10.1016/0142-9612(96)89661-X
   Wong JY, 1999, BIOPHYS J, V77, P1445, DOI 10.1016/S0006-3495(99)76992-4
   Xu Z, 2000, BIOMATERIALS, V21, P1075, DOI 10.1016/S0142-9612(00)00004-1
   Yang ZH, 1999, LANGMUIR, V15, P8405, DOI 10.1021/la990260y
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1999, BIOCHEMISTRY-US, V38, P1659, DOI 10.1021/bi982315l
   Yu YC, 1997, METHOD ENZYMOL, V289, P571
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   Zaremba CM, 1998, CHEM MATER, V10, P3813, DOI 10.1021/cm970785g
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   ZHURKOV SN, 1965, INT J FRACT MECH, V1, P311
NR 156
TC 342
Z9 347
U1 3
U2 111
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD MAR 10
PY 2002
VL 500
IS 1-3
BP 61
EP 83
AR PII S0039-6028(01)01548-5
DI 10.1016/S0039-6028(01)01548-5
PG 23
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 546YD
UT WOS:000175303400004
DA 2018-10-20
ER

PT J
AU El Feninat, F
   Laroche, G
   Fiset, M
   Mantovani, D
AF El Feninat, F
   Laroche, G
   Fiset, M
   Mantovani, D
TI Shape memory materials for biomedical applications
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Review
ID NICKEL-TITANIUM ALLOY; IN-VIVO BIOCOMPATIBILITY; CRYSTAL-STRUCTURE;
   NITINOL STENT; SURFACE CHARACTERIZATION; MECHANICAL-PROPERTIES;
   CORROSION-RESISTANCE; POLY(L-LACTIC ACID); HIP-ARTHROPLASTY; BREAST
   IMPLANTS
AB Shape memory properties provide a very attractive insight into materials science, opening unexplored horizons and giving access to unconventional functions in every material class (metals, polymers, and ceramics), In this regard, the biomedical field, forever in search of materials that display unconventional properties able to satisfy the severe specifications required by their implantation, is now showing great interest in shape memory materials, whose mechanical properties make them extremely attractive for many biomedical applications. However, their biocompatibility, particularly for long-term and permanent applications, has not yet been fully established and is therefore the object of controversy. On the other hand, shape memory polymers (SMPs) show promise, although thus far, their biomedical applications have been limited to the exploration. This paper will first review the most common biomedical applications of shape memory alloys and SMPs and address their critical biocompatibility concerns. Finally, some engineering implications of their use as biomaterials will be examined.
C1 Univ Laval, Dept Min Met & Mat Engn, St Francois Assise Hosp, Res Ctr, Quebec City, PQ G1K 7P4, Canada.
   Univ Laval, Dept Surg, Quebec City, PQ G1K 7P4, Canada.
   Univ Laval, Dept Min Met & Mat Engn, Quebec City, PQ G1K 7P4, Canada.
RP El Feninat, F (reprint author), Univ Laval, Dept Min Met & Mat Engn, St Francois Assise Hosp, Res Ctr, Pouliot Bldg,Room 1745-E, Quebec City, PQ G1K 7P4, Canada.
EM Diego.Mantovani@gmn.ulaval.ca
CR Acunas B, 1996, RADIOLOGY, V199, P648, DOI 10.1148/radiology.199.3.8637981
   AGRAWAL CM, 1995, BIOMATERIALS, V16, P1255, DOI 10.1016/0142-9612(95)98133-Y
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   AHLERS M, 1986, PROG MATER SCI, V30, P135, DOI 10.1016/0079-6425(86)90007-1
   ANDREASEN GF, 1971, J AM DENT ASSOC, V82, P1373, DOI 10.14219/jada.archive.1971.0209
   ANDREASEN GF, 1978, AM J ORTHOD DENTOFAC, V73, P141
   Asanovic VD, 1999, SHAPE MEMORY ALLOYS: FUNDAMENTALS, MODELING AND INDUSTRIAL APPLICATIONS, P185
   ASHLEY S, 2001, SHAPE SHIFTERS SHAPE
   ASSAD M, 1994, ANN CHIR, V48, P731
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Athanasiou K, 1997, TISSUE ENG, V3, P363, DOI 10.1089/ten.1997.3.363
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   BENSMANN G, 1982, T SOC BIOMATER, V4, P90
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   Bernard D, 1999, SHAPE MEMORY ALLOYS: FUNDAMENTALS, MODELING AND INDUSTRIAL APPLICATIONS, P339
   BEYAR R, 1994, CATHETER CARDIO DIAG, V32, P162, DOI 10.1002/ccd.1810320212
   BHATTACHARYYA A, 2000, J POLYM ENG SCI, V40, P2498
   Black J., 1992, BIOL PERFORMANCE MAT, P38
   Blum U, 1997, NEW ENGL J MED, V336, P13, DOI 10.1056/NEJM199701023360103
   Brennan M, 2001, CHEM ENG NEWS, V79, P5, DOI 10.1021/cen-v079n006.p005
   BRICKNELL RH, 1979, METALL TRANS A, V10, P693, DOI 10.1007/BF02658390
   BROOKS GB, 1972, GOLD BULL, V6, P8
   Buehler WJ, 1968, OCEAN ENGNG, V1, P105
   BURSTONE CJ, 1985, AM J ORTHOD DENTOFAC, V87, P445, DOI 10.1016/0002-9416(85)90083-1
   Carter AJ, 1998, CATHETER CARDIO DIAG, V44, P193, DOI 10.1002/(SICI)1097-0304(199806)44:2<193::AID-CCD13>3.0.CO;2-O
   CARTISLE ES, 2000, TISSUE ENG, V6, P45
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CHANDRA L, 1995, J MATER SCI-MATER M, V6, P581, DOI 10.1007/BF00121282
   CHANG SC, 1991, CLIN CHEM, V37, P2413
   Chen KY, 2000, BIOMATERIALS, V21, P161, DOI 10.1016/S0142-9612(99)00144-1
   CHIODO J, 1999, IEEE INT S EL ENV IS, P151
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   CRAGG A, 1983, RADIOLOGY, V147, P261, DOI 10.1148/radiology.147.1.6828742
   CRAIG RG, 1990, J DENT RES, V69, P1539, DOI 10.1177/00220345900690081801
   CUTRIGHT DE, 1973, ORAL SURG ORAL MED O, V35, P578, DOI 10.1016/0030-4220(73)90017-0
   Dai KR, 1996, BIO-MED MATER ENG, V6, P233
   de Jaegere P P, 1996, Semin Interv Cardiol, V1, P233
   DEURIG T, 1999, MAT SCI ENG A-STRUCT, V273, P149
   DOTTER CT, 1983, RADIOLOGY, V147, P259, DOI 10.1148/radiology.147.1.6828741
   DUERIG TW, 1990, MATER SCI FORUM, V56, P679
   DUGGIN MJ, 1966, ACTA METALL MATER, V14, P123, DOI 10.1016/0001-6160(66)90293-8
   ECHIGO E, 1990, ASAIO T, V36, pM195
   EISENBACH CD, 1982, POLYMERS, V21, P1175
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Endo K, 1995, Dent Mater J, V14, P199
   Endo K, 1995, Dent Mater J, V14, P185
   EVANS EJ, 1986, BIOMATERIALS, V7, P25, DOI 10.1016/0142-9612(86)90084-0
   FONTANA MG, 1986, CORROSION ENG MODERN, P445
   Frenger P, 1993, Biomed Sci Instrum, V29, P47
   GIL FJ, 1996, BIOMED MAT ENG, V6, P153
   Greninger AB, 1938, T AM I MIN MET ENG, V128, P337
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   HAYASHI, 1993, INT PROGR URETHANE, P90
   HAYASHI S, 1992, Patent No. 5135786
   HAYASHI S, 1993, INT PROGR URETHANES, P453
   HEDAYAT A, 1992, J MATER SCI-MATER M, V3, P65, DOI 10.1007/BF00702947
   Hendry JA, 2001, J BIOMED MATER RES, V58, P156, DOI 10.1002/1097-4636(2001)58:2<156::AID-JBM1002>3.3.CO;2-8
   Hester TR, 1997, PLAST RECONSTR SURG, V100, P1291, DOI 10.1097/00006534-199710000-00035
   HIRAI T, 1989, J APPL POLYM SCI, V38, P491, DOI 10.1002/app.1989.070380309
   HIRAI T, 1992, J APPL POLYM SCI, V45, P1849, DOI 10.1002/app.1992.070451019
   HODGSON DE, 1999, SHAPE MEMORY ALLOYS
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Ibim SEM, 1998, J BIOMED MATER RES, V43, P374, DOI 10.1002/(SICI)1097-4636(199824)43:4<374::AID-JBM5>3.0.CO;2-5
   Ibim SM, 1998, BIOMATERIALS, V19, P941, DOI 10.1016/S0142-9612(98)00019-2
   IRIE M, 1990, ADV POLYM SCI, V94, P27
   IRIE M, 1998, SHAPE MEMORY MAT, P203
   ISHII M, 1987, DEV SHAPE MEMORY POL, V7, P28
   IWABUCHI T, 1975, J NEUROSURG, V42, P733, DOI 10.3171/jns.1975.42.6.0733
   JACOBSEN N, 1977, SCAND J DENT RES, V85, P567
   Jacoby M, 2001, CHEM ENG NEWS, V79, P30, DOI 10.1021/cen-v079n006.p030
   JAMES EM, 1996, PHYSICAL PROPERTIES, P139
   JOHNSON AD, 1998, STATE OF THE ART SHA
   KHMELEVSKAYA IY, 1994, P 1 INT C SHAP MEM S, P495
   KIMURA H, 1987, DENT MAT APPARATUS, V6, P73
   KOMURO K, 1990, Patent No. 366486
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   KUDOH Y, 1985, ACTA METALL MATER, V33, P2049, DOI 10.1016/0001-6160(85)90128-2
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LAM CWH, 1997, P 2 INT C SHAP MEM S, P101
   LANGER RS, 2000, Patent No. 6160084
   Leininger R. I., 1986, HDB BIOMATERIALS EVA, P24
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LI C, 1994, P 1 INT C SHAP MEM S, P227
   Liang C, 1997, J INTEL MAT SYST STR, V8, P380, DOI 10.1177/1045389X9700800411
   LIU M, 1990, MATER SCI FORUM, V56, P311
   LOMBARDI S, 1995, THESIS ECOLE POLYTEC
   LOMBARDI S, 1994, P 1 INT C SHAP MEM S
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   Ma PX, 1995, MATER RES SOC SYMP P, V394, P99, DOI 10.1557/PROC-394-99
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   Mantovani D, 2000, JOM-J MIN MET MAT S, V52, P36, DOI 10.1007/s11837-000-0082-4
   MARTYNOV VV, 1983, PHYS MET METALLOGR, V55, P136
   MATSUKI T, 1990, SHAPE MEMORY THERMOP
   MATSUMOTO K, 1993, J JPN ORTHOP ASSOC, V67, P267
   MERCIER O, 1979, METALL T A, V10, P357
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MIYAZAKI S, 1982, J PHYS S12, V43, P225
   MOORLEGHEM WV, 1998, BIOMED MAT RES, V8, P55
   MORSE EE, 1977, ANN CLIN LAB SCI, V7, P17
   MULLER JM, 1990, BRIT J SURG, V77, P845, DOI 10.1002/bjs.1800770804
   Musialek J, 1998, ARCH ORTHOP TRAUM SU, V117, P341, DOI 10.1007/s004020050262
   NODA Y, 1990, MATERIALS SCI FORUM, V56, P299
   Oesterle SN, 1998, AM HEART J, V136, P578, DOI 10.1016/S0002-8703(98)70004-3
   OHBA T, 1990, MATER T JIM, V31, P12, DOI 10.2320/matertrans1989.31.12
   OHNISHI H, 1983, ARTIF ORGANS, V12, P862
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   Okuyama M, 1995, BIOMATER LIVING SYST, V3, P145
   Olander A, 1932, Z KRISTALLOGR, V83, P145
   Oonishi H, 2001, J BIOMED MATER RES, V58, P167, DOI 10.1002/1097-4636(2001)58:2<167::AID-JBM1003>3.3.CO;2-1
   OONISHI H, 1984, T SOC BIOMATER, V7, P183
   OOSAWA T, 1993, Patent No. 05305666
   OSHURA Y, 1984, J JPN ORTHOD SOC, V43, P71
   OTSUKA K, 1998, SHAPE MEMORY MAT, P149
   Palmaz JC, 1997, TEX HEART I J, V24, P156
   PALMAZ JC, 1993, AM J ROENTGENOL, V160, P613, DOI 10.2214/ajr.160.3.8430566
   Patrick C.W.J., 1998, FRONTIERS TISSUE ENG, P369
   PATRICK CW, 1998, FRONTIER TISSUE ENG, P700
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   RASHKIND WJ, 1987, CIRCULATION, V75, P583, DOI 10.1161/01.CIR.75.3.583
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   RAYNOR GV, 1976, GOLD BULL, V9, P50
   Rechavia E, 1998, CATHETER CARDIO DIAG, V45, P202, DOI 10.1002/(SICI)1097-0304(199810)45:2<202::AID-CCD20>3.0.CO;2-L
   RHYANEN J, 1999, THESIS OULU U FINLAN
   RICART O, 1997, SHAPE MEMORY SUPEREL, P623
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   Ryhanen J, 1998, J BIOMED MATER RES, V41, P481, DOI 10.1002/(SICI)1097-4636(19980905)41:3<481::AID-JBM19>3.0.CO;2-L
   SABURI T, 1986, J LESS-COMMON MET, V118, P217, DOI 10.1016/0022-5088(86)90171-2
   Saburi T, 1998, SHAPE MEMORY MAT, P49
   SACHDEVA R, 1990, MATER SCI FORUM, V56, P693
   SACHDEVA RCL, 1992, ENG ASPECT SHAPE MEM, P452
   SAKAMOTO H, 1990, MATER SCI FORUM, V56, P305
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Schwarzenberg H, 1998, AM J ROENTGENOL, V170, P1181, DOI 10.2214/ajr.170.5.9574580
   SEKIGUCHI Y, 1987, APPL SHAPE MEMORY AL, P226
   SEPAI O, 1995, TOXICOL LETT, V77, P371, DOI 10.1016/0378-4274(95)03320-3
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   SHABALOVSKAYA SA, 1995, J VAC SCI TECHNOL A, V13, P2624, DOI 10.1116/1.579461
   SHABAOVSKY S, 1994, P 1 INT C SHAP MEM S
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B
   Shih CC, 2000, J BIOMED MATER RES, V52, P323
   SHIRAI Y, 1988, TECHNICAL B, V184, P1
   SHRIER LL, 1995, CORROSION METAL ENV, P3
   SHUGO Y, 1990, MATER SCI FORUM, V56, P631
   Silvaggio J, 1997, J ENDODONT, V23, P731, DOI 10.1016/S0099-2399(97)80344-5
   SILVER JH, 1993, J BIOMED MATER RES, V27, P1443, DOI 10.1002/jbm.820271111
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   SUNDERMAN FW, 1978, FED PROC, V37, P40
   SUNDERMAN FW, 1976, CANCER RES, V36, P1790
   TABRIZIAN M, 1996, ON DAY SEM SHAP MEM
   TADAKI T, 1978, ACTA METALL MATER, V26, P883, DOI 10.1016/0001-6160(78)90038-X
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   TAKEI S, 1989, DEV APPL SHAPE MEMOR, P11
   Thierry B, 2000, J BIOMED MATER RES, V49, P88, DOI 10.1002/(SICI)1097-4636(200001)49:1<88::AID-JBM11>3.0.CO;2-I
   TOBOLSKY AV, 1971, POLYM SCI MAT, P214
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   Trepanier C, 1999, J BIOMED MATER RES, V48, P165, DOI 10.1002/(SICI)1097-4636(1999)48:2<165::AID-JBM11>3.0.CO;2-#
   Uo M, 2001, BIOMATERIALS, V22, P677, DOI 10.1016/S0142-9612(00)00230-1
   VANHUMBEECK J, 1985, P ASM MAT WEEK TMS A, P5
   Venugopalan R, 1999, J BIOMED MATER RES, V48, P829, DOI 10.1002/(SICI)1097-4636(1999)48:6<829::AID-JBM10>3.0.CO;2-#
   Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1
   Villermaux F, 1997, APPL SURF SCI, V109, P62, DOI 10.1016/S0169-4332(96)00619-8
   Villermaux F, 1996, BIO-MED MATER ENG, V6, P241
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   WATAHA JC, 1991, J BIOMED MATER RES, V25, P1133, DOI 10.1002/jbm.820250907
   WATANABE H, 1988, BLOCK COPOLYMERS SHA
   WEBB M, 1972, BRIT J CANCER, V26, P292, DOI 10.1038/bjc.1972.39
   Wen XJ, 1997, BIO-MED MATER ENG, V7, P1
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   WILLIAMS DF, 1981, TOXICITY IMPLANTED M, P45
   WORRELL FT, 1948, J APPL PHYS, V19, P929, DOI 10.1063/1.1697898
   YAHIA L, 1999, 38 ANN C MET CIM SHA, P383
   Yahia LH, 1996, MED PROG TECHNOL, V21, P187, DOI 10.1023/A:1016985212314
   YAMAURA K, 1987, J APPL POLYM SCI, V34, P2347, DOI 10.1002/app.1987.070340701
   YE J, 1990, METALL TRANS A, V21, P2669, DOI 10.1007/BF02646062
   YOSHIZAWA H, 1985, DENT IMPLANT, V10, P12
   YOSHTSUGU H, 1992, Patent No. 04100853
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 186
TC 185
Z9 187
U1 4
U2 144
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD MAR
PY 2002
VL 4
IS 3
BP 91
EP 104
DI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA 540KX
UT WOS:000174929100006
DA 2018-10-20
ER

PT J
AU Marques, AP
   Reis, RL
   Hunt, JA
AF Marques, AP
   Reis, RL
   Hunt, JA
TI The biocompatibility of novel starch-based polymers and composites: in
   vitro studies
SO BIOMATERIALS
LA English
DT Article
DE bicompatibility; starch-based polymers; biodegradable polymers; cell
   adhesion; cytotoxicity
ID IN-VITRO; CELL-CULTURES; SURFACES; BIOMATERIALS; POLYSTYRENE; PLASMA;
   GROWTH; ASSAY
AB Studies with biodegradable starch-based polymers have recently demonstrated that these materials have a range of properties, which make them suitable for use in several biomedical applications, ranging from bone plates and screws to drug delivery carriers and tissue engineering scaffolds.
   The aim of this study was to screen the cytotoxicity and evaluate starch-based polymers and composites as potential biomaterials. The biocompatibility of two different blends of corn-starch, starch/ethylene vinyl alcohol (SEVA-C) and starch/cellulose acetate (SCA), and their respective composites with hydroxyapatite (HA) was assessed by cytotoxicity and cell adhesion tests. The MTT assay was performed with the extracts of the materials in order to evaluate the short-term effect of the degradation products. The cell morphology of L929 mouse fibroblast cell line was also analysed after direct contact with polymers and composites for different time periods and the number of cells adhered to the surface of the polymers was determined by quantification of the cytosolic lactate dehydrogenase (LDH) activity.
   Both types of starch-based polymers exhibit a cytocompatibility that might allow for their use as biomaterials. SEVA-C blends were found to be the less cytotoxic for the tested cell line, although cells adhere better to SCA surface. The cytotoxicity test also revealed that SCA and SEVA-C composites have a similar response to the one obtained for SCA polymer. Scanning electron microscopy (SEM) analysis showed that cells were much more spread on the SCA polymer and LDH measurements showed a higher number of cells on this surface. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Minho, Dept Polymer Engn, P-4710057 Braga, Portugal.
   Univ Liverpool, Dept Clin Engn, Liverpool L69 3BX, Merseyside, England.
RP Marques, AP (reprint author), Univ Minho, Dept Polymer Engn, Campus Gualtar, P-4710057 Braga, Portugal.
RI Hunt, John/G-6366-2012; Marques, Alexandra/B-1238-2012; Group,
   3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Hunt, John/0000-0002-5168-4778; Marques, Alexandra/0000-0002-3222-0310;
   Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129
CR Allen Matthew, 1994, Clinical Materials, V16, P189, DOI 10.1016/0267-6605(94)90116-3
   *ASTM, 1983, 81383 ASTM F
   BRUNETTE DM, 1999, J BOMECH ENG, V121, P149
   CIAPETTI G, 1994, BIOMATERIALS, V15, P92, DOI 10.1016/0142-9612(94)90256-9
   CIAPETTI G, 1994, BIOMATERIALS, V15, P63, DOI 10.1016/0142-9612(94)90199-6
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P403, DOI 10.1002/jbm.820150311
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   *ISO EN, 1992, 109935 ISOEN 5
   ITO Y, 1997, BIOMATERIALS, V8, P464
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   MALAFAYA PB, 1999, 15 EUR C BIOM BORD F, P325
   Marois Y, 1996, BIOMATERIALS, V17, P1835, DOI 10.1016/0142-9612(95)00245-6
   Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.3.CO;2-9
   Reis RL, 1997, POLYM INT, V43, P347
   REIS RL, 1997, BIOCERAMICS, V10, P515
   REIS RL, 1998, ANTEC 98, P487
   REIS RL, 1996, PLASTICS MED SURG PI, P195
   RICHTER HG, 1981, NATURWISSENSCHAFTEN, V5, P1
   ROSEN JJ, 1980, POLYM SCI TECHNOL B, V12, P667
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VANLUYN MJA, 1991, J MATER SCI-MATER M, V2, P142, DOI 10.1007/BF00692972
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vaz CM, 2001, MATER RES INNOV, V4, P375, DOI 10.1007/s100190000112
   Williams D. F., 1986, MATER RES SOC S P, V55, P117
   WILLIAMS DF, 1992, J MAT SCI TECHNOL CO, P1
   WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210
NR 34
TC 232
Z9 247
U1 4
U2 101
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2002
VL 23
IS 6
BP 1471
EP 1478
DI 10.1016/S0142-9612(01)00272-1
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 515EC
UT WOS:000173481600009
PM 11829443
DA 2018-10-20
ER

PT J
AU Shutov, F
   Ananthanarayan, VT
AF Shutov, F
   Ananthanarayan, VT
TI Cellular UHMW polyethylene produed by non-foaming leaching technique:
   Morphology and properties
SO JOURNAL OF CELLULAR PLASTICS
LA English
DT Article
AB The objective of the research was to develop and study the properties of cellular or porous Ultra High Molecular Weight (UHMW) Polyethylene for biomedical applications. The process, based on the leaching technique, does not require any modification in processing equipment, is environment-friendly and uses raw materials approved by the FDA for in vivo medical applications. It is possible to produce porous polymers having predetermined pore size, pore shape and porosity using the leaching technique. The pores are interconnected and well-distributed throughout the three-dimensional volume of the sample. The size, shape and content of the porogen in the molding mixture greatly affect the physical properties of the pores in the final porous sample. Maximum porosity of 60% was obtained. The developed porous UHMW Polyethylene, which is permeable by liquids, can be used as a substrate matrix in bone regeneration and in hip- and knee joint replacements. With adequate lubrication, the porous implants would prevent the formation of polymer debris due to friction and thereby increase the life of the biomedical implants. The new generation of developed porous polymers could be used in a wide range of medical and bioengineering applications.
C1 Univ Minnesota, Dept Chem Engn, Duluth, MN 55812 USA.
   Tennessee Technol Univ, Dept Chem Engn, Cookeville, TN 38505 USA.
RP Shutov, F (reprint author), Univ Minnesota, Dept Chem Engn, Duluth, MN 55812 USA.
CR AGRAWAL MC, 1995, ENCY HDB BIOMATERI B, V1, P1759
   ANANTHANARAYAN VT, 2000, 2 TENN C BIOM ENG NA
   ANANTHANARAYAN VT, 2000, THESIS
   ANANTHANARAYAN VT, 2000, IMECE2000 ORL FLOR
   BANKSTON AB, 1995, CLIN ORTHOP RELAT R, P37
   COLLIER JP, 1991, CLIN ORTHOP RELAT R, P232
   MCCUTCHEN CW, 1959, NATURE, P184
   MENARD HW, 1973, BIOL GEOLOGY CORAL R, P1
   NETTER FH, 1996, ATLAS HUMAN ANATOMY
   SHUTOV FA, 1991, POLYM FOAMS
   SHUTOV FA, 1995, T 2 COMB M ORTH RES
   WEIGHTMAN B, 1991, J BONE JOINT SURG BR, V73, P806
NR 12
TC 6
Z9 8
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 0021-955X
J9 J CELL PLAST
JI J. Cell. Plast.
PD MAR
PY 2002
VL 38
IS 2
BP 163
EP 176
DI 10.1106/002195502022247
PG 14
WC Chemistry, Applied; Polymer Science
SC Chemistry; Polymer Science
GA 541BF
UT WOS:000174964800006
DA 2018-10-20
ER

PT J
AU Miclea, C
   Tanasoiu, C
   Miclea, CF
   Tanasoiu, V
AF Miclea, C
   Tanasoiu, C
   Miclea, CF
   Tanasoiu, V
TI Advanced electroceramic materials for electrotechnical applications
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE electroceramics; cobalt manganites; barium titanate; PZT
ID ULTRASONIC MOTORS; LOW-TEMPERATURE; CERAMICS; TITANATE
AB Advanced electroceramics have played a critical role in the development of new and modem technologies such as computers, telecomunications and aerospace and they will continue to play the leading role in the technology of the future. The present report presents and discusses a number of advanced electroceramic materials with special references to their specific properties that make them indispensable in a large area of applications. The materials discussed include cobalt-mangan oxides used as negative temperature coefficient thermistors, semiconducting doped barium titanate used for positive temperature coefficient thermistors with large applications in thermal protections and piezoelectric electroceramics of PZT type, which find new application as ceramic transducers and sensors in biomedical and aerospace industries or as simply buzzers, filters, igniters, ultrasonic cleaners, towed array sonars, medical imaging system, ink-jet printing heads, camera shuttlers, positioners for optical systems, micromotors and actuators. Such advanced electroceramic materials are extremely useful for the future sophisticated technologies such as heads for magnetic recording, scanning tunneling microscope, sensors for antilock braking systems, ultrasonic bone-healing devices and some other biomedical applications.
C1 Natl Inst Mat Phys, Bucharest 76900, Romania.
RP Miclea, C (reprint author), Natl Inst Mat Phys, Str Atomistilor 105 Bis,POB MG 7, Bucharest 76900, Romania.
RI Miclea, Corneliu Florin/R-8783-2017; Miclea, Corneliu
   Florin/C-5047-2011; Miclea, Cornel/B-7774-2011
OI Miclea, Corneliu Florin/0000-0002-7414-3173; 
CR ANDRICH E, 1970, BER DTSCH KERAM GES, V47, P639
   ASHIDA T, 1966, JPN J APPL PHYS, V5, P269, DOI 10.1143/JJAP.5.269
   BRAHMECHA BG, 1971, JPN J APPL PHYS, V10, P496, DOI 10.1143/JJAP.10.496
   BRAUER H, 1967, Z ANGEW PHYSIK, V23, P373
   BRAUNER H, 1970, Z ANGEN PHYS, V24, P282
   BURN I, 1975, J MATER SCI, V10, P633, DOI 10.1007/BF00566571
   DANIELS J, 1976, PHILIPS RES REP, V31, P487
   Dong D., 1993, FERROELECTRICS, V145, P125
   GOODMAN G, 1963, J AM CERAM SOC, V46, P48, DOI 10.1111/j.1151-2916.1963.tb13770.x
   Haaijman P. W., 1955, German Patent., Patent No. 929350
   HAGEDORN P, 1993, J SOUND VIB, V168, P115, DOI 10.1006/jsvi.1993.1364
   HAYWANG W, 1971, AM CER B, V50, P676
   HAYWANG W, 1971, J MATER SCI, V6, P1214
   Haywang W, 1961, SOLID STATE ELECTRON, V3, P51
   HAYWANG W, 1974, FERROELECTRICS, V7, P361
   IKUSHIMA H, 1965, JPN J APPL PHYS, V4, P328, DOI 10.1143/JJAP.4.328
   JAFFE B, 1954, J APPL PHYS, V25, P808
   JAFFE B, 1971, PIEZOELECTRIC CERAMI, P259
   JONKER GH, 1964, SOLID STATE ELECTRON, V7, P895, DOI 10.1016/0038-1101(64)90068-1
   JONKER GH, 1967, MATER RES BULL, V2, P401, DOI 10.1016/0025-5408(67)90079-7
   KAHN M, 1971, J AM CERAM SOC, V54, P455, DOI 10.1111/j.1151-2916.1971.tb12384.x
   KAINZ J, 1958, BER DEUT KERAM GES, V35, P69
   Kumada A., 1985, Japanese Journal of Applied Physics, Supplement, P739
   KUMADA A, 1991, Patent No. 5008581
   KUMADA A, 1987, Patent No. 4642509
   KUMADA A, 1989, Patent No. 4868446
   KURIBAYASHI M, 1985, J ACOUST SOC AM, V77, P1431, DOI 10.1121/1.392037
   LONGTS L, 1990, FERROELECTRICS, V101, P193
   MACCHESNEY JB, 1965, J AM CERAM SOC, V48, P81, DOI 10.1111/j.1151-2916.1965.tb11804.x
   MACCHESNEY JB, 1963, J AM CERAM SOC, V46, P197, DOI 10.1111/j.1151-2916.1963.tb19771.x
   NICOLAU P, 1979, AUTOM ELECT, V23, P20
   OHATKA O, 1995, J AM CERAM SOC, V78, P805
   RASE DE, 1955, J AM CERAM SOC, V38, P102
   SABURI O, 1959, J PHYS SOC JPN, V14, P1159, DOI 10.1143/JPSJ.14.1159
   SABURI O, 1961, J AM CERAM SOC, V44, P54, DOI 10.1111/j.1151-2916.1961.tb15350.x
   SASHIDA T, 1993, PHYS STATUS SOLIDI, V31, P121
   SCHMELZ H, 1969, PHYS STATUS SOLIDI, V31, P121, DOI 10.1002/pssb.19690310114
   SCHONER HP, 1992, EUR T ELECTR POW, V2, P367
   Shashida T., 1985, U. S. Patent, Patent No. [4,562,374, 4562374]
   SWIGGARD EM, 1966, AM CERAM SOC BULL, V45, P777
   TAKAHASHI S, 1980, JPN J APPL PHYS, V19, P771, DOI 10.1143/JJAP.19.771
   TAKANO T, 1989, JPN J APPL PHYS 1, V28, P202, DOI 10.7567/JJAPS.28S2.202
   TENNERY VJ, 1961, J AM CERAM SOC, V44, P187, DOI 10.1111/j.1151-2916.1961.tb13742.x
   TIEN TY, 1963, J AM CERAM SOC, V46, P297, DOI 10.1111/j.1151-2916.1963.tb11732.x
   TOMIKAWA Y, 1988, JPN J APPL PHYS 1, V27, P195, DOI 10.7567/JJAPS.27S1.195
   UDA S, 1993, JPN J APPL PHYS, V10, P496
   UEDA I, 1965, J PHYS SOC JPN, V20, P46
   WAKU S, 1967, REV ELEC COMMUN LAB, V15, P689
   WALLASCHEK J, 1995, J INTEL MAT SYST STR, V6, P71, DOI 10.1177/1045389X9500600110
   WITTMER DE, 1981, J AM CERAM SOC, V64, P485, DOI 10.1111/j.1151-2916.1981.tb09902.x
   Zhilun G., 1990, FERROELECTRICS, V101, P93
NR 51
TC 2
Z9 2
U1 2
U2 6
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD MAR
PY 2002
VL 4
IS 1
BP 51
EP 58
PG 8
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 534NR
UT WOS:000174592900008
DA 2018-10-20
ER

PT J
AU Ortelli, D
   Rudaz, S
   Souverain, S
   Veuthey, JL
AF Ortelli, D
   Rudaz, S
   Souverain, S
   Veuthey, JL
TI Restricted access materials for fast analysis of methadone in serum with
   liquid chromatography-mass spectrometry
SO JOURNAL OF SEPARATION SCIENCE
LA English
DT Article
DE methadone; restricted access materials; LC-MS; on-line sample
   preparation; direct injection; column switching
ID SOLID-PHASE EXTRACTION; COLUMN-SWITCHING TECHNIQUES; GAS-CHROMATOGRAPHY;
   BIOMEDICAL ANALYSIS; SAMPLE PREPARATION; STEREOSELECTIVE DETERMINATION;
   INTERINDIVIDUAL VARIABILITY; CAPILLARY ELECTROPHORESIS; ENANTIOSELECTIVE
   ANALYSIS; PRIMARY METABOLITE
AB Restricted access materials (RAM) which allow direct injection of biological fluids in a chromatographic system were evaluated for the direct analysis of methadone (MTD) in serum by liquid chromatography (LC) and mass spectrometry (MS). Two methods were developed for the determination of methadone and its major metabolite, EDDP, in serum samples in a concentration range of 10 to 500 ng mL(-1). The first method used the single column approach with a Pinkerton GFF 11 (100 x 2.1 mm ID) analytical column. In this mode, the column is the same for the sample preparation and the analysis. The total analysis time was less than 15 min with a limit of quantification of 10 ng mL(-1). At this level, repeatability values were 11.8% and 15.8% for MTD and EDDP, respectively. The second method used a column-switching device. A RP-4 ADS (25 x 2 mm ID) precolumn was coupled to a LC column and achieved a total analysis time of less than 8 minutes. At the LOO, repeatability values were 3.2% and 7.6% for MTD and EDDP, respectively. Compared to a classical liquid-liquid extraction, RAM proved to be very convenient stationary phases. Both methods a gave short analysis time with a minimum of sample handling and allowed quantitative determination of MTD and EDDP in serum.
C1 Univ Geneva, Lab Pharmaceut Analyt Chem, CH-1211 Geneva 4, Switzerland.
RP Veuthey, JL (reprint author), Univ Geneva, Lab Pharmaceut Analyt Chem, Bd Yvoy 20, CH-1211 Geneva 4, Switzerland.
CR BECK O, 1991, J CHROMATOGR-BIOMED, V570, P198, DOI 10.1016/0378-4347(91)80216-Y
   BECK O, 1990, THER DRUG MONIT, V12, P473, DOI 10.1097/00007691-199009000-00011
   Boos KS, 1997, LC GC-MAG SEP SCI, V15, P602
   CAMPINSFALCO P, 1993, J CHROMATOGR-BIOMED, V619, P177, DOI 10.1016/0378-4347(93)80107-F
   Chapuzet E., 1997, STP PHARM PRATIQUES, V7, P169
   DEVOS JW, 1995, EUR J CLIN PHARMACOL, V48, P361, DOI 10.1007/BF00194951
   Doerge DR, 2000, RAPID COMMUN MASS SP, V14, P673, DOI 10.1002/(SICI)1097-0231(20000430)14:8<673::AID-RCM935>3.3.CO;2-6
   Eap CB, 1998, ARCH GEN PSYCHIAT, V55, P89, DOI 10.1001/archpsyc.55.1.89
   Eap CB, 1996, EUR J CLIN PHARMACOL, V50, P385, DOI 10.1007/s002280050128
   Fried K, 1997, J CHROMATOGR B, V689, P91, DOI 10.1016/S0378-4347(96)00400-8
   Frost M, 1997, ELECTROPHORESIS, V18, P1026, DOI 10.1002/elps.1150180627
   HAGESTAM IH, 1985, ANAL CHEM, V57, P1757, DOI 10.1021/ac00285a058
   HAGINAKA J, 1991, TRAC-TREND ANAL CHEM, V10, P17, DOI 10.1016/0165-9936(91)85040-X
   Hennion MC, 1999, J CHROMATOGR A, V856, P3, DOI 10.1016/S0021-9673(99)00832-8
   Hogendoorn EA, 1998, ANAL CHEM, V70, P1362, DOI 10.1021/ac971030w
   Hoja H, 1997, J ANAL TOXICOL, V21, P116, DOI 10.1093/jat/21.2.116
   Hsieh YS, 2000, RAPID COMMUN MASS SP, V14, P1384, DOI 10.1002/1097-0231(20000815)14:15<1384::AID-RCM32>3.0.CO;2-#
   INTURRISI CE, 1972, J CHROMATOGR, V65, P361, DOI 10.1016/S0021-9673(00)92558-5
   KANG GI, 1982, J CHROMATOGR, V231, P311, DOI 10.1016/S0378-4347(00)81856-3
   Kintz P, 1997, J FORENSIC SCI, V42, P291
   KINTZ P, 1990, METHOD FIND EXP CLIN, V12, P193
   Kintz P, 1998, THER DRUG MONIT, V20, P35, DOI 10.1097/00007691-199802000-00007
   KRISTENSEN K, 1994, J CHROMATOGR A, V666, P283, DOI 10.1016/0021-9673(94)80390-0
   Kristensen K, 1996, THER DRUG MONIT, V18, P221, DOI 10.1097/00007691-199606000-00001
   Lee MS, 1997, LC GC-MAG SEP SCI, V15, P542
   Majors RE, 1996, LC GC-MAG SEP SCI, V14, P554
   Maurer HH, 1998, J CHROMATOGR B, V713, P3, DOI 10.1016/S0378-4347(97)00514-8
   MCDOWALL RD, 1989, J CHROMATOGR-BIOMED, V492, P3, DOI 10.1016/S0378-4347(00)84463-1
   MOLTENI S, 1994, J CHROMATOGR B, V658, P355, DOI 10.1016/0378-4347(94)00249-5
   Nedved ML, 1996, ANAL CHEM, V68, P4228, DOI 10.1021/ac9603035
   Nishikawa M, 1998, J TOXICOL-TOXIN REV, V17, P13, DOI 10.3109/15569549809006487
   NORRIS RLG, 1994, J CHROMATOGR B, V661, P346, DOI 10.1016/0378-4347(94)00341-6
   Ortelli D, 2000, J CHROMATOGR A, V871, P163, DOI 10.1016/S0021-9673(99)01001-8
   PIERCE TL, 1992, J CHROMATOGR SCI, V30, P443, DOI 10.1093/chromsci/30.11.443
   PIERCE TL, 1994, PHARMACOL BIOCHEM BE, V49, P1101, DOI 10.1016/0091-3057(94)90271-2
   PINKERTON TC, 1988, AM LAB, V20, P70
   RAMSTEINER KA, 1988, J CHROMATOGR, V456, P3, DOI 10.1016/0021-9673(86)80002-4
   Rossi DT, 2000, J CHROMATOGR A, V885, P97, DOI 10.1016/S0021-9673(99)00984-X
   Rudaz S, 1997, CHROMATOGRAPHIA, V44, P283, DOI 10.1007/BF02466396
   Rudaz S, 1996, J PHARMACEUT BIOMED, V14, P1271, DOI 10.1016/0731-7085(95)01660-0
   Schafer C, 2001, J CHROMATOGR A, V909, P73, DOI 10.1016/S0021-9673(00)01175-4
   SCHMIDT N, 1993, PHARMACEUT RES, V10, P441, DOI 10.1023/A:1018904825958
   SCHMIDT N, 1992, J CHROMATOGR-BIOMED, V583, P195, DOI 10.1016/0378-4347(92)80552-2
   SHAH VP, 1992, INT J PHARM, V82, P1, DOI 10.1016/0378-5173(92)90065-A
   SHIHABI ZK, 1988, J LIQ CHROMATOGR, V11, P1579, DOI 10.1080/01483918808076722
   SZCZERBA TJ, 1989, RES DEV, V28, P84
   Thormann W, 1998, ELECTROPHORESIS, V19, P57, DOI 10.1002/elps.1150190111
   TURNELL DC, 1989, J CHROMATOGR-BIOMED, V492, P59, DOI 10.1016/S0378-4347(00)84464-3
   UNGER KK, 1991, CHROMATOGRAPHIA, V31, P507, DOI 10.1007/BF02262398
   vanderHoeven RAM, 1997, J CHROMATOGR A, V762, P193, DOI 10.1016/S0021-9673(96)01004-7
   WESTERLUND D, 1987, CHROMATOGRAPHIA, V24, P155, DOI 10.1007/BF02688478
   WOLFF K, 1991, CLIN CHEM, V37, P1297
   WOLFF K, 1993, EUR J CLIN PHARMACOL, V44, P189, DOI 10.1007/BF00315479
   Wolff K, 1997, BRIT J CLIN PHARMACO, V44, P325, DOI 10.1046/j.1365-2125.1997.t01-1-00591.x
   WONG SHY, 1989, J PHARMACEUT BIOMED, V7, P1011, DOI 10.1016/0731-7085(89)80041-X
   Zhou SL, 1996, J CHROMATOGR A, V755, P189, DOI 10.1016/S0021-9673(96)00617-6
NR 56
TC 18
Z9 19
U1 1
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1615-9314
J9 J SEP SCI
JI J. Sep. Sci.
PD MAR
PY 2002
VL 25
IS 4
BP 222
EP 228
DI 10.1002/1615-9314(20020301)25:4<222::AID-JSSC222>3.0.CO;2-#
PG 7
WC Chemistry, Analytical
SC Chemistry
GA 539UQ
UT WOS:000174890400004
DA 2018-10-20
ER

PT J
AU Niinomi, M
AF Niinomi, M
TI Recent metallic materials for biomedical applications
SO METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND
   MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the TMS
CY FEB 11-15, 2001
CL NEW ORLEANS, LOUISIANA
SP TMS
ID CR-MO ALLOYS; MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; CORROSION-FATIGUE;
   IMPLANT MATERIALS; AMORPHOUS-ALLOYS; MARTENSITE; RESISTANCE; STRENGTH;
   DESIGN
AB Metallic biomaterials are mainly used for replacing failed hard tissue. The main metallic biomaterials are stainless steels, Co-based alloys, and titanium and its alloys. Recently, titanium alloys are getting much attention for biomaterials. The various kinds of new high strength alpha + beta and low-modulus beta-type titanium alloys composed of nontoxic elements, such as Nb, Ta, Zr, etc., are developed for biomedical applications because of the toxicity of alloying elements and lack of mechanical biocompatibility of conventional titanium alloys, such as Ti-6Al-4V. Recent research and development in other metallic alloys, such as stainless steels and Co-based alloys, also will be discussed.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RI BAI, JIE/D-7448-2016; Niinomi, Mitsuo/B-5965-2011
CR Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   Akahori T, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P91
   ALABDULLAT Y, 2000, J JAPAN DENT MAT, V19, P95
   *ASTM, 2000, STAND SPEC WROUGHT T, P1071
   *ASTM, 1994, STAND SPEC WROUGHT T, P687
   *ASTM, 2000, STAND SPEC WROUGHT T, P1250
   Berlin RM, 1999, AM SOC TEST MATER, V1365, P62, DOI 10.1520/STP14263S
   BERLIN RM, 1999, ASTM STP, V1365, P89
   Berry G, 1999, AM SOC TEST MATER, V1365, P11, DOI 10.1520/STP14260S
   BHAMBRI SK, 1996, ASTM STP, V1272, P88
   BROWN RS, 2000, 6 WORLD BIOM C KAM H, P828
   Doi H, 1998, J JPN SOC DENT MAT D, V17, P247
   Endo K., 1998, ZAIRYO TO KANKYO, V47, P570
   Eylon D., 1991, METALS HDB, V2, P634
   FUKUI H, 2000, J JAPAN SOC DENT MAT, V19, P49
   Garcia ADJS, 1999, METALL MATER TRANS A, V30, P1177, DOI 10.1007/s11661-999-0267-6
   Gil FX, 1996, J MATER SCI-MATER M, V7, P403, DOI 10.1007/BF00122008
   Gilbert CJ, 1999, METALL MATER TRANS A, V30, P1739, DOI 10.1007/s11661-999-0173-y
   Hiromoto S, 1999, J JPN I MET, V63, P352, DOI 10.2320/jinstmet1952.63.3_352
   Huang P, 1999, MATER SCI TECH-LOND, V15, P157, DOI 10.1179/026708399101505699
   IGUCHI Y, 1999, B ISIJ, V4, P9
   *ISO, 1996, 583210 ISO
   *ISO, 1994, 583211 ISO
   KASUGA T, 2000, BIOMATERIALS, V22, P577
   KATO K, 1997, J JPN SOC DENT MAT D, V16, P45
   KAWAHARA H, 1968, INT DENT J, V18, P443
   KOBAYASHI E, 1995, J J DENT MAT, V14, P321
   Kobayashi E., 1995, J JPN SOC DENT MAT D, V14, P406
   Kuroda D, 2000, TETSU TO HAGANE, V86, P610, DOI 10.2355/tetsutohagane1955.86.9_610
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kyogoku H., 1994, J JPN SOC POWDER POW, V41, P1075
   LEMONS JE, 1986, PERSPECTIVES BIOMATE, P1
   MAJIMA K, 1992, J JPN SOC BIOMATER, V10, P3
   MARUYAMA N, 2000, P ANN M JAP SOC MECH, P433
   MISHRA AK, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P61
   Morita A, 2000, MAT SCI ENG A-STRUCT, V280, P208, DOI 10.1016/S0921-5093(99)00668-1
   NAKAYAMA Y, 1988, P 3 WORLD BIOM C, P202
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 1999, JOM-J MIN MET MAT S, V51, P32, DOI 10.1007/s11837-999-0091-x
   Niinomi M., 2000, FUNCTION MAT, V20, P36
   NISHIMURA T, 1994, METALLURGY AND TECHNOLOGY OF PRACTICAL TITANIUM ALLOYS, P3
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   OKAZAKI Y, 1996, ASTM STP, V1272, P45
   OKUNO O, 1996, J JPN SOC BIOMATER, V14, P267
   Ortiz CR, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P35
   Pan J, 1999, ELEC SOC S, V98, P383
   Papakyriacou M, 2000, INT J FATIGUE, V22, P873, DOI 10.1016/S0142-1123(00)00057-8
   PARK JB, 2000, BIOMEDICAL ENG HDB, V1
   SASAKI Y, 1996, KINZOKU, V66, P812
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   SEMLITSCH M, 1987, TITAN, V2, P721
   SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   Speidel M O, 1992, P HIGH MANG HIGH NIT, P135
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   TAKAO, 1989, J JPN SOC BIOMATER, V7, P19
   TAKAYA M, 2000, J JAPAN I LIGHT META, V50, P343
   Tandon R, 1999, AM SOC TEST MATER, V1365, P3, DOI 10.1520/STP14259S
   Tesk JA, 1999, AM SOC TEST MATER, V1365, P32, DOI 10.1520/STP14261S
   UGGOWITZER PJ, 1997, ADV POWDER METALL PA, V3
   WANG K, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P49
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Whitcher FD, 1997, COMPUT STRUCT, V64, P1005, DOI 10.1016/S0045-7949(97)00014-X
   YOKOYAMA K, 2000, 6 WORLD BIOM C T MAY, P1271
   Yoshitani S., 2000, CAMP ISIJ, V13, P1345
   YOSHITANI S, 2000, IN PRESS P POWD MET
   Zardiackas L., 1996, ASTM STP, P60
   ZENBO N, 1999, STENT GRAFTING AORTI, P10
   Zwicker R, 1980, TITANIUM 80 SCI TECH, V2, P505
   ZWICKER U, 1986, Z METALLKD, V77, P714
   1991, MILITARY SPECFICATIO
NR 71
TC 643
Z9 662
U1 12
U2 167
PU MINERALS METALS MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086 USA
SN 1073-5623
J9 METALL MATER TRANS A
JI Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.
PD MAR
PY 2002
VL 33
IS 3
BP 477
EP 486
DI 10.1007/s11661-002-0109-2
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 564TA
UT WOS:000176328600002
DA 2018-10-20
ER

PT J
AU Nukaga, Y
AF Nukaga, Y
TI Between tradition and innovation in new genetics: the continuity of
   medical pedigrees and the development of combination work in the case of
   Huntington's disease
SO NEW GENETICS AND SOCIETY
LA English
DT Article
ID FAMILY
AB An extensive discussion is currently under way regarding the novelty of the 'new genetics'. Although a linear model of innovation shows the new genetics as a technology transfer from biology to medicine, an intersection model suggests the new genetics as a bi-dialectical exchange between biology and medicine. The purpose of this paper is to articulate the role of clinical tools from the viewpoint of an intersection model. This paper traces how medical pedigrees (i.e. visual tools used to transcribe family information) have been standardized by genetic counsellors in clinical settings, and subsequently combined with other biomedical inscriptions. The findings demonstrate that development of new genetics was facilitated not only by the introduction of molecular technologies, but also by their use in combination with medical pedigrees. In this manner, clinical practitioners, laboratory workers and lay support group members have collaborated in order to mobilize genealogical information and organic materials as biomedical properties.
C1 Cornell Univ, Dept Sci & Technol Studies, Ithaca, NY 14853 USA.
RP Nukaga, Y (reprint author), Cornell Univ, Dept Sci & Technol Studies, 726 Univ Ave, Ithaca, NY 14853 USA.
CR ALLEN GE, 1986, OSIRIS, V2, P225, DOI 10.1086/368657
   Armstrong D, 1998, SOC SCI MED, V47, P1653, DOI 10.1016/S0277-9536(98)00241-X
   Atkinson P, 2001, NEW GENET SOC, V20, P5, DOI 10.1080/14636770120034619
   BELL J, 1934, TREASURY HUMAN INHER, V4, P1
   BENNETT RL, 1995, AM J HUM GENET, V56, P745
   CARRSAUNDERS AM, 1912, EUGENIC REV, V5, P66
   CHA JH, 1995, HUNTINGTONS DIS VENE
   *COMM CONTR HUNT D, 1977, REP, V1
   Conrad P., 1999, SOCIOLOGICAL PERSPEC
   Crary Jonathan, 1992, INCORPORATIONS
   Davenport CB, 1916, AM J INSANITY, V73, P195, DOI 10.1176/ajp.73.2.195
   DAVENPORT CB, 1911, AM BREEDERS MAGAZINE, V2, P73
   DAVENPORT CB, 1915, SCIENCE, V41, P570
   Davenport Charles B., 1915, EUGENICS RECORD OFFI
   de Chadarevian S., 1998, MOL BIOL MED NEW PRA
   FISHER D, 1998, FACES HUNTINGTONS
   FRANKEL MS, 1993, ETHICAL LEGAL ISSUES
   Fujimura J., 1996, CRAFTING SCI SOCIOHI
   Gusella J F, 1993, Mol Genet Med, V3, P139
   GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0
   HARPER PS, 1996, HUNTINGTONS DIS
   Hayden MR, 1981, HUNTINGTONS CHOREA
   HAYES CV, 1992, NEW ENGL J MED, V327, P1449, DOI 10.1056/NEJM199211123272008
   Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213
   JELLIFE SE, 1913, J NERV MENT DIS, V40, P196
   JELLIFFE SE, 1908, NEUROGRAPHS, V1, P116
   Keating P, 2000, CONFIGURATIONS, V8, P337, DOI 10.1353/con.2000.0021
   Keating P, 2001, J HIST MED ALL SCI, V56, P321, DOI 10.1093/jhmas/56.4.321
   KESSLER S, 1989, FAM PROCESS, V28, P59, DOI 10.1111/j.1545-5300.1989.00059.x
   KESSLER S, 1993, AM J MED GENET, V48, P145, DOI 10.1002/ajmg.1320480306
   Kuhn T. S., 1962, STRUCTURE SCI REVOLU
   Laughlin H. H, 1922, EUGENICAL STERILIZAT
   LAUGHLIN HH, 1911, AM BREEDERS MAGAZINE, V2, P107
   LEALPOCK C, 1998, FACES HUNTINGTONS
   LEWIS R, 1994, BIOSCIENCE, V44, P722, DOI 10.2307/1312579
   Lowy I., 1993, MED CHANGE, P212
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E
   MacKenzie D. A., 1981, STAT BRITAIN 1865 19
   MACKLIN MT, 1945, J HERED, V36, P222, DOI 10.1093/oxfordjournals.jhered.a105506
   Mazumdar P. M. H., 1992, EUGENICS HUMAN GENET
   MUNCEY EB, 1964, CLASSICAL HUNTINGTON
   MUNSON JF, 1910, NEW YORK MED J, V91, P437
   Nukaga Y, 1997, SOCIOL HLTH ILLN MON, P29
   NUKAGA Y, 2000, THESIS MCGILL U
   Oliver C. P., 1945, DIGHT INST UNIV MINNESOTA BULL, V3, P13
   Pickstone J., 1992, MED INNOVATIONS HIST
   Punnett R. C., 1905, MENDELISM
   Rabinow P., 1996, MAKING PCR STORY BIO
   REED SC, 1949, DIGHT I, V6, P1
   Resta R G, 1993, J Genet Couns, V2, P235, DOI 10.1007/BF00961574
   RICHARDS MPM, 1996, TROUBLED HELIX SOCIA
   RUSHTON A, 1994, GENETICS MED US 1800
   SINKLER W, 1889, J NERV MENT DIS, V14, P69
   Sturdy S., 1998, MED REIGN TECHNOLOGY, V36, P421
   THEVENOT L, 1984, SOC SCI INFORM, V23, P1, DOI 10.1177/053901884023001001
   Wertz D C, 1997, J Contemp Health Law Policy, V13, P299
   WEXLER A, 1992, CODE CODES SCI SOCIA
   Wexler A., 1995, MAPPING FATE MEMOIR
NR 58
TC 12
Z9 12
U1 2
U2 5
PU CARFAX PUBLISHING
PI BASINGSTOKE
PA RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND
SN 1463-6778
J9 NEW GENET SOC
JI New Genet. Soc.
PD MAR
PY 2002
VL 21
IS 1
BP 39
EP 64
DI 10.1080/14636770220122764
PG 26
WC Biotechnology & Applied Microbiology; Genetics & Heredity; History &
   Philosophy Of Science; Social Issues; Social Sciences, Biomedical
SC Biotechnology & Applied Microbiology; Genetics & Heredity; History &
   Philosophy of Science; Social Issues; Biomedical Social Sciences
GA 542ZD
UT WOS:000175074900004
DA 2018-10-20
ER

PT J
AU Chapiro, A
AF Chapiro, A
TI XIIth international meeting on radiation processing Avignon 25-30 March
   2001 (Polymer irradiation: past-present and future)
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
AB Radiations are used efficiently and economically for the production of new or modified polymers. The following processes are considered:
   1. Radiation curing;
   2. Radiation cross-linking,
   3. Radiation grafting.
   These processes are commonly used today in industry and provide a broad range of new potential applications in various fields. The history of their development is briefly reported. The chemical reactions underlying these processes are described.
   (1) Radiation curing is used commercially on a large scale for the production of improved coatings, lacquers and inks. The process can be conducted at very high speeds. Curing of magnetic formulations leads to particularly stable products, which compete favourably with more conventional materials.
   (2) Radiation cross-linking is an established technology in the wire and cable industry. It emparts to the modified insulators improved resistance to solvents, to ageing and to elevated temperatures. The resulting cross-linked network also reduces the migration of fillers and thereby stabilizes in time any message imprinted with magnetic or colored pigments dispersed in a polymer.
   (3) Radiation g-rafting is a powerful method for modifying more profoundly the properties of a polymer and for creating numerous. entirely new materials. The chemical modification can be applied at will into the bulk of the material or limited to a surface zone of any desired depth. This method can be used for instance, for introducing polar groups in the bulk or on the surface of non-polar polymers, for increasing or reducing the wettability of a polymer, for imparting a better compatibility of a polymer to a specific coating and the like.
   The irradiation of water-soluble polymers in aqueous solutions, with or without the addition of another monomer olives rise to a variety of cross-linked gels which End useful applications in the biomedical field. Other promising applications will be considered. (C) 2002 Elsevier Science Ltd. All rights reserved.
RP Chapiro, A (reprint author), 35 Grande Coudraie, F-91190 Gif Sur Yvette, France.
NR 0
TC 34
Z9 35
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD MAR
PY 2002
VL 63
IS 3-6
BP 207
EP 209
AR PII S0969-806X(01)00621-1
DI 10.1016/S0969-806X(01)00621-1
PG 3
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 535JT
UT WOS:000174642000002
DA 2018-10-20
ER

PT J
AU Bizzarri, R
   Chiellini, F
   Solaro, R
   Chiellini, E
   Cammas-Marion, S
   Guerin, P
AF Bizzarri, R
   Chiellini, F
   Solaro, R
   Chiellini, E
   Cammas-Marion, S
   Guerin, P
TI Synthesis and characterization of new malolactonate polymers and
   copolymers for biomedical applications
SO MACROMOLECULES
LA English
DT Article
ID POLY(BETA-MALIC ACID); MALIC-ACID; DRUG-CARRIER; DEGRADATION;
   POLYESTERS; DERIVATIVES; DESIGN; ESTERS
AB A new class of malolactonate polymers and copolymers were synthesized, starting from the corresponding lactones, and then Characterized. Different lateral groups were selected for these polyesters to achieve a wide range of materials characteristics and possible biological recognition. The monomers were prepared according to two established procedures, which gave rather good overall yields. The polymers were obtained by the anionic ring-opening polymerization of the corresponding four-member ring monomers in the presence of a quaternary ammonium salt: as the initiator. Final macromolecular and thermal characteristics were in agreement with the designed monomer structures. Molecular weights in the range 4-20 kDa were obtained, as a result of chain transfer reactions. The prepared polyesters displayed stability up to 200 degreesC, and, when tested in preliminary cell culture experiments, provided indications for future applications in the biomedical field.
C1 Univ Pisa, Dept Chem & Ind Chem, I-56126 Pisa, Italy.
   Univ Paris 12, UMR C7581 CNRS, Lab Rech Polymers, F-94320 Thiais, France.
RP Chiellini, E (reprint author), Univ Pisa, Dept Chem & Ind Chem, Via Risorgimento 35, I-56126 Pisa, Italy.
RI Chiellini, Federica/F-3233-2010; Bizzarri, Ranieri/H-1779-2011
OI Chiellini, Federica/0000-0003-4680-9975; Bizzarri,
   Ranieri/0000-0002-8222-2672
CR ARNOLD SC, 1986, MAKROMOL CHEM-M SYMP, V6, P285, DOI 10.1002/masy.19860060128
   Barbaud C, 1999, POLYM BULL, V43, P297, DOI 10.1007/s002890050614
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   Bizzarri R, 1999, J BIOACT COMPAT POL, V14, P504, DOI 10.1177/088391159901400605
   Bizzarri R, 2000, J BIOACT COMPAT POL, V15, P43, DOI 10.1106/N7E5-B4HN-Y0PU-DDLQ
   BIZZARRI R, IN PRESS MARCOMOL CH
   BOUTAULT K, 1995, MACROMOLECULES, V28, P3516, DOI 10.1021/ma00114a004
   BRAUD C, 1992, POLYM BULL, V29, P177, DOI 10.1007/BF00558054
   BRAUD C, 1985, POLYM BULL, V13, P293
   Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2
   Cammas S, 1999, INT J BIOL MACROMOL, V25, P273, DOI 10.1016/S0141-8130(99)00042-2
   CAMMAS S, 1993, TETRAHEDRON-ASYMMETR, V4, P1925, DOI 10.1016/S0957-4166(00)80433-4
   Cammas-Marion S, 2000, MACROMOL CHEM PHYSIC, V201, P355, DOI 10.1002/(SICI)1521-3935(20000201)201:3<355::AID-MACP355>3.0.CO;2-9
   Cammas-Marion S, 2000, MACROMOL SYMP, V153, P167, DOI 10.1002/1521-3900(200003)153:1<167::AID-MASY167>3.0.CO;2-Q
   CHIELLINI E, 1995, J BIOMAT SCI-POLYM E, V7, P307
   CHIELLINI E, 1992, MAKROMOL CHEM-M SYMP, V54-5, P483, DOI 10.1002/masy.19920540136
   Chiellini E, 1999, J MACROMOL SCI PURE, VA36, P901, DOI 10.1080/10601329908951188
   CHIELLINI E, 1994, J BIOACT COMPAT POL, V9, P152, DOI 10.1177/088391159400900203
   Chiellini E, 1997, MACROMOL SYMP, V123, P25, DOI 10.1002/masy.19971230105
   CHIELLINI E, IN PRESS BIOPOLYMERS, V4, pCH14
   Chiellini E, 1990, J BIOACT COMPAT POLY, V5, P16
   CHIELLINI E, 1993, CHEMTECH, V7, P29
   COUCHMAN PR, 1978, MACROMOLECULES, V11, P1156, DOI 10.1021/ma60066a018
   FOURNIE P, 1992, J BIOACT COMPAT POL, V7, P113, DOI 10.1177/088391159200700201
   GUERIN P, 1987, POLYM COMMUN, V28, P11
   GUERIN P, 1985, POLYM BULL, V14, P187, DOI 10.1007/BF00708479
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Langer R, 1995, Tissue Eng, V1, P151, DOI 10.1089/ten.1995.1.151
   Langer R, 1999, J CONTROL RELEASE, V62, P7, DOI 10.1016/S0168-3659(99)00057-7
   LANZA RP, 1997, PRINCIPLES TISSUES E
   LeboucherDurand MA, 1996, POLYM BULL, V36, P35, DOI 10.1007/BF00296005
   LEBOUCHERDURAND MA, 1996, POLYM B, V35, P36
   Lenz R., 1983, POLYM MED, P219
   Mabille C, 1998, POLYM BULL, V40, P381, DOI 10.1007/s002890050266
   Moine L, 1998, MACROMOL SYMP, V130, P45, DOI 10.1002/masy.19981300105
   Parker J.R., 1992, British Arachnological Society Newsletter, P1
   Rossignol H, 1999, INT J BIOL MACROMOL, V25, P255, DOI 10.1016/S0141-8130(99)00040-9
   STOLNIK S, 1994, J CONTROL RELEASE, V30, P57, DOI 10.1016/0168-3659(94)90044-2
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   VERT M, 1986, MAKROMOL CHEM-M SYMP, V6, P109, DOI 10.1002/masy.19860060113
   Wong W. H., 1997, SYNTHETIC BIODEGRADA
NR 42
TC 52
Z9 52
U1 1
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD FEB 12
PY 2002
VL 35
IS 4
BP 1215
EP 1223
DI 10.1021/ma0111257
PG 9
WC Polymer Science
SC Polymer Science
GA 520UH
UT WOS:000173799400014
DA 2018-10-20
ER

PT J
AU Hench, LL
   Polak, JM
AF Hench, LL
   Polak, JM
TI Third-generation biomedical materials
SO SCIENCE
LA English
DT Editorial Material
ID BIOMATERIALS; MATRICES
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
   Univ London Imperial Coll Sci Technol & Med, Tissue Engn Ctr, London SW7 2BP, England.
RP Polak, JM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
CR Bielby R., 2000, Tissue Engineering, V6, P693
   BONFIELD W, 1990, CRC HDB BIOACTIVE CE, V2, pCH16
   Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323
   HASTINGS GW, 1984, MACROMOLECULAR BIOMA
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HENCH LL, 1996, CLIN PERFORMANCE SKE, pCH13
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HUNTER DD, 1991, J NEUROSCI, V11, P3960
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Klein C, 1993, INTRO BIOCERAMICS, V1, P199
   LENZA RFS, IN PRESS J MAT SCI M
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   Patel N, 1998, FASEB J, V12, P1447
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   ROMANSKA H, COMMUNICATION
   Schoen F J, 1992, Cardiovasc Pathol, V1, P29, DOI 10.1016/1054-8807(92)90006-A
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
   Wroblewski BM, 1999, J BONE JOINT SURG BR, V81B, P427, DOI 10.1302/0301-620X.81B3.9521
   XYNOS D, 2001, J BIOMED MATER RES, V55, P151
   YAMAMURO T, 1990, CRC HDB BIOACTIVE CE, P89
   Yamamuro T, 1990, CRC HDB BIOACTIVE CE, V2
NR 27
TC 1535
Z9 1660
U1 27
U2 472
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD FEB 8
PY 2002
VL 295
IS 5557
BP 1014
EP +
DI 10.1126/science.1067404
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 520QR
UT WOS:000173793000045
PM 11834817
DA 2018-10-20
ER

PT J
AU Seifert, B
   Mihanetzis, G
   Groth, T
   Albrecht, W
   Richau, K
   Missirlis, Y
   Paul, D
   von Sengbusch, G
AF Seifert, B
   Mihanetzis, G
   Groth, T
   Albrecht, W
   Richau, K
   Missirlis, Y
   Paul, D
   von Sengbusch, G
TI Polyetherimide: A new membrane-forming polymer for biomedical
   applications
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT International Conference on Adsorption Technologies and Blood
   Purification Procedures
CY MAY 05-07, 2000
CL ROSTOCK-WARNEMUNDE, GERMANY
SP Int Soc Artificial Organs, European Soc Artificial Organs, World Aphere Assoc, Int Soc Aphere, Inst Appl Biosci
DE biohybrid organs; membranes; polyetherimide; surface functionalization;
   biocompatibility
ID ARTIFICIAL LIVER SUPPORT; HOLLOW-FIBER; BLOOD COMPATIBILITY; IN-VITRO;
   BIOCOMPATIBILITY; ACTIVATION; CONTACT; BIOMATERIALS; SEPARATION;
   SURFACES
AB Membranes for biohybrid organs such as the biohybrid liver support system have to face 2 different environments, namely blood and tissue cells. Accordingly, the respective membrane surfaces must have optimal properties in terms of biocompatibility for blood or tissue. Flat membranes prepared by a phase inversion process from polyetherimide were modified by binding of tris-(hydroxymethyl)-aminomethane to obtain a surface with hydroxyl groups by binding of polyethylene imine to attach a hydrophilic macromolecule with amine groups useful as a spacer for later bonding of further ligands and by attachment of heparin. The binding of the different ligands was successful as monitored by different physicochemical methods. The blood response of plain polyetherimide was comparable to that of polyacrylonitrile, and it could be further improved by the binding of heparin. The tissue compatibility of polyetherimide and its different modifications was compared with commercial cell culture substrate membranes (Millicell) and found to be comparable for polyetherimide and even better after the modification with tris-(hydroxymethyl)-aminomethane. In conclusion, polyetherimide seems to be an interesting material for the production of membranes for application in biohybrid organ systems.
C1 GKSS Res Ctr Geesthacht GmbH, Dept Biomat, Inst Chem, D-14513 Teltow, Germany.
   Univ Patras, Dept Engn Mech, Biomed Engn Lab, Patras, Greece.
RP Groth, T (reprint author), GKSS Res Ctr Geesthacht GmbH, Dept Biomat, Inst Chem, Kantstr 55, D-14513 Teltow, Germany.
RI Seifert, Barbara/K-7569-2012
OI Groth, Thomas/0000-0001-6647-9657
CR Alpard SK, 1998, PERFUSION-UK, V13, P3, DOI 10.1177/026765919801300102
   BADER A, 1995, ARTIF ORGANS, V19, P941, DOI 10.1111/j.1525-1594.1995.tb02456.x
   BONOMINI V, 1995, CONTRIB NEPHROL, V113, P120
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   DIXIT V, 1994, ARTIF ORGANS, V18, P371, DOI 10.1111/j.1525-1594.1994.tb02219.x
   Fey-Lamprecht F, 2000, BIOMATERIALS, V21, P183, DOI 10.1016/S0142-9612(99)00147-7
   Groth T, 1997, J BIOMAT SCI-POLYM E, V8, P797, DOI 10.1163/156856297X00326
   GROTH T, 2000, P 9 INT C POL MED SU, P205
   HIRASAWA H, 1997, THER APHER, V1, P223
   IKADA Y, 1981, J BIOMED MATER RES, V15, P697, DOI 10.1002/jbm.820150507
   IMAI Y, 1983, J BIOMED MATER RES, V17, P905, DOI 10.1002/jbm.820170602
   Ivanov VB, 1996, SURF INTERFACE ANAL, V24, P257, DOI 10.1002/(SICI)1096-9918(199604)24:4<257::AID-SIA107>3.0.CO;2-1
   Jauregui HO, 1996, CELL TRANSPLANT, V5, P353, DOI 10.1016/0963-6897(95)02020-9
   Kamusewitz H, 1999, COLLOID SURFACE A, V156, P271, DOI 10.1016/S0927-7757(99)00079-5
   Kawakami H, 1997, ASAIO J, V43, pM490
   KAZATCHKINE MD, 1982, PROG ALLERGY, V30, P193
   KLINKMANN H, 1995, NEPHROL DIAL TRANSPL, V10, P39, DOI 10.1093/ndt/10.supp3.39
   KNEIFEL K, 1992, J MEMBRANE SCI, V65, P295, DOI 10.1016/0376-7388(92)87030-2
   LEDU C, 1999, MED DEV TECHN C CHES
   LINDHOUT T, 1994, NEPHROL DIAL TRANSPL, V9, P83
   Paul D, 1998, CHEM UNSERER ZEIT, V32, P197, DOI 10.1002/ciuz.19980320405
   Peinemann KV, 1998, POLYMER, V39, P3411, DOI 10.1016/S0032-3861(97)10067-2
   PELUSO G, 1994, J MATER SCI-MATER M, V4, P738
   Qiang S, 1997, INT J ARTIF ORGANS, V20, P119
   RHODES NP, 1994, BIOMATERIALS, V15, P35, DOI 10.1016/0142-9612(94)90194-5
   RHODES NP, 1997, CELLULAR ENG, V2, P1
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   Richau K, 1996, DESALINATION, V104, P19, DOI 10.1016/0011-9164(96)00022-7
   Rozga J, 1995, ASAIO J, V41, P831, DOI 10.1097/00002480-199510000-00003
   SCHMIDT B, 1995, CONTRIB NEPHROL, V113, P32
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   SEIFERT B, 1995, J BIOMAT SCI-POLYM E, V7, P227
   SMITH PK, 1980, ANAL BIOCHEM, V109, P466, DOI 10.1016/0003-2697(80)90679-X
   Stieglitz T, 1999, Med Device Technol, V10, P28
   UCHIDA E, 1993, LANGMUIR, V9, P1121, DOI 10.1021/la00028a040
   VIENKEN J, 1995, ARTIF ORGANS, V19, P398, DOI 10.1111/j.1525-1594.1995.tb02349.x
   VONSENGBUSCH G, 1993, ARTIF ORGANS, V17, P244
   Ward R. A., 1988, T AM SOC ART INT ORG, V34, P334
   WOLF CFW, 1978, INT J ARTIF ORGANS, V1, P45
NR 39
TC 55
Z9 55
U1 3
U2 23
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD FEB
PY 2002
VL 26
IS 2
BP 189
EP 199
DI 10.1046/j.1525-1594.2002.06876.x
PG 11
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 527ZY
UT WOS:000174219500021
PM 11879249
DA 2018-10-20
ER

PT J
AU Yap, AUJ
   Pek, YS
   Kumar, RA
   Cheang, P
   Khor, KA
AF Yap, AUJ
   Pek, YS
   Kumar, RA
   Cheang, P
   Khor, KA
TI Experimental studies on a new bioactive material: HAIonomer cements
SO BIOMATERIALS
LA English
DT Article
DE glass ionomer; hydroxyapatite; hardness; strength
ID GLASS-IONOMER CEMENTS; BONE-CEMENT; OTOLOGIC SURGERY; HYDROXYAPATITE;
   FLUORIDE; SUBSTITUTE; COMPOSITE; IMPLANT
AB The lack of exotherm during setting, absence of monomer and improved release of incorporated therapeutic agents has resulted in the development of glass ionomer cements (GICs) for biomedical applications. In order to improve biocompatibility and biomechanically match GICs to bone, hydroxyapatite-ionomer (HAIonomer) hybrid cements were developed. Ultra-fine hydroxyapatite(HA) powders were produced using a new induction spraying technique that utilizes a radio-frequency source to spheriodize an atomized suspension containing HA crystallites. The spheriodized particulates were then held at 800 degreesC for 4h in a carbolite furnace using a heating and cooling rate of 25 degreesC/min to obtain almost fully crystalline HA powders. The heat-treated particles were characterized and introduced into a commercial glass ionomer cement. 4 (H4), 12 (H12) and 28 (H28) vol% of fluoroalumino silicate were substituted by crystalline HA particles that were dispersed using a high-speed dispersion technique. The HAIonomer cements were subjected to hardness, compressive and diametral tensile strength testing based upon BS6039:1981. The storage time were extended to one week to investigate the effects of cement maturation on mechanical properties. Commercially available capsulated GIC (GC) and GIC at maximum powder: liquid ratio (GM) served as comparisons. Results were analyzed using factorial ANOVA/Scheffe's post-hoe tests and independent samples t-test at significance level 0.05. The effect of time on hardness was material dependent. With the exception of H12, a significant increase in hardness was observed for all materials at one week. A significant increase in compressive strength was, however, observed for H12 over time. At 1 day and 1 week, the hardness of H28 was significantly lower than for GM, H4, and H12. No significant difference in compression and diametral tensile strengths were observed between materials at both time intervals. Results show that HAIonomers is a promising material, which possess good mechanical properties. Potential uses of this new material include bone cements and performed implants for hard tissue replacement in the field of otological, oral-maxillofacial and orthopedic surgery. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Natl Univ Singapore, Dept Restorat Dent, Fac Dent, Singapore 119074, Singapore.
   Ind Mat Res & Engn, Singapore 117602, Singapore.
   Natl Univ Singapore, Fac Engn, Ctr Biomed Mat Applicat & Technol, Singapore 119260, Singapore.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   Nanyang Technol Univ, Ctr Adv Mat Res, Singapore 639798, Singapore.
RP Yap, AUJ (reprint author), Natl Univ Singapore, Dept Restorat Dent, Fac Dent, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.
RI Khor, Khiam Aik/G-2827-2010; Khor, Khiam Aik (Michael)/B-6929-2009
OI KHOR, Khiam/0000-0003-1954-8423
CR AKINMADE AO, 1993, J MATER SCI-MATER M, V4, P93
   ANSTICE HM, 1992, J MATER SCI-MATER M, V3, P447, DOI 10.1007/BF00701241
   BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   BOEREE NR, 1993, BIOMATERIALS, V14, P793, DOI 10.1016/0142-9612(93)90046-5
   *BRIT STAND I, 1981, BRIT STAND SPEC DENT, P4
   BROOK I M, 1991, Clinical Materials, V7, P295, DOI 10.1016/0267-6605(91)90073-O
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   BROOK IM, 1991, BIOMATERIALS, V12, P179, DOI 10.1016/0142-9612(91)90197-I
   Brook IM, 1998, BIOMATERIALS, V19, P565, DOI 10.1016/S0142-9612(98)00138-0
   Carter DH, 1997, BIOMATERIALS, V18, P459, DOI 10.1016/S0142-9612(96)00150-0
   CHARLTON DG, 1991, OPER DENT, V16, P231
   DOHERTY P J, 1991, Clinical Materials, V7, P335, DOI 10.1016/0267-6605(91)90078-T
   FARLEY JR, 1983, SCIENCE, V222, P330
   GEYER G, 1993, EUR ARCH OTO-RHINO-L, V250, P253
   HATTON PV, 1992, BRIT DENT J, V173, P275, DOI 10.1038/sj.bdj.4808026
   HATTON PV, 1992, MICRON MICROSC ACTA, V23, P363
   Hintschich C, 1999, GRAEF ARCH CLIN EXP, V237, P169, DOI 10.1007/s004170050214
   JOHAL K, 1995, J MAT SCI MED, V7, P690
   KAVANAGH BF, 1987, J BONE JOINT SURG AM, V69A, P1144, DOI 10.2106/00004623-198769080-00006
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   MCELVEEN JT, 1994, OTOLARYNG CLIN N AM, V27, P777
   MEHTA S, 1995, BIOMATERIALS, V16, P97, DOI 10.1016/0142-9612(95)98269-K
   MEYER U, 1993, BIOMATERIALS, V14, P917, DOI 10.1016/0142-9612(93)90133-M
   Mount GJ, 1996, AUST DENT J, V41, P118, DOI 10.1111/j.1834-7819.1996.tb05924.x
   Nicholson JW, 1998, BIOMATERIALS, V19, P485, DOI 10.1016/S0142-9612(97)00128-2
   NICHOLSON JW, 1993, J MATER SCI-MATER M, V4, P418, DOI 10.1007/BF00122202
   NIMB L, 1995, J BIOMED MATER RES, V29, P1477, DOI 10.1002/jbm.820291203
   PATEL MP, 1991, BIOMATERIALS, V12, P653, DOI 10.1016/0142-9612(91)90112-N
   QUARLES LD, 1990, J BONE MINER RES, V5, P625
   RAMSDEN RT, 1992, J LARYNGOL OTOL, V106, P949, DOI 10.1017/S0022215100121449
   RENARD JL, 1994, LANCET, V344, P63, DOI 10.1016/S0140-6736(94)91089-8
   SAITO M, 1994, BIOMATERIALS, V15, P156, DOI 10.1016/0142-9612(94)90266-6
   SOGAARD CH, 1995, BONE, V16, P163, DOI 10.1016/S8756-3282(94)00025-5
   SUZUKI Y, 1995, J DENT RES, V74, P561
   TENHUISEN KS, 1994, J DENT RES, V73, P598, DOI 10.1177/00220345940730030501
   WILSON AD, 1972, BRIT DENT J, V132, P133, DOI 10.1038/sj.bdj.4802810
NR 36
TC 48
Z9 52
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 3
BP 955
EP 962
DI 10.1016/S0142-9612(01)00208-3
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 500RF
UT WOS:000172640000040
PM 11774854
DA 2018-10-20
ER

PT J
AU Duan, XB
   Lewis, RS
AF Duan, XB
   Lewis, RS
TI Improved haemocompatibility of cysteine-modified polymers via endogenous
   nitric oxide
SO BIOMATERIALS
LA English
DT Article
DE nitric oxide; platelet adhesion; L-cysteine; transnitrosation;
   biomaterials
ID LOW-MOLECULAR-WEIGHT; HUMAN PLASMA; PLATELET-ADHESION; SERUM-ALBUMIN;
   GLUTATHIONE; RELEASE; SURFACE; THIOLS; KINETICS; FILMS
AB A novel method for improving the haemocompatibility of biomedical materials through endogenous nitric oxide (NO) is presented. L-cysteine was covalently immobilized onto two biomedical polymers: polyurethane (PU) and polyethylene terephthalate (PET). The L-cysteine content on the polymers was approximately 5-8 nmol/cm(2) as quantified via a chemiluminescence-based assay. The haemocompatibility of the modified polymers was evaluated in terms of the number of adhered platelets when exposed to a platelet suspension labeled with Cr-51. Platelet adherence on the L-cysteine-modified polymers was reduced more than 50% as compared to the control (glycine-modified polymers) when the platelet suspension contained plasma constituents. No difference in platelet adhesion was observed in the absence of plasma constituents. Further experiments demonstrated that NO was easily transferred to the L-cysteine-modified polymers from S-nitroso-albumin in PBS buffer. The NO was then released from the polymer. NO transfer or release was not observed for the control. The results suggest that L-cysteine-modified polymers are effective in reducing platelet adhesion via the transfer of NO from endogenous S-nitroso proteins in plasma to the polymer followed by the subsequent release of NO. Thus, exploiting endogenous NO is a viable option for improving the haemocompatibility of biomaterials. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Oklahoma State Univ, Sch Chem Engn, Stillwater, OK 74078 USA.
RP Lewis, RS (reprint author), Oklahoma State Univ, Sch Chem Engn, 423 EN, Stillwater, OK 74078 USA.
CR Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   Bohl KS, 2000, BIOMATERIALS, V21, P2273, DOI 10.1016/S0142-9612(00)00153-8
   Bos GW, 1999, J BIOMED MATER RES, V47, P279, DOI 10.1002/(SICI)1097-4636(19991205)47:3<279::AID-JBM1>3.0.CO;2-W
   DeQueiroz AAA, 1997, J BIOMAT SCI-POLYM E, V8, P667, DOI 10.1163/156856297X00489
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DUAN X, 2000, AICHE P LOS ANG CA N
   Goldman RK, 1998, ANAL BIOCHEM, V259, P98, DOI 10.1006/abio.1998.2651
   Gordge MP, 1996, BRIT J PHARMACOL, V119, P533, DOI 10.1111/j.1476-5381.1996.tb15704.x
   Graves DF, 1996, PERFUSION-UK, V11, P461, DOI 10.1177/026765919601100607
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P87, DOI 10.1002/jbm.820231309
   HIRD FJR, 1962, BIOCHEM J, V85, P320, DOI 10.1042/bj0850320
   Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0
   LEWIS RS, 1994, CHEM RES TOXICOL, V7, P568, DOI 10.1021/tx00040a013
   Liu ZG, 1998, J PHARMACOL EXP THER, V284, P526
   Mammen EF, 1999, CLIN APPL THROMB-HEM, V5, pS72, DOI 10.1177/107602969900500113
   MEYER DJ, 1994, FEBS LETT, V345, P177, DOI 10.1016/0014-5793(94)00429-3
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   Morra M., 1993, Clinical Materials, V14, P255, DOI 10.1016/0267-6605(93)90010-5
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   Muntean W, 1999, ARTIF ORGANS, V23, P979, DOI 10.1046/j.1525-1594.1999.06451.x
   MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0
   PEITRAFORTE D, 1995, BIOCHEMISTRY-US, V34, P7177
   Reyes H, 2000, J HEPATOL, V32, P542, DOI 10.1016/S0168-8278(00)80214-7
   SCHARFSTEIN JS, 1994, J CLIN INVEST, V94, P1432, DOI 10.1172/JCI117480
   Scorza G, 1997, FREE RADICAL BIO MED, V22, P633, DOI 10.1016/S0891-5849(96)00378-4
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444
   STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674
   Tsikas D, 1999, ANAL BIOCHEM, V270, P231, DOI 10.1006/abio.1999.4084
   Williams DLH, 1996, METHOD ENZYMOL, V268, P299
   WISE DL, 1996, HUMAN BIOMATERIALS A
NR 31
TC 52
Z9 56
U1 3
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2002
VL 23
IS 4
BP 1197
EP 1203
DI 10.1016/S0142-9612(01)00234-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 502HR
UT WOS:000172738500025
PM 11791923
DA 2018-10-20
ER

PT J
AU Edwards, B
   Barnes, L
   Gibbs, B
   Nguyen, G
AF Edwards, B
   Barnes, L
   Gibbs, B
   Nguyen, G
TI Development of a laser safety hazard evaluation procedure for the
   research university setting
SO HEALTH PHYSICS
LA English
DT Article
DE operational topic; lasers; radiation protection; safety standards
AB Laser safely often receives less attention and fewer resources than other institutional safety anti health program elements. This diminished support occurs despite the fact that the potential for laser-related occupational injuries is much greater than the potential for injury from radioactive materials used in biomedical research. Therefore, a small emphasis on laser safety can potentially produce a much greater return on investment than more conventional health physics programs. Dei,eloping and implementing a formal laser hazard evaluation procedure provides an efficient mechanism for identifying potential laser safety hazards and offers a great professional development opportunity in this important area of health physics expertise. This paper outlines a process for developing such a university laser hazard evaluation program.
C1 Duke Univ, Div Radiat Safety, Durham, NC 27710 USA.
RP Edwards, B (reprint author), Duke Univ, Div Radiat Safety, Box 3155, Durham, NC 27710 USA.
EM edwar086@mc.duke.edu
CR *AM NAT STAND I, 2000, Z13612000 ANSI
   *AM NAT STAND I, 2000, Z13652000 ANSI
   MICHEL R, 2001, ORS S, V81, pS8
   *ROCKW LAS IND, 2001, LAS ACC DAT
NR 4
TC 5
Z9 6
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD FEB
PY 2002
VL 82
IS 2
SU S
BP S37
EP S46
DI 10.1097/00004032-200202001-00010
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 514LQ
UT WOS:000173441500008
PM 11797903
DA 2018-10-20
ER

PT J
AU McElroy, DP
   Huang, SC
   Hoffman, EJ
AF McElroy, DP
   Huang, SC
   Hoffman, EJ
TI The use of retro-reflective tape for improving spatial resolution of
   scintillation detectors
SO IEEE TRANSACTIONS ON NUCLEAR SCIENCE
LA English
DT Article
DE biomedical nuclear imaging; image resolution; optical reflection;
   retro-reflection; scintillation detectors; surface treatment
ID TUBE GAMMA-CAMERA; LSO CRYSTALS; SCINTIMAMMOGRAPHY; DESIGN
AB We are investigating the use of a retro-reflective tape (3M Industries), which reflects light along a line parallel to the incident light, as a substitute for Teflon tape or other reflective material used with scintillation crystals. We expect this retro-reflective property to improve spatial resolution in large continuous crystals relative to that seen with Teflon, or other reflective coatings, when the reflective tape is coupled to the front (radiation incident) side of the crystal. Three CsI(Tl) crystals of dimensions 5.8 cm x 5.6 cm x 5 mm, 6 cm x 6 cm x 12 rum, and 6 cm x 6 cm x 20 mm were evaluated by stepping a collimated Tc-99m source across the crystal face. Images were taken with the crystal coupled to a position-sensitive photomultiplier tube. Energy resolution and signal amplitude were similar for both the reflector and Tenon. Average spatial resolution in the central region of the 5-mm-thick crystal with black sides was measured to be 3.6 +/- 0.3 mm and 5.0 +/- 0.3 mm for retro-reflective tape and Tenon tape, respectively.
C1 Univ Calif Los Angeles, Sch Med, Dept Pharmacol, Los Angeles, CA 90095 USA.
RP McElroy, DP (reprint author), Univ Calif Los Angeles, Sch Med, Dept Pharmacol, Los Angeles, CA 90095 USA.
EM dmcelroy@mednet.ucla.edu
CR BIRD AJ, 1993, IEEE T NUCL SCI, V40, P395, DOI 10.1109/23.256587
   CARRIER C, 1990, NUCL INSTRUM METH A, V292, P685, DOI 10.1016/0168-9002(90)90188-C
   CRABB DG, 1966, NUCL INSTRUM METHODS, V45, P301, DOI 10.1016/0029-554X(66)90305-3
   DeVincentis G, 1997, ANTICANCER RES, V17, P1627
   GRASSMANN H, 1985, NUCL INSTRUM METH A, V228, P323, DOI 10.1016/0168-9002(85)90276-1
   Huber JS, 1999, NUCL INSTRUM METH A, V437, P374, DOI 10.1016/S0168-9002(99)00766-4
   KEIL G, 1970, NUCL INSTRUM METHODS, V83, P145, DOI 10.1016/0029-554X(70)90813-X
   Knoll Glenn F, 1979, RAD DETECTION MEASUR
   Levin CS, 1996, J NUCL MED, V37, P200
   MacDonald LR, 2000, J NUCL MED, V41, p56P
   MARX E, 1990, APPL OPTICS, V29, P3613, DOI 10.1364/AO.29.003613
   MOISAN C, 1997, IEEE NUCL SCI S MED
   Pani R, 1997, ANTICANCER RES, V17, P1651
   ROGERS JG, 1986, PHYS MED BIOL, V31, P1061, DOI 10.1088/0031-9155/31/10/001
   Slates R, 2000, IEEE T NUCL SCI, V47, P1018, DOI 10.1109/23.856541
   SMITH T, 1972, J PHYS E SCI INSTRUM, V5, P1083, DOI 10.1088/0022-3735/5/11/017
   SORENSON JA, 1987, PHYSICS NUCL MED
   Weinberg IN, 1997, IEEE T NUCL SCI, V44, P1398, DOI 10.1109/23.597019
   WILLIAMS MB, 1997, P SPIE, V3115
   YASILLO NJ, 1990, IEEE T NUCL SCI, V37, P609, DOI 10.1109/23.106685
NR 20
TC 12
Z9 12
U1 0
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9499
EI 1558-1578
J9 IEEE T NUCL SCI
JI IEEE Trans. Nucl. Sci.
PD FEB
PY 2002
VL 49
IS 1
BP 165
EP 171
AR PII S0018-9499(02)01649-0
DI 10.1109/TNS.2002.998746
PN 1
PG 7
WC Engineering, Electrical & Electronic; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA 549CQ
UT WOS:000175427300029
DA 2018-10-20
ER

PT J
AU Tsapanos, VS
   Stathopoulou, LP
   Papathanassopoulou, VS
   Tzingounis, VA
AF Tsapanos, VS
   Stathopoulou, LP
   Papathanassopoulou, VS
   Tzingounis, VA
TI The role of Seprafilm (TM) bioresorbable membrane in the prevention and
   therapy of endometrial synechiae
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE Seprafilm (TM); biomembranes; biomedical materials; Asherman's syndrome;
   uterine adhesions; endometrial synechiae; infertility
AB This randomized controlled blind prospective study is undertaken to evaluate the safety and efficacy of Seprafilm(TM)-a novel bioresorbable membrane of chemically modified hyaluronic acid and carboxymethylcellulose-in prevention and reduction of postoperative endometrial and endocervical synechiae formation after general suction evacuation or curettage for incomplete, missed, and recurrent abortion. In total, 150 patients with incomplete or missed abortion participated in the clinical study. The study population was divided into two main groups. In the treatment (Seprafilm(TM)) group (n=50), application of Seprafilm(TM) membrane in the endometrial cavity and the cervical canal was used after the suction evacuation and/or the curettage. In the control group (n=100), nothing was inserted in the uterus. Both groups were divided into two subgroups: patients who had no previous suction or curettage, (with no previous D&C) (n=88). and patients who had at least one previous suction or curettage (with one or more previous D&C) (n=62). In the treatment (Seprafilm(TM)) group, 32 patients had no previous D&C and 18 patients had one or more previous D&C. In the control group, 56 patients had no previous D&C and 44 patients had one or more previous D&C. Further fertility was estimated by pregnancy success in all groups. Endometrial synechiae formation was evaluated with the use of hysterosalpingography (HSG) in patients of all groups without pregnancy success 8 months after the intervention. Registering any adverse reaction and performing ultrasound controls assessed the safety of Seprafilm(TM) use. From the subgroup with no previous D&C, all 32 patients (100%) who received Seprafilm(TM) had a pregnancy in the following 8 months; in the controls, pregnancy occurred only in 54%. It was also demonstrated with hysterosalpingography (HSG) that patients with one or more previous nterventions and no pregnancy 8 months later were adhesion free in 90% of the patients where Seprafilm(TM) was used, and only 50% in the untreated group. The membrane v as tested on the endometrial area of the uterus and did not produce any adverse reaction. Ultrasound controls did not show any abnormal echoes. Intrauterine insertion of Seprafilm(TM) is Safe, prevents the appearance of endocervical adhesions or endometrial synechiae after curettage, and reduces the area of the endometrial cavity occupied by them in a large percent of cases. It also seems that its use improves the possibility of a new pregnancy, and fertility. (C) 2001 John Wiley Son, Inc.
C1 Univ Patras, Sch Med, Dept Obstet & Gynecol, Patras 26223, Greece.
RP Tsapanos, VS (reprint author), Univ Patras, Sch Med, Dept Obstet & Gynecol, 32 Sarandaporou St, Patras 26223, Greece.
EM vtsapanos@yahoo.com
CR Beck DE, 1997, EUR J SURG, V163, P49
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   BUCKLEY HC, 1989, BIOPSY PATHOLOGY END, P265
   Burns JW, 1997, EUR J SURG, V163, P40
   CARVER R, 1993, 49 ANN M AM FERT SOC
   CEDARS IM, 1993, GYNECOLOGY OBSTET LO, P168
   DeCherney AH, 1997, SURG CLIN N AM, V77, P671, DOI 10.1016/S0039-6109(05)70574-0
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   GRAHAM HW, 1990, TECHNIQUES DIAGNOSTI
   HOMSTEIN DM, 1996, NOVAKS GYNECOLOGY, pCH27
   Klingler PJ, 1999, DIS COLON RECTUM, V42, P1639, DOI 10.1007/BF02236221
   MUNRO GM, 1996, NOVAKS GYNECOLOGY, pCH21
   PUTMAN EC, 1988, TXB DIAGNOSTIC IMAGI, P2058
   ROMER T, 1994, EUR J OBSTET GYN R B, V57, P171, DOI 10.1016/0028-2243(94)90295-X
   SKINNER KC, 1991, SOC SURGICAL RES, P381
   SKINNER KC, 1992, AM FERTILITY SOC, pS79
   Underwood RA, 1999, DIS COLON RECTUM, V42, P614, DOI 10.1007/BF02234137
   VONKURMAN JR, 1987, BLAUSTEINS PATHOLOGY, P315
NR 18
TC 50
Z9 56
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2002
VL 63
IS 1
BP 10
EP 14
DI 10.1002/jbm.10040
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 517BF
UT WOS:000173590700002
PM 11787023
DA 2018-10-20
ER

PT J
AU Kidd, KR
   Nagle, RB
   Williams, SK
AF Kidd, KR
   Nagle, RB
   Williams, SK
TI Angiogenesis and neovascularization associated with extracellular
   matrix-modified porous implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE angiogenesis; ePTFE; endothelium; extracellular matrix
ID TISSUE-RESPONSE; ENDOTHELIUM; MACROPHAGES; PROSTHESES; POROSITY; GRAFTS
AB Therapies directed toward stimulation of angiogenesis seek to accelerate the development of new blood vessels in tissues rendered dysfunctional because of an insufficient microvascular supply. The goal of the current study was the stimulation of an angiogenic response around and within porous biomedical implants, such as vascular grafts, constructed from a base polymer composed of expanded polytetrafluoroethylene (ePTFE). Similar to many biomaterial, ePTFE does not elicit a significant angiogenic response and the porous interstices of this material remain avascular after implantation. Studies were performed to evaluate the ability of a tumorigenic cell line, the 804-G rat kidney cell to secrete an angiogenic extracellular matrix on and within the porous structures of ePTFE. A rat model was used to evaluate and compare implant-associated healing responses between nonmodified materials and extracellular matrix-modified ePTFE. Results demonstrated that, in contrast to untreated ePTFE, the matrix-modified ePTFE stimulated both angiogenesis in implant-associated tissue and neovascularization of the pores within the ePTFE interstices. Deposition of an insoluble matrix stimulates an angiogenic response and has a potential application for the improvement of medical device function. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Arizona, Biomed Engn Program, Tucson, AZ 85724 USA.
   Univ Arizona, Physiol Sci Grad Program, Tucson, AZ 85724 USA.
   Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA.
RP Williams, SK (reprint author), Univ Arizona, Biomed Engn Program, 1501 N Campbell Ave, Tucson, AZ 85724 USA.
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Bellon JM, 1996, J BIOMED MATER RES, V31, P1, DOI 10.1002/(SICI)1097-4636(199605)31:1<1::AID-JBM1>3.0.CO;2-S
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   DIDISHEIM P, 1993, CARDIOVASC PATHOL, V2, pS1
   Didisheim P, 1994, ASAIO J, V40, P230, DOI 10.1097/00002480-199404000-00020
   Gerritsen M, 2000, DIABETES CARE, V23, P143, DOI 10.2337/diacare.23.2.143
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   POLVERINI PJ, 1984, LAB INVEST, V51, P635
   Polverini PJ, 1996, EUR J CANCER, V32A, P2430, DOI 10.1016/S0959-8049(96)00386-3
   Salzmann DL, 1999, CARDIOVASC PATHOL, V8, P63, DOI 10.1016/S1054-8807(98)00003-9
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   SCHREUDERS PD, 1988, J BIOMED MATER RES, V22, P121, DOI 10.1002/jbm.820220205
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   Updike SJ, 2000, DIABETES CARE, V23, P208, DOI 10.2337/diacare.23.2.208
   WILLIAMS SK, 1991, J ELECTRON MICR TECH, V19, P439, DOI 10.1002/jemt.1060190406
NR 19
TC 36
Z9 40
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 2002
VL 59
IS 2
BP 366
EP 377
DI 10.1002/jbm.1253
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 497JT
UT WOS:000172452300021
PM 11745574
DA 2018-10-20
ER

PT J
AU Zhang, XZ
   Yang, YY
   Chung, TS
AF Zhang, XZ
   Yang, YY
   Chung, TS
TI The influence of cold treatment on properties of temperature-sensitive
   poly(N-isopropylacrylamide) hydrogels
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE temperature-sensitive; hydrogel; poly(N-isopropylacrylamide); fast
   response; cold treatment
ID VOLUME PHASE-TRANSITION; FAST-RESPONSE; GELS; RELEASE; WATER; SWITCHES
AB Poly(N-isopropylacrylamide) (PNIPA-Am) hydrogel exhibits a response to external temperature variation and shrinks in volume abruptly as the temperature is increased above its lower critical solution temperature. It has great potential applications in biomedical fields. A rapid response rate is essential, especially when this material is designed as an on-off switch for targeted drug delivery. However, due to the appearance of a thick, dense skin layer on the hydrogel surface during the shrinking process, the deswelling rate of conventional PNIPAAm gels is low. In this article, a novel method is proposed to modify the surface morphology of PNIPAAm gel, in which the swollen gels are frozen at low temperature (-20degreesC). The scanning electron micrographs revealed that a fishnet-like skin layer appeared on the surfaces of the cold-treated gels. Dramatically rapid deswelling was achieved with the cold-treated gels since the fishnet-like structure with numerous small pores prevented the formation of a dense, thick skin layer during the deswelling process, which commonly occurs in normal PNIPAAm hydrogels. Prolonging the cold treatment from I day to 10 days resulted in a slightly higher deswelling rate. Rearrangement of the hydrogel matrix structure during the freezing process might contribute to the formation of the fishnet-like skin layer. The water uptake of the hydrogels increased nearly in proportion to the square root of time, indicating that the reswelling rate of hydrogels was controlled predominantly by water diffusion into the network. However, there were no significant differences in the equilibrated swelling ratio and reswelling kinetics at room temperature (22degreesC) between normal gels and cold-treated gels, which implied that cold treatment did not change bulk porosity and gel tortuosity much. (C) 2002 Elsevier Science.
C1 Inst Mat Res & Engn, Singapore 117602, Singapore.
   Natl Univ Singapore, Dept Environm Chem & Engn, Singapore 119260, Singapore.
RP Yang, YY (reprint author), Inst Mat Res & Engn, 3 Res Link, Singapore 117602, Singapore.
EM yy-yang@imre.org.sg
RI Yang, Yi Yan/C-1338-2014; Chung, Neal, Tai-Shung/D-1183-2009
OI Yang, Yi Yan/0000-0002-1871-5448; Chung, Neal,
   Tai-Shung/0000-0003-3704-8609
CR Bae Y.H., 1988, MAKROMOL CHEM-RAPID, V9, P185
   BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481
   BAE YH, 1991, PHARMACEUT RES, V8, P624, DOI 10.1023/A:1015860824953
   BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   ENSCORE DJ, 1977, POLYMER, V18, P793, DOI 10.1016/0032-3861(77)90183-5
   Grank J., 1975, MATH DIFFUSION
   Grinberg VY, 2000, MACROMOLECULES, V33, P8685, DOI 10.1021/ma000527w
   HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548
   INOMATA H, 1995, POLYMER, V36, P875, DOI 10.1016/0032-3861(95)93120-B
   INOMATA H, 1990, MACROMOLECULES, V23, P4887, DOI 10.1021/ma00224a023
   KABRA BG, 1991, POLYM COMMUN, V32, P322
   Kaneko Y, 1998, MACROMOLECULES, V31, P6099, DOI 10.1021/ma971899g
   KANEKO Y, 1995, MACROMOLECULES, V28, P7717, DOI 10.1021/ma00127a018
   MATSUO ES, 1988, J CHEM PHYS, V89, P1695, DOI 10.1063/1.455115
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   OTAKE K, 1990, MACROMOLECULES, V23, P283, DOI 10.1021/ma00203a049
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   TOKUHIRO T, 1991, MACROMOLECULES, V24, P2936, DOI 10.1021/ma00010a046
   Wu JZ, 1996, POLYMER, V37, P4803
   WU XS, 1992, J POLYM SCI POL CHEM, V30, P2121, DOI 10.1002/pola.1992.080301005
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   YOSHIDA R, 1992, J BIOMAT SCI-POLYM E, V3, P243, DOI 10.1163/156856292X00150
   Zhang XZ, 1999, COLLOID POLYM SCI, V277, P1079, DOI 10.1007/s003960050493
   Zhang XZ, 2001, LANGMUIR, V17, P6094, DOI 10.1021/la010105v
   Zhang XZ, 2001, LANGMUIR, V17, P12, DOI 10.1021/la000170p
   Zhang XZ, 2000, J COLLOID INTERF SCI, V223, P311, DOI 10.1006/jcis.1999.6654
NR 26
TC 51
Z9 51
U1 0
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD FEB 1
PY 2002
VL 246
IS 1
BP 105
EP 111
DI 10.1006/jcis.2001.8063
PG 7
WC Chemistry, Physical
SC Chemistry
GA 517MX
UT WOS:000173615300013
PM 16290390
DA 2018-10-20
ER

PT J
AU Maffia, GJ
   Slomiana, M
   Davis, JF
AF Maffia, GJ
   Slomiana, M
   Davis, JF
TI Recent advances in collagen based technologies
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
ID RESISTANCE MEASUREMENTS; COAGULATION; PARTICLES
AB Collagen dispersions, produced from ground bovine corium, have a remarkable water retention capability. This property has lead to research on applications in environmental remediation, biotechnology, biomedical engineering, and materials of construction. Widener researchers and collaborators are studying specific applications in all of these areas. Within the past year, research has focused on three areas: dispersion theology, weighted and magnetic matrices (especially microspheres), and building materials. Initial results are promising in each of these focus areas, although the production technology remains long and labor intensive. Collagen dispersions take a minimum of two weeks to prepare and crosslinked matrices can take as long as two months. Future research is ongoing to further develop the potential applications and to scale-up and shorten the production process.
C1 Widener Univ, Dept Chem Engn, Chester, PA 19013 USA.
   Widener Univ, Dept Engn Mech, Chester, PA 19013 USA.
   Widener Univ, Dept Civil Engn, Chester, PA 19013 USA.
RP Maffia, GJ (reprint author), Widener Univ, Dept Chem Engn, 1 Univ Pl, Chester, PA 19013 USA.
CR CHANG RC, 1993, UNPUB 1993 BIOENG C
   CHING HW, 1994, J ENVIRON ENG-ASCE, V120, P169, DOI 10.1061/(ASCE)0733-9372(1994)120:1(169)
   CHRISTENSEN GL, 1985, J ENVIRON ENG-ASCE, V111, P258, DOI 10.1061/(ASCE)0733-9372(1985)111:3(258)
   CHRISTENSEN GL, 1985, J ENVIRON ENG-ASCE, V111, P243, DOI 10.1061/(ASCE)0733-9372(1985)111:3(243)
   DAVIS JF, 1995, SEPAR TECHNOL, V5, P147, DOI 10.1016/0956-9618(94)00120-H
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   FINA D, 1997, AICHE ENV DIVISION P
   Herbst JA, 1989, Patent US, Patent No. 4863585
   KAWAMURA S, 1976, J AM WATER WORKS ASS, V68, P328
   KNOCKE WR, 1987, J AM WATER WORKS ASS, V79, P89
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   MAFFIA GJ, 1993, MAT RES SOC P, V331, P53
   MAFFIA GJ, 1987, POLY MAT SCI ENG, V57, P371
   MAFFIA GJ, 1988, THESIS DARTMOUTH COL
   NGIAN KF, 1980, BIOTECHNOL BIOENG, V22, P1834
   Pikal M.J., 1990, BIOPHARM, V3, P26
   RAY NG, 1990, ANN NY ACAD SCI, V589, P443, DOI 10.1111/j.1749-6632.1990.tb24263.x
   RAY NG, 1989, BIOTECHNOL BIOENG, V33, P724, DOI 10.1002/bit.260330610
   TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124
   TERRANOVA BE, 1991, BIOTECHNOL BIOENG, V37, P110, DOI 10.1002/bit.260370204
   TICE AR, 1984, SOIL SCI, V138, P63, DOI 10.1097/00010694-198407000-00010
   TICE AR, 1981, ENG GEOL, V18, P135, DOI 10.1016/0013-7952(81)90053-3
   TOSUN I, 1993, WATER SCI TECHNOL, V28, P91
   TOWGHANI KH, 2001, THESIS WIDENER U
   Webb C, 1996, CHEM ENG J BIOCH ENG, V61, P241, DOI 10.1016/0923-0467(95)03043-3
   WERNER SP, P INT C SOL WAST MAN, P17
   WILLIS MS, 1993, CHEM ENG RES DES, V61
   YOUNG MW, 1987, BIO-TECHNOL, V5, P835, DOI 10.1038/nbt0887-835
NR 28
TC 2
Z9 2
U1 0
U2 0
PU AMER LEATHER CHEMISTS ASSN
PI LUBBOCK
PA TEXAS TECH UNIV, BOX 45300, LUBBOCK, TX 79409-5300 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD FEB
PY 2002
VL 97
IS 2
BP 74
EP 81
PG 8
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA 596DX
UT WOS:000178149800004
DA 2018-10-20
ER

PT J
AU Duerig, TW
AF Duerig, TW
TI The use of superelasticity in modern medicine
SO MRS BULLETIN
LA English
DT Article
DE biomedical materials; intermetallic; shape memory; superelasticity
ID ALLOY
AB The value of Nitinol (Ni-Ti) in the field of medicine has proven to be far greater than just as the simple "springy metal" it was once considered to be. In particular, its use in vascular implants highlights many valuable yet subtle behaviors, including a "biased stiffness," enhanced fatigue resistance, low magnetic susceptibility, and good biocompatibility. Nitinol today is nearly as well known to medical-device designers and physicians as are stainless steel and titanium, and it is the enabling ingredient in a growing number of successful and profitable life-saving devices.
CR BERG B, 1999, MAT SCI ENG A, V273
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CHAN CM, 1990, SURF INTERFACE ANAL, V15, P349, DOI 10.1002/sia.740150602
   DOTTER CT, 1983, RADIOLOGY, V147, P259, DOI 10.1148/radiology.147.1.6828741
   Duerig TW, 2000, MINIM INVASIV THER, V9, P235, DOI 10.1080/13645700009169654
   HUGHES JL, 1976, EVALUATION NITINOL U
   NICHOLSON JK, 1986, Patent No. 4616656
   NONNENMANN MJ, 1975, THESIS U IOWA
   PELTON A, 1997, P SMST 97 SHAP MEM S, P407
   SAKAMOTO H, 1990, Patent No. 4925445
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
NR 11
TC 38
Z9 38
U1 1
U2 12
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD FEB
PY 2002
VL 27
IS 2
BP 101
EP 104
DI 10.1557/mrs2002.44
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 522TE
UT WOS:000173912400017
DA 2018-10-20
ER

PT J
AU Arie, A
   Fradkin-Kashi, K
   Shreberk, Y
AF Arie, A
   Fradkin-Kashi, K
   Shreberk, Y
TI Frequency conversion in novel materials and its application to high
   resolution gas sensing
SO OPTICS AND LASERS IN ENGINEERING
LA English
DT Article
DE optical sensor; laser
ID PERIODICALLY-POLED RBTIOASO4; OPTICAL PARAMETRIC OSCILLATOR; FLUX-GROWN
   KTIOPO4; ELECTRIC-FIELD; 2ND-HARMONIC GENERATION; SPECTROSCOPY;
   KTIOASO4; CRYSTALS; LINBO3
AB We have constructed a compact room-temperature mid-infrared spectrometer and gas sensor, based on quasi-phase matched difference-frequency generation in periodically poled ferroelectric crystals of the KTiOPO4 family, namely: KTiOPO4, KTiOASO(4) and RbTiOAsO4. The wide tunabilty of the spectrometer (3.1-3.75 mum) enables us to cover an entire vibrational band of gases such as methane and nitrous oxide. The high spectral resolution (similar to1 MHz) is used to investigate the spectral profile of the hyperfine components of a single rotational transition. The sensitivity of the described spectrometer is similar to75 parts per million. Applications of this technology include the detection of polluting or toxic gases, biomedical sensing, atmospheric research, volcanic monitoring and industrial process control. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Tel Aviv Univ, Fac Engn, Dept Elect Engn, IL-69978 Tel Aviv, Israel.
RP Arie, A (reprint author), Tel Aviv Univ, Fac Engn, Dept Elect Engn, IL-69978 Tel Aviv, Israel.
CR ARMSTRONG BH, 1967, J QUANT SPECTROSC RA, V7, P61, DOI 10.1016/0022-4073(67)90057-X
   ARMSTRONG JA, 1962, PHYS REV, V127, P1918, DOI 10.1103/PhysRev.127.1918
   BARNES WL, 1972, J CHEM PHYS, V56, P5160, DOI 10.1063/1.1677002
   BIERLEIN JD, 1989, J OPT SOC AM B, V6, P622, DOI 10.1364/JOSAB.6.000622
   BJORKLUND GC, 1980, OPT LETT, V5, P15, DOI 10.1364/OL.5.000015
   BOSENBERG WR, 1994, APPL PHYS LETT, V65, P2765, DOI 10.1063/1.112556
   CHEN Q, 1994, ELECTRON LETT, V30, P1516, DOI 10.1049/el:19941019
   Cheng L. K., 1993, Ferroelectrics, V142, P209, DOI 10.1080/00150199308237899
   Fradkin K, 1999, APPL PHYS LETT, V74, P914, DOI 10.1063/1.123408
   Fradkin-Kashi K, 2000, OPT LETT, V25, P743, DOI 10.1364/OL.25.000743
   Fradkin-Kashi K, 1999, IEEE J QUANTUM ELECT, V35, P1649, DOI 10.1109/3.798088
   Fradkin-Kashi K, 2000, APPL PHYS B-LASERS O, V71, P251, DOI 10.1007/s003400000373
   HALL JL, 1981, APPL PHYS LETT, V39, P680, DOI 10.1063/1.92867
   Hu ZW, 1996, J PHYS D APPL PHYS, V29, P1681, DOI 10.1088/0022-3727/29/6/040
   Inbar E, 1999, APPL PHYS B-LASERS O, V68, P99, DOI 10.1007/s003400050593
   Karlsson H, 1997, APPL PHYS LETT, V71, P3474, DOI 10.1063/1.120363
   Karlsson H, 1996, ELECTRON LETT, V32, P556, DOI 10.1049/el:19960402
   Karlsson H, 1999, OPT LETT, V24, P330, DOI 10.1364/OL.24.000330
   Mazzotti D, 2000, OPT LETT, V25, P350, DOI 10.1364/OL.25.000350
   MYERS LE, 1995, J OPT SOC AM B, V12, P2102, DOI 10.1364/JOSAB.12.002102
   Rosenman G, 1999, J PHYS D APPL PHYS, V32, pL49, DOI 10.1088/0022-3727/32/14/101
   Rosenman G, 1998, APPL PHYS LETT, V73, P3650, DOI 10.1063/1.122851
   Rothman LS, 1998, J QUANT SPECTROSC RA, V60, P665, DOI 10.1016/S0022-4073(98)00078-8
   Weise DR, 2000, OPT COMMUN, V184, P329, DOI 10.1016/S0030-4018(00)00950-0
   YAMADA M, 1993, APPL PHYS LETT, V62, P435, DOI 10.1063/1.108925
   ZHU SN, 1995, APPL PHYS LETT, V67, P320, DOI 10.1063/1.115431
NR 26
TC 10
Z9 11
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-8166
J9 OPT LASER ENG
JI Opt. Lasers Eng.
PD FEB-MAR
PY 2002
VL 37
IS 2-3
BP 159
EP 170
DI 10.1016/S0143-8166(01)00093-8
PG 12
WC Optics
SC Optics
GA 516BW
UT WOS:000173532500007
DA 2018-10-20
ER

PT J
AU Iwaki, M
AF Iwaki, M
TI Use of ion sources for nonsemiconductor surface modification (plenary)
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Ion Sources (ICIS)
CY SEP 03-07, 2001
CL OAKLAND, CALIFORNIA
SP Lawrence Berkeley Natl Lab, Axcells Technologies Inc, AccSys Technol Inc, Bergoz Instrumentat, Chabot Space & Sci Ctr, Dehnel Consulting Ltd, GMW Associates, INTMAG EGUN IGUN
ID IMPLANTATION
AB At RIKEN, studies have been made on surface modification of metals, ceramics, and polymers using ion implantation in order to improve surface properties of various materials. For fundamental studies of surface modification, about 60 kinds of ions have been used as implanted elements, using rf-type, Nielsen-type, and hollow cathode-type ion sources. The Nielsen-type ion source has been the most useful for obtaining various ion species by modification to the evaporation oven and by selection of the source material. High current beams of some kinds of ions were obtained using Freeman-type or microwave-type ion sources. Ion beam modification with nonmass analyzed ions was investigated for practicable use of ion implantation. In this article, these ion sources are described, and their utilization in a variety of applications is reviewed. The improvement of the lifetime of tools by nitrogen implantation is introduced as a topic in the fields of nonsemiconductor materials, and several points for expansion of the field are emphasized. As a successful example in Japan, the dynamic mixing used in industry is introduced and ion sources are shown to be one of the technologically important factors. Plasma based ion implantation is compared with traditional surface finishing. Finally, the fabrication of small vascular grafts controlling cell adhesion is introduced as the applications of ion beams to biomedical materials. (C) 2002 American Institute of Physics.
C1 RIKEN, Characterizat Ctr, Wako, Saitama 3510198, Japan.
RP Iwaki, M (reprint author), RIKEN, Characterizat Ctr, Hirosawa 2-1, Wako, Saitama 3510198, Japan.
CR BEHAR M, 2001, NUCL INSTRUM METHO B, V175
   IWAKI M, 1985, NUCL INSTRUM METH B, V6, P51, DOI 10.1016/0168-583X(85)90609-3
   IWAKI M, 1981, NUCL INSTRUM METHODS, V189, P155, DOI 10.1016/0029-554X(81)90139-7
   IWAKI M, 1989, NUCL INSTRUM METH B, V37-8, P661, DOI 10.1016/0168-583X(89)90270-X
   IWAKI M, 1985, MATER SCI ENG, V69, P211, DOI 10.1016/0025-5416(85)90393-3
   IWAKI M, 1983, NUCL INSTRUM METHODS, V209, P941, DOI 10.1016/0167-5087(83)90903-1
   IWAKI M, 1999, 1998 INT C ION IMPL, P824
   IWAKI M, 1981, RIKEN ACCELERATOR PR, V15, P10
   Kurotobi K, 2001, NUCL INSTRUM METH B, V175, P791, DOI 10.1016/S0168-583X(00)00526-7
   Mantese JV, 1996, MRS BULL, V21, P52
   Matteson S., 1982, Metastable Materials Formation by Ion Implantation. Proceedings of the Materials Research Society Annual Meeting, P3
   MIYANO T, 1994, SURF COAT TECH, V65, P179, DOI 10.1016/S0257-8972(94)80028-6
   SASAKI J, COMMUNICATION
   SATOU M, 1983, JPN J APPL PHYS, V22, P171
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V19-20, P204, DOI 10.1016/S0168-583X(87)80043-5
   SUZUKI Y, 1991, NUCL INSTRUM METH B, V59, P698, DOI 10.1016/0168-583X(91)95306-X
   SUZUKI Y, 1994, NUCL INSTRUM METH B, V91, P588
   Takeuchi T, 1998, P 27 TURB S TEX, P39
   WITTKOWER A, 1985, NUCL INSTRUM METH B, V6, P78, DOI 10.1016/0168-583X(85)90613-5
NR 19
TC 8
Z9 8
U1 1
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD FEB
PY 2002
VL 73
IS 2
BP 863
EP 867
DI 10.1063/1.1431709
PN 2
PG 5
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 522WY
UT WOS:000173921000115
DA 2018-10-20
ER

PT J
AU Miyata, T
   Uragami, T
   Nakamae, K
AF Miyata, T
   Uragami, T
   Nakamae, K
TI Biomolecule-sensitive hydrogels
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE stimuli-sensitive hydrogel; biomolecule-sensitive hydrogel;
   glucose-sensitive hydrogel; antigen-sensitive hydrogel; enzymatically
   degradable hydrogel; biomolecular interaction
ID INTERPENETRATING POLYMER NETWORKS; CRITICAL SOLUTION TEMPERATURE;
   PHENYLBORONIC ACID MOIETIES; RESPONSIVE INSULIN RELEASE; INDUCED
   PHASE-TRANSITIONS; DELIVERY SYSTEM; DRUG-DELIVERY;
   N-ISOPROPYLACRYLAMIDE; POLY(VINYL ALCOHOL); GLUCOSE-SENSITIVITY
AB Stimuli-sensitive hydrogels have attracted considerable attention as intelligent materials in the biochemical and biomedical fields, since they can sense environmental changes and induce structural changes by themselves. In particular, biomolecule-sensitive hydrogels that undergo swelling changes in response to specific biomolecules have become increasingly important because of their potential applications in the development of biomaterials and drug delivery systems. This article provides an over-view of the important and historical research regarding the synthesis and applications of glucose-sensitive hydrogels which exhibit swelling changes in response to glucose concentration. Enzymatically degradable hydrogels and antigen-sensitive hydrogels are also described in detail as protein-sensitive hydrogels that can respond to larger biomolecules. The synthetic strategies of other biomolecule-sensitive hydrogels are summarized on the basis of molecular imprinting and specific interaction. The biomolecule-sensitive hydrogels reviewed in this paper are expected to contribute significantly to the exploration and development of newer generations of intelligent biomaterials and self-regulated drug delivery systems. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Kansai Univ, Unit Chem, Fac Engn & High Technol Res Ctr, Suita, Osaka 5648680, Japan.
   Kobe Univ, Fac Engn, Dept Sci & Chem Engn, Kobe, Hyogo 6578501, Japan.
RP Miyata, T (reprint author), Kansai Univ, Unit Chem, Fac Engn & High Technol Res Ctr, Suita, Osaka 5648680, Japan.
EM tmiyata@ipcku.kansai-u.ac.jp
CR Akala EO, 1998, BIOMATERIALS, V19, P1037, DOI 10.1016/S0142-9612(98)00023-4
   ALBIN G, 1985, Journal of Controlled Release, V2, P153, DOI 10.1016/0168-3659(85)90041-0
   ALBIN G W, 1987, Journal of Controlled Release, V6, P267, DOI 10.1016/0168-3659(87)90081-2
   AMIYA T, 1987, J CHEM PHYS, V86, P2375, DOI 10.1063/1.452740
   ANDERSON JM, 1990, J CONTROL RELEASE, V11, pR7, DOI 10.1016/0168-3659(90)90116-B
   ANNAKA M, 1992, NATURE, V355, P430, DOI 10.1038/355430a0
   Aoki T, 1996, POLYM J, V28, P371, DOI 10.1295/polymj.28.371
   Aoki T, 1998, REACT FUNCT POLYM, V37, P299, DOI 10.1016/S1381-5148(97)00128-4
   Aoki T, 2001, MACROMOLECULES, V34, P3118, DOI 10.1021/ma001866s
   Aoki T, 1999, POLYM J, V31, P1185, DOI 10.1295/polymj.31.1185
   AOKI T, 1999, POLYM PREP JPN, V48, P3124
   BRANNONPEPPAS L, 1989, J CONTROL RELEASE, V8, P267, DOI 10.1016/0168-3659(89)90048-5
   BRAZEL CS, 1995, MACROMOLECULES, V28, P8016, DOI 10.1021/ma00128a007
   BROWNLEE M, 1979, SCIENCE, V206, P1190, DOI 10.1126/science.505005
   CARTIER S, 1995, J MEMBRANE SCI, V106, P17, DOI 10.1016/0376-7388(95)00073-L
   Chasin M, 1990, BIODEGRADABLE POLYM
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   DeRossi D., 1991, POLYM GELS FUNDAMENT
   DIAMONDS EP, 1996, IMMUNOASSAY
   DONG LC, 1990, J CONTROL RELEASE, V13, P21, DOI 10.1016/0168-3659(90)90071-Z
   DONG LC, 1991, J CONTROL RELEASE, V15, P141, DOI 10.1016/0168-3659(91)90072-L
   DUSEK K, 1993, ADV POLYM SCI, V109
   DUSEK K, 1993, ADV POLYM SCI, V110
   Ghandehari H, 1996, MACROMOL CHEM PHYS, V197, P965, DOI 10.1002/macp.1996.021970317
   Ghandehari H, 1997, BIOMATERIALS, V18, P861, DOI 10.1016/S0142-9612(97)00007-0
   Hassan CM, 1997, MACROMOLECULES, V30, P6166, DOI 10.1021/ma970117g
   HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   Hollinger J.O., 1995, BIOMEDICAL APPL SYNT
   HOVGAARD L, 1995, J CONTROL RELEASE, V36, P159, DOI 10.1016/0168-3659(95)00049-E
   Huh KM, 2000, MACROMOL CHEM PHYSIC, V201, P613, DOI 10.1002/(SICI)1521-3935(20000301)201:5<613::AID-MACP613>3.0.CO;2-I
   IRIE M, 1993, ADV POLYM SCI, V110, P49
   ISHIHARA K, 1986, J POLYM SCI POL LETT, V24, P413, DOI 10.1002/pol.1986.140240809
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   KATAOKA K, 1994, MACROMOLECULES, V27, P1061, DOI 10.1021/ma00082a028
   Kataoka K, 1998, J AM CHEM SOC, V120, P12694, DOI 10.1021/ja982975d
   KATONO H, 1991, J CONTROL RELEASE, V16, P215, DOI 10.1016/0168-3659(91)90045-F
   Kikuchi A, 1996, ANAL CHEM, V68, P823, DOI 10.1021/ac950748d
   KITANO S, 1991, MAKROMOL CHEM-RAPID, V12, P227
   KITANO S, 1992, J CONTROL RELEASE, V19, P162
   KOKUFATA E, 1991, NATURE, V351, P302, DOI 10.1038/351302a0
   Kurisawa M, 1998, MACROMOL CHEM PHYSIC, V199, P705, DOI 10.1002/(SICI)1521-3935(19980401)199:4<705::AID-MACP705>3.3.CO;2-0
   Kurisawa M, 1997, J BIOMAT SCI-POLYM E, V8, P691, DOI 10.1163/156856297X00506
   Kurisawa M, 1998, J CONTROL RELEASE, V54, P191, DOI 10.1016/S0168-3659(97)00247-2
   Lee SJ, 1996, J MOL RECOGNIT, V9, P549, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<549::AID-JMR299>3.0.CO;2-C
   MAKINO K, 1990, J CONTROL RELEASE, V12, P235, DOI 10.1016/0168-3659(90)90104-2
   Miyata T, 1999, MACROMOLECULES, V32, P2082, DOI 10.1021/ma981659g
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Miyata T, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P237
   Miyata T, 1997, TRENDS POLYM SCI, V5, P198
   Miyata T, 1996, MACROMOL CHEM PHYSIC, V197, P1135, DOI 10.1002/macp.1996.021970330
   MIYATA T, 1994, MACROMOL CHEM PHYSIC, V195, P1111, DOI 10.1002/macp.1994.021950401
   MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X
   MURAI N, 1995, J BIOL CHEM, V270, P19957, DOI 10.1074/jbc.270.34.19957
   Nakamae K, 1997, J BIOMAT SCI-POLYM E, V9, P43, DOI 10.1163/156856297X00254
   NAKAMAE K, 1994, J BIOMAT SCI-POLYM E, V6, P79, DOI 10.1163/156856295X00779
   NATSUME T, 1994, J BIOL CHEM, V269, P31224
   Obaidat AA, 1996, PHARM RES-DORDR, V13, P989, DOI 10.1023/A:1016090103979
   Obaidat AA, 1997, BIOMATERIALS, V18, P801, DOI 10.1016/S0142-9612(96)00198-6
   OKANO T, 1993, ADV POLYM SCI, V110, P179
   OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J
   Okano T., 1998, BIORELATED POLYM GEL
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   Oya T, 1999, SCIENCE, V286, P1543, DOI 10.1126/science.286.5444.1543
   Parker RS, 1999, IEEE T BIO-MED ENG, V46, P148, DOI 10.1109/10.740877
   Peppas N. A., 1987, HYDROGELS MED PHARM
   SAFFRAN M, 1986, SCIENCE, V233, P1081, DOI 10.1126/science.3526553
   SELLERGREN B, 1988, J AM CHEM SOC, V110, P5853, DOI 10.1021/ja00225a041
   SEMINOFF LA, 1989, INT J PHARM, V54, P241, DOI 10.1016/0378-5173(89)90101-4
   SHEA KJ, 1994, TRENDS POLYM SCI, V2, P166
   Shiino D, 1995, J CONTROL RELEASE, V37, P269, DOI 10.1016/0168-3659(95)00084-4
   SIEGEL RA, 1993, ADV POLYM SCI, V109, P233
   SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0
   TANAKA T, 1978, PHYS REV LETT, V40, P820, DOI 10.1103/PhysRevLett.40.820
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   TANAKA T, 1980, PHYS REV LETT, V45, P1636, DOI 10.1103/PhysRevLett.45.1636
   Wang GQ, 2000, P NATL ACAD SCI USA, V97, P9861, DOI 10.1073/pnas.180192597
   Watanabe M, 1998, J AM CHEM SOC, V120, P5577, DOI 10.1021/ja973070n
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   WULFF G, 1973, TETRAHEDRON LETT, P4329
   Yamamoto N, 1996, MACROMOL RAPID COMM, V17, P313, DOI 10.1002/marc.1996.030170505
   YEH PY, 1995, MACROMOL CHEM PHYS, V196, P2183, DOI 10.1002/macp.1995.021960709
   YEH PY, 1994, J POLYM SCI POL CHEM, V32, P1627, DOI 10.1002/pola.1994.080320904
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
NR 84
TC 485
Z9 497
U1 15
U2 346
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JAN 17
PY 2002
VL 54
IS 1
BP 79
EP 98
DI 10.1016/S0169-409X(01)00241-1
PG 20
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 517AU
UT WOS:000173589600006
PM 11755707
DA 2018-10-20
ER

PT J
AU Vago, R
   Plotquin, D
   Bunin, A
   Sinelnikov, I
   Atar, D
   Itzhak, D
AF Vago, R
   Plotquin, D
   Bunin, A
   Sinelnikov, I
   Atar, D
   Itzhak, D
TI Hard tissue remodeling using biofabricated coralline biomaterials
SO JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
LA English
DT Article; Proceedings Paper
CT Era of Biotechnology Internatiuonal Conference
CY OCT, 2000
CL BEN-GURION UNIV NEGEV, BEER SHEVA, ISRAEL
HO BEN-GURION UNIV NEGEV
DE bone; cartilage; biomaterial; remodeling; calcium carbonate; hydrocoral
AB Biotechnical and biomedical approaches were combined in an attempt to identify potential uses of biofabricated marine carbonate materials in biomedical applications. particularly as biomatrices for remodeling bone and cartilage tissue. After grafting, it is desirable for bone ingrowth to proceed as quickly as possible because the strength of the implanted region depends on a good mechanical bond forming between the implant and surrounding regions in the body. Ingrowth can take place as a result of growth of tissue and cells into the implanted porous material. or it may be promoted by transplanting cells seeded onto such a material. The rate at which ingrowth occurs is dependent on many factors, including pore size and the interconnectivity of the implanted structure. In vivo graftings into osteochondral defects demonstrated that our biofabricated porous material is highly biocompatible with cartilage and bone tissue. The biofabricated matrix was well incorporated into the biphasic osteochondral area. Resorption was followed by bone and cartilage formation, and after 4 months, the biomaterial had been replaced by new tissue. Ossification was induced and enhanced without introduction of additional factors. We believe that this is the first time that such biofabricated materials have been used for biomedical purposes. In face of the obvious environmental disadvantages of harvesting from limited natural resources, we propose the use of bioengineered coralline and other materials such as those cultured by our group under field and laboratory conditions as a possible biomatrix for hard tissue remodeling. (C) 2002 Elsevier Science B.V, All rights reserved.
C1 Ben Gurion Univ Negev, Inst Appl Biosci, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Orthoped Surg, IL-84105 Beer Sheva, Israel.
   Soroka Med Ctr, Dept Pathol, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Mat Engn, IL-84105 Beer Sheva, Israel.
RP Vago, R (reprint author), Ben Gurion Univ Negev, Inst Appl Biosci, IL-84105 Beer Sheva, Israel.
CR ABRAMOVITCHGOTT.L, 2001, J BIOCH BIOPHYS METH
   BENNISSAN B, 2000, BIOCERAMICS KEY ENG, V191, P959
   BRIAN K, 1993, BONE, V14, P225
   BRONZINO J, 1995, BIOMEDICAL ENG HDB
   Dee KC, 1996, BIOTECHNOL BIOENG, V50, P438, DOI 10.1002/(SICI)1097-0290(19960520)50:4<438::AID-BIT11>3.0.CO;2-F
   DUNN MG, 1994, IMPLANTATION BIOL HO, P230
   Hench L. L., 1993, INTRO BIOCERAMICS, P1
   Hu J, 2000, J MATER SCI TECHNOL, V16, P591
   LACEFIELD R, 1993, INTRO BIOCERAMICS, P223
   Shahgaldi BF, 1998, BIOMATERIALS, V19, P205, DOI 10.1016/S0142-9612(98)80002-1
   Vago R, 1997, NATURE, V386, P30, DOI 10.1038/386030a0
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
NR 12
TC 40
Z9 40
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-022X
J9 J BIOCHEM BIOPH METH
JI J. Biochem. Biophys. Methods
PD JAN 4
PY 2002
VL 50
IS 2-3
BP 253
EP 259
DI 10.1016/S0165-022X(01)00235-4
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 510CE
UT WOS:000173190500014
PM 11741712
DA 2018-10-20
ER

PT J
AU Kleps, I
   Angelescu, A
   Miu, M
AF Kleps, I
   Angelescu, A
   Miu, M
TI Measurement systems based on metal/dielectric nanostructures for
   electrochemical analyses
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT EMRS Spring Meeting
CY JUN 05-08, 2001
CL STRASBOURG, FRANCE
SP EMRS
DE nanostructures; nanoetectrodes; array; working electrode
AB In this paper, we described and compared various techniques and materials for dielectric/ metal /dielectric nanostructure fabrication in order to choose the best solution for electrochemical system applications. The metal /dielectric nanostructures proposed to be realised by standard Si technology processes are nanoelectrode (NE) arrays, and they will be used as the working electrode in the electrochemical systems. They are more suitable and reproducible than similar self-organised nanostructures. The design calculation reveals better electrical characteristics for the systems with spaced electrodes, where the inactive area is higher than the active zone. The measured current is three orders of magnitude higher for the array with micrometric distances between two adjacent nanoelectrodes than for nanometric distances. The described SiO2/pt/Si3N4 nanostructures have important applications in the electrochemical system fabrication for pollution control and biomedical measurements. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 IMT Bucharest, Natl Inst Res & Dev Microtechnol, Bucharest 72996, Romania.
RP Kleps, I (reprint author), IMT Bucharest, Natl Inst Res & Dev Microtechnol, POB 38-160, Bucharest 72996, Romania.
RI Kusko, Mihaela/C-4964-2012
OI Kusko, Mihaela/0000-0001-6773-8745
CR KLEPS I, 2001, BIOMEDICAL MICRODEVI, V3, P27
   PRUNEANU S, 2000, CAS 2000 P, V2, P475
NR 2
TC 13
Z9 13
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN 2
PY 2002
VL 19
IS 1-2
SI SI
BP 219
EP 223
DI 10.1016/S0928-4931(01)00469-6
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 508GQ
UT WOS:000173080700046
DA 2018-10-20
ER

PT S
AU Barber, HB
   Hunter, WCJ
   Peterson, TE
   Parker, BH
   Woolfenden, JM
AF Barber, HB
   Hunter, WCJ
   Peterson, TE
   Parker, BH
   Woolfenden, JM
BE Seibert, JA
TI Production of 64x64 hybrid semiconductor detector arrays for biomedical
   applications
SO 2001 IEEE NUCLEAR SCIENCE SYMPOSIUM, CONFERENCE RECORDS, VOLS 1-4
SE IEEE NUCLEAR SCIENCE SYMPOSIUM - CONFERENCE RECORD
LA English
DT Proceedings Paper
CT IEEE Nuclear Science Symposium
CY NOV 04-10, 2001
CL SAN DIEGO, CA
SP IEEE, Nucl Plasma Sci Soc
ID CDZNTE
AB Over the past year, we have produced 21 hybrid semiconductor arrays. Each hybrid is composed of a 64x64 readout integrated circuit, indium bump bonded to a pixelated semiconductor array made of CdZnTe or CdTe. The focus of this effort has been to produce a few nearly perfect devices for use in planar spot-imaging systems and a small-animal SPECT imager. We have succeeded in producing a few arrays with >99% functional pixels that can approximate a perfect detector if small numbers of bad pixels are removed by smoothing with nearest-neighbor pixels. The key to this effort is careful selection of detector materials using infrared transmission mapping and gamma-ray response mapping, as well as the limitation of pixel losses in the fabrication process.
C1 Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA.
RP Barber, HB (reprint author), Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA.
CR Barber HB, 1997, J ELECTRON MATER, V26, P765, DOI 10.1007/s11664-997-0229-y
   Kastis GA, 2000, IEEE T NUCL SCI, V47, P1923, DOI 10.1109/23.914471
   Marks D.G., 2000, THESIS U ARIZONA
   PARKER BH, 2001, P SPIE, V4507
NR 4
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1082-3654
BN 0-7803-7324-3
J9 IEEE NUCL SCI CONF R
PY 2002
BP 1045
EP 1049
PG 5
WC Engineering, Electrical & Electronic; Nuclear Science & Technology;
   Imaging Science & Photographic Technology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Engineering; Nuclear Science & Technology; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
GA BV30L
UT WOS:000178495800228
DA 2018-10-20
ER

PT S
AU Jung, HJ
   Kim, HJ
   Hong, SN
   Hong, JO
   Jeong, HK
   Je, JH
   Kim, BR
   Yoo, HS
AF Jung, HJ
   Kim, HJ
   Hong, SN
   Hong, JO
   Jeong, HK
   Je, JH
   Kim, BR
   Yoo, HS
BE Seibert, JA
TI Computed microtomography (mu CT) with unmonochromatized synchrotron
   x-rays for cancerous human breast tissue and mouse vertebra
SO 2001 IEEE NUCLEAR SCIENCE SYMPOSIUM, CONFERENCE RECORDS, VOLS 1-4
SE IEEE NUCLEAR SCIENCE SYMPOSIUM - CONFERENCE RECORD
LA English
DT Proceedings Paper
CT IEEE Nuclear Science Symposium
CY NOV 04-10, 2001
CL SAN DIEGO, CA
SP IEEE, Nucl Plasma Sci Soc
DE synchrotron radiation; unmonochromatized x-ray; computed microtomography
   (mu CT); spatial resolution; modulation transfer function (MTF)
ID RADIATION MICROTOMOGRAPHY; PHANTOM; IMAGE
AB The use of x-ray computed microtomography (gCT) has increased in biomedical research and industrial applications. The inherited high quality of synchrotron radiation (SR) x-rays such as high flux, collimation, and coherence have been used recently to produce radiographic images with high lateral resolution and contrast. A simple and stable imaging system using unmonochromatized SR source based on the principle of phase contrast x-ray imaging consists of a CCD detector coupled with optical lens system at the Pohang Light Source (PLS) 5C1 beamline. The spatial resolution of the imaging system was determined using the modulation transfer function (MTF), which was measured by sequential calculations obtained from sharp edge images. Projection image datawere obtained at 250 steps over 180 degrees of rotation with an acquisition time of 30 to 150 msec per projection image, depending on the imaged object materials, and tomographic images were reconstructed using a simple filtered backprojection algorithm. Although the use of a monochromatic x-ray beam has demonstrated for high resolution and enhanced contrast, our approach uses unmonochromatized SR x-ray beam and show similar image capability without sophisticated x-ray optics in a relatively shorter exposure time, less than two orders of exposure time. The current PLS 50 SR imaging system can produce projection images at a spatial resolution of 8.3 ?m over a field of view of about 5 mm at an exposure time of 30 msec per projection image for 1.5x optical magnification. This study presents the results of SR muCT images upon cancerous human breast tissue containing microcalcifications, mouse lumbar vertebra, and mouse coccygeal vertebra. The unmonochromatized SR muCT imaging system provides an effective means of evaluating microstructures, not only in biomedical specimens but also in inorganic samples.
C1 Yonsei Univ, Coll Med, Dept Radiol,BK21 Project Med Sci, Res Inst Radiol Sci,Seodaemoon Ku, Seoul 120751, South Korea.
RP Kim, HJ (reprint author), Yonsei Univ, Coll Med, Dept Radiol,BK21 Project Med Sci, Res Inst Radiol Sci,Seodaemoon Ku, 134 Shinchon Dong, Seoul 120751, South Korea.
CR Beckmann F, 1997, J COMPUT ASSIST TOMO, V21, P539, DOI 10.1097/00004728-199707000-00006
   Bonse U, 1996, PROG BIOPHYS MOL BIO, V65, P133, DOI 10.1016/S0079-6107(96)00011-9
   Dowd BA, 1999, P SOC PHOTO-OPT INS, V3772, P224, DOI 10.1117/12.363725
   Fetterly KA, 2000, MED PHYS, V27, P2669, DOI 10.1118/1.1326449
   Hwu Y, 1999, J APPL PHYS, V86, P4613, DOI 10.1063/1.371411
   HWU Y, 2001, NUCL INSTRUMENTS MET, P1294
   Kim HJ, 2001, PROC SPIE, V4320, P409, DOI 10.1117/12.430898
   Kim HJ, 2001, IEEE T NUCL SCI, V48, P837, DOI 10.1109/23.940172
   Kleuker U, 1998, PHYS MED BIOL, V43, P2911, DOI 10.1088/0031-9155/43/10/017
   Meyer RR, 2000, MICROSC RES TECHNIQ, V49, P269
   Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736
   Shimizu F, 2000, PROC SPIE, V3977, P196
   Stamatakis HC, 2000, DENTOMAXILLOFAC RAD, V29, P28, DOI 10.1038/sj.dmfr.4600497
   Takeda T, 1998, J SYNCHROTRON RADIAT, V5, P1133, DOI 10.1107/S0909049597020116
   Takeda T, 2000, RADIOLOGY, V214, P298, DOI 10.1148/radiology.214.1.r00ja08298
   Umetani K, 2000, PROC SPIE, V3977, P522, DOI 10.1117/12.384528
NR 16
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1082-3654
BN 0-7803-7324-3
J9 IEEE NUCL SCI CONF R
PY 2002
BP 1673
EP 1677
PG 5
WC Engineering, Electrical & Electronic; Nuclear Science & Technology;
   Imaging Science & Photographic Technology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Engineering; Nuclear Science & Technology; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
GA BV30L
UT WOS:000178495800367
DA 2018-10-20
ER

PT S
AU Wu, SJ
   Jeng, CA
   Huang, JL
AF Wu, SJ
   Jeng, CA
   Huang, JL
BE Yuhas, DE
   Schneider, SC
TI Ultrasonic evaluation of thermally shocked Cr3C2/Al2O3
SO 2002 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1 AND 2
SE ULTRASONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT IEEE International Ultrasonic Symposium
CY OCT 08-11, 2002
CL MUNICH, GERMANY
SP IEEE Ultrason, Ferroelect & Frequency Control Soc
DE ultrasound; NDE; Cr3C2/Al2O3 composite
ID MECHANICAL-PROPERTIES; COMPOSITES; MICROSTRUCTURE
AB Chromium carbide (Cr3C2) has been proved to be a potential material for toughening alumina in biomedical and industrial applications because of its high Young"s modulus and erosion resistance. On the other hand, TiC/Al2O3 composite has been used a magnetic head slider due to its good wear resistance and mechanical strength. In this study we prepare samples of Cr3C2/Al2O3 composite by injection moulding method. To use this ceramic material as structural components when the temperature varies rapidly, it is necessary to be able to estimate damage or thermal shock cracking. Ultrasonic attenuation measurements are made for assessment of thermal shock damage. Results show that the attenuation increases as the shock temperature raises. Corresponding SEM pictures show although the size of micro-crack doesn't change the depth of the micro-cracks increases. It is demonstrated that ultrasonic attenuation proves to be a reliable tool for evaluating micro-fractures in solids.
C1 I Shou Univ, Dept Mech Engn, Kaohsiung, Taiwan.
RP Wu, SJ (reprint author), I Shou Univ, Dept Mech Engn, Kaohsiung, Taiwan.
CR FU CT, 1994, J MATER SCI, V29, P2671, DOI 10.1007/BF00356816
   FU CT, 1993, J MATER SCI, V28, P6285, DOI 10.1007/BF01352185
   HEFETZ M, 1992, J AM CERAM SOC, V75, P1839, DOI 10.1111/j.1151-2916.1992.tb07205.x
   Huang JL, 1999, CERAM INT, V25, P141, DOI 10.1016/S0272-8842(98)00014-5
   Huang JL, 1997, MATER CHEM PHYS, V51, P211, DOI 10.1016/S0254-0584(97)80309-4
   JENGA CA, IN PRESS CERAMICS IN
   Lii DF, 1996, J CERAM SOC JPN, V104, P796, DOI 10.2109/jcersj.104.796
   ROKHLIN SL, 1993, CERAMIC ENG SCI P, V7, P454
NR 8
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 0-7803-7582-3
J9 ULTRASON
PY 2002
BP 873
EP 876
DI 10.1109/ULTSYM.2002.1193536
PG 4
WC Acoustics; Engineering, Electrical & Electronic; Instruments &
   Instrumentation
SC Acoustics; Engineering; Instruments & Instrumentation
GA BW47M
UT WOS:000182111700194
DA 2018-10-20
ER

PT S
AU Stokes, DJ
   Rea, SM
   Porter, AE
   Best, SM
   Bonfield, W
AF Stokes, DJ
   Rea, SM
   Porter, AE
   Best, SM
   Bonfield, W
BE Moss, SC
TI Characterisation of biomedical materials, cells & interfaces using
   environmental SEM (ESEM)
SO ADVANCED BIOMATERIALS-CHARACTERIZATION, TISSUE ENGINEERING AND
   COMPLEXITY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposia on Physical Characterization of Biological Materials and
   Systems/Polymeric Biomaterials for Tissue Engineering/BioInspired
   Materials-Moving Toward Complexity
CY NOV 26-29, 2001
CL BOSTON, MA
SP Mat Res Soc
ID ELECTRON
AB The ability of Environmental Scanning Electron Microscopy (ESEM) to image insulating and/or moist specimens without the need for the removal of volatile components or the application of a conductive coating has significantly increased the potential range of experiments and observations that can be performed at the high resolution of electron microscopy. Such a technological advance has particularly important implications for the study of soft matter, complex fluids and biological specimens [1], Thus an important field of research to which ESEM can be applied is the study of materials for biomedical applications such as tissue engineering. The bioactivity of these materials is dependent upon such factors as phase composition, chemical composition, surface activity, crystallinity and microstructure. Using ESEM it is possible to obtain surface-sensitive, specimen-dependent secondary electron images (in the absence of specimen coating), yielding potentially new perspectives on microstructure to complement information derived from other techniques. We have used ESEM to study the apposition of bone on hydroxyapatite-based biomedical materials, from both in vitro and in vivo investigations.
C1 Univ Cambridge, Dept Phys, Cavendish Lab, Polymers & Colloids Grp, Cambridge CB3 0HE, England.
RP Stokes, DJ (reprint author), Univ Cambridge, Dept Phys, Cavendish Lab, Polymers & Colloids Grp, Madingley Rd, Cambridge CB3 0HE, England.
CR BONFIELD W, 1988, J BIOMED ENG, V10, P522, DOI 10.1016/0141-5425(88)90110-0
   CAMERON RE, 1994, J MICROSC-OXFORD, V173, P227, DOI 10.1111/j.1365-2818.1994.tb03445.x
   Feenstra L, 1983, BIOCERAMICS CALCIUM, P131
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Stokes DJ, 1998, LANGMUIR, V14, P4402, DOI 10.1021/la980281c
   Vajda EG, 1998, SCANNING, V20, P527, DOI 10.1002/sca.1998.4950200708
NR 6
TC 5
Z9 5
U1 0
U2 4
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-647-8
J9 MATER RES SOC SYMP P
PY 2002
VL 711
BP 113
EP 118
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BU92B
UT WOS:000177402200016
DA 2018-10-20
ER

PT S
AU Devesa, L
   Vaz, M
   Cirne, JS
   Rilo, N
   Leal, R
AF Devesa, L
   Vaz, M
   Cirne, JS
   Rilo, N
   Leal, R
BE Vieira, T
TI Detection of impact defects in laminated composites by holographic
   interferometry
SO ADVANCED MATERIALS FORUM I
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 1st International Materials Symposium (Materials 2001)
CY APR 09-11, 2001
CL UNIV COIMBRA, COIMBRA, PORTUGAL
SP Portuguese Soc Mat
HO UNIV COIMBRA
DE composites; interferometry; non-destructive tests
ID SHEAROGRAPHY
AB The use of laminate carbon fibre composite materials has been growing in a substantial way in the last decade. Some industries like the aerospace, aeronautical, automotive and biomedical benefit from the introduction of new structural solutions that became possible by using these materials. However, during the life in service of the composite components the material is exposed to a great variety of external attacks. Casual impacts, heat variations and water ingestion may provoke invisible degradation that can lead to a posterior collapse. For this reason the detection of eventual defects is very important and its inspection using non-destructive techniques of primordial importance.
   In this paper is proposed the use of holographic interferometry techniques for non-destructive detection of defects caused by low velocity impacts in laminate carbon fibre composites.
C1 Univ Coimbra, Ctr Engn Mecan, CEMUC, Dept Engn Mecan, PT-3030 Coimbra, Portugal.
   FEUP, DEMEGI, Lab Opt & Mecan Expt, LOME, PT-4200465 Oporto, Portugal.
RP Devesa, L (reprint author), Univ Coimbra, Ctr Engn Mecan, CEMUC, Dept Engn Mecan, PT-3030 Coimbra, Portugal.
RI Vaz, Mario/I-5613-2015
OI Vaz, Mario/0000-0002-6347-9608
CR CHOUSAL JC, 1994, 10 INT C EXP MECH LI, P373
   Ettemeyer A, 2000, OPT ENG, V39, P212, DOI 10.1117/1.602354
   Hung YY, 1998, OPT ENG, V37, P1406, DOI 10.1117/1.601656
   LEENDERT.JA, 1973, J PHYS E SCI INSTRUM, V6, P1107, DOI 10.1088/0022-3735/6/11/019
   LOKBERG O, 1987, APPL OPTICS OPTICAL
   Maas AAM, 1997, OPT LASER ENG, V26, P351, DOI 10.1016/0143-8166(95)00138-7
   SANTOS F, 1996, THESIS FEUP
   Sirohi RS, 1999, OPT ENG, V38, P1582, DOI 10.1117/1.602210
NR 8
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-905-9
J9 KEY ENG MAT
PY 2002
VL 230-2
BP 279
EP 282
DI 10.4028/www.scientific.net/KEM.230-232.279
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BV62B
UT WOS:000179553200063
DA 2018-10-20
ER

PT S
AU Marques, N
   Davim, JP
AF Marques, N
   Davim, JP
BE Vieira, T
TI Tribological comparative study of conventional and composite materials
   in biomedical applications
SO ADVANCED MATERIALS FORUM I
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 1st International Materials Symposium (Materials 2001)
CY APR 09-11, 2001
CL UNIV COIMBRA, COIMBRA, PORTUGAL
SP Portuguese Soc Mat
HO UNIV COIMBRA
DE composites; hip prostheses; SEM; tribology
ID POLYETHYLENE; WEAR
AB `Ultra-High Molecular Weight Polyethylene (UHMWPE) is used as acetabular component of total hip prostheses. However, at long term, prostheses failure can occur with the increasing of wear debris. Research with composite materials is being developed for orthopaedic applications. Carbon fibre reinforced Peek (CFR Peek) is a structural composite with biomedical applications.
   The tribological performance of UHMWPE and 30% CFR Peek was studied against steel, under distilled water lubricated environment at 37degreesC.
   A pin-on-disk Plint-TE67 was used to evaluate the tribological performance of both materials. Accelerated test condition was used in order to perform a sliding distance equivalent to two years lifetime of a hip prostheses. A contact stress of 5 MPa and a sliding velocity of 0.5 m/s were applied. Counterface roughness was measured to an arithmetic mean value, Ra, of 0.05 mum.
   The best performance in terms of friction coefficient and wear rate was observed for CFR Peek.
   Scanning electron microscopy (SEM) and energy dispersive spectroscopy (EDS) X-Ray microanalysis were used to identify the effect of test conditions on the pin's contact surface.
C1 Univ Aveiro, Ctr Mech Technol & Automat, Dept Mech Engn, PT-3810193 Aveiro, Portugal.
RP Marques, N (reprint author), Univ Aveiro, Ctr Mech Technol & Automat, Dept Mech Engn, Campus Santiago, PT-3810193 Aveiro, Portugal.
RI Davim, Joao Paulo/D-2314-2009; Group, GAME/B-3464-2014
OI Davim, Joao Paulo/0000-0002-5659-3111; 
CR AGRAWAL CM, 1995, ENCY HDB BIOMATERI A, V2
   CLARKE IC, 1981, ENG MED, V10, P115
   Dong H, 1999, WEAR, V225, P146, DOI 10.1016/S0043-1648(98)00356-1
   Dumbleton J. H., 1981, TRIBOLOGY NATURAL AR
   MAHARAJ GR, 1993, ASTM PUBLICATION
   MCKELLOP H, 1978, J BIOMED MATER RES, V12, P895, DOI 10.1002/jbm.820120611
   Mcnie CM, 2000, J MATER SCI-MATER M, V11, P163, DOI 10.1023/A:1008979608563
   ROSTOKER W, 1978, J BIOMED MATER RES, V12, P317, DOI 10.1002/jbm.820120306
   STJOHN KR, 1995, ENCY HDB BIOMATERI A, V2
   UMSWORTH A, 1975, J LUBRICATION TECHNO, P377
NR 10
TC 7
Z9 7
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-905-9
J9 KEY ENG MAT
PY 2002
VL 230-2
BP 487
EP 490
DI 10.4028/www.scientific.net/KEM.230-232.487
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BV62B
UT WOS:000179553200112
DA 2018-10-20
ER

PT S
AU Yu, T
   Chiellini, F
   Schmaljohan, D
   Solaro, R
   Ober, C
AF Yu, T
   Chiellini, F
   Schmaljohan, D
   Solaro, R
   Ober, C
BE Fedynyshyn, TH
TI Microfabrication of hydrogels for biomedical applications
SO ADVANCES IN RESIST TECHNOLOGY AND PROCESSING XIX, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 19th Annual Conference on Advances in Resist Technology and Processing
CY MAR 04-06, 2002
CL SANTA CLARA, CA
SP SPIE, Semiconductor Equipment & Mat Int, Int SEMATECH
DE photolithography; microfabrication; hydrogel; 2-hydroxyethyl
   methacrylate
ID PHOTOLITHOGRAPHY; FABRICATION
AB Hydrogels have gained general acceptance as biocompatible materials and are the basis of many promising applications in tissue engineering, drug release formulations and biosensors. Polymer processing techniques that can generate miniature hydrogel micro structures are not only critical as scaffolds for tissue re-growth but also very effective for increasing the efficiency of drug delivery and biosensors. Our approach is to use both optical and soft lithographic methods to microfabricate hydrogels. In this paper, we describe a photolithographic process to pattern hydrogel materials and analyze factors influencing sensitivity and lateral resolution. The model system we are investigating is based on 2-hydroxyethyl methacrylate (HEMA), which is well known for its non-toxicity and its widespread use in the contact lens industry.
C1 Cornell Univ, Ithaca, NY 14850 USA.
RP Yu, T (reprint author), Cornell Univ, Ithaca, NY 14850 USA.
RI Chiellini, Federica/F-3233-2010
OI Chiellini, Federica/0000-0003-4680-9975; Ober,
   Christopher/0000-0002-3805-3314
CR Chen GP, 1998, LANGMUIR, V14, P6610, DOI 10.1021/la9806303
   Chiellini F, 2001, MACROMOL RAPID COMM, V22, P1284, DOI 10.1002/1521-3927(20011001)22:15<1284::AID-MARC1284>3.0.CO;2-M
   Jackman RJ, 1999, LANGMUIR, V15, P2973, DOI 10.1021/la981591y
   Martin BD, 2000, LANGMUIR, V16, P9944, DOI 10.1021/la001053x
   Naghash HJ, 1997, POLYMER, V38, P1187, DOI 10.1016/S0032-3861(96)00615-5
   NOVOTNY DB, 1986, J ELECTROCHEM SOC, V133, P2600, DOI 10.1149/1.2108487
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   SHEPPARD NF, 1995, SENSOR ACTUAT B-CHEM, V28, P95, DOI 10.1016/0925-4005(94)01542-P
   STONE JM, 1963, RAD OPTICS INTRO CLA, P191
   SUDHOLTER EJR, 1990, ANAL CHIM ACTA, V230, P59, DOI 10.1016/S0003-2670(00)82761-0
   WEN M, IS T ANN C 1997 50, P564
   YU T, 2000, POLYM PREPR AM CHEM, V41, P1699
NR 12
TC 1
Z9 1
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4436-7
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4690
BP 854
EP 860
DI 10.1117/12.474288
PG 7
WC Materials Science, Multidisciplinary; Optics; Physics, Applied; Polymer
   Science
SC Materials Science; Optics; Physics; Polymer Science
GA BV17J
UT WOS:000178056500093
DA 2018-10-20
ER

PT J
AU Wendel, A
AF Wendel, A
TI Do we need a "chair of alternative methods", and where?
SO ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN
LA English
DT Article; Proceedings Paper
CT Symposium on Use of Animals in Research: A Science-Society Controversy
CY MAR   12, 2002
CL MAINZ, GERMANY
DE professorship; research; commentary; alternative methods; humane science
AB During the last two decades, the field of in vitro technology has been successfully developed and its use is continuously growing. Advanced tests avoiding animal experiments will be increasingly required for routine industrial applications e.g. for pharmacological high-throughput screening. Moreover and even more importantly, the availability of human cell based methods is essential for future quality assurance and risk assessment in the fields of health and consumer protection as well as environmental protection. Thereby, the potential of such advanced in vitro methods extends fiar beyond the mere replacement of regulated tests.
   In practice, the introduction and expansion of this technology has been achieved predominantly by offering funding and awards to the scientific community After this initiation phase, the next consequent step to exploit this knowledge clearly consists in academic promotion of this new scientific culture in an institutionalised,form. The tasks of such a chair focussed oil advanced in vitro tests - most probably the first of its kind world-wide - would cover in addition to (a) research and (b) teaching, (c) the sharpening of social conscience for the topic. (a) While the validation of alternative methods was formally established by founding institutions like ZEBET in Berlin oil the national and ECVAM in Ispra on the European level, the development of further new and more sophisticated in vitro methods to date emerge predominantly as a by-product of basic research. A considerable push might now be given by the structured search for new methods with a spill-over,for research-based up-to-date teaching.
   (b) The field of alternative methods is more than a panel of advanced in vitro techniques: A culture of systematic evaluation and validation of in vitro tests has been developed, which has bearing far beyond the replacement of animal experiments. In vitro systems inherently prone to artefacts require the highest level of quality control and assurance. A successful initiative to establish a Good Cell Culture Practice (GCCP) in analogy to Good Laboratory Practice (GLP) has evolved out of the field of in vitro alternatives. The concept of validating the relevance of an in vitro test in comparison to the respective in vivo situation represents a consequent translation of evidence-based medicine into in vitro biomedicine. In other words: It does no longer suffice that an in vitro model is plausible - it has to prove its suitability and quality.
   (c) The broad implementation of advanced in vitro technology into curricula implies development of lectures, courses and other teaching materials including virtual education offers. Such a basis will allow efficient spreading of knowledge and ease transnational acceptance. Last but not least, taking over the leadership for erecting a chair for alternative methods represents a major political signal that demonstrates to the public the willingness to adapt academic education to modern social awareness. A location for such an initiative needs to be found that is in the centre of Europe, has the necessary infrastructure of surrounding biomedical research, international networks for the evaluation and validation of tests, technology transfer to industrial use and access to relevant publication organs.
   The unequivocal answer to the question in the heading is therefore: we need a chair for in vitro alternatives because (i) the patient is our primary concern but the animal is not just secondary (ii) man's responsibility for the integrity of all creatures including the own species makes it mandatory.
C1 Univ Konstanz, Fac Biol, D-78457 Constance, Germany.
RP Wendel, A (reprint author), Univ Konstanz, Fac Biol, Univ Str 10, D-78457 Constance, Germany.
NR 0
TC 4
Z9 4
U1 2
U2 6
PU SPEKTRUM AKADEMISCHER VERLAG
PI HEIDELBERG
PA VANGEROWSTR 20, D-69115 HEIDELBERG, GERMANY
SN 0946-7785
J9 ALTEX-ALTERN TIEREXP
JI Altex Altern. Tierexp.
PY 2002
VL 19
IS 2
BP 64
EP 68
PG 5
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 580NB
UT WOS:000177239700004
PM 12098011
DA 2018-10-20
ER

PT S
AU Corcione, CE
   Greco, A
   Licciulli, A
   Martena, M
   Maffezzoli, A
AF Corcione, CE
   Greco, A
   Licciulli, A
   Martena, M
   Maffezzoli, A
BE Kuljanic, E
TI Ceramic components built by stereolithography
SO AMST 02: ADVANCED MANUFACTURING SYSTEMS AND TECHNOLOGY, PROCEEDINGS
SE CISM COURSES AND LECTURES
LA English
DT Proceedings Paper
CT 6th International Conference on Advanced Manufacturing Systems and
   Technology (AMST 02)
CY JUN, 2002
CL UDINE, ITALY
DE stereolitography; alumina
ID SUSPENSIONS
AB Stererolithography (SL) is a rapid prototyping process traditionally used to produce polymeric parts for various applications in aerospace, biomedical, automotive and electronics fields. Though it is a promising process for production of advanced ceramics, a number of critical points need still a proper solution: develop materials for functional prototypes, avoid interlayer delamination, obtain mechanical performances. In this work the production of ceramic green starting from specially formulated photocurable suspensions is presented. In particular, Al2O3 ceramic precursor have been built with an experimental stereolithography system, and the ceramic objects have been obtained from pyrolisis of the organic binder and subsequent sintering. Finally, characterization of mechanical properties and microstructure of the samples is presented. In addition, a 3D System SLA250 machine has been modified in order to build ceramic objects. A new loading vat with varying capacity has been projected and built, in order to produce parts with lower material quantities. The building and recoating parameters of the machine have been studied and modified to work with high-viscosity formulations.
C1 Univ Lecce, Dept Innovat Engn, I-73100 Lecce, Italy.
RP Corcione, CE (reprint author), Univ Lecce, Dept Innovat Engn, I-73100 Lecce, Italy.
RI esposito corcione, carola/M-9542-2015; Greco, Antonio/H-9930-2013;
   maffezzoli, alfonso/L-7217-2015
OI esposito corcione, carola/0000-0002-3056-1162; Greco,
   Antonio/0000-0002-0621-622X; maffezzoli, alfonso/0000-0002-6371-4030
CR Agarwala M, 1995, RAPID PROTOTYPING J, V1, P26, DOI 10.1108/13552549510078113
   ALWOOD CI, 1996, SAMPE J, V32, P55
   Brady GA, 1998, J MATER SCI, V33, P4551, DOI 10.1023/A:1004416705140
   Burns M, 1993, AUTOMATED FABRICATIO
   Edirisinghe M, 1997, MATER WORLD, V5, P138
   Greco A, 2001, J MATER SCI, V36, P99, DOI 10.1023/A:1004899027360
   Jacobs PF, 1992, RAPID PROTOTYPING MA
   KNITTER R, 2001, FABRICATION CERAMIC
   MARCUS HL, 1993, ADV MATER PROCESS, V9, P28
   WALLER DJ, 1992, AM CERAM SOC BULL, V7, P1648
NR 10
TC 0
Z9 0
U1 1
U2 6
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, A-1201 VIENNA, AUSTRIA
SN 0254-1971
BN 3-211-83689-6
J9 CISM COUR L
PY 2002
IS 437
BP 731
EP 739
PG 9
WC Engineering, Manufacturing; Engineering, Electrical & Electronic;
   Engineering, Mechanical
SC Engineering
GA BV95R
UT WOS:000180518500085
DA 2018-10-20
ER

PT J
AU Kanazawa, H
   Sunamoto, T
   Ayano, E
   Matsushima, Y
   Kikuchi, A
   Okano, T
AF Kanazawa, H
   Sunamoto, T
   Ayano, E
   Matsushima, Y
   Kikuchi, A
   Okano, T
TI Temperature-responsive chromatography using poly(N-isopropylacrylamide)
   hydrogel-modified silica
SO ANALYTICAL SCIENCES
LA English
DT Article
ID SURFACES; SYSTEM
AB Poly(N-isopropylacrylamide) (PNIPAAm) has the sharpest phase transition of the class of thermo-sensitive N-alkyl acrylamide polymers. We developed a new method of HPLC using packing materials modified with cross-linked poly(N-isopropylacrylamide) (PNIPAAm) hydrogel. A temperature-responsive surface was prepared by polymerization of NIPAAm in the presence of a cross-linker on the silica support. The surface properties and functions of the stationary phases change in response to the external temperature. Therefore it easily changes the interaction of a solute with the surface with a constant aqueous mobile phase. A temperature-responsive elution behavior was observed on the separation of steroids and PTH-amino acids. The method is expected to be applicable to separation in the pharmaceutical and biomedical fields.
C1 Kyoritsu Coll Pharmaceut Sci, Tokyo 1058512, Japan.
   Tokyo Womens Med Univ, Inst Biomed Engn, Shinjuku Ku, Tokyo 1628666, Japan.
RP Kanazawa, H (reprint author), Kyoritsu Coll Pharmaceut Sci, 1-5-30 Shiba Koen, Tokyo 1058512, Japan.
RI Okano, Teruo/J-4028-2012
OI Kanazawa, Hideko/0000-0003-2550-470X
CR BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   CHEN GH, 1993, BIOCONJUGATE CHEM, V4, P509, DOI 10.1021/bc00024a013
   Kanazawa H, 1997, J PHARMACEUT BIOMED, V15, P1545, DOI 10.1016/S0731-7085(96)02004-3
   Kanazawa H, 1996, ANAL CHEM, V68, P100, DOI 10.1021/ac950359j
   Kanazawa H, 1997, ANAL CHEM, V69, P823, DOI 10.1021/ac961024k
   Kanazawa H, 2000, ANAL CHEM, V72, P5961, DOI 10.1021/ac0004658
   Kanazawa H, 1998, TRAC-TREND ANAL CHEM, V17, P435, DOI 10.1016/S0165-9936(98)00044-2
   KOBAYASHI J, 2000, IKOGAKUCHIRYO, V12, P670
   Matsukata M, 1996, BIOCONJUGATE CHEM, V7, P96, DOI 10.1021/bc950082u
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035
   TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113
   Yakushiji T, 1998, LANGMUIR, V14, P4657, DOI 10.1021/la980090+
   YAMAMOTO K, 2000, ENV SCI, V7, P1047
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   YOSHIDA R, 1991, J BIOMAT SCI-POLYM E, V3, P155, DOI 10.1163/156856291X00250
NR 17
TC 71
Z9 71
U1 1
U2 33
PU JAPAN SOC ANALYTICAL CHEMISTRY
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN
SN 0910-6340
J9 ANAL SCI
JI Anal. Sci.
PD JAN
PY 2002
VL 18
IS 1
BP 45
EP 48
DI 10.2116/analsci.18.45
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 512YK
UT WOS:000173351000009
PM 11817726
OA Bronze
DA 2018-10-20
ER

PT J
AU Zelikin, AN
   Lynn, DM
   Farhadi, J
   Martin, I
   Shastri, V
   Langer, R
AF Zelikin, AN
   Lynn, DM
   Farhadi, J
   Martin, I
   Shastri, V
   Langer, R
TI Erodible conducting polymers for potential biomedical applications
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE biomaterials; cell differentiation; conducting materials; polymers;
   polypyrroles
ID BONE-FORMATION; COPOLYMERIZATION; PYRROLE
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   Kantonsspital Basel, Dept Surg, Div Res, Basel, Switzerland.
RP Shastri, V (reprint author), MIT, Dept Chem Engn, Room E25-342, Cambridge, MA 02139 USA.
RI Zelikin, Alexander/J-3659-2012
OI Zelikin, Alexander/0000-0002-9864-321X
FU NIGMS NIH HHS [1 F32 GM20227-01, GM26698]
CR BERLIN A, 1998, ELECT OPTICAL POLYM, P47
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Donat-Bouillud A, 1997, CHEM MATER, V9, P2815, DOI 10.1021/cm9701926
   GREGORY RV, 1989, SYNTHETIC MET, V28, pC823
   GuiseppiElie A, 1996, MATER RES SOC SYMP P, V413, P439
   Heeger A.J., 2001, ANGEW CHEM, V113, P2660
   Heeger AJ, 2001, ANGEW CHEM INT EDIT, V40, P2591, DOI 10.1002/1521-3773(20010716)40:14<2591::AID-ANIE2591>3.0.CO;2-0
   HONG YL, 1995, CHEM MATER, V7, P1999, DOI 10.1021/cm00059a003
   IBRAHIM SK, 1995, J ELECTROANAL CHEM, V387, P139, DOI 10.1016/0022-0728(95)03957-I
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   LEONG KW, 1986, J BIOMED MATER RES, V20, P51, DOI 10.1002/jbm.820200106
   LIVACHE T, 1994, NUCLEIC ACIDS RES, V22, P2915, DOI 10.1093/nar/22.15.2915
   MacDiarmid A., 2001, ANGEW CHEM, V113, P2649
   MacDiarmid AG, 2001, ANGEW CHEM INT EDIT, V40, P2581, DOI 10.1002/1521-3773(20010716)40:14<2581::AID-ANIE2581>3.0.CO;2-2
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X
   REYNOLDS JR, 1987, MACROMOLECULES, V20, P958, DOI 10.1021/ma00171a011
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SHASTRI V, 1995, THESIS RENSSELAER PO
   Shastri VP, 1999, MATER RES SOC SYMP P, V550, P215
   SHIRAKAWA H, 2001, ANGEW CHEM, V113, P2642
   Shirakawa Hideki, 2001, Angew Chem Int Ed Engl, V40, P2574, DOI 10.1002/1521-3773(20010716)40:14<2574::AID-ANIE2574>3.0.CO;2-N
   Vernitskaya TV, 1997, RUSS CHEM REV, V66, P443, DOI DOI 10.1070/RC1997V066N05ABEH000261
   WONG J, 1995, P NATL ACAD SCI USA, V91, P3201
   Zelikin A, 1999, J ORG CHEM, V64, P3379, DOI 10.1021/jo9823339
NR 27
TC 77
Z9 80
U1 0
U2 29
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1433-7851
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2002
VL 41
IS 1
BP 141
EP 144
DI 10.1002/1521-3773(20020104)41:1<141::AID-ANIE141>3.0.CO;2-V
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 509BR
UT WOS:000173124900028
PM 12491465
DA 2018-10-20
ER

PT J
AU Lendlein, A
   Kelch, S
AF Lendlein, A
   Kelch, S
TI Shape-memory polymers
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Review
DE block copolymers; material science; polymers; shape-memory polymers
ID ETHYLENE-VINYL ACETATE; POLYETHER-BASED POLYURETHANES; BUTADIENE
   BLOCK-COPOLYMER; HEAT SHRINKABLE PRODUCTS; SOFT-SEGMENT; POLY(VINYL
   ALCOHOL); HYBRID-COMPOSITES; BIOMEDICAL APPLICATIONS; SMART SYSTEMS;
   HYDROGEL
C1 GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, Kantstr 55, D-14513 Teltow, Germany.
EM lendlein@gkss.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Alvarez-Lorenzo C, 2000, MACROMOLECULES, V33, P8693, DOI 10.1021/ma000603v
   AOYAGI T, 1994, J CONTROL RELEASE, V32, P87
   Ashley S., 2001, SCI AM
   Baffler WJ, 1963, J APPL PHYS, V34, P1475
   Bahary W. S., 1967, RUBBER CHEM TECHNOL, V40, P1529
   BASSIRI ITG, 1967, J POLYM SCI POL LETT, V5, P871
   BERGER M, 1963, J POLYM SCI PART A, V1, P2945, DOI 10.1002/pol.1963.100010916
   Brennan M, 2001, CHEM ENG NEWS, V79, P5, DOI 10.1021/cen-v079n006.p005
   BRIBER RM, 1983, J MACROMOL SCI PHYS, VB22, P509, DOI 10.1080/00222348308224773
   BRONZINO J, 1995, BIOMEDICAL ENG HDB
   CAPACCIO G, 1982, COLLOID POLYM SCI, V260, P46, DOI 10.1007/BF01447675
   Chang L.C., 1951, T AIME, V189, P47, DOI [10.1007/BF03398954, DOI 10.1007/BF03398954]
   CHARLESBY A, 1952, PROC R SOC LON SER-A, V215, P187, DOI 10.1098/rspa.1952.0206
   Charlesby A, 1960, ATOMIC RAD POLYM, P198
   CHEN W, 1983, RADIAT PHYS CHEM, V22, P593, DOI 10.1016/0146-5724(83)90068-7
   Chowdhury SR, 2000, POLYM DEGRAD STABIL, V70, P199, DOI 10.1016/S0141-3910(00)00107-5
   Chowdhury SR, 2000, J APPL POLYM SCI, V77, P2088, DOI 10.1002/1097-4628(20000829)77:9<2088::AID-APP27>3.0.CO;2-N
   COWIE JMG, 1991, POLYM CHEM PHYSICS M
   COWIE JMG, 1997, CHEM PHYSIK SYNTHETI, P278
   DEDEURWAERDER R, 1959, J CHIM PHYS PCB, V56, P940, DOI 10.1051/jcp/1959560940
   EDGAR OB, 1952, J POLYM SCI, V8, P1, DOI 10.1002/pol.1952.120080101
   FAKIROV S, 1975, MAKROMOL CHEM, V176, P2459
   FALBE J, 1998, ROMPP LEXIKON CHEM, V5, P3449
   FALBE J, 1998, ROMPP LEXIKON CHEM, V4, P2586
   FALBE J, 1998, ROMPP LEXIKON CHEM, V5, P3415
   FALBE J, 1998, ROMPP LEXIKON CHEM, V5, P3506
   FLORY PJ, 1969, PRINCIPLES POLYM CHE, P432
   *FLUK CHEM GMBH, 2001, LAB CHEM, P1231
   FOX TG, 1950, J APPL PHYS, V21, P581, DOI 10.1063/1.1699711
   GAUR U, 1981, J PHYS CHEM-US, V10, P1010
   GAUR U, 1983, J PHYS CHEM-US, V12, P56
   GAUR U, 1981, J PHYS CHEM-US, V10, P1023
   Goethals EJ, 1998, MACROMOL SYMP, V132, P57, DOI 10.1002/masy.19981320108
   GRIEVESON BM, 1960, POLYMER, V1, P499, DOI 10.1016/0032-3861(60)90065-3
   HAYASHI S, 1994, P ANN TECHN C EXH PL, P1998
   He XW, 1996, POLYM J, V28, P452, DOI 10.1295/polymj.28.452
   HIRAI T, 1992, J APPL POLYM SCI, V46, P1449, DOI 10.1002/app.1992.070460815
   HIRAI T, 1992, J APPL POLYM SCI, V45, P1849, DOI 10.1002/app.1992.070451019
   Hron P, 1999, ANGEW MAKROMOL CHEM, V268, P29
   HU ZB, 1995, SCIENCE, V269, P525, DOI 10.1126/science.269.5223.525
   Jeong HM, 2000, J MATER SCI, V35, P279, DOI 10.1023/A:1004728814128
   Jeong HM, 2000, POLYMER, V41, P1849, DOI 10.1016/S0032-3861(99)00334-1
   JOHNS DB, 1984, RING OPENING POLYM, V1, P461
   Kagami Y, 1996, MACROMOL RAPID COMM, V17, P539, DOI 10.1002/marc.1996.030170806
   Kim BK, 1998, POLYMER, V39, P2803, DOI 10.1016/S0032-3861(97)00616-2
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   KLEINHEINS G, 1984, KUNSTST-GER PLAST+, V74, P445
   KLEINHEINS G, 1986, KUNSTST-GER PLAST+, V76, P1069
   Kobayashi K., 1992, US-A 5128197, Patent No. 5128197
   Kumar S, 1997, J APPL POLYM SCI, V64, P823, DOI 10.1002/(SICI)1097-4628(19970502)64:5<823::AID-APP1>3.0.CO;2-R
   LAURENCIN CT, 1995, BIOMEDICAL APPL SYNT
   Lee YM, 1996, J APPL POLYM SCI, V62, P301, DOI 10.1002/(SICI)1097-4628(19961010)62:2<301::AID-APP5>3.0.CO;2-0
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Li FK, 1999, J APPL POLYM SCI, V71, P1063, DOI 10.1002/(SICI)1097-4628(19990214)71:7<1063::AID-APP4>3.0.CO;2-A
   Li FK, 1997, J APPL POLYM SCI, V64, P1511, DOI 10.1002/(SICI)1097-4628(19970523)64:8<1511::AID-APP8>3.0.CO;2-K
   Li FK, 1996, J APPL POLYM SCI, V62, P631, DOI 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U
   Li FK, 1998, POLYMER, V39, P6929, DOI 10.1016/S0032-3861(98)00099-8
   Li Y, 1997, J APPL POLYM SCI, V63, P1173, DOI 10.1002/(SICI)1097-4628(19970228)63:9<1173::AID-APP9>3.0.CO;2-E
   Lin JR, 1998, J APPL POLYM SCI, V69, P1563, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1563::AID-APP11>3.0.CO;2-W
   Lin JR, 1998, J APPL POLYM SCI, V69, P1575, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1575::AID-APP12>3.0.CO;2-U
   LIPSCOMB P, 1996, APPL SHAPE MEMORY AL
   Luo XL, 1997, J APPL POLYM SCI, V64, P2433, DOI 10.1002/(SICI)1097-4628(19970620)64:12<2433::AID-APP17>3.0.CO;2-1
   Machi S, 1996, RADIAT PHYS CHEM, V47, P333, DOI 10.1016/0969-806X(95)00125-H
   MANTOVANI D, 2000, JOM, V10, P36
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Mather PT, 1999, MACROMOLECULES, V32, P1194, DOI 10.1021/ma981210n
   Mather PT, 2000, POLYM PREPR, V41, P528
   MERKEL M, 2000, TASCHENBUCH WERKSTOF, P358
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Nakayama K, 1991, INT POLYM SCI TECHN, V18, pT43
   NATA G, 1965, SCIENCE, V147, P269
   NATHAN A, 1992, MACROMOLECULES, V25, P4476, DOI 10.1021/ma00044a004
   Osada Y, 1998, ADV MATER, V10, P827, DOI 10.1002/(SICI)1521-4095(199808)10:11<827::AID-ADMA827>3.0.CO;2-L
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   OTA S, 1981, RADIAT PHYS CHEM, V18, P81, DOI 10.1016/0146-5724(81)90066-2
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   Otsuka K., 1998, SHAPE MEMORY MAT
   REDING FP, 1962, J POLYM SCI, V57, P483, DOI 10.1002/pol.1962.1205716538
   Reyntjens WG, 1999, MACROMOL RAPID COMM, V20, P251, DOI 10.1002/(SICI)1521-3927(19990501)20:5<251::AID-MARC251>3.0.CO;2-2
   SAKURAI K, 1993, J APPL POLYM SCI, V47, P937, DOI 10.1002/app.1993.070470521
   SAKURAI K, 1994, POLYMER, V35, P4238, DOI 10.1016/0032-3861(94)90602-5
   Sakurai K, 1997, J MACROMOL SCI PHYS, V36, P703, DOI 10.1080/00222349708212397
   SAKURAI K, 1989, J APPL POLYM SCI, V38, P1191, DOI 10.1002/app.1989.070380616
   SEEFRIED CG, 1975, J APPL POLYM SCI, V19, P2493, DOI 10.1002/app.1975.070190912
   SHALABY SW, 1994, BIOMEDICAL POLYM
   SHIRAI Y, 1988, MITSUBISHI TECH B, V184, P1
   Silver F., 1989, BIOCOMPATIBILITY INT
   Skakalova V, 1997, MACROMOL CHEM PHYS, V198, P3161, DOI 10.1002/macp.1997.021981014
   SMITH TL, 1977, POLYM ENG SCI, V17, P129, DOI 10.1002/pen.760170302
   SUZUKI H, 1985, J POLYM SCI POL PHYS, V23, P1671, DOI 10.1002/pol.1985.180230818
   TAKAHASHI T, 1996, J APPL POLYM SCI, V1061, P60
   TOBUSHI H, 1992, JSME INT J I-SOLID M, V35, P296, DOI 10.1299/jsmea1988.35.3_296
   Tobushi H, 1996, J PHYS IV, V6, P377, DOI 10.1051/jp4:1996136
   UCHIDA M, 1995, MACROMOLECULES, V28, P4583, DOI 10.1021/ma00117a031
   Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2
   VanCaeter P, 1997, POLYM BULL, V39, P589, DOI 10.1007/s002890050190
   Wang MT, 1999, J POLYM SCI POL PHYS, V37, P101, DOI 10.1002/(SICI)1099-0488(19990115)37:2<101::AID-POLB1>3.0.CO;2-X
   Wang MT, 1997, POLYM ADVAN TECHNOL, V8, P136, DOI 10.1002/(SICI)1099-1581(199703)8:3<136::AID-PAT621>3.0.CO;2-I
   Wang MT, 1998, EUR POLYM J, V34, P1, DOI 10.1016/S0014-3057(97)00082-7
   Wei ZG, 1998, J MATER SCI, V33, P3743, DOI 10.1023/A:1004692329247
   Wei ZG, 1998, J MATER SCI, V33, P3763, DOI 10.1023/A:1004674630156
   WILKES KE, 2000, JOM, V10, P45
   WOODS DW, 1954, NATURE, V174, P753, DOI 10.1038/174753b0
   Yang DZ, 2000, MATER DESIGN, V21, P503, DOI 10.1016/S0261-3069(00)00008-X
   ZHANG XM, 1995, J CHEM PHYS, V102, P551, DOI 10.1063/1.469434
   1986, ENCY POLYM SCI ENG, V11, P366
   1986, ENCY POLYM SCI ENG, V6, P410
NR 110
TC 1581
Z9 1623
U1 113
U2 1376
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1433-7851
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2002
VL 41
IS 12
BP 2034
EP 2057
DI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
PG 24
WC Chemistry, Multidisciplinary
SC Chemistry
GA 565UB
UT WOS:000176386900004
PM 19746597
DA 2018-10-20
ER

PT J
AU Mair, RW
   Walsworth, RL
AF Mair, RW
   Walsworth, RL
TI Novel MRI applications of laser-polarized noble gases
SO APPLIED MAGNETIC RESONANCE
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Magnetic Resonance Microscopy
CY SEP, 2001
CL NOTTINGHAM, ENGLAND
ID NUCLEAR-MAGNETIC-RESONANCE; DEPENDENT DIFFUSION-COEFFICIENT;
   HYPERPOLARIZED XE-129 NMR; TO-VOLUME RATIO; POROUS-MEDIA;
   CROSS-POLARIZATION; FIELD-GRADIENT; LIQUID XENON; SPIN-ECHO;
   LONGITUDINAL RELAXATION
AB Gas-phase nuclear magnetic resonance (NMR) has great potential as a probe for a variety of interesting physical and biomedical problems that are not amenable to study by water or similar liquid. However, NMR of gases was largely neglected due to the low signal obtained from the thermally polarized gases with very low sample density. The advent of optical pumping techniques for enhancing the polarization of the noble gases He-3 and Xe-129 has bought new life to this field, especially in medical imaging where He-3 lung inhalation imaging is approaching a clinical application. However, there are numerous applications in materials science that also benefit from the use of these gases. We review primarily nonmedical applications of laser-polarized noble gases for both NMR imaging and spectroscopy and highlight progress with examples from our laboratory including high-resolution imaging at millitesla applied field strength and velocity imaging of convective flow. Porous media microstucture has been probed with both thermal and laser-polarized xenon, as xenon is an ideal probe due to low surface interaction with the grains of the porous media.
C1 Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA.
RP Mair, RW (reprint author), Harvard Smithsonian Ctr Astrophys, 60 Garden St,MS 59, Cambridge, MA 02138 USA.
CR Abragam A., 1983, PRINCIPLES NUCL MAGN
   ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0
   Altes TA, 2001, J MAGN RESON IMAGING, V13, P378, DOI 10.1002/jmri.1054
   Augustine MP, 1998, APPL PHYS LETT, V72, P1908, DOI 10.1063/1.121223
   BAX A, 1982, 2 DIMENSIONAL NUCL M
   Bencsik M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.065302
   BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460
   BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679
   Bock M, 1997, MAGNET RESON MED, V38, P890, DOI 10.1002/mrm.1910380607
   Bowers CR, 1999, J AM CHEM SOC, V121, P9370, DOI 10.1021/ja991443+
   BOWERS CR, 1993, CHEM PHYS LETT, V205, P168, DOI 10.1016/0009-2614(93)89223-5
   Brunner E, 1998, J MAGN RESON, V130, P145, DOI 10.1006/jmre.1997.1296
   Brunner E, 1999, J MAGN RESON, V138, P155, DOI 10.1006/jmre.1998.1675
   BUTLER JP, 2002, J PHYS CONDENS MATT, V14, P297
   CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0
   Callaghan PT, 1998, J MAGN RESON, V133, P148, DOI 10.1006/jmre.1998.1417
   Callaghan PT, 1997, REV SCI INSTRUM, V68, P4263, DOI 10.1063/1.1148340
   CALLAGHAN PT, 1991, PRINCIPLES NUCL MAGN
   CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630
   DARASSE L, 1997, CR ACAD SCI II B, V324, P691
   DAVIES GR, 1994, CHEM PHYS LETT, V230, P237, DOI 10.1016/0009-2614(94)01151-6
   deSwiet TM, 1996, J CHEM PHYS, V104, P206, DOI 10.1063/1.470890
   Dimitrov IE, 1999, MAGN RESON IMAGING, V17, P267, DOI 10.1016/S0730-725X(98)00106-4
   DONASCIMENTO GC, 1992, MEAS SCI TECHNOL, V3, P370, DOI 10.1088/0957-0233/3/4/006
   Durand E, 2002, MAGNET RESON MED, V47, P75, DOI 10.1002/mrm.10047
   ECKERT G, 1992, NUCL INSTRUM METH A, V320, P53, DOI 10.1016/0168-9002(92)90769-Z
   Fitzgerald RJ, 1998, CHEM PHYS LETT, V284, P87, DOI 10.1016/S0009-2614(97)01332-8
   Fukushima E, 1999, ANNU REV FLUID MECH, V31, P95, DOI 10.1146/annurev.fluid.31.1.95
   GAEDE HC, 1995, APPL MAGN RESON, V8, P373, DOI 10.1007/BF03162652
   Guillot G, 2001, MAGN RESON IMAGING, V19, P391, DOI 10.1016/S0730-725X(01)00254-5
   GUILLOT G, 1999, EUR RADIOL, V9, pB25
   Haake M, 1998, CHEM PHYS LETT, V292, P686, DOI 10.1016/S0009-2614(98)00732-5
   HASSON KC, 1990, PHYS REV A, V41, P3672, DOI 10.1103/PhysRevA.41.3672
   HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602
   HURLIMANN MD, 1994, J MAGN RESON SER A, V111, P169, DOI 10.1006/jmra.1994.1243
   Hurlimann MD, 1998, J MAGN RESON, V131, P232, DOI 10.1006/jmre.1998.1364
   Kaiser LG, 2000, P NATL ACAD SCI USA, V97, P2414, DOI 10.1073/pnas.050012497
   Kaiser LG, 2001, J MAGN RESON, V149, P144, DOI 10.1006/jmre.2000.2283
   Kauczor HU, 1998, EUR RADIOL, V8, P820, DOI 10.1007/s003300050479
   Kuethe DO, 1998, MAGNET RESON MED, V39, P85, DOI 10.1002/mrm.1910390114
   LATOUR LL, 1993, J MAGN RESON SER A, V101, P342, DOI 10.1006/jmra.1993.1056
   LIZAK MJ, 1991, J MAGN RESON, V95, P548, DOI 10.1016/0022-2364(91)90168-S
   LONG HW, 1993, J AM CHEM SOC, V115, P8491, DOI 10.1021/ja00071a086
   Luhmer M, 1999, J AM CHEM SOC, V121, P3502, DOI 10.1021/ja9841916
   MacNamara E, 1999, J PHYS CHEM B, V103, P1158, DOI 10.1021/jp984081l
   MacNamara E, 2000, CHEM PHYS LETT, V317, P165, DOI 10.1016/S0009-2614(99)01355-X
   Mair RW, 1998, J MAGN RESON, V135, P478, DOI 10.1006/jmre.1998.1588
   Mair RW, 1999, PHYS REV LETT, V83, P3324, DOI 10.1103/PhysRevLett.83.3324
   Mair RW, 1997, J RHEOL, V41, P901, DOI 10.1122/1.550864
   Mair RW, 2000, PHYS REV E, V61, P2741, DOI 10.1103/PhysRevE.61.2741
   Mair RW, 2001, MAGN RESON IMAGING, V19, P345, DOI 10.1016/S0730-725X(01)00247-8
   MANSFIELD P, 1982, ADV MAGNETIC RESON S, V2
   Meersmann T, 2000, J PHYS CHEM A, V104, P11665, DOI 10.1021/jp002322v
   MITRA PP, 1993, PHYS REV B, V47, P8565, DOI 10.1103/PhysRevB.47.8565
   MOHANTY S, 1970, J CHEM PHYS, V53, P461, DOI 10.1063/1.1673814
   Mohoric A, 1999, J MAGN RESON, V136, P22, DOI 10.1006/jmre.1998.1594
   Moudrakovski IL, 2000, J MAGN RESON, V144, P372, DOI 10.1006/jmre.2000.2078
   Navon G, 1996, SCIENCE, V271, P1848, DOI 10.1126/science.271.5257.1848
   Patyal BR, 1997, J MAGN RESON, V126, P58, DOI 10.1006/jmre.1997.1159
   Peled S, 1999, J MAGN RESON, V140, P320, DOI 10.1006/jmre.1999.1850
   RAFTERY D, 1991, PHYS REV LETT, V66, P584, DOI 10.1103/PhysRevLett.66.584
   Rinck P A, 1984, Rofo, V140, P239, DOI 10.1055/s-2008-1052964
   Room T, 1997, PHYS REV B, V55, P11604, DOI 10.1103/PhysRevB.55.11604
   Rubin SM, 2000, P NATL ACAD SCI USA, V97, P9472, DOI 10.1073/pnas.170278897
   Ruppert K, 2000, MAGNET RESON MED, V44, P349, DOI 10.1002/1522-2594(200009)44:3<349::AID-MRM2>3.0.CO;2-J
   Saam B, 1996, CHEM PHYS LETT, V263, P481, DOI 10.1016/S0009-2614(96)01238-9
   Sauer KL, 1997, CHEM PHYS LETT, V277, P153, DOI 10.1016/S0009-2614(97)00876-2
   Schmidt DM, 1997, J MAGN RESON, V129, P184, DOI 10.1006/jmre.1997.1258
   Song YQ, 1998, J CHEM PHYS, V108, P6233, DOI 10.1063/1.476030
   Song YQ, 2000, NATURE, V406, P178, DOI 10.1038/35018057
   Song YQ, 2000, CONCEPT MAGNETIC RES, V12, P6, DOI 10.1002/(SICI)1099-0534(2000)12:1<6::AID-CMR3>3.0.CO;2-U
   Song YQ, 1998, SOLID STATE NUCL MAG, V10, P247, DOI 10.1016/S0926-2040(97)00078-7
   Sozzani P, 2000, ANGEW CHEM INT EDIT, V39, P2695, DOI 10.1002/1521-3773(20000804)39:15<2695::AID-ANIE2695>3.0.CO;2-M
   Stapf S, 1998, PHYS REV E, V58, P6206, DOI 10.1103/PhysRevE.58.6206
   STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690
   STREEVER RL, 1961, PHYS REV, V121, P20, DOI 10.1103/PhysRev.121.20
   Swanson SD, 1999, MAGNET RESON MED, V42, P1137, DOI 10.1002/(SICI)1522-2594(199912)42:6<1137::AID-MRM19>3.3.CO;2-W
   Tseng CH, 1999, PHYS REV E, V59, P1785, DOI 10.1103/PhysRevE.59.1785
   Tseng CH, 1998, PHYS REV LETT, V81, P3785, DOI 10.1103/PhysRevLett.81.3785
   Walker TG, 1997, REV MOD PHYS, V69, P629, DOI 10.1103/RevModPhys.69.629
   West J B, 1982, Physiologist, V25, pS21
   Wolber J, 1998, CHEM PHYS LETT, V296, P391, DOI 10.1016/S0009-2614(98)01050-1
   Wong GP, 1999, J MAGN RESON, V141, P217, DOI 10.1006/jmre.1999.1904
NR 83
TC 12
Z9 12
U1 0
U2 9
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0937-9347
EI 1613-7507
J9 APPL MAGN RESON
JI Appl. Magn. Reson.
PY 2002
VL 22
IS 2
BP 159
EP 173
DI 10.1007/BF03166100
PG 15
WC Physics, Atomic, Molecular & Chemical; Spectroscopy
SC Physics; Spectroscopy
GA 562QU
UT WOS:000176211100004
DA 2018-10-20
ER

PT S
AU Rizzi, G
   Groppetti, R
   Salvarani, L
   Scrivani, A
AF Rizzi, G
   Groppetti, R
   Salvarani, L
   Scrivani, A
BE Brown, S
   Clarke, I
   Williams, P
TI A contribution to the production and characterization of new biomedical
   coatings: Fluorohydroxyapatite coatings
SO BIOCERAMICS 14
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Ceramics in Medicine (BIOCERAMICS-14)
CY NOV 14-17, 2001
CL PALM SPRINGS, CALIFORNIA
SP Int Soc Ceram Med
DE fluorohydroxyapatite coating; titanium coating; plasma spray coating;
   roughness
AB In order to improve the osteo-integration of the implant the state-of-art specifies the use of coatings such as hydroxyapatite (HA; Ca-5(PO4)(3)OH). The research deals now with new materials and modification of HA, in order to improve the stability and mechanical properties of the coatings or more generally of the implant. A promising material is fluorohydroxyapatite (FHA, Ca-5(PO4)(3)OH1-xFx). This paper addresses the production and characterization of Vacuum Plasma Sprayed Fluorohydroxyapatite coating for orthopedic endoprosthesis. The spray trials have been carried out on Ti6A14V alloy substrates preventively blasted by means of corundum. In order to improve adhesion of FHA to titanium substrates two different titanium bond coats have been tested: the first with lower roughness and porosity named Type A and the second with higher roughness and porosity named Type B. A complete structural and mechanical characterization has been carried out: coating thickness, closed porosity and superficial porosity, microhardness, roughness have been measured.
C1 Biocoatings Srl, I-43040 Parma, Italy.
   Univ Parma, Dept Ind Engn, Parma, Italy.
RP Rizzi, G (reprint author), Biocoatings Srl, Via A Volta 3, I-43040 Parma, Italy.
CR BRACALI P, 1999, P AITEM 99 BRESC IT
   RANZ X, 1997, BIOCERAMICS, V10
   VANBLITTERSWIJK CA, 1991, BONE-BIOMATERIAL INTERFACE, P295
NR 3
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-889-3
J9 KEY ENG MAT
PY 2002
VL 218-2
BP 93
EP 96
DI 10.4028/www.scientific.net/KEM.218-220.93
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BU17P
UT WOS:000175229300020
DA 2018-10-20
ER

PT S
AU Paulussen, S
   Vangeneugden, D
   Goossens, O
   Dekempeneer, E
AF Paulussen, S
   Vangeneugden, D
   Goossens, O
   Dekempeneer, E
BE Aizenberg, J
   McKittrick, JM
   Orme, CA
TI Antimicrobial coatings obtained in an atmospheric pressure dielectric
   barrier glow discharge
SO BIOLOGICAL BIOMIMETIC MATERIALS-PROPERTIES TO FUNCTION
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biological and Biomimetic Materials - Properties to
   Function held at the 2002 MRS Spring Meeting
CY APR 01-05, 2002
CL SAN FRANCISCO, CA
SP Mat Res Soc
ID PLASMA DEPOSITION; BIOMEDICAL APPLICATIONS; ADSORPTION; ADHESION;
   PROTEIN; ENERGY
AB This paper addresses the development of plasma polymer coatings that should prevent bacteria from adhering to medical devices, implants, textile fibers, packaging materials, etc. The two main parameters affecting bacterial colonization onto surfaces are the surface energy and the surface roughness. Both parameters can be adjusted by the deposition of a thin plasma polymer coating in an atmospheric pressure dielectric barrier glow discharge. According to SEM, FTIR, SPM, XPS and contact angle measurements, smooth, hydrophilic plasma polymer coatings were obtained under specific plasma conditions starting from 2-hydroxyethyl methacrylate (HEMA) and ethyl diazoacetate (EDA).
C1 Vlaamse Instelling Technol Onderzoek, Flemish Inst Technol Res, Mat Technol Div, B-2400 Mol, Belgium.
RP Paulussen, S (reprint author), Vlaamse Instelling Technol Onderzoek, Flemish Inst Technol Res, Mat Technol Div, Boeretang 200, B-2400 Mol, Belgium.
CR Arciola CR, 2002, BIOMATERIALS, V23, P1495, DOI 10.1016/S0142-9612(01)00275-7
   CLAROTTI G, 1991, J MEMBRANE SCI, V61, P289, DOI 10.1016/0376-7388(91)80022-X
   COUSSOTRICO P, 1994, EUR POLYM J, V30, P1327, DOI 10.1016/0014-3057(94)90146-5
   Dufrene YF, 1996, COLLOID SURFACE B, V7, P113, DOI 10.1016/0927-7765(96)01288-X
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Goossens O, 2001, SURF COAT TECH, V142, P474, DOI 10.1016/S0257-8972(01)01140-9
   Janocha B, 2001, SURF COAT TECH, V142, P1051, DOI 10.1016/S0257-8972(01)01279-8
   Massines F, 1998, J APPL PHYS, V83, P2950, DOI 10.1063/1.367051
   MASSINES F, 1996, AIP C P, V363, P306
   MIQIN Z, 1998, BIOMATERIALS, V19, P953
   QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   ROSENBERG M, 1986, ADV MICROB ECOL, V9, P353
   Salge J, 1996, SURF COAT TECH, V80, P1, DOI 10.1016/0257-8972(95)02676-2
NR 14
TC 1
Z9 1
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-660-5
J9 MATER RES SOC SYMP P
PY 2002
VL 724
BP 179
EP 184
PG 6
WC Materials Science, Biomaterials; Materials Science, Characterization &
   Testing; Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA BV76S
UT WOS:000179970700025
DA 2018-10-20
ER

PT J
AU Mottu, F
   Rufenacht, DA
   Laurent, A
   Doelker, E
AF Mottu, F
   Rufenacht, DA
   Laurent, A
   Doelker, E
TI Iodine-containing cellulose mixed esters as radiopaque polymers for
   direct embolization of cerebral aneurysms and arteriovenous
   malformations
SO BIOMATERIALS
LA English
DT Article
DE embolization; embolic liquids; aneurysms; arteriovenous malformations;
   cellulose esters; iodine-containing cellulose mixed esters; cellulose
   acetate iodobenzoates; radiopacity
ID VINYL ALCOHOL COPOLYMER; ACETATE POLYMER; DIRECT THROMBOSIS;
   LITHIUM-CHLORIDE; BIOMEDICAL APPLICATIONS; CLINICAL-EXPERIENCE;
   IN-VITRO; N,N-DIMETHYLACETAMIDE; BIOMATERIAL; COMBINATION
AB The present study deals with the synthesis and characterization of radiopaque polymers which could, when solubilized in an appropriate water-miscible solvent, be useful embolic materials for the treatment of cerebral aneurysms and arteriovenous malformations. For this purpose cellulose (both microcrystalline and powdered) and partially substituted cellulose acetate (two different viscosity grades) were selected as starting materials to prepare iodine-containing polymers through various synthetic routes. The materials obtained were characterized by IR and NMR spectroscopy, molecular weight, iodine content, radiopacity and solubility in selected injectable organic solvents. The embolic liquids were evaluated for their precipitation behavior in a phosphate buffer solution (pH 7.4) mimicking physiological conditions using an in vitro aneurysm model. A sheep model was also used to assess in vivo the radiopacity and precipitation properties of a highly concentrated solution of a cellulose acetate 2,3,4-triiodobenzoate mixed ester. AH materials with 4-iodo- and 2,3,5-triiodobenzoyl groups gave sufficient radiopacity to be regarded as possible embolization materials, whereas iododeoxycellulose and iododeoxycellulose acetate were not radiopaque because of their low iodine content. Esters synthesized using cellulose as starting material were not soluble in the selected organic solvents due to the presence of many residual hydroxyl groups, but could be used for other biomedical applications where insoluble radiopaque materials are used. In contrast, solubility of the materials as well as satisfactory precipitation properties were ensured using cellulose acetate as the starting material. In conclusion, cellulose acetate iodobenzoate mixed esters dissolved in diglyme or dimethyl isosorbide (dimethyl sulfoxide is probably less appropriate because of its toxicity and hemolytic properties) could be useful embolic liquids for the treatment of cerebral aneurysms or arteriovenous malformations. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland.
   Univ Hosp Geneva, Div Diagnost & Intervent Radiol, Geneva, Switzerland.
   INRA, APHP, Ctr Res Intenvent Radiol, Jouy En Josas, France.
RP Doelker, E (reprint author), Univ Geneva, Sch Pharm, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.
CR BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   CHALOUPKA JC, 1993, J NEUROSURG, V78, P1006
   CHALOUPKA JC, 1994, AM J NEURORADIOL, V15, P1107
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   DOELKER E, 1987, POWDER TECHNOL, V52, P207, DOI 10.1016/0032-5910(87)80106-7
   DOTTER CT, 1975, RADIOLOGY, V114, P227, DOI 10.1148/114.1.227
   Gailloud P, 1997, SURG RADIOL ANAT, V19, P119
   Gardner TS, 1942, J AM CHEM SOC, V64, P1539, DOI 10.1021/ja01259a014
   Hassner A., 1978, TETRAHEDRON LETT, V19, P4475
   Heinze T, 1998, MACROMOL CHEM PHYSIC, V199, P2341, DOI 10.1002/macp.1998.021991101
   HEUSER E, 1950, J AM CHEM SOC, V72, P670, DOI 10.1021/ja01158a007
   HIROTSUNE N, 1996, ADV INTERVENTIONAL N, P149
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   KINUGASA K, 1993, J NEUROSURG, V78, P1007
   KINUGASA K, 1994, NEUROSURGERY, V34, P694, DOI 10.1227/00006123-199404000-00019
   KINUGASA K, 1994, NEUROSURGERY, V35, P755, DOI 10.1227/00006123-199410000-00027
   KINUGASA K, 1992, J NEUROSURG, V77, P501, DOI 10.3171/jns.1992.77.4.0501
   KINUGASA K, 1995, J NEUROSURG, V83, P34, DOI 10.3171/jns.1995.83.1.0034
   LAURENT A, 1997, J NEURORADIOLOGY, V24, P314
   LAURENT A, 2001, UNPUB PDA J PHARM SC
   MALM CJ, 1954, ANAL CHEM, V26, P188, DOI 10.1021/ac60085a029
   MALM CJ, 1948, J AM CHEM SOC, V70, P2740, DOI 10.1021/ja01188a031
   Mandai S, 1998, INTERV NEURORADIOL, V4, P173, DOI 10.1177/15910199980040S135
   MANDAI S, 1992, J NEUROSURG, V77, P497, DOI 10.3171/jns.1992.77.4.0497
   MCCORMICK CL, 1990, CARBOHYD RES, V208, P183, DOI 10.1016/0008-6215(90)80098-N
   MCCORMICK CL, 1987, POLYMER, V28, P2317, DOI 10.1016/0032-3861(87)90393-4
   MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   Mottu F, 2000, PDA J PHARM SCI TECH, V54, P456
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Mottu F, 2001, PDA J PHARM SCI TECH, V55, P16
   MOTTU F, 1999, BIOMATERIALS, V21, P803
   MOTTU F, 2000, Patent No. 0003814
   SAMARANAYAKE G, 1993, CARBOHYD POLYM, V22, P1, DOI 10.1016/0144-8617(93)90159-2
   SAMPEI K, 1996, ADV INTERVENTIONAL N, P293
   Schoniger W., 1955, MIKROCHIM ACTA, V1, P123
   SUGIU K, 1995, J NEUROSURG, V83, P531, DOI 10.3171/jns.1995.83.3.0531
   TAKI W, 1992, J NEUROSURG, V77, P37, DOI 10.3171/jns.1992.77.1.0037
   TAKI W, 1990, AM J NEURORADIOL, V11, P163
   TERADA T, 1991, J NEUROSURG, V75, P655, DOI 10.3171/jns.1991.75.4.0655
   Tipson RS, 1944, J ORG CHEM, V9, P235, DOI 10.1021/jo01185a005
   TIPSON RS, 1947, J ORG CHEM, V12, P133, DOI 10.1021/jo01165a017
   TIPSON RS, 1953, ADV CARBOHYD CHEM, P107
   Tokunaga K, 1998, NEUROSURGERY, V42, P1135, DOI 10.1097/00006123-199805000-00108
   TOKUNAGA K, 1996, ADV INTERVENTIONAL N, P15
   Williamson SL, 1998, J MACROMOL SCI PURE, VA35, P1915, DOI 10.1080/10601329808000987
   WOLFROM ML, 1941, J AM CHEM SOC, V63, P1688
   YAMASHITA K, 1994, AM J NEURORADIOL, V15, P1103
NR 48
TC 62
Z9 64
U1 3
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2002
VL 23
IS 1
BP 121
EP 131
DI 10.1016/S0142-9612(01)00087-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 496YF
UT WOS:000172425400015
PM 11762830
DA 2018-10-20
ER

PT S
AU Thissen, H
   Hayes, JP
   Muir, BW
   Atkin, M
   Harvey, EC
AF Thissen, H
   Hayes, JP
   Muir, BW
   Atkin, M
   Harvey, EC
BE Nicolau, DV
   Lee, AP
TI Spatially controlled surface chemistry by excimer laser ablation of thin
   films
SO BIOMEDICAL APPLICATIONS OF MICRO- AND NANOENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Symposium on Smart Materials, Nano-, and Micro-Smart
   Systems
CY DEC 16-18, 2002
CL RMIT UNIV, MELBOURNE, AUSTRALIA
SP SPIE, Univ Arkansas, Natl Inst Adv Ind Sci & Technol, Cooperat Res Ctr Microtechnol, Dept Def, Australia, Swinburne Univ Technol, Adelaide Univ, Japanese Soc Electr Packaging, New Energy & Ind Technol Dev Org
HO RMIT UNIV
DE excimer laser; plasma polymerization; spatial control; surface
   modification; wettability; XPS; AFM
ID PLASMA POLYMERS; CELL; PROTEIN; CULTURE
AB Two-dimensional control over the surface chemistry of substrate materials is of interest to a wide range of applications from microelectronics to biomedical diagnostics. Here, we describe a general principle for creating spatially controlled surface chemistries by subsequent deposition of thin plasma polymer coatings followed by laser ablation. The creation of surfaces with spatially controlled wettability was used as an example. Plasma polymerization of n-heptylamine produced a hydrophilic surface on silicon wafer substrates while subsequent plasma polymerization of perfluoro-1,3- dimethylcyclohexane produced a hydrophobic surface. Excimer laser ablation at an energy density of 125 mJ/cm(2) was used to remove a defined thickness of the two-layer coating, completely removing the upper layer without exposing the substrate material. Excimer laser ablation resulted in two-dimensional control over the surface chemistry with a resolution of ca. 1 mum. Surface modifications were characterized by X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM). Contact angle measurements were used to estimate the wettability of modified surfaces. The method was shown to be suitable for the precise control over the location of droplets containing aqueous solutions. In conclusion, the method described here represents an effective tool for the production of substrates with spatially controlled surface chemistry and wettability.
C1 CSIRO, Mol Sci, Clayton, Vic 3169, Australia.
RP Thissen, H (reprint author), CSIRO, Mol Sci, Bag 10, Clayton, Vic 3169, Australia.
RI Thissen, Helmut/D-3835-2011; Muir, Benjamin/D-2206-2013
CR Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Cahill DJ, 2001, J IMMUNOL METHODS, V250, P81, DOI 10.1016/S0022-1759(01)00325-8
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dyer P. E., 1992, PHOTOCHEMICAL PROCES
   GENGENBACH TR, 1994, J POLYM SCI POL CHEM, V32, P1399, DOI 10.1002/pola.1994.080320801
   Ghantasala MK, 1999, P SOC PHOTO-OPT INS, V3874, P85, DOI 10.1117/12.361208
   GOWER MC, 1993, LASER PROCESSING MAN, pCH8
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Hartley P. G., 2000, Plasmas and Polymers, V5, P47, DOI 10.1023/A:1009508426115
   HECHT J, 1992, LASER GUIDEBOOK
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Matsuda T, 1994, ASAIO J, V40, pM594, DOI 10.1097/00002480-199407000-00068
   Rose D, 1999, DRUG DISCOV TODAY, V4, P411, DOI 10.1016/S1359-6446(99)01388-4
   Schwarz A, 1998, LANGMUIR, V14, P5526, DOI 10.1021/la980359p
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Thissen H, 2001, P SOC PHOTO-OPT INS, V4590, P57, DOI 10.1117/12.454588
   Thissen H, 2002, SMART MATER STRUCT, V11, P792, DOI 10.1088/0964-1726/11/5/326
   Thissen H, 2001, P SOC PHOTO-OPT INS, V4234, P177, DOI 10.1117/12.424405
   Xia YN, 2001, CURR OPIN COLLOID IN, V6, P54, DOI 10.1016/S1359-0294(00)00088-1
NR 21
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4732-3
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4937
BP 107
EP 114
DI 10.1117/12.469160
PG 8
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BW27F
UT WOS:000181394800013
DA 2018-10-20
ER

PT S
AU Lyoo, WS
   Kim, JH
   Kim, SS
   Ghim, HD
AF Lyoo, WS
   Kim, JH
   Kim, SS
   Ghim, HD
BE Nicolau, DV
   Lee, AP
TI Biomedical applications of stereoregular poly(vinyl alcohol) micro- and
   nanoparticles
SO BIOMEDICAL APPLICATIONS OF MICRO- AND NANOENGINEERING
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT International Symposium on Smart Materials, Nano-, and Micro-Smart
   Systems
CY DEC 16-18, 2002
CL RMIT UNIV, MELBOURNE, AUSTRALIA
SP SPIE, Univ Arkansas, Natl Inst Adv Ind Sci & Technol, Cooperat Res Ctr Microtechnol, Dept Def, Australia, Swinburne Univ Technol, Adelaide Univ, Japanese Soc Electr Packaging, New Energy & Ind Technol Dev Org
HO RMIT UNIV
DE P(VPi/VAc); PVA micro and nanoparticles; heterogeneous saponification;
   embolic material; drug release
ID SUSPENSION POLYMERIZATION; VINYL-ACETATE; SAPONIFICATION; EMBOLIZATION;
   MICROFIBRILS; STABILITY; PIVALATE)
AB Syndiotactic poly(vinyl alcohol) (PVA)/poly(vinyl pivalate/vinyl acetate) (P(VPi/VAc)) and atactic PVA/PVAc micro- and nanoparticles with skin/core structure have been prepared by heterogeneous saponification of P(VPi/VAc) and PVAc micro- and nanoparticles. Especially, to prepare P(VPi/VAc) and PVAc microparticles having various particle sizes and uniform particle size distribution, vinyl pivalate (VPi)/vinyl acetate (VAc) and VAc were suspension-polymerized using a low-temperature initiator, 2,2'-azobis(2,4-dimethylvaleronitrile). P(VPi/VAc) particles are promising precursor of stereoregular PVA embolic materials which can be introduced through catheters in the management of gastrointestinal bleeders, arteriovenous malformations, hemangiomas, and traumatic rupture of blood vessels. Monodisperse and/or nearly monodisperse P(VPi/VAc) and PVAc microparticles with various particle diameters were obtained by controlling suspension polymerization conditions. Monodisperse P(VPi/VAc) and PVAc microparticles having various particle sizes were partially saponified in the heterogeneous system. PVA/P(VPi/VAc) and PVA/PVAc microparticles having various tacticity and degree of saponification were produced by controlling various polymerization and saponification conditions. The coating of stereoregular PVA micro- and nanoparticles for drug release experiments was conducted with the strepo-avidin-alkaline phosphatase conjugate in variable conditions of pH value, coating buffer, and reaction temperature. Protein-coated syndiotactic PVA micro-and nanoparticles, which does not crosslinking, were more superior to controllability of drug release, durability, and dimensional stability to water and blood than atactic one.
C1 Yeungnam Univ, Sch Text, Adv Res Ctr, PVA, Kyongsan 712749, South Korea.
RP Lyoo, WS (reprint author), Yeungnam Univ, Sch Text, Adv Res Ctr, PVA, Kyongsan 712749, South Korea.
CR BALARAMAN KS, 1983, J POLYM SCI POL LETT, V21, P87, DOI 10.1002/pol.1983.130210203
   CHERNGJU K, 1992, J APPL POLYM SCI, V46, P2147
   Cho JD, 1999, MACROMOLECULES, V32, P6236, DOI 10.1021/ma9908402
   Choi JH, 2001, MACROMOLECULES, V34, P2964, DOI 10.1021/ma001710s
   Choi JH, 1999, MACROMOL CHEM PHYSIC, V200, P1421, DOI 10.1002/(SICI)1521-3935(19990601)200:6<1421::AID-MACP1421>3.0.CO;2-O
   CHUANG VP, 1981, AM J ROENTGENOL, V136, P729, DOI 10.2214/ajr.136.4.729
   CHUANG VP, 1980, RADIOLOGY, V135, P2959
   DEMACHI H, 1991, CARDIOVASC INTER RAD, V14, P158, DOI 10.1007/BF02577719
   GIANNETTI E, 1986, J POLYM SCI POL CHEM, V24, P2517, DOI 10.1002/pola.1986.080241012
   HA WS, 2000, Patent No. 6124033
   HERMAN WO, 1927, BER DTSCH CHEM GES, V60, P1658
   JOSEPH M, 1996, AM J NEURORADIOL, V17, P525
   Kwark YJ, 1996, POLYM J, V28, P851, DOI 10.1295/polymj.28.851
   Lyoo WS, 1998, MACROMOLECULES, V31, P4253, DOI 10.1021/ma971741w
   Lyoo WS, 1998, POLYM J, V30, P424, DOI 10.1295/polymj.30.424
   Lyoo WS, 2001, MACROMOLECULES, V34, P2615, DOI 10.1021/ma001624s
   Lyoo WS, 1998, COLLOID POLYM SCI, V276, P951, DOI 10.1007/s003960050333
   Lyoo WS, 1997, POLYM ENG SCI, V37, P1259, DOI 10.1002/pen.11770
   Lyoo WS, 1996, POLYMER, V37, P3121, DOI 10.1016/0032-3861(96)89414-6
   Lyoo WS, 1997, J POLYM SCI POL CHEM, V35, P55, DOI 10.1002/(SICI)1099-0518(19970115)35:1<55::AID-POLA7>3.0.CO;2-1
   Lyoo WS, 2001, J APPL POLYM SCI, V82, P108, DOI 10.1002/app.1829
   MASUDA M, 1991, POLYVINYL ALCOHOL DE
   MURAKAMI R, 1993, POLYM J, V25, P205, DOI 10.1295/polymj.25.205
   REMY B, 1996, AM J NEURORADIOL, V17, P541
   SAKURADA I, 1963, KOBUNSHI KAGAKU, V20, P491
   Sakurada I., 1985, POLYVINYL ALCOHOL FI
   SANDLER SR, 1980, POLYM SYNTHESIS
   Staudinger H, 1927, BER DTSCH CHEM GES, V60, P1782, DOI 10.1002/cber.19270600811
NR 28
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4732-3
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4937
BP 326
EP 333
DI 10.1117/12.487563
PG 8
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BW27F
UT WOS:000181394800036
DA 2018-10-20
ER

PT S
AU Faris, GW
   Hryndza, M
AF Faris, GW
   Hryndza, M
BE Bornhop, DJ
   Dunn, DA
   Mariella, RP
   Murphy, CJ
   Nicolau, DV
   Nie, S
   Palmer, M
   Raghavachari, R
TI Properties of upconverting chelates
SO BIOMEDICAL NANOTECHNOLOGY ARCHITECTURES AND APPLICATIONS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Biomedical Nanotechnology Architectures and Applications
CY JAN 20-24, 2002
CL SAN JOSE, CA
SP SPIE
DE upconverting chelates; biomedical diagnostics; optical reporters;
   contrast agents; optical labels
ID PHOSPHOR REPORTERS
AB Upconverting chelates are anew type of optical reporter with multiple advantages for biomedical diagnostics. We describe these materials and report spectroscopic properties relevant to their use.
C1 SRI Int, Mol Phys Lab, Menlo Pk, CA 94025 USA.
RP Faris, GW (reprint author), SRI Int, Mol Phys Lab, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.
CR AUZEL FE, 1973, P IEEE, V61, P758, DOI 10.1109/PROC.1973.9155
   Chen YH, 1997, P SOC PHOTO-OPT INS, V2980, P338, DOI 10.1117/12.273530
   Chen YH, 1999, PROC SPIE, V3600, P151, DOI 10.1117/12.351025
   ESTEROWITZ L, 1968, APPL OPTICS, V7, P2053, DOI 10.1364/AO.7.002053
   Faris G. W., 1996, OSA Trends in Optics and Photonics on Biomedical Optical Spectroscopy and Diagnostics. Vol.3. From the Topical Meeting, P225
   Hampl J, 2001, ANAL BIOCHEM, V288, P176, DOI 10.1006/abio.2000.4902
   MITA Y, 1999, PHOSPHOR HDB, P643
   Wright J. C., 1976, Radiationless processes in molecules and condensed phases, P239
   Wright WH, 1997, P SOC PHOTO-OPT INS, V2985, P248, DOI 10.1117/12.274357
   Wright WH, 1998, P SOC PHOTO-OPT INS, V3260, P245, DOI 10.1117/12.307099
NR 10
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4365-4
J9 PROC SPIE
PY 2002
VL 4626
BP 449
EP 452
DI 10.1117/12.472111
PG 4
WC Biotechnology & Applied Microbiology; Optics; Imaging Science &
   Photographic Technology
SC Biotechnology & Applied Microbiology; Optics; Imaging Science &
   Photographic Technology
GA BU92U
UT WOS:000177419500053
DA 2018-10-20
ER

PT S
AU Yu, P
   Nolte, DD
   Melloch, MR
AF Yu, P
   Nolte, DD
   Melloch, MR
BE Oraevsky, AA
TI Laser-based ultrasound detection through turbid media
SO BIOMEDICAL OPTOACOUSTICS III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Optoacoustics III
CY JAN 20-21, 2002
CL SAN JOSE, CA
SP SPIE
DE homodyne system; ultrasound detection; holographic interferometry;
   photorefractive materials
ID PHOTOREFRACTIVE QUANTUM-WELLS; OPTICAL COHERENCE TOMOGRAPHY; CRYSTAL
AB Adaptive laser-based ultrasound detection uses laser homodyne detection in an adaptive interferometer to detect ultrasound displacements. This technique has been applied to non-destructive evaluation for detection of surface displacements. However, in biomedical ultrasound applications, ultrasound displacements of interest may be inside tissue and the detection light beam may need to propagate through turbid media. Here we report laser-based adaptive ultrasonic detection that can detect ultrasound displacements inside or through turbid media using a fsec-laser as the light source in an adaptive optical coherence detection scheme. The use of an interferometer and a femtosecond laser gates out the unwanted scatter while still allowing homodyne detection. In our laser-based ultrasound system, an adaptive Mach-Zehnder interferometer is based upon two-wave mixing in semiconductor quantum-well films. It provides depth information inside the sample by adjusting the optical delay in the reference beam arm. Homodyne detection was experimentally studied for low intensity and highly wavefront distortion caused by turbid media. Using this system, ultrasonic homodyne signals through 11 MFP turbid media have been successfully detected.
C1 Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA.
RP Yu, P (reprint author), Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA.
CR BLOUIN A, 1994, APPL PHYS LETT, V65, P932, DOI 10.1063/1.112153
   CAND A, 1994, APPL PHYS LETT, V64, P414, DOI 10.1063/1.111141
   DELAYE P, 1995, APPL PHYS LETT, V67, P3251, DOI 10.1063/1.114888
   deMontmorillon LA, 1996, OPT COMMUN, V129, P293, DOI 10.1016/0030-4018(96)00190-3
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   ING RK, 1991, APPL PHYS LETT, V59, P3233, DOI 10.1063/1.105742
   Izatt JA, 1997, OPT LETT, V22, P1439, DOI 10.1364/OL.22.001439
   Lahiri I, 1998, APPL PHYS LETT, V73, P1041, DOI 10.1063/1.122078
   Nolte DD, 1999, J APPL PHYS, V85, P6259, DOI 10.1063/1.370284
   Nolte DD, 2001, J OPT SOC AM B, V18, P195, DOI 10.1364/JOSAB.18.000195
   Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037
   WATSON GH, 1987, PHYS REV LETT, V58, P945, DOI 10.1103/PhysRevLett.58.945
NR 12
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4357-3
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4618
BP 128
EP 136
DI 10.1117/12.469857
PG 9
WC Acoustics; Engineering, Biomedical; Optics
SC Acoustics; Engineering; Optics
GA BU92P
UT WOS:000177417900017
DA 2018-10-20
ER

PT J
AU Thangamani, N
   Chinnakali, K
   Gnanam, FD
AF Thangamani, N
   Chinnakali, K
   Gnanam, FD
TI The effect of powder processing on densification, microstructure and
   mechanical properties of hydroxyapatite
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE sintering; mechanical properties; apatite; biomedical applications
ID SINTERING BEHAVIOR; GRAIN-SIZE; CERAMICS; HARDNESS; HYDROXYLAPATITE;
   BRITTLENESS; STRENGTH
AB The influence of powder processing and sintering temperature on densification, microstructure and mechanical properties of hydroxyapatite (HAp) ceramics was studied. The as-dried, calcined and processed HAp powders were uniaxially compacted and sintered at various temperatures (1000-1400 degreesC) for 3 h. The as-dried and processed powders, attained 97% of theoretical density (TD) at 1100 degreesC) at higher sintering temperatures, the density of the as-dried powder compact was found to decrease. A uniform microstructure with fine grain size (2.3 pm) was observed for material obtained from processed powder, whereas exaggerated grain growth with closed pores were observed in as-dried and unprocessed powder compacts. The Vickers' hardness, fracture toughness and flexural strength of HAp were determined and a maximum value of 6.3 GPa and 0.88 MPam(1/2) and 60.3 MPa, respectively were obtained for processed compact. The processing of HAp has improved its densification, microstructure homogeneity and mechanical properties. (C) 2002 Elsevier Science Ltd and Techna S.r.l. All rights reserved.
C1 Indian Inst Sci, Dept Met, Bangalore 560012, Karnataka, India.
   Anna Univ, Ctr Ceram Technol, Chennai 600025, India.
   Anna Univ, Dept Phys, Madras 600025, Tamil Nadu, India.
RP Thangamani, N (reprint author), Indian Inst Sci, Dept Met, Bangalore 560012, Karnataka, India.
RI Chinnakali, K/D-1017-2009
OI Nithyanantham, Thangamani/0000-0002-7026-6379
CR Aizawa M, 1999, J MATER SCI, V34, P2865, DOI 10.1023/A:1004635418655
   ARITA IH, 1995, BIOMATERIALS, V16, P403, DOI 10.1016/0142-9612(95)98858-B
   BEST S, 1994, J MATER SCI-MATER M, V5, P16
   BROOK RJ, 1969, J AM CERAM SOC, V52, P339, DOI 10.1111/j.1151-2916.1969.tb11941.x
   COBLE RL, 1963, PROGR CERAMIC SCI, V3, P197
   DEPTULA A, 1992, J NON-CRYST SOLIDS, V147, P537, DOI 10.1016/S0022-3093(05)80672-6
   HILLERT M, 1965, ACTA METALL MATER, V13, P227, DOI 10.1016/0001-6160(65)90200-2
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Krell A, 1998, MAT SCI ENG A-STRUCT, V245, P277, DOI 10.1016/S0921-5093(97)00724-7
   KRELL A, 1995, J AM CERAM SOC, V78, P1417, DOI 10.1111/j.1151-2916.1995.tb08508.x
   LAWN BR, 1980, J AM CERAM SOC, V63, P574, DOI 10.1111/j.1151-2916.1980.tb10768.x
   LAWN BR, 1979, J AM CERAM SOC, V62, P347, DOI 10.1111/j.1151-2916.1979.tb19075.x
   LAWN BR, 1976, J MATER SCI, V11, P573, DOI 10.1007/BF00540940
   Luo P, 1996, BIOMATERIALS, V17, P1959, DOI 10.1016/0142-9612(96)00019-1
   MURRAY MGS, 1995, J MATER SCI, V30, P3061, DOI 10.1007/BF01209218
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   OSAKA A, 1991, J MATER SCI-MATER M, V2, P51, DOI 10.1007/BF00701687
   PUAJINDANETR S, 1994, BRIT CERAM T, V93, P96
   RICE RW, 1994, J AM CERAM SOC, V77, P2539, DOI 10.1111/j.1151-2916.1994.tb04641.x
   Richerson D.W., 1922, MODERN CERAMIC ENG P
   ROYER A, 1993, J MATER SCI-MATER M, V4, P76, DOI 10.1007/BF00122982
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   THANGAMANI N, IN PRESS BIOMATERIAL
   VANLANDUYT P, 1995, J MATER SCI-MATER M, V6, P8, DOI 10.1007/BF00121239
NR 26
TC 66
Z9 67
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PY 2002
VL 28
IS 4
BP 355
EP 362
AR PII S0272-8842(01)00102-X
DI 10.1016/S0272-8842(01)00102-X
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 557XW
UT WOS:000175935200002
DA 2018-10-20
ER

PT J
AU Dybczynski, R
AF Dybczynski, R
TI Considerations on the accuracy of determination of some essential and/or
   toxic trace elements in biological materials
SO CHEMIA ANALITYCZNA
LA English
DT Review
DE accuracy; precision; interlaboratory comparisons; CRMs; trace analysis;
   biological materials
ID NEUTRON-ACTIVATION ANALYSIS; DEFINITIVE METHOD
AB In our times many important decisions in the field of biomedical sciences, nutrition, estimation of environmental pollution etc. may depend on the reliability of chemical measurements. While most of laboratories produce the results with a good or reasonable precision, the situation with the accuracy of these results is very often much worse. The results of the determination of several essential and toxic elements obtained in some international interlaboratory comparisons are shown and discussed from the standpoint of their accuracy. It is pointed out that good precision is not always accompanied by a good accuracy and that gross errors may frequently occur. The possible origins of such errors are briefly outlined. The significance of the methods with,guaranteed accuracy" is indicated and examples of such methods based on radiochemical NAA are presented. The importance of certified reference materials (CRMs) for quality assurance in inorganic trace analysis is emphasized and the attention is given to the problem of homogeneity of these materials especially when using microchemical techniques.
C1 Inst Nucl Chem & Technol, Dept Analyt Chem, PL-03195 Warsaw, Poland.
RP Dybczynski, R (reprint author), Inst Nucl Chem & Technol, Dept Analyt Chem, Ul Dorodna 16, PL-03195 Warsaw, Poland.
CR BYRNE AR, 1987, FRESEN Z ANAL CHEM, V326, P723, DOI 10.1007/BF00473540
   Danko B, 1997, J RADIOANAL NUCL CH, V216, P51, DOI 10.1007/BF02034495
   DEBIEVRE P, 1990, FRESEN J ANAL CHEM, V337, P766, DOI 10.1007/BF00322250
   DYBCZYNSKI R, 1994, J RADIOAN NUCL CH AR, V181, P43, DOI 10.1007/BF02037546
   DYBCZYNSKI R, 1993, FRESEN J ANAL CHEM, V345, P99, DOI 10.1007/BF00322563
   Dybczynski R, 2001, FRESEN J ANAL CHEM, V370, P126, DOI 10.1007/s002160100722
   DYBCZYNSKI R, 1989, J RADIOAN NUCL CH AR, V130, P365, DOI 10.1007/BF02041356
   Dybczynski R, 1996, J ANAL CHEM+, V51, P1206
   Dybczynski R, 1998, FRESEN J ANAL CHEM, V360, P384, DOI 10.1007/s002160050718
   DYBCZYNSKI R, 1997, PREPARATION CERTIFIC
   DYBCZYNSKI R, 1996, PREPARATION CERTIFIC
   DYBCZYNSKI R, 1998, REFERENCE MAT THEIR, P1
   Dybczynski R, 1980, TRACE ELEMENT ANAL C, P657
   HORWITZ W, 1982, ANAL CHEM, V54, P67
   Namiesnik J, 1999, SCI TOTAL ENVIRON, V228, P243, DOI 10.1016/S0048-9697(99)00053-4
   SMITS R, 2000, LC GC EUR, V13, P460
   Stoeppler M., 2001, REFERENCE MAT CHEM
   URIANO GA, 1977, CRC CR REV ANAL CHEM, V6, P361, DOI 10.1080/10408347708542696
   VERSIECK J, 1980, ANAL CHIM ACTA, V116, P217, DOI 10.1016/S0003-2670(01)95205-5
   VERSIECK J, 1984, QUALITY ASSURANCE BI, P71
   von Lehmden D J, 1974, Anal Chem, V46, P239, DOI 10.1021/ac60338a004
   ZEILLER E, 1990, INTERCOMPARISON STUD, P69
NR 22
TC 4
Z9 4
U1 0
U2 3
PU INSTYTUT CHEMII FIZYCZNEJ PAN
PI WARSAW
PA UL KASPRZAKA 44/52, 01-224 WARSAW, POLAND
SN 0009-2223
J9 CHEM ANAL-WARSAW
JI Chem. Anal.
PY 2002
VL 47
IS 3
BP 325
EP 334
PG 10
WC Chemistry, Analytical
SC Chemistry
GA 565JX
UT WOS:000176367600002
DA 2018-10-20
ER

PT J
AU Boguschewski, FH
   Seyfarth, M
   Heidrich, JP
AF Boguschewski, FH
   Seyfarth, M
   Heidrich, JP
TI Evaluation of two Mg2+-selective electrodes by means of a flow-through
   device
SO CLINICAL CHEMISTRY AND LABORATORY MEDICINE
LA English
DT Article; Proceedings Paper
CT 14th European Congress of Clinical Chemistry and Laboratory Medicine
CY MAY 26-31, 2001
CL PRAGUE, CZECH REPUBLIC
SP IFCC, FESCC
DE calcium interference; ISE evaluation; online measurement; Mg2+-ISE; POCT
   : point-of-care-testing; quality control material
ID ION-SELECTIVE ELECTRODES; CONTROLLED HEMODIALYSIS; IONIZED MAGNESIUM;
   CALCIUM; IMG2+; BLOOD; NOVA; PH
AB Monitoring the ionized magnesium (Mg2+) concentration in critically ill patients can prevent development of serious and potentially fatal complications. The analyzers KONE Microlyte 6 (KONE Instruments, Espoo, Finland) and NOVA CRT (NOVA Biomedical, Waltham, MA, USA) provide the discontinuous measurement of Mg2+ and were evaluated in several studies. It was our objective to integrate the Mg2+-selective electrodes into a device for continuous online measurements. This device is suitable not only for research but also for a specific evaluation of electrode characteristics. It allowed us to compare the genuine electrodes and reference systems independently of their specific analyzers. Precision, accuracy, response time, limit of detection, drift and interferences were assessed by continuous flowthrough measurements and discussed in comparison to the results of previous studies. The NOVA electrode proved to be superior regarding accuracy, sensitivity and selectivity, especially with respect to calcium. It was demonstrated that current commercial serumlike control materials were not appropriate for quality control of the assessed Mg2+-electrodes. However, despite the fact that the electrodes are commercially used for discontinuous measurements, both sensor types can be used for continuous online measurements in an extracorporeal circulation in a rat model. The NOVA electrode showed superior characteristics with this application as well. This study should also be understood as a contribution to the development of devices for online analyzers used in pointofcaretesting.
C1 Med Univ Lubeck, Inst Clin Chem, D-23538 Lubeck, Germany.
RP Heidrich, JP (reprint author), Med Univ Lubeck, Inst Clin Chem, Ratzeburger Allee 160, D-23538 Lubeck, Germany.
EM heidrich@medinf.mu-luebeck.de
CR Altura Bella T., 1994, Scandinavian Journal of Clinical and Laboratory Investigation, V54, P53, DOI 10.3109/00365519409095211
   ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P77, DOI 10.3109/00365519409095213
   Burnett RW, 2000, CLIN CHEM LAB MED, V38, P363, DOI 10.1515/CCLM.2000.052
   ELIN RJ, 1994, AM J CLIN PATHOL, V102, P616, DOI 10.1093/ajcp/102.5.616
   Guilbault G. G., 1976, PURE APPL CHEM, V48, P129
   HEIDRICH JP, 1993, FRESEN J ANAL CHEM, V347, P299, DOI 10.1007/BF00323976
   Heidrich JP, 1998, CLIN CHEM LAB MED, V36, P847, DOI 10.1515/CCLM.1998.149
   HRISTOVA EN, 1996, CLIN CHEM, V42, P880
   Huijgen HJ, 1999, CLIN CHEM LAB MED, V37, P465, DOI 10.1515/CCLM.1999.075
   Kulpmann Wolf R., 1996, Scandinavian Journal of Clinical and Laboratory Investigation, V56, P251
   LEWENSTAM A, 1994, SCAND J CLIN LAB INV, V54, P37, DOI 10.3109/00365519409095209
   *RICHTL BUND QUAL, 1988, DTSCH ARZTEBLATT A, V11, P699
   Ritter C, 1996, SCAND J CLIN LAB INV, V56, P275, DOI 10.3109/00365519609088647
   RYAN MF, 1991, ANN CLIN BIOCHEM, V28, P19, DOI 10.1177/000456329102800103
   SAUR PMM, 1994, EUR J CLIN CHEM CLIN, V32, P539
   SCHINDLER JG, 1991, BIOMED TECH, V36, P271, DOI 10.1515/bmte.1991.36.11.271
   Spichiger-Keller U. E., 1998, CHEM SENSORS BIOSENS
   VANINGEN HE, 1994, CLIN CHEM, V40, P52
   WONG ET, 1983, AM J CLIN PATHOL, V79, P348
NR 19
TC 1
Z9 1
U1 0
U2 2
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1434-6621
EI 1437-4331
J9 CLIN CHEM LAB MED
JI Clin. Chem. Lab. Med.
PY 2002
VL 40
IS 3
BP 308
EP 311
DI 10.1515/CCLM.2002.049
PG 4
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 549XN
UT WOS:000175472700016
PM 12005223
DA 2018-10-20
ER

PT S
AU Dunsby, C
   Gu, Y
   Ansari, Z
   Parsons-Karavassilis, D
   Siegel, J
   Itoh, M
   Iwamoto, S
   Headley, W
   Melloch, MR
   Nolte, DD
   French, PMW
AF Dunsby, C
   Gu, Y
   Ansari, Z
   Parsons-Karavassilis, D
   Siegel, J
   Itoh, M
   Iwamoto, S
   Headley, W
   Melloch, MR
   Nolte, DD
   French, PMW
BE Tuchin, VV
   Izatt, JA
   Fujimoto, JG
TI Low coherence photorefractive holography for high-speed 3D imaging,
   including through scattering media
SO COHERENCE DOMAIN OPTICAL METHODS IN BIOMEDICAL SCIENCE AND CLINICAL
   APPLICATIONS VI
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Coherence Domain Optical Methods in Biomedical Science and
   Clinical Applications VI
CY JAN 21-23, 2002
CL SAN JOSE, CA
SP SPIE
DE photorefractive holography; biomedical imaging; coherence gating; low
   coherence interferometry; high frame-rate imaging; broadband laser
   source
ID MULTIPLE-QUANTUM WELLS; FRANZ-KELDYSH GEOMETRY; LIGHT; MICROSCOPY;
   TOMOGRAPHY
AB Low coherence photorefractive holography is a wide-field technique for 3-D imaging that offers a unique mechanism to discriminate against a background of diffuse light. This provides a wide-field method to image through scattering materials that we have demonstrated may be implemented at frame rates as high as similar to470/second. We present our recently developed low coherence photorefractive microscope and demonstrate how it may be realised using a spatially coherent broadband c.w. diode-pumped solid-state laser. This can provide real-time sectioned images of moving 3-D objects using only a simple uncooled 8-bit CCD camera. We also demonstrate a photorefractive 3-D imaging technique that exploits structured illumination and photorefractive holography to achieve a real-time wide-field sectioning microscope that may be applied to fluorescence, as well as reflected light. We also discuss issues for improving the sensitivity and spectral coverage of photorefractive holography using semi-insulating MQW devices.
C1 Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.
RP Dunsby, C (reprint author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.
RI Siegel, Jan/C-7031-2009
OI Siegel, Jan/0000-0002-6159-7299
CR ADLER CL, 1995, OPT COMMUN, V114, P375, DOI 10.1016/0030-4018(94)00637-A
   Balasubramanian S, 1999, APPL PHYS B-LASERS O, V68, P863, DOI 10.1007/s003400050716
   Beaurepaire E, 1998, OPT LETT, V23, P244, DOI 10.1364/OL.23.000244
   CHAN KP, 1994, ELECTRON LETT, V30, P1753, DOI 10.1049/el:19941193
   GU Y, CLEO 2001
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Hyde SCW, 1996, IEEE J SEL TOP QUANT, V2, P965, DOI 10.1109/2944.577323
   Iwamoto S, 2001, OPT LETT, V26, P22, DOI 10.1364/OL.26.000022
   Iwamoto S, 2001, J APPL PHYS, V89, P5889, DOI 10.1063/1.1370364
   Jones R, 1998, IEEE J SEL TOP QUANT, V4, P360, DOI 10.1109/2944.686743
   Jones RL, 1998, EPRI J, V23, P2
   LEITH EN, 1991, OPT LETT, V16, P1820, DOI 10.1364/OL.16.001820
   Neil MAA, 2000, J MICROSC-OXFORD, V197, P1
   Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905
   Nolte DD, 1999, J APPL PHYS, V85, P6259, DOI 10.1063/1.370284
   Parsons-Karavassilis D, 2000, OPT COMMUN, V181, P361, DOI 10.1016/S0030-4018(00)00776-8
   REBANE A, 1998, NATURE, V331, P378
   Rollins AM, 1998, OPT EXPRESS, V3, P219, DOI 10.1364/OE.3.000219
   STETSON KA, 1967, J OPT SOC AM, V57, P1060, DOI 10.1364/JOSA.57.001060
   Tziraki M, 2000, APPL PHYS B-LASERS O, V70, P151, DOI 10.1007/s003400050023
   WANG Q, 1992, J OPT SOC AM B, V9, P1626, DOI 10.1364/JOSAB.9.001626
NR 21
TC 1
Z9 1
U1 1
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4358-1
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4619
BP 98
EP 106
DI 10.1117/12.470469
PG 9
WC Engineering, Biomedical; Optics; Imaging Science & Photographic
   Technology
SC Engineering; Optics; Imaging Science & Photographic Technology
GA BU92Q
UT WOS:000177418300016
DA 2018-10-20
ER

PT J
AU Kazanci, M
   Cohn, D
   Marom, G
   Migliaresi, C
   Pegoretti, A
AF Kazanci, M
   Cohn, D
   Marom, G
   Migliaresi, C
   Pegoretti, A
TI Fatigue characterization of polyethylene fiber reinforced polyolefin
   biomedical composites
SO COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING
LA English
DT Article
DE polymer-matrix composites (PMCs); fatigue; filament winding;
   polyethylene-butene copolymers
ID HIGH-DENSITY POLYETHYLENE; FRACTURE-BEHAVIOR; CHAIN STRUCTURE;
   POLYPROPYLENE; MORPHOLOGY; MECHANISMS
AB Filament wound flat strip composites of polyethylene fiber reinforced ethylene-butene copolymers were produced and their fatigue behavior under cyclic loading was studied. Three different copolymer compositions and two different winding angles were employed in order to study the effects of branching density in the polymeric matrix and of reinforcement angle on the fatigue response of the composite. The results were in agreement with published fatigue models, showing that the short-term fatigue behavior, at relatively high stress levels, was controlled by the static properties of the materials, exhibiting better fatigue resistance for lower branching density of the copolymer and for a smaller reinforcement angle. However, the long-term fatigue behavior, at moderate stress levels, was governed by the fatigue rate of degradation, which decreased with the branching density and winding angle. The fatigue induced creep resulted in fiber reorientation in the loading direction, which in turn generated high residual properties. It was concluded that various polymer/angle combinations could result in fatigue-proof composites of significant residual properties at 10(6) fatigue cycles. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Hebrew Univ Jerusalem, Casali Inst Appl Chem, IL-91904 Jerusalem, Israel.
   Univ Trent, Dept Mat Engn, I-38050 Trent, Italy.
RP Marom, G (reprint author), Hebrew Univ Jerusalem, Casali Inst Appl Chem, Givat Ram Campus, IL-91904 Jerusalem, Israel.
RI Pegoretti, Alessandro/F-1240-2010
OI Pegoretti, Alessandro/0000-0001-9641-9735
CR EGAN BJ, 1995, J MATER SCI, V30, P3307, DOI 10.1007/BF00349874
   EGAN BJ, 1995, J MATER SCI, V30, P3351, DOI 10.1007/BF00349879
   FEIGELSHTEIN D, 2000, ADV COMPOS LETT, V9, P346
   Gamstedt EK, 1999, COMPOS SCI TECHNOL, V59, P759, DOI 10.1016/S0266-3538(98)00119-5
   Harcup JP, 2000, POLYM ENG SCI, V40, P627, DOI 10.1002/pen.11193
   KADOTA K, 1993, J APPL POLYM SCI, V49, P863, DOI 10.1002/app.1993.070490512
   Kavesh S, 1995, INT J POLYM MATER, V30, P15, DOI 10.1080/00914039508031459
   Kazanci M, 2001, J MATER SCI, V36, P2845, DOI 10.1023/A:1017990001113
   KAZANCI M, 2002, IN PRESS J MAT SCI M
   Krzypow DJ, 2000, BIOMATERIALS, V21, P2081, DOI 10.1016/S0142-9612(00)00138-1
   Martz EO, 1997, J BIOMED MATER RES, V38, P267, DOI 10.1002/(SICI)1097-4636(199723)38:3<267::AID-JBM12>3.0.CO;2-8
   Pegoretti A, 1999, COMPOS SCI TECHNOL, V59, P1055, DOI 10.1016/S0266-3538(98)00143-2
   Pegoretti A, 2000, COMPOS SCI TECHNOL, V60, P1181, DOI 10.1016/S0266-3538(00)00024-5
   Shalom S, 1997, COMPOS SCI TECHNOL, V57, P1423, DOI 10.1016/S0266-3538(97)00084-5
   Staubli HU, 1999, AM J SPORT MED, V27, P27
   STREBEL JJ, 1994, J APPL POLYM SCI, V52, P1815, DOI 10.1002/app.1994.070521216
   TALREJA R, 1981, P ROY SOC LOND A MAT, V378, P461, DOI 10.1098/rspa.1981.0163
   Talreja R, 1987, FATIGUE COMPOSITE MA
   YEH JT, 1995, MACROMOL CHEM PHYSIC, V196, P705, DOI 10.1002/macp.1995.021960302
   ZHOU Y, 1991, POLYM ENG SCI, V31, P711, DOI 10.1002/pen.760311005
NR 20
TC 21
Z9 21
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-835X
J9 COMPOS PART A-APPL S
JI Compos. Pt. A-Appl. Sci. Manuf.
PY 2002
VL 33
IS 4
BP 453
EP 458
AR PII S1359-835X(02)00002-7
DI 10.1016/S1359-835X(02)00002-7
PG 6
WC Engineering, Manufacturing; Materials Science, Composites
SC Engineering; Materials Science
GA 534ZW
UT WOS:000174620500001
DA 2018-10-20
ER

PT B
AU Vincent, L
   Fridrici, V
   Fouvry, S
   Kapsa, P
AF Vincent, L
   Fridrici, V
   Fouvry, S
   Kapsa, P
BE Zhang, S
   Zhou, ZR
   Liu, JJ
   Zhu, MH
TI Contact damage in assemblies
SO CONTRIBUTIONS OF SURFACE ENGINEERING TO MODERN MANUFACTURING AND
   REMANUFACTURING
LA English
DT Proceedings Paper
CT 3rd International Conference on Surface Engineering
CY OCT 10-13, 2002
CL CHENGDU, PEOPLES R CHINA
SP Chinese Mech Engn Soc, SW Jiaotong Univ
DE fretting; surface damage; cracking; wear; assemblies
AB To determine and optimise the durability of assemblies in industrial installations, damage induced by contacts has to be taken into account. Indeed, when two contacting surfaces are submitted to tangential loading due to vibrations for instance, small amplitude displacements are induced at the inter-face. Depending on the materials and the normal and tangential loadings, this phenomenon, known as fretting, can lead to crack nucleation (and possible propagation if one of the component is subjected to a fatigue loading) or to loss of matter. In both cases, the industrial structure is in danger. Industrial branches under concern are civil and mechanical engineering, aeronautics, nuclear, biomedical and automotive industries...
   Industrial examples of damage induced by fretting will be presented and ways of prevention and improvement (such as surface treatments, lubrication -.) will be discussed.
C1 Ecole Cent Lyon, CNRS, UMR 5513, Dept Mat & Surfaces, F-69130 Ecully, France.
RP Vincent, L (reprint author), Ecole Cent Lyon, CNRS, UMR 5513, Dept Mat & Surfaces, 36,Ave Guy de Collongue, F-69130 Ecully, France.
CR Amontons G., 1699, FROTTEMENT DIVERSES
   ATTIA MH, 1993, ASME S CONTACT PROBL
   BERTHIER Y, 1988, VELOCITY ACCOMMODATI, P25
   BILL RC, 1977, ASLE T, P236
   BLAU PJ, 1992, ASM HDB, V18, P1
   CHIVERS TC, 1985, PI MECH ENG, P325
   COULOMB M, 1773, MEMOIRES MATH PHYSIQ
   Dang Van K., 1973, MEMORIAL ARTILLERIE
   Dowson D, 1966, ELASTOHYDRODYNAMIC L
   DUBOURG MC, 1994, LONDON MECH ENG PUBL
   Fouvry S, 1996, WEAR, V200, P186, DOI 10.1016/S0043-1648(96)07306-1
   Frene J., 1988, LUBRIFICATION HYDROD
   FRIDRICI V, 2000, IN PRESS INT C TRIB
   GODET M, 1990, TRIBOLOGY SERIES, V17
   GODET M, 1987, CONTINUITY DRY FRICT
   GODET M, 1984, 3 BODY APPROACH MECH, P437
   Hertz H, 1896, MISCELLANEOUS PAPERS
   Johnson K. L., 1985, CONTACT MECH
   Kalker J., 1990, 3 DIMENSIONAL ELASTI
   LEROY J. M., 1989, THESIS INSA LYON
   LIM C, 1987, ACTA METALL, P1
   MCDOWELL OJ, 1953, ASTM, P40
   Mindlin R. D., 1953, ASME, P327
   PETIOU C, 1994, THESIS ECOLE CENTRAL
   SAUGER E, 1997, THESIS ECOLE CENTRAL
   SPROLES ES, 1978, WEAR, V47, P387, DOI 10.1016/0043-1648(78)90167-9
   VINGSBO O, 1988, WEAR, V126, P131, DOI 10.1016/0043-1648(88)90134-2
   Waterhouse R. B., 1972, FRETTING CORROSION
   Waterhouse R. B., 1981, FRETTING FATIGUE
   WATERHOUSE RB, 1992, AM SOC TEST MATER, V1159, P13, DOI 10.1520/STP25806S
   ZHOU ZR, 1992, WEAR, V155, P317, DOI 10.1016/0043-1648(92)90091-L
   ZHOU ZR, 1995, WEAR, V181, P531
NR 32
TC 0
Z9 0
U1 0
U2 0
PU SOUTHWEST JIAOTONG UNIV PRESS
PI CHENGDU
PA ERHUAN RD, CHENGDU 610031, SICHUAN, PEOPLES R CHINA
BN 7-81057-661-5
PY 2002
BP 34
EP 41
PG 8
WC Engineering, Mechanical; Materials Science, Coatings & Films
SC Engineering; Materials Science
GA BV99R
UT WOS:000180624600006
DA 2018-10-20
ER

PT B
AU Dong, H
AF Dong, H
BE Zhang, S
   Zhou, ZR
   Liu, JJ
   Zhu, MH
TI Surface engineering of prosthetic bearing surfaces
SO CONTRIBUTIONS OF SURFACE ENGINEERING TO MODERN MANUFACTURING AND
   REMANUFACTURING
LA English
DT Proceedings Paper
CT 3rd International Conference on Surface Engineering
CY OCT 10-13, 2002
CL CHENGDU, PEOPLES R CHINA
SP Chinese Mech Engn Soc, SW Jiaotong Univ
DE surface engineering; joint prostheses
ID DIAMOND-LIKE CARBON; OF-THE-ART; ORTHOPEDIC APPLICATIONS; HIP
   PROSTHESES; COATINGS; WEAR; BIOCOMPATIBILITY; HYDROXYAPATITE;
   PERFORMANCE; LAYERS
AB Surface engineering has been emerging as one of the most promising technologies to improve the tribological properties of biomedical materials. thus achieving enhanced performance and prolonged life span. One of our current researches at the University of Birmingham has been directed at developing novel surface engineering technologies for biomedical materials towards long-life total joint replacements, which has great potential of improving quality of life and contributing to social and economic sustainable development. In this paper, the state-of-the-art of surface engineering of biomedical materials is briefly overviewed. By way of example, our recent progress in surface engineering of biomedical materials for joint prosthesis is then reported. Finally, future research directions and trends in the surface engineering of biomedical materials are identified and discussed.
C1 Univ Birmingham, Sch Engn, Surface Engn Grp, Birmingham, W Midlands, England.
RP Dong, H (reprint author), Univ Birmingham, Sch Engn, Surface Engn Grp, Birmingham, W Midlands, England.
CR AISENBERG S, 1971, J APPL PHYSICS
   Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   ANTTILA A, 1999, NEW DIAM FRONT C TEC, P283
   BELL T, 1995, P INT C SURF SCI ENG, P9
   Bell T., 1998, CHINA SURFACE ENG, P40
   BLOYCE A, 1994, ASM HDB, V5, P840
   CHANDRA L, 1995, J MATER SCI-MATER M, V6, P581, DOI 10.1007/BF00121282
   CHARNLEY J, 1979, LOW FRICTION ARTHOPL
   CLARKE IC, 1992, AM SOC TEST MATER, V1144, P7, DOI 10.1520/STP14848S
   COLL BF, 1988, SURF COAT TECH, V36, P867, DOI 10.1016/0257-8972(88)90027-8
   COLL BF, 1991, ASTM F 4 WORKSH ION
   COLLINS GA, 1991, MAT SCI ENG A-STRUCT, V139, P171, DOI 10.1016/0921-5093(91)90613-R
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   Dong H, 1999, WEAR, V225, P146, DOI 10.1016/S0043-1648(98)00356-1
   Dong H, 2000, J MATER SCI LETT, V19, P1147, DOI 10.1023/A:1006755008958
   Dong H, 1999, SURF COAT TECH, V111, P29, DOI 10.1016/S0257-8972(98)00698-7
   DONG H, 2001, Patent No. 6210807
   DONG H, 1999, SPORTS ENG, P213
   DOWSON D, 1992, ASM HDB, V18, P656
   ELLIS R, 1998, TIMES           0219
   ENKE K, 1980, APPL PHYS LETT, V36, P291, DOI 10.1063/1.91465
   EVANS AC, 1991, SURF COAT TECH, V47, P662, DOI 10.1016/0257-8972(91)90338-W
   Harman MK, 1997, J ARTHROPLASTY, V12, P938, DOI 10.1016/S0883-5403(97)90164-9
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   JONES AHS, 2000, C FRICT LUBR WEAR AR
   JONES AHS, P 12 IFHTSE C I ENG, V3, P35
   LAFFARGUE P, 1998, METALS BIOMATERIALS, P486
   Lappalainen R, 1998, CLIN ORTHOP RELAT R, P118
   Lappalainen R, 1998, DIAM RELAT MATER, V7, P482, DOI 10.1016/S0925-9635(98)80003-4
   Lausmaa J., 1991, Surface Engineering, V7, P311
   LIFSHITZ Y, 1999, DIAM RELAT MATER, P1660
   Lillard RS, 1997, CORROS SCI, V39, P1605, DOI 10.1016/S0010-938X(97)00064-4
   MALCHAU H, 1996, 63 ANN M AM AC ORTH
   *MAT STRAT COMM, 1995, MAT TECHN FOR BIOM
   ONATE JI, 2001, SURFACE COATINGS TEC, P1056
   PETERSON CD, 1988, J BIOMED MATER RES, V22, P887, DOI 10.1002/jbm.820221005
   Raimondi MT, 2000, BIOMATERIALS, V21, P907
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   Rolinski E., 1987, Surface Engineering, V3, P35
   RUCK DM, 1997, PROTECTIVE COATINGS, P649
   Saikko V, 2001, BIOMATERIALS, V22, P1507, DOI 10.1016/S0142-9612(00)00306-9
   SCHMALZRIED TP, 1992, J BONE JOINT SURG
   Sheeja D, 2001, SURF COAT TECH, V146, P410, DOI 10.1016/S0257-8972(01)01425-6
   SUCHANEK W, PROCESSING PROPERTIE
   SUIRE R, 1988, Patent No. 4790851
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Sun Y, 1999, HEAT TREAT MET-UK, V26, P9
   Sun Y, 1999, SURF ENG, V15, P49, DOI 10.1179/026708499322911647
   Thanner J, 1999, ACTA ORTHOP SCAND, V70, P155, DOI 10.3109/17453679909011255
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   VIDOVSZKY TJ, 1998, HIP SURG MAT DEV, P317
   WILES P, 1957, BRIT J SURG, P488
   WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005
   Willmann G, 1996, BRIT CERAM T, V95, P212
   Zeng A., 2002, DIAM RELAT MATER, V2002, P160
   Zhang Z.L., 1985, SURF ENG, V1, P131, DOI DOI 10.1179/SUR.1985.1.2.131
NR 58
TC 1
Z9 1
U1 0
U2 1
PU SOUTHWEST JIAOTONG UNIV PRESS
PI CHENGDU
PA ERHUAN RD, CHENGDU 610031, SICHUAN, PEOPLES R CHINA
BN 7-81057-661-5
PY 2002
BP 457
EP 464
PG 8
WC Engineering, Mechanical; Materials Science, Coatings & Films
SC Engineering; Materials Science
GA BV99R
UT WOS:000180624600095
DA 2018-10-20
ER

PT J
AU Lindblad, MS
   Liu, Y
   Albertsson, AC
   Ranucci, E
   Karlsson, S
AF Lindblad, MS
   Liu, Y
   Albertsson, AC
   Ranucci, E
   Karlsson, S
TI Polymers from renewable resources
SO DEGRADABLE ALIPHATIC POLYESTERS
SE ADVANCES IN POLYMER SCIENCE
LA English
DT Review
DE monomers from renewable resources; polymers from renewable resources;
   1,3-propanediol; succinic acid; lactones; cyclohexanedimethanol;
   polyethyleneglycol; chain-extension; poly(ester-urethane)s;
   poly(ester-carbonate)s
ID POLY(LACTIC-GLYCOLIC ACID); BIODEGRADABLE POLYMERS; SUCCINIC ACID;
   1,3-PROPANEDIOL; SEGMENTS
AB From the point of view of making novel polymers with inherent environment-favorable properties such as renewability and degradability, a series of interesting monomers are found in the metabolisms and cycles of nature. This review presents and discusses a number of aliphatic polyesters which show interesting applications as biomedical materials and degradable packages. Available from nature are amino acids, microbial metabolites from the conversion of glucose and other monosaccharides (e.g., acetic acid, acetone, 2,3-butanediol, butyric acid, isopropanol, propionic acid), lactic acid, ethanol and fatty acids. A series of biodegradable polymers with different properties and different potential industrial uses were made starting with succinic acid and/or 1,3-propanediol. There were two routes for making the polyester-based materials; the direct ring-opening polymerization of lactones (cyclic esters) synthesized from 1,3-propanediol, and the chain-extension of alpha,omega-dihydroxy-terminated oligomeric polyesters produced by thermal polycondensation of 1,3-propanediol and succinic acid (oligo(propylene succinate)s).
C1 Royal Inst Technol, Dept Polymer Technol, SE-10044 Stockholm, Sweden.
RP Lindblad, MS (reprint author), Royal Inst Technol, Dept Polymer Technol, SE-10044 Stockholm, Sweden.
RI Karlsson, Sigbritt/D-6935-2014; Ranucci, Elisabetta/J-3899-2015;
   Albertsson, Ann-Christine/Q-6107-2016
OI Karlsson, Sigbritt/0000-0002-5394-7850; Ranucci,
   Elisabetta/0000-0002-6402-2650; Albertsson,
   Ann-Christine/0000-0001-8696-9143
CR ALBERTSSON AC, 1988, ACTA POLYM, V39, P95, DOI 10.1002/actp.1988.010390118
   Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523
   DECKWER WD, 1995, FEMS MICROBIOL REV, V16, P143, DOI 10.1111/j.1574-6976.1995.tb00162.x
   Freund A., 1881, MONATSH CHEM, V2, P636, DOI 10.1007/BF01516545
   Lee PC, 1999, PROCESS BIOCHEM, V35, P49, DOI 10.1016/S0032-9592(99)00031-X
   Liu Y, 2001, J POLYM SCI POL CHEM, V39, P2508, DOI 10.1002/pola.1227
   Liu Y, UNPUB
   Nghiem NP, 1997, APPL BIOCHEM BIOTECH, V63-5, P565, DOI 10.1007/BF02920454
   OIU Y, 2001, J POLYM SCI POL CHEM, V39, P630
   Penco M, 1996, POLYM ADVAN TECHNOL, V7, P536
   Penco M, 1998, MACROMOL CHEM PHYSIC, V199, P1737, DOI 10.1002/(SICI)1521-3935(19980801)199:8<1737::AID-MACP1737>3.3.CO;2-W
   Ranucci E, 2000, MACROMOL RAPID COMM, V21, P680, DOI 10.1002/1521-3927(20000601)21:10<680::AID-MARC680>3.0.CO;2-Y
   Wilke D, 1999, APPL MICROBIOL BIOT, V52, P135, DOI 10.1007/s002530051500
NR 13
TC 83
Z9 90
U1 1
U2 57
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
J9 ADV POLYM SCI
PY 2002
VL 157
BP 139
EP 161
PG 23
WC Polymer Science
SC Polymer Science
GA BU66S
UT WOS:000176673500005
DA 2018-10-20
ER

PT S
AU Sasov, A
AF Sasov, A
BE Bonse, U
TI Desktop x-ray micro-CT instruments
SO DEVELOPMENTS IN X-RAY TOMOGRAPHY III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd Conference on Developments in X-Ray Tomography
CY AUG 02-03, 2001
CL SAN DIEGO, CA
SP SPIE
DE x-ray; 3D reconstruction; micro-CT; microtomography; tomosynthesis;
   nondestructive testing
AB An X-ray microtomograph (or micro-CT) is an instrument for non-destructive 3-dimensional reconstruction of the object's internal microstructure without physical cut or time consuming specimen preparation. By using modem technology in x-ray sources and detectors several micro-CT systems were created as a simply usable desktop instrument. First micro-CT system is a laboratory instruments giving true spatial resolution over a ten million times more detailed (in the term of volume parts) than the medical CT-scanners. The instrument contains a sealed microfocus X-ray source, a cooled X-ray digital CCD-camera and a Dual Pentium computer for system control and 3D-reconstructions twining under Windows 2000. The instrument includes possibilities for image analysis in the non-destructively reconstructed internal microstructure and realistic 3D visualization. During scanning objects are displaced in normal environment conditions, without vacuum or preparation. Another micro-CT scanner is a low-cost portable instrument, which can be connected to any external Pentium-based PC. Third instrument - microlaminograph - can create nondestructive slicing in any place of big planar objects (electronic assemblies, PCBs, etc.). This system uses principles of tomosynthesis from incomplete dataset for slicing in internal object's layers. The main application areas for micro-CT and microlaminography systems are biomedical research, material sciences, electronic components, etc.
C1 Skyscan, Aartselaar, Belgium.
RP Sasov, A (reprint author), Vluchtenburgstr 3, B-2630 Aartselaar, Belgium.
CR SASOV A, 1998, MICROSCOPY ANAL, P21
   SASOV AY, 1987, J MICROSC-OXFORD, V147, P169, DOI 10.1111/j.1365-2818.1987.tb02829.x
NR 2
TC 3
Z9 3
U1 1
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4217-8
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4503
BP 282
EP 290
DI 10.1117/12.452854
PG 9
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BU16C
UT WOS:000175177400032
DA 2018-10-20
ER

PT S
AU Thoma, GR
   Ford, G
   Le, D
   Li, ZR
AF Thoma, GR
   Ford, G
   Le, D
   Li, ZR
BE Lopresti, EP
   Hu, J
   Kashi, R
TI Text verification in an automated system for the extraction of
   bibliographic data
SO DOCUMENT ANALYSIS SYSTEM V, PROCEEDINGS
SE LECTURE NOTES IN COMPUTER SCIENCE
LA English
DT Article; Proceedings Paper
CT 5th International Workshop on Document Analysis Systems
CY AUG 19-21, 2002
CL PRINCETON, NEW JERSEY
SP Avaya Inc
ID DOCUMENT IMAGES
AB An essential stage in any text extraction system is the manual verification of the printed material converted by OCR. This proves to be the most labor-intensive step in the process. In a system built and deployed at the National Library of Medicine to automatically extract bibliographic data from scanned biomedical journals, alternative means were considered to validate the text. This paper describes two approaches and gives preliminary performance data.
C1 Natl Lib Med, Bethesda, MD 20894 USA.
RP Thoma, GR (reprint author), Natl Lib Med, Bethesda, MD 20894 USA.
CR Ford G, 2001, PROC SPIE, V4307, P241
   FORD GM, P 1999 S DOC IM UND, P321
   Hauser SE, 2000, P SOC PHOTO-OPT INS, V3967, P248
   Kim J, 2001, P SOC PHOTO-OPT INS, V4307, P111
   Lasko TA, 2001, P SOC PHOTO-OPT INS, V4307, P232
   *LHNCBC NLM, 2001, AUT PROD BIBL REC ME
   LI Z, 2001, CHARACTER VERIFICATI
   MOORE A, 1994, TRICKS MAKE OCR WORK
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0302-9743
BN 3-540-44068-2
J9 LECT NOTES COMPUT SC
PY 2002
VL 2423
BP 423
EP 432
PG 10
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods
SC Computer Science
GA BY01S
UT WOS:000187252700046
OA Bronze
DA 2018-10-20
ER

PT S
AU Marquez, GJ
   Renn, MJ
   Miller, WD
AF Marquez, GJ
   Renn, MJ
   Miller, WD
BE BarCohen, Y
   Zhang, QM
   Fukada, E
   Bauer, S
   Chrisey, DB
   Danforth, SC
TI Aerosol-based direct-write of biological materials for biomedical
   applications
SO ELECTROACTIVE POLYMERS AND RAPID PROTOTYPING
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Rapid Prototyping Technologies-From Tissue Engineering to
   Conformal Electronics held at the 2001 MRS Fall Meeting
CY NOV 28-30, 2001
CL BOSTON, MA
SP Mat Res Soc
DE tissue engineering; cell-aerosolization; biomolecule; micropatterning;
   direct-write; biological material deposition
ID LIVING CELLS; SURFACE
AB Applying life sciences and engineering principles to the study of cells and engineered tissue has resulted in various successes. These endeavors are poised towards development of functional neo-organs used as native tissue substitutes. Concurrent with this goal, research arenas are directed in the general areas of biocompatible polymer scaffolds, biomimmetic extracellular matrices, control of stem cell differentiation, biomolecule signaling, and directed material delivery. Optomec Inc. is developing an aerosol-based direct-write process for deposition of biological materials into three dimensional, micron-scale patterns. The process uses pneumatic atomization to produce aerosol droplets of proteinacious colloidal dispersions and whole cell suspensions. The droplets are entrained in an air stream and deposited with a proprietary deposition tool. The biological materials can be seeded into three dimensional polymer scaffolds and various substrate surfaces. Optomec's direct write process has applicability to the additive fabrication of engineered tissue, Other applications of the direct write tool include rapid prototyping of analytical biosensors, hybrid BioMEMS, and bio-chip microarray devices.
C1 Optomec Inc, Albuquerque, NM 87109 USA.
RP Marquez, GJ (reprint author), Optomec Inc, 3911 Singer NE, Albuquerque, NM 87109 USA.
CR Bhattacharjee Y, 2000, SCIENCE, V290, P1477
   Chrisey D.B., 2002, DIRECT WRITE TECHNOL, P1
   CHRISEY DB, 2000, LASER FOCUS WORLD, P113
   COOLEY PW, 2001, METHODS MOL BIOL, V170
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   MCGILL RA, 2002, DIRECT WRITE TECHNOL, P475
   MILLER D, 2001, HDI, V4, P20
   NIKLASON LE, 1999, SCIENCE, V284, P389
   Odde DJ, 1999, TRENDS BIOTECHNOL, V17, P385, DOI 10.1016/S0167-7799(99)01355-4
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.3.CO;2-6
   Renn M. J., 2002, DIRECT WRITE TECHNOL, P475
   Simon F, 1996, MACROMOL SYMP, V103, P243, DOI 10.1002/masy.19961030122
   WU PK, IN PRESS THIN SOLID
NR 13
TC 9
Z9 9
U1 0
U2 5
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-634-6
J9 MATER RES SOC SYMP P
PY 2002
VL 698
BP 343
EP 349
PG 7
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA BU86W
UT WOS:000177251300044
DA 2018-10-20
ER

PT B
AU Zilgalvis, N
AF Zilgalvis, N
BE Glasa, J
TI Addressing research in genetics on the European level
SO ETHICS OF HUMAN GENETICS: CHALLENGES OF THE (POST) GENOMIC ERA
LA English
DT Proceedings Paper
CT International Bioethics Conference on Ethics of Human Genetics
CY OCT 23-24, 2002
CL BRATISLAVA, SLOVAKIA
SP Council Europe
DE biomedical research; biological materials; commercialisation;
   confidentiality; discrimination; ethics committees; intellectual
   property rights; genetics; stigmatisation
AB The subject of research in genetics is addressed with an emphasis on the protection of the human being as a subject of research. The focal point ranges from the issues related to an intervention undertaken on a human being to the issues related to the protection of the individual in regard to the future destination of his/her biological materials. Issues of the latter group include protection of privacy, confidentiality, discrimination, stigmatisation, commercialisation and intellectual property rights.
   The main focus is on the "system" of a Convention and protocols elaborated by the Council of Europe because of its leading role in bioethics and its focus on human rights, dating back to the European Convention on Human Rights in 1950. The proposition of the author is that observance of human rights, particularly in this field, is necessary for its own sake but also to ensure sustainable scientific and economic development. The concentration is on the provisions related to genetics and research in the Convention, and in the draft additional Protocol on Human Genetics. However, the contributions of the European Union and other international institutions to this field are also noted and discussed.
C1 Council Europe, Div Bioeth, F-67075 Strasbourg, France.
RP Zilgalvis, N (reprint author), Council Europe, Div Bioeth, F-67075 Strasbourg, France.
CR *ASS NAT, 2001, DEL UN EUR
   CHARLES B, 2001, DOCUMENTS INFORMATIO, P27
   CORDIER L, 1997, INT J PHARM MED, V11, P137
   CRAIG P, 1998, EULAW TEXT CASES MAT, P8
   Hendriks A C, 2001, Med Law, V20, P37
   HURIET C, 2000, 267, P15
   LEVITS E, 2000, LIKUMS TIESIBAS, V2, P335
   LWOFF L, 2002, SECRETARY CDBI WORKI
NR 8
TC 0
Z9 0
U1 0
U2 0
PU CHARIS
PI BRATISLAVA
PA SPOL SRO, IPELSKA 3, 821 07 BRATISLAVA, SLOVAKIA
BN 80-88743-51-6
PY 2002
BP 17
EP 25
PG 9
WC Ethics; Medical Ethics
SC Social Sciences - Other Topics; Medical Ethics
GA BX31A
UT WOS:000184907000001
DA 2018-10-20
ER

PT S
AU Motz, G
   Ziegler, G
AF Motz, G
   Ziegler, G
GP TTP
TI Simple processibility of precursor-derived SiCN coatings by optimised
   precursors
SO EURO CERAMICS VII, PT 1-3
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 7th Conference of the European-Ceramic-Society
CY SEP 09-13, 2001
CL BRUGGE, BELGIUM
SP European Ceram Soc, Belgian Ceram Soc
DE precursors; coatings; pyrolysis
AB Two different special tailored solid and very good soluble precursors in the systems Si-C-N (ABSE) and Si-C-N-Ti (TiP) have been developed for applications as polymer and ceramic-like coating materials. With corresponding precursor solutions in toluene or octane different substrates (metals, ceramics, glass, plastics) with complex-shaped geometry can be coated by using simple dip- and spray-coating techniques. The degree of ceramisation of the resulting coatings is adjustable by temperature selection.
   The relatively cheap ABSE polysilazane shows not only an excellent resistance against moisture and air, but also the ceramic yield after pyrolysis (1500 degreesC) in air is much higher than in nitrogen (85 vs. 75 %). Therefore, processing and pyrolysis are possible in air. The critical thickness of the pure ABSE layer after pyrolysis is about 5 mum. With passive fillers (ceramic and graphite powders) or active fillers (metal, polymer powder) it is possible to produce thicker coatings or layers with special properties (electrical conductivity, hardness, colour). For producing ceramic-like layers on thermally sensitive substrates or for manufacturing fine ceramic structures, for example on Al2O3 substrates, pyrolysis with different laser types is very suitable.
   In contrast to the ABSE polymer, the TiP precursor is expensive and very moisture sensitive. Because of this reactivity, the adhesion of the TiP layer to the substrates is very strong (chemical bonding between substrate and layer by bridging oxygen atoms), The incorporated titanium atoms lead to very good biomedical compatibility. Especially the functional groups at the polymer backbone make a further modification with biomolecules possible.
   Whereas the ABSE polymer is suitable for applications on an industrial scale, the TIP precursor is very advantageous for special applications.
C1 Univ Bayreuth, Inst Mat Res, IMAI, D-95440 Bayreuth, Germany.
RP Motz, G (reprint author), Univ Bayreuth, Inst Mat Res, IMAI, POB 101251, D-95440 Bayreuth, Germany.
RI Motz, Gunter/P-1653-2014
CR BEHNCKE HH, 1993, HTM, V48, P304
   KRAUSS HJ, 1968, J BIOL CHEM, V213, P6281
   MOORE S, 1968, J BIOL CHEM, V243, P6281
   Motz G, 2000, CERAMIC ENG SCI P, V21, P307
   MOTZ G, Patent No. 19847352
NR 5
TC 5
Z9 5
U1 2
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-882-6
J9 KEY ENG MAT
PY 2002
VL 206-2
BP 475
EP 478
DI 10.4028/www.scientific.net/KEM.206-213.475
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BT32X
UT WOS:000172651400118
DA 2018-10-20
ER

PT J
AU Ruiz, A
   Hernandez, M
   Jimenez, A
   Sotomayor, A
   Sanchez, O
   Ramos, A
   San Emeterio, JL
   Sanz, PT
AF Ruiz, A
   Hernandez, M
   Jimenez, A
   Sotomayor, A
   Sanchez, O
   Ramos, A
   San Emeterio, JL
   Sanz, PT
TI Approaches to simulate temporal responses in piezoelectric stages
   involved in ultrasonic sensor/actuator systems
SO FERROELECTRICS
LA English
DT Article; Proceedings Paper
CT 10th International Meeting on Ferroelectricity (IMF-10)
CY SEP 03-07, 2001
CL MADRID, SPAIN
DE piezoelectric transducers; equivalent circuits; PSPICE
ID TRANSDUCERS; MODEL
AB Commercial ultrasonic equipment employing wideband piezoelectric transduction systems, usually operate in through-transmission (T-T) or pulse-echo mode. These systems, which include one or more piezoelectric stages, are widely used in areas such as biomedical imaging, non-destructive evaluation and characterization of material properties. In this paper different electrical T-T and pulse-echo simulation schemes, modeling piezoelectric devices and associated pulsed electronics, are proposed and used for studying temporal responses under practical conditions. Employing PSPICE, several responses are analyzed for specific devices in the MHz range. Two alternative electrical models for the reception stage are comparatively evaluated in pulse-echo situations. Comparisons between simulated performances and experimental measurements are also presented, showing a good agreement in T-T and pulse-echo signal conditions.
C1 CSIC, Inst Acust, Dpto Senales Sistemas & Tecn, Madrid, Spain.
   Univ La Habana, Fac Ciencias Fis, Havana, Cuba.
   ICIMAF, Dpto Ultrason, Havana, Cuba.
RP Ruiz, A (reprint author), CSIC, Inst Acust, Dpto Senales Sistemas & Tecn, Madrid, Spain.
RI Ramos, Antonio/K-5863-2014
OI Ramos, Antonio/0000-0003-0684-8742
CR DENVENTER JV, 2000, IEEE T ULTRASON FERR, V47, P1014
   HAYWARD G, 1984, J ACOUST SOC AM, V76, P369, DOI 10.1121/1.391138
   LEACH WM, 1994, IEEE T ULTRASON FERR, V41, P60, DOI 10.1109/58.265821
   LEEDOM DA, 1971, IEEE T SON ULTRASON, VSU18, P128, DOI 10.1109/T-SU.1971.29608
   Maione E, 1999, IEEE T ULTRASON FERR, V46, P399, DOI 10.1109/58.753029
   MASON WP, 1948, ELECTROMECHANICAL TH
   MORRIS SA, 1986, IEEE T ULTRASON FERR, V33, P295, DOI 10.1109/T-UFFC.1986.26832
   Puttmer A, 1997, IEEE T ULTRASON FERR, V44, P60, DOI 10.1109/58.585191
   Ramos A, 2000, ULTRASONICS, V38, P553, DOI 10.1016/S0041-624X(99)00072-4
   REDWOOD M, 1961, J ACOUST SOC AM, V33, P527, DOI 10.1121/1.1908709
   RHYNE TL, 1978, IEEE T SON ULTRASON, V25, P98, DOI 10.1109/T-SU.1978.30994
   Wu L, 1999, SENSOR ACTUAT A-PHYS, V75, P186, DOI 10.1016/S0924-4247(99)00067-9
NR 12
TC 0
Z9 0
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0015-0193
J9 FERROELECTRICS
JI Ferroelectrics
PY 2002
VL 273
BP 2621
EP 2626
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 580CM
UT WOS:000177217000041
DA 2018-10-20
ER

PT J
AU Stoffels, E
AF Stoffels, E
TI Biomedical applications of electric gas discharges
SO HIGH TEMPERATURE MATERIAL PROCESSES
LA English
DT Article
ID ARGON PLASMA COAGULATION; ATMOSPHERIC-PRESSURE; STERILIZATION;
   MECHANISMS
AB A survey of applications of electrically generated plasmas in health cam is given. Gas discharges are common tools for surface processing in material science, and nowadays they raise much interest in the medical technology. A wide variety of plasmas facilitates many kinds of surface treatment low-pressure coating of artificial implants, plasma sterilisation of medical equipment, coagulation and vaporisation of pathological tissue using atmospheric arc-like discharges. Special attention is given to non-thermal gas discharges generated under atmospheric pressure. Possibilities of refined tissue treatment using non-destructive atmospheric plasmas are discussed.
C1 Eindhoven Univ Technol, Dept Phys, NL-5600 MB Eindhoven, Netherlands.
RP Stoffels, E (reprint author), Eindhoven Univ Technol, Dept Phys, POB 513, NL-5600 MB Eindhoven, Netherlands.
CR Bergler W, 1997, J LARYNGOL OTOL, V111, P381
   Brand CU, 1998, DERMATOLOGY, V197, P152, DOI 10.1159/000017988
   BUTTER RS, 1995, J CHEM VAPOR DEPOSIT, V3, P1892
   Dubinov AE, 2000, IEEE T PLASMA SCI, V28, P180, DOI 10.1109/27.842898
   DUMKUM C, 1997, DIAM RELAT MATER, V6, P8025
   ELKIN B, 1999, SURF COAT TECH, V116, P86
   Hagelaar GJM, 2000, J APPL PHYS, V88, P2252, DOI 10.1063/1.1287529
   Haverlag M, 1991, THESIS EINDHOVEN U T
   HERRMANN HW, 2000, 27 IEEE INT C PLASM, P82
   Hoeben WFLM, 2000, PLASMA SOURCES SCI T, V9, P361, DOI 10.1088/0963-0252/9/3/315
   Janca J, 2001, PLASMA CHEM PLASMA P, V21, P565, DOI 10.1023/A:1012051102101
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Laroussi M, 2000, IEEE T PLASMA SCI, V28, P184, DOI 10.1109/27.842899
   Liu CJ, 2001, PLASMA CHEM PLASMA P, V21, P301, DOI 10.1023/A:1011098824117
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9
   Montie TC, 2000, IEEE T PLASMA SCI, V28, P41, DOI 10.1109/27.842860
   Moreau S, 2000, J APPL PHYS, V88, P1166, DOI 10.1063/1.373792
   Moselhy M, 2001, APPL PHYS LETT, V79, P1240, DOI 10.1063/1.1397760
   Niemz M, 1996, LASER TISSUE INTERAC
   Ohl A, 1999, J MATER SCI-MATER M, V10, P747, DOI 10.1023/A:1008943625715
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   Park J, 2001, J APPL PHYS, V89, P20, DOI 10.1063/1.1323753
   PRINCE MR, 1987, IEEE J QUANTUM ELECT, V23, P1783, DOI 10.1109/JQE.1987.1073225
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Roth JR, 2000, IEEE T PLASMA SCI, V28, P56, DOI 10.1109/27.842864
   Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71
   SESSLER MJ, 1995, J CANCER RES CLIN, V121, P235, DOI 10.1007/BF01366968
   Slager C. J., 1997, THESIS ERASMUS U ROT
   STOFFELS E, 2002, UNPUB PLASMA SOURCES
   VANBLANKENSTEIN JH, 1993, J APPL PHYSIOL, V75, P1201
   WAYE JD, 1998, SURG TECHNOLOGY INT, V7, P1
   Yoshiki H, 2001, JPN J APPL PHYS 2, V40, pL360, DOI 10.1143/JJAP.40.L360
NR 32
TC 16
Z9 16
U1 1
U2 5
PU BEGELL HOUSE INC
PI NEW YORK
PA 145 MADISON AVE, NEW YORK, NY 10016 USA
SN 1093-3611
J9 HIGH TEMP MATER P-US
JI High Temp. Mater. Process
PY 2002
VL 6
IS 2
BP 191
EP 202
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 633CD
UT WOS:000180260900007
DA 2018-10-20
ER

PT J
AU Liew, CL
   Leong, KF
   Chua, CK
   Du, Z
AF Liew, CL
   Leong, KF
   Chua, CK
   Du, Z
TI Dual material rapid prototyping techniques for the development of
   biomedical devices. Part 2: Secondary powder deposition
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE drug delivery devices (DDD); dual material RP; electrography; rapid
   prototyping (RP); selective laser sintering (SLS)
AB polymeric drug-delivery devices play an important role in drug administration. However, the current polymeric drug delivery device fabrication methods lack precision. This impairs the quality of the devices, resulting in a decrease in the efficiency and effectiveness of drug delivery. The concept of building parts layer by layer out of powdered raw materials makes selective laser sintering (SLS) a suitable process for fabricating polymeric matrix drug delivery devices. The current SLS process is not capable of processing two or more materials separately. This work, explores the possibilities of using SLS to perform a dual material operation by developing two process models. The two processes can then be integrated to form a dual or multimaterial fabrication technique and act as a foundation for future work in multimaterial applications such as polymeric drug delivery device fabrication. Accordingly. two papers are presented.
   In this paper, Part 2, the emphasis is on a secondary powder-deposition method, which is an electrostatic technique based on electrography. Developed toner on the photoconductor is scraped off using mechanical shearing and is deposited using an electrostatic force by electroplating. Results have shown that by reducing the distance between the photoconductor and surface of deposition, the resolution of the printout can be refined. Other important factors include the efficiency of powder removal from the photoconductor, printing speed, and the traversing speed during deposition.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mckchua@ntu.edu.sg
RI Chua, Chee Kai/B-6171-2009; Leong, Kah-Fai/B-6183-2009
CR ANDRUS PG, 1965, XEROGRAPHY RELATED P, pCH14
   Bartenev G. M., 1981, FRICTION WEAR POLYM
   CHUA CK, 1997, RAPID PROTOTYPING J
   DEPALMA VM, 1982, PHOTOGR SCI ENG, V26, P198
   FITZGERALD S, 1996, THESIS VIRGINIA POLY
   Liew CL, 2001, INT J ADV MANUF TECH, V18, P717, DOI 10.1007/s001700170014
   LING WM, 1998, FUT RAP PROT VIRT C
   MACE T, 1988, LASER JET UNLIMITED
   MELVIN LS, 1995, P SOL FREEF FABR S
   MELVIN LS, 1991, P SOL FREEF FABR S
   Schein L. B., 1992, ELECTROPHOTOGRAPHY D
   UMAN MA, 1968, J APPL PHYS, V39, P5162, DOI 10.1063/1.1655938
   WILLIAMS EM, 1984, PHYSICS TECHNOLOGY X
NR 13
TC 31
Z9 31
U1 0
U2 10
PU SPRINGER-VERLAG LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0268-3768
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PY 2002
VL 19
IS 9
BP 679
EP 687
DI 10.1007/s001700200113
PG 9
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA 569ZF
UT WOS:000176632800008
DA 2018-10-20
ER

PT J
AU Britchi, M
   Olteanu, M
   Jitianu, G
   Neagoe, O
   Branzei, M
   Gheorghe, D
   Nita, P
AF Britchi, M
   Olteanu, M
   Jitianu, G
   Neagoe, O
   Branzei, M
   Gheorghe, D
   Nita, P
TI Vitroceramic coatings on metallic supports with biomedical applications
SO INTERNATIONAL JOURNAL OF MATERIALS & PRODUCT TECHNOLOGY
LA English
DT Article
DE vitroceramic coatings; enamelling process; titanium; CrNi austenitic
   steels; biocompatible; bioactive materials
ID BIOMATERIALS; CERAMICS
AB Vitroceramic coatings from the oxidic system SiO2-CaO-B2O3-TiO2-R2O (R = Na and K) were applied on metallic supports (titanium and austenitic steels with high Cr and Ni contents). The coating procedure was classical enamelling. The metals were coated by either immersion or by painting over a thin layer from a mixture of frit (having the best composition for each metallic support) with a liquid mixture (triethanol amine: ethyl alcohol = 1: 10), mixture which was subsequently fired at the enamelling temperature. A good adherence between the two different materials has been thus achieved. Vitroceramic coating metallic support couples were then characterized by optical microscopy (OM), electronic microscopy (EDS) and wavelength dispersive spectrometry (WDS), and X-ray diffraction (XRD). The adherence of the vitroceramic layers onto metallic supports was tested by microhardness trials at the interface. The processes at the interface, i.e. gas bubble evolution, micropore formation, chemical bonding and diffusion, were evidenced. These coating layers can be employed as both bioactive and biocompatible materials.
C1 IG Murgulescu Romanian Acad, Inst Phys Chem, Bucharest, Romania.
   Politecn Univ Bucharest, Sci & Engn Mat Fac, Bucharest, Romania.
   Aviat Met METAV SA, Bucharest, Romania.
RI BRANZEI, MIHAI/C-7101-2012
CR BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139
   COLAN H, 1968, ED DIDACTICA PEDAGOG, P117
   DAVID HK, 1998, CURRENT OPINION SOLI, P309
   Frigge M, 1996, MIKROCHIM ACTA, P299
   FUJIO T, 1982, Patent No. 2080281
   Holand W, 1997, J NON-CRYST SOLIDS, V219, P192, DOI 10.1016/S0022-3093(97)00329-3
   HOLAND W, 1991, J NON-CRYST SOLIDS, V129, P152, DOI 10.1016/0022-3093(91)90091-J
   HOLAND W, 1995, J NON-CRYST SOLIDS, V180, P292, DOI 10.1016/0022-3093(94)00464-1
   JAMES PF, 1995, J NON-CRYST SOLIDS, V181, P1, DOI 10.1016/0022-3093(94)00515-X
   Kasuga T, 1999, BIOMATERIALS, V20, P1415, DOI 10.1016/S0142-9612(99)00047-2
   LUPESCU M, 1997, THESIS BUCHAREST
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Saha SK, 1998, PHYS CHEM GLASSES, V39, P118
   Saha SK, 1996, SURF INTERFACE ANAL, V24, P113, DOI 10.1002/(SICI)1096-9918(199602)24:2<113::AID-SIA100>3.0.CO;2-C
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   YOKOKAWA H, 1993, J ELECTROCHEM SOC, V140, P3565, DOI 10.1149/1.2221127
NR 16
TC 0
Z9 0
U1 1
U2 3
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA AEROPORT
PA WORLD TRADE CENTER BLDG 110 AVE LOUSIS CASAI CP 306, CH-1215 GENEVA
   AEROPORT, SWITZERLAND
SN 0268-1900
J9 INT J MATER PROD TEC
JI Int. J. Mater. Prod. Technol.
PY 2002
VL 17
IS 7
BP 568
EP 579
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 559PW
UT WOS:000176035400003
DA 2018-10-20
ER

PT J
AU Kros, A
   Jansen, JA
   Holder, SJ
   Nolte, RJM
   Sommerdijk, NAJM
AF Kros, A
   Jansen, JA
   Holder, SJ
   Nolte, RJM
   Sommerdijk, NAJM
TI Silane-based hybrids for biomedical applications
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE sol-gel; silica; biocompatibility; biomedical; amperometric biosensor;
   polysilane; self-assembly; copolymers
ID COIL BLOCK-COPOLYMERS; SOL-GEL PROCESS; GLUCOSE SENSORS; ENCAPSULATION;
   TISSUE
AB In this paper, the preparation of different hybrid silane materials is presented and their possible use in biomedical applications is discussed. The first example describes the development of biocompatible coatings based on sol-gel silicates, which can be used as a protective coating for implantable glucose sensors. Blending the silica with different organic polymers modified the properties of the resulting sot-gel materials. Their biocompatibility, both in vivo and in vitro, and their applications on biosensors were investigated. In the second example, an amphiphilic block copolymer comprising hydrophilic poly(ethylene oxide) blocks and hydrophobic poly(methylphenylsilane) segments is presented. In aqueous medium, this polymer forms vesicles in which a fluorescent dye is encapsulated. It was demonstrated that the vesicle aggregates could be broken up using UV irradiation. indicating that these vesicles were potentially interesting as controlled release systems. Monolayer studies confirmed that after photolytic cleavage of the poly(methylphenylsilane) segments, no organized structures were formed from the remaining material.
C1 Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands.
   Univ Nijmegen, Dept Organ Chem, NSR Ctr, NL-6525 ED Nijmegen, Netherlands.
   Univ Nijmegen, Dept Biomat, NL-6500 AH Nijmegen, Netherlands.
   Univ Kent, Sch Phys Sci, Canterbury CT2 7NH, Kent, England.
RP Sommerdijk, NAJM (reprint author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.
RI Jansen, John/H-8055-2014; Sommerdijk, Nico/B-7239-2013; kros,
   alexander/H-6900-2012; Nolte, Roeland/C-9930-2013; Holder,
   Simon/B-4942-2009
OI Sommerdijk, Nico/0000-0002-8956-195X; Nolte,
   Roeland/0000-0002-5612-7815; Holder, Simon/0000-0001-8977-9257; kros,
   alexander/0000-0002-3983-3048
CR ABEL EW, 1994, ORGNAOPOLYSILANES CO
   AVNIR D, 1995, ACCOUNTS CHEM RES, V28, P328, DOI 10.1021/ar00056a002
   Brunette D., 1996, NANOFABRICATION BIOS, P335
   Chen JT, 1996, SCIENCE, V273, P343, DOI 10.1126/science.273.5273.343
   Clery D, 1997, SCIENCE, V277, P1213, DOI 10.1126/science.277.5330.1213
   DemoustierChampagne S, 1997, J POLYM SCI POL CHEM, V35, P1939, DOI 10.1002/(SICI)1099-0518(19970730)35:10<1939::AID-POLA8>3.0.CO;2-I
   Francois B, 1995, ADV MATER, V7, P1041, DOI 10.1002/adma.19950071217
   Gerritsen M, 1998, J INVEST SURG, V11, P163, DOI 10.3109/08941939809098031
   Gerritsen M, 2000, BIOMATERIALS, V21, P71, DOI 10.1016/S0142-9612(99)00136-2
   GOUGH DA, 1995, DIABETES, V44, P1005, DOI 10.2337/diab.44.9.1005
   Hempenius MA, 1998, J AM CHEM SOC, V120, P2798, DOI 10.1021/ja972910v
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hesby RM, 1997, J PROSTHET DENT, V77, P414, DOI 10.1016/S0022-3913(97)70167-7
   HOFFMAN AS, 1986, J BIOMED MATER RES, V20, P9
   Holder SJ, 1998, CHEM COMMUN, P1445, DOI 10.1039/a803250e
   Horbett TA, 1995, ACS S SERIES, V602
   Jenekhe SA, 1999, SCIENCE, V283, P372, DOI 10.1126/science.283.5400.372
   Jenekhe SA, 1998, SCIENCE, V279, P1903, DOI 10.1126/science.279.5358.1903
   KERNER W, 1993, BIOSENS BIOELECTRON, V8, P473, DOI 10.1016/0956-5663(93)80032-K
   KOOPAL CGJ, 1992, BIOSENS BIOELECTRON, V7, P461, DOI 10.1016/0956-5663(92)80003-T
   KROS A, IN PRESS ADV MAT
   Kumaki J, 1998, J AM CHEM SOC, V120, P423, DOI 10.1021/ja973613t
   Mark J.E., 1992, INORGANIC POLYM
   MILLER RD, 1989, CHEM REV, V89, P1359, DOI 10.1021/cr00096a006
   NARANG U, 1994, ANAL CHEM, V66, P3139, DOI 10.1021/ac00091a023
   OSAHENI JA, 1995, J AM CHEM SOC, V117, P7389, DOI 10.1021/ja00133a012
   Peterson KP, 1998, P SOC EXP BIOL MED, V218, P365
   Price C., 1982, DEV BLOCK COPOLYMERS, V1, P39
   Ruokolainen J, 1998, SCIENCE, V280, P557, DOI 10.1126/science.280.5363.557
   Selb J. G., 1985, DEV BLOCK COPOLYMERS, V2, P327
   Sommerdijk NAJM, 2000, MACROMOLECULES, V33, P8289, DOI 10.1021/ma0011385
   Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384
   Stupp SI, 1998, CURR OPIN COLLOID IN, V3, P20, DOI 10.1016/S1359-0294(98)80037-X
   Tian D, 1997, CHEM MATER, V9, P871, DOI 10.1021/cm960514q
   Tian D, 1996, POLYMER, V37, P3983, DOI 10.1016/0032-3861(96)00199-1
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Wright J. D., 2001, SOL GEL MAT CHEM APP
   ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728
   Zubarev ER, 1999, SCIENCE, V283, P523, DOI 10.1126/science.283.5401.523
NR 39
TC 16
Z9 16
U1 0
U2 10
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2002
VL 16
IS 2
BP 143
EP 155
DI 10.1163/156856102317293678
PG 13
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 531FA
UT WOS:000174404300003
DA 2018-10-20
ER

PT J
AU Motta, A
   Migliaresi, C
   Lloyd, AW
   Denyer, SP
   Santin, M
AF Motta, A
   Migliaresi, C
   Lloyd, AW
   Denyer, SP
   Santin, M
TI Serum protein absorption on silk fibroin fibers and films: Surface
   opsonization and binding strength
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
ID COMPLEMENT ACTIVATION; POLYMER SURFACES; SOLID-SURFACES; ADSORPTION;
   ALPHA-1-MICROGLOBULIN
AB Fibroin, the core of the silk filament protein, has been proposed as a biomaterial for different biomedical applications since it can be engineered as a thread, fabric or film. Infrared spectroscopy suggests that the dissolution of the fibroin filaments and subsequent casting of the fibroin solution into films followed by treatment with methanol alters the protein structure leading to an increase in amorphous domains. The adsorption of serum proteins on fabrics and films showed different hydrophobic binding strengths for the two materials with the protein binding being greatest for the more hydrophobic fibroin fibers. Differences between the materials were also observed in the adsorption of key immunoproteins. Although the C3 fragment of the complement system was adsorbed on both the surfaces, it appeared to be activated preferentially on the fibroin films and not on the fibroin fibers, whereas the Bb and C1q factors were only significantly present on the fibroin fabric. IgG appeared to be adsorbed, although to different extents, on both types of fibroin substrates. These results suggest that the biocompatibility of the silk fibroin may be affected by changes in protein structure induced by processing the material.
C1 Univ Trent, Dipartimento Ingn Mat, I-38050 Trent, Italy.
   Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
RP Motta, A (reprint author), Univ Trent, Dipartimento Ingn Mat, Via Mesiano 77, I-38050 Trent, Italy.
RI Lloyd, Andrew/D-1369-2011
OI Lloyd, Andrew/0000-0003-2778-8195
CR AMBROSE EJ, 1951, NATURE, V167, P264, DOI 10.1038/167264a0
   ANDERSON JM, 1988, AM SOC ARTIF INTERN, V28, P767
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   HIRABAYASHI K, 1968, SEN-I GAKKAISHI, V24, P392
   IIZUKA E, 1968, BIOCHEMISTRY-US, V7, P2218, DOI 10.1021/bi00846a026
   KATAOKA K, 1976, KOBUNSHI RONBUNSHU, V33, P453, DOI 10.1295/koron.33.453
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   MAGOSHI J, 1975, J APPL POLYM SCI, V19, P1013, DOI 10.1002/app.1975.070190410
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MONTI P, IN PRESS J RAMAN SPE
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1998, J MATER SCI-MATER M, V9, P135, DOI 10.1023/A:1008863518572
   Santin M, 1997, BIOMATERIALS, V18, P823, DOI 10.1016/S0142-9612(97)00004-5
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
NR 26
TC 29
Z9 29
U1 1
U2 16
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2002
VL 17
IS 1
BP 23
EP 35
DI 10.1106/088391102023195
PG 13
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 551KF
UT WOS:000175559600002
DA 2018-10-20
ER

PT J
AU Vaz, CA
   Mano, JF
   Fossen, M
   van Tuil, RF
   de Graaf, LA
   Reis, RL
   Cunha, AA
AF Vaz, CA
   Mano, JF
   Fossen, M
   van Tuil, RF
   de Graaf, LA
   Reis, RL
   Cunha, AA
TI Mechanical, dynamic-mechanical, and thermal properties of soy
   protein-based thermoplastics with potential biomedical applications
SO JOURNAL OF MACROMOLECULAR SCIENCE-PHYSICS
LA English
DT Article
DE thermoplastic proteins; injection molding; dynamic-mechanical analysis;
   biomaterials
ID BIOMATERIALS; GLUTEN; WATER
AB In this study the tensile and the dynamic-mechanical behavior of injection-molded samples of various soy protein thermoplastic compounds were evaluated as a function of the amount of glycerol, type and amount of ceramic reinforcement, and eventual incorporation of coupling agents. The incorporation of glycerol into a soy-based matrix resulted in its plasticization, as confirmed by the drop in stiffness (storage and elastic modulus) above 20degreesC and a decrease in the protein glass transition temperature. Differential scanning calorimetric thermograms proved the occurrence of conformational changes in the soy protein during processing. Furthermore, the developed soy protein-based thermoplastics showed a thermal stability up to 100degreesC, as confirmed by thermogravimetric analysis, The reinforcement of the soy protein matrix with a ceramic filler (tricalcium phosphate) was shown to be effective for amounts above 10% w/w. The introduction of an amino-coupling agent led to a plasticizing effect, detected in the mechanical and dynamic-mechanical properties of the resulting materials. The results also show a good qualitative agreement between the properties obtained from quasi-static and dynamic experiments. The materials present a range of properties that might allow for their use eventually in a range of biomedical applications.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Agrotechnol Res Inst, ATO, NL-6700 AA Wageningen, Netherlands.
RP Mano, JF (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
EM jinano@dep.uminho.pt
RI Mano, Joao/A-4418-2009; Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Mano, Joao/0000-0002-2342-3765; Reis, Rui L./0000-0002-4295-6129; Group,
   3Bs/0000-0002-5195-3456; Cunha M., Antonio/0000-0003-3860-7732
CR ADRIANO KP, 1994, J APPL BIOMATER, V5, P133
   Cheftel J., 1985, AMINO ACIDS PEPTIDES, P245
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Cherian G, 1996, CEREAL CHEM, V73, P618
   DANIELS AU, 1994, J APPL BIOMATER, V5, P51, DOI 10.1002/jab.770050108
   di Gioia L, 1998, CEREAL CHEM, V75, P514, DOI 10.1094/CCHEM.1998.75.4.514
   Ferreira SHP, 1993, J FOOD SCI, V58, P378
   FERRY JD, 1980, VISCOELASTIC PROPERT
   French D, 1984, ORG STARCH GRANULES, P183
   JOHNSON LA, 1992, US INFORM, V3, P282
   McCrum N.G., 1991, ANELASTIC DIELECTRIC
   PAETAU I, 1994, IND ENG CHEM RES, V33, P1821, DOI 10.1021/ie00031a023
   Richard J, 1996, TRENDS POLYM SCI, V4, P272
   Seal R, 1980, APPL PROTEIN CHEM, P87
   Sepe M., 1998, DYNAMIC MECH ANAL PL
   SHEARD PR, 1986, J FOOD TECHNOL, V21, P627
   Singh H., 1991, TRENDS FOOD SCI TECH, V2, P196, DOI DOI 10.1016/0924-2244
   Smits ALM, 1999, COLLOQ INRA, P179
   van Soest JJG, 1999, J APPL POLYM SCI, V74, P2207, DOI 10.1002/(SICI)1097-4628(19991128)74:9<2207::AID-APP10>3.3.CO;2-V
   VAZ CM, 2002, UNPUB
   Wang S, 1996, J MACROMOL SCI PURE, VA33, P557, DOI 10.1080/10601329608010878
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
NR 23
TC 32
Z9 32
U1 1
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0022-2348
J9 J MACROMOL SCI PHYS
JI J. Macromol. Sci.-Phys.
PY 2002
VL B41
IS 1
BP 33
EP 46
DI 10.1081/MB-120002344
PG 14
WC Polymer Science
SC Polymer Science
GA 534CU
UT WOS:000174567700003
DA 2018-10-20
ER

PT J
AU Giannoulis, CS
   Desai, TA
AF Giannoulis, CS
   Desai, TA
TI Characterization of proteins and fibroblasts on thin inorganic films
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SILICON SURFACES; ELLIPSOMETRY; CELLS
AB The ability of biomaterial surfaces to regulate cell behavior requires control over surface chemistry and material microstructure. One of the goals in the development of silicon-based biomedical devices such as biosensors or drug delivery systems is improved biocompatibility which may be achieved through the deposition or adsorption of thin films. In this study, films of single crystal silicon, stoichiometric and low stress silicon nitride, doped and undoped polysilicon, as well as Arg-Gly-Asp (RGD) peptide adsorbed surfaces characterized in terms of protein adsorption or cellular adhesion for a period of four days. Protein adsorption studies using fibrinogen and albumin, two proteins implicated in cellular adhesion and surface activity, reveal that low stress silicon nitride surfaces have a 223%+/-2.50% greater protein adsorption compared to undoped polysilicon surfaces, followed by silicon nitride, unmodified silicon, and doped polysilicon surfaces, respectively. The thickness of the adsorbed albumin and fibrinogen layer on various thin films was measured by ellipsometry and compared to contact angle measurements. The greatest cellular adhesion was observed on undoped polysilicon, followed by unmodified (control) silicon, low stress silicon nitride, silicon nitride, and doped polysilicon surfaces. Cellular binding supports the differential protein adsorption found on modified and unmodified silicon surfaces. Understanding the biological response to thin films will allow us to design more appropriate interfaces for implantable diagnostic and therapeutic silicon-based microdevices. (C) 2002 Kluwer Academic Publishers.
C1 Univ Illinois, Dept Bioengn MC 063, Chicago, IL 60607 USA.
RP Desai, TA (reprint author), Univ Illinois, Dept Bioengn MC 063, 851 S Morgan St, Chicago, IL 60607 USA.
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   HANSFORD DJ, 1999, THESIS U CALIFORNIA
   Henry S, 1999, J PHARM SCI, V88, P948
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   JAEGER RC, 1998, INTRO MICROELECTRONI, V5
   MALMSTEN M, 1995, PROTEINS INTERFACES, V2, P228
   MANDENIUS CF, 1984, ANAL BIOCHEM, V137, P106, DOI 10.1016/0003-2697(84)90354-3
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ratner B. D., 1997, SURFACE MODIFICATION
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   TUNER JN, 1999, EXP NEUROL, V156, P33
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 19
TC 16
Z9 16
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2002
VL 13
IS 1
BP 75
EP 80
DI 10.1023/A:1013646805593
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 509JH
UT WOS:000173144300015
PM 15348209
DA 2018-10-20
ER

PT J
AU Pradny, M
   Petrovicky, P
   Fronkova, V
   Vacik, J
   Smetana, K
AF Pradny, M
   Petrovicky, P
   Fronkova, V
   Vacik, J
   Smetana, K
TI Evaluation of biocompatibility of the copolymer of 2-hydroxyethyl
   methacrylate with 2-(methylsulfanyl)ethyl methacrylate
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FIBRONECTIN ADSORPTION; HYDROGELS; ADHESION; BINDING; NEURONS
AB This study compares subcutaneous and intracerebral biocompatibilty of two hydrogels: copolymer of 2-hydroxyethyl methacrylate with 2-(methylsulfanyl)ethyl methacrylate and poly(2-hydroxyethyl methacrylate) as reference polymer. The experimental copolymer was more biologically inert than poly(2-hydroxyethyl methacrylate) in both the studied parameters, hence the former material is a suitable candidate for biomedical application. (C) 2002 Kluwer Academic Publishers.
C1 Acad Sci Czech Republ, Inst Macromol Chem, CR-16206 Prague 6, Czech Republic.
   Charles Univ, Fac Med 1, Inst Anat, Prague 12000 2, Czech Republic.
RP Pradny, M (reprint author), Acad Sci Czech Republ, Inst Macromol Chem, CR-16206 Prague 6, Czech Republic.
RI Pradny, Martin/H-8496-2014; Smetana, Karel/D-7039-2017
OI Smetana, Karel/0000-0002-7878-8403
CR FIFKOVA E, 1961, STEREOTAXIC ATLAS BR, P653
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   Michalek J, 1996, ANGEW MAKROMOL CHEM, V239, P151, DOI 10.1002/apmc.1996.052390113
   Paxinos G., 1982, RAT BRAIN STEREOTAXI
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   PETROVICKY P, 1995, J BRAIN RES, V36, P539
   SCHERERSINGLER U, 1983, J NEUROSCI METH, V9, P229, DOI 10.1016/0165-0270(83)90085-7
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Smetana K, 1997, BIOMATERIALS, V18, P1009, DOI 10.1016/S0142-9612(97)00037-9
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   SMETANA K, 1993, J MATER SCI-MATER M, V4, P526, DOI 10.1007/BF00120134
   SMETANA K, 1995, J MATER SCI-MATER M, V6, P32, DOI 10.1007/BF00121244
   SMETANA K, 1987, EXP MOL PATHOL, V46, P258, DOI 10.1016/0014-4800(87)90048-7
   Swanson LW, 1992, BRAIN MAPS STRUCTURE
   TAKASHI I, 1970, POLYM J, V1, P278
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 17
TC 9
Z9 9
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2002
VL 13
IS 1
BP 107
EP 111
DI 10.1023/A:1013659208319
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 509JH
UT WOS:000173144300020
PM 15348214
DA 2018-10-20
ER

PT J
AU Spilimbergo, S
   Elvassore, N
   Bertucco, A
AF Spilimbergo, S
   Elvassore, N
   Bertucco, A
TI Microbial inactivation by high-pressure
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE inactivation; supercritical CO2; B. subtilis; P. aeruginosa;
   semi-continuous apparatus
ID SUPERCRITICAL CARBON-DIOXIDE; BUBBLE METHOD; MICROORGANISMS;
   STERILIZATION
AB High-pressure treatments are receiving a great deal of attention for the inactivation of micro-organisms in foodstuff processing, pressure instead of temperature is used as stabilizing factor. In this context, high hydrostatic pressure treatment is the most studied alternative process., many works reported successful results in inactivating a wide range of micro-organisms under different operative conditions such as temperature. cycles of pressure. exposure time. Furthermore. a number of processes using high pressure treatment (HPT) has already' been put into the market. Nevertheless this new technology presents the main limitation to be very expensive and difficult to control and manage because of the extremely high pressure employed. so that the widespread industrial diffusion in industry field appears cumbersome. The treatment with supercritical CO2 could become a relevant alternative to HPT in the field of microbial inactivation of food as well as an innovative technique for the sterilization of thermally and hydrolytically sensitive polymeric materials in biomedical applications, such as polymeric particles for drug delivery or polymeric implants. It has been demonstrated that the effect of microbial inactivation assuring healthy food preservation is already consistent at pressures moderated (lower than 200 bar) when compared with those employed by traditional hydrostatic-pressure HPT methods (2000-7000 bar). In this work the anti-microbial potential of compressed CO2 was investigated against gram-negative bacteria, gram-positive bacteria and spores.- as model species, Pseudomonas aeruginosa, Bacillus subtilis and spores of B. subtilis were used. The experiments were performed in a semi-continous apparatus at different but mild operative conditions. Excellent results were obtained for micro-organisms, under appropriate conditions the survival ratio of bacteria could be reduced to about seven orders of magnitude. Inactivation of spores under the same conditions, found to be conflicting in open literature. was not satisfactory. Spore inactivation was possible by coupling combination of higher temperature and longer contact time conditions. The application of pressure cycles was also found to be beneficial. (C) 2002 Elsevier Science B.V, All rights reserved.
C1 Univ Padua, Dept Chem Engn, I-35131 Padua, Italy.
RP Spilimbergo, S (reprint author), Univ Padua, Dept Chem Engn, Via Marzolo 9, I-35131 Padua, Italy.
OI Spilimbergo, Sara/0000-0002-8176-2220
CR Basset J, 1932, CR HEBD ACAD SCI, V195, P1431
   Bertucco A., 2001, HIGH PRESSURE PROCES, P626
   CLOUSTON JG, 1969, J BACTERIOL, V97, P684
   CLOUSTON JG, 1970, J BACTERIOL, V103, P140
   DEKANT W, 1998, ULLMANNS ENCY IND CH
   Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344
   ELVASSORE N, 2000, P 7 M SUP FLUIDS, V2, P773
   Enomoto A, 1997, J FERMENT BIOENG, V83, P305, DOI 10.1016/S0922-338X(97)80999-3
   Enomoto A, 1997, BIOSCI BIOTECH BIOCH, V61, P1133, DOI 10.1271/bbb.61.1133
   GOULD GW, 1970, J GEN MICROBIOL, V60, P335, DOI 10.1099/00221287-60-3-335
   HAAS GJ, 1989, J FOOD SAFETY, V9, P253, DOI 10.1111/j.1745-4565.1989.tb00525.x
   Hong SI, 1999, J FOOD SCI, V64, P728, DOI 10.1111/j.1365-2621.1999.tb15120.x
   ISHIKAWA H, 1995, BIOSCI BIOTECH BIOCH, V59, P1949, DOI 10.1271/bbb.59.1949
   Ishikawa H, 1997, BIOSCI BIOTECH BIOCH, V61, P1022, DOI 10.1271/bbb.61.1022
   JONES RP, 1982, ENZYME MICROB TECH, V4, P210, DOI 10.1016/0141-0229(82)90034-5
   KAMIHIRA M, 1987, AGR BIOL CHEM TOKYO, V51, P407, DOI 10.1080/00021369.1987.10868053
   LIN HM, 1993, CHEM ENG J BIOCH ENG, V52, pB29
   Ludwig H., 1994, HIGH PRESSURE RES, V12, P193
   LUDWIG H, 1997, PHARM IND, V59, P335
   LUNDGREN L, 1966, PHYSIOL PLANTARUM, V19, P403, DOI 10.1111/j.1399-3054.1966.tb07031.x
   NAKAMURA K, 1994, BIOSCI BIOTECH BIOCH, V58, P1297, DOI 10.1271/bbb.58.1297
   SALE AJH, 1970, J GEN MICROBIOL, V60, P323, DOI 10.1099/00221287-60-3-323
   SARTORELLO S, 2000, THESIS U PADUA
   SCHRECK C, 1997, HIGH PRESSURE RES BI
   SEYDERHELM I, 1994, ZFL, V43, P17
   Smelt JPPM, 1992, HIGH PRESSURE BIOTEC, V224, P361
   SOJKA B, 1994, PHARM IND, V56, P660
   Sojka B, 1997, PHARM IND, V59, P436
   SPECK ML, 1976, COMPENDIUM METHODS M, P107
   TIMSON WJ, 1965, BIOTECHNOL BIOENG, V7, P139, DOI 10.1002/bit.260070124
   TOEWS KL, 1995, ANAL CHEM, V67, P4040, DOI 10.1021/ac00118a002
   TOPHAM S, 1998, ULLMANNS ENCY IND CH
   ZOBELL CE, 1949, J BACTERIOL, V57, P179
NR 33
TC 132
Z9 153
U1 1
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD JAN
PY 2002
VL 22
IS 1
BP 55
EP 63
DI 10.1016/S0896-8446(01)00106-1
PG 9
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 510CN
UT WOS:000173191300005
DA 2018-10-20
ER

PT J
AU Saiki, M
   da Silva, MC
   Fulfaro, R
   Vasconcellos, MBA
AF Saiki, M
   da Silva, MC
   Fulfaro, R
   Vasconcellos, MBA
TI Study on instrumental neutron activation analysis of aluminium in
   geological and biological reference materials
SO JOURNAL OF TRACE AND MICROPROBE TECHNIQUES
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Trace Elements in Humans
CY OCT 04-06, 2001
CL ATHENS, GREECE
DE instrumental neutron activation analysis; aluminium; reference materials
ID SAMPLES
AB The determinations of Al are of great interest in the environmental and biomedical studies as well as in the evaluation of the economic potential in ore prospecting programs. Reliable determinations of this element by instrumental neutron activation analysis (INAA) have been a challenge for several researchers. The major difficulties are the interferences of P and Si that form Al-28, the same radioisotope used in the analysis of Al. The elements Na and Cl can also interfere with the detection of Al, when they are present in large quantities. The detection of Al is often masked by high radio-activities of 24 Na and 38 Cl. This work presents results of Al determinations in several kinds of biological and geological reference materials and the results indicate a good agreement with the certified values. In some samples, the contribution of P and Si interferences were considered in the Al determination by using correction factors determined experimentally. The detection limit values in Al determinations were also evaluated.
C1 IPEN CNEN SP, Div Radiochem, BR-05422970 Sao Paulo, SP, Brazil.
RP Saiki, M (reprint author), IPEN CNEN SP, Div Radiochem, POB 11049, BR-05422970 Sao Paulo, SP, Brazil.
EM mitiko@curiango.upen.br
RI Vasconcellos, Marina/E-8538-2014; Saiki, Mitiko/B-7975-2012
OI Saiki, Mitiko/0000-0003-2197-3592
CR BLOTCKY AJ, 1992, ANAL CHEM, V64, P2910, DOI 10.1021/ac00047a006
   Bode P, 1997, J RADIOANAL NUCL CH, V215, P87, DOI 10.1007/BF02109883
   BOGDANOVICH E, 1992, J RADIOAN NUCL CH LE, V164, P293, DOI 10.1007/BF02164952
   CURRIE LA, 1968, ANAL CHEM, V40, P586, DOI 10.1021/ac60259a007
   GLADNEY ES, 1983, GEOSTANDARD NEWSLETT, V7, P223
   GREENBERG RR, 1983, ANAL CHEM, V55, P1160, DOI 10.1021/ac00258a041
   *I PESQ TECN EST S, 1982, CERT AN CALC DOL
   *INT AT EN AG, 1995, SURV REF MAT, V5
   LANDSBERGER S, 1989, J RADIOAN NUCL CH LE, V137, P443, DOI 10.1007/BF02168351
   *NAT BUR STAND, 1988, CERT AN STAND REF MA
   *NAT I STAND TECHN, 1992, CERT AN STAND REF MA
   National Bureau of Standards, 1982, CERT AN STAND REF MA
   Okamoto K., 1985, ANAL SCI, V1, P206
   PICCOT D, COMMUNICATION
   Shoop DM, 1998, J RADIOANAL NUCL CH, V236, P103, DOI 10.1007/BF02386325
   Stamatelatos IE, 1999, J RADIOANAL NUCL CH, V241, P483, DOI 10.1007/BF02347201
   VANDALSEM DJ, 1995, J RADIOAN NUCL CH AR, V192, P131, DOI 10.1007/BF02037745
   WEGINWAR RG, 1989, J RADIOAN NUCL CH AR, V133, P317, DOI 10.1007/BF02060504
NR 18
TC 2
Z9 2
U1 1
U2 7
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0733-4680
J9 J TRACE MICROPROBE T
JI J. Trace Microprobe Tech.
PY 2002
VL 20
IS 4
BP 517
EP 525
DI 10.1081/TMA-120015613
PG 9
WC Chemistry, Analytical
SC Chemistry
GA 622EF
UT WOS:000179633000008
DA 2018-10-20
ER

PT S
AU Vaitkuviene, A
   Auksorius, E
   Fuchs, D
   Gavriushin, V
AF Vaitkuviene, A
   Auksorius, E
   Fuchs, D
   Gavriushin, V
BE Longo, L
   Hofstetter, AG
   Pascu, ML
   Waidelich, WRA
TI Multivariate analysis of endometrial tissue fluorescence spectra
SO LASER FLORENCE 2001: A WINDOW ON THE LASER MEDICINE WORLD
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Annual Laser Florence 2001 Conference
CY NOV 07-11, 2001
CL FLORENCE, ITALY
SP Int Acad Laser Med & Surg, Inst Laser Med Florence, SPIE, SPIE Romania Chapter, Opt Soc Amer, European Opt Soc, Int Soc Laser Med & Surg, World Assoc Laser Therapy, Romanian Soc Laser Med & Biol, Natl Inst Laser, Plasma & Radiat Phys, Eastern Europe Confederat Natl Soc Plast Aesthet Surg & Aesthet Med, Int Acad Light Med, Amer Acad Dermatol, Laser Inst Amer, Canadian Soc Aesthet Plast Surg, Czech Med Soc J E Purkynje, Radiobiol Soc, Union Int Med Esthet, Italian Soc Aesthet Med, Polish Soc Aesthet Med, Italian Coll Phlebol, Soc Italiana Teraple Integrate Flebolinfolog, Fed Nazl Coll IPASVI, President Italian Republic, Univ Degli Stud Firenze, Reg Toscana, Scuol Pie Fiorentine Republic, Ente Cassa Risparmio Firenze
DE fluorescence spectroscopy; multivariate analysis; endometrial tissue
ID LINEAR DISCRIMINANT-ANALYSIS
AB Background and Objective: The detailed multivariate analysis of endometrial tissue fluorescence spectra was done. Spectra underlying features and classification algorithm were analyzed. An effort has been made to determinate the importance of neopterin component in endometrial premalignization.
   Study Design/Materials and Methods: Biomedical tissue fluorescence was measured by excitation with the Nd YAG laser third harmonic. Multivariate analysis techniques were used to analyze fluorescence spectra. Biomedical optics group at Vilnius University analyzed the neopterin substance supplied by Institute of Medical Chemistry and Biochemistry of Innsbruck University.
   Results: Seven statistically significant spectral compounds were found. The classification algorithm classifying samples to histopathological categories was developed and resulted in sensitivity of 80% and specificity 93% for malignant vs. hyperplastic and normal.
   Conclusions: Fluorescence spectra could be classified with high accuracy. Spectral variation underlying features can be extracted.
   Neopterin component might play important role in endometrial hyperplasia development.
C1 Vilnius State Univ, Inst Mat Sci & Appl Res, Vilnius, Lithuania.
RP Vaitkuviene, A (reprint author), Vilnius State Univ, Inst Mat Sci & Appl Res, Vilnius, Lithuania.
RI Auksorius, Egidijus/I-1377-2018
OI Auksorius, Egidijus/0000-0002-3742-067X
CR Albert A., 1987, MULTIVARIATE INTERPR
   HARRIES ML, 1995, J LARYNGOL OTOL, V109, P108
   Ramadan Z, 1998, CHEMOMETR INTELL LAB, V40, P165, DOI 10.1016/S0169-7439(98)00020-3
   RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555
   Wu W, 1996, ANAL CHIM ACTA, V329, P257, DOI 10.1016/0003-2670(96)00142-0
NR 5
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4690-4
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4903
BP 29
EP 33
DI 10.1117/12.486633
PG 5
WC Engineering, Biomedical; Optics; Surgery
SC Engineering; Optics; Surgery
GA BV65A
UT WOS:000179637300004
DA 2018-10-20
ER

PT J
AU Hedia, HSM
   Shabara, MAN
AF Hedia, HSM
   Shabara, MAN
TI Effect of notch tip sharpness and pre-cracking on the stress intensity
   factor - Part I: Finite element analysis of compact tension specimen
SO MATERIALPRUFUNG
LA English
DT Article
AB The aim of the study reported in this paper was to investigate the effect of notch angle, notch tip radius and pre-cracking on the stress intensity factor, K-I, for compact tension specimens, CT. The study was conducted using finite element analysis (FEA) in association with ANSYS program. Two models were considered in the analysis. A compact tension specimen having a blunt notch without pre-crack represented the first model, while the second model was represented by a CT specimen having a blunt notch with a pre-crack. Five different engineering materials, usually used in biomedical applications were considered. A linear elastic fracture mechanics (LEFM) approach applied to plain strain condition was used.
C1 Mansoura Univ, Mansoura, Egypt.
RP Hedia, HSM (reprint author), Mansoura Univ, Mansoura, Egypt.
RI Hedia, Hassan/I-8289-2012
CR *ANSYS, 1992, ANSYS US MAN VERS 5
   ASHABY MF, 1980, ENG MAT, V1
   *ASTM, 1983, 39983 ASTM E
   Canister Jr W.D., 1994, MAT SCI ENG
   GLAUICO HP, 2001, IN PRESS FRACTURE TE
   GLINKA G, 1987, INT J FATIGUE, V9, P143, DOI 10.1016/0142-1123(87)90069-7
   NISITANI H, 1989, JSME INT J I, V32
   PAPADOPOULOS GA, 1988, ENG FRACT MECH, V31, P271, DOI 10.1016/0013-7944(88)90071-9
   RUBIO C, 1999, S REC DEV STUD IMP C
   Shabara MAN, 1996, ENG FRACT MECH, V54, P533, DOI 10.1016/0013-7944(95)00207-3
   Taylor D., 1994, ENG FAIL ANAL, V1, P275
   WILSON WK, 1974, T ASME
NR 12
TC 5
Z9 5
U1 0
U2 1
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0025-5300
J9 MATERIALPRUFUNG
JI Materialprufung
PY 2002
VL 44
IS 4
BP 117
EP 121
PG 5
WC Materials Science, Characterization & Testing
SC Materials Science
GA 550HP
UT WOS:000175497800001
DA 2018-10-20
ER

PT J
AU Hedia, HSM
   Fattah, AA
AF Hedia, HSM
   Fattah, AA
TI Effect of notch tip sharpness and pre-cracking on the stress intensity
   factor - Part II: Investigation of the shear loading mode
SO MATERIALPRUFUNG
LA English
DT Article
ID FRACTURE
AB In addition to the previous paper published in this issue, the effects of crack notch angle, crack notch radius and pre-crack length for compact tension specimen on the behavior of stress intensity factor (SIF) for the shear loading mode are presented in this contribution. Again, two models with a blunt notch have been analyzed. The first model represents a compact tension specimen with a pre-crack while the second one does not have a pre-crack. Similar to the previous contribution, five different engineering materials have been examined which are usually used for biomedical applications. The analyses were accomplished using linear elastic fracture mechanics (LEFM) approach applied in the plain strain field. The study was conducted using finite element program ANSYS.
C1 Mansoura Univ, Fac Engn, Prod Engn & Mech Design Dept, Mansoura, Egypt.
RP Hedia, HSM (reprint author), Mansoura Univ, Fac Engn, Prod Engn & Mech Design Dept, Mansoura, Egypt.
RI Hedia, Hassan/I-8289-2012
CR ASHABY MF, 1980, ENG MAT, V1
   Canister Jr W.D., 1994, MAT SCI ENG
   CHU SJ, 1990, ENG FRACT MECH, V35, P1093, DOI 10.1016/0013-7944(90)90137-6
   HE MY, 2001, ENG FRACT MECH, V65, P1
   Hedia HS, 1996, MED ENG PHYS, V18, P647, DOI 10.1016/S1350-4533(96)00025-2
   HEDIA HS, 2002, MATERIALPRUFUNG, V44
   HEDIA HS, 2000, J BIOMEDICAL MAT ENG, V10, P141
   HEYWOOD RB, 1962, DESIGNING FATIGUE
   Shabara MAN, 1996, ENG FRACT MECH, V54, P533, DOI 10.1016/0013-7944(95)00207-3
   YOON SH, 1990, INT J FRACTURE, V43, pR3, DOI 10.1007/BF00018129
   YUM YJ, 1991, INT J FRACTURE, V47, P53, DOI 10.1007/BF00037039
   1992, ANSYS US MAN VERS 5
NR 12
TC 4
Z9 4
U1 0
U2 1
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0025-5300
J9 MATERIALPRUFUNG
JI Materialprufung
PY 2002
VL 44
IS 4
BP 122
EP 125
PG 4
WC Materials Science, Characterization & Testing
SC Materials Science
GA 550HP
UT WOS:000175497800002
DA 2018-10-20
ER

PT B
AU Hench, LL
   Xynos, ID
   Edgar, AJ
   Buttery, LDK
   Polak, JM
AF Hench, LL
   Xynos, ID
   Edgar, AJ
   Buttery, LDK
   Polak, JM
BE McLean, M
TI A genetic basis for biomedical materials
SO MATERIALS SCIENCE AND ENGINEERING: ITS NUCLEATION AND GROWTH
LA English
DT Proceedings Paper
CT Conference on Materials Science and Engineering
CY MAY 14-15, 2001
CL IMPERIAL COLL SCI, TECHNOL & MED, LONDON, ENGLAND
HO IMPERIAL COLL SCI, TECHNOL & MED
ID GLASS-CERAMICS; HUMAN OSTEOBLASTS; IONIC PRODUCTS; BONE-FORMATION;
   BIOGLASS; INTERFACE; BIOCERAMICS; DISSOLUTION; EXPRESSION; TISSUE
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RP Hench, LL (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RI Buttery, Lee/C-5627-2015
OI Buttery, Lee/0000-0003-3808-6770
CR ANDERSSON O, 1990, J MAT SCI MAT MED
   BECKHAM CA, 1971, CALC TISS RES, V8, P165, DOI 10.1007/BF02010133
   CLARK AE, 1976, J AM CERAM SOC, V59, P37, DOI 10.1111/j.1151-2916.1976.tb09382.x
   DOUEK E, 1991, P 4 INT S BIOC MED L
   Fetner A E, 1994, Compendium, V15, P935
   GREENLEE TK, 1972, J BIOMED MATER RES, V6, P235, DOI 10.1002/jbm.820060312
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench L. L., 1975, NBS SPEC PUBL, V415, P19
   Hench LL, 1998, J SOL-GEL SCI TECHN, V13, P245, DOI 10.1023/A:1008643303888
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   Hench LL, 2000, CURR ORTHOPAED, V14, P7, DOI 10.1054/cuor.1999.0074
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HENCH LL, 1982, BIOCOMPATIBILITY ORT, V2, pCH6
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hulbert S. F., 1987, HIGH TECH CERAMICS, P189
   KANGASNIEMI K, 1990, HDB BIOACTIVE CERAMI, V1, P97
   KITSUGI T, 1989, J BONE JOINT SURG AM, V71A, P264, DOI 10.2106/00004623-198971020-00014
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   Kokubo T., 1990, HDB BIOACTIVE CERAMI, P41
   Lobel K., 1996, CLIN PERFORMANCE SKE, P214
   Merwin GE, 1990, HDB BIOACTIVE CERAMI, V1, P323
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   RECK R, 1988, BIOCERAMICS MAT CHAR, V253, P100
   Shapoff C A, 1997, Compend Contin Educ Dent, V18, P352
   Stanley HR, 1997, INT J ORAL MAX IMPL, V12, P95
   STANLEY HR, 1996, CLIN PERFORMANCE SKE, P255
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   WILSON J, 1990, HDB BIOACTIVE CERAMI, V1, P283
   WILSON J, 1994, BIOCERAMICS, V7, P415
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamamuro T, 1988, Ann N Y Acad Sci, V523, P107
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1
   YAMAMURO T, AW GLASS CERAMIC CLI, P89
   YOSHII S, 1988, J BIOMED MATER RES-A, V22, P327, DOI 10.1002/jbm.820221410
NR 51
TC 4
Z9 4
U1 0
U2 5
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
BN 1-902653-59-9
PY 2002
BP 283
EP 296
PG 14
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BW12K
UT WOS:000180939900022
DA 2018-10-20
ER

PT J
AU Tamizifar, M
   Omidvar, H
   Salehi, SMT
   Salehpour, Z
   Khoshkalam, O
AF Tamizifar, M
   Omidvar, H
   Salehi, SMT
   Salehpour, Z
   Khoshkalam, O
TI Effect of processing parameters on shear bands in non-isothermal hot
   forging of Ti-6Al-4V
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
ID TI-6AL-2SN-4ZR-2MO-0.1SI; DEFORMATION
AB The alloy system Ti - 6Al - 4V is the prominent Ti alloy system for aerospace and biomedical applications, as a result of its mechanical property balance and biocompatibility. Since the mechanical characterisation of Ti - 6Al - 4V is strongly sensitive to processing parameters there is relationship between processing variables, i.e. strain rate and temperature, microstructure, and properties under different loading conditions. Two phase (alpha+beta) titanium alloys undergo flow instabilities and are susceptible to shear bands or regions of localised deformation crossing many grains during hot forging under non-isothermal conditions (dies and workpiece at different temperatures). Under such conditions shear bands can be generated even in materials without flow softening attributes. This occurs if the forging parameters lead to large amounts of heat transfer between the dies and the workpiece. This study investigates the occurrence of shear bands during non-isothermal, hot forging of Ti - 6Al - 4V in order to evaluate the process parameters that generally lead to shear bands in conventional hot forging of metals. Upset compression tests on cylindrical specimens were conducted in a mechanical press and lateral side pressing tests on long, round bars were performed in either a mechanical press or a hydraulic press. The tests ranged from axisymmetric to plane strain compression. In upset specimens shear bands occurred at an angle of 45degrees to the compression axis and bands of intense deformation separated chill zones from the deforming bulk. Observation also demonstrated that the fracture might be owing to microvoids nucleated at weak points in sections of the shear surfaces. For plane strain deformation, shear bands were found to initiate along zero extension directions in a manner analogous to the formation and propagation of shear bands in isothermal hot forging. Although the shear band features at hot forging temperatures were similar to each other, there was a difference in the hardness and thickness of the shear bands depending on deformation mode, amount, and temperature.
C1 Iran Univ Sci & Technol, Tehran 16844, Iran.
RP Tamizifar, M (reprint author), Iran Univ Sci & Technol, Tehran 16844, Iran.
CR DADRAS P, 1981, METALL TRANS A, V12, P1867, DOI 10.1007/BF02643797
   IMAM MA, 1996, STP1273 ASTM, P3
   KIM YW, 1991, MICROSTRUCTURE PROPE, P647
   Lee WS, 1998, MAT SCI ENG A-STRUCT, V241, P48, DOI 10.1016/S0921-5093(97)00471-1
   OMIDVAR H, TREATISE MECH BEHAV
   Semiatin SL, 1998, MAT SCI ENG A-STRUCT, V256, P92, DOI 10.1016/S0921-5093(98)00814-4
   SEMIATIN SL, 1983, METALL TRANS A, V14, P105, DOI 10.1007/BF02643743
   Semiatin SL, 1998, MAT SCI ENG A-STRUCT, V243, P1, DOI 10.1016/S0921-5093(97)00776-4
   SEMIATIN SL, 1983, METALL TRANS A, V14, P2363, DOI 10.1007/BF02663312
   SEMIATIN SL, 1981, METALL TRANS A, V12, P1705, DOI 10.1007/BF02643753
   SEMIATIN SL, 1980, PROCESS MODELING FUN, P387
   SEMIATIN SL, 1984, FORMABILITY WORKABIL, P13
   SHMIATIN SL, 1996, ADV SCI TECHN TIT AL, P3
   WEISS I, 1986, METALL TRANS A, V17, P1935, DOI 10.1007/BF02644991
NR 14
TC 4
Z9 5
U1 1
U2 5
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD JAN
PY 2002
VL 18
IS 1
BP 21
EP 29
DI 10.1179/026708301125000168
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 524PR
UT WOS:000174022500003
DA 2018-10-20
ER

PT J
AU Vena, P
   Contro, R
AF Vena, P
   Contro, R
TI Micromechanical analysis of the trabecular bone stress state at the
   interface with metallic biomedical devices
SO MECCANICA
LA English
DT Article; Proceedings Paper
CT 15th Congress of AIMETA
CY SEP 26-29, 2001
CL SICILY, ITALY
DE microstructures; interface behaviour; finite elements; multi-scale
   computing; iterative techniques
ID FINITE-ELEMENT MODELS; ACCURACY
AB An iterative procedure for the stress analysis at interfaces between dissimilar materials is presented. The problem is specialised to the case of biomaterial interfaces with particular reference to materials which are characterised by tiny microstructures. The procedure is based on a recursive analysis of small size problems defined upon subdomains obtained by partitioning the whole structural domain. The kinematic boundary conditions are iteratively adjusted by using appropriate preconditioners. The numerical example reported in this paper shows that the procedure is effective regardless of the degree of material heterogeneity, in contrast with the results obtained by using a coarse mesh for the whole domain. The procedure seems to be a promising one for determining the structural strength of interfaces between trabecular bone and metal implants requiring accurate evaluation of stress at the scale level of the single microstructure exhibited by the bone.
C1 Politecn Milan, Dept Struct Engn, Lab Biol Struct Mech, I-20133 Milan, Italy.
RP Vena, P (reprint author), Politecn Milan, Dept Struct Engn, Lab Biol Struct Mech, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
RI Vena, Pasquale/F-6684-2013
OI Vena, Pasquale/0000-0003-2229-5156
CR Charras GT, 2000, J BIOMECH, V33, P255, DOI 10.1016/S0021-9290(99)00141-4
   Guldberg RE, 1998, J BIOMECH ENG-T ASME, V120, P289, DOI 10.1115/1.2798314
   Jacobs CR, 1999, J BIOMECH, V32, P1159, DOI 10.1016/S0021-9290(99)00115-3
   Le Tallec P, 1994, COMPUT MECH ADV, V1, P121
   Niebur GL, 2000, J BIOMECH, V33, P1575, DOI 10.1016/S0021-9290(00)00149-4
   Pistoia W, 2001, J BIOMECH ENG-T ASME, V123, P176, DOI 10.1115/1.1352734
   Terada K, 2000, INT J SOLIDS STRUCT, V37, P2285, DOI 10.1016/S0020-7683(98)00341-2
   Wentorf R, 1999, COMPUT METHOD APPL M, V172, P273, DOI 10.1016/S0045-7825(98)00232-1
   ZOHDI TI, 1999, COMPUT METHODS APPL, V172, P3
NR 9
TC 2
Z9 2
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0025-6455
J9 MECCANICA
JI Meccanica
PY 2002
VL 37
IS 4-5
BP 431
EP 439
DI 10.1023/A:1020852108109
PG 9
WC Mechanics
SC Mechanics
GA 606DG
UT WOS:000178717800012
DA 2018-10-20
ER

PT S
AU Bashkansky, M
   Reintjes, J
AF Bashkansky, M
   Reintjes, J
BE Meyendorf, N
   Baaklini, GY
   Michel, B
TI Subsurface detection and characterization of Hertzian cracks in advanced
   ceramic materials using optical coherence tomography.
SO NONDESTRUCTIVE EVALUATION AND RELIABILITY OF MICRO-AND NANOMATERIAL
   SYSTEMS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT 1st Conference on Nondestructive Evaluation and Reliability of Micro-
   and Nanomaterial Systems
CY MAR, 2002
CL SAN DIEGO, CA
SP SPIE
DE NDE; optical coherence tomography; optical gating
AB Optical Coherence Tomography (OCT) is an active optical imaging technique that is capable of three-dimensional resolution better than 10 microns in all dimensions. OCT was originally developed as a non-invasive technique in biomedical field. It also found uses in the NDE of various materials including ceramics, plastics and composites. In various ceramics OCT can be used to detect microscopic, subsurface defects at depths approaching hundreds of microns. The depth of penetration depends on the material and on the wavelength of light. Here we demonstrate an application of OCT to the subsurface imaging in various materials and, in particular, to the detection of a surface-penetrating Hertzian crack in a Si3N4 ceramic ball. We present measured subsurface trajectory of the crack and compare it to theoretical predictions. These cracks represent one of the most important failure mechanisms in advanced ceramic materials. The ability to map subsurface trajectories of cracks is a valuable tool in the evaluation of different existing theories. Better theoretical understanding of various properties of crack initiation and propagation can lead to engineering of improved ceramic materials.
C1 USN, Res Lab, Div Opt Sci, Washington, DC 20375 USA.
RP Bashkansky, M (reprint author), USN, Res Lab, Div Opt Sci, Code 5610, Washington, DC 20375 USA.
CR AMIN KE, 1995, AM CERAM SOC BULL, V74, P76
   Bashkansky M, 2001, NDT&E INT, V34, P547, DOI 10.1016/S0963-8695(01)00014-7
   Bashkansky M, 1997, OPT LETT, V22, P61, DOI 10.1364/OL.22.000061
   FRANK FC, 1967, PROC R SOC LON SER-A, V299, P291, DOI 10.1098/rspa.1967.0137
   Kamensky V, 1999, J BIOMED OPT, V4, P137, DOI 10.1117/1.429927
   Kocer C, 1998, J AM CERAM SOC, V81, P1736
   LAWN BR, 1967, PROC R SOC LON SER-A, V299, P307, DOI 10.1098/rspa.1967.0138
   PUJARI VK, DEV IMPROVED PROCESS
   PUJARI VK, 1995, AM CER SOC B, V74
   Rollins AM, 1999, OPT LETT, V24, P1484, DOI 10.1364/OL.24.001484
   SANDAY SC, 1999, P INTEGRATION MAT PR, P167
   SLOTWINSKI JA, 1993, NIST SPECIAL PUBLICA, V847, P117
   TONAKA T, 1990, J EUROPEAN CER SOC, V6, P9
   XU HHK, 1994, J AM CERAM SOC, V77, P1388, DOI 10.1111/j.1151-2916.1994.tb05424.x
NR 14
TC 4
Z9 4
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4451-0
J9 PROC SPIE
PY 2002
VL 4703
BP 46
EP 52
DI 10.1117/12.469630
PG 7
WC Materials Science, Characterization & Testing; Microscopy; Optics
SC Materials Science; Microscopy; Optics
GA BU98M
UT WOS:000177554000006
DA 2018-10-20
ER

PT S
AU Janotta, M
   Mizaikoff, A
AF Janotta, M
   Mizaikoff, A
BE Gannot, I
TI Recent developments in liquid phase mid-infrared sensor technology
SO OPTICAL FIBERS AND SENSORS FOR MEDICAL APPLICATIONS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Optical Fibers and Sensors for Medical Applications II Conference
CY JAN 22-23, 2002
CL SAN JOSE, CA
SP SPIE
DE mid-infrared sensors; evanescent field sensors; chemical sensors;
   sol-gel coatings
ID MOLECULARLY IMPRINTED POLYMERS; OPTICAL CHEMICAL SENSORS;
   EVANESCENT-WAVE SENSORS; SOL-GEL COATINGS; CHLORINATED HYDROCARBONS;
   FIBEROPTIC SENSORS; FTIR SPECTROSCOPY; BIOSENSORS; WATER; PESTICIDES
AB The potential of mid-infrared optical sensing technology for liquid phase applications is tightly related to the implementation of appropriate chemical modifications of the sensing surface. Besides recognition and enrichment of analyte molecules, suppression of interfering water absorptions is of substantial interest. Utilizing the principle of evanescent wave spectroscopy for the signal generation is the basis for the realization of powerful spectroscopic sensing systems, which provide access to molecule specific vibrations of organic analytes. With the availability of mid-infrared transparent fiberoptic materials, access to the mid-infrared spectral region from 2-20 mum is gained enabling remote qualitative and quantitative analysis. Besides polymeric molecular recognition and enrichment layers, sol-gel films are among the most promising surface modification. This highly reproducible process allows detailed control on the surface properties of the sol-gel layer formed at the waveguide surface. Due to the inertness and robustness of sol-gel coatings they can be considered among the most promising surface modification materials for optical sensors applied in the biomedical and biological field.
C1 Georgia Inst Technol, Sch Chem & Biochem, Appl Sensors Lab, Atlanta, GA 30332 USA.
RP Janotta, M (reprint author), Georgia Inst Technol, Sch Chem & Biochem, Appl Sensors Lab, Atlanta, GA 30332 USA.
RI Mizaikoff, Boris/G-9959-2013
OI Mizaikoff, Boris/0000-0002-5583-7962
CR AVNIR D, 1992, P SOC PHOTO-OPT INS, V1758, P456, DOI 10.1117/12.132037
   BRINKER CJ, 1990, SOL GEL SCI
   Dickert FL, 1999, TRAC-TREND ANAL CHEM, V18, P192, DOI 10.1016/S0165-9936(98)00123-X
   FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553
   Grant SA, 1997, SENSOR ACTUAT B-CHEM, V45, P35, DOI 10.1016/S0925-4005(97)00263-3
   Han L, 1999, APPL SPECTROSC, V53, P381, DOI 10.1366/0003702991946839
   Han L, 1998, APPL SPECTROSC, V52, P119, DOI 10.1366/0003702981942429
   Haupt K, 1998, TRENDS BIOTECHNOL, V16, P468, DOI 10.1016/S0167-7799(98)01222-0
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HOLST G, 2002, IN PRESS HDB FIBER O
   Hvozdara L, 2000, APPL OPTICS, V39, P6926, DOI 10.1364/AO.39.006926
   Ingersoll CM, 1997, CHEMTECH, V27, P26
   Jakusch M, 1997, P SOC PHOTO-OPT INS, V3105, P283, DOI 10.1117/12.276163
   Jakusch M, 1999, ANAL CHEM, V71, P4786, DOI 10.1021/ac990050q
   Jakusch M, 1997, SENSOR ACTUAT B-CHEM, V38, P83, DOI 10.1016/S0925-4005(97)80175-X
   Janata J, 2001, ANAL CHEM, V73, p150A, DOI 10.1021/ac012402a
   JANATA J, 1998, ANAL CHEM, V70, P179
   Janotta M, 2001, INT J ENVIRON AN CH, V80, P75, DOI 10.1080/03067310108044374
   Kraft M, 2000, INT J ENVIRON AN CH, V78, P367, DOI 10.1080/03067310008041354
   KRIZ D, 1995, ANAL CHIM ACTA, V300, P71, DOI 10.1016/0003-2670(94)00368-V
   Kriz D, 1997, ANAL CHEM, V69, pA345, DOI 10.1021/ac971657e
   KRIZ D, 1995, ANAL CHEM, V67, P2142, DOI 10.1021/ac00109a037
   Kron J, 1994, J SOL-GEL SCI TECHN, V2, P189, DOI 10.1007/BF00486239
   LEV O, 1995, ANAL CHEM, V67, pA22, DOI 10.1021/ac00097a001
   Lin J, 1997, TRAC-TREND ANAL CHEM, V16, P200, DOI 10.1016/S0165-9936(97)00021-6
   Lobnik A, 1998, ANAL CHIM ACTA, V367, P159, DOI 10.1016/S0003-2670(97)00708-3
   Lobnik A, 1998, SENSOR ACTUAT B-CHEM, V51, P203, DOI 10.1016/S0925-4005(98)00189-0
   MACCRAITH BD, 1995, SENSOR ACTUAT B-CHEM, V29, P51, DOI 10.1016/0925-4005(95)01662-7
   MacCraith BD, 1997, J SOL-GEL SCI TECHN, V8, P1053, DOI 10.1023/A:1018338426081
   MACCRAITH BD, 1993, SENSOR ACTUAT B-CHEM, V11, P29, DOI 10.1016/0925-4005(93)85235-3
   MACCRAITH BD, 1994, P SOC PHOTO-OPT INS, V2288, P518, DOI 10.1117/12.188986
   MACCRAITH BD, 1997, CRIT REV OPT SCI TEC, V68, P64
   McDonagh C, 1996, J NON-CRYST SOLIDS, V194, P72, DOI 10.1016/0022-3093(95)00488-2
   McDonagh C, 2001, SENSOR ACTUAT B-CHEM, V74, P124, DOI 10.1016/S0925-4005(00)00721-8
   Mendoza EA, 1997, P SOC PHOTO-OPT INS, V3136, P267, DOI 10.1117/12.290203
   Mizaikoff B, 1999, P SOC PHOTO-OPT INS, V3849, P7, DOI 10.1117/12.372799
   MIZAIKOFF B, 1995, SENSOR ACTUAT B-CHEM, V29, P58, DOI 10.1016/0925-4005(95)01663-5
   Mizaikoff B, 1999, MEAS SCI TECHNOL, V10, P1185, DOI 10.1088/0957-0233/10/12/310
   Mizaikoff B, 2001, PROC SPIE, V4253, P76, DOI 10.1117/12.427911
   MIZAIKOFF B, 2001, P SICON 01 IEEE C, P208
   Mizaikoff B., 2002, HDB VIBRATIONAL SPEC, V2, P1560
   MOLINELLI A, 2002, IN PRESS J AGR FOOD
   MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X
   Oehme I, 1997, MIKROCHIM ACTA, V126, P177, DOI 10.1007/BF01242319
   Pope EJA, 2000, P SOC PHOTO-OPT INS, V3943, P170, DOI 10.1117/12.384336
   POPE EJA, 1986, J NON-CRYST SOLIDS, V87, P185, DOI 10.1016/S0022-3093(86)80078-3
   Regan F, 1997, VIB SPECTROSC, V14, P239, DOI 10.1016/S0924-2031(96)00073-2
   Regan F, 1996, ANAL CHIM ACTA, V334, P85, DOI 10.1016/S0003-2670(96)00259-0
   SHAHRIARI MR, 1999, OPT FIBER SENS TECHN, V4, P47
   SHAHRIARI MR, 1994, SOL GEL OPTICS PROCE, P279
   WALSH JE, 1995, P SOC PHOTO-OPT INS, V2508, P233, DOI 10.1117/12.221736
   Walsh JE, 1996, ANALYST, V121, P789, DOI 10.1039/an9962100789
   WEISS R, 2002, IN PRESS BIOSEPARATI
   Wolfbeis OS, 2000, ANAL CHEM, V72, p81R
   Wulff G., 1995, ANGEW CHEM, V107, P1958
   Yano K, 1999, TRAC-TREND ANAL CHEM, V18, P199, DOI 10.1016/S0165-9936(98)00119-8
NR 56
TC 5
Z9 5
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4355-7
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4616
BP 1
EP 8
DI 10.1117/12.463796
PG 8
WC Engineering, Biomedical; Instruments & Instrumentation; Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BU44B
UT WOS:000175999200001
DA 2018-10-20
ER

PT S
AU Witte, R
   Herfurth, H
   Heinemann, S
AF Witte, R
   Herfurth, H
   Heinemann, S
BE Sugioka, K
   Gower, MC
   Haglund, RF
   Pique, A
   Dubowski, JJ
   Hoving, W
TI Laser joining of glass with silicon
SO PHOTON PROCESSING IN MICROELECTRONICS AND PHOTONICS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Photon Processing in Microelectronics and Photonics
CY JAN 21-24, 2002
CL SAN JOSE, CA
SP SPIE, AIR Force Sci Res
DE selective bonding; glass; silicon; MEMS
AB New joining techniques are required for the variety of materials used in the manufacture of microsystems. Lasers are emerging as a useful tool for joining miniaturized devices. The beam can be focused to less than .001" allowing localized joining of very small geometries. There is minimal heat input into the part so distortion and change in material properties is minimal. The high quality of the laser welds and the precise process control enable hermetic scaling.
   Glass to silicon bonds are required in a vast array of opto-electronic components, including laser sources, sensors, switches and multiplexers. Typically, adhesives as well as direct and anodic bonding techniques are used to join the different materials. Adhesive residues, low bond strength, heating of entire parts during joining and poor long-term stability are disadvantages of these conventional techniques.
   Laser bonding is a promising alternative due to the increased bond strength and high repeatability. Compact and efficient diode lasers equipped with fiber beam delivery in the power range of <50W are applied to the sandwiched glass-silicon structure. During bonding, the laser beam penetrates the upper part and is absorbed at the surface of the bottom part. A clean environment and good part fit-up is required to ensure proper bonding, high bond strength, and hemietic sealing. The process eliminates adhesives; therefore reducing costs due to shorter cycle times, lower maintenance and less inventory. The process requires no handling of toxic liquids and creates no fumes. Furthermore, the bonded parts are free of any residue or contamination, reducing scrap rates. This study investigates the process parameter window and determines the impact on the parts and the stability of the process. The results will lead to the development of several applications in the areas of telecommunications, biomedical devices and MEMS. This includes the encapsulation of MEMS, the covering of sensors and the packaging of biomedical products. The selectivity of the process will be demonstrated on flat coupons.
C1 Fraunhofer USA, Ctr Laser Technol, Plymouth, MI 48170 USA.
RP Witte, R (reprint author), Fraunhofer USA, Ctr Laser Technol, Plymouth, MI 48170 USA.
CR *CORN, 1999, GLASS SIL CONSTR SUB
   *CORN INC, 2001, PROD INF
   HOFMANN K, 1986, APPL PHYS LETT, V49, P1525, DOI 10.1063/1.97322
   Mandle R. M., 1967, US patent, no, Patent No. 3298807
   NILSSON T, 1999, ACTA U LAPPEENRANTAE, V84, P472
   PAYNE CC, 1984, Patent No. 4462188
   PUETZ H, 1997, MODERN PLASTICS  SEP, P121
   SCHOTT AG, 2001, PRODUCT INFORMATION
   SCHOTT AG, 2001, BOROFLOAT 33 PRODUCT
   TAKAHAGI T, 1994, J APPL PHYS, V76, P3140, DOI 10.1063/1.357496
   Tong Q.-Y, 1999, SEMICONDUCTOR WAFER
NR 11
TC 7
Z9 8
U1 0
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4376-X
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4637
BP 487
EP 495
DI 10.1117/12.470657
PG 9
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BU94R
UT WOS:000177443500055
DA 2018-10-20
ER

PT J
AU Hirsch, SG
   Spontak, RJ
AF Hirsch, SG
   Spontak, RJ
TI Temperature-dependent property development in hydrogels derived from
   hydroxypropylcellulose
SO POLYMER
LA English
DT Article
DE hydrogels; hydroxypropylcellulose; temperature-induced phase separation
ID AQUEOUS-SOLUTIONS; PHASE-BEHAVIOR; GELS; DIAGRAM; POLYMER; SYSTEM
AB Hydrogels constitute an important class of responsive materials that are employed in numerous biomedical and personal-care applications, most notably of which are controlled drug delivery, separations and superabsorbency. Since aqueous hydroxypropylcellulose (HPC) solutions exhibit lower critical solution behavior, hydrogels produced from this cellulose ether are temperature-responsive, swelling at low temperatures and contracting at high temperatures. If HPC hydrogels are synthesized at temperatures in the single-phase regime, they remain nonporous, whereas those crosslinked in the biphasic regime become microporous. In this work, we employ the modified temperature-induced phase separation (TIPS) protocol to generate nonporous and microporous HPC hydrogels crosslinked at different temperatures. The dynamic mechanical properties and swelling capacities of these hydrogels are reported as functions of crosslinking temperature. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA.
RP Spontak, RJ (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
EM rich_spontak@ncsu.edu
CR Alvarez-Lorenzo C, 1999, INT J PHARM, V180, P91, DOI 10.1016/S0378-5173(98)00409-8
   ANBERGEN U, 1990, POLYMER, V31, P1854, DOI 10.1016/0032-3861(90)90006-K
   Brannon-Peppas L., 1990, ABSORBENT POLYM TECH
   Buchholz F., 1998, MODERN SUPERABSORBEN
   FISCHER H, 1995, J MATER SCI, V30, P4623, DOI 10.1007/BF01153071
   FORTIN S, 1989, MACROMOLECULES, V22, P2286, DOI 10.1021/ma00195a050
   Frey MW, 1996, J POLYM SCI POL PHYS, V34, P2049
   Gao J, 2001, MACROMOLECULES, V34, P2242, DOI 10.1021/ma001631g
   GEHRKE SH, 1992, POLYM INT, V29, P29, DOI 10.1002/pi.4990290107
   GEHRKE SH, 1993, ADV POLYM SCI, V110, P81
   GUIDO S, 1995, MACROMOLECULES, V28, P4530, DOI 10.1021/ma00117a023
   HARSH DC, 1991, J CONTROL RELEASE, V17, P175, DOI 10.1016/0168-3659(91)90057-K
   HARSH DC, 1993, ACS SYM SER, V520, P105
   Hirokawa Y, 1999, MACROMOLECULES, V32, P7093, DOI 10.1021/ma990437v
   Kabra BG, 1998, MACROMOLECULES, V31, P2166, DOI 10.1021/ma970418q
   KABRA BG, 1992, POLYMER, V33, P990, DOI 10.1016/0032-3861(92)90014-N
   KABRA BG, 1994, ACS SYM SER, V573, P76
   Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6
   OConnor SM, 1997, J APPL POLYM SCI, V66, P1279, DOI 10.1002/(SICI)1097-4628(19971114)66:7<1279::AID-APP7>3.0.CO;2-D
   Okano T., 1998, BIORELATED POLYM GEL
   OTTENBRITE RM, 1996, ACS SYM SER, P627
   SPONTAK RJ, 1992, STUD POLYM SCI, V11, P273
   Wang BC, 1997, LIQ CRYST, V22, P359, DOI 10.1080/026782997209432
   WERBOWYJ RS, 1980, MACROMOLECULES, V13, P69, DOI 10.1021/ma60073a014
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   WU XS, 1992, J POLYM SCI POL CHEM, V30, P2121, DOI 10.1002/pola.1992.080301005
NR 26
TC 28
Z9 28
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD JAN
PY 2002
VL 43
IS 1
BP 123
EP 129
DI 10.1016/S0032-3861(01)00608-5
PG 7
WC Polymer Science
SC Polymer Science
GA 484TU
UT WOS:000171706300016
DA 2018-10-20
ER

PT B
AU Mano, JF
   Reis, RL
   Cunha, AM
AF Mano, JF
   Reis, RL
   Cunha, AM
BE Reis, RL
   Cohn, D
TI Dynamic mechanical analysis in polymers for medical applications
SO POLYMER BASED SYSTEMS ON TISSUE ENGINEERING, REPLACEMENT AND
   REGENERATION
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Polymer Based Systems
   on Tissue Engineering, Replacement and Regeneration
CY OCT 15-25, 2001
CL ALVOR, PORTUGAL
SP NATO, Adv Study Inst
ID ACRYLIC BONE-CEMENT; SOFT LINING MATERIALS; VISCOELASTIC PROPERTIES;
   DEGRADATION BEHAVIOR; THERMAL-PROPERTIES; TEMPERATURE; ACID);
   HYDROXYAPATITE; BIOMATERIALS; COMPOSITES
AB The Dynamic Mechanical Analysis (DMA) is a powerful thermal analysis technique, which allows to detect phase transitions and relaxation processes in a variety of materials. With this technique, the solid-state rheological properties of viscoelastic materials can be characterised over a wide range of temperature and frequencies. This chapter summarizes the principles and the capabilities of the DMA technique focusing on its uses on polymeric-based systems aimed to medical and environmental applications. The examples presented include the materials that have been investigated in our research group in the last few years, such as starch-based blends, proteins, polyethylenes, and composites thereof, among other materials. These newly developed biomaterials are being proposed for a range of biomedical applications that go from fracture replacement/fixation and tissue engineering scaffolding, to new partially degradable bone cements and hydrogels, carriers for controlled release of drugs and growth factors and new wound dressings and membranes.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Mano, JF (reprint author), Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RI Mano, Joao/A-4418-2009; Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Mano, Joao/0000-0002-2342-3765; Reis, Rui L./0000-0002-4295-6129; Group,
   3Bs/0000-0002-5195-3456
CR Alves NM, 2002, POLYMER, V43, P3627, DOI 10.1016/S0032-3861(02)00176-3
   Alves NM, 2001, MATER RES INNOV, V4, P170, DOI 10.1007/s100190000078
   Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   BROWN AF, 1997, J PHARM PHARMACOL, V49, P26
   Butler MF, 2000, POLYMER, V41, P2249, DOI 10.1016/S0032-3861(99)00366-3
   Cascone MG, 1997, POLYM INT, V43, P55
   CauichRodriguez JV, 1996, J MATER SCI-MATER M, V7, P349, DOI 10.1007/BF00154547
   CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   Cerrada ML, 2000, POLYMER, V41, P6655, DOI 10.1016/S0032-3861(99)00868-X
   Demirgoz D, 2000, POLYM DEGRAD STABIL, V70, P161, DOI 10.1016/S0141-3910(00)00102-6
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   ELVIRA C, 2001, 27 ANN M SOC BIOM ST, P271
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Frey MW, 1996, J POLYM SCI POL PHYS, V34, P2375, DOI 10.1002/(SICI)1099-0488(199610)34:14<2375::AID-POLB7>3.0.CO;2-V
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   HARRIS B, 1993, J MATER SCI, V28, P3353, DOI 10.1007/BF00354259
   JAUREGUI B, 1995, INT J BIOL MACROMOL, V17, P49, DOI 10.1016/0141-8130(95)93518-3
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   KALACHANDRA S, 1995, J MATER SCI-MATER M, V6, P218, DOI 10.1007/BF00146859
   Kalay G, 1999, J APPL POLYM SCI, V73, P2473, DOI 10.1002/(SICI)1097-4628(19990919)73:12<2473::AID-APP16>3.3.CO;2-F
   Kim S., 1997, IPNS WORLD SCI ENG
   LEONOR IB, 2002, IN PRESS J MAT SCI M
   LEONOR IB, 2002, IN PRESS BIOMATERIAL
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Mano JF, 2000, J APPL POLYM SCI, V78, P2345, DOI 10.1002/1097-4628(20001220)78:13<2345::AID-APP110>3.0.CO;2-3
   Mano JF, 1999, J MATER SCI-MATER M, V10, P857, DOI 10.1023/A:1008916901009
   Mano JF, 2001, MACROMOLECULES, V34, P8825, DOI 10.1021/ma010855b
   Mano JF, 2002, J MATER SCI, V37, P257, DOI 10.1023/A:1013635809035
   Mano JF, 2001, POLYMER, V42, P6187, DOI 10.1016/S0032-3861(01)00090-8
   Mano JF, 2001, POLYM TEST, V20, P937
   MANO JF, 2002, IN PRESS J MAT SCI M
   Maquet V, 2000, LANGMUIR, V16, P10463, DOI 10.1021/la000654l
   MARQUES AP, 2002, BIOMATERIALS, V6, P1471
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   McCrum N.G., 1991, ANELASTIC DIELECTRIC
   Menard K. P., 1999, DYNAMIC MECH ANAL PR
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Murata H, 2000, BIOMATERIALS, V21, P1421, DOI 10.1016/S0142-9612(00)00010-7
   Nazhat SN, 2000, J MATER SCI-MATER M, V11, P621, DOI 10.1023/A:1008957729512
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   OLIVEIRA AL, 2001, EUR SOC BIOM 2001 C
   PAPADOGIANNIS Y, 1993, DENT MATER, V9, P118, DOI 10.1016/0109-5641(93)90087-7
   Pascual B, 1999, BIOMATERIALS, V20, P453, DOI 10.1016/S0142-9612(98)00191-4
   Penco M, 2000, EUR POLYM J, V36, P901, DOI 10.1016/S0014-3057(99)00155-X
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Reis RL, 2001, STARCH POLYM ENCY MA, P8810
   RICHERT R, 1994, DISORDERED EFFECTS R
   Rodriguez-Perez MA, 2001, POLYM TEST, V20, P253, DOI 10.1016/S0142-9418(00)00030-1
   Saber-Sheikh K, 1999, BIOMATERIALS, V20, P817, DOI 10.1016/S0142-9612(98)00236-1
   SABERSHEIKH K, 2000, BIOMATERIALS, V20, P2055
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   SILVA RM, 2002, ESB2002
   SKROVANEK DJ, 1990, PROG ORG COAT, V18, P89, DOI 10.1016/0033-0655(90)85004-H
   Sousa RA, 2002, POLYM ENG SCI, V42, P1032, DOI 10.1002/pen.11010
   Sousa RA, 2000, J APPL POLYM SCI, V77, P1303, DOI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
   SOUSA RA, 2002, BIOCERAMICS, V14, P469
   SOUSA RA, 2002, IN PRESS POLYM ENG S
   STARKWEATHER HW, 1993, MACROMOLECULES, V26, P5084, DOI 10.1021/ma00071a016
   STROBL GR, 1996, PHYSICS POLYM
   Tian D, 1998, POLYMER, V39, P855, DOI 10.1016/S0032-3861(97)00343-1
   Tsuji H, 1996, J APPL POLYM SCI, V60, P2367, DOI 10.1002/(SICI)1097-4628(19960627)60:13<2367::AID-APP8>3.0.CO;2-C
   VAIDYANATHAN J, 1995, J MATER SCI-MATER M, V6, P670, DOI 10.1007/BF00123449
   VASQUEZTORRES H, 1994, J APPL POLYM SCI, V54, P1141
   Vaz CA, 2002, J MACROMOL SCI PHYS, VB41, P33, DOI 10.1081/MB-120002344
   Vaz CM, 2001, MATER RES INNOV, V4, P375, DOI 10.1007/s100190000112
   VAZ CM, 2002, UNPUB J BIOMAT SCI P
   VAZ CM, 2000, 6 WORLD BIOM C HAW U, P429
   WATASE M, 1989, POLYM J, V21, P567, DOI 10.1295/polymj.21.567
   Waters M, 1996, BIOMATERIALS, V17, P1627, DOI 10.1016/0142-9612(95)00330-4
   WETTON RE, 1986, DEV POLYM CHARACTERI, V5, P179
   YAMASHITA, 2002, J BIOMED MAT RES APP, V63, P31
   Yamashita J, 2001, J BIOMED MATER RES, V58, P47, DOI 10.1002/1097-4636(2001)58:1<47::AID-JBM70>3.0.CO;2-U
   Yang JM, 1999, J BIOMED MATER RES, V48, P52, DOI 10.1002/(SICI)1097-4636(1999)48:1<52::AID-JBM10>3.0.CO;2-Z
   Yang JM, 1997, J BIOMED MATER RES, V38, P361, DOI 10.1002/(SICI)1097-4636(199724)38:4<361::AID-JBM9>3.0.CO;2-M
   Yildiz ME, 2001, J RHEOL, V45, P903, DOI 10.1122/1.1380425
NR 79
TC 20
Z9 20
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-1000-1
J9 NATO SCI SER II MATH
PY 2002
VL 86
BP 139
EP 164
PG 26
WC Engineering, Biomedical; Engineering, Chemical
SC Engineering
GA BV99N
UT WOS:000180622900010
DA 2018-10-20
ER

PT B
AU Aker, MN
   Lu, TF
   Li, Q
AF Aker, MN
   Lu, TF
   Li, Q
GP IEEE
   IEEE
TI Weight optimisation of brush-type wound-field direct current motors
SO PROCEEDINGS OF THE 2002 IEEE INTERNATIONAL SYMPOSIUM ON INTELLIGENT
   CONTROL
LA English
DT Proceedings Paper
CT IEEE International Symposium on Intelligent Control
CY OCT 27-30, 2002
CL VANCOUVER, CANADA
SP IEEE, IEEE Control Syst Soc
AB Weight optimised direct current motors have been used lately as actuators for micro-robotics and biomedical equipment. The evolution of these motors originated from the need for lightweight compact motors with good response and having cheap production cost in the industry. Many techniques have been used in developing permanent magnet and wound-field motors, such as numerical analysis, selecting adequate magnetic material, finite element analysis and optimisation models. Yet, published articles reveal the development of wound-field motors with problems; for example nonproportional geometry, saturated magnetic core, weak output torque and high temperature rise. A mathematical model is introduced in this paper for developing a new design method to overcome these problems. A 900-watts DC motor is optimised separately and in concurrent with a proportional, integral and derivative (PID) controller at the end of this paper, as an example for illustrating the proposed method.
C1 Univ Adelaide, Dept Mech Engn, Adelaide, SA 5005, Australia.
RP Aker, MN (reprint author), Univ Adelaide, Dept Mech Engn, Adelaide, SA 5005, Australia.
CR CHANGZHI A, 1996, IEEE CEFC 96 7 BIENN
   CORBETT AE, 1978, P INT C EL MACH KATH
   Frielich S. D., 1987, Robotics World, V5, P28
   Hamdi E.S., 1994, DESIGN SMALL ELECT M
   HANITSCH R, 1992, P INT C EL MACH MANC
   ITOH H, 1981, T I ELECT COMMUNIC E
   Jones D., 1990, Powerconversion & Intelligent Motion, V16, P25
   KAFTANATII VT, 1988, SOVIET ELECT ENG, V59, P66
   KOPP NL, 1994, P 1994 S AUT UND VEH
   MANDRYKA OR, 1985, SOVIET ELECT ENG, V56, P49
   Nelson R., 1992, Powerconversion & Intelligent Motion, V18, P36
   PAPALAMBROS P, 1999, P 1999 ASME DES ENG
   PIEN YP, 2000, ELECT MACHINES POWER, V28, P13
   SAVANI A, 1983, IEEE T MAGN, V19, P2088
   SEOL SS, 1995, T KOREAN I ELECT ENG, V44, P858
NR 15
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7620-X
PY 2002
BP 397
EP 402
DI 10.1109/ISIC.2002.1157796
PG 6
WC Automation & Control Systems; Computer Science, Artificial Intelligence;
   Engineering, Electrical & Electronic; Robotics
SC Automation & Control Systems; Computer Science; Engineering; Robotics
GA BV67V
UT WOS:000179732300067
DA 2018-10-20
ER

PT B
AU Kupp, D
   Claar, D
   Flemmig, K
   Waag, U
   Goehler, H
AF Kupp, D
   Claar, D
   Flemmig, K
   Waag, U
   Goehler, H
BE Ghosh, A
   Sanders, TH
   Claar, TD
TI Processing of controlled porosity titanium-based materials
SO PROCESSSING AND PROPERTIES OF LIGHTWEIGHT CELLULAR METALS AND STRUCTURES
LA English
DT Proceedings Paper
CT 3rd Global Symposium on Materials Processing and Manufacturing
CY FEB 17-21, 2002
CL Seattle, WA
SP ONR
ID METALLIC FOAMS; FIXATION; SURFACES
AB Alloys and intermetallic compounds based on titanium are used extensively in aerospace and biomedical applications, based on their high strength, light weight, and excellent corrosion resistance. To extend the range of applications, designers and engineers are now seeking titanium-based materials with controlled porosity. Ultra-lightweight, porous titanium alloys and intermetallics are being fabricated based on technologies being developed at the Fraunhofer Institute and Fraunhofer USA Center for Manufacturing and Advanced Materials, located in Dresden, Germany and Newark, DE, respectively. Powder metallurgy processing routes are being utilized to fabricate hollow metal spheres and open-celled foams in titanium, Ti-6Al-4V alloy and TiAl and TiAl(3) intermetallics. The processing, microstructures, and selected properties of these controlled-porosity materials will be presented, along with a discussion of potential applications in the aerospace, biotechnology, and other industries.
C1 Fraunhofer USA, Delaware Ctr Mfg & Adv Mat, Newark, DE 19716 USA.
RP Kupp, D (reprint author), Fraunhofer USA, Delaware Ctr Mfg & Adv Mat, 501 Wyoming Rd, Newark, DE 19716 USA.
CR ANDERSON O, 1999, P MET FOAM, P183
   Banhart J, 1998, MATER RES SOC SYMP P, V521, P121, DOI 10.1557/PROC-521-121
   BOBYN JD, 1982, CLIN ORTHOP RELAT R, P301
   Bohm A, 1998, Z METALLKD, V89, P90
   DAVIES GJ, 1983, J MATER SCI, V18, P1899, DOI 10.1007/BF00554981
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   GROESSNERSCHREI.B, 1991, SEMIN ARTHROP, V2, P260
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Heimke G., 1990, OSSEOINTEGRATED IMPL, V1
   Pilliar R. M., 1995, TISSUE IMPLANT INTER, P569
   Pilliar RM, 1998, INT J POWDER METALL, V34, P33
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   SIMMONS CA, 1998, POROUS COATED IMPLAN
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   STEPHANI G, 2000, P 2000 INT C POWD ME
   WANG KK, 1989, T SOC BIOM ANN M LAK, P154
   WOLFARTH D, 1994, J BIOMED MATER RES, V28, P417, DOI 10.1002/jbm.820280403
NR 18
TC 5
Z9 5
U1 1
U2 4
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-527-1
PY 2002
BP 61
EP 71
PG 11
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BAW13
UT WOS:000223863600006
DA 2018-10-20
ER

PT J
AU Vekilov, PG
AF Vekilov, PG
TI Self-assembly of apoferritin molecules into crystals: thermodynamics and
   kinetics of molecular level processes
SO PROGRESS IN CRYSTAL GROWTH AND CHARACTERIZATION OF MATERIALS
LA English
DT Review
DE ferritin; self-assembly; molecular resolution; interaction energy;
   solvent entropy; interfacial supersaturation; solution non-ideality
ID ATOMIC-FORCE MICROSCOPY; TETRAGONAL LYSOZYME CRYSTALS; SITE-DIRECTED
   MUTAGENESIS; FACET MORPHOLOGY RESPONSE; YELLOW MOSAIC-VIRUS; PROTEIN
   CRYSTALLIZATION; ELECTRON-MICROSCOPY; SURFACE-MORPHOLOGY;
   GROWTH-MECHANISM; STEP DYNAMICS
AB Aside from the biological, biomedical and materials importance of ferritin and apoferritin, the self-assembly of these molecules into crystals is of interest because it is a suitable model for protein crystallization and aggregation that impact many fundamental and applied fields. We use the atomic force microscope in-situ, during the crystallization of apoferritin to visualize and quantify at the molecular level the processes responsible for crystal growth. We image the configuration of the incorporation sites, "kinks", on the surface of a growing crystal. We show that the kinks are due to thermal fluctuations of the molecules at the crystal-solution interface. This allows evaluation of the free energy of the intermolecular bond phi = 3.0 k(B)T = 7.3 kJ/mol. The crystallization free energy, extracted from the protein solubility, is - 42 kJ/mol. Thermodynamics analyses based on these two values suggest that the main component in the crystallization driving force is the entropy gain of the waters bound to the protein molecules in solution and released upon crystallization. Furthermore, we determine the characteristic frequency of attachment of individual molecules into the kinks at one set of conditions. We show that the macroscopic step growth velocity, scaled by the molecular size, equals the product of independently determined kink density and attachment frequency, i.e., these are the molecular-level parameters for crystallization. Finally, we show that although new crystal layers are generated by intrinsically stochastic surface nucleation, for crystals > 200 mum layer generation predominantly occurs at the crystal edges. Numerical simulations of the concentration fields in the solution allow us to assign this localization to higher interfacial concentration at the edges. As the steps propagate to cover the crystal face, step density waves, or bunches, develop and may lead to non-uniformity and-lower quality and utility of the growing crystal.
C1 Univ Houston, Dept Chem Engn, Houston, TX 77204 USA.
RP Vekilov, PG (reprint author), Univ Houston, Dept Chem Engn, Houston, TX 77204 USA.
CR ALFONSO C, 1992, SURF SCI, V262, P371, DOI 10.1016/0039-6028(92)90133-Q
   Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z
   BACHER A, 1992, J MOL BIOL, V225, P1065, DOI 10.1016/0022-2836(92)90105-S
   BARTELT NC, 1990, SURF SCI, V240, pL591, DOI 10.1016/0039-6028(90)90722-K
   BAUSER E, 1994, HDB CRYSTAL GROWTH B, V3, P879
   BERESFORDSMITH B, 1985, J COLLOID INTERF SCI, V105, P216, DOI 10.1016/0021-9797(85)90362-5
   BERLAND CR, 1992, P NATL ACAD SCI USA, V89, P1214, DOI 10.1073/pnas.89.4.1214
   Brange J., 1987, GALENICS INSULIN
   Burley SK, 1999, NAT GENET, V23, P151, DOI 10.1038/13783
   BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006
   Carter DC, 1999, J CRYST GROWTH, V196, P602, DOI 10.1016/S0022-0248(98)00857-4
   CHAYEN NE, 1994, ACTA CRYSTALLOGR D, V50, P456, DOI 10.1107/S0907444993013320
   Chayen NE, 1996, Q REV BIOPHYS, V29, P227, DOI 10.1017/S0033583500005837
   Chernov A. A., 1995, SCI TECHNOLOGY CRYST, P67
   Chernov A.A., 1980, MODERN CRYSTALLOGRAP
   Chernov AA, 1999, J PHYS-CONDENS MAT, V11, P9969, DOI 10.1088/0953-8984/11/49/314
   CHERNOV AA, 1989, CONTEMP PHYS, V30, P251, DOI 10.1080/00107518908225517
   Crichton RR, 1997, BIOCHEMISTRY-US, V36, P15049, DOI 10.1021/bi9709147
   CUDNEY B, 1994, ACTA CRYSTALLOGR D, V50, P414
   Ducruix A, 1992, CRYSTALLIZATION NUCL
   DURBIN SD, 1992, J CRYST GROWTH, V122, P71, DOI 10.1016/0022-0248(92)90228-B
   Durbin SD, 1996, ANNU REV PHYS CHEM, V47, P171, DOI 10.1146/annurev.physchem.47.1.171
   Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9
   Eaton WA, 1997, CURR OPIN STRUC BIOL, V7, P10, DOI 10.1016/S0959-440X(97)80003-6
   EISENBERG D, 1979, PHYSICAL CHEM APPL L
   GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216
   GIDER S, 1995, SCIENCE, V268, P77, DOI 10.1126/science.7701343
   Giesen M, 1996, SURF SCI, V366, P229, DOI 10.1016/0039-6028(96)00823-0
   GIESENSEIBERT M, 1993, PHYS REV LETT, V71, P3521, DOI 10.1103/PhysRevLett.71.3521
   GIESENSEIBERT M, 1995, SURF SCI, V329, P47, DOI 10.1016/0039-6028(95)00055-0
   GILLILAND GL, 1994, ACTA CRYSTALLOGR D, V50, P408, DOI 10.1107/S0907444994002003
   GILMER GH, 1994, HDB CRYSTAL GROWTH, V1, P583
   Glaser SJ, 1998, SCIENCE, V280, P421, DOI 10.1126/science.280.5362.421
   Guo B, 1999, J CRYST GROWTH, V196, P424, DOI 10.1016/S0022-0248(98)00842-2
   HAGEN MHJ, 1994, J CHEM PHYS, V101, P4093, DOI 10.1063/1.467526
   HANSMA PK, 1994, APPL PHYS LETT, V64, P1738, DOI 10.1063/1.111795
   Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9
   Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970
   HIRSCH RE, 1985, ANAL BIOCHEM, V149, P415, DOI 10.1016/0003-2697(85)90592-5
   HOUSSMANDZADEH B, 1995, J PHYS I, V5, P685
   Ihle T, 1998, PHYS REV B, V58, P2289, DOI 10.1103/PhysRevB.58.2289
   Israelachvili J., 1995, INTERMOLECULAR SURFA
   Jackson K. A., 1958, GROWTH PERFECTION CR, P319
   KAISCHEW R, 1937, Z PHYS CHEM B LPZ, V35, P427
   Kim SH, 1998, NAT STRUCT BIOL, V5, P643, DOI 10.1038/1334
   KITAMURA N, 1993, PHYS REV LETT, V71, P2081
   KUIPERS L, 1993, PHYS REV LETT, V71, P3517, DOI 10.1103/PhysRevLett.71.3517
   KUIPERS L, 1995, PHYS REV B, V52, P11387, DOI 10.1103/PhysRevB.52.11387
   Kuyper LF, 1996, J CRYST GROWTH, V168, P155, DOI 10.1016/0022-0248(96)00349-1
   Kuznetsov YG, 1999, SURF SCI, V440, P69, DOI 10.1016/S0039-6028(99)00679-2
   Kuznetsov YG, 1997, BIOPHYS J, V72, P2357, DOI 10.1016/S0006-3495(97)78880-5
   KUZNETSOV YG, 1995, J STRUCT BIOL, V114, P184, DOI 10.1006/jsbi.1995.1018
   Land TA, 1997, SURF SCI, V384, P136, DOI 10.1016/S0039-6028(97)00187-8
   LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0
   LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325
   Li HY, 1999, ACTA CRYSTALLOGR D, V55, P1023, DOI 10.1107/S090744499900339X
   LI M, 1999, ACTA CRYSTALLOGR D, V55, P1036
   Li MR, 1999, ACTA CRYSTALLOGR D, V55, P1012, DOI 10.1107/S0907444999002905
   LIN H, 1995, J CRYST GROWTH, V151, P153, DOI 10.1016/0022-0248(95)00016-X
   Lin H, 1996, J CRYST GROWTH, V158, P552, DOI 10.1016/0022-0248(95)00426-2
   Lin H, 2001, CRYST GROWTH DES, V1, P73, DOI 10.1021/cg005515g
   LIN H, 2003, PHYS REV E, V67
   Long MM, 1996, J CRYST GROWTH, V168, P233, DOI 10.1016/0022-0248(96)00325-9
   Malkin AJ, 1999, J STRUCT BIOL, V127, P35, DOI 10.1006/jsbi.1999.4128
   Malkin AJ, 1996, J PHYS CHEM-US, V100, P11736, DOI 10.1021/jp960745k
   MALKIN AJ, 1995, NAT STRUCT BIOL, V75, P2778
   Marchenko V.I., 1980, SOV PHYS JETP, V52, P129
   MASSOVER WH, 1993, MICRON, V24, P389, DOI 10.1016/0968-4328(93)90005-L
   MATSUDA S, 1989, J BIOL CHEM, V264, P13381
   MCPHERSON A, 1995, STRUCTURE, V3, P759, DOI 10.1016/S0969-2126(01)00211-8
   MCPHERSON A, 1999, CRYSTALLIZATION BIOL
   MEINING W, 1995, J MOL BIOL, V253, P208, DOI 10.1006/jmbi.1995.0545
   MILCHEV A, 1991, CONTEMP PHYS, V32, P321, DOI 10.1080/00107519108223705
   Nadarajah A, 1997, ACTA CRYSTALLOGR D, V53, P524, DOI 10.1107/S0907444997003041
   Nadarajah A, 1996, ACTA CRYSTALLOGR D, V52, P983, DOI 10.1107/S0907444996004532
   Nakada T, 1999, J CRYST GROWTH, V196, P503, DOI 10.1016/S0022-0248(98)00875-6
   Noy A, 1998, LANGMUIR, V14, P1508, DOI 10.1021/la970948f
   Pereira AS, 1997, BIOCHEMISTRY-US, V36, P7917, DOI 10.1021/bi970348f
   Peseta S., 1989, ANNU REV BIOCHEM, P727
   Petsev DN, 2000, BIOPHYS J, V78, P2060, DOI 10.1016/S0006-3495(00)76753-1
   Petsev DN, 2001, J CRYST GROWTH, V232, P21, DOI 10.1016/S0022-0248(01)01095-8
   POENSGEN M, 1992, SURF SCI, V274, P430, DOI 10.1016/0039-6028(92)90848-Z
   Prater BD, 1999, J CRYST GROWTH, V196, P674, DOI 10.1016/S0022-0248(98)00862-8
   PUHLER G, 1992, EMBO J, V11, P1607, DOI 10.1002/j.1460-2075.1992.tb05206.x
   RASHKOVICH LN, 1998, CRYSTALLOG REPORTS, V43, P669
   REICHERT P, 1995, Patent No. 5441734
   Rosenbaum D, 1996, PHYS REV LETT, V76, P150, DOI 10.1103/PhysRevLett.76.150
   ROSENBERGER F, 1996, J CRYST GROWTH, V167, P1
   Sear RP, 1999, J CHEM PHYS, V111, P4800, DOI 10.1063/1.479243
   SEEGER A, 1953, PHILOS MAG, V44, P348
   Service RF, 1999, SCIENCE, V285, P1342, DOI 10.1126/science.285.5432.1342
   Stewart PDS, 1999, J CRYST GROWTH, V196, P665, DOI 10.1016/S0022-0248(98)00854-9
   Stranski IN, 1928, Z PHYS CHEM-STOCH VE, V136, P259
   Stranski IN, 1934, Z PHYS CHEM B-CHEM E, V26, P100
   STRANSKI IN, 1934, Z PHYS CHEM B LPZ, V26, P114
   Swartzentruber BS, 1998, J CRYST GROWTH, V188, P1, DOI 10.1016/S0022-0248(98)00039-6
   SWARTZENTRUBER BS, 1990, PHYS REV LETT, V65, P1913, DOI 10.1103/PhysRevLett.65.1913
   TAFT KL, 1993, SCIENCE, V259, P1302, DOI 10.1126/science.8446898
   Takeda S, 1995, PROTEINS, V23, P548, DOI 10.1002/prot.340230409
   Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724
   tenWolde PR, 1997, SCIENCE, V277, P1975
   THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289
   THOMAS BR, 1997, J CRYST GROWTH, V187, P499
   TREFFRY A, 1995, BIOCHEMISTRY-US, V34, P15204, DOI 10.1021/bi00046a028
   Van der Eerden J. P., 1993, HANDB CRYST GROWTH, V1, P307
   VANDERHOEK B, 1982, J CRYST GROWTH, V58, P365, DOI 10.1016/0022-0248(82)90284-6
   VEKILOV PG, 1995, J CRYST GROWTH, V156, P267, DOI 10.1016/0022-0248(95)00240-5
   Vekilov PG, 1998, PHYS REV E, V57, P6979, DOI 10.1103/PhysRevE.57.6979
   Vekilov PG, 1996, J CRYST GROWTH, V158, P540, DOI 10.1016/0022-0248(95)00398-3
   Vekilov PG, 1996, PHYS REV E, V54, P6650, DOI 10.1103/PhysRevE.54.6650
   Vekilov PG, 1998, J PHYS CHEM B, V102, P5208, DOI 10.1021/jp973123n
   Vekilov PG, 2000, CHEM REV, V100, P2061, DOI 10.1021/cr9800558
   VEKILOV PG, 1993, STUDIES CONCEPTS CRY, P25
   Voigtlander B, 1998, PHYS REV LETT, V81, P858, DOI 10.1103/PhysRevLett.81.858
   VOLMER M, 1939, KINETIK PHASENBILDUN
   Warren WS, 1998, SCIENCE, V280, P398, DOI 10.1126/science.280.5362.398
   WEBER P, 1991, ADV PROTEIN CHEM, V41
   Weber PC, 1997, METHOD ENZYMOL, V276, P13, DOI 10.1016/S0076-6879(97)76048-8
   WEINKAUF S, 1991, J MOL BIOL, V221, P637, DOI 10.1016/0022-2836(91)80078-9
   WILLIAMS ED, 1991, SCIENCE, V251, P393, DOI 10.1126/science.251.4992.393
   WOLF D, 1992, SURF SCI, V277, P301, DOI 10.1016/0039-6028(92)90770-7
   Wutrich K., 1995, ACTA CRYSTALLOGR D, V51, P249
   YANG DW, 1995, BIOCHEM J, V307, P253, DOI 10.1042/bj3070253
   Yau ST, 2000, PHYS REV LETT, V85, P353, DOI 10.1103/PhysRevLett.85.353
   Yip CM, 1998, BIOPHYS J, V75, P1172, DOI 10.1016/S0006-3495(98)74036-6
   Yip CM, 1996, BIOPHYS J, V71, P1071, DOI 10.1016/S0006-3495(96)79307-4
NR 126
TC 11
Z9 11
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8974
J9 PROG CRYST GROWTH CH
JI Prog. Cryst. Growth Charact. Mater.
PY 2002
VL 45
IS 3
BP 175
EP 193
DI 10.1016/S0960-8974(03)00002-0
PG 19
WC Crystallography; Materials Science, Characterization & Testing
SC Crystallography; Materials Science
GA 689LW
UT WOS:000183495500001
DA 2018-10-20
ER

PT S
AU Janis, AD
   Lagerquist, KA
   Hinds, MT
AF Janis, AD
   Lagerquist, KA
   Hinds, MT
GP IEEE
   IEEE
   IEEE
TI Directional permeability in a porcine carotid elastin biomaterial
   vascular conduit - 2(nd) Joint Conference of the IEEE Engineering in
   Medicine and Biology Society and the Biomedical Engineering Society
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE elastin; vascular; permeability
AB Purified porcine carotid elastin is under development as a substrate for a vascular conduit. The permeability of the graft may have implications in recellularlization. Light and scanning electron microscopy indicate that the lumen and adventitial surfaces have unique extracellular matrix morphology. This study investigates the permeability of the material, with consideration of the direction of the flow. The permeability of the adventitial surface was found to be approximately twice that of the lumenal surface. The mean permeability was 0.0123 +/- 0.005 mL/min*cm(2) for flow through from lumen surface to the adventitial surface and 0.0310 +/- 0.007 mL/min*cm(2) for flow through the adventitial surface to the lumen surface. The difference in elastin architecture can be taken advantage of to optimize recellularization in vitro and in vivo This is only the second biomaterial to have this described behavior.
C1 Providence St Vincent Hosp, Oregon Med Laser Ctr, Portland, OR USA.
RP Janis, AD (reprint author), Providence St Vincent Hosp, Oregon Med Laser Ctr, Portland, OR USA.
CR FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   WESOLOWSKI SA, 1962, EVALUATION TISSUE PR
NR 2
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 413
EP 414
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800197
DA 2018-10-20
ER

PT S
AU Chiu, J
   Kim, K
   Zhong, S
   Hsiao, B
   Chu, B
   Hadjiargyrou, M
AF Chiu, J
   Kim, K
   Zhong, S
   Hsiao, B
   Chu, B
   Hadjiargyrou, M
GP IEEE
   IEEE
   IEEE
TI Development of a cell-delivery vehicle derived from electrospun
   non-woven nanostructured membranes
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE tissue engineering; electrospinning; nanostructures; cell-delivery
   vehicle; biodegradable scaffold
AB The construction and utilization of biodegradable and biocompatible scaffolds have long been practiced in tissue engineering. More recently, electrospinning has become increasingly popular as a means of manufacturing nanostructured scaffolds containing non-woven nanofibers for various biomedical applications. In this study, we expound on the prior art to potentially create a cell-delivery vehicle whose material and mechanical properties can be explicitly controlled by discriminating polymer compositions and concentrations. The introduction of a block copolymer (PLA 0.8 kD/PEG 3.4 kD/PLA 0.8 kD) as a bridging material to the hydrophobic PLA- and PLGA-based matrix has successfully inhibited in vitro conformational changes (i.e. shrinkage) while also improving cell affinity. The presence of this block copolymer in various concentrations has demonstrated characteristic degradation profiles in physiological medium - thus enabling us to specifically control breakdown rates. Furthermore, we successfully demonstrate that cells can migrate through a thin (10 gm) fibrous barrier and still remain viable for surface adhesion and proliferation. Taken together, these results indicate that a cell delivery vehicle composed of biodegradable polymers is indeed a viable option for tissue engineering.
C1 SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
RP Chiu, J (reprint author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
OI Hadjiargyrou, Michael/0000-0001-8927-2333
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Kim KS, 1999, J APPL POLYM SCI, V72, P341, DOI 10.1002/(SICI)1097-4628(19990418)72:3<341::AID-APP4>3.0.CO;2-D
   Saad B, 2000, J BIOMAT SCI-POLYM E, V11, P787, DOI 10.1163/156856200744011
NR 3
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 759
EP 760
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800364
DA 2018-10-20
ER

PT S
AU Deng, LH
   Karagiannoglou, SH
   Sakkas, WI
   Barbenel, JC
AF Deng, LH
   Karagiannoglou, SH
   Sakkas, WI
   Barbenel, JC
GP IEEE
   IEEE
   IEEE
TI Effects of geometrical factors of coplanar electrodes on biomedical
   measurements as exemplified by the electrical impedance measurement of
   saline and blood
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE coplanar electrode; geometrical configuration; biosensor; bioimpedance;
   saline; blood; hematocrit
AB In many biomedical measurements, particularly in biosensor applications, coplanar electrodes have to be used because the conventional parallel-plate configuration is either impossible or not preferred. Despite the wide use, the characteristics. of the coplanar electrodes have not been well studied, in particular the effects of the geometrical factors of the electrode on the measurement. In this report, we present our results of the effects of coplanar electrode's geometrical factors on the measurement of bioelectrical impedance, one of the most widely measured physical properties in biomedical applications. Coplanar electrodes of different shapes and sizes were used to measure the electrical impedance of saline at different concentration and blood reconstituted at different hematocrit in either plasma or serum. The results show that the impedance measurement by coplanar electrodes are sensitive-to the geometry-of the electrode as well as the sample boundary in addition to the universal determinants such as the ionic or cellular concentration of the material under test. This implies that all the geometrical parameters of a coplanar electrode ought to be taken into account collectively of-its design when it, is used in biomedical instrumentation. Thus the reliability of the instrument as well as the measurement may be assured.
C1 Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.
RP Deng, LH (reprint author), Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.
RI Deng, Linhong/C-1485-2009
OI Deng, Linhong/0000-0003-1970-8239
CR *ICSH, 1986, CLIN HEMORHEOL, V10, P436
   JACOBSON I, 1995, J OBJECT ORIENTED PR, V3, P10
   OKADA RH, 1960, IRE T MED ELECTRON, V7, P188, DOI 10.1109/IRET-ME.1960.5008044
NR 3
TC 3
Z9 3
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 1667
EP 1668
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800821
DA 2018-10-20
ER

PT S
AU Xu, JZ
   Ying, H
   Auner, G
AF Xu, JZ
   Ying, H
   Auner, G
GP IEEE
   IEEE
   IEEE
TI Development of aluminum nitride-based acoustic wave sensors #
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE acoustic wave sensor; biosensors; chemical sensors; surface acoustic
   wave; surface transverse wave; Aluminum Nitride thin films;
   immobilization
AB One of the most important applications of acoustic wave sensor systems is to detect chemical or biological agents because of their great potential for real-time and highly sensitive detection at low cost. We report preliminary experimental results on developing novel acoustic wave sensors for biomedical applications using Aluminum Nitride (AlN) thin films. Compared to conventional piezoelectric materials such as quartz, AlN is advantageous in terms of higher acoustic velocity, higher electromechanical coupling coefficient, and higher stability in harsh environment, translating to better sensor performance. We have designed, prototyped, and tested an AlN-based sensor. The center frequency is measured 174 MHz for its surface acoustic wave mode and 206 MHz for its surface transverse wave mode. The phase velocities are 5569 m/s and 6608 m/s, respectively. As expected, the frequency response of the surface transverse wave mode changed little when under water load. Immobilization was investigated using chemical compounds or magnetic microbeads. The result showed good affinity to AlN film. Finally, we found almost linear relationship between the resonant frequency of the sensor and temperature, with the temperature coefficient being about 90 PPMdegreesC.
C1 Wayne State Univ, Dept Elect & Comp Engn, Detroit, MI 48202 USA.
RP Auner, G (reprint author), Wayne State Univ, Dept Elect & Comp Engn, Detroit, MI 48202 USA.
CR Ballantine D., 1997, ACOUSTIC WAVE SENSOR
   CALIENDO C, 1992, P IEEE ULTR S, P219
   WHITE RM, 1970, PR INST ELECTR ELECT, V58, P1238, DOI 10.1109/PROC.1970.7900
   ZHAO Q, 2000, MARS INT J NITRID S1, V5
   ZHONG F, 2001, THESIS WAYNE STATE U
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 1716
EP 1717
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194800845
DA 2018-10-20
ER

PT S
AU Cogan, SF
AF Cogan, SF
GP IEEE
   IEEE
   IEEE
TI Stability of electro-active materials and coatings for charge-injection
   electrodes - 2(nd) Joint Conference of the IEEE Engineering in Medicine
   and Biology Society and the Biomedical Engineering Society
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE charge-injection; electrodes; coatings; iridium oxide; titanium nitride;
   noble metals; stability; electrochemistry
ID IRIDIUM OXIDE ELECTRODES; PACING LEAD; MICROSTIMULATION; STIMULATION;
   CAT; MICROELECTRODES; DISSOLUTION; SALINE; CORTEX
AB The stability of materials and coatings for charge injection in electrical stimulation with chronically implanted electrodes is reviewed. The focus of the review is iridium oxide, whose performance and charge-injection mechanisms are contrasted with other high-charge capacity materials such as high-surface-area titanium nitride and noble metal coatings, as well as traditional noble metals. The appropriateness of iridium oxide and these materials for applications in functional electrical stimulation is discussed with an emphasis on the stability of their electrochemical function in chronic implants. Gaps in our knowledge of the in vivo electrochemistry and chronic stability of iridium oxide are identified. The structure and electrochemical properties of iridium oxide that permit high charge injection capacities are described and thoughts on how these generally desirable features may also compromise the chronic in vivo stability of iridium oxide electrodes are presented.
C1 EIC Labs, Norwood, MA 02062 USA.
RP Cogan, SF (reprint author), EIC Labs, Norwood, MA 02062 USA.
CR BEEBE X, 1988, IEEE T BIO-MED ENG, V35, P494, DOI 10.1109/10.2122
   BOLZ A, 1993, MED PROG TECHNOL, V19, P129
   Breivik K, 1997, PACE, V20, P637, DOI 10.1111/j.1540-8159.1997.tb03882.x
   MCCREERY DB, 1994, HEARING RES, V77, P105, DOI 10.1016/0378-5955(94)90258-5
   McCreery DB, 1997, IEEE T BIO-MED ENG, V44, P931, DOI 10.1109/10.634645
   ROBBLEE LS, 1983, J NEUROSCI METH, V9, P301, DOI 10.1016/0165-0270(83)90062-6
   ROBBLEE LS, 1980, BIOMATERIALS, V1, P135, DOI 10.1016/0142-9612(80)90035-6
   ROBBLEE LS, 1983, J ELECTROCHEM SOC, V130, P731, DOI 10.1149/1.2119793
   ROBBLEE LS, 1990, NEURAL PROSTHESES FU, P25
   SCHALDACH M, 1995, MED PROG TECHNOL, V21, P1
   Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507
   Weiland JD, 2000, IEEE T BIO-MED ENG, V47, P911, DOI 10.1109/10.846685
   Woodford BJ, 1996, J NEUROPATH EXP NEUR, V55, P982, DOI 10.1097/00005072-199609000-00005
NR 13
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 2062
EP 2063
DI 10.1109/IEMBS.2002.1053168
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194801011
DA 2018-10-20
ER

PT S
AU Torosyan, G
   Nerkararyan, K
   Beigang, R
AF Torosyan, G
   Nerkararyan, K
   Beigang, R
GP IEEE
   IEEE
   IEEE
TI Application of narrowband tunable THz-radiation for biomedical sensing -
   2(nd) Joint Conference of the IEEE Engineering in Medicine and Biology
   Society and the Biomedical Engineering Society
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE THz radiation; biomedical sensor; waveguide
ID POLED LITHIUM-NIOBATE; TERAHERTZ RADIATION; GENERATION
AB The use of narrowband tunable THz radiation for biomedical sensing applications is discussed. The THz radiation is generated via optical rectification in periodically poled nonlinear materials in a frequency range from 100 GHz to 3 THz. Center frequency and bandwidth can easily be adjusted to the requirements of the application. Different THz sensors utilizing evanescent THz fields - are presented including waveguides and photonic bandgap structures.
C1 Univ Kaiserslautern, Fachbereich Phys, Kaiserslautern, Germany.
RP Torosyan, G (reprint author), Univ Kaiserslautern, Fachbereich Phys, Kaiserslautern, Germany.
CR Lee YS, 2000, APPL PHYS LETT, V76, P2505, DOI 10.1063/1.126390
   Nagel M, 2002, APPL PHYS LETT, V80, P154, DOI 10.1063/1.1428619
   QI ZM, 2002, OPT LETT, V27, P686
   Vollmer F, 2002, APPL PHYS LETT, V80, P4057, DOI 10.1063/1.1482797
   Weiss C, 2001, OPT LETT, V26, P563, DOI 10.1364/OL.26.000563
   WEISS C, 2001, OPT EXPRESS, V9, P497
NR 6
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 2335
EP 2336
DI 10.1109/IEMBS.2002.1053309
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194801144
DA 2018-10-20
ER

PT S
AU Schwartz, LB
AF Schwartz, LB
GP IEEE
   IEEE
   IEEE
TI The dilemma of bioengineering research on human subjects
SO SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE
   PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW
   TECHNOLOGIES
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 24th Annual International Conference of the
   Engineering-in-Medicine-and-Biology-Society/Annual Fall Meeting of the
   Biomedical-Engineering-Society (EMBS 2002 BMES)
CY OCT 23-26, 2002
CL HOUSTON, TX
SP Engn Med & Biol Soc, Biomed Engn Soc, Natl Sci Fdn, Natl Inst Hlth, Natl Inst Biomed Imaging & Bioengn, Whitaker Fdn
DE human subject research
AB The increased scrutiny of human subject research is underscored by the recent suspension of authority of several prestigious medical centers by the federal Office of Human Research Protection (OHRP). Fueled in part by the well-publicized death of a young patient enrolled in a gene therapy trial in 1999, the OHRP's "reign of terror" has had far-reaching implications for all scientists, patients, and administrators engaged in human subject research.
   The first fundamental ethical standards for the conduct of research involving humans was the Nuremberg Code. Recognizing a need for a broader scope, The National Commission for the protection of Human Subjects of Biomedical and Behavioral Research was created in 1974 and charged to identify and expand the basic ethical principles that should underlie all human subject research. Its deliberations are summarized in The Belmont Report which establishes three fundamental ethical principles: respect for persons, beneficence, and justice. Title 45 Code of Federal Regulations, Part 46, Protection of Human Subjects (45 CFR Part 46) embraces the findings of The Belmont Report, and provides regulations for human research conducted or supported by the Intramural Research Program (IRP) of the National Institutes of Health (NIH).
   As defined by the NIH, a "human subject" is a living individual about whom an investigator obtains either (1) data through interaction or intervention with the individual or, (2) identifiable private information. "Research" is an systematic investigation designed to develop or contribute to generalizable knowledge. These definitions naturally require considerable interpretation on a case-by-case basis. For instance, specifically excluded are (1) samples from decreased individuals, (2) samples collected for diagnostic purposes only, (3) samples or data that are available from commercial or public repositories or registries, (4) established cell lines, and (5) cell-free genetic material such as viral isolates, closed DNA, or RNA. Obviously included are prospective studies testing the efficacy of a particular drug or intervention, and studies of new devices. Less obvious inclusions are (1) case reports, (2) retrospective case series, (3) studies that tabulate the results of laboratory tests from living subjects, (4) studies including any pathologic specimen from a living subject, (5) studies which include any x-ray or imaging study from any living individual, and (6) studies which include any hemodynamic or technical data from which an individual could be retrospectively identified. In short, all experiments and experimental protocols should be submitted for review by an institution's Internal Review Board, and the determination of exemption made by the board. This includes studies initiated at the home institution, as well as any collaborative activities, which are also rather broadly defined by the regulations.
   In summary, there are fundamental differences in the way that standards are generated for clinical medicine, bioengineering research, and human subject research. The standards for both clinical medicine and research have generally been set by the practitioners and scientists through peer review. This is. not the case. with human subject research, and any practitioner or scientist that merely follows his or her internal ethical standards does so at the institution's peril. The standards for human subject research are rightfully set by agencies of the international community and federal government and strict adherence is mandated by law. Whether or not the rigid ethical standards can ever reasonably be relaxed depends on the commitment of the scientific community to the consistent performance of human subject research with vigilant respect for persons, beneficence, and justice.
C1 Univ Chicago, Vasc Surg Sect, Chicago, IL 60637 USA.
RP Schwartz, LB (reprint author), Univ Chicago, Vasc Surg Sect, Chicago, IL 60637 USA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7612-9
J9 P ANN INT IEEE EMBS
PY 2002
BP 2668
EP 2669
DI 10.1109/IEMBS.2002.1053483
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Instruments & Instrumentation; Radiology, Nuclear Medicine & Medical
   Imaging
SC Computer Science; Engineering; Instruments & Instrumentation; Radiology,
   Nuclear Medicine & Medical Imaging
GA BV84T
UT WOS:000180194801307
DA 2018-10-20
ER

PT S
AU Lee, SK
   Lee, SJ
   An, HJ
   Cha, SE
   Chang, JK
   Kim, B
   Pak, JJ
AF Lee, SK
   Lee, SJ
   An, HJ
   Cha, SE
   Chang, JK
   Kim, B
   Pak, JJ
BE BarCohen, Y
TI Biomedical applications of electroactive polymers and shape memory
   alloys
SO SMART STRUCTURES AND MATERIALS 2002: ELECTROACTIVE POLYMER ACTUATORS AND
   DEVICES (EAPAD)
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2002 Conference
CY MAR 18-21, 2002
CL SAN DIEGO, CA
SP SPIE, Amer Soc Mech Engineers, Soc Exptl Mech, Boeing Co, Rhombus Consultants Grp, CSA Engn, ISIS Canada, USAF Off Sci Res, Def Adv Res Projects Agcy, Intelligent Mat Forum, USA Res OFf, Jet Propuls Lab, Natl Sci Fdn, Ceram Soc Japan, USN Off Naval Res, Nav Res Lab
DE polypyrrole; shape memory alloy; functional materials; actuator; drug
   delivery system
AB Among many kinds of polymer materials, electronic conductive material, that is polypyrrole, shows potential possibility for bio-related actuator materials. However, it may be an impediment for practical use of polypyrrole actuator that polypyrrole usually requires electrolyte solution for actuation. Our first research theme is focused on this problem solving. We have investigated many kinds of solid polymer electrolytes for the substitution of electrolyte solution. Our goals are to find the stable solid electrolyte in the air, to establish the reliable fabrication process of it and to apply it for micropump application. Besides actuators, the reduction and oxidation property of polypyrrole can be exploited for active drug delivery systems by the control of structural deformation of it. We have investigated this kind of new and bio-related possibility of polypyrrole. Shape memory alloy has another possibility in biomedical field. Due to its inherent excellent advantages as actuator materials, it can be used for micro active intravascular catheter. We have developed thin tube type bending actuator using shape memory alloy and characterized its performance by in-vivo test.
C1 Dankook Univ, Dept Elect Engn, Seoul 140714, South Korea.
RP Lee, SK (reprint author), Dankook Univ, Dept Elect Engn, Seoul 140714, South Korea.
CR BARCOHEN Y, 2000, KEYN PRES ROB 2000 S
   Barisci JN, 1997, PROC SPIE, V3241, P10, DOI 10.1117/12.293529
   Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5
   FUNAKUBO H, 1984, SHAPE MEMORY ALLOYS
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   GANDHI MR, 1995, SYNTHETIC MET, V73, P247, DOI 10.1016/0379-6779(95)80022-0
   Gardner JW, 1995, SENSOR ACTUAT A-PHYS, V51, P57, DOI 10.1016/0924-4247(96)80053-7
   Guo S., 1995, P INT S MICR MACH HU, P131
   KIM MS, 1997, T KIEE, V46, P445
   LEE SK, 2000, P SPIES 7 INT S SMAR, P291
   LIM AS, 1999, P 10 INT C SOL STAT, V2, P1894
   LIM G, 1995, P IEEE MEMS WORKSH, P116
   PEI QB, 1992, ADV MATER, V4, P277, DOI 10.1002/adma.19920040406
   Smela E., 1993, Journal of Micromechanics and Microengineering, V3, P203, DOI 10.1088/0960-1317/3/4/008
NR 14
TC 5
Z9 5
U1 0
U2 9
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4443-X
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4695
BP 17
EP 31
DI 10.1117/12.475196
PG 15
WC Engineering, Electrical & Electronic; Materials Science, Composites;
   Robotics; Optics; Polymer Science
SC Engineering; Materials Science; Robotics; Optics; Polymer Science
GA BV10E
UT WOS:000177817700003
DA 2018-10-20
ER

PT S
AU Gulch, RW
   Weible, A
   Wallmersperger, T
AF Gulch, RW
   Weible, A
   Wallmersperger, T
BE BarCohen, Y
TI Characterization of electroactive behavior and of progress in
   developments and applications of ionic polymer gels
SO SMART STRUCTURES AND MATERIALS 2002: ELECTROACTIVE POLYMER ACTUATORS AND
   DEVICES (EAPAD)
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2002 Conference
CY MAR 18-21, 2002
CL SAN DIEGO, CA
SP SPIE, Amer Soc Mech Engineers, Soc Exptl Mech, Boeing Co, Rhombus Consultants Grp, CSA Engn, ISIS Canada, USAF Off Sci Res, Def Adv Res Projects Agcy, Intelligent Mat Forum, USA Res OFf, Jet Propuls Lab, Natl Sci Fdn, Ceram Soc Japan, USN Off Naval Res, Nav Res Lab
DE polyacrylamide gel; polyacrylonitrile fibre; chitosan; biopolymer;
   anionic polyelectrolyte; cationic polyelectolyte; Donnan potential;
   chemical stimulation; electrical stimulation; electrolysis
ID ELECTRIC-FIELDS; POLYELECTROLYTE GELS; SWELLING BEHAVIOR; CHITOSAN;
   HYDROGELS; DEFORMATION
AB Polyelectrolyte gels are distinguished by enormous swelling capabilities under the influence of external physical or chemical stimuli. No other kind of material attains similar volume expansiveness., These properties make them most attractive candidates for a new generation of much greater thanpseudomuscularmuch less than actuators. In contrast to chemical stimulations which are able to trigger large in-toto deformations, weak electric fields can only induce considerable bending strains in ionic polymer gels when confined to direct electrical effects. This, of course, restricts their potential for technical applications. To characterize their chemo-mechanical and. electrical behavior and the underlying physico-chemical processes, experimental and theoretical findings are presented. Measurements of basic mechanical and electrical parameters on polyelectrolyte gels allow quantification of their electroactive responses, especially with respect to the direct effects of external electric fields on the Donnan potential inside the gels. Model calculations on the basis of a coupled chemo-electro-mechanical multi-field formulation are in good agreement with the experimental results. Although the emphasis of this study is given to various anionic and cationic gels of the polyacrylamide family, a new class of hydrogels based on the biopolymer chitosan is included. These natural polymers have excellent properties such as biocompatibility, biodegradability, non-toxicity etc. making them predestinate to biomedical. applications.
C1 Univ Tubingen, Inst Physiol 2, D-72076 Tubingen, Germany.
RP Weible, A (reprint author), Univ Tubingen, Inst Physiol 2, Gmelinstr 5, D-72076 Tubingen, Germany.
RI Wallmersperger, Thomas/S-4822-2016
OI Wallmersperger, Thomas/0000-0002-4720-5260
CR BARCOHEN Y, 2001, ELECTROACTIVE POLYM, V98, P3
   BUCHHOLZ FL, 1992, PLASTICS PROPERTIES, V21, P143
   Calvert P., 2001, ELECTROACTIVE POLYM, VPM98, P123
   DOI M, 1992, MACROMOLECULES, V25, P5504, DOI 10.1021/ma00046a058
   GREGOR HP, 1955, J PHYS CHEM-US, V59, P34, DOI 10.1021/j150523a011
   Gulch RW, 2001, P SOC PHOTO-OPT INS, V4329, P328, DOI 10.1117/12.432664
   Gulch RW, 2000, P SOC PHOTO-OPT INS, V3987, P193, DOI 10.1117/12.387778
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Nisato G, 1999, LANGMUIR, V15, P4236, DOI 10.1021/la981027n
   Qu X, 2000, POLYMER, V41, P4589, DOI 10.1016/S0032-3861(99)00685-0
   Ramanathan S, 2001, J CONTROL RELEASE, V70, P109, DOI 10.1016/S0168-3659(00)00333-3
   Ravi Kumar M. N. V., 1999, B MATER SCI, V22, P905
   Shahinpoor M., 1994, Smart Materials and Structures, V3, P367, DOI 10.1088/0964-1726/3/3/012
   Shahinpoor M, 2000, P SOC PHOTO-OPT INS, V3987, P243, DOI 10.1117/12.387783
   SHIGA T, 1990, J APPL POLYM SCI, V39, P2305, DOI 10.1002/app.1990.070391110
   Smirnova LA, 2001, POLYM SCI SER B+, V43, P33
   Suzuki H, 1999, LANGMUIR, V15, P4283, DOI 10.1021/la981187z
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   UMEMOTO S, 1991, POLYMER GELS, P257
   Wallmersperger T, 2001, P SOC PHOTO-OPT INS, V4329, P264, DOI 10.1117/12.432655
   WALLMERSPERGER T, 2001, ELECTROACTIVE POLYM, V98, P285
   WEI YC, 1992, J POLYM SCI POL CHEM, V30, P2187, DOI 10.1002/pola.1992.080301013
   Yao KD, 1998, POLYM INT, V45, P191, DOI 10.1002/(SICI)1097-0126(199802)45:2<191::AID-PI892>3.0.CO;2-K
   YAO KD, 1993, J APPL POLYM SCI, V48, P343
NR 25
TC 4
Z9 4
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4443-X
J9 P SOC PHOTO-OPT INS
PY 2002
VL 4695
BP 367
EP 377
DI 10.1117/12.475184
PG 11
WC Engineering, Electrical & Electronic; Materials Science, Composites;
   Robotics; Optics; Polymer Science
SC Engineering; Materials Science; Robotics; Optics; Polymer Science
GA BV10E
UT WOS:000177817700040
DA 2018-10-20
ER

PT S
AU Mandelis, A
AF Mandelis, A
BE Maldague, XP
   Rozlosnik, AE
TI Review of progress in theoretical, experimental, and computational
   investigations in turbid tissue phantoms and human teeth using laser
   infrared photothermal radiometry
SO THERMOSENSE XXIV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Thermosense XXIV Conference
CY APR 01-04, 2002
CL ORLANDO, FL
SP SPIE
DE frequency-domain; laser infrared photothermal radiometry; turbid media;
   diffuse-photon-density wave; thermal wave; dental enamel; tissue
   phantoms
ID LIGHT-SCATTERING; DENTAL ENAMEL; MEDIA; REFLECTION
AB This paper reviews and describes the state-of-the-art in the development of frequency-domain infrared photothermal radiometry (FD-PTR) for biomedical and dental applications. The emphasis is placed on the measurement of the optical and thermal properties of tissue-like materials using FD-PTR. A rigorous three-dimensional thermal-wave formulation with three-dimensional diffuse and coherent photon-density-wave sources is presented, and is applied to data from model tissue phantoms and dental enamel samples. The combined theoretical, experimental and computational methodology shows good promise with regard to its analytical ability to measure optical proper-ties of turbid media uniquely, as compared to PPTR, which exhibits uniqueness problems. From data sets obtained with calibrated test phantoms, the reduced optical scattering and absorption coefficients were found to be within 20% and 10%, respectively, from the independently derived values using Mie scattering theory and spectrophotometric measurements.
   Furthermore, the state-of-the-art and recent developments in applications of laser infrared FD-PTR to dental caries research is described, with examples and histological studies from carious dental tissue. The correlation of PTR signals with modulated dental luminescence is discussed as a very promising potential quantitative methodology for the clinical diagnosis of sub-surface incipient dental caries. The application of the turbid-medium thermal-wave model to the measurement of the optical absorption and scattering coefficients of enamel is also presented.
C1 Univ Toronto, Photothermal & Optoelect Diagnost Labs, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
RP Mandelis, A (reprint author), Univ Toronto, Photothermal & Optoelect Diagnost Labs, Dept Mech & Ind Engn, 5 Kings Coll Rd, Toronto, ON M5S 3G8, Canada.
CR ANDERSON RR, 1989, APPL OPTICS, V28, P2256, DOI 10.1364/AO.28.002256
   Bohren C., 1983, ABSORPTION SCATTERIN
   BRADEN M, 1964, ARCH ORAL BIOL, V9, P479, DOI 10.1016/0003-9969(64)90033-0
   BUSSE G, 1992, PROGR PHOTOTHERMAL P, V1, P205
   FRIED D, 1995, APPL OPTICS, V34, P1278, DOI 10.1364/AO.34.001278
   Fried D, 1996, OPT ENG, V35, P1976, DOI 10.1117/1.600774
   Fried D, 1996, J Biomed Opt, V1, P455, DOI 10.1117/12.250668
   GROENHUIS RAJ, 1983, APPL OPTICS, V22, P2456, DOI 10.1364/AO.22.002456
   Imhof R.E, 1994, PROGR PHOTOTHERMAL P, V2, P185
   ISHIMARU A, 1983, J OPT SOC AM, V73, P131, DOI 10.1364/JOSA.73.000131
   LEUNG WP, 1984, J APPL PHYS, V56, P153, DOI 10.1063/1.333739
   LONG FH, 1987, APPL PHYS LETT, V51, P2076, DOI 10.1063/1.98985
   MANDELIS A, 2001, DIFFUSION WAVE FIELD, pCH10
   MANDELIS A, IN PRESS PHYS REV E
   MUNIDASA M, 1992, MAT SCI ENG A-STRUCT, V159, P111, DOI 10.1016/0921-5093(92)90404-O
   Nicolaides L, 2000, J BIOMED OPT, V5, P31, DOI 10.1117/1.429965
   OSIZIK MN, 1968, BOUNARY VALUE PROBLE
   PRAHL SA, 1992, PHYS MED BIOL, V37, P1203, DOI 10.1088/0031-9155/37/6/001
   PRESS WH, 1987, NUMERICAL RECIPES C, V1, P149
   SPITZER D, 1975, Calcified Tissue Research, V17, P129
   STAR WM, IN PRESS APPL OPT
   VITKIN IA, 1995, OPTICAL THERMAL RESP, pCH16
   Welch J., 1995, OPTICAL THERMAL RESP
   Zijp JR, 1995, J DENT RES, V74, P1891, DOI 10.1177/00220345950740121301
NR 24
TC 12
Z9 12
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-4460-X
J9 PROC SPIE
PY 2002
VL 4710
BP 373
EP 383
DI 10.1117/12.459586
PG 5
WC Engineering, Mechanical; Instruments & Instrumentation; Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BU77V
UT WOS:000176994600041
DA 2018-10-20
ER

PT J
AU Ouchi, T
   Uchida, T
   Ohya, Y
AF Ouchi, T
   Uchida, T
   Ohya, Y
TI Synthesis of poly(L-lactide) with one terminal D-glucose residue and
   wettability of its film surface
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biodegradable; biopolymers; polyesters; surfaces; wettability
ID ACID-DEPSIPEPTIDE COPOLYMERS; DRUG-DELIVERY
AB Communication: To develop the new-type poly(L-lactide)- based biomedical material having a wettable surface, Synthesis of poly(L-lactide) with one terminal D-glucose residue was investigated. After the hydroxyl group at 1-C of alpha-tetrabenzyl glucose, alpha-Glc(Bzl)(4),was converted to the corresponding potassium alkoxide by using tert-butoxide, L-lactide (L-LA) was polymerized in the,presence of alpha-Glc(Bzl)(4)-OK as an initiator in tetrahydrofuran at room temperature to prepare alpha-Glc(Bzl)(4)-polyLA. Subsequently, the removal of O-protecting benzyl groups in the terminal alpha-Glc(Bzl)(4) residue was carried put by hydrogenolysis with Pd/C to obtain the objective D-glucose-end-capped polyLA, alpha-Glc-polyLA. The wettability of surface of the alpha-Glc-polyLA material is discussed using the difference of the dynamic contact angle between a alpha-Glc-polyLA/homopolyLA blend film and a film of the polyLA homopolymer.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
RP Ouchi, T (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
CR CHABOT F, 1983, POLYMER, V24, P53, DOI 10.1016/0032-3861(83)90080-0
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   Heller J, 1984, Crit Rev Ther Drug Carrier Syst, V1, P39
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   JEOUNG SY, 1986, ARCH PHARM RES, V9, P63
   Kricheldorf HR, 1996, MACROMOL SYMP, V103, P85
   Kricheldorf HR, 2000, MACROMOLECULES, V33, P696, DOI 10.1021/ma9909915
   KRICHELDORF HR, 1993, MAKROMOL CHEM-M SYMP, V73, P47, DOI 10.1002/masy.19930730107
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Lee SH, 2001, J POLYM SCI POL CHEM, V39, P973, DOI 10.1002/1099-0518(20010401)39:7<973::AID-POLA1073>3.0.CO;2-8
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   Ouchi T, 1999, MACROMOL CHEM PHYSIC, V200, P436, DOI 10.1002/(SICI)1521-3935(19990201)200:2<436::AID-MACP436>3.0.CO;2-6
   Ouchi T, 1998, J POLYM SCI POL CHEM, V36, P1283, DOI 10.1002/(SICI)1099-0518(199806)36:8<1283::AID-POLA11>3.0.CO;2-2
   Ouchi T, 1997, J POLYM SCI POL CHEM, V35, P377
   OUCHI T, UNPUB MACROMOLECULES
   SCHMIDT OT, 1960, CHEM BER-RECL, V93, P556, DOI 10.1002/cber.19600930247
   WOOD DA, 1980, INT J PHARM, V7, P1, DOI 10.1016/0378-5173(80)90094-0
NR 18
TC 27
Z9 29
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD DEC 28
PY 2001
VL 1
IS 9
BP 371
EP 375
DI 10.1002/1616-5195(20011201)1:9<371::AID-MABI371>3.3.CO;2-N
PG 5
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 513RZ
UT WOS:000173394100001
DA 2018-10-20
ER

PT J
AU Tang, YW
   Labow, RS
   Santerre, JP
AF Tang, YW
   Labow, RS
   Santerre, JP
TI Enzyme-induced biodegradation of polycarbonate-polyurethanes: Dependence
   on hard-segment chemistry
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polyurethanes; enzymes; esterase; hard segments; biodegradation; phase
   structure; hydrogen bonding
ID MONOCYTE-DERIVED MACROPHAGES; X-RAY-SCATTERING; CHOLESTEROL ESTERASE;
   BLOCK POLYMERS; MODEL SYSTEMS; BIOSTABILITY; STABILITY; POLYETHER;
   DEGRADATION; URETHANES
AB Polycarbonate urethanes (PCNUs) have been used as a replacement for traditional biomedical polyetherurethanes due to their reported resistance to oxidative biodegradation, However, relatively little is known about their hydrolytic stability in the presence of inflammatory derived enzymes. This has in part motivated the current study relating to the effect of hard segment chemistry and the microdomain structures generated by such chemistry, on the cholesterol esterase (CE) catalyzed hydrolysis of PCNUs. The bulk structures of the studied materials were characterized using gel permeation chromatography (GPC), differential scanning calorimetry (DSC), small-angle X-ray scattering (SAXS), Fourier transform infrared spectroscopy (FTIR) for their bulk structures, and attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) for their subsurface structures. C-14-labeled PCNUs were incubated with CE (400 units/mL), for a period of 10 weeks (pH 7.0 at 37 degreesC), and radiolabel release was used to monitor the degradation. The results showed that all of the polymers synthesized in this study were susceptible to CE-catalvzed hydrolytic degradation, and that the extent of degradation was highly dependent on the nature of hard segment interactions within the polymer and at the surface. More specifically, the degree of phase separation and soft segment crystallinity were found to be less important in comparison to the hydrogen bonding among the carbonate and urethane linkages. The rank of the different chemical groups' susceptibility to hydrolysis was as follows: nonhydrogen bonded carbonate > nonhydrogen bonded urethane > hydrogen bonded carbonate > hydrogen bonded urethane. The findings suggest that the degree of hydrogen bonding, when processed into a polyurethane material could be an important parameter to consider in the design of new biostable polyurethane products. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, Toronto, ON M5G 1G6, Canada.
   Univ Ottawa, Inst Heart, Cardiovasc Devices Div, Ottawa, ON K1Y 4W7, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, 124 Edward St, Toronto, ON M5G 1G6, Canada.
CR ADHIKARI R, 1998, J APPL POLYM SCI, V73, P573
   BORETOS JW, 1972, J BIOMED MATER RES, V6, P473, DOI 10.1002/jbm.820060513
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1982, P 8 ANN SOC BIOM, P24
   BRUNETTE CM, 1981, POLYM ENG SCI, V21, P163, DOI 10.1002/pen.760210309
   CHAPMAN TM, 1989, J POLYM SCI POL CHEM, V27, P1993, DOI 10.1002/pola.1989.080270620
   Culbertson BM, 1989, MULTIPHASE MACROMOLE
   Feigin L. A., 1987, STRUCTURAL ANAL SMAL
   Fukuda M, 1997, J POLYM SCI POL PHYS, V35, P1423, DOI 10.1002/(SICI)1099-0488(19970715)35:9<1423::AID-POLB12>3.0.CO;2-8
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HILL DJT, 1980, POLYM DEGRAD STABIL, V3, P83, DOI 10.1016/0141-3910(80)90010-5
   Hiltunen K, 1997, J APPL POLYM SCI, V64, P865, DOI 10.1002/(SICI)1097-4628(19970502)64:5<865::AID-APP6>3.0.CO;2-N
   Kaminska A, 1996, POLYM DEGRAD STABIL, V51, P19, DOI 10.1016/0141-3910(95)00159-X
   Kanapitsas A, 1999, J APPL POLYM SCI, V71, P1209, DOI 10.1002/(SICI)1097-4628(19990222)71:8<1209::AID-APP1>3.0.CO;2-5
   Kim YD, 1998, POLYM DEGRAD STABIL, V62, P343, DOI 10.1016/S0141-3910(98)00017-2
   KOBERSTEIN JT, 1983, J POLYM SCI POL PHYS, V21, P1439, DOI 10.1002/pol.1983.180210814
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 1999, J BIOMATER APPL, V13, P187, DOI 10.1177/088532829901300302
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Lelah M. D., 1986, POLYURETHANES MED
   LI YJ, 1994, MACROMOLECULES, V27, P612, DOI 10.1021/ma00080a043
   Lim LT, 1999, J APPL POLYM SCI, V71, P197, DOI 10.1002/(SICI)1097-4628(19990110)71:2<197::AID-APP2>3.0.CO;2-J
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P153, DOI 10.1002/jbm.820200205
   MARCHANT RE, 1988, SURFACE CHARACTERIZA, P297
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   McCarthy SJ, 1997, BIOMATERIALS, V18, P1387, DOI 10.1016/S0142-9612(97)00083-5
   NG HN, 1973, POLYMER, V14, P255, DOI 10.1016/0032-3861(73)90085-2
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Saunders J.H., 1962, POLYURETHANES CHEM 2
   Saunders J. H., 1962, POLYURETHANES CHEM 1
   SEYMOUR RW, 1973, MACROMOLECULES, V6, P896, DOI 10.1021/ma60036a021
   Song YM, 1996, J APPL POLYM SCI, V62, P827, DOI 10.1002/(SICI)1097-4628(19961031)62:5<827::AID-APP15>3.3.CO;2-M
   SPATHIS G, 1994, J APPL POLYM SCI, V54, P831, DOI 10.1002/app.1994.070540701
   SPECKHARD TA, 1985, POLYMER, V26, P70, DOI 10.1016/0032-3861(85)90058-8
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STOKES KB, 1987, POLYM SCI TECHNOL, V35, P147
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   TAO HJ, 1994, MACROMOLECULES, V27, P1720, DOI 10.1021/ma00085a009
   Teo LS, 1997, MACROMOLECULES, V30, P1793, DOI 10.1021/ma961035f
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   TINGEY KG, 1995, ACS SYM SER, V602, P66
   Vermette P, 1999, J BIOMAT SCI-POLYM E, V10, P729, DOI 10.1163/156856299X00612
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Yontz DJ, 1998, J POLYM SCI POL PHYS, V36, P3065, DOI 10.1002/(SICI)1099-0488(199812)36:17<3065::AID-POLB7>3.0.CO;2-G
   Yu HS, 1999, MACROMOLECULES, V32, P4365, DOI 10.1021/ma990106i
   ZHANG Z, 1994, BIOMATERIALS, V15, P483
NR 56
TC 99
Z9 103
U1 1
U2 27
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2001
VL 57
IS 4
BP 597
EP 611
DI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 478YQ
UT WOS:000171376800015
PM 11553891
DA 2018-10-20
ER

PT J
AU Fallen, CT
   Costello, J
   Crawford, G
   Schmidt, JA
AF Fallen, CT
   Costello, J
   Crawford, G
   Schmidt, JA
TI Measuring the elastic properties of fine wire
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE MP35N; 304 SS; Young's modulus; shear modulus; strain
AB The elastic moduli of fine wires made from MP35N and 304SS used in implantable biomedical devices are assumed to be the same as those published in the literature. However, the cold working required to manufacture the wire significantly alters the elastic moduli of the material. We describe three experiments performed on fine wire made from MP35N and 304SS. The experimentally determined Young's and shear modulus of both wire types were significantly less than the moduli reported in the literature. Young's modulus differed by as much as 26%, and the shear modulus differed by as much as 14% from reported values. (C) 2001 John Wiley & Sons, Inc.
C1 Quetzal Biomed Inc, Durango, CO 81301 USA.
   Ft Lewis Coll, Dept Phys, Durango, CO 81301 USA.
RP Schmidt, JA (reprint author), Quetzal Biomed Inc, 3455 Main Ave,Suite 4, Durango, CO 81301 USA.
CR Altman PA, 1998, J BIOMED MATER RES, V43, P21, DOI 10.1002/(SICI)1097-4636(199821)43:1<21::AID-JBM3>3.0.CO;2-O
   *AM SOC MET, 1980, MET HDB, V3
   BOLZE RE, 1973, CRC HDB TABLES APPL
   Dieter G. E., 1976, MECH METALLURGY
   Gere J. M., 1990, MECH MAT
   Landau L., 1970, THEORY ELASTICITY
   *LATR STEEL CO, 1980, MULT MP35N ALL TECHN
   LIPSON SG, 1995, OPTICAL PHYSICS
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   ZHAO Y, 2000, P ICCMB 11, P323
   ZHAO Y, 2000, P ICCMB 11, P325
NR 11
TC 13
Z9 15
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 58
IS 6
BP 694
EP 700
DI 10.1002/jbm.1071
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 493WN
UT WOS:000172246600013
PM 11745523
DA 2018-10-20
ER

PT J
AU Lavos-Valereto, IC
   Wolynec, S
   Deboni, MCZ
   Konig, B
AF Lavos-Valereto, IC
   Wolynec, S
   Deboni, MCZ
   Konig, B
TI In vitro and in vivo biocompatibility testing of Ti-6Al-7Nb alloy with
   and without plasma-sprayed hydroxyapatite coating
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE osteoblastic-like cells; cell growth; Ti-6Al-7Nb dental implants; dog
   test; hydroxyapatite
ID IN-VITRO; METALLIC IMPLANTS; CALCIUM-PHOSPHATE; DENTAL IMPLANTS; RABBIT;
   BIOMATERIALS; OSSEOINTEGRATION; HYDROXYLAPATITE; MICROSCOPY
AB The Ti-6Al-7Nb alloy has been recently developed for biomedical use, particularly for orthopedics and dental applications. Osteosynthesis has been used to analyze biocompatibility and osseoconduction properties. The interaction of the implant with its biological environment, the formation of the implant material/tissue interface, and the long-term success or failure of integration in the human body is strongly connected with the surface properties of the implant device. This study was undertaken to evaluate the processes involved in biological responses of the Ti-6Al-7Nb alloy with and without hydroxyapatite coatings with both in vitro and in vivo tests. The results were analyzed by scanning electron microscopy (SEM) and energy-dispersive x-ray (EDX) microanalysis. The morphology of the in vitro and in vivo testing results with hydroxyapatite coating was similar to those obtained on the uncoated samples. A mineralized extracellular matrix was formed on all materials. Observation of the interface between the cell layer and substrata showed the presence of calcium and phosphorous-rich globular deposits associated with collagen fibers on all materials in vitro and in vivo. A higher density of these globular deposits was observed in all samples. (C) 2001 John Wiley & Sons, Inc.
C1 Univ Sao Paulo, Polytech Sch, Dept Met & Mat Engn, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Dent, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Biomed Sci, Sao Paulo, Brazil.
RP Lavos-Valereto, IC (reprint author), Rua Pelotas,541 Apdo 1004, BR-04012000 Sao Paulo, Brazil.
RI Deboni, Maria Cristina/G-1859-2010
OI Deboni, Maria Cristina/0000-0002-2966-6039
CR Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   Baquey C, 1999, J MATER SCI-MATER M, V10, P695, DOI 10.1023/A:1008916601608
   BAUER G, 1987, Z ZAHNARZTL IMPLANTO, V5, P263
   BLACK J, 1992, BIOL PERFORMANCE MAT, P390
   Carr AB, 1997, INT J ORAL MAX IMPL, V12, P777
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   CHUANXIAN D, 1987, P THERM SPRAY ADV CO, P407
   DEBONI MCZ, 1995, THESIS U SAO PAULO U, P62
   DEBONI MCZ, 1996, RPG, V3, P220
   Demri B, 1997, BIOMATERIALS, V18, P305, DOI 10.1016/S0142-9612(96)00130-5
   Donath K, 1991, Niedersachs Zahnarztebl, V26, P203
   DONATH K, 1995, JDZ, V12, P9
   Donath K., 1993, J HARD TISSUE BIOL, V2, P37
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   HING KA, 1995, P 12 EUR C BIOM PORT, P146
   KHUR KA, 1993, THERMAL SPRAY COATINGS: RESEARCH, DESIGN AND APPLICATIONS, P347
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   Konig B, 1998, ANN ANAT, V180, P471
   LABAT B, 1995, J BIOMED MATER RES, V29, P1395
   Lavos-Valereto IC, 2001, J MATER SCI-MATER M, V12, P273, DOI 10.1023/A:1008975418453
   LAVOSVALERETO IC, 1998, THESIS U SAO PAULO U, P129
   LAVOSVALERTO IC, IN PRESS IN VITRO RE
   LeGeros R.Z., 1991, CALCIUM PHOSPHATES O, P201
   Leitao E, 1998, J MATER SCI-MATER M, V9, P543, DOI 10.1023/A:1008896106994
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P129
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P135, DOI 10.3109/17453678909149240
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   ONG JL, 1995, J BIOMED MATER RES, V29, P165, DOI 10.1002/jbm.820290205
   Park E, 1998, J MATER SCI-MATER M, V9, P643, DOI 10.1023/A:1008931508465
   Piattelli A, 1997, BIOMATERIALS, V18, P1191, DOI 10.1016/S0142-9612(97)00055-0
   Rupp F, 1996, ADV MATER, V8, P254, DOI 10.1002/adma.19960080316
   Tomas H, 1997, J MATER SCI-MATER M, V8, P233, DOI 10.1023/A:1018543808210
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Wang SA, 1996, BIOMATERIALS, V17, P1965, DOI 10.1016/0142-9612(96)00020-8
   WILLIAMS DF, 1986, BIOMEDICAL MAT, V55, P117
NR 36
TC 46
Z9 47
U1 0
U2 22
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 58
IS 6
BP 727
EP 733
DI 10.1002/jbm.1072
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 493WN
UT WOS:000172246600017
PM 11745527
DA 2018-10-20
ER

PT J
AU Kraft, CN
   Burian, B
   Perlick, L
   Wimmer, MA
   Wallny, T
   Schmitt, O
   Diedrich, O
AF Kraft, CN
   Burian, B
   Perlick, L
   Wimmer, MA
   Wallny, T
   Schmitt, O
   Diedrich, O
TI Impact of a nickel-reduced stainless steel implant on striated muscle
   microcirculation: A comparative in vivo study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE nickel; stainless steel; osteosynthesis materials; microcirculation;
   biocompatibility
ID MICROVASCULAR RESPONSE; ORTHOPEDIC IMPLANTS; METAL-IONS; TOXICITY;
   TISSUE; MICROSCOPY; LEUKOCYTES; PRODUCTS; TITANIUM; ADHESION
AB The impairment of skeletal muscle microcirculation by a biomaterial may have profound consequences. With moderately good physical and corrosion characteristics, implant-quality stainless steel is particularly popular in orthopedic surgery. However, due to the presence of a considerable amount of nickel in the alloy, concern has been voiced in respect to local tissue responses. More recently a stainless steel alloy with a significant reduction of nickel has become commercially available. We, therefore, studied bi vivo nutritive perfusion and leukocytic response of striated muscle to this nickel-reduced alloy, and compared these results with those of the materials conventional stainless steel and titanium. Using the hamster dorsal skinfold chamber preparation and intravital microscopy, we could demonstrate that reduction of the nickel quantity in a stainless steel implant has a positive effect on local microvascular parameters. Although the implantation of a conventional stainless steel sample led to a distinct and persistent activation of leukocytes combined with disruption of the microvascular endothelial integrity, marked leukocyte extravasation, and considerable venular dilation, animals with a nickel-reduced stainless steel implant showed only a moderate increase of these parameters, with a clear tendency of recuperation. Titanium implants merely caused a transient increase of leukocyte-endothelial cell interaction within the first 120 min, and no significant change in macromolecular leakage, leukocyte extravasation, or venular diameter. Pending biomechanical and corrosion testing, nickel-reduced stainless steel may be a viable alternative to conventional implant-quality stainless steel for biomedical applications. Concerning tolerance by the local vascular system, titanium currently remains unsurpassed, (C) 2001 John Wiley & Sons, Inc.
C1 Univ Bonn, Dept Orthopaed Surg, D-53105 Bonn, Germany.
   Univ Regensburg, Dept Orthopaed Surg, D-93077 Bad Abbach, Germany.
   AO Res Inst, CH-7270 Davos, Switzerland.
RP Kraft, CN (reprint author), Univ Bonn, Dept Orthopaed Surg, D-53105 Bonn, Germany.
CR Abreu A. M., 1995, Biomedical Letters, V52, P133
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   BergerGorbet M, 1996, J BIOMED MATER RES, V32, P243, DOI 10.1002/(SICI)1097-4636(199610)32:2<243::AID-JBM14>3.0.CO;2-K
   BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   Brunner J, 2000, MICROCIRCULATION, V7, P103, DOI 10.1038/sj.mn.7300094
   Chen FS, 1999, J BIOMED MATER RES, V48, P904, DOI 10.1002/(SICI)1097-4636(1999)48:6<904::AID-JBM21>3.0.CO;2-5
   CIGADA A, 1994, COMPATIBILITY BIOMED, P185
   COTRAN RS, 1989, ROBBINS PATHOLOGIC B, P39
   DISEGI JA, 2000, P SOC BIOMATER, V6, P816
   Doran A, 1998, BIOMATERIALS, V19, P751, DOI 10.1016/S0142-9612(97)00209-3
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   FANTONE JC, 1982, AM J PATHOL, V107, P397
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662
   HENNIG FF, 1992, J TRACE ELEM ELECT H, V6, P239
   HIERHOLZER S, 1992, INTERNAL FIXATION ME
   Hosokawa Y, 1997, X-RAY SPECTROM, V26, P380
   Intergovernmental Oceanographic Commission, 1997, IARC HDB CANC PREV N, P1
   International Agency for Research on Cancer, 1995, IARC MON EV CARC RIS, P1
   JACOBS JJ, 1996, CLIN ORTHOP S, V329, P256
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O
   Menger MD, 1996, BRIT J SURG, V83, P588, DOI 10.1002/bjs.1800830506
   MERRITT K, 1993, BRIS MYER Z, P147
   MERRITT K, 1993, TECHN ORTHOP, V8, P228
   MERRITT K, 1996, CLIN ORTHOP RELAT R, V329, P233
   NIEBOER E, 1980, NICKEL TOXICOLOGY, P359
   Pereira MC, 1998, J BIOMED MATER RES, V40, P40, DOI 10.1002/(SICI)1097-4636(199804)40:1<40::AID-JBM5>3.0.CO;2-R
   PRIES AR, 1988, INT J MICROCIRC, V7, P327
   Schaser KD, 1999, J ORTHOPAED RES, V17, P678, DOI 10.1002/jor.1100170509
   Shettlemore MG, 1999, J BIOMED MATER RES, V45, P395
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   Takeshita F, 1997, BIOMATERIALS, V18, P21, DOI 10.1016/S0142-9612(96)00051-8
   Uo M, 1999, BIOMATERIALS, V20, P747, DOI 10.1016/S0142-9612(98)00224-5
   VOLLMAR B, 1993, ZBL CHIR, V118, P691
   WATAHA JC, 1993, J BIOMED MATER RES, V27, P227, DOI 10.1002/jbm.820270212
   WILLIAMS D, 1990, ENCY MED DENT MAT
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V2
   WILLIAMS DF, 1981, SYSTEMIC ASPECTS BIO, V1
NR 42
TC 30
Z9 30
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2001
VL 57
IS 3
BP 404
EP 412
DI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472AE
UT WOS:000170960200010
PM 11523035
DA 2018-10-20
ER

PT J
AU Einmahl, S
   Capancioni, S
   Schwach-Abdellaoui, K
   Moeller, M
   Behar-Cohen, F
   Gurny, R
AF Einmahl, S
   Capancioni, S
   Schwach-Abdellaoui, K
   Moeller, M
   Behar-Cohen, F
   Gurny, R
TI Therapeutic applications of viscous and injectable poly(ortho esters)
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE poly(ortho esters); biodegradable polymers; drug delivery;
   ophthalmology; dentistry; veterinary medicine
ID CONTROLLED DRUG-RELEASE; GLAUCOMA FILTERING SURGERY; POLY ORTHO ESTERS;
   IN-VITRO; PROLIFERATIVE VITREORETINOPATHY; BIODEGRADABLE POLYMERS;
   BEAGLE DOGS; INTRAOPERATIVE 5-FLUOROURACIL; IRRADIATION STERILIZATION;
   MECHANICAL-PROPERTIES
AB Poly(ortho esters) (POE) are hydrophobic and bioerodible polymers that have been investigated for pharmaceutical use since the early 1970s. Among the four described generations of POE, the third (POE III) and fourth (POE IV) are promising viscous and injectable materials which have been investigated in numerous biomedical applications. POE III has been extensively studied for ophthalmic drug delivery, it presents an excellent biocompatibility and is currently being investigated as a vehicle for sustained drug delivery to treat diseases of the posterior segment of the eye. POE IV is distinguishable by a highly reproducible and controlled synthesis, a higher hydrophobicity, and an excellent biocompatibility. It is currently under development for a variety of applications, such as ocular delivery, periodontal disease treatment and applications in veterinary medicine. This review will also focus on new perspectives for this promising family of polymers, such as guided tissue regeneration, treatment of osteoarthritis, as well as peptide and protein delivery. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Geneva, Sch Pharm, Dept Pharmaceut & Biopharmaceut, CH-1211 Geneva 4, Switzerland.
   INSERM, Lab U450, F-75016 Paris, France.
RP Gurny, R (reprint author), Univ Geneva, Sch Pharm, Dept Pharmaceut & Biopharmaceut, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.
OI Moller, Michael/0000-0002-5299-4436
CR Alward WLM, 1996, AM J OPHTHALMOL, V121, P349
   Andriano KP, 1999, J BIOMED MATER RES, V48, P528, DOI 10.1002/(SICI)1097-4636(1999)48:4<528::AID-JBM19>3.0.CO;2-F
   ANDRIANO KP, 1992, J APPL BIOMATER, V3, P197, DOI 10.1002/jab.770030306
   ANDRIANO KP, 1993, J APPL BIOMATER, V4, P1, DOI 10.1002/jab.770040102
   Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6
   APPEL LE, 1993, J CONTROL RELEASE, V26, P77, DOI 10.1016/0168-3659(93)90107-G
   Baehni PC, 1997, CURR OPIN PERIODONT, V4, P151
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   BECKETT AH, 1987, ARZNEIMITTEL-FORSCH, V37-1, P221
   BEHARCOHEN FF, 2001, EUR PHARM REV, V6, P35
   BERNATCHEZ SF, 1994, J BIOMED MATER RES, V28, P1037, DOI 10.1002/jbm.820280908
   BERNATCHEZ SF, 1993, J BIOMED MATER RES, V27, P677, DOI 10.1002/jbm.820270515
   BLUMENKRANZ MS, 1989, RETINA, P401
   BORA FW, 1987, J HAND SURG-AM, V12A, P685
   BRESSLER NM, 1995, OPHTHALMOLOGY, V102, P1206, DOI 10.1016/S0161-6420(95)30889-5
   BRUERA ED, 1994, CANCER, V74, P3204, DOI 10.1002/1097-0142(19941215)74:12<3204::AID-CNCR2820741220>3.0.CO;2-G
   Bryant DK, 1996, J CHROMATOGR A, V721, P41, DOI 10.1016/0021-9673(95)00766-0
   Burggraaf S., 1997, ADV DRUG DELIV REV, V28, P363
   Busch O, 1996, Int J Oral Maxillofac Implants, V11, P498
   CAPANCIONI S, 2001, EUR J PHARM BIOPHARM
   CAPANCIONI S, 2001, UNPUB EUR J PHARM BI
   CAPOZZA R C, 1976, National Institute on Drug Abuse Research Monograph, V4, P39
   CAPOZZA RC, 1978, POLYM DELIVERY SYSTE, P59
   CARGILL R, 1989, PHARMACEUT RES, V6, P506, DOI 10.1023/A:1015976709043
   Chang MR, 1998, J OCUL PHARMACOL TH, V14, P75, DOI 10.1089/jop.1998.14.75
   Choi NS, 1978, Patent No. [4093709, US4093709]
   CHOI NS, 1978, Patent No. 4079038
   CHOI NS, 1979, Patent No. 4180646
   CHOI NS, 1979, Patent No. 4138344
   CHOI NS, 1978, Patent No. 4131648
   Ciulla TA, 1998, SURV OPHTHALMOL, V43, P134, DOI 10.1016/S0039-6257(98)00014-9
   Cleland JL, 1996, PHARMACEUT RES, V13, P1464, DOI 10.1023/A:1016063109373
   Clem D S 3rd, 1991, J Calif Dent Assoc, V19, P67
   DANIELS AU, 1994, J APPL BIOMATER, V5, P51, DOI 10.1002/jab.770050108
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   DAVIES MC, 1991, BIOMATERIALS, V12, P305, DOI 10.1016/0142-9612(91)90038-C
   DAVIES MC, 1992, POLYM ADVAN TECHNOL, V3, P293
   Deshpande AA, 1998, CRIT REV THER DRUG, V15, P381
   DIEHL P, 1989, NMR, V21
   DOYLE JW, 1993, INVEST OPHTH VIS SCI, V34, P3313
   Du J, 1997, J CONTROL RELEASE, V43, P223, DOI 10.1016/S0168-3659(96)01487-3
   Einmahl S, 2001, INVEST OPHTH VIS SCI, V42, P695
   Einmahl S, 2000, J BIOMED MATER RES, V50, P566, DOI 10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
   Einmahl S, 1999, INT J PHARM, V185, P189, DOI 10.1016/S0378-5173(99)00149-0
   Einmahl S., 1999, ENCY CONTROLLED DRUG, P564
   EINMAHL S, 2001, CHIMIA, V55, P142
   EINMAHL S, 2001, POLYM MED MACROMOLEC, V172, P72
   EINMAHL S, 1907, UNPUB INVEST OPHTHAL
   Ekholm M, 1997, J MATER SCI-MATER M, V8, P265, DOI 10.1023/A:1018552010027
   ELSAYED YM, 1995, INT J PHARM, V123, P113, DOI 10.1016/0378-5173(95)00054-M
   FIX J A, 1986, Journal of Controlled Release, V4, P87, DOI 10.1016/0168-3659(86)90044-1
   Frenzel EM, 1998, INVEST OPHTH VIS SCI, V39, P2157
   GURNY R, 1997, Patent No. 0885014
   HACKETT RP, 1982, J AM VET MED ASSOC, V181, P292
   HARRISON FJJ, 1994, ARZNEIMITTEL-FORSCH, V44-1, P519
   HELLER J, 1987, Journal of Controlled Release, V6, P217, DOI 10.1016/0168-3659(87)90078-2
   Heller J, 2000, EUR J PHARM BIOPHARM, V50, P121, DOI 10.1016/S0939-6411(00)00085-0
   HELLER J, 1991, J CONTROL RELEASE, V16, P3, DOI 10.1016/0168-3659(91)90026-A
   HELLER J, 1993, ADV POLYM SCI, V107, P41
   HELLER J, 1990, J CONTROL RELEASE, V13, P295, DOI 10.1016/0168-3659(90)90019-P
   HELLER J, 1990, BIOMATERIALS, V11, P659, DOI 10.1016/0142-9612(90)90024-K
   HELLER J, 1987, Journal of Controlled Release, V5, P173, DOI 10.1016/0168-3659(87)90008-3
   Heller J, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P106
   HELLER J, 1981, POLYM ENG SCI, V21, P727, DOI 10.1002/pen.760211117
   HELLER J, 1990, BIOMATERIALS, V11, P235, DOI 10.1016/0142-9612(90)90003-9
   HELLER J, 1999, ENCY CONTROLLED DRUG, P852
   HELLER J, 1990, BIODEGRADABLE POLYM, P121
   HELLER J, 1981, Patent No. 4304767
   HELLER J, 1981, AICHE S SER, V77, P28
   HELLER J, 1985, J CONTROL RELEASE, V1, P225
   HELLER J, 1997, TRENDS FUTURE PERSPE, P39
   HELLER J, 1985, J CONTROL RELEASE, V1, P233
   Hellstrom I, 1998, CRIT REV IMMUNOL, V18, P1
   HSU SL, 1989, COMPREHENSIVE POLYM, P429
   Hui YN, 1999, GRAEF ARCH CLIN EXP, V237, P601, DOI 10.1007/s004170050284
   KALDAHL WB, 1993, J PERIODONTOL, V64, P243, DOI 10.1902/jop.1993.64.4.243
   Kawcak CE, 1997, AM J VET RES, V58, P1132
   Kramer G M, 1992, Int J Periodontics Restorative Dent, V12, P10
   Leadley SR, 1998, BIOMATERIALS, V19, P1353, DOI 10.1016/S0142-9612(97)00239-1
   LEWIS H, 1991, AM J OPHTHALMOL, V111, P15, DOI 10.1016/S0002-9394(14)76890-4
   Li XH, 2000, J CONTROL RELEASE, V68, P41, DOI 10.1016/S0168-3659(00)00235-2
   Lin YHE, 2000, J MICROENCAPSUL, V17, P1
   MAA YF, 1990, J CONTROL RELEASE, V14, P21, DOI 10.1016/0168-3659(90)90057-Z
   MAA YF, 1990, J CONTROL RELEASE, V13, P11, DOI 10.1016/0168-3659(90)90070-A
   MADEJ TH, 1988, BRIT J CLIN PHARMACO, V26, P747, DOI 10.1111/j.1365-2125.1988.tb05314.x
   Mader K, 1998, PHARMACEUT RES, V15, P787, DOI 10.1023/A:1011939607573
   MANNIS MJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P816
   MCILWRAITH CW, 1988, EQUINE VET J S, V1, P3
   MERKLI A, 1994, J CONTROL RELEASE, V29, P105, DOI 10.1016/0168-3659(94)90126-0
   MERKLI A, 1993, J BIOMAT SCI-POLYM E, V4, P505, DOI 10.1163/156856293X00168
   Merkli A, 1996, BIOMATERIALS, V17, P897, DOI 10.1016/0142-9612(96)83285-6
   MERKLI A, 1995, EUR J PHARM BIOPHARM, V41, P271
   MERKLI A, 1994, PHARMACEUT RES, V11, P1485, DOI 10.1023/A:1018964511053
   Merkli A, 1998, PROG POLYM SCI, V23, P563, DOI 10.1016/S0079-6700(97)00048-8
   MERKLI A, 1995, J CONTROL RELEASE, V33, P415, DOI 10.1016/0168-3659(94)00117-D
   MITRUKA BM, 1977, CLIN BIOCH HEMATOLOG, P71
   Moses VS, 2001, AM J VET RES, V62, P54, DOI 10.2460/ajvr.2001.62.54
   NEEDLEMAN IG, 1991, BRIT DENT J, V170, P405, DOI 10.1038/sj.bdj.4807569
   Ng SY, 1997, MACROMOLECULES, V30, P770, DOI 10.1021/ma9610626
   Ng SY, 2000, J CONTROL RELEASE, V65, P367, DOI 10.1016/S0168-3659(99)00218-7
   NG SY, 1985, Patent No. 4513143
   NYMAN S, 1991, J CLIN PERIODONTOL, V18, P494, DOI 10.1111/j.1600-051X.1991.tb02322.x
   PEYRON JG, 1993, J RHEUMATOL, V20, P10
   PHARRISS BB, 1976, J REPROD MED, V17, P91
   PINHOLT EM, 1991, ACTA ORTHOP SCAND, V62, P466
   Polson AM, 1996, J PERIODONTOL, V67, P1176, DOI 10.1902/jop.1996.67.11.1176
   Rathbone MJ, 1998, J CONTROL RELEASE, V54, P117, DOI 10.1016/S0168-3659(98)00003-0
   Rathbone MJ, 1998, CRIT REV THER DRUG, V15, P285
   Rathbone MJ, 2000, CONTROLLED RELEASE V
   Rathbone MJ, 1999, ENCY CONTROLLED DRUG, P1007
   Robinson T.J., 1967, CONTROL OVARIAN CYCL
   ROBINSON TJ, 1965, NATURE, V206, P39, DOI 10.1038/206039a0
   ROSKOS KV, 1995, BIOMATERIALS, V16, P313, DOI 10.1016/0142-9612(95)93259-G
   Rothen-Weinhold A, 1998, J CONTROL RELEASE, V52, P205, DOI 10.1016/S0168-3659(97)00216-2
   Rothen-Weinhold A, 2001, J CONTROL RELEASE, V71, P31, DOI 10.1016/S0168-3659(00)00348-5
   Schwach-Abdellaoui K, 2000, EUR J PHARM BIOPHARM, V50, P83, DOI 10.1016/S0939-6411(00)00086-2
   Schwach-Abdellaoui K, 1999, J BIOMAT SCI-POLYM E, V10, P375, DOI 10.1163/156856299X00432
   Schwach-Abdellaoui K, 1999, MACROMOLECULES, V32, P301, DOI 10.1021/ma981517m
   Schwach-Abdellaoui K, 2001, BIOMATERIALS, V22, P1659, DOI 10.1016/S0142-9612(00)00327-6
   SCHWACHABDELLAO.K, 2001, UNPUB INT J PHARM
   SCHWACHABDELLAO.K, 2001, UNPUB BIOERODIBLE IN
   SCHWACHABDELLAO.K, 2001, IN PRESS INT J POLYM
   SCHWACHABDELLAO.K, 2001, P INT S CONTR REL BI, V28, P305
   SCHWACHABDELLAO.K, 2001, P INT S CONTR REL BI, V28, P1245
   SEYMOUR LW, 1994, J CONTROL RELEASE, V31, P201, DOI 10.1016/0168-3659(94)00046-8
   SEYMOUR RA, 1995, J CLIN PERIODONTOL, V22, P22
   SHIH C, 1984, BIOMATERIALS, V5, P237, DOI 10.1016/0142-9612(84)90022-X
   SHIH C, 1991, J CONTROL RELEASE, V15, P55, DOI 10.1016/0168-3659(91)90103-K
   SHIH C, 1993, J CONTROL RELEASE, V25, P155, DOI 10.1016/0168-3659(93)90104-D
   Singh K, 1997, AM J OPHTHALMOL, V123, P48, DOI 10.1016/S0002-9394(14)70991-2
   Sintzel MB, 1997, DRUG DEV IND PHARM, V23, P857, DOI 10.3109/03639049709148693
   Sintzel MB, 1998, BIOMATERIALS, V19, P791, DOI 10.1016/S0142-9612(97)00229-9
   Sintzel MB, 1998, INT J PHARM, V175, P165, DOI 10.1016/S0378-5173(98)00274-9
   Sintzel MB, 1998, J CONTROL RELEASE, V55, P213, DOI 10.1016/S0168-3659(98)00051-0
   Sintzel MB, 1997, INT J PHARM, V155, P263, DOI 10.1016/S0378-5173(97)00169-5
   SOLHEIM E, 1995, J BIOMED MATER RES, V29, P1141, DOI 10.1002/jbm.820290914
   SOLHEIM E, 1992, J BONE JOINT SURG AM, V74A, P705, DOI 10.2106/00004623-199274050-00009
   Solheim E, 2000, J BIOMED MATER RES, V49, P257, DOI 10.1002/(SICI)1097-4636(200002)49:2<257::AID-JBM15>3.0.CO;2-5
   SOLHEIM E, 1991, EUR SURG RES, V23, P45, DOI 10.1159/000129135
   SOLHEIM E, 1992, J BONE JOINT SURG AM, V74A, P1456, DOI 10.2106/00004623-199274100-00004
   SOLHEIM E, 1992, J BIOMED MATER RES, V26, P791, DOI 10.1002/jbm.820260608
   SPASSKY N, 1991, MAKROMOL CHEM-M SYMP, V42-3, P15, DOI 10.1002/masy.19910420104
   SUDMANN B, 1993, ACTA ORTHOP SCAND, V64, P336, DOI 10.3109/17453679308993639
   TAMARGO RJ, 1991, CANCER RES, V51, P672
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   TODHUNTER RJ, 1993, J ORTHOPAED RES, V11, P782, DOI 10.1002/jor.1100110603
   Tolentino MJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P78
   TONETTI M, 1990, J PERIODONTAL RES, V25, P243, DOI 10.1111/j.1600-0765.1990.tb00911.x
   VANDAMME TF, 1995, J CONTROL RELEASE, V36, P209, DOI 10.1016/0168-3659(95)00012-W
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Vernino A R, 1999, Int J Periodontics Restorative Dent, V19, P56
   VISTNES LM, 1976, SURGERY, V79, P690
   WIEDEMANN P, 1992, CURR OPIN OPHTHALMOL, V3, P357, DOI 10.1097/00055735-199206000-00010
   WUTHRICH P, 1992, J CONTROL RELEASE, V21, P191, DOI 10.1016/0168-3659(92)90021-I
   YU Z, 1993, J PERIODONTAL RES, V28, P420
   Zignani M, 1997, J CONTROL RELEASE, V48, P115, DOI 10.1016/S0168-3659(97)00050-3
   Zignani M, 2000, BIOMATERIALS, V21, P1773, DOI 10.1016/S0142-9612(00)00065-X
   Zignani M, 1998, J BIOMED MATER RES, V39, P277
   Zignani M, 2000, EUR J PHARM BIOPHARM, V50, P251, DOI 10.1016/S0939-6411(00)00107-7
NR 159
TC 39
Z9 42
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 3
PY 2001
VL 53
IS 1
BP 45
EP 73
DI 10.1016/S0169-409X(01)00220-4
PG 29
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 501XZ
UT WOS:000172712500004
PM 11733117
DA 2018-10-20
ER

PT J
AU Brocchini, S
AF Brocchini, S
TI Combinatorial chemistry and biomedical polymer development
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE combinatorial chemistry; polymer synthesis; biomedical polymers
ID SYNTHETIC-POLYMERS; MASS-SPECTROMETRY; DRUG CARRIERS; SIDE-CHAINS;
   BIOMATERIALS; HEMAGGLUTINATION; INHIBITORS; LIBRARIES; PROTEIN;
   CATALYSIS
AB Polymers are ubiquitous components of products manufactured for medical and pharmaceutical applications. Widely used commodity polymers were the first polymers to be utilised in biomedical applications. These polymers were not developed with biocompatibility established at the onset and many speciality polymers have been developed in recent years to begin to meet the multifaceted demands for medical development, the optimisation of structure-property correlations and ultimately, clinical use. In the broader area of materials research, combinatorial or high throughput strategies used for drug development are recognised to have potential for discovery and process development. Much of the application of combinatorial chemistry in drugs research has been dependent on the use of polymeric reagents, substrates and supports. The chemistry of the reactions on polymers in solid and liquid phases have also played a major role in combinatorial drugs research. There is considerable interest in combinatorial materials research and this review outlines how this research may be applied for biomedical polymer development. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ London, Sch Pharm, Biomed Polymers Grp, Dept Pharmaceut, London WC1N 1AX, England.
RP Brocchini, S (reprint author), Univ London, Sch Pharm, Biomed Polymers Grp, Dept Pharmaceut, 29 Brunswick Sq, London WC1N 1AX, England.
CR ADV MED INC, 2001, Patent No. 0142243
   ALAKHOV V, 1999, COLLOID SURFACE B, V16, P114
   Alakhov V Y, 1998, Expert Opin Investig Drugs, V7, P1453, DOI 10.1517/13543784.7.9.1453
   AVILA LZ, 1993, J MED CHEM, V36, P126, DOI 10.1021/jm00053a016
   Belu AM, 2000, RAPID COMMUN MASS SP, V14, P564, DOI 10.1002/(SICI)1097-0231(20000415)14:7<564::AID-RCM910>3.0.CO;2-0
   Boal AK, 2000, NATURE, V404, P746
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   BROCCHINI S, 2000, DRUG DELIVERY CO REP, P66
   Cawse JN, 2001, ACCOUNTS CHEM RES, V34, P213, DOI 10.1021/ar000117s
   Chen TH, 2001, BIOMACROMOLECULES, V2, P456, DOI 10.1021/bm000125w
   CHOI S, 1998, Patent No. 9847002
   Choi SK, 1997, J AM CHEM SOC, V119, P4103, DOI 10.1021/ja963519x
   Chytry V, 1997, J BIOMAT SCI-POLYM E, V8, P817, DOI 10.1163/156856297X00010
   CRABTREE G, 1999, Patent No. 5869337
   Dickinson TA, 1997, ANAL CHEM, V69, P3413, DOI 10.1021/ac970501b
   Domb A.J., 1997, DRUG TARGETING DELIV
   DUNCAN R, 1984, ADV POLYM SCI, V57, P51
   DUNCAN R, 1992, ANTI-CANCER DRUG, V3, P175, DOI 10.1097/00001813-199206000-00001
   Duncan R, 1996, STP PHARMA SCI, V6, P237
   Fu K, 1999, J CONTROL RELEASE, V58, P357, DOI 10.1016/S0168-3659(98)00192-8
   GALAKATOS N, 2000, Patent No. 0059627
   Godwin A., 2001, ANGEW CHEM INT EDIT, V113, P614
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hem DL, 1998, J BIOMED MATER RES, V39, P266
   Hewes JD, 2000, CHIM OGGI, V18, P20
   Hodge P, 2001, REACT FUNCT POLYM, V48, P15, DOI 10.1016/S1381-5148(01)00037-2
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   JAMES K, 1997, EXAMPLES SYNTHETIC M, P389
   Jandeleit B., 1999, ANGEW CHEM INT EDIT, V38, P2494
   JI Y, 1999, Patent No. 9963992
   JOSEPHMCCARTHY D, 1999, Patent No. 9929280
   KABANOV A, 1999, Patent No. 9939731
   KAPLAN AM, 1980, ANIONIC POLYM DRUGS, P227
   KOHN J, 1986, BIOMATERIALS, V7, P176, DOI 10.1016/0142-9612(86)90098-0
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1996, POLYM MAT ENCY, V9, P7279
   KOHN J, 2001, Patent No. 0149249
   Langer R, 1998, NATURE, V392, P5
   Lemieux P, 2000, GENE THER, V7, P986, DOI 10.1038/sj.gt.3301189
   LINTON B, 1999, CURR OPIN CHEM BIOL, P307
   Lowe CR, 2001, CURR OPIN CHEM BIOL, V5, P248, DOI 10.1016/S1367-5931(00)00199-X
   Lundquist JJ, 2000, J ORG CHEM, V65, P8245, DOI 10.1021/jo000943e
   MAMMEN M, 1995, J MED CHEM, V38, P4179, DOI 10.1021/jm00021a007
   Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
   MANDEVILLE H, 1999, CURR OPIN CARDIOVASC, V1, P241
   MARQUESS D, 1999, Patent No. 9966944
   MCFARLAND E, 1999, TIB TECH, V17, P115
   MENGER FM, 1995, J ORG CHEM, V60, P6666, DOI 10.1021/jo00126a008
   Menger FM, 1998, J ORG CHEM, V63, P7578, DOI 10.1021/jo9812431
   Menger FM, 1997, J ORG CHEM, V62, P9083, DOI 10.1021/jo971076p
   Motherwell WB, 2001, TETRAHEDRON, V57, P4663, DOI 10.1016/S0040-4020(01)00288-5
   Nathan A., 1994, BIOMEDICAL POLYM DES, P117
   Ostuni E, 2001, LANGMUIR, V17, P2828, DOI 10.1021/la001372o
   Patel N, 2000, J BIOMAT SCI-POLYM E, V11, P319, DOI 10.1163/156856200743724
   Patterson S, 1998, TETRAHEDRON LETT, V39, P3111, DOI 10.1016/S0040-4039(98)00514-0
   PHARM FORMULATION CO, 2001, Patent No. 0149311
   Rader HJ, 1998, ACTA POLYM, V49, P272
   Ramstrom O, 1998, ANAL COMMUN, V35, P9, DOI 10.1039/a707876e
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   REECE PA, 1998, Patent No. 9821243
   REGELSON W, 1973, WATER SOLUBLE POLYME, V2, P161
   Reynolds CH, 1999, J COMB CHEM, V1, P297, DOI 10.1021/cc9900044
   Sabourin L, 1998, ANAL COMMUN, V35, P285, DOI 10.1039/a806195e
   SCHREIBER S, 1996, Patent No. 9613613
   Schultz PG, 1998, CURR OPIN SOLID ST M, V3, P153, DOI 10.1016/S1359-0286(98)80081-8
   SPARKS MA, 1993, J MED CHEM, V36, P778, DOI 10.1021/jm00058a016
   Stevens RC, 2000, CURR OPIN STRUC BIOL, V10, P558, DOI 10.1016/S0959-440X(00)00131-7
   Stockwell BR, 1998, CURR BIOL, V8, P761, DOI 10.1016/S0960-9822(98)70299-4
   Strong LE, 1999, J AM CHEM SOC, V121, P6193, DOI 10.1021/ja990223t
   Suarez N, 1998, BIOMATERIALS, V19, P2347, DOI 10.1016/S0142-9612(98)00151-3
   THAO J, 2001, J MATER RES, P1565
   TOONE E, 2000, CARBOHYDR CHEM BIOL, V2, P863
   UCHEGBU F, 1996, P INT S CONTR REL BI
   ULBRICH K, 1987, MAKROMOL CHEM, V188, P1261
   WHITESIDES G, 1998, Patent No. 9846270
NR 77
TC 34
Z9 38
U1 6
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 3
PY 2001
VL 53
IS 1
BP 123
EP 130
DI 10.1016/S0169-409X(01)00224-1
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 501XZ
UT WOS:000172712500008
PM 11733121
DA 2018-10-20
ER

PT J
AU Probst, J
   Gbureck, U
   Thull, R
AF Probst, J
   Gbureck, U
   Thull, R
TI Binary nitride and oxynitride PVD coatings on titanium for biomedical
   applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE biomedical coatings; vacuum evaporation; X-ray diffraction; titanium;
   refractory metals; steered arc technique
ID ARC-EVAPORATION; HARD COATINGS; TIN; TEMPERATURE
AB The aim of this study was the development and characterization of wear resistant and adhesive (oxy-)nitride refractory metal PVD coatings for biomedical applications. The steered are technique with a special sector target was used to vaporize two different metal components. The subjects of investigations were layers of (Ti,Zr)N, (Ti, NON and (Ti, Nb)ON with an average thickness of approximately 3-4 mum. By means of the sector target. the zirconium content of the (Ti,Zr)N layers could be varied between 50% and 70%, and the niobium content of the (Ti,Nb)N layers between 30% and 40%. X-Ray diffraction analysis showed for all materials that the cubic TiN lattice structure still dominates while a part of the titanium atoms are successively substituted by the second metal component. Zr and Nb, respectively. An excessive insertion of oxygen at interstitial sites leads to an embrittlement of the resulting coatings. All investigated coatings showed a preferred growth in the (111) direction of the cubic lattice. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Wurzburg, Dept Funct Mat Med & Dent, ZMK Clin, D-97070 Wurzburg, Germany.
RP Probst, J (reprint author), Univ Wurzburg, Dept Funct Mat Med & Dent, ZMK Clin, Pleicherwall 2, D-97070 Wurzburg, Germany.
RI Gbureck, Uwe/G-1430-2012
CR BOELENS S, 1987, SURF COAT TECH, V33, P63, DOI 10.1016/0257-8972(87)90177-0
   BRADING HJ, 1992, NUCL INSTRUM METH B, V66, P230, DOI 10.1016/0168-583X(92)96156-S
   CHRISTENSEN A, 1953, T AM SOC MET, V45, P397
   EUFINGER H, 1997, DT ARZTEBLATT, V94, P1962
   Gahlin R, 1995, SURF COAT TECH, V76, P174, DOI 10.1016/02578-9729(50)25979-
   GASSER B, 1997, MO, V51, P88
   HAKANSSON G, 1991, SURF COAT TECH, V48, P51, DOI 10.1016/0257-8972(91)90128-J
   JEROSCH J, 1997, DTSCH ARZTEBLATT, V94, P372
   KNOTEK O, 1989, PLASMA SURF ENG, V2, P643
   *NATL BUR STAND US, 1987, NATL BUR STAND US MO, V21
   *NATL BUR STAND US, 1987, NATL BUR STAND US MO, V136
   *NATL BUR STAND US, 1987, NATL BUR STAND US MO, V25
   POLO MC, 1991, SURF COAT TECH, V45, P67, DOI 10.1016/0257-8972(91)90207-D
   PROBST J, 1998, THESIS U WUERZBURG
   Rocca M, 1998, INT J ARTIF ORGANS, V21, P553
   SCHMIDBAUER SB, 1997, FRONT BIOSCI, V2, P6
   THORNTON JA, 1975, J VAC SCI TECHNOL, V12, P830, DOI 10.1116/1.568682
   THULL R, 1990, MED PROG TECHNOL, V16, P225
   THULL R, 1994, BONELOCK
NR 19
TC 85
Z9 85
U1 1
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC 3
PY 2001
VL 148
IS 2-3
BP 226
EP 233
DI 10.1016/S0257-8972(01)01357-3
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 504UZ
UT WOS:000172875400017
DA 2018-10-20
ER

PT J
AU Bumrerraj, S
   Katz, JL
AF Bumrerraj, S
   Katz, JL
TI Scanning acoustic microscopy study of human cortical and trabecular bone
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Conference on the Mechanical Properties of Cells and Tissues
CY OCT 11-13, 1999
CL AUGUSTUSBURG, GERMANY
DE scanning acoustic microscopy; cortical bone; trabecular bone; acoustic
   impedance; elastic moduli
ID ELASTIC PROPERTIES
AB Scanning acoustic microscopy (SAM) has been used in the burst mode to study the properties of human cortical and trabecular bone. An Olympus UH3 SAM (Olympus Co., Tokyo, Japan) was used with a 400 MHz burst mode lens (120degrees aperture, nominal lateral resolution 2.5 mum). The human cortical bone was from the midshaft of a femur from a 60+ male cadaver; the trabecular bone specimens were obtained from the distal femoral condyles of another 60+ human male cadaver. Elastic moduli for both trabecular and cortical bone were obtained by means of a series of calibration curves correlating SAM gray levels of known materials with their elastic moduli, specimens included: polypropylene, PMMA, Teflon, aluminum, Pyrex glass, titanium, and stainless steel. Values obtained by this method are in good agreement with those obtained by nanoindentation techniques. The three critical findings earlier by Katz and Meunier were observed here as well in both the cortical and trabecular bone samples. (C) 2001 Biomedical Engineering Society.
C1 Case Western Reserve Univ, Dept Biomed Engn, Case Sch Engn, Cleveland, OH 44106 USA.
   Khon Kaen Univ, Sch Med, Dept Biochem, Khon Kaen 40002, Thailand.
   Univ Texas, Sch Med, Dept Orthopaed, Houston, TX USA.
RP Katz, JL (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Case Sch Engn, Cleveland, OH 44106 USA.
OI Bumrerraj, Sauwanan/0000-0001-6704-5420
CR Biro L., 1983, Ultrasonics International 83. Conference Proceedings, P79
   BRIGGS GAD, 1992, ACOUSTIC MICROSCOPY
   BUMRERRAJ S, 1999, SCANNING ACOUSTIC MI
   DAS P, 1982, ULTRASON S P IEEE, P718
   Eckardt I, 2001, ANN BIOMED ENG, V29, P1043, DOI 10.1114/1.1424909
   HEIN HJ, 1995, ANN ANAT, V177, P427, DOI 10.1016/S0940-9602(11)80149-4
   KATZ JL, 1993, J BIOMECH ENG-T ASME, V115, P543, DOI 10.1115/1.2895537
   LEE S, HDB ELASTIC PROPERTI, V3, P148
   LEMONS RA, 1974, APPL PHYS LETT, V24, P163, DOI 10.1063/1.1655136
   LEMONS RA, 1979, PHYS ACOUSTICS, V14, P1
   MEUNIER A, 1988, J ORTHOPAED RES, V6, P770, DOI 10.1002/jor.1100060521
   Rho JY, 1999, J BIOMED MATER RES, V45, P48, DOI 10.1002/(SICI)1097-4636(199904)45:1<48::AID-JBM7>3.0.CO;2-5
   Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8
   ZIMMERMAN MC, 1990, IEEE T BIO-MED ENG, V37, P433, DOI 10.1109/10.55634
NR 14
TC 33
Z9 34
U1 0
U2 9
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2001
VL 29
IS 12
BP 1034
EP 1042
DI 10.1114/1.1424908
PG 9
WC Engineering, Biomedical
SC Engineering
GA 517LG
UT WOS:000173611600002
PM 11853252
DA 2018-10-20
ER

PT J
AU Kreuz, P
   Arnold, W
   Kesel, AB
AF Kreuz, P
   Arnold, W
   Kesel, AB
TI Acoustic microscopic analysis of the biological structure of insect wing
   membranes with emphasis on their waxy surface
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Conference on the Mechanical Properties of Cells and Tissues
CY OCT 11-13, 1999
CL AUGUSTUSBURG, GERMANY
DE dragonfly; locust; aeshna cyanea; locusta migratoria; cuticle; ultrathin
   membranes
ID CHITIN
AB The mechanical performance of natural materials depends on the type, and especially the composition of the molecular constituents. They are almost without exception composite materials, whose characteristics are determined by the characteristics of the individual constituents, their shape, their interaction, and in particular their orientation within the natural material. One of the most impressive natural composites is the insect cuticle. This lightweight building material impresses one with its ability to withstand extremely heavy loading. Even the ultrathin (3-10 mum) membranes of insect wings add greatly to the structural stability of the wings. By means of acoustic microscopy, the present study also shows that the thin covering of wax on the membrane is not an accidental material arrangement. Contrary to that of locust wings, dragonfly wing membranes were found to have a criss-cross fiber-like density gradient within to the waxy layer. This density gradient proved to be mechanically relevant in stabilizing the wings. (C) 2001 Biomedical Engineering Society.
C1 Univ Saarland, Dept Zool Tech Biol & Bion, D-66041 Saarbrucken, Germany.
   Univ Saarland, Fraunhofer Inst Nondestruct Testing, IZFP, D-66041 Saarbrucken, Germany.
RP Kesel, AB (reprint author), Univ Saarland, Dept Zool Tech Biol & Bion, D-66041 Saarbrucken, Germany.
EM a.kesel@rz.uni-sb.de
RI Arnold, Walter/G-4717-2011
OI Arnold, Walter/0000-0003-3588-8719
CR BLACKWELL J, 1980, J MOL BIOL, V137, P49, DOI 10.1016/0022-2836(80)90156-4
   BRIGGS GAD, 1992, ACOUSTIC MICROSCOPY
   Cho YI, 1998, J AGR FOOD CHEM, V46, P3839, DOI 10.1021/jf971047f
   DANG VL, 1995, POLYM MAT ENCY SYNTH
   Gorb SN, 2000, ARTHROPOD STRUCT DEV, V29, P129, DOI 10.1016/S1467-8039(00)00020-7
   GORDON JE, 1998, SCI STRUCTURE MAT
   Hirsekorn S, 1996, APPL PHYS LETT, V69, P2138, DOI 10.1063/1.118156
   Kesel AB, 1998, COMPUT BIOL MED, V28, P423, DOI 10.1016/S0010-4825(98)00018-3
   Kesel AB, 2001, ZOOL-ANAL COMPLEX SY, V103, P222
   KESEL AB, 1998, 12 BION, P107
   KESEL AB, 1996, P 9 INT C MECH MED B, P395
   KESEL AB, 2001, 15 BION, P164
   KREUZ P, THESIS
   KREUZ P, 1998, 12 BION, P327
   KREUZ P, 2000, 14 BION, P16
   NEVILLE AC, 1975, BIOL ARTHROPOD CUTIC, P448
   NEVILLE AC, 1993, BIOL FIBROUS COMPOSI, P214
   Vincent J.F.V., 1980, Symposia of the Society for Experimental Biology, P183
   Vincent J. F. V., 1990, STRUCTURAL BIOMATERI
   Wagner T, 1996, ACTA ZOOL-STOCKHOLM, V77, P213, DOI 10.1111/j.1463-6395.1996.tb01265.x
   Waterhouse D.F., 1980, P19
   WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553
NR 22
TC 27
Z9 32
U1 2
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2001
VL 29
IS 12
BP 1054
EP 1058
DI 10.1114/1.1424921
PG 5
WC Engineering, Biomedical
SC Engineering
GA 517LG
UT WOS:000173611600005
PM 11853255
DA 2018-10-20
ER

PT J
AU Reilly, GC
   Knapp, HF
   Stemmer, A
   Niederer, P
   Tate, MLK
AF Reilly, GC
   Knapp, HF
   Stemmer, A
   Niederer, P
   Tate, MLK
TI Investigation of the morphology of the lacunocanalicular system of
   cortical bone using atomic force microscopy
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Conference on the Mechanical Properties of Cells and Tissues
CY OCT 11-13, 1999
CL AUGUSTUSBURG, GERMANY
DE fluid flow; osteocyte; lacunae; canaliculi; collagen; corrosion casting;
   bone morphology; ultrastructure
ID ELECTRON-MICROSCOPY; FLUID-FLOW; RAT; PROTEOGLYCANS; COLLAGEN; MATRIX;
   CASTS; MODEL
AB Mechanical loading has been implicated as a powerful driving mechanism for interstitial fluid flow through bone. However, little information is available with regard to the morphology of bone fluid spaces, e.g., the canalicular wall, which would be expected to dictate the type of flow regime developing in the lacunocanalicular system under mechanical loads. The purpose of this study was to examine the fine structure of the lacumocanalicular system in cortical bone using atomic force microscopy (AFM), resin casting methods, and selective etching of the specimen surface. A resin-cast replica of the canalicular wall was produced and surface morphology and dimensions were observed using AFTVI in tapping mode. Material contrast was obtained using surface potential measurements. A striped pattern perpendicular to the canaliculus long axis with a periodicity of 125 nm dominated the structure of the canalicular wall; it is likely that this was caused by the imprint of collagen fibrils arranged in parallel, lining the canaliculus wall. The largest dimension measured for canalicular diameter was on the order of 500 nm. The regular dips and ridges caused by the collagen that lines the wall are a source of roughness which may influence shear stresses imparted by the fluid on the cell surface as well as mixing of solutes within the lacunocanalicular system. In addition, the lacunocanalicular wall lining is likely to affect physicochemical interactions between the fluid and bone matrix. This has important implications for modeling and understanding the microfluid mechanics and theology of the fluid-filled lacunocanalicular network. (C) 2001 Biomedical Engineering Society.
C1 Univ Zurich, Inst Biomed Engn & Med Informat, CH-8092 Zurich, Switzerland.
   Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland.
   Swiss Fed Inst Technol, Nanotechnol Grp, ETH Ctr CLA, CH-8092 Zurich, Switzerland.
   AO Res Inst, Davos, Switzerland.
RP Tate, MLK (reprint author), Cleveland Clin Fdn, Dept Bioengn, Lerner Res Inst ND20, 9500 Euclid Ave, Cleveland, OH 44195 USA.
EM tatem@bme.ri.ccf.org
RI Knothe Tate, Melissa L./O-2086-2015; Reilly, Gwendolen/C-3456-2009
OI Knothe Tate, Melissa L./0000-0002-3552-2525; Reilly,
   Gwendolen/0000-0003-1456-1071
CR ATKINSON PJ, 1982, PROGR ANATOMY, V2, P179
   Bigi A, 1997, BIOMATERIALS, V18, P657, DOI 10.1016/S0142-9612(96)00156-1
   BONUCCI E, 1977, VIRCHOWS ARCH A, V373, P213, DOI 10.1007/BF00432238
   Burger EH, 1999, FASEB J, V13, pS101
   CASTENHOLZ A, 1989, SCANNING MICROSCOPY, V3, P315
   CASTENHOLZ A, 1983, SCANNING ELECTRON MI, V4, P1955
   COOPER RR, 1966, J BONE JOINT SURG AM, VA 48, P1239, DOI 10.2106/00004623-196648070-00001
   COWIN SC, 1995, J BIOMECH, V28, P1281, DOI 10.1016/0021-9290(95)00058-P
   CURTIS TA, 1985, ANAT RECORD, V212, P336, DOI 10.1002/ar.1092120403
   GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330
   GUZELSU N, 1990, J BIOMECH, V23, P673, DOI 10.1016/0021-9290(90)90167-2
   HEIN HJ, 1998, J BIOMECH, V31, P22
   ISMAIL OS, 1988, ANAT REC, V222, P121, DOI 10.1002/ar.1092220203
   Jacobs HO, 1999, REV SCI INSTRUM, V70, P1756, DOI 10.1063/1.1149664
   Jacobs HO, 1997, ULTRAMICROSCOPY, V69, P39, DOI 10.1016/S0304-3991(97)00027-2
   KNAPP HF, IN PRESS SCANNING
   KRATKY RG, 1989, SCANNING MICROSCOPY, V3, P937
   LEES S, 1994, CALCIFIED TISSUE INT, V55, P180, DOI 10.1007/BF00425873
   LUK SC, 1974, J ULTRA MOL STRUCT R, V46, P184, DOI 10.1016/S0022-5320(74)80055-9
   MARTI O, 1998, P SCANN PROB MICR, P105
   MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x
   NICOLELLA DP, 1999, P BIOENG C BED, V42, P319
   RALIS ZA, 1981, MICROSC ACTA, V84, P385
   Raspanti M, 1997, J STRUCT BIOL, V119, P118, DOI 10.1006/jsbi.1997.3865
   SAUREN YMHF, 1992, ANAT REC, V232, P36, DOI 10.1002/ar.1092320105
   SCHERFT JP, 1972, J ULTRA MOL STRUCT R, V38, P318, DOI 10.1016/S0022-5320(72)90008-1
   Sims PA, 1999, MICROSC MICROANAL, V5, P99, DOI 10.1017/S1431927699000070
   SKERRY TM, 1990, CALCIFIED TISSUE INT, V46, P318, DOI 10.1007/BF02563823
   TAKAGI M, 1991, J HISTOCHEM CYTOCHEM, V39, P41, DOI 10.1177/39.1.1898498
   TAO NJ, 1992, BIOPHYS J, V63, P1165, DOI 10.1016/S0006-3495(92)81692-2
   Tate MLK, 2000, J EXP BIOL, V203, P2737
   Tate MLK, 1998, BONE, V22, P107
   Tate MLK, 2000, J BIOMECH, V33, P247, DOI 10.1016/S0021-9290(99)00143-8
   TATE MLK, 2001, BONE BIOMECHANICS HD
   TATE MLK, 2001, T ORTHOPAED RES SOC, V26, P138
   WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8
   Wiesmann HP, 1998, CELL TISSUE RES, V294, P93, DOI 10.1007/s004410051159
   You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161
   YOU L, 1999, ADV BIOENGINEERING B, V43, P171
NR 39
TC 32
Z9 38
U1 2
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2001
VL 29
IS 12
BP 1074
EP 1081
DI 10.1114/1.1424910
PG 8
WC Engineering, Biomedical
SC Engineering
GA 517LG
UT WOS:000173611600008
PM 11853258
DA 2018-10-20
ER

PT J
AU Hildebrand, G
   Kunze, S
   Driver, M
AF Hildebrand, G
   Kunze, S
   Driver, M
TI Blood cell adhesion on sensor materials studied by light, scanning
   electron, and atomic-force microscopy
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT Conference on the Mechanical Properties of Cells and Tissues
CY OCT 11-13, 1999
CL AUGUSTUSBURG, GERMANY
DE haemocompatibility; cell substrate interaction; bioreactor; flow through
   chamber; on-line adhesion kinetic; PC-polymer coatings
ID COPOLYMER; SURFACES
AB Unwanted interactions of biomedical sensors with surrounding tissues, body fluids, and cells are one of the most crucial problems affecting their long-term stability. In vivo processes were simulated in a computer-controlled bioreactor connected to a flow chamber system. Optical sensor materials were inserted into a parallel-plate chamber and monitored by light microscopy in order to get information about the number of adhered cells. Tests with thrombocyte-enriched plasma show that novel phosphorylcholine (PC)-polymer-coated sensors appear to be more bioinert, and thus demonstrate better haemo-copatibility in comparison with untreated ass sensors. The influence of different materials on the morphology of adhered cells was investigated by off-line methods such as scanning electron microscopy (SEM) and atomic-force microscopy (AFM). SEM showed a reduction in the number of adhered thrombocytes and the lack of any fibrin network on the PC-polymer-modified glass surface, in contrast to the pure glass surface. AFM gives topographical information, and the calculated contact areas and cell volumes indicate smaller interactions between cells and sensor material in the case of PC-polymer-coated sensors. (C) 2001 Biomedical Engineering Society.
C1 Inst Bioproc & Analyt Measurement Tech EV, D-37308 Heilbad, Heiligenstadt, Germany.
   Biocompatibles Ltd, Farnham GU9 8QL, Surrey, England.
RP Hildebrand, G (reprint author), Inst Bioproc & Analyt Measurement Tech EV, D-37308 Heilbad, Heiligenstadt, Germany.
CR Friedbacher G, 1999, PURE APPL CHEM, V71, P1337, DOI 10.1046/j.1365-3075.1999.00266.x
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HILDEBRAND G, 2000, OPTO 2000 P WUNST GE, P199
   IP WF, 1985, J BIOMED MATER RES, V19, P161, DOI 10.1002/jbm.820190206
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   ISHIHARA K, 1990, POLYM J, V22, P255
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   LIEFEITH K, 2000, UNPUB P 10 HEIL KOLL
   LIEFEITH K, 1995, MATER CORROS, V46, P157
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   SCHMIDT R, 1994, WERKSTOFFVERHALTEN B, P269
   Sjollema J., 1988, Biofouling, V1, P101
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Zhang SF, 1998, BIOMATERIALS, V19, P691, DOI 10.1016/S0142-9612(97)00174-9
   Zhang SF, 1996, BIOSENS BIOELECTRON, V11, P1019, DOI 10.1016/0956-5663(96)87661-5
   ZHANG SF, 1996, CELL ENG, V1, P103
NR 17
TC 4
Z9 4
U1 0
U2 3
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2001
VL 29
IS 12
BP 1100
EP 1105
DI 10.1114/1.1424919
PG 6
WC Engineering, Biomedical
SC Engineering
GA 517LG
UT WOS:000173611600012
PM 11853262
DA 2018-10-20
ER

PT J
AU Grant, GGS
   Koktysh, DS
   Yun, BG
   Matts, RL
   Kotov, NA
AF Grant, Gregory G. S.
   Koktysh, Dmitry S.
   Yun, BoGeon
   Matts, Robert L.
   Kotov, Nicholas A.
TI Layer-By-Layer Assembly of Collagen Thin Films: Controlled Thickness and
   Biocompatibility
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE layer-by-layer assembly; thin films; polyelectrolytes; collagen;
   biocompatibility
AB The extracellular matrix molecular collagen is the one of the most widely utilized scaffolding materials in tissue engineering. However, obtaining uniform bioactive collagen films in the nanoscale range and precisely controlling the physical and chemical properties of these biological films is still a challenge for biomedical engineering. Layer-by-layer assembly, i.e., sequential adsorption of oppositely charged macromolecular species, is a powerful new film preparation technique that can be applied to the design of versatile biomaterials, with well-controlled interfacial, mechanical and biological functions. To demonstrate the feasibility of biomaterial design by means of layer-by-layer assembly, type-I collagen thin films were prepared by using this technique with poly(styrene) sulfonate as a partner polyelectrolyte. The gradual build-up of the collagen films was confirmed by UV-vis spectroscopy and ellipsometry, while their surface morphology was assessed by atomic force microscopy. The thickness of the collagen layers can be changed by increasing the number of bilayers adsorbed with an increment of 13 nm. It was found that the layer-by-layer assembled collagen scaffolds can support the attachment and growth of C2C12 myoblast cells and PC12 pheochromocytoma cells. Accurate thickness control and compatibility with nerve cell precursors indicate the utility of layer-by-layer assembled films in neuroprosthesis.
C1 [Grant, Gregory G. S.; Koktysh, Dmitry S.; Kotov, Nicholas A.] Oklahoma State Univ, Dept Chem, Stillwater, OK 74078 USA.
   [Yun, BoGeon; Matts, Robert L.] Oklahoma State Univ, Noble Res Ctr, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.
RP Kotov, NA (reprint author), Oklahoma State Univ, Dept Chem, 107 PS I, Stillwater, OK 74078 USA.
OI Kotov, Nicholas/0000-0002-6864-5804
FU NSF [CHE-9876265]; AFOSR [F49620-99-C-0072]; OCAST, NSF/NATO (NSF-NATO)
   OSU Sensor Center [DGE-9902637]; NSF/NATO (NSF-NATO) [DGE-9902637]
FX N.A.K. thanks NSF CAREER (CHE-9876265), AFOSR (F49620-99-C-0072), and
   OCAST, NSF/NATO (NSF-NATO Grant # DGE-9902637) OSU Sensor Center, for
   partial financial support of this research. D.S.K. acknowledges support
   from the NSF/NATO (NSF-NATO Grant # DGE-9902637) for the postdoctoral
   fellowship.
CR Aliev FG, 1999, ADV MATER, V11, P1006, DOI 10.1002/(SICI)1521-4095(199908)11:12<1006::AID-ADMA1006>3.0.CO;2-2
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Falini G, 1998, CHEM-EUR J, V4, P1048, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1048::AID-CHEM1048>3.0.CO;2-U
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Koktysh D.S., 2001, UNPUB
   Mamedov A, 2000, LANGMUIR, V16, P3941, DOI 10.1021/la990957j
   Nakamura O., 1994, J BONE MINER METAB, V12, P17
   Ngankam PA, 2000, J AM CHEM SOC, V122, P8998, DOI 10.1021/ja000783o
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   Pins GD, 1995, MAT SCI ENG C-BIOMIM, V3, P101, DOI 10.1016/0928-4931(95)00109-3
   Silver F.H., 1997, HDB BIODEGRADABLE PO, V7, P319
   Uemura T, 1997, MAT SCI ENG C-BIO S, V4, P303, DOI 10.1016/S0928-4931(97)00015-5
NR 18
TC 51
Z9 53
U1 1
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2001
VL 3
IS 4
BP 301
EP 306
DI 10.1023/A:1012456714628
PG 6
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KX
UT WOS:000209018800006
DA 2018-10-20
ER

PT J
AU Bower, CK
   Bothwell, MK
   McGuire, J
AF Bower, CK
   Bothwell, MK
   McGuire, J
TI Lantibiotics as surface active agents for biomedical applications
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Review
DE antimicrobial coating; drug absorption; lantibiotic; nisin
ID COLLOIDAL SILICA; DRUG-DELIVERY; T4 LYSOZYME; NISIN; ADSORPTION;
   PEPTIDE; WATER; RESISTANCE; ABSORPTION; PROTEINS
AB The unique physical structure of lantibiotics, (e.g. double bonds. thioethers rings, and unusual amino acid residues), makes these antimicrobial peptides highly reactive, and thus different in mode-of-action from clinical antibiotics. Members of the lantibiotic group have been successfully tested against pathogenic organisms for decades. Some lantibiotics have been studied for use in treating skin infections, and several have been characterized for their anti-viral activity. In addition to their antimicrobial capabilities, lantibiotics possess amphiphilic characteristics, making them potentially valuable as emulsifiers in drug formulations. The small size and surface activity of these peptides also may allow them to enhance the transport of therapeutic compounds across cell membranes. Over 30 lantibiotics are presently known, and more are being discovered each year. With the rising incidence of resistant bacteria, lantibiotics offer considerable potential as safe, antimicrobial barriers for use on synthetic material surfaces, as emulsifiers in formulation of hydrophobic drugs, and as absorption promoters for selected compounds across mucosal membranes. The major hindrance to research in this area is that lantibiotics are difficult to obtain. But with improved methods for production and purification of these unusual antimicrobial agents, the promise of cost-effective application of lantibiotics may eventually be realized. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Oregon State Univ, Corvallis, OR 97331 USA.
CR AMSELEM S, 1993, LIPOSOME TECHNOLOGY, V1, pCH28
   ANDRADE JD, 1996, INTERFACIAL PHENOMEN, pCH2
   Bani-Jaber A, 2000, J FOOD SCI, V65, P502, DOI 10.1111/j.1365-2621.2000.tb16036.x
   Bower CK, 1998, BIOTECHNOL BIOENG, V58, P658, DOI 10.1002/(SICI)1097-0290(19980620)58:6<658::AID-BIT13>3.0.CO;2-3
   BOWER CK, 1995, APPL ENVIRON MICROB, V61, P992
   BOWER CK, UNPUB COLL SURF B
   BRASH J, 1995, PROTEINS INTERFACE 2, V602, pCH1
   COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050
   DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006
   Elliott TSJ, 1998, J HOSP INFECT, V40, P193, DOI 10.1016/S0195-6701(98)90137-2
   ENNIS RD, 1990, PHARMACEUT RES, V7, P468, DOI 10.1023/A:1015856430657
   FIELDING RM, 1991, CLIN PHARMACOKINET, V21, P155, DOI 10.2165/00003088-199121030-00001
   FLIER JS, 1985, TRANSNASAL SYSTEMIC, P217
   FUKASE K, 1988, TETRAHEDRON LETT, V29, P795, DOI 10.1016/S0040-4039(00)80212-9
   GARCERA MJG, 1993, EUR J BIOCHEM, V212, P417, DOI 10.1111/j.1432-1033.1993.tb17677.x
   GLASBY JS, 1992, DICT ANTIBIOTIC PROD
   Guder A, 2000, BIOPOLYMERS, V55, P62, DOI 10.1002/1097-0282(2000)55:1<62::AID-BIP60>3.3.CO;2-P
   HANSEN JN, 1993, ANNU REV MICROBIOL, V47, P535, DOI 10.1146/annurev.mi.47.100193.002535
   Jung G., 1991, NISIN NOVEL LANTIBIO, P1
   KELLNER R, 1988, EUR J BIOCHEM, V177, P53, DOI 10.1111/j.1432-1033.1988.tb14344.x
   KIDO Y, 1983, J ANTIBIOT, V36, P1295, DOI 10.7164/antibiotics.36.1295
   KIM S, 1993, DRUGS, V46, P618, DOI 10.2165/00003495-199346040-00004
   KLEINKAUF H, 1982, P INT C TRENDS ANT R, P220
   Kupke T, 1996, ANTON LEEUW INT J G, V69, P139, DOI 10.1007/BF00399419
   Lakamraju M, 1996, J COLLOID INTERF SCI, V178, P495, DOI 10.1006/jcis.1996.0144
   LEE WA, 1992, DRUG TARGETING DELIV, pCH16
   Lee WK, 1999, J COLLOID INTERF SCI, V213, P265, DOI 10.1006/jcis.1999.6135
   LIAN LY, 1991, P 1 INT WORKSH LANT, P43
   LIU W, 1990, APPL ENVIRON MICROB, V56, P2551
   MCGUIRE J, 1995, PROTEINS INTERFACE 2, V602, pCH4
   MCMARTIN C, 1987, J PHARM SCI, V76, P535, DOI 10.1002/jps.2600760709
   NARUSE N, 1989, J ANTIBIOT, V42, P837, DOI 10.7164/antibiotics.42.837
   Natsume H, 1999, INT J PHARM, V185, P1, DOI 10.1016/S0378-5173(99)00100-3
   Nes IF, 1996, ANTON LEEUW INT J G, V69, P89, DOI 10.1007/BF00399414
   NIU WW, 1991, ANTIMICROB AGENTS CH, V35, P998, DOI 10.1128/AAC.35.5.998
   NORDE W, 1992, COLLOID SURFACE, V64, P87, DOI 10.1016/0166-6622(92)80164-W
   RAUCH PJG, 1994, BACTERIOCINS LACTIC, pCH6
   REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F
   Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41
   SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0
   Shiba T., 1991, NISIN NOVEL LANTIBIO, P113
   STURZEL W, 1997, SURFACTANTS COSMETIC, pCH25
   SUTTIPRASIT P, 1993, FOOD HYDROCOLLOID, V7, P241, DOI 10.1016/S0268-005X(09)80175-6
   Tian MH, 1998, J COLLOID INTERF SCI, V200, P146, DOI 10.1006/jcis.1997.5348
   Wang J, 1997, J COLLOID INTERF SCI, V185, P317, DOI 10.1006/jcis.1996.4619
   WOOLLINS JD, 1996, BIOL INTERACTIONS SU, pCH1
NR 46
TC 15
Z9 15
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC
PY 2001
VL 22
IS 4
BP 259
EP 265
DI 10.1016/S0927-7765(01)00199-0
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 479NE
UT WOS:000171409800001
DA 2018-10-20
ER

PT J
AU Gotz, A
   Gracia, I
   Cane, C
   Morrissey, A
   Alderman, J
AF Gotz, A
   Gracia, I
   Cane, C
   Morrissey, A
   Alderman, J
TI Manufacturing and packaging of sensors for their integration in a
   vertical MCM microsystem for biomedical applications
SO JOURNAL OF MICROELECTROMECHANICAL SYSTEMS
LA English
DT Article
DE ion sensitive field-effect transistor (ISFET); microsystem; monolithic
   integration; pressure sensor; sensor packaging; vertical multichip
   module (MCM-V)
AB The goal of this work is to demonstrate the feasibility of integrating fragile micromachined chips into a complex three-dimensional (3-D) multichip module (MCM) microsystem for a biomedical application. The system is based on the vertical integration of the different parts: micropumps and valves, a multisensor chip for on-line control of the system and a signal-processing chip. In this paper, packaging of the microsystem is studied in order to minimize the induced stress that can affect the integrity of the different micromachined parts of the system. Standard commercially available components and materials were used so as to minimize costs for the case of high volume packaging. For testing the approach, a multisensor chip which includes thin silicon membrane-based devices has been used as the main test structure to compare different packaging materials. In addition, for the fabrication of such a sensor chip in an efficient mode, technological modules needed to fabricate sensors on complementary metal-oxide-semiconductor (CMOS) wafers are discussed. The definition of standardized "add-on" sensor modules to the CMOS process of a foundry is intended to limit the development cost of smart sensors.
C1 CSIC, CNM, E-08193 Bellaterra, Spain.
   NMRC, Cork, Ireland.
RP Gotz, A (reprint author), CSIC, CNM, Campus UAB, E-08193 Bellaterra, Spain.
RI Gracia, Isabel/P-7208-2015; Cane, Carles/O-5927-2016
OI Gracia, Isabel/0000-0001-8563-9468; Cane, Carles/0000-0003-0676-9294
CR BRYZEK J, 1996, SENSORS, V13, P4
   BRZOZKA Z, 1994, SENSOR ACTUAT B-CHEM, V18, P38, DOI 10.1016/0925-4005(94)87052-7
   ESTEVE D, 1997, BARMINT BASIC RES MI
   Gotz A, 1998, P SOC PHOTO-OPT INS, V3514, P112, DOI 10.1117/12.323924
   KELLY G, 1992, P ELECTR C, P467, DOI 10.1109/ECTC.1992.204247
   KO WH, 1994, P 4 INT C EXH MICR E, P545
   Martensson L, 1996, INT J HUM FACTOR MAN, V6, P29
   Morrissey A, 1997, P SOC PHOTO-OPT INS, V3224, P161, DOI 10.1117/12.284511
   REINHOUDT DN, 1995, SENSOR ACTUAT B-CHEM, V24, P197, DOI 10.1016/0925-4005(95)85042-2
   Senturia SD, 1998, SENSOR ACTUAT A-PHYS, V67, P1, DOI 10.1016/S0924-4247(97)01754-8
   van den Berg A., 1994, Sensors and Materials, V6, P23
   VANDERSHOOT BH, 1993, SENSOR ACTUAT B-CHEM, V13, P66
   WALSH S, 1999, P 4 INT C COMM MICR
   WONG HS, 1989, IEEE T ELECTRON DEV, V36, P479, DOI 10.1109/16.19957
NR 14
TC 4
Z9 4
U1 0
U2 5
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1057-7157
J9 J MICROELECTROMECH S
JI J. Microelectromech. Syst.
PD DEC
PY 2001
VL 10
IS 4
BP 569
EP 579
DI 10.1109/84.967380
PG 11
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 496GM
UT WOS:000172387900012
DA 2018-10-20
ER

PT J
AU Brovarone, CV
   Verne, E
   Krajewski, A
   Ravaglioli, A
AF Brovarone, CV
   Verne, E
   Krajewski, A
   Ravaglioli, A
TI Graded coatings on ceramic substrates for biomedical applications
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE Al(2)O(3)-substrate; bioactivity; coatings; glass matrix; thermal
   expansion; ZrO(2)
ID PLASMA SPRAY DEPOSITION; MEDICAL APPLICATIONS
AB Bioactive glasses and particles reinforced composites were used to coat alumina substrates, in order to combine the mechanical properties of the high-strength alumina with the bioactivity of the coatings. The coatings were either monolithic glass or glass-matrix, zirconia particle composite and were prepared by a low-cost firing method. A multilayer approach was applied to minimize crack propagation at the interface between the coating and the substrate. Functionally graded structures were developed to achieve a compliant material to withstand the stresses due to the expansion coefficient mismatch between the substrate and the coatings. The sequential coating of the alumina with glass-matrix/zirconia particle composite layers produced a structurally stable composite structure. A systematic study revealed that multiple layers were necessary to provide a gradual compliance of the thermal expansion coefficient. The glass-matrix/zirconia particles composites layers were also essential for the control of the Al(3) diffusion from the substrate through the glass. This is in accordance with the experimental results of previous works. Thus, the alumina content in the coating should be maintained as low as possible in order to preserve its bioactivity. The composite layers were further coated by a glass belonging to the system SiO(2)-CaO-P(2)O(5)-Na(2)O- MGO-F(-), known for its bioactivity. The experimental results were substantiated by optical and scanning electron microscopy (SEM) with compositional analysis (EDS) and by a mechanical characterization. The in vitro behavior of the coated samples was investigated by means of soaking in simulated body fluid (SBF) followed by SEM observation and XRD analysis. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Politecn Torino, Mat Sci & Chem Engn Dept, I-10129 Turin, Italy.
   CNR, IRTEC, I-48018 Faenza, Italy.
RP Brovarone, CV (reprint author), Politecn Torino, Mat Sci & Chem Engn Dept, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
EM vitale@athena.polito.it
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Verne,
   Enrica/0000-0002-8649-4739
CR Berger G, 1992, 4 WORLD BIOM C APR 2, P33
   DUCHEYNE P, 1993, INTRO BIOCERAMICS, P281
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Ferraris M, 1996, J AM CERAM SOC, V79, P1515, DOI 10.1111/j.1151-2916.1996.tb08759.x
   FERRARIS M, 1996, BIOCERAMIC COATINGS, P31
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HULBERT SF, 1983, INTRO CERAMICS, V1, P25
   RAVAGLIOLI A, 1992, INTERCERAM, V41, P69
   SHELBY JE, 1979, J APPL PHYS, V50, P8010, DOI 10.1063/1.325986
   TORRICELLI P, BIOL GLASS COATING C
   Verne E, 1998, J EUR CERAM SOC, V18, P363, DOI 10.1016/S0955-2219(97)00134-9
NR 11
TC 25
Z9 28
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD DEC
PY 2001
VL 21
IS 16
BP 2855
EP 2862
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA 499XD
UT WOS:000172595200008
DA 2018-10-20
ER

PT J
AU Gitter, DM
AF Gitter, DM
TI International conflicts over patenting human DNA sequences in the United
   States and the European Union: An argument for compulsory licensing and
   a fair-use exemption
SO NEW YORK UNIVERSITY LAW REVIEW
LA English
DT Review
ID INTELLECTUAL PROPERTY-RIGHTS; GENE PATENTS; HUMAN-GENOME;
   BIOMEDICAL-RESEARCH; BIOTECHNOLOGY; SCIENCE; LAW; DISCRIMINATION;
   INFRINGEMENT; INVENTIONS
AB The thought of a large biotech company holding an exclusive right to research and manipulate human genetic material provokes many reactions-from moral revulsion to enthusiasm about the possibilities for therapeutic advancement. While most agree that such a right must exist, debate continues over the appropriate extent of its entitlements and preclusive effects. In this Article, Professor Donna Gitter addresses this multidimensional problem of patents on human deoxyribonucleic acid (DNA) sequences in the United States and the European Union. Professor Gitter chronicles not only the development of the law in this area, but also the array of policy, and moral arguments that proponents and detractors of such patents raise. She emphasizes the specific issue of patents on DNA sequences whose function has not filly been identified, and the chilling effect these patents may, have on beneficial research. From this discussion emerges a troubling realization: While the legal framework governing "life patents" may be similar in the United States and the European Union, the public perceptions and attitudes toward them are not, Professor Gitter thus proposes a dual reform: a compulsory licensing regime requiring holders of DNA sequence patents to license them to commercial researchers, in return for a royalty keyed to the financial success of the product that the licensee develops; and an experimental-use exemption from this regime for government and nonprofit researchers.
C1 Fordham Univ, Sch Business, Bronx, NY 10458 USA.
RP Gitter, DM (reprint author), Fordham Univ, Sch Business, Bronx, NY 10458 USA.
CR Abbott A, 2000, NATURE, V404, P802
   ADLER R, 1988, HARVARD J LAW TECH, V1, P1
   ADLER RG, 1992, SCIENCE, V257, P908, DOI 10.1126/science.1502557
   ADLER RG, 1988, HARV JL TECH, V1, P11
   Alberts B, 2000, NATURE, V404, P325, DOI 10.1038/35006245
   ANDERSON A, 1988, NATURE, V336, P300
   ANDERSON C, 1991, NATURE, V353, P486
   ANDERSON C, 1991, NATURE, V353, P485
   Angier Natalie, 2000, NY TIMES        0627, pA1
   ARNOLD BE, 2001, BIOTECHNOLOGY LAW  S, P2
   ARTHUR C, 1995, INDEPENDENT LON 1120, P2
   ARTHUR C, 2000, INDEPENDENT LON 0316, P21
   ATKINS R, 2000, FIN TIMES LONDO 0811, P6
   Ball H, 1944, LAW COPYRIGHT LIT PR, P260
   BAUMGARDT D, 1952, BENTHAM ETHICS TODAY, P171
   BELSIE L, 1999, CHRISTIAN SCI M 0819, P18
   Belsie Laurent, 1999, Christ Sci Monitor, P18
   BENDER GA, 2000, IDEA, V40, P52
   Bender Gretchen Ann, 2000, IDEA, V40, P49
   BERNSON A, 2000, NY TIMES        0315, pA1
   BLAKENEY M, 1996, TRADE RELATED ASPECT, P87
   BLOUNT S, 1997, SCIENCE, V276, P187
   Blount Steve, 1999, J PAT TRADEMARK OFF, V81, P13
   Blount Steve, 1999, J PAT TRADEMARK OFF, V81, P11
   Bobrow M, 2001, NATURE, V409, P763, DOI 10.1038/35057480
   BOBROW M, 2001, NATURE, V409, P764
   BORSON DB, 1995, IDEA, V35, P461
   BORSON DB, 1995, IDEA, V35, P483
   BOSTYN SJR, 1999, INTELL PROP Q, V3, P14
   BOYCE N, 2000, NEW SCI         0520, P15
   BROWN P, 1994, NEW SCI         1112, P4
   Burk Dan L., 1998, SECTON HALL CONST LJ, V8, P683
   Burk DL, 2000, TEX LAW REV, V79, P99
   BURK DL, 1998, SECTON HALL CONST LJ, V8, P690
   BURK DL, 2000, TEX LAW REV, V79, P153
   Butler D, 2000, NATURE, V404, P324
   BUTLER D, 1992, INDEPENDENT LON 1102, P14
   Carey J, 2000, BUS WEEK, P147
   CAREY J, 2000, BUS WK          0612, P152
   CELERA, 2001, SCIENCE, V291, P1191
   CHAPMAN J, 2000, EXPRESS         0222
   CHARTRAND S, 2000, NY TIMES        0306, pC9
   COLETURNER R, 1995, SCIENCE, V270, P52, DOI 10.1126/science.270.5233.52
   CONNOR S, 2000, INDEPENDENT LON 1115, P11
   COOKSON C, 1993, FIN TIMES LONDO 1220, P12
   Cornish WR, 1998, IIC-INT REV IND PROP, V29, P735
   CORNISH WR, 1996, INTELLECTUAL PROPERT, P20
   CORREA CM, 1998, INTELLECTUAL PROPERT, P189
   Crespi RS, 1997, BIOTECHNOLOGY, PATENTS AND MORALITY, P219
   CURIEN H, 1991, SCIENCE, V254, P1710
   DAVIES K, 2001, CRACKING GENOME
   Dickson D, 2000, NATURE, V405, P3
   Dickson D, 1998, NATURE, V392, P423, DOI 10.1038/32964
   Doll JJ, 1998, SCIENCE, V280, P689, DOI 10.1126/science.280.5364.689
   DRAHOS P, 1999, EUR INTELL PROP REV, V21, P442
   Drahos P., 1999, EUROPEAN INTELLECTUA, V21, P441
   DRONAMRAJU KR, 1998, BIOL SOCIAL ISSUES B, P112
   DUCOR P, 1995, J PAT TRADEMARK OFF, V77, P871
   DUCOR P, 1995, J PAT TRADEMARK OFF, V77, P888
   DUCOR PG, 1998, PATENTING RECOMBINAN, P10
   DUNLEAVY KJ, 1999, NATL LJ         0524, pC11
   Eisenberg Rebecca S, 1990, Emory Law J, V39, P721
   EISENBERG RS, 1987, YALE LAW J, V97, P177, DOI 10.2307/796481
   EISENBERG RS, 1995, AM INTELL PROP L ASS, V23, P3
   EISENBERG RS, 1987, YALE LAW J, V97, P217
   EISENBERG RS, 1990, EMORY LJ, V39, P722
   Enserink M, 2000, SCIENCE, V287, P1196, DOI 10.1126/science.287.5456.1196
   ENSERINK M, 2000, SCIENCE, V287, P1197
   Erramouspe M, 1996, UCLA LAW REV, V43, P961
   ERRAMOUSPE M, 1996, UCLA LAW REV, V43, P966
   FARRANT P, 1999, IP WORLDWIDE     JUL
   Ford R, 1997, Eur Intellect Prop Rev, V19, P315
   Gavaghan H, 1998, SCIENCE, V280, P1188, DOI 10.1126/science.280.5367.1188
   Gitter D., 2001, BERKELEY J INT L, V19, P1
   GITTER DM, 2001, BERKELEY J INT L, V19, P7
   GOLDSTEIN P, 1993, COPYRIGHT PATENT TRA, P402
   GOSTIN L, 1991, AM J LAW MED, V17, P109
   Gostin Larry, 1991, AM JL MED, V17, p[109, 110]
   HANTMAN RD, 1985, J PATENT TRADEMARK, V67, P617
   HANTMAN RD, 1985, J PAT TRADEMARK OFF, V67, P639
   HARMON A, 2001, NY TIMES        1019, pA1
   HAWLEY RS, 1999, HUMAN GENOME USERS G, P8
   Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698
   HERMAN R, 1992, WASH POST       0616, P11
   Holman MA, 2000, IOWA LAW REV, V85, P735
   HOLMAN MA, 2000, IOWA LAW REV, V85, P750
   HOWARTH A, 1992, SCIENCE, V256, P11, DOI 10.1126/science.1566049
   HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391
   ISRAELSEN N, 1988, AM INTELECT PROP L A, V16, P457
   JAENICHEN HR, 1997, EUROPEAN PATENT OFFI, P243
   KRIMSKY S, 1999, CHICAGO KENT LAW REV, V75, P15
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   LANGRETH R, 2000, WALL ST J       0316, pA18
   LANGRETH R, 2000, WALL ST J       0316, pA19
   LEAKE J, 2001, SUN TIMES LONDO 0225, P5
   LEDANTAM S, 2001, WASH POST       1021, pA4
   LEDER P, 1988, Patent No. 4736866
   Licking E, 2000, BUS WEEK, P152
   LLEWELYN M, 1994, EUR INTELL PROP REV, V16, P476
   LLEWELYN M, 1994, EUR INTELL PROP REV, V16, P473
   LOREN LP, 1997, J INTELL PROP L, V5, P15
   Loren Lydia Pallas, 1997, J INTELL PROP L, V5, P1
   Machin N, 1999, CALIF LAW REV, V87, P421, DOI 10.2307/3481089
   MACHIN N, 1999, CAL L, V87, P423
   Magnani T A, 1999, Berkeley Technol Law J, V14, P443
   MAGNANI TA, 1999, BERKELEY TECH LJ, V14, P448
   MARSHALL E, 2000, SCI NOW         0223
   MARTIN E, 2000, OXFORD DICT BIOL, P62
   MCCOY J, 1993, FORDHAM INTELL PROP, V4, P501
   MCCOY J, 1993, FORDHAM INTELL PROP, V4, P509
   MCGOURTY C, 2000, DAILY TELEGRAPH 0607
   MEEK J, 2000, GUARDIAN LONDON 0626, P8
   MEEK J, 2000, GUARDIAN LONDON 0126, P6
   MEEK J, 2000, GUARDIAN LONDON 1115
   Merges Robert P., 1995, AIPLA Q J, V23, P1
   Merges RP, 1996, CALIF LAW REV, V84, P1293, DOI 10.2307/3480996
   Mueller JM, 2001, WASH LAW REV, V76, P1
   MUELLER JM, 2001, WASH L REV, V76, P51
   MURRAY J, 1999, CHI KENT L REV, V75, P234
   Murray J., 1999, CHI KENT L REV, V75, P231
   NAYSMITH S, 2000, SUNDAY HERALD   0723, P4
   Newby TG, 1999, STANFORD LAW REV, V51, P1633, DOI 10.2307/1229532
   NEWBY TG, 1999, STANFORD LAW REV, V51, P1648
   O'Rourke MA, 2000, COLUMBIA LAW REV, V100, P1177, DOI 10.2307/1123488
   OROURKE MA, 2000, COLUMBIA LAW REV, V100, P1191
   Oser A, 1999, IIC-INT REV IND PROP, V30, P1
   OSER A, 1999, INT REV IND PROP COP, V30, P8
   Pelias M Z, 2000, Emory Law J, V49, P837
   PELIAS MZ, 2000, EMORY LJ, V49, P849
   POLLACK A, 2000, NY TIMES        1023, pC1
   PRESTON R, 2000, NEW YORKER      0612, P66
   QUINN B, 2001, COMMUNICATION   0711
   RADFORD T, 2000, GUARDIAN UK     1115, P4
   RAI A, 2000, WASH U JL POLY, V2, P205
   Rai A. K., 2000, WASH U JL POLY, V2, P199
   Rai AK, 1999, NORTHWEST U LAW REV, V94, P77
   RAI AK, 1999, NORTHWEST U LAW REV, V94, P110
   RAM NS, 1998, BIOSCI L REV, V2, P43
   REGALADO A, 2000, TECHNOLOGY REV   SEP, P50
   Reichhardt T, 1998, NATURE, V396, P499, DOI 10.1038/24929
   Reynolds T, 2000, J NATL CANCER I, V92, P596, DOI 10.1093/jnci/92.8.596
   Reynolds T, 2000, J NATL CANCER I, V92, P184, DOI 10.1093/jnci/92.3.184
   RIDLEY M, 1999, GENOME, P6
   RIFKIN J, 2001, HOUSTON CHRON   0702, pC5
   RIFKIN J, 1998, BIOTECH CENTURY, P160
   ROBERTS L, 1992, SCIENCE, V255, P912, DOI 10.1126/science.1546285
   ROBERTS L, 1991, SCIENCE, V252, P498, DOI 10.1126/science.2020849
   ROSENBERG PD, 1999, PATENT LAW FUNDAMENT, V3, P19
   RUBERTI A, 1992, SCIENCE, V256, P11, DOI 10.1126/science.1566050
   SCALISE DG, 1993, FORDHAM INT LJ, V16, P990
   SCALISE DG, 1993, FORDHAM INT LJ, V16, P999
   SCHAFFER R, 1999, INT BUSINESS LAW ITS, P88
   Schapira R, 1997, BIOTECHNOLOGY, PATENTS AND MORALITY, P171
   Schatz U, 1998, IIC-INT REV IND PROP, V29, P2
   Schiermeier Q, 2000, NATURE, V406, P111, DOI 10.1038/35018230
   Scott A, 1999, EUROPEAN INTELLECTUA, V21, P212
   SELLERS ME, 1994, ARK L REV, V47, P290
   SELLERS ME, 1994, ARK L REV, V47, P269
   SHULMAN S, 2000, TECH REV         SEP, P67
   Smaglik P, 2000, NATURE, V404, P322
   Sterckx S, 1997, BIOTECHNOLOGY, PATENTS AND MORALITY, P1
   STONE R, 1995, SCIENCE, V268, P1126, DOI 10.1126/science.7761825
   Straus J, 1995, IIC-INT REV IND PROP, V26, P920
   STRAUS J, 1994, PATENTING HUMAN GENE, P12
   STRAUS J, 1995, INT REV IND PROP COP, V26, P926
   TSEVDOS EJ, 1997, NATL LJ         0616, pC1
   VANDEKAMP GJ, 1998, EUR ENV L REV, V7, P235
   VANDEKAMP GJ, 1998, EUR ENV L REV, V7, P234
   Venter J. C., 2001, SCIENCE, V291, P1305
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   VINJE TC, 1995, EUR INTELL PROP REV, V17, P361
   VONMEIBOM W, 1997, PAT WORLD        JUN, P29
   VONMEIBOM W, 1997, PATENT WORLD     JUN, P27
   Wade N, 2000, N Y Times Web, pA18
   Wade Nicolas, 2000, NY TIMES        0407, pA20
   WALDHOLZ M, 1994, WALL ST J       0211, pB1
   Waldholz Michael, 2000, WALL ST J       0316, pA1
   Walter CF, 1998, INDIANA LAW J, V73, P1025
   WALTER CF, 1998, IND LJ, V73, P1029
   1995, FED REG         0714, V60, P36264
   FED REG, V66, P1095
   2000, GLOBAL NEWS WIR 0307
   2000, INSTRUMENT BUS  0915
   FED REG, V66, P1096
   2001, FED REG         0105, V62, P1098
   1997, NATURE, V385, P670
   1997, NATURE, V385, P671
   2001, FED REG         0105, V66, P1098
   1995, FED REG         0714, V60, P36263
   2001, FED REG         0105, V66, P1092
   2001, NY TIMES        0106, pC3
   2001, LANCET, V357, P81
NR 192
TC 37
Z9 38
U1 3
U2 8
PU NEW YORK UNIV SCHOOL LAW
PI NEW YORK
PA 110 WEST THIRD ST, NEW YORK, NY 10012 USA
SN 0028-7881
J9 NEW YORK U LAW REV
JI N. Y. Univ. Law Rev.
PD DEC
PY 2001
VL 76
IS 6
BP 1623
EP 1691
PG 69
WC Law
SC Government & Law
GA 499UF
UT WOS:000172588200003
PM 12741387
DA 2018-10-20
ER

PT J
AU Seliktar, D
   Nerem, RM
   Galis, ZS
AF Seliktar, D
   Nerem, RM
   Galis, ZS
TI The role of matrix metalloproteinase-2 in the remodeling of cell-seeded
   vascular constructs subjected to cyclic strain
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE tissue engineering; matrix metalloproteinases; mechanical properties;
   cyclic strain; vascular remodeling
ID SMOOTH-MUSCLE CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; COLLAGEN LATTICES;
   GENE-EXPRESSION; FOAM CELLS; STROMELYSIN; TISSUE
AB Tissue engineering offers the opportunity to develop vascular substitutes that mimic the responsive nature of native arteries. A good blood vessel substitute should be able to remodel its matrix in response to mechanical stimulation, as imposed by the hemodynamic environment. We have developed a novel method of studying the influence of mechanical strain on the remodeling of cell-seeded collagen gel blood vessel analogs. We assessed the remodeling capacity by examining the effect of mechanical conditioning upon the expression of enzymes which remodel the extracellular matrix, called matrix metalloproteinases (MMPs), and upon the mechanical properties of the constructs. We found that subjecting collagen constructs to a 10% cyclic radial distention, over a course of 4 days, resulted in an overall increase in the production of MMP-2. Cyclic mechanical strain also stimulated enzymatic activation of latent MMP-2. We found that cyclic strain also significantly increased the mechanical strength and material modulus, as indicated by an increase in circumferential tensile properties of the constructs. These observations suggested that MMP-2-dependent remodeling affects the material properties of vascular tissue analogs. To further investigate this possible connection we examined the effects of dynamic conditioning in the presence of two nonspecific inhibitors of MMP activity. Interestingly, we found that nonspecific inhibition of MMP ablated the benefits of mechanical conditioning upon mechanical properties. Our observations suggest that a better understanding of the complex relation between mechanical stimulation and construct remodeling is key for the proper design of tissue-engineered blood vessel substitutes. (C) 2001 Biomedical Engineering Society.
C1 Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA.
RP Seliktar, D (reprint author), ETH Zurich, Inst Biomed Engn, Moussonstr 18, CH-8044 Zurich, Switzerland.
OI Seliktar, Dror/0000-0001-6964-8567
FU NIGMS NIH HHS [GM08433]
CR Bullard KM, 1999, J SURG RES, V84, P31, DOI 10.1006/jsre.1999.5599
   GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181
   GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619
   Galis ZS, 1999, FIBRINOLYSIS PROTEOL, V13, P54, DOI 10.1016/S0268-9499(99)90080-2
   Galis ZS, 1998, CIRCULATION, V97, P2445, DOI 10.1161/01.CIR.97.24.2445
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604
   Howard AB, 1997, AM J PHYSIOL-CELL PH, V272, pC421
   JAMES TW, 1993, J CELL PHYSIOL, V157, P426, DOI 10.1002/jcp.1041570227
   KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605
   KHAW PT, 1995, Patent No. 9500576
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209
   MURPHY G, 1994, ANN NY ACAD SCI, V732, P31, DOI 10.1111/j.1749-6632.1994.tb24722.x
   Myers S A, 1998, Adv Dent Res, V12, P86
   NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Vorp DA, 1999, ANN BIOMED ENG, V27, P366, DOI 10.1114/1.158
   Yang JH, 1998, J BIOL CHEM, V273, P6550, DOI 10.1074/jbc.273.11.6550
NR 21
TC 107
Z9 109
U1 0
U2 1
PU BIOMEDICAL ENGINEERING SOC AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD NOV
PY 2001
VL 29
IS 11
BP 923
EP 934
DI 10.1114/1.1415522
PG 12
WC Engineering, Biomedical
SC Engineering
GA 502UE
UT WOS:000172760500001
PM 11791675
DA 2018-10-20
ER

PT J
AU Ji, J
   Feng, LX
   Barbosa, MA
AF Ji, J
   Feng, LX
   Barbosa, MA
TI Stearyl poly(ethylene oxide) grafted surfaces for preferential
   adsorption of albumin
SO BIOMATERIALS
LA English
DT Article
DE amphiphilic copolymer; biocompatible materials; albumin; fibrinogen;
   surface property; protein adsorption
ID BINDING SURFACES; LINEAR-POLYMERS; POLYETHYLENE; AFFINITY; BLENDS
AB An ideal surface for many biomedical applications would resist non-specific protein adsorption while at the same time triggering a specific biological pathway. Based on the approach of selectively binding albumin to free fatty acids, stearyl groups were immobilized onto poly(styrene) backbone via poly(ethylene oxide) side chains. X-ray photoelectron spectroscopy (XPS) analysis indicates substantial surface enrichment of the stearyl poly(ethylene oxide) (SPEO). In an aqueous environment, the surface rearrangement is limited, as proved by dynamic contact angle tests. The comb-like copolymer presents a special hydrophobic surface with high SPEO surface density, which may be due to the 'tail like' SPEO architecture at the copolymer/water interface. Protein adsorption tests confirm that the comb-like surfaces adsorb high levels of albumin and resist fibrinogen adsorption very significantly. The surfaces prepared in this research attract and reversibly bind albumin due to the synergistic action of the PEO chains and the stearyl end groups. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Zhejiang Univ, Dept Polymer Sci, Hangzhou 310027, Peoples R China.
   INEB, Inst Engn Biomed, Lab Biomat, P-4150180 Oporto, Portugal.
   Univ Porto, Fac Engn, Dept Met & Mat Engn, Oporto, Portugal.
RP Ji, J (reprint author), Zhejiang Univ, Dept Polymer Sci, Hangzhou 310027, Peoples R China.
EM jija_99@yahoo.com
RI Barbosa, Mario/F-5964-2011
OI Barbosa, Mario/0000-0003-3568-7482; Ji, Jian/0000-0001-9870-4038
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   BRASH JL, 1976, THROMB RES, V9, P249, DOI 10.1016/0049-3848(76)90214-0
   CAREL JVO, 1994, INTERFACIAL FORCES A, P170
   FRAUTSCHI JR, 1983, T AM SOC ART INT ORG, V29, P242
   GALLO BM, 1975, COPOLYMER POLYM COMP, P85
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   LIDE DR, 1996, SURFACE TENSION COMM, P6
   Mayes AM, 1998, MATER RES SOC SYMP P, V530, P73, DOI 10.1557/PROC-530-73
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   NEUMANN AW, 1979, SURF COLLOID SCI, V11, P31, DOI DOI 10.1007/978-1-4615-7969-4_2
   PITT WG, 1988, J BIOMED MATER RES, V22, P359, DOI 10.1002/jbm.820220502
   QIU YX, 1992, MAKROMOL CHEM, V173, P1377
   RANTER BD, 1996, J MOL RECOGNIT, V9, P617
   Walton DG, 1997, MACROMOLECULES, V30, P6947, DOI 10.1021/ma970698+
   Walton DG, 1996, PHYS REV E, V54, P2811, DOI 10.1103/PhysRevE.54.2811
   WU D, 1995, SCI CHINA SER B, V25, P1121
   WU D, 1995, SCI CHINA SER B, V26, P409
NR 22
TC 31
Z9 32
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2001
VL 22
IS 22
BP 3015
EP 3023
DI 10.1016/S0142-9612(01)00048-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 474FD
UT WOS:000171094900008
PM 11575476
DA 2018-10-20
ER

PT J
AU Long, MC
   Kisielewski, RW
   Richardson, DC
   Schroeder, LW
AF Long, MC
   Kisielewski, RW
   Richardson, DC
   Schroeder, LW
TI An experimental technique for determining biaxial fatigue lifetimes in
   biomedical elastomers
SO INTERNATIONAL JOURNAL OF FATIGUE
LA English
DT Article
DE multiaxial fatigue; rubber; polymers; crack detection; fatigue test
   methods
ID LATEX
AB A novel test apparatus was developed to determine fatigue lifetimes of elastomeric materials. Thin elastomeric sheets (membranes) are biaxially fatigued while contained within a temperature controlled liquid environment. Membranes are displaced in a smooth sinusoidal motion by pumping the surrounding fluid through the equipment's inner cells. An electrical signal (AC) passes through the membrane during fatigue and is used to monitor changes in the elastomer's physical characteristics. In addition, the test cell is designed to allow optical observation of the membrane throughout the fatiguing process. Thus the design results in a test rig apparatus that permits failure determination by both material property changes and obvious fracture. Cyclic fatigue frequencies range from 0.2 to 1.2 Hz. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 US FDA, Div Mech & Mat Sci, Off Sci & Technol, Ctr Devices & Radiol Hlth, Rockville, MD 20850 USA.
RP Long, MC (reprint author), US FDA, Div Mech & Mat Sci, Off Sci & Technol, Ctr Devices & Radiol Hlth, 9200 Corp Blvd,HFZ-150, Rockville, MD 20850 USA.
CR Baumeister T, 1967, STANDARD HDB MECH EN
   Dillon JG, 1997, J APPL POLYM SCI, V64, P553, DOI 10.1002/(SICI)1097-4628(19970418)64:3<553::AID-APP12>3.0.CO;2-Z
   GOLDSTEIN A, 1992, LAT BARR MAT P JUL, P175
   KISIELEWSKI RW, 2000, J TESTING EVAL   MAR, P136
   KORNIEWICZ DM, 1990, J CLIN MICROBIOL, V28, P787
   Lytle CD, 1999, J TEST EVAL, V27, P231
   Moet A., 1986, FAILURE PLASTICS, P345
   VARGAS A, 1979, PLAST RECONSTR SURG, V64, P252, DOI 10.1097/00006534-197908000-00025
NR 8
TC 3
Z9 3
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-1123
J9 INT J FATIGUE
JI Int. J. Fatigue
PD NOV
PY 2001
VL 23
IS 10
BP 911
EP 916
DI 10.1016/S0142-1123(01)00046-9
PG 6
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 484JW
UT WOS:000171687300009
DA 2018-10-20
ER

PT J
AU Leng, YX
   Sun, H
   Yang, P
   Chen, JY
   Wang, J
   Wan, GJ
   Huang, N
   Tian, XB
   Wang, LP
   Chu, PK
AF Leng, YX
   Sun, H
   Yang, P
   Chen, JY
   Wang, J
   Wan, GJ
   Huang, N
   Tian, XB
   Wang, LP
   Chu, PK
TI Biomedical properties of tantalum nitride films synthesized by reactive
   magnetron sputtering
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 28th International Conference on Metallurgical Coatings and Thin Films
CY APR 30-MAY 05, 2001
CL SAN DIEGO, CALIFORNIA
SP AVS Sci & Technol Soc, Adv Surface Engn Div
DE tantalum nitride; blood compatibility; low-temperature isotropic
   pyrolytic carbon; platelet adhesion; artificial heart valve; mechanical
   properties
AB The biomedical properties of tantalum nitride thin films synthesized by reactive magnetron sputtering employing orthogonal design technology are investigated. The adhesion properties between the film and substrate can be enhanced by optimizing the sputtering gas pressure and substrate temperature. The hardness of the tantalum nitride films is greatly affected by the nitrogen partial pressure, and our results show that films deposited under the optimal conditions can achieve a hardness value of approximately 40 GPa. The blood compatibility of the tantalum nitride films, as evaluated by clotting time measurement and platelet adhesion tests, is compared to that of TiN, Ta and low-temperature isotropic pyrolytic carbon (LTIC). Our data reveal that the blood compatibility of our tantalum nitride films is better, and tantalum nitride is thus an excellent material for the fabrication of commercial artificial heart valves. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Sichuan, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
RI Wan, Guojiang/A-6651-2013; Chu, Paul/B-5923-2013; Leng,
   Yongxiang/G-5488-2010; Wan, GJ/A-3648-2009
OI Wan, Guojiang/0000-0002-1636-5405; Chu, Paul/0000-0002-5581-4883; Leng,
   Y.X./0000-0001-6823-1233
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAURSCHMIDT P, 1977, J BIOENG, V1, P261
   BOLZ A, 1990, ARTIF ORGANS, V144, P260
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   Gutmann F, 1986, MODERN BIOELECTROCHE
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   LENG YX, 1998, J MAT ENG, V9, P18
   Mitamura Y, 1989, J Biomater Appl, V4, P33, DOI 10.1177/088532828900400103
   REN L, 1987, EXP OPTIMIZATION TEC, P263
   THROMSON A, 1991, BIOMATERIALS, V12, P37
   XI TF, 1988, T 3 WORLD BIOM C JAP, P32
   ZENG XL, 1998, J SW JIATONG U, V33, P263
NR 14
TC 91
Z9 98
U1 1
U2 31
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD NOV 1
PY 2001
VL 398
BP 471
EP 475
DI 10.1016/S0040-6090(01)01448-1
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 505GZ
UT WOS:000172906200080
DA 2018-10-20
ER

PT J
AU Silagy, CA
   Stead, LF
   Lancaster, T
AF Silagy, CA
   Stead, LF
   Lancaster, T
TI Use of systematic reviews in clinical practice guidelines: case study of
   smoking cessation
SO BRITISH MEDICAL JOURNAL
LA English
DT Article
ID BIOMEDICAL-RESEARCH; EVALUATING PAYBACK
AB Objective To examine the extent to which recommendations in the national guidelines for the cessation of smoking are based on evidence from systematic reviews of controlled trials.
   Design Retrospective analysis of recommendations for the national guidelines for the cessation of smoking.
   Materials National guidelines in clinical practice on smoking cessation published in English.
   Main outcome measures The type of evidence (systematic review of controlled trials, individual trials, other studies, expert opinion) used to support each recommendation. We also assessed whether a Cochrane systematic review was available and could have been used in formulating the recommendation.
   Results Four national smoking cessation guidelines (from Canada, New Zealand, the United Kingdom, and the United States) covering 105 recommendations were identified. An explicit evidence base for 100%, 89%, 68%, and 98% of recommendations, respectively, was detected, of which 60%, 56%, 59%, and 47% were based on systematic reviews of controlled studies. Cochrane systematic reviews could have been used to develop between 39% and 73% of recommendations but were actually used in 0% to 36% of recommendations. The UK guidelines had the highest proportion of recommendations based on Cochrane systematic reviews.
   Conclusions Use of systematic reviews in guidelines is a measure of the "payback" on investment in research synthesis. Systematic reviews commonly underpinned recommendations in guidelines on smoking cessation. The extent to which they were used varied by country and there was evidence of duplication of effort in some areas. Greater international collaboration in developing and maintaining an evidence base of systematic reviews can improve the efficiency of use of research resources.
C1 Monash Med Ctr, Monash Inst Hlth Serv Res, Clayton, Vic 3168, Australia.
   Inst Hlth Sci, Dept Primary Hlth Care, Imperial Canc Res Fund Gen Practice Res Grp, Cochrane Tobacco Addict Grp, Oxford OX3 7LF, England.
RP Silagy, CA (reprint author), Monash Med Ctr, Monash Inst Hlth Serv Res, Clayton, Vic 3168, Australia.
CR Chalmers I, 2000, BRIT MED J, V321, P566, DOI 10.1136/bmj.321.7260.566
   CHALMERS L, 1992, BRIT MED J, V340, P786
   Cohen D, 1998, SMOKING CESSATION ME
   FIORE MC, 1996, US DEP HHS PUBLICATI
   Fiore MC, 2000, TREATING TOBACCO USE
   Grant J, 2000, BRIT MED J, V321, P566
   Grant J, 2000, BRIT MED J, V320, P1107, DOI 10.1136/bmj.320.7242.1107
   Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858
   LANCASTER T, 2000, COCHRANE COLLABORATI
   MCDONALD S, 2000, SYSTEMATIC REV CITED
   *NAT HLTH COMM, 1999, GUID SMOK CESS LIT R
   *NAT HLTH COMM, 1999, GUID SMOK CESS
   Raw M, 1998, THORAX, V53, pS1, DOI 10.1136/thx.53.2008.S1
   Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593
   TAYLOR MC, 1994, CANADIAN GUIDE CLIN, P500
   West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987
   Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527
NR 17
TC 32
Z9 33
U1 0
U2 2
PU BRITISH MED JOURNAL PUBL GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0959-535X
J9 BRIT MED J
JI Br. Med. J.
PD OCT 13
PY 2001
VL 323
IS 7317
BP 833
EP 836
DI 10.1136/bmj.323.7317.833
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 483RW
UT WOS:000171650500024
PM 11597966
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Sahoo, H
   Pavoor, T
   Vancheeswaran, S
AF Sahoo, H
   Pavoor, T
   Vancheeswaran, S
TI Actuators based on electroactive polymers
SO CURRENT SCIENCE
LA English
DT Article
ID ARTIFICIAL MUSCLES
AB Conducting polymers and ionic polymer-metal composites (IPMCs) are among those electro-active polymer materials that have shown tremendous potential to make efficient actuators. The volume change that a conducting polymer undergoes upon electrochemical oxidation and reduction is used to make microactuators, which find various biomedical applications and can be used for manipulation of particles of micrometre dimensions. IPMCs undergo strong bending on application of an electric field, Actuators using IPMCs have space applications. Further development of IPMCs is being done to make it overcome the present obstacles. Conducting polymers and IPMCs have gained recognition due to their low cost, low operating potential and high, efficiency.
C1 Univ Bombay, Dept Chem Technol, Dept Chem Engn, Bombay 400019, Maharashtra, India.
RP Pavoor, T (reprint author), Univ Bombay, Dept Chem Technol, Dept Chem Engn, Matunga, Bombay 400019, Maharashtra, India.
CR Bar-Cohen Y, 2001, P 42 AIAA STRUCT STR
   Bar-Cohen Y., 1999, MRS S FF EL POL, V31295
   BARCOHEN Y, 1998, ROBOTICS 98
   BARCOHEN Y, 2000, HDB BIOMIMETICS
   BARCOHEN Y, 1999, P SPIES 6 ANN INT S
   Jager EWH, 1999, P SOC PHOTO-OPT INS, V3669, P377, DOI 10.1117/12.349696
   Jager EWH, 2000, SCIENCE, V288, P2335, DOI 10.1126/science.288.5475.2335
   OTERO TF, 1995, BIOELECTROCH BIOENER, V38, P411, DOI 10.1016/0302-4598(95)01802-L
   Shahinpoor M, 2000, SMART MATER STRUCT, V9, P543, DOI 10.1088/0964-1726/9/4/318
   Shahinpoor M., 1998, P SPIES 5 ANN INT S
NR 10
TC 14
Z9 14
U1 0
U2 5
PU CURRENT SCIENCE ASSN
PI BANGALORE
PA C V RAMAN AVENUE, PO BOX 8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD OCT 10
PY 2001
VL 81
IS 7
BP 743
EP 746
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 483KD
UT WOS:000171633800010
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU van Hest, JCM
   Tirrell, DA
AF van Hest, JCM
   Tirrell, DA
TI Protein-based materials, toward a new level of structural control
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID TRANSFER-RNA SYNTHETASE; UNNATURAL AMINO-ACIDS; SITE-SPECIFIC
   INCORPORATION; DRAGLINE SILK PROTEINS; IN-VIVO INCORPORATION; SPIDER
   SILK; ESCHERICHIA-COLI; MUSSEL BYSSUS; EFFICIENT INCORPORATION; PERIODIC
   POLYPEPTIDES
AB Through billions of years of evolution nature has created and refined structural proteins for a wide variety of specific purposes. Amino acid sequences and their associated folding patterns combine to create elastic, rigid or tough materials. In many respects, nature's intricately designed products provide challenging examples for materials scientists, but translation of natural structural concepts into bio-inspired materials requires a level of control of macromolecular architecture far higher than that afforded by conventional polymerization processes. An increasingly important approach to this problem has been to use biological systems for production of materials. Through protein engineering, artificial genes can be developed that encode protein-based materials with desired features. Structural elements found in nature, such as P-sheets and a-helices, can be combined with great flexibility, and can be outfitted with functional elements such as cell binding sites or enzymatic domains. The possibility of incorporating non-natural amino acids increases the versatility of protein engineering still further. It is expected that such methods will have large impact in the field of materials science, and especially in biomedical materials science, in the future.
C1 Catholic Univ Nijmegen, Dept Organ Chem, NL-6525 ED Nijmegen, Netherlands.
   CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
RP van Hest, JCM (reprint author), Catholic Univ Nijmegen, Dept Organ Chem, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.
EM vanhest@sci.kun.nl; tirrell@Caltech.edu
RI Sanguansri, Luz/B-6630-2011; van Hest, Jan/D-5625-2012
OI Sanguansri, Luz/0000-0003-1908-7604; van Hest, Jan/0000-0001-7973-2404
CR Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Asakura T, 1999, MACROMOLECULES, V32, P4940, DOI 10.1021/ma990442z
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830
   Coyne KJ, 2000, J EXP BIOL, V203, P1425
   Deming TJ, 1997, ADV MATER, V9, P299, DOI 10.1002/adma.19970090404
   Deming TJ, 1997, J MACROMOL SCI PURE, VA34, P2143, DOI 10.1080/10601329708010331
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   Dougherty DA, 2000, CURR OPIN CHEM BIOL, V4, P645, DOI 10.1016/S1367-5931(00)00148-4
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Furter R, 1998, PROTEIN SCI, V7, P419
   GOLDBERG I, 1989, GENE, V80, P305, DOI 10.1016/0378-1119(89)90294-1
   Hamano-Takaku F, 2000, J BIOL CHEM, V275, P40324, DOI 10.1074/jbc.M003696200
   He SJ, 1998, MACROMOLECULES, V31, P9387, DOI 10.1021/ma981286j
   Hohsaka T, 1999, J AM CHEM SOC, V121, P34, DOI 10.1021/ja9813109
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   HUYNH HT, 1991, EXP CELL RES, V197, P191, DOI 10.1016/0014-4827(91)90422-Q
   Jelinski LW, 1998, CURR OPIN SOLID ST M, V3, P237, DOI 10.1016/S1359-0286(98)80097-1
   Jelinski LW, 1996, SCIENCE, V273, P1481
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   Kiick KL, 2000, ANGEW CHEM INT EDIT, V39, P2148, DOI 10.1002/1521-3773(20000616)39:12<2148::AID-ANIE2148>3.0.CO;2-7
   Kiick KL, 2000, TETRAHEDRON, V56, P9487, DOI 10.1016/S0040-4020(00)00833-4
   Kitamura M, 1999, J POLYM SCI POL CHEM, V37, P729, DOI 10.1002/(SICI)1099-0518(19990315)37:6<729::AID-POLA8>3.3.CO;2-V
   KOTHAKOTA S, 1995, J AM CHEM SOC, V117, P536, DOI 10.1021/ja00106a064
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   Krejchi MT, 1997, MACROMOLECULES, V30, P5012, DOI 10.1021/ma9614050
   Lee TAT, 2000, ADV MATER, V12, P1105, DOI 10.1002/1521-4095(200008)12:15<1105::AID-ADMA1105>3.0.CO;2-1
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Liivak O, 1998, MACROMOLECULES, V31, P2947, DOI 10.1021/ma971626l
   Liu DR, 1997, P NATL ACAD SCI USA, V94, P10092, DOI 10.1073/pnas.94.19.10092
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580
   Matyjaszewski K., 2000, ACS S SERIES, V768
   McGrath K. P., 1997, PROTEIN BASED MAT
   McMillan RA, 2000, ABSTR PAP AM CHEM S, V219, pU453
   Nicol A., 1994, BIOTECHNOLOGY BIOACT
   NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980
   O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.3.CO;2-K
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Panitch A, 1997, MACROMOLECULES, V30, P42, DOI 10.1021/ma961059m
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623
   Qu Y, 2000, J AM CHEM SOC, V122, P5014, DOI 10.1021/ja9935761
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   RICHMOND MH, 1962, BACTERIOL REV, V26, P398
   Riekel C, 1999, MACROMOLECULES, V32, P4464, DOI 10.1021/ma990067a
   ROBINSON C, 1957, NATURE, V180, P1183, DOI 10.1038/1801183a0
   Rutjes FPJT, 2000, J CHEM SOC PERK T 1, P4197, DOI 10.1039/b001538p
   Sambrook J, 1986, MOL CLONING
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Shao Z, 1999, POLYMER, V40, P2493, DOI 10.1016/S0032-3861(98)00475-3
   Sharma N, 2000, FEBS LETT, V467, P37, DOI 10.1016/S0014-5793(00)01120-0
   Tang Y, 2001, BIOCHEMISTRY-US, V40, P2790, DOI 10.1021/bi0022588
   TIRRELL DA, 1991, MRS BULL, V16, P23
   Urry DW, 1998, BIOTECHNOL BIOENG, V58, P175, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<175::AID-BIT10>3.0.CO;2-C
   Urry DW, 1998, BIOPOLYMERS, V47, P167, DOI 10.1002/(SICI)1097-0282(1998)47:2<167::AID-BIP6>3.0.CO;2-S
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j
   van Hest JCM, 1998, FEBS LETT, V428, P68, DOI 10.1016/S0014-5793(98)00489-X
   VANDERREST M, 1990, BIOCHIMIE, V72, P473, DOI 10.1016/0300-9084(90)90071-N
   Waite JH, 1999, ANN NY ACAD SCI, V875, P301, DOI 10.1111/j.1749-6632.1999.tb08513.x
   Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077
   Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y
   Warner SB, 1999, J MACROMOL SCI R M C, VC39, P643
   Watt SW, 1999, MACROMOLECULES, V32, P8671, DOI 10.1021/ma991223g
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P14002, DOI 10.1021/bi005119z
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   YOSHIKAWA E, 1994, MACROMOLECULES, V27, P5471, DOI 10.1021/ma00097a029
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
   Yu SJM, 1997, NATURE, V389, P167
NR 74
TC 264
Z9 264
U1 6
U2 107
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PD OCT 7
PY 2001
IS 19
BP 1897
EP 1904
DI 10.1039/b105185g
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 482PJ
UT WOS:000171584200001
PM 12240211
DA 2018-10-20
ER

PT J
AU Banas, A
   Kwiatek, WM
   Zajac, W
AF Banas, A
   Kwiatek, WM
   Zajac, W
TI Trace element analysis of tissue section by means of synchrotron
   radiation: the use of GNUPLOT for SRIXE spectra analysis
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article; Proceedings Paper
CT 5th International School and Symposium on Synchrotron Radiation in
   Natural Science (ISSRNS)
CY JUN 12-17, 2000
CL POLAND
DE SRIXE; trace elements; GNUPLOT; prostate; kidney
AB Synchrotron Radiation Induced X-ray Emission (SRIXE) is a powerful technique for Trace Element (TE) analysis in biomedical samples. Recently, SRIXE technique has been applied to TE determination in 20 mum thick kidney and prostate tissue sections, taken from cancerous and healthy organs. Results obtained for the latter two are compared. Matrices of biomedical samples are mostly composed of low-Z elements, and trace elements are at low levels. This is why SRIXE data analysis in such materials may be quite a challenge. In order to solve analytical problems, sophisticated fitting procedures have to be applied since a proper spectra analysis requires additional information about the sample. This is usually carried out by dedicated computer software. We are showing that satisfactory results can be obtained by employing GNUPLOT, a public domain script-driven engine for data visualization and curve fitting. The results of GNUPLOT are compared with ones obtained from QXAS. an open domain software (obtained from IAEA). (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Jagiellonian Univ, Inst Phys, PL-30059 Krakow, Poland.
   H Niewodniczanski Inst Nucl Phys, PL-31342 Krakow, Poland.
RP Banas, A (reprint author), Jagiellonian Univ, Inst Phys, Reymonta 4, PL-30059 Krakow, Poland.
RI Zajac, Wojciech/R-1218-2017
OI Zajac, Wojciech/0000-0001-9957-1206; Kwiatek,
   Wojciech/0000-0002-2197-8572
CR BRANDENBURG T, 1992, THESIS HAMBURG U
   HALLIWELL B, 1984, BIOCHEM J, V219, P1
   Jones K. W., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V749, P37
   JONES KW, 1992, HDB XRAY SPECTROMETR, P411
   KWIATEK WM, 1994, ACTA PHYS POL A, V86, P695, DOI 10.12693/APhysPolA.86.695
   1970, NUCL DATA TABLES A, V7, P688
NR 6
TC 10
Z9 10
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD OCT 4
PY 2001
VL 328
IS 1-2
BP 135
EP 138
DI 10.1016/S0925-8388(01)01334-2
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 473RZ
UT WOS:000171063000024
DA 2018-10-20
ER

PT J
AU Righetti, PG
AF Righetti, PG
TI Capillary electrophoretic analysis of proteins and peptides of
   biomedical and pharmacological interest
SO BIOPHARMACEUTICS & DRUG DISPOSITION
LA English
DT Review
DE capillary electrophoresis; proteins; peptides; peptide maps; isoelectric
   buffers; protein folding/unfolding
ID INDUCED FLUORESCENCE DETECTION; RECOMBINANT-HUMAN-ERYTHROPOIETIN;
   ELECTROSPRAY MASS-SPECTROMETRY; BARE SILICA WALL; MICELLAR
   ELECTROKINETIC CHROMATOGRAPHY; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   ZONE-ELECTROPHORESIS; ISOELECTRIC BUFFERS; GLOBIN CHAINS;
   DISSOCIATION-CONSTANTS
AB Capillary electrophoresis (CE) is an automated approach to electrokinetic separations that has had a deep impact in all fields of life sciences, including biomedical and biotechnological research and clinical and forensic practice. The present review highlights aspects of peptides and proteins separations, with particular emphasis on macromolecular analytes of biomedical interest. Among the various CE techniques available, a novel methodology is here illustrated consisting in separations in acidic, isoelectric buffers, which have the advantage of protonating the silica wall, thus minimizing interactions of proteinaceous material with the siliceous surface, while allowing delivery of high voltage gradients, due to their low conductivities. The review ends with applications of CE to the analysis of folding/unfolding/refolding/misfolding of proteins, a field which has deep implications in the biomedical arena, since it is connected to a host of disorders, such as prion protein diseases. Copyright (C) 2001 John Wiley Sons, Ltd.
C1 Univ Verona, Dept Agr & Ind Biotechnol, I-37134 Verona, Italy.
RP Righetti, PG (reprint author), Univ Verona, Dept Agr & Ind Biotechnol, Strada Le Grazie 15, I-37134 Verona, Italy.
OI Righetti, Pier Giorgio/0000-0001-8321-9187
CR Adamson NJ, 1997, J CHROMATOGR B, V699, P133, DOI 10.1016/S0378-4347(97)00202-8
   Asermely KE, 1997, J CHROMATOGR B, V695, P67, DOI 10.1016/S0378-4347(97)00172-2
   Baars MJ, 1999, ANAL CHEM, V71, P667, DOI 10.1021/ac980714g
   Ban EM, 1997, ANAL SCI, V13, P489, DOI 10.2116/analsci.13.Supplement_489
   Banks JF, 1997, ELECTROPHORESIS, V18, P2255, DOI 10.1002/elps.1150181216
   Bardelmeijer HA, 1997, ELECTROPHORESIS, V18, P2214, DOI 10.1002/elps.1150181212
   Bardelmeijer HA, 1998, J CHROMATOGR A, V807, P3, DOI 10.1016/S0021-9673(98)00230-1
   BECKERS JL, 1988, J CHROMATOGR, V452, P591, DOI 10.1016/S0021-9673(01)81482-5
   Bietlot HP, 1997, J CHROMATOGR A, V759, P177, DOI 10.1016/S0021-9673(96)00767-4
   Boss HJ, 1998, ELECTROPHORESIS, V19, P2654, DOI 10.1002/elps.1150191515
   Bossi A, 1997, ELECTROPHORESIS, V18, P2012, DOI 10.1002/elps.1150181122
   Bossi A, 1999, J CHROMATOGR A, V853, P71, DOI 10.1016/S0021-9673(99)00519-1
   Bossi A, 1999, J CHROMATOGR A, V840, P117, DOI 10.1016/S0021-9673(99)00215-0
   Boulis Y, 1998, J CHROMATOGR A, V805, P285, DOI 10.1016/S0021-9673(97)01303-4
   Capelli L, 1997, J CHROMATOGR A, V791, P313, DOI 10.1016/S0021-9673(97)00790-5
   Castagnola M, 1998, ELECTROPHORESIS, V19, P2273, DOI 10.1002/elps.1150191304
   CASTAGNOLA M, 1994, J CHROMATOGR B, V656, P87, DOI 10.1016/0378-4347(94)00082-4
   CASTAGNOLA M, 1991, J CHROMATOGR-BIOMED, V572, P51, DOI 10.1016/0378-4347(91)80472-O
   Castagnola M, 1996, CRC SER ANAL BIOTECH, P239
   Castelletti L, 2000, J CHROMATOGR A, V894, P281, DOI 10.1016/S0021-9673(00)00664-6
   Chen CP, 1997, J CHROMATOGR B, V697, P149, DOI 10.1016/S0378-4347(97)00062-5
   CHIARI M, 1996, CRC SER ANAL BIOTECH, P1
   CHIESA C, 1996, CAPILLARY ELECTROPHO, P155
   Cho BY, 1997, J CHROMATOGR B, V697, P163, DOI 10.1016/S0378-4347(97)00285-5
   Cifuentes A, 1997, ELECTROPHORESIS, V18, P2362, DOI 10.1002/elps.1150181227
   Cifuentes A, 1999, J CHROMATOGR A, V830, P453, DOI 10.1016/S0021-9673(98)00875-9
   Clarke NJ, 1997, J AM SOC MASS SPECTR, V8, P743, DOI 10.1016/S1044-0305(97)00084-6
   COMI P, 1979, BIOCHEM BIOPH RES CO, V87, P1, DOI 10.1016/0006-291X(79)91639-5
   COMPTON BJ, 1991, J CHROMATOGR, V559, P357, DOI 10.1016/0021-9673(91)80085-U
   COMPTON BJ, 1991, ANAL CHEM, V63, P2587
   Cousino MA, 1997, ANAL CHEM, V69, pA544, DOI 10.1021/ac9717651
   Dolnik V, 1997, ELECTROPHORESIS, V18, P2353, DOI 10.1002/elps.1150181226
   Farchaus JW, 1998, APPL ENVIRON MICROB, V64, P982
   GANZLER K, 1996, CRC SER ANAL BIOTECH, P183
   GAO J, 1998, HIGH PERFORMANCE CAP, P947
   Gelfi C, 2001, ANAL CHEM, V73, P3862, DOI 10.1021/ac001478o
   Gelfi C, 1998, ELECTROPHORESIS, V19, P1677, DOI 10.1002/elps.1150191026
   Goldman MH, 1998, BIOTECHNOL BIOENG, V60, P596, DOI 10.1002/(SICI)1097-0290(19981205)60:5<596::AID-BIT10>3.0.CO;2-5
   GROSSMAN PD, 1989, ANAL BIOCHEM, V179, P28, DOI 10.1016/0003-2697(89)90195-4
   Guijt-van Duijn RM, 2000, ELECTROPHORESIS, V21, P3905
   Hearn MTW, 2000, ANAL CHEM, V72, P1964, DOI 10.1021/ac990369a
   Heegaard NHH, 1999, ELECTROPHORESIS, V20, P3122, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3122::AID-ELPS3122>3.3.CO;2-D
   HILSER VJ, 1993, J CHROMATOGR, V630, P329, DOI 10.1016/0021-9673(93)80469-O
   HIROKAWA T, 1987, J CHROMATOGR, V408, P27, DOI 10.1016/S0021-9673(01)81788-X
   Hjerten S, 1967, Chromatogr Rev, V9, P122, DOI 10.1016/0009-5907(67)80003-6
   Hjerten S, 1992, CAPILLARY ELECTROPHO, P191
   Hoitink MA, 1997, J CHROMATOGR A, V776, P319, DOI 10.1016/S0021-9673(97)00349-X
   Jiskra J, 1997, J CHROMATOGR A, V761, P285, DOI 10.1016/S0021-9673(96)00831-X
   JORGENSON JW, 1981, ANAL CHEM, V53, P1298, DOI 10.1021/ac00231a037
   KAIJWARA H, 1998, ELECTROPHORESIS, V19, P1270
   KALMAN F, 1995, J CHROMATOGR A, V705, P135, DOI 10.1016/0021-9673(94)00549-O
   Kasicka V, 1999, ELECTROPHORESIS, V20, P3084, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3084::AID-ELPS3084>3.0.CO;2-4
   KELLY KA, 1998, HIGH PERFORMANCE CAP, P277
   Khaledi M. G, 1998, HIGH PERFORMANCE CAP, P77
   Klyushnichenko V, 1997, J BIOTECHNOL, V58, P187, DOI 10.1016/S0168-1656(97)00149-1
   Kopp K, 1996, ARZNEIMITTEL-FORSCH, V46, P1191
   KRIVANKOVA L, 1998, HIGH PERFORMANCE CAP, P251
   Kubota H, 1998, J CHROMATOGR A, V803, P315, DOI 10.1016/S0021-9673(97)01229-6
   Kundu S, 1997, J CAPILLARY ELECTROP, V4, P7
   Lagu AL, 1999, ELECTROPHORESIS, V20, P3145, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3145::AID-ELPS3145>3.0.CO;2-0
   Lai M, 1998, J PHARMACEUT BIOMED, V18, P421, DOI 10.1016/S0731-7085(98)00049-1
   LAUER HH, 1986, ANAL CHEM, V58, P166, DOI 10.1021/ac00292a041
   Matsubara N, 1996, CRC SER ANAL BIOTECH, P155
   MCCORMICK RM, 1988, ANAL CHEM, V60, P2322, DOI 10.1021/ac00172a003
   MCCORMICK RM, 1993, HDB CAPILLARY ELECTR, P287
   McLaughlin GM, 1998, HIGH PERFORMANCE CAP, P637
   McNerney TM, 1996, J CHROMATOGR A, V744, P223, DOI 10.1016/0021-9673(96)00421-9
   Messana I, 1997, J CHROMATOGR B, V699, P149, DOI 10.1016/S0378-4347(97)00198-9
   MEYER S, 1994, ELECTROPHORESIS, V15, P1151, DOI 10.1002/elps.11501501174
   Moorhouse KG, 1996, ELECTROPHORESIS, V17, P423, DOI 10.1002/elps.1150170223
   Moring S.E., 1996, CRC SER ANAL BIOTECH, P37
   Nieto O, 1996, ANAL COMMUN, V33, P425, DOI 10.1039/ac9963300425
   OFFORD RE, 1966, NATURE, V211, P591, DOI 10.1038/211591a0
   Olivieri E, 2000, J CHROMATOGR A, V894, P273, DOI 10.1016/S0021-9673(00)00665-8
   PALMIERI R, 1993, HDB CAPILLARY ELECTR, P325
   PARK SS, 1997, NEUROPEPTIDE PROTOCO, P101
   Pesek JJ, 1999, ELECTROPHORESIS, V20, P2343, DOI 10.1002/(SICI)1522-2683(19990801)20:12<2343::AID-ELPS2343>3.3.CO;2-0
   Pinto DM, 1997, ANAL CHEM, V69, P3015, DOI 10.1021/ac9611677
   POLASEK M, 1992, J CHROMATOGR, V596, P265, DOI 10.1016/0021-9673(92)85015-L
   POSPICHAL J, 1987, J CHROMATOGR, V390, P17, DOI 10.1016/S0021-9673(01)94356-0
   Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363
   Regnier F. E., 1998, HIGH PERFORMANCE CAP, P683
   Reubsaet JLE, 1998, J PHARMACEUT BIOMED, V17, P979, DOI 10.1016/S0731-7085(98)00064-8
   Reubsaet JLE, 1998, J PHARMACEUT BIOMED, V17, P955, DOI 10.1016/S0731-7085(98)00063-6
   RICKARD EC, 1991, ANAL BIOCHEM, V197, P197, DOI 10.1016/0003-2697(91)90379-8
   Ridge S, 1998, J CHROMATOGR A, V817, P215, DOI 10.1016/S0021-9673(98)00313-6
   Righetti P. G., 1994, J CAP ELEC, V1, P27
   Righetti P. G., 1996, CAPILLARY ELECTROPHO
   Righetti P. G., 1993, CAPILLARY ELECTROPHO, P89
   Righetti P. G., 1996, CRC SER ANAL BIOTECH, P509
   Righetti P. G., 1979, J BIOCHEM BIOPH METH, V1, P47
   Righetti PG, 1997, ELECTROPHORESIS, V18, P2145, DOI 10.1002/elps.1150181205
   Righetti PG, 2000, ELECTROPHORESIS, V21, P4046, DOI 10.1002/1522-2683(200012)21:18<4046::AID-ELPS4046>3.0.CO;2-5
   Righetti PG, 2001, ELECTROPHORESIS, V22, P603, DOI 10.1002/1522-2683(200102)22:4<603::AID-ELPS603>3.0.CO;2-N
   Righetti PG, 1997, J CHROMATOGR A, V772, P203, DOI 10.1016/S0021-9673(97)00105-2
   Righetti PG, 1999, J BIOCHEM BIOPH METH, V40, P1, DOI 10.1016/S0165-022X(99)00010-X
   Righetti PG, 1990, IMMOBILIZED PH GRADI
   Roche ME, 1998, ANAL BIOCHEM, V258, P87, DOI 10.1006/abio.1997.2553
   Roddy TP, 1997, J CHROMATOGR B, V695, P49, DOI 10.1016/S0378-4347(97)00100-X
   Sabah S, 1998, J PHARMACEUT BIOMED, V16, P1089, DOI 10.1016/S0731-7085(97)00054-X
   Saccomani A, 1999, J CHROMATOGR A, V832, P225, DOI 10.1016/S0021-9673(98)00963-7
   Sanz-Nebot V, 2001, J CHROMATOGR A, V921, P69, DOI 10.1016/S0021-9673(01)00730-0
   SCHOMBURG G, 1998, HIGH PERFORMANCE CAP, P481
   Sebastiano R, 2001, J CHROMATOGR A, V924, P71, DOI 10.1016/S0021-9673(01)00804-4
   Sebastiano R, 2000, J CHROMATOGR A, V894, P53, DOI 10.1016/S0021-9673(00)00801-3
   Settlage RE, 1998, J MICROCOLUMN SEP, V10, P281, DOI 10.1002/(SICI)1520-667X(1998)10:3<281::AID-MCS7>3.0.CO;2-C
   SHIEH P, 1998, HIGH PERFORMANCE CAP, P185
   Shihabi ZK, 1998, J CHROMATOGR A, V807, P129, DOI 10.1016/S0021-9673(98)00055-7
   Strege MA, 1997, ELECTROPHORESIS, V18, P2343, DOI 10.1002/elps.1150181225
   SWEDBERG SA, 1993, HDB CAPILLARY ELECTR, P513
   Szoko E, 1997, ELECTROPHORESIS, V18, P74, DOI 10.1002/elps.1150180116
   TANFORD C, 1961, PHYSICAL CHEM MACROM, pCH3
   Thorne JM, 1996, J CHROMATOGR A, V744, P155, DOI 10.1016/0021-9673(96)00513-4
   TIMPERMAN AT, 1995, ANAL CHEM, V67, P3421, DOI 10.1021/ac00115a009
   TOMER KB, 1996, CRC SER ANAL BIOTECH, P123
   Tomlinson AJ, 1997, J AM SOC MASS SPECTR, V8, P15, DOI 10.1016/S1044-0305(96)00133-X
   TSUDA T, 1993, HDB CAPILLARY ELECTR, P563
   Verzola B, 2000, J CHROMATOGR A, V874, P293, DOI 10.1016/S0021-9673(00)00090-X
   Verzola B, 2000, J CHROMATOGR A, V868, P85, DOI 10.1016/S0021-9673(99)01207-8
   Verzola B, 2000, ANAL BIOCHEM, V282, P239, DOI 10.1006/abio.2000.4620
   Vessillier S, 1997, J CHROMATOGR A, V776, P133, DOI 10.1016/S0021-9673(97)00434-2
   Voelter W, 1998, J CHROMATOGR A, V807, P135, DOI 10.1016/S0021-9673(98)00178-2
   WIKTOROWICZ JE, 1998, HIGH PERFORMANCE CAP, P223
   Yang Q, 1999, J BIOCHEM BIOPH METH, V38, P103, DOI 10.1016/S0165-022X(98)00032-3
   Zhou GH, 1998, ELECTROPHORESIS, V19, P2348, DOI 10.1002/elps.1150191315
NR 125
TC 48
Z9 49
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2782
J9 BIOPHARM DRUG DISPOS
JI Biopharm. Drug Dispos.
PD OCT-NOV
PY 2001
VL 22
IS 7-8
BP 337
EP 351
DI 10.1002/bdd.276
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 524EM
UT WOS:000173999500005
PM 11835253
DA 2018-10-20
ER

PT J
AU Ananthanarayan, VT
   Shutov, F
AF Ananthanarayan, VT
   Shutov, F
TI Development of fabric sintering/compaction process to produce porous
   UHMW polyethylene composites
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE porous Ultra High Molecular Weight (UHMW) polyethylene; biomedical
   implant; porous polymer composites; biomedical application
AB Implants based on solid (nonporous) Ultra High Molecular Weight (UHMW) polyethylene have serious disadvantages such as generation of fine polymer particles, because of the lack of internal natural lubricant inside the implant body. A novel family of porous multilayer composites based on Ultra High Molecular Weight (UHMW) polyethylene commercial fabrics has been developed. These composites are produced using a compaction/sintering process with a compression molding technique. The developed porous materials have much higher tensile strength than solid (nonporous) UHMW polyethylene materials.
C1 Tennessee Technol Univ, Dept Chem Engn, Cookeville, TN 38501 USA.
CR AGRAWAL MC, 1995, ENCY HDB BIOMATERIAL
   ANANTHANARAYAN VT, 2000, THESIS TENNESSEE TU
   FUREY MJ, 1993, BIOTR BUD HUNG 6 INT
   MILLER DA, 1995, ENCY HDB BIOMATERIAL
   SHUTOV FA, 1995, T 2 COMB M ORTH RES
NR 5
TC 3
Z9 5
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 2001
VL 16
IS 2
BP 139
EP 148
DI 10.1106/LL58-TM8B-9PUD-X2X1
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 507TJ
UT WOS:000173045100004
PM 11794723
DA 2018-10-20
ER

PT J
AU Belanger, MC
   Marois, Y
AF Belanger, MC
   Marois, Y
TI Hemocompatibility, biocompatibility, inflammatory and in vivo studies of
   primary reference materials low-density polyethylene and
   polydimethylsiloxane: A review
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Review
DE primary reference materials; low-density polyethylene;
   polydimethylsiloxane; biocompatibility; hemocompatibility; inflammatory
   response; in vivo studies; tissue reactions
ID BIO-MEDICAL POLYMERS; BIOMEDICAL POLYMERS; MACROPHAGE ACTIVATION; BLOOD
   COMPATIBILITY; PROTEIN ADSORPTION; PLASMA-PROTEINS; FACTOR-XII;
   BIOMATERIALS; MODEL; VITRO
AB In 1984, low-density polyethylene (LDPE) and polymethylsiloxane (PDMS), two primary reference materials (PRM), were made available by the National Heart, Lung, and Blood Institute (NHLBI) as discriminatory tools for the validation of standardized and novel in vitro and in vivo tests in the evaluation of biomaterials. This article reviews the results and conclusions obtained by several studies investigating the hemocompatibility, in vitro biocompatibility, inflammatory response, and in vivo tissue reactions of these two reference materials. Variable results obtained with LDPE and PDMS in ex vivo hemocompatibility studies were attributed to the type of animal model used, the flow velocity of the circulating blood, the time of exposure, and the methodology used to measure blood cell adhesion or activation at the surface of the materials. In contrast, both the LDPE and PDMS appeared to be suitable reference materials when used in in vitro biocompatibility, inflammatory response, and in vivo studies. However, caution must be taken when interpreting the results, because gamma sterilization of these two materials as well as their origin (for example PDMS) are two critically important factors. In conclusion, we see a definite need for standardized hemocompatible parameters and better high-quality hemocompatibility studies on PRM. This review also suggests other materials as potential PRM candidates, namely, Biomer((R)) and Intra-medic (TM) polyethylene. (C) 2001 John Wiley & Sons.
C1 CHUQ, Quebec Biomat Inst, Hop St Francois Assise, Quebec City, PQ G1L 3L5, Canada.
   Univ Laval, Fac Med, Dept Surg, Quebec City, PQ, Canada.
RP Marois, Y (reprint author), CHUQ, Quebec Biomat Inst, Hop St Francois Assise, 10 Rue Espinay, Quebec City, PQ G1L 3L5, Canada.
CR Akoum A, 1992, J Invest Surg, V5, P129, DOI 10.3109/08941939209012429
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   BONFIELD TL, 1991, J BIOMED MATER RES, V25, P165, DOI 10.1002/jbm.820250204
   BONFIELD TL, 1994, J BIOMED MATER RES, V28, P137, DOI 10.1002/jbm.820280118
   BORDENAVE L, 1992, J BIOMAT SCI-POLYM E, V3, P509, DOI 10.1163/156856292X00475
   BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816
   CAIX J, 1994, J BIOMAT SCI-POLYM E, V5, P279, DOI 10.1163/156856294X00022
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   Fages J, 1998, ASAIO J, V44, P278
   FREYRIA AM, 1991, BIOMATERIALS, V12, P111, DOI 10.1016/0142-9612(91)90187-F
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HUANG B, 1992, BIOMATERIALS, V13, P209, DOI 10.1016/0142-9612(92)90186-R
   IP WF, 1991, J BIOMED MATER RES, V25, P1321, DOI 10.1002/jbm.820251012
   Jakubiec B, 1998, J BIOMED MATER RES, V41, P519, DOI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   KEOUGH EM, 1985, J BIOMED MATER RES, V19, P577, DOI 10.1002/jbm.820190509
   Marois Y, 1999, ASAIO J, V45, P272, DOI 10.1097/00002480-199907000-00005
   MCCOY TJ, 1989, BIOMATERIALS, V10, P243, DOI 10.1016/0142-9612(89)90100-2
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   PELZER H, 1986, J BIOMED MATER RES, V20, P1401, DOI 10.1002/jbm.820200913
   PETILLO O, 1994, J BIOMED MATER RES, V28, P635, DOI 10.1002/jbm.820280514
   SCHMIDT JA, 1993, J APPL BIOMATER, V4, P73, DOI 10.1002/jab.770040110
   SEVASTIANOV VI, 1984, T AM SOC ART INT ORG, V30, P137
   SHINTANI H, 1995, J BIOMATER APPL, V10, P23, DOI 10.1177/088532829501000102
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   Stroman PW, 1999, MAGNET RESON MED, V42, P210, DOI 10.1002/(SICI)1522-2594(199907)42:1<210::AID-MRM29>3.0.CO;2-Q
   VANDERKAMP KWHJ, 1994, J BIOMED MATER RES, V28, P349, DOI 10.1002/jbm.820280309
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
   1980, GUIDELINES BLOOD MAT
   1980, GUIDELINES PHYSIOCHE
   1985, GUIDELINES BLOOD MAT
NR 36
TC 228
Z9 230
U1 8
U2 98
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2001
VL 58
IS 5
BP 467
EP 477
DI 10.1002/jbm.1043
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 472VR
UT WOS:000171006100001
PM 11505420
DA 2018-10-20
ER

PT J
AU Furness, PN
AF Furness, PN
TI Research using human tissues - a crisis of supply?
SO JOURNAL OF PATHOLOGY
LA English
DT Review
DE human tissues; medical ethics; consent
ID ETHICS
AB It is a paradox that the pursuit of ethical practice can sometimes produce distinctly unethical results. Pathologists seek to study diseased human tissues for the benefit of mankind, but in the UK there has been a sudden restriction in the availability of this basic resource, supposedly on ethical grounds. This was triggered by adverse publicity about the inappropriate retention of whole organs at paediatric post-mortem, but the reaction has spread to influence the use of 'surgical waste' left over after routine analysis of therapeutic resections, diagnostic biopsies, and even blood samples. The use of such material for research is being restricted, and its use in teaching and laboratory quality control is being questioned. This has occurred despite the facts that public opinion favours using such 'waste' material for research; that the tissues would otherwise be incinerated; and that until very recently, such tissues were regarded as having been 'abandoned' by the patient. This review attempts to chart how this dramatic change has occurred. It then considers some of the ethical problems in using such 'surplus' tissues and proposes mechanisms by which this valuable resource can remain available for most biomedical research, while maintaining or enhancing the autonomy of individual patients. This crisis has shown a tendency for regulatory authorities to apply very restrictive, oversimplified rules, without due consideration of the character of each project. The motivation is to avoid the possibility of media criticism, even though such rules block ethically sound work which is of value to all, including the individuals whose protection is supposedly being sought. The moral need for logical ethical arguments instead of such 'one size fits all' regulations is emphasized. Copyright (C) 2001 John Wiley & Sons, Ltd.
C1 Univ Leicester, Dept Pathol, Leicester, Leics, England.
RP Furness, PN (reprint author), Leicester Gen Hosp, Dept Pathol, Gwendolen Rd, Leicester LE5 4PW, Leics, England.
CR [Anonymous], 2000, INQUIRY MANAGEMENT C
   [Anonymous], 2001, REPORT ROYAL LIVERPO
   Ashcroft R, 2000, NEUROPATH APPL NEURO, V26, P408, DOI 10.1046/j.1365-2990.2000.00276.x
   Beauchamp T, 1994, PRINCIPLES BIOMEDICA, P4
   de Zulueta P, 2000, J MED ETHICS, V26, P16, DOI 10.1136/jme.26.1.16
   Department of Health, 2001, REF GUID CONS EX TRE
   DEZULUETA P, 2000, J MED ETHICS, V26, P22
   *HOUS LORDS, 2001, SEL COMM SCI TECHN 4
   Human Genetics Commission, 2001, WHOS HANDS YOUR GEN
   Hutton JL, 2000, HEALTH CARE ANAL, V8, P41, DOI 10.1023/A:1009421824028
   *MED RES COUNC, 1999, HUM TISS BIOL SAMPL
   *MED RES COUNC, 2001, HUM TISS BIOL SAMPL
   Medical Research Council, 2000, PERS INF MED RES
   Medical Research Council and Wellcome Trust, 2001, PUBL PERC COLL HUM B
   Nuffield Council on Bioethics, 1995, HUM TISS ETH LEG ISS
   Start RD, 1996, BRIT MED J, V313, P1366, DOI 10.1136/bmj.313.7069.1366
NR 16
TC 11
Z9 11
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0022-3417
J9 J PATHOL
JI J. Pathol.
PD OCT
PY 2001
VL 195
IS 3
BP 277
EP 284
PG 8
WC Oncology; Pathology
SC Oncology; Pathology
GA 481MK
UT WOS:000171522900002
PM 11673823
DA 2018-10-20
ER

PT J
AU Kunzi-Rapp, K
   Genze, F
   Kufer, R
   Reich, E
   Hautmann, RE
   Gschwend, JE
AF Kunzi-Rapp, K
   Genze, F
   Kufer, R
   Reich, E
   Hautmann, RE
   Gschwend, JE
TI Chorioallantoic membrane assay: Vascularized 3-dimensional cell culture
   system for human prostate cancer cells as an animal substitute model
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostate; prostatic neoplasms; chick embryo; chorion; membrane
ID CARCINOMA; ESTABLISHMENT; EMBRYO; GROWTH; LINES; DEATH
AB Purpose: Chorioallantoic membranes have been used as a reliable biomedical assay system for many years. Chicken eggs in the early phase of breeding are between in vitro and in vivo systems but may provide an immunodeficient, vascularized test environment. We tested this model as an in vivo system for prostate cancer research.
   Materials and Methods: Single cell suspensions of LNCaP, PC-3 and Tsu-Prl human prostatic cancer cell lines as well as 2 immortalized normal human prostate epithelial cell lines were inoculated on the chorioallantoic membrane of fertilized chicken eggs on day 5 or 6 of breeding. Tumor growth and viability of the embryo was evaluated by stereo microscopy. At day 10 the membranes were removed and embedded in paraffin. Cell morphology was assessed after hematoxylin and eosin staining. Cellular expression of cytokeratin, prostate specific antigen and androgen receptor as well as apoptosis induction was confirmed by immunohistochemistry.
   Results: Three days after tumor cell inoculation on the extraembryonic vascular system of the chorioallantoic membrane cell growth and formation of 3-dimensional tumors became apparent in 100% of inoculated membranes. Strong neo-angiogenesis was detected next to the established tumors and tumor cells invading the stroma of the chorioallantoic membrane. Cytokeratin expression as well as prostate specific antigen and androgen receptor in LNCaP cells confirmed the human prostate tumor origin. Assessment of quantitative in vivo apoptosis induction in LNCaP cells after intravenous injection of the phorbol ester 12-0-tetradecanoylphorbol-13-acetate confirmed the model as a versatile in vivo system.
   Conclusions: The well vascularized chorioallantoic membrane of bred chicken eggs is a suitable system for early in vivo cancer research. Reliable growth of prostate cancer cell lines is feasible and allows the evaluation of proliferation and apoptosis induction after intravascular or topic application of anticancer drugs. Exploitation of this assay enables a substantial reduction in or substitution for subsequent animal experiments.
C1 Univ Ulm, Dept Urol, D-89075 Ulm, Germany.
   Univ Ulm, Inst Laser Technol Med & Metrol, D-89075 Ulm, Germany.
RP Gschwend, JE (reprint author), Univ Ulm, Dept Urol, Prittwitz Str 43, D-89075 Ulm, Germany.
CR ARMSTRONG PB, 1982, CANCER RES, V42, P1826
   AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9
   AUSPRUNK DH, 1975, AM J PATHOL, V79, P597
   DAGG CP, 1956, CANCER RES, V16, P589
   DAY ML, 1994, CELL GROWTH DIFFER, V5, P735
   Garzotto M, 1997, PROSTATE, V33, P60, DOI 10.1002/(SICI)1097-0045(19970915)33:1<60::AID-PROS10>3.0.CO;2-J
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GLEAVE M, 1991, CANCER RES, V51, P3753
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809
   IIZUMI T, 1987, J UROLOGY, V137, P1304, DOI 10.1016/S0022-5347(17)44488-0
   ISAACS JT, 1992, J ANDROL, V13, P457
   ISAACS WB, 1991, CANCER RES, V51, P4716
   JANSE EM, 1991, IMMUNOBIOLOGY, V182, P472
   KAIGHN ME, 1979, INVEST UROL, V17, P16
   KAUFMAN N, 1956, AM J PATHOL, V32, P271
   KOOP S, 1995, CANCER RES, V55, P2520
   KunziRapp K, 1996, P SOC PHOTO-OPT INS, V2924, P176, DOI 10.1117/12.260754
   KUNZIRAPP K, 1992, IN VITRO CELL DEV-AN, V28A, P565
   Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8
   Murphy JB, 1912, J AMER MED ASSOC, V59, P874
   Webber MM, 1997, PROSTATE, V30, P136, DOI 10.1002/(SICI)1097-0045(19970201)30:2<136::AID-PROS9>3.0.CO;2-M
NR 22
TC 67
Z9 70
U1 1
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD OCT
PY 2001
VL 166
IS 4
BP 1502
EP 1507
DI 10.1016/S0022-5347(05)65820-X
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 471VV
UT WOS:000170950100092
PM 11547121
DA 2018-10-20
ER

PT J
AU Hoyt, RF
   Clevenger, RR
   McGehee, JA
AF Hoyt, RF
   Clevenger, RR
   McGehee, JA
TI Introduction to microsurgery: An emerging discipline in biomedical
   research
SO LAB ANIMAL
LA English
DT Article
AB Using microsurgical techniques, biomedical researchers are able to perform procedures that would otherwise be impossible on small laboratory animals. The authors provide a primer on learning microsurgical technique, from correct posture and hand position, to understanding lenses and proper handling of surgical needles and suture material.
C1 NHLBI, LAMS, NIH, Bethesda, MD 20892 USA.
RP Hoyt, RF (reprint author), NHLBI, LAMS, NIH, Serv Rd S,Bldg 14E,105B, Bethesda, MD 20892 USA.
CR FORSTER B, 1985, MICROSURGERY UROLOGY, P2
   GILBERT BR, 1995, SURG MALE INFERTILIT
   GREEN C, 1987, BASIC MICROSURGICAL, P1
   GREEN CJ, 1987, LAB ANIM, V21, P1, DOI 10.1258/002367787780740734
   LANZ O, 1998, CURRENT TECHNIQUES S, P713
   LEE S, 1987, EXPT MICROSURGERY, P15
   LICHTMAN DM, 1987, PRINCIPLES SURG TECH, P113
   MILLER CW, 1990, VET CLIN N AM-SMALL, V20, P189, DOI 10.1016/S0195-5616(90)50010-8
   SERAFIN D, 1986, LAB MANUAL MICROSURG, P1
   WOODRUFF WE, 1992, ATLAS MICROVASCULAR, P1
NR 10
TC 3
Z9 3
U1 0
U2 0
PU NATURE AMERICA INC
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 0093-7355
J9 LAB ANIMAL
JI Lab Anim.
PD OCT
PY 2001
VL 30
IS 9
BP 26
EP 35
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA 482NX
UT WOS:000171583100003
PM 11687781
DA 2018-10-20
ER

PT J
AU Sadoqi, M
   Riseborough, P
   Kumar, S
AF Sadoqi, M
   Riseborough, P
   Kumar, S
TI Analytical models for time resolved fluorescence spectroscopy in tissues
SO PHYSICS IN MEDICINE AND BIOLOGY
LA English
DT Article
ID TURBID MEDIA; SPECTRA
AB Laser induced fluorescence is a rapidly growing technique for diagnostics and imaging in scattering material, most notably in in vivo biomedical testing. Most previous applications have relied on the measurements of the steady-state emission spectrum, with subsequent analysis of the spectrum for relative concentrations of potential fluorophores. Only recently a few investigators have explored the use of the fluorescence lifetimes as a diagnostic tool by taking advantage of the perturbation of the lifetime by multiple scattering of the excitation and emission light in the tissue.
   We have developed a model to study the fluorescence signal generated by fluorophores distributed in a scattering medium. This model is based on two coupled time-dependent photon migration phenomena: the transport of the pulsed source laser light and the transport of the induced fluorescent light excited by the source. The coupling of these two is through the source for the induced fluorescence where the strength of the local fluorescence emission depends on the absorption of the laser intensity at that location. Whereas previous research focused mainly on the fluorescence properties of various dyes, compounds and materials, transport phenomena have only recently been addressed by researchers. We have presented general analytical and numerical solutions for finite, infinite, cylindrical and spherical geometries.
C1 St Johns Univ, Dept Phys, Jamaica, NY 11439 USA.
   Temple Univ, Dept Phys, Philadelphia, PA 19122 USA.
   Polytech Univ, Dept Mech Engn, Brooklyn, NY 11201 USA.
RP Sadoqi, M (reprint author), St Johns Univ, Dept Phys, Jamaica, NY 11439 USA.
RI Riseborough, Peter/D-4689-2011; Kumar, Sunil/H-1082-2012
CR Avrillier S, 1998, APPL OPTICS, V37, P2781, DOI 10.1364/AO.37.002781
   BAKER KJ, 1966, P SOC EXP BIOL MED, V122, P957
   CERRUSI AE, 1997, P SOC PHOTO-OPT INS, V2979, P139
   DEMAS JN, 1971, J PHYS CHEM-US, V75, P991
   DURKIN AJ, 1994, APPL OPTICS, V33, P414, DOI 10.1364/AO.33.000414
   HAGLUND MM, 1994, NEUROSURGERY, V35, P930, DOI 10.1227/00006123-199411000-00019
   HASKELL RC, 1994, J OPT SOC AM A, V11, P2727, DOI 10.1364/JOSAA.11.002727
   HUTCHINSON CL, 1995, BIOPHYS J, V68, P1574, DOI 10.1016/S0006-3495(95)80330-9
   LI XD, 1996, OSA TOPS BIOMEDICAL, V3, P195
   PATTERSON MS, 1994, APPL OPTICS, V33, P1963, DOI 10.1364/AO.33.001963
   SEVICKMURACA EM, 1994, OPT LETT, V19, P1928, DOI 10.1364/OL.19.001928
   SEVICKMURACA EM, 1996, OSA TRENDS OPTICS PH, V3, P166
   Sheridan R. L., 1995, Journal of Burn Care and Rehabilitation, V16, P602, DOI 10.1097/00004630-199511000-00007
   VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507
   WEISS GH, 1989, J MOD OPTIC, V36, P348
   WU J, 1993, APPL OPTICS, V32, P3585, DOI 10.1364/AO.32.003585
NR 16
TC 26
Z9 26
U1 0
U2 1
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0031-9155
J9 PHYS MED BIOL
JI Phys. Med. Biol.
PD OCT
PY 2001
VL 46
IS 10
BP 2725
EP 2743
DI 10.1088/0031-9155/46/10/314
PG 19
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA 487HA
UT WOS:000171866700014
PM 11686285
DA 2018-10-20
ER

PT J
AU Revenko, I
   Tang, Y
   Santerre, JP
AF Revenko, I
   Tang, Y
   Santerre, JP
TI Surface structure of polycarbonate urethanes visualized by atomic force
   microscopy
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 2nd Internatinal Conference on Scanning Probe Microscopy in Biomaterials
   Science
CY JUN   23, 2000
CL BRISTOL, ENGLAND
DE atomic force microscopy; surface structure, morphology, roughness, and
   topography
ID SOFT CONTACT-LENSES; ENERGY-DISSIPATION; POLYMER SURFACES; AFM;
   POLYURETHANES; BIOMATERIALS; BIOSTABILITY; STABILITY
AB Polycarbonate polyurethanes are utilized for the production of long-term biomedical implants. The thermodynamic incompatibility between the hard and soft segments that make up these materials induces a two-phase microstructure. This two-phase structure (i.e. hard and soft segment phases) has unique features which contribute to its mechanical stability and moderate biocompatibility at the surface. As AFM was used to study the structure of six different polyurethane elastomers, where the reagent stoichiometrics, as well as the chemistry of the hard segments, were changed. The results (especially phase-mode images) indicated that the microdomain structures depend on the hard segment chemistry and are relatively less dependent on the stoichiometry. This type of data could be used in the future to relate biological responses to the surface architecture and chemistry of polyurethanes. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Digital Instruments, Santa Barbara, CA 93117 USA.
   Univ Toronto, Fac Dent, Toronto, ON M5S 1A8, Canada.
RP Revenko, I (reprint author), Digital Instruments, 112 Robin Hill Rd, Santa Barbara, CA 93117 USA.
RI He, Yong/F-8752-2012
CR BAGUET J, 1995, BIOMATERIALS, V16, P3, DOI 10.1016/0142-9612(95)91089-H
   BAGUET J, 1993, BIOMATERIALS, V14, P279, DOI 10.1016/0142-9612(93)90118-L
   Bar G, 2000, SURF SCI, V444, pL11, DOI 10.1016/S0039-6028(99)00975-9
   Bhatia Sameer, 1997, CLAO Journal, V23, P264
   Bourauel C, 1998, EUR J ORTHODONT, V20, P79, DOI 10.1093/ejo/20.1.79
   CAMPBELL PA, 1998, APPL PHYS A, V66, pS1
   Chen X, 1998, MACROMOLECULES, V31, P2278, DOI 10.1021/ma9704525
   Chen XQ, 1998, JPN J APPL PHYS 1, V37, P3834, DOI 10.1143/JJAP.37.3834
   Cleveland JP, 1998, APPL PHYS LETT, V72, P2613, DOI 10.1063/1.121434
   Czajkowsky DM, 1998, ULTRAMICROSCOPY, V74, P1, DOI 10.1016/S0304-3991(98)00024-2
   DUCHET J, 1997, LANGMUIR, V13, P2273
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   FRIEDBACHER G, 1991, SCIENCE, V253, P1261, DOI 10.1126/science.253.5025.1261
   Garrison MD, 1997, ANN NY ACAD SCI, V831, P101
   GLOMM BH, 1994, POLYMER, V35, P878, DOI 10.1016/0032-3861(94)90890-7
   Goldberg Eugene P., 1997, CLAO Journal, V23, P243
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Grobe GL, 1996, J BIOMED MATER RES, V32, P45, DOI 10.1002/(SICI)1097-4636(199609)32:1<45::AID-JBM6>3.0.CO;2-P
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   JAENCHEN G, 1999, SURF INTERFACE ANAL, V27, P44
   Ji GD, 1996, POLYMER, V37, P3255, DOI 10.1016/0032-3861(96)88470-9
   Kilpadi DV, 2000, INT J ORAL MAX IMPL, V15, P219
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lelah M. D., 1986, POLYURETHANES MED
   Li TL, 1998, PHARMACEUT RES, V15, P1222, DOI 10.1023/A:1011939824353
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Magonov S. N., 2000, ENCY ANAL CHEM, P7432
   Magonov SN, 1997, ANNU REV MATER SCI, V27, P175, DOI 10.1146/annurev.matsci.27.1.175
   Magonov SN, 1997, SURF SCI, V375, P385
   MARTI O, 1988, SCIENCE, V239, P50, DOI 10.1126/science.3336773
   OLCHERO PJ, 2000, PHYS REV B, V61, P14179
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Rebeix V, 2000, BIOMATERIALS, V21, P1197, DOI 10.1016/S0142-9612(99)00221-5
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   SPECKHARD TA, 1985, POLYMER, V26, P70, DOI 10.1016/0032-3861(85)90058-8
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   TANG YW, IN PRESS J BIOMED MA
   Thierry B, 2000, J BIOMED MATER RES, V49, P88, DOI 10.1002/(SICI)1097-4636(200001)49:1<88::AID-JBM11>3.0.CO;2-I
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   TINGEY KG, 1995, ACS SYM SER, V602, P66
   VANBOGART JWC, 1980, J MACROMOL SCI PHYS, VB17, P267, DOI 10.1080/00222348008213125
   YU D, 2000, BIOMED SCI INSTRUM, V36, P1
   YUKA S, 1999, J CRYST GROWTH, V203, P244
   ZHONG O, 1993, SURF SCI LETT, V290, pL688
NR 50
TC 41
Z9 42
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 1
PY 2001
VL 491
IS 3
BP 346
EP 354
DI 10.1016/S0039-6028(01)01298-5
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 482DQ
UT WOS:000171559900004
DA 2018-10-20
ER

PT J
AU Harada, O
   Kadota, K
   Yamamoto, T
AF Harada, O
   Kadota, K
   Yamamoto, T
TI Collagen-based new biomedicial films: Synthesis, property, and cell
   adhesion
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE collagen; graft polymerization; biomedical films; cell adhesion; high
   wet-strength
ID COPOLYMERIZATION
AB Grafted-collagen films with poly(methyl methacrylate), poly(butyl methacrylate), and poly(styrene) were prepared by photoirradiation of the collagen films in the presence of respective monomers. Cell adhesion onto the films was investigated, and the amount of cells adhered onto every grafted films was almost the same as that onto the collagen film crosslinked with glutaraldehyde. Because the swollen grafted films are stronger than the collagen film, they are expected to be good biomedical materials. (C) 2001 John Wiley & Sons, Inc. J Appl Polym Sci 81: 2433-2438, 2001.
C1 Hyogo Prefectural Inst Ind Res, Tech Ctr Leather, Himeji, Hyogo 6700811, Japan.
   Himeji Inst Technol, Himeji, Hyogo 6712201, Japan.
RP Harada, O (reprint author), Hyogo Prefectural Inst Ind Res, Tech Ctr Leather, Himeji, Hyogo 6700811, Japan.
CR Dufrene YF, 1999, LANGMUIR, V15, P2871, DOI 10.1021/la981066z
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   HARADA O, 1993, KOBUNSHI RONBUNSHU, V50, P471, DOI 10.1295/koron.50.471
   Harada O, 1999, KOBUNSHI RONBUNSHU, V56, P307, DOI 10.1295/koron.56.307
   HARADA O, 1994, KOBUNSHI RONBUNSHU, V51, P710, DOI 10.1295/koron.51.710
   SHIMIZU Y, 1977, BIOMATER ARTIF CELL, V5, P49, DOI 10.3109/10731197709118665
   STOL M, 1985, BIOMATERIALS, V6, P193, DOI 10.1016/0142-9612(85)90009-2
NR 7
TC 0
Z9 1
U1 1
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 6
PY 2001
VL 81
IS 10
BP 2433
EP 2438
DI 10.1002/app.1684
PG 6
WC Polymer Science
SC Polymer Science
GA 447HT
UT WOS:000169566400014
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Survey of biomedical materials
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
AB Biomedical materials must do no damage to the body, must sustain minimal damage from the body, and must provide required strength and toughness for joints and other implants.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 0882-7958
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD SEP
PY 2001
VL 159
IS 9
BP 26
EP 29
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 468GL
UT WOS:000170749700003
DA 2018-10-20
ER

PT J
AU Laguna, R
   Romo, J
   Read, BA
   Wahlund, TM
AF Laguna, R
   Romo, J
   Read, BA
   Wahlund, TM
TI Induction of phase variation events in the life cycle of the marine
   coccolithophorid Emiliania huxleyi
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID PHOTOSYNTHETIC BACTERIUM; RHODOSPIRILLUM-CENTENUM; SWARMING MOTILITY;
   CALCIUM-CARBONATE; FLOW-CYTOMETRY; CELL-CYCLE; DIATOM; BIOMATERIALS;
   LIGHT; BONE
AB Emiliania huxleyi is a unicellular marine alga that is considered to be the world's major producer of calcite. The life cycle of this alga is complex and is distinguished by its ability to synthesize exquisitely sculptured calcium carbonate cell coverings known as coccoliths. These structures have been targeted by materials scientists for applications relating to the chemistry of biomedical materials, robust membranes for high-temperature separation technology, lightweight ceramics, and semiconductor design. To date, however, the molecular and biochemical events controlling coccolith production have not been determined. In addition, little is known about the life cycle of E. huxleyi and the environmental and physiological signals triggering phase switching between the diploid and haploid life cycle stages. We have developed laboratory methods for inducing phase variation between the haploid (S-cell) and diploid (C-cell) life cycle stages of E. huxleyi. Plating E. huxleyi C cells on solid media was shown to induce phase switching from the C-cell to the S-cell life cycle stage, the latter of which has been maintained for over 2 years under these conditions. Pure cultures of S cells were obtained for the first time. Laboratory conditions for inducing phase switching from the haploid stage to the diploid stage were also established. Regeneration of the C-cell stage from pure cultures of S cells followed a predictable pattern involving formation of large aggregations of S cells and the subsequent production of cultures consisting predominantly of diploid C cells. These results demonstrate the ability to manipulate the life cycle of E. huxleyi under controlled laboratory conditions, providing us with powerful tools for the development of genetic techniques for analysis of coccolithogenesis and for investigating the complex life cycle of this important marine alga.
C1 Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA.
RP Wahlund, TM (reprint author), Calif State Univ San Marcos, Dept Biol Sci, 333 S Twin Oaks Valley Rd, San Marcos, CA 92096 USA.
CR ARMBRUST EV, 1990, J PHYCOL, V26, P470, DOI 10.1111/j.0022-3646.1990.00470.x
   Arnaud E, 1994, Ann Chir Plast Esthet, V39, P491
   BHATTACHARYA D, 1992, EVOLUTION, V46, P1801, DOI 10.1111/j.1558-5646.1992.tb01170.x
   Billard C., 1994, HAPTOPHYTE ALGAE SYS, P167
   BROWN CW, 1994, J GEOPHYS RES-OCEANS, V99, P7467, DOI 10.1029/93JC02156
   COMPRASSE G, 1988, C R ACAD SCI 3, V307, P485
   Damien C J, 1993, Ann Chir Gynaecol Suppl, V207, P117
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   Edlund MB, 1997, J PHYCOL, V33, P897, DOI 10.1111/j.0022-3646.1997.00897.x
   FABRY V, 1994, CARBON DIOXIDE CHEM, P301
   Falciatore A, 2000, SCIENCE, V288, P2363, DOI 10.1126/science.288.5475.2363
   FAVINGER J, 1989, A VAN LEEUW J MICROB, V55, P291, DOI 10.1007/BF00393857
   Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634
   FUJIWARA S, 1994, J PHYCOL, V30, P863, DOI 10.1111/j.0022-3646.1994.00863.x
   Green J.C., 1994, Systematics Association Special Volume Series, V51, P47
   Green JC, 1996, J MARINE SYST, V9, P33, DOI 10.1016/0924-7963(96)00014-0
   Guillard R. R. L, 1975, CULTURE MARINE INVER, P29, DOI DOI 10.1007/978-1-4615-8714-9_3
   HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731
   KLAVENESS D, 1972, Protistologica, V8, P335
   Lindum PW, 1998, J BACTERIOL, V180, P6384
   LINSCHOOTEN C, 1991, J PHYCOL, V27, P82, DOI 10.1111/j.0022-3646.1991.00082.x
   LUPORINI P, 1995, J EUKARYOT MICROBIOL, V42, P208, DOI 10.1111/j.1550-7408.1995.tb01567.x
   Marie D, 1997, APPL ENVIRON MICROB, V63, P186
   Medlin LK, 1996, J MARINE SYST, V9, P13, DOI 10.1016/0924-7963(96)00013-9
   MITCHELL AP, 1988, MEIOTIC INHIBITION M, P47
   Piattelli A, 1997, BIOMATERIALS, V18, P623, DOI 10.1016/S0142-9612(96)00158-5
   RAGATZ L, 1995, ARCH MICROBIOL, V163, P1
   RAGATZ L, 1994, NATURE, V370, P104, DOI 10.1038/370104a0
   REMES A, 1991, BIOMATERIALS, V12, P661, DOI 10.1016/0142-9612(91)90114-P
   RIPAMONTI U, 1992, PLAST RECONSTR SURG, V90, P382, DOI 10.1097/00006534-199209000-00004
   Sikes C. S., 1994, PHOTOSYNTHETIC CARBO, P217
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   VANBLEIJSWIJK JDL, 1995, MAR ECOL PROG SER, V121, P271, DOI 10.3354/meps121271
   WALSH D, 1995, NATURE, V377, P320, DOI 10.1038/377320a0
   WESTBROEK P, 1984, PHILOS T ROY SOC B, V304, P435, DOI 10.1098/rstb.1984.0037
   Young GM, 1999, J BACTERIOL, V181, P2823
   Young Jeremy R., 1996, P261
   YOUNG JR, 1994, SARSIA, V79, P417, DOI 10.1080/00364827.1994.10413573
NR 38
TC 11
Z9 14
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD SEP
PY 2001
VL 67
IS 9
BP 3824
EP 3831
DI 10.1128/AEM.67.9.3824-3831.2001
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 468FH
UT WOS:000170747100008
PM 11525973
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Li, YL
   Pfohl, T
   Kim, JH
   Yassa, M
   Wen, ZY
   Kim, MW
   Safinya, CR
AF Li, Youli
   Pfohl, Thomas
   Kim, Joon Heon
   Yassa, Mario
   Wen, Zhiyu
   Kim, Mahn Won
   Safinya, Cyrus R.
TI Selective Surface Modification in Silicon Microfluidic Channels for
   Micromanipulation of Biological Macromolecules
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE microchannel arrays; surface modification techniques; micromanipulation
   of biological macromolecules
AB Interactions between biological macromolecules and micrometer- and sub-micrometer-scale surface structures are directly influenced by the surface wettability, chemical reactivity and surface charge. Understanding these interactions is crucial for developing integrated microsystems for biological and biomedical processing and analysis. We report development of selective surface modification techniques based on microcontact printing and polyelectrolyte adsorption. These techniques were applied to lithographically patterned silicon microfluidic channels and flat silicon substrates to create surface microstructures with contrasting wetting properties and surface charges. These controls enabled us to devise various techniques for controlled loading and processing of biomaterials in the channels. Solutions containing long chain biological macromolecules DNA and microtubules were directly loaded into the microchannels by using a micromanipulator/microinjector system. Structural arrangements of these linear macromolecules, which were probed by using fluorescence and laser scanning confocal microscopy, were found to be quite different from bulk solutions. As expected, the filamentous molecules were observed to align linearly along the channels, with the degree of alignment dependent on channel width as well as the length of the molecule. This molecular alignment, which is induced by both the surface confinement effect and capillary flow during sample loading, may be used to enhance processing of biological materials in silicon biomedical microdevices. It also opens up the possibility of carrying out direct combinatorial structural characterization of proteins in the microchannels utilizing X-ray diffraction, which so far has not been possible.
C1 [Li, Youli; Pfohl, Thomas; Kim, Joon Heon; Yassa, Mario; Kim, Mahn Won; Safinya, Cyrus R.] Univ Calif Santa Barbara, Dept Mat, Dept Phys, Mat Res Lab, Santa Barbara, CA 93106 USA.
   [Li, Youli; Pfohl, Thomas; Kim, Joon Heon; Yassa, Mario; Kim, Mahn Won; Safinya, Cyrus R.] Univ Calif Santa Barbara, Biochem & Mol Biol Program, Santa Barbara, CA 93106 USA.
   [Wen, Zhiyu] Chongqing Univ, Coll Optoelect Engn, Chongqing 630044, Peoples R China.
   [Kim, Joon Heon; Kim, Mahn Won] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea.
RP Li, YL (reprint author), Univ Calif Santa Barbara, Dept Mat, Dept Phys, Mat Res Lab, Santa Barbara, CA 93106 USA.
EM youli@mrl.ucsb.edu
RI Pfohl, Thomas/D-7296-2016
OI Pfohl, Thomas/0000-0002-7879-5216
FU NIH [GM59288]; University of California Biotech Research and Education
   training [99-14]; DFG [pf 375/1-1]; Chongqing University through the
   Ministry of Education of China; KISTEP [99-I-01-03-A-064]; 
   [NSF-DMR-9972246];  [NSF-DMR-0076357];  [ONR-N00014-00-1-0214]; 
   [NSF-DMR-0080034]
FX This work was supported by NSF-DMR-9972246, NSF-DMR-0076357,
   ONR-N00014-00-1-0214, NIH Grant GM59288, and the University of
   California Biotech Research and Education training grant 99-14. The
   Materials Research Laboratory at UC Santa Barbara is supported by
   NSF-DMR-0080034. In addition, T.P. acknowledges support by a DFG (pf
   375/1-1) scholarship, Y.L. acknowledges support by a visiting scientist
   grant from Chongqing University through the Ministry of Education of
   China and M.W.K. acknowledges partial support by KISTEP
   (99-I-01-03-A-064).
CR Abramowitz S., 1999, J BIOMEDICAL MICRODE, V1, P1
   Craighead HG, 1998, BIOMED MICRODEVICES, V1, P49, DOI 10.1023/A:1009982306118
   Feldstein M. J., 1999, J BIOMED MICRODEVICE, V1, P139
   Graf K, 1998, COLLOID SURFACE A, V131, P215, DOI 10.1016/S0927-7757(96)03923-4
   Koltover I, 1996, J PHYS II, V6, P893, DOI 10.1051/jp2:1996218
   Li YL, 1998, REV SCI INSTRUM, V69, P2844, DOI 10.1063/1.1149022
   Oda T, 1998, BIOPHYS J, V75, P2672, DOI 10.1016/S0006-3495(98)77712-4
   Pfohl T., LANGMUIR IN PRESS
   Pompe T, 1999, LANGMUIR, V15, P2398, DOI 10.1021/Ia980429s
   Wong GCL, 1998, APPL PHYS LETT, V73, P2042, DOI 10.1063/1.122361
NR 10
TC 18
Z9 18
U1 1
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD SEP
PY 2001
VL 3
IS 3
BP 239
EP 244
DI 10.1023/A:1011467431506
PG 6
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KW
UT WOS:000209018700009
DA 2018-10-20
ER

PT J
AU Hu, QL
   Fang, ZP
   Zhao, Y
   Xu, CW
AF Hu, QL
   Fang, ZP
   Zhao, Y
   Xu, CW
TI A new method to prepare chitosan membrane as a biomedical material
SO CHINESE JOURNAL OF POLYMER SCIENCE
LA English
DT Article
DE chitosan; membrane; sol-gel transformation; fixation agent
AB This paper reports a new method to prepare chitosan membrane which could be used as a biomedical material. Addition of a fixation agent composed of alcohol, glycerol and potassium hydroxide can accelerate the sol-gel transformation process and hence shorten the preparation period. The present method takes about 6 h to get a flexible membrane with fine appearance, The physical and biological properties of the membrane were also investigated and compared with the membrane prepared by conventional method.
C1 Zhejiang Univ, Inst Polymer Composites, Hangzhou 310027, Peoples R China.
RP Fang, ZP (reprint author), Zhejiang Univ, Inst Polymer Composites, Hangzhou 310027, Peoples R China.
RI Fang, Zhengping/D-6167-2011
CR LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   LU F, 1996, J BIOMED ENG, V13, P375
   MIYAZAKI S, 1985, CHEM PHARM BULL, V33, P2490
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   MUZZARELLI R, 1989, BIOMATERIALS, V10, P598, DOI 10.1016/0142-9612(89)90113-0
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   Rao SB, 1995, J BIOMATER APPL, V10, P136, DOI 10.1177/088532829501000204
   Schipper NGM, 1996, PHARMACEUT RES, V13, P1686, DOI 10.1023/A:1016444808000
   Su CH, 1997, BIOMATERIALS, V18, P1169, DOI 10.1016/S0142-9612(97)00048-3
NR 9
TC 12
Z9 22
U1 0
U2 8
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0256-7679
J9 CHINESE J POLYM SCI
JI Chin. J. Polym. Sci.
PD SEP
PY 2001
VL 19
IS 5
BP 467
EP 470
PG 4
WC Polymer Science
SC Polymer Science
GA 466ZH
UT WOS:000170675700005
DA 2018-10-20
ER

PT J
AU Zhitomirsky, I
   Petric, A
AF Zhitomirsky, I
   Petric, A
TI The electrodeposition of ceramic and organoceramic films for fuel cells
SO JOM-JOURNAL OF THE MINERALS METALS & MATERIALS SOCIETY
LA English
DT Article
ID ELECTROPHORETIC DEPOSITION; ELECTROLYTIC DEPOSITION; ELECTROCHEMICAL
   DEPOSITION; OXIDE; COATINGS; ZIRCONIA
AB The electrodeposition of metals from aqueous solutions is a longstanding technique, commonly known as electroplating. Now, electrodeposition is being used to produce ceramic coatings. Two such processes are known as electrolytic and electrophoretic deposition. They may be applied to protective coatings, biomedical implants, electronic devices, chemical sensors, piezoelectric transducers, displays, and electrode materials. Electrodeposition offers important processing advantages and allows new possibilities in the design of materials and devices. This paper describes recent developments in the application of electrodeposition for fabrication of fuel cell membranes.
C1 McMaster Univ, Dept Mat Sci & Engn, Hamilton, ON L8S 4L7, Canada.
RP Zhitomirsky, I (reprint author), McMaster Univ, Dept Mat Sci & Engn, 1280 Main St W, Hamilton, ON L8S 4L7, Canada.
EM zhitom@mcmaster.ca
CR Basu RN, 1999, ELEC SOC S, V99, P153
   ELSHERIK AM, 1998, IONIC MIXED CONDUCTI, P643
   ISHIHARA T, 1992, CHEM LETT, P943, DOI 10.1246/cl.1992.943
   Ishihara T, 2000, J AM CERAM SOC, V83, P1921
   Ishihara T, 1996, J AM CERAM SOC, V79, P913, DOI 10.1111/j.1151-2916.1996.tb08525.x
   KONNO H, 1990, J ELECTROCHEM SOC, V137, P361, DOI 10.1149/1.2086430
   KONNO H, 1992, ELECTROCHIM ACTA, V37, P2421, DOI 10.1016/0013-4686(92)87077-D
   MATSUMOTO Y, 1992, INORG CHEM, V31, P738, DOI 10.1021/ic00031a009
   Minh N. Q., 1995, SCI TECHNOLOGY CERAM
   Negishi H, 2000, J ELECTROCHEM SOC, V147, P1682, DOI 10.1149/1.1393418
   Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x
   Therese GHA, 1998, CHEM MATER, V10, P3364, DOI 10.1021/cm980046f
   Zhitomirsky I, 2000, AM CERAM SOC BULL, V79, P57
   Zhitomirsky I, 1999, INTERMETALLIC AND CERAMIC COATINGS, P83
   Zhitomirsky I, 2000, MATER LETT, V46, P1, DOI 10.1016/S0167-577X(00)00133-6
   Zhitomirsky I, 2000, J MATER CHEM, V10, P1215, DOI 10.1039/b000311p
   Zhitomirsky I, 2001, CERAM INT, V27, P149, DOI 10.1016/S0272-8842(00)00054-7
   Zhitomirsky I, 2000, MATER LETT, V42, P273, DOI 10.1016/S0167-577X(99)00193-7
   Zhitomirsky I, 1998, J EUR CERAM SOC, V18, P849, DOI 10.1016/S0955-2219(97)00213-6
   Zhitomirsky I, 1999, ELEC SOC S, V99, P217
   Zhitomirsky I, 2000, MAT SCI ENG B-SOLID, V78, P125, DOI 10.1016/S0921-5107(00)00535-3
   Zhitomirsky I, 2000, J EUR CERAM SOC, V20, P2055, DOI 10.1016/S0955-2219(00)00098-4
   ZHITOMIRSKY I, IN PRESS MAT LETT
   ZHITOMIRSKY I, 2000, OXIDE FILMS
   ZHITOMIRSKY I, 2000, JOM E, V52
NR 25
TC 20
Z9 21
U1 1
U2 3
PU MINERALS METALS MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086 USA
SN 1047-4838
J9 JOM-J MIN MET MAT S
JI JOM-J. Miner. Met. Mater. Soc.
PD SEP
PY 2001
VL 53
IS 9
BP 48
EP 50
DI 10.1007/s11837-001-0071-2
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 470LE
UT WOS:000170872800012
DA 2018-10-20
ER

PT J
AU Bubb, DM
   Horwitz, JS
   Callahan, JH
   McGill, RA
   Houser, EJ
   Chrisey, DB
   Papantonakis, MR
   Haglund, RF
   Galicia, MC
   Vertes, A
AF Bubb, DM
   Horwitz, JS
   Callahan, JH
   McGill, RA
   Houser, EJ
   Chrisey, DB
   Papantonakis, MR
   Haglund, RF
   Galicia, MC
   Vertes, A
TI Resonant infrared pulsed-laser deposition of polymer films using a
   free-electron laser
SO JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; MASS-SPECTROMETRY; FAR-ULTRAVIOLET; THIN-FILM;
   ABLATION; METHACRYLATE); DESORPTION; IONIZATION; ABSORPTION; SURFACES
AB Thin films of polyethylene glycol (MW 1500) have been prepared by pulsed-laser deposition (PLD) using both a tunable infrared (lambda =2.9 mum, 3.4 mum) and an ultraviolet laser (lambda =193 nm). A comparison of the physicochemical properties of the films by means of Fourier transform infrared spectroscopy, electrospray ionization mass spectrometry, and matrix-assisted laser desorption and ionization shows that when the IR laser is tuned to a resonant absorption in the polymer, the IR PLD thin films are identical to the starting material, whereas the UV PLD show significant structural modification. These results are important for several biomedical applications of organic and polymeric thin films. (C) 2001 American Vacuum Society.
C1 USN, Res Lab, Washington, DC 20375 USA.
   Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.
   Vanderbilt Univ, WM Keck Fdn Free Electron Laser Ctr, Nashville, TN 37235 USA.
   George Washington Univ, Dept Chem, Washington, DC 20001 USA.
RP Bubb, DM (reprint author), Seton Hall Univ, Dept Phys, 400 S Orange Ave, S Orange, NJ 07079 USA.
EM bubbdani@shu.edu
RI Papantonakis, Michael/G-3888-2012; Vertes, Akos/B-7159-2008
OI Vertes, Akos/0000-0001-5186-5352
CR BLANCHET GB, 1995, MACROMOLECULES, V28, P4603, DOI 10.1021/ma00117a034
   Blanchet GB, 1996, J APPL PHYS, V80, P4082, DOI 10.1063/1.363278
   BLANCHET GB, 1993, APPL PHYS LETT, V62, P1026, DOI 10.1063/1.108514
   BLANCHET GB, 1993, SCIENCE, V262, P719, DOI 10.1126/science.262.5134.719
   BLANCHET GB, 1994, APPL PHYS LETT, V65, P1311, DOI 10.1063/1.112038
   Blanchet GB, 2000, J APPL PHYS, V88, P2975, DOI 10.1063/1.1288501
   BRANNON JH, 1985, J APPL PHYS, V58, P2036, DOI 10.1063/1.336012
   Bubb DM, 2001, APPL PHYS A-MATER, V73, P121, DOI 10.1007/s003390100884
   Bubb DM, 2001, J APPL PHYS, V89, P5739, DOI 10.1063/1.1362405
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Cramer R, 1997, INT J MASS SPECTROM, V169, P51, DOI 10.1016/S0168-1176(97)00223-1
   EDWARDS G, 1999, LASER ABLATION MECH, P457
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Fuson MM, 1997, MACROMOLECULES, V30, P5704, DOI 10.1021/ma9700340
   HANSEN SG, 1988, J APPL PHYS, V64, P2122, DOI 10.1063/1.341722
   HARRIS JM, 1991, ACS SYM SER, V467, P418
   Henry CM, 2000, CHEM ENG NEWS, V78, P49, DOI 10.1021/cen-v078n028.p049
   JELLINEK HHG, 1984, J PHYS CHEM-US, V88, P3048, DOI 10.1021/j150658a024
   KACZMAREK H, 1995, EUR POLYM J, V31, P1037, DOI 10.1016/0014-3057(95)00094-1
   KANEKO Y, 1998, BIORELATED POLYM GEL, P29
   Manoravi P, 1998, J PHYS CHEM SOLIDS, V59, P1271, DOI 10.1016/S0022-3697(98)00059-6
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   MONTAUDO G, 1995, RAPID COMMUN MASS SP, V9, P453, DOI 10.1002/rcm.1290090514
   NOHMI T, 1992, J AM CHEM SOC, V114, P3241, DOI 10.1021/ja00035a012
   Owrutsky JC, 1999, J CHEM PHYS, V111, P7329, DOI 10.1063/1.480056
   Patel N, 1998, FASEB J, V12, P1447
   PHILIPP HR, 1986, APPL PHYS LETT, V48, P192, DOI 10.1063/1.96940
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   Smith BC, 1999, INFRARED SPECTRAL IN
   SRINIVASAN R, 1993, J APPL PHYS, V73, P2743, DOI 10.1063/1.353048
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
   Suggs L.J., 1998, POLYM TISSUE ENG, P99
   SUMPTER BG, 1999, LASER ABLATION MECH, P334
   Tsuboi Y, 1999, APPL PHYS LETT, V74, P3896, DOI 10.1063/1.124216
   TURRO NJ, 1991, MODERN MOL PHOTOCHEM, P174
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Yokoyama M, 1998, BIORELATED POLYM GEL, P193
NR 38
TC 70
Z9 70
U1 2
U2 14
PU A V S AMER INST PHYSICS
PI MELVILLE
PA STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA
SN 0734-2101
EI 1520-8559
J9 J VAC SCI TECHNOL A
JI J. Vac. Sci. Technol. A
PD SEP-OCT
PY 2001
VL 19
IS 5
BP 2698
EP 2702
DI 10.1116/1.1387052
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 478YP
UT WOS:000171376700101
DA 2018-10-20
ER

PT J
AU Sivakumar, M
   Manjubala, I
AF Sivakumar, M
   Manjubala, I
TI Preparation of hydroxyapatite/fluoroapatite-zirconia composites using
   Indian corals for biomedical applications
SO MATERIALS LETTERS
LA English
DT Article
DE hydroxyapatite; fluoroapatite; zirconia composite; decomposition;
   tricalcium phosphate
ID MECHANICAL-PROPERTIES
AB Hydroxyapatite (HA) has been widely used in the field of orthopaedics and dentistry. Due to HA's lack of mechanical properties, composites containing hydroxyapatite and zirconia have been suggested for the purpose of increasing strength and fracture toughness. This paper reports the preparation of fluorine-doped hydroxyapatite from Indian coast corals and zirconia composites using coralline hydroxyapatite and coralline fluoroapatite. The fluoroapatite and composites were prepared by two methods: (i) low temperature (LT) or hydrothermal method and (ii) high temperature (HT) or solid state reaction method. These materials were characterized by X-ray diffraction (XRD) analysis, Fourier-transform. infrared spectroscopy (FT-IR) and thermal analysis. Decrease in the a-axis of HA lattice was observed in the fluoroapatite, suggesting partial fluorination of hydroxyapatite resulting in hydroxy/fluoroapatite solid solution. The analysis of the composites shows the formation of beta -tricalcium phosphate due to the decomposition of hydroxyapatite. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Cent Leather Res Inst, Biomat Div, Chennai 600020, Tamil Nadu, India.
   Univ Madras, Ctr Mat Sci, Dept Nucl Phys, Chennai 600025, Tamil Nadu, India.
RP Sivakumar, M (reprint author), Cent Leather Res Inst, Biomat Div, Chennai 600020, Tamil Nadu, India.
EM msivaclri@hotmail.com
RI Inderchand, Manjubala/B-9020-2012
OI Manjubala, I/0000-0003-4873-2377
CR AOKI H, 1991, J ANAL AT SPECTROM
   DeGroot K., 1981, SCI CERAM, V11, P433
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   *JCPDS, 1988, 9169 JCPDS
   *JCPDS, 1988, 9432 JCPDS
   *JCPDS, 1988, 15876 JCPDS
   KASUGA T, 1993, J MATER SCI-MATER M, V4, P36, DOI 10.1007/BF00122975
   LI J, 1993, J MATER SCI-MATER M, V4, P50, DOI 10.1007/BF00122977
   MAGER C, 1998, P MRS FALL M
   PARTENFELDER U, 1993, J MATER SCI-MATER M, V4, P292, DOI 10.1007/BF00122283
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sivakumar M, 1996, BIOMATERIALS, V17, P1709, DOI 10.1016/0142-9612(96)87651-4
   TAMARI N, 1987, NIPPON SERAM KYO GAK, V95, P806
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
NR 15
TC 39
Z9 40
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD SEP
PY 2001
VL 50
IS 4
BP 199
EP 205
DI 10.1016/S0167-577X(01)00225-7
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 473ZU
UT WOS:000171080400003
DA 2018-10-20
ER

PT J
AU Wei, Q
   Sankar, J
   Narayan, J
AF Wei, Q
   Sankar, J
   Narayan, J
TI Structure and properties of novel functional diamond-like carbon
   coatings produced by laser ablation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 28th International Conference on Metallurgical Coatings and Thin Films
CY APR 30-MAY 05, 2001
CL SAN DIEGO, CALIFORNIA
DE diamond-like carbon; pulsed laser deposition; functional materials
ID TETRAHEDRAL AMORPHOUS-CARBON; THIN-FILMS; ELASTIC PROPERTIES; STRESS
   REDUCTION; WEAR-RESISTANCE; DEPOSITION; GRADIENT
AB Diamond-like carbon (DLC) mainly consists of sp(3) bonded carbon atoms. It can have properties that rival those of crystalline diamond. Its beneficial properties stem from the continuous rigid random networks of sp(3) carbon atoms, and the properties can essentially be tailored by the sp(3)/sp(2) ratio. DLC coatings or thin films can be prepared by pulsed laser ablation (PLA), filtered cathodic vacuum arc (FCVA) deposition and mass selected ion beam (MSIB) deposition. In the past decade, tremendous progress has been made in experimental and theoretical investigations of hydrogen-free DLC. Experimental and commercial applications in microelectronics, micro- tribology, biomedical technologies, etc., have been demonstrated. Potential applications include sensors, flat panel displays (field emitters), photodiode, etc. In this paper, we report comprehensively the past and recent efforts in the research of functional diamond-like carbon coatings prepared by pulsed laser ablation in our group. In order to alleviate the internal compressive stress problem associated with high quality DLC coatings, we have adopted a novel and simple target design. The films were characterized by Raman spectroscopy, transmission electron microscopy, IR range optical measurements, tribological measurement. etc. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 N Carolina Agr & Tech State Univ, Dept Mech Engn, NSF Ctr Adv Mat & Smart Struct, Greensboro, NC 27411 USA.
   N Carolina State Univ, Burlington Labs, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
RP Wei, Q (reprint author), Johns Hopkins Univ, Dept Engn Mech, N Charles St, Baltimore, MD 21218 USA.
RI Wei, Qiuming/B-7579-2008; Narayan, Jagdish/D-1874-2009
CR Achard J.F., 1953, J APPL PHYS, V24, P981
   ATKINS P, 1994, PHYSICAL CHEM
   BENTZON MD, 1994, SURF COAT TECH, V68, P651, DOI 10.1016/0257-8972(94)90232-1
   Chhowalla M, 1997, DIAM RELAT MATER, V6, P207, DOI 10.1016/S0925-9635(96)00760-1
   COCKAYNE DJH, 1988, ACTA CRYSTALLOGR A, V44, P870, DOI 10.1107/S0108767388004957
   CRISCHKE M, 1995, SURF COAT TECH, V74, P739
   Dikshit SJ, 1996, J MATER RES, V11, P2236, DOI 10.1557/JMR.1996.0284
   EFROS AL, 1975, J PHYS C SOLID STATE, V8, P49
   ENKE K, 1990, MATER SCI FORUM, V52, P559
   Ferrari AC, 1999, APPL PHYS LETT, V75, P1893, DOI 10.1063/1.124863
   Ferrari AC, 1999, J APPL PHYS, V85, P7191, DOI 10.1063/1.370531
   Friedmann TA, 1997, APPL PHYS LETT, V71, P3820, DOI 10.1063/1.120515
   HE H, 1985, PHYS REV LETT, V54, P2107, DOI 10.1103/PhysRevLett.54.2107
   KELIRES PC, 1994, PHYS REV LETT, V73, P2460, DOI 10.1103/PhysRevLett.73.2460
   Koidl P., 1989, MATER SCI FORUM, V52 & 53, P41
   KRISHNASWAMY J, 1989, APPL PHYS LETT, V54, P2455, DOI 10.1063/1.101070
   KULIK J, 1994, J APPL PHYS, V76, P5063, DOI 10.1063/1.357218
   Madelung O., 1996, INTRO SOLID STATE TH
   MCKENZIE DR, 1991, PHYS REV LETT, V67, P773, DOI 10.1103/PhysRevLett.67.773
   Milne WI, 1996, J NON-CRYST SOLIDS, V198, P605, DOI 10.1016/0022-3093(95)00773-3
   Milnes A. G., 1973, DEEP IMPURITIES SEMI
   Mott N. F., 1979, ELECT PROCESSES NONC
   NARAYAN J, 1995, J ADHES SCI TECHNOL, V9, P753, DOI 10.1163/156856195X00653
   NIR D, 1987, THIN SOLID FILMS, V146, P27, DOI 10.1016/0040-6090(87)90337-3
   PAPPAS DL, 1992, J APPL PHYS, V71, P5672
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   ROHLFING EA, 1988, J CHEM PHYS, V89, P6013
   SATO T, 1987, JPN J APPL PHYS 2, V26, pL1487, DOI 10.1143/JJAP.26.L1487
   SIEGAL MP, 1998, COVALENTLY BONDED DI, V498
   SULLIVAN JP, 1997, J ELECT MAT, V26, P102
   Voevodin AA, 1996, SURF COAT TECH, V82, P199, DOI 10.1016/0257-8972(95)02734-3
   Voevodin AA, 1998, DIAM RELAT MATER, V7, P463, DOI 10.1016/S0925-9635(97)00214-8
   Voevodin AA, 1997, THIN SOLID FILMS, V298, P107, DOI 10.1016/S0040-6090(96)09145-6
   Wei Q, 1998, MAT SCI ENG B-SOLID, V53, P262, DOI 10.1016/S0921-5107(98)00150-0
   Wei Q, 1999, J VAC SCI TECHNOL A, V17, P3406, DOI 10.1116/1.582074
   Wei Q, 1998, MATER RES SOC SYMP P, V498, P61
   Wei Q, 1998, MATER RES SOC SYMP P, V505, P331
   Wei Q, 1999, MATER RES SOC SYMP P, V555, P303
   Wei Q, 2000, INT MATER REV, V45, P133, DOI 10.1179/095066000101528340
   Wei Q, 2001, J VAC SCI TECHNOL A, V19, P311, DOI 10.1116/1.1322641
   Wei Q, 2000, J MATER RES, V15, P633, DOI 10.1557/JMR.2000.0094
   Weiler M, 1996, PHYS REV B, V53, P1594, DOI 10.1103/PhysRevB.53.1594
NR 42
TC 41
Z9 45
U1 0
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP-OCT
PY 2001
VL 146
BP 250
EP 257
DI 10.1016/S0257-8972(01)01394-9
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 500DY
UT WOS:000172611700037
DA 2018-10-20
ER

PT J
AU Glocker, DA
   Romach, MM
   Lindberg, VW
AF Glocker, DA
   Romach, MM
   Lindberg, VW
TI Recent developments in inverted cylindrical magnetron sputtering
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 28th International Conference on Metallurgical Coatings and Thin Films
CY APR 30-MAY 05, 2001
CL SAN DIEGO, CALIFORNIA
DE sputtering; cylindrical magnetron; Dielectric material
AB Inverted cylindrical magnetron cathodes sputter from the interior surfaces of cylindrical targets and simultaneously deposit material on all sides of three-dimensional substrates. Since their invention in the 1970s, they have been widely used to coat wires, fibers and ribbons. As the use of coatings on complex shapes has increased, cylindrical magnetrons have been adopted for a variety of applications, ranging from X-ray telescope mirrors to biomedical implants. This paper describes the features of these devices and compares their operation and coating characteristics to those of planar magnetrons. Recent developments in sputtering dielectric materials are described and new methods that take advantage of cylindrical magnetron designs to produce high ionization densities at the substrates are discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Isoflux Inc, Henrietta, NY 14467 USA.
   Rochester Inst Technol, Dept Phys, Rochester, NY 14623 USA.
RP Glocker, DA (reprint author), Isoflux Inc, 245 Summit Point Dr,Suite 2A, Henrietta, NY 14467 USA.
CR GLOCKER DA, 1993, J VAC SCI TECHNOL A, V11, P2989, DOI 10.1116/1.578286
   GLOCKER DA, 1999, SOC VAC COAT ANN TEC, P97
   GLOCKER DA, 1999, SOC VAC COAT ANN TEC, P517
   Lindberg VW, 2000, SURF COAT TECH, V133, P484, DOI 10.1016/S0257-8972(00)00920-8
   PETROV I, 1993, APPL PHYS LETT, V63, P36, DOI 10.1063/1.109742
   SIEGFRIED DE, 1996, SOC VACC COAT ANN TE, P97
   THORNTON JA, 1975, J VAC SCI TECHNOL, V12, P93, DOI 10.1116/1.568631
   THORNTON JA, 1978, THIN FILM PROCESSES, P76
NR 8
TC 20
Z9 20
U1 1
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP-OCT
PY 2001
VL 146
BP 457
EP 462
DI 10.1016/S0257-8972(01)01487-6
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 500DY
UT WOS:000172611700069
DA 2018-10-20
ER

PT J
AU Wu, JR
AF Wu, JR
TI Tofu as a tissue-mimicking material
SO ULTRASOUND IN MEDICINE AND BIOLOGY
LA English
DT Article
DE acoustic properties; tofu; tissue-mimicking material
ID TEMPERATURE RISE; ATTENUATION; ULTRASOUND; WAVES
AB The acoustic properties of one kind of tofu (soft, firm and extra-firm types) commercially available in grocery markets were measured. It was found that density, speed of sound and attenuation coefficient of tofu were close to those of some soft tissues. It is suggested that tofu may serve as a tissue-mimicking material for some biomedical ultrasound (US) through transmission applications in vitro.
C1 Univ Vermont, Dept Phys, Burlington, VT 05405 USA.
RP Wu, JR (reprint author), Univ Vermont, Dept Phys, Cook Phys Sci Bldg, Burlington, VT 05405 USA.
CR BURLEW MM, 1980, RADIOLOGY, V134, P517, DOI 10.1148/radiology.134.2.7352242
   CARSTENSEN EL, 1986, TISSUE CHARACTERIZAT, V1, P57
   DUCK FA, 1990, PHYSICAL PROPERTIES
   Madsen EL, 1998, ULTRASOUND MED BIOL, V24, P535, DOI 10.1016/S0301-5629(98)00013-1
   MADSEN EL, 1982, ULTRASOUND MED BIOL, V8, P277, DOI 10.1016/0301-5629(82)90034-5
   *NCRP, 1992, EXP CRIT MED DIAN UL, V1, P20814
   ROGERS PH, 1974, J ACOUST SOC AM, V55, P724, DOI 10.1121/1.1914589
   SACHSE W, 1978, J APPL PHYS, V49, P4320, DOI 10.1063/1.325484
   Szabo TL, 2000, J ACOUST SOC AM, V107, P2437, DOI 10.1121/1.428630
   SZABO TL, 1999, J ACOUST SOC AM, V2, P2255
   Wu JR, 1996, J ACOUST SOC AM, V99, P2871, DOI 10.1121/1.414880
   Wu JR, 1996, J ACOUST SOC AM, V99, P3380, DOI 10.1121/1.414894
   WU JR, 1992, ULTRASOUND MED BIOL, V18, P495, DOI 10.1016/0301-5629(92)90089-S
   WU JR, 1995, ULTRASOUND MED BIOL, V21, P561, DOI 10.1016/0301-5629(94)00151-3
NR 14
TC 22
Z9 22
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0301-5629
J9 ULTRASOUND MED BIOL
JI Ultrasound Med. Biol.
PD SEP
PY 2001
VL 27
IS 9
BP 1297
EP 1300
DI 10.1016/S0301-5629(01)00424-0
PG 4
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA 481JF
UT WOS:000171515600018
PM 11597372
DA 2018-10-20
ER

PT J
AU Stern, T
   Cohn, D
AF Stern, T
   Cohn, D
TI Surface tailoring of biomedical polymers: An FTIR study
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE surface modification; plasma; biostability; biocompatibility; vascular
   grafts
ID DERIVATIZATION
AB A multistep, surface-tailoring process of polymeric materials was developed with two consecutive plasma treatments and followed by derivatization reactions. In the first step, tetrafluoroethylene was plasma-polymerized, generating a highly crosslinked perfluoric surface layer. The next step introduced amine groups into the plasma polymer through exposure of the surface to plasma of ammonia. The reactive amine moieties were then used as anchoring sites for further derivatization. Finally, poly(ethylene glycol) chains were grafted onto the surface via a hexamethylene diisocyanate spacer. This method, aimed at the chemical modification of polymers for biomedical applications, was first demonstrated with poly(ethylene terephthalate) (PET) as a substrate in a previously published study (Cohn, D.; Stern, T. Macromolecules 2000, 33, 137). The aim of this study was to demonstrate the applicability of the method described previously to different polymers: poly(lactic acid), poly(ethylene) (PE), polystyrene (PST), poly(methyl methacrylate), a polybutadiene-based polyurethane (PEUOXAB-20), and Lycra. Fourier transform infrared (FTIR) spectroscopy was used to characterize the surface-modified substrates and the various control treatments. The results obtained were consistent with the derivatization scheme and in full agreement with the FTIR and ESCA results previously obtained for PET. (C) 2001 John Wiley & Sons, Inc.
C1 Hebrew Univ Jerusalem, Casali Inst Appl Sci, IL-91904 Jerusalem, Israel.
RP Cohn, D (reprint author), Hebrew Univ Jerusalem, Casali Inst Appl Sci, IL-91904 Jerusalem, Israel.
EM danielc@vms.huji.ac.il
CR Cohn D, 2000, POLYMER, V41, P6519, DOI 10.1016/S0032-3861(99)00835-6
   Cohn D, 2000, MACROMOLECULES, V33, P137, DOI 10.1021/ma9900784
   STERN T, 1995, BIOMATERIALS, V16, P17, DOI 10.1016/0142-9612(95)91091-C
NR 3
TC 9
Z9 9
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 29
PY 2001
VL 81
IS 9
BP 2203
EP 2209
DI 10.1002/app.1657.abs
PG 7
WC Polymer Science
SC Polymer Science
GA 442XD
UT WOS:000169309500021
DA 2018-10-20
ER

PT J
AU Kowalski, ZW
AF Kowalski, ZW
TI Ion sputter induced surface morphology - biomedical implications
SO VACUUM
LA English
DT Article; Proceedings Paper
CT International Symposium on Ion Implantation and Other Applications of
   IOns and Electrons (ION 2000)
CY JUN 12-15, 2000
CL KAZIMIERS DOLNY, POLAND
SP Inst Phys, Maria Curie Sklodowska Univ, Tech Univ Lublin, Tech Univ Wroclaw
DE ion sputtering; ion etching; surface morphology; surface topography;
   surface roughness; biocompatible materials; biomaterials; implants;
   biological response
ID LINE-EDGE ROUGHNESS; CELL-ADHESION; BOMBARDMENT; BIOMATERIALS; IMPLANTS;
   PROTEIN; BONE; SI
AB This is a short review of surface morphological changes induced by ion sputtering of solids (mainly biocompatible materials) as well as potential and practical biomedical applications of the sputtering process. Usually changes of two aspects of surface morphology are studied, i.e. surface topography and roughness. It can be generally accepted that, among other factors which affect the so-called biological response to biomaterial, surface morphology is one of the more important. Depending on surface topography and/or roughness various biological responses could be expected, generally, changes in: (a) attachment of the surrounding tissue or thrombus to the material in question and (b) cell attachment kinetics that can influence the heating process resulting from the presence of the sputtered implant and/or tissue inflammatory in the tissue surrounding the implanted material. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Wroclaw Univ Technol, Inst Microsyst Technol, PL-50372 Wroclaw, Poland.
RP Kowalski, ZW (reprint author), Wroclaw Univ Technol, Inst Microsyst Technol, Z Janiszewskiego 11-17, PL-50372 Wroclaw, Poland.
EM zwkoval@wtm.ite.pwr.wroc.pl
CR Auciello O., 1984, ION BOMBARDMENT MODI
   BEHRISCH R, 1983, TOPICS APPL PHYSICS, V52
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Carter G, 1996, VACUUM, V47, P409, DOI 10.1016/0042-207X(95)00239-1
   CHASON E, 1994, PHYS REV LETT, V72, P3040, DOI 10.1103/PhysRevLett.72.3040
   EKLUND EA, 1991, PHYS REV LETT, V67, P1759, DOI 10.1103/PhysRevLett.67.1759
   EKLUND EA, 1993, SURF SCI, V285, P157, DOI 10.1016/0039-6028(93)90427-L
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   HAUFFE W, 1991, TOP APPL PHYS, V64, P305
   Henry S, 1998, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE ELEVENTH ANNUAL INTERNATIONAL WORKSHOP PROCEEDINGS, P494, DOI 10.1109/MEMSYS.1998.659807
   Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+
   Ivanova OP, 1996, VACUUM, V47, P67, DOI 10.1016/0042-207X(95)00180-8
   Iwaki M, 1995, NUCL INSTRUM METH B, V106, P618, DOI 10.1016/0168-583X(96)80035-8
   Kowalski Z. W., 1998, Electron Technology, V31, P477
   KOWALSKI ZW, 1985, J MATER SCI, V20, P1521, DOI 10.1007/BF00555259
   KOWALSKI ZW, 1989, MONOGRAPHS TU WOCL, V13
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Leitao E, 1998, J MATER SCI-MATER M, V9, P543, DOI 10.1023/A:1008896106994
   Lhoest JB, 1995, NUCL INSTRUM METH B, V105, P322, DOI 10.1016/0168-583X(95)00524-2
   Loesing R, 2000, J VAC SCI TECHNOL B, V18, P509, DOI 10.1116/1.591222
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MAZOLDI P, 1987, ION BEAM MODIFICATIO
   Namatsu H, 1998, J VAC SCI TECHNOL B, V16, P3315, DOI 10.1116/1.590375
   Nelson C, 1999, J VAC SCI TECHNOL B, V17, P2488, DOI 10.1116/1.591117
   NOWICKI B, 1991, STRUKTURA GEOMETRYCZ
   Otte K, 1999, J VAC SCI TECHNOL A, V17, P19, DOI 10.1116/1.581548
   Reynolds GW, 1999, J VAC SCI TECHNOL B, V17, P2723, DOI 10.1116/1.591053
   Saitoh H, 1996, J MATER SCI, V31, P603, DOI 10.1007/BF00367874
   SIGMUND P, 1995, APPL PHYS LETT, V66, P433, DOI 10.1063/1.114047
   Verdonschot N, 1998, J BIOMED MATER RES, V42, P554, DOI 10.1002/(SICI)1097-4636(19981215)42:4<554::AID-JBM11>3.3.CO;2-B
   VISHNYAKOV V, 1995, VACUUM, V46, P637, DOI 10.1016/0042-207X(95)00003-8
   WILK J, 1997, 27 ITE TUW
   Wittmaack K, 2000, J VAC SCI TECHNOL B, V18, P524, DOI 10.1116/1.591225
NR 33
TC 11
Z9 11
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD AUG 16
PY 2001
VL 63
IS 4
BP 603
EP 608
DI 10.1016/S0042-207X(01)00247-0
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 470TH
UT WOS:000170886900028
DA 2018-10-20
ER

PT J
AU Serafetinides, AA
   Makropoulou, MI
   Skordoulis, CD
   Kar, AK
AF Serafetinides, AA
   Makropoulou, MI
   Skordoulis, CD
   Kar, AK
TI Ultra-short pulsed laser ablation of polymers
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE polymer ablation; picosecond laser ablation; ultra-short laser ablation
ID INDUCED DAMAGE; PICOSECOND; UV; FILMS; NITROCELLULOSE; POLYIMIDE;
   RADIATION; VIOLET
AB We report the experimental results of the ablation rate per pulse as a function of the laser fluence and images of the surface morphology, as examined by atomic force microscopy, for a number of organic polymer materials of special interest in microelectronics and biomedical applications. The ablation parameters and the surface modifications are examined under various irradiation conditions using laser wavelengths ranging from the ultraviolet through the visible to the infrared and pulse widths ranging from nanoseconds to femtoseconds. Our results are discussed in the view of interplay between the material properties and the radiation dependent parameters governing the ablation process. Visible and infrared ultra-short pulsed laser ablation of the polymer samples was performed with a very low threshold fluence of approximately 0.2 mJ/mm(2). The irradiated polymers exhibit different optical transmission properties in the corresponding spectral regions. The quantitative results on ablation rate versus laser energy fluence show that the picosecond laser ablation is more efficient than the subpicosecond and nanosecond ablation, i.e., it exhibits higher etch rates before the onset of any saturation. (C) 2001 Elsevier Science B.V All rights reserved.
C1 Natl Tech Univ Athens, Dept Phys, Athens 15780, Greece.
   Univ Ioannina, Dept Phys, Atom & Mol Phys Lab, GR-45110 Ioannina, Greece.
   Heriot Watt Univ, Dept Phys, Edinburgh EH14 4AS, Midlothian, Scotland.
RP Makropoulou, MI (reprint author), Natl Tech Univ Athens, Dept Phys, Zografou Campus, Athens 15780, Greece.
OI Serafetinides, Alexandros/0000-0001-5284-0050
CR BOR Z, 1995, APPL PHYS A-MATER, V60, P365, DOI 10.1007/BF01538335
   DAVIS CR, 1992, APPL PHYS B-PHOTO, V54, P227, DOI 10.1007/BF00325507
   DICKINSON JT, 1993, J APPL PHYS, V74, P4729, DOI 10.1063/1.354341
   Himmelbauer M, 1996, APPL PHYS A-MATER, V63, P337, DOI 10.1007/BF01567323
   Jandeleit J, 1996, APPL PHYS A-MATER, V63, P117, DOI 10.1007/BF01567638
   KOSMIDIS CE, 1993, APPL PHYS A-MATER, V56, P64, DOI 10.1007/BF00351904
   Kruger J, 1996, APPL SURF SCI, V96-8, P430, DOI 10.1016/0169-4332(95)00446-7
   KUMAGAI H, 1994, APPL PHYS LETT, V65, P1850, DOI 10.1063/1.112863
   KUPER S, 1987, APPL PHYS B-PHOTO, V44, P199, DOI 10.1007/BF00692122
   Makropoulou M, 1995, LASER MED SCI, V10, P201, DOI 10.1007/BF02133332
   MAKROPOULOU MI, 1997, SPIE, V3423, P384
   Serafetinides AA, 1999, LASER MED SCI, V14, P168, DOI 10.1007/s101030050080
   Serafetinides AA, 1998, APPL SURF SCI, V135, P276, DOI 10.1016/S0169-4332(98)00276-1
   SKORDOULIS CD, 1995, OPT LASER TECHNOL, V27, P185, DOI 10.1016/0030-3992(95)93639-9
   SKORDOULIS CD, 1995, APPL SURF SCI, V86, P239, DOI 10.1016/0169-4332(94)00413-7
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
   SRINIVASAN R, 1987, APPL PHYS LETT, V51, P1285, DOI 10.1063/1.99001
   STUART BC, 1995, PHYS REV LETT, V74, P2248, DOI 10.1103/PhysRevLett.74.2248
   Varel H, 1996, APPL PHYS A-MATER, V62, P293, DOI 10.1007/BF01575098
   ZWEIG AD, 1992, APPL PHYS B-PHOTO, V54, P76, DOI 10.1007/BF00331737
   1990, LAMBDA HIGHLIGHTS, V25, P1
NR 21
TC 42
Z9 43
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 1
PY 2001
VL 180
IS 1-2
BP 42
EP 56
DI 10.1016/S0169-4332(01)00324-5
PG 15
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 462LL
UT WOS:000170421500006
DA 2018-10-20
ER

PT J
AU Huang, LY
   Xu, KW
   Lu, J
   Guelorget, B
   Chen, H
AF Huang, LY
   Xu, KW
   Lu, J
   Guelorget, B
   Chen, H
TI Nano-scratch and fretting wear study of DLC coatings for biomedical
   application
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article
DE diamond-like carbon (DLC); nanoindentation; nano-scratch; biomaterials
ID DIAMOND-LIKE-CARBON; A-C-H; FILMS; DEPOSITION; RESISTANCE; SI;
   NANOINDENTATION; POLYETHYLENE; TI-6AL-4V; ALLOY
AB The generation of wear particles is now considered one of the most important failures in total arthroplasty. It is especially needed to study damage process of the particles at slight movement and lower load for long-term service of implanted materials. The wear and abrasion behavior of particles on Ti-6Al-4V coated with diamond-like carbon (DLC) were appropriately simulated in the present paper by fretting wear and nano-scratch test. The coatings with a thickness of 2.5 mum were deposited with an r.f.-plasma enhanced chemical vapor deposition method. The analytic techniques employed to assess DLC coatings characterization include SEM, ATM, Raman and IR spectroscopy. Assessment of hardness, elastic modulus, abrasion and adhesion of the coatings were performed using a Nano Indenter XP system with attachments of continuous stiffness measurements (CSM) and lateral force measurements (LFM). Tribological properties of the coatings were evaluated by a fretting wear test. It was concluded that the DLC coatings had a smooth surface morphology with a rms of 6.8 nm and possessed good adhesion to the substrate, they recovered fully elastic at lower load (60 mN) and were ploughed and delaminated only partially at higher load (400 mN). Nevertheless, there was wear debris concurrently generated during the nano-scratch and fretting test, which was more evident at high loads for a definite coatings, indicating an essential necessity of the work to improve the wear resistant of the coatings to avoid the generation of wear debris. The friction coefficient of DLC coatings against corundum obtained by fretting test decreased with the increase of relative humidity, it was below 0.1 in an aqueous condition, this may be beneficial to their biomedical applications in body fluids. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Xian Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
   Univ Technol Troyes, LASMIS, F-10010 Troyes, France.
RP Xu, KW (reprint author), Xian Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
RI LU, JIAN/C-6044-2013
OI LU, Jian/0000-0001-5362-0316
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   ALLOUARD M, 1995, MATER MANUF PROCESS, V10, P1093, DOI 10.1080/10426919508935091
   BEEMAN D, 1984, PHYS REV B, V30, P870, DOI 10.1103/PhysRevB.30.870
   Bell T., 1986, Surface Engineering, V2, P133
   Besong AA, 1997, BIO-MED MATER ENG, V7, P59
   BHATTACHARYA AK, 1988, INT J SOLIDS STRUCT, V24, P1287, DOI 10.1016/0020-7683(88)90091-1
   BOS I, 1991, Z ORTHOP GRENZGEB, V129, P507, DOI 10.1055/s-2008-1040281
   CHANDRA L, 1995, J MATER SCI-MATER M, V6, P581, DOI 10.1007/BF00121282
   Charitidis C, 2000, SURF COAT TECH, V125, P201, DOI 10.1016/S0257-8972(99)00546-0
   Charitidis C, 1999, DIAM RELAT MATER, V8, P558, DOI 10.1016/S0925-9635(98)00285-4
   DEMARTINO C, 1995, DIAM RELAT MATER, V4, P1215
   Fisher J, 1995, Proc Inst Mech Eng H, V209, P263, DOI 10.1243/PIME_PROC_1995_209_353_02
   Fu YQ, 1998, SURF COAT TECH, V106, P193, DOI 10.1016/S0257-8972(98)00528-3
   GRANT DM, 1992, DIAM RELAT MATER, V1, P727, DOI 10.1016/0925-9635(92)90198-W
   Grill A, 1997, SURF COAT TECH, V94-5, P507, DOI 10.1016/S0257-8972(97)00458-1
   Grill A., 1994, SYNTHETIC DIAMOND EM, P91
   Hauert R, 1997, THIN SOLID FILMS, V308, P191, DOI 10.1016/S0040-6090(97)00422-7
   Heinrich G, 1997, SURF COAT TECH, V94-5, P514, DOI 10.1016/S0257-8972(97)00459-3
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   Johns SM, 1996, SURF COAT TECH, V85, P7, DOI 10.1016/0257-8972(96)02884-8
   LAPPALAINEN R, 1991, DIAM RELAT MATER, V29, P462
   Lee KR, 1997, THIN SOLID FILMS, V308, P263, DOI 10.1016/S0040-6090(97)00411-2
   LI X, 1999, J MATER RES, V14, P2
   Liu DX, 1999, SURF COAT TECH, V116, P234, DOI 10.1016/S0257-8972(99)00279-0
   Liu E, 1999, SURF COAT TECH, V120, P601, DOI 10.1016/S0257-8972(99)00442-9
   Liu Y, 1997, SURF COAT TECH, V94-5, P463, DOI 10.1016/S0257-8972(97)00450-7
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   MCCOLL IR, 1993, DIAM RELAT MATER, V3, P83
   Michler T, 1999, SURF COAT TECH, V111, P41, DOI 10.1016/S0257-8972(98)00701-4
   NARYAN J, 1994, MAT SCI ENG B-FLUID, V25, P5
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   PARKER TL, 1994, DIAM RELAT MATER, V3, P1120, DOI 10.1016/0925-9635(94)90104-X
   Peng XL, 1998, THIN SOLID FILMS, V312, P207, DOI 10.1016/S0040-6090(97)00588-9
   PILIAR RM, 1986, CLIN ORTHOP RELAT R, V206, P108
   QIU X, 1989, WEAR CORROSION INTER, P109
   Scharf TW, 1997, THIN SOLID FILMS, V308, P340, DOI 10.1016/S0040-6090(97)00568-3
   SUSHANSI P, 1996, SURF COAT TECH, V83, P175
   TAKADOUM J, 1996, SURF COAT TECH, V88, P231
   Voevodin AA, 1995, SURF COAT TECH, V76-77, P534, DOI 10.1016/0257-8972(95)02521-9
   WILLIAMS JM, 1985, MATER SCI ENG, V69, P237, DOI 10.1016/0025-5416(85)90398-2
NR 40
TC 66
Z9 71
U1 1
U2 33
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD AUG
PY 2001
VL 10
IS 8
BP 1448
EP 1456
DI 10.1016/S0925-9635(00)00501-X
PG 9
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 456HG
UT WOS:000170076600002
DA 2018-10-20
ER

PT J
AU Freund, P
AF Freund, P
TI Bodies, disability and spaces: the social model and disabling spatial
   organisations
SO DISABILITY & SOCIETY
LA English
DT Article
ID CHRONIC ILLNESS; PLACE; GEOGRAPHY; POLITICS; HEALTH; PEOPLE; BODY
AB This essay examines the relevance of socio-material space to the social model. The social model has been criticised as being disembodied. While there is some basis for this critique, the social model, in fact, has 'bodies in space' as a central concern. A distinction is made between disability as a sociocultural and biomedical category, and as a state of 'not being able to'. The latter usage is not just relevant to people with disabilities. In order to illustrate the strength of the social model, disabling social organisations of space-time practises are examined with a special emphasis on transport-public space. It is concluded that the social model offers insights into relationships between bodies, embodied agency and the social organisation of space-time.
C1 Montclair State Univ, Dept Sociol, Montclair, NJ 07043 USA.
RP Freund, P (reprint author), Montclair State Univ, Dept Sociol, Montclair, NJ 07043 USA.
CR BARNES C, 1998, DISABILITY READER
   Bourdieu P, 1977, OUTLINE THEORY PRACT
   COCKBURN A, 1988, ZETA MAGAZINE, V1, P5
   Corker M., 1999, DISABILITY DISCOURSE
   Curtis S, 1998, SOCIOL HEALTH ILL, V20, P645, DOI 10.1111/1467-9566.00123
   David Harvey Justice, 1996, JUSTICE NATURE GEOGR
   ELIAS N, 1995, THEOR CULT SOC, V12, P7, DOI 10.1177/026327695012003002
   Elias N, 1982, CIVILIZING PROCESS, V2
   Elias N, 1996, GERMANS POWER STRUGG
   FREUND P, 1999, HLTH ILLNESS SOCIAL
   Freund Peter, 1993, ECOLOGY AUTOMOBILE
   Gleeson B., 1999, GEOGRAPHIES DISABILI
   Hahn H., 1994, RES SOCIOLOGY HLTH C, V11, P3
   Hillier Bill, 1996, SPACE IS THE MACHINE
   HOXIE RE, 1994, J AM GERIATR SOC, V42, P241, DOI 10.1111/j.1532-5415.1994.tb01745.x
   Hughes B, 1997, DISABIL SOC, V12, P325, DOI 10.1080/09687599727209
   Humphrey JC, 2000, DISABIL SOC, V15, P63, DOI 10.1080/09687590025775
   Imrie R, 2000, DISABIL SOC, V15, P5, DOI 10.1080/09687590025748
   IMRIE R, 1998, DISABILITY READER
   Kitchin R, 1998, DISABIL SOC, V13, P343, DOI 10.1080/09687599826678
   LINDEMANN G, 1996, IDENTITAT LEIBLICHKE
   Oliver M., 1996, UNDERSTANDING DISABI
   Paterson K, 1999, DISABIL SOC, V14, P597, DOI 10.1080/09687599925966
   PINDER R, 1995, SOCIOL HEALTH ILL, V17, P605, DOI 10.1111/1467-9566.ep10932129
   Pinder R, 1997, DISABIL SOC, V12, P301, DOI 10.1080/09687599727399
   Popay J, 1998, SOCIOL HEALTH ILL, V20, P619, DOI 10.1111/1467-9566.00122
   Radley A, 1996, THEOR PSYCHOL, V6, P559, DOI 10.1177/0959354396064002
   RADLEY A, 1995, BODY SOC, V1, P3
   Relph E, 1981, RATIONAL LANDSCAPES
   Shakespeare T, 1997, DISABIL SOC, V12, P293, DOI 10.1080/09687599727380
   Shakespeare T., 1999, DISABILITY DIVERS AB
   SMITH RG, 1999, DISABILITY DIVERS AB
   Wendell Susan, 1996, REJECTED BODY
   Williams G, 1998, DISABILITY READER
   Williams G, 2000, HLTH MED SOC
   Williams SJ, 1999, SOCIOL HEALTH ILL, V21, P797, DOI 10.1111/1467-9566.00184
   Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191
   Wolf W., 1996, CAR MANIA CRITICAL H
   Zarb G., 1995, CRITICAL PUBLIC HLTH, V6, P21
   ZOLA IK, 1989, MILBANK Q, V67, P401, DOI 10.2307/3350151
   Zola Irving. K., 1982, MISSING PIECES CHRON
   1992, DISABILITY RAG, V12, P4
NR 42
TC 66
Z9 71
U1 3
U2 14
PU CARFAX PUBLISHING
PI BASINGSTOKE
PA RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND
SN 0968-7599
J9 DISABIL SOC
JI Disabil. Soc.
PD AUG
PY 2001
VL 16
IS 5
BP 689
EP 706
DI 10.1080/09687590120070079
PG 18
WC Rehabilitation; Social Sciences, Interdisciplinary
SC Rehabilitation; Social Sciences - Other Topics
GA 459UC
UT WOS:000170269000004
DA 2018-10-20
ER

PT J
AU Liu, HF
   Lussier, YA
   Friedman, C
AF Liu, HF
   Lussier, YA
   Friedman, C
TI Disambiguating ambiguous biomedical terms in biomedical narrative text:
   An unsupervised method
SO JOURNAL OF BIOMEDICAL INFORMATICS
LA English
DT Article
DE natural language processing; word sense disambiguation; corpus-based
   machine learning; MedLEE; UMLS; MEDLINE
ID SPECIAL ISSUE; LANGUAGE
AB With the growing use of Natural Language Processing (NLP) techniques for information extraction and concept indexing in the biomedical domain, a method that quickly and efficiently assigns the correct sense of an ambiguous biomedical term in a given context is needed concurrently. The current status of word sense disambiguation (WSD) in the biomedical domain is that handcrafted rules are used based on contextual material. The disadvantages of this approach are (i) generating WSD rules manually is a time-consuming and tedious task, (ii) maintenance of rule sets becomes increasingly difficult over time, and (iii) handcrafted rules are often incomplete and perform poorly in new domains comprised of specialized vocabularies and different genres of text. This paper presents a two-phase unsupervised method to build a WSD classifier for an ambiguous biomedical term W The first phase automatically creates a sense-tagged corpus for W, and the second phase derives a classifier for W using the derived sense-tagged corpus as a training set. A formative experiment was performed, which demonstrated that classifiers trained on the derived sense-tagged corpora achieved an overall accuracy of about 97%, with greater than 90% accuracy for each individual ambiguous term. (C) 2001 Elsevier Science (USA).
C1 CUNY Grad Sch & Univ Ctr, Div Comp Sci, New York, NY 10016 USA.
   CUNY Queens Coll, Dept Comp Sci, New York, NY USA.
   Columbia Univ Coll Phys & Surg, Dept Med Informat, New York, NY 10032 USA.
RP Liu, HF (reprint author), CUNY Grad Sch & Univ Ctr, Div Comp Sci, New York, NY 10016 USA.
RI Lussier, Yves/N-4891-2017
OI Lussier, Yves/0000-0001-9854-1005
FU NLM NIH HHS [LM06274, K22 LM008308, K22 LM008308-01]
CR ARONSON AR, 1994, P RIAO, P197
   BLOOM D, 2000, BJU INT, P1
   BRUCE R, P ACL, V32, P139
   BRUCE R, 1994, P ACL, V32, P139
   Campbell D A, 2001, Proc AMIA Symp, P90
   CARDIE C, P NAT C AI, V11, P798
   CHEUNG T, 1999, AM HEART J, V134, P726
   COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964
   Dreiseitl S, 2001, J BIOMED INFORM, V34, P28, DOI 10.1006/jbin.2001.10004
   Duda R. O., 1973, PATTERN CLASSIFICATI
   Escudero G., 2000, P 14 EUR C ART INT E, P421
   Fellbaum Christiane, 1998, WORDNET ELECT LEXICA
   Friedman C, 2000, Proc AMIA Symp, P270
   Friedman C, 2001, Proc AMIA Symp, P189
   Friedman C, 1998, METHOD INFORM MED, V37, P334
   FRIEDMAN C, 1994, J AM MED INFORM ASSN, V1, P161, DOI 10.1136/jamia.1994.95236146
   GALE WA, 1992, P 4 INT C THEOR METH, P101
   HRIPCSAK G, 1995, ANN INTERN MED, V122, P681, DOI 10.7326/0003-4819-122-9-199505010-00007
   Ide N, 1998, COMPUT LINGUIST, V24, P1
   Johnson SB, 1999, J AM MED INFORM ASSN, V6, P205, DOI 10.1136/jamia.1999.0060205
   Kilgarriff A, 2000, COMPUT HUMANITIES, V34, P1, DOI 10.1023/A:1002619001915
   Knirsch CA, 1998, INFECT CONT HOSP EP, V19, P94
   Leacock C, 1998, COMPUT LINGUIST, V24, P147
   LEACOCK C, 1993, P ARPA WORKSH HUM LU
   LI M, T NEURAL NETW, V11, P647
   Liu H, 2001, Proc AMIA Symp, P393
   MOONEY RJ, 1996, P EMNLP, V1, P82
   NADKAMI P, 2001, J AM MED INFORM ASSN, V80, P80
   NG HT, 1996, P ACL, V34, P40
   NG HT, 1997, P EMNLP2
   NG HT, 1997, AI MAGAZINE      WIN, P45
   Reis BY, 2001, J BIOMED INFORM, V34, P15, DOI 10.1006/jbin.2001.1005
   Rindflesch T C, 1994, Proc Annu Symp Comput Appl Med Care, P240
   Rivest R. L., 1987, Machine Learning, V2, P229, DOI 10.1007/BF00058680
   ROTH L, 2000, P AMIA ANN FALL S 20, P1124
   STEVENSON M, 1999, P INT JOINT C AI
   *US DHHS NIH NAT L, UMLS KNOWL SOURC
   YAROWSKY D, 1994, P ACL, V32, P88
   YAROWSKY D, P ACL, V32, P88
NR 39
TC 37
Z9 38
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-0464
J9 J BIOMED INFORM
JI J. Biomed. Inform.
PD AUG
PY 2001
VL 34
IS 4
BP 249
EP 261
DI 10.1006/jbin.2001.1023
PG 13
WC Computer Science, Interdisciplinary Applications; Medical Informatics
SC Computer Science; Medical Informatics
GA 541RX
UT WOS:000174998900002
PM 11977807
OA Bronze
DA 2018-10-20
ER

PT J
AU Yan, XL
   Khor, E
   Lim, LY
AF Yan, XL
   Khor, E
   Lim, LY
TI Chitosan-alginate films prepared with chitosans of different molecular
   weights
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE chitosan-alginate PEC film; molecular weight; surface morphology; water
   vapor transmission; X-ray diffraction; cytotoxicity
ID MICROSPHERES; MICROCAPSULES
AB Chitosan-alginate polyelectrolyte complex (CS-AL PEG) is water insoluble and more effective in limiting the release of encapsulated materials compared to chitosan or alginate, Coherent CS-AL PEC films have been prepared in our laboratory hy casting and drying suspensions of chitosan-alginate coacervates. The objective of this study was to evaluate the properties of the CS-AL PEC films prepared with chitosans of different molecular weights. Films prepared with low-molecular-weight chitosan (M-v 1.30 x 10(5)) were twice as thin and transparent, as well as 55% less permeable to water vapor, compared to films prepared with high-molecular-weight chitosan (M-v 10.0 x 10(5)), It may be inferred that the low-molecular-weight chitosan reacted more completely with the sodium alginate (M-v 1.04 x 10(5)) than chitosan of higher molecular weight. A threshold molecular weight may be required, because chitosans of M-v 10.0 x 10(5) and 5.33 x 10(5) yielded films with similar physical properties. The PEC films exhibited different surface properties from the parent films, and contained a higher degree of chain alignment with the possible formation of new crystal types. The PEC films exhibited good in vitro biocompatibility with mouse and human fibroblasts, suggesting that they can be further explored for biomedical applications. (C) 2001 John Wiley & Sons. Inc.
C1 Natl Univ Singapore, Dept Pharm, Singapore 119260, Singapore.
   Natl Univ Singapore, Dept Chem, Singapore 119260, Singapore.
RP Lim, LY (reprint author), Natl Univ Singapore, Dept Pharm, 10 Lower Kent Ridge Rd, Singapore 119260, Singapore.
EM phalimly@nus.edu.sg
RI Lim, Lee Yong/C-6144-2013; Yan, Xiaoliang/D-3640-2009
OI Lim, Lee Yong/0000-0002-7307-0742; 
CR ALEXAKIS T, 1995, APPL BIOCHEM BIOTECH, V50, P93, DOI 10.1007/BF02788043
   *ASTM, E9695 ASTM
   Bartkowiak A, 1999, CHEM MATER, V11, P2486, DOI 10.1021/cm9910456
   BOHDANECKY M, 1982, VISCOSITY POLYM SOLU, P108
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   FILIPOVICGRCIC J, 1995, INT J PHARMACEUT, V116, P39, DOI 10.1016/0378-5173(94)00269-B
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   Liu LS, 1997, J CONTROL RELEASE, V43, P65, DOI 10.1016/S0168-3659(96)01471-X
   MARTINSEN A, 1991, CARBOHYD POLYM, V15, P171, DOI 10.1016/0144-8617(91)90031-7
   OVERGAARD S, 1991, CAN J CHEM ENG, V69, P439, DOI 10.1002/cjce.5450690206
   RemunanLopez C, 1997, J CONTROL RELEASE, V44, P215, DOI 10.1016/S0168-3659(96)01525-8
   Tan SC, 1998, TALANTA, V45, P713, DOI 10.1016/S0039-9140(97)00288-9
   WEI W, 1991, INT J BIOL MACROMOL, V13, P281, DOI 10.1016/0141-8130(91)90027-R
   Yamamoto A, 1997, BIOSCI BIOTECH BIOCH, V61, P1230, DOI 10.1271/bbb.61.1230
   Yan XL, 2000, CHEM PHARM BULL, V48, P941
   Yao K. D., 1996, J APPL POLYM SCI, V60, P279
NR 16
TC 119
Z9 123
U1 2
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 2001
VL 58
IS 4
BP 358
EP 365
DI 10.1002/jbm.1029
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 452CL
UT WOS:000169839500004
PM 11410893
DA 2018-10-20
ER

PT J
AU Mujat, M
   Dogariu, A
AF Mujat, M
   Dogariu, A
TI Measurements of structure-induced polarization features in forward
   scattering from collections of cylindrical fibers
SO JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER
LA English
DT Article; Proceedings Paper
CT 5th Conference on Light Scattering by Nonspherical Particles
CY AUG 28-SEP 01, 2000
CL DALHOUSIE UNIV, HALIFAX, CANADA
SP USA Res Lab, Opt Soc Amer
HO DALHOUSIE UNIV
AB Many applications in remote sensing, material sciences and biomedical field are characterized by a transition domain between single scattering and multiple-scattering regimes. This regime is described by typical polarization features which can be used to retrieve structural information. An electronically agile technique was used for measuring in real time the Stokes vectors of light incident on and emerging from an inhomogeneous medium. Subsequently. the Mueller matrix associated with the scattering medium is determined. We focus our attention on forward scattering from systems consisting of random as well as partially oriented long cylindrical fibers. We discuss the effects of: (1) shape of individual scattering centers, (2) structure parameter, and (3) optical density of the scattering medium. The anisotropic behavior of the structure function at different packing fractions determines nontrivial characteristics of the polarization transfer. The complex effective index of refraction can be polarization dependent as a result of the optical anisotropy due to both the shape of the individual scatterers and the structure characteristics of the scattering system. Some of the Mueller matrix elements are shown to be related to the optical anisotropy of the system for the case of long cylindrical fibers. The polarization efficiency, the structure parameter, and the packing fraction are used to quantify this relationship. We also found that some of the matrix elements are more sensitive to the degree of structural anisotropy and the packing fraction, while other elements are sensitive to structural non-uniformities across the investigated area. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Cent Florida, CREOL, Sch Opt, Orlando, FL 32816 USA.
RP Dogariu, A (reprint author), Univ Cent Florida, CREOL, Sch Opt, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.
CR Bickel W. S., 1980, Light Scattering by Irregularly Shaped Particles, Proceedings of the International Workshop, P299
   BICOUT D, 1994, PHYS REV E, V49, P1767, DOI 10.1103/PhysRevE.49.1767
   Bohren C., 1983, ABSORPTION SCATTERIN
   CARIOU J, 1990, APPL OPTICS, V29, P1689, DOI 10.1364/AO.29.001689
   FULLER GG, 1995, OPTICAL RHEOMETRY CO
   Hovenier JW, 1998, J QUANT SPECTROSC RA, V60, P483, DOI 10.1016/S0022-4073(98)00022-3
   Kadyshevich Y. A., 1971, IZV AS USSR ATMOS OC, V7, P367
   MISHCHENKO MI, 2000, LIGHT SCATTERING NON, P147
   Mujat M, 2000, P SOC PHOTO-OPT INS, V4035, P390, DOI 10.1117/12.397810
   Mujat M, 2001, APPL OPTICS, V40, P34, DOI 10.1364/AO.40.000034
   ONUKI A, 1986, J CHEM PHYS, V85, P1190, DOI 10.1063/1.451315
   Perrin F, 1942, J CHEM PHYS, V10, P415, DOI 10.1063/1.1723743
   VANDEHULST HC, 1981, LIGHT SCATTERING SMA, pCH9
   VANDEHULST HC, 1981, LIGHT SCATTERING SMA
NR 14
TC 4
Z9 4
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-4073
J9 J QUANT SPECTROSC RA
JI J. Quant. Spectrosc. Radiat. Transf.
PD AUG-SEP
PY 2001
VL 70
IS 4-6
BP 555
EP 567
DI 10.1016/S0022-4073(01)00029-2
PG 13
WC Optics; Spectroscopy
SC Optics; Spectroscopy
GA 454ME
UT WOS:000169975700014
DA 2018-10-20
ER

PT J
AU Taddei, P
   Tinti, A
   Fini, G
AF Taddei, P
   Tinti, A
   Fini, G
TI Vibrational spectroscopy of polymeric biomaterials
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Review
ID MOLECULAR-WEIGHT POLYETHYLENE; INFRARED CORRELATION SPECTROSCOPY;
   PLA/PEO/PLA TRIBLOCK COPOLYMERS; PEO/PLA BLOCK COPOLYMERS;
   FOURIER-TRANSFORM-RAMAN; HYDROLYTIC DEGRADATION; POLY(L-LACTIC ACID);
   L-LACTIDE; POLY(ETHYLENE GLYCOL); IN-VIVO
AB This review highlights the potential of vibrational spectroscopy for investigating the molecular structure of some polymeric materials used in biomedical applications in relation to their biocompatibility. Many types of polymers are used for biomedical purposes; depending on the application, bioresorbable or non-bioresorbable (semi-crystalline or amorphous) polymers are used. Among bioresorbable polymers, we focused on homopolymers and copolymers based on poly(lactic acid), poly(glycolic acid) and poly(epsilon -caprolactone). Being a nondestructive technique, Raman spectroscopy proved particularly suitable for evaluating the molecular structure and crystallinity of bioresorbable polymers and their degradation products. For various biomedical applications, non-degradable semi-crystalline polymers have been widely employed; in this class of polymers, we concentrated on ultra-high molecular weight polyethylene (UHMWPE) used in orthopaedic implants (total hip and knee joints). Vibrational spectroscopy appeared particularly suitable in studying the oxidation and crystallinity of UHMWPE. Copyright (C) 2001 John Wiley & Sons, Ltd.
C1 Univ Bologna, Dipartimento Biochim G Moruzzi, Sez Chim & Propedeut Biochim, I-40126 Bologna, Italy.
RP Fini, G (reprint author), Univ Bologna, Dipartimento Biochim G Moruzzi, Sez Chim & Propedeut Biochim, Via Belmeloro 8-2, I-40126 Bologna, Italy.
OI TADDEI, PAOLA/0000-0001-8478-4508; TINTI, ANNA/0000-0001-8452-815X
CR AFFATATO S, IN PRESS BIOMATERIAL
   Agarwal M, 1998, BIOTECHNOL PROGR, V14, P517, DOI 10.1021/bp980015p
   Berrill SA, 1999, J MATER CHEM, V9, P1059, DOI 10.1039/a808718k
   Bertoluzza A, 1997, SPECTROSCOPY OF BIOLOGICAL MOLECULES: MODERN TRENDS, P431
   Bertoluzza A, 1997, SPECTROSCOPY OF BIOLOGICAL MOLECULES: MODERN TRENDS, P507
   Bertoluzza A, 1999, SPECTROSCOPY OF BIOLOGICAL MOLECULES: NEW DIRECTIONS, P603
   BERTOLUZZA A, 1992, Clinical Materials, V9, P49, DOI 10.1016/0267-6605(92)90010-Q
   Bertoluzza A, 1998, BIOM HLTH R, V16, P45
   BERTOLUZZA A, 1997, CERAMICS CELLS TISSU, V4, P7
   BERTOLUZZA A, 2000, J MOL STRUCT, V251, P89
   Blazewicz M, 1999, J MOL STRUCT, V482, P519, DOI 10.1016/S0022-2860(98)00695-4
   Buchanan FJ, 1999, BIOMATERIALS, V20, P823, DOI 10.1016/S0142-9612(98)00237-3
   Cai Q, 2000, J BIOMAT SCI-POLYM E, V11, P273, DOI 10.1163/156856200743698
   Cai Q, 2000, POLYM ADVAN TECHNOL, V11, P159, DOI 10.1002/1099-1581(200004)11:4<159::AID-PAT956>3.0.CO;2-N
   CASSANAS G, 1991, J RAMAN SPECTROSC, V22, P409, DOI 10.1002/jrs.1250220709
   CASSANAS G, 1991, J RAMAN SPECTROSC, V22, P11, DOI 10.1002/jrs.1250220103
   CASSANAS G, 1993, SPECTROCHIM ACTA A, V49, P271, DOI 10.1016/0584-8539(93)80181-9
   CERRAI P, 1989, POLYMER, V30, P338, DOI 10.1016/0032-3861(89)90126-2
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P33, DOI 10.1007/BF00121151
   CERRAI P, 1993, MAKROMOL CHEM-RAPID, V14, P529
   Cerrai P, 1999, J MATER SCI-MATER M, V10, P283, DOI 10.1023/A:1008905529461
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P308, DOI 10.1007/BF00058953
   Chenery DH, 1997, BIOMATERIALS, V18, P415, DOI 10.1016/S0142-9612(96)00149-4
   COHN D, 1988, J BIOMED MATER RES, V22, P993, DOI 10.1002/jbm.820221104
   Costa L, 1998, BIOMATERIALS, V19, P1371, DOI 10.1016/S0142-9612(98)00013-1
   Costa L, 1998, BIOMATERIALS, V19, P659, DOI 10.1016/S0142-9612(97)00160-9
   delPrever EB, 1996, BIOMATERIALS, V17, P873, DOI 10.1016/0142-9612(96)83282-0
   Edidin AA, 2000, BIOMATERIALS, V21, P1451, DOI 10.1016/S0142-9612(00)00021-1
   ElBaseir MM, 1997, INT J PHARM, V151, P145, DOI 10.1016/S0378-5173(96)04873-9
   Elkheshen SA, 2000, J MICROENCAPSUL, V17, P425
   Epple M, 1998, J BIOMED MATER RES, V43, P83
   EYERER P, 1987, J BIOMED MATER RES, V21, P275, DOI 10.1002/jbm.820210302
   EYERER P, 1984, J BIOMED MATER RES, V18, P1137, DOI 10.1002/jbm.820180915
   Goldman M, 1997, J BIOMED MATER RES, V37, P43, DOI 10.1002/(SICI)1097-4636(199710)37:1<43::AID-JBM6>3.0.CO;2-J
   Gonsalves KE, 1998, BIOMATERIALS, V19, P1501, DOI 10.1016/S0142-9612(98)00066-0
   HANH DW, 1997, J BIOMED MATER RES, V35, P31
   He Y, 2000, POLYM INT, V49, P623, DOI 10.1002/1097-0126(200006)49:6<623::AID-PI435>3.0.CO;2-8
   IZUMIKAWA S, 1991, J CONTROL RELEASE, V15, P133, DOI 10.1016/0168-3659(91)90071-K
   JAMES SP, 1993, BIOMATERIALS, V14, P643, DOI 10.1016/0142-9612(93)90062-7
   JIN S, 1998, ACS SYM SER, V704, P276
   Kader A, 1998, DRUG DEV IND PHARM, V24, P535, DOI 10.3109/03639049809085654
   KAHN J, 1996, BIOMATERIALS SCI INT, P64
   KERESZTURY G, 1990, POLYM TEST, V9, P329, DOI 10.1016/0142-9418(90)90004-W
   KISTER G, 1992, EUR POLYM J, V28, P1273, DOI 10.1016/0014-3057(92)90218-Q
   KISTER G, 1995, J RAMAN SPECTROSC, V26, P307, DOI 10.1002/jrs.1250260409
   Kister G, 1998, POLYMER, V39, P3335, DOI 10.1016/S0032-3861(97)10057-X
   Kister G, 1997, SPECTROCHIM ACTA A, V53, P1399, DOI 10.1016/S0584-8539(97)00039-1
   Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2
   Kister G, 2000, POLYMER, V41, P925, DOI 10.1016/S0032-3861(99)00223-2
   Lang MD, 1999, J BIOMAT SCI-POLYM E, V10, P501
   LI S, 1994, J BONE JOINT SURG AM, V76A, P1080, DOI 10.2106/00004623-199407000-00020
   Li SM, 1998, POLYMER, V39, P5421, DOI 10.1016/S0032-3861(97)10272-5
   Li SM, 1998, J APPL POLYM SCI, V68, P989, DOI 10.1002/(SICI)1097-4628(19980509)68:6<989::AID-APP12>3.0.CO;2-J
   LUU DV, 1980, J RAMAN SPECTROSC, V9, P172, DOI 10.1002/jrs.1250090309
   Matsushita A, 2000, VIB SPECTROSC, V24, P171, DOI 10.1016/S0924-2031(00)00062-X
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Nelson DGA, 1982, CALCIFIED TISSUE INT, V34, P69
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   Petrova T, 1998, POLYM INT, V45, P419
   Qin D, 1998, APPL SPECTROSC, V52, P488, DOI 10.1366/0003702981943950
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   Ren Y, 2000, VIB SPECTROSC, V23, P207, DOI 10.1016/S0924-2031(00)00063-1
   RULL F, 1993, J RAMAN SPECTROSC, V24, P545, DOI 10.1002/jrs.1250240813
   Shen FW, 1999, J BIOMED MATER RES, V48, P203, DOI 10.1002/(SICI)1097-4636(1999)48:3<203::AID-JBM1>3.0.CO;2-R
   STROBL GR, 1978, J POLYM SCI POL PHYS, V16, P1181, DOI 10.1002/pol.1978.180160704
   TADDEI P, IN PRESS J MAT SCI M
   TADDEI P, J MOL STRUCT, V317, P565
   Thosar SS, 1999, J PHARMACEUT BIOMED, V20, P107, DOI 10.1016/S0731-7085(99)00002-3
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Williams DF, 1986, P CONS C EUR SOC BIO
   WILLIAMS KPJ, 1995, J RAMAN SPECTROSC, V26, P427, DOI 10.1002/jrs.1250260606
   YOUNES H, 1987, J BIOMED MATER RES, V21, P1301, DOI 10.1002/jbm.820211103
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 73
TC 32
Z9 32
U1 3
U2 27
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0377-0486
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD AUG
PY 2001
VL 32
IS 8
BP 619
EP 629
DI 10.1002/jrs.723
PG 11
WC Spectroscopy
SC Spectroscopy
GA 465KN
UT WOS:000170588300001
DA 2018-10-20
ER

PT J
AU Jones, JR
   Hench, LL
AF Jones, JR
   Hench, LL
TI Materials perspective - Biomedical materials for new millennium:
   perspective on the future
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
ID SOL-GEL GLASSES; IN-VITRO; BIOACTIVE GLASS; HYDROXYAPATITE FORMATION;
   BONE-FORMATION; SURFACE; PHOSPHATE; SILICA; DISSOLUTION; BIOMATERIALS
AB Millions of orthopaedic prostheses made of bioinert materials have been implanted with an excellent 15 year survivability of 75-85%. Improved metal alloys, special polymers, and medical grade ceramics are the basis for this success, which has enhanced the quality of life for millions of patients. However, an increasing percentage of our aging population require greater than 30 years survivability of the devices. It is proposed that to satisfy this growing need for very long term orthopaedic repair a paradigm shift is needed; a shift in emphasis from the replacement of tissues to the regeneration of tissues. Such a shift from a materials and mechanics approach to tissue repair requires an increase in the understanding and utilisation of biologically approaches. Two new biologically orientated alternatives in biomaterials for orthopaedics in the new millennium are discussed: tissue regeneration, where in situ repair is initiated in the host tissue, and tissue engineering, where repair is initiated in vitro on cellularly seeded scaffolds and then transplanted to the recipient. The concept of the use of class A bioactive materials to stimulate the regeneration of trabecular bone is described along with clinical applications. Eleven reaction stages lead to the enhanced proliferation and differentiation of osteoblasts and the recreation of trabecular bone architecture. Recent results showing the effects of microchemical gradients on the genetic activation of bone cells are related to the molecular design of hierarchical bioactive resorbable scaffolds for the tissue engineering of bone constructs. (C) 2001 IoM Communications Ltd.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RP Jones, JR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RI Jones, Julian/B-1007-2012
OI Jones, Julian/0000-0002-2647-8024
CR Aksay IA, 1998, CURR OPIN SOLID ST M, V3, P219, DOI 10.1016/S1359-0286(98)80093-4
   ALBAZIE S, 1998, J DENT RES, V77, P1664
   Andersson OH, 1999, J NON-CRYST SOLIDS, V246, P9, DOI 10.1016/S0022-3093(99)00072-1
   Bonfield W., 1998, BIOCERAMICS, V11, P37
   BRADLEY JG, 2000, P 13 C BIOC, P1013
   BRONZINO JD, 1995, BIOMEDICAL ENG HDB, P532
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CLARK AE, 1979, CORROSION GLASS, P1
   COSTA JM, 1996, J SOLGEL SCI TECHNOL, V7, P45
   DOREMUS RH, 1983, J MATER SCI, V18, P612, DOI 10.1007/BF00560651
   DOUGLAS RW, 1967, J AM CERAM SOC, V50, P1, DOI 10.1111/j.1151-2916.1967.tb14960.x
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   ELSBERG LL, UNPUB
   GREENSPAN DC, 1998, P 11 C BIOC, P345
   GREENSPAN DC, 1997, P 19 C BIOC, P391
   GREENSPAN DC, 1994, P M C BIOC, P28
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench LL, 1998, J SOL-GEL SCI TECHN, V13, P245, DOI 10.1023/A:1008643303888
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1997, KIRK OTHMER ENCY CHE, V22, P497
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HENCH LL, 1996, CLIN PERFORMANCE SKE
   HILL RG, 1996, J MATER SCI LETT, V15, P112
   Ishizaki K, 1998, POROUS MAT PROCESS T, P67
   Kirkwood T, 1999, TIME OUR LIVES
   Kuijer R, 1998, J MATER SCI-MATER M, V9, P449, DOI 10.1023/A:1008867300634
   LEFANU J, 1999, FALL RISE MODERN MED, P104
   LI PJ, 1990, J NON-CRYST SOLIDS, V119, P112, DOI 10.1016/0022-3093(90)90247-J
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   LI RN, 1992, CHEMICAL PROCESSING OF ADVANCED MATERIALS, P627
   LIVAGE J, 1992, J NON-CRYST SOLIDS, V145, P11, DOI 10.1016/S0022-3093(05)80422-3
   Livage J, 1997, CURR OPIN SOLID ST M, V2, P132, DOI 10.1016/S1359-0286(97)80057-5
   MAZER JJ, 1994, J NON-CRYST SOLIDS, V170, P32, DOI 10.1016/0022-3093(94)90100-7
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Padrines M, 2000, CONNECT TISSUE RES, V41, P101, DOI 10.3109/03008200009067662
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   PEREIRA MM, 1994, J MATER SYNTH PROCES, V2, P189
   Perez-Pariente J, 1999, J BIOMED MATER RES, V47, P170, DOI 10.1002/(SICI)1097-4636(199911)47:2<170::AID-JBM6>3.0.CO;2-J
   RATNER BD, 1996, INTRO MAT MED BIOMAT, V484
   Rinehart JD, 1999, J BIOMED MATER RES, V48, P833, DOI 10.1002/(SICI)1097-4636(1999)48:6<833::AID-JBM11>3.0.CO;2-#
   Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.3.CO;2-Y
   SCHEPERS E, 1993, IMPLANT DENTISTRY, V2, P156
   SEPULVEDA P, 2000, P 13 C BIOC, P629
   SIMON SR, 1994, ORTHOPAEDIC BASIC SC
   STAMBOULIS A, 2000, P 13 C BIOC, P729
   THOMPSON I, 2000, COMPREHENSIVE COMPOS, P727
   Tsuru K, 1997, J MATER SCI-MATER M, V8, P157, DOI 10.1023/A:1018523203667
   *US BIOM INC, DET CLIN CAS
   VIDUEAU JJ, 1991, EUR J SOL STATE INOR, V28, P303
   Wallace KE, 1999, J MATER SCI-MATER M, V10, P697, DOI 10.1023/A:1008910718446
   WARREN LD, 1989, J BIOMED MATER RES-A, V23, P201
   WHEELER DL, 1997, P 10 C BOIC, P349
   WHEELER DL, 1997, P 23 ANN M SOC BIOM
   WILSON J, 1990, P 3 C BIOC, P283
   WIRTH GS, 1979, J COLLOID INTERF SCI, V68, P492, DOI 10.1016/0021-9797(79)90307-2
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   XYNOS ID, 2000, BIOCHEM BIOPH RES CO, V277, P604
   ZHONG JP, 1994, P 7 C BIOC, P61
   ZHONG JP, 1997, P 10 C BIOC, P391
NR 66
TC 66
Z9 66
U1 0
U2 22
PU I O M COMMUNICATIONS LTD INST MATERIALS
PI LONDON
PA 1 CARLTON HOUSE TERRACE, LONDON SW1Y 5DB, ENGLAND
SN 0267-0836
J9 MATER SCI TECH SER
JI Mater. Sci. Technol.
PD AUG
PY 2001
VL 17
IS 8
BP 891
EP 900
DI 10.1179/026708301101510762
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 466XC
UT WOS:000170670600001
DA 2018-10-20
ER

PT J
AU Liang, CH
   Mou, ZQ
AF Liang, CH
   Mou, ZQ
TI Effects of different simulated fluids on anticorrosion biometallic
   materials
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE simulated body fluids; biomedical material; corrosion; corrosion
   inhibition
ID CORROSION
AB The corrosion behaviors of SUS316L stainless steel, Co-Cr alloy and Ti-6Al-4V alloy in Ringer's, PBS(-) and Hank's solutions have been investigated. The results indicate that the corrosion of Ringer's solution is the strongest, then followed by PBS(-) and Hank's solution. The presence of HPO42-, H2PO4-, SO42- and glucose in the PBS(-)and Hank's solution probably reduces the corrosion inhibitor and corrosion current. The decrease of the solution's pH significantly increases the corrosion rate and susceptibility to localized corrosion of SUS316L SS and Co-Cr alloy. However, Ti-6Al-4V alloy exhibits an exceptional stability and has only a slight increase of corrosion rate with decreasing pH.
C1 Dalian Univ Technol, Sch Chem Engn, Dalian 116012, Peoples R China.
CR BROWN SA, 1980, J BIOMED MATER RES, V14, P173, DOI 10.1002/jbm.820140208
   CLARK GCF, 1982, J BIOMED MATER RES, V16, P125, DOI 10.1002/jbm.820160205
   DAISUKE K, 2000, JAPAN TETSU TO HAGAN, V66, P610
   GUO L, 2000, ELECTROCHEMISTRY, V6, P208
   LUCAS LC, 1982, J BIOMED MATER RES, V16, P799, DOI 10.1002/jbm.820160606
   Mueller H J, 1970, J Biomed Mater Res, V4, P29, DOI 10.1002/jbm.820040105
   TOSHIHIRO K, 2000, MAT JAPAN, V39, P250
   TOSHIKAZU A, 2000, J JAPAN I METALS, V64, P895
   UHLIG HH, 1985, CORROSION CORROSION, P291
   Wang Guisheng, 1996, CHINESE J NONFERROUS, V6, P147
   YOSHIMITSU O, 1993, J JAPAN I METALS, V57, P338
   YOSHIMITSU O, 1996, J JAPAN I METALS, V60, P890
NR 12
TC 6
Z9 9
U1 0
U2 1
PU ALLERTON PRESS INC
PI NEW YORK
PA 18 WEST 27TH ST, NEW YORK, NY 10001 USA
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD AUG
PY 2001
VL 11
IS 4
BP 579
EP 582
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 461PX
UT WOS:000170373600026
DA 2018-10-20
ER

PT J
AU Tasaka, F
   Ohya, Y
   Ouchi, T
AF Tasaka, F
   Ohya, Y
   Ouchi, T
TI One-pot synthesis of novel branched polylactide through the
   copolymerization of lactide with mevalonolactone
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
ID TRIMETHYLSILYL PROTECTION METHOD; RING-OPENING COPOLYMERIZATION;
   HYPERBRANCHED POLYESTERS; BIODEGRADABLE POLYMERS; MECHANICAL-PROPERTIES;
   BLOCK-COPOLYMERS; POLY(L-LACTIDE); POLYMERIZATION; DEGRADATION; BACKBONE
AB Polylactide, which is a biodegradable and bio-absorbable polymer having low immunogenicity and good biocompatibility, has been mainly studied for biomedical applications. Branched polymers have different rheological and mechanical properties compared with their linear counterparts owing to their molecular architectures. we synthesized novel biodegradable polylactide having a branched structure composed of metabolically degradable and/or absorbable materials only. The branched polylactide was obtained from a one-pot copolymerization of L-lactide using metabolic intermediate DL-mevalonolactone as a bifunctional comonomer having both lactone ring and pendant hydroxy group. The glass transition point, melting point and crystallinity of the branched polylactide are lower than those of linear polylactide.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Osaka 5648680, Japan.
RP Ouchi, T (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Osaka 5648680, Japan.
CR ARVANITOYANNIS I, 1995, POLYMER, V36, P2947, DOI 10.1016/0032-3861(95)94344-S
   Atthoff B, 1999, MACROMOL CHEM PHYS, V200, P1333
   Breitenbach A, 1998, POLYMER, V39, P3261, DOI 10.1016/S0032-3861(97)10077-5
   Chasin M, 1990, BIODEGRADABLE POLYM
   Cho KY, 1999, MACROMOL RAPID COMM, V20, P598, DOI 10.1002/(SICI)1521-3927(19991101)20:11<598::AID-MARC598>3.0.CO;2-1
   Choi YR, 1998, MACROMOLECULES, V31, P8766, DOI 10.1021/ma981069i
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   HOLLINGER JO, 1983, J BIOMED MATER RES, V17, P71, DOI 10.1002/jbm.820170107
   HOLLINGER JO, 1995, BIOCH APPL SYNTHETIC
   Hori Y, 1999, MACROMOLECULES, V32, P3537, DOI 10.1021/ma981846e
   HORI Y, 1993, MACROMOLECULES, V26, P4388, DOI 10.1021/ma00068a053
   John G, 1999, MACROMOLECULES, V32, P1853, DOI 10.1021/ma981729j
   Joziasse CAP, 2000, MACROMOL CHEM PHYSIC, V201, P107, DOI 10.1002/(SICI)1521-3935(20000101)201:1<107::AID-MACP107>3.0.CO;2-W
   KRICHELDORF HR, 1995, POLYMER, V36, P1253, DOI 10.1016/0032-3861(95)93928-F
   LEENSLAG JW, 1984, J APPL POLYM SCI, V29, P2829, DOI 10.1002/app.1984.070290913
   LI TY, 1998, BEITRAGE ALGEBRA GEO, V39, P1
   Li YX, 1997, POLYMER, V38, P6197, DOI 10.1016/S0032-3861(97)00178-X
   LIU HJ, 1994, POLYM BULL, V32, P463, DOI 10.1007/BF00587889
   Liu MJ, 1999, MACROMOLECULES, V32, P6881, DOI 10.1021/ma990785x
   Nguyen C, 2000, MACROMOLECULES, V33, P4281, DOI 10.1021/ma991407v
   Nijenhuis AJ, 1996, POLYMER, V37, P2783, DOI 10.1016/0032-3861(96)87642-7
   Ohya Y, 1998, MACROMOL CHEM PHYSIC, V199, P2017, DOI 10.1002/(SICI)1521-3935(19980901)199:9<2017::AID-MACP2017>3.0.CO;2-9
   Ohya Y, 1998, MACROMOLECULES, V31, P4662, DOI 10.1021/ma980377d
   PITT CG, 1987, J POLYM SCI POL CHEM, V25, P955, DOI 10.1002/pola.1987.080250402
   Tasaka F, 1999, MACROMOLECULES, V32, P6386, DOI 10.1021/ma990766n
   TASAKA F, 2000, POLYM PREPR AM CHEM, V41, P1552
   Trollsas M, 1999, MACROMOLECULES, V32, P9062, DOI 10.1021/ma991039v
NR 28
TC 48
Z9 50
U1 0
U2 27
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 1022-1336
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD JUL 30
PY 2001
VL 22
IS 11
BP 820
EP 824
DI 10.1002/1521-3927(20010701)22:11<820::AID-MARC820>3.0.CO;2-7
PG 5
WC Polymer Science
SC Polymer Science
GA 461KB
UT WOS:000170362500003
DA 2018-10-20
ER

PT J
AU Li, YH
   Rong, LJ
   Li, YY
AF Li, YH
   Rong, LJ
   Li, YY
TI Pore characteristics of porous NiTi alloy fabricated by combustion
   synthesis
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE porous NiTi alloy; pure morphology; mean pore size; porosity; combustion
   synthesis
ID NICKEL-TITANIUM; TISSUE; HARD
AB Biomedical porous NiTi shape memory alloy (SMA) is a promising implant material. The pore characteristics, such as pore morphology and distribution, mean pore size and porosity of porous NiTi SMA fabricated by combustion synthesis were investigated in this paper by optical microscopy, scanning electron microscopy (SEM), image processing and density determination and the mechanism of pore formation was proposed. The result indicated that pore morphology and distribution of porous NiTi SMA exhibited features of isotropy or anisotropy, depending upon preheating temperature during synthesis. Mean pore size and porosity range was 300-600 mum and 60-64% respectively, and open porosity ratio was bigger than 90% which indicates that porous NiTi SMA. is suitable for biomedical application. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Chinese Acad Sci, Met Res Inst, Shenyang 110016, Peoples R China.
RP Li, YH (reprint author), Chinese Acad Sci, Met Res Inst, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
OI Li, Yong-Hua/0000-0003-0005-3789
CR HIRANO K, 1968, J JAPAN I METALS, V32, P613
   Ishizaki K., 1998, POROUS MAT PROCESS T, P202
   ISHIZAKI K, 1998, POROUS MAT PROCESS T, P198
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Munir Z. A., 1989, Material Science Reports, V3, P277, DOI 10.1016/0920-2307(89)90001-7
   MUNIR ZA, 1988, AM CERAM SOC BULL, V67, P342
   RATNER BD, 1996, BIOMATERIALS SCI INT, P37
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
NR 10
TC 52
Z9 53
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD JUL 26
PY 2001
VL 325
IS 1-2
BP 259
EP 262
DI 10.1016/S0925-8388(01)01382-2
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 455YF
UT WOS:000170054800046
DA 2018-10-20
ER

PT J
AU Mandelis, A
   Nicolaides, L
   Chen, Y
AF Mandelis, A
   Nicolaides, L
   Chen, Y
TI Structure and the reflectionless/refractionless nature of parabolic
   diffusion-wave fields
SO PHYSICAL REVIEW LETTERS
LA English
DT Article
ID PHOTON DENSITY WAVES; REFRACTION
AB We show the impossibility of reflection and refraction phenomena at linear diffusion-wave-field (DWF) interfaces. Instead, interfacial flux expressions are derived which involve coherent accumulation or depletion phenomena subject to an interface flux conservation principle. The conditions for reflectionless and refractionless interfaces are the parabolic nature and the concomitant Fickian constitutive relations satisfied by DWFs. Simulations show that the reflection and Snell's laws can be adequate approximations only under near-normal incidence conditions, in agreement with published experimental evidence in wide areas of biomedical, electronic, and materials physics.
C1 Univ Toronto, Dept Mech & Ind Engn, Photothermal & Optoelect Diagnost Labs, Toronto, ON M5S 3G8, Canada.
RP Mandelis, A (reprint author), Univ Toronto, Dept Mech & Ind Engn, Photothermal & Optoelect Diagnost Labs, Toronto, ON M5S 3G8, Canada.
CR BENNETT CA, 1982, APPL OPTICS, V21, P49, DOI 10.1364/AO.21.000049
   Bertolotti M, 1999, J APPL PHYS, V85, P3540, DOI 10.1063/1.369713
   BOAS DA, 1993, PHYS REV E, V47, pR2999, DOI 10.1103/PhysRevE.47.R2999
   BURT JA, 1986, CAN J PHYS, V64, P1053, DOI 10.1139/p86-179
   Mandelis A, 2001, PHYS TODAY, V54, P100, DOI 10.1063/1.4796266
   Mandelis A, 2000, PHYS TODAY, V53, P29, DOI 10.1063/1.1310118
   Mandelis A, 1994, PROGR PHOTOTHERMAL P, VII
   Mandelis A., 2000, PROGR PHOTOTHERMAL P, V4
   MANDELIS A, 2000, PROGR PHOTOTHERMAL P, V3
   Mandelis A., 2001, DIFFUSION WAVE FIELD
   Mandelis A., 1992, PROGR PHOTOTHERMAL P, VI
   Morse P. M., 1968, THEORETICAL ACOUSTIC
   OLEARY MA, 1992, PHYS REV LETT, V69, P2658, DOI 10.1103/PhysRevLett.69.2658
   Patel PM, 1996, PHOTOTHERMAL SCI TEC
NR 14
TC 52
Z9 52
U1 0
U2 3
PU AMERICAN PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD JUL 9
PY 2001
VL 87
IS 2
AR 020801
DI 10.1103/PhysRevLett.87.020801
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 451VM
UT WOS:000169823100002
DA 2018-10-20
ER

PT J
AU Gao, W
   Lui, ZY
   Li, ZW
AF Gao, W
   Lui, ZY
   Li, ZW
TI Nano- and microcrystal coatings and their high-temperature applications
SO ADVANCED MATERIALS
LA English
DT Article
ID CR-AL ALLOY; OXIDATION BEHAVIOR; SELECTIVE OXIDATION; DEPOSITION;
   RESISTANCE
AB Nano- and microcrystal materials often possess special properties that materials with identical compositions but ordinary crystal size do not have, These materials are finding wide applications especially as electronic, photonic, magnetic and biomedical materials.([1]) Nano- and microcrystal materials are also known to have superior mechanical properties due to the extremely fine grain size.([2]) However, it has not been well known that alloy and alloy-oxide coatings with nano- and microcrystal grains have special properties at high temperatures. Nanocrystal structures promote selective oxidation, forming protective oxidation scales with superior adhesion to the substrate. Progress has been made in this area as micro- and nanocrystal alloy and oxide dispersive alloy coatings show superior high-temperature corrosion resistance.([3])
C1 Univ Auckland, Sch Engn, Auckland 1, New Zealand.
RP Gao, W (reprint author), Univ Auckland, Sch Engn, Private Bag 92019, Auckland 1, New Zealand.
OI Gao, Wei/0000-0002-5064-0917
CR ARNELL RD, 1993, SURF COAT TECH, V59, P105, DOI 10.1016/0257-8972(93)90063-T
   GAO W, 2000, CORROS ENG JPN, V49, P592
   Goldstein A., 1997, HDB NANOPHASE MAT
   He K, 2000, MATER LETT, V46, P53, DOI 10.1016/S0167-577X(00)00142-7
   He Y, 2000, MATER LETT, V45, P79, DOI 10.1016/S0167-577X(00)00080-X
   He Y, 2000, HIGH TEMP MATER PROC, V19, P71
   JOHNSON RN, 1995, ELEVATED TEMPERATURE, V1, P265
   Li ZW, 2000, HIGH TEMP MATER PROC, V19, P443
   LIANG J, 2000, P HIGH TEMP CORR PRO, P383
   Liu ZY, 1998, SCRIPTA MATER, V39, P1497, DOI 10.1016/S1359-6462(98)00360-1
   Liu ZY, 1997, SCRIPTA MATER, V37, P1551, DOI 10.1016/S1359-6462(97)00291-1
   Liu ZY, 2000, OXID MET, V53, P341, DOI 10.1023/A:1004545421739
   Liu ZY, 1997, HIGH TEMP MATER PROC, V16, P159
   Liu ZY, 1998, OXID MET, V50, P51, DOI 10.1023/A:1018871817578
   Liu ZY, 1998, SCRIPTA MATER, V38, P877, DOI 10.1016/S1359-6462(97)00576-9
   Liu ZY, 1998, ACTA MATER, V46, P1691, DOI 10.1016/S1359-6454(97)00346-7
   Morris D. G., 1998, MECH BEHAV NANOSTRUC
   NICHOLLS J, 1986, MAT SCI TECH, V5, P799
   SIEGEL RW, 1998, PHYSICS NEW MAT, P66
   WALLWORK GR, 1971, OXID MET, V3, P171, DOI 10.1007/BF00603485
NR 20
TC 44
Z9 45
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD JUL 4
PY 2001
VL 13
IS 12-13
BP 1001
EP +
DI 10.1002/1521-4095(200107)13:12/13<1001::AID-ADMA1001>3.0.CO;2-V
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 451XA
UT WOS:000169826800030
DA 2018-10-20
ER

PT J
AU Bubb, DM
   Ringeisen, BR
   Callahan, JH
   Galicia, M
   Vertes, A
   Horwitz, JS
   McGill, RA
   Houser, EJ
   Wu, PK
   Pique, A
   Chrisey, DB
AF Bubb, DM
   Ringeisen, BR
   Callahan, JH
   Galicia, M
   Vertes, A
   Horwitz, JS
   McGill, RA
   Houser, EJ
   Wu, PK
   Pique, A
   Chrisey, DB
TI Vapor deposition of intact polyethylene glycol thin films
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID MASS-SPECTROMETRY; LASER-ABLATION; BIOMEDICAL APPLICATIONS; POLYMER;
   SURFACES
AB Thin films of polyethylene glycol (PEG) of average molecular weight, 1400 amu, were deposited by both matrix-assisted pulsed laser evaporation (MAPLE) and pulsed laser deposition (PLD). The deposition was carried out in vacuum (similar to 10(-6) Torr) with an ArF (lambda = 193 nm) laser at a fluence between 150 and 300 mJ/cm(2). Films were deposited on NaCl plates, Si(lll) wafers, and glass slides. The physiochemical properties of the films are compared via Fourier transform infrared spectroscopy (FTIR), electrospray ionization (ESI) mass spectrometry, and matrix-assisted laser desorption and ionization (MALDI) time-of-flight mass spectrometry. The results show that the MAPLE films nearly identically resemble the starting material, whereas the PLD films do not. These results are discussed within the context of biomedical applications such as drug delivery coatings and in vivo applications where there is a need for transfer of polymeric coatings of PEG without significant chemical modification.
C1 USN, Res Lab, Surface Modificat Lab, Washington, DC 20375 USA.
   USN, Res Lab, Chem Dynam & Diagnost Branch, Washington, DC 20375 USA.
   George Washington Univ, Dept Chem, Washington, DC 20001 USA.
   So Oregon State Univ, Ashland, OR 97520 USA.
RP Bubb, DM (reprint author), USN, Res Lab, Surface Modificat Lab, Code 6370,4555 Overlook Ave SW, Washington, DC 20375 USA.
EM dbubb@nrl.navy.mil
RI Vertes, Akos/B-7159-2008
OI Vertes, Akos/0000-0001-5186-5352
CR Blanchet GB, 1996, J APPL PHYS, V80, P4082, DOI 10.1063/1.363278
   BLANCHET GB, 1993, SCIENCE, V262, P719, DOI 10.1126/science.262.5134.719
   BLANCHET GB, 1994, APPL PHYS LETT, V65, P1311, DOI 10.1063/1.112038
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Fei X, 1996, ANAL CHEM, V68, P3555, DOI 10.1021/ac960352h
   HANSEN SG, 1990, J APPL PHYS, V68, P1878, DOI 10.1063/1.346577
   HARRIS JM, 1991, ACS SYM SER, V467, P418
   Henry CM, 2000, CHEM ENG NEWS, V78, P49, DOI 10.1021/cen-v078n028.p049
   KANEKO Y, 1998, BIORELATED POLYM GEL, P29
   Manoravi P, 1998, J PHYS CHEM SOLIDS, V59, P1271, DOI 10.1016/S0022-3697(98)00059-6
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   MONTAUDO G, 1995, RAPID COMMUN MASS SP, V9, P453, DOI 10.1002/rcm.1290090514
   NOHMI T, 1992, J AM CHEM SOC, V114, P3241, DOI 10.1021/ja00035a012
   Patel N, 1998, FASEB J, V12, P1447
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   RINGEISEN BR, IN PRESS LANGMUIR
   Suggs L.J., 1998, POLYM TISSUE ENG, P99
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Yokoyama M, 1998, BIORELATED POLYM GEL, P193
NR 20
TC 46
Z9 46
U1 2
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD JUL
PY 2001
VL 73
IS 1
BP 121
EP 123
DI 10.1007/s003390100884
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 447QN
UT WOS:000169584100018
DA 2018-10-20
ER

PT J
AU Gomes, ME
   Reis, RL
   Cunha, AM
   Blitterswijk, CA
   de Bruijn, JD
AF Gomes, ME
   Reis, RL
   Cunha, AM
   Blitterswijk, CA
   de Bruijn, JD
TI Cytocompatibility and response of osteoblastic-like cells to
   starch-based polymers: effect of several additives and processing
   conditions
SO BIOMATERIALS
LA English
DT Article
DE starch-based polymers biodegradable; polymers; cytotoxicity;
   orthopaedics
ID IN-VITRO; BIOCOMPATIBILITY; BIOMATERIALS; SCAFFOLDS; BEHAVIOR
AB This work reports on the biocompatibility evaluation of new biodegradable starch-based polymers that are under consideration for use in orthopaedic temporary applications and as tissue engineering scaffolds. It has been shown in previous works that by using these polymers it is both possible to produce polymer/hydroxyapatite (HA) composites (with or without the use of coupling agents) with mechanical properties matching those of the human bone, and to obtain 3D structures generated by solid blowing agents, that are suitable for tissue engineering applications. This study was focused on establishing the influence of several additives (ceramic fillers, blowing agents and coupling agents) and processing methods/conditions on the biocompatibility of the materials described above. The cytotoxicity of the materials was evaluated using cell culture methods, according to ISO/EN 109935 guidelines. A cell suspension of human osteosarcoma cells (HOS) was also seeded on a blend of corn starch with ethylene vinyl alcohol (SEVA-C) and on SEVA-C/HA composites, in order to have a preliminary indication on cell adhesion and proliferation on the materials surface. In general, the obtained results show that all tile different materials based on SEVA-C, (which are being investigated for use in several biomedical applications), as well as all the additives (including the novel coupling agents) and different processing methods required to obtain the different properties/products, can be used without inducing a cytotoxic behaviour to the developed biomaterials. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Minho, Dept Polymer Engn, P-4710057 Braga, Portugal.
   IsoTis Bv, NL-3723 MB Bilthoven, Netherlands.
RP Gomes, ME (reprint author), Univ Minho, Dept Polymer Engn, Campus Gualtar, P-4710057 Braga, Portugal.
EM megomes@eng.uminho.pt
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Gomes,
   Manuela/B-6282-2009
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Gomes,
   Manuela/0000-0002-2036-6291; Cunha M., Antonio/0000-0003-3860-7732; van
   Blitterswijk, Clemens/0000-0003-2371-4615
CR [Anonymous], 109935 ISO EN
   DEKKER A, 1994, CELL MATER, V4, P101
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KIRKPATRICK CJ, 1992, REGULATORY AFFAIRS, V4, P13
   KOOTEN TG, 1997, J MATER SCI-MATER M, V8, P835
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MENDES S, 2001, IN PRESS BIOMATERIAL
   Oliva A, 1998, BIOMATERIALS, V19, P1019, DOI 10.1016/S0142-9612(97)00249-4
   Pachence J. M., 1997, PRINCIPLES TISSUE EN, P263
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Ratner BD, 1997, NATO ADV SCI I E-APP, V346, P453
   REIS RL, 1998, J APPL MED POLYM, V2, P49
   VAZ CM, 2001, IN PRESS MAT RES INN
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2
NR 19
TC 143
Z9 155
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2001
VL 22
IS 13
BP 1911
EP 1917
DI 10.1016/S0142-9612(00)00377-X
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 435YE
UT WOS:000168909100026
PM 11396897
DA 2018-10-20
ER

PT J
AU Ramakrishna, S
   Mayer, J
   Wintermantel, E
   Leong, KW
AF Ramakrishna, S
   Mayer, J
   Wintermantel, E
   Leong, KW
TI Biomedical applications of polymer-composite materials: a review
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Review
DE biomaterials; biocomposites; polymer composites; implants; prosthesis;
   medical devices; biomedical engineering; bioengineering
ID MOLECULAR-WEIGHT POLYETHYLENE; FIBER-REINFORCED PEEK; HYDROXYLAPATITE
   POLY(L-LACTIDE) COMPOSITES; ANTERIOR CRUCIATE LIGAMENT; VERTEBRAL BODY
   REPLACEMENT; INTERNAL-FIXATION PLATES; MATRIX INTERFACIAL BOND;
   HIP-PROSTHESIS DESIGN; FINITE-ELEMENT METHOD; CARBON-FIBER
AB An overview of various biomedical applications of polymer-composite materials reported in the literature over the last 30 years is presented in this paper. For the benefit of the readers, general information regarding structure and function of tissues, types and purpose of implants/medical devices, and various other materials used, are also briefly presented. Different types of polymer composite that are already in use or are investigated for various biomedical applications are presented. Specific advantages of using polymer-composite biomaterials in selected applications are also highlighted. The paper also examines the critical issues and scientific challenges that require further research and development of polymer composite materials for their increased acceptance in the biomedical industry. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
   Swiss Fed Inst Technol, Chair Biocompatible Mat Sci & Engn, Dept Mat, CH-8952 Schlieren, Switzerland.
   Tech Univ Munich, Cent Inst Biomed Engn, D-85748 Garching, Germany.
   Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.
RP Ramakrishna, S (reprint author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
EM engsr@nus.edu.sg
RI Leong, Kam/A-7270-2009
OI Leong, Kam/0000-0002-8133-4955
CR ADAMS D, 1978, J BIOMED MATER RES, V12, P35, DOI 10.1002/jbm.820120104
   AEBISCHER P, 1988, BIOMATERIALS, V9, P80, DOI 10.1016/0142-9612(88)90075-0
   Akay M, 1996, J BIOMED MATER RES, V31, P167
   ALI MS, 1990, J BONE JOINT SURG BR, V72, P586
   Ambrosio L, 1998, J BIOMED MATER RES, V42, P6, DOI 10.1002/(SICI)1097-4636(199810)42:1<6::AID-JBM2>3.0.CO;2-U
   Ambrosio L, 1996, J MATER SCI-MATER M, V7, P251, DOI 10.1007/BF00058561
   AMBROSIO L, 1998, HDB BIOMATERIAL PROP, P214
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, V276, P7
   ANDERSSON BJG, 1993, MECH HUMAN JOINTS PH, P293
   Andreopoulos AG, 1998, J BIOMATER APPL, V13, P66, DOI 10.1177/088532829801300104
   ARNOCZKY SP, 1988, AM J SPORT MED, V16, P106, DOI 10.1177/036354658801600204
   Baidya K. P., 2001, J ENG MED, V215, P11
   Baidya KP, 2001, J BIOMATER APPL, V15, P279, DOI 10.1106/BKLQ-E2YG-D2LA-RG3R
   BAIDYA KP, P ICCM 12 PAR FRANC, P496
   Bao QB, 1996, BIOMATERIALS, V17, P1157, DOI 10.1016/0142-9612(96)84936-2
   BERRY JL, 1988, CLIN ORTHOP RELAT R, P270
   BJORK N, 1986, BIOMATERIALS, V7, P73, DOI 10.1016/0142-9612(86)90093-1
   Black J, 1998, HDB BIOMATERIALS PRO
   Black J., 1988, ORTHOPAEDIC BIOMATER, P197
   BLACK J, 1992, BIOL PERFORMANCE MAT
   Blazewicz S, 1997, BIOMATERIALS, V18, P437, DOI 10.1016/S0142-9612(96)00067-1
   BLUMENTHAL NC, 1994, J APPL BIOMATER, V5, P191, DOI 10.1002/jab.770050303
   BONFIELD W, 1988, J BIOMED ENG, V10, P522, DOI 10.1016/0141-5425(88)90110-0
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   BRADLEY JS, 1981, BIOMATERIALS, V2, P124, DOI 10.1016/0142-9612(81)90011-9
   BRADLEY JS, 1980, BIOMATERIALS, V1, P38, DOI 10.1016/0142-9612(80)90057-5
   BRADLEY JS, MECH PROPERTIES BIOM, P379
   Bragdon C. R., 1995, DEFECTS CEMENT MANTL
   BRANTIGAN JW, 1991, SPINE, V16, pS277, DOI 10.1097/00007632-199106001-00020
   BRIDWELL KH, 1991, TXB SPINAL SURG
   BROWN SA, 1990, BIOMATERIALS, V11, P541, DOI 10.1016/0142-9612(90)90075-2
   BRUCKMANN H, 1980, BIOMATERIALS, V1, P67, DOI 10.1016/0142-9612(80)90002-2
   BRUCKMANN H, 1980, BIOMATERIALS, V1, P73, DOI 10.1016/0142-9612(80)90003-4
   BUCHERT PK, 1986, J BONE JOINT SURG AM, V68A, P606, DOI 10.2106/00004623-198668040-00020
   CAILLETEAU JG, 1992, J ENDODONT, V18, P540, DOI 10.1016/S0099-2399(06)81210-0
   Cao Y, 1995, MATER RES SOC SYMP P, V394, P83
   CHALIAN VA, 1974, J BIOMED MATER RES, V8, P349, DOI 10.1002/jbm.820080415
   CHANG FK, 1990, J BIOMED MATER RES, V24, P873, DOI 10.1002/jbm.820240707
   Chao Edmund Y. S., 1997, P317
   CHOUEKA A, 1995, J BIOMED MATER RES, V29, P1309
   CHRISTEL P, 1987, J BIOMED MATER RES-A, V21, P191
   Christel P., 1991, HIGH PERFORMANCE BIO, P499
   Christel P., 1980, MECHANICAL PROPERTIE, P367
   Ciappetta P, 1997, NEUROSURGERY, V41, P1203, DOI 10.1097/00006123-199711000-00040
   Claes L, 1999, J BIOMED MATER RES, V48, P82, DOI 10.1002/(SICI)1097-4636(199921)48:1<82::AID-JBM14>3.3.CO;2-Z
   Claes L., 1997, BIOL BIOMECHANICAL P, P81
   CLAES L E, 1992, Clinical Materials, V10, P41, DOI 10.1016/0267-6605(92)90083-6
   Cogswell F.N., 1992, THERMOPLASTIC AROMAT
   Coombes Allan G. A., 1996, P215
   Culleton T. P., 1993, Clinical Materials, V12, P95, DOI 10.1016/0267-6605(93)90056-D
   DARENDELILER S, 1992, J ORAL REHABIL, V19, P371, DOI 10.1111/j.1365-2842.1992.tb01579.x
   Dauner M, 1998, J MATER SCI-MATER M, V9, P173, DOI 10.1023/A:1008823804460
   Davy KWM, 1998, BIOMATERIALS, V19, P2007, DOI 10.1016/S0142-9612(98)00047-7
   Deb S, 1996, J MATER SCI-MATER M, V7, P191, DOI 10.1007/BF00119729
   DEHAAN J, 1996, P ECCM 7 LOND, P421
   DEHL RE, 1982, J BIOMED MATER RES, V16, P715, DOI 10.1002/jbm.820160517
   DELUCA PA, 1988, J BONE JOINT SURG AM, V70A, P1372, DOI 10.2106/00004623-198870090-00015
   Deng M, 1997, BIOMATERIALS, V18, P645, DOI 10.1016/S0142-9612(96)00194-9
   Durselen L, 1996, BIOMATERIALS, V17, P977, DOI 10.1016/0142-9612(96)84671-0
   ESSLINGER JO, 1973, J BIOMED MATER RES, V7, P187, DOI 10.1002/jbm.820070312
   FEITH R, 1975, ACTA ORTHOP SCAND, P1
   Flahiff CM, 1996, J BIOMED MATER RES, V32, P419
   Forster I. W., 1980, EVALUATION BIOMATERI, P367
   Freilich M. A., 2000, FIBER REINFORCED COM
   Fujihara K, 2001, ADV COMPOS LETT, V10, P13
   GALLETTI PM, 1988, SURGERY, V103, P231
   Ganesh V. K., 1998, Q MAGAZINE, V29, P56
   Ganesh VK, 1998, ADV COMPOS LETT, V7, P111
   GERHART TN, 1988, J BIOMED MATER RES, V22, P1071, DOI 10.1002/jbm.820221110
   GERSHON B, 1990, BIOMATERIALS, V11, P548, DOI 10.1016/0142-9612(90)90076-3
   GERSHON B, 1992, BIOMATERIALS, V13, P38, DOI 10.1016/0142-9612(92)90093-4
   GESE H, ZEMENTLOSE HUFTPROTH, P75
   Giardino R., 1993, BIODEGRADABLE IMPLAN, P143
   GILBERT JL, 1995, BIOMATERIALS, V16, P1043, DOI 10.1016/0142-9612(95)98900-Y
   GILLETT N, 1985, BIOMATERIALS, V6, P113, DOI 10.1016/0142-9612(85)90074-2
   GOH JCH, 1994, GAIT POSTURE, V2, P95
   GOLDNER JL, 1973, J BIOMED MATER RES, V7, P137, DOI 10.1002/jbm.820070310
   HA SW, 1994, J MATER SCI-MATER M, V5, P481, DOI 10.1007/BF00058987
   Ha SW, 1997, J MATER SCI-MATER M, V8, P881, DOI 10.1023/A:1018557922690
   HA SW, 1997, THESIS ETH ZURICH SW
   HAKE U, 1991, LANGENBECK ARCH CHIR, V376, P323
   HALSTEAD A, 1979, J BIOMED MATER RES, V13, P121, DOI 10.1002/jbm.820130113
   HARRIS B, 1980, MECH PROPERTIES BIOL, P37
   HASTINGS GW, CARBON FIBRE THEIR C, P261
   HASTINGS GW, 1993, BIODEGRADABLE IMPLAN, P19
   Heiner AD, 1996, BIOMATERIALS, V17, P2211, DOI 10.1016/0142-9612(96)00070-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1995, ADV CHEM SER, V245, P523
   HENCH LL, 1982, BIOMATERIALS INTERFA
   HENDERSON JD, 1987, J BIOMED MATER RES, V21, P59, DOI 10.1002/jbm.820210110
   HIDAKA S, 1984, J BONE JOINT SURG AM, V66A, P1241, DOI 10.2106/00004623-198466080-00012
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   HIRT SW, 1993, J VASC SURG, V17, P538
   HIRT SW, 1991, THORAC CARDIOV SURG, V39, P365, DOI 10.1055/s-2007-1020001
   HO MH, 1994, J PROSTHET DENT, V72, P367, DOI 10.1016/0022-3913(94)90555-X
   HOAG EP, 1982, J PROSTHET DENT, V47, P177, DOI 10.1016/0022-3913(82)90183-4
   Huang ZM, 1999, ADV COMPOS LETT, V8, P289
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   HUISKES R, 1980, ACTA ORTHOP SCAND S, P185
   Hunt M. S., 1987, MATER DESIGN, V8, P113
   Huttner W., 1984, BIOMATERIALS BIOMECH, P167
   IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G
   Ignatius A, 1997, J MATER SCI-MATER M, V8, P753, DOI 10.1023/A:1018508511787
   IMAI T, 1999, AM J ORTHOD DENTOFAC, P533
   Inoue N., 1994, MAT TECHNIQUES, V4, P23
   Isidor F, 1996, INT J PROSTHODONT, V9, P131
   ISSIDOR F, 1992, INT J PROSTHODONT, V5, P257
   JAMES SP, 1992, J BIOMED MATER RES, V26, P651, DOI 10.1002/jbm.820260507
   JANCAR J, 1993, J MATER SCI-MATER M, V4, P555, DOI 10.1007/BF00125593
   JANCAR J, 1993, J MATER SCI-MATER M, V4, P562, DOI 10.1007/BF00125594
   JENKINS DHR, 1977, J BONE JOINT SURG BR, V59, P501
   JOCKISCH KA, 1992, J BIOMED MATER RES, V26, P133, DOI 10.1002/jbm.820260202
   KAHL S, 1993, BIOMED TECH, V38, P298, DOI 10.1515/bmte.1993.38.12.298
   KAJIWARA H, 1995, ARTIF ORGANS, V19, P64, DOI 10.1111/j.1525-1594.1995.tb02246.x
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   Kennedy KC, 1998, J MATER SCI-MATER M, V9, P243, DOI 10.1023/A:1008896425841
   Kettunen J, 1999, J BIOMAT SCI-POLYM E, V10, P33, DOI 10.1163/156856299X00261
   King M. W., 1996, CAN TEXT J, V113, P53
   KLEIN CPAT, 1987, BIOMATERIALS, V8, P308
   KLEIN N, 1993, J MATER SCI-MATER M, V4, P285, DOI 10.1007/BF00122282
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   KNOWLES JC, 1993, J MATER SCI-MATER M, V4, P102, DOI 10.1007/BF00120377
   KO FK, 1999, LECT TEXTILE STRUCTU
   KOCVARA S., 1967, J BIOMED MAT RES, V1, P325, DOI 10.1002/jbm.820010304
   KRAUSE W, 1988, J BIOMED MATER RES-A, V22, P37
   KRAUSE WR, 1989, J BIOMED MATER RES, V23, P1195, DOI 10.1002/jbm.820231008
   KREBS J, 1997, P ICCM 11, P509
   Kuiper JH, 1997, J BIOMECH ENG-T ASME, V119, P166, DOI 10.1115/1.2796076
   KWARTENG KB, 1990, SAMPE QUART, V22, P10
   LACROIX H, 1995, ANN VASC SURG, V9, P152, DOI 10.1007/BF02139657
   LAKES R, 1995, BIOMEDICAL ENG HDB, P598
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANGER R, 1995, SCI AM           SEP, P100
   LATOUR RA, 1992, J BIOMED MATER RES, V26, P593, DOI 10.1002/jbm.820260504
   LATOUR RA, 1993, J BIOMED MATER RES, V27, P1281, DOI 10.1002/jbm.820271008
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   LEE IY, 1994, J BIOMED MATER RES, V28, P1055, DOI 10.1002/jbm.820280910
   LEE SM, 1991, INT ENCY COMPOSITES, V4, P74
   LEONG KW, IN PRESS ANN REV BIO
   Lin TW, 1997, J BIOMEDICAL MAT RES, V36, P37
   Liu Q, 1998, J BIOMED MATER RES, V40, P490, DOI 10.1002/(SICI)1097-4636(19980605)40:3<490::AID-JBM20>3.0.CO;2-M
   Loh PL, 2000, J DENT RES, V79, P1317
   LOHER U, 1993, 7 INT C POL MED SURG, P88
   LOUIS JP, 1990, BIOMATERIALS, V11, P525, DOI 10.1016/0142-9612(90)90071-W
   LOVDAHL PE, 1977, J PROSTHET DENT, V38, P507, DOI 10.1016/0022-3913(77)90025-7
   MAJOLA A, 1991, CLIN ORTHOP RELAT R, V268, P260
   Marcolongo M, 1998, J BIOMED MATER RES, V39, P161, DOI 10.1002/(SICI)1097-4636(199801)39:1<161::AID-JBM18>3.0.CO;2-I
   MAROIS Y, 1993, BIOMATERIALS, V14, P255, DOI 10.1016/0142-9612(93)90115-I
   MATSUMOTO A, 1995, ARTIF ORGANS, V19, P51, DOI 10.1111/j.1525-1594.1995.tb02244.x
   Mayer J., 1997, COMPOSITE SHEET FORM, P403
   Mayer J., 1994, THESIS ETH ZURICH SW
   MAYER J, 1993, BIOMED ENG-APP BAS C, V5, P778
   MCGRATH MH, 1992, TXB PLASTIC MAXILLOF, P93
   MCKENNA GB, 1979, J BIOMED MATER RES, V13, P783, DOI 10.1002/jbm.820130509
   MCKENNA GB, 1980, BIOMATERIALS, V1, P189, DOI 10.1016/0142-9612(80)90015-0
   MENDES DG, 1986, J BIOMED MATER RES, V20, P699, DOI 10.1002/jbm.820200604
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   MESSNER K, 1993, J BIOMED MATER RES, V27, P1165, DOI 10.1002/jbm.820270907
   Miettinen VM, 1997, BIOMATERIALS, V18, P181, DOI 10.1016/S0142-9612(96)00123-8
   MJOBERG B, 1991, ACTA ORTHOP SCAND, V62, P500, DOI 10.3109/17453679108996658
   MORE N, 1988, BIOMATERIALS, V9, P328, DOI 10.1016/0142-9612(88)90028-2
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   MOYEN BJL, 1978, J BONE JOINT SURG AM, V60, P940, DOI 10.2106/00004623-197860070-00012
   NAZRE A, 1994, AM SOC TEST MATER, V1217, P53, DOI 10.1520/STP12221S
   NEUGEBAUER R, 1981, BIOMATERIALS, V2, P182, DOI 10.1016/0142-9612(81)90049-1
   Noishiki Y, 1993, J Invest Surg, V6, P231, DOI 10.3109/08941939309141614
   NOISHIKI Y, 1992, J THORAC CARDIOV SUR, V104, P770
   Noishiki Y, 1994, ASAIO J, V40, pM267, DOI 10.1097/00002480-199407000-00006
   OKAZAKI M, 1988, BIOMATERIALS, V9, P345, DOI 10.1016/0142-9612(88)90031-2
   Paganetto G., 1991, BIOMATERIALI, V2, P179
   Park JB, 1984, BIOMATERIALS SCI ENG
   Park JB, 1992, BIOMATERIALS INTRO, P169
   Parson J. R., 1983, BIOCOMPATIBLE POLYM, P873
   Pascaud RS, 1997, BIOMATERIALS, V18, P727, DOI 10.1016/S0142-9612(96)00207-4
   Patel M, 1992, Ann Vasc Surg, V6, P244, DOI 10.1007/BF02000270
   PELUSO G, 1991, BIOMATERIALS, V12, P231, DOI 10.1016/0142-9612(91)90205-O
   Peter T., 1997, P 9 C BIOM ENG SING, P317
   PETERSON CJ, 1985, J BIOMED MATER RES, V19, P589, DOI 10.1002/jbm.820190510
   Philips D., 1999, THESIS KATHOLIEKE U
   PIETRUCHA K, 1991, BIOMATERIALS, V12, P320, DOI 10.1016/0142-9612(91)90041-8
   PILLIAR RM, 1976, J BIOMED MATER RES, V10, P893, DOI 10.1002/jbm.820100608
   PONGOR P, 1992, BIOMATERIALS, V13, P1070, DOI 10.1016/0142-9612(92)90139-F
   Poss R, 1987, J Arthroplasty, V2, P259, DOI 10.1016/S0883-5403(87)80057-8
   POURDEYHIMI B, 1989, J BIOMED MATER RES, V23, P63, DOI 10.1002/jbm.820230106
   Profio A.E., 1993, BIOMEDICAL ENG
   Purton D G, 1996, Quintessence Int, V27, P93
   RAMAKRISHNA S, 1998, Patent No. 98008741
   Ramakrishna S., 2000, P 2 AS AUSTR C COMP, pA431
   RAMAKRISHNA S, 2000, 29 FRP S JAP SOC MAT, P11
   RAMAKRISHNA S, 2000, TEXTILE SCAFFOLDS TI
   RAMAKRISHNA S, 1996, INT C NEW TEXT COMP, P27
   Ramakrishna S., 1997, P ICCM 11 CON JUP GO, V1, P458
   RAMAKRISHNA S, 1997, JAPANESE J ARTIFICIA, V26, pS61
   RATNEV BD, 1996, INTRO MAT MED, P308
   Robin G. C., 1981, BIOMECHANICS MED DEV, P535
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   ROMAN JS, 1991, BIOMATERIALS, V12, P236, DOI 10.1016/0142-9612(91)90206-P
   RUBIN P, 1983, BIOCOMPATBILE POLYM, P941
   RUBIN P, 1992, HIP JOINT REPLACEMEN, P189
   RUSHTON N, 1984, BIOMATERIALS, V5, P352, DOI 10.1016/0142-9612(84)90034-6
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   SBARBATI R, INT J ARTIFICIAL ORG, V491, P14
   Schmitt-Thomas K. H. G., 1997, P ICCM 11 GOLD COAST, pV277
   SCHNEIDER E, 1989, CLIN ORTHOP RELAT R, V248, P200
   Scholz C., 1993, BIODEGRADABLE IMPLAN, P67
   SCLIPPA E, 1973, J BIOMED MATER RES, V7, P59, DOI 10.1002/jbm.820070105
   SEEDHAM BB, 1993, PHYSL PATHOPHYSIOLOG, P163
   Silverton C, 1996, J BONE JOINT SURG AM, V78A, P340, DOI 10.2106/00004623-199603000-00004
   Simoes JA, 2000, COMPOS SCI TECHNOL, V60, P559, DOI 10.1016/S0266-3538(99)00155-4
   SPEIDEL MO, 1998, MAT MED, P191
   Suwanprateeb J, 1997, J MATER SCI-MATER M, V8, P469, DOI 10.1023/A:1018522025474
   Szycher M., 1991, HIGH PERFORMANCE BIO, P519
   Szycher M., 1983, BIOCOMPATIBLE POLYM, P861
   TALLENT MA, 1990, INT ENCY COMPOSITES, V2, P466
   TAMURA J, 1995, J BIOMED MATER RES, V29, P551, DOI 10.1002/jbm.820290502
   TAYTON K, 1983, J BONE JOINT SURG BR, V65, P312
   TAYTON K, 1982, J BONE JOINT SURG BR, V64, P105
   TAYTON K, 1982, J BONE JOINT SURG BR, V64, P112
   TAYTON KJJ, 1983, J MED ENG TECHNOL, V7, P271, DOI 10.3109/03091908309018173
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
   TOH SL, 1993, PROSTHET ORTHOT INT, V17, P180
   TONINO AJ, 1976, J BONE JOINT SURG BR, V58, P107
   TOPOLESKI LDT, 1992, J BIOMED MATER RES, V26, P1599, DOI 10.1002/jbm.820261206
   Torbjorner A, 1996, EUR J ORAL SCI, V104, P605, DOI 10.1111/j.1600-0722.1996.tb00149.x
   TORMALA P, 1991, J BIOMED MATER RES, V25, P1, DOI 10.1002/jbm.820250102
   TORMALA P, 1987, BIOMATERIALS, V8, P42, DOI 10.1016/0142-9612(87)90027-5
   TRABERT KC, 1984, DENT CLIN N AM, V28, P923
   UHTHOFF HK, 1983, J BONE JOINT SURG BR, V65, P66
   URBANIAK JR, 1973, J BIOMED MATER RES, V7, P165, DOI 10.1002/jbm.820070311
   Valdevit A. D. C., 1996, SPINE, V10, P231
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   WAGNER HD, 1989, BIOMATERIALS, V10, P139, DOI 10.1016/0142-9612(89)90049-5
   Walker Peter S., 1997, P461
   WALKER PS, 1987, J BIOMECH, V20, P693, DOI 10.1016/0021-9290(87)90035-2
   WARD R, 1989, BIOMATERIALS, V10, P425, DOI 10.1016/0142-9612(89)90135-X
   Weinans H., 1991, THESIS U NIJMEGEN NE
   WENING JV, 1995, BIOMATERIALS, V16, P337, DOI 10.1016/0142-9612(95)93262-C
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   Werkmeister JA, 1998, J BIOMED MATER RES, V39, P429, DOI 10.1002/(SICI)1097-4636(19980305)39:3<429::AID-JBM12>3.0.CO;2-5
   WHITESIDE LA, 1989, CLIN ORTHOP RELAT R, V247, P138
   WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005
   Williams D., 1990, CONCISE ENCY MED DEN
   WILLIAMS DF, 1987, J MATER SCI LETT, V6, P188, DOI 10.1007/BF01728981
   Williams DF, 1979, MAT CLIN DENT
   Williams DF., 1988, ADV BIOMATER, P11
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   WINTERMANTEL E, 1994, J BIOMEDICAL ENG APP, V6, P18
   Wintermantel E., 1998, MAT MED, P1
   Wintermantel E, 1998, BIOKOMPATIBLE WERKST, V2
   Wintermantel Erich, 1995, P3
   WOO SLY, 1974, J BIOMED MATER RES, V8, P321, DOI 10.1002/jbm.820080513
   WOO SLY, 1976, J BONE JOINT SURG AM, V58, P190, DOI 10.2106/00004623-197658020-00005
   WRIGHT TM, 1981, J BIOMED MATER RES, V15, P719, DOI 10.1002/jbm.820150508
   WROBLEWSKI BM, 1988, ORTHOP CLIN N AM, V19, P627
   Yang JM, 1997, J BIOMED MATER RES, V38, P361, DOI 10.1002/(SICI)1097-4636(199724)38:4<361::AID-JBM9>3.0.CO;2-M
   Yildiz H, 1998, J BIOMED MATER RES, V39, P102, DOI 10.1002/(SICI)1097-4636(199801)39:1<102::AID-JBM13>3.0.CO;2-H
   YILDIZ H, 1993, J BIOMEDICAL MAT RES, V39, P92
   Yu T J, 1994, J Invest Surg, V7, P195, DOI 10.3109/08941939409018286
   YU TJ, 1993, J BIOMED MATER RES, V27, P1329, DOI 10.1002/jbm.820271013
   ZIMMERMAN M, 1987, J BIOMED MATER RES-A, V21, P345
   Zufall SW, 1998, J MATER SCI-MATER M, V9, P611, DOI 10.1023/A:1008977106648
NR 263
TC 689
Z9 700
U1 23
U2 357
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
EI 1879-1050
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD JUL
PY 2001
VL 61
IS 9
BP 1189
EP 1224
DI 10.1016/S0266-3538(00)00241-4
PG 36
WC Materials Science, Composites
SC Materials Science
GA 454YF
UT WOS:000169998800002
DA 2018-10-20
ER

PT J
AU Miller, DL
   Spooner, GJR
   Williams, AR
AF Miller, DL
   Spooner, GJR
   Williams, AR
TI Photodisruptive laser nucleation of ultrasonic cavitation for biomedical
   applications
SO JOURNAL OF BIOMEDICAL OPTICS
LA English
DT Article
DE laser photodisruption; ultrasonic cavitation; hemolysis; biological
   effect
ID IN-VITRO; OPTICAL-BREAKDOWN; EXPOSURE CHAMBER; PULSE DURATION;
   SHOCK-WAVES; LITHOTRIPTER; WATER; ERYTHROCYTES; DEPENDENCE; PICOSECOND
AB Pulses of high intensity laser light, when focused into transparent materials, may produce localized electron-ion plasmas through optical breakdown. By simultaneously incorporating the resulting volume of vaporized material within the focal volume of a high intensity ultrasound source, the photodisruption (1.05 mum wavelength) void served as a nucleation site for ultrasonic cavitation. Dilute suspensions of canine erythrocytes in phosphate buffered saline were exposed in a flow-through exposure chamber and the percentage of lysed cells was used as a measure of the biologically effective cavitation activity produced in the chamber. Brief (about 30 mus) acoustic emissions were detected from the photodisruption alone (indicating laser nucleation of bubbles), but the cell lysis produced was undetectable against the background. However, combined exposure greatly increased both the duration of the acoustic emissions (up to 1.5 ms) and the amount of cell lysis above an ultrasonic pressure amplitude threshold of about 4.3 MPa at 2.5 MHz. The amount of cell lysis (sometimes approaching 100%) increased with increasing ultrasonic intensity, laser pulse energy and laser PRF Addition of 5% serum albumin enhanced the effect, apparently by stabilizing bubbles and nuclei. Photodisruptive laser nucleation of ultrasonic cavitation can provide controlled and synergistic enhancement of bioeffects. (C) 2001 Society of Photo-Optical Instrumentation Engineers.
C1 Univ Michigan, Med Ctr, Dept Radiol, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Elect Engn & Comp Sci, Ctr Ultrafast Opt Sci, Ann Arbor, MI 48109 USA.
   Haemacoust Ltd, Swansea SA9 1EX, W Glam, Wales.
RP Miller, DL (reprint author), Univ Michigan, Med Ctr, Dept Radiol, 3315 Kresge III,200 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
FU NCI NIH HHS [CA42947]
CR Bao SP, 1998, CANCER RES, V58, P219
   BILLE JF, 1993, PHYS UNSERER Z, V24, P280
   Brayman AA, 1996, ULTRASOUND MED BIOL, V22, P927, DOI 10.1016/0301-5629(96)00108-1
   CHURCH CC, 1989, J ACOUST SOC AM, V86, P215, DOI 10.1121/1.398328
   Dierickx C, 1999, DERMATOL CLIN, V17, P357, DOI 10.1016/S0733-8635(05)70092-9
   FISCHER JP, 1994, APPL PHYS B-LASERS O, V58, P493, DOI 10.1007/BF01081080
   HOLST A, 1993, CURR EYE RES, V12, P359, DOI 10.3109/02713689308999460
   HYNYNEN K, 1991, ULTRASOUND MED BIOL, V17, P157, DOI 10.1016/0301-5629(91)90123-E
   Jochle K, 1996, ULTRASOUND MED BIOL, V22, P329, DOI 10.1016/0301-5629(96)00031-2
   Juhasz T, 1996, LASER SURG MED, V19, P23, DOI 10.1002/(SICI)1096-9101(1996)19:1<23::AID-LSM4>3.0.CO;2-S
   LAUTERBORN W, 1977, APPL PHYS LETT, V31, P663, DOI 10.1063/1.89495
   Lawrence N, 1997, DERMATOL SURG, V23, P1197, DOI 10.1111/j.1524-4725.1997.tb00474.x
   Loesel FH, 1996, IEEE J QUANTUM ELECT, V32, P1717, DOI 10.1109/3.538774
   Miller DL, 1998, ULTRASONICS, V36, P947, DOI 10.1016/S0041-624X(98)00017-1
   MILLER DL, 1995, ULTRASOUND MED BIOL, V21, P1059, DOI 10.1016/0301-5629(95)93252-U
   Miller DL, 1997, ULTRASOUND MED BIOL, V23, P625, DOI 10.1016/S0301-5629(97)00042-2
   MILLER DL, 1992, J ULTRAS MED, V11, P407
   Miller DL, 2000, J ACOUST SOC AM, V107, P3480, DOI 10.1121/1.429418
   NEPPIRAS EA, 1980, PHYS REP, V61, P159, DOI 10.1016/0370-1573(80)90115-5
   Noack J, 1998, J APPL PHYS, V83, P7488, DOI 10.1063/1.367512
   PRAT F, 1993, BRIT J CANCER, V68, P13, DOI 10.1038/bjc.1993.279
   Sacks ZS, 2000, PROC SPIE, V4162, P20, DOI 10.1117/12.405935
   Sliney DH, 1993, MED LASERS THEIR SAF
   Steinert RF, 1985, ND YAG LASER OPHTHAL
   SUSLICK KS, 1988, ULTRASOUND ITS CHEM
   Vogel A, 1996, J ACOUST SOC AM, V100, P148, DOI 10.1121/1.415878
   WILLARD GW, 1953, J ACOUST SOC AM, V25, P669, DOI 10.1121/1.1907161
   ZELICKSON BD, 1994, LASER SURG MED, V15, P364, DOI 10.1002/lsm.1900150406
NR 28
TC 9
Z9 10
U1 0
U2 6
PU SPIE-INT SOCIETY OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1083-3668
J9 J BIOMED OPT
JI J. Biomed. Opt.
PD JUL
PY 2001
VL 6
IS 3
BP 351
EP 358
DI 10.1117/1.1380669
PG 8
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 462DR
UT WOS:000170405900013
PM 11516327
DA 2018-10-20
ER

PT J
AU Erckens, RJ
   March, WF
   Jongsma, FH
   Wicksted, JP
   Hendrikse, F
   Smit, EE
   Motamedi, M
AF Erckens, RJ
   March, WF
   Jongsma, FH
   Wicksted, JP
   Hendrikse, F
   Smit, EE
   Motamedi, M
TI Noninvasive Raman spectroscopic identification of intraocular lens
   material in the living human eye
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology
CY APR 30-MAY 05, 2000
CL FT LAUDERDALE, FLORIDA
SP Assoc Res Vis & Ophthalmol
ID SILICONE OIL; POLY(METHYL METHACRYLATE); IN-VITRO; SURFACE;
   BIOCOMPATIBILITY
AB Purpose: To develop a safe noninvasive technique for identifying the material of intraocular lenses (IOLs) implanted in patients.
   Setting: Center for Biomedical Engineering and the Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas, USA. Methods: Raman spectroscopy was used to noninvasively identify the type of IOL implanted after previous cataract surgery in 9 eyes of 6 patients who were legally blind as a result of eye disease. Three IOLs were characterized: poly(methyl methacrylate) (PMMA) (n = 5), acrylic (n = 3), and silicone (n = 1). Confocal Raman spectroscopy was used with a laser power of 95 muW and exposure time of 1 second.
   Results: Distinct spectral peaks associated with each type of IOL were obtained. These included spectra peaks at 2840 cm(-1), 2946 cm(-1), and 3000 cm(-1) for PMMA; 2917 cm(-1), 2939 cm(-1), and 3055 cm(-1) for acrylic; and 2900 cm-1, 2961 cm(-1), and 3048 cm(-1) for silicone. The procedure was well accepted by patients, and there were no complications.
   Conclusions: The specific Raman spectra of the IOLs allowed for noninvasive determination of IOL material with the use of a safe light dose and an exposure time of 1 second.
C1 Univ Texas, Med Branch, Laser & Spect Program, Ctr Biomed Engn, Galveston, TX 77555 USA.
   Univ Texas, Med Branch, Dept Ophthalmol & Visual Sci, Galveston, TX 77555 USA.
   Oklahoma State Univ, Ctr Sensors & Sensor Technol, Dept Phys, Stillwater, OK 74078 USA.
   Acad Hosp Maastricht, Dept Ophthalmol, Maastricht, Netherlands.
RP March, WF (reprint author), Univ Texas, Med Branch, Dept Ophthalmol, 700 Univ Blvd,Suite 400, Galveston, TX 77555 USA.
CR *ANSI, 1993, 13611986 ANSI
   Apple DJ, 1996, OPHTHALMOLOGY, V103, P1555, DOI 10.1016/S0161-6420(96)30463-6
   BARTZSCHMIDT KU, 1995, KLIN MONATSBL AUGENH, V207, P162, DOI 10.1055/s-2008-1035362
   Bauer NJC, 1998, INVEST OPHTH VIS SCI, V39, P831
   BAUER NJC, 1999, THESIS U MAASTRICHT
   BERTOLUZZA A, 1987, J RAMAN SPECTROSC, V18, P151, DOI 10.1002/jrs.1250180218
   BRADNAM MS, 1995, OPHTHALMOLOGY, V102, P799, DOI 10.1016/S0161-6420(95)30954-2
   Carey P R, 1982, BIOMEDICAL APPL RAMA
   Chehade M, 1997, AUST NZ J OPHTHALMOL, V25, P255, DOI 10.1111/j.1442-9071.1997.tb01512.x
   Erckens RJ, 1997, J RAMAN SPECTROSC, V28, P293
   Fyodorov S, 1991, OPHTHALMOSURGERY, V3, P57
   GERRARD DL, 1994, ANAL CHEM, V66, pR547, DOI 10.1021/ac00084a020
   Gills JP, 1998, CATARACT SURG STATE
   Hoerauf H, 2000, GRAEF ARCH CLIN EXP, V238, P8, DOI 10.1007/s004170050002
   Hoerauf H, 1999, KLIN MONATSBL AUGENH, V214, P71, DOI 10.1055/s-2008-1034752
   Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6
   Jongsma FHM, 1997, OPT ENG, V36, P3193, DOI 10.1117/1.601529
   Kusaka S, 1996, AM J OPHTHALMOL, V121, P574, DOI 10.1016/S0002-9394(14)75436-4
   Langefeld S, 1999, GRAEF ARCH CLIN EXP, V237, P201, DOI 10.1007/s004170050219
   Legeais JM, 1998, J CATARACT REFR SURG, V24, P371, DOI 10.1016/S0886-3350(98)80326-X
   Lyon LA, 1998, ANAL CHEM, V70, p341R
   Newland TJ, 1999, J CATARACT REFR SURG, V25, P72, DOI 10.1016/S0886-3350(99)80014-5
   Nishi O, 1998, J CATARACT REFR SURG, V24, P975, DOI 10.1016/S0886-3350(98)80054-0
   RIDLEY H, 1951, T OPHTHAL SOC UK, V71, P617
   Senn P, 1997, OPHTHALMIC SURG LAS, V28, P776
   Smit EE, 1999, J CATARACT REFR SURG, V25, P1498, DOI 10.1016/S0886-3350(99)00239-4
   Tosch U, 1994, Aktuelle Radiol, V4, P218
   TU AT, 1984, RAMAN SPECTROSCOPY B
NR 28
TC 6
Z9 6
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD JUL
PY 2001
VL 27
IS 7
BP 1065
EP 1070
DI 10.1016/S0886-3350(00)00828-2
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 459VK
UT WOS:000170272000029
PM 11489577
DA 2018-10-20
ER

PT J
AU Gonnella, JS
   Hojat, M
AF Gonnella, JS
   Hojat, M
TI Biotechnology and ethics in medical education of the new millennium:
   physician roles and responsibilities
SO MEDICAL TEACHER
LA English
DT Article; Proceedings Paper
CT Conference on Biomedicine and Ethics in the New Millennium
CY SEP, 2000
CL ROME, ITALY
ID HUMAN-GENOME-PROJECT; HUMAN CLONING; CARE; CANCER
AB Although the medical education curriculum varies internationally, we suggest that it is desirable for medical educators to share a universal responsibility to prepare physicians to perform three distinct, yet interrelated professional roles. The first is that of a clinician who has the knowledge and technical skills to care for individual patients, as well as the public. The second role can be viewed as that of an educator, a teacher, or a consultant who has the interpersonal skills and personal qualities to teach, advise and counsel patients and the public about their health and illness, risk factors and healthy lifestyle. The third role is that of a resource manager to enable physicians to care for patients and serve the public not only by drawing on available material assets but also by prudent use of the resources for better serving the most number of people at the least expense without compromising the quality of care. The very nature of the medical profession also obligates medical educators through the world to sensitize medical students and physicians to the ethical responsibilities that are implicit to each of the three aforementioned roles. Although the basic ethical responsibilities of do no harm and confidentiality are universal, certain global changes, such as rapid advancements in biotechnology and resource allocation, are now reshaping medical ethics on every continent. Spawned by the rapid advances in the biomedical sciences, biotechnology is revolutionizing human reproduction, sustaining human life, cloning human beings, and mapping the entire human genetic terrain. These advances imply changes in medical education and formal preparation of physicians in performing their roles as clinicians, educators and resource managers. These biotechnological developments, coupled with the increasing cost of healthcare and maldistribution of resources worldwide, present unprecedented ethical-social challenges that need to be addressed in the education of the physician in the new millennium.
C1 Thomas Jefferson Univ, Jefferson Med Coll, Ctr Res Med Educ & Hlth Care, Philadelphia, PA 19107 USA.
RP Gonnella, JS (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, Ctr Res Med Educ & Hlth Care, 1025 Walnut St, Philadelphia, PA 19107 USA.
CR ANNAS GI, 1998, NEW ENGL J MED, V339, P118
   CALMAN K, 1994, BRIT MED J, V309, P1140, DOI 10.1136/bmj.309.6962.1140
   Chao T. C., 1995, Annals Academy of Medicine Singapore, V24, P919
   Clever LH, 2000, ANN INTERN MED, V132, P85, DOI 10.7326/0003-4819-132-1-200001040-00014
   Cohen MM, 1998, JAMA-J AM MED ASSOC, V279, P748, DOI 10.1001/jama.279.10.748
   Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106
   Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682
   CRAWSHAW R, 1995, JAMA-J AM MED ASSOC, V273, P1553, DOI 10.1001/jama.273.19.1553
   FAGELL PL, 2000, HARVARD MED ALUM WIN, P12
   Fins JJ, 2000, ACAD MED, V75, P662, DOI 10.1097/00001888-200006000-00021
   Ganske G, 1999, PLAST RECONSTR SURG, V103, P1280
   Glass RM, 1996, JAMA-J AM MED ASSOC, V275, P147, DOI 10.1001/jama.275.2.147
   Gonnella J.S., 1993, ASSESSMENT MEASURES, P155
   GONNELLA JS, 1984, JAMA-J AM MED ASSOC, V251, P637
   GONNELLA JS, 1993, ASSESSMENT MEASURES
   GONNELLA JS, 1983, P 22 ANN C RES MED E, P3
   Hojat M, 2000, J COMMUN HEALTH, V25, P455, DOI 10.1023/A:1005192613992
   Hojat M, 1997, ACAD MED S, V72, P1
   Hoover RN, 2000, NEW ENGL J MED, V343, P135, DOI 10.1056/NEJM200007133430210
   Kassirer JP, 1998, NEW ENGL J MED, V338, P905, DOI 10.1056/NEJM199803263381309
   LEWONTIN RC, 1997, NEW YORK REV BO 1023, P146
   Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201
   Lupton M L, 1999, Med Law, V18, P107
   NELSON AR, 1999, AM J OBSTET GYNECOL, V178, P755
   Novielli KD, 2000, ACAD MED, V75, pS53, DOI 10.1097/00001888-200010001-00017
   Obermann K, 1999, LANCET, V353, P1103, DOI 10.1016/S0140-6736(05)76465-5
   Plows CW, 1999, JAMA-J AM MED ASSOC, V281, P937
   Robertson JA, 1998, NEW ENGL J MED, V339, P119, DOI 10.1056/NEJM199807093390212
   Shapiro HT, 1997, SCIENCE, V277, P195, DOI 10.1126/science.277.5323.195
   Singer PA, 1998, CAN MED ASSOC J, V159, P159
   Verrees M, 1996, JAMA-J AM MED ASSOC, V276, P1285, DOI 10.1001/jama.276.16.1285
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
NR 32
TC 12
Z9 12
U1 1
U2 5
PU CARFAX PUBLISHING
PI BASINGSTOKE
PA RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND
SN 0142-159X
J9 MED TEACH
JI Med. Teach.
PD JUL
PY 2001
VL 23
IS 4
BP 371
EP 377
DI 10.1080/01421590120042982
PG 7
WC Education, Scientific Disciplines; Health Care Sciences & Services
SC Education & Educational Research; Health Care Sciences & Services
GA 453CH
UT WOS:000169898700008
DA 2018-10-20
ER

PT J
AU Moretto, P
   Michelet, C
   Le Gallet, S
   Rebillat, F
   Guette, A
   Vignoles, G
AF Moretto, P
   Michelet, C
   Le Gallet, S
   Rebillat, F
   Guette, A
   Vignoles, G
TI STIM tomography: A potential tool for the non-destructive
   characterisation of SiC microcomposite materials
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 7th International Conference on Nuclear Microprobe Technology and
   Applications
CY SEP 10-15, 2000
CL BORDEAUX, FRANCE
SP CNRS, CEA, CNRS Univ Bordeaux, CNRS Minist Culture & Commun
DE scanning transmission ion microscopy; computed tomography; ceramic
   matrix microcomposites; interphase; non-destructive characterisation
ID MICROPROBE; MICROBEAM; IONS
AB Despite the fact that ion micro-tomography techniques were initiated several years ago, useful applications are still rare in material sciences. This work is a preliminary study on the non-destructive characterisation of a thin BN interphase in a ceramic matrix composite material by scanning transmission ion microscopy (STIM) tomography. The technique, initially developed at CENBG for applications in the biomedical field, was used here to investigate several model composites as processed and after oxidation tests at high temperature.
   The data reduction codes, based on analytic reconstruction methods, made it possible to determine the spatial extension of the BN interphase in transversal planes at different positions along the microcomposites (25 mum in diameter). This measurement was performed taking advantage of the density contrast between SiC and BN even for a layer thickness down to 3 mum. A first attempt was also made to separate the initial BN interphase from the B2O3 layer formed on its surface during oxidation, (C) 2001 Elsevier Science B.V. All rights reserved.
C1 CEN Bordeaux Gradignan, F-33175 Gradignan, France.
   UB1, UMR 5801, Lab Composites Thermostruct, CNRS,SNECMA,CEA, F-33600 Pessac, France.
RP Moretto, P (reprint author), CEN Bordeaux Gradignan, BP 120, Le Haut Vigneau, F-33175 Gradignan, France.
RI VIGNOLES, Gerard/A-2406-2013
OI VIGNOLES, Gerard/0000-0003-1606-6867
CR ANDERSEN HH, 1977, STOPPING POWERS RANG, V3
   ANTOLAK AJ, 1994, NUCL INSTRUM METH A, V353, P568, DOI 10.1016/0168-9002(94)91725-6
   AZEVEDO SG, 1990, IEEE T NUCL SCI, V37, P1525, DOI 10.1109/23.55866
   CHOLEWA M, 1994, NUCL INSTRUM METH B, V89, P157, DOI 10.1016/0168-583X(94)95164-0
   DOOLITTLE LR, 1985, NUCL INSTRUM METH B, V9, P344, DOI 10.1016/0168-583X(85)90762-1
   FISCHER BE, 1990, NUCL INSTRUM METH B, V47, P271, DOI 10.1016/0168-583X(90)90757-L
   HUESMAN RH, 1977, PUB L BERKELEY LAB, V214
   LEFEVRE HW, 1991, NUCL INSTRUM METH B, V54, P363, DOI 10.1016/0168-583X(91)95538-O
   LLABADOR Y, 1990, NUCL INSTRUM METH B, V49, P435, DOI 10.1016/0168-583X(90)90289-7
   Michelet C, 1999, NUCL INSTRUM METH B, V150, P173, DOI 10.1016/S0168-583X(98)01015-5
   Michelet C, 1999, NUCL INSTRUM METH B, V158, P361, DOI 10.1016/S0168-583X(99)00348-1
   MICHELET C, 1998, THESIS U BORDEAUX FR
   Morse DH, 1997, NUCL INSTRUM METH B, V130, P740, DOI 10.1016/S0168-583X(97)00180-8
   NASLAIN R, 1996, PROGR ADV MAT MECH, P198
   PONTAU AE, 1989, NUCL INSTRUM METH B, V40-1, P646, DOI 10.1016/0168-583X(89)91067-7
   Rebillat F, 1998, J EUR CERAM SOC, V18, P1809, DOI 10.1016/S0955-2219(98)00120-4
NR 16
TC 7
Z9 7
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JUL
PY 2001
VL 181
BP 238
EP 243
DI 10.1016/S0168-583X(01)00461-X
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 470RR
UT WOS:000170885400039
DA 2018-10-20
ER

PT J
AU Lugscheider, E
   Bobzin, K
   Lake, MK
AF Lugscheider, E
   Bobzin, K
   Lake, MK
TI Deposition of solder for micro-joining on MEMS components by means of
   magnetron sputtering
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Conference on Plasma Surface Engineering (PSE 2000)
CY SEP 17-21, 2000
CL PARTENKIRCHEN, GERMANY
DE MSIP PVD process; MEMS; micro-joining; solder application; TLP process
AB Micro electro-mechanical systems (M.E.M.S.) are used in many different technical areas, e.g. automotive control, information technology, biomedical or environmental application. Due to an increasing miniaturisation of components and devices and a great variety of materials, the M.E.M.S. has become very interesting. To mount different materials like ceramics, plastics or metals to hybrid M.E.M.S., sophisticated joining technologies have to be developed. The assembly and mounting of micro-components can be performed by a low temperature joining process, e.g. transient liquid phase bonding (TLP) or low temperature active compound joining. For these joining techniques, a solder system has to be deposited on the M.E.M.S. components locally. The TLP solder system is a composition of a thin film layer with a high melting point (e.g. Cu, Ni and Ag) and a second thin film with a low melting point (e.g. Sn, In and In-Bi). The deposition of a low temperature active compound solder system recommends an ingenious field of process parameters because of the multiplicity of solder elements, their stoichiometry and distribution within the deposited film. The deposition process can be carried out by the magnetron sputter ion plating (MSIP) PVD technique by adapting process parameters like discharge power, total gas pressure, substrate bias, or substrate heating, to obtain a defined film constitution. This paper presents the first results of solder deposition on different M.E.M.S. materials like silicon and glass, for the TLP joining process. The microstructure, morphology, and bond strength of the deposited solder layers are discussed in the context of deposition parameters. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Rhein Westfal TH Aachen, Inst Mat Sci, Aachen, Germany.
RP Lake, MK (reprint author), Rhein Westfal TH Aachen, Inst Mat Sci, Aachen, Germany.
CR BADER S, 1989, BILDUNG INTERMETALLI, P16
   JACOBSON DM, 1996, NOVEL APPL 13DIFFUSI, V23, P12
   JACOBSON DM, 1992, DIFFUS SOLDER SOLDER, V10, P27
   Lugscheider E, 1996, SURF COAT TECH, V86, P177, DOI 10.1016/S0257-8972(96)03041-1
   LUGSCHEIDER E, 1999, LOTEN MIKROSYSTEMTEC, V1
   Thornton J.A., 1974, J VAC SCI TECHNOL, V11, P660
   THORNTON JA, 1975, J VAC SCI TECHNOL, V12, P830, DOI 10.1116/1.568682
   1994, 2409 EN ISO
NR 8
TC 14
Z9 14
U1 0
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL
PY 2001
VL 142
BP 813
EP 816
DI 10.1016/S0257-8972(01)01182-3
PG 4
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 474KA
UT WOS:000171104600136
DA 2018-10-20
ER

PT J
AU Min, SK
   Kim, JH
   Chung, DJ
AF Min, SK
   Kim, JH
   Chung, DJ
TI Swelling behavior of biodegradable crosslinked gel based on
   poly(aspartic acid) and PEG-diepoxide
SO KOREA POLYMER JOURNAL
LA English
DT Article
ID L-ASPARTIC ACID; THERMAL POLYCONDENSATION; POLY(SUCCINIMIDE)
AB Poly(aspartic acid), PASP, is a biodegradable water-soluble polymer and offers a biodegradable alternative to polycarboxylates and other non-degradable water-soluble polymers. PASP, one of poly (amino acid)s, possesses carboxylic acid pendant group in its repeating unit. which can be used for various further modification put-poses. In this study we prepared high molecular weight polysuccinimide, as the precursor polymer for PASP by thermal polycondensation of L-aspartic acid in the presence of phosphoric acid. The polysuccinimide was hydrolyzed with 0.1 N sodium hydroxide, and then acidified to give PASP. High water-absorbent gels were produced by thermal crosslinking of freeze-dried mixture of partially-neutralized PASP and different amount of low mel. wt. PEG-diepoxide compounds in aqueous medium. The swelling behavior of the prepared gels from different size and composition of crosslinking reagent in different media was investigated and the results were discussed. This PASP-based hydrogel materials possessing inherent biodegradability, potential non-toxicity and biocompatibility, is expected to be used as a substrate for various biomedical applications as well as a general purpose super-absorbent polymer.
C1 Sungkyunkwan Univ, Polymer Technol Inst, Dept Chem Engn, Suwon 440746, Kyunggi, South Korea.
   Sungkyunkwan Univ, Polymer Technol Inst, Dept Polymer Sci & Engn, Suwon 440746, Kyunggi, South Korea.
EM kimjh@skku.ac.kr
CR Allen DS, 1998, MODERN SUPERABSORBEN
   Andrade JD, 1996, ACS S SERIES, V31
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   Giammona G., 1994, COLLOID POLYM SCI, V272, P12
   Matsubara K, 1997, MACROMOLECULES, V30, P2305, DOI 10.1021/ma961579h
   Min SK, 2000, J IND ENG CHEM, V6, P276
   Mosig J, 1997, IND ENG CHEM RES, V36, P2163, DOI 10.1021/ie960678g
   Nakato T, 1998, MACROMOLECULES, V31, P2107, DOI 10.1021/ma971629y
   Nakato T, 2000, J POLYM SCI POL CHEM, V38, P117, DOI 10.1002/(SICI)1099-0518(20000101)38:1<117::AID-POLA15>3.0.CO;2-F
   NAKATO T, 1996, ACS POLYM PREPRINT, V31, P555
   NERI P, 1973, J MED CHEM, V16, P893, DOI 10.1021/jm00266a006
   Sung YK, 2000, KOREA POLYM J, V8, P199
   TAMATAI H, 1995, ANTEC, P1511
   Tomida M, 1997, POLYMER, V38, P2791, DOI 10.1016/S0032-3861(97)85616-9
   WHEELER AP, 1993, MATER RES SOC S P, V292, P279
   WOLK SK, 1994, MACROMOLECULES, V27, P7613, DOI 10.1021/ma00104a016
   WONG WH, 1997, SYNTHETIC BIODEGRADA, pCH4
NR 17
TC 14
Z9 14
U1 0
U2 2
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1225-5947
J9 KOREA POLYM J
JI Korea Polym. J.
PD JUN 30
PY 2001
VL 9
IS 3
BP 143
EP 149
PG 7
WC Polymer Science
SC Polymer Science
GA 449LM
UT WOS:000169686100002
DA 2018-10-20
ER

PT J
AU Lee, CH
   Singla, A
   Lee, Y
AF Lee, CH
   Singla, A
   Lee, Y
TI Biomedical applications of collagen
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Review
DE collagen; biomaterial; drug/protein/gene delivery; tissue engineering
ID DRUG-DELIVERY SYSTEM; CROSS-LINKED COLLAGEN; BIOPROSTHETIC HEART-VALVES;
   CULTURED SKIN SUBSTITUTES; SOLID LIPID NANOPARTICLES; FIBROBLAST
   GROWTH-FACTOR; RECOMBINANT HUMAN BMP-2; SOFT CONTACT-LENSES; IN-VITRO;
   CORNEAL SHIELDS
AB Collagen is regarded as one of the most useful biomaterials. The excellent biocompatibility and safety due to its biological characteristics. such as biodegradability and weak antigenecity, made collagen the primary resource in medical applications. The main applications of collagen as drug delivery systems are collagen shields in ophthalmology, sponges for burns/wounds, mini-pellets and tablets for protein delivery, gel formulation in combination with liposomes for sustained drug delivery, as controlling material for transdermal delivery, and nanoparticles for gene delivery and basic matrices for cell culture systems. wt was also used for tissue engineering including skin replacement, bone substitutes, and artificial blood vessels and valves. This article reviews biomedical applications of collagen including the collagen film, which we have developed as a matrix system fur evaluation of tissue calcification and for the embedding of a single cell suspension for tumorigenic study. The advantages and disadvantages of each system are also discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Missouri, Coll Pharm, Dept Pharmaceut, Kansas City, MO 64110 USA.
   Univ Missouri, Sch Interdisciplinary Comp & Engn, Kansas City, MO 64110 USA.
RP Lee, CH (reprint author), Univ Missouri, Coll Pharm, Dept Pharmaceut, 5005 Rockhill Rd Katz Bdg 108, Kansas City, MO 64110 USA.
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   ALHENDY A, 1995, HUM GENE THER, V6, P165, DOI 10.1089/hum.1995.6.2-165
   Angella GJ, 2000, INVEST OPHTH VIS SCI, V41, P4158
   AQUAVELLA JV, 1988, J CATARACT REFR SURG, V14, P492, DOI 10.1016/S0886-3350(88)80004-X
   ASSIL KK, 1992, AM J OPHTHALMOL, V113, P418, DOI 10.1016/S0002-9394(14)76165-3
   Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Bank RA, 2000, ARTHRITIS RHEUM-US, V43, P2202, DOI 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E
   BARBANI N, 1995, J BIOMAT SCI-POLYM E, V7, P461
   BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212
   BAZIUK N, 1992, INT OPHTHALMOL, V16, P101, DOI 10.1007/BF00918940
   BELL E, 1983, J INVEST DERMATOL, V81, P2
   Bender AR, 1996, ANTIMICROB AGENTS CH, V40, P1467, DOI 10.1128/AAC.40.6.1467
   Bergeon M T, 1967, J Okla State Med Assoc, V60, P330
   Berthold A, 1998, EUR J PHARM BIOPHARM, V45, P23, DOI 10.1016/S0939-6411(97)00119-7
   BLOOMFIELD SE, 1978, ARCH OPHTHALMOL-CHIC, V96, P885
   BOYCE ST, 1993, ANTIMICROB AGENTS CH, V37, P1890, DOI 10.1128/AAC.37.9.1890
   BOYCE ST, 1992, J BIOMED MATER RES, V26, P547, DOI 10.1002/jbm.820260410
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   BOYCE ST, 1995, ANN SURG, V222, P743, DOI 10.1097/00000658-199512000-00008
   Boyce ST, 1998, MED BIOL ENG COMPUT, V36, P791, DOI 10.1007/BF02518886
   BRADLEY WG, 1977, BIOMATER ARTIF CELL, V5, P159, DOI 10.3109/10731197709118671
   BRAUKER J, 1995, J CELL BIOCH B, V21, pD1
   BROWDER IW, 1986, AM SURGEON, V52, P492
   BURGE RE, 1964, P NATO ADV STUDY GRO, P2
   CAMERON WJ, 1978, OBSTET GYNECOL, V51, P118
   CARROLL RE, 1989, J HAND SURG-BRIT EUR, V14B, P218, DOI 10.1016/0266-7681(89)90131-9
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   CHEN JM, 1995, J BIOMOL STRUCT DYN, V12, P1129, DOI 10.1080/07391102.1995.10508804
   CHEN YF, 1990, AM J OPHTHALMOL, V109, P132, DOI 10.1016/S0002-9394(14)75976-8
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   CHVAPIL M, 1993, J BIOMED MATER RES, V27, P313, DOI 10.1002/jbm.820270305
   CHVAPIL M, 1985, AM J OBSTET GYNECOL, V151, P325, DOI 10.1016/0002-9378(85)90296-0
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   DANIELSEN CC, 1990, BIOCHEM J, V272, P697, DOI 10.1042/bj2720697
   DEATHERAGE JR, 1987, COLLAGEN REL RES, V7, P225
   Desgrandchamps F, 2000, Curr Opin Urol, V10, P201, DOI 10.1097/00042307-200005000-00003
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DORIGO MT, 1995, CHEMOTHERAPY, V41, P1, DOI 10.1159/000239317
   DORR RT, 1982, J BIOMED MATER RES, V16, P839, DOI 10.1002/jbm.820160609
   ELSAMALIGY MS, 1983, J PHARM PHARMACOL, V35, P537, DOI 10.1111/j.2042-7158.1983.tb04831.x
   Farrugia CA, 1999, J PHARM PHARMACOL, V51, P643, DOI 10.1211/0022357991772925
   FELL JT, 1970, J PHARM SCI, V59, P688, DOI 10.1002/jps.2600590523
   FERKOL T, 1993, J CLIN INVEST, V92, P2394, DOI 10.1172/JCI116845
   FINKELSTEIN I, 1991, CAN J OPHTHALMOL, V26, P129
   Fonseca MJ, 1996, BBA-BIOMEMBRANES, V1279, P259
   FRIEDBERG ML, 1991, OPHTHALMOLOGY, V98, P725
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   FUJIOKA K, 1995, J CONTROL RELEASE, V33, P307, DOI 10.1016/0168-3659(94)00107-6
   GEBHARDT BM, 1995, J OCUL PHARMACOL TH, V11, P319, DOI 10.1089/jop.1995.11.319
   Geesin JC, 1996, J BIOMED MATER RES, V33, P1
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   GLOECKNER DC, 2000, BIOMATERIALS, V52, P365
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   Grammer JB, 1996, CURR EYE RES, V15, P815, DOI 10.3109/02713689609017622
   GROSS J., 1963, COMP BIOCHEM, V5, P307
   GUSSLER JR, 1990, J CATARACT REFR SURG, V16, P719, DOI 10.1016/S0886-3350(13)81013-9
   HARKNESS RD, 1966, SCI PROGRESS-UK, V54, P257
   HARKNESS RD, 1961, BIOL REV, V36, P399, DOI 10.1111/j.1469-185X.1961.tb01596.x
   Harriger MD, 1997, J BIOMED MATER RES, V35, P137, DOI 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O
   HARRIS PT, 1989, CORAL REEFS, V8, P97
   HEARTLEIN MW, 1994, P NATL ACAD SCI USA, V91, P10967, DOI 10.1073/pnas.91.23.10967
   HOBDEN JA, 1988, ARCH OPHTHALMOL-CHIC, V106, P1605, DOI 10.1001/archopht.1988.01060140773053
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   HWANG DG, 1989, ARCH OPHTHALMOL-CHIC, V107, P1375, DOI 10.1001/archopht.1989.01070020445052
   Jerome A., 1992, BIOMATERIALS, V9, P137
   JEYANTHI R, 1991, J PHARM PHARMACOL, V43, P60, DOI 10.1111/j.2042-7158.1991.tb05453.x
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   KAUFMAN HE, 1994, J OCUL PHARMACOL, V10, P17, DOI 10.1089/jop.1994.10.17
   KAUFMAN HE, 1988, J CATARACT REFR SURG, V14, P487, DOI 10.1016/S0886-3350(88)80002-6
   Kemp PD, 2000, METH MOL B, V139, P287
   KIMURA M, 2000, J PLAST RECONSTR SUR, V34, P289
   Kobayashi Y, 2000, Hinyokika Kiyo, V46, P869
   Kohmura E, 1999, BRAIN RES, V849, P235, DOI 10.1016/S0006-8993(99)02163-0
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Kuwano M, 1997, J OCUL PHARMACOL TH, V13, P31, DOI 10.1089/jop.1997.13.31
   KUZUYA M, 1994, EXP CELL RES, V215, P310, DOI 10.1006/excr.1994.1347
   Lam PK, 1999, ANN PLAS SURG, V43, P523, DOI 10.1097/00000637-199911000-00010
   LEADERS F E, 1973, Annals of Ophthalmology, V5, P513
   Lee CH, 1998, J BIOMED MATER RES, V42, P30, DOI 10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P
   LEE VHL, 1990, J OCUL PHARMACOL, V6, P157, DOI 10.1089/jop.1990.6.157
   LEFEBVRE F, 1992, BIOMATERIALS, V13, P28, DOI 10.1016/0142-9612(92)90091-2
   Lefebvre F, 1996, BIOMATERIALS, V17, P1813, DOI 10.1016/0142-9612(95)00346-0
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   LIANG FQ, 1992, INVEST OPHTH VIS SCI, V33, P2194
   LIU HW, 1993, HUM GENE THER, V4, P291, DOI 10.1089/hum.1993.4.3-291
   LUCAS PA, 1989, J BIOMED MATER RES-A, V23, P23, DOI 10.1002/jbm.820231306
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   MARMER RH, 1988, J CATARACT REFR SURG, V14, P496, DOI 10.1016/S0886-3350(88)80005-1
   MARTY JJ, 1978, PHARM ACTA HELV, V53, P17
   MATINCHOULY CA, 1999, INVEST RADIOL, V34, P663
   Matsuoka J, 1988, T AM SOC ART INT ORG, V34, P729
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   Meaney D F, 1995, Clin Podiatr Med Surg, V12, P363
   Mendicute Javier, 1995, CLAO Journal, V21, P252
   MILANI JK, 1993, AM J OPHTHALMOL, V116, P622, DOI 10.1016/S0002-9394(14)73206-4
   MILLER JM, 1964, ARCH SURG-CHICAGO, V88, P167, DOI 10.1001/archsurg.1964.01310200005002
   MINABE M, 1989, J PERIODONTOL, V60, P113, DOI 10.1902/jop.1989.60.2.113
   MINABE M, 1989, J PERIODONTOL, V60, P552, DOI 10.1902/jop.1989.60.10.552
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   MONDINO BJ, 1991, AM J OPHTHALMOL, V112, P587, DOI 10.1016/S0002-9394(14)76863-1
   MOULLIER P, 1993, NAT GENET, V4, P154, DOI 10.1038/ng0693-154
   MOULLIER P, 1995, NAT MED, V1, P353, DOI 10.1038/nm0495-353
   MOULLIER P, 1993, TRANSPLANTATION, V56, P427, DOI 10.1097/00007890-199308000-00034
   Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4
   Mullins RJ, 1996, AUST NZ J OPHTHALMOL, V24, P257, DOI 10.1111/j.1442-9071.1996.tb01589.x
   Muniruzzaman M, 1998, J BIOMAT SCI-POLYM E, V9, P459, DOI 10.1163/156856298X00569
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   Murata M, 2000, CLIN ORAL IMPLAN RES, V11, P289, DOI 10.1034/j.1600-0501.2000.011004289.x
   MURRAY TG, 1990, ARCH OPHTHALMOL-CHIC, V108, P104, DOI 10.1001/archopht.1990.01070030110039
   Nakagawa T, 2000, ORAL DIS, V6, P172
   NARAZAKI H, 1994, INT J APPROX REASON, V11, P1, DOI 10.1016/0888-613X(94)90017-5
   NICHOLAS FL, 1997, BIOMATERIALS, V18, P815
   NIMNI ME, 1988, COLLAGEN, V1, P1
   Nimni ME, 1988, COLLAGEN, VIII, P1
   OBRIEN TP, 1988, J CATARACT REFR SURG, V14, P505, DOI 10.1016/S0886-3350(88)80007-5
   Ochiya T, 1999, NAT MED, V5, P707
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   PAJEAN M, 1993, INT J PHARM, V91, P209, DOI 10.1016/0378-5173(93)90340-L
   PALMER RM, 1995, J CATARACT REFR SURG, V21, P125, DOI 10.1016/S0886-3350(13)80497-X
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   PENG YM, 1986, INVEST NEW DRUG, V4, P245
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PHINNEY RB, 1988, ARCH OPHTHALMOL-CHIC, V106, P1599, DOI 10.1001/archopht.1988.01060140767052
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   PLEYER U, 1994, CURR EYE RES, V13, P177, DOI 10.3109/02713689408995775
   PODOS SM, 1972, AM J OPHTHALMOL, V73, P336, DOI 10.1016/0002-9394(72)90062-1
   POLAND DE, 1988, J CATARACT REFR SURG, V14, P489, DOI 10.1016/S0886-3350(88)80003-8
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Prajapati RT, 2000, WOUND REPAIR REGEN, V8, P226, DOI 10.1046/j.1524-475x.2000.00226.x
   RAMACHANDRAN GN, 1965, BIOCHIM BIOPHYS ACTA, V109, P314, DOI 10.1016/0926-6585(65)90119-6
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   RAO KP, 1992, J MEMBRANE SCI, V71, P161, DOI 10.1016/0376-7388(92)85015-B
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REIDY JJ, 1990, CORNEA, V9, P196
   REMACLE M, 1995, ANN OTO RHINOL LARYN, V104, P437, DOI 10.1177/000348949510400604
   ROBIN JB, 1990, INVEST OPHTH VIS SCI, V31, P1294
   Rosenthal FM, 1997, ANTICANCER RES, V17, P1179
   ROSSLER B, 1995, J MICROENCAPSUL, V12, P49, DOI 10.3109/02652049509051126
   ROSSLER B, 1994, PHARMAZIE, V49, P175
   ROYCE PM, 1995, J DERMATOL SCI, V10, P42, DOI 10.1016/0923-1811(95)93713-B
   RUBIN AL, 1973, J CLIN PHARMACOL, V13, P309, DOI 10.1002/j.1552-4604.1973.tb00217.x
   RUDERMAN RJ, 1973, J BIOMED MATER RES, V7, P263, DOI 10.1002/jbm.820070213
   Sahai A., 1995, Pharmaceutical Research (New York), V12, pS227
   Samuel CS, 1998, J ENDOCRINOL, V159, P117, DOI 10.1677/joe.0.1590117
   SASTRY TP, 1991, COMPREHENSIVE GUIDE, P171
   Sato H, 1996, PHARMACEUT RES, V13, P1565, DOI 10.1023/A:1016096016642
   SAWUSCH MR, 1988, AM J OPHTHALMOL, V106, P279, DOI 10.1016/0002-9394(88)90361-3
   SAWUSCH MR, 1988, J CATARACT REFR SURG, V14, P625
   SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626
   SCHOEN FJ, 1992, J THORAC CARDIOV SUR, V104, P1285
   SCHWARTZ SD, 1990, AM J OPHTHALMOL, V109, P701, DOI 10.1016/S0002-9394(14)72439-0
   Sekine T, 2001, J BIOMED MATER RES, V54, P305, DOI 10.1002/1097-4636(200102)54:2<305::AID-JBM18>3.0.CO;2-B
   Sela J, 2000, INFLAMM RES, V49, P679, DOI 10.1007/s000110050646
   SHAKER GJ, 1989, INVEST OPHTH VIS SCI, V30, P1565
   SHANTHA KL, 1993, J BIOACT COMPAT POL, V8, P142, DOI 10.1177/088391159300800204
   SHORTLIFFE LMD, 1989, J UROLOGY, V141, P538
   SOBOLEWSKI K, 1995, ACTA BIOCHIM POL, V42, P301
   Stemberger A, 1997, EUR J SURG, V163, P17
   STENZEL KH, 1969, SCIENCE, V164, P1282, DOI 10.1126/science.164.3885.1282
   STOMPRO BE, 1989, J SURG RES, V46, P413, DOI 10.1016/0022-4804(89)90153-4
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Supp AP, 1999, WOUND REPAIR REGEN, V7, P226, DOI 10.1046/j.1524-475X.1999.00226.x
   Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   TAKENAKA H, 1986, PHARM TECH JAPAN, V2, P1083
   TANI K, 1989, BLOOD, V74, P1274
   Taravella MJ, 1999, J CATARACT REFR SURG, V25, P562, DOI 10.1016/S0886-3350(99)80056-X
   Thacharodi D, 1996, BIOMATERIALS, V17, P1307, DOI 10.1016/0142-9612(96)88676-5
   Timpl R, 1984, EXTRACELLULAR MATRIX, P159
   Trasciatti S, 1998, BIOMATERIALS, V19, P897, DOI 10.1016/S0142-9612(97)00175-0
   Traub W, 1971, ADV PROTEIN CHEM, V25, P245
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   Uitterlinden AG, 2001, J BONE MINER RES, V16, P379, DOI 10.1359/jbmr.2001.16.2.379
   Ulrich U, 2001, ARCH GYNECOL OBSTET, V264, P186, DOI 10.1007/s004040000105
   UNTERMAN SR, 1988, J CATARACT REFR SURG, V14, P500, DOI 10.1016/S0886-3350(88)80006-3
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   Vaneerdeweg W, 1998, EUR J SURG, V164, P617
   Vaneerdeweg W, 2000, EUR J SURG, V166, P959
   Vardaxis NJ, 1996, BIOMATERIALS, V17, P1489, DOI 10.1016/0142-9612(96)89773-0
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166
   WALTMAN SR, 1970, INVEST OPHTH VISUAL, V9, P250
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P555, DOI 10.1016/0304-4165(78)90330-6
   WEBSTER RC, 1984, ARCH OTOLARYNGOL, V110, P652
   WEDGE CI, 1992, CAN J OPHTHALMOL, V27, P295
   WEINER AL, 1985, J PHARM SCI, V74, P922, DOI 10.1002/jps.2600740903
   WILLEY DE, 1991, CURR EYE RES, V10, P167, DOI 10.3109/02713689109020374
   Woolley D. E., 1984, EXTRACELLULAR MATRIX, P119
   Yamada N, 1999, SCAND J PLAST RECONS, V33, P147
   YAMAHIRA Y, 1991, Patent No. 841123136
   Yang SC, 1999, J CONTROL RELEASE, V59, P299, DOI 10.1016/S0168-3659(99)00007-3
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 202
TC 970
Z9 1046
U1 24
U2 460
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD JUN 19
PY 2001
VL 221
IS 1-2
BP 1
EP 22
DI 10.1016/S0378-5173(01)00691-3
PG 22
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 443XJ
UT WOS:000169368300001
PM 11397563
DA 2018-10-20
ER

PT J
AU Kumar, R
   Cheang, P
   Khor, KA
AF Kumar, R
   Cheang, P
   Khor, KA
TI RF plasma processing of ultra-fine hydroxyaptite powders
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 5th Asia-Pacific Conference on Materials Processing
CY JUN 25-27, 2001
CL SEOUL, SOUTH KOREA
DE hydroxyaptite; tricalcium phosphate; calcium oxide; RF plasma
   processing; bioactive material
ID HYDROXYLAPATITE; COATINGS
AB The study of biocompatible materials has intensified over the last decade driven by the growing awareness of an aging population. The need for alternative medical solutions has not only extended the requirement for biomedical devices to offer more than just functionality but also bioactivity. A new generation of bioactive materials has emerged promising better properties over existing biomaterials because of their ability-to promote intimate bone growth and rapid fixation. In particular, hydroxyapatite (HA) has been recognised as one bioactive material having the potential and opportunity for development as bone substitutes. Although HA has a similar chemical composition to that of natural bone, it lacks sufficient strength and toughness for use in load bearing applications. Very often it requires blending with a low modulus polymer to achieve adequate toughness. However, the properties of HA composites is highly dependent on the particle size and morphology of the HA filler. Much has been suggested on the benefit of nano particulate materials in achieving higher mechanical properties. The need now arises in developing and processing HA of sufficient fineness for this purpose. As such the synthesis of ultra-fine HA was initiated using RF induction suspension plasma spraying with a wet suspension of HA as feedstock. This was axially injected into the RF plasma at various plate powers (plasma energies), chamber pressures, probe distances and plasma gas flow rates. The processed powders varied in size according to the cyclones designed to collect the powders from medium to ultra-fine. The chamber collecting ultrafine powder contained particles ranging from 10 nm to 4 mum. The particle size, morphology and phase concentration of the powders were characterised using SEM, TEM, XRD and FTIR. In general, the particle size decreased with increasing plate power, while the reverse was observed for the volume of nano-sized particles produced. Decomposition into other phases such as tricalcium phosphate (TCP), tetracalcium phosphate (TTCP) and calcium oxide (CaO) increased with increasing plate power. This study suggests that the processing parameters associated with the production of the ultra-fine powders interact in a complex manner but can be rationalised by considering the overall thermal treatment experienced by the particulates during plasma treatment. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Nanyang Technol Univ, Adv Mat Res Ctr, Sch Mat Engn, Singapore 639789, Singapore.
RP Cheang, P (reprint author), Nanyang Technol Univ, Adv Mat Res Ctr, Sch Mat Engn, Nanyang Ave, Singapore 639789, Singapore.
RI Khor, Khiam Aik (Michael)/B-6929-2009; Khor, Khiam Aik/G-2827-2010
OI KHOR, Khiam/0000-0003-1954-8423
CR Babat G.I., 1947, Journal of the Institution of Electrical Engineers. III. Radio and Communication Engineering, V94, P27
   Bouyer E, 1997, IEEE T PLASMA SCI, V25, P1066, DOI 10.1109/27.649627
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   KHON DH, 1992, MAT SCI TECHNOLOGY, V14, P66
   Khor KA, 1997, JOM-J MIN MET MAT S, V49, P51, DOI 10.1007/BF02915482
   KNOWLES JC, BIOCERAMICS, V8, P311
   KUMAR R, 2000, P 14 INT C SURF MOD
   MATEJKA D, 1989, PLASMA SPRAYING META, P15
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Penel G, 1997, J MATER SCI-MATER M, V8, P271, DOI 10.1023/A:1018504126866
   REED TB, 1961, J APPL PHYS, V32, P821, DOI 10.1063/1.1736112
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Ye R, 1999, INT J HEAT MASS TRAN, V42, P1585, DOI 10.1016/S0017-9310(98)00260-9
   Zhang S, 1997, J MATER SCI-MATER M, V8, P25, DOI 10.1023/A:1018586128257
NR 16
TC 52
Z9 53
U1 0
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD JUN 15
PY 2001
VL 113
IS 1-3
BP 456
EP 462
DI 10.1016/S0924-0136(01)00611-2
PG 7
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 444TA
UT WOS:000169415000078
DA 2018-10-20
ER

PT J
AU Golosio, B
   Brunetti, A
   Cesareo, R
   Amendolia, SR
   Rao, DV
   Seltzer, SM
AF Golosio, B
   Brunetti, A
   Cesareo, R
   Amendolia, SR
   Rao, DV
   Seltzer, SM
TI Images of soft materials: a 3D visualization of interior of the sample
   in terms of attenuation coefficient
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article
DE X-ray computed tomography; 3D graphics; non-destructive evaluation;
   imaging
ID MICROTOMOGRAPHY; TOMOGRAPHY
AB Images of soft materials are obtained using image intensifier based X-ray system (Rao et al., Nucl. Instr. and Meth. A 437 (1999) 141). The interior of the soft material is visualized using the novel software in order to know the distribution of attenuation coefficient in terms of density. The novel software is based mainly on graphical library and applicable to several operating systems without any change. It can be applied to several applications starting from biomedical to industries, for example, quality control. The results for walnut and brew tooth are presented as a set of images from the internal parts of the sample. A description of the principal parameters required for tomographic visualization is given and some results based on this technique are reported and discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Sir CRR Autonomous Coll, Dept Phys, Eluru 534007, AP, India.
   Univ Sassari, Ist Matemat Fis, I-07100 Sassari, Italy.
   Natl Inst Stand & Technol, Ionizing Radiat Div, Photon & Charged Particle Data Ctr, Gaithersburg, MD 20899 USA.
RP Rao, DV (reprint author), Sir CRR Autonomous Coll, Dept Phys, Eluru 534007, AP, India.
RI brunetti, antonio/F-3370-2011
OI brunetti, antonio/0000-0002-0116-1899; Golosio,
   Bruno/0000-0001-5144-6932
CR CESAREO R, 1994, APPL RADIAT ISOTOPES, V45, P613, DOI 10.1016/0969-8043(94)90205-4
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   FLANNERY BP, 1987, SCIENCE, V237, P1439, DOI 10.1126/science.237.4821.1439
   HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016
   Jain A. K, 1989, FUNDAMENTALS DIGITAL
   JONES KW, HDB XRAY SPECTROMETR, V192, P443
   LORENSEN WE, 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422
   MARTZ HE, 1990, APPL RADIAT ISOTOPES, V41, P943
   NEIDER J, 1992, OPENGL ARCHITECTURE
   Rao DV, 2000, J TRACE MICROPROBE T, V18, P257
   RAO DV, 1999, NUCL INSTRUM METH A, V437, P437
   SPANNE P, 1994, PHYS REV LETT, V73, P2001, DOI 10.1103/PhysRevLett.73.2001
   WEBB S, 1987, IEE PROC-A, V134, P126, DOI 10.1049/ip-a-1.1987.0019
   1992, OPENGL ARCHITECTURE
NR 14
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD JUN 11
PY 2001
VL 465
IS 2-3
BP 577
EP 583
DI 10.1016/S0168-9002(01)00674-X
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 445GD
UT WOS:000169449000026
DA 2018-10-20
ER

PT J
AU Ritter, SK
AF Ritter, SK
TI The changing face of chemical engineering
SO CHEMICAL & ENGINEERING NEWS
LA English
DT Article
AB Century-old discipline is ripe for expansion into materials and biomedical product development.
NR 0
TC 10
Z9 10
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD JUN 4
PY 2001
VL 79
IS 23
BP 63
EP 66
DI 10.1021/cen-v079n040.p063
PG 4
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 439YD
UT WOS:000169144400043
DA 2018-10-20
ER

PT J
AU Abraham, GA
   Gallardo, A
   Roman, JS
   Olivera, ER
   Jodra, R
   Garcia, B
   Minambres, B
   Garcia, JL
   Luengo, JM
AF Abraham, GA
   Gallardo, A
   Roman, JS
   Olivera, ER
   Jodra, R
   Garcia, B
   Minambres, B
   Garcia, JL
   Luengo, JM
TI Microbial synthesis of poly(beta-hydroxyalkanoates) bearing phenyl
   groups from Pseudomonas putida: Chemical structure and characterization
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYHYDROXYALKANOIC ACIDS; BACTERIAL PRODUCTION; ALKANOIC ACIDS; COA
   CATABOLON; OLEOVORANS; POLY(3-HYDROXYALKANOATES);
   POLY-3-HYDROXYALKANOATES; BIOSYNTHESIS; PURIFICATION; DEGRADATION
AB New poly(beta-hydroxyalkanoates) having aromatics groups (so-called PHPhAs) from a microbial origin have been characterized. These polymers were produced and accumulated as reserve materials when a beta-oxidation mutant of Pseudomonas putida U, disrupted in the gene that encodes the 3-ketoacyl-CoA thiolase (fadA), was cultured in a chemically defined medium containing different aromatic fatty acids (6-phenylhexanoic acid, 7-phenylheptanoic acid, a mixture of them, or 8-phenyloctanoic acid) as carbon sources. The polymers were extracted from the bacteria, purified and characterized by using C-13 nuclear magnetic resonance spectroscopy (NMR), gel permeation chromatography (GPC), and differential scanning calorimetry (DSC). Structural studies revealed that when 6-phenylhexanoic acid was added to the cultures, an homopolymer (poly-3-hydroxy-6-phenylhexanoate) was accumulated. The feeding with 8-phenyloctanoic acid and 7-phenylheptanoic acid leads to the formation of copolymers of the corresponding units with the n - 2 carbons formed after deacetylation, copoly(3-hydroxy-8-phenyloctanoate-3-hydroxy-6-phenylhexanoate) and copoly(3-hydroxy-7-phenytheptanoate-3-hydroxy-5-phenylvalerate), respectively. The mixture of 6-phenylhexanoic acid and 7-phenylheptanoic acid gave rise to the corresponding terpolymer, copoly(3-hydroxy-7-phenylheptanoate-3-hydroxy-6-phenylhexanoate-3-hydroxy-5,phenylvalerate). Studies on the chemical structure of these three polyesters revealed that they were true copolymers but not a mixture of homopolymers and that the different monomeric units were randomly incorporated in the macromolecular chains. Thermal behavior and molecular weight distribution were also discussed. These compounds had a dual attractive interest in function of (i) their broad use as biodegradable polymers and (ii) their possible biomedical applications.
C1 CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
   Univ Leon, Dept Bioquim & Biol Mol, E-24007 Leon, Spain.
   CSIC, Ctr Invest Biol, Dept Mol Microbiol, Madrid, Spain.
   UNMdP, CONICET, Inst Invest Ciencia & Tecnol Mat, RA-7600 Mar Del Plata, Argentina.
RP Roman, JS (reprint author), CSIC, Inst Ciencia & Tecnol Polimeros, Juan de la Cierva 3, E-28006 Madrid, Spain.
RI Abraham, Gustavo/E-2820-2014; RODRIGUEZ OLIVERA, ELIAS/H-6385-2016;
   Gallardo, Alberto/B-4794-2011
OI Abraham, Gustavo/0000-0001-7094-1031; RODRIGUEZ OLIVERA,
   ELIAS/0000-0003-2315-8524; Gallardo, Alberto/0000-0003-4614-4299;
   Luengo, Jose M./0000-0002-4984-6256; Garcia Lopez, Jose
   Luis/0000-0002-9238-2485; Minambres Rodriguez,
   Baltasar/0000-0003-4590-4911
CR BYROM D, 1987, TRENDS BIOTECHNOL, V5, P246, DOI 10.1016/0167-7799(87)90100-4
   Byrom D., 1994, PLASTICS MICROBES MI, P5
   Curley JM, 1996, MACROMOLECULES, V29, P1762, DOI 10.1021/ma951185a
   FERNANDEZ A, 1998, J BIOL CHEM, V273, P25974
   FRITZSCHE K, 1990, MAKROMOL CHEM, V191, P1957
   Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228
   GROSS RA, 1989, MACROMOLECULES, V22, P1106, DOI 10.1021/ma00193a018
   Hazer B, 1996, POLYMER, V37, P5951, DOI 10.1016/S0032-3861(96)00570-8
   HUISMAN GW, 1991, J BIOL CHEM, V266, P2191
   KAMIYA N, 1989, MACROMOLECULES, V22, P1676, DOI 10.1021/ma00194a030
   Kim YB, 1999, MACROMOLECULES, V32, P6058
   KIM YB, 1992, MACROMOLECULES, V25, P1852, DOI 10.1021/ma00033a002
   Kim YB, 1996, MACROMOLECULES, V29, P3432
   KIM YB, 1991, MACROMOLECULES, V24, P5256, DOI 10.1021/ma00019a004
   LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924
   LENZ RW, 1993, ADV POLYM SCI, V107, P1
   LUENGO JM, 2001, IN PRESS MOL MICROBI
   MARTINEZBLANCO H, 1990, J BIOL CHEM, V265, P7084
   MULLIS KB, 1987, METHOD ENZYMOL, V155, P335
   Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419
   RITTER H, 1994, MACROMOL CHEM PHYSIC, V195, P1665, DOI 10.1002/macp.1994.021950517
   SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
   SCHIRMER A, 1993, APPL ENVIRON MICROB, V59, P1220
   STEINBUCHEL A, 1992, FEMS MICROBIOL LETT, V103, P217, DOI 10.1111/j.1574-6968.1992.tb05841.x
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Steinbuchel A, 1991, BIOMATERIALS NOVEL M, P124
   STEINBUCHEL A, 1991, BIOMATERIALS
   STEINBUECHEL A, 1992, Current Opinion in Biotechnology, V3, P291, DOI 10.1016/0958-1669(92)90107-T
NR 28
TC 30
Z9 30
U1 1
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SUM
PY 2001
VL 2
IS 2
BP 562
EP 567
DI 10.1021/bm010018h
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 528RF
UT WOS:000174256200033
PM 11749221
DA 2018-10-20
ER

PT J
AU Menard, C
   Smith, ICP
   Somorjai, RL
   Leboldus, L
   Patel, R
   Littman, C
   Robertson, SJ
   Bezabeh, T
AF Menard, C
   Smith, ICP
   Somorjai, RL
   Leboldus, L
   Patel, R
   Littman, C
   Robertson, SJ
   Bezabeh, T
TI Magnetic resonance spectroscopy of the malignant prostate gland after
   radiotherapy: A histopathologic study of diagnostic validity
SO INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
LA English
DT Article; Proceedings Paper
CT 42nd Annual Meeting of the
   American-Society-for-Therapeutic-Radiology-and-Oncology (ASTRO)
CY OCT 22-26, 2000
CL BOSTON, MASSACHUSETTS
SP Amer Soc Therapeut Radiol & Oncol
DE classifier; magnetic resonance spectroscopy; multivariate analysis;
   prostate cancer; radiotherapy
ID RADIATION-THERAPY; NEOPLASTIC PROSTATE; LOCAL-CONTROL; MR SPECTRA;
   CANCER; H-1; BIOPSY; CARCINOMA; BENIGN; ADENOCARCINOMA
AB Purpose: Accurate spatial representation of tumor clearance after conformal radiotherapy is an endpoint of clinical importance. Magnetic resonance spectroscopy (MRS) can diagnose malignancy in the untreated prostate gland through measurements of cellular metabolites, In this study we sought to describe spectral metabolic changes in prostatic tissue after radiotherapy and validate a multivariate analytic strategy (based on MRS) that could identify viable tumor.
   Methods and Materials: Transrectal ultrasound-guided prostate biopsies from 35 patients were obtained 18-36 months after external beam radiotherapy. One hundred sixteen tissue specimens were subjected to H-1 MRS, submitted to histopathology, and analyzed for correlation with a multivariate strategy specifically developed for biomedical spectra,
   Results: The sensitivity and specificity of MRS in identifying a malignant biopsy were 88.9% and 92% respectively, with an overall classification accuracy of 91.4%, The diagnostic spectral regions identified by our algorithm included those due to choline, creatine, glutamine, and lipid. Citrate, an important discriminating resonance in the untreated prostate gland, was invisible in all spectra, regardless of histology,
   Conclusions: Although the spectral features of prostate tissue markedly change after radiotherapy, MRS combined with multivariate methods of analysis can accurately identify histologically malignant biopsies. MRS shows promise as a modality that could integrate three-dimensional measures of tumor response. (C) 2001 Elsevier Science Inc.
C1 Natl Res Council Canada, Inst Biodiagnost, Winnipeg, MB R3B 1Y6, Canada.
   Univ Manitoba, Dept Radiat Oncol, Winnipeg, MB, Canada.
   Univ Manitoba, Dept Pathol, Winnipeg, MB R3T 2N2, Canada.
   Winnipeg Clin, Winnipeg, MB, Canada.
   Ottawa Hosp, Dept Pathol, Ottawa, ON, Canada.
RP Bezabeh, T (reprint author), Natl Res Council Canada, Inst Biodiagnost, 435 Ellice Ave, Winnipeg, MB R3B 1Y6, Canada.
CR Bezabeh T, 2001, AM J GASTROENTEROL, V96, P442
   BOCKING A, 1987, DIAGN CYTOPATHOL, V3, P108, DOI 10.1002/dc.2840030204
   BOSTWICK DG, 1982, AM J SURG PATHOL, V6, P541, DOI 10.1097/00000478-198209000-00006
   BRAWER MK, 1989, CANCER, V63, P454, DOI 10.1002/1097-0142(19890201)63:3<454::AID-CNCR2820630311>3.0.CO;2-E
   CORNEL EB, 1993, J UROLOGY, V150, P2019, DOI 10.1016/S0022-5347(17)35957-8
   COSTELLO LC, 1991, PROSTATE, V19, P181, DOI 10.1002/pros.2990190302
   Cox JD, 1999, J CLIN ONCOL, V17, P1155
   Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
   Crook J, 2000, INT J RADIAT ONCOL, V48, P355, DOI 10.1016/S0360-3016(00)00637-4
   CROOK JM, 1995, UROLOGY, V45, P524
   DALY PF, 1987, J BIOL CHEM, V262, P14875
   FUKS Z, 1991, INT J RADIAT ONCOL, V21, P537, DOI 10.1016/0360-3016(91)90668-T
   Garcia-Segura JM, 1999, MAGN RESON IMAGING, V17, P755, DOI 10.1016/S0730-725X(99)00006-5
   GRIGNON DJ, 1995, CANCER, V75, P1837, DOI 10.1002/1097-0142(19950401)75:7+<1837::AID-CNCR2820751613>3.0.CO;2-S
   Hahn P, 1997, CANCER RES, V57, P3398
   Hanks GE, 1998, INT J RADIAT ONCOL, V41, P501, DOI 10.1016/S0360-3016(98)00089-3
   KAPLAN ID, 1992, J UROLOGY, V147, P917, DOI 10.1016/S0022-5347(17)37422-0
   Kotzerke J, 2000, EUR J NUCL MED, V27, P1415, DOI 10.1007/s002590000309
   KUBAN DA, 1987, UROLOGY, V30, P420, DOI 10.1016/0090-4295(87)90372-4
   KUBAN DA, 1992, INT J RADIAT ONCOL, V24, P409, DOI 10.1016/0360-3016(92)91053-P
   KUESEL AC, 1992, MAGNET RESON MED, V27, P340
   Kurhanewicz J, 1996, RADIOLOGY, V198, P795, DOI 10.1148/radiology.198.3.8628874
   Kurhanewicz J, 1996, RADIOLOGY, V200, P489, DOI 10.1148/radiology.200.2.8685346
   KURHANEWICZ J, 1993, MAGN RESON MED, V29, P149, DOI 10.1002/mrm.1910290202
   NEGANDANK WG, 1992, RADIOLOGY, V185, P875
   Nikulin AE, 1998, NMR BIOMED, V11, P209, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<209::AID-NBM510>3.0.CO;2-5
   PEREZ CA, 1993, INT J RADIAT ONCOL, V26, P581, DOI 10.1016/0360-3016(93)90273-X
   Pinover WH, 2000, INT J RADIAT ONCOL, V47, P649, DOI 10.1016/S0360-3016(00)00465-X
   PRESTIDGE BR, 1992, INT J RADIAT ONCOL, V24, P403, DOI 10.1016/0360-3016(92)91052-O
   Scardino P T, 1988, NCI Monogr, P95
   Scheidler J, 1999, RADIOLOGY, V213, P473, DOI 10.1148/radiology.213.2.r99nv23473
   SCHELLHAMMER PF, 1987, J UROLOGY, V137, P897, DOI 10.1016/S0022-5347(17)44289-3
   Siegelman ES, 1999, SEMIN ROENTGENOL, V34, P295, DOI 10.1016/S0037-198X(99)80007-8
   SMITH ICP, 2000, METHODS BIOMEDICAL M, P891
   SOMORJAI RL, 1995, MAGN RESON MED, V33, P257, DOI 10.1002/mrm.1910330217
   SOMORJAI RL, 1999, J MED BIOCH, V3, P17
   SOMORJAI RL, IN PRESS VIBRATIONAL
   Speck O, 1996, ANTICANCER RES, V16, P1581
   Speight JL, 2000, RADIOL CLIN N AM, V38, P159, DOI 10.1016/S0033-8389(05)70154-8
   Tedeschi G, 1997, J NEUROSURG, V87, P516, DOI 10.3171/jns.1997.87.4.0516
   Valicenti R, 2000, J CLIN ONCOL, V18, P2740, DOI 10.1200/JCO.2000.18.14.2740
   Wald LL, 1997, J NEUROSURG, V87, P525, DOI 10.3171/jns.1997.87.4.0525
   Yu KK, 1999, RADIOLOGY, V213, P481, DOI 10.1148/radiology.213.2.r99nv26481
   Zaider M, 2000, INT J RADIAT ONCOL, V47, P1085, DOI 10.1016/S0360-3016(00)00557-5
NR 44
TC 54
Z9 60
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0360-3016
J9 INT J RADIAT ONCOL
JI Int. J. Radiat. Oncol. Biol. Phys.
PD JUN 1
PY 2001
VL 50
IS 2
BP 317
EP 323
DI 10.1016/S0360-3016(01)01480-8
PG 7
WC Oncology; Radiology, Nuclear Medicine & Medical Imaging
SC Oncology; Radiology, Nuclear Medicine & Medical Imaging
GA 433VG
UT WOS:000168781000005
PM 11380217
DA 2018-10-20
ER

PT J
AU Buczkowski, M
   Sartowska, B
   Wawszczak, D
   Starosta, W
AF Buczkowski, M
   Sartowska, B
   Wawszczak, D
   Starosta, W
TI Radiation resistance of track etched membranes
SO RADIATION MEASUREMENTS
LA English
DT Article; Proceedings Paper
CT 20th International Conference on Nuclear Tracks in Solids
CY AUG 28-SEP 01, 2000
CL PORTOROZ, SLOVENIA
SP Minist Sci & Technol Slovenia, European Nucl Soc
DE track etched membrane; heavy ion beam; radiation sterilization; strength
   properties of polymer films and membranes
AB Track etched membranes (TEMs) obtained by irradiation of polymer films with heavy ions and subsequent etching of latent tracks can be applied in many fields and among others in biomedicine as well. It is important to know radiation resistance of TEMs because of Aide use of radiation sterilization in the case of biomedical devices.
   Tensile properties of TEMs made of PET and PC films with the thickness of 10 mum after electron irradiation at different doses are known from literature. Nowadays TEMs are being manufactured from thicker (20 mum) PET and PC films as well as polyethylene naphthalate (PEN) films are proposed for TEMs. It seems to be important to get data about radiation resistance of new kinds of TEMs.
   Samples of polymer films made of PET and PEN with the thickness of 19-25 mum and TEMs made of such materials have been irradiated using 10 MeV electron beam with doses up to 990 kGy. Tensile properties and SEM photographs of the samples after irradiation are given in the paper. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Inst Nucl Chem & Technol, PL-03195 Warsaw, Poland.
RP Buczkowski, M (reprint author), Inst Nucl Chem & Technol, Dorodna 16, PL-03195 Warsaw, Poland.
CR APEL PY, 1995, RADIAT MEAS, V25, P667, DOI 10.1016/1350-4487(95)00219-5
   BUCZKOWSKI M, 1997, P 6 INT SCH SEM HEAV, P761
   SPOHR R, 1990, ION TRACK MICROTECHN
   Starosta W, 1999, RADIAT MEAS, V31, P149, DOI 10.1016/S1350-4487(99)00184-5
   Zhitariuk NI, 1996, EUR POLYM J, V32, P391, DOI 10.1016/0014-3057(95)00199-9
NR 5
TC 9
Z9 11
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1350-4487
J9 RADIAT MEAS
JI Radiat. Meas.
PD JUN
PY 2001
VL 34
IS 1-6
BP 597
EP 599
DI 10.1016/S1350-4487(01)00236-0
PG 3
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA 471EW
UT WOS:000170916200122
DA 2018-10-20
ER

PT J
AU Hennemeyer, CT
   Wicklow, K
   Feinberg, DA
   Derdeyn, CP
AF Hennemeyer, CT
   Wicklow, K
   Feinberg, DA
   Derdeyn, CP
TI In vitro evaluation of platinum Guglielmi detachable coils at 3 T with a
   porcine model: Safety issues and artifacts
SO RADIOLOGY
LA English
DT Article
DE aneurysm, cerebral; head, MR; magnetic resonance (MR), safety; radiology
   and radiologists, iatrogenic injury
ID MR-ANGIOGRAPHY; BIOMEDICAL IMPLANTS; POTENTIAL HAZARDS; METALLIC
   IMPLANTS; FERROMAGNETISM; ANEURYSMS; DEVICES; TIME
AB PURPOSE: To evaluate safety-related issues and imaging artifacts of Guglielmi detachable coils in vitro with 3-T magnetic resonance (MR) imaging.
   MATERIALS AND METHODS: Two aneurysm models were constructed: one from porcine carotid artery and the other from a pharmaceutical capsule. Both were filled with Guglielmi detachable coils. The models were tested with a 3-T MR imager for :heating, deflection, and imaging artifact. Testing for heating and deflection was performed (a) at static points both inside and outside the bore, (b) during movement into the imager, and (c) during clinical imaging sequences.
   RESULTS: No change in temperature was measured during movement into the imager bore or at different points within the bore. No differences in heating from radio-frequency energy were found between aneurysm models and controls. Similarly, no evidence of deflection of the coil mass (capsule model) was found. Minor susceptibility artifacts were found in the readout direction during gradient-echo sequences. Magnetic field mapping showed no induced field inhomogeneity.
   CONCLUSION: MR imaging at field strengths of 3 T in patients with aneurysms treated with Guglielmi detachable coils is safe. Imaging artifacts are likely to be minimal.
C1 Washington Univ, Sch Med, Neuroradiol Sect, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Neuroimaging Lab, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.
RP Derdeyn, CP (reprint author), Washington Univ, Sch Med, Neuroradiol Sect, Edward Mallinckrodt Inst Radiol, 510 S Kingshighway Blvd, St Louis, MO 63110 USA.
CR DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   Derdeyn CP, 1997, AM J NEURORADIOL, V18, P279
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   Gonner F, 1998, AM J NEURORADIOL, V19, P1324
   Hartman J, 1997, AM J NEURORADIOL, V18, P497
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   Kahara VJ, 1999, AM J NEURORADIOL, V20, P1470
   Kanal E, 1996, RADIOLOGY, V200, P576, DOI 10.1148/radiology.200.2.8685361
   KANAL E, 1994, AM J NEURORADIOL, V15, P1394
   KELLY WM, 1986, AM J NEURORADIOL, V7, P243
   MARSHALL MW, 1991, CARDIOVASC INTER RAD, V14, P163, DOI 10.1007/BF02577720
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1993, RADIOLOGY, V189, P587, DOI 10.1148/radiology.189.2.8210394
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
NR 15
TC 37
Z9 41
U1 0
U2 1
PU RADIOLOGICAL SOC NORTH AMER
PI EASTON
PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD JUN
PY 2001
VL 219
IS 3
BP 732
EP 737
DI 10.1148/radiology.219.3.r01jn33732
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 435EQ
UT WOS:000168864800022
PM 11376262
DA 2018-10-20
ER

PT J
AU Ringeisen, BR
   Callahan, J
   Wu, PK
   Pique, A
   Spargo, B
   McGill, RA
   Bucaro, M
   Kim, H
   Bubb, DM
   Chrisey, DB
AF Ringeisen, BR
   Callahan, J
   Wu, PK
   Pique, A
   Spargo, B
   McGill, RA
   Bucaro, M
   Kim, H
   Bubb, DM
   Chrisey, DB
TI Novel laser-based deposition of active protein thin films
SO LANGMUIR
LA English
DT Article
ID LANGMUIR-BLODGETT-FILMS; MICROFLUIDIC NETWORKS; BIOMEDICAL APPLICATIONS;
   MASS-SPECTROMETRY; SOFT LITHOGRAPHY; BIOSENSORS; SURFACES;
   OLIGONUCLEOTIDE; FABRICATION; GLUCOSE
AB This paper reports the deposition of active protein thin films by a novel laser-based approach termed matrix-assisted pulsed laser evaporation (MAPLE). We have deposited uniform 10 nm to nearly 1 mum thin films of insulin and horseradish peroxidase (HRP). We performed several experiments to characterize the chemical integrity of the deposited films. Matrix assisted laser desorption/ionization and liquid chromatography/electrospray ionization mass spectrometry experiments performed on MAPLE-deposited insulin films indicate that the laser-material interaction involved in this deposition technique does not modify the protein's mass. Fourier transform infrared spectroscopy experiments show that the chemical functionality and secondary structure of MAPLE-deposited HRP are nearly identical to those of the native protein. We also find that deposited HRP films retain their ability to catalyze the reduction of 3,3'-diaminobenzidine (DAB), suggesting that the active site of transferred proteins is unaffected by the MAPLE process. We also produced patterns and multilayers with feature sizes from 20 to 250 mum by depositing different biomaterials through a shadow mask. Patterns of physisorbed HRP were then protected from dissolution in an aqueous environment by a semipermeable polymer overlayer that was deposited in situ using pulsed laser deposition. This polymer membrane protects the protein pattern when it is exposed to DAB solution and enables the optical observation of HRP activity for spots as small as 2000 mum(2). These results demonstrate that MAPLE is a preferred technique for depositing active biomolecules for applications ranging from microfluidic sensor devices to gene and protein recognition microarrays.
C1 USN, Res Lab, Washington, DC 20375 USA.
   So Oregon Univ, Dept Phys, Ashland, OR 97520 USA.
RP Ringeisen, BR (reprint author), USN, Res Lab, Code 6372, Washington, DC 20375 USA.
CR Albareda-Sirvent M, 2000, SENSOR ACTUAT B-CHEM, V69, P153, DOI 10.1016/S0925-4005(00)00536-0
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Borman S, 2000, CHEM ENG NEWS, V78, P31, DOI 10.1021/cen-v078n031.p031
   Brooks SA, 2000, ANAL CHEM, V72, P3253, DOI 10.1021/ac9914531
   BUBB DM, UNPUB
   BUBB DM, IN PRESS APPL PHYS A
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chrisey D, 2000, LASER FOCUS WORLD, V36, P113
   Chrisey D., 1994, PULSED LASER DEPOSIT
   CHUARD C, 1993, ANTIMICROB AGENTS CH, V37, P625, DOI 10.1128/AAC.37.4.625
   COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441
   Delamarche E, 1998, J AM CHEM SOC, V120, P500, DOI 10.1021/ja973071f
   Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779
   Folch A, 1998, BIOTECHNOL PROGR, V14, P388, DOI 10.1021/bp980037b
   FUJIWARA I, 1992, LANGMUIR, V8, P2219, DOI 10.1021/la00045a025
   Gooding JJ, 1998, ELECTROANAL, V10, P1130, DOI 10.1002/(SICI)1521-4109(199811)10:16<1130::AID-ELAN1130>3.0.CO;2-6
   Graves DJ, 1998, ANAL CHEM, V70, P5085, DOI 10.1021/ac980456n
   Guschin D, 1997, ANAL BIOCHEM, V250, P203, DOI 10.1006/abio.1997.2209
   James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kimura J., 1998, BIOSENSORS, V4, P41
   Konig S, 1998, ANAL CHEM, V70, P4453, DOI 10.1021/ac980169j
   Kumar CV, 2000, J AM CHEM SOC, V122, P830, DOI 10.1021/ja993310u
   Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970
   Li TS, 2000, CHEM LETT, P608, DOI 10.1246/cl.2000.608
   McGill RA, 1998, IEEE T ULTRASON FERR, V45, P1370, DOI 10.1109/58.726464
   MCGILL RA, 1998, P SPIE LASER APPL MI, V3, P255
   Miyachi H, 2000, BIOTECHNOL BIOENG, V69, P323, DOI 10.1002/1097-0290(20000805)69:3<323::AID-BIT10>3.0.CO;2-T
   Mulchandani A, 1999, ANAL CHEM, V71, P2246, DOI 10.1021/ac9813179
   NELSON RW, 1990, RAPID COMMUN MASS SP, V4, P348, DOI 10.1002/rcm.1290040911
   NEWMAN JD, 1995, ANAL CHEM, V67, P4594, DOI 10.1021/ac00120a027
   NEWMAN JD, 1992, ANAL CHIM ACTA, V262, P13, DOI 10.1016/0003-2670(92)80002-O
   Odde DJ, 1999, TRENDS BIOTECHNOL, V17, P385, DOI 10.1016/S0167-7799(99)01355-4
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.3.CO;2-6
   Panick G, 2000, BIOCHEMISTRY-US, V39, P1862, DOI 10.1021/bi992176n
   Patel N, 1999, LANGMUIR, V15, P7252, DOI 10.1021/la981268v
   Phadke RS, 1998, MAT SCI ENG C-BIOMIM, V5, P237, DOI 10.1016/S0928-4931(97)00051-9
   PIQUE A, 1999, THIN SOLID FILMS, V356, P536
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   Sirkar K, 2000, ANAL CHEM, V72, P2930, DOI 10.1021/ac991041k
   SUN SC, 1991, LANGMUIR, V7, P727, DOI 10.1021/la00052a022
   TANG XD, 1995, ANAL CHEM, V67, P4542, DOI 10.1021/ac00120a018
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
   Tsuboi Y, 1998, CHEM LETT, P521, DOI 10.1246/cl.1998.521
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
   Zhang SQ, 2000, ANAL CHIM ACTA, V421, P175, DOI 10.1016/S0003-2670(00)01043-6
NR 52
TC 101
Z9 101
U1 0
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 29
PY 2001
VL 17
IS 11
BP 3472
EP 3479
DI 10.1021/la0016874
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 436UY
UT WOS:000168955300048
DA 2018-10-20
ER

PT J
AU Kweon, H
   Ha, HC
   Um, IC
   Park, YH
AF Kweon, H
   Ha, HC
   Um, IC
   Park, YH
TI Physical properties of silk fibroin/chitosan blend films
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE silk fibroin; chitosan; blend film; mechanical properties; permeability
ID FIBROIN MEMBRANES; COMPATIBILITY; PERMEABILITY; CHITOSAN; METHANOL;
   ALCOHOL)
AB Silk fibroin/chitosan blend films were examined through IR spectroscopy to determine the conformational changes of silk fibroin. The effects of the fibroin/chitosan blend ratios (chitosan content) on the physical and mechanical properties were investigated to discover the feasibility of using these films as biomedical materials such as artificial skin and wound dressing. The mechanical properties of the blend films containing 10-40% chitosan were found to be excellent. The tensile strength, breaking elongation, and Young's modulus were affected by the chitosan contents of the blend films, which were also related to the density and degree of swelling. The coefficient of water vapor permeability of the blend films increased linearly with the chitosan content, and the values of 1000-2000 g m(-2) day(-1) were comparable to those of commercial wound dressings. Silk fibroin/chitosan blend films had good oxygen and water vapor permeabilities, making them useful as biomaterials. In particular, the blend film containing 40-50% chitosan showed very high oxygen permeability. (C) 2001 John Wiley & Sons, Inc.
C1 Seoul Natl Univ, Dept Nat Fiber Sci, Suwon 441744, South Korea.
RP Park, YH (reprint author), Seoul Natl Univ, Dept Nat Fiber Sci, Suwon 441744, South Korea.
CR CANETTI M, 1989, BIOPOLYMERS, V28, P1613, DOI 10.1002/bip.360280910
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Chen X, 1999, J APPL POLYM SCI, V73, P975, DOI 10.1002/(SICI)1097-4628(19990808)73:6<975::AID-APP15>3.0.CO;2-#
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   IIZUKA E, 1968, BIOCHEMISTRY-US, V7, P2218, DOI 10.1021/bi00846a026
   KANE JB, 1996, BIOMATERIALS SCI, pCH7
   Ketelaars AAJ, 1997, J APPL POLYM SCI, V66, P921, DOI 10.1002/(SICI)1097-4628(19971031)66:5<921::AID-APP12>3.0.CO;2-Q
   LAMKE LO, 1977, BURNS, V3, P159, DOI 10.1016/0305-4179(77)90004-3
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   LIANG CX, 1991, SEN-I GAKKAISHI, V47, P334
   MAGOSHI J, 1985, J APPL POLYM SCI, V41, P189
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   Nakamura T, 1999, SEN-I GAKKAISHI, V55, P369, DOI 10.2115/fiber.55.8_369
   SANNAN T, 1978, POLYMER, V19, P4789
   Tanaka T, 1997, POLYM INT, V42, P107, DOI 10.1002/(SICI)1097-0126(199701)42:1<107::AID-PI686>3.0.CO;2-9
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P243, DOI 10.1002/polb.1994.090320205
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Um I.C., 1998, KOREAN J SERIC SCI, V40, P169
   WARNER SB, 1995, FIBER SCI, P40
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
   YAMAURA K, 1990, J APPL POLYM SCI, V41, P2409, DOI 10.1002/app.1990.070410941
   YANNAS IV, 1982, BIOMATERIALS INTERFA, P474
   YOSHIKAWA A, 1990, SEN L KAKO, V42, P351
NR 25
TC 122
Z9 128
U1 5
U2 58
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAY 16
PY 2001
VL 80
IS 7
BP 928
EP 934
DI 10.1002/app.1172
PG 7
WC Polymer Science
SC Polymer Science
GA 410KG
UT WOS:000167438700004
DA 2018-10-20
ER

PT J
AU Bosetti, M
   Verne, E
   Ferraris, M
   Ravaglioli, A
   Cannas, M
AF Bosetti, M
   Verne, E
   Ferraris, M
   Ravaglioli, A
   Cannas, M
TI In vitro characterisation of zirconia coated by bioactive glass
SO BIOMATERIALS
LA English
DT Article
DE zirconia; in vitro biocompatibility; osteoblast-like cells; glass
   coating
ID MEDICAL APPLICATIONS
AB An in vitro evaluation of a biomedical device, which combines the mechanical properties of zirconia substrates with the bioactivity of two different glass layers (AP40 and RKKP), was performed. In this work, data on different kinds of analysis were reported both on as-sintered zirconia samples and on RKKP- and AP40-coated zirconia substrates. Structure, composition and morphology of the apatite layer growth on the coated samples after 30 days of soaking in an acellular simulated body fluid, serum protein adsorption, fibroblasts and human osteoblast-like cells adhesion, growth, morphology and biochemical aspects were studied. Results of soaking test in SBF, revealed the growth of an apatite layer on the surface of the glass-coated samples. Proteins adsorbed to the materials were analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and results evidenced that the two glass-coated materials bound a higher amount of total protein than did the zirconia substrate. Fibroblasts and osteoblast-like cells cultured on RKKP- and AP40-coated zirconia showed a higher proliferation rate, leading to confluent cultures with higher cell density and a generally better expression of osteoblast alkaline phosphatase activity in comparison with zirconia substrate. In conclusion, our results indicate that the surface chemical characteristics of the two glass coatings AP40 and RKKP, with no great differences between them, substantially enhance zirconia integration with bone cells at least in vitro. This effect may be of significance in the stability of glass-coated zirconia orthopaedic and dental implants. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Eastern Piemont A Avogadro, Dept Med Sci Human Anat, I-28100 Novara, Italy.
   Politecn Torino, Dept Mat Sci & Chem Engn, Turin, Italy.
RP Cannas, M (reprint author), Univ Eastern Piemont A Avogadro, Dept Med Sci Human Anat, Via Solaroli 17, I-28100 Novara, Italy.
EM cannas@med.unipmn.it
OI Verne, Enrica/0000-0002-8649-4739
CR Berger G, 1992, 4 WORLD BIOM C APR 2, P33
   Bosetti M, 1998, J BIOMED MATER RES, V40, P307, DOI 10.1002/(SICI)1097-4636(199805)40:2<307::AID-JBM16>3.0.CO;2-I
   CANNAS M, 1999, TISSUE RESPONSE IMPL, P95
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   FERRARIS M, 1996, BIOCERAMIC COATINGS, P31
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   KEPNER RL, 1994, MICROBIOL REV, V58, P603
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   KOKUBO T, 1993, ADV SERIES CERAMICS, V175, P889
   Krajewski A, 1998, J MATER SCI-MATER M, V9, P309, DOI 10.1023/A:1008846728859
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   SODEK J, 1987, METHOD ENZYMOL, V145, P303
   SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2
   Verne E, 1998, J EUR CERAM SOC, V18, P363, DOI 10.1016/S0955-2219(97)00134-9
   WILSON J, 1993, ADV SERIES CERAMICS, V175, P63
NR 21
TC 51
Z9 52
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2001
VL 22
IS 9
BP 987
EP 994
DI 10.1016/S0142-9612(00)00264-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 418NU
UT WOS:000167898900014
PM 11311018
DA 2018-10-20
ER

PT J
AU Gross, M
   Cramton, SE
   Gotz, F
   Peschel, A
AF Gross, M
   Cramton, SE
   Gotz, F
   Peschel, A
TI Key role of teichoic acid net charge in Staphylococcus aureus
   colonization of artificial surfaces
SO INFECTION AND IMMUNITY
LA English
DT Article
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; BIOFILM FORMATION; BACTERIAL
   ADHESION; MOLECULAR-BASIS; EPIDERMIDIS; INFECTIONS; INSERTION; MECHANISM
AB Staphylococcus aureus is responsible for a large percentage of infections associated with implanted biomedical devices. The molecular basis of primary adhesion to artificial surfaces is not yet understood. Here, we demonstrate that teichoic acids, highly charged cell wall polymers, play a key role in the first step of biofilm formation. An S. aureus mutant bearing a stronger negative surface charge due to the lack of D-alanine esters in its teichoic acids can no longer colonize polystyrene or glass. The mutation abrogates primary adhesion to plastic while production of the glucosamine-based polymer involved in later steps of biofilm formation is not affected. Our data suggest that repulsive electrostatic forces can lead to reduced staphylococcal biofilm formation, which could have considerable impact on the design of novel implanted materials.
C1 Univ Tubingen, D-72076 Tubingen, Germany.
RP Peschel, A (reprint author), Univ Tubingen, Morgenstelle 28, D-72076 Tubingen, Germany.
CR Ausubel FM, 1990, CURRENT PROTOCOLS MO
   Biedlingmaier JF, 1998, OTOLARYNG HEAD NECK, V118, P444, DOI 10.1177/019459989811800403
   Bierbaum G., 1991, NISIN NOVEL LANTIBIO, P386
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   FISCHER W, 1997, NEW TARGETS NEW ANTI, P47
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gotz F, 2000, INFECT ASS INDWELLIN, P55
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Homma H, 1996, J GASTROENTEROL, V31, P836, DOI 10.1007/BF02358611
   Hyyrylainen HL, 2000, J BIOL CHEM, V275, P26696
   ING BM, 1997, STAPHYLOCOCCI HUMAN, P331
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   Jenni R, 1998, ARCH MICROBIOL, V170, P171, DOI 10.1007/s002030050630
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Loosdrecht M. C. M. V., 1987, APPL ENVIRON MICROB, V53, P1898
   Loosdrecht MCV, 1987, APPL ENVIRON MICROB, V53, P1893
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000
   Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405
   Proctor RA, 2000, J LAB CLIN MED, V135, P14, DOI 10.1016/S0022-2143(00)70015-1
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P5, DOI DOI 10.1016/0927-7765(94)01146-V
   RUPP ME, 1997, STAPHYLOCOCCI HUMAN, P379
   SONOHARA R, 1995, BIOPHYS CHEM, V55, P273, DOI 10.1016/0301-4622(95)00004-H
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
NR 29
TC 296
Z9 304
U1 1
U2 34
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD MAY
PY 2001
VL 69
IS 5
BP 3423
EP 3426
DI 10.1128/IAI.69.5.3423-3426.2001
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 423CT
UT WOS:000168158400080
PM 11292767
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Moszner, N
   Salz, U
AF Moszner, N
   Salz, U
TI New developments of polymeric dental composites
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE dental monomers; restorative composite; ring-opening polymerization;
   liquid-crystalline monomers; dendrimers; ormocers; radiopacity;
   nanoparticles; polymerization shrinkage; bioactivity; composite
   reinforcement
ID RING-OPENING POLYMERIZATION; CALCIUM PHOSPHATE/METHACRYLATE COMPOSITES;
   GLASS-IONOMER CEMENTS; SOL-GEL-PROCESS; RADICAL POLYMERIZATION; CYCLIC
   MONOMERS; FLUORIDE RELEASE; MECHANICAL-PROPERTIES; CATIONIC
   POLYMERIZATION; BIOMEDICAL APPLICATIONS
AB The currently used commercial restorative composites contain a mixture of various cross-linking dimethacrylates, glass- and/or silicon dioxide fillers, and a photoinitiator system. They are cured by irradiation with visible light. New developments of polymeric composites for restorative filling materials are mainly focused on the reduction of polymerization shrinkage, and improvement of biocompatibility, wear resistance and processing properties. This can be partially achieved by using new tailor-made monomers and optimized filler particles.
   This review describes the polymeric chemical aspects of the application of new monomers, e.g. cyclic monomers, liquid-crystalline monomers, ormocers, branched monomers, compomers or Bis-GMA analogues or substitutes for restorative composites. In addition, the contribution of new filler-technologies for the improvement of restorative composites is discussed. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Ivoclar AG, Res & Dev, FL-9494 Schaan, Liechtenstein.
RP Moszner, N (reprint author), Ivoclar AG, Res & Dev, FL-9494 Schaan, Liechtenstein.
CR ALSTER D, 1992, J DENT RES, V71, P1619, DOI 10.1177/00220345920710091401
   ANTONUCCI JM, 1997, POLYM PREPR, V38, P118
   ANZAI M, 1992, J NIHON U SCH DENT, V34, P120
   ATTIN T, 1998, DTSCH ZAHNARZTL Z, V53, P766
   BAILEY WJ, 1990, MAT SCI ENG A-STRUCT, V126, P271, DOI 10.1016/0921-5093(90)90133-N
   BAILEY WJ, 1972, POLYM PREPR AM CHEM, V13, P281
   BAILEY WJ, 1983, Patent No. 438215
   BAILEY WJ, 1989, COMPREHENSIVE POLYM, V3, P283
   BAUER CM, 1995, DTSCH ZAHNARZTL Z, V50, P335
   Bayne SC, 1998, J AM DENT ASSOC, V129, P567, DOI 10.14219/jada.archive.1998.0274
   Belfield KD, 1997, MACROMOLECULES, V30, P6985, DOI 10.1021/ma9613446
   BLACKWELL GB, 1993, Patent No. 5218070
   BOLLN C, 1995, J POLYM SCI POL CHEM, V33, P587, DOI 10.1002/pola.1995.080330326
   Bosman AW, 1999, CHEM REV, V99, P1665, DOI 10.1021/cr970069y
   Bouschlicher MR, 1999, OPER DENT, V24, P20
   Bowen R.L., 1962, USPatent, Patent No. [US3066112A, 3066112, 3, 066, 112]
   BRADY RF, 1992, J MACROMOL SCI R M C, VC32, P135, DOI 10.1080/15321799208021424
   BRAUER GM, 1981, J AM DENT ASSOC, V101, P347
   Burke FJT, 1999, QUINTESSENCE INT, V30, P234
   BYERLEY TJ, 1992, DENT MATER, V8, P345, DOI 10.1016/0109-5641(92)90016-6
   Carvalho AS, 1999, OPER DENT, V24, P14
   Chan DCN, 1999, DENT MATER, V15, P219, DOI 10.1016/S0109-5641(99)00039-1
   CHAPPELOW CC, 1998, Patent No. 5808215
   CHAPPELOW CC, 1997, J DENT RES, V76, P40
   CHO I, 1991, MAKROMOL CHEM-RAPID, V12, P141
   Choi KM, 1996, CHEM MATER, V8, P2704, DOI 10.1021/cm9603260
   Condon JR, 1998, DENT MATER, V14, P256, DOI 10.1016/S0109-5641(98)00036-0
   Condon JR, 2000, J AM DENT ASSOC, V131, P497, DOI 10.14219/jada.archive.2000.0207
   Culbertson BM, 1999, POLYM ADVAN TECHNOL, V10, P206, DOI 10.1002/(SICI)1099-1581(199904)10:4<206::AID-PAT861>3.0.CO;2-C
   Culbertson BM, 1997, J MACROMOL SCI PURE, VA34, P2405, DOI 10.1080/10601329708010056
   Culbertson BM, 1999, POLYM ADVAN TECHNOL, V10, P275, DOI 10.1002/(SICI)1099-1581(199905)10:5<275::AID-PAT874>3.0.CO;2-V
   CULBERTSON BM, 1997, POLYM PREPR, V38, P100
   DAVIDSON CL, 1984, J DENT RES, V63, P146, DOI 10.1177/00220345840630021001
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   DAVY KWM, 1982, J DENT, V10, P254, DOI 10.1016/0300-5712(82)90058-6
   DONLY KJ, 1999, J AM DENT ASSOC, V130, P497
   DOORNKAMP AT, 1992, POLYMER, V33, P2863, DOI 10.1016/0032-3861(92)90468-C
   EBENHOCH J, 1999, Patent No. 19816148
   EICK JD, 1993, DENT MATER, V9, P123, DOI 10.1016/0109-5641(93)90088-8
   Eliades G, 1998, DENT MATER, V14, P57, DOI 10.1016/S0109-5641(98)00010-4
   ELLSWORTH MW, 1993, CHEM MATER, V5, P839, DOI 10.1021/cm00030a020
   ERICSON D, 1990, Patent No. 8910736
   EVANS EA, 1996, Patent No. 9619471
   Evans RA, 1996, MACROMOLECULES, V29, P6983, DOI 10.1021/ma960573p
   FEILZER AJ, 1987, J DENT RES, V66, P1636, DOI 10.1177/00220345870660110601
   FIFE WK, 1996, Patent No. 9622761
   FISCHER U, 1995, THESIS HTL CHUR
   FONTANA M, 1999, AM J DENT, V12, P8
   Francci C, 1999, J DENT RES, V78, P1647, DOI 10.1177/00220345990780101001
   FURMAN BR, 2000, J DENT RES, V246, P824
   Gasser O., 1998, Patent No. [DE 19648283 A1, 19648283]
   Geurtsen W, 1999, DENT MATER, V15, P196, DOI 10.1016/S0109-5641(99)00034-2
   HALLER B, 2000, DTSCH ZAHNARZTL Z, V55, P331
   HAMMERSFAHR PD, 1997, POLYM PREPR, V38, P131
   HEINDL D, 1997, Patent No. 19615763
   Herrera M, 1999, OPER DENT, V24, P286
   Hickel R, 1998, INT DENT J, V48, P3, DOI 10.1111/j.1875-595X.1998.tb00688.x
   HICKEL R, 1997, DTSCH ZAHNARZTL Z, V52, P572
   HIKMET RAM, 1992, POLYMER, V33, P89, DOI 10.1016/0032-3861(92)90564-D
   Holter D, 1996, MACROMOLECULES, V29, P7003, DOI 10.1021/ma960327d
   Holter D, 1998, ADV MATER, V10, P864, DOI 10.1002/(SICI)1521-4095(199808)10:11<864::AID-ADMA864>3.0.CO;2-H
   Imazato S, 1999, BIOMATERIALS, V20, P899, DOI 10.1016/S0142-9612(98)00247-6
   Jackson RD, 2000, J AM DENT ASSOC, V131, P375, DOI 10.14219/jada.archive.2000.0182
   JACOBINE AF, 1990, ACS SYM SER, V417, P160
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   Kaisaki D, 1996, Int Pat Appl PCT, Patent No. [WO 96/13538, 9613538]
   Kakaboura A, 1998, J DENT RES, V77, P658
   Karantakis P, 2000, OPER DENT, V25, P20
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   Klee JE, 1998, ANGEW MAKROMOL CHEM, V260, P71
   Klee JE, 1999, MACROMOL CHEM PHYSIC, V200, P517, DOI 10.1002/(SICI)1521-3935(19990301)200:3<517::AID-MACP517>3.0.CO;2-4
   KLEE JE, 1998, Patent No. 9836729
   KRAUSE WR, 1989, J BIOMED MATER RES, V23, P1195, DOI 10.1002/jbm.820231008
   Krejci I, 1993, Schweiz Monatsschr Zahnmed, V103, P614
   Labella R, 1999, DENT MATER, V15, P128, DOI 10.1016/S0109-5641(99)00022-6
   Leinfelder K F, 1999, J Esthet Dent, V11, P234, DOI 10.1111/j.1708-8240.1999.tb00405.x
   Liu C F, 1990, Am J Dent, V3, P44
   LU K, 1994, Patent No. 5338773
   Luo JH, 1998, DENT MATER, V14, P29, DOI 10.1016/S0109-5641(98)00006-2
   Lutz F, 1983, SSO Schweiz Monatsschr Zahnheilkd, V93, P914
   Manhart J, 2000, DENT MATER, V16, P33, DOI 10.1016/S0109-5641(99)00082-2
   MANHART J, 1999, DTSCH ZAHNARZTL Z, V54, P89
   MARRITTI A, 1998, EUR J ORAL SCI, V106, P1022
   MASUHARA E, 1982, Patent No. 8201708
   MATSUMURA H, 1992, J DENT RES, V71, P2, DOI 10.1177/00220345920710010201
   McLean J W, 1994, Quintessence Int, V25, P587
   Meyer JM, 1998, BIOMATERIALS, V19, P529, DOI 10.1016/S0142-9612(97)00133-6
   MICHL RJ, 1986, Patent No. 3502594
   MILLICH F, 1993, J POLYM SCI POL PHYS, V31, P729, DOI 10.1002/polb.1993.090310613
   MINNS RA, 1992, J MACROMOL SCI PURE, V29, P19, DOI 10.1080/10101329208054104
   Moszner N, 1997, MACROMOL CHEM PHYSIC, V198, P749, DOI 10.1002/macp.1997.021980307
   Moszner N, 1999, J APPL POLYM SCI, V72, P1775, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1775::AID-APP13>3.0.CO;2-F
   Moszner N, 1999, ANGEW MAKROMOL CHEM, V265, P31
   Moszner N, 1999, MACROMOL CHEM PHYSIC, V200, P2173, DOI 10.1002/(SICI)1521-3935(19991001)200:10<2173::AID-MACP2173>3.3.CO;2-1
   Moszner N, 1996, MACROMOL CHEM PHYSIC, V197, P621, DOI 10.1002/macp.1996.021970217
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   Moszner N, 1998, POLYM BULL, V40, P447, DOI 10.1007/s002890050275
   MOSZNER N, 1995, MACROMOL RAPID COMM, V16, P667, DOI 10.1002/marc.1995.030160906
   Moszner N, 1997, MACROMOL RAPID COMM, V18, P775, DOI 10.1002/marc.1997.030180904
   MOSZNER N, 1997, POLYM PREPR, V38, P86
   MOSZNER N, UNPUB
   MOSZNER N, 1996, POLYM B, V73, P289
   MOSZNER N, 1998, MACROMOL RAPID COMM, V20, P33
   MOSZNER N, 1998, Patent No. 19714324
   MUELHAUPT R, 2000, 219 ACS NAT M, P26
   Murchison DF, 1999, QUINTESSENCE INT, V30, P179
   NICHOLSON J, 1994, TRENDS POLYM SCI, V2, P272
   NOACK MJ, 1993, J DENT RES, V72, P178
   NOWAK R, 1996, Patent No. 0717977
   Nuyken O, 1996, MACROMOL SYMP, V107, P125, DOI 10.1002/masy.19961070113
   Oguri M., 2004, US Patent, Patent No. [6 815 470, 9714674]
   OXMAN J, 1998, Patent No. 9847046
   Park MS, 1998, DENT MATER, V14, P137, DOI 10.1016/S0109-5641(98)00020-7
   PARTHA PP, 1999, Patent No. 600502
   RAWLS HR, 1997, POLYM PREPR, V38, P167
   REED B, 1972, POLYM PREPR, V33, P520
   RHEINBERGER  V, 1999, Patent No. 5886212
   Rheinberger V, 1999, Dental material, Patent No. [US 1999; 5889132, 5889132]
   RHEINBERGER V, Patent No. 19619046
   RHEINBERGER V, 1991, Patent No. 3939998
   RHEINBERGER V, 1999, Patent No. 5886064
   RHEINBERGER V, 1992, Patent No. 4029230
   RHEINBERRGER V, 1997, Patent No. 5703249
   RITTER H, 2000, Patent No. 6031015
   RITTER H, 1997, Patent No. 19525941
   RUMPHORST A, 1999, Patent No. 19818210
   RUYTER IE, 1987, J BIOMED MATER RES, V21, P11, DOI 10.1002/jbm.820210107
   SALZ U, 1996, Patent No. 19520016
   SANDA F, 1994, J POLYM SCI POL CHEM, V32, P323, DOI 10.1002/pola.1994.080320214
   Sankarapandian M, 1997, J MATER SCI-MATER M, V8, P465, DOI 10.1023/A:1018569908635
   SANKARAPANDIAN M, 1997, POLYM PREPR, V38, P92
   SASAKI H, 1995, POLYM MAT SCI ENG, V72, P475
   SCHAEFER R, 1998, Patent No. 5750590
   SELLINGER A, 1994, J POLYM SCI POL CHEM, V32, P3069, DOI 10.1002/pola.1994.080321608
   SELLINGER A, 1994, POLYM PREPR, V35, P665
   Sellinger A., 1995, POLYM PREPR, V36, P282
   Shah PMM, 1996, ORAL SURG ORAL MED O, V81, P476, DOI 10.1016/S1079-2104(96)80028-X
   Skrtic D, 1996, J DENT RES, V75, P1679, DOI 10.1177/00220345960750091001
   SOLTEZ U, 1998, ZAHNARZTL MITTEIL, V88, P52
   Stansbury JW, 1999, DENT MATER, V15, P166, DOI 10.1016/S0109-5641(99)00028-7
   STANSBURY JW, 1992, J DENT RES, V71, P1408, DOI 10.1177/00220345920710070901
   STANSBURY JW, 1990, PROGRESS IN BIOMEDICAL POLYMERS, P133
   STANSBURY JW, 1995, POLYM PREPR, V36, P831
   STANSBURY JW, 1997, POLYM PREPR, V38, P96
   Stansbury JW, 1992, POLYM PREPR, V33, P518
   Stein S, 1998, MATER RES SOC SYMP P, V519, P357, DOI 10.1557/PROC-519-357
   SUGIYAMA J, 1994, MACROMOLECULES, V27, P5543, DOI 10.1021/ma00098a005
   TAIRA M, 1993, DENT MATER, V9, P167, DOI 10.1016/0109-5641(93)90115-7
   TAKATA T, 1992, EXPANDING MONOMERS S, P63
   ten Cate JM, 1999, ACTA ODONTOL SCAND, V57, P325, DOI 10.1080/000163599428562
   THOMPSON VP, 1979, J DENT RES, V58, P1522, DOI 10.1177/00220345790580051701
   TIBA A, 1997, J MACROMOL SCI PURE, V36, P489
   TIBA A, 1998, J MACROMOL SCI PURE, V39, P1445
   Vieira AR, 1999, AM J DENT, V12, P14
   WAN Q, 2000, POLYM PREPR, V41, P155
   WAN Q, 2000, POLYM PREPR, V41, P101
   Wang G, 1999, J MACROMOL SCI PURE, VA36, P225, DOI 10.1081/MA-100101527
   Wang G, 1999, J MACROMOL SCI PURE, VA36, P373, DOI 10.1081/MA-100101536
   WEI Y, 1990, CHEM MATER, V2, P337, DOI 10.1021/cm00010a001
   WEI Y, 1997, POLYM PREPR AM CHEM, V38, P122
   WELLINGHOFF VT, 1997, J DENT RES, V76, P279
   WICTORIN L, 1995, Patent No. 9530402
   WILSON AD, 1988, GLASS IONOMER CEMENT
   Wilson N H, 1997, Quintessence Int, V28, P245
   Wolter H, 1996, MATER RES SOC SYMP P, V435, P67, DOI 10.1557/PROC-435-67
   WOLTER H, 1992, MATER RES SOC SYMP P, V271, P719, DOI 10.1557/PROC-271-719
   WOLTER H, 1994, MATER RES SOC SYMP P, V346, P143
   WOLTER H, 1996, Patent No. 4133494
   Xu HHK, 1999, J DENT RES, V78, P1304, DOI 10.1177/00220345990780070401
   Yamamoto H, 2000, OPER DENT, V25, P104
   Zeuner F, 1996, MACROMOL CHEM PHYSIC, V197, P2745, DOI 10.1002/macp.1996.021970912
NR 171
TC 391
Z9 402
U1 10
U2 138
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD MAY
PY 2001
VL 26
IS 4
BP 535
EP 576
DI 10.1016/S0079-6700(01)00005-3
PG 42
WC Polymer Science
SC Polymer Science
GA 445LU
UT WOS:000169459600001
DA 2018-10-20
ER

PT J
AU Wilson, DJ
   Williams, RL
   Pond, RC
AF Wilson, DJ
   Williams, RL
   Pond, RC
TI Plasma modification of PTFE surfaces Part II: Plasma-treated surfaces
   following storage in air or PBS
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE plasma modification; PTFE; XPS; SIMS; DCA; AFM; ageing
AB The mechanisms and kinetics of the ageing process of polytetrafluoroethylene (PTFE) samples stored in either phosphate-buffered saline (PBS) or air for periods of up to 1 month have been investigated. Changes of surface chemistry and wettability were studied as a function of ageing time using the complementary techniques of x-ray photoelectron spectroscopy, static secondary ion mass spectroscopy and dynamic contact angle measurements. Specimens were aged either in the as-received condition or after treatment by O-2, Ar, N-2 and NH3 plasma as described in Part I. Evidence was obtained for two ageing mechanisms, namely chemical reaction with the storage medium and relaxation in the surface region of the polymer. The extent of these mechanisms depended on the initial plasma treatment and the nature of the storage medium. These issues are discussed in a framework that correlates wettability with surface chemistry in a semiquantitative manner. This analysis facilitates comparison of the changes induced on virgin material by plasma treatment and ageing in storage environments relevant to the biomedical application of PTFE. Copyright (C) 2001 John Wiley & Sons, Ltd.
C1 Univ Liverpool, Dept Clin Engn, Liverpool L69 3GA, Merseyside, England.
   Univ Liverpool, Dept Engn, Liverpool L69 3GH, Merseyside, England.
RP Williams, RL (reprint author), Univ Liverpool, Dept Clin Engn, Liverpool L69 39A, Merseyside, England.
OI Williams, Rachel/0000-0002-1954-0256
CR CHATELIER RC, 1995, LANGMUIR, V11, P2576, DOI 10.1021/la00007a042
   CLARK DT, 1987, J POLYM SCI POL CHEM, V25, P2643, DOI 10.1002/pola.1987.080251002
   FOERCH R, 1990, J APPL POLYM SCI, V40, P1903, DOI 10.1002/app.1990.070401109
   GERENSER LJ, 1987, J ADHES SCI TECHNOL, V1, P303
   GRIESSER HJ, 1990, PAP AM CHEM S 2, V199
   ISRAELACHVILI JN, 1989, LANGMUIR, V5, P288, DOI 10.1021/la00085a059
   JOHANNES G, 1995, J APPL POLYM SCI, V57, P969
   MORRA M, 1990, SURF INTERFACE ANAL, V16, P412, DOI 10.1002/sia.740160186
   OCCHIELLO E, 1991, J APPL POLYM SCI, V42, P551, DOI 10.1002/app.1991.070420228
   OKELL S, 1995, SURF INTERFACE ANAL, V23, P319, DOI 10.1002/sia.740230508
   Pringle SD, 1996, SURF INTERFACE ANAL, V24, P821, DOI 10.1002/(SICI)1096-9918(199611)24:12<821::AID-SIA189>3.0.CO;2-B
   WILSON DJ, 2000, THESIS U LIVERPOOL L
   WITTENBECK P, 1993, J APPL POLYM SCI, V50, P187, DOI 10.1002/app.1993.070500201
   XIE X, 1993, CONTACT ANGLE WETTAB, P509
   YASUDA H, 1981, J POLYM SCI POL PHYS, V19, P1255
NR 15
TC 44
Z9 46
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD MAY
PY 2001
VL 31
IS 5
BP 397
EP 408
DI 10.1002/sia.1066
PG 12
WC Chemistry, Physical
SC Chemistry
GA 437VR
UT WOS:000169014700007
DA 2018-10-20
ER

PT J
AU Leng, YX
   Yang, P
   Chen, JY
   Sun, H
   Wang, J
   Wang, GJ
   Huang, N
   Tian, XB
   Chu, PK
AF Leng, YX
   Yang, P
   Chen, JY
   Sun, H
   Wang, J
   Wang, GJ
   Huang, N
   Tian, XB
   Chu, PK
TI Fabrication of Ti-O/Ti-N duplex coatings on biomedical titanium alloys
   by metal plasma immersion ion implantation and reactive plasma
   nitriding/oxidation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE titanium oxide and nitride; biomedical materials; plasma implantation;
   plasma nitriding; plasma oxidation
ID SURFACE MODIFICATION; DEPOSITION; BEAM
AB Ti-O/Ti-N duplex coatings were fabricated on titanium alloys by metal plasma immersion ion implantation and reactive plasma nitriding/oxidation. The purpose of Ti-O is to improve the blood compatibility, and that of Ti-N is to improve the mechanical properties. X-Ray diffraction (XRD), microhardness tests, pin-on-disk wear experiments, and platelet adhesion investigation were conducted to evaluate the properties and blood compatibility of the coatings. The results reveal that the blood compatibility of the Ti-O/Ti-N duplex coatings is better than that of low temperature isotropic pyrolytic carbon (LTIC). The microhardness of Ti-O/Ti-N duplex coatings can reach 14 GPa. The wear resistance is also much better than that of Ti6Al4V alloy.,The semiconductor nature of non-stoichiometric titanium oxide may be responsible for the observed improvement in the blood compatibility. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Sichuan, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
RI Chu, Paul/B-5923-2013; Leng, Yongxiang/G-5488-2010
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAURSCHMIDT P, 1977, J BIOENG, V1, P261
   Chu PK, 1997, REV SCI INSTRUM, V68, P1866, DOI 10.1063/1.1147959
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   EBERT R, 1982, P WORLD C MED PHYS B, P307
   FENG Z, 1997, CHINESE J FUNCT MAT, V3, P47
   Gutmann F, 1986, MODERN BIOELECTROCHE
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   Jarzebski ZM, 1973, OXIDE SEMICONDUCTORS
   Liu XH, 1996, J BIOMATER APPL, V10, P330
   Staia MH, 1995, SURF COAT TECH, V76, P231
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   TENDYS J, 1988, APPL PHYS LETT, V53, P2143, DOI 10.1063/1.100299
NR 14
TC 61
Z9 66
U1 1
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 16
PY 2001
VL 138
IS 2-3
BP 296
EP 300
DI 10.1016/S0257-8972(00)01172-5
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 410QG
UT WOS:000167450200024
DA 2018-10-20
ER

PT J
AU Langer, RS
AF Langer, RS
TI Novel biomedical materials.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 1
PY 2001
VL 221
MA 143-POLY
BP U315
EP U315
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 434PJ
UT WOS:000168824801865
DA 2018-10-20
ER

PT J
AU Bigi, A
   Cojazzi, G
   Panzavolta, S
   Rubini, K
   Roveri, N
AF Bigi, A
   Cojazzi, G
   Panzavolta, S
   Rubini, K
   Roveri, N
TI Mechanical and thermal properties of gelatin films at different degrees
   of glutaraldehyde crosslinking
SO BIOMATERIALS
LA English
DT Article
DE gelatin; glutaraldehyde; crosslinking; mechanical properties; d.s.c.;
   swelling
ID CROSS-LINKING; IN-VITRO; COLLAGEN; BIOCOMPATIBILITY; BIOPROSTHESES;
   BIOMATERIALS; CARBODIIMIDE; MATRICES; GELS
AB The mechanical, thermal, swelling and release properties of glutaraldehyde (GTA) crosslinked gelatin films have been investigated in order to verify the influence of GTA concentration on the stability of the films. Air-dried films were submitted to treatment with GTA solutions at concentrations ranging from 0.05 to 2.5 wt%. At the smallest GTA concentration, the crosslinking degree, determined by trinitrobenzensulfonic acid assay, amounts to about 60% and increases up to values near 100%, obtained with GTA concentrations greater than or equal to 1 wt%. Simultaneously, the deformability of the films decreases, whereas the stress at break, sigma (b), and the Young's modulus, E, increase. A crosslinking degree of about 85%, obtained using 0.25% GTA, is enough to prevent gelatin release in buffer solution and to provoke a significant reduction of the swelling in physiological solution. Furthermore, crosslinking greatly affects the thermal stability of the samples, as indicated by the results of differential scanning calorimetry (d.s.c.) investigation carried out on wet and air-dried films. The data suggest that the use of GTA at low concentration, which is desiderable to prevent toxicity, allows to modulate the physico-chemical properties of gelatin films, in order to obtain stable materials with a wide range of possible biomedical applications. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Bologna, Dipartimento Chim G Ciamician, CNR, Ctr Study Macromol Phys, I-40126 Bologna, Italy.
RP Bigi, A (reprint author), Univ Bologna, Dipartimento Chim G Ciamician, CNR, Ctr Study Macromol Phys, Via Selmi 2, I-40126 Bologna, Italy.
RI Bigi, adriana/R-6341-2016
OI Bigi, adriana/0000-0003-2668-8627; Panzavolta,
   Silvia/0000-0002-2937-2284
CR ACHET D, 1995, POLYMER, V36, P787, DOI 10.1016/0032-3861(95)93109-Y
   Bailey AJ, 1999, P INDIAN AS-CHEM SCI, V111, P57
   Bigi A, 1998, BIOMATERIALS, V19, P2335, DOI 10.1016/S0142-9612(98)00149-5
   Bigi A, 2000, J THERM ANAL CALORIM, V61, P451, DOI 10.1023/A:1010117401098
   BIGI A, 1987, INT J BIOL MACROMOL, V9, P363, DOI 10.1016/0141-8130(87)90010-9
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   ESPOSITO E, 1995, BIOMATERIALS, V20, P2009
   FINCH A, 1972, BIOCHIM BIOPHYS ACTA, V278, P433, DOI 10.1016/0005-2795(72)90003-7
   FRAGA AN, 1985, POLYMER, V26, P113, DOI 10.1016/0032-3861(85)90066-7
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   HASTINGS GW, 1984, MACROMOLECULAR BIOMA
   Hataka T, 1994, CHEM PHARM BULL, V42, P1138
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KOPP J, 1989, Matrix, V9, P443
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   Ofner CM, 1996, PHARM RES-DORDR, V13, P1821
   Otani Y, 1998, BIOMATERIALS, V19, P2091, DOI 10.1016/S0142-9612(98)00121-5
   PEZRON I, 1991, POLYMER, V32, P3201, DOI 10.1016/0032-3861(91)90143-7
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Rose P. J., 1987, ENCY POLYM SCI ENG, V7
   ROSSMURPHY SB, 1992, POLYMER, V33, P2622, DOI 10.1016/0032-3861(92)91146-S
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   TANIOKA A, 1976, BIOPOLYMERS, V15, P1505, DOI 10.1002/bip.1976.360150806
   van Wachem PB, 1999, J BIOMED MATER RES, V47, P270, DOI 10.1002/(SICI)1097-4636(199911)47:2<270::AID-JBM18>3.0.CO;2-D
   Veis A., 1964, MACROMOLECULAR CHEM
   WISSEMANN KW, 1985, IN VITRO CELL DEV B, V21, P391
NR 29
TC 424
Z9 443
U1 17
U2 201
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2001
VL 22
IS 8
BP 763
EP 768
DI 10.1016/S0142-9612(00)00236-2
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 404UK
UT WOS:000167120000002
PM 11246944
DA 2018-10-20
ER

PT J
AU Lloyd, AW
   Faragher, RGA
   Denyer, SP
AF Lloyd, AW
   Faragher, RGA
   Denyer, SP
TI Ocular biomaterials and implants
SO BIOMATERIALS
LA English
DT Article
DE ocular biomaterials; ophthalmic implants and devices
ID INTRAOCULAR-LENS MATERIALS; GLAUCOMA DRAINAGE DEVICES; IN-VITRO
   EVALUATION; SURFACE MODIFICATION; CELL-PROLIFERATION; BACTERIAL
   ADHESION; ORBITAL IMPLANTS; CONTACT-LENSES; KERATOPROSTHESIS;
   HYDROXYAPATITE
AB The maintenance of vision is a key determinant of healthy ageing. This has been facilitated over recent decades by the development of a wide range of implants and biomedical devices to correct the functional deficiencies of disease, age and ocular trauma. This brief overview provides an insight into the structure of this unique organ, the major physiological functions of the component tissues and the present state of the art with respect to modern ocular implants. The review focuses primarily on the existing limitations of existing ocular biomaterials used in the fabrication of contact lenses, intraocular lenses, glaucoma filtration implants, keratoprostheses, intracorneal implants, scleral buckles and viscoelastic replacement agents. The challenge of improving ocular compatibility and ensuring the longevity of indwelling ocular devices is addressed along with the need to improve the physicochemical and mechanical properties of existing ocular biomaterials. (C) 2001 Published by Elsevier Science Ltd.
C1 Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
RP Lloyd, AW (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
EM a.w.lloyd@brighton.ac.uk
RI Lloyd, Andrew/D-1369-2011
OI Lloyd, Andrew/0000-0003-2778-8195
CR ARIAZ JJ, 1993, INVEST OPHTH VIS SCI, V34, P522
   ARROYO MH, 1993, RETINA-J RET VIT DIS, V13, P245, DOI 10.1097/00006982-199313030-00011
   BARBER JC, 1980, INVEST OPHTH VIS SCI, V19, P182
   BAYLISS J, 1981, OPHTHALMIC SURG, P313
   BILYK JR, 1992, INT OPHTHALMOL CLIN, V32, P151, DOI 10.1097/00004397-199203230-00011
   Bours J, 1990, Lens Eye Toxic Res, V7, P491
   Capone A Jr, 1995, Curr Opin Ophthalmol, V6, P33
   CARDONA H, 1969, AM J OPHTHALMOL, V68, P604, DOI 10.1016/0002-9394(69)91239-2
   CATROVEIJO R, 1969, AM J OPHTHALMOL, V68, P613
   CHIRILA TV, 1994, TRENDS POLYM SCI, V2, P296
   CHIRILA TV, 1998, TRIP, V5, P346
   CUMMINGS SJ, 1997, Patent No. 1997439651
   Ding SL, 1998, PHARM SCI TECHNOL TO, V1, P328, DOI 10.1016/S1461-5347(98)00087-X
   Doane MG, 1996, CORNEA, V15, P179, DOI 10.1097/00003226-199603000-00011
   Drubaix I, 1996, EXP EYE RES, V62, P367, DOI 10.1006/exer.1996.0042
   DUTTON JJ, 1991, OPHTHALMOLOGY, V98, P370
   Faragher RGA, 1997, BRIT J OPHTHALMOL, V81, P814, DOI 10.1136/bjo.81.10.814
   Filipec M, 1997, INVEST OPHTH VIS SCI, V38, P883
   FINI ME, 1990, J CELL SCI, V97, P373
   Fleming J F, 1989, CLAO J, V15, P146
   Flowers C W Jr, 1994, Curr Opin Ophthalmol, V5, P81, DOI 10.1097/00055735-199408000-00012
   GEROSHI DH, 1995, OPHTHALMOLOGY, V92, P1
   Girard L J, 1977, Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol, V83, P252
   GIRARD LJ, 1983, CORNEA, V2, P207
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Hanlon GW, 1997, INVEST OPHTH VIS SCI, V38, P885
   HIGHTOWER KR, 1995, CURR EYE RES, V14, P71, DOI 10.3109/02713689508999916
   HOFFMANN F, 1993, CURR OPIN OPHTHALMOL, V4, P84, DOI 10.1097/00055735-199308000-00013
   JONGEBLOED WL, 1994, BIOMATERIALS, V15, P766, DOI 10.1016/0142-9612(94)90030-2
   Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566
   KIRKHAM SM, 1991, OPHTHALMIC SURG LAS, V22, P455
   Kohnen T, 1996, J CATARACT REFR SURG, V22, P1255, DOI 10.1016/S0886-3350(96)80079-4
   KRAUSE U, 1969, OPHTHALMOLOGICA, V159, P178, DOI 10.1159/000305901
   Kunzler J. F., 1995, CHEM IND, V16, P651
   LANE SS, 1991, INT OPHTHALMOL CLIN, V31, P37, DOI 10.1097/00004397-199103110-00007
   Lee SD, 1996, BIOMATERIALS, V17, P587, DOI 10.1016/0142-9612(96)88709-6
   LEGEAIS JM, 1994, EXP EYE RES, V58, P41, DOI 10.1006/exer.1994.1193
   LEGEAIS JM, 1992, CORNEA, V11, P538, DOI 10.1097/00003226-199211000-00010
   Lehrer MS, 1998, J CELL SCI, V111, P2867
   LIESEGANG TJ, 1990, SURV OPHTHALMOL, V34, P268, DOI 10.1016/0039-6257(90)90027-S
   Lim KS, 1998, BRIT J OPHTHALMOL, V82, P1083, DOI 10.1136/bjo.82.9.1083
   LIPMAN RD, 1987, CURR EYE RES, V6, P1453, DOI 10.3109/02713688709044509
   Lloyd AW, 1997, INVEST OPHTH VIS SCI, V38, P884
   Lloyd AW, 1996, VISION RES, V36, P73
   MCDONALD MB, 1993, J CATARACT REFR SURG, V19, P213, DOI 10.1016/S0886-3350(13)80945-5
   MCDONALD MB, 1993, EXIMER LASER SURG, P43
   MOLTENO ACB, 1969, BRIT J OPHTHALMOL, V53, P161, DOI 10.1136/bjo.53.3.161
   MOSHYEDI P, 1995, CURR EYE RES, V14, P555, DOI 10.3109/02713689508998402
   NOSE W, 1993, REFRACT CORNEAL SURG, V19, P182
   OBSTBAUM SA, 1992, J CATARACT REFR SURG, V18, P219, DOI 10.1016/S0886-3350(13)80897-8
   Pande MV, 1996, BRIT J OPHTHALMOL, V80, P469, DOI 10.1136/bjo.80.5.469
   Perry A C, 1990, Adv Ophthalmic Plast Reconstr Surg, V8, P75
   PERRY AC, 1991, OPHTHALMOL CLIN N AM, V4, P173
   Porter JM, 1997, OPHTHALMOLOGY, V104, P1701, DOI 10.1016/S0161-6420(97)30077-3
   Ravi N, 1996, INVEST OPHTH VIS SCI, V37, P3539
   REMULLA HD, 1995, OPHTHALMOLOGY, V102, P586
   RUBIN PAD, 1993, CURR OPIN OPHTHALMOL, V4, P39, DOI 10.1097/00055735-199310000-00009
   RUBIN PAD, 1994, OPHTHALMIC PLAST REC, V10, P96, DOI 10.1097/00002341-199406000-00005
   SCHEPENS CL, 1991, SURV OPHTHALMOL, V35, P447, DOI 10.1016/0039-6257(91)90108-R
   SHARMA A, 1993, BIOPHYS CHEM, V47, P87, DOI 10.1016/0301-4622(93)80036-I
   SHIELDS CL, 1992, ARCH OPHTHALMOL-CHIC, V110, P333, DOI 10.1001/archopht.1992.01080150031022
   SMITH SG, 1989, Patent No. 198950782
   Soll D B, 1986, Ophthalmic Plast Reconstr Surg, V2, P163, DOI 10.1097/00002341-198601060-00009
   STRAMPELLI B, 1963, Ann Ottalmol Clin Ocul, V89, P1039
   SUTULA FC, 1991, OPHTHALMOL CLIN N AM, V4, P183
   Taylor RL, 1998, OPTOMETRY VISION SCI, V75, P23, DOI 10.1097/00006324-199801000-00021
   Trinkaus-Randall VCJ, 1988, INVEST OPHTH VIS SCI, V29, P293
   Werblin T P, 1992, Refract Corneal Surg, V8, P12
   Williams TJ, 1998, OPTOMETRY VISION SCI, V75, P266, DOI 10.1097/00006324-199804000-00023
   Wilson SE, 1997, J REFRACT SURG, V13, P171
   ZIGMAN S, 1985, OCULA LENS STRUCTURE, P117
   1979, INTRAOCULAR LENS IMP, V2, P37
NR 72
TC 168
Z9 170
U1 3
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2001
VL 22
IS 8
BP 769
EP 785
DI 10.1016/S0142-9612(00)00237-4
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 404UK
UT WOS:000167120000003
PM 11246945
DA 2018-10-20
ER

PT J
AU Williams, MD
   Gish, KW
   Giuse, NB
   Sathe, NA
   Carrell, DL
AF Williams, MD
   Gish, KW
   Giuse, NB
   Sathe, NA
   Carrell, DL
TI The Patient Informatics Consult Service (PICS): an approach for a
   patient-centered service
SO BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION
LA English
DT Article
ID HEALTH INFORMATION
AB The Patient Informatics Consult Service (PICS) at the Eskind Biomedical Library at Vanderbilt University Medical Center (VUMC) provides patients with consumer-friendly information by using an information prescription mechanism. Clinicians refer patients to the PICS by completing the prescription and noting the patients condition and any relevant factors. In response, PICS librarians critically appraise and summarize consumer-friendly materials into a targeted information report. Copies of the report are given to both patient and clinician, thus facilitating doctor-patient communication and closing the clinician-librarian feedback loop. Moreover, the prescription form also circumvents many of the usual barriers for patients in locating information, namely, patients' unfamiliarity with medical terminology and lack of knowledge of authoritative sources. PICS librarians capture the time and expertise put into these reports by creating Web-based pathfinders on prescription topics. Pathfinders contain Librarian-created disease overviews and links to authoritative resources and seek to minimize the consumer's exposure to unreliable information. Pathfinders also adhere to strict guidelines that act as a model for locating, appraising, and summarizing information for consumers. These mechanisms-the information prescription, research reports, and pathfinders - serve as steps toward the long-term goal of full integration of consumer health information into patient care at VUMC.
C1 Vanderbilt Univ, Ctr Med, Annette & Irwin Eskind Biomed Lib, Nashville, TN 37232 USA.
RP Williams, MD (reprint author), Vanderbilt Univ, Ctr Med, Annette & Irwin Eskind Biomed Lib, Nashville, TN 37232 USA.
RI Giuse, Nunzia/N-2032-2016
OI Giuse, Nunzia/0000-0002-7644-9803
CR BARTLETT EE, 1995, PATIENT EDUC COUNS, V26, P87, DOI 10.1016/0738-3991(95)00723-D
   BEISECKER AE, 1990, MED CARE, V28, P19, DOI 10.1097/00005650-199001000-00004
   COSGROVE TL, 1994, B MED LIBR ASSOC, V82, P57
   Earl M., 1998, AM LIB, V29, P44
   Giuse N B, 1998, Bull Med Libr Assoc, V86, P412
   Giuse NB, 1997, B MED LIBR ASSOC, V85, P437
   GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921
   HUMPHRIES AW, 1994, B MED LIBR ASSOC, V82, P52
   Ley P, 1982, SOCIAL PSYCHOL BEHAV, P339
   MCLELLAN F, 1998, LANCET S, V2, P39
   Morris TA, 1997, J AM MED INFORM ASSN, V4, P6, DOI 10.1136/jamia.1997.0040006
   *NAT LIB MED, 1998, NLM NEWSLINE
   NOTKIN H, 1994, WESTERN J MED, V161, P184
   Scheitel SM, 1996, MAYO CLIN PROC, V71, P1131, DOI 10.4065/71.12.1131
   TYSON TR, 2000, J AMBULATORY CARE MA, V53, P1
NR 15
TC 25
Z9 25
U1 0
U2 3
PU MEDICAL LIBRARY ASSOC
PI CHICAGO
PA 65 EAST WACKER PLACE, STE 1900, CHICAGO, IL 60601-7298 USA
SN 0025-7338
J9 B MED LIBR ASSOC
JI Bull. Med. Libr. Assoc.
PD APR
PY 2001
VL 89
IS 2
BP 185
EP 193
PG 9
WC Information Science & Library Science
SC Information Science & Library Science
GA 544DE
UT WOS:000175142300006
PM 11337950
DA 2018-10-20
ER

PT J
AU He, BL
   Guo, XQ
   Chen, Y
AF He, BL
   Guo, XQ
   Chen, Y
TI Blood purification and hemoperfusion
SO CHINESE SCIENCE BULLETIN
LA English
DT Review
DE biomedical materials; blood purification; hemoperfusion; adsorption
AB The method of blood purification is a new overlapping frontier discipline which develops quickly in recent years, It helps overcoming many serious and complicated diseases, even including some incurable illnesses.
C1 Nankai Univ, State Key Lab Funct Polymer Mat Adsorpt & Separat, Inst Polymer Chem, Tianjin 300071, Peoples R China.
RP He, BL (reprint author), Nankai Univ, State Key Lab Funct Polymer Mat Adsorpt & Separat, Inst Polymer Chem, Tianjin 300071, Peoples R China.
CR AN M, 1994, ION EXCHANGE ADSORPT, V10, P97
   BABB AL, 1971, T AM SOC ART INT ORG, V17, P81
   CHEN Y, 1996, ION EXCHANGE ADSORPT, V12, P304
   FURST P, 1976, CLIN NEPHROL, V5, P178
   GUO X, 1991, CHEM J CHINESE U, V12, P1130
   GUO X, 1997, MED SOC, V10, P51
   GUO X, 1997, ION EXCHANGE ADSORPT, V13, P203
   GUO X, 1993, ION EXCHANGE ADSORPT, V9, P352
   GUO X, 1995, ION EXCHANGE ADSORPT, V11, P289
   GUO X, 1997, ION EXCHANGE ADSORPT, V13, P9
   HE B, 1990, CHEM J CHINESE U, V11, P739
   HE B, 1990, CHEM J CHINESE U, V11, P873
   HE B, 1987, 3 C ION EXCH ADS NIN, P1
   MA T, 1991, 4 NAT AC EXCH C SHEN, P1
   ROSENBAUM J, 1970, KIDNEY INT S10, V18, P106
   WANG Z, 1992, BLOOD PURIFICATION
   XI Y, 1995, CHINESE J INFECT DIS, V13, P152
   YANG Y, 1988, ARTIF ORGANS, V12, P444
   YANG Y, 1991, ACTA POLYM SINICA, P169
   YANG Y, 1990, ION EXCHANGE ADSORPT, V11, P739
   YANG Y, 1985, CHEM J CHINESE U, V6, P843
   YANG Y, 1986, CHINESE J MICROBIOLO, V6, P353
   Yatzidis H., 1964, P EUROP DIALYSIS TRA, V1, P83
   YU S, 1998, FDN CLIN APPL BIOMED, P159
   YU Z, 1986, MODERN THERAPEUTICS
NR 25
TC 0
Z9 0
U1 2
U2 21
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD APR
PY 2001
VL 46
IS 8
BP 617
EP 621
DI 10.1007/BF03182818
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 433CN
UT WOS:000168737900001
DA 2018-10-20
ER

PT J
AU Thomsen, P
   Gretzer, C
AF Thomsen, P
   Gretzer, C
TI Macrophage interactions with modified material surfaces
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
ID GROWTH-FACTOR-BETA; TUMOR-NECROSIS-FACTOR; BODY GIANT-CELLS; ACUTE
   INFLAMMATORY RESPONSES; PERIPHERAL-BLOOD MONOCYTES; ADHERENT
   HUMAN-NEUTROPHILS; INDUCED PULMONARY-FIBROSIS; MESSENGER-RNA EXPRESSION;
   SOFT-TISSUE RESPONSE; IN-VITRO
AB An understanding of the biological response at material surfaces is a key biomaterials research area. Inflammation, tissue repair and regeneration are hallmarks of this response. Macrophages are long-lived and versatile cells and have a pivotal role at surfaces of implanted medical devices. The present review provides an update on macrophage behaviour at material surfaces. The interactions between cells and material surfaces are dynamic processes which require additional experimental models with different degrees of environmental complexity. It is concluded that both modifications of material surface properties and cellular signalling pathways will provide strategies for optimising the performance of biomedical devices. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Gothenburg Univ, Inst Anat & Cell Biol, S-40530 Gothenburg, Sweden.
RP Thomsen, P (reprint author), Gothenburg Univ, Inst Anat & Cell Biol, Box 420, S-40530 Gothenburg, Sweden.
EM peter.thomsen@dof.se
OI Thomsen, Peter/0000-0003-3910-6665
CR ABRAMSON SL, 1990, J IMMUNOL, V144, P625
   Al-Saffar N, 1999, J LONG-TERM EFF MED, V9, P319
   ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   ANDERSON JM, 1991, J VASC SURG, V13, P750, DOI 10.1016/0741-5214(91)90375-5
   Aspenberg P, 1996, J BONE JOINT SURG BR, V78B, P641
   BABIOR BM, 1984, BLOOD, V64, P959
   BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403
   Baran J, 1996, INFECT IMMUN, V64, P4242
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Bladier C, 1997, CELL GROWTH DIFFER, V8, P589
   Blaine TA, 1996, J BONE JOINT SURG AM, V78A, P1181, DOI 10.2106/00004623-199608000-00008
   BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549
   BOLK HD, 2000, CD14 INFLAMMAOTRY RE, P162
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   BROHIM RM, 1992, ANN PLAS SURG, V28, P354, DOI 10.1097/00000637-199204000-00010
   Burdon RH, 1996, FEBS LETT, V383, P150, DOI 10.1016/0014-5793(96)00230-X
   BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3
   CAMARERO VCPC, 1990, J CELL PHYSIOL, V145, P481, DOI 10.1002/jcp.1041450313
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Catelas I, 1998, J BIOMED MATER RES, V41, P600, DOI 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.3.CO;2-7
   Champaiboon C, 2000, J PERIODONTOL, V71, P468, DOI 10.1902/jop.2000.71.3.468
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chou LS, 1996, J BIOMED MATER RES, V31, P209
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   Cornelissen AMH, 2000, J DENT RES, V79, P1782, DOI 10.1177/00220345000790100901
   Dalu A, 2000, BIOMATERIALS, V21, P1947, DOI 10.1016/S0142-9612(00)00078-8
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   DE WMR, 1991, J EXP MED, V174, P1209
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Dinarello Charles A., 1997, Cytokine and Growth Factor Reviews, V8, P253, DOI 10.1016/S1359-6101(97)00023-3
   DONOFRIO C, 1984, IMMUNOBIOLOGY, V167, P414, DOI 10.1016/S0171-2985(84)80074-1
   ENK AH, 1992, J IMMUNOL, V149, P92
   Eriksson AS, 1996, J CELL PHYSIOL, V166, P138, DOI 10.1002/(SICI)1097-4652(199601)166:1<138::AID-JCP16>3.0.CO;2-B
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   ESSNER R, 1989, J IMMUNOL, V142, P3857
   Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404
   FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081
   FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
   Flad HD, 1998, RES IMMUNOL, V149, P733, DOI 10.1016/S0923-2494(99)80048-0
   GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792
   GINIS I, 1990, BLOOD, V76, P1233
   GINIS I, 1997, AM J PHYSIOL, V41, pC295
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   GRANSTEIN RD, 1987, CLIN INVESTIGATOR, V4, P1254
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   Gretzer C, 2000, CYTOKINE, V12, P32, DOI 10.1006/cyto.1999.0523
   Gretzer C, 2000, BIOMATERIALS, V21, P1047, DOI 10.1016/S0142-9612(99)00279-3
   GRETZER C, 2000, THESIS GOTEBORG U
   GROTENDORST GR, 1989, J CELL PHYSIOL, V140, P396, DOI 10.1002/jcp.1041400226
   HANSSON HA, 1988, ACTA PHYSIOL SCAND, V134, P199, DOI 10.1111/j.1748-1716.1988.tb08480.x
   Harada Y, 1996, J BIOMED MATER RES, V31, P19, DOI 10.1002/(SICI)1097-4636(199605)31:1<19::AID-JBM3>3.3.CO;2-L
   HART PH, 1990, LYMPHOKINE RES, V9, P147
   HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   Heidenreich S, 1999, J LEUKOCYTE BIOL, V65, P737
   HEINE UI, 1987, J CELL BIOL, V105, P2861, DOI 10.1083/jcb.105.6.2861
   HIGAZI AA, 1994, INFLAMMATION, V18, P525, DOI 10.1007/BF01560699
   HOFFSTEIN ST, 1985, LAB INVEST, V52, P515
   HOGQUIST KA, 1991, J IMMUNOL, V147, P2181
   HONG HL, 1987, J CELL SCI, V87, P259
   Horowitz SM, 1996, CALCIFIED TISSUE INT, V59, P392, DOI 10.1007/s002239900145
   Horowitz SM, 1998, J BIOMED MATER RES, V41, P468, DOI 10.1002/(SICI)1097-4636(19980905)41:3<468::AID-JBM17>3.3.CO;2-7
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   HURME M, 1991, SCAND J IMMUNOL, V33, P713, DOI 10.1111/j.1365-3083.1991.tb02545.x
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Ingham E, 2000, BIOMATERIALS, V21, P1005, DOI 10.1016/S0142-9612(99)00261-6
   Ishiguro N, 1996, J BIOMED MATER RES, V32, P611, DOI 10.1002/(SICI)1097-4636(199612)32:4<611::AID-JBM14>3.3.CO;2-4
   Iwaki K, 1997, J BIOL CHEM, V272, P20665, DOI 10.1074/jbc.272.33.20665
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   JIRANEK W, 1995, J BONE JOINT SURG AM, V77A, P1650, DOI 10.2106/00004623-199511000-00003
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   Kalltorp M, 1999, J BIOMED MATER RES, V47, P251, DOI 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O
   KALLTORP M, 2000, UNPOUB MORPHOMETRIC
   KAO WJ, 1995, J BIOMED MATER RES, V19, P1267
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   KAPLAN G, 1982, J EXP MED, V156, P1101, DOI 10.1084/jem.156.4.1101
   KEHRL JH, 1991, INT J CELL CLONING, V9, P438, DOI 10.1002/stem.1991.5530090502
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Kohilas K, 1999, J BIOMED MATER RES, V47, P95, DOI 10.1002/(SICI)1097-4636(199910)47:1<95::AID-JBM14>3.0.CO;2-8
   KOVACS EJ, 1991, IMMUNOL TODAY, V12, P17, DOI 10.1016/0167-5699(91)90107-5
   KREIPE H, 1988, AM J PATHOL, V130, P232
   Kremer EA, 1998, J BONE MINER RES, V13, P1890, DOI 10.1359/jbmr.1998.13.12.1890
   Kuhn A, 2000, ANN PLAS SURG, V44, P387, DOI 10.1097/00000637-200044040-00006
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LARSSON C, 2001, TITANIUM MED, pCH18
   LEHN M, 1989, J IMMUNOL, V143, P3020
   LOSSING C, 1993, PLAST RECONSTR SURG, V91, P1277, DOI 10.1097/00006534-199306000-00014
   LOSSING C, 2000, UNPUB SCAND J PLAST
   MALEFYT RD, 1991, J EXP MED, V174, P915
   MANGAN DF, 1991, J IMMUNOL, V146, P1541
   Matthews JB, 2000, BIOMATERIALS, V21, P2033, DOI 10.1016/S0142-9612(00)00089-2
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MOHANTY M, 1992, BIOMATERIALS, V13, P651, DOI 10.1016/0142-9612(92)90123-6
   MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894
   MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121
   Moulin V, 1998, EXP CELL RES, V238, P283, DOI 10.1006/excr.1997.3827
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   NAKAGAWARA A, 1981, J CLIN INVEST, V68, P1243, DOI 10.1172/JCI110370
   NATHAN CF, 1989, BLOOD, V73, P301
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314
   OLDHAM KT, 1988, FREE RADICAL BIO MED, V4, P387, DOI 10.1016/0891-5849(88)90090-1
   PAPADIMITRIOU JM, 1975, AM J PATHOL, V78, P343
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   PHAN SH, 1992, EXP LUNG RES, V18, P29, DOI 10.3109/01902149209020649
   Picha GJ, 1996, J BIOMED MATER RES, V30, P305
   PIGUET PF, 1990, NATURE, V344, P245, DOI 10.1038/344245a0
   Pollice PF, 1998, J ORTHOP RES, V16, P697, DOI 10.1002/jor.1100160611
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   RICH A, 1981, J CELL SCI, V50, P1
   ROOS D, 1991, KLIN WOCHENSCHR, V69, P975, DOI 10.1007/BF01645142
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   ROSENGREN A, 1994, BIOMATERIALS, V15, P17, DOI 10.1016/0142-9612(94)90190-2
   Rosengren A, 1999, J MATER SCI-MATER M, V10, P75, DOI 10.1023/A:1008964819101
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   Rubin E, 1994, PATHOLOGY
   Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304
   Sandhu J, 1998, J RHEUMATOL, V25, P1794
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   SAVIDGE RA, 1993, IAWA J, V14, P3
   Savio J. A. Iii, 1994, Clinical Materials, V15, P101, DOI 10.1016/0267-6605(94)90076-0
   Schmidt M, 2000, EUR J IMMUNOL, V30, P1769, DOI 10.1002/1521-4141(200006)30:6<1769::AID-IMMU1769>3.0.CO;2-9
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5
   SIMON DI, 1993, BLOOD, V82, P2414
   SMETANA K, 1989, J BIOMED MATER RES, V23, P947, DOI 10.1002/jbm.820230810
   Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687
   SPORN MB, 1989, JAMA-J AM MED ASSOC, V262, P938, DOI 10.1001/jama.262.7.938
   Stea S, 2000, BIOMATERIALS, V21, P1393, DOI 10.1016/S0142-9612(00)00041-7
   TAKAGI M, 1995, J RHEUMATOL, V22, P2285
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1994, CELL MATER, V4, P429
   THERIN M, 1994, J BIOMED MATER RES, V28, P1267, DOI 10.1002/jbm.820281104
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   TREZZINI C, 1988, BIOCHEM BIOPH RES CO, V156, P477, DOI 10.1016/S0006-291X(88)80866-0
   Udipi K, 2000, J BIOMED MATER RES, V51, P549, DOI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
   VANFURTH R, 1992, INFLAMMATION BASIC P, P325
   VIGNERY A, 1989, AM J PATHOL, V135, P565
   Voronov I, 1998, J BIOMED MATER RES, V39, P40, DOI 10.1002/(SICI)1097-4636(199801)39:1<40::AID-JBM6>3.3.CO;2-Y
   WALLIWAARA B, 1994, BIOMATERIALS, V15, P827
   WEBSTER NR, 1988, BRIT J ANAESTH, V60, P98, DOI 10.1093/bja/60.1.98
   Werthen M, 2001, BIOMATERIALS, V22, P827, DOI 10.1016/S0142-9612(00)00246-5
   Wolk K, 2000, BLOOD, V96, P218
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zambonin G, 2000, J BONE JOINT SURG BR, V82B, P457, DOI 10.1302/0301-620X.82B3.9310
   Zhang XS, 1999, J MATER SCI-MATER M, V10, P879, DOI 10.1023/A:1008937419664
   Zhang YZ, 1996, BIOMATERIALS, V17, P2265, DOI 10.1016/0142-9612(96)00055-5
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 167
TC 92
Z9 93
U1 1
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
EI 1879-0348
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD APR-JUN
PY 2001
VL 5
IS 2-3
BP 163
EP 176
DI 10.1016/S1359-0286(01)00004-3
PG 14
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 451CJ
UT WOS:000169783300009
DA 2018-10-20
ER

PT J
AU Lazzi, G
AF Lazzi, G
TI Unconditionally stable D-H FDTD formulation with anisotropic PML
   boundary conditions
SO IEEE MICROWAVE AND WIRELESS COMPONENTS LETTERS
LA English
DT Article
DE ADI; FDTD methods; PML
ID TIME-DOMAIN METHOD; ALGORITHM; MEDIA
AB An unconditionally stable finite difference time domain (FDTD) method based on a D-H formulation and the recently proposed alternating-direction-implicit (ADI) marching scheme is presented, The advantage of the D-H algorithm over the conventional E-W is the possibility to easily implement an unsplit field components formulation of the PML absorbing boundary condition that is independent from the background material used in the FDTD grid. The method allows therefore immersing any dielectric in the PML layers without any special consideration, and is amenahle for models truncation often used in biomedical simulations. Furthermore, the proposed scheme can be extended to account for frequency dispersive dielectrics.
C1 N Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC 27695 USA.
RP Lazzi, G (reprint author), N Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC 27695 USA.
CR LAZZI G, 2000, IEEE T MICROWAVE NOV
   Liu G, 2000, IEEE MICROW GUIDED W, V10, P261, DOI 10.1109/75.856982
   Namiki T, 1999, IEEE T MICROW THEORY, V47, P2003, DOI 10.1109/22.795075
   Namiki T, 2000, IEEE T MICROW THEORY, V48, P1743, DOI 10.1109/22.873904
   Sullivan D. M., 2000, ELECTROMAGNETIC SIMU
   Sullivan DM, 1997, IEEE MICROW GUIDED W, V7, P184, DOI 10.1109/75.594858
   Taflove A, 2000, COMPUTATIONAL ELECTR
   Zhao AP, 1998, IEEE MICROW GUIDED W, V8, P52, DOI 10.1109/75.658638
   Zheng FH, 2000, IEEE T MICROW THEORY, V48, P1550, DOI 10.1109/22.869007
   Zheng FH, 1999, IEEE MICROW GUIDED W, V9, P441, DOI 10.1109/75.808026
NR 10
TC 10
Z9 13
U1 0
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 1531-1309
J9 IEEE MICROW WIREL CO
JI IEEE Microw. Wirel. Compon. Lett.
PD APR
PY 2001
VL 11
IS 4
BP 149
EP 151
DI 10.1109/7260.916326
PG 3
WC Engineering, Electrical & Electronic
SC Engineering
GA 435RJ
UT WOS:000168894700001
OA Green Published
DA 2018-10-20
ER

PT J
AU Mebouta-Nkamgueu, E
   Adnet, JJ
   Ittelet, D
   Laurent-Maquin, D
   Bouthors, S
   Potron, G
   Guenounou, M
   Bernard, J
AF Mebouta-Nkamgueu, E
   Adnet, JJ
   Ittelet, D
   Laurent-Maquin, D
   Bouthors, S
   Potron, G
   Guenounou, M
   Bernard, J
TI Human monocyte-derived macrophages and dendritic cells as targets for
   biomaterial cytocompatibility studies using an improved in vitro culture
   system
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; INTERLEUKIN-1 GENERATION; BIOMEDICAL POLYMERS;
   MONONUCLEAR-CELLS; BLOOD MONOCYTES; BONE-RESORPTION; INVITRO;
   IMMUNOTHERAPY; REPLACEMENTS; DEGRADATION
AB Since macrophage plays a key role in the biocompatibility process, neoplastic macrophage cell lines and human blood monocytes are commonly used as target cells for in vitro biomaterial tolerance evaluation. However, tumor cells profoundly differ from normal tissue cells and monocytes are only precursors of macrophages. It has become possible to generate recently, under adherent-free conditions, fully mature macrophages and dendritic cells from human blood monocytes in the presence of GM-CSF and GM-CSF + IL4 respectively. In the present work, we examined the effects of titanium-alloy on morphology, adhesion, cell phenotype and TNF-alpha release activity of such differentiated cells grown in hydrophobic teflon bags. Scanning electron microscopy showed that macrophages substantially adhered and spread on titanium-alloy surface throughout the culture period, whereas only a few dendritic cells were adherent. The phenotype of both cell types remained unchanged in the presence of the tested material. However, titanium-alloy stimulated the secretion of TNF-alpha by the macrophages of some donors. This model of culture may offer new insights into the biomaterial evaluation and may be useful for studying individual responses induced by biomaterials. (C) 2001 Kluwer Academic Publishers.
C1 UFR Med, Lab Histol Embryol Cytogenet, F-51095 Reims, France.
   Inst Jean Godinot, Immunol Lab, F-51100 Reims, France.
   Ctr Etud Biomat & Interfaces, EA 2068, F-51095 Reims, France.
   CHU, Hematol Lab, F-51092 Reims, France.
   UFR Pharm, Immunol Lab, F-51095 Reims, France.
RP Mebouta-Nkamgueu, E (reprint author), UFR Med, Lab Histol Embryol Cytogenet, 51 Rue Cognacq Jay, F-51095 Reims, France.
CR ADAMS DO, 1979, METHOD ENZYMOL, V58, P4
   ANDREESEN R, 1990, CANCER RES, V50, P7450
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8
   Bernard J, 1998, HEMATOL CELL THER, V40, P17
   Bernatchez SF, 1996, BIOMATERIALS, V17, P2077, DOI 10.1016/0142-9612(96)00014-2
   BHARDWAJ N, 1988, CELL IMMUNOL, V114, P405, DOI 10.1016/0008-8749(88)90332-2
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Caux C, 1996, HEMATOL CELL THER, V38, P463, DOI 10.1007/s00282-996-0463-4
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P304
   DARVILLE T, 1992, IMMUNOL INVEST, V21, P539, DOI 10.3109/08820139209069389
   FREUNDLICH B, 1984, J IMMUNOL, V132, P1255
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GLANT TT, 1994, T ORTHOP RES SOC, V19, P152
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, P182
   HASKILL S, 1988, J IMMUNOL, V140, P1690
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   HELFGOTT DC, 1989, J IMMUNOL, V142, P948
   ISHIMI Y, 1990, J IMMUNOL, V145, P3297
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   Koerten H. K., 1997, Cells and Materials, V7, P191
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   LOPEZ M, 1992, J IMMUNOTHER, V11, P209, DOI 10.1097/00002371-199204000-00008
   LOPEZ M, 1993, J IMMUNOL METHODS, V159, P29, DOI 10.1016/0022-1759(93)90138-W
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NAVARRO S, 1989, J IMMUNOL, V142, P4339
   Nivbrant B, 1999, J BONE JOINT SURG BR, V81B, P163, DOI 10.1302/0301-620X.81B1.8664
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83
   ROSENSTREICH DL, 1978, IMMUNOL REV, V40, P102, DOI 10.1111/j.1600-065X.1978.tb00403.x
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Saad B, 1996, J BIOMED MATER RES, V30, P429, DOI 10.1002/(SICI)1097-4636(199604)30:4<429::AID-JBM1>3.3.CO;2-D
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SNYDERMAN R, 1971, J IMMUNOL, V119, P926
   THOMAS R, 1994, J IMMUNOL, V152, P2613
   Wang JY, 1996, BIOMATERIALS, V17, P2233, DOI 10.1016/0142-9612(96)00072-5
   WATAHA JC, 1995, DENT MATER, V11, P239, DOI 10.1016/0109-5641(95)80056-5
   ZVAIFLER NJ, 1985, J CLIN INVEST, V76, P76
NR 46
TC 4
Z9 5
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2001
VL 12
IS 4
BP 351
EP 357
DI 10.1023/A:1011255406438
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 419DN
UT WOS:000167934200011
PM 15348298
DA 2018-10-20
ER

PT J
AU Gore, JC
   Anderson, AW
   Does, MD
   Gochberg, DF
   Joers, JM
   Kennan, RP
   Parsons, EC
   Schachter, M
AF Gore, JC
   Anderson, AW
   Does, MD
   Gochberg, DF
   Joers, JM
   Kennan, RP
   Parsons, EC
   Schachter, M
TI The relationship of problems in biomedical MRI to the study of porous
   media
SO MAGNETIC RESONANCE IMAGING
LA English
DT Editorial Material
ID MAGNETIZATION-TRANSFER; DIFFUSION; RELAXATION
AB The NMR methods that are used to characterize inanimate porous media measure relaxation times and related phenomena and material transport, fluid displacement and flow. Biological tissues are comprised of multiple small, fluid-filled compartments, such as cells, that restrict the movement of the bulk solvent water and whose constituents influence water proton relaxation times via numerous interactions with macromolecular surfaces. Several of the methods and concepts that have been developed in one field of application are also of great value in the Ether, and it may be expected that technical developments that have been spurred by biomedical applications of MR imaging will be used in the continuing study of porous media. Some recent specific studies from our laboratory include the development of multiple quantum coherence methods for studies of ordered water in anisotropic macromolecular assemblies, studies of the degree of restriction of water diffusion in cellular systems, multiple selective inversion imaging to depict the ratios of proton pool sizes and rates of magnetization transfer between proton populations, and diffusion tensor imaging to depict tissue anisotropies. These illustrate how approaches to obtain structural information from biological media are also relevant to porous media. For example, the recent development of oscillating gradient spin echo techniques (OGSE), an approach that extends our ability to resolve apparent diffusion changes over different time scales in tissues, has also been used to compute surface to volume measurements in assemblies of pores. Each of the new methods can be adapted to provide spatially resolved quantitative measurements of properties of interest, and these can be efficiently acquired with good accuracy using fast imaging methods such as echo planar imaging. The community of NMR scientists focused on applications to porous media should remain in close communication with those who use MRI to study problems in biomedicine, to their mutual benefits. (C) 2001 Elsevier Science Inc. All rights reserved.
C1 Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA.
   Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.
RP Gore, JC (reprint author), Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA.
RI Does, Mark/G-8975-2011
CR Bear J, 1988, DYNAMICS FLUIDS PORO
   CALLAGHAN PT, 1991, PRINCIPLES NUCL MAGN
   Does MD, 2000, MAGNET RESON MED, V43, P837, DOI 10.1002/1522-2594(200006)43:6<837::AID-MRM9>3.0.CO;2-O
   EDZES HT, 1977, NATURE, V265, P521, DOI 10.1038/265521a0
   Gochberg DF, 1999, MAGNET RESON MED, V41, P1065, DOI 10.1002/(SICI)1522-2594(199905)41:5<1065::AID-MRM27>3.0.CO;2-9
   Gochberg DF, 1998, J MAGN RESON, V131, P191, DOI 10.1006/jmre.1998.1371
   HENKELMAN RM, 1993, MAGNET RESON MED, V29, P759, DOI 10.1002/mrm.1910290607
   Kennan RP, 1996, J MAGN RESON SER B, V110, P267, DOI 10.1006/jmrb.1996.0042
   LATOUR LL, 1993, J MAGN RESON SER A, V101, P342, DOI 10.1006/jmra.1993.1056
   SCHACHTER M, 2000, J MAGN RESON, V174, P232
   SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516
NR 11
TC 14
Z9 14
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0730-725X
J9 MAGN RESON IMAGING
JI Magn. Reson. Imaging
PD APR-MAY
PY 2001
VL 19
IS 3-4
BP 295
EP 300
DI 10.1016/S0730-725X(01)00239-9
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 455YU
UT WOS:000170056000003
PM 11445302
DA 2018-10-20
ER

PT J
AU Vaz, CM
   Reis, RL
   Cunha, AM
AF Vaz, CM
   Reis, RL
   Cunha, AM
TI Degradation model of starch-EVOH plus HA composites
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE in-vitro degradation; composites; starch/ethylene-vinyl alcohol;
   biodegradable; enzymes; coupling agents
ID POLYMERS
AB Composites of starch based blends (starch-EVOH) reinforced with bioactive bone-like hydroxyapatite (HA) have been recently proposed for temporary biomedical implants. Very promising mechanical results were obtained so far, both by the introduction of coupling agents (titanates, zirconates and silanes) or by optimizing the respective processing route. In this study coupled and non-coupled composites were aged up to 30 days in two types of simulated physiological solutions (with and without added proteins/enzymes) and the respective property variation was evaluated by means of: weight loss, water-uptake and mechanical performance (strength, stiffness and ductility). The interfacial attack generated by the solutions was observed by scanning electron microscopy (SEM) and quantified (calcium and phosphorous amounts in the solution) by atomic emission spectrometry (ICP). The in-vitro degradation process of starch-EVOH+HA composites consists apparently of three main stages: i) for short periods (0-6 days) it is characterized by a high degradation rate due to the leaching of plasticizers, low molecular weight polymeric chains and some dissolution of HA; ii) for longer periods (7-15 days), the major extraction of the plasticizers oc curs and the material becomes brittle and; iii) from the 15th immersion day on, the degradation rate is lower and, eventually chemical attack on the polymer structure takes place, mainly in the presence of enzymes/proteins.
   The confirmation of this type of behavior will support the potential use of these composites, already tested for their non-cytotoxic character, in temporary applications where the retention of mechanical properties for 3 to 6 weeks is required.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Vaz, CM (reprint author), Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Cunha
   M., Antonio/0000-0003-3860-7732
CR ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   ANDRIANO KP, 1994, J APPL BIOMATER, V5, P133, DOI 10.1002/jab.770050206
   BASTIOLI C, 1995, Patent No. 9102025
   DANNIELS AU, 1994, J APPL BIOMATER, V5, P51
   GILDING DK, 1981, BIOCOMPATIBILITY CLI, P210
   GOMES ME, 1999, 15 EUR C BIOM BORD F
   Hench LL, 1996, BIOMATERIALS SCI INT, P73
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   KLEMCHUK PP, 1990, POLYM DEGRAD STABIL, V27, P183, DOI 10.1016/0141-3910(90)90108-J
   KNOWLES JC, 1992, J MATER SCI-MATER M, V3, P352, DOI 10.1007/BF00705367
   MENDES SC, 2000, UNPUB BIOMATERIALS
   MIDDLETON JC, 1998, MED PLAST BIOMATER, V2, P30
   MONTE SJ, 1993, KEN REACTRO REFERENC
   PISKIN E, 1992, Clinical Materials, V11, P3, DOI 10.1016/0267-6605(92)90023-M
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.3.CO;2-9
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   SCOTT G, 1995, POLYM DEGRAD STABIL, V48, P315, DOI 10.1016/0141-3910(95)00090-9
   TORMALA P, 1993, CLIN MATER, V13, P35, DOI 10.1016/0267-6605(93)90087-N
   VAZ CM, 1999, 15 EUR C BIOM BORD F
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   ZAIKOV GE, 1989, DEGRADATION STABILIS, P469
NR 22
TC 32
Z9 32
U1 0
U2 3
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 1432-8917
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD APR
PY 2001
VL 4
IS 5-6
BP 375
EP 380
DI 10.1007/s100190000112
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 431DX
UT WOS:000168617500017
DA 2018-10-20
ER

PT J
AU Iwaki, M
AF Iwaki, M
TI Ion surface treatments on organic materials
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on Ion Beam Modification of Materials
   (IBMM2000)
CY SEP 03-08, 2000
CL CANELA, BRAZIL
SP Inst Fis UFRGS, Ion Implantat Lab
DE ion implantation; polymer; surface analysis; cell adhesion
ID IMPLANTED POLYIMIDE FILMS; CELL-ADHESION
AB A study has been made of surface modification of various organic materials by ion bombardment or implantation to make the surface properties of high and multiple functions in RIKEN. Substrates used were polyimide (PI), polyacetylene, polytetrafluoroethylene (PTFE), polystyrene (PS), silicone rubber, various kinds of proteins and so on. Bombarded or implanted ions were inert gas elements, chemically active gaseous elements and metallic elements. Surface properties such as electrical conductivity, wettability and cell adhesion of implanted layers have been investigated. Surface characterization of implanted materials has been carried out by means of transmission electron microscopy, laser Raman spectroscopy, X-ray photoelectron spectroscopy and Rutherford backscattering spectroscopy. In this paper, studies in RIKEN are reviewed of electrical conductivity, optical absorbance, wettability and cell adhesion depending on current densities and doping elements. Applications of ion bombardment to biomedical materials are introduced using cell adhesion control. It is concluded that ion bombardment or implantation is useful to change and control surface properties of various organic materials. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 RIKEN, Surface Characterizat Div, Wako, Saitama 3510198, Japan.
RP Iwaki, M (reprint author), RIKEN, Surface Characterizat Div, Hirosawa 2-1, Wako, Saitama 3510198, Japan.
CR DAVENAS J, 1993, NUCL INSTRUM METH B, V80-1, P1021, DOI 10.1016/0168-583X(93)90729-P
   FISCHER BE, 1990, NUCL INSTRUM METH B, V30, P284
   HOLMAN R, 1984, UV EB CURING FORMULA
   INOUE Y, 2000, COLLOID SURFACE B, V19, P263
   IWAKI M, 1993, NUCL INSTRUM METH B, V80-1, P1080, DOI 10.1016/0168-583X(93)90741-N
   IWAKI M, 1999, P 1998 INT C ION IMP, P824
   Kobayaski T, 2001, NUCL INSTRUM METH B, V175, P548, DOI 10.1016/S0168-583X(01)00342-1
   Murayama Y, 1999, AM J NEURORADIOL, V20, P1992
   Nakao A, 1998, J COLLOID INTERF SCI, V197, P257, DOI 10.1006/jcis.1997.5289
   SAKAMOTO K, 1996, J MATER RES, V11, P1656
   SUZUKI Y, 1992, NUCL INSTRUM METH B, V65, P142, DOI 10.1016/0168-583X(92)95027-O
   Suzuki Y, 1997, NUCL INSTRUM METH B, V127, P1019, DOI 10.1016/S0168-583X(97)00050-5
   SUZUKI Y, 1994, NUCL INSTRUM METH B, V91, P588
   Watanabe H, 1995, MATER RES SOC SYMP P, V354, P369
   YOSHIDA K, 1987, NUCL INSTRUM METH B, V19-20, P878, DOI 10.1016/S0168-583X(87)80175-1
NR 15
TC 34
Z9 34
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD APR
PY 2001
VL 175
BP 368
EP 374
DI 10.1016/S0168-583X(00)00543-7
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 444FH
UT WOS:000169389100067
DA 2018-10-20
ER

PT J
AU Helminen, A
   Korhonen, H
   Seppala, JV
AF Helminen, A
   Korhonen, H
   Seppala, JV
TI Biodegradable crosslinked polymers based on triethoxysilane terminated
   polylactide oligomers
SO POLYMER
LA English
DT Article
DE silane; lactide; crosslinking
ID MOLAR-MASS POLYBUTADIENE; ORGANIC HYBRID MATERIALS; SOL-GEL PROCESS;
   SILANE MOIETIES; URETHANE LINKAGE; COMPOSITES; DEGRADATION; BEHAVIOR
AB Lactic acid based polymers and their copolymers are widely used in biomedical applications. Different properties are introduced by modifying the composition. In this study, crosslinked polymers were produced from DL-lactide oligomers, which were functionalised with (3-isocyanatopropyl)triethaxysilane (IPTS) and crosslinked by acid catalysis in the presence of water without the use of solvent. The polymers were characterised by fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC), and their crosslinking density and compressive properties were measured. Functionalised linear and star-shaped oligomers were characterised by FTIR and DSC and also by H-1 NMR and size exclusion chromatography (SEC). According to H-1 NMR, 79-95% of the hydroxyl groups were functionalised by IPTS during the early part of the synthesis. The formation of a strong polymer network was found to require a curing temperature of at least 90 degreesC. The best mechanical properties were achieved with the oligomer initiated with 5% pentaerythritol. The properties of the polymer were then compressive yield strength 81 MPa, modulus 2260 MPa and 4.4% strain at yield point. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Helsinki Univ Technol, Dept Chem Technol, Lab Polymer Technol, FIN-02015 Helsinki, Finland.
RP Seppala, JV (reprint author), Helsinki Univ Technol, Dept Chem Technol, Lab Polymer Technol, POB 6100, FIN-02015 Helsinki, Finland.
RI Seppala, Jukka/G-7698-2012
CR ALGER MSM, 1989, POLYM SCI DICT, P93
   Colthup N.B., 1975, INTRO INFRARED RAMAN
   Gresser Joseph D., 1996, P169
   GRIJPMA DW, 1994, MACROMOL CHEM PHYSIC, V195, P1633, DOI 10.1002/macp.1994.021950515
   HAN YK, 1988, J MACROMOL SCI CHEM, VA25, P847, DOI 10.1080/00222338808053402
   Hiltunen K, 1997, J APPL POLYM SCI, V63, P1091
   HUANG HH, 1989, POLYMER, V30, P2001, DOI 10.1016/0032-3861(89)90286-3
   Jokinen M, 2000, J EUR CERAM SOC, V20, P1739, DOI 10.1016/S0955-2219(00)00036-4
   Kharas GB, 1997, J APPL POLYM SCI, V66, P1123
   KIOUL A, 1994, J NON-CRYST SOLIDS, V175, P169, DOI 10.1016/0022-3093(94)90009-4
   KORHONEN H, 2000, UNPUB J APPL POLYM S
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Mascia L, 1998, POLYMER, V39, P3045, DOI 10.1016/S0032-3861(97)10088-X
   MATTSON B, 1996, COMPOS INTERFACE, V4, P57
   MATTSON B, 1996, COMPOS INTERFACE, V4, P77
   Park J. B., 1992, BIOMATERIALS INTRO, V2nd, P141
   Schapman F, 2000, POLYMER, V41, P17, DOI 10.1016/S0032-3861(99)00133-0
   Schapman F, 1998, POLYMER, V39, P965, DOI 10.1016/S0032-3861(97)00354-6
   Schapman F, 1998, POLYMER, V39, P973, DOI 10.1016/S0032-3861(97)00355-8
   Schapman F, 1998, POLYMER, V39, P4955, DOI 10.1016/S0032-3861(97)10244-0
   STOREY RF, 1993, POLYM COMPOSITE, V14, P7, DOI 10.1002/pc.750140103
   Tian D, 1997, CHEM MATER, V9, P871, DOI 10.1021/cm960514q
   Tian D, 1998, POLYMER, V39, P855, DOI 10.1016/S0032-3861(97)00343-1
   Tian D, 1997, J POLYM SCI POL CHEM, V35, P2295, DOI 10.1002/(SICI)1099-0518(199708)35:11<2295::AID-POLA21>3.0.CO;2-8
   Tian D, 1996, POLYMER, V37, P3983, DOI 10.1016/0032-3861(96)00199-1
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   VERT M, 1995, J MACROMOL SCI PURE, VA32, P787, DOI 10.1080/10601329508010289
   WILLIAMS DH, 1989, SPECTROSCOPIC METHOD, P29
NR 28
TC 54
Z9 58
U1 4
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD APR
PY 2001
VL 42
IS 8
BP 3345
EP 3353
DI 10.1016/S0032-3861(00)00708-4
PG 9
WC Polymer Science
SC Polymer Science
GA 396CX
UT WOS:000166619700005
DA 2018-10-20
ER

PT J
AU Hao, JY
   Deng, XM
AF Hao, JY
   Deng, XM
TI Semi-interpenetrating networks of bacterial poly(3-hydroxybutyrate) with
   net-poly(ethylene glycol)
SO POLYMER
LA English
DT Article
DE semi-interpenetrating network; poly(3-hydroxybutyrate);
   net-poly(ethylene glycol)
ID POLY(ETHYLENE GLYCOL); BETA-CHITIN; HYDROGELS; MACROMER; BLENDS
AB Semi-interpenetrating network (IPN) hydrogels based on bacterial poly(3-hydroxybutyrate) (PHB) and net-poly(ethylene glycol) (net-PEG) were prepared by the UV irradiation technique. The swelling and thermal behavior of the hydrogels, os well as their mechanical properties were studied by means of swelling tests, differential scanning calorimetry and tensile experiments. Net-PEG-based hydrogels all show higher equilibrium water contents (EWCs), while a remarkably decreased EWC is observed for the hydrogel containing 75% PHB. The thermal behavior of PHB in the semi-IPNs is not greatly affected by hydrogel composition. However, the crystallinity of PEG segments is noticeably decreased by crosslinking and would further drop with increasing amount of PHB. Incorporation of semi-IPN structure with PHB could significantly improve the mechanical properties of hydrogels when compared with that of pure net-PEG. The PHB/net-PEG 150/50) semi-IPN2. ranking as that possessing the best mechanical properties in the wet state, is expected to be useful as a biomedical material. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Acad Sinica, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
RP Hao, JY (reprint author), Acad Sinica, Chengdu Inst Organ Chem, POB 415, Chengdu 610041, Peoples R China.
CR AKHTAR S, 1987, J PHARM PHARMACOL, V39, P43
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   AVELLA M, 1988, POLYMER, V29, P1731, DOI 10.1016/0032-3861(88)90384-9
   CORKHILL PH, 1990, POLYMER, V31, P1526, DOI 10.1016/0032-3861(90)90161-Q
   CORKHILL PH, 1993, J BIOMAT SCI-POLYM E, V4, P615, DOI 10.1163/156856293X00834
   Doi Y., 1990, MICROBIAL POLYESTERS
   ESCHBACH FO, 1994, ADV CHEM SER, P239
   GRASSIE N, 1984, POLYM DEGRAD STABIL, V6, P47, DOI 10.1016/0141-3910(84)90016-8
   KIM SS, 1995, POLYMER, V36, P4497, DOI 10.1016/0032-3861(95)96859-7
   KIM SS, 1995, J POLYM SCI POL CHEM, V33, P2285, DOI 10.1002/pola.1995.080331324
   Lee YM, 1997, POLYMER, V38, P2415, DOI 10.1016/S0032-3861(96)00789-6
   PEARCE R, 1994, POLYMER, V35, P3990, DOI 10.1016/0032-3861(94)90285-2
   REHBERG CE, 1945, J AM CHEM SOC, V67, P208, DOI 10.1021/ja01218a019
   VYAVAHARE N, 1994, J POLYM SCI POL CHEM, V32, P1271, DOI 10.1002/pola.1994.080320708
NR 14
TC 21
Z9 25
U1 2
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD APR
PY 2001
VL 42
IS 9
BP 4091
EP 4097
DI 10.1016/S0032-3861(00)00465-1
PG 7
WC Polymer Science
SC Polymer Science
GA 403NY
UT WOS:000167050400018
DA 2018-10-20
ER

PT J
AU Hasirci, V
   Lewandrowski, K
   Gresser, JD
   Wise, DL
   Trantolo, DJ
AF Hasirci, V
   Lewandrowski, K
   Gresser, JD
   Wise, DL
   Trantolo, DJ
TI Versatility of biodegradable biopolymers: degradability and an in vivo
   application
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Interim Meeting of the
   International-Society-of-Environmental-Biotechnology (ISEB)
CY MAR 02-05, 1999
CL LEIPZIG, GERMANY
SP Int Soc Environm Biotechnol
DE biodegradation; interpenetrating networks; molecular reinforcement;
   osteointegration; polypropylene fumarate
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; STRUCTURE PROPERTY
   RELATIONSHIPS; GUIDED TISSUE REGENERATION; ETHYLENE GLYCOL) HYDROGELS;
   IN-VITRO; FRACTURE FIXATION; BONE REGENERATION; MEDICAL DEVICES;
   AQUEOUS-MEDIA; DEGRADATION
AB Biodegradable materials have various important applications in the biomedical field. There are basically two groups of polyesters which have significant importance in this field. These are polylactides and polyhydroxybutyrates. Both groups degrade via hydrolysis with the rates of degradation depending on medium properties such as pH, temperature, solvent and presence of biocatalysts, as well as on chemical compositions. In order for these biomaterials to be suitable for use in load bearing applications without deformation or warping their strengths and their capability to maintain their form must be improved. To insure dimensional stability during degradation and to match modulus and strength to that of bone, introduction of a reinforcing structure for those applications to plate fixation through the creation of an interpenetrating network might be a feasible approach. In this study, poly(lactide-co-glycolide) (PLGA), was the major structural element to be strengthened by a three-dimensional network or 'scaffold' of another biodegradable polymer, poly(propylene fumarate) (PPF). PPF would be crosslinked with a biocompatible vinyl monomer, vinylpyrrolidone (VP). Three different approaches were tested to create dimensionally stable bone plates. First, via in situ crosslinking of PPF in the presence of PLGA. Secondly, by blending of precrosslinked PPF with PLGA. Finally, by simultaneous crosslinking and molding of the PLGA, PPF and VP. These were compared against extruded or compression molded PLGA controls. Results showed that compression molding at room temperature followed by crosslinking under pressure at elevated temperature and subsequently by gamma -irradiation appeared to yield the most favorable product as judged by swelling, hardness and flexural strength data. The composition of the implant material, PLGA(3):PPF(1):VP(0.7), appeared to be suitable and formed the compositional and procedural basis for in vivo biocompatibility studies. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
   Massachusetts Gen Hosp, Orthopaed Res Labs, Boston, MA 02114 USA.
   Cambridge Sci Inc, Belmont, MA 02478 USA.
RP Hasirci, V (reprint author), Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey.
FU NIAMS NIH HHS [1 R43 AR44317-01]
CR BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   CHA Y, 1990, BIOMATERIALS, V11, P108, DOI 10.1016/0142-9612(90)90124-9
   CHRISTEL P, 1982, BIOMATERIALS 1980, P271
   Ferguson SJ, 1996, MED ENG PHYS, V18, P241, DOI 10.1016/1350-4533(95)00041-0
   Fini M, 1995, INT J ARTIF ORGANS, V18, P772
   GALGUT P, 1991, J CLIN PERIODONTOL, V18, P581, DOI 10.1111/j.1600-051X.1991.tb00093.x
   GERHART TN, 1989, J BIOMED MATER RES, V23, P1, DOI 10.1002/jbm.820230102
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   GOTFREDSEN K, 1994, CLIN ORAL IMPLAN RES, V5, P83, DOI 10.1034/j.1600-0501.1994.050204.x
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   GURSEL I, 1995, J MICROENCAPSUL, V12, P185, DOI 10.3109/02652049509015289
   Gursel I, 1998, BIOMATERIALS, V19, P1137, DOI 10.1016/S0142-9612(98)00009-X
   HOLLAND SJ, 1990, BIOMATERIALS, V11, P206, DOI 10.1016/0142-9612(90)90157-L
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P75, DOI 10.1034/j.1600-0501.1994.050203.x
   LI SM, 1990, J MATER SCI-MATER M, V1, P131, DOI 10.1007/BF00700872
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   MALM T, 1994, EUR SURG RES, V26, P298, DOI 10.1159/000129349
   MALM T, 1992, SCAND J THORACIC CAR, V1, P9
   Matsusue Y, 1996, CLIN ORTHOP RELAT R, P166
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Parsons J. R., 1979, Proceedings of the Seventh New England (Northeast) Bioengineering Conference, P162
   Partidos CD, 1996, MOL IMMUNOL, V33, P485, DOI 10.1016/0161-5890(96)00032-6
   PETER SJ, 1988, J BIOMED MATER RES, V41, P1
   POLSON AM, 1995, J PERIODONTOL, V66, P377
   ROBINSON BP, 1995, OTOLARYNG HEAD NECK, V112, P707
   SHIH C, 1995, J CONTROL RELEASE, V34, P9, DOI 10.1016/0168-3659(94)00100-9
   SKIRVING AP, 1987, CLIN ORTHOP RELAT R, P117
   SPENLEHAUER G, 1989, BIOMATERIALS, V10, P557, DOI 10.1016/0142-9612(89)90063-X
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   Suggs LJ, 1998, J BIOMED MATER RES, V42, P312, DOI 10.1002/(SICI)1097-4636(199811)42:2<312::AID-JBM17>3.0.CO;2-K
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Timmins M. R., 1994, Trends in Polymer Science, V2, P15
   WILLIAMS DF, 1997, MED DEVICE TECHNOL, P8
   WISE DL, 1984, BIOPOLYMERIC CONTROL, V2, pCH11
   YASIN M, 1990, BIOMATERIALS, V11, P451, DOI 10.1016/0142-9612(90)90057-W
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
NR 38
TC 88
Z9 98
U1 3
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD MAR 30
PY 2001
VL 86
IS 2
SI SI
BP 135
EP 150
DI 10.1016/S0168-1656(00)00409-0
PG 16
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 415XU
UT WOS:000167749500007
PM 11245902
DA 2018-10-20
ER

PT J
AU Seal, S
   Barr, TL
   Krezoski, S
   Petering, D
AF Seal, S
   Barr, TL
   Krezoski, S
   Petering, D
TI Surface modification of silicon and silica in biological environment: an
   X-ray photoelectron spectroscopy study
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE silicon; silica; XPS or ESCA; biocells; pathogenesis; surface analysis
ID TOXICITY; HEMOLYSIS; PARTICLES; CHEMISTRY; CELLS
AB The Earth's crust is primarily made of various silicate materials upon which we successfully dwell everyday. Numerous biomedical studies, however, have documented the toxicity of some of these materials when interacted with biological cells. It has become apparent that the surface chemistry of these silicates plays a key role in the cell pathogenesis, thus enhancing the value of the use of electron spectroscopy for chemical analysis (ESCA) or X-ray photoelectron spectroscopy (XPS) as a key method for analysis. Recent studies suggest that many common silicates, including silica itself, may not be innocuous to cell pathogenecity, thus suggesting their inclusion in these XPS studies. This paper presents a detailed study of the surface chemical modification of silicon and silica when interacting with Ehrlich cells. XPS studies at selected stages of cell treatment reveal cell-induced alteration in the carbon, silicon, and oxygen of these silicon-based materials as well as changes in the carbon, iron, and nitrogen of the cell chemistry. Supporting results from the atomic absorption spectroscopy show similar changes. (C) 2001 Published by Elsevier Science B.V.
C1 Univ Cent Florida, Adv Mat Proc Anal Ctr, Orlando, FL 32816 USA.
   Univ Cent Florida, Mech Mat & Aerosp Engn, Orlando, FL 32816 USA.
   Univ Wisconsin, Dept Mat Engn, Milwaukee, WI 53201 USA.
   Univ Wisconsin, Surface Studies Lab, Milwaukee, WI 53201 USA.
   Univ Wisconsin, Dept Chem, Milwaukee, WI 53201 USA.
RP Seal, S (reprint author), Univ Cent Florida, Adv Mat Proc Anal Ctr, Eng 381,4000 Univ Blvd, Orlando, FL 32816 USA.
CR ALLISON AC, 1966, J EXP MED, V124, P141, DOI 10.1084/jem.124.2.141
   ALLISON AC, 1971, ARCH INTERN MED, V128, P131, DOI 10.1001/archinte.128.1.131
   Barr T L, 1994, MODERN ESCA PRINCIPL
   BARR TL, 1995, J VAC SCI TECHNOL A, V13, P1239, DOI 10.1116/1.579868
   BARR TL, 1995, VACUUM, V46, P1391, DOI 10.1016/0042-207X(95)00159-X
   Barr TL, 1996, SURF INTERFACE ANAL, V24, P99, DOI 10.1002/(SICI)1096-9918(199602)24:2<99::AID-SIA98>3.0.CO;2-I
   BATEMAN ED, 1982, BRIT J EXP PATHOL, V63, P414
   Beamson G., 1992, HIGH RESOLUTION XPS
   BRIGGS D, 1990, PRACTICAL SURFACE AN, P6355
   DUMITRUSTANESCU R, 1994, ANALYST, V119, P689, DOI 10.1039/an9941900689
   GOODGLICK LA, 1986, CANCER RES, V46, P5558
   KAW JL, 1975, ACTA PHARMACOL TOX, V36, P225
   KESSLER DA, 1992, NEW ENGL J MED, V326, P1713, DOI 10.1056/NEJM199206183262525
   KOSKINEN H, 1983, CHEST, V83, P848, DOI 10.1378/chest.83.6.848
   KOZIN F, 1982, J COLLOID INTERF SCI, V88, P326, DOI 10.1016/0021-9797(82)90262-4
   MARKS J, 1957, Br J Ind Med, V14, P81
   MILLER DM, 1990, FREE RADICAL BIO MED, V8, P95, DOI 10.1016/0891-5849(90)90148-C
   MILLER K, 1972, BRIT J EXP PATHOL, V53, P397
   MOSSMAN BT, 1985, INVITRO EFFECTS MINE, P66
   NOLAN RP, 1981, ENVIRON RES, V26, P503, DOI 10.1016/0013-9351(81)90226-7
   NOWEIR MH, 1980, BRIT J IND MED, V37, P399
   PARAZZI E, 1968, ARCH ENVIRON HEALTH, V17, P850, DOI 10.1080/00039896.1968.10665341
   RAASK E, 1980, ANN OCCUP HYG, V23, P147, DOI 10.1093/annhyg/23.2.147
   REISER KM, 1979, TOXICOLOGY, V13, P51, DOI 10.1016/0300-483X(79)90055-6
   SCHEPERS G W, 1960, Ind Med Surg, V29, P326
   Seal S, 1997, J VAC SCI TECHNOL A, V15, P1235, DOI 10.1116/1.580601
   Seal S, 1996, J VAC SCI TECHNOL A, V14, P1770, DOI 10.1116/1.580335
   SEAL S, 1995, J VAC SCI TECHNOL A, V13, P1260, DOI 10.1116/1.579871
   Seal S, 1996, P ROY SOC B-BIOL SCI, V263, P943, DOI 10.1098/rspb.1996.0140
   SEAL S, 1997, J HAZARD MATER, V53, P55
   Sherwood P. M. A., 1983, PRACTICAL SURFACE AN, P445
   SHERWOOD PMA, 1990, DATA ANAL XPS AES PR, P555
   SHI XL, 1989, J TOXICOL ENV HEALTH, V27, P435, DOI 10.1080/15287398909531314
   SUMMERTON J, 1977, EXP MOL PATHOL, V26, P113, DOI 10.1016/0014-4800(77)90071-5
   THORNE PS, 1985, ENVIRON RES, V36, P89, DOI 10.1016/0013-9351(85)90010-6
   WOLFF RK, 1981, J AEROSOL SCI, V12, P119, DOI 10.1016/0021-8502(81)90044-6
   ZISKIND M, 1976, AM REV RESPIR DIS, V113, P643
NR 37
TC 14
Z9 16
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 29
PY 2001
VL 173
IS 3-4
BP 339
EP 351
DI 10.1016/S0169-4332(01)00018-6
PG 13
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 411CD
UT WOS:000167479800020
DA 2018-10-20
ER

PT J
AU Kraft, O
   Volkert, CA
AF Kraft, O
   Volkert, CA
TI Mechanical testing of thin films and small structures
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Review
ID SENSING INDENTATION EXPERIMENTS; X-RAY-DIFFRACTION; YOUNGS MODULUS;
   BULGE TEST; MICROBEAM DEFLECTION; FRACTURE STRENGTH; HIGH-TEMPERATURE;
   SILICON-NITRIDE; THERMAL HISTORY; ALUMINUM FILMS
AB Thin films, as well as small structures, are used in many technical applications, such as semiconductor devices, information storage media, microelectromechanical systems (MEMS), and biomedical devices. The knowledge of materials properties is essential for the design and fabrication of these devices, particularly since small structures often have different properties than their bulk counterparts. This article describes the most common experimental techniques used to measure mechanical properties in small dimensions.
C1 Max Planck Inst Met Forsch, D-70174 Stuttgart, Germany.
RP Kraft, O (reprint author), Max Planck Inst Met Forsch, Seestr 92, D-70174 Stuttgart, Germany.
CR ACOSTA RE, 1992, MICROELECTRON ENG, V17, P189, DOI 10.1016/0167-9317(92)90039-T
   ALLEN MG, 1987, APPL PHYS LETT, V51, P241, DOI 10.1063/1.98460
   Arzt E, 1998, ACTA MATER, V46, P5611, DOI 10.1016/S1359-6454(98)00231-6
   Attia P, 1998, MATER RES SOC SYMP P, V518, P3, DOI 10.1557/PROC-518-3
   BADER S, 1995, MATER RES SOC SYMP P, V356, P435
   BADER S, 1995, THIN SOLID FILMS, V263, P175, DOI 10.1016/0040-6090(95)06556-3
   BADER S, 1994, J MATER RES, V9, P318, DOI 10.1557/JMR.1994.0318
   Baker SP, 1997, THIN SOLID FILMS, V308, P289, DOI 10.1016/S0040-6090(97)00556-7
   BAKER SP, 1994, J MATER RES, V9, P3145, DOI 10.1557/JMR.1994.3145
   Baker SP, 1998, MATER RES SOC SYMP P, V505, P605
   BAKER SP, 1994, J MATER RES, V9, P3131, DOI 10.1557/JMR.1994.3131
   Beams J. W., 1959, STRUCTURE PROPERTIES, P183
   BESSER PR, 1994, J MATER RES, V9, P13, DOI 10.1557/JMR.1994.0013
   BHATTACHARYA AK, 1988, INT J SOLIDS STRUCT, V24, P1287, DOI 10.1016/0020-7683(88)90091-1
   BLEVINS RD, 1987, FORMULAS NATURAL FRE
   BROMLEY EI, 1983, J VAC SCI TECHNOL B, V1, P1364, DOI 10.1116/1.582744
   BROTZEN FR, 1994, INT MATER REV, V39, P24, DOI 10.1179/imr.1994.39.1.24
   BROTZEN FR, 1990, VACUUM, V41, P1287, DOI 10.1016/0042-207X(90)93935-C
   Buckle H., 1971, SCI HARDNESS TESTING, P453
   CARDINALE GF, 1992, THIN SOLID FILMS, V207, P126, DOI 10.1016/0040-6090(92)90112-O
   CLEMENS BM, 1992, MRS BULL, V17, P46, DOI 10.1557/S0883769400041658
   Cornella G, 1998, MATER RES SOC SYMP P, V518, P81, DOI 10.1557/PROC-518-81
   *CSEM INSTR, NAN HARDN TEST
   *CSIRO, UMIS 2000
   *DIN, 50359 DIN
   Emery R, 1998, MATER RES SOC SYMP P, V505, P57
   FLINN PA, 1991, J MATER RES, V6, P1498, DOI 10.1557/JMR.1991.1498
   FLINN PA, 1987, IEEE T ELECTRON DEV, V34, P689, DOI 10.1109/T-ED.1987.22981
   Florando J, 1999, MATER RES SOC SYMP P, V563, P231, DOI 10.1557/PROC-563-231
   GARDNER DS, 1988, MATER RES SOC S P, V130, P69
   Gerberich WW, 1996, ACTA MATER, V44, P3585, DOI 10.1016/1359-6454(96)00010-9
   Gouldstone A, 1998, J MATER RES, V13, P1956, DOI 10.1557/JMR.1998.0275
   Gudmundson P, 1999, AIP CONF PROC, V491, P217
   *HELM FISCH GMBH, FISCH
   *HELM FISCH GMBH, NAN HARDN TEST
   Hommel M, 1999, J MATER RES, V14, P2373, DOI 10.1557/JMR.1999.0317
   HOMMEL M, 1999, THESIS U STUTTGART
   *HYS INC, TRIB
   *ISO DIS, 14577 ISODIS
   Josell D, 1998, J MATER RES, V13, P2902, DOI 10.1557/JMR.1998.0397
   Kang YS, 1997, J ELECTRON MATER, V26, P805, DOI 10.1007/s11664-997-0255-9
   Keller RM, 1999, ACTA MATER, V47, P415, DOI 10.1016/S1359-6454(98)00387-5
   Keller RM, 1998, J MATER RES, V13, P1307, DOI 10.1557/JMR.1998.0186
   KING RB, 1987, INT J SOLIDS STRUCT, V23, P1657, DOI 10.1016/0020-7683(87)90116-8
   KNAUSS M, 1996, THESIS U STUTTGART
   KOLA RR, 1989, J VAC SCI TECHNOL B, V9, P3297
   Kraft O, 1998, MATER RES SOC SYMP P, V518, P39, DOI 10.1557/PROC-518-39
   Kraft O, 1998, MATER RES SOC SYMP P, V516, P201, DOI 10.1557/PROC-516-201
   KRETSCHMANN A, 1997, THESIS U STUTTGART
   Kretschmann A., 1996, MAT RES SOC P, V436, P59
   KUNERT M, 2000, THESIS U STUTTGART
   KUSCHKE WM, 1994, APPL PHYS LETT, V64, P1097, DOI 10.1063/1.110944
   LAHAV A, 1990, J APPL PHYS, V67, P734, DOI 10.1063/1.345779
   LAURSEN TA, 1992, J MATER RES, V7, P618, DOI 10.1557/JMR.1992.0618
   LIDDLE JA, 1994, MATER RES SOC SYMP P, V338, P501
   Lucas BN, 1999, METALL MATER TRANS A, V30, P601, DOI 10.1007/s11661-999-0051-7
   Macionczyk F, 1998, J MATER RES, V13, P2852, DOI 10.1557/JMR.1998.0390
   Maier-Schneider D., 1995, Sensors and Materials, V7, P121
   Mann AB, 1999, J MATER RES, V14, P2195, DOI 10.1557/JMR.1999.0643
   McElhaney KW, 1998, J MATER RES, V13, P1300, DOI 10.1557/JMR.1998.0185
   MOODY NR, 1998, MATER RES SOC S P, P522
   MOSKE M, 1988, REV SCI INSTRUM, V59, P2012, DOI 10.1063/1.1140017
   MOSKE MA, 1993, J APPL PHYS, V74, P1716, DOI 10.1063/1.354826
   *MTS SYST CORP, NANOXP
   Nakladal A, 1998, MATER RES SOC SYMP P, V518, P105, DOI 10.1557/PROC-518-105
   NIX WD, 1989, METALL TRANS A, V20, P2217, DOI 10.1007/BF02666659
   NIX WD, UNPUB
   NOYAN IC, 1987, RESIDUAL STRESS MEAS
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PAVIOT VM, 1995, MATER RES SOC SYMP P, V356, P579
   PETERSEN KE, 1979, J APPL PHYS, V50, P6761, DOI 10.1063/1.325870
   READ DT, 1993, J MATER RES, V8, P1542, DOI 10.1557/JMR.1993.1542
   Read DT, 1998, INT J FATIGUE, V20, P203, DOI 10.1016/S0142-1123(97)00080-7
   RUUD JA, 1993, J MATER RES, V8, P112, DOI 10.1557/JMR.1993.0112
   SANCHEZ JE, 1992, SCRIPTA METALL MATER, V27, P285, DOI 10.1016/0956-716X(92)90513-E
   SCHADLER L, 1995, APPL PHYS LETT, V66, P22, DOI 10.1063/1.114168
   Schlax MP, 1999, J VAC SCI TECHNOL B, V17, P2714, DOI 10.1116/1.591051
   SCHLAX MP, 1999, S EM LIGH TECHN 3 SP, V3676, P556
   Schwaiger R, 1999, SCRIPTA MATER, V41, P823, DOI 10.1016/S1359-6462(99)00231-6
   Schwaiger R., UNPUB
   SCHWEITZ JA, 1992, MRS BULL, V17, P34, DOI 10.1557/S0883769400041646
   Sharpe WN, 1997, J MICROELECTROMECH S, V6, P193, DOI 10.1109/84.623107
   Shojaei OR, 1998, THIN SOLID FILMS, V332, P202, DOI 10.1016/S0040-6090(98)01057-8
   STEWART RA, 1991, SENS MATER, V2, P285
   Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021
   Suresh S, 1998, ACTA MATER, V46, P5755, DOI 10.1016/S1359-6454(98)00226-2
   TABATA O, 1990, APPL PHYS LETT, V56, P1314, DOI 10.1063/1.103199
   TOWNSEND PH, 1992, MATER RES SOC SYMP P, V239, P37
   Tsui TY, 1996, J MATER RES, V11, P752, DOI 10.1557/JMR.1996.0091
   van Leeuwen M, 1999, J APPL PHYS, V86, P1904, DOI 10.1063/1.370986
   VENKATRAMAN R, 1992, J MATER RES, V7, P2040, DOI 10.1557/JMR.1992.2040
   VINCI RP, 1995, MATER RES SOC SYMP P, V356, P459
   VLASSAK JJ, 1992, J MATER RES, V7, P3242, DOI 10.1557/JMR.1992.3242
   VOLKERT CA, 1994, J MATER RES, V9, P1147, DOI 10.1557/JMR.1994.1147
   von Preissig FJ, 1998, MATER RES SOC SYMP P, V518, P117, DOI 10.1557/PROC-518-117
   WEIHS TP, 1988, J MATER RES, V3, P931, DOI 10.1557/JMR.1988.0931
   Yu CL, 1997, MATER RES SOC SYMP P, V446, P261
   Ziebart V, 1998, J MICROELECTROMECH S, V7, P320, DOI 10.1109/84.709651
NR 98
TC 103
Z9 103
U1 2
U2 60
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD MAR
PY 2001
VL 3
IS 3
BP 99
EP 110
DI 10.1002/1527-2648(200103)3:3<99::AID-ADEM99>3.3.CO;2-U
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 416AW
UT WOS:000167756600002
DA 2018-10-20
ER

PT J
AU Anderson, R
   Balls, M
   Burke, MD
   Cummins, M
   Fehily, D
   Gray, N
   de Groot, MG
   Helin, H
   Hunt, C
   Jones, D
   Price, D
   Richert, L
   Ravid, R
   Shute, D
   Sladowski, D
   Stone, H
   Thasler, W
   Trafford, J
   van der Valk, J
   Weiss, T
   Womack, C
   Ylikomi, T
AF Anderson, R
   Balls, M
   Burke, MD
   Cummins, M
   Fehily, D
   Gray, N
   de Groot, MG
   Helin, H
   Hunt, C
   Jones, D
   Price, D
   Richert, L
   Ravid, R
   Shute, D
   Sladowski, D
   Stone, H
   Thasler, W
   Trafford, J
   van der Valk, J
   Weiss, T
   Womack, C
   Ylikomi, T
TI The establishment of human research tissue banking in the UK and several
   western European countries - The report and recommendations of ECVAM
   Workshop 44
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
AB This is the report of the forty-fourth of a series of workshops organised by the European Centre for the Validation of Alternative Methods (ECVAM). ECVAM's main goal, as defined in 1993 by its Scientific Advisory Committee, is to promote the scientific and regulatory acceptance of alternative methods which are of importance to the biosciences and which reduce, refine or replace the use of laboratory animals. One of the first priorities set by ECVAM was the implementation of procedures that would enable it to become well-informed about the state-of-the-art of non-animal test development and validation, and the potential for the possible incorporation of alternative tests into regulatory procedures. It was decided that this would be best achieved by the organisation of ECVAM workshops on specific topics, at which small groups of invited experts would review the current status of in vitro tests and their potential uses, and make recommendations about the best ways forward (1). In addition, other topics relevant to the Three Rs concept of alternatives to animal experiments have been considered in several ECVAM workshops.
   A workshop on the establishment of human research tissue banking in the UK and several western European countries was held at The Belfry, Birmingham. UK, on 8-10 September 2000, under the chairmanship of Robert Anderson (UK Human Tissue Bank [UK HTB]). There were 22 participants from six western European countries.
   The principal aim of the workshop was to explore the feasibility of establishing research tissue banks (RTBs) in the countries represented, in order to facilitate programmes of medical and pharmacotoxicological research. This report builds upon the conclusions and recommendations of ECVAM Workshop 32 on the availability of human tissue for biomedical research (2) and summarises discussions and progress made since the publication of that report, toward the provision of tissue banking services in European countries. A number of recommendations are proposed for improving the availability of human material for research through the formation of a European Network of Research Tissue Banks (ENRTB).
C1 De Montfort Univ, UK Human Tissue Bank, Leicester LE1 5XY, Leics, England.
RP Anderson, R (reprint author), De Montfort Univ, UK Human Tissue Bank, Innovat Ctr, Leicester LE1 5XY, Leics, England.
RI Weiss, Thomas/G-3989-2012; van der Valk, Jan/A-8529-2008
OI Weiss, Thomas/0000-0003-0336-0581; Sladowski,
   Dariusz/0000-0002-2453-5160
CR Anderson R, 1998, ATLA-ALTERN LAB ANIM, V26, P763
   GURNEY J, 1993, HUMAN CELLS IN IN VITRO PHARMACO-TOXICOLOGY, P315
   *NUFF COUNC BIOETH, 1995, HUM TISS ETH LEG ISS, P113
   1997, ATLA, V22, P7
NR 4
TC 20
Z9 21
U1 0
U2 2
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD MAR-APR
PY 2001
VL 29
IS 2
BP 125
EP 134
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 420VN
UT WOS:000168026100010
PM 11262758
DA 2018-10-20
ER

PT J
AU Kleps, I
   Angelescu, A
   Vasilco, R
   Dascalu, D
AF Kleps, Irina
   Angelescu, Anca
   Vasilco, Roxana
   Dascalu, Dan
TI New Micro- and Nanoelectrode Arrays for Biomedical Applications
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE nanoelectrode array technology; biotechnology; nano-tools
AB A very simple fabrication technology for a new electrode array architecture with pyramidal micro- or nano-electrodes (ultramicroelectrodes, or UME) is described in this paper. This technology is based on standard processes used in silicon device fabrication such as: silicon etching, metallic and dielectric film deposition. In order to release the dielectric material from the top of the pyramidal electrode, the photolithographic exposure takes place on the whole silicon surface without photolithographic mask. Different applications of these micro- and nano-electrode array in bio-medical field are presented.
C1 [Kleps, Irina; Angelescu, Anca; Vasilco, Roxana; Dascalu, Dan] Natl Inst Res & Dev Microtechnol IMT Bucharest, Bucharest, Romania.
RP Kleps, I (reprint author), Natl Inst Res & Dev Microtechnol IMT Bucharest, POB 38-160, Bucharest, Romania.
EM irinak@imt.ro
CR [Anonymous], 1997, P WTEC WORKSH ROSSL
   BIRGE RR, 1995, SCI AM, V272, P90, DOI 10.1038/scientificamerican0395-90
   Borkholder D. A., 1998, THESIS
   Dabrowski MJ, 1995, ADV MATER, V7, P1015, DOI 10.1002/adma.19950071209
   Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029
NR 5
TC 10
Z9 10
U1 9
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD MAR
PY 2001
VL 3
IS 1
BP 29
EP 33
DI 10.1023/A:1011469102224
PG 5
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33KU
UT WOS:000209018500004
DA 2018-10-20
ER

PT J
AU Gurrappa, I
AF Gurrappa, I
TI Corrosion and its importance in selection of materials for biomedical
   applications
SO CORROSION PREVENTION & CONTROL
LA English
DT Article
ID ALLOYING ELEMENTS; ION-IMPLANTATION; TITANIUM-ALLOYS; WEAR BEHAVIOR;
   HYDROXYAPATITE; ADHESION; CELLS
AB BIOMEDICAL PROSTHETIC devices are artificial replacements that are used in the human body to function as original parts. Corrosion is one of the major processes that cause failures of the implant devices. In this paper, the factors responsible for causing corrosion, and the importance of corrosion in selecting suitable materials, are emphasized. The different biomaterials that have been used are reviewed, and the advantages and disadvantages of each type of alloy are reviewed. The paper also describes various laboratory-testing solutions for evaluating the performance of newer materials and coatings, to improve their properties. The role of surface engineering techniques in enhancing the biocompatibility of a variety of biomaterials is highlighted, and the results in improving corrosion resistance are presented. Finally, the necessity for innovation and development of smart materials/coatings with improved functional and biocompatible properties, either by employing surface engineering or through improving process parameters is discussed.
C1 Def Met Res Lab, Hyderabad 500258, Andhra Pradesh, India.
RP Gurrappa, I (reprint author), Def Met Res Lab, PO Kanchanbagh, Hyderabad 500258, Andhra Pradesh, India.
CR Acharya A., 1979, ASTM STP, V684, P229
   ARNAUD Y, 1986, APPL SURF SCI, V26, P12, DOI 10.1016/0169-4332(86)90049-8
   BAILEY OT, 1952, J NEUROSURG, V9, P83, DOI 10.3171/jns.1952.9.1.0083
   Bechtol CO., 1959, METALS ENG BONE JOIN
   BOROWY KH, TITANIUM BIOMEDICAL, P1381
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   BRIGHTON CT, 1984, ORTHOP CLIN N AM, V15, P1
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   CLINARD K, 1981, J DENT RES, V60, P682
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   DFARNALFY G, 1986, SURF ENG, V2, P213
   Donachie M., 1998, ADV MATER PROCESS, V7, P63
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   FRAKER AC, 1985, 853166 NBSIR
   Fu L, 2000, SURF COAT TECH, V127, P66, DOI 10.1016/S0257-8972(00)00559-4
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Genkins G. N., 1978, PHYSL BIOCH MOUTH, P284
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   GURRAPPA I, IN PRESS
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   HANSMANN H, 1993, VEREIN DTSCH GESELLS, V15, P134
   HARUYUKI K, 1992, B JAPAN I METALS, V31, P1033
   HILLE GH, 1966, J MATER, V1, P373
   Hirschhorn J.S., 1969, RES DENTAL MED MATER, P137
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   Howlett C. R., 1993, Clinical Materials, V14, P57, DOI 10.1016/0267-6605(93)90048-C
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   Hubler R, 1999, SURF COAT TECH, V116, P1111, DOI 10.1016/S0257-8972(99)00221-2
   ICART, 1775, J MED CHIR PHARM, V44, P169
   JERGESEN FH, 1951, STUDIES VARIOUS FACT
   JI HX, 1991, SURF COAT TECH, V45, P121, DOI 10.1016/0257-8972(91)90214-H
   JOHNSSON CB, 1993, J MAT SCI MAT MED, V4, P132
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KIRKPATRICK CJ, 1992, CELL MATER, V2, P169
   KRIGMAN MR, 1984, NEUROTOXICOLOGY, V5, P129
   KUMAR MK, 2000, P GLOB 2000 CORR M N, V1, P561
   KUMAR P, 1985, ASTM STP, V859, P30
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LAING PG, 1977, P RETR AN ORTH IMP G, P31
   LEVENTHAL GC, 1951, J BONE JOINT SURG, V33, P573
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Lister J, 1883, Br Med J, V2, P855
   LUDWIGSO.DC, 1965, MET ENG QUART, V5, P1
   MARTINELLA R, 1984, MATER RES SOC S P, V27, P711
   MASMONTEIL F, 1935, PRESSE MED, V43, P1915
   MEYER M, 1999, Z METALLKD, V90, P12
   MIROWSKY AM, 1950, J NEUROSURG, V7, P485
   Moffa J P, 1984, CDA J, V12, P45
   MORISHITA M, 1990, J JPN I MET, V54, P568, DOI 10.2320/jinstmet1952.54.5_568
   Nielsen K., 1987, British Corrosion Journal, V22, P272
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   OKAZAKI Y, 1994, MATER T JIM, V35, P58, DOI 10.2320/matertrans1989.35.58
   OLIVER WC, 1984, METALL TRANS A, V15, P2221, DOI 10.1007/BF02647105
   PARGES G, 1988, SURF COAT TECH, V35, P611
   RAVASINI G, 1985, ATLAS, P136
   RHINELANDER FW, 1967, J BIOMED MATER RES, V1, P235
   RIFU J, 1991, BIOMATER, V12, P39
   ROSTOKER W, 1976, J BIOMED MATER RES, V10, P303, DOI 10.1002/jbm.820100211
   Salman N. N., 1980, THESIS CLEMSON U
   SARKAR N, 1980, J DENT RES, V59, P28
   SARKAR NK, 1983, J ORAL REHABIL, V10, P121, DOI 10.1111/j.1365-2842.1983.tb00106.x
   SELLA C, 1991, SURF COAT TECH, V45, P145
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V19-20, P204, DOI 10.1016/S0168-583X(87)80043-5
   SOLAR RJ, 1985, ASTM STP, V859, P161
   SOLAR RJ, 1985, ASTM STP, V859, P253
   Solar RJ, 1979, ASTM STP, P259
   STEWART KL, 1983, CLIN REMOVABLE PARTI, P31
   Venable CS, 1937, ANN SURG, V105, P917, DOI 10.1097/00000658-193706000-00006
   VENABLE CS, INTERNAL FIXATION FR
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   WILLIAMS DF, 1973, IMPLANTS SURG
   WILLIS AL, 1974, PROSTAGLANDINS, V5, P1, DOI 10.1016/S0090-6980(74)80126-7
   WINSHIP KA, 1988, ADVERSE DRUG REACT, V1, P19
NR 73
TC 11
Z9 18
U1 0
U2 1
PU SCIENTIFIC SURVEYS LTD
PI BEACONSFIELD
PA PO BOX 21, BEACONSFIELD, BUCKS, ENGLAND HP9 1NS
SN 0010-9371
J9 CORROS PREVENT CONTR
JI Corrosion Prev. Control
PD MAR
PY 2001
VL 48
IS 1
BP 23
EP 37
PG 15
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 421FU
UT WOS:000168054800005
DA 2018-10-20
ER

PT J
AU Sunday, J
   Eyles, J
   Upshur, R
AF Sunday, J
   Eyles, J
   Upshur, R
TI Applying Aristotle's doctrine of causation to Aboriginal and biomedical
   understandings of diabetes
SO CULTURE MEDICINE AND PSYCHIATRY
LA English
DT Article
DE aboriginal; Aristotle; Canada; cause; diabetes
ID EXPLANATIONS; DISEASE
AB Aristotle's doctrine on causation identifies four distinct types of cause: formal, efficient, material, and final. Science is said to have differentiated itself from philosophy by concentrating solely on efficient causes. Nonetheless, when applied to narratives of causation, Aristotle's doctrine provides a useful heuristic to explore the issues such as Aboriginal and biomedical perceptions of causal factors for non-insulin dependent diabetes mellitus (NIDDM) on Manitoulin Island, Ontario. This paper also outlines two divergent causal stories for NIDDM and the associated moral positions regarding the `righteous' pursuit of health. Biomedical narratives emphasize the role of lifestyle factors, particularly the impact of obesity, in causation. In the case of diabetes, the moral course of action is pursued through lifestyle choices. In contrast, Aboriginal narratives emphasize the role of genetics in causation. These narratives describe diabetes as collectively affecting Aboriginal people - thus identifying Aboriginal people as different. Aboriginal frameworks for health venture beyond the 'efficient' cause of biomedicine and thus the moral pursuit of health within this framework involves returning to an initial state of health and purity through traditional knowledge.
C1 McMaster Univ, Hamilton, ON L8S 4K1, Canada.
RP Sunday, J (reprint author), McMaster Univ, BSB B150,1280 Main St W, Hamilton, ON L8S 4K1, Canada.
OI Upshur, Ross/0000-0003-1128-0557
CR Aristotle, 1998, METAPHYSICS
   Bernard H.R., 1995, RES METHODS ANTHR QU
   BLAXTER M, 1983, SOC SCI MED, V17, P59, DOI 10.1016/0277-9536(83)90356-8
   Boston P, 1997, Chronic Dis Can, V18, P5
   BROWN P, 1992, J HEALTH SOC BEHAV, V33, P267, DOI 10.2307/2137356
   Doyal L., 1986, EMPIRICISM EXPLANATI
   ELLIOTT S, 1994, U VICTORIA W GEOGRAP, V29, P135
   FIFE BL, 1994, SOC SCI MED, V38, P309, DOI 10.1016/0277-9536(94)90400-6
   Garro L C, 1995, Soc Sci Med, V40, P37, DOI 10.1016/0277-9536(94)00125-D
   Garro LC, 1996, CULT MED PSYCHIAT, V20, P381, DOI 10.1007/BF00117086
   GARRO LC, 1993, DIABETES DIS CIVILIZ
   GOOD BJ, 1994, MED RATIONALITY EXPE
   Hage J., 1988, SOCIAL CAUSALITY
   HAGEY R, 1984, SOC SCI MED, V18, P265, DOI 10.1016/0277-9536(84)90089-3
   HEFFERNAN MC, 1995, PERSISTENT SPIRIT UN
   HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064
   Hollis Martin, 1982, RATIONALITY RELATIVI
   Horton R., 1973, MODES THOUGHT ESSAYS
   HORTON R, 1970, RATIONALITY
   JOE JR, 1995, DIABETES DIS CIVILIZ
   KLEINMAN A, 1988, ILLNESS NARRATIVES S
   Leplin J, 1984, SCI REALISM
   LITVA A, 1994, SOC SCI MED, V39, P1083, DOI 10.1016/0277-9536(94)90380-8
   *QUAL SOL RES PTY, 1994, NUD IST VERS 4 0
   Russell B, 1984, HIST W PHILOS
   Shweder R, 1984, CULTURE THEORY ESSAY
   SMITH BE, 1981, INT J HEALTH SERV, V11, P343, DOI 10.2190/LMPT-4G1J-15VQ-KWEK
   Sontag S, 1989, ILLNESS METAPHOR AID
   Sperber D., 1985, ANTHR KNOWLEDGE
   Stacey M., 1988, SOCIOLOGY HLTH HEALI
   SZATHMARY EJE, 1994, ANNU REV ANTHROPOL, V23, P457
   Tambiah S.J, 1990, MAGIC SCI RELIG SCOP
   Taylor Charles, 1985, PHILOS HUMAN SCI
   WAKEFIELD S, 1998, QUALITATIVE ANAL PRO, P111
   Warry W., 1998, UNFINISHED DREAMS CO
   Wilson B. R, 1970, RATIONALITY
   Wilson J. D., 1991, HARRISONS PRINCIPLES
   YOUNG TK, 1990, SOC SCI MED, V31, P129, DOI 10.1016/0277-9536(90)90054-V
   YOUNG TK, 1987, DIABETES CANADIAN NA
   YOUNG TK, 1994, DIABETES DIS CIVILIZ, P21
NR 40
TC 23
Z9 23
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0165-005X
J9 CULT MED PSYCHIAT
JI Cult. Med. Psychiatr.
PD MAR
PY 2001
VL 25
IS 1
BP 63
EP 85
DI 10.1023/A:1005638900581
PG 23
WC Anthropology; Psychiatry; Social Sciences, Biomedical
SC Anthropology; Psychiatry; Biomedical Social Sciences
GA 397BU
UT WOS:000166674100003
PM 11270666
DA 2018-10-20
ER

PT J
AU White, MJ
   Yun, ZQ
   Iskander, MF
AF White, MJ
   Yun, ZQ
   Iskander, MF
TI A new 3-D FDTD multigrid technique with dielectric traverse capabilities
SO IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES
LA English
DT Article
DE complex structures; dielectric traverse; electrically large;
   finite-difference time-domain method; multigrid; sub-gridding
ID SIMULATION
AB The finite-difference time-domain (FDTD) technique has become increasingly popular and is being used to model extremely complex and electrically large structures, These simulations are computationally demanding and often exceed available limits on computer resources, In this paper, we present an FDTD sub-gridding technique that allows for increased resolution in regions of interest without increasing the overall computational requirements beyond the available resources. Furthermore, the formulation presented here allows for traversing dielectric boundaries using any integer refinement factor and the maximum Courant number By allowing the coarse-/fine-grid boundary to traverse dielectric boundaries, numerical simulations that were previously either extremely difficult or impossible to perform are now possible. The technique presented here uses a weighted current value from the coarse region at the boundary between the fine- and coarse-grid regions to update the fine-region tangential fields on that boundary, The weighting function depends on the material properties and the relative position of the fine-region electric field within the current contour at the boundary. The complete formulation of this new technique is described and some results of simulation cases are presented to validate the accuracy and stability of the newly developed FDTD code. Simulations include simple cases where the analytical solution exists and more complex cases, which were impossible to model using a uniform-grid FDTD code, In some simulation examples, computer memory savings as high as 70 times what would have been necessary with a uniform-grid code were achieved, It is shown that errors of less than 2% are achievable with ratios of coarse-to-fine grid sizes exceeding ten, The new technique is expected to be used in simulating many electrically large and complex structures in the biomedical microwave processing of materials and the wireless communications areas.
C1 Univ Utah, Dept Elect Engn, Salt Lake City, UT 84112 USA.
RP White, MJ (reprint author), Univ Utah, Dept Elect Engn, Salt Lake City, UT 84112 USA.
CR BRINGHURST S, 1996, P MAT RES SOC S DIG, V430, P487
   Chevalier MW, 1997, IEEE T ANTENN PROPAG, V45, P411, DOI 10.1109/8.558656
   CHOI DH, 1986, IEEE T MICROW THEORY, V34, P1464
   Okoniewski M, 1997, IEEE T ANTENN PROPAG, V45, P422, DOI 10.1109/8.558657
   Prescott D. T., 1992, IEEE Microwave and Guided Wave Letters, V2, P434, DOI 10.1109/75.165634
   Subirats M, 1996, MATER RES SOC SYMP P, V430, P29, DOI 10.1557/PROC-430-29
   White MJ, 1997, IEEE T ANTENN PROPAG, V45, P1512, DOI 10.1109/8.633859
   White MJ, 1996, MATER RES SOC SYMP P, V430, P487, DOI 10.1557/PROC-430-487
   ZIVANOVIC SS, 1991, IEEE T MICROW THEORY, V39, P471, DOI 10.1109/22.75289
NR 9
TC 35
Z9 36
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394 USA
SN 0018-9480
J9 IEEE T MICROW THEORY
JI IEEE Trans. Microw. Theory Tech.
PD MAR
PY 2001
VL 49
IS 3
BP 422
EP 430
DI 10.1109/22.910545
PG 9
WC Engineering, Electrical & Electronic
SC Engineering
GA 410WF
UT WOS:000167463500002
DA 2018-10-20
ER

PT J
AU Lavos-Valereto, IC
   Konig, B
   Rossa, C
   Marcantonio, E
   Zavaglia, AC
AF Lavos-Valereto, IC
   Konig, B
   Rossa, C
   Marcantonio, E
   Zavaglia, AC
TI A study of histological responses from Ti-6Al-7Nb alloy dental implants
   with and without plasma-sprayed hydroxyapatite coating in dogs
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SURFACE MODIFICATION
AB Titanium alloys are hoped to be used much more for applications as implant materials in the medical and dental fields because of their basic properties, such as biocompatibility, corrosion resistance and specific strength compared with other metallic implant materials. Thus, the Ti-6Al-7Nb alloy that has recently been developed for biomedical use, that is, primarily developed for orthopaedic use, is to be studied in this paper, for application in dental implants. The biocompatibility test in vivo was carried out in dogs and the osseointegration was verified through histological analysis of the samples of the Ti-6Al-7Nb alloy with and without hydroxyapatite coating that were inserted in the alveoli. Within the controlled conditions the samples did not show any toxic effects on the cells. (C) 2001 Kluwer Academic Publishers.
C1 Univ Sao Paulo, IPEN CNEN SP, BR-05508 Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Biomed Sci, BR-05508 Sao Paulo, Brazil.
   State Univ Sao Paulo, Fac Dent Araraquara, Sao Paulo, Brazil.
   Univ Estadual Campinas, Dept Mat, Campinas, Brazil.
RP Lavos-Valereto, IC (reprint author), Univ Sao Paulo, IPEN CNEN SP, BR-05508 Sao Paulo, Brazil.
EM iclvaler@usp.br
RI Rossa Jr, Carlos/D-8328-2012; Marcantonio, Elcio/A-4784-2008
OI Rossa Jr, Carlos/0000-0003-1705-5481; Marcantonio,
   Elcio/0000-0003-1294-2305
CR Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   HAMAN JD, 1995, J THERM SPRAY TECHN, V4, P179, DOI 10.1007/BF02646110
   KHUR KA, 1993, P NTSC, P347
   MEFFERT RM, 1992, J PERIODONTOL, V63, P859, DOI 10.1902/jop.1992.63.11.859
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   PILLIAR RM, 1991, BIOMATERIALS, V12, P95, DOI 10.1016/0142-9612(91)90185-D
   Rupp F, 1996, ADV MATER, V8, P254, DOI 10.1002/adma.19960080316
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   STREICHER RM, 1991, BIOMATERIALS, V12, P125, DOI 10.1016/0142-9612(91)90190-L
   WILLIAMS D F, 1991, Mammalian Species, P1
   WILLIAMS DF, 1987, DEFINITIONS BIOMATER, P9
NR 11
TC 22
Z9 25
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2001
VL 12
IS 3
BP 273
EP 276
DI 10.1023/A:1008975418453
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 403LW
UT WOS:000167045100012
PM 15348312
DA 2018-10-20
ER

PT J
AU Guinovart-Diaz, R
   Bravo-Castillero, J
   Rodriguez-Ramos, R
   Sabina, FJ
   Martinez-Rosado, R
AF Guinovart-Diaz, R
   Bravo-Castillero, J
   Rodriguez-Ramos, R
   Sabina, FJ
   Martinez-Rosado, R
TI Overall properties of piezocomposite materials 1-3
SO MATERIALS LETTERS
LA English
DT Article
DE piezocomposite; effective properties; asymptotic homogenization;
   biomedical application
ID ULTRASONIC TRANSDUCER APPLICATIONS; COMPOSITES
AB The purpose of this paper is to present analytical expressions of the effective constants of reinforced piezoelectric composite materials with periodically distributed unidirectional cylindrical fibers for transducer applications. Each periodic cell of the medium is a binary piezoelectric composite wherein both constituents are homogeneous piezoelectric materials with hexagonal symmetry. The general formulae obtained allow the prediction of global properties of an important class of piezocomposites. Numerical calculations show an adequate concordance with other theoretical models. In the analysis, the periodicity of the structure is assumed to be much smaller than the elastic wavelength. Finally, we apply these results to a 1-3 material and obtain new piezocomposites with better global properties for biomedical imaging and hydrophone applications, (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ La Habana, Fac Matemat & Computac, Havana 10400, Cuba.
   Inst Tecnol Estudios Super Monterrey, Div Arquitectura & Ingn, Atizapan 52926, Mexico.
   Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Mexico City 01000, DF, Mexico.
RP Guinovart-Diaz, R (reprint author), Univ La Habana, Fac Matemat & Computac, Havana 10400, Cuba.
RI Sabina, Federico/A-1974-2008
OI Guinovart-Sanjuan, David/0000-0002-0687-0993; Martinez-Rosado, Raul
   /0000-0001-9952-2519; Bravo-Castillero, Julian/0000-0002-7499-3821
CR BRAVOCASTILLERO J, 1998, INT J SOLIDS STRUCT, V35, P527
   BRAVOCASTILLERO R, 1997, MECH COMPOS MATER, V33, P670
   CHAN HLW, 1989, IEEE T ULTRASON FERR, V36, P434, DOI 10.1109/58.31780
   Galka A, 1996, COMPUT ASSISTED MECH, V3, P133
   Geng XC, 1999, J APPL PHYS, V85, P1342, DOI 10.1063/1.369265
   Geng XC, 1997, IEEE T ULTRASON FERR, V44, P857, DOI 10.1109/58.655201
   Hashimoto K. Y., 1986, IEEE 1986 Ultrasonics Symposium Proceedings (Cat. No.86CH2375-4), P697
   NEWNHAM RE, 1978, MATER RES BULL, V13, P525, DOI 10.1016/0025-5408(78)90161-7
   Pastor J, 1997, MECH RES COMMUN, V24, P145, DOI 10.1016/S0093-6413(97)00006-2
   Rodriguez-Ramos R., 1996, MECH COMPOS MATER, V32, P410
   SMITH WA, 1991, IEEE T ULTRASON FERR, V38, P40, DOI 10.1109/58.67833
NR 11
TC 33
Z9 33
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD MAR
PY 2001
VL 48
IS 2
BP 93
EP 98
DI 10.1016/S0167-577X(00)00285-8
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 415ZC
UT WOS:000167752600006
DA 2018-10-20
ER

PT J
AU Samset, E
   Mala, T
   Ellingsen, R
   Gladhaug, I
   Soreide, O
   Fosse, E
AF Samset, E
   Mala, T
   Ellingsen, R
   Gladhaug, I
   Soreide, O
   Fosse, E
TI Temperature measurement in soft tissue using a distributed fibre
   Bragg-grating sensor system
SO MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
LA English
DT Article
DE biomedical engineering; fibreoptics; thermometers; magnetic resonance
   imaging; freezing; cryosurgery
ID THERMOMETRY; PROBE
AB Currently used temperature sensor systems do not provide sufficient spatial resolution and can not be used as an integrated part of minimally invasive treatment. Few magnetic resonance (MR) compatible sensor systems are available. A distributed fibre Bragg-grating sensor system for use in biological tissue was constructed. Ten Bragg gratings were inscribed in the core of an optical fibre. The fibre was mounted into tubes made of MR-compatible materials. An opto-electronic unit connected to the fibre was used for signal generation and detection. Communication with a PC allowed presentation and logging of temperature data. The system was calibrated to the temperature range -195.8 degreesC to 100 degreesC. Experiments were conducted during freezing (cryoablation) of porcine liver in vivo. The system yielded a temperature profile with 6.5 mm spatial resolution and 5 s temporal resolution. Both mechanical stability and MR compatibility were acceptable and will allow routine use.
C1 Natl Hosp Norway, Intervent Ctr, Oslo, Norway.
RP Samset, E (reprint author), Rikshosp, Intervensjonssenteret, N-0027 Oslo, Norway.
CR Daniel BL, 1999, MAGNET RESON MED, V41, P627, DOI 10.1002/(SICI)1522-2594(199903)41:3<627::AID-MRM28>3.3.CO;2-H
   DEPOORTER J, 1995, MAGNET RESON MED, V33, P74
   ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606
   LINDE DR, 1998, CRC HDB CHEM PHYSICS
   Morey W. W., 1989, P SOC PHOTO-OPT INS, V1169, P98
   Rao YJ, 1997, J LIGHTWAVE TECHNOL, V15, P779, DOI 10.1109/50.580812
   RYAN TP, 1991, J BIOMED ENG, V13, P348, DOI 10.1016/0141-5425(91)90118-Q
   Shankaranarayanan A, 1998, JMRI-J MAGN RESON IM, V8, P197, DOI 10.1002/jmri.1880080133
   Stone JG, 1997, NEUROSURGERY, V41, P20, DOI 10.1097/00006123-199707000-00007
   WANG DJ, 1994, J MAGN RESON SER B, V105, P25, DOI 10.1006/jmrb.1994.1095
   WICKERSHEIM KA, 1987, J MICROWAVE POWER EE, V22, P85
NR 11
TC 14
Z9 14
U1 0
U2 2
PU MARTIN DUNITZ LTD
PI LONDON
PA LIVERY HOUSE, 7-9 PRATT ST, LONDON NW1 0AE, ENGLAND
SN 1364-5706
J9 MINIM INVASIV THER
JI Minim. Invasive Ther. Allied Technol.
PD MAR
PY 2001
VL 10
IS 2
BP 89
EP 93
DI 10.1080/13645700152601379
PG 5
WC Surgery
SC Surgery
GA 477DP
UT WOS:000171268100004
DA 2018-10-20
ER

PT J
AU Chu, PK
   Tang, BY
   Wang, LP
   Wang, XF
   Wang, SY
   Huang, N
AF Chu, PK
   Tang, BY
   Wang, LP
   Wang, XF
   Wang, SY
   Huang, N
TI Third-generation plasma immersion ion implanter for biomedical materials
   and research
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID TITANIUM-OXIDE FILMS; DOSE UNIFORMITY; CATHODIC ARC; SURFACE
   MODIFICATION; AUXILIARY ELECTRODE; BALL-BEARINGS; SILICON;
   CONFIGURATION; DEPOSITION; METAL
AB A third generation plasma immersion ion implanter dedicated to biomedical materials and research has been designed and constructed. The distinct improvement over first and second generation multipurpose plasma immersion ion implantation equipment is that hybrid and combination techniques utilizing metal and gas plasmas, sputter deposition, and ion beam enhanced deposition can be effectively conducted in the same machine. The machine consists of four sets of high-efficiency metal arc plasma sources with magnetic filters, a custom designed high voltage modulator for operation up to 60 kV, a separate high-frequency, low-voltage power supply for hybrid treatment processes, special rotating sample stage for samples with an irregular shape, and other advanced features. The machine has been installed at Southwest Jiaotong University and operated reliably for 6 months. This article describes the design principles and performances of the machine as well as pertinent biomedical applications. (C) 2001 American Institute of Physics.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Harbin Inst Technol, Natl Key Lab, Harbin 150001, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR Aksenov I. I., 1980, Soviet Physics - Technical Physics, V25, P1164
   Anders A, 2000, HDB PLASMA IMMERSION, P2
   Anders S, 1997, IEEE T PLASMA SCI, V25, P670, DOI 10.1109/27.640683
   Bilek MMM, 1996, IEEE T PLASMA SCI, V24, P1291, DOI 10.1109/27.538803
   Chu PK, 1998, IEEE T PLASMA SCI, V26, P79, DOI 10.1109/27.659535
   Chu PK, 1997, REV SCI INSTRUM, V68, P1866, DOI 10.1063/1.1147959
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   DILLON RO, 1984, PHYS REV B, V29, P3482, DOI 10.1103/PhysRevB.29.3482
   EBERT R, 1982, UNP P WORLD C MED PH, P307
   Fan ZN, 1999, IEEE T PLASMA SCI, V27, P633, DOI 10.1109/27.772296
   Fan ZN, 1998, APPL PHYS LETT, V73, P202, DOI 10.1063/1.121755
   GUENZEL R, 1998, UNP 6 INT C PLASM SU
   GUENZEL R, 1999, UNP P 2 AS EUR INT C, P58
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   HUANG N, 1999, UNP 8 INT C SURF MOD
   HUANG N, 1999, UNP 5 IUMRS INT C AD
   HUANG N, UNPUB J VAC SCI TE A
   HUANG N, 2000, UNP 2 INT C IN MATT
   KOWK TK, 1999, J APPL PHYS, V85, P1
   Kwok DTK, 1999, IEEE T PLASMA SCI, V27, P225, DOI 10.1109/27.763123
   Kwok DTK, 1998, IEEE T PLASMA SCI, V26, P1669, DOI 10.1109/27.747885
   Lee BH, 1999, APPL PHYS LETT, V74, P3143, DOI 10.1063/1.124089
   LENG Y, 2000, UNP 2000 WORLD BIOM
   LENG YX, 2000, UNP 2 INT C IN MAT S
   LENG YX, IN PRESS THIN SOLID
   LI JG, 1993, BIOMATERIALS, V14, P229, DOI 10.1016/0142-9612(93)90028-Z
   Liu AG, 1999, J VAC SCI TECHNOL B, V17, P875, DOI 10.1116/1.590667
   Liu XH, 1996, J BIOMATER APPL, V10, P330
   Mantese JV, 1996, MRS BULL, V21, P52
   Martin N, 1998, SURF COAT TECH, V107, P172, DOI 10.1016/S0257-8972(98)00647-1
   Tang BY, 1998, SURF COAT TECH, V104, P248, DOI 10.1016/S0257-8972(98)00403-4
   TENDYS J, 1988, APPL PHYS LETT, V53, P2143, DOI 10.1063/1.100299
   Tian XB, 1999, J VAC SCI TECHNOL A, V17, P3255, DOI 10.1116/1.582051
   Tian XB, 2000, SURF COAT TECH, V128, P226, DOI 10.1016/S0257-8972(00)00652-6
   Tian XB, 2000, J APPL PHYS, V88, P2221, DOI 10.1063/1.1287221
   Tian XB, 2000, SCRIPTA MATER, V43, P417, DOI 10.1016/S1359-6462(00)00436-X
   Wang SY, 1997, SURF COAT TECH, V93, P309, DOI 10.1016/S0257-8972(97)00066-2
   Wiggins MD, 1996, J VAC SCI TECHNOL A, V14, P772, DOI 10.1116/1.580387
   ZANG T, 1999, J VAC SCI TECHNOL A, V17, P3074
   Zeng XC, 1998, J APPL PHYS, V83, P44, DOI 10.1063/1.366699
   Zeng ZM, 2000, IEEE T PLASMA SCI, V28, P394, DOI 10.1109/27.848098
   Zeng ZM, 1999, J APPL PHYS, V86, P120, DOI 10.1063/1.370708
   Zeng ZM, 1999, IEEE T PLASMA SCI, V27, P1203, DOI 10.1109/27.782301
   Zhang T, 1999, REV SCI INSTRUM, V70, P3329, DOI 10.1063/1.1149913
   Zhang T, 1999, IEEE T PLASMA SCI, V27, P786, DOI 10.1109/27.774684
   Zhang T, 1999, REV SCI INSTRUM, V70, P4359, DOI 10.1063/1.1150094
   Zhang T, 2000, SURF COAT TECH, V128, P231, DOI 10.1016/S0257-8972(00)00653-8
NR 49
TC 96
Z9 105
U1 3
U2 19
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD MAR
PY 2001
VL 72
IS 3
BP 1660
EP 1665
DI 10.1063/1.1340029
PG 6
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 406BK
UT WOS:000167194900009
DA 2018-10-20
ER

PT J
AU Bobbitt, DR
   Linder, SW
AF Bobbitt, DR
   Linder, SW
TI Recent advances in chiral detection for high performance liquid
   chromatography
SO TRAC-TRENDS IN ANALYTICAL CHEMISTRY
LA English
DT Article
DE polarimeter; optical rotatory dispersion; circular dichroism; chirality;
   optical activity; enantiomer
ID POLARIMETRIC DETECTION; CIRCULAR-DICHROISM; CAPILLARY-ELECTROPHORESIS;
   ENANTIOMERIC PURITY; HPLC SEPARATION; QUANTITATION; IDENTIFICATION;
   MODEL
AB The unique response characteristics of optical activity detectors make them an important adjunct to high performance liquid chromatography (HPLC) for the analysis of biologically active molecules. The recent commercial introduction of turnkey, circular dichroism (CD) and polarimetric detection systems compatible with the sensitivity and volume requirements of HPLC will allow these detection approaches to be applied to measurement problems in a number of areas including biomedical research and diagnosis, biotechnology, as well as pharmaceutical science. The CD and polarimetric detectors respond directly to the intrinsic optical activity of the analyte, and both the magnitude and sign of the response can be used for quantitative and qualitative determinations. The information available from these detectors is difficult or impossible to obtain by other methods. In this article, the instrumental basis for both the CD and laser-based polarimetric detectors will be reviewed. Several applications will be described in which the unique response characteristics of these detection systems, either alone or in tandem with other detectors, can be used to identify chiral materials, and determine enantiomeric excess. It will be shown that this methodology is effective either without enantiomeric separation, or under conditions of low enantio-selective resolution. With this technology, a real-time assessment of enantiomeric excess can be obtained as a means to optimize and guide enantio-selective separation processes. (C)2001 Elsevier Science B.V. All rights reserved.
C1 Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.
RP Bobbitt, DR (reprint author), Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.
CR ARMSTRONG DW, 1987, ANAL CHEM, V59, P84
   Bertucci C, 2000, CHIRALITY, V12, P84, DOI 10.1002/(SICI)1520-636X(2000)12:2<84::AID-CHIR5>3.0.CO;2-G
   BOBBITT DR, 1994, ANAL APPL CIRCULAR D, pCH2
   Charney E., 1979, MOL BASIS OPTICAL AC
   de Boer T, 2000, ELECTROPHORESIS, V21, P3220, DOI 10.1002/1522-2683(20000901)21:15<3220::AID-ELPS3220>3.0.CO;2-X
   Desiderio C, 1998, J CHROMATOGR A, V807, P37, DOI 10.1016/S0021-9673(98)00061-2
   Edkins TJ, 1996, ENANTIOMER, V1, P97
   GOODALL DM, 1988, Patent No. 2197467
   Hoglund P, 1998, J PHARMACOKINET BIOP, V26, P363, DOI 10.1023/A:1021008016719
   KUDO K, 1999, J CHROMATOGR, V20, P59
   Lodevico RG, 1997, TALANTA, V44, P1353, DOI 10.1016/S0039-9140(96)02082-6
   Lodevico RG, 1998, TALANTA, V46, P907, DOI 10.1016/S0039-9140(97)00329-9
   MANNSCHRECK A, 1980, ANGEW CHEM INT EDIT, V19, P469, DOI 10.1002/anie.198004691
   MEINARD C, 1985, J CHROMATOGR, V349, P109, DOI 10.1016/S0021-9673(00)90640-X
   NG K, 1991, MICROCHEM J, V44, P25, DOI 10.1016/0026-265X(91)90071-V
   NOVOTNY M, 1994, ANAL CHEM, V66, pA646, DOI 10.1021/ac00083a002
   Pasteur L., 1848, CR HEBD ACAD SCI, V26, P535
   PURDIE N, 1989, ANAL CHEM, V61, pA77, DOI 10.1021/ac00177a001
   RICE PD, 1989, TALANTA, V36, P985, DOI 10.1016/0039-9140(89)80179-1
   RICE PD, 1989, TALANTA, V36, P473, DOI 10.1016/0039-9140(89)80231-0
   SALVADORI P, 1991, CHIRALITY, V3, P376, DOI 10.1002/chir.530030424
   Salvadori P., 1994, CIRCULAR DICHROISM P, P541
   SOLOMONS TWG, 1992, SOLOMONS ORGANIC CHE, P186
   WELCH CJ, 1995, ADV CHROMATOGR, V35, P171
   WU ZC, 1990, J CHROMATOGR, V513, P209, DOI 10.1016/S0021-9673(01)89437-1
   YEUNG ES, 1986, ANAL CHEM, V58, P1237
   YEUNG ES, 1980, ANAL CHEM, V52, P1399, DOI 10.1021/ac50059a006
NR 27
TC 46
Z9 47
U1 2
U2 11
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0165-9936
J9 TRAC-TREND ANAL CHEM
JI Trac-Trends Anal. Chem.
PD MAR
PY 2001
VL 20
IS 3
BP 111
EP 123
DI 10.1016/S0165-9936(00)00083-2
PG 13
WC Chemistry, Analytical
SC Chemistry
GA 407JM
UT WOS:000167268500004
DA 2018-10-20
ER

PT J
AU Griffith, LG
   Grodzinsky, AJ
AF Griffith, LG
   Grodzinsky, AJ
TI Advances in biomedical engineering
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
ID PROTEIN; FUTURE
AB The most visible contributions of biomedical engineering to clinical practice involve instrumentation for diagnosis, therapy, and rehabilitation. Cell and tissue engineering also have emerged as clinical realities. In the next 25 years, advances in electronics, optics, materials, and miniaturization will accelerate development of more sophisticated devices for diagnosis and therapy, such as imaging and virtual surgery. The emerging new field of bioengineering-engineering based in the science of molecular cell biology-will greatly expand the scope of biomedical engineering to tackle challenges in molecular and genomic medicine.
C1 MIT, Ctr Biomed Engn, Dept Chem Engn, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA.
   MIT, Ctr Biomed Engn, Dept Mech Engn, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA.
   MIT, Ctr Biomed Engn, Dept Elect Engn, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA.
RP Griffith, LG (reprint author), MIT, Ctr Biomed Engn, Dept Chem Engn, Div Bioengn & Environm Hlth, 77 Mass Ave,Room 66-466, Cambridge, MA 02139 USA.
CR Bronzino J D, 2000, BIOMEDICAL ENG HDB
   BROWN CS, IN PRESS P NATL ACAD
   CORMACK AM, 1980, MED PHYS, V7, P277, DOI 10.1118/1.594708
   COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   Fagette P, 1997, IEEE ENG MED BIOL, V16, P164, DOI 10.1109/51.620510
   GEDDES LA, 1983, AM J CARDIOL, V52, P403, DOI 10.1016/0002-9149(83)90147-9
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720
   HOUNSFIELD GN, 1980, MED PHYS, V7, P283, DOI 10.1118/1.594709
   KISIDAY J, 2001, SELF ASSEMBLING PEPT, V26
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Lardo AC, 2000, PEDIATR CARDIOL, V21, P80, DOI 10.1007/s002469910010
   Lauffenburger DA, 1998, CHEM BIOL, V5, pR257, DOI 10.1016/S1074-5521(98)90110-7
   LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0
   Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709
   Riccobene TA, 1999, J THEOR BIOL, V200, P207, DOI 10.1006/jtbi.1999.0988
   SCHWAN HP, 1991, IEEE ENG MED BIOL, V10, P25, DOI 10.1109/51.84182
   SEVERINGHAUS JW, 1992, ANESTHESIOLOGY, V76, P1018
   Spelman FA, 1999, IEEE ENG MED BIOL, V18, P27, DOI 10.1109/51.765186
   Stokes CL, 2000, AICHE J, V46, P430, DOI 10.1002/aic.690460302
   WELLS PNT, 1969, PHYSICAL PRINCIPLES, P282
   Yang GZ, 2000, IEEE ENG MED BIOL, V19, P120, DOI 10.1109/51.816253
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   ZOLLIKOFER CL, 1992, CARDIOVASC INTER RAD, V15, P272, DOI 10.1007/BF02733950
NR 28
TC 18
Z9 19
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610 USA
SN 0098-7484
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD FEB 7
PY 2001
VL 285
IS 5
BP 556
EP 561
DI 10.1001/jama.285.5.556
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 397TV
UT WOS:000166714200011
PM 11176858
OA Bronze
DA 2018-10-20
ER

PT J
AU Geddes, LA
   Roeder, R
AF Geddes, LA
   Roeder, R
TI Measurement of the direct-current (Faradic) resistance of the
   electrode-electrolyte interface for commonly used electrode materials
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
ID IMPEDANCE
AB The direct-current (Faradic) resistance is important because it is the highest impedance that an electrode-electrolyte interface can attain. In this study, the Faradic resistance (Rf) of identical pairs of 0.5 cm(2) electrodes of bare and chlorided silver, tin and chlorided tin, nickel-silver, copper, and carbon was measured in contact with 0.9% saline at room temperature. It was found that for positive and negative current flow, the data fit the expression R-f=R(f0)e(-alphai) (with a high coefficient of determination), where R-f0 is the zero-current Faradic resistance and alpha is a constant that describes the manner in which R-f decreases with increasing current (i). It was found that chlorided silver exhibited the lowest R-f0; removing the chloride deposit increased R-f0 by more than sixfold. Likewise, chloriding tin reduced R-f0 by a factor of about 2. Electrolytically cleaning an electrode reduced R-f0. The highest value for R-f0 was for carbon. This paper concludes with a summary of the data for R-f0 scaled to 1 cm2 electrode area for the electrode materials measured in the present study and data from the published literature. (C) 2001 Biomedical Engineering Society.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Geddes, LA (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
CR *AAMI ANSI, 1991, 3330 AAMI
   Artz W, 1970, Biomed Eng, V5, P300
   DARSONVAL A, 1986, COMPTES RENDUS, V38, P288
   Faraday M., 1834, PHILOS T ROY SOC LON, V124, P77
   FERRARI RK, Patent No. 5571165
   Geddes L. A., 1975, PRINCIPLES APPL BIOM
   GEDDES LA, 1969, MED BIOL ENG, V7, P49, DOI 10.1007/BF02474669
   Geddes LA, 1997, ANN BIOMED ENG, V25, P1, DOI 10.1007/BF02738534
   GETZEL WA, 1976, IEEE T BIO-MED ENG, V23, P87, DOI 10.1109/TBME.1976.324626
   GRUBBS DS, 1983, MED BIOL ENG COMPUT, V21, P232, DOI 10.1007/BF02441545
   HEATH R, 1989, Patent No. 4852585
   James WB, 1910, AM J MED SCI, V140, P408
   JENKNER FL, 1967, ELECTROEN CLIN NEURO, V23, P570, DOI 10.1016/0013-4694(67)90026-0
   KADO RT, 1964, P ANN C ENG MED BIOL, V6, P1
   MARMONT G, 1949, J CELL COMPAR PHYSL, V34, P351, DOI 10.1002/jcp.1030340303
   Mayer S, 1992, Australas Phys Eng Sci Med, V15, P38
   MAYER S, 1992, MED BIOL ENG COMPUT, V30, P538, DOI 10.1007/BF02457834
   MONTER RP, 1976, Patent No. 3976055
   RAGHEB T, 1991, ANN BIOMED ENG, V19, P151, DOI 10.1007/BF02368466
   SCHWAN HP, 1968, PHYSICAL TECHNIQ V B, V1
   Volta A., 1800, PHILOS T ROY SOC LON, V90, P403
   Warburg E, 1901, ANN PHYS-BERLIN, V6, P125
   Warburg E., 1899, Annalen der Physik und Chemie, V67, P493
NR 23
TC 20
Z9 22
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2001
VL 29
IS 2
BP 181
EP 186
DI 10.1114/1.1349699
PG 6
WC Engineering, Biomedical
SC Engineering
GA 413EA
UT WOS:000167595900009
PM 11284673
DA 2018-10-20
ER

PT J
AU Miller, KL
   Erdman, MC
   King, SH
AF Miller, KL
   Erdman, MC
   King, SH
TI Contaminating incident investigation in medicine and biomedical research
SO HEALTH PHYSICS
LA English
DT Article
DE operational topic; radioactive materials; contamination; radiation
   protection
AB Regardless of how well trained, experienced and careful individuals are, if they handle radioactive materials often enough they will eventually have a contaminating incident. When the incident occurs it is imperative that the proper actions are taken to control the incident, minimize contamination and exposure, assure that proper remediation is implemented, assure that the incident remains confined, that no others become contaminated or exposed and that effective remediation is documented. This paper discusses our approach to such incidents and discusses the incident report form and our philosophy of information recording.
C1 Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA.
EM kmiller@psu.edu
CR U. S. Nuclear Regulatory Commission, 1987, REG GUID 10 8 REV 2
NR 1
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD FEB
PY 2001
VL 80
IS 2
SU S
BP S9
EP S11
PG 3
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 392PN
UT WOS:000166420200004
PM 11197516
DA 2018-10-20
ER

PT J
AU Young, FW
AF Young, FW
TI An explanation of the persistent doctor-mortality association
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Article
ID INFANT-MORTALITY; DEVELOPED-COUNTRIES; DETERMINANTS
AB Study objective-The aim of the study is to explain the persistent but puzzling positive correlation of physicians per capita and mortality rates, when income is controlled, which has been reported many times since it was first observed in 1978. The explanation that is proposed and tested is that expanding urban-industrial regions attract an oversupply of doctors. Also, but independently, rural people migrate to urban-industrial areas where they suffer from the stress of adapting to urban-industrial life. Consequently, their death rates rise.
   Source material-Using data from the 47 Japanese prefectures, the 3000+ counties of the USA and a set of 29 mostly European countries, the explanation was examined by adding the appropriate test variable to a basic equation linking physicians per capita to mortality, net of income.
   Results-The test variables dissolved or reduced the original correlation in two of the three samples, but the signs did not change from positive to negative, as would be expected on the basis of conventional biomedical theory. The available test variable (refugees) did not reduce the correlation for the 29 countries but a particular subset of countries was identified that did.
   Conclusion-The conceptual and empirical analysis exposed the positive correlation as spurious, but the availability of medical specialists had little impact on mortality rates in competition with the social and economic variables that were used as controls.
C1 Cornell Univ, Dept Rural Sociol, Ithaca, NY 14853 USA.
RP Young, FW (reprint author), Cornell Univ, Dept Rural Sociol, Ithaca, NY 14853 USA.
CR ALVAREZDARDET C, 1993, BRIT MED J, V306, P1252, DOI 10.1136/bmj.306.6887.1252
   CHEN MK, 1985, INT J EPIDEMIOL, V14, P300, DOI 10.1093/ije/14.2.300
   CLARKE LL, 1994, RURAL SOCIOL, V59, P84
   COCHRANE AL, 1978, J EPIDEMIOL COMMUN H, V32, P200, DOI 10.1136/jech.32.3.200
   COCHRANE AL, 1972, EFFECTIVENESS EFFICI
   JAYACHANDRAN J, 1986, SOC BIOL, V33, P301
   KORNHAUSER DH, 1982, JAPAN GEOGRAPHIC BAC
   MACKENBACH JP, 1990, J EPIDEMIOL COMMUN H, V44, P106, DOI 10.1136/jech.44.2.106
   Matteson DW, 1998, SOC SCI MED, V47, P1841, DOI 10.1016/S0277-9536(98)00229-9
   McKeown T, 1976, ROLE MED DREAM MIRAG
   MCKINLAY JB, 1977, MILBANK FUND Q, V55, P405, DOI 10.2307/3349539
   SANKRITHI U, 1991, INT J EPIDEMIOL, V20, P565, DOI 10.1093/ije/20.2.565
   STLEGER AS, 1978, LANCET, V2, P1153
   United Nations Development Programme, 1999, HUM DEV REP 1999
   WILLIAMS R, 1993, LOCATING HLTH SOCIOL, P179
   WIMBERLEY DW, 1990, AM SOCIOL REV, V55, P75, DOI 10.2307/2095704
   YOUNG FW, IN PRESS AM J PUBLIC
NR 17
TC 14
Z9 15
U1 0
U2 0
PU BRITISH MED JOURNAL PUBL GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD FEB
PY 2001
VL 55
IS 2
BP 80
EP 84
DI 10.1136/jech.55.2.80
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 393WX
UT WOS:000166493600005
PM 11154245
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Hellberg, A
   Ulus, AT
   Christiansson, L
   Westman, J
   Leppanen, O
   Bergqvist, D
   Karacagil, S
AF Hellberg, A
   Ulus, AT
   Christiansson, L
   Westman, J
   Leppanen, O
   Bergqvist, D
   Karacagil, S
TI Monitoring of intrathecal oxygen tension during experimental aortic
   occlusion predicts ultrastructural changes in the spinal cord
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID SOMATOSENSORY EVOKED-POTENTIALS; BLOOD-FLOW; THORACOABDOMINAL AORTA;
   SURGICAL-PROCEDURES; ISCHEMIA; PERFUSION; ANEURYSM; INJURY;
   IDENTIFICATION; REPLACEMENT
AB Objective: To study the correlation between intrathecal PO2 and ultrastructural changes in the spinal cord during thoracic aortic occlusion in pigs.
   Material and methods: In 18 pigs, online intrathecal oxygenation was monitored by a multiparameter Paratrend catheter (Biomedical Sensors, High Wycombe, United Kingdom) during 60 minutes' clamping of the proximal and distal descending thoracic aorta. The animals were randomly divided into 2 groups (A and B) depending on the level of distal aortic clamping. Distal aortic perfusion was restored through an aorto-iliac shunt, which also maintained low thoracic segmental perfusion of the spinal cord in group B. Perfusion-fixation technique was used before harvesting the spinal cord specimens, which later were evaluated with light and electron microscopy by an independent observer. Intrathecal parameters were interpreted as normal if PO2 was more than 0.8 kPa and PCO2 was less than 12 kPa, as intermediate ischemia if PO2 was 0.8 or less or PCO2 was more than 12 kPa, and as absolute ischemia if PO2 was 0.8 or less and PCO2 was more than 12 kPa.
   Results: Among 6 animals with ultrastructural changes of absolute spinal cord ischemia-reperfusion injury, 5 also had absolute ischemia according to variables derived by the Paratrend catheter, The 2 methods were in agreement in 3 of 5 animals with intermediate ischemia-reperfusion changes and in 5 of 6 animals with normal findings. The accuracy of cerebrospinal fluid PO2 and PCO2 to predict electron microscopy-verified intermediate or absolute ischemia-reperfusion injury was 94%.
   Conclusions: Monitoring of intrathecal PO2 after clamping of the descending aorta correlated with ultrastructural changes in the spinal cord in this pig model.
C1 Univ Hosp, Dept Surg, SE-75185 Uppsala, Sweden.
   Univ Hosp, Dept Anesthesiol, Uppsala, Sweden.
   Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.
RP Hellberg, A (reprint author), Univ Hosp, Dept Surg, SE-75185 Uppsala, Sweden.
CR BALENTINE JD, 1978, LAB INVEST, V39, P254
   BLISARD KS, 1995, PARAPLEGIA, V33, P136, DOI 10.1038/sc.1995.30
   Christiansson L, 1998, EUR J VASC ENDOVASC, V15, P78, DOI 10.1016/S1078-5884(98)80076-2
   Christiansson L, 2000, SURGERY, V127, P571, DOI 10.1067/msy.2000.105036
   CRAWFORD ES, 1988, J THORAC CARDIOV SUR, V95, P357
   CUNNINGHAM JN, 1987, J THORAC CARDIOV SUR, V94, P275
   de Haan P, 1998, Semin Thorac Cardiovasc Surg, V10, P19
   DUCKER TB, 1978, SURG NEUROL, V10, P64
   ELMORE JR, 1991, J VASC SURG, V14, P131
   GALLA JD, 1994, J CARDIAC SURG, V9, P662, DOI 10.1111/j.1540-8191.1994.tb00900.x
   Grabitz K, 1996, J VASC SURG, V23, P230, DOI 10.1016/S0741-5214(96)70267-7
   GRUBBS PE, 1988, SURGERY, V104, P216
   Hellberg A, 2000, J VASC SURG, V31, P164, DOI 10.1016/S0741-5214(00)70078-4
   Hellberg A, 2000, EUR J VASC ENDOVASC, V19, P318, DOI 10.1053/ejvs.1999.1027
   Ishizaki M, 1999, EUR J VASC ENDOVASC, V18, P17, DOI 10.1053/ejvs.1999.0845
   Laschinger J C, 1988, J Vasc Surg, V7, P161
   LASCHINGER JC, 1987, J THORAC CARDIOV SUR, V94, P271
   LESSER RP, 1986, ANN NEUROL, V19, P22, DOI 10.1002/ana.410190105
   Mackey ME, 1997, STROKE, V28, P2012, DOI 10.1161/01.STR.28.10.2012
   MARSALA M, 1994, STROKE, V25, P2038, DOI 10.1161/01.STR.25.10.2038
   MONGAN PD, 1994, ANESTH ANALG, V78, P257, DOI 10.1213/00000539-199402000-00011
   NASLUND TC, 1992, ANN SURG, V215, P409, DOI 10.1097/00000658-199205000-00002
   Prough DS, 1998, CRIT CARE MED, V26, P1482, DOI 10.1097/00003246-199809000-00010
   Rhee RY, 1996, INT ANGIOL, V15, P153
   SHIIYA N, 1995, J VASC SURG, V21, P970, DOI 10.1016/S0741-5214(95)70225-3
   Tonnessen TI, 1997, ACTA ANAESTH SCAND, V41, P659
   TURREN LL, 1936, ARCH NEUROL PSYCHOL, V35, P789
   Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029
   Yamada T, 1998, NEUROSURGERY, V42, P626, DOI 10.1097/00006123-199803000-00033
   YAMAMOTO N, 1994, J SPINAL DISORD, V7, P285
NR 30
TC 8
Z9 8
U1 0
U2 0
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD FEB
PY 2001
VL 121
IS 2
BP 316
EP 323
DI 10.1067/mtc.2001.112204
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 402XW
UT WOS:000167014300017
PM 11174737
OA Bronze
DA 2018-10-20
ER

PT J
AU Mischie, A
   Maior, O
   Badea, F
   Vasilescu, M
   Caragheorgheopol, A
   Caldararu, H
   Socoteanu, R
   Pencu, G
   Constantinescu, A
AF Mischie, A
   Maior, O
   Badea, F
   Vasilescu, M
   Caragheorgheopol, A
   Caldararu, H
   Socoteanu, R
   Pencu, G
   Constantinescu, A
TI Advanced organic materials. Esters of the free stable radical
   3-carboxy-proxyl having fluorescent or complexing properties
SO REVUE ROUMAINE DE CHIMIE
LA English
DT Article
ID INSULIN MIMETIC AGENT; NITROXIDE RADICALS; DERIVATIVES; CHEMISTRY;
   BIS(MALTOLATO)OXOVANADIUM(IV); LABELS; BMOV; IONS
AB In order to design new advanced organic structures, possessing prestablished hybrid properties, the stable free radical the esters 3a-c (where: a 3-(2-phenoxathiinacetylcarbonyloxy)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy; b 3-(3-phenoxathiinacetylcarbonyloxy)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy; c 3-(3-hydroxy-6-methylcarbonyloxy-4H-pyran-4-one)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy) were synthesized, starting from the persistent and stable nitroxide free radical 3-carboxy-2,2,5,5-tetramethyl-1-pyrrolidinyloxy, 1, (3-CARBOXY-PROXYL) and the bromoderivatives 2a-c (where: a 2-(alpha-bromoacetyl)-phenoxathiin; b 3-(alpha-bromoacetyl) phenoxathiin; c 6-bromomethyl-3-hydroxy-4H-pyran-4-one) in the presence of 18C6 and potassium hydroxide. The new compounds, bearing the phenoxathiin fluorescent fragment (3a,b) or the 3--hydroxy-4pyrone chelating structure (3c) linked to the proxy I-paramagnetic unit may be suitable labels in physico-chemical or biomedical processes. The spectral characteristics (IR, UV-VIS, fluorescence and EPR), the lipophilicities (determined by the RPTLC method) and the purities (from TLC densitometric analysis) of the synthesized compounds 3a-c are presented. The nitroxide free radical esters 3a-c were reduced, using ascorbic acid, cysteine, or glutathione, to the corresponding diamagnetic hydroxylamines 4a-c (where: a 3-(2-phenoxathiinacetylcarbonyloxy)-2,2,5,5-tetramethyl-1-hydroxypyrrolidine; b 3-(3-phenoxathiinacetylcarbonyloxy)-2,2,5,5-tetramethyl-1-hydroxypyrrolidine; c 3-(3-hydroxy-6-methylcarbonyloxy-4H-pyran-4-one)-2,2,5 5-tetramethyl-1-hydroxypyrrolidine). This process is reversible, the compounds 4a-c undergoing rapid reoxidation to the initial nitroxides 3a-c by air exposure. The hydroxylamines 4a-c were found to exhibit a greater fluorescence than the nitroxide radicalic species 3a-c.
C1 Romanian Acad, IG Murgulescu Inst Phys Chem, Bucharest 77208, Romania.
   Univ Bucharest, Dept Organ Chem, Bucharest, Romania.
   Politehn Univ, Dept Organ Chem, Bucharest, Romania.
   Inst Drugs Control & Pharmaceut Res, Bucharest, Romania.
RP Mischie, A (reprint author), Romanian Acad, IG Murgulescu Inst Phys Chem, 202 Splaiul Independentei, Bucharest 77208, Romania.
RI Vasilescu, Marilena/A-5275-2012
OI Radu, Socoteanu/0000-0003-1529-3603
CR Badea F, 1997, REV ROUM CHIM, V42, P3
   Caravan P, 1995, J AM CHEM SOC, V117, P12759
   CHIACCHIERINI E, 1968, COLLECT CHZECH CHEM, V33, P4125
   Cires L, 1998, J LUMIN, V79, P91, DOI 10.1016/S0022-2313(98)00023-4
   Constantinescu T, 2000, REV ROUM CHIM, V45, P1009
   DARWISH Y, 1994, J CHROMATOGR A, V668, P485, DOI 10.1016/0021-9673(94)80144-4
   DEGRAND C, 1993, J ORG CHEM, V58, P2573, DOI 10.1021/jo00061a037
   FORRESTER AR, 1968, ORGANIC CHEM STABLE, P180
   Hanson GR, 1996, INORG CHEM, V35, P6507, DOI 10.1021/ic960490p
   HEDLUND T, 1988, ACTA CHEM SCAND A, V42, P702, DOI 10.3891/acta.chem.scand.42a-0702
   HEWITT SD, 1989, ANN RHEUM DIS, V48, P382, DOI 10.1136/ard.48.5.382
   HIDAG K, 1986, CAN J CHEM, V64, P1482
   HIDER RC, 1990, ANN NY ACAD SCI, P237
   HILLEBRAND M, 1969, J CHEM SOC B, P755, DOI 10.1039/j29690000755
   Ionita G, 1998, JPC-J PLANAR CHROMAT, V11, P141
   KEANA JFW, 1978, CHEM REV, V78, P37, DOI 10.1021/cr60311a004
   KONTOGHIORGHES NT, 1987, CLIN CHIM ACTA, V163, P137
   LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003
   LEE TD, 1978, J ORG CHEM, V43, P4266
   LEHN JM, 1995, SUPRAMOL CHEM, P57
   LIKHTENSTEIN GI, 1990, PURE APPL CHEM, V62, P281, DOI 10.1351/pac199062020281
   LIOTTA CL, 1974, J AM CHEM SOC, V96, P2250, DOI 10.1021/ja00814a044
   LUCA C, 1993, REV ROUM CHIM, V38, P123
   MEHLHORN A, 1977, TETRAHEDRON, V33, P1489, DOI 10.1016/0040-4020(77)88010-1
   MUKKALA VM, 1989, ANAL BIOCHEM, V176, P319, DOI 10.1016/0003-2697(89)90316-3
   NELHMISH VH, 1961, J PHYS CHEM-US, V65, P229
   NICOLAE A, 1998, S BRAZ J CHEM, V6, P33
   PETROLA R, 1986, FINN CHEM LETT, V13, P129
   PETROLA R, 1985, FINN CHEM LETT, P219
   PETROLA R, 1985, FINN CHEM LETT, P207
   POU S, 1993, ANAL BIOCHEM, V212, P85, DOI 10.1006/abio.1993.1295
   REWCASTLE GW, 1991, J MED CHEM, V34, P491, DOI 10.1021/jm00106a003
   ROZANTZE.EG, 1965, TETRAHEDRON, V21, P491, DOI 10.1016/S0040-4020(01)82219-5
   SCHMILLER A, 1967, LANDOLTBORNSTEIN, V3, P300
   SHINE J, 1965, J ORG CHEM, V30, P2140
   STARKS CM, 1973, J AM CHEM SOC, V95, P3613, DOI 10.1021/ja00792a025
   STREATER M, 1990, J MED CHEM, V33, P1749, DOI 10.1021/jm00168a033
   SzajdzinskaPietek E, 1997, CHEM PHYS LETT, V270, P527, DOI 10.1016/S0009-2614(97)00395-3
   TAMURA R, 1994, ANGEW CHEM INT EDIT, V33, P878, DOI 10.1002/anie.199408781
   Vasilescu M, 1998, J PHYS CHEM B, V102, P7740, DOI 10.1021/jp981932g
   Vasiliu G., 1964, ANAL U BUC, V13, P103
   WHITE HL, 1992, DRUG DEVELOP RES, V25, P191, DOI 10.1002/ddr.430250303
   YAMAGUCHI M, 1990, PURE APPL CHEM, V62, P217, DOI 10.1351/pac199062020217
NR 43
TC 7
Z9 7
U1 1
U2 5
PU EDITURA ACADEMIEI ROMANE
PI BUCHAREST
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCHAREST RO-76117, ROMANIA
SN 0035-3930
J9 REV ROUM CHIM
JI Rev. Roum. Chim.
PD FEB
PY 2001
VL 46
IS 2
BP 107
EP 113
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 521PQ
UT WOS:000173850000005
DA 2018-10-20
ER

PT J
AU Hanada, T
   Li, YJ
   Nakaya, T
AF Hanada, T
   Li, YJ
   Nakaya, T
TI Synthesis and hemocompatibilities of cellulose-containing segmented
   polyurethanes
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID CHAIN ALKYL-GROUPS; PHOSPHATIDYLCHOLINE ANALOGOUS MOIETIES;
   BLOOD-COMPATIBLE POLYURETHANES; POLY(BUTADIENE) SOFT SEGMENTS; MAIN
   CHAINS; SIDE-CHAINS; PHOSPHOLIPID POLYURETHANES; BIOMEDICAL
   APPLICATIONS; POLAR HEADGROUPS; SURFACE
AB Novel segmented polyurethanes (SPUs) have been synthesized using hydrolyzed cellulose triacetate (HCTA) and 1,4-butanediol (BD) as diol component. By altering the molar ratio of HCTA to diphenylmethane diisocyanate (MDI), a series of polymers having poly(butadiene) (PBD) diol soft segments and varying content of HCTA was prepared. Then the polymers were further deacetylated with NaOCH3/CH3OH. Viscosity measurements showed the polymers had the viscosity behavior of common polyelectrolytes. Attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) and water contact angle measurements revealed that the cellulose is oriented on the surface of these materials. The hemocompatibility in vitro was evaluated with platelet-rich plasma (PRP) contact tests and viewed by scanning electron microscopy (SEM) using commercial BioSpan(R) and cellulose-free SPU as control samples. platelet adhesion to cellulose-containing SPUs was inhibited by 30-75% compared with cellulose-free polyurethanes, Cell spreading was observed on the control SPUs but not on any of the other surfaces. The incorporation of cellulose into the SPUs backbone effectively reduced platelet adhesion and thus potentially could result in better hemocompatibility.
C1 Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Nakaya, T (reprint author), Osaka City Univ, Fac Engn, Dept Bioappl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
CR Chen TM, 1996, MACROMOL CHEM PHYSIC, V197, P1587, DOI 10.1002/macp.1996.021970501
   Huang SL, 1999, J MEMBRANE SCI, V161, P21, DOI 10.1016/S0376-7388(99)00096-4
   Jo NJ, 1999, POLYM-KOREA, V23, P552
   Korematsu A, 1999, J MATER CHEM, V9, P647, DOI 10.1039/a806279j
   Korematsu A, 1997, POLYM BULL, V38, P133, DOI 10.1007/s002890050029
   Li YJ, 1997, MACROMOL SYMP, V122, P363, DOI 10.1002/masy.19971220156
   Li YJ, 1996, J APPL POLYM SCI, V62, P687
   Li YJ, 1996, CHEM MATER, V8, P1441, DOI 10.1021/cm960014x
   Li YJ, 1996, BIOMATERIALS, V17, P2179, DOI 10.1016/0142-9612(96)00048-8
   Li YJ, 1998, CHEM MATER, V10, P1596, DOI 10.1021/cm9707869
   Li YJ, 1996, MACROMOL RAPID COMM, V17, P737, DOI 10.1002/marc.1996.030171009
   Li YJ, 1999, CHEM MATER, V11, P763, DOI 10.1021/cm9806432
   Li YJ, 1997, CHEM MATER, V9, P1570, DOI 10.1021/cm960615o
   LI YJ, 1995, MACROMOL CHEM PHYSIC, V196, P3143, DOI 10.1002/macp.1995.021961006
   LI YJ, 1995, MACROMOL RAPID COMM, V16, P253, DOI 10.1002/marc.1995.030160404
   Li YJ, 1996, EUR J PHARMACOL, V311, P163, DOI 10.1016/0014-2999(96)00426-8
   Li YJ, 1996, MACROMOL CHEM PHYSIC, V197, P2827, DOI 10.1002/macp.1996.021970920
   Li YJ, 1996, J BIOMAT SCI-POLYM E, V7, P893, DOI 10.1163/156856296X00066
   Marra KG, 1997, MACROMOLECULES, V30, P6483, DOI 10.1021/ma970481f
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   NAKAYA T, 1993, MAKROMOL CHEM-RAPID, V14, P77
   NAKAYA T, 1993, MACROMOL REPORTS A, V30, P349
   NISHIO K, 1978, MAKROMOL CHEM, V179, P1117
   NISHIO K, 1974, MAKROMOL CHEM, V175, P3319
   Ramesh S, 1998, J MACROMOL SCI R M C, VC38, P481
   Saunders J. H., 1962, POLYURETHANE CHEM 1
   SHIGEMASA Y, 1992, INT J BIOL MACROMOL, V14, P274, DOI 10.1016/S0141-8130(05)80040-6
   STEINMANN HW, 1970, POLYMER PREPRINTS, V11, P285
   Sugiyama K, 1997, NIPPON KAGAKU KAISHI, P816, DOI 10.1246/nikkashi.1997.816
   Sugiyama K, 1996, KOBUNSHI RONBUNSHU, V53, P115, DOI 10.1295/koron.53.115
   Sugiyama K, 1996, KOBUNSHI RONBUNSHU, V53, P496, DOI 10.1295/koron.53.496
   Tomita T, 1999, CHEM MATER, V11, P2155, DOI 10.1021/cm9901257
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1235, DOI 10.1080/10601329508009351
   YASUZAWA M, 1986, J MACROMOL SCI CHEM, VA23, P963, DOI 10.1080/00222338608081104
NR 35
TC 17
Z9 17
U1 0
U2 10
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD JAN 24
PY 2001
VL 202
IS 1
BP 97
EP 104
DI 10.1002/1521-3935(20010101)202:1<97::AID-MACP97>3.0.CO;2-C
PG 8
WC Polymer Science
SC Polymer Science
GA 398QR
UT WOS:000166767600013
DA 2018-10-20
ER

PT S
AU Dhamdhere, AR
   Malshe, AP
   Yedave, SN
   Schmidt, WF
   Brown, WD
AF Dhamdhere, AR
   Malshe, AP
   Yedave, SN
   Schmidt, WF
   Brown, WD
GP SPIE
   SPIE
TI Failure mechanisms in high power optical device packaging: Semiconductor
   laser diodes - A case study
SO 2001 INTERNATIONAL SYMPOSIUM ON MICROELECTRONICS, PROCEEDINGS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT International Symposium on Microelectronics
CY OCT 09-11, 2001
CL BALTIMORE, MD
SP Int Microelectr & Packaging Soc, SPIE
DE semiconductor laser diode; die attach; solder; reliability; optical
   packaging
AB High power semiconductor laser diodes are finding increasing applications in diverse areas like the biomedical field, cosmetics, etc. Dissimilar materials integration and thermal management are some of the primary challenges in the fabrication and packaging of reliable laser diode systems. For example, in a specific case, a high power diode needs to be mounted in a certain configuration, with the epitaxy-side down, so as to achieve efficient heat transfer. The device and package junction, particularly the die attach interface, is required to he void (micro defect)-free, stress-free, and contamination-free for uniform optical delivery and reliable optical alignment. Soft solders used in optoelectronic applications are typically subjected to extreme service conditions that may exceed temperatures in excess of two-thirds of the melting point. As a result, it is expected that the solder microstructure is metastable and subjected to nearly constant modification during processing and device operation. In this study, we investigated high power laser diode packages aged under different conditions. Analyses of the die attach interface and microscopic defects were carried out primarily using metallography, scanning electron microscopy (SEM), and scanning acoustic microscopy (SAM). It was observed that intermetallic compounds and microscopic physical defects at the die attach interface are detrimental to the transient heat transfer, and thus, to the overall package reliability.
C1 Univ Arkansas, Dept Mech Engn, Fayetteville, AR 72701 USA.
RP Dhamdhere, AR (reprint author), Univ Arkansas, Dept Mech Engn, Fayetteville, AR 72701 USA.
EM apm2@engr.uark.edu
CR ANTLER M, 1970, PLATING, V6, P615
   CINQUE RB, 1994, J ELECTRON MATER, V23, P533, DOI 10.1007/BF02670656
   GOLDSTEIN JLF, 1994, J ELECTRON MATER, V23, P477, DOI 10.1007/BF02671233
   Lee C. C., 1997, Proceedings of the Technical Program. NEPCON West '97. Conference, P1395
   Liu YM, 2000, J ELECTRON MATER, V29, P405, DOI 10.1007/s11664-000-0152-y
   Merritt SA, 1997, IEEE T COMPON PACK B, V20, P141, DOI 10.1109/96.575565
   MORRIS JW, 1997, C P INT INT EL PHOT, V2, P1529
   Nakwaski W., 1990, Electron Technology, V23, P33
   PARSEY JM, 1999, J MAT, V31, P28
   PLOTNER M, 1991, P INT C MICR EL OPT, P358
   VIANCO PT, 1994, J ELECTRON MATER, V23, P583, DOI 10.1007/BF02653343
   WEN L, 1997, S P TMS ANN M, P219
NR 12
TC 1
Z9 1
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4317-4
J9 PROC SPIE
PY 2001
VL 4587
BP 212
EP 217
PG 2
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BT85F
UT WOS:000174225600035
DA 2018-10-20
ER

PT B
AU Drozd, Z
   Hackiewicz, H
   Jezior, R
   Lasocki, J
   Lukasik, W
   Orzechowski, J
   Szwech, M
AF Drozd, Z
   Hackiewicz, H
   Jezior, R
   Lasocki, J
   Lukasik, W
   Orzechowski, J
   Szwech, M
BE Dumitrache, I
   Svasta, P
TI New flip-chip assembly system for prototyping and process investigations
SO 24TH INTERNATIONAL SPRING SEMINAR ON ELECTRONICS TECHNOLOGY: CONCURRENT
   ENGINEERING IN ELECTRONIC PACKAGING, CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 24th International Spring Seminar on Electronics Technology (ISSE 2001)
CY MAY 05-09, 2001
CL POLITEHNICA UNIV BUCHAREST, CALIMANESTI, ROMANIA
SP Hydraul & Pneumat Res Inst, Chamber Commerce & Ind Valcea, Minist Educ & Res, IEEE Romania Sect, Romanian Assoc Electr & Software Ind, Elma Trenew Electr SRL, RondElectr SRL, Diana SRL, Bere Alutus SA, Boromir SA
HO POLITEHNICA UNIV BUCHAREST
DE FC packaging; assembly system; interconnection process
AB The Flip - Chip assembly technology and new laboratory stand for investigation of FC bonding processes are presented. The prototype system was developed by Division of Precision and Electronic Product Technology in Institute of Precision and Biomedical Engineering of Warsaw University of Technology, in cooperation with Tele & Radio Research Institute in Warsaw. New idea of the system consist in application of unique measuring and positioning subsystem assuring high precision of the chip position on the substrate. Simplicity, high precision and versatility are main advantages of presented system. The assembly processes are realized in prototype scale, however the principles and physical parameters of the process are comparable with mass production processes.
   The stand will be applied for essential tests and investigations of FC technology and materials, especially for SME. It will be also useful for didactic applications.
C1 Warsaw Univ Technol, Inst Precis & Biomed Engn, Div Precis & Elect Prod Technol, PL-03922 Warsaw, Poland.
RP Drozd, Z (reprint author), Warsaw Univ Technol, Inst Precis & Biomed Engn, Div Precis & Elect Prod Technol, Ul Chodkiewicza 8, PL-03922 Warsaw, Poland.
CR ASCHENBRENNER R, 1995, KLEBETECHNOLOGIEN FL
   DROZD Z, 1999, T PRECISION ELECT TE, V4, P191
   DROZD Z, 2001, NEW LAB STAND FLIP C, P555
   DROZD Z, NEW LAB STAND INVEST
   DROZD Z, 2000, P ISSE 2000, P253
   OPPERMANN H, 1999, T PRECISION ELECTRON, V4
NR 6
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7111-9
PY 2001
BP 68
EP 72
DI 10.1109/ISSE.2001.931014
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA BS68V
UT WOS:000170861900015
DA 2018-10-20
ER

PT S
AU Gesualdi, MRR
   Soga, D
   Muramatsu, M
AF Gesualdi, MRR
   Soga, D
   Muramatsu, M
BE Kaufmann, GH
TI Holographic interferometry techniques using photorefractives crystals of
   sillenite family Bi12SiO20 (BSO) and their applications in analysis of
   surfaces
SO 4TH IBEROAMERICAN MEETING ON OPTICS AND 7TH LATIN AMERICAN MEETING ON
   OPTICS, LASERS, AND THEIR APPLICATIONS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 4th Iberoamerican Meeting on Optics and 7th Latin American Meeting on
   Optics, Lasers, and Their Applications
CY SEP 03-07, 2001
CL TANDIL, ARGENTINA
SP Agcy Nacl Promoc Cient & Technol, Cent Latinamer Fis, Consejo Nacl Investi Cient & Tecn, Filial Buenos Aires Asociac Fis Argentina, Int Commiss Opt, Laseroptics SA, Opt Soc Amer, Spectra Phys GmbH, Abdus Salam Int Ctr Theoret Phys, SPIE, Univ Nacl Cent Provincia Buenos Aires
DE holographic interferometry; photorefractives crystals; surfaces analysis
AB The Holographic Interferometry is a Non-Destrutive Testing of analysis on surfaces in basic research, technological and biomedical fields. However, the holographic interferometry techniques in real-time with conventional materials (silver halide emulsions, photothermoplastics...) present serious difficulties. The photorefractives crystals are presenting as a attractive holographic recording medium. The phenomenon that characterizes these crystals is the photorefractive effect, consists of the refractive index modulation through photo-induced and linear electro-optic effect, allows the register of holograms of phase. Also it presents advantages as in situ self-proceeding of the recording medium and its indefinite reusability, i.e., it does not present fatigue. Thus, the objective of this work is the development of a Holographic Interferometer that uses the Photorefractive Crystal of the Sillenite Family Bi12SiO20(BSO) as holographic recording medium. Iri this direction, we search to characterize BSO crystal determining some figures of merit in diffusive regime (without applied external electric field) and drift regime (with applied external electric field). The holographic techniques of metrology axe presented in three methods: Real-Time Holographic Interferometry (RTM), Double-Exposure Holographic Interferometry (2EHI), and Time-Average Holographic Interferometry (TAM) had been studied with some applications in analisys of statics and dynamics processes on surfaces.
C1 Univ Sao Paulo, Inst Fis, Depto Fis Geral, Lab Opt, BR-05315970 Sao Paulo, Brazil.
RP Gesualdi, MRR (reprint author), Univ Sao Paulo, Inst Fis, Depto Fis Geral, Lab Opt, CP 66318, BR-05315970 Sao Paulo, Brazil.
RI Institute of Physics, USP/H-5191-2017; Gesualdi, Marcos/A-6348-2008
OI Gesualdi, Marcos/0000-0001-6839-4374; Soga, Diogo/0000-0002-4267-4244
CR Barbosa EA, 1997, OPT LASER TECHNOL, V29, P359, DOI 10.1016/S0030-3992(97)00041-8
   Georges MP, 1999, APPL PHYS B-LASERS O, V68, P1073, DOI 10.1007/s003400050749
   GUNTER P, 1988, SPRINGER TOPICS APPL, V61, P62
   KAMSHILIN AA, 1985, OPT COMMUN, V53, P23, DOI 10.1016/0030-4018(85)90254-8
   Rickermann F, 1998, OPT COMMUN, V155, P91, DOI 10.1016/S0030-4018(98)00357-5
   Yeh P., 1993, INTRO PHOTOREFRACTIV
NR 6
TC 0
Z9 0
U1 1
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4126-0
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4419
BP 256
EP 260
DI 10.1117/12.437068
PG 3
WC Optics; Physics, Applied
SC Optics; Physics
GA BT28M
UT WOS:000172533500064
DA 2018-10-20
ER

PT J
AU Klajnert, B
   Bryszewska, M
AF Klajnert, B
   Bryszewska, M
TI Dendrimers: properties and applications
SO ACTA BIOCHIMICA POLONICA
LA English
DT Review
DE dendrimers; cascade molecules; PAMAM dendrimers
ID NEUTRON-CAPTURE THERAPY; DENDRITIC MACROMOLECULES; IN-VITRO; MOLECULAR
   ARCHITECTURE; STARBURST DENDRIMERS; ENERGY-TRANSFER; DELIVERY; POLYMERS;
   CHEMISTRY; WATER
AB Dendrimers are a new class of polymeric materials. They are highly branched, monodisperse macromolecules. The structure of these materials has a great impact on their physical and chemical properties. As a result of their unique behaviour dendrimers are suitable for a wide range of biomedical and industrial applications. The paper gives a concise review of dendrimers' physico-chemical properties and their possible use in various areas of research, technology and treatment.
C1 Univ Lodz, Dept Gen Biophys, PL-90237 Lodz, Poland.
RP Klajnert, B (reprint author), Univ Lodz, Dept Gen Biophys, St Banacha 12-16, PL-90237 Lodz, Poland.
RI Klajnert-Maculewicz, Barbara/J-4574-2014; Kapczynski, Marcin/K-9682-2018
OI Klajnert-Maculewicz, Barbara/0000-0003-3459-8947; Kapczynski,
   Marcin/0000-0003-3334-2835; Bryszewska, Maria/0000-0003-4676-3743
CR Adronov A, 2000, J AM CHEM SOC, V122, P1175, DOI 10.1021/ja993272e
   ALPER J, 1991, SCIENCE, V251, P1562, DOI 10.1126/science.2011736
   Archut A, 1998, J AM CHEM SOC, V120, P12187, DOI 10.1021/ja9822409
   BARTH RF, 1994, BIOCONJUGATE CHEM, V5, P58, DOI 10.1021/bc00025a008
   Bielinska A, 1996, NUCLEIC ACIDS RES, V24, P2176, DOI 10.1093/nar/24.11.2176
   Bourne MW, 1996, JMRI-J MAGN RESON IM, V6, P305, DOI 10.1002/jmri.1880060209
   Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J
   CAMINATI G, 1990, J AM CHEM SOC, V112, P8515, DOI 10.1021/ja00179a041
   Capala J, 1996, BIOCONJUGATE CHEM, V7, P7, DOI 10.1021/bc950077q
   Cooper AI, 1997, NATURE, V389, P368, DOI 10.1038/38706
   FISCHER M, 1999, ANGEW CHEM INT EDIT, V38, P884, DOI DOI 10.1002/SICI)1521-3773(19990401)38:7<884::AID-ANIE884>3.0.CO
   FRECHET JMJ, 1994, SCIENCE, V263, P1710, DOI 10.1126/science.8134834
   Gilat SL, 1999, ANGEW CHEM INT EDIT, V38, P1422, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1422::AID-ANIE1422>3.0.CO;2-V
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027
   HAWKER CJ, 1992, J AM CHEM SOC, V114, P8405, DOI 10.1021/ja00048a009
   HAWTHORNE MF, 1993, ANGEW CHEM INT EDIT, V32, P950, DOI 10.1002/anie.199309501
   HODGE P, 1993, NATURE, V362, P18, DOI 10.1038/362018a0
   JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226
   JANSEN JFGA, 1995, J AM CHEM SOC, V117, P4417, DOI 10.1021/ja00120a032
   KNAPEN JWJ, 1994, NATURE, V372, P659, DOI 10.1038/372659a0
   Kukowska-Latallo JF, 2000, HUM GENE THER, V11, P1385, DOI 10.1089/10430340050057468
   Liu L, 1995, J Hematother, V4, P477, DOI 10.1089/scd.1.1995.4.477
   Liu MJ, 2000, J CONTROL RELEASE, V65, P121, DOI 10.1016/S0168-3659(99)00245-X
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   MOUREY TH, 1992, MACROMOLECULES, V25, P2401, DOI 10.1021/ma00035a017
   NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   ROY R, 1993, J CHEM SOC CHEM COMM, P1869, DOI 10.1039/c39930001869
   Sigal GB, 1996, J AM CHEM SOC, V118, P3789, DOI 10.1021/ja953729u
   TOMALIA D, 1994, NATURE, V372, P617, DOI 10.1038/372617a0
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   Twyman LJ, 1999, TETRAHEDRON LETT, V40, P1743, DOI 10.1016/S0040-4039(98)02680-X
   Weener JW, 1999, J AM CHEM SOC, V121, P10346, DOI 10.1021/ja984432+
   Wiener EC, 1996, J AM CHEM SOC, V118, P7774, DOI 10.1021/ja9536126
   Zanini D, 1998, J ORG CHEM, V63, P3486, DOI 10.1021/jo972061u
   Zhuo RX, 1999, J CONTROL RELEASE, V57, P249, DOI 10.1016/S0168-3659(98)00120-5
   Zimmerman SC, 1996, SCIENCE, V271, P1095, DOI 10.1126/science.271.5252.1095
NR 39
TC 235
Z9 239
U1 1
U2 50
PU ACTA BIOCHIMICA POLONICA
PI WARSAW
PA PASTEURA 3, 02-093 WARSAW, POLAND
SN 0001-527X
J9 ACTA BIOCHIM POL
JI Acta Biochim. Pol.
PY 2001
VL 48
IS 1
BP 199
EP 208
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 417ZQ
UT WOS:000167865700021
PM 11440170
DA 2018-10-20
ER

PT S
AU Henriques, VAR
   da Silva, CRM
AF Henriques, VAR
   da Silva, CRM
BE Salgado, L
   Filho, FA
   Muccilo, R
TI Production of titanium alloys for medical implants by powder metallurgy
SO ADVANCED POWDER TECHNOLOGY II
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 2nd International Latin-American Conference on Power Technology
CY NOV, 1999
CL FOZ DO IGUACU, BRAZIL
SP Air Liquide, Belgo Brasileira, brassinter, CCDM, Cofap, Combusto Metalpo, CCP, Degussa Huls, Forjisnter, Gasbarre Sinterite, Hoeganaes, Hoganas, Mahle Metal Leve Miba, OMG Amer, Osterwalder, Penn Team, Zoz
DE powder metallurgy; surgical implants; titanium alloy
AB Titanium alloys are expected to be much more widely used for implant materials in the medical and dental fields because of their superior biocompatibillity, corrosion resistance and specific strength compared with other metallic implant materials. Vanadium free alloys like Ti-6Al-7Nb and Ti-5Al-2,5Fe have been recently developed for biomedical use. More recently vanadium and aluminum free alloys composed of non-toxic elements like Nb, Ta, Zr and so on with lower modulus have been started to be developed. The beta type alloys like Ti-15Mo are now the main target for medical materials. A blended elemental titanium powder metallurgy process has been developed to offer low cost products. The process employs hydride-dehydride (HDH) powders and near-net shape techniques. In this work, the influence of the processing parameters and chemical composition of the elementary powders on the final microstructure was investigated. The alloys were characterized by means of scanning electron microscopy, X-ray diffraction, Vickers microhardness measurements, chemical analysis and density. The results indicate that the samples presented high densification, homogeneous chemical composition and coherent microstructures. The process parameters were defined aiming to reduce the interstitial pick-up (O, N) and to avoid the grain growth.
C1 Fac Engn Quim Lorena FAENQUIL, Dept Engn Mat DEMAR, BR-12600000 Lorena, SP, Brazil.
   AMR, IAE, CTA, Div Mat, BR-12228904 Sao Jose Dos Campos, Brazil.
RP Henriques, VAR (reprint author), Fac Engn Quim Lorena FAENQUIL, Dept Engn Mat DEMAR, Caixa Postal 116, BR-12600000 Lorena, SP, Brazil.
RI da Silva, Cosme/J-1394-2018; Henriques, Vinicius/G-2465-2012
OI da Silva, Cosme/0000-0001-6301-6446; 
CR Andersen P. J., 1980, PRECIS MET, V104, P34
   BOBROVA E, 1994, POWDER METALLURGY
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   BOBYN JD, 1990, CLIN ORTHOP RELAT R, P196
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   BULLY RL, 1992, J ARTHOPLASTY, V7, P315
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   Froes F.H., 1998, J MET, V9, P41
   Froes F.H., 1985, POWDER METALLURGY IN, V17, P47
   German R. M., 1996, SINTERING THEORY PRA
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Mitkov M, 1996, MATER CHARACT, V37, P53, DOI 10.1016/S1044-5803(96)00061-7
   PRENDERGAST P, 1990, J BIOMED ENG, V1295, P370
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   SLANINA P, 1985, ACTA PHARMACOL TOX, V56, P3331
   VANDERVOET GB, 1991, ALUMINUM NEROTOXITY, P235
   ZWICKER R, 1980, MET SOC AIME, P505
NR 17
TC 9
Z9 9
U1 2
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-864-8
J9 KEY ENG MAT
PY 2001
VL 189-1
BP 443
EP 448
DI 10.4028/www.scientific.net/KEM.189-191.443
PG 6
WC Materials Science, Ceramics; Metallurgy & Metallurgical Engineering;
   Materials Science, Composites
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BS01C
UT WOS:000168303300070
DA 2018-10-20
ER

PT J
AU Pena-Rodriguez, G
   Arenas, AC
   Hernandez, RAM
   Stolik, S
   Orea, AC
   Sinencio, FS
AF Pena-Rodriguez, G
   Arenas, AC
   Hernandez, RAM
   Stolik, S
   Orea, AC
   Sinencio, FS
TI Measurement of thermal diffusivity of bone, hydroxyapatite and metals
   for biomedical application
SO ANALYTICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT 11th International Conference on Photoacoustic and Photothermal
   Phenomena
CY JUN 06-09, 2000
CL KYOTO, JAPAN
SP Japan Soc Analyt Chem, Spectroscop Soc Japan, Japan Soc Promot Sci, Commemorat Assoc Japan World Exposit (1970), Inoue Fdn Sci, Tokyo Ohka Fdn Promot Sci & Technol Japan, Asahi Glass Fdn, Kao Fdn Arts & Sci, Fdn Promot Mat Sci & Technol Japan
ID SILICON; SOLIDS
AB We present a microstructural study and thermal diffusivity measurements at room temperature in two different sections of bull dense bone, bull bone and commercial hydroxyapatite, the last two in powder form. A comparison tvas made between these measured values and those obtained from metallic samples frequently used in implants such as high purity titanium and 316L stainless steel. Our results show that the porosity and its orientation in the bone are two important factors for the heat flux through the bone. The hydroxyapatite, in compact powder form, presents a thermal diffusivity value very near to those obtained for the bone samples which gives a good thermal agreement between these materials. Finally, one order of magnitude of difference among the thermal diffusivity values of metallic samples and those corresponding values to bone and hydroxyapatite was obtained, this difference being greater in titanium than in stainless steel.
C1 IPN, Ctr Invest Ciencia Aplicada & Tecnol Avanzada, Phys Lab, Mexico City 11500, DF, Mexico.
   Univ Francisco de Paula Santander, Cucuta, Colombia.
   Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis, Mexico City 07000, DF, Mexico.
RP Arenas, AC (reprint author), IPN, Ctr Invest Ciencia Aplicada & Tecnol Avanzada, Phys Lab, Legaria 694,Colonia Irrigac, Mexico City 11500, DF, Mexico.
CR Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   Calderon A, 1998, J APPL PHYS, V84, P6327, DOI 10.1063/1.368957
   Calderon A, 1997, PHYS REV LETT, V79, P5022, DOI 10.1103/PhysRevLett.79.5022
   Campbell PA, 1996, J VAC SCI TECHNOL B, V14, P1167, DOI 10.1116/1.588422
   LOPEZ CV, 2000, J MATER RES, V15, P85
   MARQUEZINI MV, 1991, MEAS SCI TECHNOL, V2, P396, DOI 10.1088/0957-0233/2/4/020
   NAGAI M, 1991, J MATER SCI, V26, P2949, DOI 10.1007/BF01124826
   ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296
   Rosencwaig A., 1980, PHOTOACOUSTICS PHOTO
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   ZIEGLER G, 1981, J MATER SCI, V16, P495, DOI 10.1007/BF00738642
NR 11
TC 0
Z9 0
U1 0
U2 1
PU JAPAN SOC ANALYTICAL CHEMISTRY
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN
SN 0910-6340
J9 ANAL SCI
JI Anal. Sci.
PY 2001
VL 17
SI SI
BP S378
EP S381
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 428UZ
UT WOS:000168481200108
DA 2018-10-20
ER

PT J
AU Rodriguez, GP
   Arenas, AC
   Hernandez, RAM
   Stolik, S
   Orea, AC
   Sinencio, FS
AF Rodriguez, GP
   Arenas, AC
   Hernandez, RAM
   Stolik, S
   Orea, AC
   Sinencio, FS
TI Measurement of thermal diffusivity of bone, hydroxyapatite and metals
   for biomedical application
SO ANALYTICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT 11th International Conference on Photoacoustic and Photothermal
   Phenomena
CY JUN 06-09, 2000
CL KYOTO, JAPAN
SP Japan Soc Analyt Chem, Spectroscop Soc Japan, Japan Soc Promot Sci, Commemorat Assoc Japan World Exposit (1970), Inoue Fdn Sci, Tokyo Ohka Fdn Promot Sci & Technol Japan, Asahi Glass Fdn, Kao Fdn Arts & Sci, Fdn Promot Mat Sci & Technol Japan
ID SILICON; SOLIDS
AB We present a microstructural study and thermal diffusivity measurements at room temperature in two different sections of bull dense bone, bull bone and commercial hydroxyapatite, the last two in powder form. A comparison was made between these measured values and those obtained from metallic samples frequently used in implants such as high purity titanium and 316L stainless steel. Our results show that the porosity and its orientation in the bone are two important factors for the heat flux through the bone. The hydroxyapatite, in compact powder form, presents a thermal diffusivity value very near to those obtained for the bone samples which give a good thermal agreement between these materials. Finally, one order of magnitude of difference among the thermal diffusivity values of metallic samples and those corresponding values to bone and hydroxyapatite was obtained, this difference being greater in titanium than in stainless steel.
C1 IPN, Ctr Invest Ciencia Aplicada & Tecnol Avanzada, Mexico City 11500, DF, Mexico.
   Univ Francisco de Paula Santander, Cucuta, Colombia.
   Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Phys, Mexico City 07000, DF, Mexico.
RP Arenas, AC (reprint author), IPN, Ctr Invest Ciencia Aplicada & Tecnol Avanzada, Legaria 694,Colonia Irrigac, Mexico City 11500, DF, Mexico.
CR Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   Calderon A, 1998, J APPL PHYS, V84, P6327, DOI 10.1063/1.368957
   Calderon A, 1997, PHYS REV LETT, V79, P5022, DOI 10.1103/PhysRevLett.79.5022
   Campbell PA, 1996, J VAC SCI TECHNOL B, V14, P1167, DOI 10.1116/1.588422
   LOPEZ CV, 2000, J MATER RES, V15, P85
   MARQUEZINI MV, 1991, MEAS SCI TECHNOL, V2, P396, DOI 10.1088/0957-0233/2/4/020
   NAGAI M, 1991, J MATER SCI, V26, P2949, DOI 10.1007/BF01124826
   ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296
   Rosencwaig A., 1980, PHOTOACOUSTICS PHOTO
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   ZIEGLER G, 1981, J MATER SCI, V16, P495, DOI 10.1007/BF00738642
NR 11
TC 8
Z9 8
U1 0
U2 3
PU JAPAN SOC ANALYTICAL CHEMISTRY
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN
SN 0910-6340
J9 ANAL SCI
JI Anal. Sci.
PY 2001
VL 17
SI SI
BP S357
EP S360
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 428UZ
UT WOS:000168481200102
DA 2018-10-20
ER

PT J
AU Risbud, M
AF Risbud, M
TI Tissue engineering: implications in the treatment of organ and tissue
   defects
SO BIOGERONTOLOGY
LA English
DT Article
DE artificial organs; biomaterials; cell culture; tissue engineering
ID POLYVINYL PYRROLIDONE HYDROGELS; IN-VITRO; ARTICULAR-CARTILAGE;
   CELL-CULTURE; BIOARTIFICIAL PANCREAS; ISLET TRANSPLANTATION; SURFACE
   MODIFICATION; ENDOCRINE PANCREAS; ARTIFICIAL CORNEA; HOLLOW FIBERS
AB The loss or failure of organs and tissues due to injury/trauma or ageing is one of the major causes for concern in human health care. Tissue engineering, a new emerging field in modem biomedical sciences, promises a new ray of hope for transplantation biology by creating viable substitutes for such failing organs or tissues. Tissue engineering is rapidly growing in both scope and importance within biomedical engineering. It represents the marriage of rapid developments in cellular and molecular biology on the one hand and materials, chemical and mechanical engineering on the other. The ability to manipulate and reconstitute tissue function has tremendous clinical implications and is likely to play a key role in cell and gene therapies in the coming years. This article discusses the basic principles of tissue engineering and some of the attempts made to provide solutions by engineering tissues in vitro.
C1 Natl Ctr Cell Sci, Tissue Engn & Banking Lab, Pune 411007, Maharashtra, India.
RP Risbud, M (reprint author), Natl Ctr Cell Sci, Tissue Engn & Banking Lab, Pune 411007, Maharashtra, India.
EM mrisbud@hotmail.com
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   *AM LIV FDN, 1988, VIT STAT US A, V2
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bruining MJ, 2000, BIOMATERIALS, V21, P595, DOI 10.1016/S0142-9612(99)00223-9
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487
   BUTOR C, 1992, EXP CELL RES, V203, P115, DOI 10.1016/0014-4827(92)90046-B
   Campbell JH, 1999, CIRC RES, V85, P1173
   CHICK WL, 1977, SCIENCE, V197, P780, DOI 10.1126/science.407649
   CHICK WL, 1975, SCIENCE, V187, P847, DOI 10.1126/science.187.4179.847
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   GALLETTI PM, 1981, T AM SOC ART INT ORG, V27, P185
   GATES RJ, 1977, LANCET, V2, P1257
   Germain L, 1999, PATHOBIOLOGY, V67, P140, DOI 10.1159/000028064
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GRIFFITH M, 1998, INVEST OPHTH VIS SCI, V38, P3948
   Gruessner R W, 1996, Transpl Int, V9 Suppl 1, pS251, DOI 10.1111/j.1432-2277.1996.tb01624.x
   Hardikar AA, 2000, TRANSPLANT P, V32, P824, DOI 10.1016/S0041-1345(00)00995-7
   Hardikar AA, 1999, J BIOSCIENCE, V24, P371, DOI 10.1007/BF02941251
   Hickey DP, 1997, J UROLOGY, V157, P2042, DOI 10.1016/S0022-5347(01)64670-6
   Hicks CR, 1997, SURV OPHTHALMOL, V42, P175, DOI 10.1016/S0039-6257(97)00024-6
   Honda M, 2000, J ORAL MAXIL SURG, V58, P767, DOI 10.1053/joms.2000.7262
   Hou QP, 1999, ADV DRUG DELIVER REV, V35, P271, DOI 10.1016/S0169-409X(98)00077-5
   HYMER WC, 1981, NEUROENDOCRINOLOGY, V32, P339, DOI 10.1159/000123184
   IWATA H, 1992, J BIOMED MATER RES, V26, P967, DOI 10.1002/jbm.820260711
   Kawakami Y, 1997, CELL TRANSPLANT, V6, P541, DOI 10.1016/S0963-6897(97)00074-2
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Klapperich C, 1999, J ARTHROPLASTY, V14, P877, DOI 10.1016/S0883-5403(99)90042-6
   KOECHLIN N, 1991, EUR J CELL BIOL, V54, P224
   KOO J, 1993, INT J ARTIF ORGANS, V16, P557
   L'Heureux N, 1998, FASEB J, V12, P47
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanza RP, 1999, TRANSPLANTATION, V67, P1105, DOI 10.1097/00007890-199904270-00004
   Latkany R, 1997, J BIOMED MATER RES, V36, P29, DOI 10.1002/(SICI)1097-4636(199707)36:1<29::AID-JBM4>3.3.CO;2-3
   Laurencin CT, 1996, BONE, V19, pS93, DOI 10.1016/S8756-3282(96)00132-9
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   Legeais JM, 1998, BIOMATERIALS, V19, P1517, DOI 10.1016/S0142-9612(98)00069-6
   Lhommeau C, 1997, J MATER SCI-MATER M, V8, P163, DOI 10.1023/A:1018575220505
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lindner MD, 1998, CELL TRANSPLANT, V7, P165, DOI 10.1016/S0963-6897(97)00169-3
   LIU CM, 1993, PLANT J, V3, P291, DOI 10.1111/j.1365-313X.1993.tb00179.x
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   Marchand-Brynaert J, 1999, BIOMATERIALS, V20, P1773, DOI 10.1016/S0142-9612(99)00072-1
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   Nagamori S, 2000, J GASTROENTEROL, V35, P493, DOI 10.1007/s005350070071
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   Prevost P, 1997, ANN NY ACAD SCI, V831, P344
   Risbud H, 2000, CELL TRANSPLANT, V9, P25
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   Risbud MV, 2001, J MATER SCI-MATER M, V12, P75, DOI 10.1023/A:1026769422026
   Risbud MV, 2001, J BIOMED MATER RES, V54, P436, DOI 10.1002/1097-4636(20010305)54:3<436::AID-JBM180>3.3.CO;2-#
   RISBUD MV, 2000, IN PRESS CELL TRANSP
   Ritter EF, 1997, SURGERY, V122, P888, DOI 10.1016/S0039-6060(97)90329-9
   Robert L, 2000, BIOGERONTOLOGY, V1, P123, DOI 10.1023/A:1010048014925
   Saito A, 1997, SURG TODAY, V27, P907, DOI 10.1007/BF02388137
   Schneider AI, 1999, IN VITRO CELL DEV-AN, V35, P515
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   SOLDANI G, 1992, J MATER SCI-MATER M, V3, P371, DOI 10.1007/BF00705370
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   Stegall MD, 1996, TRANSPLANTATION, V61, P1272, DOI 10.1097/00007890-199604270-00027
   Stockley TL, 2000, J LAB CLIN MED, V135, P484, DOI 10.1067/mlc.2000.106804
   Tatarkiewicz K, 1999, TRANSPLANTATION, V67, P665, DOI 10.1097/00007890-199903150-00005
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tun T, 1996, CELL TRANSPLANT, V5, pS59, DOI 10.1016/0963-6897(96)00042-5
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   WALSHREITZ MM, 1984, AM J PHYSIOL, V247, pC321
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   Winn SR, 1999, J BIOMED MATER RES, V45, P414, DOI 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z
   WINN SR, 1994, P NATL ACAD SCI USA, V91, P2324, DOI 10.1073/pnas.91.6.2324
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   YANG MB, 1994, CELL TRANSPLANT, V3, P373, DOI 10.1177/096368979400300504
   ZEKORN T, 1989, TRANSPLANT P, V21, P2748
NR 86
TC 32
Z9 34
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2001
VL 2
IS 2
BP 117
EP 125
DI 10.1023/A:1011585117310
PG 9
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 448EF
UT WOS:000169613400006
PM 11708378
DA 2018-10-20
ER

PT S
AU Shaw, MA
   Spillman, WB
   Meissner, KE
   Gabbard, J
AF Shaw, MA
   Spillman, WB
   Meissner, KE
   Gabbard, J
BE Bearman, GH
   Bornhop, DJ
   Levenson, RM
TI Virtual reality techniques for the visualization of biomedical imaging
   data
SO BIOMARKERS AND BIOLOGICAL SPECTRAL IMAGING
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Biomarkers and Biological Spectral Imaging
CY JAN 23, 2001
CL SAN JOSE, CA
SP USAF Off Sci Res, SPIE
AB The Optical Sciences & Engineering Research Center (OSER) at Virginia Polytechnic and State University investigates advanced laser surgery optics, biocompatible material for implants, and diagnostic patches and other diagnostic and drug delivery tools. The Center employs optics to provide new biological research tools for visualization, measurement, analysis and manipulation. The Center's Research into Multispectral Medical Analysis and Visualization techniques will allow human and veterinary medical professionals to diagnose various conditions of the body in much the same way that satellite information is used to study earth resources. Each pixel in the image has an associated spectra. Advanced image analysis techniques are combined with cross-correlation of the spectra with signatures of known conditions, allowing automated diagnostic assistance to physicians. The analysis and visualization system consists of five components: data acquisition, data storage, data standardization, data analysis, and data visualization. OSER research efforts will be directed toward investigations of these system components as an integrated tool for next generation medical diagnosis. OSER will research critical data quality and data storage issues, mult-spectral sensor technologies, data analysis techniques, and diagnostic visualization systems including the V-T-CAVE,(www.cave.vt.edu). The VT-CAVE is Virginia Tech's configuration of Fakespace Systems, Inc Virtual Reality system.
C1 Virginia Polytech Inst & State Univ, Opt Sci & Engn Res Ctr, Blacksburg, VA 24061 USA.
RP Shaw, MA (reprint author), Virginia Polytech Inst & State Univ, Opt Sci & Engn Res Ctr, Blacksburg, VA 24061 USA.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3937-1
J9 PROC SPIE
PY 2001
VL 4259
BP 24
EP 28
DI 10.1117/12.432497
PG 5
WC Engineering, Biomedical; Optics; Imaging Science & Photographic
   Technology
SC Engineering; Optics; Imaging Science & Photographic Technology
GA BT01W
UT WOS:000171643400005
DA 2018-10-20
ER

PT J
AU Coombes, AGA
   Breeze, V
   Wu, LL
   Gray, T
   Parker, KG
   Parker, T
AF Coombes, AGA
   Breeze, V
   Wu, LL
   Gray, T
   Parker, KG
   Parker, T
TI Lactic acid-stabilised albumin for microsphere formulation and
   biomedical coatings
SO BIOMATERIALS
LA English
DT Article
DE albumin stabilisation; microspheres; coatings; vascular grafts
ID VASCULAR PROSTHESES; SERUM-ALBUMIN; PROTEIN; GRAFT; COMPATIBILITY;
   POLYURETHANE; DELIVERY; INVIVO
AB Microspheres of ovalbumin (OVA) ranging from 1 to 15 mum were prepared by emulsifying an aqueous solution of albumin in soya oil at room temperature then raising the temperature to 45 degreesC for 30 min, prior to harvesting of the microspheres. Production of OVA nanospheres with size less than 500 nm was achieved by desolvation from aqueous albumin solutions using acetone. In both cases, lactic acid was added to the starting albumin solution to stabilise the resulting particles. Utilisation of an endogenous substance avoids the use of chemical crosslinking agents such as glutaraldehyde and associated toxicological concerns. Protein coating of knitted Dacron vascular grafts was performed by impregnation of the textile structure with lactic acid-stabilised ovalbumin nanospheres thereby providing a surface potentially resistant to blood platelet adhesion but conducive to endothelialisation, Protein release testing carried out in PBS at 37 degreesC revealed that approximately 60% of the original albumin coating was retained by the Dacron graft material after 4 days and remained at this level for upto 4 weeks. Apart from the formulation of albumin microspheres for drug delivery, diagnostic applications and coating of biomedical textiles, the process of albumin stabilisation using lactic acid may be usefully applied to improve protein immobilisation on a wide range of biomaterial surfaces. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Nottingham, Dept Pharmaceut Sci, Nottingham NG7 2RD, England.
   Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Sch Med, Nottingham NG2 7FP, England.
   Univ Hosp, Queens Med Ctr, Dept Histopathol, Nottingham NG2 7FP, England.
RP Coombes, AGA (reprint author), Aston Univ, Aston Pharm Sch, Aston Triangle, Birmingham B4 7ET, W Midlands, England.
CR AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   ARSHADY R, 1990, J CONTROL RELEASE, V14, P111, DOI 10.1016/0168-3659(90)90149-N
   BENSLIMANE S, 1988, EUR SURG RES, V20, P18
   CAPPELLO J, 1997, CONTROLLED DRUG DELI, P439
   CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307
   Coombes AGA, 1996, VACCINE, V14, P1429, DOI 10.1016/S0264-410X(96)00077-1
   CZIPERLE DJ, 1992, J CARDIOVASC SURG, V33, P407
   EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78, DOI 10.1111/j.1749-6632.1987.tb33032.x
   GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002
   HAKE U, 1991, THORAC CARDIOV SURG, V39, P208, DOI 10.1055/s-2007-1022711
   HIRT SW, 1993, J VASC SURG, V17, P538
   HORA MS, 1990, PHARMACEUT RES, V7, P1190, DOI 10.1023/A:1015948829632
   Lin W, 1993, J DRUG TARGET, V1, P237, DOI 10.3109/10611869308996081
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   PAVANETTO F, 1994, J MICROENCAPSUL, V11, P445, DOI 10.3109/02652049409034262
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   REMY M, 1994, J MATER SCI-MATER M, V5, P808, DOI 10.1007/BF00213139
   RUMISEK JD, 1986, J VASC SURG, V4, P136, DOI 10.1067/mva.1986.avs0040136
   RYU G, 1992, T AM SOC ART INT ORG, V38, pM644
   SCHWENDEMAN SP, 1997, CONTROLLED DRUG DELI, P229
   STANSBY G, 1994, BRIT J SURG, V81, P1286, DOI 10.1002/bjs.1800810908
   Takahata H, 1998, J CONTROL RELEASE, V50, P237, DOI 10.1016/S0168-3659(97)00145-4
   TOMLINSON E, 1987, POLYM CONTROLLED DRU, P25
   ZDANOWSKI Z, 1993, APMIS, V101, P926, DOI 10.1111/j.1699-0463.1993.tb00203.x
NR 24
TC 12
Z9 24
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2001
VL 22
IS 1
BP 1
EP 8
DI 10.1016/S0142-9612(00)00074-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 367BG
UT WOS:000090041200001
PM 11085377
DA 2018-10-20
ER

PT S
AU Lechna-Marczynska, MA
   Podbielska, H
   Ulatowska-Jarza, A
   Holowacz, I
   Andrzejewski, D
AF Lechna-Marczynska, MA
   Podbielska, H
   Ulatowska-Jarza, A
   Holowacz, I
   Andrzejewski, D
BE Chiou, AET
   Podbielska, H
   Jacques, SL
TI Sol-gel optics for biomeasurements
SO BIOPHOTONICS INSTRUMENTATION AND ANALYSIS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biophotonics Instrumentation and Analysis
CY NOV 28-29, 2001
CL SINGAPORE, SINGAPORE
SP SPIE, Nanyang Technol Univ
DE sol-gel bulks; films; optodes; biomeasurements
ID BIOSENSOR; SENSOR
AB Sol-gel technique is a method for producing of glass-like materials without involving a melting process. Organic compounds such as alcoholates of silicon, sodium or calcium can be used. The irregular noncrystalline network forms a gel structure where the metallic atoms are bonded to oxygen atoms. Low-temperature treatment turns this gel into an inorganic glass-like structure. There are numbers of applications C of these materials that can be produced in various forms and shapes. Here, silica based sol-gel bulks and thin films optodes for biomedical applications will be presented.
C1 Wroclaw Univ Technol, Inst Phys, Bioopt Grp, Wroclaw, Poland.
RP Lechna-Marczynska, MA (reprint author), Wroclaw Univ Technol, Inst Phys, Bioopt Grp, Wybrzeze Wyspianskiego 27, Wroclaw, Poland.
RI Podbielska, Halina/A-7311-2012
OI Podbielska, Halina/0000-0001-7162-8530
CR Andrzejewski D, 2001, OPTIK, V112, P158, DOI 10.1078/0030-4026-00029
   Andrzejewski D, 2000, OPT APPL, V30, P503
   BALDINI F, 1993, Patent No. 93A125
   Blyth DJ, 1996, ANALYST, V121, P1975, DOI 10.1039/an9962101975
   Bottcher H, 1998, J SOL-GEL SCI TECHN, V13, P277, DOI 10.1023/A:1008603622543
   BRAUN S, 1992, J NON-CRYST SOLIDS, V147, P739, DOI 10.1016/S0022-3093(05)80708-2
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   EBELMEN M, 1845, CR HEBD ACAD SCI, V21, P502
   GLEZER V, 1993, J AM CHEM SOC, V115, P2533, DOI 10.1021/ja00059a072
   KONCKI R, 1995, BIOSENS BIOELECTRON, V10, P653, DOI 10.1016/0956-5663(95)96955-X
   LOBNIK A, 1997, 9 INT WORKSH GLASS C
   Maruszewski K, 1998, J MOL STRUCT, V450, P193, DOI 10.1016/S0022-2860(98)00428-1
   POPE EJA, 1997, 9 INT WORKSH GLASS C
   PREININGER C, 1994, ANAL CHEM, V66, P1841, DOI 10.1021/ac00083a011
   SCHAEFER DW, 1994, MRS BULL, V19, P14
   Sieminska L, 1996, J PHYS CHEM-US, V100, P4591, DOI 10.1021/jp952759g
   Stachs O, 1999, J SOL-GEL SCI TECHN, V15, P23, DOI 10.1023/A:1008767720995
   Trinkel M, 1996, ANAL CHIM ACTA, V320, P235, DOI 10.1016/0003-2670(95)00540-4
   ULATOWSKAJARZA A, 2001, THESIS WROCLAW U TEC
   Wolfbeis O. S., 1991, FIBER OPTIC CHEM SEN
   WOLFBEIS OS, 1993, SPIE P, V2085
   ZUSMAN R, 1990, J NON-CRYST SOLIDS, V122, P107, DOI 10.1016/0022-3093(90)90232-B
NR 22
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4327-1
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4597
BP 75
EP 80
DI 10.1117/12.446640
PG 6
WC Engineering, Biomedical; Instruments & Instrumentation; Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BT92Z
UT WOS:000174463700011
DA 2018-10-20
ER

PT J
AU Heras, A
   Rodriguez, NM
   Ramos, VM
   Agullo, E
AF Heras, A
   Rodriguez, NM
   Ramos, VM
   Agullo, E
TI N-methylene phosphonic chitosan: A novel soluble derivative
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE N-methylene phosphonic chitosan; phosphonomethylation; chitosan soluble
   derivative; H-1 NMR; C-13 NMR
ID SOLUBILITY; H-1-NMR
AB A novel water-soluble chitosan derivative carrying phosphonic groups was synthesized using a one-step reaction that allowed homogeneous modifications without any sharp decrease in its properties, such as filmogenic capacity (this compound and its synthesis have been protected with a patent). The H-1 NMR, C-13 NMR assignments and H-1-C-13 NMR correlation permitted the identification of the structure by the subtituent distribution of the product, which is partly N-monophosphonomethylated (0.24) and N,N-diphosphonomethylated (0.14) and N-acetylated (0.16) without modification of the initial degree of acetylation. The identity of the N-methylene phosphonic chitosan was confirmed by FT-IR spectrometry, X-ray diffraction and elemental analysis. Taking advantage of the known chelating ability of the phosphonic groups, especially for calcium, this new derivative opens new perspectives as biomedical material. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Univ Nacl Sur, Dept Quim & Ingn Quim, Catedra Bromatol, RA-8000 Bahia Blanca, Argentina.
   Univ Complutense Madrid, Fac Farm, Dept Quim Fis 2, Unidad RMN, E-28040 Madrid, Spain.
   Univ Nacl Sur, Dept Quim & Ingn Quim, Inst Invest Quim Organ, RA-8000 Bahia Blanca, Argentina.
RP Agullo, E (reprint author), Univ Nacl Sur, Dept Quim & Ingn Quim, Catedra Bromatol, Avenida Alem 1253, RA-8000 Bahia Blanca, Argentina.
RI Ramos, Viviana/A-1905-2009; Heras, Angeles/H-7421-2015
OI Heras, Angeles/0000-0002-7209-6190
CR DUNG P, 1994, CARBOHYD POLYM, V24, P209
   FLEISCH H, 1969, SCIENCE, V165, P1262, DOI 10.1126/science.165.3899.1262
   HENDRICKSON HS, 1967, ANAL CHEM, V39, P998, DOI 10.1021/ac60252a022
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   JUNG A, 1973, CALC TISS RES, V11, P269, DOI 10.1007/BF02547227
   MOEDRITZ.K, 1966, J ORG CHEM, V31, P1603, DOI 10.1021/jo01343a067
   Muzzarelli R. A. A., 1997, CHITIN HDB, P109
   MUZZARELLI RA, 1969, TALANTA, V16, P1571, DOI 10.1016/0039-9140(69)80218-3
   MUZZARELLI RAA, 1986, INT J BIOL MACROMOL, V8, P137, DOI 10.1016/0141-8130(86)90014-0
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P99, DOI 10.1016/0144-8617(93)90084-H
   MUZZARELLI RAA, 1992, CARBOHYD POLYM, V19, P231, DOI 10.1016/0144-8617(92)90074-Z
   Muzzarelli RAA, 1998, CARBOHYD POLYM, V36, P267, DOI 10.1016/S0144-8617(98)00008-3
   MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X
   MUZZARELLI RAA, 1982, CARBOHYD RES, V107, P199, DOI 10.1016/S0008-6215(00)80539-X
   MUZZARELLI RAA, 1994, INT J BIOL MACROMOL, V16, P177, DOI 10.1016/0141-8130(94)90048-5
   MUZZARELLI RAA, 1985, CHITIN ENCY POLYM SC, V3, P430
   MUZZARELLI RAA, 1977, CHITIN
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4745, DOI 10.1021/ma00017a003
   RINAUDO M, 1992, INT J BIOL MACROMOL, V14, P122, DOI 10.1016/S0141-8130(05)80001-7
   Roberts G. A. F., 1992, CHITIN CHEM, P106
   Roberts G.A.F., 1992, CHITIN CHEM, P274
   SCHWARZENBACH G, 1949, HELV CHIM ACTA, V32, P1175, DOI 10.1002/hlca.19490320403
   WESTERBACK S, 1965, J AM CHEM SOC, V87, P2567, DOI 10.1021/ja01090a008
   WESTERBACK SJ, 1956, NATURE, V178, P321, DOI 10.1038/178321a0
   Wojtasz-Pajak A, 1994, CHITIN WORLD, P435
   1980, Patent No. 2942898A1
NR 26
TC 135
Z9 145
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN
PY 2001
VL 44
IS 1
BP 1
EP 8
DI 10.1016/S0144-8617(00)00195-8
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 367RC
UT WOS:000090074400001
DA 2018-10-20
ER

PT J
AU Einmahl, S
   Schwach-Abdellaoui, K
   Heller, J
   Gurny, R
AF Einmahl, S
   Schwach-Abdellaoui, K
   Heller, J
   Gurny, R
TI Poly(ortho esters): Recent developments for biomedical applications
SO CHIMIA
LA English
DT Article; Proceedings Paper
CT Meeting of the Polymer-Group-of-Switzerland
CY OCT   20, 2000
CL ETH ZURICH, ZURICH, SWITZERLAND
SP Polymer Grp Switzerland
HO ETH ZURICH
DE biodegradable polymers; dentistry; drug delivery; ophthalmology;
   poly(ortho esters)
ID GLAUCOMA FILTERING SURGERY; CONTROLLED DRUG-RELEASE; IRRADIATION
   STERILIZATION; DELIVERY SYSTEMS; OCULAR DELIVERY; LOCAL-DELIVERY;
   5-FLUOROURACIL; BIOCOMPATIBILITY; DEXAMETHASONE; ACID
AB Poly(ortho esters) (POE) are hydrophobic and bioerodible polymers that have been under development since the early 1970s. Up to now, four generations of such polymers have been described. Of most interest are poly(ortho esters) III and poly(ortho esters) IV. POE III is a semi-solid material that has been shown to be highly biocompatible and is currently being investigated as a carrier for sustained drug delivery to treat diseases of the posterior segment of the eye. However, the polymerization is difficult to control and is not readily scaled up. POE IV can be easily prepared in a highly reproducible manner, is very stable provided moisture is rigorously excluded and has also been shown to be biocompatible. It is currently under development for a variety of applications, such as ocular delivery, protein release, and periodontal disease treatment.
C1 Univ Geneva, Sch Pharm, Dept Pharmaceut Technol & Biopharmaceut, CH-1211 Geneva 4, Switzerland.
   Adv Polymer Syst, Redwood City, CA 94063 USA.
RP Einmahl, S (reprint author), Univ Geneva, Sch Pharm, Dept Pharmaceut Technol & Biopharmaceut, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.
CR APPEL LE, 1993, J CONTROL RELEASE, V26, P77, DOI 10.1016/0168-3659(93)90107-G
   BENAGIANO G, 1979, J STEROID BIOCHEM, V11, P449, DOI 10.1016/0022-4731(79)90066-9
   BERNATCHEZ SF, 1994, J BIOMED MATER RES, V28, P1037, DOI 10.1002/jbm.820280908
   CAPOZZA RC, 1978, POLYM DELIVERY SYSTE, P59
   Chang MR, 1998, J OCUL PHARMACOL TH, V14, P75, DOI 10.1089/jop.1998.14.75
   DANIELS AU, 1994, J APPL BIOMATER, V5, P51, DOI 10.1002/jab.770050108
   EINHAMHL S, 1999, ENCY CONTROLLED DRUG, P564
   Einmahl S, 2001, INVEST OPHTH VIS SCI, V42, P695
   Einmahl S, 2000, J BIOMED MATER RES, V50, P566, DOI 10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
   Einmahl S, 1999, INT J PHARM, V185, P189, DOI 10.1016/S0378-5173(99)00149-0
   EINMAHL S, 2001, UNPUB INVEST OPHTHAL
   Einmahl SC, 2000, INVEST OPHTH VIS SCI, V41, pS81
   HELLER J, 1985, Journal of Controlled Release, V2, P167, DOI 10.1016/0168-3659(85)90042-2
   Heller J, 2000, EUR J PHARM BIOPHARM, V50, P121, DOI 10.1016/S0939-6411(00)00085-0
   HELLER J, 1990, J CONTROL RELEASE, V13, P295, DOI 10.1016/0168-3659(90)90019-P
   HELLER J, 1990, BIOMATERIALS, V11, P659, DOI 10.1016/0142-9612(90)90024-K
   HELLER J, 1990, BIOMATERIALS, V11, P235, DOI 10.1016/0142-9612(90)90003-9
   HELLER J, 1999, ENCY CONTROLLED DRUG, P852
   HELLER J, 1988, J BIOACT COMPAT POLY, V3, P97
   Li XH, 2000, J CONTROL RELEASE, V68, P41, DOI 10.1016/S0168-3659(00)00235-2
   MAA YF, 1990, J CONTROL RELEASE, V13, P11, DOI 10.1016/0168-3659(90)90070-A
   MERKLI A, 1994, J CONTROL RELEASE, V29, P105, DOI 10.1016/0168-3659(94)90126-0
   MERKLI A, 1993, J BIOMAT SCI-POLYM E, V4, P505, DOI 10.1163/156856293X00168
   Merkli A, 1996, BIOMATERIALS, V17, P897, DOI 10.1016/0142-9612(96)83285-6
   MERKLI A, 1994, PHARMACEUT RES, V11, P1485, DOI 10.1023/A:1018964511053
   MERKLI A, 1995, J CONTROL RELEASE, V33, P415, DOI 10.1016/0168-3659(94)00117-D
   Ng SY, 2000, J CONTROL RELEASE, V65, P367, DOI 10.1016/S0168-3659(99)00218-7
   ROTHENWEINHOLD A, 2001, IN PRESS J CONTROLLE
   Schwach-Abdellaoui K, 2000, EUR J PHARM BIOPHARM, V50, P83, DOI 10.1016/S0939-6411(00)00086-2
   Schwach-Abdellaoui K, 1999, J BIOMAT SCI-POLYM E, V10, P375, DOI 10.1163/156856299X00432
   Schwach-Abdellaoui K, 1999, MACROMOLECULES, V32, P301, DOI 10.1021/ma981517m
   SCHWACHABDELLAO.K, 2001, IN PRESS BIOMATERIAL
   Sintzel MB, 1997, DRUG DEV IND PHARM, V23, P857, DOI 10.3109/03639049709148693
   Sintzel MB, 1998, BIOMATERIALS, V19, P791, DOI 10.1016/S0142-9612(97)00229-9
   Sintzel MB, 1998, INT J PHARM, V175, P165, DOI 10.1016/S0378-5173(98)00274-9
   Sintzel MB, 1998, J CONTROL RELEASE, V55, P213, DOI 10.1016/S0168-3659(98)00051-0
   Sintzel MB, 1997, INT J PHARM, V155, P263, DOI 10.1016/S0378-5173(97)00169-5
   SOLHEIM E, 1995, J BIOMED MATER RES, V29, P1141, DOI 10.1002/jbm.820290914
   SPARER RV, 1984, J CONTROL RELEASE, V1, P23
   VISTNES LM, 1976, SURGERY, V79, P690
   Zignani M, 1997, J CONTROL RELEASE, V48, P115, DOI 10.1016/S0168-3659(97)00050-3
   Zignani M, 2000, BIOMATERIALS, V21, P1773, DOI 10.1016/S0142-9612(00)00065-X
   Zignani M, 1998, J BIOMED MATER RES, V39, P277
   Zignani M, 2000, EUR J PHARM BIOPHARM, V50, P251, DOI 10.1016/S0939-6411(00)00107-7
NR 44
TC 1
Z9 1
U1 2
U2 3
PU NEW SWISS CHEMICAL SOC
PI BASEL
PA C/O NOVARTIS AG, K-25 1 45, CH-4002 BASEL, SWITZERLAND
SN 0009-4293
J9 CHIMIA
JI Chimia
PY 2001
VL 55
IS 3
BP 218
EP 222
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 419PE
UT WOS:000167956900025
DA 2018-10-20
ER

PT J
AU Brandstatter, B
   Scharfetter, H
   Magele, C
AF Brandstatter, B
   Scharfetter, H
   Magele, C
TI Multi frequency electrical impedance tomography
SO COMPEL-THE INTERNATIONAL JOURNAL FOR COMPUTATION AND MATHEMATICS IN
   ELECTRICAL AND ELECTRONIC ENGINEERING
LA English
DT Article
DE biomedical; impedance; conductivity profile
ID TISSUE CHARACTERIZATION
AB Electrical impedance tomography (EIT) is a non-invasive method to monitor conductivity changes in regions of the human body. Its robust, miniaturizable instrumentation makes EIT particularly suitable for online-monitoring without too much inconvenience for the patient. A major methodological problem is the poor quality of the conductivity images, which is due to the low spatial resolution and low sensitivity for structures far away from the object's surface as well as large qualitative errors in the reconstructed conductivity values. This paper outlines the advantages of multi-frequency EIT for a simple two-dimensional model In the first Part of the paper we assume that some a priori information from MR images is at hand, providing good starting values for the reconstruction process, while in the second part it is assumed that no a priori information about regions of different material values is available.
C1 Inst Fundamentals & Theory Elect Engn, Graz, Austria.
   Inst Biomed Engn, Graz, Austria.
RP Brandstatter, B (reprint author), Inst Fundamentals & Theory Elect Engn, Graz, Austria.
CR Chang AM, 1999, INT J ELECTRON COMM, V4, P85, DOI 10.1080/10864415.1999.11518358
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   FLETCHER M, 1987, PRACTICAL METHODS OP
   KUSHNER RF, 1992, J AM COLL NUTR, V11, P199
   RIGAUD B, 1994, PHYSIOL MEAS, V15, pA13, DOI 10.1088/0967-3334/15/2A/002
   RIGAUD B, 1995, PHYSIOL MEAS, V16, pA15, DOI 10.1088/0967-3334/16/3A/002
   SCHWAN H P, 1957, Adv Biol Med Phys, V5, P147
   Vauhkonen M, 1997, THESIS U KUOPIO FINL
   Webster JG, 1990, ELECT IMPEDANCE TOMO
NR 9
TC 1
Z9 1
U1 0
U2 3
PU MCB U P LIMITED
PI BRADFORD
PA 60/62 TOLLER LANE, BRADFORD BD8 9BY, W YORKSHIRE, ENGLAND
SN 0332-1649
J9 COMPEL
JI Compel-Int. J. Comp. Math. Electr. Electron. Eng.
PY 2001
VL 20
IS 3
BP 828
EP 847
DI 10.1108/03321640110394003
PG 20
WC Computer Science, Interdisciplinary Applications; Engineering,
   Electrical & Electronic; Mathematics, Applied
SC Computer Science; Engineering; Mathematics
GA 473UH
UT WOS:000171066100015
DA 2018-10-20
ER

PT J
AU Silva, VV
   Lameiras, FS
   Domingues, RZ
AF Silva, VV
   Lameiras, FS
   Domingues, RZ
TI Microstructural and mechanical study of zirconia-hydroxyapatite (ZH)
   composite ceramics for biomedical applications
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE hydroxyapatite; zirconia; composite; microstructure; mechanical
   properties
ID PARTIALLY-STABILIZED ZIRCONIA; BONE; PSZ; INTERFACE; IMPLANTS
AB Hydroxyapatite is the mineral component of natural hard tissues and, as such, it has been studied extensively as a candidate biomaterial for its use in prosthetic applications. However. the main weakness of this material lies in its poor mechanical strength which makes it unsuitable for load-bearing applications. On the other hand, partially stabilized zirconia has been widely studied on account of its high strength and fracture toughness, and good biocompatibility. Therefore, it is believed that the addition of a particulate zirconia phase to a hydroxyapatite one may lead to an improvement of the mechanical properties of this kind of composite and will not affect its biocompatibility. In this study, two series of zirconia- hydroxyapatite composites, Z4H6 and Z6H4 with 40 and 60 vol.% of zirconia content respectively, were prepared by powder uniaxial pressing at 700 MPa and sintering in air at 120-1500 degreesC for 3 h. The sintering behavior. microstructural characteristics and mechanical properties were evaluated. Variation of average grain size for the zirconia and hydroxyapatite phases with sintering temperature was observed. Relative densities ranging from 89 to 91% of the theoretical values were reached for the Z6H4 ceramic series and for the Z4H6 sample sintered at 1400 degreesC, although microcracks were present in all specimens sintered at 1400 and 1500 degreesC. Values of ultimate compressive strength, Young's modulus. micro-Vickers hardness and Poisson's ratio near to those for human cortical bone and human tooth (dentine and enamel) were found for almost all samples investigated suggesting that these materials present potential applications as structural implants. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 CNEC, CDTN, BR-30123970 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, ICEx, Dept Quim, Mat Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Silva, VV (reprint author), CNEC, CDTN, R Prof Mario Werneck S-N,Pampulha,CP 941, BR-30123970 Belo Horizonte, MG, Brazil.
RI Domingues, Rosana/P-2017-2014; Domingues, Rosana/C-3174-2013
OI Domingues, Rosana/0000-0001-5667-2031; Domingues,
   Rosana/0000-0001-5667-2031
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   GARVIE RC, 1972, J AM CERAM SOC, V55, P152, DOI 10.1111/j.1151-2916.1972.tb11241.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Gregorie M., 1990, J BIOMED MATER RES, V24, P163
   GROSS V, 1987, BIOCERAMICS MAT CHAR
   HEALY KE, 1998, HDB BIOMATERIALS PRO
   HOLMES RE, 1987, INT J ORAL MAX SURG, V16, P718, DOI 10.1016/S0901-5027(87)80059-0
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   KROON PO, 1992, J BONE JOINT SURG BR, V74, P518
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Legeros R. Z., 1991, ADV SERIES CERAMICS, V1
   Legeros RZ, 1988, J DENT RES, V67, P177
   LI J, 1995, BIOMATERIALS, V16, P417, DOI 10.1016/0142-9612(95)98860-G
   MattioliBelmonte M, 1997, J MATER SCI-MATER M, V8, P85, DOI 10.1023/A:1018554715962
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   Park K, 1997, MATER LETT, V32, P229, DOI 10.1016/S0167-577X(97)00041-4
   PINTO LCM, 1996, ACTA MICROSCOPIA B, V5, P168
   PORTER DL, 1977, J AM CERAM SOC, V60, P183, DOI 10.1111/j.1151-2916.1977.tb15509.x
   RAVAGLIOLI A, BIOCERAMICS MAT PROP, P292
   SEDEL L, 1991, BIOCERAMICS, V4
   Silva VV, 1997, J MATER SCI-MATER M, V8, P907, DOI 10.1023/A:1018566124507
   Silva VV, 2000, MATER CHARACT, V45, P51, DOI 10.1016/S1044-5803(00)00048-6
   SILVA VV, P MAT SOC RES 1998 F, P261
   SUBBARAO EC, 1981, ADV CERAMICS SCI TEC, V3
NR 33
TC 96
Z9 104
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PY 2001
VL 61
IS 2
BP 301
EP 310
DI 10.1016/S0266-3538(00)00222-0
PG 10
WC Materials Science, Composites
SC Materials Science
GA 398HF
UT WOS:000166750300012
DA 2018-10-20
ER

PT J
AU Tang, ZG
   Teoh, SH
AF Tang, ZG
   Teoh, SH
TI Mechanical properties of elastomeric composite membranes made from the
   porous biaxially drawn ultrahigh-molecular-weight polyethylene film and
   polyether polyurethane materials
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE fibrous composites; mechanical properties; microstructure
ID BIOMEDICAL APPLICATIONS
AB Fibrous composites are commonly found in soft tissue but few man-made composites are used for soft tissue replacement. In this study, fibrous composites, made from biaxially drawn ultra-high molecular-weight polyethylene (BD-UHMWPE) and polyether polyurethane materials, were fabricated by solution casting and heat compaction. The effects of processing conditions on tensile properties of the composites were evaluated, in terms of the molecular structures of the polyurethane materials, thermal behavior of the UHMWPE, and the microstructures of the as-made composites. The results indicated that composites of improved tensile properties were constructed in the form of interpenetration of polyurethane through the stacks of the BD-UHMWPE. The tensile strength and modulus of the composites (made from Toyobo TM5 and Solupor (TM) 7PO3) are approximately 69 and 210 MPa. The as-made composite has a significant improvement on its toughness, about 5 times increase in the tensile toughness if compared to that of the BD-UHMWPE. A possible interlocking structure was suggested for those polyurethane materials (Toyobo TM5) that might be recrystallized during heat compaction. The polyurethane like Tecoflex 80A, not indicating a symptom of annealing crystallization, has no impact on increasing the tensile properties but a decrease with plasticizing the materials. (C) 2001 Published by Elsevier Science Ltd. All rights reserved.
C1 Natl Univ Singapore, Dept Mech & Prod Engn, Ctr Biomed Mat Applicat & Technol, Singapore 117548, Singapore.
RP Tang, ZG (reprint author), Blk 359,10-311,Clementi Ave 2, Singapore 120359, Singapore.
EM zgtang@gintic.gov.sg
CR Carlsson LA, 1987, EXPT CHARACTERIZATIO
   GERRITS NSJA, 1991, POLYMER, V32, P1770, DOI 10.1016/0032-3861(91)90361-L
   HOW TV, 1992, CARDIOVASCULAR BIOMA, P1
   LEEPER HM, 1983, RUBBER CHEM TECHNOL, V56, P523, DOI 10.5254/1.3538140
   LIU SH, 1985, J BIOMED ENG, V2, P157
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   Montagna W., 1992, ATLAS NORMAL HUMAN S
   Nimni M., 1992, CARDIOVASCULAR BIOMA, P81
   PIENKOWSKI D, 1995, J BIOMED MATER RES, V29, P1167, DOI 10.1002/jbm.820291002
   PLUYTER PB, 1997, Patent No. 5643511
   PLUYTER PB, 1993, Patent No. 5248461
   PORTER RS, 1994, POLYMER, V35, P4979, DOI 10.1016/0032-3861(94)90652-1
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   Schubert MA, 1997, J BIOMED MATER RES, V35, P319, DOI 10.1002/(SICI)1097-4636(19970605)35:3<319::AID-JBM6>3.0.CO;2-K
   SZYCHER M, 1991, BLOOD COMPATIBLE MAT
   Tang ZG, 2000, COLLOID SURFACE B, V19, P19, DOI 10.1016/S0927-7765(00)00134-X
   Teoh S.H., 1998, HDB BIOMATERIAL PROP, P270
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
NR 18
TC 7
Z9 7
U1 2
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
EI 1879-1050
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PY 2001
VL 61
IS 16
BP 2371
EP 2380
DI 10.1016/S0266-3538(01)00175-0
PG 10
WC Materials Science, Composites
SC Materials Science
GA 502RL
UT WOS:000172756500003
DA 2018-10-20
ER

PT S
AU Ferguson, B
   Mickan, S
   Hubbard, S
   Pavlidis, D
   Abbott, D
AF Ferguson, B
   Mickan, S
   Hubbard, S
   Pavlidis, D
   Abbott, D
BE Bergmann, NW
   Abbott, D
   Hariz, AJ
   Varadan, VK
TI Investigation of gallium nitride T-ray transmission characteristics
SO ELECTRONICS AND STRUCTURES FOR MEMS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Electronics and Structures for MEMS II
CY DEC 17-19, 2001
CL ADELAIDE, AUSTRALIA
SP SPIE, USAF, Off Sci Res, Asian Off Aerosp Res & Dev, Ctr Biomed Engn, Def Sci & Technol Org, Dept Ind & Trade
DE terahertz; gallium nitride; T-rays; photoconductive antenna
ID GENERATION; PULSES; SPECTROSCOPY; THZ
AB T-ray imaging and spectroscopy both exploit the terahertz (THz) region of the spectrum. This gives rise to very promising industrial and biomedical applications, where non-invasive and sensitive identification of a substance is achievable, through a material's distinct absorption features in the THz band. Present T-ray systems are limited by low output power, and the race is now on to find more efficient THz emitters. We discuss the feasibility of a novel high-power gallium nitride emitter for terahertz generation. This paper details the advantages of such an emitter, primarily by virtue of its high-voltage capability, and evaluates the benefits of sapphire and silicon carbide substrates. The far-infrared transmission spectra for thin samples of GaN, sapphire and SiC are reported. A high-power THz emitter, that operates at room temperature and is potentially low-cost will open up a host of new possibilities and applications. The central result in this paper demonstrates that sapphire is the better choice over SiC, for the GaN supporting substrate, as we show that it has superior THz transmission characteristics.
C1 Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RP Ferguson, B (reprint author), Univ Adelaide, Ctr Biomed Engn, Adelaide, SA 5005, Australia.
RI Abbott, Derek/E-8352-2011
OI Abbott, Derek/0000-0002-0945-2674
CR ARNONE D, 2000, PHYSICS WORLD, P35
   Arnone DD, 1999, P SOC PHOTO-OPT INS, V3828, P209, DOI 10.1117/12.361037
   AUSTON DH, 1983, APPL PHYS LETT, V43, P631, DOI 10.1063/1.94468
   BUDIARTO E, 1997, P C QELS BALT, V12, P41
   Cole BE, 2001, NATURE, V410, P60, DOI 10.1038/35065032
   FERGUSON B, 2001, SPIE, V4236, P157
   GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006
   GUNZUN D, 2000, OPT COMMUN, V180, P367
   Kawase K, 1999, OPT LETT, V24, P1065, DOI 10.1364/OL.24.001065
   Kim HM, 2001, MATER LETT, V47, P276, DOI 10.1016/S0167-577X(00)00249-4
   Markelz AG, 2000, CHEM PHYS LETT, V320, P42, DOI 10.1016/S0009-2614(00)00227-X
   McLaughlin R, 2000, J MOD OPTIC, V47, P1847, DOI 10.1080/095003400417007
   Melnik YV, 1997, MRS INTERNET J N S R, V2
   MICKAN S, 2001, SMART STRUCTURES D 2, V4235, P434
   Mittleman DM, 1996, IEEE J SEL TOP QUANT, V2, P679, DOI 10.1109/2944.571768
   Mittleman DM, 1999, APPL PHYS B-LASERS O, V68, P1085, DOI 10.1007/s003400050750
   Morris J. R., 1971, Optics Communications, V3, P81, DOI 10.1016/0030-4018(71)90182-9
   MOUROU G, 1981, APPL PHYS LETT, V39, P295, DOI 10.1063/1.92719
   MOUROU G, 1981, APPL PHYS LETT, V38, P470, DOI 10.1063/1.92407
   Nuss MC, 1996, IEEE CIRCUIT DEVIC, V12, P25, DOI 10.1109/101.485909
   Proakis JG, 1996, DIGITAL SIGNAL PROCE
   Shen Y. R., 1976, PROG QUANT ELECTRON, V4, P207
   Steinbach D, 1998, J OPT SOC AM B, V15, P1231, DOI 10.1364/JOSAB.15.001231
   Weiner AM, 1998, OPT LETT, V23, P1441, DOI 10.1364/OL.23.001441
   Woodward R. M., 2001, C LAS EL 2001, P329
   YANG KH, 1971, APPL PHYS LETT, V19, P320, DOI 10.1063/1.1653935
   YOU D, 1993, OPT LETT, V18, P290, DOI 10.1364/OL.18.000290
NR 27
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4321-2
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4591
BP 210
EP 220
DI 10.1117/12.449150
PG 3
WC Computer Science, Hardware & Architecture; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA BT92X
UT WOS:000174463500022
DA 2018-10-20
ER

PT B
AU Kancharla, VV
   Chen, SC
AF Kancharla, VV
   Chen, SC
BE Zhu, GM
   Peng, SQ
   Li, QP
TI UV laser micromachining of biodegradable polymers
SO ENERGY CONVERSION AND APPLICATION, VOL I AND II
LA English
DT Proceedings Paper
CT International Conference on Energy Conversion and Application (ICECA
   2001)
CY JUN 17-20, 2001
CL WUHAN, PEOPLES R CHINA
SP Huazhong Univ Sci & Technol, Univ Calif Los Angeles, Univ Nottingham, Nippon Inst Technol, Hong Kong Univ Sci & Technol, Univ Otago
ID EXCIMER
AB This paper reports on Ultra-Violet (UV) laser micromachining or two biodegradable polymeric materials for applications in biomedical engineering. Parametric studies have been conducted on Poly-vinyl Alcohol (PVA) and Poly-D-Lactic acid (PDLA) to produce microchannels and microholes. Laser micromachining of microchannels is studied usinga XeCl excimer laser at 308 nm wavelength and laser microdrilling is studied using a Q-switched Nd: YAG laser at 266 nm wave length. Feature sizes ranging from 4 to 10 mum were obtained for the microholes and the features of microchannels were 20 mum and 10 mum deep. This work demonstrated that UV laser micromachining is a well-suited technique for patterning of biodegradable polymers with minimum thermal damage to the surrounding material.
C1 Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.
RP Kancharla, VV (reprint author), Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.
CR Chen SC, 2000, J HEAT TRANS-T ASME, V122, P107, DOI 10.1115/1.521441
   CHEN YH, 1995, P SOC PHOTO-OPT INS, V3184, P202
   GANNEPALLI A, 1998, POLYM MAT SCI ENG P, V78, P3
   Gower MC, 1999, P SOC PHOTO-OPT INS, V3618, P251, DOI 10.1117/12.352688
   KUMAR GS, 1986, BIODEGRADABLE POLYM
   Lin LW, 1999, J MICROELECTROMECH S, V8, P78, DOI 10.1109/84.749406
   Matsui S, 1995, MATER RES SOC SYMP P, V380, P49, DOI 10.1557/PROC-380-49
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
NR 8
TC 0
Z9 0
U1 0
U2 0
PU HUAZHONG UNIVERSITY SCIENCE & TECHNOLOGY PRESS
PI WUHAN
PA YUJIASHAN, WUHAN, HUPEI, PEOPLES R CHINA
BN 7-5609-2420-4
PY 2001
BP 1274
EP 1277
PG 4
WC Thermodynamics; Energy & Fuels; Engineering, Mechanical; Mechanics
SC Thermodynamics; Energy & Fuels; Engineering; Mechanics
GA BS85M
UT WOS:000171232700274
DA 2018-10-20
ER

PT S
AU Soboyejo, WO
   Mercer, C
   Allameh, S
   Nemetski, B
   Marcantonio, N
   Ricci, JL
AF Soboyejo, WO
   Mercer, C
   Allameh, S
   Nemetski, B
   Marcantonio, N
   Ricci, JL
BE Katsube, N
   Soboyejo, WO
   Sacks, M
TI Multi-scale microstructural characterization of micro-textured Ti-6Al-4V
   surfaces
SO FUNCTIONAL BIOMATERIALS
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT Symposium on Functional Biomaterials held at the ASME Winter Annual
   Meeting
CY NOV, 2000
CL ORLANDO, FLORIDA
SP ASME
DE microstructural characterization; micro-textured surfaces; Ti-6Al-4V
ID CELL BEHAVIOR; TOPOGRAPHICAL CONTROL; CONTACT GUIDANCE; TITANIUM
   SUBSTRATA; IMPLANT MATERIALS; IN-VITRO; FIBROBLASTS; INVITRO;
   TRANSMISSION; GROWTH
AB This paper presents the results of a multi-scale microstructural characterization of microtextured Ti-6Al-4V surfaces that are used in biomedical implants. The hierarchies of substructural and microstructural features associated with laser micro-texturing, mechanical polishing and surface blasting with alumina pellets are elucidated via atomic force microscopy (AFM), transmission electron microscopy (TEM), scanning electron microscopy (SEM) and optical microscopy (OM). The nano-scale roughness profiles for the different surface textures are characterized via AFM. Sub-micron precipitates and dislocation substructures associated with wrought processing and laser processing are revealed by TEM. OM and SEM micro- and mesoscale images of the groove structures and then described before discussing the implications of the result for the optimization of laser processing schemes. The implications of the results are examined for the fabrication of micro-textured surfaces that will facilitate the self organization of proteins, and the attachment of mammalian cells to the Ti-6Al-4V surfaces in biomedical implants.
C1 Princeton Mat Inst, Princeton, NJ 08544 USA.
   Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.
   Brown Univ, Div Engn, Providence, RI 02912 USA.
   Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Orthodont, Newark, NJ 07103 USA.
RP Soboyejo, WO (reprint author), Princeton Mat Inst, Olden St, Princeton, NJ 08544 USA.
RI MERCER, Christopher/H-2654-2011
OI Allameh, Seyed/0000-0001-7726-415X
CR BAESLACK WA, 1990, J MATER SCI, V21, P698
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Brunette D., 1996, NANOFABRICATION BIOS, P335
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   Chehroudi B., 1990, J BIOMED MATER RES, V24, P1067
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1987, DEVELOPMENT, V99, P439
   COEN MC, 2000, P 6 WORLD C BIOM BIO, P665
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Davidon WC, 1991, SIAM J OPTIMIZ, V1, P1, DOI 10.1137/0801001
   DECUPERE VM, 2000, P 6 WORLD C BIOM BIO, P635
   Dee KC, 2000, MATER TODAY, V3, P7
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   DOBBS HS, 1983, STP, V796, P174
   DOSERRO APV, 2000, P 6 WORLD C BIOM BIO, P376
   DUCHEYNE WD, J BIOMEDICAL MAT RES, V28, P417
   ECKERDAL J, 2000, P 6 WORLD C BIOM BIO, P1184
   HADDAD RJ, 1987, J BONE JOINT SURG AM, V69A, P1459
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kam L, 1999, BIOMATERIALS, V20, P2343, DOI 10.1016/S0142-9612(99)00163-5
   KANE RS, 1999, BIOMATERIALS, V20, P2353
   LEDUNG G, 2000, P 6 WORLD C BIOM BIO, P676
   Lu LC, 1999, BIOMATERIALS, V20, P2351, DOI 10.1016/S0142-9612(99)00164-7
   LU W, 2000, UNPUB J MECH PHYSICS
   Mandelbrot B. B, 1982, FRACTAL GEOMETRY NAT
   MEAGHER L, 2000, P 6 WORLD C BIOM BIO, P24
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Recum A F, 1996, Tissue Eng, V2, P241, DOI 10.1089/ten.1996.2.241
   Ricci J.L., 2000, BONE ENG, P1
   RICCI JL, 1991, MODULATION BONE INGR, P334
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   TZIAMPAZIS E, 2000, P 6 WORLD C BIOM BIO, P166
   UNDERWOOD EE, 1987, METALS HDB, V12, P211
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   WAGNER MS, 2000, P 6 WORLD C BIOM BIO, P22
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
NR 48
TC 23
Z9 23
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-871-0
J9 KEY ENG MAT
PY 2001
VL 198-1
BP 203
EP 227
DI 10.4028/www.scientific.net/KEM.198-199.203
PG 25
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BS10M
UT WOS:000168666500008
DA 2018-10-20
ER

PT S
AU Barnes, AS
   Pantano, CG
   Conzone, SD
AF Barnes, AS
   Pantano, CG
   Conzone, SD
BE Marker, AJ
   Davis, MJ
TI Surface cleaning and etching of rare-earth doped phosphate glass
SO INORGANIC OPTICAL MATERIALS III
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Inorganic Optical Materials III
CY AUG 02, 2001
CL SAN DIEGO, CA
SP SPIE
DE phosphate glasses; surface preparation; cleaning; etching; surface
   finishing
ID SOLUBILITIES; SILICA
AB The surface reactions of phosphate glasses are important for the processing and application of photonic devices. biomedical materials and conventional optical components. Of particular concern are the leaching of optically-active dopant species. surface layer formation and roughening during polishing, cleaning and other fabrication processes. In this study. the effects of various cleaning treatments, and both acid and base etching, were evaluated using surface analytical techniques (XPS, AFM). It is shown that in these phosphate glasses, the aluminum and rare-earth oxides have limited aqueous solubility. whereas the phosphate network is soluble over a wider range of pH. Thus. under those conditions where polishing damage can be removed by etching the surface, a localized precipitation of rare-earth oxides occurs which influences the final roughness and surface composition. Conversely, under conditions where this precipitation can be eliminated. an in-depth leaching of the surface occurs. These aqueous surface reactions were similar for both the optically-active and passive IOG-1 glasses. An optimized surface preparation method is described.
C1 Penn State Univ, Mat Res Inst, Dept Mat Sci & Engn, University Pk, PA 16801 USA.
RP Barnes, AS (reprint author), Penn State Univ, Mat Res Inst, Dept Mat Sci & Engn, 198 MRI Bldg, University Pk, PA 16801 USA.
EM asb6@psu.edu; pantano@ems.psu.edu; sconzone@schottglasstech.com
CR Affatigato M, 1996, J AM CERAM SOC, V79, P688
   ALEKSEEV NE, 1983, GLASS CERAM+, V40, P344, DOI 10.1007/BF00701918
   BROW RK, 1993, J AM CERAM SOC, V76, P913, DOI 10.1111/j.1151-2916.1993.tb05315.x
   BUNKER BC, 1984, J NON-CRYST SOLIDS, V64, P291, DOI 10.1016/0022-3093(84)90184-4
   Carr JW, 1999, CERAM TRANS, V102, P163
   Deberdt S, 1998, CHEM GEOL, V151, P349, DOI 10.1016/S0009-2541(98)00089-8
   Hao Sun, 1997, Chemosphere, V34, P1753
   HAYDEN JS, 1990, P SOC PHOTO-OPT INS, V1277, P121, DOI 10.1117/12.20590
   JONASSON RG, 1985, GEOCHIM COSMOCHIM AC, V49, P2133, DOI 10.1016/0016-7037(85)90071-7
   Mellott NP, 2001, SURF INTERFACE ANAL, V31, P362, DOI 10.1002/sia.971.abs
   SANDERS DM, 1973, AM CERAM SOC BULL, V52, P666
   SPRENGER D, 1993, SURF INTERFACE ANAL, V20, P796, DOI 10.1002/sia.740200908
NR 12
TC 10
Z9 10
U1 0
U2 9
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4166-X
J9 PROC SPIE
PY 2001
VL 4452
BP 115
EP 125
DI 10.1117/12.446886
PG 11
WC Materials Science, Ceramics; Optics
SC Materials Science; Optics
GA BT90P
UT WOS:000174396000014
DA 2018-10-20
ER

PT J
AU Liew, CL
   Leong, KF
   Chua, CK
   Du, Z
AF Liew, CL
   Leong, KF
   Chua, CK
   Du, Z
TI Dual material rapid prototyping techniques for the development of
   biomedical devices. Part 1: Space creation
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE drug delivery devices (DDD); dual material RP; electrography; rapid
   prototyping (RP); selective laser sintering (SLS)
AB Polymeric drug delivery devices play an important role in drug administration. However, the current polymeric drug delivery device fabrication methods lack precision. This impairs the quality of the devices, resulting in a decrease in the efficiency and effectiveness of drug delivery. The concept of building parts laver by layer out of powdered raw materials makes selective laser sintering (SLS) a suitable process for fabricating polymeric matrix drug delivery devices. The current SLS process is not capable of processing two or more materials separately. This work explores the possibilities of SLS performing a dual material operation by developing two process models. These two processes can then be integrated to form a dual or expanded multimaterial fabrication technique and act as a foundation for future work in multimaterial applications such as polymeric drug delivery device fabrication. Accordingly, two papers are presented.
   In this paper, Part 1, the focus is on the first process, which is a "space" creation technique in which a "space" is created by varying the density of a first representative material using heat during sintering. Three methods - one based on a vacuum and a place method, and the other two based on two variations of a laser compacting method - were tested. Results have shown that by varying the laser power during sintering, it is possible to create channels in which a second material can be deposited.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mckchua@ntu.edu.sg
RI Leong, Kah-Fai/B-6183-2009; Chua, Chee Kai/B-6171-2009
CR BEAMAN JJ, 1997, INDIRECT METHODS MET, V1
   CARDINAL JR, 1980, CONTROLLED RELEASE B
   CHUA CK, 1997, RAPID PROTOTYPING J
   Cima L. G, 1996, U. S. Patent, Patent No. [5,490,962, 5490962]
   COLTER KD, 1997, BIOMATERIALS MEDICAL
   De Rossi D, 1991, POLYM GELS
   GOLDBERG EP, 1979, BIOMEDICAL POLYM
   GOOD WR, 1981, AICHE S SERV, V206
   LEE ES, 1980, J MEMBRANE SCI, V7, P293, DOI 10.1016/S0376-7388(00)80474-3
   Sachs E. M., 1993, Three-Dimensional Printing Techniques, Patent No. [U. S. 5204055, 5204055]
NR 10
TC 32
Z9 34
U1 0
U2 7
PU SPRINGER-VERLAG LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0268-3768
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PY 2001
VL 18
IS 10
BP 717
EP 723
DI 10.1007/s001700170014
PG 7
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA 503XL
UT WOS:000172826900004
DA 2018-10-20
ER

PT J
AU Hisao, FK
   Yang, W
   Morita, A
   Hayashi, S
   Niinomi, M
   Hasegawa, J
AF Hisao, FK
   Yang, W
   Morita, A
   Hayashi, S
   Niinomi, M
   Hasegawa, J
TI Study of biocompatible and high melting point Ti-Ta-Nb ternary alloys:
   development of a non-contaminating melting process
SO INTERNATIONAL JOURNAL OF MATERIALS & PRODUCT TECHNOLOGY
LA English
DT Article
DE biomedical materials; Ti-Ta-Nb alloys; cold crucible levitation melting
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS
AB A one-coil type Cold Crucible Levitation Melting furnace, with capacity of 100g and supplied by a frequency inverter power system, is used successfully for melting Ti-10Ta-20Nb, Ti-20Ta-30Nb and Ti-30Nb alloys under argon atmosphere of 7.4x 10(4) Pa, adopting supply conditions of 60kHz, 50kw/30sec for fusing the raw materials and 30kw/5min for homogenization. 70g ingots were gained, and then were analyzed by EPMA. The cast microstructure of all alloys presents dendrite-type. Elements almost distribute uniformly in ingots, only a Ta-rich bond is found in the lower part of some Ti-20Ta-30Nb and Ti-30Ta ingots. The real contents of Nb in all the samples are smaller than the nominal. Improving measures are also pointed out.
C1 Aichi Gakuin Univ, Sch Dent, Dept Dent Mat Sci, Chikusa Ku, Nagoya, Aichi 4648650, Japan.
   Fuji Elect Furnace Co, Suzuka 5138633, Japan.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR FUKUI H, 2000, J JAPAN SOC DENT MAT, V19, P49
   FUKUZAWA A, 1994, P INT S ELECTROMAGNE, P172
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   MORITA A, 1999, P 1 IUMRS INT C ADV
   MORITA A, 2000, P 3 INT S EL PROC MA, P358
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   OKUNO I, 1991, QDT, V16, P5
   SAKURAYA K, 1994, P INT S SIM DES APPL, P483
   TADANO H, 1997, P EPM FRANC, P377
   WINTER GD, 1980, EVALUATION BIOMATERI
NR 10
TC 0
Z9 0
U1 0
U2 2
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA AEROPORT
PA WORLD TRADE CENTER BLDG 110 AVE LOUSIS CASAI CP 306, CH-1215 GENEVA
   AEROPORT, SWITZERLAND
SN 0268-1900
J9 INT J MATER PROD TEC
JI Int. J. Mater. Prod. Technol.
PY 2001
SU 2
BP 461
EP 467
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 534UG
UT WOS:000174604900005
DA 2018-10-20
ER

PT J
AU Costello, J
AF Costello, J
TI Nursing older dying patients: findings from an ethnographic study of
   death and dying in elderly care wards
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE older patients; terminal care; death and dying; nursing; biomedicine;
   nurses; physicians
ID HOSPITAL-CARE; PALLIATIVE CARE; NURSES; COMMUNICATION; PROFESSIONALS;
   RESPONSES; AWARENESS; PEOPLE
AB Background and aim. The aim of the study was to explore the experiences of dying patients and nurses working in three elderly care wards focusing on the management of care for dying patients. The majority of patients who die in hospital are over the age of 65 and evidence suggests that three fifths are over the age of 75. Older patients pose tremendous problems and challenges to nurses and doctors regarding the provision of good terminal care, particularly in relation to developing effective communication.
   Method. An ethnographic research design was chosen. The research sample consisted of 74 patients, 29 nurses and 8 physicians. The principle data collection methods were participant observation and semi-structured interviews. All respondents were interviewed following a period of observation on each of the ward areas. The data obtained from participant observation were then used to structure the interview questions. The purpose of asking questions about meanings associated with observational material was to evaluate the extent to which convergence or divergence of the data was taking place.
   Findings. The findings demonstrate that the care of older dying patients was defined by a lack of 'emotional engagement' with the patient and the institutionalized nondisclosure of information about death and dying. The study raises issues concerning the lack of effective communication about terminal diagnosis and the strategies used by nurses and doctors for disclosing information about death and dying. The findings suggest that although nurses provide individual care to dying patients, much of this was aimed at meeting patients' physical needs. Nurses reported psychosocial aspects including spiritual and emotional care to be important, although there was little evidence of them being orientated towards this in practice.
   Conclusion. The indicative conclusions from this study suggest that terminal care for some elderly patients remains hampered by a reluctance of nurses and doctors to be more open in their communication about death. It would appear that hospital culture and the mores, beliefs and ideologies that emanate from the biomedical model, significantly shape the experiences of older dying patients.
C1 Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Manchester M60 7LP, Lancs, England.
RP Costello, J (reprint author), Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Gateway House, Manchester M60 7LP, Lancs, England.
CR AHMEDZAI S, 1982, BRIT MED J, V285, P712, DOI 10.1136/bmj.285.6343.712
   Bartlett D., 1997, UNDERSTANDING SOCIAL, P173
   BLACKBURN A, 1994, BRIT MED J, V309, P1579, DOI 10.1136/bmj.309.6968.1579b
   BLACKBURN AM, 1989, PALLIATIVE MED, V3, P203
   BLUMER H, 1956, AM SOCIOL REV, V21, P683, DOI 10.2307/2088418
   CANDY CE, 1991, J ADV NURS, V16, P138, DOI 10.1111/j.1365-2648.1991.tb01617.x
   Cartwright A, 1973, LIFE BEFORE DEATH
   CLARK D., 1999, REFLECTIONS PALLIATI
   COPP G, 1999, EXPERIENCES NURSES T
   COSTELLO J, 2000, INT J PALLIATIVE NUR, V6, P152
   COSTELLO J, 1994, REV CLIN GERONTOLOGY, V4, P169
   COSTELLO J, 2000, THESIS MANCHESTER ME
   DAVEY B, 2000, DEATH DYING BEREAVEM, P250
   EMERSON RM, 1988, HUM ORGAN, V47, P189, DOI 10.17730/humo.47.3.8tm323u28p760863
   Eve A, 1997, PALLIATIVE MED, V11, P31, DOI 10.1177/026921639701100104
   Field D, 1999, PALLIATIVE MED, V13, P459, DOI 10.1191/026921699668763479
   FIELD D, 1987, THESIS U LEICESTER
   FIELD D, 1994, EUROPEAN J CANC CARE, V3, P358
   Field D., 2000, DEATH DYING BEREAVEM, P91
   Field D, 1989, NURSING DYING
   Glaser BG, 1965, AWARENESS DYING
   HIGGINSON I, 1997, EPIDEMIOLOGICALLY BA
   HINTON JM, 1967, DYING
   JAMES N, 1992, SOC SCI MED, V34, P1363, DOI 10.1016/0277-9536(92)90145-G
   JAMES V, 1986, THESIS U ABERDEEN
   KELNER MJ, 1993, SOC SCI MED, V36, P757, DOI 10.1016/0277-9536(93)90036-4
   LAWLER J, 1991, SCREENS NURSING SOMO
   Maeve MK, 1998, J ADV NURS, V27, P1136
   Magnusson S, 1996, BRIT MED J, V313, P1601, DOI 10.1136/bmj.313.7072.1601
   Mallik M, 1997, J ADV NURS, V25, P130, DOI 10.1046/j.1365-2648.1997.1997025130.x
   MAY C, 1993, INT J NURS STUD, V30, P181, DOI 10.1016/0020-7489(93)90067-5
   MILLS M, 1994, BRIT MED J, V309, P583, DOI 10.1136/bmj.309.6954.583
   MOORE LW, 1999, J ADV NURS, V35, P1034
   MOUNT BM, 1995, PALLIATIVE MED, V9, P165, DOI 10.1177/026921639500900207
   PARKES CM, 1984, POSTGRAD MED J, V60, P120, DOI 10.1136/pgmj.60.700.120
   PARKES CM, 1985, LANCET, V1, P155
   Payne S, 2000, J ADV NURS, V32, P277, DOI 10.1046/j.1365-2648.2000.01474.x
   Payne S, 1996, SOC SCI MED, V43, P1785, DOI 10.1016/S0277-9536(96)00077-9
   PEARSALL M, 1965, NURS RES, V14, P37, DOI 10.1097/00006199-196501410-00011
   PINE VR, 1975, J THANATOL, V3, P1
   PORTER S, 1991, J ADV NURS, V16, P728, DOI 10.1111/j.1365-2648.1991.tb01731.x
   QUINT JC, 1967, NURSE DYING PATIENT
   Randall F, 1996, PALLIATIVE CARE ETHI
   REVANS RW, 1964, STANDARDS MORALE
   Rogers A, 2000, J ADV NURS, V31, P768, DOI 10.1046/j.1365-2648.2000.01347.x
   SAUNDERS C, 1963, P ROY SOC MED, V56, P195
   Scottish Health Advisory Council, 1991, EV DEATH SHOULD MATT
   SEALE C, 1991, SOC SCI MED, V32, P943, DOI 10.1016/0277-9536(91)90249-C
   Seale C, 1997, PALLIATIVE MED, V11, P93, DOI 10.1177/026921639701100202
   Sheldon F, 1997, PSYCHOSOCIAL PALLIAT
   SHELDON JH, 1961, REPORT BIRMINGHAM RE
   SIDELL M, 1995, HLTH OLD AGE
   SMITH P, 1992, EMOTIONAL LABOUR NUR
   Strauss A, 1982, Sociol Health Illn, V4, P254, DOI 10.1111/1467-9566.ep10487954
   Strauss A. L., 1990, BASICS QUALITATIVE R
   Thompson S., 1999, ILLNESS CRISIS LOSS, V7, P122
   Townsend P., 1962, LAST REFUGE
   Tuckett A, 1998, INT J NURS STUD, V35, P292, DOI 10.1016/S0020-7489(98)00043-1
   TURNER BA, 1981, QUAL QUANT, V15, P225
   VACHON MLS, 1987, OCCUPATIONAL STRESS, P51
   WIDGERY D, 1988, NATL HLTH SERVICE RA
   WILKES E, 1984, LANCET, V1, P950
   WILKES E, 1965, LANCET, V1, P799
   WILKINSON S, 1991, J ADV NURS, V16, P677, DOI 10.1111/j.1365-2648.1991.tb01726.x
   Willard C, 1996, J ADV NURS, V24, P60, DOI 10.1046/j.1365-2648.1996.01698.x
   WILLIAMS A, 1989, THESIS U MANCHESTER
NR 66
TC 80
Z9 81
U1 1
U2 7
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0309-2402
J9 J ADV NURS
JI J. Adv. Nurs.
PY 2001
VL 35
IS 1
BP 59
EP 68
DI 10.1046/j.1365-2648.2001.01822.x
PG 10
WC Nursing
SC Nursing
GA 452YW
UT WOS:000169888100015
PM 11442683
DA 2018-10-20
ER

PT J
AU Gimenez, S
   Ponsart, S
   Coudane, J
   Vert, M
AF Gimenez, S
   Ponsart, S
   Coudane, J
   Vert, M
TI Synthesis, properties and in vitro degradation of carboxyl-bearing PCL
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
ID DRUG DELIVERY SYSTEMS; POLY(DL-LACTIC ACID); SUSTAINED-RELEASE;
   HYDROLYTIC DEGRADATION; MULTIBLOCK COPOLYMERS; POLY(L-LACTIC ACID);
   GENTAMICIN SULFATE; AQUEOUS-MEDIA; POLY(EPSILON-CAPROLACTONE); POLYMERS
AB Aliphatic polyesters derived from lactic and glycolic acids (PLAGA) are the most attractive degradable polymers with respect to biomedical and environmental applications.Poly(-epsilon -caprolactone), PCL, is a hydrophobic highly crystalline aliphatic polyester that is more resistant to hydrolytic degradation than PLA. It is not biodegradable in animal body but is rapidly degraded by outdoor microorganisms. In order to increase the rate of hydrolysis of the material, carboxyl-bearing PCL copolymers (PCLCOOH) were synthesized by anionic activation with LDA and reaction of CO2 on the polycarbanion. Variations in crystallinity, thermal properties and hydrophilicity caused by the presence of the pendent carboxyl groups were investigated. The degradation behavior of PCLCOOH was assessed by the evaluation of water uptake, mass loss, molecular masses and ESEM microphotographs. A dramatic increase in the hydrolytic degradation rate was observed compared with pure PCL, thus PCLCOOH can now be considered as a hydrolytically degradable polymer.
C1 Fac Pharm, Ctr Rech Biopolymers Artificiels, F-34060 Montpellier 2, France.
RP Coudane, J (reprint author), Fac Pharm, Ctr Rech Biopolymers Artificiels, 15 Ave Charles Flahault, F-34060 Montpellier 2, France.
CR Bei JZ, 1997, POLYM ADVAN TECHNOL, V8, P693, DOI 10.1002/(SICI)1099-1581(199711)8:11<693::AID-PAT702>3.0.CO;2-B
   CHABOT F, 1983, POLYMER, V24, P53, DOI 10.1016/0032-3861(83)90080-0
   DOMB AJ, 1994, POLYM BIOMATERIALS
   Gan ZH, 1997, POLYM DEGRAD STABIL, V56, P209, DOI 10.1016/S0141-3910(96)00208-X
   HECQUET B, 1986, ANTICANCER RES, V6, P1251
   HUTCHINSON FG, 1985, BIOCHEM SOC T, V13, P520, DOI 10.1042/bst0130520
   Li SM, 1998, J APPL POLYM SCI, V68, P989, DOI 10.1002/(SICI)1097-4628(19980509)68:6<989::AID-APP12>3.0.CO;2-J
   LI SM, 1990, J MATER SCI-MATER M, V1, P198, DOI 10.1007/BF00701077
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Li SM, 1996, J BIOMAT SCI-POLYM E, V8, P165, DOI 10.1163/156856296X00237
   MAUDUIT J, 1993, J CONTROL RELEASE, V23, P221, DOI 10.1016/0168-3659(93)90003-N
   MAUDUIT J, 1993, J CONTROL RELEASE, V23, P209, DOI 10.1016/0168-3659(93)90002-M
   MAUDUIT J, 1995, J BIOMAT SCI-POLYM E, V7, P207
   NAKAMURA T, 1987, BIOMATERIALS CLIN AP
   Petrova T, 1998, POLYM INT, V45, P419
   Pitt C. G., 1984, LONG ACTING CONTRACE
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   PITT CG, 1992, BIODEGRADABLE POLYM
   Ponsart S, 2000, BIOMACROMOLECULES, V1, P275, DOI 10.1021/bm005521t
   VERT M, 1989, ANGEW MAKROMOL CHEM, V166, P155, DOI 10.1002/apmc.1989.051660111
   ZHANG XC, 1993, J MACROMOL SCI PURE, VA30, P933, DOI 10.1080/10601329308009437
   ZIMMERMAN M, 1987, J BIOMED MATER RES-A, V21, P345
NR 23
TC 25
Z9 25
U1 0
U2 16
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2001
VL 16
IS 1
BP 32
EP 46
DI 10.1106/MF92-TCJC-KC2X-J0FB
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 413NZ
UT WOS:000167619800003
DA 2018-10-20
ER

PT J
AU Baidya, KP
   Ramakrishna, S
   Rahman, M
   Ritchie, A
AF Baidya, KP
   Ramakrishna, S
   Rahman, M
   Ritchie, A
TI Quantitative radiographic analysis of fiber reinforced polymer
   composites
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE radiolucency; fiber reinforced polymer composite material; total mass
   attenuation coefficient (TMAC)
ID VERTEBRAL BODY REPLACEMENT; RADIOLUCENT
AB X-ray radiographic examination of the bone fracture healing process is a widely used method in the treatment and management of patients. Medical devices made of metallic alloys reportedly produce considerable artifacts that make the interpretation of radiographs difficult. Fiber reinforced polymer composite materials have been proposed to replace metallic alloys in certain medical devices because of their radiolucency, light weight, and tailorable mechanical properties. The primary objective of this paper is to provide a comparable radiographic analysis of different fiber reinforced polymer composites that are considered suitable for biomedical applications. Composite materials investigated consist of glass, aramid (Kevlar-29), and carbon reinforcement fibers, and epoxy and polyether-ether-ketone (PEEK) matrices. The total mass attenuation coefficient of each material was measured using clinical X-rays (50 kev). The carbon fiber reinforced composites were found to be more radiolucent than the glass and kevlar fiber reinforced composites.
C1 Natl Univ Singapore, Dept Mech & Prod Engn, Singapore 119260, Singapore.
   Nanyang Technol Univ, Dept Mech & Prod Engn, Singapore 639798, Singapore.
RI Rahman, Mustafizur/G-1998-2012
CR Ciappetta P, 1997, NEUROSURGERY, V41, P1203, DOI 10.1097/00006123-199711000-00040
   Claes L, 1999, J BIOMED MATER RES, V48, P82, DOI 10.1002/(SICI)1097-4636(199921)48:1<82::AID-JBM14>3.3.CO;2-Z
   COMPTON, 1935, XRAYS THEORY EXPT
   GOLVAKOVSKY V, 1993, OPERATIVE MANUAL ILI
   *NUS, MASS ATT XDB SOFTW
   OKUDERA H, 1994, ACTA NEUROCHIR, V127, P121, DOI 10.1007/BF01808559
   ROWLEY DI, 1985, ARCH ORTHOP TRAUMA S, V103, P40
   Skalak R., 1987, HDB BIOENGINEERING
   WYTCH R, 1991, INJURY, V22, P41, DOI 10.1016/0020-1383(91)90160-G
NR 9
TC 29
Z9 33
U1 2
U2 12
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604 USA
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2001
VL 15
IS 3
BP 279
EP 289
DI 10.1106/BKLQ-E2YG-D2LA-RG3R
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 413NN
UT WOS:000167618400005
PM 11261603
DA 2018-10-20
ER

PT J
AU Skarja, GA
   Woodhouse, KA
AF Skarja, GA
   Woodhouse, KA
TI In vitro degradation and erosion of degradable, segmented polyurethanes
   containing an amino acid-based chain extender
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyurethane; enzyme; degradation; in vitro
ID BIS(L-PHENYLALANINE) ALPHA,OMEGA-ALKYLENE DIESTERS; BIOANALOGOUS
   POLYMERS; POLY(ESTER-URETHANE) ELASTOMER; COMPARATIVE REACTIVITIES;
   BIODEGRADABLE POLYMERS; PEPTIDE 4-NITROANILIDE; ENZYMATIC DEGRADATION;
   EPSILON-CAPROLACTONE; LYSINE DIISOCYANATE; L-ALANINE
AB In vitro degradation and erosion of novel, degradable segmented polyurethanes containing a phenylalanine diester chain extender were investigated by exposing the polymers to buffer, chymotrypsin, and trypsin solutions for up to 28 days. Polyurethane degradation and erosion were monitored by gravimetry, scanning electron microscopy (SEM), and gel permeation chromatography (GPC) and compared to a control polyurethane. Polyurethanes were synthesized using two different soft segments (polycaprolactone diol and polyethylene oxide) of variable molecular weight. Inclusion of the phenylalanine-based chain extender resulted in an increased susceptibility to enzyme-mediated, but not buffer-mediated, erosion in comparison to the control polyurethane. SEM analysis indicated that enzyme-mediated erosion proceeded via a surface-limited mechanism resulting in a progressive removal of material from the surface inwards with time. The magnitude of degradation and erosion was highly variable and was dependent on soft segment type and molecular weight. The range of degradation rates, as well as physicochemical properties, makes these polyurethanes potentially useful for a wide range of biomedical applications.
C1 Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
RP Woodhouse, KA (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.
CR Anderson JM, 1998, POLYM INT, V46, P163, DOI 10.1002/(SICI)1097-0126(199807)46:3<163::AID-PI972>3.0.CO;2-9
   ARABULI N, 1994, MACROMOL CHEM PHYSIC, V195, P2279, DOI 10.1002/macp.1994.021950633
   BARRETT AJ, 1980, MAMMALIAN PROTEASES, V1
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   BRUIN P, 1990, BIOMATERIALS, V11, P291, DOI 10.1016/0142-9612(90)90013-G
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Coury A, 1987, PROGR RUBBER PLASTIC, V3, P24
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   Darwis D, 1998, POLYM DEGRAD STABIL, V62, P259, DOI 10.1016/S0141-3910(98)00005-6
   Deslandes Y, 1998, POLYMER, V39, P2361, DOI 10.1016/S0032-3861(97)00533-8
   Doi Y, 1992, BIODEGRADABLE POLYM, P139
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   HANSCH C, 1972, J ORG CHEM, V37, P92, DOI 10.1021/jo00966a025
   Hettrich W, 1997, POLYMER, V38, P2437, DOI 10.1016/S0032-3861(96)00798-7
   HUANG SJ, 1979, J APPL POLYM SCI, V23, P429, DOI 10.1002/app.1979.070230212
   Kartvelishvili T, 1997, MACROMOL CHEM PHYSIC, V198, P1921, DOI 10.1002/macp.1997.021980620
   Kartvelishvili T, 1996, MACROMOL CHEM PHYSIC, V197, P249, DOI 10.1002/macp.1996.021970119
   Katsarava R, 1999, J POLYM SCI POL CHEM, V37, P391, DOI 10.1002/(SICI)1099-0518(19990215)37:4<391::AID-POLA3>3.0.CO;2-E
   Kylma J, 1997, MACROMOLECULES, V30, P2876, DOI 10.1021/ma961569g
   Labow RS, 1996, BIOMATERIALS, V17, P2381, DOI 10.1016/S0142-9612(96)00088-9
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   Li FK, 1996, J APPL POLYM SCI, V62, P631, DOI 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U
   LIPATOVA TE, 1983, BIOMATERIALS, V4, P201, DOI 10.1016/0142-9612(83)90011-X
   Paredes N, 1998, J APPL POLYM SCI, V69, P1537, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1537::AID-APP8>3.0.CO;2-D
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   POWERS JC, 1985, BIOCHEMISTRY-US, V24, P2048, DOI 10.1021/bi00329a037
   Rodriguez-Galan A, 2000, POLYMER, V41, P5967, DOI 10.1016/S0032-3861(99)00756-9
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   SILVER JH, 1993, J BIOMED MATER RES, V27, P735, DOI 10.1002/jbm.820270606
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Spyros A, 1997, MACROMOLECULES, V30, P8218, DOI 10.1021/ma971193m
   STOREY RF, 1994, J POLYM SCI POL CHEM, V32, P2345, DOI 10.1002/pola.1994.080321216
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   TANAKA T, 1983, J BIOL CHEM, V258, P3552
   WADE LG, 1987, ORGANIC CHEM
   Wang GB, 1997, J BIOMED MATER RES, V36, P407, DOI 10.1002/(SICI)1097-4636(19970905)36:3<407::AID-JBM16>3.3.CO;2-U
NR 43
TC 84
Z9 88
U1 1
U2 28
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 8
BP 851
EP 873
DI 10.1163/156856201753113060
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 490TE
UT WOS:000172066500002
PM 11718481
DA 2018-10-20
ER

PT J
AU Shen, MC
   Pan, YV
   Wagner, MS
   Hauch, KD
   Castner, DG
   Ratner, BD
   Horbett, TA
AF Shen, MC
   Pan, YV
   Wagner, MS
   Hauch, KD
   Castner, DG
   Ratner, BD
   Horbett, TA
TI Inhibition of monocyte adhesion and fibrinogen adsorption on glow
   discharge plasma deposited tetraethylene glycol dimethyl ether
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE monocyte adhesion; fibrinogen adsorption; glow discharge plasma
   deposited tetraglyme; polyethylene oxide (PEO); time of flight secondary
   ion mass spectrometry (ToF-SIMS)
ID POLY(ETHYLENE OXIDE); INFLAMMATORY RESPONSES; RESISTANT SURFACES;
   POLYETHYLENE OXIDE; CELL-ADHESION; IN-VITRO; PROTEINS; PEO;
   BIOMATERIALS; COPOLYMERS
AB Monocytes and macrophages play important roles in host responses to implanted biomedical devices. Monocyte and macrophage interactions with biomaterial surfaces are thought to be mediated by adsorbed adhesive proteins such as fibrinogen and fibronectin. Non-fouling surfaces that minimize protein adsorption may therefore minimize monocyte adhesion, activation, and the foreign body response. Radio-frequency glow discharge plasma deposition (RF-GDPD) of tetraethylene glycol dimethyl ether (tetraglyme) was used to produce polyethylene oxide (PEO)-like coatings on a fluorinated ethylene-propylene (FEP) surface. Electron spectroscopy for chemical analysis (ESCA) and static time of flight secondary ion mass spectrometry (ToF-SIMS) were used to characterize the surface chemistry of tetraglyme coating. Fibrinogen adsorption to the tetraglyme surface was measured with I-125-labeled fibrinogen and ToF-SIMS. Adsorption of fibrinogen to plasma deposited tetraglyme was less than 10 ng cm(-2), a 20-fold decrease compared to untreated FEP or tissue culture polystyrene (TCPS). Monocyte adhesion to plasma deposited tetraglyme was significantly lower than adhesion to FEP or TCPS. In addition, when the surfaces were preadsorbed with fibrinogen, fibronectin, or blood plasma, monocyte adhesion to plasma deposited tetraglyme after 2 h or 1 day was much lower than adhesion to FEP. RF-GDPD tetraglyme coating provides a promising approach to make non-fouling biomaterials that can inhibit non-specific material-host interactions and reduce the foreign body response.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Horbett, TA (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
FU NCRR NIH HHS [RR01296]
CR ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687
   ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   ALTIERI DC, 1988, J BIOL CHEM, V263, P7007
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   CHILKOTI A, 1991, THESIS U WASHINGTON
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   GNANOU Y, 1984, MACROMOLECULES, V17, P945, DOI 10.1021/ma00134a069
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAINGER DW, 1988, J BIOMED MATER RES, V22, P231, DOI 10.1002/jbm.820220307
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT, V2, P214
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JOHNSTON EE, 1997, THESIS U WASHINGTON
   Kidane A, 1999, J BIOMAT SCI-POLYM E, V10, P1089, DOI 10.1163/156856299X00702
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Litauszki L, 1997, J BIOMED MATER RES, V35, P1
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2415, DOI 10.1002/pola.1992.080301116
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   McCarthy JB, 1997, J IMMUNOL, V159, P2424
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   NAGAOKA S, 1990, BIOMATERIALS, V11, P119, DOI 10.1016/0142-9612(90)90126-B
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   O'Connor SM, 1997, ANN NY ACAD SCI, V831, P138
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   OWEN CA, 1992, J LEUKOCYTE BIOL, V51, P400
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   SCHMIERER AS, 1998, THESIS U WASHINGTON
   SHAN J, 1999, THESIS U WASHINGTON
   SHEN M, 2001, UNPUB
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680
   VICKERMAN JC, 1999, STATIC SIMS LIB
NR 51
TC 64
Z9 68
U1 1
U2 11
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2001
VL 12
IS 9
BP 961
EP 978
DI 10.1163/156856201753252507
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 506TL
UT WOS:000172987800002
PM 11787523
DA 2018-10-20
ER

PT J
AU Smeds, KA
   Grinstaff, MW
AF Smeds, KA
   Grinstaff, MW
TI Photocrosslinkable polysaccharides for in situ hydrogel formation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE in situ polymerization; hydrogels; hyaluronan; photocrosslinkable
   polysaccharides; sutureless surgery
ID TISSUE; PHOTOPOLYMERIZATION; BIOMATERIALS; BEHAVIOR; ALGINATE; MATRIX;
   CELLS; GELS
AB In situ photopolymerization is an exciting new technique for tissue engineering. Two photocrosslinkable polysaccharides composed of alginate and hyaluronan are described that upon photolysis form soft, flexible, and viscoelastic hydrogels. The degree of methacrylate modification and thus covalent affects mechanical properties such as swelling, compression, and creep compliance. Significant swelling is observed in aqueous solution; these hydrogels can swell up to 14 times their dry weight. Both hydrogels exhibit low phase angles and I G* I values indicative of viscoelastic materials. The hyaluronan based hydrogel is stronger and more resilient than the corresponding alginate gel. SEM and AFM studies on both hydrogels show smooth and uniform surfaces at the macroscopic level with salient features observed only on the nanometer scale. Rapid polymerization by an optical trigger allows for controlled in situ photopolymerization in a minimally invasive manner, indicating that these hydrogels are relevant for biomedical applications such as sealing wounds and reconstructing soft tissues. (C) 2000 John Wiley & Sons, Inc.
C1 Duke Univ, Dept Chem, Paul M Gross Chem Lab, Durham, NC 27708 USA.
   Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.
   Duke Univ, Med Ctr, Durham, NC 27708 USA.
RP Grinstaff, MW (reprint author), Duke Univ, Dept Chem, Paul M Gross Chem Lab, Durham, NC 27708 USA.
EM mwg@chem.duke.edu
OI Grinstaff, Mark/0000-0002-5453-3668
CR Aharoni S. M., 1992, SYNTHESIS CHARACTERI
   ANDRADE JD, 1976, S AM CHEM SOC, V31
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Christenson L, 1997, TISSUE ENG, V3, P71, DOI 10.1089/ten.1997.3.71
   DeRossi D., 1991, POLYM GELS FUNDAMENT
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   Holzman S, 1994, J Invest Surg, V7, P431, DOI 10.3109/08941939409016509
   HONG GL, 1994, ANAL BIOCHEM, V219, P278
   Honig MA, 1997, CORNEA, V3, P1815
   Hubbell JA, 1996, MRS BULL, V21, P33
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009
   Keys KB, 1998, MACROMOLECULES, V31, P8149, DOI 10.1021/ma980999z
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   LARSEN NE, 1991, ADV DRUG DELIVER REV, V7, P279, DOI 10.1016/0169-409X(91)90007-Y
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   LYNMAN MD, 1996, BIOMATER, V17, P359
   MIKI D, 2000, UNPUB INVEST OPHTHAL
   Muggli DS, 1998, MACROMOLECULES, V31, P4120, DOI 10.1021/ma980108n
   Mulder G T, 1999, J Wound Care, V8, P21
   OTTENBRITE RM, 1994, ACS S SER
   PARK K, 1993, BIODEGRADABLE HYDROG
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   Peppas N. A., 1987, HYDROGELS MED PHARM, V1-3
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   SAWHNEY AS, 1994, BIOTECHNOL BIOENG, V44, P383, DOI 10.1002/bit.260440317
   SCHOICHET MS, 1996, BIOTECHNOL BIOENG, V50, P374
   SEFTON MV, 1998, J CUTAN MED SURG, V3, P18
   Smeds KA, 1999, J MACROMOL SCI PURE, VA36, P981, DOI 10.1081/MA-100101577
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P4639, DOI 10.1021/ma9704018
   WATTS DC, 1991, MAT SCI TECHNOLOGY C, P14
   WEISS JL, 1983, OPHTHALMOLOGY, V90, P610
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   1994, SCI AM, P4
NR 40
TC 254
Z9 259
U1 17
U2 154
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 2001
VL 54
IS 1
BP 115
EP 121
DI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 378MW
UT WOS:000165589000014
PM 11077410
DA 2018-10-20
ER

PT J
AU Bouhadir, KH
   Mooney, DJ
AF Bouhadir, KH
   Mooney, DJ
TI Promoting angiogenesis in engineered tissues
SO JOURNAL OF DRUG TARGETING
LA English
DT Article
DE endothelial cells; blood vessels; growth factors; plasmid DNA
ID ENDOTHELIAL GROWTH-FACTOR; POLY(ALDEHYDE GULURONATE) HYDROGELS;
   CALCIUM-ALGINATE BEADS; IN-VIVO; INCREASED VASCULARIZATION; BIOMEDICAL
   APPLICATIONS; COLLATERAL DEVELOPMENT; DELIVERY SYSTEMS; MATRICES;
   RELEASE
AB There is a tremendous need for organs and tissues to replace those lost due to diseases or trauma. In theory, transplanting cells on biomaterial matrices can create functional tissue. A critical question, however, is how to supply cells embedded within large cell-polymer constructs with sufficient oxygen and nutrients to sustain their survival and proliferation, and allow for the integration of the developing tissue with the surrounding tissue. A rapid and high level of vascularization of transplanted polymer-cell matrices is essential in tissue engineering approaches to meet these challenges. This review summarizes the current approaches and materials under development in our laboratory to promote angiogenesis in engineered tissues.
C1 Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   Amer Univ Beirut, Dept Chem, Beirut, Lebanon.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Biol & Mat Sci, 2300 Hayward St,3074 HH Dow Bldg, Ann Arbor, MI 48109 USA.
CR Ahrendt G, 1998, TISSUE ENG, V4, P117, DOI 10.1089/ten.1998.4.117
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Bouhadir KH, 1998, ANN NY ACAD SCI, V842, P188, DOI 10.1111/j.1749-6632.1998.tb09647.x
   Bouhadir KH, 2000, J PHARM SCI-US, V89, P910, DOI 10.1002/1520-6017(200007)89:7<910::AID-JPS8>3.0.CO;2-#
   Bouhadir KH, 1999, POLYMER, V40, P3575, DOI 10.1016/S0032-3861(98)00550-3
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   COOK W, 1986, J BIOMED MATER RES, V20, P1, DOI 10.1002/jbm.820200103
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   DOWNS EC, 1992, J CELL PHYSIOL, V152, P422, DOI 10.1002/jcp.1041520225
   DVORAK HF, 1995, AM J PATHOL, V146, P1029
   Eiselt P, 1998, BIOTECHNOL PROGR, V14, P134, DOI 10.1021/bp970135h
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KING K, 1994, FOOD HYDROCOLLOID, V8, P83, DOI 10.1016/S0268-005X(09)80035-0
   Klock G, 1997, BIOMATERIALS, V18, P707, DOI 10.1016/S0142-9612(96)00204-9
   KOKUBO T, 1991, NIPPON SERAM KYO GAK, V99, P965
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lazarous DF, 1996, CIRCULATION, V94, P1074, DOI 10.1161/01.CIR.94.5.1074
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mooney DJ, 1996, BIOTECHNOL BIOENG, V50, P422, DOI 10.1002/(SICI)1097-0290(19960520)50:4<422::AID-BIT9>3.0.CO;2-N
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   MOONEY DJ, 1994, TRANSP P, V26, P4025
   MUMPER RJ, 1994, J CONTROL RELEASE, V30, P241, DOI 10.1016/0168-3659(94)90030-2
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   MURPHY WL, 1999, MINERALIZATION NATUR, V599, P347
   MURPHY WL, 2001, BIOMATERIALS
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4
   Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733
   PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5
   Peters KG, 1998, CIRC RES, V83, P342, DOI 10.1161/01.RES.83.3.342
   Peters M. C., 1999, POLYM PREPRINTS, V40, P273
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   REDDI AH, 2000, PRINCIPLES TISSUE EN, P81
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468
   Thirumurti V, 1998, J AM COLL CARDIOL, V31, p54A, DOI 10.1016/S0735-1097(97)83941-1
   Tsurumi Y, 1996, CIRCULATION, V94, P3281, DOI 10.1161/01.CIR.94.12.3281
   Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
NR 56
TC 50
Z9 55
U1 1
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK,, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1061-186X
J9 J DRUG TARGET
JI J. Drug Target.
PY 2001
VL 9
IS 6
BP 397
EP 406
DI 10.3109/10611860108998775
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 513ZC
UT WOS:000173397300002
PM 11822813
DA 2018-10-20
ER

PT J
AU Bosetti, M
   Masse, A
   Tobin, E
   Cannas, M
AF Bosetti, M
   Masse, A
   Tobin, E
   Cannas, M
TI In vivo evaluation of bone tissue behavior on ion implanted surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID JOINT PROSTHESIS MATERIALS; WEAR; IMPROVEMENT; MECHANISMS; TI-6AL-4V
AB The ion implantation process offers several unique advantages over other surfaces modifications techniques, in regard to ion release and material mechanical characteristics. The aim of this study was to evaluate the in vivo bone tissue response to ion implanted surfaces. Untreated and nitrogen-ion-implanted stainless steel implants were inserted in the tibia diaphysis (cortical bone) and proximal tibia epiphysis (trabecular bone) of 12 New Zealand White rabbits. The animals were divided into three groups of four animals each, which were maintained for 4, 12 and 24 weeks according to internationally accepted and standardized procedures. At sacrifice, the implants were retrieved with surrounding bone and fixed in 4% neutral buffered formaldehyde and embedded in polymethylmethacrylate (PMMA). The samples were reducted in slices and stained with hematoxylin-eosin, light-green, fuchsin acid and giemsa solution for histological evaluation; fluorescent markers were also used to assess bone apposition. Histomorphometric evaluation was used to determine the extent of bone-material contact. Results from histological and morphometrical analyses revealed active remodeling of bone around both types of implants (control and ion implanted). However, faster bone deposition was observed around the treated material (12 weeks). Both materials reached similar endpoints, as no significant differences between them were evident at 24 weeks. The results demonstrate that ion implanted stainless steel has similar, or slightly enhanced, biological compatibility in contact with bone compared to untreated material; thus it may be a useful material in biomedical applications where reduced ion release or enhanced mechanical properties (as provided by ion implantation) are required. (C) 2001 Kluwer Academic Publishers.
C1 Univ Eastern Piedmont, Dept Med Sci, Novara, Italy.
   Univ Turin, Orthopaed Clin CTO 1, I-10124 Turin, Italy.
   Spire Corp, Bedford, MA 01730 USA.
RP Cannas, M (reprint author), Univ Eastern Piedmont, Dept Med Sci, Novara, Italy.
OI MASSE', Alessandro/0000-0003-3999-4121
CR BIANCHI V, 1980, TOXICOLOGY, V17, P219, DOI 10.1016/0300-483X(80)90097-9
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P367, DOI 10.1002/jbm.820210309
   DAVIDSON JA, 1993, CLIN ORTHOP RELAT R, P361
   DEARNALEY G, 1982, J MET, P18
   HEATH JC, 1967, BRIT J CANCER, V21, P768, DOI 10.1038/bjc.1967.90
   JOHNSTON RC, 1990, J BONE JOINT SURG AM, V72A, P161, DOI 10.2106/00004623-199072020-00002
   KOVACS P, 1990, P 16 ANN M SOC BIOM, P20
   LIU YK, 1990, SPINE, V15, P311, DOI 10.1097/00007632-199004000-00012
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   Picraux S. T., 1985, Scientific American, V252, P84
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   RIEU J, 1990, BIOMATERIALS, V11, P51
   SIOSHANSI P, 1985, J VAC SCI TECHNOL A, V3, P2670, DOI 10.1116/1.572811
   WELSCH G, 1983, P INT C MET COAT SAN, P305
   WILLIAMS JM, 1984, MATERIALS RES SOC S, V27, P735
NR 16
TC 11
Z9 11
U1 1
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 5
BP 431
EP 435
DI 10.1023/A:1011253121063
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 427YP
UT WOS:000168434600010
PM 15348283
DA 2018-10-20
ER

PT J
AU Mohammadi, S
   Esposito, M
   Cucu, M
   Ericson, LE
   Thomsen, P
AF Mohammadi, S
   Esposito, M
   Cucu, M
   Ericson, LE
   Thomsen, P
TI Tissue response to hafnium
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NODULAR LYMPHATIC CELLS; ABDOMINAL-WALL; ELECTRON-MICROPROBE;
   SOFT-TISSUE; TITANIUM; IMPLANTS; RAT; INTERFACE; ZIRCONIUM; PTFE
AB The aim of the present experimental study was to evaluate the tissue response to hafnium (Hf) a reactive metal closely related to titanium (Ti) and zirconium (Zr). Hf has not been previously evaluated as implant material in a biologic environment. In a first experiment, 21 machined Hf non-threaded implants (test) and 21 similar Ti implants (control) were inserted in the abdominal wall of 21 rats. Animals were sacrificed after 8 days (6 rats), 6 (7 rats) and 12 weeks (8 rats). In a second experiment, 18 rabbits received 18 Hf and 18 Ti threaded implants in their tibiae, one implant in each tibia. The rabbits were sacrificed after 6, 12 and 24 weeks (6 animals/time interval). The bulk metal of the abdominal wall implants, embedded together with the surrounding tissue, was electrolytically dissolved and semithin (1 mum) sections of the intact tissue-implant interface were evaluated by light microscopy (morphometry). Bone-implant contact and bone area within threads were evaluated in ground sections. In soft tissues, a fluid space containing predominantly monocytes/macrophages surrounded the abdominal implants at 8 days. At 6 and 12 weeks, a fibrous capsule, consisting of layers of macrophages and fibroblasts, surrounded the implants. Macrophages, including multinuclear giant cells, always formed the innermost layer in contact with the implant surface. No quantitative or qualitative difference in the tissue organization was detected between Ti and Hf implants. In rabbits, 6 weeks after insertion, the proximal two threads located within the cortical bone were filled with bone in contact with Hf and Ti. The distal threads contained bone marrow. After 12 and 24 weeks, mature bone was present in the proximal 3-4 implant threads. No statistically significant difference was found between Hf and Ti implants at any time periods. It is concluded that Hf is an interesting metal for biomedical applications in bone and soft tissue. (C) 2001 Kluwer Academic Publishers.
C1 Univ Gothenburg, Inst Anat & Cell Biol, Gothenburg, Sweden.
   Univ Gothenburg, Dept Orthodont, Gothenburg, Sweden.
RP Mohammadi, S (reprint author), Univ Gothenburg, Inst Anat & Cell Biol, Gothenburg, Sweden.
OI Thomsen, Peter/0000-0003-3910-6665
CR ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   ANDERSON JM, 2000, BONE ENG
   BERRY JP, 1990, TOXICOLOGY, V62, P239, DOI 10.1016/0300-483X(90)90113-U
   BERRY JP, 1992, J SUBMICR CYTOL PATH, V24, P15
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P569
   Branemark PI, 1985, TISSUE INTEGRATED PR, p[11, 253]
   BRUNETTE D, 2000, TITANIUM MED
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   ERIKSSON AS, 1994, J MATER SCI-MATER M, V5, P269, DOI 10.1007/BF00122396
   ERIKSSON AS, 1991, BIOMATERIALS, V12, P827, DOI 10.1016/0142-9612(91)90069-M
   GALANTE J, 1972, CLIN ORTHOP RELAT R, P237
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   HUGGINS CB, 1966, J EXP MED, V124, P1099, DOI 10.1084/jem.124.6.1099
   KALLTORP M, 1999, THESIS GOTEBORG U GO
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LIDE DR, 1999, CRC HDB CHEM PHYSICS
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   Rosengren A, 1998, J MATER SCI-MATER M, V9, P415, DOI 10.1023/A:1013239731256
   ROSENGREN A, 1997, THESIS LUND U LUND
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SHELLEY WB, 1973, CANCER RES, V33, P287
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   THOMSEN P, 1986, SCAND J PLAST RECONS, V20, P173, DOI 10.3109/02844318609006316
   THOMSEN P, 2000, IN PRESS BONE ENG, P117
   WEINGART D, 1994, INT J ORAL MAX SURG, V23, P450, DOI 10.1016/S0901-5027(05)80045-1
NR 27
TC 12
Z9 13
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 7
BP 603
EP 611
DI 10.1023/A:1011237610299
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 446KL
UT WOS:000169512400006
PM 15348253
DA 2018-10-20
ER

PT J
AU Borzacchiello, A
   Ambrosio, L
   Netti, PA
   Nicolais, L
   Peniche, C
   Gallardo, A
   San Roman, J
AF Borzacchiello, A
   Ambrosio, L
   Netti, PA
   Nicolais, L
   Peniche, C
   Gallardo, A
   San Roman, J
TI Chitosan-based hydrogels: Synthesis and characterization
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 16th Conference of the European-Society-for-Biomaterials
CY SEP 12-14, 2001
CL LONDON, ENGLAND
SP European Soc Biomat
ID ACID) INTERPOLYMER COMPLEX; POLY(ACRYLIC ACID); SOLUBLE CHITOSAN;
   BRANCHED-CHAIN; DERIVATIVES; NETWORK
AB Chitosan (CHI) is a polysaccharide of beta -1,4-linked 2-amino-2-deoxy-D-glucopyranose derived by N-deacetylation of chitin in aqueous alkaline medium. The shells of crustaceans such as crabs, shrimp, and lobster are the current source of chitosan. It is known to be non-toxic, odourless, biocompatible in animal tissues and enzymatically biodegradable. For these reasons much research interest has been paid to its biomedical, ecological, and industrial applications over the past decade. However, its rigid crystalline structure, poor solubility in organic solvents and poor processability have limited its use. To broadening its range of applications, a growth research effort has been devoted to explore ways of modifying Chitosan. Here it has been reported on the synthesis of new hydrogels, obtained by self-curing chitosan with acrylic acid (AA) and methyl acrylate (MA). The hydrogels were characterized by FTIR, swelling and rheological analysis. The results of this study showed that the swelling and mechanical properties of chitosan are highly improved by the presence of poly acrylate. The swelling degree of these materials does not depend upon the ratio MA/AA. It is possible to improve and modulate the mechanical properties of the hydrogels by changing the relative MA/AA ratio. (C) 2001 Kluwer Academic Publishers.
C1 Univ Naples Federico II, CNR, Inst Composite Mat Technol, I-80125 Naples, Italy.
   Univ Naples Federico II, CRIB, I-80125 Naples, Italy.
   CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
RP Borzacchiello, A (reprint author), Univ Naples Federico II, CNR, Inst Composite Mat Technol, Ple Tecchio 80, I-80125 Naples, Italy.
RI Gallardo, Alberto/B-4794-2011
OI Gallardo, Alberto/0000-0003-4614-4299; AMBROSIO,
   LUIGI/0000-0002-8367-2405; Peniche Covas, Carlos
   Andres/0000-0003-2563-0132; NETTI, PAOLO/0000-0002-2435-7181
CR ARGUELLESMONAL W, 1988, MAKROMOL CHEM-RAPID, V9, P693
   CLARK AH, 1987, ADV POLYM SCI, V83, P61
   DEUCHI K, 1994, BIOSCI BIOTECH BIOCH, V58, P1613, DOI 10.1271/bbb.58.1613
   Ferry J. D., 1970, VISCOELASTIC PROPERT
   HALL LD, 1980, J CHEM SOC CHEM COMM, P1153, DOI 10.1039/c39800001153
   HIRANO S, 1976, CARBOHYD RES, V47, P315, DOI 10.1016/S0008-6215(00)84198-1
   Hirano S, 1999, POLYM INT, V48, P732, DOI 10.1002/(SICI)1097-0126(199908)48:8<732::AID-PI211>3.3.CO;2-L
   Jiang H, 1999, POLYMER, V40, P4593, DOI 10.1016/S0032-3861(99)00070-1
   Lee YM, 1997, J MATER SCI-MATER M, V8, P537, DOI 10.1023/A:1018594614087
   MOORE GK, 1981, INT J BIOL MACROMOL, V3, P292, DOI 10.1016/0141-8130(81)90045-3
   MUZZARELLI RAA, 1982, PURE APPL CHEM, V54, P2141, DOI 10.1351/pac198254112141
   Peniche C, 1998, POLYMER, V39, P6549, DOI 10.1016/S0032-3861(98)00059-7
   Peniche C, 1999, BIOMATERIALS, V20, P1869, DOI 10.1016/S0142-9612(99)00048-4
   ROSSMURPHY SB, 1993, BIORHEOLOGY, V30, P217
   ROSSMURPHY SB, 1991, POLYMER GELS, P21
   Shen F, 2000, POLYM INT, V49, P1596, DOI 10.1002/1097-0126(200012)49:12<1596::AID-PI553>3.3.CO;2-J
   Wang HF, 1997, J APPL POLYM SCI, V65, P1445
   Wang HF, 1996, J APPL POLYM SCI, V61, P2221, DOI 10.1002/(SICI)1097-4628(19960919)61:12<2221::AID-APP22>3.0.CO;2-8
   YALPANI M, 1984, MACROMOLECULES, V17, P272, DOI 10.1021/ma00133a003
   Yin YJ, 1999, POLYM INT, V48, P429, DOI 10.1002/(SICI)1097-0126(199906)48:6<429::AID-PI160>3.3.CO;2-T
   Zong Z, 2000, POLYMER, V41, P899, DOI 10.1016/S0032-3861(99)00270-0
NR 21
TC 51
Z9 53
U1 0
U2 21
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 10-12
BP 861
EP 864
DI 10.1023/A:1012851402759
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 494KB
UT WOS:000172280300004
PM 15348330
DA 2018-10-20
ER

PT J
AU Rodriguez, D
   Manero, JM
   Gil, FJ
   Planell, JA
AF Rodriguez, D
   Manero, JM
   Gil, FJ
   Planell, JA
TI Low cycle fatigue behavior of Ti6Al4V thermochemically nitrided for its
   use in hip prostheses
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 16th Conference of the European-Society-for-Biomaterials
CY SEP 12-14, 2001
CL LONDON, ENGLAND
SP European Soc Biomat
AB Titanium and its alloys have many attractive properties including high specific strength, low density, and excellent corrosion resistance. Besides, titanium and the Ti6Al4V alloy have long been recognized as materials with high biocompatibility. These properties have led to the use of these materials in biomedical applications. Despite these advantages, the lack of good wear resistance makes difficult the use of titanium and Ti6Al4V in some biomedical applications, like articulating components of prostheses.
   Some surface treatments are available in order to correct these problems, like thermal surface treatment by means of nitrogen gaseous diffusion at high temperature. Nitrogen enters into the material by diffusion, creating a surface layer of increased hardness.
   Low cycle fatigue behavior in air of Ti6Al4V alloy has been studied. Results show a reduction of low cycle fatigue life up to 10% compared to the not-treated material. Studies suggest it is not related to the titanium nitride surface layer, but to microstructural changes caused by the high temperature treatment. (C) 2001 Kluwer Academic Publishers.
C1 ETSEIB, CREB, Dept Ciencia Mat & Engn Met, Barcelona 08028, Spain.
RP Rodriguez, D (reprint author), ETSEIB, CREB, Dept Ciencia Mat & Engn Met, Av Diagonal 647, Barcelona 08028, Spain.
RI Manero, Jose Maria/B-4169-2015
OI Manero, Jose Maria/0000-0002-1673-4389
CR BLOYCE A, 1997, WEAR PROTECTION TITA, P155
   GIL FJ, 1996, P 5 WORLD BIOM C CAN, V2, P477
   MANERO JM, 1997, THESIS U POLITECNICA
   Morton P. H., 1988, P 6 WORLD C TIT, P1705
   RODRIGUEZ D, 2000, THESIS U POLITECNICA
   SHIBATA H, 1994, INT J FATIGUE, V16, P370, DOI 10.1016/0142-1123(94)90448-0
   WELSH G, 1994, HDB MAT PROPERTIES T
NR 7
TC 5
Z9 5
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PY 2001
VL 12
IS 10-12
BP 935
EP 937
DI 10.1023/A:1012892511845
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 494KB
UT WOS:000172280300017
PM 15348343
DA 2018-10-20
ER

PT J
AU Tolmachev, V
   Lundqvist, H
AF Tolmachev, V
   Lundqvist, H
TI Separation of arsenic from germanium oxide targets by dry distillation
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
LA English
DT Article
AB Positron-emitting isotopes of arsenic, As-70 (T-1/2 = 53 min), As-71 (T-1/2 = 64 h), (72)AS (T-1/2 = 26 h), and As-73 (T-1/2 = 17.8 d) are of interest in biomedical investigations using PET. A fast and simple method for their production using low-energy proton and deuteron reactions on enriched Ge-targets is presented. Dry distillation of GeO2 at 1105 degreesC during 2 hours provides a separation efficiency of more than 60%. The loss of target material is less than one per cent and the irradiated targets can be used several times. The method allows production of diagnostically useful amounts of positron-emitting arsenic isotopes using accelerators commonly available at PET-centres.
C1 Univ Uppsala, Sect Biomed Radiat Sci, Dept Oncol Radiol & Clin Immunol, Rudbecklaboratoriet, S-75185 Uppsala, Sweden.
RP Tolmachev, V (reprint author), Univ Uppsala, Sect Biomed Radiat Sci, Dept Oncol Radiol & Clin Immunol, Rudbecklaboratoriet, S-75185 Uppsala, Sweden.
RI Tolmachev, Vladimir/I-3076-2012; Tolmachev, Vladimir/T-3722-2017
OI Tolmachev, Vladimir/0000-0002-6122-1734
CR ALKOURAISHI SH, 1978, INT J APPL RADIAT IS, V29, P607, DOI 10.1016/0020-708X(78)90093-5
   BASILE D, 1981, INT J APPL RADIAT IS, V32, P403, DOI 10.1016/S0020-708X(81)81007-1
   Browne E., 1986, TABLE RADIOACTIVE IS
   BROWNELL GL, 1953, NUCLEONICS, V11, P40
   DMITRIEV PP, 1986, EHNERGOATOMIZDAT, P144
   EMRAN A, 1982, J LABELLED COMPD RAD, V19, P1505
   EMRAN AM, 1991, NEW TRENDS IN RADIOPHARMACEUTICAL SYNTHESIS, QUALITY ASSURANCE, AND REGULATORY CONTROL, P153
   EMRAN AM, 1986, APPL RADIAT ISOTOPES, V37, P545
   GANDARIASCRUZ D, 1988, P IAEA CONS M DAT RE, P145
   GRUVERMAN I J, 1959, Int J Appl Radiat Isot, V5, P21, DOI 10.1016/0020-708X(59)90347-3
   HOSAIN F, 1982, INT J APPL RADIAT IS, V33, P477
   KELLER KA, 1974, NUCL PARTICLE PHYS C, V5
   Leonard A., 1991, METALS THEIR COMPOUN, P751
   MORRISON GH, 1957, SOLVENT EXTRACTION A, P193
   NOZAKI T, 1979, INT J APPL RADIAT IS, V30, P595, DOI 10.1016/0020-708X(79)90076-0
   WEINREICH R, 1989, J LAB COMP RADIOPHAR, V27, P146
   Zweit J, 1996, PHYS MED BIOL, V41, P1905, DOI 10.1088/0031-9155/41/10/004
NR 17
TC 12
Z9 12
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0236-5731
J9 J RADIOANAL NUCL CH
JI J. Radioanal. Nucl. Chem.
PD JAN
PY 2001
VL 247
IS 1
BP 61
EP 66
DI 10.1023/A:1006706913108
PG 6
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA 412RC
UT WOS:000167567300010
DA 2018-10-20
ER

PT J
AU Vallet-Regi, M
AF Vallet-Regi, M
TI Ceramics for medical applications
SO JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
LA English
DT Article
ID SOL-GEL GLASSES; CALCIUM-PHOSPHATE FORMATION; IN-VITRO BIOACTIVITY;
   BIOMEDICAL APPLICATIONS; MINERAL PHASE; SURFACE; BONE; SYSTEM;
   DEPENDENCE; COMPOSITE
AB Ceramics, glasses and glass ceramics include a broad range of inorganic non-metallic compositions. The apatite and related calcium phosphates have been of remarkable interest to biologists, mineralogists, inorganic and industrial chemists for many years. Calcium phosphate biomaterials, mainly hydroxyapatite, find many clinical applications in the repair of bone defects, bone augmentation and coatings for metal implants. Certain compositions of ceramics, glasses, glass ceramics and composites have shown bone bonding behaviour. These materials have become known as bioactive ceramics. A common characteristic of bioactive ceramics is a time-dependent, kinetic modification of the surface that occurs upon implantation. The surface forms a biologically active carbonate hydroxyapatite layer that provides the bonding interface with living tissues. The aim of this perspective is to present an overview of the different types of ceramics available for medical applications, focused mainly on bioactive glasses.
C1 Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RI Vallet-Regi, Maria/M-3378-2014
OI Vallet-Regi, Maria/0000-0002-6104-4889
CR ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   AOKI H, 1977, J DENT OUTLOOK, V49, P567
   Aoki H., 1994, MED APPL HYDROXYAPAT
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   BARRALET JE, 1993, BIOCERAMICS, V6, P179
   Brink M, 1997, J BIOMED MATER RES, V36, P109, DOI 10.1002/(SICI)1097-4636(199707)36:1<109::AID-JBM13>3.0.CO;2-D
   Brink M, 1997, J BIOMED MATER RES, V37, P114, DOI 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   CHOW LC, 1998, CEMENTS RES PROGR
   CONSTANTINO PD, 1996, CLIN N AM, V27, P1037
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   Driessens FCM, 1995, ENCY HDB BIOMATERIAL
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Dupraz A, 1999, BIOMATERIALS, V20, P663, DOI 10.1016/S0142-9612(98)00222-1
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   ELLIOTT JC, 1980, J APPL CRYSTALLOGR, V13, P618, DOI 10.1107/S0021889880012927
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Falaize S, 1999, J AM CERAM SOC, V82, P969, DOI 10.1111/j.1151-2916.1999.tb01861.x
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   GREENSPAN DC, 1976, J BIOMED MATER RES, V10, P503, DOI 10.1002/jbm.820100405
   GREENSPAN DC, 1999, T 25 ANN M SOC BIOM, V22, P346
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   HEIMKE G, 1989, ANGEW CHEM INT EDIT, V28, P111, DOI 10.1002/anie.198901111
   HEIMKE G, 1986, HDB BIOMATERIALS EVA
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench L. L., 1996, BIOMATERIALS SCI INT
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hulbert S. F., 1982, CERAM INT, V8, P121
   Hulbert S. F., 1993, INTRO BIOCERAMICS
   Izquierdo-Barba I, 1999, J BIOMED MATER RES, V47, P243, DOI 10.1002/(SICI)1097-4636(199911)47:2<243::AID-JBM15>3.0.CO;2-S
   Izquierdo-Barba I, 2000, J BIOMED MATER RES, V51, P191, DOI 10.1002/(SICI)1097-4636(200008)51:2<191::AID-JBM7>3.0.CO;2-T
   JANSEN JA, 2000, T 6 WORLD BIOM C MAY, P337
   Karatzas S, 1999, INT J PERIODONT REST, V19, P489
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   KIKUCHI M, 1998, BIOCERAMICS, V11, P153
   KNAACK D, 1998, BIOCERAMICS, V11, P357
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kokubo T., 1993, ADV SERIES CERAMICS, V1
   Laczka M, 1997, J ALLOY COMPD, V248, P42, DOI 10.1016/S0925-8388(96)02648-5
   LeGeros R. Z., 1970, DEV APPL SPECTROSC B, V7B, P13
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   LeGeros RZ, 1991, CALCIUM PHOSPHATES O
   Lemaitre J, 1987, SIL IND CERAM SCI TE, V52, P141
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   NAINWRIGHT SA, 1976, MECH DESIGN ORGANISM
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   Okazaki M., 1998, BIOCERAMICS, V11, P85
   PANTANO CG, 1974, J AM CERAM SOC, V57, P412, DOI 10.1111/j.1151-2916.1974.tb11429.x
   Peltola T, 1999, J BIOMED MATER RES, V44, P12, DOI 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E
   Pena J, 1997, J BIOMED MATER RES, V35, P129, DOI 10.1002/(SICI)1097-4636(199704)35:1<129::AID-JBM13>3.0.CO;2-E
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PEREIRA MM, 1996, J SOL-GEL SCI TECHN, V7, P231
   Perez-Pariente J, 1999, J BIOMED MATER RES, V47, P170, DOI 10.1002/(SICI)1097-4636(199911)47:2<170::AID-JBM6>3.0.CO;2-J
   Perez-Pariente J, 2000, CHEM MATER, V12, P750, DOI 10.1021/cm9911114
   Radin S, 1997, J BIOMED MATER RES, V37, P363, DOI 10.1002/(SICI)1097-4636(19971205)37:3<363::AID-JBM7>3.0.CO;2-J
   Rodriguez-Lorenzo LM, 2000, CHEM MATER, V12, P2460, DOI 10.1021/cm001033g
   RODRIGUEZLORENZ.M, 2001, BIOMATERIALS, V22, P583
   RODRIGUEZLORENZ.M, 2000, IN PRESS BIOMATERIAL
   RodriguezLorenzo LM, 1996, J BIOMED MATER RES, V30, P515, DOI 10.1002/(SICI)1097-4636(199604)30:4<515::AID-JBM10>3.0.CO;2-G
   SALINAS AJ, IN PRESS J SOL GEL S
   Takagi S, 1998, BIOMATERIALS, V19, P1593, DOI 10.1016/S0142-9612(97)00119-1
   Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b
   Vallet-Regi M, 1999, J MATER CHEM, V9, P515, DOI 10.1039/a808679f
   Vallet-Regi M, 1999, J BIOMED MATER RES, V46, P560
   Vallet-Regi M, 1999, J BIOMED MATER RES, V44, P416, DOI 10.1002/(SICI)1097-4636(19990315)44:4<416::AID-JBM7>3.0.CO;2-S
   Vallet-Regi M, 2000, J BIOMED MATER RES, V51, P23, DOI 10.1002/(SICI)1097-4636(200007)51:1<23::AID-JBM4>3.0.CO;2-B
   VALLETREGI M, 1998, NONCRYSTALLINE NANOS, P55
   VOGEL W, 1986, J NON-CRYST SOLIDS, V80, P34, DOI 10.1016/0022-3093(86)90377-7
   Wan ACA, 1998, J BIOMED MATER RES, V41, P541, DOI 10.1002/(SICI)1097-4636(19980915)41:4<541::AID-JBM5>3.0.CO;2-C
   Wang M., 1996, BIOCERAMICS, V9, P387
   WANG PE, 1995, J MATER SCI-MATER M, V6, P94, DOI 10.1007/BF00120415
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
   Zhong J. P., 1998, BIOCERAMICS, V11, P415
NR 82
TC 239
Z9 248
U1 1
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1472-7773
J9 J CHEM SOC DALTON
JI J. Chem. Soc.-Dalton Trans.
PY 2001
IS 2
BP 97
EP 108
DI 10.1039/b007852m
PG 12
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 396AC
UT WOS:000166613300001
DA 2018-10-20
ER

PT S
AU Rechmann, P
   Pilgrim, C
   Hennig, T
AF Rechmann, P
   Pilgrim, C
   Hennig, T
BE Rechmann, P
   Fried, D
   Hennig, T
TI Laser treatment of first degree carious lesions.
SO LASERS IN DENTISTRY VII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Lasers in Dentistry VII Conference
CY JAN 21-22, 2001
CL SAN JOSE, CA
SP SPIE
DE Er : YAG laser; non contact or contact mode delivered; effect in enamel;
   clinical rating; light microscopy; caries diagnosis; laser fluorescence
   measurements
ID ER-YAG LASER; ABLATION; ENAMEL
AB The therapy of initial carious lesions aims in a minimal invasive removal of infected dental hard tissues. Typically standard preparation instruments bear the risk of removing a big amount of sound structures as a result of access. On the other hand the competence of Er:YAG lasers for caries removal has been repeatedly proven.
   Aim of this study was to compare cavity preparations at simulated clinical conditions performed by two different Er:YAG laser systems, one working in non-contact mode (KaVo Key Laser; Biberach, Germany) the other working in contact mode (Continuum Biomedical DELight Er:YAG Laser System, Santa Clara, CA).
   The sample material consisted of 15 randomized selected extracted human molars clinically presenting initial carious lesions located in the occlusal fissure area. In the first part of the study each lesion passed standard clinical examinations. Visual examination, probing, x-rays and Fluorescence measurements (DIAGNOdent 2095; KaVo, Biberach, Germany) were performed. A clinical diagnosis for each lesion was given. Finally, the percentage of correct caries diagnosis obtained from the different diagnostic aids was calculated. The fluorescence measurement tool showed an extremely high success rate in the diagnosis of depth of caries.
   In the second part of the study the sample material was split into two groups showing equivalent clinical extension of the assumed first degree caries in horizontal direction. Each group was randomized assigned to a single laser system and laser caries removal was performed until no residual caries was clinically detectable. Afterwards a blinded evaluation on the treated samples was performed. They were judged by the quality and completeness of caries removal, the quality and extension of the cavity outline, quality of cavity walls, bevels and surface of the cavity floor. Additionally macroscopical and histological evaluations were performed.
   The results support initial caries therapy with Er:YAG lasers. Differences between the use of a contact mode or a non contact Er:YAG laser delivery mode came to light. In case of tiny carious fissures the contact mode delivered Er:YAG laser seems to have advantages over the non contact mode laser. The overall rating for the quality of the cavity preparation is better using the contact mode delivered Er:YAG laser than engaging the non contact mode laser at the same parameter settings.
C1 Univ Dusseldorf, Sch Dent, Dept Oral Surg, Dusseldorf, Germany.
RP Rechmann, P (reprint author), Univ Dusseldorf, Sch Dent, Dept Oral Surg, Dusseldorf, Germany.
CR BURKES EJ, 1992, J PROSTHET DENT, V67, P847, DOI 10.1016/0022-3913(92)90599-6
   Cozean CD, 1998, P SOC PHOTO-OPT INS, V3248, P14, DOI 10.1117/12.306018
   DENBESTEN PK, 2000, SPIE P LASER DENT 6, V3910, P171
   FREID D, 2000, SPIE P LASER DENT 6, V3910, P136
   HARRIS DM, 2000, SPIE P LASER DENT 6, V3910, P184
   HENNIG T, 1991, SPIE, V1424, P99
   Hibst R, 1999, P SOC PHOTO-OPT INS, V3593, P141, DOI 10.1117/12.348341
   HIBST R, 1989, LASER SURG MED, V9, P338, DOI 10.1002/lsm.1900090405
   Keller U, 1997, LASER SURG MED, V20, P32, DOI 10.1002/(SICI)1096-9101(1997)20:1<32::AID-LSM5>3.0.CO;2-#
   KELLER U, 1994, SPIE ADV LASER DENT, V1984, P85
   Lussi A, 1999, CARIES RES, V33, P261, DOI 10.1159/000016527
   Rechmann P, 1998, P SOC PHOTO-OPT INS, V3248, P62, DOI 10.1117/12.306038
   Rechmann P, 1998, P SOC PHOTO-OPT INS, V3248, P2, DOI 10.1117/12.306009
NR 13
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3927-4
J9 PROC SPIE
PY 2001
VL 4249
BP 104
EP 114
DI 10.1117/12.424502
PG 11
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical; Optics;
   Physics, Applied
SC Dentistry, Oral Surgery & Medicine; Engineering; Optics; Physics
GA BS31X
UT WOS:000169435600016
DA 2018-10-20
ER

PT S
AU Duarte, J
   Tadeu, M
   Pacheco, T
   Silveira, L
   Machado, RZ
   Martins, RA
   Zangaro, RA
   Villaverde, AB
AF Duarte, J
   Tadeu, M
   Pacheco, T
   Silveira, L
   Machado, RZ
   Martins, RA
   Zangaro, RA
   Villaverde, AB
BE Anderson, RR
   Bartels, KE
   Bass, LS
   Garrett, CG
   Gregory, KW
   Katzir, A
   Kollias, N
   Lucroy, MD
   Malek, RS
   Nelson, JS
   Peavy, GM
   Reidenbach, HD
   Reinisch, L
   Robinson, DS
   Tate, LP
   Trowers, EA
   Woodward, TA
TI Near-infrared Raman spectroscopy to detect anti-Toxoplasma gondii
   antibodies in blood sera of domestic cats
SO LASERS IN SURGERY: ADVANCED CHARACTERIZATION THERAPEUTICS, AND SYSTEMS
   XI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Lasers in Surgery - Advanced Characterization,
   Therapeutics, and Systems XI
CY JAN 20-23, 2001
CL SAN JOSE, CA
SP SPIE
DE toxoplasmosis; serological analysis; disease diagnosis; NIR Raman
   spectroscopy; PCA method
ID LASER; THERAPY
AB Near Infrared (NIR) Raman Spectroscopy has been study for the last years for many biomedical applications. It is a powerful tool for biological materials analysis. Toxoplasmosis is an important zoonosis in public health, being the cats the principal responsible for the transmission of the disease in Brazil. The objective of this work is to investigate a new method of diagnosis of this disease. NIR Raman Spectroscopy was used to detect anti Toxoplasma gondii antibodies in blood sera from domestic cats, without sample preparation. In all, six blood serum samples were used for this study. A previous serological test was done by the Indirect Immunoenzymatic Assay (ELISA) to permit a comparative study between both techniques and it showed that three serum samples were positive and the other three were negative to toxoplasmosis. Raman spectra were taken for all the samples and analyzed by using the Principal Components Analysis (PCA). A diagnosis parameter was defined from the analysis of the second and third principal components of the Raman spectra. It was found that this parameter can detect the infection level of the animal. The results have indicated that NIR Raman Spectroscopy, associated to the PCA can be a promising technique for serological analysis, such as toxoplasmosis, allowing a fast and sensitive method of diagnosis.
C1 Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
RP Duarte, J (reprint author), Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
RI Silveira, Landulfo/I-2474-2012; Machado, Rosangela/C-4850-2012
OI Silveira, Landulfo/0000-0002-6616-3334; 
CR Barnett SM, 1999, P SOC PHOTO-OPT INS, V3608, P124, DOI 10.1117/12.345393
   Berger AJ, 1996, APPL OPTICS, V35, P209, DOI 10.1364/AO.35.000209
   DENIUM G, 1999, APPL SPECTROSC, V53, P938
   ELLISON GW, 1995, VET SURG, V24, P140, DOI 10.1111/j.1532-950X.1995.tb01308.x
   GANESH DS, 1999, SPIE C BIOM APPL RAM, V3608, P185
   Ghamsari SM, 1997, VET SURG, V26, P114, DOI 10.1111/j.1532-950X.1997.tb01473.x
   GOODMAN JW, 1992, IMUNOLOGIA BASICA, P85
   Hahn KA, 1998, VET DERMATOL, V9, P3, DOI 10.1046/j.1365-3164.1998.00071.x
   Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201
   Harlow E, 1988, ANTIBODIES LAB MANUA, P726
   Hayden CA, 1996, APPL SPECTROSC, V50, P708, DOI 10.1366/0003702963905772
   Lindsay DS, 1997, COMP CONT EDUC PRACT, V19, P448
   Lucroy MD, 1999, VET SURG, V28, P292, DOI 10.1053/jvet.1999.0292
   PUPPELS GJ, 1996, 15 INT C RAM SPECTR, V15, P522
   QU YJ, 1999, APPL OPTICS, V38, P5491
   Sullivan TC, 1997, VET CLIN N AM-SMALL, V27, P1193, DOI 10.1016/S0195-5616(97)50109-4
   Svobodova V, 1998, VET PARASITOL, V80, P173, DOI 10.1016/S0304-4017(98)00201-5
   Torreggiani A, 1998, J RAMAN SPECTROSC, V29, P229, DOI 10.1002/(SICI)1097-4555(199803)29:3<229::AID-JRS229>3.0.CO;2-X
   WOLLMAN ST, 1993, APPL SPECTROSC, V47, P125, DOI 10.1366/0003702934048479
NR 19
TC 2
Z9 2
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3922-3
J9 PROC SPIE
PY 2001
VL 4244
BP 536
EP 543
DI 10.1117/12.427767
PG 8
WC Engineering, Biomedical; Optics; Physics, Applied; Surgery
SC Engineering; Optics; Physics; Surgery
GA BS36N
UT WOS:000169641700072
DA 2018-10-20
ER

PT J
AU Anastassopoulou, N
   Arapoglou, B
   Demakakos, P
   Makropoulou, MI
   Paphiti, A
   Serafetinides, AA
AF Anastassopoulou, N
   Arapoglou, B
   Demakakos, P
   Makropoulou, MI
   Paphiti, A
   Serafetinides, AA
TI Spectroscopic characterisation of carotid atherosclerotic plaque by
   laser induced fluorescence
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE laser biomedical applications; optical spectroscopy
ID TISSUE ABLATION; WALL FLUORESCENCE; HUMAN AORTA; ANGIOPLASTY;
   AUTOFLUORESCENCE; DIAGNOSIS; DEPOSITS; DESIGN
AB Background and Objective: An effort has been made to distinguish the composition of carotid atherosclerotic plaques (CAP) from patients undergoing carotid endarterectomy, by laser induced fluorescence spectroscopy.
   Study Design/Materials and Methods: Different excitation wavelengths were used: 476, 488, and 458 nm of a continuous wave krypton/argon ion laser, and 337 nm of a pulsed nitrogen laser. Twenty-three CAP samples from different patients were investigated and several spectra from each plaque were obtained.
   Results: Results were crossed-examined with conventional histologic techniques, which showed three areas of different composition on the pathologic samples: fibrous tissue, lipid constituents, and calcified plaque. Gaussian fittings were performed to reproduce the fluorescence spectra as a correlation of multiple Gaussian curves.
   Conclusion: The accuracy for discrimination of the heterogeneous composition of the atherosclerotic plaque is still limited, due to superposition of the fluorescence emission of various plaque components. Lasers Surg. Med. 28: 67-73, 2001. (C) 2001 Wiley-Liss, Inc.
C1 Natl Tech Univ Athens, Dept Phys, Athens 15780, Greece.
   Univ Athens, Areteion Hosp, Sch Med, Dept Surg, Athens, Greece.
RP Makropoulou, MI (reprint author), Natl Tech Univ Athens, Dept Phys, Zografou Campus, Athens 15780, Greece.
OI Serafetinides, Alexandros/0000-0001-5284-0050
CR ALEXANDER AL, 1994, OPT ENG, V33, P167, DOI 10.1117/12.152018
   ALFANO RR, 1984, IEEE J QUANTUM ELECT, V20, P1507, DOI 10.1109/JQE.1984.1072322
   Anastassopoulou N, 1996, P SOC PHOTO-OPT INS, V3052, P394, DOI 10.1117/12.262964
   ANDERSSON P S, 1987, Lasers in Medical Science, V2, P261, DOI 10.1007/BF02594170
   ANDERSSONENGELS S, 1988, LASER MED SCI, V4, P71
   BARAGA JJ, 1989, SPECTROCHIM ACTA A, V45, P95, DOI 10.1016/0584-8539(89)80032-7
   BARAGA JJ, 1991, ATHEROSCLEROSIS, V88, P1, DOI 10.1016/0021-9150(91)90251-W
   BARAGA JJ, 1990, LASER SURG MED, V10, P245, DOI 10.1002/lsm.1900100305
   CLARKE RH, 1988, LASER SURG MED, V8, P45, DOI 10.1002/lsm.1900080110
   DECKELBAUM LI, 1989, LASER SURG MED, V9, P205, DOI 10.1002/lsm.1900090303
   FURZIKOV NP, 1988, P INT SCH QUANT EL L, P243
   Gardner CM, 1996, APPL OPTICS, V35, P1780, DOI 10.1364/AO.35.001780
   GARRAND TJ, 1991, LASER SURG MED, V11, P106, DOI 10.1002/lsm.1900110204
   GINDI GR, 1991, IEEE T BIO-MED ENG, V38, P246, DOI 10.1109/10.133205
   GMITRO AF, 1988, APPL OPTICS, V27, P1844, DOI 10.1364/AO.27.001844
   KITTRELL C, 1985, APPL OPTICS, V24, P2280, DOI 10.1364/AO.24.002280
   LAIFER LI, 1989, CIRCULATION, V80, P1893, DOI 10.1161/01.CIR.80.6.1893
   LAUFER G, 1988, CIRCULATION, V78, P1031, DOI 10.1161/01.CIR.78.4.1031
   Lee DJ, 1998, ULTRASOUND MED BIOL, V24, P1291, DOI 10.1016/S0301-5629(98)00125-2
   Makropoulou M, 2000, OPT WITHIN LIFE SCI, V5, P328
   MAKROPOULOU M, 1998, P SOC PHOTO-OPT INS, V3564, P68
   MORQUET A, 1994, LASER SURG MED, V14, P238
   OBRIEN KM, 1989, IEEE T BIO-MED ENG, V36, P424, DOI 10.1109/10.18748
   PAPAZOGLOU TG, 1994, J PHOTOCH PHOTOBIO B, V22, P139, DOI 10.1016/1011-1344(93)06960-B
   PAPAZOGLOU TG, 1990, APPL OPTICS, V29, P4950, DOI 10.1364/AO.29.004950
   PASCU ML, 1994, P SOC PHOTO-OPT INS, V2630, P120
   RICHARDSKORTUM R, 1989, SPECTROCHIM ACTA A, V45, P87, DOI 10.1016/0584-8539(89)80031-5
   RICHARDSKORTUM R, 1989, AM HEART J, V118, P381, DOI 10.1016/0002-8703(89)90199-3
   SARTORI M, 1987, IEEE J QUANTUM ELECT, V23, P1794, DOI 10.1109/JQE.1987.1073221
   SERAFETINIDES AA, 1998, P SOC PHOTO-OPT INS, V3570, P28
   SERAFETINIDES AA, 1994, P SOC PHOTO-OPT INS, V2328, P244
   SERAFETINIDES AA, 1998, P SOC PHOTO-OPT INS, V3570, P12
   STAVRIDI M, 1995, MED ENG PHYS, V17, P595, DOI 10.1016/1350-4533(95)00016-G
   Strebel RT, 1998, J LASER APPL, V10, P34, DOI 10.2351/1.521831
   TAYLOR RS, 1990, LASER SURG MED, V10, P414, DOI 10.1002/lsm.1900100503
   VERBUNT RJAM, 1992, AM HEART J, V123, P208, DOI 10.1016/0002-8703(92)90767-P
   YAN WD, 1995, LASER SURG MED, V16, P164, DOI 10.1002/lsm.1900160206
   ZANG JY, 1990, LASER MED SCI, V5, P303
NR 38
TC 8
Z9 10
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PY 2001
VL 28
IS 1
BP 67
EP 73
DI 10.1002/1096-9101(2001)28:1<67::AID-LSM1018>3.0.CO;2-E
PG 7
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 388WW
UT WOS:000166206900010
PM 11430445
DA 2018-10-20
ER

PT B
AU Barroso, RC
   Lopes, RT
   de Jesus, EFO
   de Oliveira, LF
   Braz, D
AF Barroso, RC
   Lopes, RT
   de Jesus, EFO
   de Oliveira, LF
   Braz, D
BE Magjarevic, R
   Tonkovic, S
   Bilas, V
   Lackovic, I
TI X-ray synchrotron diffraction tomography for using in biomedical
   applications
SO MEDICON 2001: PROCEEDINGS OF THE INTERNATIONAL FEDERATION FOR MEDICAL &
   BIOLOGICAL ENGINEERING, PTS 1 AND 2
LA English
DT Proceedings Paper
CT 9th Mediterranean Conference on Medical and Biological Engineering and
   Computing
CY JUN 12-15, 2001
CL PULA, CROATIA
SP Croatian Med & Biol Engn Soc, Int Federat Med & Biol Engn, Minist Sci & Technol Republ Croatia, Univ Zagreb, Croatian Med Assoc, Assoc Italiana Ingegner Med & Biol, Cyprus Assoc Med Phys & Biomed Engn, Greek Soc Biomed Engn, Israel Soc Med & Biol Engn, Slovenian Soc Med & Biol Engn, Soc Electriciens & Electroniciens Francais, Spanish Soc Biomed Engn
AB This work reports the feasibility of a nondestructive synchrotron radiation X-ray diffraction imaging technique. This research was performed at the X-ray Diffraction beam line of the National Synchrotron Light Laboratory (LNLS) in Brazil. The X-ray diffraction measurements were carried out with an 11.101 keV and the diffracted beam was detected by a fast scintillation detector. The obtained diffraction patterns form the basis of a method of characterizing tissue samples according to their atomic structure rather than X-ray attenuation properties. Two different samples were constructed in order to evaluate the capability of the technique in distinguish between two polycrystalline solids of very similar attenuation coefficients and discriminate powder materials. Each sample was scanned at both Bragg scattering angles characteristic of each scatter and at zero degree. In this way, it was possible to obtain a transmission CT image with which to compare the diffraction CT images. All the tomographic images presented have been reconstructed by using a back-projection reconstruction technique. The results encourage us to examine further the application of the two-dimensional selective method to biomedical imaging.
C1 Univ Estado Rio de Janeiro, Inst Fis, BR-20550900 Rio De Janeiro, Brazil.
RP Barroso, RC (reprint author), Univ Estado Rio de Janeiro, Inst Fis, Rua Sao Francisco Xavier 524 Sala 3001A, BR-20550900 Rio De Janeiro, Brazil.
RI Braz, Delson/C-4971-2013
CR Barroso RC, 1998, NUCL INSTRUM METH A, V418, P458, DOI 10.1016/S0168-9002(98)00759-1
   Barroso RC, 1999, NUCL INSTRUM METH A, V422, P718, DOI 10.1016/S0168-9002(98)01024-9
   Cusatis C, 1998, J SYNCHROTRON RADIAT, V5, P491, DOI 10.1107/S0909049598000685
   EVANS SH, 1991, PHYS MED BIOL, V36, P7, DOI 10.1088/0031-9155/36/1/002
   FOWLER BA, 1993, ENVIRON HEALTH PERSP, V100, P57, DOI 10.2307/3431521
   HARDING G, 1987, J OPT SOC AM A, V4, P933, DOI 10.1364/JOSAA.4.000933
   Shimojo N, 1997, LIFE SCI, V60, P2129, DOI 10.1016/S0024-3205(97)00222-1
   Westmore MS, 1996, MED PHYS, V23, P723, DOI 10.1118/1.597720
NR 8
TC 0
Z9 0
U1 0
U2 1
PU UNIV ZAGREB
PI ZAGREB
PA P O BOX 327, 41001 ZAGREB, CROATIA
BN 953-184-023-7
PY 2001
BP 508
EP 511
PG 2
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA BU46P
UT WOS:000176065600145
DA 2018-10-20
ER

PT J
AU Shih, A
   Wang, G
   Cheng, PC
AF Shih, A
   Wang, G
   Cheng, PC
TI Fast algorithm for X-ray cone-beam microtomography
SO MICROSCOPY AND MICROANALYSIS
LA English
DT Article
DE X-ray computed tomography; cone-beam; microtomography; image
   reconstruction; real-time; nondestructive evaluation
ID RECONSTRUCTION ALGORITHM; PROJECTION
AB Cone-beam X-ray microtomography attracts increasing attention due to its applications in biomedical sciences, material engineering, and industrial nondestructive evaluation. Rapid volumetric image reconstruction is highly desirable in all these areas for prompt visualization and analysis of complex structures of interest. In this article, we reformulate a generalized Feldkamp cone-beam image reconstruction algorithm, utilize curved voxels and mapping tables, improve the reconstruction efficiency by an order of magnitude relative to a direct implementation of the standard algorithm, and demonstrate the feasibility with numerical simulation and experiments using a prototype cone-beam X-ray microtomographic system. Our fast algorithm reconstructs a 256-voxel cube from 100 projections within 2 min on an Intel Pentium II(R) 233 MHz personal computer, produces satisfactory image quality, and can be further accelerated using special hardware and/or parallel processing techniques.
C1 SUNY Buffalo, Dept Elect Engn, Adv Microscopy & Imaging Lab, Buffalo, NY 14260 USA.
   Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA.
RP Cheng, PC (reprint author), SUNY Buffalo, Dept Elect Engn, Adv Microscopy & Imaging Lab, Buffalo, NY 14260 USA.
CR Cheng P. C., 1991, J SCANNING MICROSCOP, V13, P10
   Cheng PC, 1999, FOCUS MULTIDIMENSION, P233
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   Gullberg GT, 1996, IEEE T NUCL SCI, V43, P295, DOI 10.1109/23.485969
   HE YJ, 1993, IEEE T MED IMAGING, V12, P555, DOI 10.1109/42.241883
   Kak AC, 1988, PRINCIPLE COMPUTERIZ, P99
   KINNEY JH, 1989, REV SCI INSTRUM, V60, P2471, DOI 10.1063/1.1140702
   KRIETE A, 1994, MULTIDIMENSIONAL MICROSCOPY, P209
   PAN SJ, 1997, J ANAL MORPHOL, V4, P16
   PETERS TM, 1981, IEEE T NUCL SCI, V28, P3641, DOI 10.1109/TNS.1981.4331812
   RUSS JC, 1988, T AM NUCL SOC, V56, P14
   SHEPP LA, 1974, IEEE T NUCL SCI, VNS21, P21, DOI 10.1109/TNS.1974.6499235
   Wang G, 1996, IEEE T MED IMAGING, V15, P657, DOI 10.1109/42.538943
   WANG G, 1993, IEEE T MED IMAGING, V12, P486, DOI 10.1109/42.241876
   WANG G, 1992, SCANNING, V14, P350, DOI 10.1002/sca.4950140607
NR 15
TC 15
Z9 15
U1 0
U2 1
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 1431-9276
J9 MICROSC MICROANAL
JI Microsc. microanal.
PD JAN-FEB
PY 2001
VL 7
IS 1
BP 13
EP 23
PG 11
WC Materials Science, Multidisciplinary; Microscopy
SC Materials Science; Microscopy
GA 409KF
UT WOS:000167382300001
DA 2018-10-20
ER

PT S
AU Girkin, JM
   Wokosin, DL
AF Girkin, JM
   Wokosin, DL
BE Periasamy, A
   So, PTC
TI Novel compact sources for multiphoton microscopy
SO MULTIPHOTON MICROSCOPY IN THE BIOMEDICAL SCIENCES
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Multiphoton Microscopy in the Biomedical Sciences
CY JAN 21-23, 2001
CL SAN JOSE, CA
SP SPIE, Bio Rad Labs Inc, Carl Zeiss Inc, Coherent Laser Grp, Chroma Technol Corp, Nikon Instruments Inc, Omega Opt Inc, Spectra Phys Lasers
DE femtosecond lasers; multiphoton microscopy; biomedical imaging
ID FLUORESCENCE; LASERS
AB Most multiphoton imaging has been undertaken using tuneable femtosecond Ti:Sapphire lasers which are large, expensive and require a level of laser expertise to operate. Although new commercial, computer controlled systems are becoming available they are still complex instruments. We report on the development of a range of novel laser sources for multiphoton microscopy based upon optically pumped semiconductor materials.
C1 Univ Strathclyde, Inst Photon, Glasgow G4 0NW, Lanark, Scotland.
RP Girkin, JM (reprint author), Univ Strathclyde, Inst Photon, Glasgow G4 0NW, Lanark, Scotland.
OI Girkin, John/0000-0003-2568-3576
CR CURLEY PF, 1992, OPT QUANT ELECTRON, V24, P851, DOI 10.1007/BF00620198
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Guild JB, 1997, APPL OPTICS, V36, P397, DOI 10.1364/AO.36.000397
   Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x
   Kuznetsov M, 1997, IEEE PHOTONIC TECH L, V9, P1063, DOI 10.1109/68.605500
   STRADLING RA, GROWTH CHARACTERISAT
   Wokosin DL, 1996, IEEE J SEL TOP QUANT, V2, P1051, DOI 10.1109/2944.577337
NR 7
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3940-1
J9 PROC SPIE
PY 2001
VL 4262
BP 186
EP 191
DI 10.1117/12.424553
PG 6
WC Engineering, Biomedical; Microscopy; Optics
SC Engineering; Microscopy; Optics
GA BS31Y
UT WOS:000169435900023
DA 2018-10-20
ER

PT S
AU Seo, JW
   Park, SL
   Hee, LJ
   Yoon, HK
   Gweon, DG
AF Seo, JW
   Park, SL
   Hee, LJ
   Yoon, HK
   Gweon, DG
BE Cho, H
   Knopf, GK
TI Optimal rejection of the image extinction in confocal scanning
   microscopy
SO OPTOMECHATRONIC SYSTEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Optomechatronic Systems
CY NOV 05-06, 2000
CL BOSTON, MA
SP SPIE, Inst Control, Automat & Syst Engineers
DE confocal scanning microscopy (CSM); image extinction; AO deflector;
   optical fields; unitary lens
AB Confocal scanning microscopy(CSM) has been used in biomedical application, materials science, semiconductor quality measurement and forensic application. CSM consists of a beam projector with which a small spot is formed on a specimen, a point detector with a pinhole or slit [I], and a mechanism for two-dimensional beam scanning. An image distribution can be reconstructed by a correlation of spots with many advantages of non-contact, high speed, high resolution of thick specimen comparatively But it is a serious problem for the high performance to align pinhole and other optical components. Especially, the parasitic motion of focus on the point detector gives rise to the fatal distortion of an image profile named the image extinction while the beam is scanned. The intensity of detecting signal truncated by the finite aperture of detector diminishes by the order of two or more when the spot is focused with more than a half aperture.
   This paper shows the mathematical expression of the Light such as the extinction curve in the optical fields [2] of system using AO deflector, and the axial/lateral response experimentally when the error sources change. We propose the progressive methods for the rejection of image extinction as the following. At first for having the corrected image, small spot and long scan range, this paper shows that the optimal design having the multi-objects can be used by choosing the unitary lens [3] device in CSM. At second, in order to compensate for the intensity cancellation at the end profile that may be the cause of waviness for the optical image, this paper shows that it is efficient to schedule the frequency of scan. According to characteristics of the extinction curve and axial/lateral response having the error property, we can define the frequency and sensitivity of as their robustness.
C1 Korea Adv Inst Sci & Technol, Dept Mech Engn, Yusong Gu, Taejon 305701, South Korea.
RP Seo, JW (reprint author), Korea Adv Inst Sci & Technol, Dept Mech Engn, Yusong Gu, 373-1 Kusung Dong,ME3265, Taejon 305701, South Korea.
CR Boddeke FR, 1997, J MICROSC-OXFORD, V186, P270, DOI 10.1046/j.1365-2818.1997.2060766.x
   Born M, 1980, PRINCIPLES OPTICS
   BRACEWELL BR, 1965, FOURIER TRANSFORM IT
   Goodman J.W., 1968, INTRO FOURIER OPTICS
   GU M, PRINCIPLES 3 DIMENSI
   SHEPPARD CJR, 1997, CONFOCAL LASER SCANN
   SHEPPARD CJR, CONFOCAL LASER SCANN
   STARK H, 1982, APPL OPTICAL FOURIER
   WILSON T, THEORY PRACTICE SCAN
NR 9
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3855-3
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4190
BP 62
EP 70
DI 10.1117/12.417234
PG 9
WC Automation & Control Systems; Engineering, Mechanical; Robotics; Optics
SC Automation & Control Systems; Engineering; Robotics; Optics
GA BS18U
UT WOS:000169001400007
DA 2018-10-20
ER

PT B
AU Mondelaers, W
   Lahorte, P
AF Mondelaers, W
   Lahorte, P
BE DeCuyper, M
   Bulte, JWM
TI Radiation-induced bioradicals: Physical, chemical and biological aspects
SO PHYSICS AND CHEMISTRY BASIS OF BIOTECHNOLOGY, VOL 7
SE FOCUS ON BIOTECHNOLOGY
LA English
DT Proceedings Paper
CT 9th European Congress on Biotechnology (ECB9)
CY JUL 11-15, 1999
CL BRUSSELS, BELGIUM
SP Commiss European Comm, Gen Director Technol, Res & Energy Wallonia Reg, J Chabert, Minist Econ Brussels Capit Reg
ID HYPERFINE COUPLING-CONSTANTS; MONTE-CARLO SIMULATION; TUMOR-SUPPRESSOR
   GENE; STRAND BREAK REPAIR; CELL-CYCLE CHECKPOINTS; DNA-DAMAGE;
   IONIZING-RADIATION; AQUEOUS-SOLUTION; TRACK STRUCTURE;
   CHROMOSOMAL-ABERRATIONS
AB This chapter is part one of a review in which the production and application of radiation-induced bioradicals is discussed. Bioradicals play a pivotal role in the complex chain of processes starting with the absorption of radiation in biological materials and ending with the radiation-induced biological after-effects. The general aspects of the four consecutive stages (physical, physicochemical, chemical and biological) are discussed from an interdisciplinary point of view. The close relationship between radiation dose and track structure, induced DNA damage and cell survival or killing is treated in detail. The repair mechanisms that cells employ, to insure DNA stability following irradiation, are described. Because of their great biomedical importance tumour suppressor genes involved in radiation-induced DNA repair and in checkpoint activation will be treated briefly, together with the molecular genetics of radiosensitivity. Part two of this review will deal with modem theoretical methods and experimental instrumentation for quantitative studies in this research field. Also an extensive overview of the applications of radiation-induced bioradicals will be given. A comprehensive list of references allows further exploration of this research field, characterised in the last decade by a substantial advance, both in fundamental knowledge and in range of applications.
C1 State Univ Ghent, Lab Subatom & Radiat Phys, Radiat Phys Grp, B-9000 Ghent, Belgium.
RP Mondelaers, W (reprint author), State Univ Ghent, Lab Subatom & Radiat Phys, Radiat Phys Grp, Proeftuinstr 86, B-9000 Ghent, Belgium.
RI Bulte, Jeff/A-3240-2008
OI Bulte, Jeff/0000-0003-1202-1610
CR ADAMS GE, 1991, RADIOTHER ONCOL, V20, P85, DOI 10.1016/0167-8140(91)90194-L
   ALBERTS B, 1994, MOL BIOL CELL
   ALPER T, 1980, RAD BIOL CANCER RES, P3
   ANDREO P, 1991, PHYS MED BIOL, V36, P861, DOI 10.1088/0031-9155/36/7/001
   Attix F. H., 1986, INTRO RADIOLOGICAL P
   Ballarini F, 1999, INT J RADIAT BIOL, V75, P35, DOI 10.1080/095530099140780
   BECKER D, 1993, ADV RADIAT BIOL, V17, P121
   BEDFORD JS, 1991, INT J RADIAT ONCOL, V21, P1457, DOI 10.1016/0360-3016(91)90320-4
   Begusova M, 1999, INT J RADIAT BIOL, V75, P913, DOI 10.1080/095530099139971
   BIAGLOW JE, 1987, RAD CHEM PRINCIPLES, P527
   BOX HC, 1995, RADIAT RES, V141, P91, DOI 10.2307/3579095
   BRENNER D, 1990, RADIAT RES, V124, P29
   Briesmeister J. F, 1993, LA12625 LOS AL NAT L
   Britt AB, 1996, ANNU REV PLANT PHYS, V47, P75, DOI 10.1146/annurev.arplant.47.1.75
   Brown JM, 1999, CANCER RES, V59, P1391
   BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805
   Cadet J, 1999, NUCL INSTRUM METH B, V151, P1, DOI 10.1016/S0168-583X(99)00117-2
   Callens F, 1996, APPL RADIAT ISOTOPES, V47, P1241, DOI 10.1016/S0969-8043(96)00166-2
   CARTWRIGHT R, 1993, MOL BIOL ONCOLOGISTS
   CASSONI AM, 1992, EUR J CANCER, V28A, P1610, DOI 10.1016/0959-8049(92)90052-4
   COLSON AO, 1995, INT J RADIAT BIOL, V67, P627, DOI 10.1080/09553009514550751
   COOPER M, 1997, RADIAT PHYS CHEM, V50, P102
   COURDI A, 1993, PATHOL BIOL, V41, P117
   CURTIS SB, 1986, RADIAT RES, V106, P252, DOI 10.2307/3576798
   Dahm-Daphi J, 1998, STRAHLENTHER ONKOL, V174, P8
   Dasika GK, 1999, ONCOGENE, V18, P7883
   DEACON J, 1984, RADIOTHER ONCOL, V2, P317, DOI 10.1016/S0167-8140(84)80074-2
   DEALMODOVAR JMR, 1994, BRIT J CANCER, V69, P457
   DEMARCO J, 1998, MED PHYS, V21, P1943
   DIEHL J, 1981, RADIOLYTIC EFFECTS F
   Diehl J.F., 1995, SAFETY IRRADIATED FO
   EVANS HH, 1994, RADIAT RES, V137, P131, DOI 10.2307/3578804
   *FAO IAEA, 1996, FOOD IRR NEWSL
   Ferradini C, 1999, CAN J CHEM, V77, P1542, DOI 10.1139/v99-162
   FERTIL B, 1981, INT J RADIAT ONCOL, V7, P621, DOI 10.1016/0360-3016(81)90377-1
   FRANKENBURGSCHWAGER M, 1994, INT J RADIAT BIOL, V66, P543, DOI 10.1080/09553009414551591
   Fulford J, 1999, J PHYS CHEM A, V103, P11345, DOI 10.1021/jp993087n
   Gallagher WM, 1999, ANN ONCOL, V10, P139, DOI 10.1023/A:1008368500557
   GERWARD L, 1993, RADIAT PHYS CHEM, V41, P783, DOI 10.1016/0969-806X(93)90326-P
   GLASS WA, 1991, PHYSICAL CHEM MECH M
   GOODHEAD DT, 1989, INT J RADIAT BIOL, V55, P513, DOI 10.1080/09553008914550571
   GOODHEAD DT, 1988, HEALTH PHYS, V55, P231, DOI 10.1097/00004032-198808000-00015
   HALBEIB JA, 1984, SAND840573 SAND NAT
   HALL EJ, 1994, RADIOBIOLOGY RADIOBI
   HALL PA, 1994, EUR J CANCER, V30A, P2001, DOI 10.1016/0959-8049(94)00394-K
   Hardy CJ, 1997, J APPL SPORT PSYCHOL, V9, P1, DOI 10.1080/10413209708415381
   HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013
   HILDENBRAND K, 1990, FREE RADICAL RES COM, V11, P195, DOI 10.3109/10715769009088916
   Hill MA, 1999, RADIAT MEAS, V31, P15, DOI 10.1016/S1350-4487(99)00090-6
   HOUEELEVIN C, 1994, J CHIM PHYS PCB, V91, P1107, DOI 10.1051/jcp/1994911107
   Hubbell J. H., 1999, PHYS MED BIOL, V44, P1
   *ICRU, 1992, 46 ICRU
   *ICRU, 1984, 37 ICRU
   ICRU, 1993, 49 ICRU
   ISABELLE V, 1995, INT J RADIAT BIOL, V67, P169, DOI 10.1080/09553009514550211
   ISABELLE V, 1993, INT J RADIAT BIOL, V63, P749, DOI 10.1080/09553009314552151
   Joiner MC, 1993, BASIC CLIN RADIOBIOL, P40
   KATZ R, 1994, RADIAT RES, V140, P356, DOI 10.2307/3579113
   Kiefer J., 1990, BIOL RAD EFFECTS
   KLASSEN NV, 1987, RAD CHEM PRINCIPLES, P29
   Knoll G, 1989, RAD DETECTION MEASUR
   Lahorte P, 1999, J PHYS CHEM A, V103, P6650, DOI 10.1021/jp990942u
   Lahorte P, 1999, J PHYS CHEM A, V103, P11130, DOI 10.1021/jp992489s
   LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0
   LAVERNE JA, 1993, RADIAT RES, V135, P16, DOI 10.2307/3578391
   LEE JM, 1994, MUTAT RES, V307, P573, DOI 10.1016/0027-5107(94)90267-4
   LEE JM, 1995, CANCER METAST REV, V14, P149, DOI 10.1007/BF00665797
   LEHMANN AR, 1992, MUTAT RES, V273, P1, DOI 10.1016/0921-8777(92)90046-6
   Ma C-M, 1999, PHYS MED BIOL, V44, P157
   MCKENNA W, 1992, RAD RES 20 CENTURY P, P392
   MCLAUGHLIN WL, 1993, RADIAT PHYS CHEM, V41, P45, DOI 10.1016/0969-806X(93)90041-R
   MCMILLAN TJ, 1990, INT J RADIAT BIOL, V58, P427, DOI 10.1080/09553009014551781
   MCMILLAN TJ, 1993, BASIC CLIN RADIOBIOL, P211
   Mee L. K., 1987, RAD CHEM PRINCIPLES, P477
   MEEK D, 1999, ONCOGENE, V13, P7666
   Michalik V, 1995, J BIOMOL STRUCT DYN, V13, P565, DOI 10.1080/07391102.1995.10508867
   Michalik V, 1995, NUCL INSTRUM METH B, V105, P328, DOI 10.1016/0168-583X(95)00635-4
   MURRAY AW, 1992, NATURE, V359, P599, DOI 10.1038/359599a0
   NIEMANN EG, 1982, BIOPHYSIK, P300
   Nikjoo H, 1998, INT J RADIAT BIOL, V73, P355, DOI 10.1080/095530098142176
   Nunez MI, 1996, RADIOTHER ONCOL, V39, P155, DOI 10.1016/0167-8140(96)01732-X
   OBE G, 1992, MUTAGENESIS, V7, P3, DOI 10.1093/mutage/7.1.3
   OLEINICK NL, 1990, RADIAT RES, V124, P1, DOI 10.2307/3577686
   Olive PL, 1999, INT J RADIAT BIOL, V75, P395, DOI 10.1080/095530099140311
   OVERGAARD J, 1994, ONCOL RES, V6, P509
   OVERGAARD J, 1993, BASIC CLIN RADIOBIOL, P163
   Platzer I, 1998, RADIAT PHYS CHEM, V51, P73, DOI 10.1016/S0969-806X(97)00105-9
   POLLARD E, 1983, PRESERVATION FOOD IO, V2, P219
   RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741
   ROGERS DWO, 1991, APPL RADIAT ISOTOPES, V42, P965
   ROSENWALD JC, 1993, PATHOL BIOL, V41, P115
   Rowley R, 1999, INT J RADIAT BIOL, V75, P267, DOI 10.1080/095530099140456
   Sachs RK, 1997, INT J RADIAT BIOL, V72, P351
   SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600
   SCHULTEFROHLINDE D, 1989, FREE RADICAL RES COM, V6, P181, DOI 10.3109/10715768909073465
   SEYMOUR CB, 1989, INT J RADIAT BIOL, V56, P999, DOI 10.1080/09553008914552451
   Shackelford RE, 1999, ENVIRON HEALTH PERSP, V107, P5, DOI 10.2307/3434468
   SHARPATYI VA, 1995, HIGH ENERG CHEM+, V29, P77
   Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130
   SpotheimMaurizot M, 1995, NUCL INSTRUM METH B, V105, P308, DOI 10.1016/0168-583X(95)00552-8
   STEEL G, 1993, BASIC CLIN RADIOBIOL, P211
   STEEL G, 1999, PHYS MED BIOL, V41, P205
   Steele RJC, 1998, BRIT J SURG, V85, P1460
   THAMES H, 1987, FRACTIONATION RADIOT
   THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160
   Tomita H, 1997, RADIAT ENVIRON BIOPH, V36, P105, DOI 10.1007/s004110050061
   TURNER JE, 1992, RAD PROTECT MANAGEME, V9, P25
   TURNER JE, 1995, ATOMS RAD RAD PROTEC
   VANLAERE K, 1993, APPL RADIAT ISOTOPES, V44, P33, DOI 10.1016/0969-8043(93)90192-D
   VONSONNTAG C, 1991, ANGEW CHEM INT EDIT, V30, P1229, DOI 10.1002/anie.199112291
   VONSONNTAG C, 1994, INT J RADIAT BIOL, V65, P19, DOI 10.1080/09553009414550031
   VONSONNTAG C, 1987, CHEM BASIS RAD ACTIO
   WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251
   WEICHSELBAUM RR, 1991, J NATL CANCER I, V83, P480, DOI 10.1093/jnci/83.7.480
   Wetmore SD, 1998, J PHYS CHEM B, V102, P9332, DOI 10.1021/jp982437n
   Wetmore SD, 1998, J PHYS CHEM B, V102, P10602, DOI 10.1021/jp982417l
   *WHO, 1984, COD GEN STAND IRR FO
   Woods R. J., 1994, APPL RAD CHEM RAD PR
NR 118
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-7091-0
J9 FOCUS BIOTECHNOL
PY 2001
VL 7
BP 249
EP 276
PG 28
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BS91G
UT WOS:000171368300010
DA 2018-10-20
ER

PT B
AU Lahorte, P
   Mondelaers, W
AF Lahorte, P
   Mondelaers, W
BE DeCuyper, M
   Bulte, JWM
TI Radiation-induced bioradicals: Technologies and research
SO PHYSICS AND CHEMISTRY BASIS OF BIOTECHNOLOGY, VOL 7
SE FOCUS ON BIOTECHNOLOGY
LA English
DT Proceedings Paper
CT 9th European Congress on Biotechnology (ECB9)
CY JUL 11-15, 1999
CL BRUSSELS, BELGIUM
SP Commiss European Comm, Gen Director Technol, Res & Energy Wallonia Reg, J Chabert, Minist Econ Brussels Capit Reg
ID ELECTRON-SPIN-RESONANCE; MOLECULAR-ORBITAL CALCULATIONS; FREE-RADICAL
   FORMATION; DENSITY-FUNCTIONAL THEORY; NUCLEAR DOUBLE-RESONANCE;
   IRRADIATED SINGLE-CRYSTALS; HYPERFINE COUPLING-CONSTANTS; GUANINE
   HYDROBROMIDE MONOHYDRATE; FOOD-PACKAGING MATERIALS; PROTON-TRANSFER
   BEHAVIOR
AB This chapter represents the second part of a review in which the production and application of radiation-induced radicals in biological matter are discussed. In part one the general aspects of the four stages (physical, physicochemical, chemical and biological) of interaction of radiation with matter in general and biological matter in particular, were discussed. Here an overview is presented of modern technologies and theoretical methods available for studying these radiation effects. The relevance is highlighted of electron paramagnetic resonance spectroscopy and quantum chemical calculations with respect to obtaining structural information on bioradicals, and a survey is given of the research studies in this field. We also discuss some basic aspects of modem accelerator technologies which can be used for creating radicals and we conclude with an overview of applications of radiation processing in biology and related fields such as biomedical and environmental engineering, food technology, medicine and pharmacy.
C1 Univ Ghent, Lab Subatom & Radiat Phys, Radiat Phys Grp, B-9000 Ghent, Belgium.
RP Lahorte, P (reprint author), Univ Ghent, Lab Subatom & Radiat Phys, Radiat Phys Grp, Proeftuinstr 86, B-9000 Ghent, Belgium.
RI Bulte, Jeff/A-3240-2008
OI Bulte, Jeff/0000-0003-1202-1610
CR Ambroz HB, 1998, RADIAT PHYS CHEM, V53, P491, DOI 10.1016/S0969-806X(98)00209-6
   Atherton N. M., 1993, PRINCIPLES ELECT SPI
   ATHERTON NM, 1996, ELECT SPIN RESONANCE, V15
   Baerends EJ, 1997, J PHYS CHEM A, V101, P5383, DOI 10.1021/jp9703768
   Ban FQ, 1999, J PHYS CHEM A, V103, P4303, DOI 10.1021/jp990257n
   Barbarin N, 1996, RADIAT PHYS CHEM, V48, P787, DOI 10.1016/S0969-806X(96)00056-4
   BARNES J, 1994, J PHYS CHEM-US, V98, P10969, DOI 10.1021/j100093a045
   BARNES J, 1991, RADIAT RES, V126, P104, DOI 10.2307/3578177
   BARNES JP, 1995, J PHYS CHEM-US, V99, P11248, DOI 10.1021/j100028a028
   BARNES JP, 1995, RADIAT RES, V143, P85, DOI 10.2307/3578929
   Barone V., 1995, RECENT ADV DENSITY 1, P287
   Basly JP, 1996, INT J PHARM, V142, P125, DOI 10.1016/0378-5173(96)04654-6
   Basly JP, 1997, PHARMACEUT RES, V14, P810, DOI 10.1023/A:1012119026422
   Basly JP, 1997, INT J PHARM, V152, P201, DOI 10.1016/S0378-5173(97)00084-7
   Basly JP, 1998, ANALYST, V123, P1753, DOI 10.1039/a802719f
   Basly JP, 1997, PHARMACEUT RES, V14, P1186, DOI 10.1023/A:1012102806800
   Basly JP, 1998, INT J RADIAT BIOL, V74, P521
   Basly JP, 1998, J PHARMACEUT BIOMED, V17, P871, DOI 10.1016/S0731-7085(98)00014-4
   Basly JP, 1996, INT J PHARM, V139, P219, DOI 10.1016/0378-5173(96)04597-8
   Basly JP, 1999, INT J RADIAT BIOL, V75, P259, DOI 10.1080/095530099140726
   Basly JP, 1998, INT J PHARM, V170, P265, DOI 10.1016/S0378-5173(98)00152-5
   Basly JP, 1998, FREE RADICAL RES, V29, P67, DOI 10.1080/10715769800300081
   Basly JP, 1998, ANAL CHIM ACTA, V372, P373, DOI 10.1016/S0003-2670(98)00319-5
   Basly JP, 1998, ANAL CHIM ACTA, V359, P107, DOI 10.1016/S0003-2670(97)00672-7
   Basly JP, 1997, INT J PHARM, V158, P241, DOI 10.1016/S0378-5173(97)00257-3
   Basly JP, 1997, PHARMACEUT RES, V14, P1192, DOI 10.1023/A:1012154823638
   Basly JP, 1997, INT J PHARM, V149, P85, DOI 10.1016/S0378-5173(96)04855-7
   Basly JP, 1997, J PHARMACEUT BIOMED, V15, P1137, DOI 10.1016/S0731-7085(96)01947-4
   Basly JP, 1997, INT J PHARM, V154, P109, DOI 10.1016/S0378-5173(97)00119-1
   Basly JP, 1996, J CHIM PHYS PCB, V93, P1
   Becker D, 1996, RADIAT RES, V146, P361, DOI 10.2307/3579297
   BECKER D, 1993, ADV RADIAT BIOL, V17, P121
   BECKER D, 1994, RADIAT RES, V140, P123, DOI 10.2307/3578577
   BERNHARD WA, 1994, RADIAT RES, V140, P199, DOI 10.2307/3578904
   BERNHARD WA, 1989, J PHYS CHEM-US, V93, P2187, DOI 10.1021/j100343a003
   BERNHARD WA, 1994, INT J RADIAT BIOL, V66, P491, DOI 10.1080/09553009414551511
   BERTHOMIEU C, 1995, BIOSPECTROSCOPY, V1, P187, DOI 10.1002/bspy.350010304
   Binks PR, 1996, J CHEM TECHNOL BIOT, V67, P319
   Boess C, 1996, DRUG DEV IND PHARM, V22, P495, DOI 10.3109/03639049609108354
   Bohm P, 1998, Z ORTHOP GRENZGEB, V136, P197, DOI 10.1055/s-2008-1054222
   Bolch WE, 1998, RADIAT ENVIRON BIOPH, V37, P157, DOI 10.1007/s004110050111
   BOX HC, 1990, J CHEM PHYS, V93, P55, DOI 10.1063/1.459556
   Briden PE, 1999, RADIAT ENVIRON BIOPH, V38, P175, DOI 10.1007/s004110050153
   BUCHALLA R, 1993, J FOOD PROTECT, V56, P998, DOI 10.4315/0362-028X-56.11.998
   Buchalla R, 1999, RADIAT PHYS CHEM, V56, P353, DOI 10.1016/S0969-806X(99)00311-4
   BURG KJL, 1996, ADV FOOD IRRADIATION, P254
   Cadet J, 1998, FREE RADICAL RES, V29, P541, DOI 10.1080/10715769800300581
   Cadet J, 1999, NUCL INSTRUM METH B, V151, P1, DOI 10.1016/S0168-583X(99)00117-2
   Capizzi S, 1999, RADIAT PHYS CHEM, V56, P591, DOI 10.1016/S0969-806X(99)00271-6
   CARENZA M, 1994, J CONTROL RELEASE, V29, P187, DOI 10.1016/0168-3659(94)90135-X
   Chalak L, 1997, SCI HORTIC-AMSTERDAM, V68, P83, DOI 10.1016/S0304-4238(96)00976-4
   Claverie JM, 1999, HUM MOL GENET, V8, P1821, DOI 10.1093/hmg/8.10.1821
   Close DM, 1998, J PHYS CHEM A, V102, P6737, DOI 10.1021/jp981610c
   CLOSE DM, 1993, RADIAT RES, V135, P1, DOI 10.2307/3578390
   Close DM, 1997, RADIAT RES, V147, P663, DOI 10.2307/3579478
   CLOSE DM, 1994, RADIAT RES, V137, P300, DOI 10.2307/3578703
   CLOSE DM, 1989, FREE RADICAL RES COM, V6, P83, DOI 10.3109/10715768909073433
   CLOSE DM, 1988, RADIAT RES, V116, P379, DOI 10.2307/3577382
   COLSON AO, 1992, J PHYS CHEM-US, V96, P9787, DOI 10.1021/j100203a039
   Colson AO, 1996, J PHYS CHEM-US, V100, P4420, DOI 10.1021/jp953032v
   COLSON AO, 1992, J PHYS CHEM-US, V96, P661, DOI 10.1021/j100181a028
   COLSON AO, 1993, J PHYS CHEM-US, V97, P13852, DOI 10.1021/j100153a067
   COLSON AO, 1995, J PHYS CHEM-US, V99, P3867, DOI 10.1021/j100011a064
   COLSON AO, 1995, J PHYS CHEM-US, V99, P13033, DOI 10.1021/j100034a051
   COLSON AO, 1993, J PHYS CHEM-US, V97, P8092, DOI 10.1021/j100132a045
   COLSON AO, 1995, INT J RADIAT BIOL, V67, P627, DOI 10.1080/09553009514550751
   CRUCQ AS, 1995, FREE RADICAL BIO MED, V18, P841, DOI 10.1016/0891-5849(94)00204-W
   Crucq AS, 1996, FREE RADICAL BIO MED, V21, P827, DOI 10.1016/0891-5849(96)00181-5
   Cullis PM, 1996, J AM CHEM SOC, V118, P2775, DOI 10.1021/ja9536025
   CULLIS PM, 1992, J CHEM SOC PERK T 2, P1409, DOI 10.1039/p29920001409
   CULLIS PM, 1995, J PHYS CHEM-US, V99, P9293, DOI 10.1021/j100022a051
   CULLIS PM, 1992, J CHEM SOC PERK T 2, P1695, DOI 10.1039/p29920001695
   Davies MJ, 1996, ARCH BIOCHEM BIOPHYS, V336, P163, DOI 10.1006/abbi.1996.0545
   DAVIES MJ, 1993, RES CHEM INTERMEDIAT, V19, P669, DOI 10.1163/156856793X00307
   DAVIES MJ, 1995, J CHEM SOC PERK T 2, P13, DOI 10.1039/p29950000013
   Demertzis PG, 1999, PACKAG TECHNOL SCI, V12, P119, DOI 10.1002/(SICI)1099-1522(199905/06)12:3<119::AID-PTS460>3.0.CO;2-G
   DEWITTE K, 1994, EUPHYTICA, V77, P141, DOI 10.1007/BF02551477
   Dodd NJF, 1995, BIOCHEM SOC SYMP, P247
   DORE C, 1993, PLANT BREEDING, V111, P142, DOI 10.1111/j.1439-0523.1993.tb00620.x
   Duroux JL, 1996, APPL RADIAT ISOTOPES, V47, P1565, DOI 10.1016/S0969-8043(96)00208-4
   Duroux JL, 1997, J CHIM PHYS PCB, V94, P405, DOI 10.1051/jcp/1997940405
   Dyer MR, 1999, DRUG DISCOV TODAY, V4, P109, DOI 10.1016/S1359-6446(99)01310-0
   EATON SS, 1996, ELECT SPIN RESONANCE, V15, P169
   FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3
   FALQUE M, 1994, EUPHYTICA, V75, P19, DOI 10.1007/BF00024527
   Fattibene P, 1996, APPL RADIAT ISOTOPES, V47, P1375, DOI 10.1016/S0969-8043(96)00254-0
   Fauconnet AL, 1996, INT J PHARM, V144, P123, DOI 10.1016/S0378-5173(96)04724-2
   Garde JA, 1998, J FOOD PROTECT, V61, P1000, DOI 10.4315/0362-028X-61.8.1000
   GIBELLA M, 1993, J CHIM PHYS PCB, V90, P1041, DOI 10.1051/jcp/1993901041
   GIBELLA M, 1994, J CHIM PHYS PCB, V91, P1868, DOI 10.1051/jcp/1994911868
   GOLDFARB D, 1996, ELECT SPIN RESONANCE, V15, P186
   GOPAL NGS, 1988, RADIAT PHYS CHEM, V32, P619
   Gordy W., 1980, THEORY APPL ELECT SP
   Goulas AE, 1996, Z LEBENSM UNTERS FOR, V202, P250, DOI 10.1007/BF01263549
   Haire DL, 1997, FOOD RES INT, V30, P249, DOI 10.1016/S0963-9969(97)00036-7
   Hamm RN, 1998, RADIAT ENVIRON BIOPH, V37, P151, DOI 10.1007/s004110050110
   Hawkins CL, 1998, J CHEM SOC PERK T 2, P1937, DOI 10.1039/a802949k
   Herak JN, 1997, RADIAT PHYS CHEM, V50, P141, DOI 10.1016/S0969-806X(97)00027-3
   Herak JN, 1999, RADIAT RES, V151, P319, DOI 10.2307/3579944
   HERAK JN, 1994, INT J RADIAT BIOL, V66, P3, DOI 10.1080/09553009414550891
   Hill MA, 1999, RADIAT MEAS, V31, P15, DOI 10.1016/S1350-4487(99)00090-6
   HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864
   Hole EO, 1998, RADIAT RES, V149, P109, DOI 10.2307/3579919
   HOLE EO, 1991, J PHYS CHEM-US, V95, P1494, DOI 10.1021/j100156a086
   HOLE EO, 1995, RADIAT RES, V144, P258, DOI 10.2307/3578944
   HOLE EO, 1989, FREE RADICAL RES COM, V6, P87, DOI 10.3109/10715768909073434
   HOLE EO, 1992, RADIAT RES, V129, P1, DOI 10.2307/3577897
   HOLE EO, 1991, RADIAT RES, V125, P119, DOI 10.2307/3577878
   HOLE EO, 1992, RADIAT RES, V129, P119, DOI 10.2307/3578149
   HOLE EO, 1992, RADIAT RES, V130, P148, DOI 10.2307/3578271
   Huang WD, 1998, NUCL INSTRUM METH B, V140, P137, DOI 10.1016/S0168-583X(97)00552-1
   *IAEA, IAEATECDOC1023
   IAEA, 1997, IAEATECDOC971
   Ibrahim R, 1998, PLANT CELL TISS ORG, V54, P37, DOI 10.1023/A:1006072205608
   ILIAKIS G, 1991, BIOESSAYS, V13, P641
   JACOBS GP, 1995, J BIOMATER APPL, V10, P59, DOI 10.1177/088532829501000104
   Jacobs GP, 1998, RADIAT PHYS CHEM, V53, P511, DOI 10.1016/S0969-806X(98)00185-6
   JACOBS GP, 1988, RADIAT PHYS CHEM, V31, P685
   Jensen F, 1999, INTRO COMPUTATIONAL
   KABILJO Z, 1990, INT J RADIAT BIOL, V58, P439, DOI 10.1080/09553009014551791
   Kaetsu I, 1996, RADIAT PHYS CHEM, V47, P419, DOI 10.1016/0969-806X(95)00129-L
   Kaetsu I, 1999, RADIAT PHYS CHEM, V55, P193, DOI 10.1016/S0969-806X(98)00326-0
   KIM H, 1989, J CHEM PHYS, V90, P1448, DOI 10.1063/1.456086
   Kohn W, 1996, J PHYS CHEM-US, V100, P12974, DOI 10.1021/jp960669l
   KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133
   Koppen G, 1999, MECH AGEING DEV, V110, P13, DOI 10.1016/S0047-6374(99)00038-X
   KRZYMINIEWSKI R, 1995, RADIAT PHYS CHEM, V45, P883, DOI 10.1016/0969-806X(94)E0041-G
   KRZYMINIEWSKI R, 1990, J MOL STRUCT, V240, P133, DOI 10.1016/0022-2860(90)80504-D
   Kubli-Garfias C, 1999, INT J QUANTUM CHEM, V71, P433, DOI 10.1002/(SICI)1097-461X(1999)71:5<433::AID-QUA4>3.0.CO;2-1
   Kubli-Garfias C, 1998, J MOL STRUC-THEOCHEM, V425, P171, DOI 10.1016/S0166-1280(97)00212-1
   Kubli-Garfias C, 1998, J MOL STRUC-THEOCHEM, V454, P267, DOI 10.1016/S0166-1280(98)00296-6
   Kubli-Garfias C, 1998, THEOCHEM-J MOL STRUC, V422, P167, DOI 10.1016/S0166-1280(97)00116-4
   Kubli-Garfias C, 1998, J MOL STRUC-THEOCHEM, V452, P175, DOI 10.1016/S0166-1280(98)00149-3
   Kubli-Garfias C, 1998, J MOL STRUC-THEOCHEM, V428, P189, DOI 10.1016/S0166-1280(97)00278-9
   Kumagai J, 2000, RADIAT PHYS CHEM, V57, P75, DOI 10.1016/S0969-806X(99)00306-0
   Lahorte P, 1999, RADIAT PHYS CHEM, V55, P761, DOI 10.1016/S0969-806X(99)00226-1
   Lahorte P, 1999, J PHYS CHEM A, V103, P6650, DOI 10.1021/jp990942u
   Lahorte P, 1999, J PHYS CHEM A, V103, P11130, DOI 10.1021/jp992489s
   Langer-Safer PR, 1997, DRUG DEVELOP RES, V41, P173, DOI 10.1002/(SICI)1098-2299(199707/08)41:3/4<173::AID-DDR7>3.0.CO;2-I
   Lardon A, 1999, GENETICS, V151, P1173
   Lassmann G, 1999, J PHYS CHEM A, V103, P1283, DOI 10.1021/jp9843454
   LETT JT, 1994, RENAISSANCE BASIC CE, P181
   Levine IN, 1991, QUANTUM CHEM
   Lin WZ, 1998, RADIAT PHYS CHEM, V53, P651, DOI 10.1016/S0969-806X(97)00271-5
   Luo N, 1999, J PHYS CHEM A, V103, P592, DOI 10.1021/jp982799v
   Mader K, 1998, PHYS MED BIOL, V43, P1931, DOI 10.1088/0031-9155/43/7/014
   Malkin V. G., 1995, MODERN DENSITY FUNCT, P273
   MALONE ME, 1995, J PHYS CHEM-US, V99, P9299, DOI 10.1021/j100022a052
   Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405
   MCLAUGHLIN WL, 1993, RADIAT PROT DOSIM, V47, P255
   Mehnert R, 1996, NUCL INSTRUM METH B, V113, P81, DOI 10.1016/0168-583X(95)01344-X
   MIASKIEWICZ K, 1994, J AM CHEM SOC, V116, P232, DOI 10.1021/ja00080a027
   MIYAZAKI T, 1994, J PHARM SCI, V83, P68, DOI 10.1002/jps.2600830116
   MIYAZAKI T, 1994, J PHARM SCI, V83, P1643, DOI 10.1002/jps.2600831122
   Moiseenko VV, 1998, RADIAT ENVIRON BIOPH, V37, P167, DOI 10.1007/s004110050112
   Moiseenko VV, 1998, INT J RADIAT BIOL, V74, P533, DOI 10.1080/095530098141113
   MONDELAERS W, 1993, NUCL INSTRUM METH B, V79, P898, DOI 10.1016/0168-583X(93)95494-P
   Mondelaers W, 1998, NUCL INSTRUM METH B, V139, P43, DOI 10.1016/S0168-583X(97)00944-0
   MONK JD, 1995, J FOOD PROTECT, V58, P197, DOI 10.4315/0362-028X-58.2.197
   Moroff G, 1997, TRANSFUSION, V37, P1084, DOI 10.1046/j.1537-2995.1997.371098016450.x
   MROCZKA NE, 1995, RADIAT RES, V144, P251, DOI 10.2307/3578943
   Mroczka NE, 1997, RADIAT RES, V147, P560, DOI 10.2307/3579622
   Musial K, 1998, ANN BOT-LONDON, V82, P747, DOI 10.1006/anbo.1998.0747
   Musial K, 1999, SEX PLANT REPROD, V12, P110, DOI 10.1007/s004970050179
   Naess SK, 1998, EUPHYTICA, V99, P57, DOI 10.1023/A:1018372709235
   NELSON WH, 1992, RADIAT RES, V131, P272, DOI 10.2307/3578416
   NELSON WH, 1989, FREE RADICAL RES COM, V6, P81, DOI 10.3109/10715768909073432
   Nelson WH, 1998, RADIAT RES, V149, P75, DOI 10.2307/3579684
   NELSON WH, 1992, RADIAT RES, V131, P10, DOI 10.2307/3578310
   NELSON WH, 1988, INT J RADIAT BIOL, V54, P963, DOI 10.1080/09553008814552361
   Onori S, 1996, APPL RADIAT ISOTOPES, V47, P1569, DOI 10.1016/S0969-8043(96)00210-2
   PATTERSON LK, 1987, RAD CHEM PRINCIPLES, P65
   PODMORE ID, 1991, J CHEM SOC FARADAY T, V87, P3647, DOI 10.1039/ft9918703647
   Pouget JP, 1999, J CHIM PHYS PCB, V96, P143, DOI 10.1051/jcp:1999122
   Pouget JP, 1999, INT J RADIAT BIOL, V75, P51, DOI 10.1080/095530099140807
   Prise KM, 1998, INT J RADIAT BIOL, V74, P173, DOI 10.1080/095530098141564
   RAFFI J, 1993, J CHIM PHYS PCB, V90, P1009, DOI 10.1051/jcp/1993901009
   Riganakos KA, 1999, RADIAT PHYS CHEM, V54, P527, DOI 10.1016/S0969-806X(98)00263-1
   ROSIAK JM, 1995, RADIAT PHYS CHEM, V46, P161, DOI 10.1016/0969-806X(95)00007-K
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
   Sabo D, 1999, UNFALLCHIRURG, V102, P580, DOI 10.1007/s001130050453
   SAGSTUEN E, 1992, J PHYS CHEM-US, V96, P8269, DOI 10.1021/j100200a014
   Sagstuen E, 1997, J PHYS CHEM A, V101, P9763, DOI 10.1021/jp972158k
   SAGSTUEN E, 1988, RADIAT RES, V116, P196, DOI 10.2307/3577457
   SAGSTUEN E, 1989, FREE RADICAL RES COM, V6, P91, DOI 10.3109/10715768909073435
   SAGSTUEN E, 1989, J PHYS CHEM-US, V93, P5974, DOI 10.1021/j100353a008
   SAGSTUEN E, 1992, J PHYS CHEM-US, V96, P1121, DOI 10.1021/j100182a019
   SAGSTUEN E, 1986, J PHYS CHEM-US, V90, P5584, DOI 10.1021/j100280a022
   Sagstuen E, 1996, RADIAT RES, V146, P425, DOI 10.2307/3579304
   Sagstuen E, 1998, RADIAT RES, V149, P120, DOI 10.2307/3579920
   Sanderud A, 1998, J PHYS CHEM B, V102, P9353, DOI 10.1021/jp982932j
   Sankovic K, 1996, INT J RADIAT BIOL, V70, P603
   SANKOVIC K, 1991, RADIAT RES, V128, P119, DOI 10.2307/3578128
   Sauvaigo S, 1998, ANAL BIOCHEM, V259, P1, DOI 10.1006/abio.1998.2628
   SCHARF WH, 1994, BIOMEDICAL PARTICLE, P45
   SEMINARIO JM, 1995, MODERN DENSITY FUNCT, P1
   Sendra E, 1996, FOOD SCI TECHNOL INT, V2, P1, DOI 10.1177/108201329600200101
   SEVILLA MD, 1991, J PHYS CHEM-US, V95, P3409, DOI 10.1021/j100161a080
   SEVILLA MD, 1989, FREE RADICAL RES COM, V6, P99, DOI 10.3109/10715768909073439
   SEVILLA MD, 1995, J PHYS CHEM-US, V99, P1060, DOI 10.1021/j100003a032
   Shalaby SW, 1996, ACS SYM SER, V620, P246
   Shao C, 1999, RADIAT PHYS CHEM, V56, P547, DOI 10.1016/S0969-806X(99)00296-0
   SIGNORETTI EC, 1993, DRUG DEV IND PHARM, V19, P1693, DOI 10.3109/03639049309050161
   SIGNORETTI EC, 1994, DRUG DEV IND PHARM, V20, P2493, DOI 10.3109/03639049409042653
   SPALLETTA RA, 1993, RADIAT RES, V133, P143, DOI 10.2307/3578349
   Steel G. G., 1993, BASIC CLIN RADIOBIOL
   Stehlik D, 1997, ANNU REV PHYS CHEM, V48, P745, DOI 10.1146/annurev.physchem.48.1.745
   Swarts SG, 1996, RADIAT RES, V145, P304, DOI 10.2307/3578986
   SWARTS SG, 1992, RADIAT RES, V129, P333, DOI 10.2307/3578034
   SZYCZEWSKI A, 1994, J MOL STRUCT, V318, P87, DOI 10.1016/0022-2860(93)07909-G
   Szyczewski A, 1996, APPL RADIAT ISOTOPES, V47, P1675, DOI 10.1016/S0969-8043(96)00234-5
   Szyczewski A, 1998, APPL RADIAT ISOTOPES, V49, P59, DOI 10.1016/S0969-8043(97)00215-7
   TALROSE VL, 1995, RADIAT PHYS CHEM, V46, P633, DOI 10.1016/0969-806X(95)00232-M
   THAKUR BR, 1994, FOOD REV INT, V10, P437, DOI 10.1080/87559129409541012
   Tilquin B, 1999, J CHIM PHYS PCB, V96, P167, DOI 10.1051/jcp:1999126
   TRIOLET J, 1992, FREE RADICAL RES COM, V16, P183, DOI 10.3109/10715769209049171
   TRIOLET J, 1990, FREE RADICAL RES COM, V10, P57, DOI 10.3109/10715769009145933
   TRIOLET J, 1992, MAGN RESON CHEM, V30, P1051, DOI 10.1002/mrc.1260301105
   TRIOLET J, 1991, J CHIM PHYS PCB, V88, P1237, DOI 10.1051/jcp/1991881237
   Turro NJ, 1999, RES CHEM INTERMEDIAT, V25, P505, DOI 10.1163/156856799X00536
   Van Lancker M, 1999, NUCL INSTRUM METH B, V151, P242, DOI 10.1016/S0168-583X(99)00099-3
   Vanhaelewyn GCAM, 1999, RADIAT RES, V151, P590, DOI 10.2307/3580035
   Ventura ON, 1997, ADV QUANTUM CHEM, V28, P293, DOI 10.1016/S0065-3276(08)60222-1
   VONSONNTAG C, 1995, RADIAT PHYS CHEM, V46, P527, DOI 10.1016/0969-806X(95)00209-G
   WANG W, 1994, INT J RADIAT BIOL, V66, P683
   Wang W, 1997, INT J RADIAT BIOL, V71, P387
   WANG WD, 1994, RADIAT RES, V137, P2, DOI 10.2307/3578784
   WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251
   WARDMAN P, 1991, FREE RADICAL BIO MED, V10, P243, DOI 10.1016/0891-5849(91)90081-D
   WARDMAN P, 1994, INT J RADIAT BIOL, V65, P35, DOI 10.1080/09553009414550051
   WEIL JA, 1994, ELECT PARAMAGNETIC R
   Weiland B, 1996, INT J RADIAT BIOL, V70, P327, DOI 10.1080/095530096145067
   Wetmore SD, 1998, J PHYS CHEM B, V102, P7484, DOI 10.1021/jp981691c
   Wetmore SD, 1998, J PHYS CHEM B, V102, P5369, DOI 10.1021/jp9809078
   Wetmore SD, 1998, J PHYS CHEM B, V102, P9332, DOI 10.1021/jp982437n
   Wetmore SD, 1998, J PHYS CHEM B, V102, P7674, DOI 10.1021/jp9824407
   Wetmore SD, 1998, J PHYS CHEM B, V102, P10602, DOI 10.1021/jp982417l
   Woods R. J., 1994, APPL RAD CHEM RAD PR
   YAN MY, 1992, J PHYS CHEM-US, V96, P1983, DOI 10.1021/j100183a082
NR 239
TC 0
Z9 0
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-7091-0
J9 FOCUS BIOTECHNOL
PY 2001
VL 7
BP 277
EP 303
PG 27
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BS91G
UT WOS:000171368300011
DA 2018-10-20
ER

PT S
AU Perichon, S
   Lysenko, V
   Remaki, B
   Barbier, D
AF Perichon, S
   Lysenko, V
   Remaki, B
   Barbier, D
BE Bonnaud, O
   MohammedBrahim, T
   Strunk, HP
   Werner, JH
TI Porous silicon in microsystems: Thermal isolation applications
SO POLYCRYSTALLINE SEMICONDUCTORS IV MATERIALS, TECHNOLOGIES AND LARGE AREA
   ELECTRONICS
SE SOLID STATE PHENOMENA
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Polycrystalline Semiconductors
CY SEP 03-07, 2000
CL ST MALO, FRANCE
SP Ctr Natl Rech Sci, Reg Bretagne, Conseil Gen Vilaine, Univ Rennes 1, STMicroelectr Rennes, STMicroelectr Tours, SOPRA, KarlSuss
DE microsystems; porous silicon; thermal conductivity
ID MICRO-RAMAN SCATTERING; HEAT-CONDUCTION; LAYERS; TECHNOLOGY;
   MICROSENSOR; SENSORS; DESIGN; FILMS
AB Porous silicon morphology confers on this new silicon structure astonishing properties leading to numerous applications in microsystems (Silicon On Insulator structures, gas and biochemical sensors, optical devices, etc.). A distinctive application of porous silicon is related to its low thermal conductivity (about two orders of magnitude lower than that of mono-silicon) ensuring a new thermal insulation strategy for thermal effects microsystems. The basic phenomena responsible for such a low thermal conductivity are described. A new measurement method based on micro-Raman scattering is used to relate technological and morphological parameters of this material to its thermal properties. Finally a biomedical microsensor based on a porous silicon thermal insulation was realized.
C1 Inst Natl Sci Appl Lyon, Phys Mat Lab, FR-69621 Villeurbanne, France.
RP Perichon, S (reprint author), Inst Natl Sci Appl Lyon, Phys Mat Lab, Bat 502,20 Ave A Einstein, FR-69621 Villeurbanne, France.
RI Lysenko, Vladimir/G-6376-2014; Lacour, Stephanie/E-6375-2010
OI Lysenko, Vladimir/0000-0003-1076-7064
CR BARRET S, 1992, SENSOR ACTUAT A-PHYS, V33, P19, DOI 10.1016/0924-4247(92)80218-R
   BEALE MIJ, 1985, J CRYST GROWTH, V73, P622, DOI 10.1016/0022-0248(85)90029-6
   Benedetto G, 1997, APPL PHYS A-MATER, V64, P155, DOI 10.1007/s003390050457
   Betzner TM, 1996, J MICROMECH MICROENG, V6, P217, DOI 10.1088/0960-1317/6/2/003
   Bomchil G., 1988, Microelectronic Engineering, V8, P293, DOI 10.1016/0167-9317(88)90022-6
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   Chen G, 1996, J HEAT TRANS-T ASME, V118, P539, DOI 10.1115/1.2822665
   CruzOrea A, 1996, J APPL PHYS, V79, P8951, DOI 10.1063/1.362626
   Drost A., 1995, Sensors and Materials, V7, P111
   Edelberg E, 1996, APPL PHYS LETT, V68, P1415, DOI 10.1063/1.116098
   ELBEL T, 1994, SENSOR ACTUAT A-PHYS, V41, P493
   Foucaran A, 1997, THIN SOLID FILMS, V297, P317, DOI 10.1016/S0040-6090(96)09437-0
   FULKERSON W, 1968, PHYS REV, V167, P765, DOI 10.1103/PhysRev.167.765
   Gesele G, 1997, J PHYS D APPL PHYS, V30, P2911, DOI 10.1088/0022-3727/30/21/001
   Gruning U, 1996, APPL PHYS LETT, V68, P747, DOI 10.1063/1.116729
   Halimaoui A, 1995, POROUS SILICON SCI T, P33
   HERINO R, 1987, J ELECTROCHEM SOC, V134, P1994, DOI 10.1149/1.2100805
   Hilbrich S, 1997, THIN SOLID FILMS, V297, P250, DOI 10.1016/S0040-6090(96)09364-9
   IMAI K, 1984, IEEE T ELECTRON DEV, V31, P297, DOI 10.1109/T-ED.1984.21518
   Jones LA, 1996, J VAC SCI TECHNOL A, V14, P1505, DOI 10.1116/1.579977
   KATO Y, 1989, APPL SURF SCI, V41-2, P614, DOI 10.1016/0169-4332(89)90131-1
   Lang W, 1996, MAT SCI ENG R, V17, P1, DOI 10.1016/0927-796X(96)00190-8
   Lang W, 1995, SENSOR ACTUAT A-PHYS, V51, P31, DOI 10.1016/0924-4247(96)80048-3
   Loni A, 1996, THIN SOLID FILMS, V276, P143, DOI 10.1016/0040-6090(95)08075-9
   Luth H, 2000, MAT SCI ENG B-SOLID, V69, P104, DOI 10.1016/S0921-5107(99)00275-5
   Lysenko V, 1999, MICROELECTR J, V30, P1141, DOI 10.1016/S0026-2692(99)00077-4
   Lysenko V, 1999, J APPL PHYS, V86, P6841, DOI 10.1063/1.371760
   Lysenko V, 2000, ADV MATER, V12, P516, DOI 10.1002/(SICI)1521-4095(200004)12:7<516::AID-ADMA516>3.0.CO;2-G
   MAJUMDAR A, 1993, J HEAT TRANS-T ASME, V115, P7, DOI 10.1115/1.2910673
   MOREL M, 2000, IN PRESS MAT SC MICR
   Obraztsov AN, 1997, SEMICONDUCTORS+, V31, P534, DOI 10.1134/1.1187209
   Perichon S, 1999, J APPL PHYS, V86, P4700, DOI 10.1063/1.371424
   Roussel P, 1999, SENSOR ACTUAT A-PHYS, V74, P100, DOI 10.1016/S0924-4247(98)00330-6
   Smith L., 1992, J APPL PHYS, V71, pR1
   SMITH RL, 1990, SENSOR ACTUAT A-PHYS, V21, P825
NR 35
TC 1
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1012-0394
BN 3-908450-63-2
J9 SOL ST PHEN
PY 2001
VL 80-81
BP 417
EP 427
DI 10.4028/www.scientific.net/SSP.80-81.417
PG 11
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA BS91J
UT WOS:000171369300060
DA 2018-10-20
ER

PT J
AU Araujo, MA
   Vaz, CM
   Cunha, AM
   Mota, M
AF Araujo, MA
   Vaz, CM
   Cunha, AM
   Mota, M
TI In-vitro degradation behaviour of starch/EVOH biomaterials
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE biodegradable polymer; in-vitro degradation; biomedical;
   starch/poly(ethylene-vinyl alcohol)
ID POLYMERS; BLENDS; BIODEGRADATION
AB Blends of corn starch with poly(ethylene-vinyl alcohol) copolymer (SEVA-C) were aged up to 120 days on NaCl sterile isotonic solution (9 g/l) and the degradation solutions were analysed by several techniques. Mechanical properties (i.e. strength, stiffness and ductility), weight loss, and water uptake were also assessed. The evolution of the material structure was followed by scanning electron microscopy (SEM), contact angle measurements and thermogravimetric analysis (TGA). The degradation solutions were monitored with anionic chromatography (HPAE-PAD), colorimetric methods, and Fourier transformed infra-red spectrophotomety (FT-IR) in order to quantify the amount of plasticisers and sugars. SEVA-C micrographs presented an increase in the surface porosity as a function of immersion time. The main compound released to the solution is glycerol, the other degradation products are low molecular weight polymeric chains. From the physical-chemical point of view the material degradation is principally associated with the leaching of glycerol, since the other metabolites were not released. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Minho, Ctr Engn Biol, IBQF, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Mota, M (reprint author), Univ Minho, Ctr Engn Biol, IBQF, Campus Gualtar, P-4710057 Braga, Portugal.
OI Cunha M., Antonio/0000-0003-3860-7732; Mota, Manuel/0000-0002-1084-2688
CR ANDRIANO KP, 1994, J APPL BIOMATER, V5, P133, DOI 10.1002/jab.770050206
   BASTIOLI C, 1994, RHEOL ACTA, V33, P307, DOI 10.1007/BF00366957
   Bastioli C, 1993, J ENVIRON POLYM DEGR, V1, P181
   Bastiolli C, 1995, J ENVIRON POLYM DEGR, V3, P2
   Bastiotti C, 1991, PCT International Patent Appl., Patent No. [9102025, WO 91/02025]
   BAUMGART FW, 1994, AM SOC TEST MATER, V1217, P42, DOI 10.1520/STP12220S
   BHATTACHARYA M, 1995, J APPL POLYM SCI, V57, P539, DOI 10.1002/app.1995.070570504
   DANNIELS AU, 1994, J APPL BIOMATER, V5, P51
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   GRIFFIN GJL, 1994, POLYM DEGRAD STABIL, V45, P241, DOI 10.1016/0141-3910(94)90141-4
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   RATNER BD, 1996, BIOMATERIALS SCI INT, P201
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   Soest JJG, 1996, POLYMER, V37, P3543
   Tjong SC, 1998, POLYM ENG SCI, V38, P3
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   WOOL R, 1995, SCI ENG POLYM COMPOS, P138
   Zaikov GE, 1989, DEGRADATION STABILIS, V2, P469
NR 21
TC 14
Z9 14
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PY 2001
VL 73
IS 2
BP 237
EP 244
PG 8
WC Polymer Science
SC Polymer Science
GA 452WQ
UT WOS:000169883000005
DA 2018-10-20
ER

PT B
AU Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
AF Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Asahina, T
   Mabuchi, M
BE Hanada, S
   Zhong, Z
   Nam, SW
   Wright, RN
TI Processing and mechanical properties of Biocompatible cancellous
   titanium
SO PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE sintering; titanium; biomaterials; bone; foams; mechanical properties
ID PORE-SIZE; CYTOCOMPATIBILITY; IMPLANTS; ALLOYS; FOAMS; METAL
AB Pure titanium and some of its alloys are currently considered as the most attractive metallic materials for biomedical applications due to their excellent mechanical properties, corrosion resistance, and biocompatibility. It has been demonstrated that titanium and some titanium-based alloys are well accepted by human tissues as compared to other metals such as SUS316L stainless steel and Co-Cr-Mo type alloys. Furthermore, open-cellular metallic foams with a pore size of 200-500 mu m are acknowledged as very promising biomaterial candidates for bone implants because its open-cellular structure permits the ingrowths of new-bone tissues and the transport, of body fluids. In the present study, highly porous titanium foams with a porosity of 80% are produced by using a novel powder metallurgical process, which includes the adding of the selected spacers into the starting powders. The porous titanium foams are characterized by using optical microscopy and scanning electron microscopy. Mechanical properties are investigated by compressive tests. These biocompatible porous titanium foams are expected to be used as implants for medical applications due to its porous structure permits the ingrowths of the new-bone tissues and the transport of the body fluids.
C1 Natl Inst Adv Ind Sci & Technol Chubu, Inst Struct & Engn Mat, Kita Ku, Nagoya, Aichi 4628510, Japan.
RP Wen, CE (reprint author), Natl Inst Adv Ind Sci & Technol Chubu, Inst Struct & Engn Mat, Kita Ku, Hirate Cho, Nagoya, Aichi 4628510, Japan.
RI Chino, Yasumasa/L-9782-2018
OI Chino, Yasumasa/0000-0002-0725-8237
CR ARDILL J, 1995, THESIS QUEENS U BELF
   *ASTM, 1994, F6789 ASTM
   *ASTM, 1994, F13682 ASTM
   BANHART J, 1998, P 1998 POWD MET WORL, P201
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   DAVIES GJ, 1983, J MATER SCI, V18, P1899, DOI 10.1007/BF00554981
   Dowson D., 1992, BIOMECHANICS DIARTHR, V2, P305
   Gibson L. J., 1997, CELLULAR SOLIDS STRU, P1
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Maine E, 2000, ADV ENG MATER, V2, P205, DOI 10.1002/(SICI)1527-2648(200004)2:4<205::AID-ADEM205>3.0.CO;2-J
   NAKAMURA Y, 1998, 3 WORLD BIOM C KYOT, P202
   Niinomi M, 2000, INT J FATIGUE, V22, P887, DOI 10.1016/S0142-1123(00)00058-X
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Pineda LM, 1996, J BIOMED MATER RES, V31, P385
   SCHUMACHER HR, 1988, PRIMER RHEUMATIC DIS
   Steinemann S., 1980, EVALUATION BIOMATERI
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Yamada Y, 1999, J MATER SCI LETT, V18, P1477, DOI 10.1023/A:1006677930532
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 20
TC 0
Z9 0
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-404-8
PY 2001
BP 247
EP 250
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BV26R
UT WOS:000178391600062
DA 2018-10-20
ER

PT B
AU Itoh, G
   Motohashi, Y
   Shiraishi, T
   Niinomi, M
AF Itoh, G
   Motohashi, Y
   Shiraishi, T
   Niinomi, M
BE Hanada, S
   Zhong, Z
   Nam, SW
   Wright, RN
TI High temperature deformation behavior in a beta-type Ti-29Nb-13Ta-5Zr
   alloy for biomedical applications
SO PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, VOLS I AND II
LA English
DT Proceedings Paper
CT 4th Pacific Rim International Conference on Advanced Materials and
   Processing (PRICM4)
CY DEC 11-15, 2001
CL HONOLULU, HI
SP Japan Inst Met, Chinese Soc Met, Korean Inst Met & Mat, Minerals, Met & Mat Soc, Iketani Sci & Technol Fdn, USN, Off Naval Res Int Field Off, Asian Off Aerosp Res & Dev, USA Res Off Far E
DE high temperature deformation; beta titanium alloy; biomedical
   application; strain to failure; superplasticity; stain-rate sensitivity
AB With increasing human lifetime, demands for artificially produced part of human body is growing rapidly. Artificial crotch joint is one of the most important and demand-growing parts. Metallic materials initially used for this application were Co-Cr alloys and stainless steels, but titanium alloys has now been highlighted because of their excellent corrosion resistance. However, since an artificial crotch joint is mounted in the human body usually for years, the alloying element is required preferably not to have poisoning effect on human body cells. To fulfill this requirement as well as that in mechanical properties, one of the authors (M. N.) developed a new beta titanium alloy, Ti-29Nb-13Ta-5Zr.
   High temperature deformation behavior, one of the most important aspects for fabricating the crotch joint, for this alloy has been studied in comparison with that for an Ti-15V-3Cr-3Sn-3Al alloy, one of the most popular beta-type alloys. The possibility of superplastic forming has been searched for. The alloy was induction-skull-melted, hot-forged, cold-rolled into 1.5mm. thickness, machined into tensile-test pieces, and finally tested at a temperature of 750 C at constant cross-head speeds (initial strain rates ranging from 10(-4)s(-1) to 10(-2)s(-1)). Nominal strain to failure was smaller in Ti-29Nb-13Ta-SZr alloy than in Ti-15V-3Cr-3Sn-3Al alloy, which was ascribed to the smaller strain-rate sensitivity exponent, m, and to the cracks on the specimen surface that were formed mostly perpendicular to the tensile direction. Strain to failure decreased as the crack depth increased with decreasing the strain rate.
C1 Ibaraki Univ, Dept Mech Engn, Hitachi, Ibaraki 3168511, Japan.
RP Itoh, G (reprint author), Ibaraki Univ, Dept Mech Engn, Hitachi, Ibaraki 3168511, Japan.
CR KUBOKI I, 1994, J JAPAN I LIGHT META, V44, P269
   KURODA D, 2000, 98 SPRING M JAP I LI, P29
NR 2
TC 0
Z9 0
U1 0
U2 0
PU JAPAN INST METALS
PI SENDAI
PA AOBA ARAMAKI, SENDAI, 980, JAPAN
BN 4-88903-404-8
PY 2001
BP 2089
EP 2092
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BV26R
UT WOS:000178391600529
DA 2018-10-20
ER

PT S
AU Tognola, G
   Parazzini, M
   Ravazzani, P
   Svelto, C
   Grandori, F
AF Tognola, G
   Parazzini, M
   Ravazzani, P
   Svelto, C
   Grandori, F
GP IEEE
   IEEE
   IEEE
TI 3D reconstruction of anatomical surfaces from unorganized range data
SO PROCEEDINGS OF THE 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: BUILDING NEW
   BRIDGES AT THE FRONTIERS OF ENGINEERING AND MEDICINE
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 23rd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 25-28, 2001
CL ISTANBUL, TURKEY
SP Natl Sci Fdn, TUBITAK, Sci & Tech Res Ctr Turkey, ISIK Univ, COMNET, EREL Techno Grp, GUZEL SANATLAR Printinghouse, JOHNSON&JOHNSON Med, PFIZER, SIEMENS Med, TURKCELL Iletism Hizmetler A S, ALSTOM Elect Ltd Co, GANTEK Technol & SUN Microsyst, TURCOM Co Grp
DE surface reconstruction; range data; geometrical deformable model;
   triangular mesh
AB Three-dimensional range data acquired through digital scanning of anatomical surfaces are used in this study as test material for the validation of an innovative approach for the reconstruction of closed surfaces. Although based on a straightforward theoretical approach, the proposed method exhibits an extreme accuracy in the reconstruction of a variety of target surfaces of different topologies. The method does not require any additional information about the target surface than the raw range data and is robust to noise. A triangular mesh approximates the target surface. Also, a few examples on the possible biomedical applications of the reconstructed surface are provided in this paper.
C1 Politecn Milan, CNR, Ctr Biomed Engn, I-20133 Milan, Italy.
RP Tognola, G (reprint author), Politecn Milan, CNR, Ctr Biomed Engn, I-20133 Milan, Italy.
RI Parazzini, Marta/J-8175-2014; Tognola, Gabriella/B-9025-2015; Ravazzani,
   Paolo/B-9139-2015
OI Parazzini, Marta/0000-0001-9008-7530; Tognola,
   Gabriella/0000-0002-2433-449X; Ravazzani, Paolo/0000-0003-0282-3329
CR Cignoni P, 1998, COMPUT GRAPH FORUM, V17, P167, DOI 10.1111/1467-8659.00236
   Cignoni P, 1998, COMPUT GRAPH-UK, V22, P37, DOI 10.1016/S0097-8493(97)00082-4
   Hoppe H., 1993, Computer Graphics Proceedings, P19, DOI 10.1145/166117.166119
   MENCL R, 1998, EUROGRAPHICS 98 STAT, P51
   MILLER JV, 1991, COMP GRAPH, V25, P217
   Taubin G., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P351
   TERZOPOULOS D, 1991, IEEE T PATTERN ANAL, V13, P703, DOI 10.1109/34.85659
NR 7
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7211-5
J9 P ANN INT IEEE EMBS
PY 2001
VL 23
BP 2534
EP 2536
PN 1-4
PG 3
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Neurosciences
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Neurosciences & Neurology
GA BV41G
UT WOS:000178871900689
OA Green Published
DA 2018-10-20
ER

PT S
AU Oktar, FN
   Sayrak, H
   Ozsoy, S
   Heybeli, N
AF Oktar, FN
   Sayrak, H
   Ozsoy, S
   Heybeli, N
GP IEEE
   IEEE
   IEEE
TI Histological study on a novel bone graft substitute: Human derived
   tooth-hydroxyapatite compared with coralline hydroxyapatite
SO PROCEEDINGS OF THE 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: BUILDING NEW
   BRIDGES AT THE FRONTIERS OF ENGINEERING AND MEDICINE
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 23rd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 25-28, 2001
CL ISTANBUL, TURKEY
SP Natl Sci Fdn, TUBITAK, Sci & Tech Res Ctr Turkey, ISIK Univ, COMNET, EREL Techno Grp, GUZEL SANATLAR Printinghouse, JOHNSON&JOHNSON Med, PFIZER, SIEMENS Med, TURKCELL Iletism Hizmetler A S, ALSTOM Elect Ltd Co, GANTEK Technol & SUN Microsyst, TURCOM Co Grp
DE hydroxyapatite; grafting; bone graft; osteoconduction
ID BOVINE CANCELLOUS BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS;
   IN-VITRO; OSTEOINDUCTIVITY; CERAMICS; MATRIX
AB Different types of bone-graft substitutes have been developed, and are on the market worldwide to eliminate the drawbacks of autogenous grafting. They vary in composition, strength, osteoinductive and osteoconductive properties, mechanism and rates at which they are resorbed and remodelled. Of these, THA is a novel material produced by one of us (FNO). This study was performed to determine the histological properties of THA on animals, and to achieve this a standard on the market coralline HA (CHA) was used as control. 20 sheep were used in this study and divided into 2 groups. Human THA (Group-A) and CHA (Group-B) materials were implanted to the tibiae of 10 sheep in each group. The histological examinations of surrounding bone response of the implant materials were done 12 weeks after implantation. There was no significant difference histologically between groups A and B. All materials were found to be surrounded by new bone tissue. THA was found to be as efficient as standard CHA on histological basis. In addition, economical production of THA should be taken into consideration. In future, THA may be a viable alternative on bone grafting when clinical trials were completed.
C1 Marmara Univ, Biomed Equipment Technol Program, Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Biomed Equipment Technol Program, Istanbul, Turkey.
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Anderson LA, 2000, J MATER SCI-MATER M, V11, P743
   Broz JJ, 1997, J MATER SCI-MATER M, V8, P395, DOI 10.1023/A:1018545303184
   Durucan C, 2000, J MATER SCI-MATER M, V11, P365, DOI 10.1023/A:1008934024440
   Guizzardi S, 2000, J BIOMED MATER RES, V53, P227, DOI 10.1002/(SICI)1097-4636(2000)53:3<227::AID-JBM7>3.3.CO;2-5
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Ikeda N, 1999, BIOMATERIALS, V20, P1087, DOI 10.1016/S0142-9612(99)00005-8
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P725, DOI 10.1023/A:1008979929632
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Lin FH, 1999, BIOMATERIALS, V20, P475, DOI 10.1016/S0142-9612(98)00193-8
   Ohbayashi Y, 2000, BIOMATERIALS, V21, P501, DOI 10.1016/S0142-9612(99)00208-2
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   OKTAR FN, 1997, P NAT BIOM ENG S BIY, P54
   PONGKAO D, 1999, P 12 INT S CER MED, V12, P357
   VARGAS G, 1997, P 10 INT S CER MED, V10, P565
   VEHOF WM, 2000, BIOMATER, V21, P2001
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
   Zhang M, 1997, J PERIODONTOL, V68, P1076, DOI 10.1902/jop.1997.68.11.1076
NR 20
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7211-5
J9 P ANN INT IEEE EMBS
PY 2001
VL 23
BP 3005
EP 3008
PN 1-4
PG 4
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Neurosciences
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Neurosciences & Neurology
GA BV41G
UT WOS:000178871900821
DA 2018-10-20
ER

PT S
AU Watson, S
   Williams, RJ
   Griffiths, H
   Gough, W
   Morris, A
AF Watson, S
   Williams, RJ
   Griffiths, H
   Gough, W
   Morris, A
GP IEEE
   IEEE
   IEEE
TI A transceiver for direct phase measurement Magnetic Induction Tomography
SO PROCEEDINGS OF THE 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: BUILDING NEW
   BRIDGES AT THE FRONTIERS OF ENGINEERING AND MEDICINE
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 23rd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 25-28, 2001
CL ISTANBUL, TURKEY
SP Natl Sci Fdn, TUBITAK, Sci & Tech Res Ctr Turkey, ISIK Univ, COMNET, EREL Techno Grp, GUZEL SANATLAR Printinghouse, JOHNSON&JOHNSON Med, PFIZER, SIEMENS Med, TURKCELL Iletism Hizmetler A S, ALSTOM Elect Ltd Co, GANTEK Technol & SUN Microsyst, TURCOM Co Grp
DE Magnetic Induction Tomography; Electrical Impedance Tomography
AB Magnetic Induction Tomography (MIT) is a technique for imaging the electromagnetic properties of materials. Excitation coils are used to induce eddy currents within the sample volume which are then sensed by receiver coils. The technique has attracted interest for biomedical application due to the non-contacting nature of the measurements, which may provide advantages over electrode based impedance tomography in certain applications.
   The paper describes a transceiver designed for use in a prototype biomedical MIT system operating with a single excitation frequency of 10MHz. To improve channel isolation and phase stability during signal distribution, the received signals undergo heterodyne downconversion to 10kHz, filtering and limiting at the transceiver. Direct phase measurement between the downconverted reference and received signals is then undertaken to measure the signal perturbation due to the induced conduction eddy currents.
C1 Univ Glamorgan, Sch Elect, Pontypridd CF37 1DL, M Glam, Wales.
RP Watson, S (reprint author), Univ Glamorgan, Sch Elect, Pontypridd CF37 1DL, M Glam, Wales.
EM swatson1@glam.ac.uk
RI Watson, Stuart/H-7124-2015
OI Watson, Stuart/0000-0002-9643-5580
CR Griffiths H, 1999, ANN NY ACAD SCI, V873, P335, DOI 10.1111/j.1749-6632.1999.tb09481.x
   Korjenevsky A, 2000, PHYSIOL MEAS, V21, P89, DOI 10.1088/0967-3334/21/1/311
   Korzhenevskii A. V., 1997, Journal of Communications Technology and Electronics, V42, P469
   MORRIS A, 2000, P 2 EPSRC EGINEERING
   WATSON SA, UNPUB PHASE MEASUREM
NR 5
TC 4
Z9 4
U1 0
U2 6
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7211-5
J9 P ANN INT IEEE EMBS
PY 2001
VL 23
BP 3182
EP 3184
PN 1-4
PG 3
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Neurosciences
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Neurosciences & Neurology
GA BV41G
UT WOS:000178871900877
DA 2018-10-20
ER

PT S
AU Roback, K
   Hass, U
   Persson, J
AF Roback, K
   Hass, U
   Persson, J
GP IEEE
   IEEE
   IEEE
TI Transfer of health care technology in university-industry research
   collaboration environment
SO PROCEEDINGS OF THE 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: BUILDING NEW
   BRIDGES AT THE FRONTIERS OF ENGINEERING AND MEDICINE
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 23rd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 25-28, 2001
CL ISTANBUL, TURKEY
SP Natl Sci Fdn, TUBITAK, Sci & Tech Res Ctr Turkey, ISIK Univ, COMNET, EREL Techno Grp, GUZEL SANATLAR Printinghouse, JOHNSON&JOHNSON Med, PFIZER, SIEMENS Med, TURKCELL Iletism Hizmetler A S, ALSTOM Elect Ltd Co, GANTEK Technol & SUN Microsyst, TURCOM Co Grp
DE Technology transfer; innovation; medical devices; biomedical
   engineering; clinical procedures; qualitative study
AB The traditional innovation research has focused on the diffusion process and adoption of new technologies. This paper deals with health care technology in the early innovation stages preceding targeted development and marketing. A model of early research processes in the biomedical field and determinants of technology transfer will be presented. The study material is eleven projects in the Competence Center Noninvasive Medical Measurements (NIMED), Linkoping University, which is a collaboration center where academic researchers cooperate with industry and clinical departments. Data collection was made through semi-structured interviews. A qualitative approach has been adopted for data analysis. Research initiative of the investigated projects do in most. cases originate in the academic knowledge base and. earlier connections in industry and health care play an important role in formation of cooperation constellation. A number of internal factors are perceived as positive to project advancement, such as stable economy, proximity to clinical departments, and positive feedback from collaboration partners. Significant negative factors are all related to changes in cooperation structure. Clusters of related projects seem to be beneficial to research work and is an evident external factor which has to be added in a new model of technology transfer.
C1 Linkoping Univ, Competence Ctr Noninvas Med Measurements, Dept Biomed Engn, Linkoping, Sweden.
RP Roback, K (reprint author), Linkoping Univ, Competence Ctr Noninvas Med Measurements, Dept Biomed Engn, Linkoping, Sweden.
RI Hass, Ursula/I-4519-2012
OI Roback, Kerstin/0000-0002-1353-8059
CR BANTA D, 1990, LIFE CYCLES MED TECH, P21
   Battista R N, 1989, Int J Technol Assess Health Care, V5, P227
   BONAIR A, 1996, ASSESSMENT HLTH CARE, P17
   Edquist C., 1977, TEKNIK SAMHALLE ENER
   Ely M., 1991, DOING QUALITATIVE RE
   Gelijns A. C., 1990, MODERN METHODS CLIN
   Henrekson M., 2001, J TECHNOLOGY TRANSFE, V26, P207, DOI DOI 10.1023/A:1011153922906
   MAITAL S, 2001, J TECHNOLOGY TRANSFE, V26, P115
   OBERG A, 1995, BIOMED ENG HDB, P2549
   Rogers E., 1983, DIFFUSION INNOVAITON
   Schumpeter J. A., 1983, THEORY EC DEV INQUIR
   Starrin B, 1994, KVALITATIV METOD VET
   Usher Abbott P., 1988, HIST MECH INVENTIONS
NR 13
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7211-5
J9 P ANN INT IEEE EMBS
PY 2001
VL 23
BP 3938
EP 3941
PN 1-4
PG 4
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Neurosciences
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Neurosciences & Neurology
GA BV41G
UT WOS:000178871901083
OA Green Published
DA 2018-10-20
ER

PT S
AU Koutsojannis, C
   Prentzas, J
   Hatzilygeroudis, I
AF Koutsojannis, C
   Prentzas, J
   Hatzilygeroudis, I
GP IEEE
   IEEE
   IEEE
TI A web-based intelligent tutoring system teaching nursing students
   fundamental aspects of biomedical technology
SO PROCEEDINGS OF THE 23RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE
   ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-4: BUILDING NEW
   BRIDGES AT THE FRONTIERS OF ENGINEERING AND MEDICINE
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 23rd Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY OCT 25-28, 2001
CL ISTANBUL, TURKEY
SP Natl Sci Fdn, TUBITAK, Sci & Tech Res Ctr Turkey, ISIK Univ, COMNET, EREL Techno Grp, GUZEL SANATLAR Printinghouse, JOHNSON&JOHNSON Med, PFIZER, SIEMENS Med, TURKCELL Iletism Hizmetler A S, ALSTOM Elect Ltd Co, GANTEK Technol & SUN Microsyst, TURCOM Co Grp
DE intelligent tutoring systems; health care technology
AB In this paper, we present the architecture of a Web-based Intelligent Tutoring System (ITS) for distant education of nursing students in fundamental aspects of the most common medical equipment. It offers course units covering the needs of users with different knowledge levels and characteristics. It tailors the presentation of the educational material to the users' diverse needs by using AI techniques to specify each user's model as well as to make pedagogical decisions. This is achieved via an expert system that uses a hybrid knowledge representation formalism integrating symbolic rules with neurocomputing.
C1 Univ Patras, Sch Engn, Dept Comp Engn & Informat, Patras, Greece.
RP Koutsojannis, C (reprint author), Univ Patras, Sch Engn, Dept Comp Engn & Informat, Patras, Greece.
CR Anderson J. R., 1993, RULES MIND
   BECK J, 1996, APPL AI ED
   Brusilovsky P., 1998, ADAPTIVE HYPERTEXT H
   Brusilovsky P, 1996, LNCS, P261, DOI DOI 10.1007/3-540-61327-7
   Hanson A C, 1994, Comput Nurs, V12, P29
   Hatzilygeroudis I., 2000, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V9, P113, DOI 10.1142/S0218213000000094
   Hatzilygeroudis I., 2001, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V10, P87, DOI 10.1142/S021821300100043X
   Kommers P, 1996, HYPERMEDIA LEARNING
   Lappe J M, 1990, J Nurs Educ, V29, P244
   MITROVIC A, 2000, ITS 2000 WORKSH AD I, P37
   Ozbolt J G, 1985, J Med Syst, V9, P57, DOI 10.1007/BF00992522
   SALEEM N, 1994, COMPUT NURS, V121, P35
   STERN M, LECT NOTES COMPUTER, V1452, P98
   Vassileva J., 1997, Journal of Computing and Information Technology - CIT, V5, P87
   Woolf B., 1992, ENCY ARTIFICIAL INTE, P434
NR 15
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-7211-5
J9 P ANN INT IEEE EMBS
PY 2001
VL 23
BP 4024
EP 4027
PN 1-4
PG 4
WC Cardiac & Cardiovascular Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Biomedical; Neurosciences
SC Cardiovascular System & Cardiology; Computer Science; Engineering;
   Neurosciences & Neurology
GA BV41G
UT WOS:000178871901107
DA 2018-10-20
ER

PT J
AU Minari, C
   Baleani, M
   Cristofolini, L
   Baruffaldi, F
AF Minari, C
   Baleani, M
   Cristofolini, L
   Baruffaldi, F
TI The effect on the fatigue strength of bone cement of adding sodium
   fluoride
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE acrylic cement; additives; sodium fluoride; fatigue
ID INITIATION; FAILURE
AB New bone cements that include several additives are currently being investigated and tested. One such additive is sodium fluoride (NaF), which promotes bone formation, facilitating implant integration and success. The influence of NaF on the fatigue performance of the cement as used in biomedical applications was tested in this paper. In fact fatigue failure of the cement mantle is a major factor limiting the longevity of a cemented implant.
   An experimental bone cement with added NaF (12 wt %) was investigated. The fatigue strength of the novel bone cement was evaluated in comparison with the cement without additives; fatigue tests were conducted according to current standards. The load levels were arranged based on a validated, statistically based optimization algorithm. The curve of stress against number of load cycles and the endurance limit were obtained and compared for both formulations. The results showed that the addition of NaF (12 wt %) to polymethylmethacrylate (PMMA) bone cement does not affect the fatigue resistance of the material. Sodium fluoride can safely be added to the bone cement without altering the fatigue performance of the PMMA bone cement.
C1 Ist Ortoped Rizzoli, Ist Tecnol Med, I-40136 Bologna, Italy.
   Univ Bologna, Fac Ingn, DIEM, Bologna, Italy.
RP Baleani, M (reprint author), Ist Ortoped Rizzoli, Ist Tecnol Med, Via Di Barbiano 1-10, I-40136 Bologna, Italy.
RI Cristofolini, Luca/C-4402-2013
OI Cristofolini, Luca/0000-0002-7473-6868; Baleani,
   Massimiliano/0000-0002-9759-6474
CR AMSTUTZ HC, 1991, HIP ARTHROPLASTY, V1
   Armitage P., 1994, STAT METHODS MED RES
   BHAMBRI SK, 1995, J BIOMED MATER RES, V29, P233, DOI 10.1002/jbm.820290214
   CRAWFORD RJ, 1975, POLYMER, V16, P908, DOI 10.1016/0032-3861(75)90212-8
   Cristofolini L, 2000, FATIGUE FRACT ENG M, V23, P953, DOI 10.1046/j.1460-2695.2000.00327.x
   Hertzberg R. W., 1980, FATIGUE ENG PLASTICS
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Magnan B, 1994, Acta Orthop Belg, V60, P72
   NAKAZAWA H, 1987, STAT RES FATIGUE FRA
   TOPOLESKI LDT, 1990, J BIOMED MATER RES, V24, P135, DOI 10.1002/jbm.820240202
   TOPOLESKI LDT, 1993, BIOMATERIALS, V14, P1165, DOI 10.1016/0142-9612(93)90162-U
NR 12
TC 13
Z9 13
U1 0
U2 0
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI BURY ST EDMUNDS
PA NORTHGATE AVENUE,, BURY ST EDMUNDS IP32 6BW, SUFFOLK, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 2001
VL 215
IS H2
BP 251
EP 253
DI 10.1243/0954411011533643
PG 3
WC Engineering, Biomedical
SC Engineering
GA 435KM
UT WOS:000168880700014
PM 11382084
DA 2018-10-20
ER

PT J
AU Haight, RC
AF Haight, RC
TI Medium energy neutron and proton nuclear data for therapy
SO RADIOCHIMICA ACTA
LA English
DT Article
DE neutrons; protons; nuclear data; cross sections; standards; KERMA
   coefficient; dosimetry; benchmarks
ID TOTAL CROSS-SECTIONS; CHARGED-PARTICLE PRODUCTION; SIMPLE RAMSAUER
   MODEL; KERMA FACTORS; SCATTERING; BOMBARDMENT; OXYGEN; SI; CA; FE
AB The range and status of nuclear data on the interaction of medium-energy neutrons and protons with biomedical materials are discussed. Microscopic data (cross sections) include results of experimental measurements, indices and compilations of such data, and evaluated data. Experimental data, while usually available only in partial ranges of interest, are essential for validating and normalizing nuclear models used to produce comprehensive evaluated data libraries. Integral measurements of radiation transport such as depth-dose curves and of KERMA coefficients test the data and their application in transport calculations.
C1 Univ Calif Los Alamos Natl Lab, Los Alamos Neutron Sci Ctr, Los Alamos, NM 87545 USA.
RP Haight, RC (reprint author), Univ Calif Los Alamos Natl Lab, Los Alamos Neutron Sci Ctr, POB 1663, Los Alamos, NM 87545 USA.
CR ABFALTERER WP, IN PRESS PHYS REV C
   Bateman FB, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.064609
   Bauer RW, 1998, NUCL SCI ENG, V130, P348, DOI 10.13182/NSE98-A2011
   BAUHOFF W, 1986, ATOM DATA NUCL DATA, V35, P429, DOI 10.1016/0092-640X(86)90016-1
   Benck S, 1998, PHYS MED BIOL, V43, P3427, DOI 10.1088/0031-9155/43/12/003
   Benck S, 1998, PHYS REV C, V58, P1558, DOI 10.1103/PhysRevC.58.1558
   BERTRAND FE, 1973, PHYS REV C, V8, P1045, DOI 10.1103/PhysRevC.8.1045
   BHAT MR, 1980, P S NEUTR CROSS SECT
   BHAT MR, 1977, P S NEUTR CROSS SECT
   BORELI F, 1968, PHYS REV, V174, P1147, DOI 10.1103/PhysRev.174.1147
   BRADY FP, 1979, NEUTRON INDUCED REAC
   BROERSE JJ, 1997, TECDOC992 IAEA
   Carlson RF, 1996, ATOM DATA NUCL DATA, V63, P93, DOI 10.1006/adnd.1996.0010
   Chadwick MB, 1996, NUCL SCI ENG, V123, P17, DOI 10.13182/NSE96-A24210
   Chadwick MB, 1996, NUCL SCI ENG, V123, P1
   Chadwick MB, 1999, NUCL SCI ENG, V131, P293, DOI 10.13182/NSE98-48
   CONDE H, 1992, INDCSEC101 NEANDC
   CONDE H, 1992, NEANDC31 INDC
   *CSISRS, CROSS SECT INF STOR
   DEJUREN J, 1950, PHYS REV, V77, P606, DOI 10.1103/PhysRev.77.606
   FINLAY RW, 1993, PHYS REV C, V47, P237, DOI 10.1103/PhysRevC.47.237
   Grimes SM, 1998, NUCL SCI ENG, V130, P340, DOI 10.13182/NSE98-A2010
   HAIGHT RC, 1995, P SOC PHOTO-OPT INS, V2339, P256, DOI 10.1117/12.204165
   HAIGHT RC, 2000, LAUR00442 LOS AL NAT
   HARTMANN CL, 1992, RADIAT PROT DOSIM, V44, P25
   HJORT EL, 1994, PHYS REV C, V50, P275, DOI 10.1103/PhysRevC.50.275
   *ICRU, 2000, 63 ICRU
   ILJINOV AS, 1991, PRODUCTION RADIONU B, V13, P211
   ISHIBASHI K, 2000, COMMUNICATION
   Jones DTL, 2001, RADIOCHIM ACTA, V89, P265, DOI 10.1524/ract.2001.89.4-5.265
   KELLOGG DA, 1953, PHYS REV, V90, P224, DOI 10.1103/PhysRev.90.224
   Kelly JJ, 1996, PHYS REV C, V54, P2547, DOI 10.1103/PhysRevC.54.2547
   LEVKOVAKI VN, 1991, CROSS SECTIONS MEDIU
   LISOWSKI PW, 1991, P SPEC M NEUTR CROSS
   MACGREGOR MH, 1958, PHYS REV, V111, P1155, DOI 10.1103/PhysRev.111.1155
   Michel R, 1997, NUCL INSTRUM METH B, V129, P153, DOI 10.1016/S0168-583X(97)00213-9
   NELSON RO, IN PRESS NUCL SCI EN
   *NUCL EN AG, 1996, P SPEC M NUCL NUCL O
   *NUCL EN AG, 1991, P SPEC M NEUTR CROSS
   QAIM SM, 1978, NUCL PHYS A, V295, P150, DOI 10.1016/0375-9474(78)90026-X
   SCHIMMERLING W, 1971, PHYS LETT B, VB 37, P177, DOI 10.1016/0370-2693(71)90044-X
   SCHIMMERLING W, 1973, PHYS REV C, V7, P248, DOI 10.1103/PhysRevC.7.248
   SCHREWE UJ, 1995, RADIAT PROT DOSIM, V61, P275
   SCHREWE UJ, 1997, P INT C NUCL DAT SCI, P1643
   Shibata S, 1996, RADIOCHIM ACTA, V75, P1
   SHUBIN YN, IAEANDS204
   SLYPEN I, 1997, P INT C NUCL DAT SCI, P1640
   STEYN GF, 1990, APPL RADIAT ISOTOPES, V41, P315
   SUTTON M, 1998, COMMUNICATION
   VANZYL CP, 1956, PHILOS MAG, V1, P1003, DOI 10.1080/14786435608238182
   VOSS RGP, 1956, PROC R SOC LON SER-A, V236, P52, DOI 10.1098/rspa.1956.0112
   VOSS RGP, 1956, PROC R SOC LON SER-A, V236, P41, DOI 10.1098/rspa.1956.0111
   WILLIAMS IR, 1967, PHYS REV, V162, P1055, DOI 10.1103/PhysRev.162.1055
   WINFIELD JS, 1986, PHYS REV C, V33, P1, DOI 10.1103/PhysRevC.33.1
   ZANELLI CI, 1981, PHYS REV C, V23, P1015, DOI 10.1103/PhysRevC.23.1015
NR 55
TC 0
Z9 0
U1 0
U2 0
PU R OLDENBOURG VERLAG
PI MUNICH
PA LEKTORAT M/N, K BERBER-NERLINGER, POSTFACH 80 13 60, D-81613 MUNICH,
   GERMANY
SN 0033-8230
J9 RADIOCHIM ACTA
JI Radiochim. Acta
PY 2001
VL 89
IS 4-5
BP 289
EP 296
DI 10.1524/ract.2001.89.4-5.289
PG 8
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology
SC Chemistry; Nuclear Science & Technology
GA 441HT
UT WOS:000169225500012
DA 2018-10-20
ER

PT S
AU Tadigadapa, S
   Najafi, N
AF Tadigadapa, S
   Najafi, N
BE Ramesham, R
TI Reliability of microelectromechanical systems (MEMS)
SO RELIABILITY, TESTING AND CHARACTERIZATION OF MEMS/MOEMS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Reliability, Testing, and Characterization of MEMS/MOEMS
CY OCT 22-24, 2001
CL SAN FRANCISCO, CA
SP SPIE
DE microelectromechanical systems; packaging; reliability testing;
   capacitive pressure sensors; pressure sensor reliability; biomedical
   pressure sensors
ID SURFACE
AB Reliability is a key parameter for the eventual prevalence of microelectromechanical systems (MEMS) as either sub-components or as standalone products. Traditionally, micromachined components have been made by separating the micromachined chip design and fabrication processes from the packaging and reliability issues. This "evolutionary" partitioning of microsystems has led to long incubation times for the commercial success of MEMS based products. Packaging involves bringing together (i) multitude of design geometries of the various constituent parts, (ii) interfacing diverse materials, (iii) providing required input/output connections and (iv) optimization of all of these for performance, cost and reliability. On the other hand, reliability depends on (i) the mutual compatibility of the various parts with respect to the desired functionality, and (ii) the designs and materials from the standpoint of long-term repeatability and performance accuracy. Reliability testing provides techniques for compensation, and an understanding of the catastrophic failure mechanisms in microsystems. It is imperative that the successful design and realization of microsystems or MEMS products must include all levels of packaging and reliability issues from the onset of the project. Although, such a holistic top-down approach poses formidable technical challenges, the problem can be simplified by using the rapidly evolving MEMS infrastructure in the areas of materials, fabrication and design. This paper will discuss, overall MEMS reliability issues and present results on reliability testing of micromachined capacitive pressure sensors for high vacuum and biomedical applications currently being commercialized at Integrated Sensing Systems Inc.
C1 Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
RP Tadigadapa, S (reprint author), Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
OI Tadigadapa, Srinivas/0000-0002-8700-2476
CR Adams A. C., 1983, VLSI technology, P93
   BART S, 1995, IEEE INT REL PHYS P, P311
   BRATTER RL, 2000, IEEE INT C OPT MEMS, P29
   BROWN S, 1996, IEEE DESIGN TEST WIN, P9
   BROWN SB, 1997, P INT SOL STAT SENS, P591
   DELAMBILLY H, 1996, P SENS EXP, P173
   Douglass M.R., 1998, P 36 ANN INT REL PHY, P9
   Dyrbye K, 1996, J MICROMECH MICROENG, V6, P187, DOI 10.1088/0960-1317/6/1/038
   EDELL D, COMMUNICATION
   French PJ, 1998, J MICROMECH MICROENG, V8, P45, DOI 10.1088/0960-1317/8/2/002
   GIANCHANDANI YB, 1995, P TRANSD 95 EUR STOC, V9, P79
   HARTZELL A, 1999, 37 INT REL PHYS S IR, P202
   HILTMANN KM, 1997, P IEEE INT C SOL STA, P1157
   Kazinczi R, 1999, P SOC PHOTO-OPT INS, V3875, P174, DOI 10.1117/12.360469
   KOVACS GTA, 1998, MICROMACHINES TRANSD
   Maboudian R, 1997, J VAC SCI TECHNOL B, V15, P1, DOI 10.1116/1.589247
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   MALLON J, 1988, 3 IEEE SOL STAT SENS, P123
   MARXER C, 1998, SENSOR ACTUAT A-PHYS, V71, P153
   MILLER SL, 1995, IEEE INT RELIABILITY, P311
   MONK DJ, 1996, P SOL STAT SENS ACT
   NAGEL DJ, 1998, ADV PACKAGING    MAR
   NAJAFI K, 1985, IEEE T ELECTRON DEV, V32, P1206, DOI 10.1109/T-ED.1985.22102
   Patton S.T., 1999, P IEEE 37 ANN INT RE, P179
   Ramesham R, 2000, P ELECTR C, P666, DOI 10.1109/ECTC.2000.853230
   RISTIC L, 1994, SENSOR TECHNOLOGY DE
   ROMIG AD, 1997, MICROELECTRON RELIAB, V37, P10
   SENTURIA SD, 1988, SENSOR ACTUATOR, V15, P221, DOI 10.1016/0250-6874(88)87012-4
   Tadigadapa S., 1999, Proceedings SENSORS EXPO Baltimore, P389
   TADIGADAPA S, 2000, GOMAC 2000 C AN CA M
   Tanner D.M., 2000, P 22 INT C MICR NIS, V1, P97
   Tanner D. M., 2000, 38 ANN INT REL PHYS, P139
   YU HG, 2001, P SPIE S MICR MICR S
   ZHANG Y, 1995, P TRANSD 95 EUR STOC, V9, P608
NR 34
TC 14
Z9 17
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4286-0
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4558
BP 197
EP 205
DI 10.1117/12.443002
PG 9
WC Materials Science, Characterization & Testing
SC Materials Science
GA BT48E
UT WOS:000173103600024
DA 2018-10-20
ER

PT S
AU Nicolau, DV
   Cross, R
   Taguchi, T
AF Nicolau, DV
   Cross, R
   Taguchi, T
BE Wilson, AR
   Asanuma, H
TI Protein and cell patterning using bilayer lithography and confocal
   microscopy
SO SMART MATERIALS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Symposium on Smart Materials and MEMS
CY DEC 13-15, 2000
CL MELBOURNE, AUSTRALIA
SP SPIE, Dept Def, Australia, Def Sci & Technol Org, State Govt Victoria, Australia, Victorian Dept State & Reg Dev, Swinburne Univ Technol
DE protein immobilization; confocal microscopy; biosensors; cellular
   engineering
AB Protein patterns were printed using conventional microlithographic materials in a bilayer arrangement and unconventional exposure tools. The bilayer resist stack consists of a bottom Poly(tertButylMethAcrylate) layer and a top DNQ/novolak layer. The protein features were printed in "step & repeat" mode, that is a flow-cell, "real-time" process, as follows: (i) the exposure step is carried out by the focused beam of a confocal microscope tuned to 488nm wavelength; (ii) the development step is performed flowing the photoresist developer through the cell; (iii) the selective deposition of the protein (a green fluorescent protein, FITC avidin for visualisation) is achieved via the flow of the protein solution through the cell until a desired contrast has been reached; (iv) the control step consists of an on-line monitoring of the red fluorescence for the control of the development of the top layer, and of the green fluorescence for the control of the protein patterning, respectively. The techniques have of a seamless portability in a biomedical environment, and for "step & repeat" protein patterning the advantage of a high and controllable resolution. The process can be applied for the in-house fabrication of model biomolecular and cellular devices. Examples for the patterning of neuronal cells are also given.
C1 Ind Res Inst Swinburne, Hawthorn, Vic 3122, Australia.
RP Nicolau, DV (reprint author), Ind Res Inst Swinburne, Hawthorn, Vic 3122, Australia.
CR ALLEN RD, 1994, ACS SYM SER, V537, pCH11
   DAMMEL R, 1993, DIAZONAPHTOQUINOE BA
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   GALLOP MA, 1994, J MED CHEM, V37, P1233, DOI 10.1021/jm00035a001
   HATZAKIS M, 1969, J ELECTROCHEM SOC, V116, P1033, DOI 10.1149/1.2412145
   McGall G, 1996, P NATL ACAD SCI USA, V93, P13555, DOI 10.1073/pnas.93.24.13555
   Nicolau DV, 1998, LANGMUIR, V14, P1927, DOI 10.1021/la970802g
   Nicolau DV, 1999, LANGMUIR, V15, P3845, DOI 10.1021/la980914n
   Nicolau DV, 2000, BIOSENS BIOELECTRON, V15, P85, DOI 10.1016/S0956-5663(99)00072-X
NR 9
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-3908-8
J9 P SOC PHOTO-OPT INS
PY 2001
VL 4234
BP 244
EP 248
DI 10.1117/12.424413
PG 5
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing; Optics
SC Materials Science; Optics
GA BS26C
UT WOS:000169262800033
DA 2018-10-20
ER

PT B
AU Niinomi, M
AF Niinomi, M
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Recent biocompatible metallic materials
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
ID MECHANICAL-PROPERTIES; AMORPHOUS-ALLOYS; TITANIUM-ALLOYS; IMPLANT ALLOY;
   CR; MARTENSITE; DESIGN
AB Biocompatible metallic materials are mainly used for replacing failed hard tissue. Main biocompatible metallic materials, that is, metallic biomaterials are stainless steels, Co based alloys, and titanium and its alloys. Recently titanium alloys are getting much attention for biomaterials. The various kinds of new high strength alpha + beta and low modulus beta type titanium alloys composed of non-toxic elements like Nb, Ta, Zr, etc are developed for biomedical applications because of the toxicity of alloying elements and lack of mechanical biocompatibility of conventional titanium alloys like Ti6Al-4V: Recent research and development in the other metallic alloys like stainless steels, Co based alloys etc, will be also discussed.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
RI BAI, JIE/D-7448-2016
CR ALABDULLAT Y, 2000, J JAPAN DENT MAT, V19, P95
   BERLIN RM, 1999, ASTM STP, V1365, P89
   Berry G, 1999, AM SOC TEST MATER, V1365, P11, DOI 10.1520/STP14260S
   BROWN RS, 2000, 6 WORLD BIOM C KAM H, P828
   Doi H, 1998, J JPN SOC DENT MAT D, V17, P247
   Endo K., 1998, ZAIRYO TO KANKYO, V47, P570
   Garcia ADJS, 1999, METALL MATER TRANS A, V30, P1177, DOI 10.1007/s11661-999-0267-6
   Gilbert CJ, 1999, METALL MATER TRANS A, V30, P1739, DOI 10.1007/s11661-999-0173-y
   HANADA S, 1999, FALL M JAP I MET, P299
   Hiromoto S, 1999, J JPN I MET, V63, P352, DOI 10.2320/jinstmet1952.63.3_352
   Huang P, 1999, MATER SCI TECH-LOND, V15, P157, DOI 10.1179/026708399101505699
   IGUCHI Y, 1999, B ISIJ, V4, P9
   KATO S, 1997, J JAPANESE SOC DENT, V16, P45
   KOBAYASHI E, 1995, J J DENT MAT, V14, P321
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   LEMONS JE, 1986, PERSPECTIVES BIOMATE, P1
   MARUYAMA N, 2000, P ANN M JAP SOC MECH, P433
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   NIINOMI M, IN PRESS RES SIGNPOS
   PAN J, 1999, ELECTROCHEMICAL SOC, V9817, P383
   Papakyriacou M, 1999, FATIGUE '99: PROCEEDINGS OF THE SEVENTH INTERNATIONAL FATIGUE CONGRESS, VOLS 1-4, P1789
   PARK JB, 2000, BIOMEDICAL ENG HDB, V1
   SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   Speidel M O, 1992, P HIGH MANG HIGH NIT, P135
   TAKAYA M, 2000, J JAPAN I LIGHT META, V50, P343
   Tandon R, 1999, AM SOC TEST MATER, V1365, P3, DOI 10.1520/STP14259S
   Tesk JA, 1999, AM SOC TEST MATER, V1365, P32, DOI 10.1520/STP14261S
   UGGOWITZER PJ, 1997, ADV POWDER METAL PAR, V3, P18113
   Whitcher FD, 1997, COMPUT STRUCT, V64, P1005, DOI 10.1016/S0045-7949(97)00014-X
   Yamamuro T, 1989, J JPN SOC BIOMATER, V7, P19
   YOKOYAMA K, 2000, 6 WORLD BIOM C T MAY
   ZENBO N, 1999, STENT GRAFTING AORTI, P10
NR 32
TC 12
Z9 12
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 3
EP 14
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700001
DA 2018-10-20
ER

PT B
AU Kuroda, D
   Niinomi, M
   Akahori, T
   Fukui, H
   Suzuki, A
   Hasegawa, J
AF Kuroda, D
   Niinomi, M
   Akahori, T
   Fukui, H
   Suzuki, A
   Hasegawa, J
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Mechanical performance of newly developed beta-type titanium alloy,
   Ti-29Nb-13Ta-4.6Zr, for biomedical applications
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
AB Titanium and its alloys have been used as most attractive bio-compatible metallic materials due to their excellent combination of strength, corrosion resistance and bio-compatibility. beta -type titanium alloy, Ti-29Nb-13Ta-4.6Zr, which composed of non-toxic elements with low modulus of elasticity is newly developed for biomedical applications. Forging, cold rolling and heat treatments were conducted with Ti-29Nb-13Ta-4.6Zr in order to achieve excellent mechanical performance. The tensile tests, fatigue tests, measurements of modulus of elasticity and evaluation of cyto-toxicity were carried out in order to investigate the basic mechanical and biological properties of Ti-29Nb-13Ta-4.6Zr. The balance of strength and ductility, and fatigue ratio of Ti-29Nb-13Ta-4.6Zr are equivalent or greater, and the modulus of elasticity and cyto-toxicity of Ti-29Nb-13Ta-4.6Zr are equivalent or lower comparing with those of conventional biomedical titanium alloys. Newly developed beta -type titanium alloy, Ti-29Nb-13Ta-4.6Zr, is, therefore, judged to be suitable for biomedical applications.
C1 Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
RP Kuroda, D (reprint author), Toyohashi Univ Technol, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
CR Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   KUDO S, 1990, J CERAM SOC JPN, V98, P653
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
NR 4
TC 8
Z9 8
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 99
EP 106
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700011
DA 2018-10-20
ER

PT B
AU Kobayashi, E
   Mochizuki, H
   Doi, H
   Yoneyama, T
   Otsuka, M
   Hamanaka, H
AF Kobayashi, E
   Mochizuki, H
   Doi, H
   Yoneyama, T
   Otsuka, M
   Hamanaka, H
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Mechanical properties of Ti-6Al-7Nb and Ti-5Al-13Ta alloys under
   combined (tensile/torsional) stress
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
AB Evaluation of mechanical properties of biomedical materials in the simulated environment and situation became important. Considering the mechanical situation in the living body as a field under complex stresses, e.g. consisting of tensile and torsional stresses, biomedical materials are required to have sufficient torsional strength together with enough tensile strength. In the present study, mechanical properties of a biomedical Ti-6Al-7Nb alloy and Ti-5Al-13Ta alloy were evaluated by the tensile/torsional test.
   Mechanical properties of the alloys under tensile/torsional stress were evaluated using a multi-axial testing machine. The strength of the alloys under combined stress was estimated by applying of von Mises-type yield condition and effective stress. In the complex stress (tensile/torsional) tests, mechanical properties in tensile direction, such as strength and elongation to rupture, decrease with increasing torsional rate applied. Torsional rate dependence of maximum torsional shear stress is clearly seen. It is considered that it might be caused from sudden decreasing of shear stress by tensile yielding. By applying effective (equivalent) stress of suitable yield condition to the results of tensile and torsional tests, it is considered to be possible to estimate of yield strength of Ti-6Al-7Nb alloy and Ti-5Al-13Ta alloy under the complex stress.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Kobayashi, E (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadi, Tokyo 1010062, Japan.
CR DOI H, 1998, J JAPANESE SOC DENT, V17, P452
   *INT ORG STAND, 1994, 68711 ISO INT ORG ST
   KOBAYASHI E, 1999, J JAPANESE SOC DENT, V18, P359
   KOBAYASHI E, 2000, T 6 WORLD BIOM C MIN, P925
   SOGA Y, 2000, J JAPANESE SOC DENT, V19, P145
   ZARDIACKAS LD, 1991, J BIOMED MATER RES, V25, P281, DOI 10.1002/jbm.820250302
NR 6
TC 1
Z9 1
U1 0
U2 0
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 115
EP 119
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700013
DA 2018-10-20
ER

PT B
AU Al-Watban, AS
AF Al-Watban, AS
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Friction and wear behavior of diamond films compared with bulk diamond
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
ID CARBON-FILMS; DEPOSITION
AB The superior technical properties of bulk diamond in wear-resistant application have driven the expectation that diamond film and diamondlike carbon films (DLC) could posses similar properties. Coated diamond and diamondlike films have great application in biomedical instrumentation sector. They can be used as optical, friction-reducing, corrosion-preventing and wear-resistant coatings. Since the properties of synthesized materials are in large measure determined not only by their compositions, but also by the method of processing and their resultant microstructure, it is of interest to compare the tribological properties of PCD and DLC films with those of natural diamond, Most of the tribological studies have indicated the strong effect of several scales of surface roughness on friction. For example, the sliding friction coefficients of certain PCD surfaces against steel and sapphire can be ten times higher than that of smooth diamond surfaces under similar conditions. The residual stresses on the surface of the coating layer and the integrity between the substrate and the coating have great impact on their wear properties. The purpose of this study is to compare the tribological properties of diamond films with those of bulk diamond.
C1 Riyadh Tech Coll, Riyadh 11593, Saudi Arabia.
RP Al-Watban, AS (reprint author), Riyadh Tech Coll, POB 53699, Riyadh 11593, Saudi Arabia.
CR ALWATBAN AS, 2000, C PROC MAT PROP SAN, V2
   Blau P. J., 1990, MECHANICS COATINGS, P399
   BLAU PJ, 1992, NATO ADV SCI I E-APP, V220, P523
   BOWDEN FP, 1951, PROC R SOC LON SER-A, V208, P444, DOI 10.1098/rspa.1951.0173
   BOWDEN FP, 1958, PROC R SOC LON SER-A, V248, P350, DOI 10.1098/rspa.1958.0248
   BOWDEN FP, 1966, PROC R SOC LON SER-A, V295, P244, DOI 10.1098/rspa.1966.0238
   BOWDEN FP, 1964, FRICTION LUBRICATION, V11, P169
   BOWDEN FP, 1964, FRICTION LUBRICATION, V11, P174
   BRAZA JF, 1992, ENCY MAT SCI ENG S, V3, P1609
   Brookes C. A., 1994, Journal of Hard Materials, V5, P77
   CASEY M, 1973, J PHYS D APPL PHYS, V6, P1772, DOI 10.1088/0022-3727/6/15/303
   DUGGER MT, 1992, ADV TRIBOLOGY
   ENOMOTO Y, 1980, NATURE, V283, P51, DOI 10.1038/283051a0
   GARDOS MK, 1990, MECH COATINGS, P154
   GARDOS MN, 1989, 1 INT S DIAM DIAM LI, P18
   HARKER AB, 1990, R D MAGAZINE     MAR, P84
   HEINZELMANN H, 1989, WEAR, V135, P109, DOI 10.1016/0043-1648(89)90099-9
   JAHANMIR S, 1989, WEAR, V133, P73, DOI 10.1016/0043-1648(89)90114-2
   KOKAKU Y, 1989, J VAC SCI TECHNOL A, V7, P2311, DOI 10.1116/1.575934
   KONIG W, 1993, WEAR, V162, P12, DOI 10.1016/0043-1648(93)90479-6
   MATSUMOTO S, MAT SCI LETT, V4, P600
   MEMMING R, 1986, THIN SOLID FILMS, V143, P31, DOI 10.1016/0040-6090(86)90144-6
   MIYOSHI K, 1980, APPL SURF SCI, V6, P161, DOI 10.1016/0378-5963(80)90142-7
   OKADA K, 1989, J VAC SCI TECHNOL A, V7, P132, DOI 10.1116/1.575741
   RUDDER RA, 1992, MATER RES SOC SYMP P, V242, P23, DOI 10.1557/PROC-242-23
   SAMUELS B, 1988, J MATER SCI, V23, P2846, DOI 10.1007/BF00547459
   SATO Y, 1992, PROPERTIES NATURAL S
   SPITSYN BV, 1981, J CRYST GROWTH, V52, P219, DOI 10.1016/0022-0248(81)90197-4
   TABOR D, 1979, PROPERTIES DIAMOND, P547
   TSAI HC, 1987, J VAC SCI TECHNOL A, V5, P3287, DOI 10.1116/1.574188
   WONG MS, 1989, MATER RES SOC S P, V140, P483
   1991, MAT ALERT        JUN, P5
NR 32
TC 0
Z9 0
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 181
EP 191
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700021
DA 2018-10-20
ER

PT B
AU Leng, Y
   Zhang, C
AF Leng, Y
   Zhang, C
BE Niinomi, M
   Okabe, T
   Taleff, EM
   Lesuer, DR
   Lippard, HE
TI Mechanical integrity of hydroxyapatite coatings on titanium implants
SO STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY
LA English
DT Proceedings Paper
CT Symposium on Structural Biomaterials for the 21st Century
CY FEB 11-12, 2001
CL NEW ORLEANS, LA
SP SMD, Struct Mat & Titanium Comm, ASM, MSCTS, Corros & Environm Effects Comm
ID STABILITY
AB Hydroxyapatite (I-IA) coated Ti alloy is a promising material for biomedical implants. The successful applications of such implants rely on fundamental understandings of mechanical behavior of the HA coatings, particularly, the fatigue resistance. In this work the mechanical stability of IFA coatings under cyclic loading was systematically investigated using four-point bending tests and the indentation tests in both air and simulated body fluid (SBF). Also, a shear cyclic test was developed for the coatings, considering the coatings of implants often failure under shearing loading in human body. Experiments revealed the conventional cyclic bending tests could not effectively evaluate the fatigue resistance of the HA coatings on Ti substrates. The contact fatigue under indentation might represent the worst service conditions of coatings. The cyclic indentation revealed that the fatigue damages in the HA coatings were severer in SBF than in air, and thin HA coatings exhibited less fatigue damages than the thick ones. The newly developed shear test for the coatings successfully generated similar shear loading as the conventional ones, however it is easier for alignment and for adapting coating thickness variation. Using the new method, the coating resistance to cyclic shear loading was evaluated with S-N curves. Also the tests revealed the existence of threshold stress which was required to generate fatigue damages in the coating.
C1 Hong Kong Univ Sci & Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
RP Leng, Y (reprint author), Hong Kong Univ Sci & Technol, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
CR KUMMER FJ, 1992, J APPL BIOMATER, V3, P211, DOI 10.1002/jab.770030308
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   MANELY MT, 1987, CLIN ORTHOP RELAT R, V157, P293
   Reis RL, 1996, J MATER SCI-MATER M, V7, P407, DOI 10.1007/BF00122009
   REIS RL, 1994, J MATER SCI-MATER M, V5, P457, DOI 10.1007/BF00058983
   ZHANG C, 2000, THESIS HONG KONG U S, P99
NR 6
TC 0
Z9 0
U1 0
U2 1
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-487-9
PY 2001
BP 221
EP 228
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA BS16A
UT WOS:000168874700025
DA 2018-10-20
ER

PT S
AU Erdemir, A
AF Erdemir, A
BE Meng, WJ
   Kumar, A
   Doll, GL
   Cheng, YT
   Veprek, S
   Chung, YW
TI Superlubricity and wearless sliding in diamondlike carbon films
SO SURFACE ENGINEERING 2001 - FUNDAMENTALS AND APPLICATIONS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Advances in Surface Engineering - Fundamentals and
   Applications held at the 2001 MRS Fall Meeting
CY NOV 26-29, 2001
CL BOSTON, MA
SP Mat Res Soc
ID TRIBOLOGICAL PROPERTIES; SUPERLOW FRICTION; COATINGS; PERFORMANCE;
   ENVIRONMENT; BEHAVIOR
AB Diamondlike carbon (DLC) films have attracted great interest in recent years mainly because of their unusual optical, electrical, mechanical, and tribological properties. Such properties are currently being exploited for a wide range of engineering applications including magnetic hard disks, gears, sliding and roller bearings, scratch resistant glasses, biomedical implants, etc. Systematic studies on carbon-based materials in our laboratory have led to the development of a new class of amorphous DLC films that provide extremely low friction and wear coefficients of 0.001 to 0.005 and 10(-11) to 10(-10) mn(3)/N.m, respectively, when tested in inert-g as or high-vacuum environments. These films were produced in highly hydrogenated gas discharge plasmas by a plasma enhanced chemical vapor deposition process at room temperature. The carbon source gases used in the deposition of these films included methane, acetylene, and ethylene. Tribological studies in our laboratory have established a very close correlation between the composition of the plasmas and the friction and wear coefficients of the resultant DLC films. Specifically, the friction and wear coefficients of DLC films grown in plasmas with higher hydrogen-to-carbon ratios were much lower than films derived from source gases with lower hydrogento-carbon ratios. Fundamental tribological and surface analytical studies have led us to conclude that hydrogen (within the film, as well as on the sliding surfaces) is extremely important for the superlubricity and wearless sliding behavior of these films. Based on these studies, a mechanistic model is proposed to explain the superlow friction and wear properties of the new DLC films.
C1 Argonne Natl Lab, Div Energy Technol, Argonne, IL 60439 USA.
RP Erdemir, A (reprint author), Argonne Natl Lab, Div Energy Technol, 9700 S Cass Ave, Argonne, IL 60439 USA.
RI Erdemir, Ali/P-7643-2018
OI Erdemir, Ali/0000-0002-6489-9620
CR BHUSHAN B, 1993, APPL PHYS LETT, V62, P3253, DOI 10.1063/1.109090
   BOWDEN FP, 1951, PROC R SOC LON SER-A, V208, P444, DOI 10.1098/rspa.1951.0173
   CHANDRASEKAR S, 1992, WEAR, V153, P79, DOI 10.1016/0043-1648(92)90262-7
   DONNET C, 1994, SURF COAT TECH, V68, P626, DOI 10.1016/0257-8972(94)90228-3
   Donnet C, 1997, SURF COAT TECH, V94-5, P456, DOI 10.1016/S0257-8972(97)00275-2
   DUGGER MT, 1992, ACS SYM SER, V485, P72
   ERDEMIR A, 1991, SURF COAT TECH, V50, P17, DOI 10.1016/0257-8972(91)90187-2
   Erdemir A, 1996, TRIBOL T, V39, P735, DOI 10.1080/10402009608983591
   Erdemir A, 2000, DIAM RELAT MATER, V9, P632, DOI 10.1016/S0925-9635(99)00361-1
   Erdemir A, 2000, J VAC SCI TECHNOL A, V18, P1987, DOI 10.1116/1.582459
   Erdemir A, 1997, SURF COAT TECH, V94-5, P537, DOI 10.1016/S0257-8972(97)00496-9
   ERDEMIR A, 2000, MODERN TRIBOLOGY HDB, P871
   ERDEMIR A, 2001, P 44 ANN M SOC VAC C, P397
   ERDEMIR A, 1999, SURF COAT TECH, V121, P565
   ERDEMIR A, 1999, SURF COAT TECH, V121, P589
   ERDEMIR A, 1993, DIAM RELAT MATER, V3, P119
   ERDEMIR A, 2001, Patent No. 6255234
   Ersoy DA, 2000, TRIBOL T, V43, P809, DOI 10.1080/10402000008982412
   Falvo MR, 1999, NATURE, V397, P236
   FUSARO RL, 1970, ASLE TRANS, V13, P56
   GARDOS MN, 1990, J MATER RES, V5, P2599, DOI 10.1557/JMR.1990.2599
   Gardos MN, 1999, SURF COAT TECH, V113, P183, DOI 10.1016/S0257-8972(98)00842-1
   GUPTA BK, 1994, J TRIBOL-T ASME, V116, P445, DOI 10.1115/1.2928862
   HAYWARD IP, 1992, WEAR, V157, P215, DOI 10.1016/0043-1648(92)90063-E
   Heimberg JA, 2001, APPL PHYS LETT, V78, P2449, DOI 10.1063/1.1366649
   KIM DS, 1991, SURF COAT TECH, V49, P537, DOI 10.1016/0257-8972(91)90113-B
   Liu Y, 1996, SURF COAT TECH, V82, P48, DOI 10.1016/0257-8972(95)02623-1
   Liu Y, 1997, SURF COAT TECH, V94-5, P463, DOI 10.1016/S0257-8972(97)00450-7
   MIYOSHI K, 1993, J APPL PHYS, V74, P4446, DOI 10.1063/1.354386
   MIYOSHI K, 1989, MATER SCI FORUM, V52, P645
   Olsen JE, 1996, WEAR, V200, P233, DOI 10.1016/S0043-1648(96)07295-X
   RONKAINEN H, 1994, DIAM RELAT MATER, V3, P1329, DOI 10.1016/0925-9635(94)90147-3
   SAVAGE RH, 1948, J APPL PHYS, V19, P1, DOI 10.1063/1.1697867
   TABOR D, 1979, PROPERTIES DIAMOND, P325
NR 34
TC 1
Z9 1
U1 0
U2 5
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-633-8
J9 MATER RES SOC SYMP P
PY 2001
VL 697
BP 391
EP 403
PG 13
WC Materials Science, Coatings & Films
SC Materials Science
GA BV23W
UT WOS:000178303600059
DA 2018-10-20
ER

PT J
AU Jones, FH
AF Jones, FH
TI Teeth and bones: applications of surface science to dental materials and
   related biomaterials
SO SURFACE SCIENCE REPORTS
LA English
DT Review
ID X-RAY PHOTOELECTRON; SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY;
   SCANNING-TUNNELING-MICROSCOPY; ION MASS-SPECTROMETRY; OSTEOBLAST-LIKE
   CELLS; LASER-DESORPTION IONIZATION; CALCIUM-PHOSPHATE COATINGS; BOVINE
   SERUM-ALBUMIN; PHOTON-STIMULATED DESORPTION
AB Recent years have seen a considerable upsurge in publications concerning the surface structure and chemistry of materials with biological or biomedical applications. Within the body, gas-solid interactions become relatively less significant and solid-liquid or solid-solid interfaces dominate, providing new challenges for the surface scientist. The current paper aims to provide a timely review of the use of surface analysis and modification techniques within the biomaterials field. A broad overview of applications in a number of related areas is given with particular attention focusing on those materials commonly encountered in dentistry and oral or maxillofacial implantology. Several specific issues of current interest are discussed. The interaction between synthetic and natural solids, both in the oral environment and elsewhere in the body is important in terms of adhesion, related stresses and strains and ultimately the longevity of a dental restoration, biomedical implant, or indeed the surrounding tissue. Exposure to body fluids, of course, can also affect stability, leading to the degradation or corrosion of materials within the body. Whilst this could potentially be harmful, e.g., if cytotoxic elements are released, it may alternatively provide a route to the preferential release of beneficial substances. Furthermore, in some cases, the controlled disintegration of a biomaterial is desirable, allowing the removal of an implant, e.g., without the need for further surgery, The presence of cells in the immediate bioenvironment additionally complicates the situation. A considerable amount of current research activity is targeted at the development of coatings or surface treatments to encourage tissue growth. Lf this is to be achieved by stimulating enhanced cell productivity, determination of the relationship between cell function and surface composition is essential. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 UCL, Dept Biomat, Eastman Dent Inst Oral Hlth Care Sci, London WC1X 8LD, England.
RP Jones, FH (reprint author), UCL, Dept Biomat, Eastman Dent Inst Oral Hlth Care Sci, 256 Grays Inn Rd, London WC1X 8LD, England.
EM f.jones@eastman.ucl.ac.uk
CR ABBOTT NL, 1994, CHEM MATER, V6, P596, DOI 10.1021/cm00041a007
   ABIKO Y, 1993, CELL MATER, V3, P161
   Abrahams I, 1997, J MATER CHEM, V7, P1573, DOI 10.1039/a608325k
   Adler HJ, 1999, ACTA POLYM, V50, P232, DOI 10.1002/(SICI)1521-4044(19990701)50:7<232::AID-APOL232>3.3.CO;2-4
   ADURU S, 1987, LANGMUIR, V3, P543, DOI 10.1021/la00076a017
   Afanasyeva NI, 1999, SURF INTERFACE ANAL, V27, P204, DOI 10.1002/(SICI)1096-9918(199904)27:4<204::AID-SIA545>3.0.CO;2-U
   ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   ALBREKTSSON T, 1991, ACTA ORTHOP SCAND, V17, P132
   ALBREKTSSON T, 1982, CLIN APPL BIOMATERIA
   ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8
   Allen GC, 1996, NUCL INSTRUM METH B, V116, P457, DOI 10.1016/0168-583X(96)00088-2
   Allen S, 1997, TRENDS BIOTECHNOL, V15, P101, DOI 10.1016/S0167-7799(97)01015-9
   Alonso F, 1997, SURF COAT TECH, V93, P305, DOI 10.1016/S0257-8972(97)00065-0
   *AM SOC TEST MAT, 1991, SURF INTERFACE ANAL, V17, P893
   Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   AMEEN AP, 1993, CLIN ORAL IMPLAN RES, V4, P144, DOI 10.1034/j.1600-0501.1993.040305.x
   Ameen AP, 1996, J MATER SCI-MATER M, V7, P195, DOI 10.1007/BF00119730
   AMRAHBOUALI S, 1994, BIOMATERIALS, V15, P269, DOI 10.1016/0142-9612(94)90050-7
   An YH, 1995, J MICROBIOL METH, V24, P29, DOI 10.1016/0167-7012(95)00051-8
   ANDRADE JD, 1985, PROTEIN ADSORPTION S, V2
   Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Antonov EN, 1997, BIOMATERIALS, V18, P1043, DOI 10.1016/S0142-9612(97)00030-6
   ANUSAVICE KJ, 1996, PHILLIPS SCI DENTAL
   AOBA T, 1991, ACS SYM SER, V444, P85
   APARICIO C, 1992, International Journal of Oral and Maxillofacial Implants, V7, P94
   ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3
   ARENDS J, 1985, CARIES RES, V19, P450, DOI 10.1159/000260880
   Armstrong SR, 1998, DENT MATER, V14, P91, DOI 10.1016/S0109-5641(98)00014-1
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   ARSOV L, 1975, VIDE A, V30, P114
   Arwin H, 1998, THIN SOLID FILMS, V313, P764, DOI 10.1016/S0040-6090(97)00993-0
   Arys A, 1998, J BIOMED MATER RES, V43, P300, DOI 10.1002/(SICI)1097-4636(199823)43:3<300::AID-JBM11>3.0.CO;2-J
   Ashino M, 2000, PHYS REV B, V61, P13955, DOI 10.1103/PhysRevB.61.13955
   ASMUSSEN E, 1987, J DENT RES, V66, P1386, DOI 10.1177/00220345870660082001
   ATANASOSKA LL, 1978, SURF SCI, V72, P189, DOI 10.1016/0039-6028(78)90388-6
   AVERY JK, 1994, ORAL DEV HISTOLOGY
   Azoulay A, 1997, SURF SCI, V370, P1, DOI 10.1016/S0039-6028(96)00927-2
   Azoulay A, 1999, SURF SCI, V422, P141, DOI 10.1016/S0039-6028(98)00923-6
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   BACKMAN B, 1993, ACTA ODONTOL SCAND, V51, P79, DOI 10.3109/00016359309041152
   BADDILEY J, 1973, NATURE, V243, P43, DOI 10.1038/243043a0
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   BAKKE R, 1990, BIOFILMS
   BALL V, 1994, P NATL ACAD SCI USA, V91, P7330, DOI 10.1073/pnas.91.15.7330
   Ball V, 1996, LANGMUIR, V12, P1614, DOI 10.1021/la950735v
   Balooch M, 1998, J BIOMED MATER RES, V40, P539, DOI 10.1002/(SICI)1097-4636(19980615)40:4<539::AID-JBM4>3.3.CO;2-O
   Bar G, 1996, J VAC SCI TECHNOL A, V14, P1794, DOI 10.1116/1.580338
   Bar G, 1997, LANGMUIR, V13, P373, DOI 10.1021/la960935m
   Baranauskas V, 1998, APPL BIOCHEM BIOTECH, V69, P91, DOI 10.1007/BF02919391
   Barlow SM, 1998, SURF SCI, V401, P322, DOI 10.1016/S0039-6028(97)01086-8
   BARO AM, 1986, BIOMATERIALS, V7, P463, DOI 10.1016/0142-9612(86)90036-0
   Barron AE, 1999, CURR OPIN CHEM BIOL, V3, P681, DOI 10.1016/S1367-5931(99)00026-5
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Bartzoka V, 1998, LANGMUIR, V14, P1892, DOI 10.1021/la9711138
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   Bates SP, 1998, SURF SCI, V409, P336, DOI 10.1016/S0039-6028(98)00278-7
   Baty AM, 1997, LANGMUIR, V13, P5702, DOI 10.1021/la9610720
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Beech IB, 1999, J MICROBIOL METH, V36, P3, DOI 10.1016/S0167-7012(99)00005-6
   Behm JM, 1996, LANGMUIR, V12, P2121, DOI 10.1021/la950811u
   BennaniZiatni M, 1997, ANN CHIM-SCI MAT, V22, P537
   Bennett RA, 1999, FARADAY DISCUSS, V114, P267, DOI 10.1039/a903731d
   Bennett RA, 1999, PHYS REV LETT, V82, P3831, DOI 10.1103/PhysRevLett.82.3831
   Bennett RA, 1999, PHYS REV B, V59, P10341, DOI 10.1103/PhysRevB.59.10341
   Bentaleb A, 1998, J BIOMED MATER RES, V40, P449, DOI 10.1002/(SICI)1097-4636(19980605)40:3<449::AID-JBM16>3.0.CO;2-E
   Bentaleb A, 1997, LANGMUIR, V13, P729, DOI 10.1021/la9605192
   BERGER H, 1993, J CRYST GROWTH, V130, P108, DOI 10.1016/0022-0248(93)90842-K
   BERNDT R, 1994, SURF SCI, V310, P85, DOI 10.1016/0039-6028(94)91373-0
   BERTEL E, 1984, SURF SCI, V141, P355, DOI 10.1016/0039-6028(84)90137-7
   BERUBE YG, 1968, J COLLOID INTERF SCI, V27, P305, DOI 10.1016/0021-9797(68)90038-6
   BESSHO K, 1995, J BIOMED MATER RES, V29, P901, DOI 10.1002/jbm.820290716
   BETON PH, 1995, APPL PHYS LETT, V67, P1075, DOI 10.1063/1.114469
   BETT JAS, 1967, J AM CHEM SOC, V89, P5535, DOI 10.1021/ja00998a003
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   BIERBAUM K, 1995, LANGMUIR, V11, P512, DOI 10.1021/la00002a025
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNIG G, 1983, PHYS REV LETT, V50, P120, DOI 10.1103/PhysRevLett.50.120
   BIWER BM, 1986, SURF SCI, V167, P207, DOI 10.1016/0039-6028(86)90795-8
   BLAISE G, 1978, SURF SCI, V71, P630
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Blomberg E, 1998, BIOMATERIALS, V19, P371, DOI 10.1016/S0142-9612(97)00114-2
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   Bohm I, 1999, APPL SURF SCI, V141, P237, DOI 10.1016/S0169-4332(98)00510-8
   BOLAND T, 1995, P NATL ACAD SCI USA, V92, P5297, DOI 10.1073/pnas.92.12.5297
   BONNELL DA, 2000, SCANNING TUNNELING M
   Booth NA, 1998, SURF SCI, V397, P258, DOI 10.1016/S0039-6028(97)00742-5
   Born R, 1998, FRESEN J ANAL CHEM, V361, P697, DOI 10.1007/s002160050997
   BOSKEY AL, 1976, J PHYS CHEM-US, V80, P40, DOI 10.1021/j100542a009
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   BotteroCornillac MJ, 1995, SCANNING MICROSCOPY, V9, P1179
   Bowen WH, 1993, CARIOLOGY 90S
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1995, CELL MATER, V5, P323
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyde A, 1997, CIBA F SYMP, V205, P18
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BREARLEY W, 1977, SURF SCI, V64, P372, DOI 10.1016/0039-6028(77)90284-9
   BREDOW T, 1995, SURF SCI, V327, P398, DOI 10.1016/0039-6028(94)00851-5
   Briggs D., 1992, PRACTICAL SURFACE AN, V2
   Briggs D., 1990, PRACTICAL SURFACE AN, V1
   BRINK C, 1992, COLLOID SURFACE, V66, P149, DOI 10.1016/0166-6622(92)80131-K
   Brinkley D, 1998, SURF SCI, V395, P292, DOI 10.1016/S0039-6028(97)00633-X
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Brown WA, 2000, J PHYS CHEM B, V104, P2578, DOI 10.1021/jp9930907
   BRUGNIAU D, 1984, SURF SCI, V141, P639, DOI 10.1016/0039-6028(84)90154-7
   BRUNER RJ, 1993, T SOC BIOMATER, V16, P219
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   BUCHS J, 1988, APPL MICROBIOL BIOT, V29, P119
   BUMGARDNER JD, 1993, DENT MATER, V9, P252, DOI 10.1016/0109-5641(93)90070-7
   BUMGARDNER JD, 1994, J APPL BIOMATER, V5, P203, DOI 10.1002/jab.770050305
   BURR DB, 1993, J BIOMED MATER RES, V27, P645, DOI 10.1002/jbm.820270512
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   BUSSCHER HJ, 1990, SURF INTERFACE ANAL, V15, P344, DOI 10.1002/sia.740150508
   BUSTILLO FJ, 1989, VACUUM, V39, P659, DOI 10.1016/0042-207X(89)90010-9
   BUSTILLO FJ, 1990, VACUUM, V41, P19, DOI 10.1016/0042-207X(90)90258-Z
   Campbell AA, 1996, J BIOMED MATER RES, V32, P111, DOI 10.1002/(SICI)1097-4636(199609)32:1<111::AID-JBM13>3.0.CO;2-P
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   CARLEY AF, 1987, J CHEM SOC FARAD T 1, V83, P351, DOI 10.1039/f19878300351
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   CASSINELLI C, 1994, J MATER SCI-MATER M, V5, P606, DOI 10.1007/BF00120339
   CASSINELLI C, 1994, J BIOMED MATER RES, V28, P1427, DOI 10.1002/jbm.820281207
   CHANDER S, 1985, COLLOID SURFACE, V13, P137
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Chandra S, 2000, ANAL CHEM, V72, p104A, DOI 10.1021/ac002716i
   Characklis W. G., 1990, BIOFILMS
   Charlton G, 1997, PHYS REV LETT, V78, P495, DOI 10.1103/PhysRevLett.78.495
   Chauvy PF, 1998, SURF COAT TECH, V110, P48, DOI 10.1016/S0257-8972(98)00608-2
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Chehroudi B, 1995, CELL MATER, V5, P334
   CHEN CJ, 1993, OXFORD SERIES OPTICA, V4
   CHEN O, 1999, PHYS CHEM COMMUN, V9
   CHEN S, 1993, J VAC SCI TECHNOL A, V11, P2419, DOI 10.1116/1.578587
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   CHERNOFF EAG, 1992, J VAC SCI TECHNOL A, V10, P596, DOI 10.1116/1.577736
   CHIEGO DJ, 1994, ORAL DEV HISTOLOGY
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CHOW LC, 1988, J DENT RES, V67, P1058, DOI 10.1177/00220345880670070901
   CHRISTENSEN BE, 1990, BIOFILMS
   Chusuei CC, 1999, ANAL CHEM, V71, P149, DOI 10.1021/ac9806963
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Clasen ABS, 1997, ACTA ODONTOL SCAND, V55, P339
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   COLBOURN EA, 1992, SURF SCI REP, V15, P281, DOI 10.1016/0167-5729(92)90013-2
   Colliver TL, 1997, ANAL CHEM, V69, P2225, DOI 10.1021/ac9701748
   Combe E C, 1999, DENTAL BIOMATERIALS
   Combes C, 1999, J MATER SCI-MATER M, V10, P231, DOI 10.1023/A:1008922029096
   Combes C, 1995, J MATER SCI-MATER M, V6, P699, DOI 10.1007/BF00134304
   Combes C, 1998, COLLOID SURFACE B, V11, P15, DOI 10.1016/S0927-7765(98)00014-9
   Conesa JC, 2000, RES CHEM INTERMEDIAT, V26, P103, DOI 10.1163/156856700X00138
   Connor PA, 1999, LANGMUIR, V15, P2402, DOI 10.1021/la980855d
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   Cooper E, 1997, J MATER CHEM, V7, P435, DOI 10.1039/a607204f
   Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37
   CORBRIDGE DEC, 1990, STUDIES INORGANIC CH, V10
   CORNELL RM, 1975, J COLLOID INTERF SCI, V53, P6, DOI 10.1016/0021-9797(75)90028-4
   CORPRON RE, 1992, J DENT RES, V71, P828, DOI 10.1177/002203459207100S07
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86
   COWLEY JM, 1995, HDB SURFACE IMAGING, P148
   CULLEN DC, 1994, J COLLOID INTERF SCI, V166, P102, DOI 10.1006/jcis.1994.1276
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   CUTRESS TW, 1972, ARCH ORAL BIOL, V17, P93, DOI 10.1016/0003-9969(72)90137-9
   Czajkowsky DM, 2000, J ELECTRON MICROSC, V49, P395, DOI 10.1093/oxfordjournals.jmicro.a023821
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   deBeer D, 1995, WATER SCI TECHNOL, V32, P11, DOI 10.1016/0273-1223(96)00002-9
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   DELAMAR M, 1990, J ELECTRON SPECTROSC, V53, pC11, DOI 10.1016/0368-2048(90)80335-8
   DELMAESTRO RF, 1980, ACTA PHYSIOL SCAND, P153
   DENBESTEN PK, 1986, J DENT RES, V65, P1272, DOI 10.1177/00220345860650101401
   DENGIS PB, 1995, COLLOID SURFACE B, V4, P199, DOI 10.1016/0927-7765(94)01171-Z
   Dengis PB, 1996, J MICROBIOL METH, V26, P171, DOI 10.1016/0167-7012(96)00909-8
   Dengis PB, 1997, YEAST, V13, P931, DOI 10.1002/(SICI)1097-0061(199708)13:10<931::AID-YEA149>3.0.CO;2-T
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   Diebold U, 1998, SURF SCI, V411, P137, DOI 10.1016/S0039-6028(98)00356-2
   Diebold U, 1996, PHYS REV LETT, V77, P1322, DOI 10.1103/PhysRevLett.77.1322
   DIEBOLD U, 2000, COMMUNICATION
   Dieluweit S, 1998, SUPRAMOL SCI, V5, P15, DOI 10.1016/S0968-5677(97)00073-4
   DMYTRYK JJ, 1990, J PERIODONTOL, V61, P491, DOI 10.1902/jop.1990.61.8.491
   do Serro APVA, 1997, COLLOID SURFACE B, V10, P95, DOI 10.1016/S0927-7765(97)00060-X
   Dombrowski KE, 1996, FASEB J, V10, P2854
   Dorozhkin SV, 1997, J CRYST GROWTH, V182, P125, DOI 10.1016/S0022-0248(97)00330-8
   Dorozhkin SV, 1997, J CRYST GROWTH, V182, P133, DOI 10.1016/S0022-0248(97)00331-X
   Dorozhkin SV, 1997, J COLLOID INTERF SCI, V191, P489, DOI 10.1006/jcis.1997.4942
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   DUCKWORTH RM, 1992, J DENT RES, V71, P934, DOI 10.1177/002203459207100S29
   Dufrene YF, 1996, COLLOID SURFACE B, V7, P271, DOI 10.1016/0927-7765(96)01295-7
   Dufrene YF, 1996, CAN J MICROBIOL, V42, P548, DOI 10.1139/m96-074
   Dufrene YF, 1997, J BACTERIOL, V179, P1023, DOI 10.1128/jb.179.4.1023-1028.1997
   Dufrene YF, 1996, BIOFOULING, V9, P307, DOI 10.1080/08927019609378312
   Dunn AW, 1996, J VAC SCI TECHNOL B, V14, P1596, DOI 10.1116/1.589197
   DUNN GA, 1986, J CELL SCI, V83, P313
   Dupraz AMP, 1996, J BIOMED MATER RES, V30, P231, DOI 10.1002/(SICI)1097-4636(199602)30:2<231::AID-JBM13>3.0.CO;2-P
   DURINCK G, 1991, SOLID STATE COMMUN, V80, P579, DOI 10.1016/0038-1098(91)90155-O
   Eck W, 2000, ADV MATER, V12, P805, DOI 10.1002/(SICI)1521-4095(200006)12:11<805::AID-ADMA805>3.3.CO;2-S
   EDGAR WM, 1990, SALIVA ORAL HLTH
   EFFAH EAB, 1995, J BIOMED MATER RES, V29, P73, DOI 10.1002/jbm.820290111
   Egdell RG, 1998, J MATER CHEM, V8, P469, DOI 10.1039/a706191i
   Eick J D, 1993, Quintessence Int, V24, P632
   Eick JD, 1997, CRIT REV ORAL BIOL M, V8, P306, DOI 10.1177/10454411970080030501
   Eick JD, 1996, J DENT RES, V75, P1027, DOI 10.1177/00220345960750040501
   EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0
   EIKENBERRY EF, 1980, J MOL BIOL, V144, P397, DOI 10.1016/0022-2836(80)90098-4
   Einstein A, 1905, ANN PHYS-BERLIN, V17, P132
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   EJOV AA, 1994, J VAC SCI TECHNOL B, V12, P1547, DOI 10.1116/1.587283
   Ektessabi AM, 1996, NUCL INSTRUM METH B, V109, P278, DOI 10.1016/0168-583X(95)00922-1
   EKTESSABI AM, 1994, INT J PIXE, V4, P81
   El Feninat F, 1998, J BIOMED MATER RES, V42, P549, DOI 10.1002/(SICI)1097-4636(19981215)42:4<549::AID-JBM10>3.0.CO;2-L
   ELDER B, 1993, CARIOLOGY 90S
   Eley BM, 1997, BRIT DENT J, V183, P11, DOI 10.1038/sj.bdj.4809419
   Elftonson JE, 1996, J ADHES SCI TECHNOL, V10, P761, DOI 10.1163/156856196X00643
   Eliades G, 1997, DENT MATER, V13, P24, DOI 10.1016/S0109-5641(97)80005-X
   Eliades T, 1997, INT J ORAL MAX IMPL, V12, P621
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Elliott JC, 1997, CIBA F SYMP, V205, P54
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   EMSLEY J, 1976, CHEM PHOSPHOROUS ENV
   ERIKSEN S, 1987, SPECTROCHIM ACTA A, V43, P1535, DOI 10.1016/S0584-8539(87)80043-0
   Es-Souni M, 1999, COLLOID POLYM SCI, V277, P382, DOI 10.1007/s003960050396
   Esposito M, 1999, J BIOMED MATER RES, V48, P559, DOI 10.1002/(SICI)1097-4636(1999)48:4<559::AID-JBM23>3.0.CO;2-M
   Evans GT, 1998, J CHEM PHYS, V109, P2519, DOI 10.1063/1.476824
   Evans S, 1997, SURF INTERFACE ANAL, V25, P924, DOI 10.1002/(SICI)1096-9918(199711)25:12<924::AID-SIA317>3.0.CO;2-2
   FAHMI A, 1994, SURF SCI, V304, P343, DOI 10.1016/0039-6028(94)91345-5
   Farina M, 1999, J STRUCT BIOL, V125, P39, DOI 10.1006/jsbi.1998.4069
   FEJERSKOV O, 1996, FLUORIDE DENTISTRY
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Feng QL, 1999, J CRYST GROWTH, V200, P550, DOI 10.1016/S0022-0248(98)01402-X
   Fenter P, 2000, J COLLOID INTERF SCI, V225, P154, DOI 10.1006/jcis.2000.6756
   Fernandes MH, 1999, J BIOMATER APPL, V14, P113, DOI 10.1177/088532829901400202
   FERRER S, 1980, SURF SCI, V94, P41, DOI 10.1016/0039-6028(80)90155-7
   Ferris KF, 1998, J VAC SCI TECHNOL A, V16, P956, DOI 10.1116/1.581219
   Feugeas F, 1997, J PHYS III, V7, P631, DOI 10.1051/jp3:1997147
   FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011
   Fincham AG, 1997, CIBA F SYMP, V205, P118
   Fischer D, 1997, J VAC SCI TECHNOL A, V15, P2173, DOI 10.1116/1.580529
   FISCHER S, 1995, SURF SCI, V337, P17, DOI 10.1016/0039-6028(95)00572-2
   FISHER SJ, 1987, ARCH ORAL BIOL, V32, P509, DOI 10.1016/S0003-9969(87)80013-4
   FITZPATRICK H, 1992, J COLLOID INTERF SCI, V149, P1, DOI 10.1016/0021-9797(92)90384-X
   FLAVELL WR, 1997, SURFACE ANAL PRINCIP, P376
   FLEISCH H, 1981, J CRYST GROWTH, V53, P120, DOI 10.1016/0022-0248(81)90059-2
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FLOWER HM, 1974, ACTA METALL MATER, V22, P1339, DOI 10.1016/0001-6160(74)90034-0
   FOX SC, 1990, J PERIODONTOL, V61, P485, DOI 10.1902/jop.1990.61.8.485
   FRANCIS MD, 1971, CALC TISS RES, V6, P335
   Frauchiger L, 1999, APPL SURF SCI, V143, P67, DOI 10.1016/S0169-4332(98)00932-5
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   FRISBIE CD, 1995, LANGMUIR, V11, P2563, DOI 10.1021/la00007a040
   FRITSCH HW, 1993, INT J MASS SPECTROM, V126, P191, DOI 10.1016/0168-1176(93)80084-R
   Fukui K, 1997, PHYS REV LETT, V79, P4202, DOI 10.1103/PhysRevLett.79.4202
   GABRIEL BL, 1994, BIOMATERIALS, V15, P628, DOI 10.1016/0142-9612(94)90214-3
   GANGLER P, 1993, SCAND J DENT RES, V101, P345
   GARRETT SJ, 1990, J ELECTRON SPECTROSC, V54, P1065, DOI 10.1016/0368-2048(90)80296-M
   GEIGER SB, 1993, DENT MATER, V9, P33, DOI 10.1016/0109-5641(93)90102-V
   Gellings PJ, 2000, CATAL TODAY, V58, P1, DOI 10.1016/S0920-5861(00)00240-6
   GILLEN G, 1994, ANAL CHEM, V66, P2170, DOI 10.1021/ac00085a036
   Gimzewski JK, 1997, SURF SCI, V386, P101, DOI 10.1016/S0039-6028(97)00301-4
   GLIMCHER MJ, TREATISE COLLAGEN B, V2
   GOLANDER CG, 1988, J COLLOID INTERF SCI, V121, P240, DOI 10.1016/0021-9797(88)90428-6
   GOLANDER CG, 1986, COLLOID SURFACE, V21, P149, DOI 10.1016/0166-6622(86)80088-9
   GOLDSTEIN JI, 1994, SCANNING ELECT MICRO
   Goniakowski J, 1996, SURF SCI, V350, P145, DOI 10.1016/0039-6028(95)01252-4
   GONIAKOWSKI J, 1995, SURF SCI, V330, P337, DOI 10.1016/0039-6028(95)00348-7
   GONIAKOWSKI J, 1993, SURF SCI, V284, P315, DOI 10.1016/0039-6028(93)90502-B
   GOODMAN DW, 1994, SURF SCI, V299, P837, DOI 10.1016/0039-6028(94)90701-3
   Gotfredsen K, 1992, Clin Oral Implants Res, V3, P77, DOI 10.1034/j.1600-0501.1992.030205.x
   Gracias DH, 1999, ACCOUNTS CHEM RES, V32, P930, DOI 10.1021/ar990034f
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Greenspan DC, 1999, CURR OPIN SOLID ST M, V4, P389, DOI 10.1016/S1359-0286(99)00021-2
   GRIESSER HJ, 2000, BIOM SURF AN NEW MIL
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Gun'ko VM, 1999, LANGMUIR, V15, P6405, DOI 10.1021/la9809372
   Guo Q, 1996, PHYS REV LETT, V77, P3851, DOI 10.1103/PhysRevLett.77.3851
   GUY SC, 1993, J PERIODONTOL, V64, P542, DOI 10.1902/jop.1993.64.6.542
   GUYOTSIONNEST P, 1987, PHYS REV LETT, V59, P1597, DOI 10.1103/PhysRevLett.59.1597
   Gwinnett A J, 1994, Am J Dent, V7, P144
   Haber J, 1996, ACS SYM SER, V638, P20
   HADJIIVANOV KI, 1996, CHEM SOC REV, V25, P66
   HAHNER G, 1992, J VAC SCI TECHNOL A, V10, P2758
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Hanawa T, 1996, CORROS SCI, V38, P1579, DOI 10.1016/0010-938X(96)00053-4
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   HANAWA T, 1989, J JPN SOC DENT MATER, V8, P832
   HANSON DM, 1981, PHYS REV B, V24, P5513, DOI 10.1103/PhysRevB.24.5513
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   Hartman L C, 1989, Int J Oral Maxillofac Implants, V4, P11
   Hasselstrom J, 1998, SURF SCI, V407, P221, DOI 10.1016/S0039-6028(98)00190-3
   Hautaniemi JA, 1996, SURF INTERFACE ANAL, V24, P763, DOI 10.1002/(SICI)1096-9918(199610)24:11<763::AID-SIA178>3.0.CO;2-E
   HAUTANIEMI JA, 1995, SURF INTERFACE ANAL, V23, P833, DOI 10.1002/sia.740231206
   HAY DI, 1967, ARCH ORAL BIOL, V12, P937, DOI 10.1016/0003-9969(67)90088-X
   HAY DI, 1979, J DENT RES, V58, P930, DOI 10.1177/00220345790580024701
   Heaney TG, 1996, J BIOMED MATER RES, V32, P593, DOI 10.1002/(SICI)1097-4636(199612)32:4<593::AID-JBM12>3.0.CO;2-F
   Heiz U, 2000, J PHYS D APPL PHYS, V33, pR85, DOI 10.1088/0022-3727/33/11/201
   HENCH LJ, 1991, BIOCERAMICS MRS B, V9, P62
   Hench LL, 1999, MRS BULL, V24, P13
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1996, BIOMATERIALS SCI INT, P75
   Henderson B, 1999, CELLULAR MICROBIOLOG
   Henderson MA, 1996, SURF SCI, V355, P151, DOI 10.1016/0039-6028(95)01357-1
   Henderson MA, 1996, LANGMUIR, V12, P5093, DOI 10.1021/la960360t
   HENDERSON MA, 1995, SURF SCI, V343, pL1156, DOI 10.1016/0039-6028(95)00849-7
   Henderson MA, 1999, FARADAY DISCUSS, V114, P313, DOI 10.1039/a902070e
   HENGLEIN A, 1987, ULTRASONICS, V25, P6, DOI 10.1016/0041-624X(87)90003-5
   HENRICH VE, 1977, SOLID STATE COMMUN, V24, P623, DOI 10.1016/0038-1098(77)90376-3
   HERCULES DM, 1976, J DENT RES, V55, P829, DOI 10.1177/00220345760550051901
   Herman GS, 2000, SURF SCI, V447, P201, DOI 10.1016/S0039-6028(99)01186-3
   Herman GS, 2000, PHYS REV LETT, V84, P3354, DOI 10.1103/PhysRevLett.84.3354
   Hiemenz P. C., 1977, PRINCIPLES COLLOID S
   Himmelhaus M, 2000, J PHYS CHEM B, V104, P576, DOI 10.1021/jp992073e
   HIROSE C, 1992, J CHEM PHYS, V96, P997, DOI 10.1063/1.462120
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   Holgers KM, 1999, BIOMATERIALS, V20, P1319, DOI 10.1016/S0142-9612(99)00033-2
   Holgers KM, 1994, INT J ORAL MAXILLOF, V9, P689
   Holmberg K, 1997, COLLOID SURFACE A, V123, P297, DOI 10.1016/S0927-7757(96)03810-1
   Horbett TA, 1995, ACS SYM SER, V602, P1
   HORBETT TA, 1982, ADV CHEM SER, P233
   Horbett Thomas A., 1996, P133
   Howard A, 2000, SURF SCI, V448, P131, DOI 10.1016/S0039-6028(99)01229-7
   Howlett C. R., 1993, Clinical Materials, V14, P57, DOI 10.1016/0267-6605(93)90048-C
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   Howlett CR, 1999, J BIOMED MATER RES, V44, P352, DOI 10.1002/(SICI)1097-4636(19990305)44:3<352::AID-JBM14>3.0.CO;2-A
   Hristova E, 1997, J ELECTROCHEM SOC, V144, P2318, DOI 10.1149/1.1837811
   Hu K, 1997, J PHYS CHEM B, V101, P8298, DOI 10.1021/jp971887x
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   HUETZ P, 1995, LANGMUIR, V11, P3145, DOI 10.1021/la00008a046
   HUGENSCHMIDT MB, 1994, SURF SCI, V302, P329, DOI 10.1016/0039-6028(94)90837-0
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   IHS A, 1990, J COLLOID INTERF SCI, V140, P192, DOI 10.1016/0021-9797(90)90335-L
   IHS A, 1991, J COLLOID INTERF SCI, V144, P282, DOI 10.1016/0021-9797(91)90259-B
   IIJIMA M, 1992, J CRYST GROWTH, V116, P319, DOI 10.1016/0022-0248(92)90639-Z
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   Ishikawa K, 1997, J BIOMED MATER RES, V38, P129, DOI 10.1002/(SICI)1097-4636(199722)38:2<129::AID-JBM7>3.0.CO;2-S
   ISHIKAWA T, 1991, LANGMUIR, V7, P596, DOI 10.1021/la00051a031
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   JANSEN JA, 1991, BIOMATERIALS, V12, P25, DOI 10.1016/0142-9612(91)90127-V
   JANSEN JA, 1990, J MATER SCI-MATER M, V1, P192, DOI 10.1007/BF00701076
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JEON NL, 1995, LANGMUIR, V11, P3024, DOI 10.1021/la00008a029
   Jha LJ, 1996, J BIOMED MATER RES, V31, P481, DOI 10.1002/(SICI)1097-4636(199608)31:4<481::AID-JBM7>3.0.CO;2-H
   JOBIN M, 1995, J APPL PHYS, V77, P5149, DOI 10.1063/1.359259
   JOHANSEN E, 1964, J DENT RES, V43, P1007, DOI 10.1177/00220345640430060201
   JOHANSSON CB, 1993, J MATER SCI-MATER M, V4, P132, DOI 10.1007/BF00120382
   Johnson MA, 1998, J PHYS CHEM B, V102, P6391, DOI 10.1021/jp9813995
   Jones DW, 1996, KEY ENG MATER, V122-1, P345, DOI 10.4028/www.scientific.net/KEM.122-124.345
   JONES FH, UNPUB
   JONKER BT, 1981, PHYS REV B, V24, P2951, DOI 10.1103/PhysRevB.24.2951
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   KANDORI K, 1995, J COLLOID INTERF SCI, V174, P124, DOI 10.1006/jcis.1995.1373
   KANDORI K, 1992, COLLOID SURFACE, V68, P283, DOI 10.1016/0166-6622(92)80214-M
   KANDORI K, 1995, COLLOID SURFACE B, V5, P81, DOI 10.1016/0927-7765(95)98210-E
   KANGASNIEMI IMO, 1994, J BIOMED MATER RES, V28, P563, DOI 10.1002/jbm.820280506
   Kanzaki N, 1998, J PHYS CHEM B, V102, P6471, DOI 10.1021/jp981512r
   KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028
   KASAS S, 1993, P SOC PHOTO-OPT INS, V1855, P17, DOI 10.1117/12.146381
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kasemo B, 1998, CURR OPIN SOLID ST M, V3, P451, DOI 10.1016/S1359-0286(98)80006-5
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KASEMO B, 1999, ADV DENT RES, V13
   KAUFMANN R, 1993, RAPID COMMUN MASS SP, V7, P902, DOI 10.1002/rcm.1290071010
   Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l
   Kawahara D, 1996, Int J Oral Maxillofac Implants, V11, P435
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   KELLER JC, 1989, J ADHESION, V28, P115, DOI 10.1080/00218468908030878
   Kelly JR, 1997, ANNU REV MATER SCI, V27, P443, DOI 10.1146/annurev.matsci.27.1.443
   Kerber SJ, 1998, J MATER ENG PERFORM, V7, P334, DOI 10.1361/105994998770347774
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KIESWETTER K, 1994, BIOMATERIALS, V15, P183, DOI 10.1016/0142-9612(94)90065-5
   KILNER AMC, 1991, SURF INTERFACE ANAL, V17, P158, DOI 10.1002/sia.740170307
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   KILPADI DV, 1994, J BIOMED MATER RES, V28, P1419, DOI 10.1002/jbm.820281206
   Kilpadi DV, 1998, COLLOID SURFACE A, V135, P89, DOI 10.1016/S0927-7757(97)00237-9
   Kim DG, 1999, BIO-MED MATER ENG, V9, P89
   Kim HM, 1999, J BIOMED MATER RES, V45, P100, DOI 10.1002/(SICI)1097-4636(199905)45:2<100::AID-JBM4>3.0.CO;2-0
   Kim HM, 1997, J BIOMED MATER RES, V38, P121
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kingshott P, 2000, J BIOMED MATER RES, V49, P36, DOI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
   Kinney JH, 1996, J BIOMECH ENG-T ASME, V118, P133, DOI 10.1115/1.2795939
   Kirkham J, 1998, CONNECT TISSUE RES, V38, P91, DOI 10.3109/03008209809017025
   Klauber C, 1990, Int J Oral Maxillofac Implants, V5, P264
   Klee D, 1999, ADV POLYM SCI, V149, P1
   KNOBLER CM, 1991, CURR OPIN COLLOID IN, V4, P46
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Konishi K, 1987, J Osaka Dent Univ, V21, P1
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Korn D, 1997, J MATER SCI-MATER M, V8, P613, DOI 10.1023/A:1018567302700
   Kratz F, 1999, CRIT REV THER DRUG, V16, P245, DOI 10.1615/CritRevTherDrugCarrierSyst.v16.i3.10
   KREIS T, 1993, GUIDEBOOK EXTRACELLU
   KUBOKI Y, 1987, J DENT RES, V66, P1016, DOI 10.1177/00220345870660050401
   KUEMPEL DR, 1995, J PERIODONTOL, V66, P228, DOI 10.1902/jop.1995.66.3.228
   Kuliralo M, 1991, J Biol Buccale, V19, P247
   KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003
   KUMAR A, 1992, J AM CHEM SOC, V114, P9188, DOI 10.1021/ja00049a061
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   Kurahashi M, 1999, J VAC SCI TECHNOL A, V17, P1047, DOI 10.1116/1.581681
   KURTZ RL, 1989, SURF SCI, V218, P178, DOI 10.1016/0039-6028(89)90626-2
   Kusu F, 1998, ELECTROCHIM ACTA, V43, P1873, DOI 10.1016/S0013-4686(97)00308-3
   LakatosVarsanyi M, 1997, INT J ORAL MAX IMPL, V12, P387
   LANDIS WJ, 1984, J VAC SCI TECHNOL A, V2, P1108, DOI 10.1116/1.572680
   LANGE W, 1984, SURF SCI, V136, P419, DOI 10.1016/0039-6028(84)90621-6
   Larsen NB, 1997, J AM CHEM SOC, V119, P3017, DOI 10.1021/ja964090c
   LARSON I, 1993, J AM CHEM SOC, V115, P11885, DOI 10.1021/ja00078a029
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Larsson C, 1997, J MATER SCI-MATER M, V8, P721, DOI 10.1023/A:1018548225899
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   LARSSON SJ, 1977, CALC TISS RES, V24, P179, DOI 10.1007/BF02223313
   Lasserre A, 1998, CRIT REV THER DRUG, V15, P1
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lausmaa J, 1999, J BIOMED MATER RES, V44, P227, DOI 10.1002/(SICI)1097-4636(19990305)44:3<227::AID-JBM1>3.0.CO;2-H
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1985, BIOMATERIALS, V6, P23, DOI 10.1016/0142-9612(85)90033-X
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Lavelle C L, 1981, J Oral Implantol, V9, P357
   Lawrence JR, 1999, METHOD ENZYMOL, V310, P131
   Leadley SR, 1997, BIOMATERIALS, V18, P311, DOI 10.1016/S0142-9612(96)00134-2
   LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J
   LEFEVRE R, 1976, CALC TISS RES, V19, P251
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   LeGeros RZ, 1991, CALCIUM PHOSPHATES O
   Leggett GJ, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P393
   Leitao E, 1998, J MATER SCI-MATER M, V9, P543, DOI 10.1023/A:1008896106994
   Leonard D, 1999, FRESEN J ANAL CHEM, V365, P3, DOI 10.1007/s002160051437
   Leonhard A, 1995, MICROB ECOL HEALTH D, V8, P293, DOI 10.3109/08910609509140108
   LEONHARDT A, 1995, J DENT RES, V74, P1607, DOI 10.1177/00220345950740091701
   LERCEL MJ, 1994, APPL PHYS LETT, V65, P974, DOI 10.1063/1.113012
   LERCEL MJ, 1994, J VAC SCI TECHNOL B, V12, P3663, DOI 10.1116/1.587635
   LERCEL MJ, 1995, MICROELECTRON ENG, V27, P43, DOI 10.1016/0167-9317(94)00052-V
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Li M, 1999, SURF SCI, V437, P173, DOI 10.1016/S0039-6028(99)00720-7
   Li M, 1998, SURF SCI, V414, pL951, DOI 10.1016/S0039-6028(98)00549-4
   Li M, 1999, FARADAY DISCUSS, V114, P245, DOI 10.1039/a903598b
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   Li XD, 1997, BIOMATERIALS, V18, P1487, DOI 10.1016/S0142-9612(97)00085-9
   Li XL, 1999, CHINESE J ANAL CHEM, V27, P47
   Li YM, 1998, J AM DENT ASSOC, V129, P494
   LIEDBERG B, 1984, J BIOCHEM BIOPH METH, V9, P233, DOI 10.1016/0165-022X(84)90028-9
   LIN A, 1992, J DENT RES, V71, P1836, DOI 10.1177/00220345920710111401
   Lindan PJD, 1996, CHEM PHYS LETT, V261, P246, DOI 10.1016/0009-2614(96)00934-7
   Lindan PJD, 1998, PHYS REV LETT, V80, P762, DOI 10.1103/PhysRevLett.80.762
   Lisle JT, 1999, METHOD ENZYMOL, V310, P166
   Liu FY, 1998, APPL RADIAT ISOTOPES, V49, P67
   LO WJ, 1978, SURF SCI, V71, P199
   LODDING A, 1985, SCAND J DENT RES, V93, P315
   LODDING A, 1983, SCAN ELECTRON MICROS, P1229
   LODDING AR, 1990, ANAL CHIM ACTA, V241, P299, DOI 10.1016/S0003-2670(00)83660-0
   Lofgren P, 1997, SURF SCI, V370, P277, DOI 10.1016/S0039-6028(96)00961-2
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   LOWENBERG B, 1991, CELL MATER, V1, P177
   Lu HBB, 1999, ABSTR PAP AM CHEM S, V217, pU670
   Lundgren T, 1998, HISTOCHEM J, V30, P351, DOI 10.1023/A:1003284511863
   Lundgren T, 1998, ARCH ORAL BIOL, V43, P841, DOI 10.1016/S0003-9969(98)00074-0
   LUNDSTROM I, 1990, J COLLOID INTERF SCI, V136, P68, DOI 10.1016/0021-9797(90)90079-4
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Mader C, 2000, BBA-BIOMEMBRANES, V1463, P142, DOI 10.1016/S0005-2736(99)00190-X
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   Marshall G W Jr, 1993, Quintessence Int, V24, P606
   1998, MRS B, V23, P11
   1993, J APPL BACTERIOL S S, V74, pS87
   1973, J CLIN INVEST, V51, P741
   1996, J ELECT SPECTROSC RE, V81
   1975, J LAB CLIN MED, V85, P235
   1998, MRS B, V23, P14
   1998, BIOMATERIALS, V19
   AR Ten Cate, 1994, ORAL HISTOLOGY DEV S
   MARSHALL GW, 1993, DENT MATER, V9, P265, DOI 10.1016/0109-5641(93)90072-X
   Marshall GW, 1997, DENT MATER, V13, P338, DOI 10.1016/S0109-5641(97)80104-2
   MARSHALL GW, 1995, J BIOMED MATER RES, V29, P1381, DOI 10.1002/jbm.820291109
   MARSHALL KC, 1994, COLLOID SURFACE B, V2, P371, DOI 10.1016/0927-7765(94)80050-2
   Martin JY, 1996, CLIN ORAL IMPLAN RES, V7, P27, DOI 10.1034/j.1600-0501.1996.070104.x
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mathieu HJ, 1997, SURFACE ANALYSIS - THE PRINCIPAL TECHNIQUES, P99
   Matkovic P, 1998, METALURGIJA, V37, P15
   MATTHEWS RW, 1988, J CATAL, V111, P264, DOI 10.1016/0021-9517(88)90085-1
   MATTHEWS WG, 1993, ARCH ORAL BIOL, V38, P517, DOI 10.1016/0003-9969(93)90188-R
   McCafferty E, 1999, APPL SURF SCI, V143, P92, DOI 10.1016/S0169-4332(98)00927-1
   McCafferty E, 1998, SURF INTERFACE ANAL, V26, P549, DOI 10.1002/(SICI)1096-9918(199807)26:8<549::AID-SIA396>3.3.CO;2-H
   McCafferty E, 1999, J ELECTROCHEM SOC, V146, P2849, DOI 10.1149/1.1392019
   McCANN HAROLD G., 1955, JOUR DENTAL RES, V34, P59, DOI 10.1177/00220345550340011601
   MCDOWELL SG, 1995, LETT APPL MICROBIOL, V21, P1, DOI 10.1111/j.1472-765X.1995.tb00992.x
   McKendry R, 1998, NATURE, V391, P566, DOI 10.1038/35339
   McLean KM, 2000, COLLOID SURFACE B, V17, P23, DOI 10.1016/S0927-7765(99)00055-7
   MEACHIN G, 1973, J BIOMED MATER RES, V7, P572
   MEISENHEIMER RG, 1976, BIOCHEM BIOPH RES CO, V68, P994, DOI 10.1016/0006-291X(76)91244-4
   Meschenmoser A, 1996, J PERIODONTOL, V67, P229, DOI 10.1902/jop.1996.67.3.229
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MIAKE Y, 1993, CALCIFIED TISSUE INT, V53, P249, DOI 10.1007/BF01320910
   MICHAELS C M, 1991, Journal of Oral Implantology, V17, P132
   MILLER RG, 1994, J DENT RES, V73, P1457, DOI 10.1177/00220345940730081001
   MILLER RG, 1993, J DENT MAT, V9, P280
   Mitchell RJ, 1996, CRIT REV ORAL BIOL M, V7, P12, DOI 10.1177/10454411960070010101
   Moffitt CE, 1998, BIOMATERIALS, V19, P1319, DOI 10.1016/S0142-9612(97)00169-5
   Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x
   MORENO EC, 1991, CALCIFIED TISSUE INT, V49, P6, DOI 10.1007/BF02555895
   Morita S, 1999, APPL SURF SCI, V140, P406, DOI 10.1016/S0169-4332(98)00563-7
   Morra M, 1998, SURF INTERFACE ANAL, V26, P742, DOI 10.1002/(SICI)1096-9918(199809)26:10<742::AID-SIA417>3.0.CO;2-P
   Morra M, 1997, SURF INTERFACE ANAL, V25, P983, DOI 10.1002/(SICI)1096-9918(199712)25:13<983::AID-SIA345>3.0.CO;2-X
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   MORRIS VJ, 2000, ATOMIC FORCE MICROSC
   Mottu F, 1999, INVEST RADIOL, V34, P323, DOI 10.1097/00004424-199905000-00001
   Mount GJ, 1999, OPER DENT, V24, P115
   MOUNT GJ, 1998, PRESERVATION RESTORA
   MOZES N, 1988, BIOCHIM BIOPHYS ACTA, V945, P324, DOI 10.1016/0005-2736(88)90495-6
   Mozes N., 1991, MICROBIAL CELL SURFA
   Mugele F, 2000, J PHYS CHEM B, V104, P3140, DOI 10.1021/jp9935236
   Muller HU, 1995, J VAC SCI TECHNOL B, V13, P2846, DOI 10.1116/1.588302
   MURGA R, 1995, BIOTECHNOL BIOENG, V45, P503, DOI 10.1002/bit.260450607
   MURRAY PW, 1992, PHYS REV B, V46, P12877, DOI 10.1103/PhysRevB.46.12877
   MURRAY PW, 1995, PHYS REV B, V51, P10989, DOI 10.1103/PhysRevB.51.10989
   MURRAY PW, 1994, SURF SCI, V321, P217, DOI 10.1016/0039-6028(94)90187-2
   MURRAY PW, 1994, PHYS REV LETT, V72, P689, DOI 10.1103/PhysRevLett.72.689
   NAKABAYASHI N, 1992, DENT MATER, V8, P125, DOI 10.1016/0109-5641(92)90067-M
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Naray-Szabo S, 1930, Z KRISTALLOGR, V75, P387
   NAUJOKS R., 1967, CARIES RES, V1, P137
   NAYAK PL, 1999, CHEM PHYS C, V39, P481
   NEWMAN HN, 1999, DENTAL PLAQUE REVISI
   Nicholson JW, 1998, BIOMATERIALS, V19, P485, DOI 10.1016/S0142-9612(97)00128-2
   Nicholson JW, 2000, INT J ADHES ADHES, V20, P11, DOI 10.1016/S0143-7496(99)00009-3
   Nilsson T, 1996, ARTIF INTELL MED, V8, P515, DOI 10.1016/S0933-3657(96)00350-8
   Nilsson T, 1998, CONNECT TISSUE RES, V38, P81, DOI 10.3109/03008209809017024
   Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.0.CO;2-C
   Nishimura N, 1998, J MATER SCI-MATER M, V9, P99, DOI 10.1023/A:1008851115846
   Nooney MG, 1998, LANGMUIR, V14, P2750, DOI 10.1021/la9702695
   NORDE W, 1979, J COLLOID INTERF SCI, V71, P350, DOI 10.1016/0021-9797(79)90245-5
   NOREN JG, 1984, CARIES RES, V18, P242, DOI 10.1159/000260772
   NOREN JG, 1983, CARIES RES, V17, P496, DOI 10.1159/000260709
   Norenberg H, 1999, PHYS REV B, V59, P9842, DOI 10.1103/PhysRevB.59.9842
   Norenberg H, 1998, SURF SCI, V396, P52, DOI 10.1016/S0039-6028(97)00658-4
   Norenberg H, 1998, SURF SCI, V402, P738, DOI 10.1016/S0039-6028(97)01000-5
   Noth U, 1999, BIOMED TECH, V44, P6, DOI 10.1515/bmte.1999.44.1-2.6
   Noy A, 1997, ANNU REV MATER SCI, V27, P381, DOI 10.1146/annurev.matsci.27.1.381
   Nugues S, 1996, J ELECTROANAL CHEM, V408, P125, DOI 10.1016/0022-0728(96)04523-8
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   OKAMOTO Y, 1991, J ORAL REHABIL, V18, P507, DOI 10.1111/j.1365-2842.1991.tb00073.x
   OKAZAKI M, 1989, BIOMATERIALS, V10, P564, DOI 10.1016/0142-9612(89)90064-1
   Okazaki M, 1999, BIOMATERIALS, V20, P1073, DOI 10.1016/S0142-9612(98)00244-0
   Okazaki M, 1997, BIOMATERIALS, V18, P795, DOI 10.1016/S0142-9612(97)00009-4
   OLIN H, 1992, ULTRAMICROSCOPY, V42, P567, DOI 10.1016/0304-3991(92)90325-E
   Oliver PM, 1997, J MATER CHEM, V7, P563, DOI 10.1039/a606353e
   OLSSON J, 1991, COLLOID POLYM SCI, V269, P1295, DOI 10.1007/BF00652539
   OLSSON J, 1990, J DENT RES, V69, P1586, DOI 10.1177/00220345900690091001
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   ONG JL, 1995, J BIOMED MATER RES, V29, P165, DOI 10.1002/jbm.820290205
   Ong JL, 1998, BIOMATERIALS, V19, P455, DOI 10.1016/S0142-9612(97)00224-X
   ONISHI H, 1994, CHEM PHYS LETT, V226, P111, DOI 10.1016/0009-2614(94)00712-8
   ONISHI H, 1995, B CHEM SOC JPN, V68, P2447, DOI 10.1246/bcsj.68.2447
   Onishi H, 1996, PHYS REV LETT, V76, P791, DOI 10.1103/PhysRevLett.76.791
   ONISHIM H, 1998, SURF SCI, V313, pL783
   Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c
   Onuma K, 1996, J CRYST GROWTH, V167, P773, DOI 10.1016/0022-0248(96)00421-6
   ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4
   OREILLY BJ, 1991, J LARYNGOL OTOL, V105, P573, DOI 10.1017/S0022215100116640
   Orstavik D, 1973, J Oral Pathol, V2, P68, DOI 10.1111/j.1600-0714.1973.tb01675.x
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   Palka V, 1998, J MATER SCI-MATER M, V9, P369, DOI 10.1023/A:1013275311692
   Pan J, 1998, J BIOMED MATER RES, V40, P244, DOI 10.1002/(SICI)1097-4636(199805)40:2<244::AID-JBM9>3.0.CO;2-L
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan S, 1998, LANGMUIR, V14, P3545, DOI 10.1021/la971212l
   Pang CL, 2000, PHYS REV B, V62, pR7775, DOI 10.1103/PhysRevB.62.R7775
   Pang CL, 1998, PHYS REV B, V58, P1586, DOI 10.1103/PhysRevB.58.1586
   Pang CL, 2000, APPL SURF SCI, V157, P233, DOI 10.1016/S0169-4332(99)00532-2
   PANTANO CG, 1981, APPL SURF SCI, V7, P115, DOI 10.1016/0378-5963(81)90065-9
   Pashley DH, 1997, J DENT, V25, P355, DOI 10.1016/S0300-5712(96)00057-7
   Patthey L, 1999, J CHEM PHYS, V110, P5913, DOI 10.1063/1.478491
   PATTHEY L, 1995, THESIS U LAUSANNE
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PEARCE EIF, 1988, J DENT RES, V67, P1056, DOI 10.1177/00220345880670070801
   PELBLE ME, 1997, SURFACE ANAL PRINCIP, P307
   Perera IK, 1995, J MASS SPECTROM, pS3
   Pertsin AJ, 1998, J PHYS CHEM B, V102, P4918, DOI 10.1021/jp9806617
   PETERSSON LG, 1995, SWED DENT J, V19, P83
   Peyton BM, 1996, WATER RES, V30, P29, DOI 10.1016/0043-1354(95)00110-7
   PICKART L, 1978, BIOCHIM BIOPHYS ACTA, V544, P138, DOI 10.1016/0304-4165(78)90217-9
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pierres A, 1998, CURR OPIN COLLOID IN, V3, P525, DOI 10.1016/S1359-0294(98)80028-9
   PIESCO NP, 1994, ORAL DEV HISTOLOGY
   Pohle W, 1999, VIB SPECTROSC, V19, P321, DOI 10.1016/S0924-2031(98)00067-8
   POPE NM, 1993, BIOCONJUGATE CHEM, V4, P166, DOI 10.1021/bc00020a009
   POSNER S, 1961, PHOSPHOROUS ITS COMP, V2
   PRAKOBPHOL A, 1993, CARIOLOGY 90S
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Puleo DA, 1996, BIOMATERIALS, V17, P217, DOI 10.1016/0142-9612(96)85766-8
   PUM D, 1994, THIN SOLID FILMS, V244, P882, DOI 10.1016/0040-6090(94)90592-4
   Pum D, 1999, TRENDS BIOTECHNOL, V17, P8, DOI 10.1016/S0167-7799(98)01221-9
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   RACHINGER WA, 1982, CALCIFIED TISSUE INT, V34, P209, DOI 10.1007/BF02411235
   RADEGRAN G, 1991, J ELECTRON MICR TECH, V19, P99, DOI 10.1002/jemt.1060190110
   RAIKAR GN, 1995, J VAC SCI TECHNOL A, V13, P2633, DOI 10.1116/1.579462
   RATEITSCHAK KH, 1989, COLOUR ATLAS DENTAL, V1
   RATNER BD, 1995, SURF INTERFACE ANAL, V23, P521, DOI 10.1002/sia.740230712
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1
   RATNER BD, 1994, COLLOID SURFACE B, V2, P333, DOI 10.1016/0927-7765(94)80048-0
   RATNER BD, 1997, SURFACE ANAL PRINCIP, P44
   RATNER BD, 1988, SURFACE CHARACTERIZA
   Raval R, 1998, NUOVO CIMENTO D, V20, P553, DOI 10.1007/BF03185548
   Raza H, 1999, APPL SURF SCI, V140, P271, DOI 10.1016/S0169-4332(98)00539-X
   Raza H, 1999, PHYS REV LETT, V82, P5265, DOI 10.1103/PhysRevLett.82.5265
   REINTSEMA H, 1986, CARIES RES, V20, P419, DOI 10.1159/000260967
   Reusch B, 1997, FRESEN J ANAL CHEM, V358, P64, DOI 10.1007/s002160050346
   Reusch B, 1998, APPL PHYS A-MATER, V66, pS805, DOI 10.1007/s003390051246
   REVENKO I, 1994, BIOL CELL, V80, P67, DOI 10.1016/0248-4900(94)90019-1
   Rezania A, 1999, LANGMUIR, V15, P6931, DOI 10.1021/la990024n
   RIEKE PC, 1994, LANGMUIR, V10, P619, DOI 10.1021/la00015a003
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   Roberts MW, 2000, CATAL LETT, V69, P253, DOI 10.1023/A:1019063132413
   Roberts MW, 2000, CATAL LETT, V67, pI
   ROBINSON C, 1992, J DENT RES, V71, P1270, DOI 10.1177/00220345920710060101
   ROBINSON C, 1984, TOOTH ENAMEL, V4, P216
   Rodriguez-Clemente R, 1998, J EUR CERAM SOC, V18, P1351, DOI 10.1016/S0955-2219(98)00064-8
   ROHRER GS, 1990, SCIENCE, V250, P1239, DOI 10.1126/science.250.4985.1239
   ROHRER GS, 1992, SURF SCI, V278, P146, DOI 10.1016/0039-6028(92)90590-3
   ROLLA G, 1983, SCAND J DENT RES, V91, P186
   ROLLA G, 1994, COLLOID SURFACE B, V3, P177
   ROLLASON G, 1993, BIOMATERIALS, V14, P153, DOI 10.1016/0142-9612(93)90230-Y
   ROMAN E, 1990, VACUUM, V41, P40, DOI 10.1016/0042-207X(90)90265-Z
   ROSEN MJ, 1989, SURFACTANTS INTERFAC
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   ROUXHET PG, 1994, COLLOID SURFACE B, V2, P347, DOI 10.1016/0927-7765(94)80049-9
   RUSE ND, 1991, J DENT RES, V70, P1002, DOI 10.1177/00220345910700060101
   Russell BG, 1998, BIOSPECTROSCOPY, V4, P257, DOI 10.1002/(SICI)1520-6343(1998)4:4<257::AID-BSPY4>3.0.CO;2-#
   Rustad JR, 1996, GEOCHIM COSMOCHIM AC, V60, P1553, DOI 10.1016/0016-7037(96)00046-4
   Sakai N, 1998, LANGMUIR, V14, P5918, DOI 10.1021/la980623e
   SANDER M, 1994, SURF SCI, V302, pL263, DOI 10.1016/0039-6028(94)91086-3
   Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000
   SARID D, 1991, J VAC SCI TECHNOL B, V9, P431, DOI 10.1116/1.585585
   SARID D, 1994, SCANNING FORCE MICRO
   Sato H, 1999, J BIOMATER APPL, V14, P169, DOI 10.1177/088532829901400203
   Sato K, 2000, J COLLOID INTERF SCI, V224, P23, DOI 10.1006/jcis.1999.6623
   Sauberlich S, 1999, CLIN ORAL IMPLAN RES, V10, P379, DOI 10.1034/j.1600-0501.1999.100505.x
   Saxena AK, 1999, TISSUE ENG, V5, P525, DOI 10.1089/ten.1999.5.525
   SCHAAD P, 1993, SCANNING MICROSCOPY, V7, P1149
   Schakenraad J.M., 1996, BIOMATERIALS SCI INT, P141
   SchenkMeuser K, 1997, FRESEN J ANAL CHEM, V358, P265, DOI 10.1007/s002160050402
   SCHIERBAUM KD, 1995, SENSOR ACTUAT B-CHEM, V24, P239, DOI 10.1016/0925-4005(95)85051-1
   SCHINDLER PW, 1972, KOLLOID Z Z POLYM, V250, P759, DOI 10.1007/BF01498568
   SCHMIDT CF, 1990, BIOPHYS J, V57, P577, DOI 10.1016/S0006-3495(90)82573-X
   SCHMIDT M, 1991, HELV PHYS ACTA, V64, P900
   Schreckenbach JP, 1999, J MATER SCI-MATER M, V10, P453, DOI 10.1023/A:1008988706980
   SCHULTZ JS, 1982, ADV CHEM SER, P43
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Seah MP, 1999, J ELECTRON SPECTROSC, V100, P55, DOI 10.1016/S0368-2048(99)00040-7
   SEAH MP, 1990, PRACTICAL SURFACE AN, V1
   Sennou HE, 1999, DENT MATER, V15, P229, DOI 10.1016/S0109-5641(99)00036-6
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   Serro APV, 1997, COLLOID SURFACE A, V125, P209, DOI 10.1016/S0927-7757(97)00017-4
   Shapovalov V, 2000, CHEM PHYS LETT, V320, P186, DOI 10.1016/S0009-2614(00)00191-3
   SHARKNESS CM, 1993, J LONG-TERM EFF MED, V3, P237
   Shen TC, 1997, PHYS REV LETT, V78, P1271, DOI 10.1103/PhysRevLett.78.1271
   Shen Y. R., 1984, PRINCIPLES NONLINEAR
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shiku H, 1999, ANAL CHEM, V71, p23A, DOI 10.1021/ac9900984
   SHIRKHANZADEH M, 1992, J MATER SCI-MATER M, V3, P322, DOI 10.1007/BF00705362
   Shirkhanzadeh M, 1997, J MATER SCI-MATER M, V8, P595, DOI 10.1023/A:1018563201792
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P355, DOI 10.1023/A:1008859131585
   SHIRKHANZADEH M, 1995, NANOSTRUCT MATER, V5, P33, DOI 10.1016/0965-9773(95)00006-Z
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Sigee DC, 1998, MIKROCHIM ACTA, P283
   Silikas N, 1999, J DENT, V27, P137, DOI 10.1016/S0300-5712(98)00032-3
   SIMKISS K, 1989, BIOMINERALIZATION CE
   SIMMELINK JW, 1974, ARCH ORAL BIOL, V19, P183, DOI 10.1016/0003-9969(74)90213-1
   SIMMELINK JW, 1994, ORAL DEV HISTOLOGY
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Skjorland KK, 1995, ACTA ODONTOL SCAND, V53, P358, DOI 10.3109/00016359509006001
   Slack SM, 1995, ACS SYM SER, V602, P112
   SLACK SM, 1996, BIOMATERIALS SCI INT, P470
   Sleytr UB, 1999, ANGEW CHEM INT EDIT, V38, P1035, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1034::AID-ANIE1034>3.0.CO;2-#
   Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9
   Smith DC, 1998, BIOMATERIALS, V19, P467, DOI 10.1016/S0142-9612(97)00126-9
   SMITH PB, 1987, SURF SCI, V188, P241, DOI 10.1016/S0039-6028(87)80155-3
   SODERHOLM KJM, 1909, DENT MATER, V7, P74
   SODHI RNS, 1992, J DENT RES, V71, P1493, DOI 10.1177/00220345920710080601
   SOLLBOHMER O, 1995, THIN SOLID FILMS, V264, P176, DOI 10.1016/0040-6090(95)05847-8
   SOLOKOV IY, 1999, J APPL PHYS, V86, P5537
   SOMORJAI GA, 1981, PREFACE CHEM 2 DIMEN
   SOMORJAI GA, 2000, BIOM SURF AN NEW MIL
   SONG S, 1993, J PHYS CHEM-US, V97, P6564, DOI 10.1021/j100126a037
   SOSULNIKOV MI, 1992, RELAT PHENOM, V59, P101
   SPECTOR M, 1994, P 20 ANN M SOC BIOM, P330
   SPENCER P, 1992, DENT MATER, V8, P10, DOI 10.1016/0109-5641(92)90046-F
   SPIEKERMANN H, 1995, IMPLANTOLOGY COLOR A
   SRINIVASAN R, 1995, BIOTECHNOL BIOENG, V46, P553, DOI 10.1002/bit.260460608
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Stangel I, 1996, J BIOMED MATER RES, V31, P287, DOI 10.1002/(SICI)1097-4636(199606)31:2<287::AID-JBM17>3.0.CO;2-I
   STANGEL I, 1994, J ADHESION, V47, P133, DOI 10.1080/00218469408027095
   STARKEBAUM W, 1979, J BIOMED MATER RES, V13, P729, DOI 10.1002/jbm.820130506
   Stefanovich EV, 1997, J CHEM PHYS, V106, P7700, DOI 10.1063/1.473748
   STEINBERG D, 1995, BIOMATERIALS, V16, P1339, DOI 10.1016/0142-9612(95)91050-9
   Stermer EM, 1996, EUR J ORAL SCI, V104, P253, DOI 10.1111/j.1600-0722.1996.tb00075.x
   Stewart PS, 1998, BIOTECHNOL BIOENG, V59, P261, DOI 10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-9
   STOCKBAUER R, 1982, PHYS REV B, V26, P1885, DOI 10.1103/PhysRevB.26.1885
   STOCKBAUER RL, 1982, J VAC SCI TECHNOL, V20, P562, DOI 10.1116/1.571433
   Stone P, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/008
   STRANICK MA, 1991, COLLOID SURFACE, V55, P137, DOI 10.1016/0166-6622(91)80088-6
   STRONG RL, 1985, J VAC SCI TECHNOL A, V3, P1428, DOI 10.1116/1.572795
   STULTS JT, 1995, CURR OPIN STRUC BIOL, V5, P691, DOI 10.1016/0959-440X(95)80063-8
   STUMM W., 1992, CHEM SOLID WATER INT
   SUBIRADE M, 1994, THIN SOLID FILMS, V243, P442, DOI 10.1016/0040-6090(93)04014-J
   Suetsugu Y, 1996, J MATER SCI, V31, P4541, DOI 10.1007/BF00366349
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   SUGIMURA H, 1993, APPL PHYS LETT, V63, P1288, DOI 10.1063/1.110771
   SUGIMURA H, 1994, J VAC SCI TECHNOL B, V12, P2884, DOI 10.1116/1.587208
   Sugimura W, 1997, JPN J APPL PHYS 1, V36, P7358, DOI 10.1143/JJAP.36.7358
   SUKENIK CN, 1990, J BIOMED MATER RES, V24, P1307, DOI 10.1002/jbm.820241004
   SULJAK JP, 1995, J DENT, V23, P171, DOI 10.1016/0300-5712(95)93575-M
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P893, DOI 10.1016/0142-9612(93)90130-T
   SUZUKI M, 1991, J DENT RES, V70, P1092, DOI 10.1177/00220345910700071501
   SUZUKI Y, 1994, NUCL INSTRUM METH B, V91, P588
   SWANCAR JR, 1971, TOOTH ENAMEL, V2
   Swart K M, 1992, J Oral Implantol, V18, P130
   Swift P, 1967, Br Dent J, V123, P326
   SZABO A, 1995, SURF SCI, V329, P241, DOI 10.1016/0039-6028(95)00050-X
   SZE SM, 1981, PHYSICS SEMICONDUCTO
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Takamura R, 1997, J DENT RES, V76, P1177
   Talley CE, 1996, APPL PHYS LETT, V69, P3809, DOI 10.1063/1.117112
   TAM LE, 1994, J DENT RES, V73, P607, DOI 10.1177/00220345940730030601
   Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI DOI 10.1002/RCM.1290020802
   TANIZAWA Y, 1990, J CHEM SOC FARADAY T, V86, P4025, DOI 10.1039/ft9908604025
   TANIZAWA Y, 1991, J CHEM SOC FARADAY T, V87, P2235, DOI 10.1039/ft9918702235
   TANIZAWA Y, 1993, J CHEM SOC FARADAY T, V89, P2901, DOI 10.1039/ft9938902901
   TANIZAWA Y, 1995, J CHEM SOC FARADAY T, V91, P3499, DOI 10.1039/ft9959103499
   TANIZAWA Y, 1998, J CHEM SOC FARADAY T, V86, P1071
   Tanner RE, 1998, SURF SCI, V412-13, P672, DOI 10.1016/S0039-6028(98)00464-6
   TANZER JM, 1995, J DENT RES, V74, P1536, DOI 10.1177/00220345950740090601
   TAO L, 1988, DENT MATER, V4, P208, DOI 10.1016/S0109-5641(88)80066-6
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   Thompson ID, 1998, P I MECH ENG H, V212, P127, DOI 10.1243/0954411981533908
   THOMPSON VP, 1992, J ADHESION, V39, P157, DOI 10.1080/00218469208026547
   THOMSEN P, 1989, J MATER SCI-MATER M, V8, P653
   Todd PJ, 1997, ANAL CHEM, V69, pA529, DOI 10.1021/ac971763g
   TORIYAMA M, 1995, NIPPON SERAM KYO GAK, V103, P46
   TORNKVIST C, 1991, LANGMUIR, V7, P479
   TORRISI L, 1992, NUCL INSTRUM METH B, V65, P139, DOI 10.1016/0168-583X(92)95026-N
   Tougaard S, 1997, SURF INTERFACE ANAL, V25, P404, DOI 10.1002/(SICI)1096-9918(199706)25:6<404::AID-SIA250>3.0.CO;2-A
   UDVAL K, 1992, J COLLOID INTERF SCI, V149, P162
   UDVAL K, 1990, J COLLOID INTERF SCI, V140, P207
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Valsami-Jones E, 1998, CHEM GEOL, V151, P215, DOI 10.1016/S0009-2541(98)00081-3
   VANBLITTERSWIJK CA, 1991, BIOMATERIALS, V12, P187, DOI 10.1016/0142-9612(91)90198-J
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   VANDERMEI HC, 1991, CARIES RES, V25, P415, DOI 10.1159/000261404
   VANDERMEI HC, 1989, J DENT RES, V68, P620
   VANDERVEGT W, 1993, J COLLOID INTERF SCI, V156, P129, DOI 10.1006/jcis.1993.1091
   VANDERVEGT W, 1994, LANGMUIR, V10, P1314, DOI 10.1021/la00016a055
   VANMEERBEEK B, 1993, J DENT RES, V72, P1423, DOI 10.1177/00220345930720101201
   VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501
   VANRAEMDONCK W, 1984, J AM CERAM SOC, V67, P381
   Vansteenkiste SO, 1998, PROG SURF SCI, V57, P95, DOI 10.1016/S0079-6816(98)00014-8
   VASQUEZ RP, 1990, THIN SOLID FILMS, V192, P173, DOI 10.1016/0040-6090(90)90489-Z
   VASUDEVAN TV, 1994, LANGMUIR, V10, P320, DOI 10.1021/la00013a047
   VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633
   Vereecke G, 1999, SURF INTERFACE ANAL, V27, P761, DOI 10.1002/(SICI)1096-9918(199908)27:8<761::AID-SIA570>3.3.CO;2-5
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P775, DOI 10.1002/jbm.820270610
   Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1
   VICKERMAN JC, 1997, SURFACES ANAL PRINCI, P134
   Vittadini A, 1998, PHYS REV LETT, V81, P2954, DOI 10.1103/PhysRevLett.81.2954
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogtenhuber D, 1998, SURF SCI, V402, P798, DOI 10.1016/S0039-6028(97)01083-2
   Volkel B, 1997, J VAC SCI TECHNOL B, V15, P2877, DOI 10.1116/1.589748
   VONRECUM AF, 1990, CLIN IMPLANT MAT
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Wadu-Mesthrige K, 1999, LANGMUIR, V15, P8580, DOI 10.1021/la991196n
   Wakamura M, 1998, COLLOID SURFACE A, V142, P107, DOI 10.1016/S0927-7757(98)00486-5
   Wakamura M, 1997, POLYHEDRON, V16, P2047, DOI 10.1016/S0277-5387(96)00513-X
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wang LQ, 1999, SURF SCI, V440, P60, DOI 10.1016/S0039-6028(99)00677-9
   Wang LQ, 1995, SURF SCI, V344, P237, DOI 10.1016/0039-6028(95)00859-4
   Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233
   Wang R, 1999, J PHYS CHEM B, V103, P2188, DOI 10.1021/jp983386x
   Wang R, 1998, ADV MATER, V10, P135, DOI 10.1002/(SICI)1521-4095(199801)10:2<135::AID-ADMA135>3.0.CO;2-M
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   WASSERMAN SR, 1989, J AM CHEM SOC, V111, P5852, DOI 10.1021/ja00197a054
   WATAHA JC, 1992, J DENT RES, V71, P1417, DOI 10.1177/00220345920710071101
   Wataha JC, 1996, J ORAL REHABIL, V23, P583, DOI 10.1046/j.1365-2842.1996.d01-204.x
   WATKINS RW, 1977, J BIOMED MATER RES, V11, P915, DOI 10.1002/jbm.820110611
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000
   Weiner R, 1999, METHOD ENZYMOL, V310, P403
   Wen HB, 1997, BIOMATERIALS, V18, P1471, DOI 10.1016/S0142-9612(97)82297-1
   WEN HB, 1995, CARIES RES, V29, P122, DOI 10.1159/000262053
   Wen HB, 1998, J MATER SCI-MATER M, V9, P121, DOI 10.1023/A:1008859417664
   WENNERBERG A, 1995, J MATER SCI-MATER M, V6, P302, DOI 10.1007/BF00120275
   Wennerberg A, 1997, J MATER SCI-MATER M, V8, P757, DOI 10.1023/A:1018560528625
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   Weygand M, 2000, J MATER CHEM, V10, P141, DOI 10.1039/a905196a
   WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013
   Whitford GM, 1997, CIBA F SYMP, V205, P226
   Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513
   Whitters CJ, 1999, J DENT, V27, P401, DOI 10.1016/S0300-5712(99)00007-X
   Wieliczka DM, 1996, J DENT RES, V75, P1865, DOI 10.1177/00220345960750110801
   Wiesendanger R., 1994, SCANNING PROBE MICRO
   Wieser E, 1999, SURF COAT TECH, V111, P103, DOI 10.1016/S0257-8972(98)00717-8
   Wiesmann HP, 1998, CELL TISSUE RES, V294, P93, DOI 10.1007/s004410051159
   WILBUR JL, 1995, LANGMUIR, V11, P825, DOI 10.1021/la00003a025
   WILKE HJ, 1990, ADV BIOMAT, V9, P309
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   WILLIAMS DF, 1981, BIOCOMPATIBILITY IMP
   Williams DF., 1986, MAT SCI IMPLANT ORTH, P107
   Williams J, 1996, SURF SCI, V368, P303, DOI 10.1016/S0039-6028(96)01067-9
   WILLIAMS JA, 1996, T 5 WORLD BIOM C TOR, V2, P762
   WILLIAMS RL, 1991, SURF INTERFACE ANAL, V17, P496, DOI 10.1002/sia.740170714
   WILSON R, 1997, SURFACES ANAL PRINCI, P10
   WILSON RG, 1989, SCONDARY ION MASS SP
   Wilson WD, 1997, J COLLOID INTERF SCI, V187, P201, DOI 10.1006/jcis.1996.4693
   WINTER GD, 1980, ADV BIOMATERIALS, V1
   WISBEY A, 1991, BIOMATERIALS, V12, P470, DOI 10.1016/0142-9612(91)90144-Y
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
   Wu W, 1997, LANGMUIR, V13, P861, DOI 10.1021/la960689e
   Wu WJ, 1997, J BIOMED MATER RES, V35, P93, DOI 10.1002/(SICI)1097-4636(199704)35:1<93::AID-JBM9>3.0.CO;2-H
   Wu WJ, 1997, COLLOID SURFACE B, V10, P87, DOI 10.1016/S0927-7765(97)00054-4
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xia YN, 1997, LANGMUIR, V13, P2059, DOI 10.1021/la960936e
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Xu S, 1997, LANGMUIR, V13, P127, DOI 10.1021/la962029f
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
   Yang BC, 1999, J BIOMED MATER RES, V47, P213, DOI 10.1002/(SICI)1097-4636(199911)47:2<213::AID-JBM11>3.0.CO;2-C
   Yoshino N, 1997, J BIOMAT SCI-POLYM E, V8, P623, DOI 10.1163/156856297X00218
   Yoshino N, 1998, REACT FUNCT POLYM, V37, P271, DOI 10.1016/S1381-5148(97)00114-4
   Zablotsky M H, 1992, Implant Dent, V1, P253, DOI 10.1097/00008505-199200140-00004
   ZEGENHAGEN J, 1993, SURF SCI REP, V18, P199
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zenobi R, 1998, MASS SPECTROM REV, V17, P337, DOI 10.1002/(SICI)1098-2787(1998)17:5<337::AID-MAS2>3.0.CO;2-S
   Zhang LP, 1998, SURF SCI, V412-13, P242, DOI 10.1016/S0039-6028(98)00432-4
   Zhao XY, 1999, SURF SCI, V442, pL995, DOI 10.1016/S0039-6028(99)00970-X
   Zhao XY, 1999, SURF SCI, V424, pL347, DOI 10.1016/S0039-6028(99)00211-3
   Ziegler C, 1998, FRESEN J ANAL CHEM, V361, P547, DOI 10.1007/s002160050944
   Zolk M, 2000, LANGMUIR, V16, P5849, DOI 10.1021/la0003239
NR 890
TC 104
Z9 105
U1 2
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5729
EI 1879-274X
J9 SURF SCI REP
JI Surf. Sci. Rep.
PY 2001
VL 42
IS 3-5
BP 79
EP 205
PG 127
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 431LK
UT WOS:000168632500001
DA 2018-10-20
ER

PT S
AU Murphy, ME
   Laugier, MT
   Beake, BD
   Newcomb, SB
AF Murphy, ME
   Laugier, MT
   Beake, BD
   Newcomb, SB
BE Brebbia, CA
TI Surface microstructural modification of biomedical grade alpha-alumina
   by ion implantation
SO SURFACE TREATMENT V: COMPUTER METHODS AND EXPERIMENTAL MEASUREMENTS
SE COMPUTATIONAL AND EXPERIMENTAL METHODS
LA English
DT Proceedings Paper
CT 5th International Conference on Computer Methods and Experimental
   Measurements for Surface Treatment Effects
CY JUN 20-22, 2001
CL SEVILLE, SPAIN
SP Wessex Inst Technol
ID MECHANICAL-PROPERTIES; RESIDUAL-STRESS; POLYCRYSTALLINE ALUMINA;
   CERAMICS; ALPHA-AL2O3; MODULUS
AB Biomedical grade (> 99.5% purity) polycrystalline alpha-alumina has been implanted with C ions (75 keV) at fluences ranging from 5x10(16) to 5x10(17) C ions/cm(2) and Zr ions (100 keV) at fluences ranging from 5x10(15) to 5x10(16) Zr ions/cm(2). The surfaces of the alumina have been examined in cross-section using transmission electron microscopy (TEM) and the data obtained correlated with both nanohardness measurements and computer based simulations (Transport and Range of Ions in Matter, TRIM). The nanohardness of the near-surface alumina was determined as a function of depth and was found to be strongly dependent on the fluence used. The data is discussed in relation to the mechanisms by which the properties of this material are modified by ion implantation.
C1 Univ Limerick, Dept Phys, Limerick, Ireland.
RP Murphy, ME (reprint author), Univ Limerick, Dept Phys, Limerick, Ireland.
CR Boudoukha L, 1997, J MATER SCI, V32, P2911, DOI 10.1023/A:1018632819115
   BURNETT PJ, 1984, J MATER SCI, V19, P3524, DOI 10.1007/BF00552266
   Canut B, 1997, NUCL INSTRUM METH B, V122, P335, DOI 10.1016/S0168-583X(96)00576-9
   Halitim F, 1997, J PHYS D APPL PHYS, V30, P330, DOI 10.1088/0022-3727/30/3/004
   Halitim F, 1997, THIN SOLID FILMS, V300, P197, DOI 10.1016/S0040-6090(96)09492-8
   Halitim F, 1997, CERAM INT, V23, P509, DOI 10.1016/S0272-8842(96)00062-4
   HIOKI T, 1986, J MATER SCI, V21, P1321, DOI 10.1007/BF00553270
   HIOKI T, 1984, J MATER SCI LETT, V3, P1099, DOI 10.1007/BF00719777
   MCHARGUE CJ, 1989, MAT SCI ENG A-STRUCT, V115, P361, DOI 10.1016/0921-5093(89)90704-1
   MCHARGUE CJ, 1984, J AM CERAM SOC, V67, P117, DOI 10.1111/j.1151-2916.1984.tb09627.x
   McHargue CJ, 1998, MAT SCI ENG A-STRUCT, V253, P94, DOI 10.1016/S0921-5093(98)00714-X
   Misra A, 1999, NUCL INSTRUM METH B, V148, P211, DOI 10.1016/S0168-583X(98)00780-0
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PALETTO S, 1996, NUCL INSTRUMENTS MET, V108, P87
   SMETHURST E, 1977, J MATER SCI, V12, P1781, DOI 10.1007/BF00566238
   Strobel M, 1998, COMP MATER SCI, V10, P457, DOI 10.1016/S0927-0256(97)00114-6
   Tian J, 1998, NUCL INSTRUM METH B, V143, P488
   Ziegler J F, 1985, STOPPING RANGE IONS
   ZUMDAHL SS, 1993, CHEMISTRY
NR 19
TC 2
Z9 2
U1 0
U2 3
PU WIT PRESS
PI SOUTHAMPTON
PA ASHURST LODGE, SOUTHAMPTON SO40 7AA, ASHURST, ENGLAND
SN 1466-7266
BN 1-85312-873-2
J9 COMP EXPTL METHODS
PY 2001
VL 6
BP 13
EP 22
PG 10
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA BT16C
UT WOS:000172146300002
DA 2018-10-20
ER

PT B
AU Kancharla, VV
   Chen, SC
   Zamzow, DS
   Baldwin, DP
AF Kancharla, VV
   Chen, SC
   Zamzow, DS
   Baldwin, DP
GP NAMRI/SME
   NAMRI/SME
TI Laser micromachining of a biodegradable polymer
SO TRANSACTIONS OF THE NORTH AMERICAN MANUFACTURING RESEARCH INSTITUTION OF
   SME, VOL XXIX, 2001
LA English
DT Proceedings Paper
CT 29th North American Manufacturing Research Conference (NAMRC XXIX)
CY MAY 22-25, 2001
CL GAINESVILLE, FL
SP Soc Mfg Engineers, N Amer Mfg Res Inst
AB This paper reports on UV laser micromachining of a biodegradable polymer for applications in biomedical engineering. Parametric studies have been conducted on Poly-vinyl Alcohol (PVA), a biodegradable polymer, to produce micro channels and micro holes. Laser micromachining of micro channels is studied using a XeCl excimer laser at 308 nm wavelength and laser micro drilling is studied using a Q-switched Nd:YAG laser at 266 nm wavelength. Feature sizes ranging from 4 to 10 mum were obtained for the micro holes and the features of micro channels ranged from 33 to 65 mum wide and 22 to 123 mum deep. This work demonstrated that UV laser micromachining is a well-suited technique for biodegradable polymers with minimum thermal damage to the surrounding material.
C1 Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.
RP Kancharla, VV (reprint author), Iowa State Univ, Dept Ind & Mfg Syst Engn, Ames, IA 50011 USA.
CR Chen SC, 2000, J HEAT TRANS-T ASME, V122, P107, DOI 10.1115/1.521441
   CHEN YH, 1995, P SOC PHOTO-OPT INS, V3184, P202
   GANNEPALLI A, 1998, POLYM MAT SCI ENG P, V78, P3
   GARRISON BJ, 1984, APPL PHYS LETT, V44, P849, DOI 10.1063/1.94947
   Gower MC, 1999, P SOC PHOTO-OPT INS, V3618, P251, DOI 10.1117/12.352688
   KUMAR GS, 1986, BIODEGRADABLE POLYM
   Lin LW, 1999, J MICROELECTROMECH S, V8, P78, DOI 10.1109/84.749406
   Matsui S, 1995, MATER RES SOC SYMP P, V380, P49, DOI 10.1557/PROC-380-49
   SAUERBREY R, 1989, APPL PHYS LETT, V55, P421, DOI 10.1063/1.101884
   SCHWOPE AD, 1977, MIDLAND MACROMOLECUL, V5
   SRINIVASAN R, 1982, APPL PHYS LETT, V41, P576, DOI 10.1063/1.93601
   SRINIVASAN V, 1986, J APPL PHYS, V59, P3861, DOI 10.1063/1.336728
NR 12
TC 1
Z9 1
U1 0
U2 0
PU SOC MANUFACTURING ENGINEERS
PI DEARBORN
PA ONE SME DR, PO BOX 930, DEARBORN, MI 48128 USA
BN 0-87263-600-3
PY 2001
BP 407
EP 412
PG 6
WC Engineering, Manufacturing; Engineering, Mechanical; Metallurgy &
   Metallurgical Engineering
SC Engineering; Metallurgy & Metallurgical Engineering
GA BV60L
UT WOS:000179483900054
DA 2018-10-20
ER

PT J
AU Jamitzky, F
   Stark, RW
   Bunk, W
   Thalhammer, S
   Rath, C
   Aschenbrenner, T
   Morfill, GE
   Heckl, WM
AF Jamitzky, F
   Stark, RW
   Bunk, W
   Thalhammer, S
   Rath, C
   Aschenbrenner, T
   Morfill, GE
   Heckl, WM
TI Scaling-index method as an image processing tool in scanning-probe
   microscopy
SO ULTRAMICROSCOPY
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Scanning Probe Microscopy, Sensors, and
   Nanostructures
CY MAY 28-31, 2000
CL HEIDELBERG, GERMANY
SP Ultramicroscopy
DE atomic force microscopy; image processing
ID ATOMIC-FORCE MICROSCOPE; HUMAN-CHROMOSOMES; PATTERNS
AB The scaling-index method (SIM) is a novel tool for image processing in scanning-probe microscopy. Originating from the theory of complex systems, the SIM can be used in order to extract structural information from arbitrary data sets. This method can readily be applied to the analysis of digital atomic-force microscopy (AFM) images. Especially for biomedical diagnostics, where genetic material is investigated by various microscopic methods, a reliable image segmentation based on the SIM algorithm is helpful. As a first application, AFM-images of CTC-banded human metaphase chromosomes (with G bands obtained by Trypsin using Giemsa) are compared with micrographs from conventional light microscopy by means of a scaling-index analysis. While the grey-level distributions of the optical and the AFM-images are largely different from each other, the scaling-index images are remarkably similar. Using this method, a fingerprint of an image can be produced which helps in the classification and interpretation of the measured data. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Max Planck Inst Extraterr Phys, D-85749 Garching, Germany.
   Univ Munich, Inst Kristallog & Angew Mineral, D-80333 Munich, Germany.
RP Jamitzky, F (reprint author), Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85749 Garching, Germany.
EM f.jamitzky@mpe-garching.mpg.de
RI Stark, Robert/A-2886-2008; Thalhammer, Stefan/C-1031-2011
OI Stark, Robert/0000-0001-8678-8449; 
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   *ISCN, 1995, INT SYST HUM CYT NOM, V21
   JAMITZKY F, IN PRESS J COMPUT AS
   Musio A, 1997, GENOME, V40, P127, DOI 10.1139/g97-018
   MUSIO A, 1994, CHROMOSOMA, V103, P225, DOI 10.1007/BF00368016
   PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712
   PUTMAN CAJ, 1992, P SOC PHOTO-OPT INS, V1639, P198, DOI 10.1117/12.58191
   PUTMAN CAJ, 1992, ULTRAMICROSCOPY, V42, P1549, DOI 10.1016/0304-3991(92)90481-X
   RASCH P, 1993, P NATL ACAD SCI USA, V90, P2509, DOI 10.1073/pnas.90.6.2509
   Rath C, 1997, J OPT SOC AM A, V14, P3208, DOI 10.1364/JOSAA.14.003208
   Stark RW, 1998, APPL PHYS A-MATER, V66, pS579, DOI 10.1007/s003390051205
   Tamayo J, 1999, J STRUCT BIOL, V128, P200, DOI 10.1006/jsbi.1999.4191
   Thalhammer S, 1997, J STRUCT BIOL, V119, P232, DOI 10.1006/jsbi.1997.3869
NR 13
TC 35
Z9 35
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3991
J9 ULTRAMICROSCOPY
JI Ultramicroscopy
PD JAN
PY 2001
VL 86
IS 1-2
BP 241
EP 246
DI 10.1016/S0304-3991(00)00111-X
PG 6
WC Microscopy
SC Microscopy
GA 398AB
UT WOS:000166730600029
PM 11215629
DA 2018-10-20
ER

PT J
AU Howson, A
AF Howson, A
TI "Watching you - watching me": Visualising techniques and the cervix
SO WOMENS STUDIES INTERNATIONAL FORUM
LA English
DT Article
AB Feminist accounts of 1970s women's health activism in the Anglophone world highlight cervical self-examination as a means of reclaiming the female body from biomedical monopoly. Whilst cervical screening programmes have become part of health policy in the United Kingdom and other Western countries, cervical self-examination does not appear to be widespread. nor have many women seen their own cervix. Feminism has also drawn attention to the significance of biomedical imagery and discourse in the engendering of knowledge about one's own body, particularly through visualisation techniques. This paper presents interview material in which women describe the experience of cervical colposcopy and their responses to magnified images of their own cervix during this procedure. The data are used to consider how visualisation techniques shape bodily experience. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Aberdeen, Dept Sociol, Aberdeen AB24 3QY, Scotland.
RP Howson, A (reprint author), Univ Aberdeen, Dept Sociol, Edward Wright Bldg,Dunbar St, Aberdeen AB24 3QY, Scotland.
CR ARMSTRONG D, 1995, SOCIOL HEALTH ILL, V17, P393, DOI 10.1111/1467-9566.ep10933329
   ARMSTRONG D, 1983, POLITICAL ANATOMY BO
   ARNEY W, 1982, POWER PROFESSION OBS
   Atkinson P, 1995, MED TALK MED WORK
   Bell Susan, 1988, GENDER DISCOURSE POW, P97
   Birke L., 1999, FEMINISM BIOL BODY
   Cartwright L., 1995, SCREENING BODY TRACI
   CROSSLEY N, 1995, BODY SOC, V1, P13
   CSORDAS TJ, 1990, ETHOS, V18, P5, DOI 10.1525/eth.1990.18.1.02a00010
   DALY A, 1991, WOMEN KNIFE HIST SUR
   Denzin N. K., 1988, INTERPRETIVE INTERAC
   *DEP HLTH, 1989, GEN PRACT NAT HLTH S
   Diprose R., 1994, BODIES WOMEN ETHICS
   Douglas M., 1996, PURITY DANGER ANAL P
   DOYAL L, 1983, CRITICAL SOCIAL  SUM, P21
   DUNCAN ID, 1992, GUIDELINES CLIN PRAC
   Ehrenreich B., 1979, HER OWN GOOD 150 YEA
   EVANS DMD, 1986, J CLIN PATHOL, V39, P933, DOI 10.1136/jcp.39.9.933
   Foucault Michel, 1973, BIRTH CLIN
   FRANKFORT E, 1972, SEIZING OUR BODIES, P263
   GARDNER K, 1981, WOMEN HLTH REPROD, P129
   Graham H., 1981, WOMEN HLTH REPROD, P50
   Grosz Elizabeth, 1994, VOLATILE BODIES CORP
   HOPWOOD J, 1990, BACKGROUND COLPOSCOP
   HOWSON A, 1996, THESIS U EDINBURGH
   Howson A., 1998, HEALTH, V2, P195
   ILLICH I, 1986, LANCET, V2, P1325
   Kavanagh AM, 1997, BRIT MED J, V314, P1388
   Kitzinger S., 1992, WOMENS HLTH MATTERS, P63
   Kristeva J., 1982, POWERS HORROR ESSAY
   Lane K, 1995, MED HLTH RISK SOCIOL, P53
   Laqueur T., 1991, MAKING SEX BODY GEND
   LAWLER J, 1991, SCREENS NURSING SOMO
   Laws S., 1990, ISSUES BLOOD POLITIC
   LEWIN E, 1985, WOMEN HLTH HEALING N
   MARTIN E, 1984, SOC SCI MED, V19, P1201, DOI 10.1016/0277-9536(84)90371-X
   Martin E., 1989, WOMAN BODY
   Merleau-Ponty M, 1962, PHENOMENOLOGY PERCEP
   Moscucci O., 1990, SCI WOMAN GYNAECOLOG
   Oakley A, 1998, WOMEN STUD INT FORUM, V21, P133, DOI 10.1016/S0277-5395(98)00005-3
   OAKLEY A, 1984, CAPTURED WOMB
   Patterson JT, 1987, DREAD DIS CANC MODER
   PHILLIPS A, 1971, OUR BODIES OURSELVES
   Poovey Mary, 1987, MAKING MODERN BODY S, P137
   POSNER T, 1988, PATIENTS VIEW
   RAFFLE AE, 1995, LANCET, V345, P1469, DOI 10.1016/S0140-6736(95)91036-0
   Ruzek S, 1978, WOMENS HLTH MOVEMENT
   SCULLY D, 1978, CULTURAL CRISIS MODE, P212
   Shildrick M., 1997, LEAKY BODIES BOUNDAR
   Singleton V., 1995, GENDER TECHNOLOGY RE, P146
   Stabile C., 1994, FEMINISM TECHNOLOGIC
   STAFFORD B, 1991, BODY CRITICISM IMAGI
   Thomas H., 1992, TIME HLTH MED, P56
   TURNER B, 1987, MED POWER SOCIAL KNO
   Young I., 1990, THROWING GIRL OTHER
NR 55
TC 13
Z9 13
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-5395
J9 WOMEN STUD INT FORUM
JI Women Stud. Int. Forum
PD JAN-FEB
PY 2001
VL 24
IS 1
BP 97
EP 109
DI 10.1016/S0277-5395(00)00162-X
PG 13
WC Women's Studies
SC Women's Studies
GA 432MJ
UT WOS:000168695400008
DA 2018-10-20
ER

PT J
AU Ikeyama, M
   Nakao, S
   Morikawa, H
   Yokogawa, Y
   Wielunski, LS
   Clissold, RA
   Bell, T
AF Ikeyama, M
   Nakao, S
   Morikawa, H
   Yokogawa, Y
   Wielunski, LS
   Clissold, RA
   Bell, T
TI Surface hardness changes induced by O-, Ca- or P-ion implantation into
   titanium
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article; Proceedings Paper
CT 9th RIKEN Symposium on Surface Modification and Characterization by Ion
   Beams/5th RIKEN-OKAYAMA Joint Forum
CY 1999
CL INST PHYS & CHEM RES, SAITAMA, JAPAN
HO INST PHYS & CHEM RES
DE hardness; ion implantation; titanium
ID NITROGEN
AB Titanium or titanium alloys are very attractive biomedical materials. Biocompatible elements of oxygen, calcium and phosphorus were implanted into titanium and changes of surface hardness were measured using an ultra micro indenter (UMIS-2000). A multiple load-partial unload procedure that can reveal a hardness versus depth profile was adopted. Depth profiles of concentration of implanted ions were obtained by SIMS measurement. For O and P implantation, it is observed that the hardness increases with the increases in the dose. O implantation produced the largest increase in hardness, up to 2.2 times higher than the unimplanted titanium. On the other hand, Ca implantation produced only a small increase in the hardness that was independent of the ion dose. The surface oxide layer of a Ca implanted titanium sample was much thicker than the unimplanted samples or those implanted with O and P ions. The depth of maximum hardness increases with increasing energy of implanted ions. The depths of the maximum hardness occur at indentation depths of one-third to one-eighth of the mean ranges of implanted ions. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Natl Ind Res Inst Nagoya, Kita Ku, Nagoya, Aichi 4628510, Japan.
   CSIRO, Div Telecommun & Ind Phys, Lindfield, NSW 2070, Australia.
CR Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   Bell TJ, 1998, MATER RES SOC SYMP P, V522, P15, DOI 10.1557/PROC-522-15
   FIELD JS, 1993, J MATER RES, V8, P297, DOI 10.1557/JMR.1993.0297
   GANIA A, 1997, SURF COAT TECH, V97, P499
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   Krupa D, 1997, SURF COAT TECH, V96, P223, DOI 10.1016/S0257-8972(97)00107-2
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Sarkissian AH, 1998, SURF COAT TECH, V98, P1336, DOI 10.1016/S0257-8972(97)00399-X
   Seidel F, 1998, SURF COAT TECH, V98, P1174, DOI 10.1016/S0257-8972(97)00148-5
   YOKOGAWA Y, 1999, PHOSPHORUS RES B, V10, P301
   ZIEGLER JF, 1985, STOPPING RANGE ION S
NR 11
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC 20
PY 2000
VL 19
IS 3
BP 263
EP 268
DI 10.1016/S0927-7765(00)00164-8
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 366WZ
UT WOS:000090030400008
DA 2018-10-20
ER

PT J
AU Snellings, GMBF
   Vansteenkiste, SO
   Corneillie, SI
   Davies, MC
   Schacht, EH
AF Snellings, GMBF
   Vansteenkiste, SO
   Corneillie, SI
   Davies, MC
   Schacht, EH
TI Protein adhesion at poly(ethylene glycol) modified surface
SO ADVANCED MATERIALS
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; SCANNING PROBE MICROSCOPY; HUMAN-PLASMA;
   ADSORPTION
AB The inhibition of protein adsorption to the surfaces of biomedical devices is a crucial requirement for avoiding implant-associated infections or thrombus formation on blood-contacting artificial surfaces and thus for increasing the long-term biocompatibility of the devices. Here, the use of surface plasmon resonance and scanning force microscopy using protein-modified tips (see Figure) to study protein adhesion on poly (ethylene glycol) grafted polymer materials is discussed. The PEG-grafted materials are revealed to have significantly reduced affinity to proteins.
C1 State Univ Ghent, Dept Organ Chem, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
   Univ Nottingham, Dept Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Schacht, EH (reprint author), State Univ Ghent, Dept Organ Chem, Polymer Mat Res Grp, Krijgslaan 281, B-9000 Ghent, Belgium.
OI Davies, Martyn/0000-0001-7695-0596
CR Bain C. D., 1989, ANGEW CHEM, V101, P522
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   Bottomley LA, 1996, ANAL CHEM, V68, pR185, DOI 10.1021/a1960008+
   BUTT HJ, 1995, BIOELECTROCH BIOENER, V38, P191, DOI 10.1016/0302-4598(95)01800-T
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Chen X, 1997, LANGMUIR, V13, P4106, DOI 10.1021/la970172i
   CORNEILLIE SI, 1998, MED DEVICE TECHN JAN, P28
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GRAINGER DW, 1997, PROG COLL POL SCI S, V103, P243
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   HARRIS JM, 1992, PEG CHEM BIOTECHNICA
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   IKADA Y, 1981, J BIOMED MATER RES, V15, P697, DOI 10.1002/jbm.820150507
   LEE UG, 1994, SCIENCE, V6, P771
   Magonov SN, 1997, ANNU REV MATER SCI, V27, P175, DOI 10.1146/annurev.matsci.27.1.175
   Mrksich M, 1997, CURR OPIN COLLOID IN, V2, P83, DOI 10.1016/S1359-0294(97)80012-X
   NAKAGAWA T, 1994, J VAC SCI TECHNOL B, V12, P2215, DOI 10.1116/1.587744
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PERRY SS, 1994, ANAL CHEM, V66, pA403, DOI 10.1021/ac00079a001
   Ratner B. D., 1981, BIOCOMPATIBILITY CLI
   Snelting G., 2000, Proceedings of the Fourth European Conference on Software Maintenance and Reengineering, P3, DOI 10.1109/CSMR.2000.827299
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   Vansteenkiste SO, 1998, PROG SURF SCI, V57, P95, DOI 10.1016/S0079-6816(98)00014-8
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   VINCKIER A, 1995, ULTRAMICROSCOPY, V57, P337, DOI 10.1016/0304-3991(94)00194-R
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 28
TC 41
Z9 41
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI BERLIN
PA PO BOX 10 11 61, D-69451 BERLIN, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD DEC 15
PY 2000
VL 12
IS 24
BP 1959
EP +
DI 10.1002/1521-4095(200012)12:24<1959::AID-ADMA1959>3.3.CO;2-M
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 393XM
UT WOS:000166495000018
DA 2018-10-20
ER

PT J
AU Iwasaki, Y
   Aiba, Y
   Morimoto, N
   Nakabayashi, N
   Ishihara, K
AF Iwasaki, Y
   Aiba, Y
   Morimoto, N
   Nakabayashi, N
   Ishihara, K
TI Semi-interpenetrating polymer networks composed of biocompatible
   phospholipid polymer and segmented polyurethane
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydrogel; phospholipid polymer; segmented polyurethane; interpenetrating
   polymer networks; protein adsorption; biocompatibility
ID IMPROVED BLOOD COMPATIBILITY; PROTEIN ADSORPTION; POLAR GROUP;
   ADDITIVES; HYDROGELS; MEMBRANE; SURFACE
AB 2-Methacryloyloxyethyl phosphorylcholine (MPC) polymers, which have excellent biocompatibility, have been receiving increasing attention in biomedical and bioengineering fields; however, the mechanical strength of the hydrated MPC polymers is not sufficient for use in these fields as a bulk material. Therefore, we hypothesized that a novel material might be realized by reinforcing the MPC polymer network with segmented polyurethane (SPU). Semi-interpenetrating polymer networks (IPNs) composed of crosslinked MPC polymer and SPU were prepared. The mechanical properties of the IPN membrane were significantly improved compared with those of the MPC polymer membrane. Three-dimensional polymer networks of the MPC polymer in the IPNs were observed after solvent extraction of SPU. An X-ray photoelectron spectrum analysis revealed that the MPC units were exposed on the IPN surface. When the IPN was alternately soaked in water and ethanol, the swelling ratio was found to be completely reversible and no disintegration of the network structure was observed. The permeation coefficient of 1,4-di(2-hydroxyethoxy)benzene through the IPN membrane was 1.11 x 10(-7) cm(-2)s(-1). The amount of adsorbed protein and the number of adherent platelets on the IPN membrane were effectively reduced compared with those on SPU. We concluded that IPNs composed of the MPC polymer and SPU are a new bulk biomaterial, which possesses both blood compatibility and good mechanical properties. (C) 2000 John Wiley & Sons, Inc.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan.
RP Iwasaki, Y (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
RI Iwasaki, Yasuhiko/D-6870-2011
OI Iwasaki, Yasuhiko/0000-0003-1603-6174
CR FRISCH HL, 1985, BRIT POLYM J, V17, P149, DOI 10.1002/pi.4980170212
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1996, J BIOMED MATER RES, V32, P391, DOI 10.1002/(SICI)1097-4636(199611)32:3<391::AID-JBM12>3.0.CO;2-K
   Ishihara K, 1996, J BIOMED MATER RES, V32, P401, DOI 10.1002/(SICI)1097-4636(199611)32:3<401::AID-JBM13>3.0.CO;2-J
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 1997, J BIOMED MATER RES, V36, P508, DOI 10.1002/(SICI)1097-4636(19970915)36:4<508::AID-JBM8>3.0.CO;2-I
   KADOMA Y, 1978, KOBUNSHI RONBUNSHU, V35, P423, DOI 10.1295/koron.35.423
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kawano H, 1998, KOBUNSHI RONBUNSHU, V55, P334, DOI 10.1295/koron.55.334
   Kurisawa M, 1997, J BIOMAT SCI-POLYM E, V8, P691, DOI 10.1163/156856297X00506
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   TSURUTA T, 1996, ADV POLYM SCI, P1
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   UEDA T, 1990, MAKROMOL CHEM-RAPID, V11, P345
   ZHOU PU, 1992, J POLYM SCI POL CHEM, V30, P835, DOI 10.1002/pola.1992.080300514
NR 18
TC 50
Z9 51
U1 2
U2 16
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2000
VL 52
IS 4
BP 701
EP 708
DI 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.3.CO;2-Y
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 358UY
UT WOS:000089576600015
PM 11033553
DA 2018-10-20
ER

PT J
AU Asoo, B
   McNaney, JM
   Mitamura, Y
   Ritchie, RO
AF Asoo, B
   McNaney, JM
   Mitamura, Y
   Ritchie, RO
TI Cyclic fatigue-crack propagation in sapphire in air and simulated
   physiological environments
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE heart valve prostheses; sapphire; static fatigue; cyclic fatigue; crack
   growth
ID STRESS-CORROSION; MECHANISM; CERAMICS; BEHAVIOR; GROWTH; MODEL
AB Single-crystal aluminas are being considered for use in the manufacture of prosthetic heart valves. To characterize such materials for biomedical application, subcritical crack growth by stress corrosion (static fatigue) and by cyclic fatigue has been examined in sapphire along (1 (1) over bar 00) planes in 24 degrees C humid air and 37 degrees C Ringer's solution (the latter as a simulated physiological environment). The relationships between crack-propagation rates and the linear-elastic stress intensity have been determined for the first time in sapphire for both modes of subcritical cracking. It was found that growth rates were significantly faster at a given stress intensity in the Ringer's solution compared to the humid air environment. Mechanistically, a true cyclic fatigue effect was not found in sapphire as experimentally measured cyclic fatigue-crack growth rates could be closely predicted simply by integrating the static fatigue-crack growth data over the cyclic lending cycle. (C) 2000 John Wiley & Sons, Inc.
C1 Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mat Sci & Mineral Engn, Berkeley, CA 94720 USA.
   Hokkaido Univ, Dept Biomed Syst Engn, Sapporo, Hokkaido 0608628, Japan.
RP Ritchie, RO (reprint author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RI McNaney, James/F-5258-2013; Ritchie, Robert/A-8066-2008
OI Ritchie, Robert/0000-0002-0501-6998
CR [Anonymous], 1993, ANN BOOK ASTM STAND
   BECHER PF, 1976, J AM CERAM SOC, V59, P59
   DAUSKARDT RH, 1993, ACTA METALL MATER, V41, P2765, DOI 10.1016/0956-7151(93)90145-I
   DAUSKARDT RH, 1989, CLOSED LOOP, V17, P7
   EVANS AG, 1974, METALL TRANS, V5, P27
   GILBERT CJ, 1995, J AM CERAM SOC, V78, P2291, DOI 10.1111/j.1151-2916.1995.tb08660.x
   IWASA M, 1984, ADV CERAM, V10, P767
   KIMURA Y, 1993, P 5 INT C FAT FAT TH, V3, P1331
   LATHABAI S, 1991, J AM CERAM SOC, V74, P1348
   MAI YW, 1987, J AM CERAM SOC, V70, P289, DOI 10.1111/j.1151-2916.1987.tb04983.x
   MICHALSKE TA, 1983, J AM CERAM SOC, V66, P284, DOI 10.1111/j.1151-2916.1983.tb15715.x
   MITAMURA Y, 1994, J BIOMED MATER RES, V28, P813, DOI 10.1002/jbm.820280708
   Ritchie RO, 1996, J HEART VALVE DIS, V5, pS9
   TANAKA T, 1985, RES REP KOGAKUIN U, V78, P55
   TZOU JL, 1985, ACTA METALL MATER, V33, P117, DOI 10.1016/0001-6160(85)90225-1
   VEKINIS G, 1990, ACTA METALL MATER, V38, P1151, DOI 10.1016/0956-7151(90)90188-M
   WIEDERHORN SM, 1970, J AM CERAM SOC, V53, P543, DOI 10.1111/j.1151-2916.1970.tb15962.x
   WIEDERHORN SM, 1969, J AM CERAM SOC, V52, P485, DOI 10.1111/j.1151-2916.1969.tb09199.x
   Yi KS, 1997, ACTA MATER, V45, P2671, DOI 10.1016/S1359-6454(96)00408-9
NR 19
TC 16
Z9 16
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2000
VL 52
IS 3
BP 488
EP 491
DI 10.1002/1097-4636(20001205)52:3<488::AID-JBM6>3.0.CO;2-W
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 356CQ
UT WOS:000089427100006
PM 11007616
DA 2018-10-20
ER

PT J
AU Gonzales, RJ
   Carter, RW
   Kanagy, NL
AF Gonzales, RJ
   Carter, RW
   Kanagy, NL
TI Laboratory demonstration of vascular smooth muscle function using rat
   aortic ring segments
SO ADVANCES IN PHYSIOLOGY EDUCATION
LA English
DT Article
DE endothelial cell; teaching; physiology
ID CONTRACTION; ARTERY; CELLS
AB This laboratory exercise uses a simple preparation and a straightforward protocol to illustrate many of the basic principles of vascular biology covered in an introductory physiology course. The design of this laboratory allows students to actively participate in an exercise demonstrating the regulation of arterial tone by endothelial and extrinsic factors. In addition, this hands-on laboratory allows students to gather data using well-known basic biomedical research techniques. Specifically, students are introduced to an isolated organ-chamber technique that is widely used to study cellular mechanisms of many tissues including vascular smooth muscle contraction and dilation. On the basis of student evaluations, participation in the experiments and interpreting data reinforce lecture materials on smooth muscle and endothelial cell function and illustrate mechanisms regulating vascular tone. Students come away with a greater understanding of vascular biology, a deeper appreciation of integrative physiology, and an understanding of the process of conducting tissue-chamber experiments.
C1 Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Vasc Physiol Grp,Biomed Res Facil 237, Albuquerque, NM 87131 USA.
RP Kanagy, NL (reprint author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Vasc Physiol Grp,Biomed Res Facil 237, Albuquerque, NM 87131 USA.
CR ALEXANDER PB, 1994, EUR J PHARM-MOLEC PH, V288, P79, DOI 10.1016/0922-4106(94)90012-4
   Barany M., 1996, BIOCH SMOOTH MUSCLE
   BLATTER LA, 1995, AM J PHYSIOL-CELL PH, V268, pC503
   BOLTON TB, 1996, SMOOTH MUSCLE EXCITI
   FREHN C, 1991, AM HEART J, V121, P958
   FUKUIZUMI Y, 1995, BRIT J PHARMACOL, V114, P329, DOI 10.1111/j.1476-5381.1995.tb13231.x
   GONZALES RJ, 1999, CARDIOVASC PHARM THE, V4, P227
   HIINURA JT, 1990, AM J PHYSIOL-HEART C, V259, pH2
   Ishibashi Y, 1997, CIRC RES, V80, P196, DOI 10.1161/01.RES.80.2.196
   Kanagy NL, 1997, AM J PHYSIOL-HEART C, V273, pH2756
   KITAZAWA T, 1991, J BIOL CHEM, V266, P1708
   Lamb FS, 1998, AM J PHYSIOL-HEART C, V275, pH151, DOI 10.1152/ajpheart.1998.275.1.H151
   MORGAN JP, 1991, AM HEART J, V121, P961, DOI 10.1016/0002-8703(91)90227-9
   NAHORSKI SR, 1994, J HYPERTENS, V12, pS133
   Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341
   Tseng CML, 2000, J PHARMACOL EXP THER, V292, P737
   VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315
   WALSH MP, 1995, CAN J PHYSIOL PHARM, V73, P565, DOI 10.1139/y95-072
   XIONG ZL, 1995, J MOL CELL CARDIOL, V27, P75, DOI 10.1016/S0022-2828(08)80009-0
NR 19
TC 12
Z9 12
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1043-4046
J9 ADV PHYSIOL EDUC
JI Adv. Physiol. Educ.
PD DEC
PY 2000
VL 24
IS 1
BP 13
EP 21
PG 9
WC Education, Scientific Disciplines; Physiology
SC Education & Educational Research; Physiology
GA 378NN
UT WOS:000165590600004
PM 11209559
DA 2018-10-20
ER

PT J
AU Ferrari, M
AF Ferrari, Mauro
TI Nanomechanics, and Biomedical Nanomechanics: Eshelby's Inclusion and
   Inhomogeneity Problems at the Discrete/Continuum Interface
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE nanomechanics; continuum/discrete; multi-side; inclusion; inhomogeneity;
   Eshelby
AB The solution of the problem of a large elastostatic matrix, with an embedded eigenstraining inclusion is presented. The inclusion is modeled as an array of discrete points, in accordance with the theory of doublet mechanics (DM), while the matrix is viewed as a conventional continuum. The integration of the two representations affords the simultaneous access to atomic-scale stress and deformation analysis, and retention of the modeling benefits associated with the macroscopic continuum treatment of non-critical material regions. Thus, the theory presented appears suitable for the analysis of the mechanical states in nanotechnological devices, embedded within constraining matrices, biological and otherwise. The linear eigenstrain model employed is applicable to the analysis of nanomechanical states arising from thermal expansion, phase changes, crystallization, differential hygral absorption, and environmental effects such as changes in pH, all occurring within a small subdomain of an homogeneous medium. In parallel with the celebrated approach employed by J. Eshelby in the theory of linear continuum elastostatics, the solution to the nanomechanical inclusion problem is also used to solve the nanomechanical inhomogeneity problem. This consists of a nanoscale material domain embedded within a large volume of a different material, treated herein as a continuum-level matrix. The assembly is loaded by homogeneous displacement conditions at the outer boundary. Modeling the inhomogeneity as an array of discrete nodes, again following the methods of DM, and employing a stress equivalence approach, the nanomechanical states within the inhomogeneity are determined.
C1 Ohio State Univ, Ctr Biomed Engn, Columbus, OH 43210 USA.
RP Ferrari, M (reprint author), Ohio State Univ, Ctr Biomed Engn, Columbus, OH 43210 USA.
CR Boley B.A., 1985, THEORY THERMAL STRES, P1
   CHOPRA NG, 1997, LECT N PH M, V45, P189
   CHU W, 1998, Patent No. 5798042
   Chu WH, 1999, J MICROELECTROMECH S, V8, P34, DOI 10.1109/84.749400
   DESAI TA, 1999, J MEMBRANE SCI, V4132, P1
   Desai TA, 1999, BIOMED MICRODEVICES, V2, P11, DOI 10.1023/A:1009903215959
   ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133
   FERRARI M, 1994, COMPOS ENG, V4, P37, DOI 10.1016/0961-9526(94)90005-1
   FERRARI M, 1994, MAT SCI ENG A-STRUCT, V175, P21, DOI 10.1016/0921-5093(94)91040-5
   Ferrari M., 1997, LECT N PH M, V45, P1
   Imam A., 1997, LECT NOTES PHYS M, V45, P177
   MADDALENA F, 1995, MECH MATER, V20, P241, DOI 10.1016/0167-6636(94)00064-6
   Madou M.J, 1997, FUNDAMENTALS MICROFA, P1
   Matalon O., 1999, THESIS
   Moorthy S, 1998, COMPUT METHOD APPL M, V151, P377, DOI 10.1016/S0045-7825(97)00160-6
   Mura T., 1991, MICROMECHANICS DEFEC, P1
   Nadeau JC, 1998, J ELASTICITY, V52, P43, DOI 10.1023/A:1007539929374
   NADEAU JC, 1997, LECT N PH M, V45, P157
   Peppas NA, 1987, HYDROGELS MED PHARM, P109
   Roco MC, 1999, NAN RES DIR VIS NAN
   Tu JK, 1999, BIOMED MICRODEVICES, V1, P113, DOI 10.1023/A:1009944423778
   Zdeblick M.J., 1993, DESIGN NEWS, P67
NR 22
TC 14
Z9 16
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2000
VL 2
IS 4
BP 273
EP 281
DI 10.1023/A:1009903205275
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA V33LB
UT WOS:000209019200006
DA 2018-10-20
ER

PT J
AU Goldman, M
   Hedetniemi, JN
   Herbert, ER
   Sassaman, JS
   Walker, BC
AF Goldman, M
   Hedetniemi, JN
   Herbert, ER
   Sassaman, JS
   Walker, BC
TI Community outreach at biomedical research facilities
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT Leadership Conference on Biomedical Research and the Environment
CY NOV 01-02, 1999
CL BETHESDA, MARYLAND
SP Natl Assoc Physicians Environm, Assoc Higher Educ Facil Officers, US Natl Inst Environm Hlth Sci, W Alton Jones Fdn, Mitchell Kapor Fdn, Shulsky Fdn, Hahn Family Fdn, Baxter Int Inc
DE active and informed public outreach; community involvement; defusing
   public outrage; public/private partnerships
AB For biomedical researchers to fulfill their responsibility for protecting the environment, they must do more than meet the scientific challenge of reducing the number and volume of hazardous materials used in their laboratories and the engineering challenge of reducing pollution and shifting to cleaner energy sources. They must also meet the public relations challenge of informing and involving their neighbors in these efforts. The experience of the Office of Community Liaison of the National Institutes of Health (NIH) in meeting the latter challenge offers a model and several valuable lessons for other biomedical research facilities to follow. This paper is based on presentations by an expert panel during the Leadership Conference on Biomedical Research and the Environment held 1-2 November 1999 at NIH, Bethesda, Maryland. The risks perceived by community members are often quite different from those identified by officials at the biomedical research facility. The best antidote for misconceptions is more and better information. If community organizations are to be informed participants in the decision-making process, they need a simple but robust mechanism for identifying and evaluating the environmental hazards in their community. Local government can and should be an active and fully informed partner in planning and emergency preparedness. In some cases this can reduce the regulatory burden on the biomedical research facility. In other cases it might simplify and expedite the permitting process or help the facility disseminate reliable information to the community. When a particular risk, real or perceived, is of special concern to the community, community members should be involved in the design, implementation, and evaluation of targeted risk assessment activities. Only by doing so will the community have confidence in the results of those activities. NIH has involved community members in joint efforts to deal with topics as varied as recycling and soil testing. These ad hoc efforts are more likely to succeed if community members and groups have also been included in larger and longer term advisory committees. These committees institutionalize the outreach process. This can provide the facility with vocal and influential allies who create an independent line of communication with the larger community.
C1 NIH, Off Community Liaison, Bethesda, MD 20892 USA.
   Dept Environm Protect, Rockville, MD USA.
   Opus Grp LLC, Chapel Hill, NC USA.
   Howard Univ, Med Ctr, Off Environm & Occupat Med, Washington, DC 20059 USA.
RP Hedetniemi, JN (reprint author), NIH, Off Community Liaison, Bldg 1,Rm 259, Bethesda, MD 20892 USA.
CR SASSAMAN JF, 1981, MTR80W298 US EPA
NR 1
TC 0
Z9 0
U1 0
U2 1
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD DEC
PY 2000
VL 108
SU 6
BP 1009
EP 1013
DI 10.1289/ehp.00108s61009
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 386TP
UT WOS:000166077900009
PM 11124126
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Dufault, R
   Abelquist, E
   Crooks, S
   Demers, D
   DiBerardinis, L
   Franklin, T
   Horowitz, M
   Petullo, C
   Sturchio, G
AF Dufault, R
   Abelquist, E
   Crooks, S
   Demers, D
   DiBerardinis, L
   Franklin, T
   Horowitz, M
   Petullo, C
   Sturchio, G
TI Reducing environmental risk associated with laboratory decommissioning
   and property transfer
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT Leadership Conference on Biomedical Research and the Environment
CY NOV 01-02, 1999
CL BETHESDA, MARYLAND
SP Natl Assoc Physicians Environm, Assoc Higher Educ Facil Officers, US Natl Inst Environm Hlth Sci, W Alton Jones Fdn, Mitchell Kapor Fdn, Shulsky Fdn, Hahn Family Fdn, Baxter Int Inc
DE assessment; characterization; decommissioning; decontamination;
   demolition; environmental; laboratory; liability; remediation;
   renovation
AB The need for more or less space is a common laboratory problem. Solutions may include renovating existing space, leaving or demolishing old space, or acquiring new space or property for building. All of these options carry potential environmental risk. Such risk can be the result of activities related to the laboratory facility or property (e.g., asbestos, underground storage tanks, lead paint), or the research associated with it (e.g., radioactive, microbiological, and chemical contamination). Regardless of the option chosen to solve the space problem, the potential environmental risk must be mitigated and the laboratory space and/or property must be decommissioned or rendered safe prior to any renovation, demolition, or property transfer activities. Not mitigating the environmental risk through a decommissioning process can incur significant financial liability for any costs associated with future decommissioning cleanup activities. Out of necessity, a functioning system, environmental due diligence auditing, has evolved over time to assess environmental risk and reduce associated financial liability. This system involves a 4-phase approach to identify, document, manage, and clean up areas of environmental concern or liability, including contamination. Environmental due diligence auditing includes a) historical site assessment, b) characterization assessment, c) remedial effort and d) final status survey. General practice standards from the American Society for Testing and Materials are available for conducting the first two phases. However, standards have not yet been developed for conducting the third and final phases of the environmental due diligence auditing process. Individuals involved in laboratory decommissioning work in the biomedical research industry consider this a key weakness.
C1 US FDA, Div Facilities Planning Engn & Safety, Rockville, MD 20857 USA.
   Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA.
   MIT, Cambridge, MA 02139 USA.
   USDA, Beltsville, MD USA.
   Analog Devices Inc, Cambridge, MA USA.
   US EPA, Las Vegas, NV 89193 USA.
   Merck Res Labs, Rahway, NJ USA.
RP Dufault, R (reprint author), US FDA, Div Facilities Planning Engn & Safety, HFA-34,5630 Fishers Lane, Rockville, MD 20857 USA.
CR *ASTM, 1997, STAND PRACT ENV SIT, pE1903
   *ASTM, 2000, STAND PRACT ENV STAT, pE1527
   *ASTM, 1999, D3987 ASTM
   Bader M, 1999, Appl Occup Environ Hyg, V14, P369
   Edwards R., 1999, CHEM HLTH SAFE, V6, P4
   *MASCO, 1998, INFR SUBC MAINT GUID
   *NAT AC SCI, 1995, PRUD PRACT HANDL STO
   *NAT I OCC SAF HLT, 1998, NIOSH MAN AN METH
   Ness S., 1994, SURFACE DERMAL MONIT
   Rutala WA, 1996, AM J INFECT CONTROL, V24, P313, DOI 10.1016/S0196-6553(96)90066-8
   SHLEIEN B, 1992, HLTH PHYSICS RADIOLO
   TURNER R, 1995, WATER AIR SOIL PLANT, V80, P1295
   U. S. EPA, 1992, 1311 EPA
   *US EPA, MULT AG RAD SURV SIT
   *US EPA, 1992, 2455 EPA NAT TECHN I
   *US EPA, 1992, 822R93001AB EPA NAT
   *US NUCL REG COMM, 1998, FED REGISTER, V63, P64134
   *US NUCL REG COMM, REG GUID 1 86
NR 18
TC 2
Z9 2
U1 0
U2 1
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD DEC
PY 2000
VL 108
SU 6
BP 1015
EP 1022
DI 10.1289/ehp.00108s61015
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 386TP
UT WOS:000166077900010
PM 11121365
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Guzman, NA
AF Guzman, NA
TI Determination of immunoreactive gonadotropin-releasing hormone in serum
   and urine by on-line immunoaffinity capillary electrophoresis coupled to
   mass spectrometry
SO JOURNAL OF CHROMATOGRAPHY B
LA English
DT Review
DE gonadotropin-releasing hormone; immunoaffinity capillary
   electrophoresis; on-line preconcentration CE
ID ZONE-ELECTROPHORESIS; CLINICAL-CHEMISTRY; LIQUID-CHROMATOGRAPHY; ONLINE
   PRECONCENTRATION; SAMPLE PRECONCENTRATION; FLUORESCENCE MICROSCOPY;
   BIOMEDICAL APPLICATIONS; PROTEIN IDENTIFICATION; GEL-ELECTROPHORESIS;
   BIOLOGICAL-FLUIDS
AB The need for urgent diagnoses has propelled the development of automated analyses that can be performed in a short time at reasonable cost. One such method is immunoaffinity capillary electrophoresis. This emerging hybrid technology employs two powerful techniques coupled on-line for the direct and rapid determination of analytes present in biological fluids. The first technique, immunoaffinity, is used for the selective extraction of a molecule present in a complex matrix, utilizing a microscale-format chamber affinity device. An analyte (affinity target) present in serum or urine is captured by an immobilized molecular recognition antibody molecule (affinity ligand) bound to a solid support constituent (glass beads or an appropriate porous structure) of a microchamber affinity device. The second technique, capillary electrophoresis, is used for the high-resolution analytical separation of the purified and concentrated affinity target material after elution from the microchamber affinity device. In this work, immunoaffinity capillary electrophoresis was developed for the identification and characterization of a single constituent of a complex matrix. Immunoreactive gonadotropin-releasing hormone was determined in serum and urine specimens derived from a normal individual and from a patient suffering from benign prostatic hyperplasia. Furthermore, the on-line immune-separation system was coupled in tandem to mass spectrometry to obtain molecular mass information of the affinity isolated and CE separated neuropeptide. This hybrid immune-analytical technology is simple, rapid, selective and sensitive. In addition, an attempt was also made to characterize other urinary constituents by CE-MS that may lead to marker activity in the urine of the diseased subject. The hyphenation of analytical techniques has proved valuable in enhancing their individual features. The future of bioanalysis using miniaturized affinity systems is discussed in this paper. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 RW Johnson Pharmaceut Res Inst, Raritan, NJ 08896 USA.
RP Guzman, NA (reprint author), RW Johnson Pharmaceut Res Inst, Room B-356, Raritan, NJ 08896 USA.
CR ADVIS JP, 1993, J LIQ CHROMATOGR, V16, P2129, DOI 10.1080/10826079308019920
   Altria KD, 1999, LC GC-MAG SEP SCI, V17, P28
   Altria KD, 1999, J CHROMATOGR A, V856, P443, DOI 10.1016/S0021-9673(99)00830-4
   Anderson BB, 1999, J PHARMACEUT BIOMED, V19, P15, DOI 10.1016/S0731-7085(98)00088-0
   Baba Y, 1999, J BIOCHEM BIOPH METH, V41, P91, DOI 10.1016/S0165-022X(99)00040-8
   Baldwin RP, 1999, J PHARMACEUT BIOMED, V19, P69, DOI 10.1016/S0731-7085(98)00135-6
   Banks JF, 1997, ELECTROPHORESIS, V18, P2255, DOI 10.1002/elps.1150181216
   Bao JJ, 1997, J CHROMATOGR B, V699, P481, DOI 10.1016/S0378-4347(96)00244-7
   Bardelmeijer HA, 1997, ELECTROPHORESIS, V18, P2214, DOI 10.1002/elps.1150181212
   Bardelmeijer HA, 1998, J CHROMATOGR A, V807, P3, DOI 10.1016/S0021-9673(98)00230-1
   Barroso MB, 1998, J CAPILLARY ELECTROP, V5, P1
   Barroso MB, 1999, J AM SOC MASS SPECTR, V10, P1271
   Basso D, 2000, UROLOGY, V55, P710, DOI 10.1016/S0090-4295(99)00596-8
   Bateman KP, 1998, J MASS SPECTROM, V33, P1109, DOI 10.1002/(SICI)1096-9888(199811)33:11<1109::AID-JMS728>3.0.CO;2-1
   BEATTIE JH, 1995, ELECTROPHORESIS, V16, P322, DOI 10.1002/elps.1150160153
   BIGGINS JA, 1984, J NEUROL SCI, V66, P47, DOI 10.1016/0022-510X(84)90140-0
   BLANC T, 1997, ANAL INSTRUM, P1351
   Blaschke G, 2000, J CHROMATOGR A, V875, P3, DOI 10.1016/S0021-9673(00)00134-5
   BOURGUIGNON JP, 1979, J CLIN ENDOCR METAB, V48, P78, DOI 10.1210/jcem-48-1-78
   BURGI DS, 1991, ANAL CHEM, V63, P2042, DOI 10.1021/ac00018a028
   CHIEN RL, 1991, J CHROMATOGR, V559, P141, DOI 10.1016/0021-9673(91)80066-P
   CHIEN RL, 1992, ANAL CHEM, V64, pA489, DOI 10.1021/ac00032a002
   COHEN SM, 1995, FOOD CHEM TOXICOL, V33, P715, DOI 10.1016/0278-6915(95)00040-9
   Colyer CL, 1997, ELECTROPHORESIS, V18, P1733, DOI 10.1002/elps.1150181006
   CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391
   CONN PM, 1991, NEW ENGL J MED, V324, P93
   Cook T, 2000, Oncologist, V5, P162, DOI 10.1634/theoncologist.5-2-162
   Dalluge JJ, 1998, ANAL CHEM, V70, P5339, DOI 10.1021/ac980773u
   de Boer T, 1999, ELECTROPHORESIS, V20, P2989, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<2989::AID-ELPS2989>3.0.CO;2-X
   De Lorenzi E, 1999, Boll Chim Farm, V138, P332
   Dean P.D.G., 1985, AFFINITY CHROMATOGRA
   Dermaux A, 1999, ELECTROPHORESIS, V20, P3027, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3027::AID-ELPS3027>3.0.CO;2-Z
   DEYL Z, 1994, J CHROMATOGR B, V656, P3, DOI 10.1016/0378-4347(94)00035-2
   DICE JF, 1987, FASEB J, V1, P349
   Ding JM, 1999, ANAL CHEM, V71, p378A, DOI 10.1021/ac9904415
   Dolnik V, 2000, ELECTROPHORESIS, V21, P41, DOI 10.1002/(SICI)1522-2683(20000101)21:1<41::AID-ELPS41>3.0.CO;2-7
   Effenhauser CS, 1997, ELECTROPHORESIS, V18, P2203, DOI 10.1002/elps.1150181211
   EGGERS M, 1995, HEMATOL PATHOL, V9, P1
   Ensing K, 1996, J PHARMACEUT BIOMED, V14, P305, DOI 10.1016/0731-7085(95)01607-4
   Figeys D, 1997, J CHROMATOGR A, V763, P295, DOI 10.1016/S0021-9673(96)00847-3
   Figeys D, 1998, ELECTROPHORESIS, V19, P885, DOI 10.1002/elps.1150190603
   Figeys D, 1996, NAT BIOTECHNOL, V14, P1579, DOI 10.1038/nbt1196-1579
   Figeys D, 1998, ELECTROPHORESIS, V19, P2338, DOI 10.1002/elps.1150191314
   GELLER J, 1989, UROLOGY, V34, P57, DOI 10.1016/0090-4295(89)90235-5
   Guetens G, 2000, J CHROMATOGR B, V739, P139, DOI 10.1016/S0378-4347(99)00553-8
   Guzman N.A., 1993, CAPILLARY ELECTROPHO, P643
   GUZMAN NA, 1991, J LIQ CHROMATOGR, V14, P997, DOI 10.1080/01483919108049300
   GUZMAN NA, 1995, J LIQ CHROMATOGR, V18, P3751, DOI 10.1080/10826079508014623
   GUZMAN NA, 1990, J LIQ CHROMATOGR, V13, P3833, DOI 10.1080/01483919008049573
   Guzman NA, 1999, LC GC-MAG SEP SCI, V17, P16
   Guzman NA, 1997, J CHROMATOGR B, V697, P37, DOI 10.1016/S0378-4347(97)00275-2
   GUZMAN NA, 1992, J CELL BIOCHEM, V48, P172, DOI 10.1002/jcb.240480209
   Guzman NA, 1998, CHEM ANAL SERIES MON, V146, P879
   GUZMAN NA, 1989, TECHNIQUES PROTEIN C, P456
   Haginaka J, 2000, J CHROMATOGR A, V875, P235, DOI 10.1016/S0021-9673(99)01168-1
   He JY, 1996, ANAL SCI, V12, P177, DOI 10.2116/analsci.12.177
   Heegaard NHH, 1998, J CHROMATOGR B, V715, P29, DOI 10.1016/S0378-4347(98)00258-8
   Heiger D. N., 1992, HIGH PERFORMANCE CAP
   Hempel G, 2000, ELECTROPHORESIS, V21, P691, DOI 10.1002/(SICI)1522-2683(20000301)21:4<691::AID-ELPS691>3.0.CO;2-U
   HERNANDEZ L, 1991, J CHROMATOGR, V559, P183, DOI 10.1016/0021-9673(91)80069-S
   HERNANDEZ L, 1990, J CHROMATOGR, V502, P247, DOI 10.1016/S0021-9673(01)89589-3
   Herring CJ, 1999, RAPID COMMUN MASS SP, V13, P1, DOI 10.1002/(SICI)1097-0231(19990115)13:1<1::AID-RCM435>3.0.CO;2-A
   HOYT AM, 1993, J MICROCOLUMN SEP, V5, P325, DOI 10.1002/mcs.1220050405
   Jankowiak R, 2000, ELECTROPHORESIS, V21, P1251, DOI 10.1002/(SICI)1522-2683(20000401)21:7<1251::AID-ELPS1251>3.0.CO;2-D
   JELLUM E, 1994, J CAPILLARY ELECTROP, V1, P97
   Jenkins MA, 1997, J CHROMATOGR B, V699, P257, DOI 10.1016/S0378-4347(97)00180-1
   Jenkins MA, 1996, J CHROMATOGR B, V682, P23, DOI 10.1016/0378-4347(95)00552-8
   Jonler Morten, 1994, Drugs, V47, P66
   Kasicka V, 1999, ELECTROPHORESIS, V20, P3084, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3084::AID-ELPS3084>3.0.CO;2-4
   KIESEL L, 1989, J CLIN ENDOCR METAB, V68, P1167, DOI 10.1210/jcem-68-6-1167
   King C, 1998, Clin Lab Sci, V11, P44
   Kinoshita M, 2000, J CHROMATOGR A, V866, P261, DOI 10.1016/S0021-9673(99)01080-8
   Knudsen CB, 1997, J CHROMATOGR A, V792, P463, DOI 10.1016/S0021-9673(97)00857-1
   Kricka LJ, 1998, CLIN CHEM, V44, P2008
   Kutter D, 1998, CLIN CHEM LAB MED, V36, P929, DOI 10.1515/CCLM.1998.161
   LANDERS JP, 1995, CLIN CHEM, V41, P495
   Lehmann R, 1997, J CHROMATOGR B, V697, P3, DOI 10.1016/S0378-4347(97)00183-7
   Lehmann R, 1996, J CAPILLARY ELECTROP, V3, P89
   Lorincz AE, 1999, ANN CLIN LAB SCI, V29, P169
   Manetto G, 2000, THER DRUG MONIT, V22, P84, DOI 10.1097/00007691-200002000-00018
   Marshall T, 1998, ELECTROPHORESIS, V19, P1752, DOI 10.1002/elps.1150191037
   MCDERMOTT JR, 1983, PEPTIDES, V4, P25, DOI 10.1016/0196-9781(83)90160-2
   MCDERMOTT JR, 1981, REGUL PEPTIDES, V2, P69, DOI 10.1016/0167-0115(81)90001-X
   METCALF G, 1982, BRAIN RES REV, V4, P389, DOI 10.1016/0165-0173(82)90012-1
   Miller C, 1998, J PEPT RES, V51, P444
   Misdraji J, 1996, Postgrad Med, V100, P173
   NERENBER C, 1984, ANAL BIOCHEM, V15, P10
   PARK SS, 1996, METHODS MOL BIOL NEU, P101
   PAVONEMACALUSO M, 1991, EUR UROL, V1, P41
   Perrett D, 1999, ANN CLIN BIOCHEM, V36, P133, DOI 10.1177/000456329903600202
   Phillips TM, 1998, ELECTROPHORESIS, V19, P2991, DOI 10.1002/elps.1150191632
   PHILLIPS TM, 1994, BIOMED CHROMATOGR, V8, P242, DOI 10.1002/bmc.1130080509
   REISSMANN T, 1995, HUM REPROD, V10, P1974, DOI 10.1093/oxfordjournals.humrep.a136219
   Schally AV, 1999, PEPTIDES, V20, P1247, DOI 10.1016/S0196-9781(99)00130-8
   SCHALLY AV, 1978, SCIENCE, V202, P18, DOI 10.1126/science.99816
   SCHLEGEL PN, 1994, ADV INTERNAL MED, V39, P569
   Settlage RE, 1998, J MICROCOLUMN SEP, V10, P281, DOI 10.1002/(SICI)1520-667X(1998)10:3<281::AID-MCS7>3.0.CO;2-C
   STRAUSBAUCH MA, 1995, J CHROMATOGR A, V717, P279, DOI 10.1016/0021-9673(95)00743-6
   Strausbauch MA, 1996, ANAL CHEM, V68, P306, DOI 10.1021/ac9503217
   STRAUSBAUCH MA, 1995, ELECTROPHORESIS, V16, P541, DOI 10.1002/elps.1150160189
   SWARTZ ME, 1993, J CHROMATOGR, V632, P209, DOI 10.1016/0021-9673(93)80046-B
   Swinney K, 2000, ELECTROPHORESIS, V21, P1239, DOI 10.1002/(SICI)1522-2683(20000401)21:7<1239::AID-ELPS1239>3.0.CO;2-6
   Swinney K, 2000, CRIT REV ANAL CHEM, V30, P1, DOI 10.1080/10408340091164162
   Timerbaev AR, 1998, J CAPILLARY ELECTROP, V5, P185
   Tomlinson AJ, 1996, J CHROMATOGR A, V744, P3, DOI 10.1016/0021-9673(96)00332-9
   Tomlinson AJ, 1995, J CAPILLARY ELECTROP, V2, P247
   Tong W, 1999, ANAL CHEM, V71, P2270, DOI 10.1021/ac9901182
   UENO H, 1991, J CHROMATOGR-BIOMED, V566, P57, DOI 10.1016/0378-4347(91)80110-X
   von Heeren F, 1997, ELECTROPHORESIS, V18, P2415, DOI 10.1002/elps.1150181232
   von Schalburg KR, 1999, BIOL REPROD, V60, P1338, DOI 10.1095/biolreprod60.6.1338
   Wan H, 1999, ELECTROPHORESIS, V20, P2705, DOI 10.1002/(SICI)1522-2683(19990901)20:13<2705::AID-ELPS2705>3.3.CO;2-7
   Wijnen PAHM, 1996, EUR J CLIN CHEM CLIN, V34, P535
   Yahalom D, 2000, MOL PHARMACOL, V57, P718
   Yang Q, 1999, ANAL CHEM, V71, p183A, DOI 10.1021/ac990246q
   Zaugg S, 2000, J CHROMATOGR A, V875, P27, DOI 10.1016/S0021-9673(99)01042-0
NR 115
TC 61
Z9 62
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4347
J9 J CHROMATOGR B
JI J. Chromatogr. B
PD DEC 1
PY 2000
VL 749
IS 2
BP 197
EP 213
DI 10.1016/S0378-4347(00)00410-2
PG 17
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 378MM
UT WOS:000165588200007
PM 11145057
DA 2018-10-20
ER

PT J
AU Sepulveda, P
   Ortega, FS
   Innocentini, MDM
   Pandolfelli, VC
AF Sepulveda, P
   Ortega, FS
   Innocentini, MDM
   Pandolfelli, VC
TI Properties of highly porous hydroxyapatite obtained by the gelcasting of
   foams
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID CELLULAR CERAMICS
AB Open-cell hydroxyapatite (HA) foams, produced through the novel technique of gelcasting foams with relative porosities ranging from 0.72 to 0.90, were characterized for pore-size distribution, surface area, permeability, compressive strength, elastic modulus, and microstructural features. The porous structure, which is composed of an array of spherical cells interconnected through windows, had a mode pore diameter in the range 17-122 mum, as demonstrated by mercury porosimetry, The BET specific surface area increased from 1.5 to 3.8 m(2)/g as the sample porosity increased. The compressive strength and elastic modulus were in the range 1.6-5.8 MPa and 3.6-21.0 GPa, respectively. The permeability constants, k(1) (Darcian) and k(2) (non-Darcian), were strongly dependent on porosity fraction and varied widely, from 1.22 x 10(-11) to 4.31 x 10(-10) m(2) and from 1.75 x 10(-6) to 8.06 x 10(-5) m, respectively. This combination of properties make the HA foams suitable for a variety of potential applications in the biomedical field, preferentially nonloading, including materials for bone repair, carriers for controlled drug-delivery systems, and matrixes for tissue engineering.
C1 Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP Sepulveda, P (reprint author), Univ London Imperial Coll Sci Technol & Med, London, England.
RI Ortega, Fernando/J-9762-2012; Innocentini, Murilo/B-8775-2012;
   Sepulveda, Pilar/D-4093-2009
OI Ortega, Fernando/0000-0001-5915-2453; Innocentini,
   Murilo/0000-0002-5396-7798
CR Brezny R., 1987, J AM CERAM SOC, V70, P827
   FABRI M, 1995, BIOMATERIALS, V16, P225
   Gibson LJ, 1997, CAMBRIDGE SOLID STAT
   HENCH L, 1993, INTRO BIOCERAMICS
   Innocentini MDM, 1998, J AM CERAM SOC, V81, P3349, DOI 10.1111/j.1151-2916.1998.tb02782.x
   INNOCENTINI MDM, 1999, B AM CERAM SOC, V78, P78
   Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Sepulveda P, 1997, AM CERAM SOC BULL, V76, P61
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   Sepulveda P, 2000, J BIOMED MATER RES, V50, P27, DOI 10.1002/(SICI)1097-4636(200004)50:1<27::AID-JBM5>3.0.CO;2-6
NR 11
TC 163
Z9 180
U1 3
U2 45
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, PO BOX 6136, WESTERVILLE, OH 43081-6136 USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD DEC
PY 2000
VL 83
IS 12
BP 3021
EP 3024
DI 10.1111/j.1151-2916.2000.tb01677.x
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 381DD
UT WOS:000165746300020
DA 2018-10-20
ER

PT J
AU Ektessabi, AM
   Yamaguchi, K
AF Ektessabi, AM
   Yamaguchi, K
TI Changes in chemical states of PET films due to low and high energy
   oxygen ion beam
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 27th International Conference on Metallurgical Coatings and Thin Films
CY APR 10-14, 2000
CL SAN DIEGO, CALIFORNIA
SP Amer Vacuum Soc, Adv Surface Engn Div
DE oxygen ion beam irradiation; polymer; XPS; high energy ion beam
ID POLY(METHYL METHACRYLATE); SURFACE; XPS; POLYSTYRENE; IRRADIATION;
   POLYIMIDE; AFM
AB The effects of low (1.0, 3.0 keV) and high (1.0 MeV) energy reactive oxygen ion beam irradiation on surface nano-morphology and chemical state of the constituent elements in the surface layer of a polyethylene terephthalate thin him (thickness 25 mum) are studied in this paper. PET thin film, which has a high potential as a material for biomedical and electrical industries, was irradiated by oxygen ions of variable doses. The treated films were investigated by Atomic Force Microscopy (AFM) and X-ray Photoelectron Spectroscopy (XPS). AFM observation revealed that an increase in dose increased the surface roughness. The significant changes in the chemical composition of the surface layer were confirmed by XPS quantitatively. The scission of the chains in the surface layer of PET film was induced by oxygen ion beam irradiation, and the atomic ratio (O1s/C1s) was decreased. The selective sputtering of oxygen atoms in PET film was occurred. This phenomenon is responsible for the creation of carbon-rich surface layer. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Kyoto Univ, Grad Sch Engn, Dept Precis Engn, Sakyo Ku, Kyoto 6068501, Japan.
RP Ektessabi, AM (reprint author), Kyoto Univ, Grad Sch Engn, Dept Precis Engn, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.
CR BOULANGER P, 1993, J ELECTRON SPECTROSC, V63, P53, DOI 10.1016/0368-2048(93)85014-C
   BRIGGS D, 1990, PRACTICAL SURFACE AN
   CALCAGNO L, 1993, J APPL PHYS, V74, P7572, DOI 10.1063/1.354983
   CALCAGNO L, 1992, PHYS REV B, V46, P10573, DOI 10.1103/PhysRevB.46.10573
   De Bonis A, 1999, NUCL INSTRUM METH B, V151, P101, DOI 10.1016/S0168-583X(99)00135-4
   Eckstein W., 1991, COMPUTER SIMULATION
   Ektessabi AM, 2000, REV SCI INSTRUM, V71, P1012, DOI 10.1063/1.1150375
   Ektessabi AM, 2000, THIN SOLID FILMS, V377, P621, DOI 10.1016/S0040-6090(00)01444-9
   GODOVSKY YK, 1992, THERMOPHYSICAL PROPE, pCH2
   Hayes NW, 1996, SURF INTERFACE ANAL, V24, P723, DOI 10.1002/(SICI)1096-9918(19960930)24:10<723::AID-SIA186>3.0.CO;2-Y
   LIDE DR, 1992, CRC HDB CHEM PHYSICS
   MARLETTA G, 1990, NUCL INSTRUM METH B, V46, P295, DOI 10.1016/0168-583X(90)90716-8
   PAPALEO RM, 1996, PHYS REV B, V53
   Pignataro B, 1997, NUCL INSTRUM METH B, V131, P141, DOI 10.1016/S0168-583X(97)00297-8
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   SOMMER F, 1995, LANGMUIR, V11, P440, DOI 10.1021/la00002a013
   Svorcik V, 1998, NUCL INSTRUM METH B, V142, P349, DOI 10.1016/S0168-583X(98)00288-2
   Svorcik V, 1999, POLYM DEGRAD STABIL, V65, P131, DOI 10.1016/S0141-3910(98)00228-6
   Svorcik V, 1998, MATER LETT, V36, P128, DOI 10.1016/S0167-577X(98)00030-5
   UENO K, 1991, NUCL INSTRUM METH B, V59, P1263
   VENKATESAN T, 1987, ION BEAM MODIFICATIO, V2, P8
   Voronin G, 2000, NUCL INSTRUM METH B, V161, P1118, DOI 10.1016/S0168-583X(99)00988-X
   VORONIN G, 2000, METHODS PHYS RES B, V161, P1118
   WONG PC, 1995, APPL SURF SCI, V84, P245, DOI 10.1016/0169-4332(94)00549-4
NR 24
TC 44
Z9 45
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD DEC 1
PY 2000
VL 377
BP 793
EP 797
DI 10.1016/S0040-6090(00)01454-1
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 385VD
UT WOS:000166024600135
DA 2018-10-20
ER

PT J
AU Teoh, SH
AF Teoh, SH
TI Fatigue of biomaterials: a review
SO INTERNATIONAL JOURNAL OF FATIGUE
LA English
DT Review
DE fatigue; biomaterials; wear debris; host tissue reaction; fatigue and
   wear resistant
ID CARBON-COATED GRAPHITE; MECHANICAL HEART-VALVE; CYCLIC FATIGUE;
   BIOMEDICAL APPLICATIONS; FRACTURE-TOUGHNESS; CRACK PROPAGATION; LIFE
   PREDICTION; WEAR; POLYETHYLENE; BEHAVIOR
AB Fatigue fracture and wear have been identified as some of the major problems associated with implant failure of medical devices. The actual in vivo mechanisms are complex and involve the hostile body environment. The response of the host tissue to wear debris is a real issue. Fatigue-wear corrosion and environmental stress cracking are common. Although fatigue fracture and wear are frequently reported in orthopaedic applications such as hip joint prostheses, they can be fatal in mechanical heart valves. While it is not possible to avoid failure, recent work has focused on predictive tools to enable more accurate prediction so as to avoid catastrophic failure in vivo. This paper presents an overview of fatigue fracture problems in metallic, polymeric and ceramic implant materials, looks at some recent techniques of testing and discusses the future development of fracture and wear resistant biomaterials. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Natl Univ Singapore, Dept Mech & Prod Engn, Ctr Biomed Mat Applicat & Technol, Lab Biomed Engn,Inst Engn Sci, Singapore 119260, Singapore.
RP Teoh, SH (reprint author), Natl Univ Singapore, Dept Mech & Prod Engn, Ctr Biomed Mat Applicat & Technol, Lab Biomed Engn,Inst Engn Sci, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
CR Auger D D, 1995, Proc Inst Mech Eng H, V209, P73, DOI 10.1243/PIME_PROC_1995_209_323_02
   BERGER G, 1989, P 15 INT C GLASS A, V3, P120
   Black J, 1998, HDB BIOMATERIALS P 2
   Black J, 1999, BIOL PERFORMANCE MAT
   CAI HD, 1994, J MATER RES, V9, P762, DOI 10.1557/JMR.1994.0762
   CHO SJ, 1989, J AM CERAM SOC, V72, P249
   CHOW AB, 1994, T 20 ANN M SOC BIOM, P434
   CLARKE I, 1980, MECH PROPERTIES BIOM, P27
   DAUSKARDT RH, 1994, J BIOMED MATER RES, V28, P791, DOI 10.1002/jbm.820280706
   DUMBLETON JH, 1979, ASTM STP, V684, P41
   ENGH GA, 1992, J BONE JOINT SURG BR, V74, P9
   EVAN AG, 1980, INT J FRACTURE, V108, P153
   FRANZEN H, 1990, ACTA ORTHOP SCAND, V61, P499, DOI 10.3109/17453679008993570
   GIBBSON DF, 1979, ASTM STP, V684, P20
   Greco R., 1994, IMPLANTATION BIOL HO
   KELLY JR, 1995, DENT MATER, V11, P103, DOI 10.1016/0109-5641(95)80043-3
   KELPETKO V, 1989, J THORAC CARDIOVASC, V97, P90
   Kepner J, 1996, J HEART VALVE DIS, V5, pS50
   KOKUBO T, 1989, MULTIPHASE BIOMEDICA
   LI J, 1998, HDB BIOMATERIALS PRO, P341
   LLOYD CH, 1984, J ORAL REHABIL, V11, P257, DOI 10.1111/j.1365-2842.1984.tb00575.x
   LUCKEY HA, 1980, MECH PROPERTIES BIOM, P311
   MANSON SS, 1971, ASTM STP, V495, P254
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   Medley JB, 1997, P I MECH ENG H, V211, P89, DOI 10.1243/0954411971534719
   Paris P., 1963, J BASIC ENG, V8, P528, DOI DOI 10.1115/1.3656900
   Pruitt L, 1998, POLYMER, V39, P1545, DOI 10.1016/S0032-3861(97)00448-5
   Reul H, 1996, J HEART VALVE DIS, V5, pS97
   RITCHIE RO, 1991, NIPPON SERAM KYO GAK, V99, P1047
   RITCHIE RO, 1990, J BIOMED MATER RES, V24, P189, DOI 10.1002/jbm.820240206
   Ritchie RO, 1996, J HEART VALVE DIS, V5, pS9
   RITCHIE RO, 1991, P ENG FDN INT C SANT, P485
   SAIKAYA M, 1992, STRUCTURE CELLULAR S, pCH1
   SEMLITSCH M, 1984, METAL CERAMIC BIOMAT, V2, P1
   STJOHN KR, 1992, ASTM STP, V1144
   Suresh S., 1998, FATIGUE MAT
   SYRETT BC, 1979, ASTM STP, V684
   TAIRA M, 1992, J BIOMED MATER RES, V26, P1131, DOI 10.1002/jbm.820260903
   Teoh S H, 1993, ASAIO J, V39, P929
   Teoh S. H., 1992, International Journal of Damage Mechanics, V1, P245, DOI 10.1177/105678959200100205
   Teoh S H, 1990, ASAIO Trans, V36, pM417
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
   Teoh SH, 1998, WEAR, V214, P237, DOI 10.1016/S0043-1648(97)00231-7
   TEOH SH, 1994, AM SOC TEST MATER, V1173, P77, DOI 10.1520/STP18095S
   TEOH SH, 1993, BIOMATERIALS, V14, P132, DOI 10.1016/0142-9612(93)90226-R
   TEOH SH, 1990, POLYMER, V31, P2260, DOI 10.1016/0032-3861(90)90311-L
   TEOH SH, 1994, AM SOC TEST MATER, V1173, P43, DOI 10.1520/STP18092S
   TRAINOR A, 1980, MECH PROPERTIES BIOM, P65
   TRUONG VT, 1988, DENT MATER, V4, P318, DOI 10.1016/S0109-5641(88)80044-7
   TSURUTA T, 1989, MULIPHASE BIOMEDICAL
   *US DHHS, 1994, REPL HEART VALV GUID
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   YAMADA H, 1970, STRENGTH BIOL MAT
   YAMAMOTO A, 1995, J JPN I MET, V59, P463, DOI 10.2320/jinstmet1952.59.4_463
NR 54
TC 187
Z9 188
U1 1
U2 77
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-1123
J9 INT J FATIGUE
JI Int. J. Fatigue
PD NOV
PY 2000
VL 22
IS 10
BP 825
EP 837
DI 10.1016/S0142-1123(00)00052-9
PG 13
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 373WU
UT WOS:000165313700002
DA 2018-10-20
ER

PT J
AU Niinomi, M
   Saga, A
   Fukunaga, K
AF Niinomi, M
   Saga, A
   Fukunaga, K
TI Long crack growth behavior of implant material Ti-5Al-2.5Fe in air and
   simulated body environment related to microstructure
SO INTERNATIONAL JOURNAL OF FATIGUE
LA English
DT Article
DE Ti-5Al-2.5Fe; Ti-6Al-4V ELI; SUS 316L stainless steel; implant material;
   fatigue crack propagation; crack closure; secondary crack; fracture
   surface roughness; microstructure
ID FATIGUE
AB The fatigue crack propagation behavior of Ti-5Al-2.5Fe with various microstructures for biomedical applications was investigated in air and in a simulated body environment, Ringer's solution, in comparison with that of Ti-6Al-4V ELI and that of SUS 316L stainless steel. The crack propagation rate, da/dN, of Ti-5Al-2.5Fe in the case of each microstructure is greater than that of the Widmanstatten alpha structure in Ti-6Al-4V ELI in air whereas da/dN of Ti-5Al-2.5Fe is nearly equal to that of the equiaxed a structure in Ti-6Al-4V ELI in air when da/dN is plotted versus the nominal cyclic stress intensity factor range, DeltaK. da/dN of the equiaxed a structure and that of the Widmanstatten a structure in Ti-5Al-2.5Fe are nearly the same in air when da/dN is plotted Versus DeltaK. da/dN of Ti-5Al-2.5Fe is nearly equal to that of SUS 316L stainless steel in the Paris Law region, whereas da/dN of Ti-5Al-2.5Fe is greater than that of SUS 316L stainless steel in the threshold region in air, when da/dN is plotted versus DeltaK. da/dN of Ti-5Al-2.5Fe or Ti-6Al-4V ELI is nearly the same in air and in Ringer's solution when da/dN is plotted versus the effective cyclic stress intensity factor range, DeltaK(eff), whereas da/dN of Ti-5Al-2.5Fe or Ti-6Al-4V ELI is greater in Ringer's solution than in air when da/dN is plotted versus DeltaK. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR *ASTM, 1997, E64795A ASTM
   *ASTM, 1994, F6789 ASTM
   *ASTM, 1994, F13682 ASTM
   *ASTM, 1992, F129592 ASTM
   CHOI SD, 1997, J JAPAN SOC MECH ENG, V63, P2387
   *ISO, 1994, 583211 ISO
   *ISO, 1994, 583210 ISO
   MCCARVER JF, 1982, MATER SCI ENG, V55, P63, DOI 10.1016/0025-5416(82)90084-2
   MINAKAWA K, 1989, TETSU TO HAGANE, V75, P1104, DOI 10.2355/tetsutohagane1955.75.7_1104
   SUMITA M, 1988, TETSU TO HAGANE, V74, P1854, DOI 10.2355/tetsutohagane1955.74.9_1854
   ZWICKER R, 1980, TITANIUM 80 SCI TECH, P505
NR 11
TC 10
Z9 11
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-1123
J9 INT J FATIGUE
JI Int. J. Fatigue
PD NOV
PY 2000
VL 22
IS 10
BP 887
EP 897
DI 10.1016/S0142-1123(00)00058-X
PG 11
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 373WU
UT WOS:000165313700008
DA 2018-10-20
ER

PT J
AU Johnson, GS
   Mucalo, MR
   Lorier, MA
   Gieland, U
   Mucha, H
AF Johnson, GS
   Mucalo, MR
   Lorier, MA
   Gieland, U
   Mucha, H
TI The processing and characterization of animal-derived bone to yield
   materials with biomedical applications. Part II: milled bone powders,
   reprecipitated hydroxyapatite and the potential uses of these materials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IMMOBILIZATION
AB Further studies on the processing and use of animal-bone-derived calcium phosphate materials in biomedical applications are presented. Bone powders sourced either from the direct crushing and milling of bovine, ovine and cervine bone or after being subjected to defatting and acid digestion/NaOH reprecipitation and sodium hypochlorite hydrogen peroxide treatment of animal bones were characterized using Fourier transform infra-red (FTIR) spectroscopy, C-13 solid state magic angle spinning (MAS) nuclear magnetic resonance (NMR) spectroscopy, atomic absorption (AA) and inductively coupled plasma (ICP) spectrometric techniques. Bone powders were trialled for their potential use as a substrate for phosphine coupling and enzyme immobilization as well as a feedstock powder for plasma spraying on titanium metal substrates. Results indicated that enzyme immobilization by phosphine coupling could be successfully achieved on milled cervine bone with the immobilized enzyme retaining some activity. It was found that the presence of impurities normally carried down with the processing of the bone materials (viz., fat and collagen) played an important role in influencing the adsorbency and reactivity of the powders. Plasma spraying studies using reprecipitated bovine-derived powders produced highly adherent coatings on titanium metal, the composition of which was mostly hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) with low levels of alpha-tricalcium phosphate (alpha-Ca-3(PO4)(2)) and tetracalcium phosphate (Ca4P2O9) also detected. In general, animal derived calcium phosphate materials constitute a potentially cheaper source of calcium phosphate materials for biomedical applications and make use of a largely under-utilized resource from abattoir wastes. (C) 2000 Kluwer Academic Publishers.
C1 Univ Waikato, Dept Chem, Hamilton, New Zealand.
   MIRINZ Food Technol & Res Ltd, Hamilton, New Zealand.
   Chemnitz Tech Univ, Inst Verbundwerkstoffe, D-09125 Chemnitz, Germany.
RP Mucalo, MR (reprint author), Univ Waikato, Dept Chem, Private Bag 3105, Hamilton, New Zealand.
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR *ASS OFF AN CHEM, 1995, AOAC INT, V2, P7
   *ASTEMF, 118588 ASTEMF
   Cochrane FC, 1996, ENZYME MICROB TECH, V18, P373, DOI 10.1016/0141-0229(95)00134-4
   EVERSE J, 1981, METHOD BIOCHEM ANAL, P135
   FRAYSSINET P, 1995, J MATER SCI-MATER M, V6, P473, DOI 10.1007/BF00123372
   HENCH L, 1993, ADV SERIES CERAMICS, V1, P154
   HENDERSON W, 1994, J CHEM SOC CHEM COMM, P1863, DOI 10.1039/c39940001863
   HENDERSON W, 1994, EUR POLYM J, V31, P981
   HENDERSON W, COMMUNICATION
   JOHNSON GS, IN PRESS J MAT SCI M
   KANO S, 1992, APATITE, V1, P91
   KEMP W, 1986, NMR CHEM MULTINUCLEA, P217
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   PETACH HH, 1994, J CHEM SOC CHEM COMM, P2181, DOI 10.1039/c39940002181
   Savarino L, 1998, J MATER SCI-MATER M, V9, P109, DOI 10.1023/A:1008855216755
   *US PHARM CONV INC, 1985, US PHARM 21 REV, P1104
   Weil E. D., 1992, HDB ORGANOPHOSPHORUS
   YETERDAL BF, 1992, P INT CER C AUSTR 19, P617
NR 18
TC 22
Z9 24
U1 2
U2 15
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2000
VL 11
IS 11
BP 725
EP 741
DI 10.1023/A:1008979929632
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359KX
UT WOS:000089611000009
PM 15348079
DA 2018-10-20
ER

PT J
AU Anderson, LA
   Mucalo, MR
   Johnson, GS
   Lorier, MA
AF Anderson, LA
   Mucalo, MR
   Johnson, GS
   Lorier, MA
TI The processing and characterization of animal-derived bone to yield
   materials with biomedical applications. Part III: material and
   mechanical properties of fresh and processed bovine cancellous bone
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BEHAVIOR; MODULUS
AB Conversion of bovine cancellous bone to a useful biomedical xenograft material involves several processing steps which include boiling, defatting and deproteination (i.e. bleaching). This study has shown how these processes can influence cancellous bone modulus and strength. It was found that prolonged boiling in water for six hours followed by NaOCI bleaching had a deleterious effect on the overall strength of the bovine bone. In contrast, bone samples subjected to only moderate boiling (1.5 hours) exhibited a 22% stiffness increase due mainly to the effects of drying. The same stiffened samples, when subjected to the bleaching procedure, retained some strength with only a small reduction in moduli values. It can be concluded that careful control of defatting and bleaching procedures on bovine bone is able to give a strong, albeit, brittle material with preservation of the original bone architecture. The bone xenograft materials are worthy of further investigation in in vivo clinical trials to assess their performance in contact with biological fluids. (C) 2000 Kluwer Academic Publishers.
C1 Ind Res Ltd, Engn Dynam Team, Auckland, New Zealand.
   Univ Waikato, Dept Chem, Hamilton, New Zealand.
   MIRINZ Food Technol & Res Ltd, Hamilton, New Zealand.
RP Anderson, LA (reprint author), Ind Res Ltd, Engn Dynam Team, POB 2225, Auckland, New Zealand.
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR *AM SOC MET, MET HDB, V2, P117
   ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4
   EVANS FG, 1973, MECH PROPERTIES BONE
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   GONG JK, 1964, ANAT REC, V149, P325, DOI 10.1002/ar.1091490303
   JOHNSON GS, 2000, IN PRESS J MAT SCI M
   KEAVENY TM, 1994, J BIOMECH, V27, P1137, DOI 10.1016/0021-9290(94)90054-X
   LINDE F, 1989, J BIOMECH, V22, P485, DOI 10.1016/0021-9290(89)90209-1
   PIEKARSKI K, 1973, INT J ENG SCI, V11, P557, DOI 10.1016/0020-7225(73)90018-9
   SINGH I, 1978, J ANAT, V127, P305
   TOWNSEND PR, 1975, J BIOMECH, V8, P199, DOI 10.1016/0021-9290(75)90025-1
   TURNER C H, 1989, Journal of Biomechanical Engineering, V111, P256
   TURNER CH, 1988, J BIOMECH ENG-T ASME, V110, P213, DOI 10.1115/1.3108433
NR 13
TC 15
Z9 15
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2000
VL 11
IS 11
BP 743
EP 749
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359KX
UT WOS:000089611000010
PM 15348080
DA 2018-10-20
ER

PT J
AU El Fray, M
   Bartkowiak, A
   Prowans, P
   Slonecki, J
AF El Fray, M
   Bartkowiak, A
   Prowans, P
   Slonecki, J
TI Physical and mechanical behavior of electron-beam irradiated and
   ethylene oxide sterilized multiblock polyester
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLYACTIVE(TM); COPOLYMERS
AB The effect of two sterilization treatments (electron-beam radiation and ethylene oxide gas) on the structure and mechanical properties of a multiblock copolymer were investigated to establish the effects of the sterilizing procedures on potential biomedical material. The material was exposed for different radiation doses in order to find an optimum dose of electron-beam radiation. Characterization techniques employed include gel permeation chromatography, infrared spectroscopy, differential scanning calorimetry, dynamic mechanical thermal analysis and tensile testing. The optimal dose of radiation at which no change in structure and mechanical properties occurred was found as 25 kGy. Ethylene oxide gas treatment also did not affect the structure and properties of the polymer and it can be recommended as an alternative sterilization route for the studied polymer. (C) 2000 Kluwer Academic Publishers.
C1 Tech Univ Szczecin, Sect Elastomers & Polymer Fibers Technol, PL-70322 Szczecin, Poland.
   Tech Univ Szczecin, Inst Polymer, PL-70322 Szczecin, Poland.
   Pomeranian Acad Med, Szczecin, Poland.
RP El Fray, M (reprint author), Tech Univ Szczecin, Sect Elastomers & Polymer Fibers Technol, Pulaskiego 10 Str, PL-70322 Szczecin, Poland.
RI Bartkowiak, Artur/C-3322-2011; El Fray, Miroslawa/J-4128-2016; Prowans,
   Piotr/B-5495-2015
OI Prowans, Piotr/0000-0002-6102-364X; El Fray,
   Miroslawa/0000-0002-2474-3517
CR ADAMS RK, 1996, THERMOPLASTIC ELASTO, P192
   BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BAKKUM EA, 1995, J MATER SCI-MATER M, V6, P41, DOI 10.1007/BF00121246
   Bouwmeester SJM, 1998, J MATER SCI-MATER M, V9, P181, DOI 10.1023/A:1008875821298
   CAMBERLIN Y, 1984, J POLYM SCI POL PHYS, V22, P1835, DOI 10.1002/pol.1984.180221011
   Domb AJ, 1994, BIOMEDICAL POLYM, P69
   El Fray M, 1998, J MACROMOL SCI PHYS, VB37, P143
   El Fray M, 1996, ANGEW MAKROMOL CHEM, V234, P103
   ELFRAY M, 1996, KAUTSCH GUMMI KUNSTS, V10, P691
   Hoeschele G K, 1976, Patent No. [US 3954689, 3954689]
   LEMBICZ F, 1991, KAUT GUMMI KUNSTST, V44, P668
   Lembicz F, 1998, J MACROMOL SCI PHYS, VB37, P161, DOI 10.1080/00222349808220464
   Liu Q, 1998, J MATER SCI-MATER M, V9, P23, DOI 10.1023/A:1008826410395
   MacRae HM, 1997, SURGERY, V122, P335, DOI 10.1016/S0039-6060(97)90025-8
   MODY PC, 1981, J APPL POLYM SCI, V26, P2853, DOI 10.1002/app.1981.070260904
   RADDER AM, 1995, J MATER SCI-MATER M, V6, P510, DOI 10.1007/BF00151031
   Shivers Jr J. C., 1962, US patent, Patent No. [3,023,192, 3023192]
   VANHAASTERT RM, 1994, J MATER SCI-MATER M, V5, P764, DOI 10.1007/BF00120373
NR 18
TC 22
Z9 22
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2000
VL 11
IS 11
BP 757
EP 762
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359KX
UT WOS:000089611000012
PM 15348082
DA 2018-10-20
ER

PT J
AU Cooper, LF
AF Cooper, LF
TI A role for surface topography in creating and maintaining bone at
   titanium endosseous implants
SO JOURNAL OF PROSTHETIC DENTISTRY
LA English
DT Review
ID OSTEOBLAST-LIKE CELLS; SINGLE-TOOTH IMPLANTS; ACID-ETCHED SURFACE;
   RABBIT INTRAMEDULLARY MODEL; COMMERCIALLY PURE TITANIUM; SCREW-SHAPED
   IMPLANTS; DENTAL IMPLANTS; IN-VIVO; HISTOMORPHOMETRIC EVALUATION;
   MINIATURE PIGS
AB Statement of problem. A variety of claims are made regarding the effects of surface topography on implant osseointegration. Many in vivo and in vitro experimental observations have key limitations in their interpretations.
   Purpose. This review considers the major claims made concerning the effects of commercially pure (cp) titanium implant surface topography on osseointegration. Important findings of consensus are highlighted, and, existing controversies are revealed.
   Material and methods. This review considers many of the research publications listed in MEDLINE and presented in biomedical research publications and textbooks.
   Results. Implant surface topography is not well defined in the marketplace or consistently reported among experimental studies. Many in vitro evaluations art. not predictive of or correlated with in vivo outcomes. In some culture models, increased surface topography positively affects pro-osteogenic cellular activities. Animal models reveal modest increases in bone-to-implant contact and increases in the biomechanical interlock of the implant with bone for implants of increased surface topography. Existing information fails to define increased surface topography as a risk factor for peri-implant inflammation.
   Conclusion. Increased cp titanium implant surface topography improves the bone-to-implant contact and the mechanical properties of the enhanced interface. Growing clinical evidence for increased bone-to-implant: contact at altered cp titanium implants confirms the temporally limited observations made in preclinical studies. In the absence of controlled comparative clinical trials, the aggregate experimental evidence supports the use of cp titanium implants with increased surface topography.
C1 Univ N Carolina, Sch Dent, Dept Prosthodont, Chapel Hill, NC 27599 USA.
RP Cooper, LF (reprint author), Univ N Carolina, Sch Dent, Dept Prosthodont, 404 Brauer Hall,CB 7450, Chapel Hill, NC 27599 USA.
OI Cooper, Lyndon/0000-0002-6577-781X
CR ABRON A, IN PRESS J PROSTHET
   ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Babbush C A, 1993, Int J Oral Maxillofac Implants, V8, P245
   Baker D, 1999, INT J ORAL MAX IMPL, V14, P722
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x
   Bianco PD, 1996, BIOMATERIALS, V17, P1937, DOI 10.1016/0142-9612(96)00023-3
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   BRUNSKI JB, 1979, J DENT RES, V58, P1953, DOI 10.1177/00220345790580100201
   Buser D, 1998, INT J ORAL MAX IMPL, V13, P611
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Chen GF, 1998, BIO-MED MATER ENG, V8, P61
   Clokie C M, 1995, Int J Oral Maxillofac Implants, V10, P155
   Cochran DL, 1996, CLIN ORAL IMPLAN RES, V7, P240, DOI 10.1034/j.1600-0501.1996.070306.x
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Cole BJ, 1997, CLIN ORTHOP RELAT R, P219
   Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37
   Cooper LF, 1998, J PROSTHET DENT, V80, P439, DOI 10.1016/S0022-3913(98)70009-5
   D'Lima DD, 1998, J ARTHROPLASTY, V13, P928, DOI 10.1016/S0883-5403(98)90201-7
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Deporter D, 1999, CLIN ORAL IMPLAN RES, V10, P95, DOI 10.1034/j.1600-0501.1999.100203.x
   Deporter D A, 1996, Int J Oral Maxillofac Implants, V11, P87
   Drummond J F, 1995, J Oral Implantol, V21, P295
   Edge M J, 1988, Int J Oral Maxillofac Implants, V3, P57
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   Ellingsen JE, 1998, PERIODONTOL 2000, V17, P36, DOI 10.1111/j.1600-0757.1998.tb00121.x
   ERICSSON I, 1994, CLIN ORAL IMPLAN RES, V5, P202, DOI 10.1034/j.1600-0501.1994.050402.x
   FEIGHAN JE, 1995, J BONE JOINT SURG AM, V77, P1380, DOI 10.2106/00004623-199509000-00015
   FROUM SJ, 2000, 86 ANN M AM AC PER H
   Garetto L P, 1995, Implant Dent, V4, P235, DOI 10.1097/00008505-199500440-00002
   Goodman S, 1996, ACTA ORTHOP SCAND, V67, P599, DOI 10.3109/17453679608997764
   GOTFREDSEN K, 1995, J BIOMED MATER RES, V29, P1223, DOI 10.1002/jbm.820291009
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Haas R, 1996, Int J Oral Maxillofac Implants, V11, P581
   Hammerle CHF, 1996, CLIN ORAL IMPLAN RES, V7, P111, DOI 10.1034/j.1600-0501.1996.070204.x
   Han CH, 1998, CLIN ORAL IMPLAN RES, V9, P1, DOI 10.1034/j.1600-0501.1998.090101.x
   Hansson S, 1999, J BIOMECH, V32, P829, DOI 10.1016/S0021-9290(99)00058-5
   Hansson S, 1999, CLIN ORAL IMPLAN RES, V10, P394, DOI 10.1034/j.1600-0501.1999.100506.x
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   Hure G, 1996, Int J Oral Maxillofac Implants, V11, P506
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   Johansson CB, 1998, INT J ORAL MAX IMPL, V13, P315
   Karabuda C, 1999, INT J ORAL MAX IMPL, V14, P510
   Karlsson U, 1997, INT J PROSTHODONT, V10, P318
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KELLER J C, 1985, Dental Materials, V1, P41, DOI 10.1016/S0109-5641(85)80022-1
   Kemppainen P, 1997, J PROSTHET DENT, V77, P382, DOI 10.1016/S0022-3913(97)70163-X
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   KOVACS EJ, 1994, FASEB J, V8, P854
   La Budde J K, 1994, J Arthroplasty, V9, P291, DOI 10.1016/0883-5403(94)90084-1
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lazzara RJ, 1999, INT J PERIODONT REST, V19, P117
   Lekholm U, 1996, Int J Oral Maxillofac Implants, V11, P599
   Levy D, 1996, J CLIN PERIODONTOL, V23, P517, DOI 10.1111/j.1600-051X.1996.tb01819.x
   Li JG, 1997, BIO-MED MATER ENG, V7, P379
   Li JG, 1997, BIOMATERIALS, V18, P691, DOI 10.1016/S0142-9612(96)00185-8
   Liao HH, 1997, CLIN ORAL IMPLAN RES, V8, P68, DOI 10.1111/j.1600-0501.1997.tb00009.x
   Lifland M. I., 1993, Clinical Materials, V14, P13, DOI 10.1016/0267-6605(93)90042-6
   Lind M, 2000, J ARTHROPLASTY, V15, P339, DOI 10.1016/S0883-5403(00)90693-4
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   Luthy H, 1987, Int J Oral Maxillofac Implants, V2, P197
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Masuda T, 1998, INT J ORAL MAX IMPL, V13, P17
   Masuda T, 1997, INT J ORAL MAX IMPL, V12, P472
   Meredith N, 1998, CRIT REV BIOMED ENG, V26, P275, DOI 10.1615/CritRevBiomedEng.v26.i4.20
   MUSTAFA K, 2000, J DENT RES, V79, P101
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Norton MR, 1998, CLIN ORAL IMPLAN RES, V9, P91, DOI 10.1034/j.1600-0501.1998.090204.x
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Ohtsu A, 1997, J PERIODONTOL, V68, P270, DOI 10.1902/jop.1997.68.3.270
   Ong JL, 1997, INT J ORAL MAX IMPL, V12, P649
   OSBORN JF, 1990, ADV BIOMAT, V9, P75
   Palmer RM, 1997, CLIN ORAL IMPLAN RES, V8, P173, DOI 10.1034/j.1600-0501.1997.080303.x
   Pebe P, 1997, Implant Dent, V6, P259
   Pilliar R M, 1998, Implant Dent, V7, P305, DOI 10.1097/00008505-199807040-00009
   Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   Ramp LC, 2000, INT J ORAL MAX IMPL, V15, P197
   Rasmusson L, 1998, INT J ORAL MAX SURG, V27, P229, DOI 10.1016/S0901-5027(98)80019-2
   Rimondini L, 1997, J PERIODONTOL, V68, P556, DOI 10.1902/jop.1997.68.6.556
   Roberts W E, 1988, J Dent Educ, V52, P804
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   Schliephake H, 1993, Int J Oral Maxillofac Implants, V8, P502
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   Skripitz R, 1998, ACTA ORTHOP SCAND, V69, P315, DOI 10.3109/17453679809000938
   Smith DC, 1997, INT J ORAL MAX IMPL, V12, P828
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   STANFORD CM, 1994, J DENT RES, V73, P1061, DOI 10.1177/00220345940730050801
   Stanford CM, 1999, J PROSTHET DENT, V81, P553, DOI 10.1016/S0022-3913(99)70209-X
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4
   TAKATSUKA K, 1995, J BIOMED MATER RES, V29, P157, DOI 10.1002/jbm.820290204
   TORGERSEN S, 1995, ACTA ODONTOL SCAND, V53, P65, DOI 10.3109/00016359509005948
   Trisi P, 1999, INT J ORAL MAX IMPL, V14, P689
   Vaillancourt H, 1996, Int J Oral Maxillofac Implants, V11, P351
   Wang JC, 1999, SPINE, V24, P899, DOI 10.1097/00007632-199905010-00011
   WENNEBERG A, IN PRESS CLIN ORAL I
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Wennerberg A, 1996, J BIOMED MATER RES, V30, P251, DOI 10.1002/(SICI)1097-4636(199602)30:2<251::AID-JBM16>3.0.CO;2-P
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   Wennerberg A, 1997, INT J ORAL MAX IMPL, V12, P486
   WENNERBERG A, 1992, J BIOMED ENG, V14, P412, DOI 10.1016/0141-5425(92)90087-2
   Wennerberg A., 1996, THESIS U GOTHENBURG
   Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P340
   Wiskott HWA, 1999, CLIN ORAL IMPLAN RES, V10, P429, DOI 10.1034/j.1600-0501.1999.100601.x
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   YAMANAKA E, 1992, TRANSPLANTS IMPLANTS, V2, P245
NR 129
TC 195
Z9 203
U1 2
U2 37
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-3913
J9 J PROSTHET DENT
JI J. Prosthet. Dent.
PD NOV
PY 2000
VL 84
IS 5
BP 522
EP 534
DI 10.1067/mpr.2000.111966
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 380JA
UT WOS:000165697000008
PM 11105008
DA 2018-10-20
ER

PT J
AU Biederman, H
AF Biederman, H
TI RF sputtering of polymers and its potential application
SO VACUUM
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Sputtering and Plasma Precesses (ISSP 99)
CY JUN 16-18, 1999
CL KANAZAWA, JAPAN
SP Japan Soc Appl Phys
ID PLASMA POLYMERIZATION; FILMS
AB Plasma polymerization processes are commonly used for the deposition of thin films of plasma polymers that have been proposed for a variety of applications ranging from surface modifications for biomedical purposes to optical coatings and variable and protective films in electronics. RF sputtering of polymeric materials in an inert gas (Ar) or in its own fragmented polymer vapours can be applied in order to avoid the conventional supply of gaseous monomer. Volatile fragments of polymeric target serve as plasma polymerization precursors in the case of RF sputtering. RF sputtering of polytetrafluoroethylene (PTFE), polyimide (PI), etc. are reviewed. Recent results from our laboratory on balanced and unbalanced magnetron RF sputtering of polytetrafluoroethylene and polyethylene (PE) are presented. The dependence of structure and morphology Of RF sputtered plasma polymers on plasma parameters and substrate temperature is discussed. In conclusion potential applications are summarized. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Charles Univ, Fac Math & Phys, Dept Macromol Phys, CR-18000 Prague 8, Czech Republic.
RP Biederman, H (reprint author), Charles Univ, Fac Math & Phys, Dept Macromol Phys, V Holesovickach 2, CR-18000 Prague 8, Czech Republic.
OI Biederman, Hynek/0000-0003-4061-8481
CR BIEDERMAN H, 1978, THIN SOLID FILMS, V55, pL11, DOI 10.1016/0040-6090(78)90170-0
   BIEDERMAN H, 1977, THIN SOLID FILMS, V41, P329, DOI 10.1016/0040-6090(77)90319-4
   Biederman H, 1997, J NON-CRYST SOLIDS, V218, P44, DOI 10.1016/S0022-3093(97)00196-8
   BIEDERMAN H, 1983, NUCL INSTRUM METHODS, V212, P497, DOI 10.1016/0167-5087(83)90735-4
   BIEDERMAN H, 1981, VACUUM, V31, P285, DOI 10.1016/S0042-207X(81)80498-8
   BIEDERMAN H, 1998, 3 C P PHYS CHEM MOL, P35
   BIEDERMAN H, 1992, PLAMA POLYMERISATION
   BIEDERMAN H, 1997, P ISPC 13, V3, P1264
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   HARROP R, 1969, THIN SOLID FILMS, V3, P109, DOI 10.1016/0040-6090(69)90083-2
   HISMEH GA, 1996, J VAC SCI TECHNOL A, V14, P1330
   HOLLAND L, 1997, THIN SOLID FILMS, V35, P19
   Kitoh M, 1995, THIN SOLID FILMS, V271, P92, DOI 10.1016/0040-6090(95)06697-7
   LEHMANN HW, 1978, THIN SOLID FILMS, V52, P231, DOI 10.1016/0040-6090(78)90141-4
   MARECHAL N, 1992, J VAC SCI TECHNOL A, V10, P477, DOI 10.1116/1.578174
   MORRISON DT, 1973, THIN SOLID FILMS, V15, P87, DOI 10.1016/0040-6090(73)90207-1
   PRATT IH, 1972, THIN SOLID FILMS, V10, P151, DOI 10.1016/0040-6090(72)90281-7
   ROY RA, 1983, THIN SOLID FILMS, V109, P27, DOI 10.1016/0040-6090(83)90028-7
   RYAN ME, 1995, J PHYS CHEM-US, V99, P7060, DOI 10.1021/j100018a044
   TIBBITT JM, 1975, THIN SOLID FILMS, V39, pL43
   YAMADA Y, 1990, SURF COAT TECH, V43-4, P618, DOI 10.1016/0257-8972(90)90006-X
NR 21
TC 63
Z9 64
U1 2
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD NOV-DEC
PY 2000
VL 59
IS 2-3
BP 594
EP 599
DI 10.1016/S0042-207X(00)00321-3
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 371BE
UT WOS:000165157100031
DA 2018-10-20
ER

EF